Citrus Sinensis ID: 010882

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------50
Protein Sequence
MADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHccccccccccccccccEEEEEEcccEEEEEEccccccccHHHHHHHHHHHHcccccccccccccccccccEEEEEcccccHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccccHHHHHHcccccccccHHHHHHHHHHHHcccccccHHHHHHHHHcccccHHcccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccHHHcccccccccccccHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccEEEEEEcHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHccccHHccccccccccEEEEEccccEEEEEEEcccccccHHHHHHHHHHHHHHccHcHHHEEcccccccEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccHHHEEEcccccEEEcccccccccccccccccccEEEEEcEEEEEEccccHHHHHccccccccHHHHHHHHHHHHHcccccccHHHHHHHHHHcccHHHHcccccccccHHHHHHHHHHHHHHHHHcHHccccHHHHHHHHHHHccccccccccccccccccccccccccccHHHHHcccccEccccccHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
MADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSrkeasssshmpqffsdfsfseiegathnfdpslkigeggygSIYKGLLRHMQVAIKMlhphslqgpseFQQEIDILskirhpnlvtlvgaCPEVWTLVYEYlpngsledrlsckdnspplswQTRIRIATELCSVLIFlhsckphsivhgdlkpanilldanfvskLSDFgisrflsqneissnnttlccrtdpkgtfaymdpeflasgeltpksdvysFGIILLRLLtgrpalgiTKEVQYALDtgklknlldplagdwpfVQAEQLANLAMRCCEmsrksrpelgkDVWRVLepmrascggstsyrlgseercepppyftcpifqevmqdphvaadgfTYEAEALKGwldsghetspmtnlplahknlvpnLALRSAIQEWLQQH
Flexible Loop (DISEMBL)
madnlqakaseslyaEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKsrkeasssshmpqFFSDFSFSEIEGAThnfdpslkigEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLsqneissnnttlcCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSrksrpelgkdvwRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH
Low Complexity Region (SEG)
MADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH
Disordered region (IsUnstruct)
******************************************************************************************************************************DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMS******LGKDVWRVLEPMRASCG****Y*******CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSG*******NLPLAHKNLVPNLALRSAIQEW****
Disordered Region (DISOPRED)
******A************************************************************************AV*******************************************FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKM***********FQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE******************************FQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQ**
Disordered Region (DISEMBL)
********ASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE******************************MPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH
Disordered Region (DISPRO)
*ADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEE****************FFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA*******************PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MADNLQAKASESLYAEELKRxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	498	2.2.26 [Sep-21-2011]
Q8GUH1	834	U-box domain-containing p	yes	no	0.973	0.581	0.677	0.0
Q94A51	805	U-box domain-containing p	no	no	0.953	0.590	0.462	1e-118
Q0DR28	518	U-box domain-containing p	no	no	0.771	0.741	0.466	1e-101
Q9FKG6	845	U-box domain-containing p	no	no	0.923	0.544	0.406	2e-99
Q9SW11	835	U-box domain-containing p	no	no	0.941	0.561	0.399	9e-99
Q9FKG5	796	U-box domain-containing p	no	no	0.799	0.5	0.455	5e-98
Q9LU47	819	Putative U-box domain-con	no	no	0.825	0.501	0.430	5e-96
Q8S8S7	801	U-box domain-containing p	no	no	0.730	0.454	0.424	3e-86
Q9FGD7	765	Putative U-box domain-con	no	no	0.911	0.593	0.326	3e-63
O80623	815	Probable receptor-like pr	no	no	0.528	0.322	0.385	4e-51

>sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2

 Score =  700 bits (1806), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/493 (67%), Positives = 401/493 (81%), Gaps = 8/493 (1%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +AK SES Y+EELKRRK+ E A+A  K     +K + + +MEELQ A+ QK++LESQIA+
Sbjct: 349 RAKQSESAYSEELKRRKDTEIAVAKEKERFITIKNEQEVIMEELQSAMAQKAMLESQIAK 408

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
           SD T ++L QK+  AV+LLQ  + E++ELQ ERD+A++EAEELR   +  +S+  +PQ+F
Sbjct: 409 SDGTMEKLNQKLDIAVKLLQKLRDEREELQTERDRALREAEELRSHAE--TSTLQLPQYF 466

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
           +DFSFSEIE AT++FD +LKIGEGGYGSIY GLLRH QVAIKML+P+S QGP E+QQE+D
Sbjct: 467 TDFSFSEIEEATNHFDSTLKIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVD 526

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           +LSK+RHPN++TL+GACPE W+LVYEYLP GSLEDRL+CKDNSPPLSWQ R+RIATE+C+
Sbjct: 527 VLSKMRHPNIITLIGACPEGWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICA 586

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            L+FLHS K HS+VHGDLKPANILLD+N VSKLSDFG    L  N   S       RTD 
Sbjct: 587 ALVFLHSNKAHSLVHGDLKPANILLDSNLVSKLSDFGTCSLLHPNGSKS------VRTDV 640

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
            GT AY+DPE  +SGELTPKSDVYSFGIILLRLLTGRPAL I+ EV+YALD G L +LLD
Sbjct: 641 TGTVAYLDPEASSSGELTPKSDVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLD 700

Query: 366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEER 425
           PLAGDWPFVQAEQLA LA+RCCE   ++RP+LG +VWRVLEPMRAS GGS+S+ LG  E 
Sbjct: 701 PLAGDWPFVQAEQLARLALRCCETVSENRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEH 760

Query: 426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 485
              PPYF CPIFQEVMQDPHVAADGFTYEAEA++ WLDS H+TSPMTN+ L+H +L+ N 
Sbjct: 761 RIAPPYFICPIFQEVMQDPHVAADGFTYEAEAIRAWLDSEHDTSPMTNVKLSHTSLIANH 820

Query: 486 ALRSAIQEWLQQH 498
           ALRSAIQEWLQ H
Sbjct: 821 ALRSAIQEWLQHH 833

Functions as an E3 ubiquitin ligase.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1

 Score =  427 bits (1097), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 229/495 (46%), Positives = 341/495 (68%), Gaps = 20/495 (4%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +AKA E L  +E  +RK  EE L   KLE++ + +Q++  M+ELQ+   +   LESQ+ +
Sbjct: 327 KAKALEGLCIKESSQRKRLEELLEKEKLEVKMVIEQNNGFMKELQMVQGRNLKLESQMRK 386

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
                KE  +K  +A+ELL+++++++DE++++ + AVKE   LR+  K  +  S   +  
Sbjct: 387 LQDLEKEHGEKFDTAMELLKSFRQKRDEIRIDHENAVKEVNALRRLVKGETGESSGSEML 446

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
            D+SF EI  AT+ FDPS K+GEG YGS+YKG L+H+QVA+KML  +      EF++ ++
Sbjct: 447 -DYSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVE 505

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           ILS++RHPNLVTL+GACPE  +L+Y+Y+PNGSLED  S ++N P LSW++RIRIA+E+CS
Sbjct: 506 ILSRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICS 565

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            L+FLHS  P  I+HG+LKP+ ILLD+N V+K++D+GIS+ +  + +         ++DP
Sbjct: 566 ALLFLHSNIP-CIIHGNLKPSKILLDSNLVTKINDYGISQLIPIDGLD--------KSDP 616

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
                ++DP +  S E+T +SD+Y+FGIILL+LLT RP  GI ++V+ AL+   +  +LD
Sbjct: 617 -----HVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLD 671

Query: 366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA---SCGGSTSYRLGS 422
             AGDWP  + ++LAN+A+RCC+ +  +RP+L   V R ++ M+A       ++SY   +
Sbjct: 672 NSAGDWPVARGKKLANVAIRCCKKNPMNRPDLAV-VLRFIDRMKAPEVPSSETSSYANQN 730

Query: 423 EERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV 482
             R  PP ++ CPIFQEVM+DP +AADGFTYEAEA++ WL +GH+TSPMTNL +   NL+
Sbjct: 731 VPR-RPPSHYLCPIFQEVMKDPLIAADGFTYEAEAIREWLANGHDTSPMTNLKMEDCNLI 789

Query: 483 PNLALRSAIQEWLQQ 497
           PN AL  AIQ+W  Q
Sbjct: 790 PNHALHLAIQDWQNQ 804

Functions as an E3 ubiquitin ligase.

Arabidopsis thaliana (taxid: 3702)

EC: 6

EC: .

EC: 3

EC: .

EC: 2

EC: .

EC: -

>sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1

 Score =  369 bits (948), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 190/407 (46%), Positives = 257/407 (63%), Gaps = 23/407 (5%)

Query: 92  DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGY 151
           D+L+ ERD AV++  ELR        S+H+     DFS  ++E AT +F  + ++G+  Y
Sbjct: 120 DQLKHERDNAVQQVNELR------DQSTHI---ILDFSRKDMEQATEHFKNAREVGDTEY 170

Query: 152 GSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYE 211
           G  YKG++ +M+V IK+     L     FQQE+ IL + RHPN++T +G C EV  LVYE
Sbjct: 171 GHTYKGMIHNMKVLIKLSSSQKL-----FQQEVSILRQWRHPNIITFIGVCSEVSALVYE 225

Query: 212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 271
           +LPNG+LEDR+ C +NS PLSW  R +I  E+C  L+FLHS K  ++VHGDL+P NIL+D
Sbjct: 226 WLPNGNLEDRIICTNNSAPLSWYNRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILID 285

Query: 272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 331
           AN+ SK+ +FG+S    Q      N T            YMDPEF  +GELT  SDVYS 
Sbjct: 286 ANYRSKICNFGMSNLFLQLGTFPPNLT--------ARLPYMDPEFNTTGELTTLSDVYSL 337

Query: 332 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 391
           G+I+LRLLTG P L ++++V  AL +  L  L+D  AGDWP+++A+QLA + + C  M+R
Sbjct: 338 GVIILRLLTGMPPLTLSEKVAEALGSDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTR 397

Query: 392 KSRPELGKDVWRVLEPM-RASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADG 450
           K RP+L  +VW V+EP+ R     +  Y   +      P  F CPI  E+M+DP VA+DG
Sbjct: 398 KKRPDLLNEVWIVIEPLTRKPPAATWPYLQSASGDSSVPAAFICPISMEIMKDPQVASDG 457

Query: 451 FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 497
           FTYEAEA++ W D G   SPMTNL L + NLVPN  LRS I  +LQQ
Sbjct: 458 FTYEAEAIRCWFDRGISRSPMTNLALPNLNLVPNRVLRSFIHGYLQQ 504

Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 6

EC: .

EC: 3

EC: .

EC: 2

EC: .

EC: -

>sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1

 Score =  363 bits (931), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 199/490 (40%), Positives = 290/490 (59%), Gaps = 30/490 (6%)

Query: 29  ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 88
            N   E+E+++ +   V E   +A  +      ++ E +Q   E  +K++   E  +  K
Sbjct: 357 VNLNFEIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAK 416

Query: 89  KEQDELQMERDKAVKEAEELR-----------------------KSRKEASSSSHMPQFF 125
               + +   ++A+KEAE+++                       K + +AS  S   Q+ 
Sbjct: 417 DTASKEKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQY- 475

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
             +++ EI  AT +F  +LKIG G YGS+YK  L H   A+K+LH    Q   +F QE++
Sbjct: 476 QHYTWEEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELE 535

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           ILSKIRHP+LV L+GACPE   LVYEY+ NGSL+DRL   +++PP+ W  R RIA E+ S
Sbjct: 536 ILSKIRHPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVAS 595

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            L+FLH  KP  I+H DLKP NILLD NFVSKL D G+S  ++Q+++SS   T+  +T P
Sbjct: 596 ALVFLHKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSR--TIFKQTSP 653

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-DTGKLKNLL 364
            GT  Y+DPE+  +G ++PKSDVYS G+++L+L+T +PA+ IT  V+ A+ D  +   +L
Sbjct: 654 VGTLCYIDPEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAIL 713

Query: 365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE 424
           D  AG WP     +LA L + C EM R+ RP+L   +   LE +R     + +  L S  
Sbjct: 714 DKKAGSWPISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQN--LLSRT 771

Query: 425 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 484
              PP +F CP+ + VM +P VAADG+TY+ EA++ WL    +TSP+TNLPL +KNL+ N
Sbjct: 772 PSGPPSHFICPLLKGVMNEPCVAADGYTYDREAIEEWLRQ-KDTSPVTNLPLPNKNLIAN 830

Query: 485 LALRSAIQEW 494
             L SAI EW
Sbjct: 831 YTLYSAIMEW 840

Functions as an E3 ubiquitin ligase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2

 Score =  360 bits (925), Expect = 9e-99,   Method: Compositional matrix adjust.
 Identities = 198/496 (39%), Positives = 296/496 (59%), Gaps = 27/496 (5%)

Query: 22  KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA-------KELE 74
           + + +   N   E+E+++ +   V E   +A  +      ++ E +Q         +EL+
Sbjct: 340 QSYTDNQVNLNFEVEKLRAELRHVQEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELK 399

Query: 75  QKIISAVELL----QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH---------- 120
            K   A EL     QN++K + + +  R++A +E  + R++ ++++  +           
Sbjct: 400 LKEYEARELAEKEKQNFEKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLG 459

Query: 121 MPQF-FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE 179
            PQ  +  F++ EI  AT +F   LKIG G YG++YK  L H    +K+L     Q   +
Sbjct: 460 SPQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQ 519

Query: 180 FQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI 239
           FQQE++ILSKIRHP+LV L+GACPE   LVYEY+ NGSLEDRL   +NSPPL W  R RI
Sbjct: 520 FQQELEILSKIRHPHLVLLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRI 579

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+ + L+FLH  KP  I+H DLKPANILLD NFVSK+ D G+S  +  + +S+   T+
Sbjct: 580 AWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLST-KFTI 638

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG- 358
             +T P GT  Y+DPE+  +G ++ KSD+YSFG+ILL+LLT +PA+ +T  V+ A+D+  
Sbjct: 639 YKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSND 698

Query: 359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSY 418
           +   +LD  AG+WP  +  +LA LA+ C E+  K RP+L   +   LE ++     + + 
Sbjct: 699 EFLKILDQKAGNWPIEETRELAALALCCTELRGKDRPDLKDQILPALENLKKVAEKARNS 758

Query: 419 RLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH 478
             G     +PP +F CP+ ++VM +P VAADG+TY+  A++ WL   H TSPMT+ PL  
Sbjct: 759 FSGVS--TQPPTHFICPLLKDVMNEPCVAADGYTYDRHAIEEWLKE-HNTSPMTDSPLHS 815

Query: 479 KNLVPNLALRSAIQEW 494
           KNL+PN  L +AI EW
Sbjct: 816 KNLLPNYTLYTAIMEW 831

Functions as an E3 ubiquitin ligase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2

 Score =  358 bits (919), Expect = 5e-98,   Method: Compositional matrix adjust.
 Identities = 189/415 (45%), Positives = 264/415 (63%), Gaps = 17/415 (4%)

Query: 97  ERDKAVKEAEELRKSRKEASSSSH----MPQFFSDFSFSEIEGATHNFDPSLKIGEGGYG 152
           ER +A   AEE+RK ++    +        Q +  F + EI  AT +F   LKIG GGYG
Sbjct: 382 ERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYG 441

Query: 153 SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEY 212
           S+Y+  L H  VA+K+LH        +F QE++ILSKIRHP+L+ L+GACPE  +LVYEY
Sbjct: 442 SVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEY 501

Query: 213 LPNGSLEDRLSCKD------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 266
           + NGSLE+RL  +         PPL W  R RIA E+ S L FLH+ +P  IVH DLKPA
Sbjct: 502 MHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPA 561

Query: 267 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 326
           NILLD N VSK+ D G+S+ +  N   S+ +T+   T P GTF Y+DPE+  +G +TP+S
Sbjct: 562 NILLDRNNVSKIGDVGLSKMV--NLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPES 619

Query: 327 DVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGDWPFVQAEQLANLAM 384
           D+Y+FGIILL+L+T R A+G+   ++ AL   TGK   +LD  AGDWP  +A+++  + +
Sbjct: 620 DIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGL 679

Query: 385 RCCEMSRKSRPELGKDVWRVLEPMR--ASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQ 442
           RC EM ++ RP+LGK++  VLE ++  AS   +       +     P +F CPI ++VM+
Sbjct: 680 RCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPTHFYCPITKDVME 739

Query: 443 DPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 497
           +P VA+DG+TYE  A+K WL   H+ SPMT+LP    +L+PN +L SAI+EW  Q
Sbjct: 740 NPCVASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLLPNHSLLSAIKEWRSQ 793

Functions as an E3 ubiquitin ligase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1

 Score =  352 bits (902), Expect = 5e-96,   Method: Compositional matrix adjust.
 Identities = 180/418 (43%), Positives = 264/418 (63%), Gaps = 7/418 (1%)

Query: 81  VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHN 139
            E  +  ++E+ E    R+  +K   E ++  K   SS   P+  + +F++ EI  AT +
Sbjct: 400 TEKFEQKRREEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSS 459

Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           F   LKIG G YG +YK  L H   A+K+LH        +F QE++ILSKIRHP+LV L+
Sbjct: 460 FSEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLL 519

Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
           GACP+   LVYEY+ NGSLEDRL   ++S P+ W  R+RIA E+ S L+FLH  KP  I+
Sbjct: 520 GACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPII 579

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DLKPANILL+ NFVSK+ D G+S  +   +  S   T+  +T P GT  Y+DPE+  +
Sbjct: 580 HRDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRT 639

Query: 320 GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG---KLKNLLDPLAGDWPFVQA 376
           G ++PKSDVY+FG+I+L+LLTG+ A+ +T  V+ A++     +L  +LD  AG+WP  + 
Sbjct: 640 GRISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEET 699

Query: 377 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPI 436
            QLA LA++C E+  K RP+L   +  VLE ++     + +    S    +PP +F CP+
Sbjct: 700 RQLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSL--SAAPSQPPSHFFCPL 757

Query: 437 FQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 494
            ++VM++P +AADG+TY+  A++ W++  H TSP+TN PL + NL+PN  L +AI EW
Sbjct: 758 LKDVMKEPCIAADGYTYDRRAIEEWME-NHRTSPVTNSPLQNVNLLPNHTLYAAIVEW 814

Functions as an E3 ubiquitin ligase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1

 Score =  319 bits (818), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 157/370 (42%), Positives = 231/370 (62%), Gaps = 6/370 (1%)

Query: 125 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEI 184
           +  ++  EI  AT  F P   IGEGGYG +Y+  L     A+K++   + +   EF +E+
Sbjct: 427 YRKYTIEEIVTATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEV 486

Query: 185 DILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 244
           ++LS++RHP++V L+GACPE   LVYEYL NGSLE+ +  + N PPL W  R R+  E+ 
Sbjct: 487 EVLSQLRHPHVVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVA 546

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
             L FLHS KP  IVH DLKP NILL+ N+VSK++D G+++ ++  +++ +N T+   + 
Sbjct: 547 CGLAFLHSSKPEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVT--DVAPDNVTMYRNSV 604

Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 364
             GT  Y+DPE+  +G + PKSD+Y+FGII+L+LLT R   GI   V+ A+  G L  +L
Sbjct: 605 LAGTLHYIDPEYHRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEML 664

Query: 365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE 424
           D    DWP  + E+LA + ++C E   + RP+L  +V  VL+ +      S   + GS  
Sbjct: 665 DKSVTDWPLAETEELARIGLKCAEFRCRDRPDLKSEVIPVLKRL-VETANSKVKKEGSNL 723

Query: 425 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 484
           R   P ++ CPI +E+M++P +AADGFTYE +A+  WL+  H  SP+T   L H  L PN
Sbjct: 724 RA--PSHYFCPILREIMEEPEIAADGFTYERKAILAWLEK-HNISPVTRQKLDHFKLTPN 780

Query: 485 LALRSAIQEW 494
             LRSAI++W
Sbjct: 781 HTLRSAIRDW 790

Functions as an E3 ubiquitin ligase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FGD7|PUB50_ARATH Putative U-box domain-containing protein 50 OS=Arabidopsis thaliana GN=PUB50 PE=3 SV=1

 Score =  243 bits (620), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 174/533 (32%), Positives = 267/533 (50%), Gaps = 79/533 (14%)

Query: 5   LQAKASESLYAEELKRRKEFEEALANGKL-ELERMKKQHDEVMEELQIALDQ-KSLLE-- 60
           +  K+ E     E   R E+  +L N ++ E E   K+  E  E+LQ  LD  K  +E  
Sbjct: 259 IDEKSREVKVNAERSNRAEWAISLCNSRIGEFEAWIKEESERREKLQATLDSDKECIEEA 318

Query: 61  SQIAESDQTA----KELEQKIISAVELLQNYKK----EQDELQMERDKAVKEAEELRKSR 112
               E  +T      EL++ + S V+ +   K     E + + ++R + + E E+LR  R
Sbjct: 319 KNYVEKGKTKLHSLAELQEVLSSKVKTMMEAKSQAEVELERVVLQRGEMITEIEKLRSQR 378

Query: 113 ----------KE-----ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGG-YGSIYK 156
                     KE     + S   +   + ++   +I  AT  +   L++  GG + ++Y+
Sbjct: 379 DVFNRRIEFCKEREVIGSVSKEEVKCGYREYVAEDIRLATETYSDRLRLKSGGNWTNVYR 438

Query: 157 GLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV-WTLVYEYLPN 215
           G ++H  VA+K++   SL   + F  ++ +L++IRHPNLV + G C +    L++EY+ N
Sbjct: 439 GRIKHTTVAVKVI-GDSLSDEA-FGAKVKLLNEIRHPNLVAIAGFCSQRPKCLLFEYMHN 496

Query: 216 GSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 271
           G+L D L         S  L W  RIRIA ++CS L FLHS KP  IVHG L P+ ILLD
Sbjct: 497 GNLRDNLFTSQRKSRRSKILKWHDRIRIAHQVCSGLGFLHSVKPKPIVHGRLTPSKILLD 556

Query: 272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 331
            N V K++ FG+                                 + S +   K DV +F
Sbjct: 557 RNLVPKITGFGL--------------------------------IMHSDQSDTKPDVMAF 584

Query: 332 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 391
           G++LL LLTGR   G+ K +  +++   +   LD  AG WP   A++   LA++C  ++R
Sbjct: 585 GVLLLHLLTGRNWHGLLKAM--SMNQTSILRDLDQTAGKWPLELAKEFGALAVKCSSVNR 642

Query: 392 KSRPELG-KDVWRVLEPMRASC------GG---STSYRLGSEERCEPPPYFTCPIFQEVM 441
               +   K++   L  +R         GG   +T+  +   +  + P  F CPI QEVM
Sbjct: 643 GGNMDFSTKEIMEELGKIREKADEFKTKGGYEEATNSNMDEGDPNDIPSVFMCPILQEVM 702

Query: 442 QDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 494
           ++PHVAADGF+YE EA++ WL  GH+TSPMTNL L ++ L PN  LRS IQ+W
Sbjct: 703 KNPHVAADGFSYELEAIQEWLSMGHDTSPMTNLRLDYQMLTPNHTLRSLIQDW 755

Functions as an E3 ubiquitin ligase.

Arabidopsis thaliana (taxid: 3702)

EC: 6

EC: .

EC: 3

EC: .

EC: 2

EC: .

EC: -

>sp|O80623|Y2393_ARATH Probable receptor-like protein kinase At2g39360 OS=Arabidopsis thaliana GN=At2g39360 PE=1 SV=1

 Score =  202 bits (515), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 176/288 (61%), Gaps = 25/288 (8%)

Query: 133 IEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR 191
           I+ AT +FD SL IG GG+G +YKG+LR   +VA+K   P S QG +EF+ E+++L++ R
Sbjct: 480 IKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEFKTEVEMLTQFR 539

Query: 192 HPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 249
           H +LV+L+G C E     +VYEY+  G+L+D L   D+ P LSW+ R+ I       L +
Sbjct: 540 HRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAARGLHY 599

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF---LSQNEISSNNTTLCCRTDPK 306
           LH+    +I+H D+K ANILLD NF++K++DFG+S+    L Q  +S         T  K
Sbjct: 600 LHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVS---------TAVK 650

Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL--GITKE----VQYAL---DT 357
           G+F Y+DPE+L   +LT KSDVYSFG+++L ++ GRP +   + +E    +++A+     
Sbjct: 651 GSFGYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKK 710

Query: 358 GKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
           GKL++++DP L G     + ++   +  +C   +   RP +G  +W +
Sbjct: 711 GKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNL 758

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	498
224064033	809	predicted protein [Populus trichocarpa]	0.985	0.606	0.791	0.0
118487785	521	unknown [Populus trichocarpa]	0.985	0.942	0.791	0.0
359489801	881	PREDICTED: U-box domain-containing prote	0.981	0.555	0.742	0.0
147772798	881	hypothetical protein VITISV_015820 [Viti	0.981	0.555	0.744	0.0
224127680	810	predicted protein [Populus trichocarpa]	0.973	0.598	0.759	0.0
356568394	883	PREDICTED: U-box domain-containing prote	0.987	0.557	0.746	0.0
357507363	896	U-box domain-containing protein [Medicag	0.987	0.549	0.746	0.0
87240964	884	Protein kinase; U box [Medicago truncatu	0.987	0.556	0.746	0.0
449433077	875	PREDICTED: U-box domain-containing prote	0.981	0.558	0.722	0.0
356531997	883	PREDICTED: U-box domain-containing prote	0.983	0.554	0.739	0.0

>gi|224064033|ref|XP_002301358.1| predicted protein [Populus trichocarpa] gi|222843084|gb|EEE80631.1| predicted protein [Populus trichocarpa]

 Score =  792 bits (2046), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/493 (79%), Positives = 434/493 (88%), Gaps = 2/493 (0%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +AKASE+LY EE KRRKE EE LA  K ELER+ ++ DEVMEEL+IA DQKSLLE QI E
Sbjct: 319 KAKASENLYTEESKRRKEVEEELAKEKEELERINRECDEVMEELRIAEDQKSLLEKQIKE 378

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
           SDQ  KELEQKIISAV LLQNYKKEQDELQ ERD A+KE EELR+S+ EAS + HM QFF
Sbjct: 379 SDQMVKELEQKIISAVGLLQNYKKEQDELQKERDNALKEVEELRRSQTEASGT-HMSQFF 437

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
           S+FS SEIE AT +FDPSLKIGEGGYGSIYKG+LR  QVA+KMLH +SLQGP+EFQQE+D
Sbjct: 438 SEFSLSEIEEATQHFDPSLKIGEGGYGSIYKGVLRQTQVAVKMLHSNSLQGPAEFQQEVD 497

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           +LSK+RHPNL+TL+GACPE WTL+YEYLPNGSLEDRLSC+DNSPPLSWQTRIRIA ELCS
Sbjct: 498 VLSKMRHPNLITLIGACPEAWTLIYEYLPNGSLEDRLSCRDNSPPLSWQTRIRIAAELCS 557

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           VLIFLHS K HSIVHGDLKPANILLD NFV+KLSDFGI R L   E SSNNT +C RTDP
Sbjct: 558 VLIFLHSSKQHSIVHGDLKPANILLDENFVTKLSDFGICRLLHHKEGSSNNTAIC-RTDP 616

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
           KGTF+YMDPEFL++GELTPKSDVYSFGIILLRLLT R  LGITKEVQ  LD G LK LLD
Sbjct: 617 KGTFSYMDPEFLSTGELTPKSDVYSFGIILLRLLTARQPLGITKEVQCELDKGNLKTLLD 676

Query: 366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEER 425
           PLAGDWPFVQAEQLA+LA+RCCEMSRK+RP+L  +VWRVLEPM+ASCGGS+ ++LGSEE 
Sbjct: 677 PLAGDWPFVQAEQLAHLALRCCEMSRKNRPDLLSEVWRVLEPMKASCGGSSFFQLGSEEH 736

Query: 426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 485
            +PP YF CPIFQEVM+DPHVAADG+TYEAEALKGWLDSGH+TSPMTNL LAH++L+PN 
Sbjct: 737 FQPPSYFICPIFQEVMRDPHVAADGYTYEAEALKGWLDSGHDTSPMTNLKLAHRDLIPNR 796

Query: 486 ALRSAIQEWLQQH 498
           ALRSAIQEWLQQ 
Sbjct: 797 ALRSAIQEWLQQQ 809

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|118487785|gb|ABK95716.1| unknown [Populus trichocarpa]

 Score =  790 bits (2041), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/493 (79%), Positives = 434/493 (88%), Gaps = 2/493 (0%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +AKASE+LY EE KRRKE EE LA  K ELER+ ++ DEVMEEL+IA DQKSLLE QI E
Sbjct: 31  KAKASENLYTEESKRRKEVEEELAKEKEELERINRECDEVMEELRIAEDQKSLLEKQIKE 90

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
           SDQ  KELEQKIISAV LLQNYKKEQDELQ ERD A+KE EELR+S+ EAS + HM QFF
Sbjct: 91  SDQMVKELEQKIISAVGLLQNYKKEQDELQKERDNALKEVEELRRSQTEASGT-HMSQFF 149

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
           S+FS SEIE AT +FDPSLKIGEGGYGSIYKG+LR  QVA+KMLH +SLQGP+EFQQE+D
Sbjct: 150 SEFSLSEIEEATQHFDPSLKIGEGGYGSIYKGVLRQTQVAVKMLHSNSLQGPAEFQQEVD 209

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           +LSK+RHPNL+TL+GACPE WTL+YEYLPNGSLEDRLSC+DNSPPLSWQTRIRIA ELCS
Sbjct: 210 VLSKMRHPNLITLIGACPEAWTLIYEYLPNGSLEDRLSCRDNSPPLSWQTRIRIAAELCS 269

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           VLIFLHS K HSIVHGDLKPANILLD NFV+KLSDFGI R L   E SSNNT +C RTDP
Sbjct: 270 VLIFLHSSKQHSIVHGDLKPANILLDENFVTKLSDFGICRLLHHKEGSSNNTAIC-RTDP 328

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
           KGTF+YMDPEFL++GELTPKSDVYSFGIILLRLLT R  LGITKEVQ  LD G LK LLD
Sbjct: 329 KGTFSYMDPEFLSTGELTPKSDVYSFGIILLRLLTARQPLGITKEVQCELDKGNLKTLLD 388

Query: 366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEER 425
           PLAGDWPFVQAEQLA+LA+RCCEMSRK+RP+L  +VWRVLEPM+ASCGGS+ ++LGSEE 
Sbjct: 389 PLAGDWPFVQAEQLAHLALRCCEMSRKNRPDLLSEVWRVLEPMKASCGGSSFFQLGSEEH 448

Query: 426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 485
            +PP YF CPIFQEVM+DPHVAADG+TYEAEALKGWLDSGH+TSPMTNL LAH++L+PN 
Sbjct: 449 FQPPSYFICPIFQEVMRDPHVAADGYTYEAEALKGWLDSGHDTSPMTNLKLAHRDLIPNR 508

Query: 486 ALRSAIQEWLQQH 498
           ALRSAIQEWLQQ 
Sbjct: 509 ALRSAIQEWLQQQ 521

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359489801|ref|XP_002274993.2| PREDICTED: U-box domain-containing protein 33-like [Vitis vinifera] gi|297745303|emb|CBI40383.3| unnamed protein product [Vitis vinifera]

 Score =  778 bits (2008), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/493 (74%), Positives = 426/493 (86%), Gaps = 4/493 (0%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +AK +E  ++EELK R++ EEAL     ELE ++ +  E+MEEL+I+L+ KSLLE+QIA+
Sbjct: 391 RAKEAERSFSEELKLRRDIEEALQAQGKELESLRNKQQEIMEELKISLNHKSLLENQIAD 450

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
           S+Q  KELE+KII+AVELLQNYKKE+DELQ+ERD A+K AEEL+K   + +S+SH PQ+F
Sbjct: 451 SEQVVKELEEKIIAAVELLQNYKKERDELQIERDNAIKTAEELKK---KGASTSHTPQYF 507

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
           ++FSF+EIE AT NFDPS+KIGEGGYGSIYKG LRH QVAIKMLH  S QGP+EFQQE+D
Sbjct: 508 AEFSFAEIEKATQNFDPSVKIGEGGYGSIYKGCLRHTQVAIKMLHSDSFQGPTEFQQEVD 567

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           ILSK+RHPNLVTL+GACPE W L+YEYLPNGSLEDRL+C+DN+PPLSWQ RIRIA ELCS
Sbjct: 568 ILSKLRHPNLVTLIGACPEAWALIYEYLPNGSLEDRLNCRDNTPPLSWQARIRIAAELCS 627

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           VLIFLHS  P SIVHGDLKP+NILLDANF SKLSDFGI R +S +  SSN+ T+CCRT P
Sbjct: 628 VLIFLHSNNPDSIVHGDLKPSNILLDANFGSKLSDFGICRVISHDGNSSNSATMCCRTGP 687

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
           KGTFAYMDPEFL+SGELT KSDVYSFGIILLRLLTG+PA+GITKEVQ+ALD G L  LLD
Sbjct: 688 KGTFAYMDPEFLSSGELTVKSDVYSFGIILLRLLTGKPAIGITKEVQHALDQGNLNTLLD 747

Query: 366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGG-STSYRLGSEE 424
           PLAGDWPFVQA+QLA +A+RCCEM+RKSRP+L  +VWRVLEPM+ SCG  S+S+R+GSEE
Sbjct: 748 PLAGDWPFVQAKQLALMALRCCEMNRKSRPDLVSEVWRVLEPMKVSCGASSSSFRVGSEE 807

Query: 425 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 484
           R + PPYF CPIFQE+MQDP VAADGFTYEAEAL+GWLD GH TSPMTNL L H NLVPN
Sbjct: 808 RGQIPPYFICPIFQEIMQDPCVAADGFTYEAEALRGWLDGGHSTSPMTNLKLGHLNLVPN 867

Query: 485 LALRSAIQEWLQQ 497
            ALRSAIQEWLQQ
Sbjct: 868 RALRSAIQEWLQQ 880

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772798|emb|CAN67166.1| hypothetical protein VITISV_015820 [Vitis vinifera]

 Score =  776 bits (2003), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/493 (74%), Positives = 425/493 (86%), Gaps = 4/493 (0%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +AK +E  ++EELK R++ EEAL     ELE ++ +  E+MEEL+I+L+ KSLLE+QIA+
Sbjct: 391 RAKEAERSFSEELKLRRDIEEALQAQGKELESLRNKQQEIMEELKISLNHKSLLENQIAD 450

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
           S+Q  KELE+KIISAVELLQNYKKE+DELQ+ERD A+K AEEL+K   + +S+SH PQ+F
Sbjct: 451 SEQVVKELEEKIISAVELLQNYKKERDELQIERDNAIKTAEELKK---KGASTSHTPQYF 507

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
           ++FSF+EIE AT NFDPS+KIGEGGYGSIYKG LRH QVAIKMLH  S QGPSEFQQE+D
Sbjct: 508 AEFSFAEIEKATQNFDPSVKIGEGGYGSIYKGCLRHTQVAIKMLHSDSFQGPSEFQQEVD 567

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           ILSK+RHPNLVTL+GACPE W L+YEYLPNGSLEDRL+C+DN+PPLSWQ RIRIA ELCS
Sbjct: 568 ILSKLRHPNLVTLIGACPEAWALIYEYLPNGSLEDRLNCRDNTPPLSWQARIRIAAELCS 627

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           VLIFLHS  P SIVHGDLKP+NILLDANF SKLSDFGI R +S +  SSN+ T+CCRT P
Sbjct: 628 VLIFLHSNNPDSIVHGDLKPSNILLDANFGSKLSDFGICRVISHDGNSSNSATMCCRTGP 687

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
           KGTFAYMDPEFL+SGELT KSDVYSFGIILLRLLTG+PA+GITKEVQ+ALD G L  LLD
Sbjct: 688 KGTFAYMDPEFLSSGELTVKSDVYSFGIILLRLLTGKPAIGITKEVQHALDQGNLNTLLD 747

Query: 366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGG-STSYRLGSEE 424
           PLAGDWPFVQA+QLA +A+RC EM+RKSRP+L  +VWRVLEPM+ SCG  S+S+R+GSEE
Sbjct: 748 PLAGDWPFVQAKQLALMALRCXEMNRKSRPDLVSEVWRVLEPMKVSCGASSSSFRVGSEE 807

Query: 425 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 484
           R + PPYF CPIFQE+MQDP VAADGFTYEAEAL+GWLD GH TSPMTNL L H NLVPN
Sbjct: 808 RGQIPPYFICPIFQEIMQDPCVAADGFTYEAEALRGWLDGGHSTSPMTNLKLGHLNLVPN 867

Query: 485 LALRSAIQEWLQQ 497
            ALRSAIQEWLQQ
Sbjct: 868 RALRSAIQEWLQQ 880

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127680|ref|XP_002320134.1| predicted protein [Populus trichocarpa] gi|222860907|gb|EEE98449.1| predicted protein [Populus trichocarpa]

 Score =  770 bits (1988), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 375/494 (75%), Positives = 424/494 (85%), Gaps = 9/494 (1%)

Query: 6   QAKASESLYAEELKRR-------KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSL 58
           +AKASESLY EE KRR        + +E L     ELE++ K+ DEVM EL IA D KSL
Sbjct: 316 KAKASESLYTEESKRRTVVEEELAKEKEELEKINKELEKINKEQDEVMGELCIAQDHKSL 375

Query: 59  LESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 118
           LE QI ESD+  KELEQKIISAV LLQNYKKE+D L   RD A+KEAEELR+++ EASS+
Sbjct: 376 LEKQIEESDEMVKELEQKIISAVGLLQNYKKERDHLHKGRDYALKEAEELRRNQTEASST 435

Query: 119 SHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS 178
            HMP+FFSDFSFSEIE ATH+FDPS KIGEGGYG+IYKG+LR  QVA+KML  +S+QGP+
Sbjct: 436 -HMPRFFSDFSFSEIEEATHHFDPSRKIGEGGYGNIYKGVLRQTQVAVKMLDSNSMQGPA 494

Query: 179 EFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
           EFQQE+++LSK+RHPNL+TLVGACPE WTL+YEYLPNGSLEDRLSCKDNSPPLSWQTRIR
Sbjct: 495 EFQQEVNVLSKMRHPNLITLVGACPEAWTLIYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 554

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
           IATELCSVLIFLHS KPHSIVHGDLKPANILLD NFV+KLSDFGI R L   E SSNNTT
Sbjct: 555 IATELCSVLIFLHSSKPHSIVHGDLKPANILLDENFVTKLSDFGICRLLDHKEGSSNNTT 614

Query: 299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 358
           +C RTDPKGTF YMDPEF+++GEL+PKSDVYSFGIILLRLLT R ALGITKEV+YALD G
Sbjct: 615 IC-RTDPKGTFVYMDPEFVSTGELSPKSDVYSFGIILLRLLTARQALGITKEVRYALDKG 673

Query: 359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSY 418
            LK LLDPLAGDWPFVQAE LA++A+RCCEM+RK+RP+L  +VWRVLEPM+ASCG S+  
Sbjct: 674 TLKTLLDPLAGDWPFVQAEMLAHMALRCCEMNRKNRPDLASEVWRVLEPMKASCGTSSFS 733

Query: 419 RLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH 478
           +LGSEE  +PP YFTCPIFQEVM+DPHVAADGFTYEAEALKGWLDSGH+TSPMTN  LAH
Sbjct: 734 QLGSEEHFQPPSYFTCPIFQEVMRDPHVAADGFTYEAEALKGWLDSGHDTSPMTNFKLAH 793

Query: 479 KNLVPNLALRSAIQ 492
            +L+PN ALRSAIQ
Sbjct: 794 CDLIPNRALRSAIQ 807

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356568394|ref|XP_003552396.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max]

 Score =  755 bits (1950), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/493 (74%), Positives = 419/493 (84%), Gaps = 1/493 (0%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           + KASESLY EEL  RK  EE L   K ELE MK   D+V EEL +ALDQK  LESQIA 
Sbjct: 392 KVKASESLYTEELNLRKMTEEKLRKEKEELESMKSLRDKVKEELCLALDQKESLESQIAS 451

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
           S+   KELEQKI+SAV+LLQ+YK E+DELQM+RD A++EAEELRK + EAS + ++PQ F
Sbjct: 452 SELMVKELEQKILSAVDLLQSYKNERDELQMQRDNALREAEELRKKQGEASGT-NVPQLF 510

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
           S+FSFSEI+ AT NF+PS KIGEGGYGSI+KG+LRH +VAIKML+  S+QGP EFQQE+D
Sbjct: 511 SEFSFSEIKEATSNFNPSSKIGEGGYGSIFKGVLRHTEVAIKMLNSDSMQGPLEFQQEVD 570

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           +LSK+RHPNL+TL+GACP+ W LVYEYLPNGSLEDRL+CK+N+PPLSWQ RIRIA ELCS
Sbjct: 571 VLSKLRHPNLITLIGACPDSWALVYEYLPNGSLEDRLACKNNTPPLSWQARIRIAAELCS 630

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            LIFLHS KPHS+VHGDLKP+NILLDAN +SKLSDFGI R LS  E SS+NTT   RTDP
Sbjct: 631 ALIFLHSSKPHSVVHGDLKPSNILLDANLISKLSDFGICRILSNCESSSSNTTEFWRTDP 690

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
           KGTF YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV+YALDTGKLK+LLD
Sbjct: 691 KGTFVYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVKYALDTGKLKSLLD 750

Query: 366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEER 425
           PLAGDWPFVQAEQLA LA+RCC+M+RKSRP+L  DVWRVL+ MR S GG+ S+ L SE  
Sbjct: 751 PLAGDWPFVQAEQLARLALRCCDMNRKSRPDLYSDVWRVLDAMRVSSGGANSFGLSSEGL 810

Query: 426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 485
            +PP YF CPIFQEVM+DPHVAADGFTYEAEA++GWLD GH+ SPMTN  LAH NLVPN 
Sbjct: 811 LQPPSYFICPIFQEVMRDPHVAADGFTYEAEAIRGWLDGGHDNSPMTNSKLAHHNLVPNR 870

Query: 486 ALRSAIQEWLQQH 498
           ALRSAIQ+WLQ H
Sbjct: 871 ALRSAIQDWLQNH 883

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357507363|ref|XP_003623970.1| U-box domain-containing protein [Medicago truncatula] gi|355498985|gb|AES80188.1| U-box domain-containing protein [Medicago truncatula]

 Score =  749 bits (1934), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/493 (74%), Positives = 424/493 (86%), Gaps = 1/493 (0%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +AKASESLY +EL  RK  EE L   K ELE +  Q D+V EEL++A+D KS LESQ+A 
Sbjct: 405 RAKASESLYTDELNLRKMAEEELRKEKEELESVTSQRDKVNEELRLAVDLKSSLESQLAS 464

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
           S+   +ELEQKIISAVELLQ+YK E+DELQ++RD A++EAE+LRK + E SS+ H+PQ F
Sbjct: 465 SEVMIQELEQKIISAVELLQSYKNERDELQIQRDNALREAEDLRKKQGEGSST-HVPQLF 523

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
           S+FSFSEIE AT NF+PSLKIGEGGYG+IYKGLLRH +VAIK+LH +S+QGP EFQQE+D
Sbjct: 524 SEFSFSEIEEATSNFNPSLKIGEGGYGNIYKGLLRHTEVAIKILHANSMQGPLEFQQEVD 583

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           +LSK+RHPNL+TL+GACPE W+LVYEYLPNGSLEDRL+CKDN+ PLSWQTRIRIA ELCS
Sbjct: 584 VLSKLRHPNLITLIGACPESWSLVYEYLPNGSLEDRLACKDNTHPLSWQTRIRIAAELCS 643

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            LIFLHS KPHSIVHGDLKP+NI+LD N VSKLSDFGI R LS  E SSNN T   +TDP
Sbjct: 644 ALIFLHSSKPHSIVHGDLKPSNIILDGNLVSKLSDFGICRVLSNYENSSNNNTQFWKTDP 703

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
           KGTF YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV+YA+DTGKL +LLD
Sbjct: 704 KGTFVYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVKYAVDTGKLTSLLD 763

Query: 366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEER 425
           PLAGDWPFVQAEQLA LA+RCCEM+RKSRP+L  DVWR+L+ MRAS GG+ S+ L SE  
Sbjct: 764 PLAGDWPFVQAEQLARLALRCCEMNRKSRPDLHSDVWRILDAMRASSGGTNSFGLSSEGP 823

Query: 426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 485
            +PP YF CPIFQEVM+DPHVAADGFTYEAEA++GWLDSGH+ SPMTN  L+H+NLVPN 
Sbjct: 824 HQPPSYFICPIFQEVMRDPHVAADGFTYEAEAIRGWLDSGHDASPMTNSTLSHQNLVPNR 883

Query: 486 ALRSAIQEWLQQH 498
           ALRSAIQ+WLQ H
Sbjct: 884 ALRSAIQDWLQSH 896

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|87240964|gb|ABD32822.1| Protein kinase; U box [Medicago truncatula]

 Score =  749 bits (1933), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/493 (74%), Positives = 424/493 (86%), Gaps = 1/493 (0%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +AKASESLY +EL  RK  EE L   K ELE +  Q D+V EEL++A+D KS LESQ+A 
Sbjct: 393 RAKASESLYTDELNLRKMAEEELRKEKEELESVTSQRDKVNEELRLAVDLKSSLESQLAS 452

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
           S+   +ELEQKIISAVELLQ+YK E+DELQ++RD A++EAE+LRK + E SS+ H+PQ F
Sbjct: 453 SEVMIQELEQKIISAVELLQSYKNERDELQIQRDNALREAEDLRKKQGEGSST-HVPQLF 511

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
           S+FSFSEIE AT NF+PSLKIGEGGYG+IYKGLLRH +VAIK+LH +S+QGP EFQQE+D
Sbjct: 512 SEFSFSEIEEATSNFNPSLKIGEGGYGNIYKGLLRHTEVAIKILHANSMQGPLEFQQEVD 571

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           +LSK+RHPNL+TL+GACPE W+LVYEYLPNGSLEDRL+CKDN+ PLSWQTRIRIA ELCS
Sbjct: 572 VLSKLRHPNLITLIGACPESWSLVYEYLPNGSLEDRLACKDNTHPLSWQTRIRIAAELCS 631

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            LIFLHS KPHSIVHGDLKP+NI+LD N VSKLSDFGI R LS  E SSNN T   +TDP
Sbjct: 632 ALIFLHSSKPHSIVHGDLKPSNIILDGNLVSKLSDFGICRVLSNYENSSNNNTQFWKTDP 691

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
           KGTF YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV+YA+DTGKL +LLD
Sbjct: 692 KGTFVYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVKYAVDTGKLTSLLD 751

Query: 366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEER 425
           PLAGDWPFVQAEQLA LA+RCCEM+RKSRP+L  DVWR+L+ MRAS GG+ S+ L SE  
Sbjct: 752 PLAGDWPFVQAEQLARLALRCCEMNRKSRPDLHSDVWRILDAMRASSGGTNSFGLSSEGP 811

Query: 426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 485
            +PP YF CPIFQEVM+DPHVAADGFTYEAEA++GWLDSGH+ SPMTN  L+H+NLVPN 
Sbjct: 812 HQPPSYFICPIFQEVMRDPHVAADGFTYEAEAIRGWLDSGHDASPMTNSTLSHQNLVPNR 871

Query: 486 ALRSAIQEWLQQH 498
           ALRSAIQ+WLQ H
Sbjct: 872 ALRSAIQDWLQSH 884

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449433077|ref|XP_004134324.1| PREDICTED: U-box domain-containing protein 33-like [Cucumis sativus]

 Score =  744 bits (1920), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/494 (72%), Positives = 420/494 (85%), Gaps = 5/494 (1%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           + +A+E LYAEELK+RKE E+ LA  K +LE +K Q +E ME+L+IA D+K+ LE  + E
Sbjct: 386 RVRAAEGLYAEELKQRKEVEQELAKEKGKLESIKTQLNEEMEKLRIAQDEKASLERDLLE 445

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
           SD TAKELEQKI+SAVELLQ+YK+E++ELQ+ RD A++EAEELRK++   S+   + QFF
Sbjct: 446 SDLTAKELEQKILSAVELLQSYKREREELQIHRDSALREAEELRKNQ---STGRDLTQFF 502

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
           ++F F EIE AT NFDPSLKIGEGGYGSI++  LRH  VAIK+LH  S QGPSEFQQE++
Sbjct: 503 TEFPFREIEEATKNFDPSLKIGEGGYGSIFRANLRHTMVAIKILHSDSSQGPSEFQQEVN 562

Query: 186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           +LSK+RHPNLVTL+GACPE W L+YEYL NGSLEDRLSCKDN+PPLSWQTRIRIATELCS
Sbjct: 563 VLSKMRHPNLVTLIGACPEAWVLIYEYLCNGSLEDRLSCKDNTPPLSWQTRIRIATELCS 622

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD- 304
            L+FLHS KPHSI+HGDLKPAN+LLDANFV KL DFGI R LS++E+  N+ TL  RTD 
Sbjct: 623 ALMFLHSSKPHSIIHGDLKPANVLLDANFVCKLGDFGICRLLSRDEML-NSETLVWRTDN 681

Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 364
           PKGTFAYMDPEFL+SGELT KSDVYSFGIILLRLLTGR A+GI KEVQYA+  GKL+++L
Sbjct: 682 PKGTFAYMDPEFLSSGELTTKSDVYSFGIILLRLLTGRSAVGIAKEVQYAMGNGKLESIL 741

Query: 365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE 424
           DPLAGDWPFVQAEQLA LA+RCC+M+RKSRP+L  DVWRVL PMRASCGG  S +LGS E
Sbjct: 742 DPLAGDWPFVQAEQLARLALRCCDMNRKSRPDLITDVWRVLGPMRASCGGRLSIQLGSAE 801

Query: 425 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 484
             +PP YF CPIFQE+MQDPHVAADG+TYEAEA++GWLDSGHETSPMTNL L ++NLVPN
Sbjct: 802 HSQPPSYFICPIFQEIMQDPHVAADGYTYEAEAIRGWLDSGHETSPMTNLRLENRNLVPN 861

Query: 485 LALRSAIQEWLQQH 498
            ALRSAIQEWL  +
Sbjct: 862 RALRSAIQEWLHHN 875

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356531997|ref|XP_003534561.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max]

 Score =  743 bits (1918), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/491 (73%), Positives = 414/491 (84%), Gaps = 1/491 (0%)

Query: 8   KASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESD 67
           KASESLYAEEL +RK  EE L   K ELE MK   D V EEL++ALDQK+ LESQIA ++
Sbjct: 394 KASESLYAEELNQRKMAEEKLRKEKEELENMKSLRDTVKEELRLALDQKASLESQIASTE 453

Query: 68  QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSD 127
              KELEQKI+SAV LLQ+YK E+DELQM+ D A++EAEELRK + EAS + H+PQ  S+
Sbjct: 454 LMIKELEQKILSAVGLLQSYKNERDELQMQCDNALREAEELRKKQGEASGT-HVPQLCSE 512

Query: 128 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDIL 187
           FSFSEI+ AT NF+PS KIGEGGYGSI+KG+L H +VAIKML+  S+QGP EFQQE+D+L
Sbjct: 513 FSFSEIKEATSNFNPSSKIGEGGYGSIFKGVLHHTEVAIKMLNSDSMQGPLEFQQEVDVL 572

Query: 188 SKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           SK+RHPNL+TL+GACP+ W LVYEYLPNGSLEDRL+CKDN+PPLSWQ RIRIA ELCS L
Sbjct: 573 SKLRHPNLITLIGACPDSWALVYEYLPNGSLEDRLACKDNTPPLSWQARIRIAAELCSAL 632

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
           IFLHS KPHS+VHGDLKP+NILLDAN +SKLSDFGI R LS  E S +NTT   RTDPKG
Sbjct: 633 IFLHSSKPHSVVHGDLKPSNILLDANLISKLSDFGICRILSNCESSGSNTTEFWRTDPKG 692

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 367
           TF YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT EV+YALDTGKLK+LLDPL
Sbjct: 693 TFVYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITMEVKYALDTGKLKSLLDPL 752

Query: 368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCE 427
           AGDWPFVQAEQLA LA+RCC+M+RKSRP+L  DVWR+L+ MR S GG+ S+ L SE   +
Sbjct: 753 AGDWPFVQAEQLARLALRCCDMNRKSRPDLYSDVWRILDAMRVSSGGANSFGLSSEGLLQ 812

Query: 428 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLAL 487
            P YF CPIFQEVM+DPHVAADGFTYEAEA++GWLD GH+ SPMTN  LAH NLVPN AL
Sbjct: 813 SPSYFICPIFQEVMRDPHVAADGFTYEAEAIRGWLDGGHDNSPMTNSKLAHHNLVPNRAL 872

Query: 488 RSAIQEWLQQH 498
           RSAIQ+WLQ H
Sbjct: 873 RSAIQDWLQNH 883

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	498
TAIR|locus:2050669	834	AT2G45910 [Arabidopsis thalian	0.973	0.581	0.681	8.1e-179
TAIR|locus:2101353	805	AT3G49060 [Arabidopsis thalian	0.953	0.590	0.462	6.4e-115
TAIR|locus:2117343	835	AT4G25160 [Arabidopsis thalian	0.977	0.583	0.405	2.3e-95
TAIR|locus:2176177	819	AT5G51270 [Arabidopsis thalian	0.917	0.557	0.412	3.4e-94
TAIR|locus:2151641	796	AT5G61560 [Arabidopsis thalian	0.931	0.582	0.414	1.8e-93
UNIPROTKB|Q0DR28	518	PUB57 "U-box domain-containing	0.941	0.905	0.408	5e-92
TAIR|locus:504954932	789	AT5G57035 [Arabidopsis thalian	0.931	0.588	0.390	1.9e-87
TAIR|locus:2047605	801	AT2G19410 [Arabidopsis thalian	0.939	0.584	0.370	1.2e-81
TAIR|locus:2128131	764	AT4G31230 [Arabidopsis thalian	0.777	0.506	0.443	9.7e-80
TAIR|locus:2180677	703	AT5G26150 [Arabidopsis thalian	0.765	0.541	0.424	5.4e-79

TAIR|locus:2050669 AT2G45910 [Arabidopsis thaliana (taxid:3702)]

 Score = 1736 (616.2 bits), Expect = 8.1e-179, P = 8.1e-179
 Identities = 336/493 (68%), Positives = 402/493 (81%)

Query:     6 QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
             +AK SES Y+EELKRRK+ E A+A  K     +K + + +MEELQ A+ QK++LESQIA+
Sbjct:   349 RAKQSESAYSEELKRRKDTEIAVAKEKERFITIKNEQEVIMEELQSAMAQKAMLESQIAK 408

Query:    66 SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
             SD T ++L QK+  AV+LLQ  + E++ELQ ERD+A++EAEELR S  E +S+  +PQ+F
Sbjct:   409 SDGTMEKLNQKLDIAVKLLQKLRDEREELQTERDRALREAEELR-SHAE-TSTLQLPQYF 466

Query:   126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
             +DFSFSEIE AT++FD +LKIGEGGYGSIY GLLRH QVAIKML+P+S QGP E+QQE+D
Sbjct:   467 TDFSFSEIEEATNHFDSTLKIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVD 526

Query:   186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
             +LSK+RHPN++TL+GACPE W+LVYEYLP GSLEDRL+CKDNSPPLSWQ R+RIATE+C+
Sbjct:   527 VLSKMRHPNIITLIGACPEGWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICA 586

Query:   246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
              L+FLHS K HS+VHGDLKPANILLD+N VSKLSDFG    L  N   S       RTD 
Sbjct:   587 ALVFLHSNKAHSLVHGDLKPANILLDSNLVSKLSDFGTCSLLHPNGSKS------VRTDV 640

Query:   306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
              GT AY+DPE  +SGELTPKSDVYSFGIILLRLLTGRPAL I+ EV+YALD G L +LLD
Sbjct:   641 TGTVAYLDPEASSSGELTPKSDVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLD 700

Query:   366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEER 425
             PLAGDWPFVQAEQLA LA+RCCE   ++RP+LG +VWRVLEPMRAS GGS+S+ LG  E 
Sbjct:   701 PLAGDWPFVQAEQLARLALRCCETVSENRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEH 760

Query:   426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 485
                PPYF CPIFQEVMQDPHVAADGFTYEAEA++ WLDS H+TSPMTN+ L+H +L+ N 
Sbjct:   761 RIAPPYFICPIFQEVMQDPHVAADGFTYEAEAIRAWLDSEHDTSPMTNVKLSHTSLIANH 820

Query:   486 ALRSAIQEWLQQH 498
             ALRSAIQEWLQ H
Sbjct:   821 ALRSAIQEWLQHH 833

GO:0000151 "ubiquitin ligase complex" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004842 "ubiquitin-protein ligase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016567 "protein ubiquitination" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2101353 AT3G49060 [Arabidopsis thaliana (taxid:3702)]

 Score = 1133 (403.9 bits), Expect = 6.4e-115, P = 6.4e-115
 Identities = 229/495 (46%), Positives = 341/495 (68%)

Query:     6 QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
             +AKA E L  +E  +RK  EE L   KLE++ + +Q++  M+ELQ+   +   LESQ+ +
Sbjct:   327 KAKALEGLCIKESSQRKRLEELLEKEKLEVKMVIEQNNGFMKELQMVQGRNLKLESQMRK 386

Query:    66 SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 125
                  KE  +K  +A+ELL+++++++DE++++ + AVKE   LR+  K  +  S   +  
Sbjct:   387 LQDLEKEHGEKFDTAMELLKSFRQKRDEIRIDHENAVKEVNALRRLVKGETGESSGSEML 446

Query:   126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 185
              D+SF EI  AT+ FDPS K+GEG YGS+YKG L+H+QVA+KML  +      EF++ ++
Sbjct:   447 -DYSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVE 505

Query:   186 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
             ILS++RHPNLVTL+GACPE  +L+Y+Y+PNGSLED  S ++N P LSW++RIRIA+E+CS
Sbjct:   506 ILSRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICS 565

Query:   246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
              L+FLHS  P  I+HG+LKP+ ILLD+N V+K++D+GIS+ +  + +         ++DP
Sbjct:   566 ALLFLHSNIP-CIIHGNLKPSKILLDSNLVTKINDYGISQLIPIDGLD--------KSDP 616

Query:   306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
                  ++DP +  S E+T +SD+Y+FGIILL+LLT RP  GI ++V+ AL+   +  +LD
Sbjct:   617 -----HVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLD 671

Query:   366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS---CGGSTSYRLGS 422
               AGDWP  + ++LAN+A+RCC+ +  +RP+L   V R ++ M+A       ++SY   +
Sbjct:   672 NSAGDWPVARGKKLANVAIRCCKKNPMNRPDLAV-VLRFIDRMKAPEVPSSETSSYANQN 730

Query:   423 EERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV 482
               R  PP ++ CPIFQEVM+DP +AADGFTYEAEA++ WL +GH+TSPMTNL +   NL+
Sbjct:   731 VPR-RPPSHYLCPIFQEVMKDPLIAADGFTYEAEAIREWLANGHDTSPMTNLKMEDCNLI 789

Query:   483 PNLALRSAIQEWLQQ 497
             PN AL  AIQ+W  Q
Sbjct:   790 PNHALHLAIQDWQNQ 804

GO:0000151 "ubiquitin ligase complex" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004842 "ubiquitin-protein ligase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016567 "protein ubiquitination" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2117343 AT4G25160 [Arabidopsis thaliana (taxid:3702)]

 Score = 923 (330.0 bits), Expect = 2.3e-95, Sum P(2) = 2.3e-95
 Identities = 206/508 (40%), Positives = 299/508 (58%)

Query:     2 ADNLQAKASESLYAE-ELKRRKEFEEALANGKLELERMKKQHDEVMEELQIA--LDQKSL 58
             A N+    SE  Y + ++    E E+  A  +   E       E  +  +    L+Q+ L
Sbjct:   330 ASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMYAVAQTETFDASRKLGELNQRRL 389

Query:    59 LESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKS-RKEASS 117
              E  I   +   KE E + ++  E  QN++K + + +  R++A +E  + R++ RK A  
Sbjct:   390 -EEAIKLEELKLKEYEARELAEKEK-QNFEKARRDAESMRERAEREIAQRREAERKSARD 447

Query:   118 SSHM---------PQF-FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIK 167
             +            PQ  +  F++ EI  AT +F   LKIG G YG++YK  L H    +K
Sbjct:   448 TKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVYKCNLHHTTAVVK 507

Query:   168 MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDN 227
             +L     Q   +FQQE++ILSKIRHP+LV L+GACPE   LVYEY+ NGSLEDRL   +N
Sbjct:   508 VLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYMENGSLEDRLFQVNN 567

Query:   228 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 287
             SPPL W  R RIA E+ + L+FLH  KP  I+H DLKPANILLD NFVSK+ D G+S  +
Sbjct:   568 SPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFVSKVGDVGLSTMV 627

Query:   288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 347
               + +S+   T+  +T P GT  Y+DPE+  +G ++ KSD+YSFG+ILL+LLT +PA+ +
Sbjct:   628 QVDPLSTK-FTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILLQLLTAKPAIAL 686

Query:   348 TKEVQYALDTG-KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 406
             T  V+ A+D+  +   +LD  AG+WP  +  +LA LA+ C E+  K RP+L   +   LE
Sbjct:   687 THFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELRGKDRPDLKDQILPALE 746

Query:   407 PMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGH 466
              ++     + +   G     +PP +F CP+ ++VM +P VAADG+TY+  A++ WL   H
Sbjct:   747 NLKKVAEKARNSFSGVST--QPPTHFICPLLKDVMNEPCVAADGYTYDRHAIEEWLKE-H 803

Query:   467 ETSPMTNLPLAHKNLVPNLALRSAIQEW 494
              TSPMT+ PL  KNL+PN  L +AI EW
Sbjct:   804 NTSPMTDSPLHSKNLLPNYTLYTAIMEW 831

GO:0000151 "ubiquitin ligase complex" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004842 "ubiquitin-protein ligase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016567 "protein ubiquitination" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2176177 AT5G51270 [Arabidopsis thaliana (taxid:3702)]

 Score = 915 (327.2 bits), Expect = 3.4e-94, Sum P(2) = 3.4e-94
 Identities = 194/470 (41%), Positives = 288/470 (61%)

Query:    32 KLELERMKKQHDEVMEELQI-ALDQKSLLESQIAESDQTAKELEQKIISA--VELLQNYK 88
             KL  E ++  H E+    Q+  LD    L +++   + T  E E K I+    E  +  +
Sbjct:   351 KLRAE-LRHAH-EMYAVAQVETLDASRKL-NELKFEELTLLEHETKGIAKKETEKFEQKR 407

Query:    89 KEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPSLKIG 147
             +E+ E    R+  +K   E ++  K   SS   P+  + +F++ EI  AT +F   LKIG
Sbjct:   408 REEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSEDLKIG 467

Query:   148 EGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT 207
              G YG +YK  L H   A+K+LH        +F QE++ILSKIRHP+LV L+GACP+   
Sbjct:   468 MGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACPDHGA 527

Query:   208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 267
             LVYEY+ NGSLEDRL   ++S P+ W  R+RIA E+ S L+FLH  KP  I+H DLKPAN
Sbjct:   528 LVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDLKPAN 587

Query:   268 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 327
             ILL+ NFVSK+ D G+S  +   +  S   T+  +T P GT  Y+DPE+  +G ++PKSD
Sbjct:   588 ILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRISPKSD 647

Query:   328 VYSFGIILLRLLTGRPALGITKEVQYALDTG---KLKNLLDPLAGDWPFVQAEQLANLAM 384
             VY+FG+I+L+LLTG+ A+ +T  V+ A++     +L  +LD  AG+WP  +  QLA LA+
Sbjct:   648 VYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLAALAL 707

Query:   385 RCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDP 444
             +C E+  K RP+L   +  VLE ++     + +    S    +PP +F CP+ ++VM++P
Sbjct:   708 QCTELRSKDRPDLEDQILPVLESLKKVADKARNSL--SAAPSQPPSHFFCPLLKDVMKEP 765

Query:   445 HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 494
              +AADG+TY+  A++ W+++ H TSP+TN PL + NL+PN  L +AI EW
Sbjct:   766 CIAADGYTYDRRAIEEWMEN-HRTSPVTNSPLQNVNLLPNHTLYAAIVEW 814

GO:0000151 "ubiquitin ligase complex" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004842 "ubiquitin-protein ligase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016567 "protein ubiquitination" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2151641 AT5G61560 [Arabidopsis thaliana (taxid:3702)]

 Score = 913 (326.5 bits), Expect = 1.8e-93, Sum P(2) = 1.8e-93
 Identities = 202/487 (41%), Positives = 296/487 (60%)

Query:    27 ALANGKLELERMKKQHDEVMEELQIALDQKSLL--ESQIAESDQTAKELEQKIISAVELL 84
             A+A  ++ ++  KK  D      + A   K+L   E +  E  +  +E ++   +  EL+
Sbjct:   314 AVAQSEV-IDASKKMQDLNQRRSEEATRLKNLTIREEEADEVVEMERERQEDAENEAELV 372

Query:    85 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH----MPQFFSDFSFSEIEGATHNF 140
             +   + + E   ER +A   AEE+RK ++    +        Q +  F + EI  AT +F
Sbjct:   373 RECIERETE---ERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEWEEIVEATSSF 429

Query:   141 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
                LKIG GGYGS+Y+  L H  VA+K+LH        +F QE++ILSKIRHP+L+ L+G
Sbjct:   430 SDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLG 489

Query:   201 ACPEVWTLVYEYLPNGSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCK 254
             ACPE  +LVYEY+ NGSLE+RL  +         PPL W  R RIA E+ S L FLH+ +
Sbjct:   490 ACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNE 549

Query:   255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
             P  IVH DLKPANILLD N VSK+ D G+S+ ++ +   S+ +T+   T P GTF Y+DP
Sbjct:   550 PRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDP--SHASTVFNETGPVGTFFYIDP 607

Query:   315 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGDWP 372
             E+  +G +TP+SD+Y+FGIILL+L+T R A+G+   ++ AL   TGK   +LD  AGDWP
Sbjct:   608 EYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWP 667

Query:   373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR--ASCGGSTSYRLGSEERCEPPP 430
               +A+++  + +RC EM ++ RP+LGK++  VLE ++  AS   +       +     P 
Sbjct:   668 VKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPT 727

Query:   431 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSA 490
             +F CPI ++VM++P VA+DG+TYE  A+K WL   H+ SPMT+LP    +L+PN +L SA
Sbjct:   728 HFYCPITKDVMENPCVASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLLPNHSLLSA 786

Query:   491 IQEWLQQ 497
             I+EW  Q
Sbjct:   787 IKEWRSQ 793

GO:0000151 "ubiquitin ligase complex" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004842 "ubiquitin-protein ligase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016567 "protein ubiquitination" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009507 "chloroplast" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

UNIPROTKB|Q0DR28 PUB57 "U-box domain-containing protein 57" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 917 (327.9 bits), Expect = 5.0e-92, P = 5.0e-92
 Identities = 205/502 (40%), Positives = 295/502 (58%)

Query:     6 QAKASESLYAEELKRRKEFE--EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI 63
             + K   S++ E +     F   E +    +  +++ K  D + +   +A   + + + + 
Sbjct:    26 EIKFEPSVWCEAIDIHNTFSAGEIITGDIICFQKILKPPD-IPKYPSVASFLQHVCDRKT 84

Query:    64 AESDQTAKELEQKIISAVELLQNY--KKEQ-----DELQMERDKAVKEAEELRKSRKEAS 116
              E  +    LE++I++       Y  +KE+     D+L+ ERD AV++  ELR       
Sbjct:    85 YEEVRKVHILEEEIVTLKHQADTYLVQKEKAVTAYDQLKHERDNAVQQVNELR------D 138

Query:   117 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG 176
              S+H+     DFS  ++E AT +F  + ++G+  YG  YKG++ +M+V IK+     L  
Sbjct:   139 QSTHI---ILDFSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKLSSSQKL-- 193

Query:   177 PSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
                FQQE+ IL + RHPN++T +G C EV  LVYE+LPNG+LEDR+ C +NS PLSW  R
Sbjct:   194 ---FQQEVSILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWYNR 250

Query:   237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              +I  E+C  L+FLHS K  ++VHGDL+P NIL+DAN+ SK+ +FG+S    Q      N
Sbjct:   251 TQIIGEICCALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGTFPPN 310

Query:   297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 356
              T            YMDPEF  +GELT  SDVYS G+I+LRLLTG P L ++++V  AL 
Sbjct:   311 LT--------ARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALG 362

Query:   357 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGST 416
             +  L  L+D  AGDWP+++A+QLA + + C  M+RK RP+L  +VW V+EP+      +T
Sbjct:   363 SDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPLTRKPPAAT 422

Query:   417 -SYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLP 475
               Y   +      P  F CPI  E+M+DP VA+DGFTYEAEA++ W D G   SPMTNL 
Sbjct:   423 WPYLQSASGDSSVPAAFICPISMEIMKDPQVASDGFTYEAEAIRCWFDRGISRSPMTNLA 482

Query:   476 LAHKNLVPNLALRSAIQEWLQQ 497
             L + NLVPN  LRS I  +LQQ
Sbjct:   483 LPNLNLVPNRVLRSFIHGYLQQ 504

GO:0004842 "ubiquitin-protein ligase activity" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

TAIR|locus:504954932 AT5G57035 [Arabidopsis thaliana (taxid:3702)]

 Score = 847 (303.2 bits), Expect = 1.9e-87, Sum P(2) = 1.9e-87
 Identities = 187/479 (39%), Positives = 279/479 (58%)

Query:    18 LKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKI 77
             L   K+  E L + + +++ +  +  +  E +  AL+++ +     AE     KE   K 
Sbjct:   309 LSMYKQACEELVHKQTQVQSLSSECIKETERVITALEKEEMRRKAAAEE----KEKHLKA 364

Query:    78 ISAVELLQNY-KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGA 136
             +  VE  ++   KE  E Q+    A+K++ E +K  ++          +  ++  EI  A
Sbjct:   365 VKEVEEAKSMLAKEFCERQLAELDALKQSIEKQKVIEQLFLRDGR---YRKYTKEEIAAA 421

Query:   137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
             T NF     IGEGGYG +YK  L H  VA+K+L P S++   EF +EI +LS++RHP++V
Sbjct:   422 TDNFSSRKIIGEGGYGKVYKCSLDHTPVALKVLKPDSVEKKEEFLKEISVLSQLRHPHVV 481

Query:   197 TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
              L+GACPE   LVYEY+ NGSL+  +S K   P LSW  R RI  E    L FLH+ KP 
Sbjct:   482 LLLGACPENGCLVYEYMENGSLDCHISPKKGKPSLSWFIRFRIIYETACGLAFLHNSKPE 541

Query:   257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
              IVH DLKP NILLD NFVSK+ D G+++ +S    + ++ T+   +   GT  YMDPE+
Sbjct:   542 PIVHRDLKPGNILLDRNFVSKIGDVGLAKLMSDE--APDSVTVYRNSIIAGTLYYMDPEY 599

Query:   317 LASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 376
               +G + PKSD+Y+FGII+L+LLT R   G+   V+ A+  G  +++LD    DWP  +A
Sbjct:   600 QRTGTIRPKSDLYAFGIIILQLLTARHPNGLLFCVEDAVKRGCFEDMLDGSVKDWPIAEA 659

Query:   377 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE-RCEPPPYFTCP 435
             ++LA +A+RC ++  + RP+L   V   L+ +  S       RL +E+     P ++ CP
Sbjct:   660 KELARIAIRCSQLKCRDRPDLSTQVLPALKRILESANS----RLKTEQANARAPTHYYCP 715

Query:   436 IFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 494
             I +E+M+DP +AADGFTYE +A+K W+    + SP+T   L H +L PN  LRSAI+EW
Sbjct:   716 ILKEIMEDPQIAADGFTYERKAIKEWIQKHQDVSPVTKHRLKHSDLTPNHTLRSAIREW 774

GO:0000151 "ubiquitin ligase complex" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004842 "ubiquitin-protein ligase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016567 "protein ubiquitination" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047605 AT2G19410 [Arabidopsis thaliana (taxid:3702)]

 Score = 819 (293.4 bits), Expect = 1.2e-81, P = 1.2e-81
 Identities = 182/491 (37%), Positives = 281/491 (57%)

Query:    20 RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQ-IAESDQTAKELE---- 74
             ++ E EE +   K EL+    ++ +  EEL    ++  +L ++ + ES +    +E    
Sbjct:   307 KKVEIEEEVERLKNELQSTVFKYKQACEELFSTQNKVKMLSTEYLNESKRVNNAVEKEEL 366

Query:    75 QKIISAVELLQNYKKEQDELQ-----MERDKAVKEAEELRKSRKEASSSSHMPQF----- 124
             Q+  +A+E  + Y K   E++     + R+   ++  E+   R        + Q      
Sbjct:   367 QRNTAALEK-ERYMKAVKEVETAKALLAREFCQRQIAEVNALRTYLEKKKVIDQLLGTDH 425

Query:   125 -FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQE 183
              +  ++  EI  AT  F P   IGEGGYG +Y+  L     A+K++   + +   EF +E
Sbjct:   426 RYRKYTIEEIVTATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKE 485

Query:   184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
             +++LS++RHP++V L+GACPE   LVYEYL NGSLE+ +  + N PPL W  R R+  E+
Sbjct:   486 VEVLSQLRHPHVVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEV 545

Query:   244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
                L FLHS KP  IVH DLKP NILL+ N+VSK++D G+++ ++  +++ +N T+   +
Sbjct:   546 ACGLAFLHSSKPEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVT--DVAPDNVTMYRNS 603

Query:   304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 363
                GT  Y+DPE+  +G + PKSD+Y+FGII+L+LLT R   GI   V+ A+  G L  +
Sbjct:   604 VLAGTLHYIDPEYHRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEM 663

Query:   364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSE 423
             LD    DWP  + E+LA + ++C E   + RP+L  +V  VL+ +      S   + GS 
Sbjct:   664 LDKSVTDWPLAETEELARIGLKCAEFRCRDRPDLKSEVIPVLKRL-VETANSKVKKEGSN 722

Query:   424 ERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVP 483
              R  P  YF CPI +E+M++P +AADGFTYE +A+  WL+  H  SP+T   L H  L P
Sbjct:   723 LRA-PSHYF-CPILREIMEEPEIAADGFTYERKAILAWLEK-HNISPVTRQKLDHFKLTP 779

Query:   484 NLALRSAIQEW 494
             N  LRSAI++W
Sbjct:   780 NHTLRSAIRDW 790

GO:0000151 "ubiquitin ligase complex" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004842 "ubiquitin-protein ligase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016567 "protein ubiquitination" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2128131 AT4G31230 [Arabidopsis thaliana (taxid:3702)]

 Score = 801 (287.0 bits), Expect = 9.7e-80, P = 9.7e-80
 Identities = 181/408 (44%), Positives = 251/408 (61%)

Query:    17 ELKRRKEF-----EEAL-ANGKL-ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQT 69
             ELK+  E      +EAL A  K  EL+R K   +   EE ++A ++ +L    IAE ++ 
Sbjct:   347 ELKQTMEMYSTACKEALTAKHKATELQRWKLAEERKFEEAKLA-EEAALA---IAEKEK- 401

Query:    70 AKELEQKIISAVELLQNYKKEQDELQMERD-KAVKEAEELRKSRKEASSSSHMPQFFSDF 128
             AK   +  + A E  Q     +   +++ + KA+KE+E    +R +A ++      +  +
Sbjct:   402 AKS--KAAMEAAEAAQRIADIESRKRVDAETKALKESE----ARTKAVNALAKDVRYRKY 455

Query:   129 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILS 188
             S  EIE AT  FD   KIGEG YG +YK  L H  VA+K L P + QG S+FQ+E+++L 
Sbjct:   456 SIEEIEDATEFFDDKYKIGEGSYGPVYKCYLDHTPVAVKALRPDAAQGRSQFQKEVEVLC 515

Query:   189 KIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
              IRHPN+V L+GACPE   LVYE++ NGSLEDRL  + +SP LSWQTR RIA E+ +VL+
Sbjct:   516 SIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFRQGDSPALSWQTRFRIAAEIGTVLL 575

Query:   249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
             FLH  KP  +VH DLKPANILLD NFVSKL+D G++R +  +   +N  T    T   GT
Sbjct:   576 FLHQTKPEPLVHRDLKPANILLDRNFVSKLADVGLARLVPPSV--ANTVTQYHMTSTAGT 633

Query:   309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 368
             F Y+DPE+  +G L  KSD+YS GI+ L+L+TG+P +G+T  V+ AL+ G LK+LLDP  
Sbjct:   634 FCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITGKPPMGLTHYVERALEKGNLKDLLDPAV 693

Query:   369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGST 416
              DWP     + A LA++C E+ RK RP+L K +   L  +R     ST
Sbjct:   694 SDWPVEDTTEFAKLALKCAEIRRKDRPDLSKVILPELNRLRVLAEEST 741

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2180677 AT5G26150 [Arabidopsis thaliana (taxid:3702)]

 Score = 794 (284.6 bits), Expect = 5.4e-79, P = 5.4e-79
 Identities = 169/398 (42%), Positives = 247/398 (62%)

Query:     5 LQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIA 64
             L+ K +  +Y+   K     +   AN   EL + K +     E+ +++ ++ +L  ++I 
Sbjct:   300 LELKQTMDMYSSACKEALTAKRK-AN---ELNQWKIEEARKFEKARLS-EEAALAVAEIE 354

Query:    65 ESD-QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 123
             ++  +TA E  +K     EL +  +++Q E+     KAV E ++  K R   S+ +H   
Sbjct:   355 KAKCRTAVEAAEKAQRMAEL-EGQRRKQAEM-----KAVSEEKD--KDRA-VSALAHNDV 405

Query:   124 FFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQE 183
              +  +S  EIE AT  F    KIGEGGYG +Y G L H  VAIK+L P + QG  +FQQE
Sbjct:   406 RYRKYSIEEIEEATERFANHRKIGEGGYGPVYNGELDHTPVAIKVLRPDAAQGKKQFQQE 465

Query:   184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
             +++L  IRHP++V L+GACPE   LVYE++ NGSLEDRL    NSPPLSW+ R  IA E+
Sbjct:   466 VEVLCSIRHPHMVLLLGACPEYGCLVYEFMENGSLEDRLFRTGNSPPLSWRKRFEIAAEI 525

Query:   244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
              + L FLH  KP  +VH DLKPANILLD N+VSK+SD G++R +  +   +++ T    T
Sbjct:   526 ATALSFLHQAKPEPLVHRDLKPANILLDKNYVSKISDVGLARLVPAS--IADSVTQFHMT 583

Query:   304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 363
                GTF Y+DPE+  +G LT KSDVYS GI+LL+++TGRP +G+  +V  A+  G  K +
Sbjct:   584 SAAGTFCYIDPEYQQTGMLTTKSDVYSLGILLLQIITGRPPMGLAHQVSRAISKGTFKEM 643

Query:   364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 401
             LDP+  DWP  +A+  A LA++C E+ ++ RP+LGK+V
Sbjct:   644 LDPVVPDWPVQEAQSFATLALKCAELRKRDRPDLGKEV 681

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	6.3.2	0.691
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	498
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-39
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-26
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-25
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-22
smart00504	63	smart00504, Ubox, Modified RING finger domain	2e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-20
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-19
pfam04564	73	pfam04564, U-box, U-box domain	5e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-12
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-06
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	3e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-06
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	4e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-05
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	5e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-05
COG1579	239	COG1579, COG1579, Zn-ribbon protein, possibly nucl	5e-05
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	7e-05
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	7e-05
PTZ00121	2084	PTZ00121, PTZ00121, MAEBL; Provisional	7e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-05
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	9e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	2e-04
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	2e-04
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	2e-04
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-04
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	3e-04
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	3e-04
COG1579	239	COG1579, COG1579, Zn-ribbon protein, possibly nucl	3e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-04
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	4e-04
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-04
PRK12704	520	PRK12704, PRK12704, phosphodiesterase; Provisional	5e-04
PTZ00121	2084	PTZ00121, PTZ00121, MAEBL; Provisional	7e-04
COG0419	908	COG0419, SbcC, ATPase involved in DNA repair [DNA	8e-04
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	9e-04
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.001
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.001
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.001
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.001
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.001
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	0.001
PTZ00121	2084	PTZ00121, PTZ00121, MAEBL; Provisional	0.001
pfam13863	126	pfam13863, DUF4200, Domain of unknown function (DU	0.001
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.001
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.002
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.002
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	0.002
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	0.002
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.002
COG4026	290	COG4026, COG4026, Uncharacterized protein containi	0.002
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.003
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.003
PTZ00121	2084	PTZ00121, PTZ00121, MAEBL; Provisional	0.003
COG0419	908	COG0419, SbcC, ATPase involved in DNA repair [DNA	0.003
COG1340	294	COG1340, COG1340, Uncharacterized archaeal coiled-	0.003
PRK00409	782	PRK00409, PRK00409, recombination and DNA strand e	0.003
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.003
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004
TIGR04211	198	TIGR04211, SH3_and_anchor, SH3 domain protein	0.004
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  174 bits (444), Expect = 9e-52
 Identities = 79/200 (39%), Positives = 110/200 (55%), Gaps = 20/200 (10%)

Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC 202
           +GEGG+G++Y    +    +VAIK++          E  +EI+IL K+ HPN+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                  LV EY   GSL+D L  K+N   LS    +RI  ++   L +LHS   + I+H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 261 GDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 318
            DLKP NILLD+ N   KL+DFG+S+ L+ +   S   T+       GT AYM PE  L 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIV------GTPAYMAPEVLLG 167

Query: 319 SGELTPKSDVYSFGIILLRL 338
            G  + KSD++S G+IL  L
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  167 bits (425), Expect = 1e-48
 Identities = 83/268 (30%), Positives = 117/268 (43%), Gaps = 30/268 (11%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           K+GEG +G +Y    +     VAIK++      +      +EI IL K++HPN+V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                +++ LV EY   G L D L        LS         ++ S L +LHS     I
Sbjct: 66  FEDEDKLY-LVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGI 118

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           VH DLKP NILLD +   KL+DFG++R L   E     TT        GT  YM PE L 
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFV------GTPEYMAPEVLL 169

Query: 319 SGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 377
                   D++S G+IL  LLTG+ P  G  + ++     GK K    P   D       
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS----P 225

Query: 378 QLANLAMRCCEMSRKSRP---ELGKDVW 402
           +  +L  +      + R    E  +  +
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPF 253

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  164 bits (418), Expect = 2e-47
 Identities = 98/273 (35%), Positives = 137/273 (50%), Gaps = 34/273 (12%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLV 199
           K+G G +G++YK   +     VA+K+L   S +   + Q    EI IL ++ HPN+V L+
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 200 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
            A      ++ LV EY   G L D LS      PLS     +IA ++   L +LHS   +
Sbjct: 65  DAFEDKDHLY-LVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS---N 117

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            I+H DLKP NILLD N V K++DFG+++ L ++  SS+ TT        GT  YM PE 
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFV------GTPWYMAPEV 169

Query: 317 LASGEL-TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFV 374
           L  G    PK DV+S G+IL  LLTG+P   G     Q  L     + L  PL  D P  
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI---RRILGPPLEFDEPKW 226

Query: 375 --QAEQLANLAMRCCEMSRKSRP---ELGKDVW 402
              +E+  +L  +C       RP   E+ +  W
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (416), Expect = 4e-47
 Identities = 85/263 (32%), Positives = 127/263 (48%), Gaps = 32/263 (12%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           K+GEG +G +YKG L+       ++VA+K L    S Q   EF +E  I+ K+ HPN+V 
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 198 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           L+G C   E   +V EY+  G L   L  + N P LS    +  A ++   + +L S   
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESKN- 122

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
              +H DL   N L+  N V K+SDFG+SR L  ++          +   K    +M PE
Sbjct: 123 --FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-------YRKRGGKLPIRWMAPE 173

Query: 316 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWP 372
            L  G+ T KSDV+SFG++L  + T   +P  G++ +EV   L  G     L       P
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQ-----P 225

Query: 373 FVQAEQLANLAMRCCEMSRKSRP 395
                +L +L ++C     + RP
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRP 248

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (396), Expect = 3e-44
 Identities = 87/264 (32%), Positives = 125/264 (47%), Gaps = 33/264 (12%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           K+GEG +G +YKG L+       ++VA+K L    S Q   EF +E  I+ K+ HPN+V 
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 198 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPP-LSWQTRIRIATELCSVLIFLHSCK 254
           L+G C   E   +V EY+P G L D L  + N P  LS    +  A ++   + +L S  
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLESKN 123

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   N L+  N V K+SDFG+SR L  ++              K    +M P
Sbjct: 124 ---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-------VKGGKLPIRWMAP 173

Query: 315 EFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDW 371
           E L  G+ T KSDV+SFG++L  + T    P  G++  EV   L  G     L       
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---YRLPK----- 225

Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P     +L  L ++C     + RP
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDRP 249

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  150 bits (381), Expect = 4e-42
 Identities = 83/265 (31%), Positives = 131/265 (49%), Gaps = 35/265 (13%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 197
           K+GEG +G +YKG L+        +VA+K L    S +   EF +E  I+ K+ HPN+V 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 198 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           L+G C   E   +V EY+P G L D L  + +   L+ +  +++A ++   + +L S   
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 313
            + VH DL   N L+  N V K+SDFG+SR + +++          R    G     +M 
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY--------RKRGGGKLPIKWMA 172

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGD 370
           PE L  G+ T KSDV+SFG++L  + T   +P  G++ +EV   L+ G     L      
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG---YRLPRPENC 229

Query: 371 WPFVQAEQLANLAMRCCEMSRKSRP 395
                  +L  L ++C     + RP
Sbjct: 230 PD-----ELYELMLQCWAYDPEDRP 249

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  148 bits (375), Expect = 3e-41
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 145 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 198
           K+GEG +G +YKG L+       +VA+K L    S +   +F +E  ++ K+ HPN+V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 199 VGACPEV--WTLVYEYLPNGSLEDRL------SCKDNSPPLSWQTRIRIATELCSVLIFL 250
           +G C E     LV EY+  G L D L              LS +  +  A ++   + +L
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
            S K    VH DL   N L+  + V K+SDFG+SR +  ++             P     
Sbjct: 122 ASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD---YYRKKTGGKLP---IR 172

Query: 311 YMDPEFLASGELTPKSDVYSFGIIL 335
           +M PE L  G  T KSDV+SFG++L
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLL 197

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  142 bits (360), Expect = 4e-39
 Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 20/209 (9%)

Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           F+   KIG+GG+G +YK   +     VAIK++   S +   +   EI IL K +HPN+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 198 LVGA--CP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
             G+     E+W +V E+   GSL+D L  K  +  L+      +  EL   L +LHS  
Sbjct: 62  YYGSYLKKDELW-IVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS-- 116

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
            + I+H D+K ANILL ++   KL DFG+S  LS  +  + NT +       GT  +M P
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMV-------GTPYWMAP 166

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E +       K+D++S GI  + L  G+P
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  142 bits (360), Expect = 4e-39
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)

Query: 145 KIGEGGYGSIYKGLLRHM--QVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
            +G G +GS+Y  L +     +A+K   L   S +     ++EI ILS ++HPN+V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 201 ACPEVWTLVY----EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +  +          EY+  GSL   L        L      +   ++   L +LHS   +
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEGLAYLHS---N 120

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            IVH D+K ANIL+D++ V KL+DFG ++ L   E      ++      +GT  +M PE 
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV------RGTPYWMAPEV 174

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
           +   E    +D++S G  ++ + TG+P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  133 bits (334), Expect = 2e-34
 Identities = 88/269 (32%), Positives = 123/269 (45%), Gaps = 22/269 (8%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP-NLVTL-- 198
           K+GEG +G +Y        VA+K+L         E   F +EI IL+ + HP N+V L  
Sbjct: 7   KLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 199 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                    LV EY+  GSLED L       PLS    + I  ++ S L +LHS     I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122

Query: 259 VHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           +H D+KP NILLD +  V KL DFG+++ L     +S+   L   +   GT  YM PE L
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP--STSVGTPGYMAPEVL 180

Query: 318 ASGEL---TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------LKNLLDPLA 368
               L   +  SD++S GI L  LLTG P     K       T K        +L  PL+
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240

Query: 369 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
              P + ++  ++L  +      K+R   
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  118 bits (299), Expect = 2e-30
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 145 KIGEGGYGSIYKGLLRH----MQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +IG+G +G +Y  L+R         +K   L   S +   +   E+ IL K+ HPN++  
Sbjct: 7   QIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 199 VGACPEVWT------LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLH 251
                E +       +V EY   G L  ++   K    P   +  +    +LC  L +LH
Sbjct: 65  Y----ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           S K   I+H D+KP NI L +N + KL DFGIS+ LS     +   T+       GT  Y
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK--TVV------GTPYY 169

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 344
           + PE   +     KSD++S G +L  L T +  
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  113 bits (286), Expect = 1e-28
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
            +G+G  G +YK   +      A+K +H     +   +  +E+  L     P +V   GA
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 202 C--PEVWTLVYEYLPNGSLEDRL--SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
                  ++V EY+  GSL D L    K   P L+      IA ++   L +LH      
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLH--TKRH 120

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H D+KP+N+L+++    K++DFGIS+ L        NT   C T   GT  YM PE +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLE-------NTLDQCNTF-VGTVTYMSPERI 172

Query: 318 ASGELTPKSDVYSFGIILLRLLTGR 342
                +  +D++S G+ LL    G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 200
            IG G +G +YKGL       VAIK +    ++  +     QEID+L  ++HPN+V  +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 201 ACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           +     +L  + EY  NGSL   +       P           ++   L +LH      +
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHE---QGV 120

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K ANIL   + V KL+DFG++  L+                  GT  +M PE + 
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--------DASVVGTPYWMAPEVIE 172

Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
               +  SD++S G  ++ LLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 7e-28
 Identities = 73/220 (33%), Positives = 108/220 (49%), Gaps = 18/220 (8%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           K+G G +G ++ G      +VA+K L P ++  P  F QE  I+ K+RH  LV L   C 
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 203 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
             E   +V EY+  GSL D L        L     + +A ++   + +L S    + +H 
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   NIL+  N V K++DFG++R +  +E          R   K    +  PE    G 
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDE-------YTAREGAKFPIKWTAPEAANYGR 180

Query: 322 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
            T KSDV+SFGI+L  ++T GR P  G+T  EV   ++ G
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  111 bits (279), Expect = 2e-27
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 34/230 (14%)

Query: 138 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML---HPHSLQGPSEFQQEIDILSKI-R 191
            +F     IGEG + ++     +    + AIK+L        +     + E ++L+++  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 192 HPNLVTLVG--ACPEVWTLVYEYLPNGSLED---RLSCKDNSPPLSWQTRIR-IATELCS 245
           HP ++ L       E    V EY PNG L     +    D       +   R  A E+  
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-------EKCTRFYAAEILL 113

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            L +LHS     I+H DLKP NILLD +   K++DFG ++ L  N    +N       D 
Sbjct: 114 ALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 306 K------------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           +            GT  Y+ PE L        SD+++ G I+ ++LTG+P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 3e-26
 Identities = 73/208 (35%), Positives = 101/208 (48%), Gaps = 27/208 (12%)

Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G+G +G +   L+R        A+K+L    +    E +    E +ILS+I HP +V L
Sbjct: 1   LGKGSFGKVL--LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKP 255
             A    E   LV EY P G L   LS        S + R R  A E+   L +LHS   
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFS-EERARFYAAEIVLALEYLHS--- 111

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             I++ DLKP NILLDA+   KL+DFG+++ LS     S   T C      GT  Y+ PE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC------GTPEYLAPE 163

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L         D +S G++L  +LTG+P
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 4e-26
 Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 18/220 (8%)

Query: 145 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G +++GL  +   VA+K L P ++  P +F  E  I+ K+RHP L+ L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 204 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
             E   +V E +  GSL + L        L     I +A ++ S + +L +    + +H 
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N+L+  N + K++DFG++R + ++   +       R   K    +  PE      
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEA-------REGAKFPIKWTAPEAALYNR 180

Query: 322 LTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQYALDTG 358
            + KSDV+SFGI+L  ++T GR P  G+T  EV   +D G
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 6e-26
 Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 18/192 (9%)

Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV 205
           IG+G +G +  G  R  +VA+K L   S    + F  E  +++ +RHPNLV L+G   + 
Sbjct: 14  IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQG 72

Query: 206 WTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 263
             L  V EY+  GSL D L  +  +  ++   ++  A ++C  + +L        VH DL
Sbjct: 73  NPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHRDL 128

Query: 264 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 323
              N+L+  + V+K+SDFG+++  SQ + S            K    +  PE L   + +
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSG-----------KLPVKWTAPEALREKKFS 177

Query: 324 PKSDVYSFGIIL 335
            KSDV+SFGI+L
Sbjct: 178 TKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (263), Expect = 2e-25
 Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 50/222 (22%)

Query: 146 IGEGGYGSIYKGLL------RHMQ-VAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 197
           +GEG +G +YKG L           VAIK L      +   EF+QE +++S ++HPN+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 198 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSP---------------PLSWQTRIRIA 240
           L+G C   +   +++EYL +G L + L    NSP                L     + IA
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLV--RNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS------ 294
            ++ + + +L S   H  VH DL   N L+      K+SDFG+SR     +I S      
Sbjct: 131 IQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSR-----DIYSADYYRV 182

Query: 295 -NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 335
            + + L  R        +M PE +  G+ T +SD++SFG++L
Sbjct: 183 QSKSLLPVR--------WMPPEAILYGKFTTESDIWSFGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 3e-25
 Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 29/213 (13%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 200
           KIG G +G +Y    L     +A+K +        +  E   E+ +L  ++HPNLV   G
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 201 ACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHSCKP 255
              EV      +  EY   G+LE+ L           +  IR+ T +L   L +LHS   
Sbjct: 67  V--EVHREKVYIFMEYCSGGTLEELLEHGRILD----EHVIRVYTLQLLEGLAYLHSHG- 119

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT--DPKGTFAYMD 313
             IVH D+KPANI LD N V KL DFG +          NNTT          GT AYM 
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQSLAGTPAYMA 171

Query: 314 PEFLASGELTPK---SDVYSFGIILLRLLTGRP 343
           PE +  G+       +D++S G ++L + TG+ 
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  103 bits (259), Expect = 5e-25
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGA 201
           ++G G  G + K L R     + +         +  +Q   E+DIL K   P +V   GA
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 202 C---PEVWTLVYEYLPNGSLEDRL-SCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKP 255
                ++  +  EY+  GSL+  L   +   P   L      +IA  +   L +LH    
Sbjct: 68  FYNNGDIS-ICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE--K 119

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           H I+H D+KP+NIL+++    KL DFG+S  L  N ++             GT +YM PE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKTFV---------GTSSYMAPE 169

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGR 342
            +   + + KSD++S G+ L+ L TGR
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  102 bits (256), Expect = 1e-24
 Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           I +G YG ++  L +        AIK++    +   ++  Q   E DILS+ + P +V L
Sbjct: 1   ISKGAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 199 VGACPEVWTL--VYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
             +      L  V EYLP G   SL + +   D         RI IA E+   L +LHS 
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLALEYLHS- 111

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCCRTDPKGTFAY 311
             + I+H DLKP NIL+D+N   KL+DFG+S+          +++     R    GT  Y
Sbjct: 112 --NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI--VGTPDY 167

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           + PE +     +   D +S G IL   L G P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (256), Expect = 2e-24
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 48/225 (21%)

Query: 146 IGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVT 197
           +GEG +G ++ G   H         VA+K L   +     + F++E ++L+  +H N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 198 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSP-------------PLSWQTRIRIATE 242
             G C E     +V+EY+ +G L   L  + + P              L+    ++IA +
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFL--RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN------ 296
           + S +++L S      VH DL   N L+  + V K+ DFG+SR     ++ + +      
Sbjct: 131 IASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVGG 182

Query: 297 -TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            T L  R        +M PE +   + T +SDV+SFG++L  + T
Sbjct: 183 HTMLPIR--------WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  101 bits (254), Expect = 2e-24
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)

Query: 145 KIGEGGYGSIYKG-----LLRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 198
           K+G+G +G + +G       + + VA+K L    L     +F +E  I+  + H NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 199 VGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G    V T    +V E  P GSL DRL  KD        T    A ++ + + +L S  
Sbjct: 62  YGV---VLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYLES-- 115

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE---ISSNNTTLCCRTDPKGTFAY 311
               +H DL   NILL ++   K+ DFG+ R L QNE   +   +         K  FA+
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL--------KVPFAW 166

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLT 340
             PE L +   +  SDV+ FG+ L  + T
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (255), Expect = 3e-24
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 30/215 (13%)

Query: 145 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNL 195
           ++GEG +G +     R+         QVA+K L+     Q  S+F++EI+IL  + H N+
Sbjct: 11  QLGEGHFGKVELC--RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 196 VTLVGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           V   G C +       L+ EYLP+GSL D L  + +   ++ +  +  ++++C  + +L 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTF 309
           S +    +H DL   NIL+++  + K+SDFG+++ L +++               P   F
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP----GESP--IF 177

Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP 343
            Y  PE L + + +  SDV+SFG+ L  L T G P
Sbjct: 178 WYA-PECLRTSKFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 8e-24
 Identities = 70/208 (33%), Positives = 100/208 (48%), Gaps = 25/208 (12%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNLVTL 198
           K+GEG YG +YK   R  +    VA+K +   +  +G PS   +EI +L +++HPN+V L
Sbjct: 6   KLGEGTYGVVYKA--RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 199 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             V        LV+EY     L+  L       PLS      I  +L   L + HS   H
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCHS---H 117

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE- 315
            I+H DLKP NIL++ + V KL+DFG++R            T    T    T  Y  PE 
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARA-----FGIPLRTY---THEVVTLWYRAPEI 169

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L S   +   D++S G I   ++TG+P
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)

Query: 146 IGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 204
           +G G +G ++ G  R  + VAIKM+   ++    +F +E  ++ K+ HPNLV L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 205 VWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
              +  V EY+ NG L + L  ++    L  +  + + +++C  + +L S   +  +H D
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRD 125

Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L   N L+  + V K+SDFG++R++  ++ +S+  T       K    +  PE       
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT-------KFPVKWAPPEVFDYSRF 178

Query: 323 TPKSDVYSFGIILLRLLTG 341
           + KSDV+SFG+++  + + 
Sbjct: 179 SSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 99.2 bits (247), Expect = 2e-23
 Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 25/256 (9%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G ++ G    H +VAIK L   S+  P  F  E +++ +++HP LV L     
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L   +    L+    I +A ++   + F+      + +H D
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIER---KNYIHRD 127

Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 180

Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQL 379
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G       P   + P    E+L
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----PRPDNCP----EEL 232

Query: 380 ANLAMRCCEMSRKSRP 395
             L   C +   + RP
Sbjct: 233 YELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 21/224 (9%)

Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +GS+ KG+        ++VA+K L   H   G  EF +E  +++++ HP +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 200 GAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           G C  E   LV E  P G L   L  K     +       +A ++   + +L S      
Sbjct: 63  GVCKGEPLMLVMELAPLGPLLKYL--KKR-REIPVSDLKELAHQVAMGMAYLESKH---F 116

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           VH DL   N+LL     +K+SDFG+SR L      + +      T  +    +  PE + 
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRAL-----GAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 319 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
            G+ + KSDV+S+G+ L    +   +P   +   EV   L++G+
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE 215

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 31/265 (11%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVT 197
            IG+G +G++ K  +R       +  K +   ++    E QQ   E++IL +++HPN+V 
Sbjct: 7   TIGKGSFGTVRK--VRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVR 63

Query: 198 ----LVGACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLH- 251
               ++    +   +V EY   G L   +  CK     +  +   RI T+L   L   H 
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 252 -SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
            S   ++++H DLKPANI LDAN   KL DFG+++ L      S+           GT  
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYV-----GTPY 175

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 370
           YM PE L       KSD++S G ++  L    P      ++Q A    K+K         
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA---SKIKEGKFR---R 229

Query: 371 WPFVQAEQLANLAMRCCEMSRKSRP 395
            P+  + +L  +      +    RP
Sbjct: 230 IPYRYSSELNEVIKSMLNVDPDKRP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 97.4 bits (242), Expect = 7e-23
 Identities = 82/257 (31%), Positives = 125/257 (48%), Gaps = 25/257 (9%)

Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 12  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 126

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 179

Query: 322 LTPKSDVYSFGIILLRLLT-GR-PALG-ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 378
            T KSDV+SFGI+L  L T GR P  G + +EV   ++ G       P   + P    E 
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----PCPPECP----ES 231

Query: 379 LANLAMRCCEMSRKSRP 395
           L +L  +C     + RP
Sbjct: 232 LHDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  101 bits (253), Expect = 1e-22
 Identities = 92/314 (29%), Positives = 137/314 (43%), Gaps = 43/314 (13%)

Query: 123 QFF-SDFSFS-EIEGATHNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS 178
           QFF S  S S  I     +      I  G  G+ YKG  +   MQ  +K ++  +    S
Sbjct: 673 QFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS 732

Query: 179 EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E       + K++HPN+V L+G C   +   L++EY+   +L + L        LSW+ R
Sbjct: 733 EIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERR 782

Query: 237 IRIATELCSVLIFLH-SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
            +IA  +   L FLH  C P ++V G+L P  I++D      L               S 
Sbjct: 783 RKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHL-------------RLSL 828

Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR----PALG----I 347
              LC  T    + AY+ PE   + ++T KSD+Y FG+IL+ LLTG+       G    I
Sbjct: 829 PGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888

Query: 348 TKEVQYALDTGKLKNLLDP-LAGDWPFVQAE--QLANLAMRCCEMSRKSRPELGKDVWRV 404
            +  +Y      L   +DP + GD    Q E  ++ NLA+ C      +RP    DV + 
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP-CANDVLKT 947

Query: 405 LEPMRASCGGSTSY 418
           LE    S     + 
Sbjct: 948 LESASRSSSSCVTG 961

Length = 968

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 25/204 (12%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G +++GL +  ++VAIK+L    L    +FQ+E+  L ++RH +L++L   C 
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 204 E---VWTLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
               V+ ++ E +  GSL   L   +        L     I +A ++   + +L      
Sbjct: 73  VGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLEE---Q 123

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           + +H DL   NIL+  + V K++DFG++R + ++   S++         K  + +  PE 
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK--------KIPYKWTAPEA 175

Query: 317 LASGELTPKSDVYSFGIILLRLLT 340
            + G  + KSDV+SFGI+L  + T
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain

 Score = 90.4 bits (225), Expect = 2e-22
 Identities = 36/64 (56%), Positives = 45/64 (70%), Gaps = 1/64 (1%)

Query: 431 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSA 490
            F CPI  EVM+DP +   G TYE  A++ WL S H T P+T  PL H++L+PNLAL+SA
Sbjct: 1   EFLCPISLEVMKDPVILPSGQTYERSAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSA 59

Query: 491 IQEW 494
           IQEW
Sbjct: 60  IQEW 63

Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 50/271 (18%)

Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G + +G L+      + VAIK L    S +   +F  E  I+ +  HPN++ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 200 GACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +   +  + EY+ NGSL+  L  ++N    +    + +   + S + +L      +
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSE---MN 126

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD---- 313
            VH DL   NIL+++N V K+SDFG+SR L                D + T+        
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLE---------------DSEATYTTKGGKIP 171

Query: 314 -----PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLL 364
                PE +A  + T  SDV+SFGI++  +++   RP   ++ ++V  A++ G +L    
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---- 227

Query: 365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
            P   D P    +    L + C +  R  RP
Sbjct: 228 -PPPMDCPSALYQ----LMLDCWQKDRNERP 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 26/207 (12%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 200
           KIGEG  G +YK   R    +VAIK +    L+  ++     EI I+   +HPN+V    
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 201 AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI-RIATELCSVLIFLHSCKPH 256
           +     E+W +V EY+  GSL D ++   N   ++ + +I  +  E+   L +LHS    
Sbjct: 83  SYLVGDELW-VVMEYMDGGSLTDIITQ--NFVRMN-EPQIAYVCREVLQGLEYLHS---Q 135

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           +++H D+K  NILL  +   KL+DFG +  L++ E S  N+ +       GT  +M PE 
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-EKSKRNSVV-------GTPYWMAPEV 187

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
           +   +  PK D++S GI+ + +  G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 24/208 (11%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 198
           +IGEG +G ++K   +  +    VA+K +    L+G  P++  +EI  L   +HP +V L
Sbjct: 7   RIGEGAHGIVFKA--KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +        + LV EY+P   L + L  +D   PL           L   + ++H+   +
Sbjct: 65  LDVFPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYMHA---N 118

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            I+H DLKPAN+L+ A+ V K++DFG++R  S+ E           +    T  Y  PE 
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-------YSHQVATRWYRAPEL 171

Query: 317 L-ASGELTPKSDVYSFGIILLRLLTGRP 343
           L  + +  P  D+++ G I   LL G P
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.3 bits (235), Expect = 8e-22
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 35/216 (16%)

Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 195
           FD   K+GEG YGS+YK +  H +    VAIK++         E  +EI IL +   P +
Sbjct: 5   FDILEKLGEGSYGSVYKAI--HKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60

Query: 196 VTLVGAC---PEVWTLVYEYLPNGSLED--RLSCKDNSPPLSWQTRIRIATELCSV---L 247
           V   G+     ++W +V EY   GS+ D  +++ K     L+ +    IA  L      L
Sbjct: 61  VKYYGSYFKNTDLW-IVMEYCGAGSVSDIMKITNK----TLTEE---EIAAILYQTLKGL 112

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +LHS   +  +H D+K  NILL+    +KL+DFG+S  L  + ++  NT +       G
Sbjct: 113 EYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVI-------G 161

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           T  +M PE +       K+D++S GI  + +  G+P
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.4 bits (234), Expect = 8e-22
 Identities = 73/220 (33%), Positives = 113/220 (51%), Gaps = 17/220 (7%)

Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  I+ K+RH  LV L    
Sbjct: 12  VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V E++  GSL D L   D    L     + +A ++   + ++      + +H 
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERM---NYIHR 126

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 179

Query: 322 LTPKSDVYSFGIILLRLLT-GR-PALG-ITKEVQYALDTG 358
            T KSDV+SFGI+L  L+T GR P  G + +EV   ++ G
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.4 bits (235), Expect = 9e-22
 Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 27/229 (11%)

Query: 146 IGEGGYGSIYKG-------LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +GS+Y+G            +V++        +   + +QEI +LSK++HPN+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 199 VGACPEVWTL-VY-EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE-LCSVLIFLHSCKP 255
           +G   E   L ++ E +P GSL   L    + P    +  IR+ T  +   L +LH    
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP----EPVIRLYTRQILLGLEYLHD--- 120

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
            + VH D+K ANIL+D N V KL+DFG+++     ++   +         KG+  +M PE
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSF----KGSPYWMAPE 171

Query: 316 FLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 363
            +A  G     +D++S G  +L + TG+P     + V      G+ K L
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL 220

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 30/211 (14%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIK-MLHPHSLQGPSEF-QQEIDILSKIRHPNLVTLVG 200
            +GEG YG + K   +     VAIK        +   +   +E+ +L ++RH N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPP-----LSWQTRIRIATELCSVLIFLHSC 253
           A        LV+EY+    LE   +     PP       WQ        L   + + HS 
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS- 118

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
             H+I+H D+KP NIL+  + V KL DFG +R L         + L   TD   T  Y  
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR----PASPL---TDYVATRWYRA 169

Query: 314 PEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
           PE L          DV++ G I+  LL G P
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 16/196 (8%)

Query: 143 SLKIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
             +IG G +G ++ G  L   +VAIK +   ++    +F +E  ++ K+ HP LV L G 
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 202 CPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
           C E     LV+E++ +G L D L  +      S +T + +  ++C  + +L S    +++
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLES---SNVI 122

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N V K+SDFG++RF+  ++ +S+  T       K    +  PE  + 
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWSSPEVFSF 175

Query: 320 GELTPKSDVYSFGIIL 335
            + + KSDV+SFG+++
Sbjct: 176 SKYSSKSDVWSFGVLM 191

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 31/214 (14%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLH----PHSLQGPSEFQQEIDILSKIRHPNLVT- 197
            IG G    +Y    L  + +VAIK +       S+    E ++E+  +S+  HPN+V  
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD---ELRKEVQAMSQCNHPNVVKY 64

Query: 198 ----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL---IFL 250
               +VG   E+W LV  YL  GSL D +    +S P        IAT L  VL    +L
Sbjct: 65  YTSFVVGD--ELW-LVMPYLSGGSLLDIMK---SSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS   +  +H D+K  NILL  +   K++DFG+S  L+     +       R    GT  
Sbjct: 119 HS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV----RKTFVGTPC 171

Query: 311 YMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRP 343
           +M PE +        K+D++SFGI  + L TG  
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 73/224 (32%), Positives = 99/224 (44%), Gaps = 41/224 (18%)

Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 202
           IGEG YG +YK   +     VAIK++         E ++E +IL K   HPN+ T  GA 
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 203 ---------PEVWTLVYEYLPNGSLED---RLSCKDNSPPLSWQTRIRIA---TELCSVL 247
                     ++W LV E    GS+ D    L  K       W     IA    E    L
Sbjct: 73  IKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGL 126

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +LH    + ++H D+K  NILL  N   KL DFG+S  L  + +   NT +       G
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFI-------G 175

Query: 308 TFAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPALG 346
           T  +M PE +A  E        +SDV+S GI  + L  G+P L 
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 91.6 bits (227), Expect = 8e-21
 Identities = 78/256 (30%), Positives = 124/256 (48%), Gaps = 25/256 (9%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G ++ G    + +VA+K L P ++  P  F +E  I+ K+RH  LV L     
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 204 E-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
           E    +V EY+  GSL D L   +    L     + +A ++ + + ++      + +H D
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIHRD 127

Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+    V K++DFG++R +  NE ++       R   K    +  PE    G  
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRF 180

Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGI-TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 379
           T KSDV+SFGI+L  L+T GR P  G+  +EV   ++ G       P   D P      L
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----PCPQDCPI----SL 232

Query: 380 ANLAMRCCEMSRKSRP 395
             L ++C +   + RP
Sbjct: 233 HELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.4 bits (227), Expect = 8e-21
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIK---MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
           KIG+G +G +YKG+L+ + +VA+K      P  L+   +F QE +IL +  HPN+V L+G
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIG 59

Query: 201 ACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
            C +   +  V E +P GSL   L  K N   +    ++ +  +  + + +L S    + 
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLES---KNC 114

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   N L+  N V K+SDFG+SR       + ++     +  P     +  PE L 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL---KQIP---IKWTAPEALN 168

Query: 319 SGELTPKSDVYSFGIILLRLLTG 341
            G  T +SDV+S+GI+L    + 
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.5 bits (227), Expect = 8e-21
 Identities = 59/203 (29%), Positives = 107/203 (52%), Gaps = 22/203 (10%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNS--PPLSWQTRIRIATELCSVLIFLHSCKPHS 257
              P  + ++ E++  G+L D L   +      +     + +AT++ S + +L      +
Sbjct: 72  TREPPFY-IITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KN 124

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            +H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE L
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESL 177

Query: 318 ASGELTPKSDVYSFGIILLRLLT 340
           A  + + KSDV++FG++L  + T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 9e-21
 Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
            IG+G +G +YK + +     VAIK++    +     + QQEI  LS+ R P +    G+
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 202 CPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
             +   L  + EY   GS  D L        L       I  E+   L +LH       +
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGK---I 120

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H D+K ANILL      KL+DFG+S  L+   +S  NT +       GT  +M PE +  
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTST-MSKRNTFV-------GTPFWMAPEVIKQ 172

Query: 320 GELTPKSDVYSFGIILLRLLTGRPAL 345
                K+D++S GI  + L  G P L
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPL 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 34/216 (15%)

Query: 145 KIGEGGYGSIYKGL-LRHMQ-VAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVG 200
           +IGEG YG +YK    +  + VA+K +   + +   P    +EI +L K+RHPN+V L  
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK- 64

Query: 201 ACPEVWT--------LVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFL 250
              E+ T        +V+EY+ +  L   L   +   +     Q +     +L   L +L
Sbjct: 65  ---EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES---QIK-CYMKQLLEGLQYL 116

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H D+K +NIL++ + V KL+DFG++R  +    S++ T          T  
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVI------TLW 166

Query: 311 YMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 345
           Y  PE L  +    P+ D++S G IL  L  G+P  
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)

Query: 146 IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           +G+G +G +YK   +   +  A K++   S +   +F  EIDILS+ +HPN+V L  A  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
              ++W L+ E+   G+L D +  +        Q R  +  ++   L FLHS   H ++H
Sbjct: 73  YENKLWILI-EFCDGGAL-DSIMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIH 126

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-- 318
            DLK  NILL  +   KL+DFG+S        + N +TL  R    GT  +M PE +A  
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVS--------AKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 319 ---SGELTPKSDVYSFGIILLRLLTGRP 343
                    K+D++S GI L+ L    P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 31/211 (14%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIK-MLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVG 200
           KIGEG YG +YK    L    VAIK +      +G P    +EI +L ++ HPN++ L+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL- 64

Query: 201 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSC 253
              +V+       LV+E++ +  L   +  KD    L  ++ I+    +L   L F HS 
Sbjct: 65  ---DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLP-ESLIKSYLYQLLQGLAFCHS- 116

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
             H I+H DLKP N+L++   V KL+DFG++R        S        T    T  Y  
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLAR-----SFGSPVRPY---THYVVTRWYRA 166

Query: 314 PE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE  L     +   D++S G I   LL+ RP
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 47/275 (17%)

Query: 146 IGEGGYGSIYKGLLRH-------MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 197
           +G+G +G +Y+GL +         +VAIK ++ + S++   EF  E  ++ +    ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 198 LVGAC----PEVWTLVYEYLPNGSLEDRL-SCK------DNSPPLSWQTRIRIATELCSV 246
           L+G      P +  +V E +  G L+  L S +          P + Q  I++A E+   
Sbjct: 74  LLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           + +L + K    VH DL   N ++  +   K+ DFG++R + + +          R   K
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY--------RKGGK 180

Query: 307 GTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE--VQYALDTGKL 360
           G     +M PE L  G  T KSDV+SFG++L  + T   +P  G++ E  +++ +D G L
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240

Query: 361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                    D P    ++L  L   C + + K RP
Sbjct: 241 ---------DLPENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 90.7 bits (225), Expect = 2e-20
 Identities = 74/269 (27%), Positives = 132/269 (49%), Gaps = 31/269 (11%)

Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G + +G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 200 G----ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           G    + P +  ++ E++ NG+L+  L   D        T I++   L  +   +     
Sbjct: 72  GVVTKSRPVM--IITEFMENGALDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYLSE 124

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
            + VH DL   NIL+++N V K+SDFG+SRFL  +   +++ T       K    +  PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD---TSDPTYTSSLGGKIPIRWTAPE 181

Query: 316 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWP 372
            +A  + T  SDV+S+GI++  +++   RP   ++ ++V  A++    ++   P   D P
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----QDYRLPPPMDCP 237

Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDV 401
                 L  L + C +  R +RP+ G+ V
Sbjct: 238 TA----LHQLMLDCWQKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 29/266 (10%)

Query: 146 IGEGGYGSIYKGLL----RHMQVAIKMLHPHSLQGPSEFQQ--------EIDILSKIRHP 193
           IG+G YG +Y  L       M V    L           Q+        EI+ L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 194 NLVTLVG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V  +G     E  ++  EY+P GS+    SC         Q       ++   L +LH
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIG---SCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           S     I+H DLK  N+L+DA+ + K+SDFGIS+       +  N ++      +G+  +
Sbjct: 126 S---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM------QGSVFW 176

Query: 312 MDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 369
           M PE + S     + K D++S G ++L +  GR      + +      G  ++   P+  
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-APPIPP 235

Query: 370 DWPFVQAEQLANLAMRCCEMSRKSRP 395
           D     +    +    C  ++  +RP
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 94.1 bits (234), Expect = 3e-20
 Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 16/192 (8%)

Query: 163 QVAIKML---HPHSLQGPSEFQQEIDILSKIRHPNLVTLV--GACPEVWTL-VYEYLPNG 216
           +VAIK+L    P      + F++E  + +++ HPN+V L+  G  P      V+EY+P  
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64

Query: 217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV- 275
           +L + L+       L      R+  ++   L   H+     IVH DLKP NI++    V 
Sbjct: 65  TLREVLA---ADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVR 118

Query: 276 --SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 333
             +K+ DFGI   L      ++  TL   T+  GT  Y  PE L    +TP SD+Y++G+
Sbjct: 119 PHAKVLDFGIGTLLPGVR-DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 334 ILLRLLTGRPAL 345
           I L  LTG+  +
Sbjct: 178 IFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 89.9 bits (224), Expect = 4e-20
 Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 36/211 (17%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ------EIDILSKIRHPNL 195
           +G G +G +   L+RH       A+K+L    +    + +Q      E  IL  IRHP L
Sbjct: 9   LGTGSFGRVM--LVRHKGSGKYYALKILSKAKI---VKLKQVEHVLNEKRILQSIRHPFL 63

Query: 196 VTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           V L G+  +   L  V EY+P G L   L  K    P     R   A ++   L +LHS 
Sbjct: 64  VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEP-VARFYAA-QVVLALEYLHSL 120

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCRTDPKGTFAYM 312
               IV+ DLKP N+LLD++   K++DFG ++ +         T TLC      GT  Y+
Sbjct: 121 D---IVYRDLKPENLLLDSDGYIKITDFGFAKRV------KGRTYTLC------GTPEYL 165

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE + S       D ++ GI++  +L G P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 56/299 (18%)

Query: 146 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNL 195
           +GEG +G + K     ++       VA+KML  ++    SE +    E ++L ++ HP++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHV 65

Query: 196 VTLVGACP--EVWTLVYEYLPNGSLE------------------DRLSCKDNSP---PLS 232
           + L GAC       L+ EY   GSL                   +R S   ++P    L+
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
               I  A ++   + +L   K   +VH DL   N+L+      K+SDFG+SR + + + 
Sbjct: 126 MGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED- 181

Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE 350
                +   R+  +    +M  E L     T +SDV+SFG++L  ++T  G P  GI  E
Sbjct: 182 -----SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236

Query: 351 VQYALDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
                   +L NLL      + P   +E++ NL + C +     RP    D+ + LE M
Sbjct: 237 --------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF-ADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 30/194 (15%)

Query: 163 QVAIKMLHP----HSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 216
            VA+K+L P    ++ +   +F +E+ ILS++  PN+  L+G C       ++ EY+ NG
Sbjct: 48  LVAVKVLRPDASDNARE---DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104

Query: 217 SLEDRLS--------CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 268
            L   L            NS  LS+ T + +AT++ S + +L S    + VH DL   N 
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161

Query: 269 LLDANFVSKLSDFGISRFLSQNEIS--SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 326
           L+  N+  K++DFG+SR L  ++         L  R        +M  E +  G+ T KS
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKS 213

Query: 327 DVYSFGIILLRLLT 340
           DV++FG+ L  +LT
Sbjct: 214 DVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 81/297 (27%), Positives = 137/297 (46%), Gaps = 58/297 (19%)

Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 197
           IG+G +G +++    GLL +     VA+KML    S    ++FQ+E  ++++  HPN+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 198 LVGACP--EVWTLVYEYLPNGSLEDRL-------------------SCKDNSPPLSWQTR 236
           L+G C   +   L++EY+  G L + L                    C  N  PLS   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR--FLSQNEISS 294
           + IA ++ + + +L   K    VH DL   N L+  N V K++DFG+SR  + +    +S
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEV 351
            N  +  R        +M PE +     T +SDV+++G++L  + +   +P  G+  +EV
Sbjct: 190 ENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241

Query: 352 QYALDTGKLKNLLD--PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 406
            Y +  G + +  D  PL          +L NL   C       RP     + R+L+
Sbjct: 242 IYYVRDGNVLSCPDNCPL----------ELYNLMRLCWSKLPSDRPSFA-SINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 32/268 (11%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQE--ID---ILSKIRHP 193
           +F+   KIG+G +G ++K ++R     +  +    L   +  ++E  ID   +L+K+   
Sbjct: 1   DFEILNKIGKGSFGVVFK-VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59

Query: 194 NLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP---PLSWQTRIRIATELCSVLI 248
            ++    +  +   L  V EY  NG L   L  +   P      W+  I+I   L     
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---- 115

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            LHS K   I+H D+K  N+ LDA    K+ D G+++ LS N   +N           GT
Sbjct: 116 HLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--------GT 164

Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 368
             Y+ PE         KSDV++ G++L    TG+         Q AL    ++ +  P++
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA--NNQGALILKIIRGVFPPVS 222

Query: 369 GDWPFVQAEQLANLAMRCCEMSRKSRPE 396
               + Q  QLA L  +C     + RP+
Sbjct: 223 Q--MYSQ--QLAQLIDQCLTKDYRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 75/284 (26%), Positives = 131/284 (46%), Gaps = 50/284 (17%)

Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +++G+L+      + VAIK L P ++ +   +F  E  I+ +  H N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     ++ EY+ NG+L+  L   D        +  ++   L  +   +      +
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGE-----FSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA------- 310
            VH DL   NIL+++N   K+SDFG+SR L                DP+GT+        
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLED--------------DPEGTYTTSGGKIP 173

Query: 311 --YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLL 364
             +  PE +A  + T  SDV+SFGI++  +++   RP   ++  EV  A++ G +L    
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---- 229

Query: 365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
            P   D P      +  L ++C +  R  RP    D+  +L+ +
Sbjct: 230 -PAPMDCP----SAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 36/213 (16%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGP----SEFQQEIDILSKIRH---PN 194
           IG G YG++Y+G   H+     VA+K++   +L  P    S+ Q+E+ +LS++R    PN
Sbjct: 9   IGRGAYGAVYRGK--HVPTGRVVALKII---NLDTPDDDVSDIQREVALLSQLRQSQPPN 63

Query: 195 LVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           +    G+    P +W ++ EY   GS+   +     + P++ +    I  E+   L ++H
Sbjct: 64  ITKYYGSYLKGPRLW-IIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 ++H D+K ANIL+      KL DFG++  L+QN  SS  +T        GT  +
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFV------GTPYW 167

Query: 312 MDPEFLASG-ELTPKSDVYSFGIILLRLLTGRP 343
           M PE +  G     K+D++S GI +  + TG P
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 27/257 (10%)

Query: 145 KIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G ++     +H +VA+K + P S+     F  E +++  ++H  LV L     
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 204 -EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E   ++ E++  GSL D L   + +  PL     I  + ++   + F+      + +H 
Sbjct: 72  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHR 126

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+ A+ V K++DFG++R +  NE ++       R   K    +  PE +  G 
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 179

Query: 322 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQ 378
            T KSDV+SFGI+L+ ++T GR P  G++  EV  AL+ G      +           E+
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC--------PEE 231

Query: 379 LANLAMRCCEMSRKSRP 395
           L N+ MRC +   + RP
Sbjct: 232 LYNIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 80/278 (28%), Positives = 122/278 (43%), Gaps = 26/278 (9%)

Query: 137 THNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIR 191
             NF    KIG+G +  +YK   LL    VA+K +    +      Q   +EID+L ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 192 HPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLI 248
           HPN++  + +  E   L  V E    G L   +   K     +  +T  +   +LCS L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            +HS     I+H D+KPAN+ + A  V KL D G+ RF S    ++++          GT
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GT 169

Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 368
             YM PE +       KSD++S G +L  +   +      K   Y+L     K    PL 
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229

Query: 369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 406
            D     +E+L +L  RC     + RP    D+  VL+
Sbjct: 230 AD---HYSEELRDLVSRCINPDPEKRP----DISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|203049 pfam04564, U-box, U-box domain

 Score = 80.8 bits (200), Expect = 5e-19
 Identities = 27/70 (38%), Positives = 38/70 (54%)

Query: 429 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALR 488
           P  F  PI  E+M+DP +   G TY+   ++  L S   T P T  PL H  L+PNL L+
Sbjct: 2   PDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLELK 61

Query: 489 SAIQEWLQQH 498
             I  WL+++
Sbjct: 62  EKIDAWLEEN 71

This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 7e-19
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 146 IGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G+G +G +Y          L   QV      P + +  +  + EI +L  ++H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 199 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
            G     E  ++  EY+P GS++D+L        L+     +   ++   + +LHS   +
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS---N 123

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK----GTFAYM 312
            IVH D+K ANIL D+    KL DFG S+ L          T+C          GT  +M
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ---------TICSSGTGMKSVTGTPYWM 174

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE ++      K+DV+S G  ++ +LT +P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 31/268 (11%)

Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +  G L     R + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 200 GA---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           G       V  +V EY+ NGSL+  L   D        T I++   L  +   +      
Sbjct: 72  GVVTKSKPV-MIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYLSDM 125

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
             VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE 
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTAPEA 180

Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 373
           +A  + T  SDV+S+GI++  +++   RP   ++ ++V  A++ G    L  P+  D P 
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG--YRLPAPM--DCPA 236

Query: 374 VQAEQLANLAMRCCEMSRKSRPELGKDV 401
                L  L + C +  R  RP+  + V
Sbjct: 237 A----LHQLMLDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 22/207 (10%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 201
           +IG G YG +YK         VAIK++           QQEI +L + RHPN+V   G+ 
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69

Query: 202 --CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               ++W +V EY   GSL+D    +    PLS      +  E    L +LH       +
Sbjct: 70  LRRDKLW-IVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHETG---KI 123

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA- 318
           H D+K ANILL  +   KL+DFG+S  L+   I+   + +       GT  +M PE  A 
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFI-------GTPYWMAPEVAAV 175

Query: 319 --SGELTPKSDVYSFGIILLRLLTGRP 343
              G    K D+++ GI  + L   +P
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 21/210 (10%)

Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHPN 194
           IG G +GS+Y G+       +A+K +   S+   S+           +EI +L +++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V  +G+    +   +  EY+P GS+   L+          +  +R   ++   L +LH+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYLHN 124

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
                I+H D+K ANIL+D     K+SDFGIS+ L  N +S+       R   +G+  +M
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG--ARPSLQGSVFWM 179

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            PE +     T K+D++S G +++ +LTG+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 66/299 (22%)

Query: 145 KIGEGGYGSIY----KGLLRHMQ------------VAIKMLHPHSLQGP-SEFQQEIDIL 187
           K+GEG +G ++    +GL   +             VA+KML     +   ++F +EI I+
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 188 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL---------EDRLSCKDNSPPLSWQTR 236
           S++++PN++ L+G C   +   ++ EY+ NG L         E   +  +N P +S    
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS--S 294
           + +A ++ S + +L S    + VH DL   N L+  ++  K++DFG+SR L   +     
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA 354
               L  R        +M  E +  G+ T  SDV++FG+ L  + T      + KE  Y+
Sbjct: 189 GRAVLPIR--------WMAWESILLGKFTTASDVWAFGVTLWEMFT------LCKEQPYS 234

Query: 355 L--DTGKLKNLLDPLAGDWPFVQAEQ------------LANLAMRCCEMSRKSRPELGK 399
           L  D   ++N      G++   Q  Q            +  L MRC     K RP   K
Sbjct: 235 LLSDEQVIEN-----TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 18/200 (9%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  R    VAIKM+   S+    EF +E  ++ K+ H  LV L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 204 EVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +   +  V EY+ NG L + L  +++         + +  ++C  + +L S      +H 
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
           DL   N L+D     K+SDFG+SR++  +E  SS  +    R  P        PE L   
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--------PEVLLYS 176

Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSDV++FG+++  + +
Sbjct: 177 KFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 67/259 (25%), Positives = 119/259 (45%), Gaps = 21/259 (8%)

Query: 146 IGEGGYGSIYKGLLRHMQ-VAIKM--LHPHS-LQGPSEF---QQEIDILSKIRHPNLVTL 198
           +G+G YG++Y GL    Q +A+K   L   + L    E+   Q+E+D+L  ++H N+V  
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C +  T+    E++P GS+   L   +   PL      +   ++   + +LH+   +
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHN---N 121

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH D+K  N++L  N + KL DFG +R L+   +   ++ +       GT  +M PE 
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWMAPEV 179

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 376
           +       KSD++S G  +  + TG+P L     +      G  + L+  L    P   +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL----PDSFS 235

Query: 377 EQLANLAMRCCEMSRKSRP 395
               +    C    +  RP
Sbjct: 236 AAAIDFVTSCLTRDQHERP 254

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 65/231 (28%), Positives = 93/231 (40%), Gaps = 54/231 (23%)

Query: 146 IGEGGYGSIYKGLLRHMQV-----AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
           +G GG+G +    ++          +K  H            E +IL +  HP +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 201 -------------ACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
                         C   E+WT++ +    G  ++            +  R  IA   C 
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD---RGLFDE------------YTARFYIA---CV 102

Query: 246 VLIF--LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCR 302
           VL F  LH+     I++ DLKP N+LLD+N   KL DFG ++ L     S   T T C  
Sbjct: 103 VLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK----SGQKTWTFC-- 153

Query: 303 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 353
               GT  Y+ PE + +       D +S GI+L  LLTGRP  G   E   
Sbjct: 154 ----GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 20/202 (9%)

Query: 146 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF--QQEIDILSKIRHPNLVTLVGA 201
           +G G +G ++  +       V IK +    +        Q E  +L  + HPN++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 202 CPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
             E   L  V EY P G+L + +  + NS  L   T +    +   +L+ LH      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQ---ILLALHHVHTKLIL 123

Query: 260 HGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           H DLK  NILLD +  V K+ DFGIS+ LS    S   T +       GT  Y+ PE   
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSK--SKAYTVV-------GTPCYISPELCE 174

Query: 319 SGELTPKSDVYSFGIILLRLLT 340
                 KSD+++ G +L  L +
Sbjct: 175 GKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 72/206 (34%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 145 KIGEGGYGSIYK-GLLRHMQV-AIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 200
           K+G+G YGS+YK   L   Q  A+K +   S+  +   +   EI IL+ + HPN+++   
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 201 ACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           A  +   L  V EY P G L   +S  K     +  Q   RI  +L   L  LH  K   
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--- 123

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK ANILL AN + K+ D GIS+ L +N      T +       GT  YM PE  
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQI-------GTPHYMAPEVW 173

Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
                + KSD++S G +L  + T  P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAP 199

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 83.4 bits (206), Expect = 9e-18
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 201
           KIG+G  G++Y  +      +VAIK ++            EI ++ + +HPN+V  + + 
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 202 --CPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
               E+W +V EYL  GSL D ++  C D     +      +  E    L FLHS   + 
Sbjct: 86  LVGDELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS---NQ 135

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           ++H D+K  NILL  +   KL+DFG    ++  +  S  +T+       GT  +M PE +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPEVV 187

Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
                 PK D++S GI+ + ++ G P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 21/203 (10%)

Query: 145 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 198
            IGEG +G +Y+G+        + VA+K     +     E F QE  I+ +  HP++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G   E  VW +V E  P G L   L     S  L+  + I  + +L + L +L S +  
Sbjct: 73  IGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLA--SLILYSYQLSTALAYLESKR-- 127

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
             VH D+   N+L+ +    KL DFG+SR+L        +         K    +M PE 
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-------KLPIKWMAPES 179

Query: 317 LASGELTPKSDVYSFGIILLRLL 339
           +     T  SDV+ FG+ +  +L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 35/220 (15%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           ++GEG +G ++     +       M VA+K L   +L    +FQ+E ++L+ ++H ++V 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 198 LVGAC--PEVWTLVYEYLPNGSLE--------DRLSCKDNSP-----PLSWQTRIRIATE 242
             G C   +   +V+EY+ +G L         D +   D  P      L     + IA++
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLC 300
           + S +++L S      VH DL   N L+ AN + K+ DFG+SR +   +      +T L 
Sbjct: 132 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            R        +M PE +   + T +SDV+SFG+IL  + T
Sbjct: 189 IR--------WMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 56/224 (25%), Positives = 105/224 (46%), Gaps = 22/224 (9%)

Query: 146 IGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPS-EFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKG+         + VAIK+L   +    + E   E  +++ + HP++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 199 VGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C      L+ + +P G L D +  +++   +  Q  +    ++   + +L       
Sbjct: 75  LGICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEE---KR 129

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           +VH DL   N+L+      K++DFG+++ L  +E   +          K    +M  E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH------AEGGKVPIKWMALESI 183

Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTG 358
                T KSDV+S+G+ +  L+T   +P  GI   E+   L+ G
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 195
           NF    K+GEG Y ++YKG  R     VA+K +H  + +G PS   +EI ++ +++H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 196 VTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           V L  V        LV+EY+ +  L+  +        L   T      +L   + F   C
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF---C 116

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRF--LSQNEISSNNTTLCCRTDPKGTFAY 311
             + ++H DLKP N+L++     KL+DFG++R   +  N  S+   TL           Y
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW----------Y 166

Query: 312 MDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
             P+  L S   +   D++S G I+  ++TGRP
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 46/284 (16%)

Query: 145 KIGEGGYGSIYKGLL-----RHMQ-VAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVT 197
           ++GE  +G IYKG L      H Q VAIK L   +  Q   EFQQE  +++++ HPN+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 198 LVGACPEVW--TLVYEYLPNGSLEDRL---------SCKDNS-----PPLSWQTRIRIAT 241
           L+G   +     +++EYL  G L + L          C  +        L     + IA 
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 301
           ++ + + +L S   H  VH DL   NIL+      K+SD G+SR     EI S +     
Sbjct: 132 QIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSR-----EIYSADYY--- 180

Query: 302 RTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALDT 357
           R  PK      +M PE +  G+ +  SD++SFG++L  + +   +P  G +   Q  ++ 
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM 238

Query: 358 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 401
            + + LL P + D P     ++ +L   C +     RP   KD+
Sbjct: 239 VRKRQLL-PCSEDCP----PRMYSLMTECWQEGPSRRPRF-KDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 35/226 (15%)

Query: 146 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 199
           IGEG +G + + +++     M  AIKML   + +    +F  E+++L K+  HPN++ L+
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 200 GACPEVWTL--VYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELC 244
           GAC     L    EY P G+L D L                  +  L+ Q  ++ A+++ 
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
           + + +L        +H DL   N+L+  N  SK++DFG+SR                +T 
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---------GEEVYVKKTM 177

Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 348
            +    +M  E L     T KSDV+SFG++L  +  L G P  G+T
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 36/217 (16%)

Query: 145 KIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSE---FQ--QEIDILSKIRHPNLVT 197
           K+GEG Y  +YK   +     VAIK +     +   +   F   +EI +L +++HPN++ 
Sbjct: 7   KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66

Query: 198 LVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFL 250
           L+    +V+       LV+E++    LE  +  KD S  L+    I+         L +L
Sbjct: 67  LL----DVFGHKSNINLVFEFME-TDLEKVI--KDKSIVLT-PADIKSYMLMTLRGLEYL 118

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDPKGTF 309
           HS   + I+H DLKP N+L+ ++ V KL+DFG++R F S N   ++            T 
Sbjct: 119 HS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV---------TR 166

Query: 310 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 345
            Y  PE    +       D++S G I   LL   P L
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 22/194 (11%)

Query: 146 IGEGGYGSIYKGLLRHMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 204
           IG+G +G +  G  R  +VA+K + +  + Q    F  E  +++++RH NLV L+G   E
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 205 ---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
                 +V EY+  GSL D L  +  S  L     ++ + ++C  + +L +   ++ VH 
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEA---NNFVHR 126

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N+L+  + V+K+SDFG+++     E SS   T       K    +  PE L   +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT------GKLPVKWTAPEALREKK 175

Query: 322 LTPKSDVYSFGIIL 335
            + KSDV+SFGI+L
Sbjct: 176 FSTKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 22/267 (8%)

Query: 139 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 193
           NF    KIG G +  +Y+   LL  + VA+K +    L          +EID+L ++ HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFL 250
           N++    +  E     +V E    G L   +   K     +  +T  +   +LCS L  +
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     ++H D+KPAN+ + A  V KL D G+ RF S    ++++          GT  
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GTPY 171

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 370
           YM PE +       KSD++S G +L  +   +      K   Y+L     +    PL  D
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231

Query: 371 WPFVQAEQLANLAMRCCEMSRKSRPEL 397
                +E+L  L   C     + RP++
Sbjct: 232 H---YSEELRQLVNMCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 42/227 (18%)

Query: 145 KIGEGGYGSIY----KGLLRHMQ--------------VAIKMLHPHSLQGP-SEFQQEID 185
           K+GEG +G ++    +G+ + M               VA+KML   + +   ++F +EI 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 186 ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS--------CKDNSPPLSWQT 235
           I+S+++ PN++ L+  C     L  + EY+ NG L   LS         K +   +S+ T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 236 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS-- 293
            I +AT++ S + +L S    + VH DL   N L+  N+  K++DFG+SR L   +    
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
                L  R        +M  E +  G+ T  SDV++FG+ L  +LT
Sbjct: 189 QGRAVLPIR--------WMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.9 bits (199), Expect = 6e-17
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 201
           +IG+G +G +YKG+    +  VAIK++     +   E  QQEI +LS+   P +    G+
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 202 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                ++W ++ EYL  GS  D L       PL       I  E+   L +LHS +    
Sbjct: 71  YLKGTKLW-IIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K AN+LL      KL+DFG++  L+  +I  N           GT  +M PE + 
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 174

Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
                 K+D++S GI  + L  G P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.5 bits (198), Expect = 6e-17
 Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 18/220 (8%)

Query: 145 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--VGA 201
           K+G G +G ++ G   +  +VA+K L P ++   + F +E +++  ++H  LV L  V  
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71

Query: 202 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
             E   ++ EY+  GSL D L   D    +     I  + ++   + ++      + +H 
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ AN+L+  + + K++DFG++R +  NE ++       R   K    +  PE +  G 
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 180

Query: 322 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
            T KSDV+SFGI+L  ++T G+ P  G++  +V  AL  G
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 80.3 bits (198), Expect = 6e-17
 Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 46/270 (17%)

Query: 145 KIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTL 198
           KIGEG +G     L++      Q  IK ++   +      E ++E+ +LS ++HPN+V  
Sbjct: 7   KIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP-----PLSWQTRIRIATELCSVLIFLH 251
             +  E   L  V +Y   G L  +++ +          L W        ++C  L  +H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVH 118

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             K   I+H D+K  NI L  +   KL DFGI+R L       N+T    RT   GT  Y
Sbjct: 119 DRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL-------NSTVELART-CIGTPYY 167

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL-LDPLAGD 370
           + PE   +     KSD+++ G +L  + T          +++A + G +KNL L  + G 
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT----------LKHAFEAGNMKNLVLKIIRGS 217

Query: 371 WPFVQAE---QLANLAMRCCEMSRKSRPEL 397
           +P V +     L NL  +  + + + RP +
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSV 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 80.3 bits (198), Expect = 6e-17
 Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 30/237 (12%)

Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 189
           E E         + +G+G YG +Y    L   +++AIK +     +      +EI + S 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 190 IRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATE 242
           ++H N+V  +G+  E   + +  E +P GSL   L  K     DN   + + T+     +
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----Q 116

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQ-NEISSNNTTLC 300
           +   L +LH  +   IVH D+K  N+L++  + V K+SDFG S+ L+  N  +   T   
Sbjct: 117 ILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--- 170

Query: 301 CRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 355
                 GT  YM PE +  G       +D++S G  ++ + TG+P      E Q A+
Sbjct: 171 ------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.1 bits (197), Expect = 9e-17
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 201
           KIG+G +G ++KG+    Q  VAIK++     +   E  QQEI +LS+   P +    G+
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                ++W ++ EYL  GS  D L       PL       I  E+   L +LHS K    
Sbjct: 71  YLKDTKLW-IIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKK--- 122

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K AN+LL  +   KL+DFG++  L+  +I  N           GT  +M PE + 
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 174

Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
                 K+D++S GI  + L  G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 84/248 (33%), Positives = 116/248 (46%), Gaps = 44/248 (17%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIR---HPNLV 196
           IGEG YG++YK   R +     VA+K +  P S +G P    +EI +L ++    HPN+V
Sbjct: 7   IGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 197 TLVGAC--PEVW-----TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 249
            L+  C  P        TLV+E++ +  L   LS K   P L  +T   +  +L   + F
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLS-KCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS   H IVH DLKP NIL+ ++   K++DFG++R      I S    L   T    T 
Sbjct: 123 LHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMAL---TSVVVTL 170

Query: 310 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD--- 365
            Y  PE  L S   TP  D++S G I   L   RP    T E        +L  + D   
Sbjct: 171 WYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEAD------QLDKIFDVIG 223

Query: 366 -PLAGDWP 372
            P   +WP
Sbjct: 224 LPSEEEWP 231

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 37/218 (16%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
             D  +KIGEG  G +     +    QVA+K +     Q       E+ I+   +HPN+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 197 T-----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVL- 247
                 LVG   E+W +V E+L  G+L D ++           TR+   +IAT   +VL 
Sbjct: 80  EMYSSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIATVCLAVLK 126

Query: 248 --IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
              FLH+     ++H D+K  +ILL ++   KLSDFG   F +Q  +S     +  R   
Sbjct: 127 ALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQ--VSKE---VPRRKSL 175

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            GT  +M PE ++      + D++S GI+++ ++ G P
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ------QEIDILSKIRHPN 194
            +GEG YG + K   +H +    VAIK      L+   +        +EI +L ++RH N
Sbjct: 8   LVGEGSYGMVMK--CKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           LV L+      +   LV+E++ +  L+D L    N   L      +   ++   + F HS
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNG--LDESRVRKYLFQILRGIEFCHS 118

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL-SQNEISSNNTTLCCRTDPKGTFAY 311
              H+I+H D+KP NIL+  + V KL DFG +R L +  E+          TD   T  Y
Sbjct: 119 ---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---------TDYVATRWY 166

Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 343
             PE L       ++ D+++ G ++  +LTG P
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)

Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG+G +G +Y G L     + +  A+K L+    L+   +F +E  I+    HPN+++L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 63  GICLPSEGSPLV---VLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK 117

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD +F  K++DFG++R +   E  S +      T  K    +M 
Sbjct: 118 K---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN----HTGAKLPVKWMA 170

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT 340
            E L + + T KSDV+SFG++L  L+T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 26/203 (12%)

Query: 147 GEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVTLVGAC 202
           G GG  S  K +     +A K++H   +   S  ++    E+ I+ + R P +V+  GA 
Sbjct: 16  GNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                +  +  E++  GSL DR+  K    P+  +   +IA  +   L +L++   H I+
Sbjct: 73  LNENNI-CMCMEFMDCGSL-DRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV--HRIM 126

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H D+KP+NIL+++    KL DFG+S  L    I+S   T        GT  YM PE +  
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGEL----INSIADTFV------GTSTYMSPERIQG 176

Query: 320 GELTPKSDVYSFGIILLRLLTGR 342
           G+ T KSDV+S GI ++ L  G+
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 35/226 (15%)

Query: 146 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 199
           IGEG +G + K  ++     M  AIK +  ++ +    +F  E+++L K+  HPN++ L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 200 GACPEVWTL--VYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELC 244
           GAC     L    EY P+G+L D L                  +  LS Q  +  A ++ 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
             + +L        +H DL   NIL+  N+V+K++DFG+SR                +T 
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 170

Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 348
            +    +M  E L     T  SDV+S+G++L  +  L G P  G+T
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 18/208 (8%)

Query: 139 NFDPSLKIGEGGYGS--IYKGLLRHMQVAIKMLHPHSLQGPSEF--QQEIDILSKIRHPN 194
           ++ P   +G+G +G   +Y+       V  K ++   L          EI ILS ++HPN
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60

Query: 195 LVTLVGACPEVWTLV--YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           ++       +  TL+   EY   G+L D++  +        +  +    ++ S + ++H 
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHK 119

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
                I+H D+K  NI L    + KL DFGIS+ L  +E S   T +       GT  YM
Sbjct: 120 ---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVV-------GTPYYM 168

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLT 340
            PE     +   KSD+++ G +L  LLT
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 71/260 (27%), Positives = 123/260 (47%), Gaps = 47/260 (18%)

Query: 111 SRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV----AI 166
           S   +SSS+      +  S SE+E          +IG G  G++YK  + H       A+
Sbjct: 54  SSSSSSSSASGSAPSAAKSLSELERVN-------RIGSGAGGTVYK--VIHRPTGRLYAL 104

Query: 167 KMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVW------TLVYEYLPNGSLE 219
           K+++  H      +  +EI+IL  + HPN+V     C +++       ++ E++  GSLE
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLE 160

Query: 220 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
                 +    L+      +A ++ S + +LH      IVH D+KP+N+L+++    K++
Sbjct: 161 GTHIADE--QFLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIA 210

Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF----LASGELTPKS-DVYSFGII 334
           DFG+SR L+Q     N++         GT AYM PE     L  G     + D++S G+ 
Sbjct: 211 DFGVSRILAQTMDPCNSSV--------GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262

Query: 335 LLRLLTGRPALGITKEVQYA 354
           +L    GR   G+ ++  +A
Sbjct: 263 ILEFYLGRFPFGVGRQGDWA 282

Length = 353

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 42/279 (15%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGP-SEFQQEIDILSKI 190
           N      +G G +G ++    + ++       V +K L     +   SEF++E+D+  K+
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 191 RHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRL------SCKDNSPPLSWQTRIRIATE 242
            H N+V L+G C E     ++ EY   G L+  L        K   PPLS + ++ + T+
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCC 301
           +   +  L +      VH DL   N L+ +    K+S   +S+   +       N  +  
Sbjct: 126 IALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTG 358
           R        ++ PE +   + + KSDV+SFG+++  + T    P  G++ +EV   L  G
Sbjct: 183 R--------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234

Query: 359 KLKNLLDPLAGDWPFVQA--EQLANLAMRCCEMSRKSRP 395
           KL+          P  +    +L  L  RC  ++ K RP
Sbjct: 235 KLE---------LPVPEGCPSRLYKLMTRCWAVNPKDRP 264

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 34/219 (15%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           ++GEG +G ++     +       M VA+K L   S     +FQ+E ++L+ ++H ++V 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 198 LVGACPE--VWTLVYEYLPNGSLEDRLSC-----------KDNSP-PLSWQTRIRIATEL 243
             G C E     +V+EY+ +G L   L             +D +P  L+    + IA+++
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCC 301
            S +++L S      VH DL   N L+    V K+ DFG+SR +   +       T L  
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           R        +M PE +   + T +SD++SFG++L  + T
Sbjct: 189 R--------WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 70/260 (26%), Positives = 124/260 (47%), Gaps = 31/260 (11%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-P 203
            IGEG +G++ +G     +VA+K +          F +E  +++K+ H NLV L+G    
Sbjct: 13  IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 204 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 263
               +V E +  G+L + L  +  +  +S    ++ + ++   + +L S K   +VH DL
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126

Query: 264 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 323
              NIL+  + V+K+SDFG++R      +  +N+ L  +        +  PE L   + +
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVK--------WTAPEALKHKKFS 175

Query: 324 PKSDVYSFGIILLRLLT-GR---PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 379
            KSDV+S+G++L  + + GR   P + + KEV+  ++ G     ++P  G    V     
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECVEKGY---RMEPPEGCPADVYV--- 228

Query: 380 ANLAMRCCEMSRKSRPELGK 399
             L   C E   K RP   K
Sbjct: 229 --LMTSCWETEPKKRPSFHK 246

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 146 IGEGGYGSIYKGLLRH--------MQVAIKMLHPHSLQGPS-EFQQEIDILSKIRHPNLV 196
           +GEG +G +   L R+         QVA+K L P S      + ++EI+IL  + H N+V
Sbjct: 12  LGEGHFGKVE--LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 197 TLVGACPEVW----TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
              G C E       L+ E+LP+GSL++ L    N   ++ + +++ A ++C  + +L S
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP--RNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
                 VH DL   N+L+++    K+ DFG+++      I ++      + D      + 
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTVKDDLDSPVFWY 179

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLT 340
            PE L   +    SDV+SFG+ L  LLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 20/205 (9%)

Query: 146 IGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V   
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 200 GACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           G C         LV EYLP GSL D L    +   L  +  +  A+++C  + +L S + 
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLGSKR- 128

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
              VH DL   NIL+++    K+ DFG+++ L Q++          R   +    +  PE
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-----EYYKVREPGESPIFWYAPE 181

Query: 316 FLASGELTPKSDVYSFGIILLRLLT 340
            L   + +  SDV+SFG++L  L T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 19/164 (11%)

Query: 182 QEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI 239
            E  IL ++ HP LV L  +    E   LV + L  G L   LS K      S + +++ 
Sbjct: 49  NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFS-EEQVKF 104

Query: 240 -ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
              E+   L +LHS     I+H D+KP NILLD      ++DF I+  ++ +      T+
Sbjct: 105 WICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTS 158

Query: 299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
                   GT  YM PE L     +   D +S G+     L G+
Sbjct: 159 TS------GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 23/224 (10%)

Query: 179 EFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
             ++EI +++++ HP+++ ++GA  E   + L  E++  GS+   LS             
Sbjct: 49  ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS---KYGAFKEAVI 105

Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSN 295
           I    +L   L +LH    + I+H D+K AN+L+D+     +++DFG +  L        
Sbjct: 106 INYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL-------- 154

Query: 296 NTTLCCRTDPKG----TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV 351
                   + +G    T A+M PE L   +     DV+S G +++ + T +P     K  
Sbjct: 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214

Query: 352 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
            +     K+ +         P   +  L ++ +RC E+  + RP
Sbjct: 215 NHLALIFKIASATTA--PSIPEHLSPGLRDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 42/274 (15%)

Query: 146 IGEGGYGSIYKGLLRHM--------QVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLV 196
           +G G +G +Y+G    +        +VA+K L   +  Q   EF +E  ++S   HPN+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 197 TLVGAC--PEVWTLVYEYLPNGSL----EDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            L+G C   E   ++ E +  G L     D    +   P L+ +  + I  ++    ++L
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 251 HSCKPHSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
              + H  +H DL   N L+     DA+ V K+ DFG++R + +++            + 
Sbjct: 123 E--QMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK------EGEG 173

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GR---PALGITKEVQYALDTGKLK 361
                +M PE L  G+ T +SDV+SFG+++  +LT G+   PAL   + +Q+    G+L+
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233

Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                     P    +++  L   C       RP
Sbjct: 234 K---------PENCPDKIYQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 29/214 (13%)

Query: 139 NFDPSLKIGEGGYGSIY--KGLLRHMQVAIKM--LHPHSLQGPSEFQQEIDILSKIRHPN 194
            ++   KIGEG +G IY  K         IK   L    ++     ++E+ +L+K++HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATELCSVL 247
           +VT   +  E   L  V EY   G L  R++ +          LSW  +I +       L
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLG------L 114

Query: 248 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
             +H  K   I+H D+K  NI L  N  V+KL DFGI+R L       N++     T   
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-------NDSMELAYT-CV 163

Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           GT  Y+ PE   +     K+D++S G +L  L T
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G  R  ++VAIK ++  ++    +F +E  ++ K+ HP LV L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 204 EVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +   L  V E++ NG L + L  +     LS    + +  ++C  + +L     +S +H 
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHR 124

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N L+ +  V K+SDFG++R++  +E +S+       +  K    +  PE     +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-------SGAKFPVKWSPPEVFNFSK 177

Query: 322 LTPKSDVYSFGIILLRLLT 340
            + KSDV+SFG+++  + T
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 78.4 bits (193), Expect = 5e-16
 Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 54/236 (22%)

Query: 145 KIGEGGYGSIY--------------------KGLLRHMQVAIKMLHPHSLQGP-SEFQQE 183
           K+GEG +G ++                    KG  R + VA+K+L P + +   ++F +E
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG--RPLLVAVKILRPDANKNARNDFLKE 69

Query: 184 IDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK----------DNSPP- 230
           + ILS+++ PN++ L+G C   +   ++ EY+ NG L   LS            D  PP 
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 231 -----LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 285
                +S+ + + +A ++ S + +L S    + VH DL   N L+  N   K++DFG+SR
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 286 FLSQNEIS--SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
            L   +         L  R        +M  E +  G+ T  SDV++FG+ L  +L
Sbjct: 187 NLYAGDYYRIQGRAVLPIR--------WMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 26/212 (12%)

Query: 140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPN 194
           F    ++G+GGYG ++    +     VA+K +    L   +E +    E DIL+  +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSW-QTRIRIATELCSVLIFLH 251
           LV L+ A    E   L  EY+P G     L+   N   LS    R  +A    +V     
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAV----D 115

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           +      +H DLKP N L+DA+   KL+DFG    LS+  ++  N+ +       G+  Y
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFG----LSKGIVTYANSVV-------GSPDY 164

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           M PE L         D +S G +L   L G P
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 25/208 (12%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLV 199
           ++GEG  GS+ K  L++  M  A+K +       P   +Q   E++I    + P +V   
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 200 GACPEVWT----LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           GA  +  +    +  EY   GSL+      K     +  +   +IA  +   L +LHS K
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              I+H D+KP+NILL      KL DFG+S  L    ++S   T        GT  YM P
Sbjct: 126 ---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL----VNSLAGTFT------GTSFYMAP 172

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGR 342
           E +     +  SDV+S G+ LL +   R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 77.8 bits (191), Expect = 7e-16
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 32/224 (14%)

Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQGPSEFQQEIDILSKI 190
           HN     ++GEG +G ++     ++        VA+K L   S     +F +E ++L+ +
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 191 RHPNLVTLVGACPE--VWTLVYEYLPNGSLE--------DRLSCKDNSPP--LSWQTRIR 238
           +H ++V   G C E     +V+EY+ +G L         D +   + + P  L+    + 
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNN 296
           IA ++ + +++L S      VH DL   N L+  N + K+ DFG+SR +   +      +
Sbjct: 125 IAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           T L  R        +M PE +   + T +SDV+S G++L  + T
Sbjct: 182 TMLPIR--------WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 69/229 (30%), Positives = 118/229 (51%), Gaps = 30/229 (13%)

Query: 146 IGEGGYGSIYKGL------LRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 196
           +G G +G++YKG+         + VAIK+L+  +  GP    EF  E  I++ + HP+LV
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLV 72

Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
            L+G C  P +  LV + +P+G L D +   KDN   +  Q  +    ++   +++L   
Sbjct: 73  RLLGVCLSPTI-QLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE- 127

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               +VH DL   N+L+ +    K++DFG++R L  +E   N          K    +M 
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN------ADGGKMPIKWMA 179

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
            E +   + T +SDV+S+G+ +  L+T  G+P  GI T+E+   L+ G+
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 228

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 201
           +IG+G +G ++KG+    Q  VAIK++     +   E  QQEI +LS+   P +    G+
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKP 255
                ++W ++ EYL  GS  D L     + P       +IAT   E+   L +LHS K 
Sbjct: 71  YLKGTKLW-IIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYLHSEKK 122

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
              +H D+K AN+LL      KL+DFG++  L+  +I  N           GT  +M PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPE 171

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +       K+D++S GI  + L  G P
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 40/220 (18%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPH---SLQGPSEFQQEIDILSKIR 191
           + +    +G G +G ++  L+R        A+K++       L+       E  +L ++ 
Sbjct: 2   DLERIKTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59

Query: 192 HPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           HP ++ L       WT        ++ EY+P G L   L    NS   S  T +  A+E+
Sbjct: 60  HPFIIRLF------WTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEI 110

Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
              L +LHS     IV+ DLKP NILLD     KL+DFG ++     ++     TLC   
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLC--- 159

Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
              GT  Y+ PE + S       D ++ GI++  +L G P
Sbjct: 160 ---GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 47/242 (19%)

Query: 146 IGEGGYGSIYKGLLR-------HMQVAIKML----HPHSLQGPSEFQQEIDILSKI-RHP 193
           +GEG +G + K              VA+KML        L   S+   E++++  I +H 
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL---SDLVSEMEMMKMIGKHK 76

Query: 194 NLVTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPP---------------LSWQT 235
           N++ L+G C +   ++ +V EY  +G+L D L  +   PP               L+ + 
Sbjct: 77  NIINLLGVCTQEGPLYVVV-EYAAHGNLRDFL--RARRPPGEYASPDDPRPPEETLTQKD 133

Query: 236 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
            +  A ++   + FL S K    +H DL   N+L+  + V K++DFG++R +   +    
Sbjct: 134 LVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQY 353
                  T+ +    +M PE L     T +SDV+SFG++L  + T  G P  GI  E  +
Sbjct: 191 ------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244

Query: 354 AL 355
            L
Sbjct: 245 KL 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 43/274 (15%)

Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G  R +       +VA+K ++   SL+   EF  E  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 197 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 247
            L+G     +   +V E + +G L+  L             PP + Q  I++A E+   +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH DL   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------RKGGKG 181

Query: 308 TF--AYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SD++SFG++L  +  L  +P  G++ E  +++ +D G L 
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 240

Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   D P    E++ +L   C + + K RP
Sbjct: 241 --------DQPDNCPERVTDLMRMCWQFNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL-- 198
           KIGEG YG +YKG  +     VA+K +   S +   PS   +EI +L +++HPN+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 199 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           V        L++E+L +  L+  L   D+ P   +     + + L  +L  +  C    +
Sbjct: 67  VLMQESRLYLIFEFL-SMDLKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FL 317
           +H DLKP N+L+D   V KL+DFG++R        +    +   T    T  Y  PE  L
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLAR--------AFGIPVRVYTHEVVTLWYRAPEVLL 174

Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
            S   +   D++S G I   + T +P
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 19/208 (9%)

Query: 139 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 193
           NF    KIG G +  +Y+   LL    VA+K +    +      Q   +EID+L ++ HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFL 250
           N++  + +  E     +V E    G L   +   K     +  +T  +   +LCS +  +
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     ++H D+KPAN+ + A  V KL D G+ RF S    ++++          GT  
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GTPY 171

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRL 338
           YM PE +       KSD++S G +L  +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 44/216 (20%)

Query: 146 IGEGGYGSIYKGLLRH-------MQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+GL R        +QVA+K L    S Q  S+F  E  I+SK  H N+V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 198 LVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSP------PLSWQTRIRIATELCSVLIF 249
           L+G   E     ++ E +  G L+  L  ++N P       L+ +  +  A     V   
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERPSSLTMKDLLFCA---RDVAKG 128

Query: 250 LHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD-- 304
               + +  +H D+   N LL       V+K++DFG++R     +I         R    
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIY--------RASYY 175

Query: 305 PKGTFA-----YMDPEFLASGELTPKSDVYSFGIIL 335
            KG  A     +M PE    G  T K+DV+SFG++L
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 35/226 (15%)

Query: 146 IGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 199
           IGEG +G + K  ++     M  AIK +  ++ +    +F  E+++L K+  HPN++ L+
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 200 GACPE--VWTLVYEYLPNGSLEDRLS-------------CKDNSPPLSWQTRIRIATELC 244
           GAC       L  EY P+G+L D L                  +  LS Q  +  A ++ 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
             + +L        +H DL   NIL+  N+V+K++DFG+SR                +T 
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 182

Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 348
            +    +M  E L     T  SDV+S+G++L  +  L G P  G+T
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 29/208 (13%)

Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 197
           KIG+G  G++Y  +      +VAIK ++            EI ++ + ++PN+V      
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 198 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           LVG   E+W +V EYL  GSL D ++  C D     +      +  E    L FLHS   
Sbjct: 86  LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALDFLHS--- 133

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           + ++H D+K  NILL  +   KL+DFG    ++  +  S  +T+       GT  +M PE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPE 185

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +      PK D++S GI+ + ++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 17/182 (9%)

Query: 164 VAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEYLPNGSL 218
           VA+K L      Q  S +++EI+IL  + H N+V   G C E       L+ EY+P GSL
Sbjct: 36  VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95

Query: 219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 278
            D L  K     L+    +  A ++C  + +LHS      +H DL   N+LLD + + K+
Sbjct: 96  RDYLP-KHK---LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKI 148

Query: 279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL 338
            DFG+++ + +            R D      +   E L   + +  SDV+SFG+ L  L
Sbjct: 149 GDFGLAKAVPEGHEYYR-----VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203

Query: 339 LT 340
           LT
Sbjct: 204 LT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 20/196 (10%)

Query: 146 IGEGGYGSIYKGLLR-HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G+G +G ++KG L+    VA+K      P  L+   +F  E  IL +  HPN+V L+G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKLIGV 60

Query: 202 CPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
           C +     +V E +P G     L  K +   L  +  ++ A +  + + +L S    + +
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLES---KNCI 115

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N V K+SDFG+SR       SS+          +    +  PE L  
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK-------QIPIKWTAPEALNY 168

Query: 320 GELTPKSDVYSFGIIL 335
           G  + +SDV+S+GI+L
Sbjct: 169 GRYSSESDVWSYGILL 184

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 39/221 (17%)

Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVG 200
           +G G YG +YKG  RH++     AIK++   +     E + EI++L K   H N+ T  G
Sbjct: 24  VGNGTYGQVYKG--RHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 201 A----CP-----EVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFL 250
           A     P     ++W LV E+   GS+ D + + K N+    W   I    E+   L  L
Sbjct: 81  AFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAHL 137

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           H+   H ++H D+K  N+LL  N   KL DFG+S  L +  +   NT +       GT  
Sbjct: 138 HA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFI-------GTPY 186

Query: 311 YMDPEFLASGELTP------KSDVYSFGIILLRLLTGRPAL 345
           +M PE +A  E  P      +SD++S GI  + +  G P L
Sbjct: 187 WMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 20/205 (9%)

Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           K+GEG Y +++KG   L    VA+K +   H    P    +E+ +L  ++H N+VTL  +
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                  TLV+EYL +  L+  L   DN   L     ++I   +  +L  L  C    I+
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIF--MFQLLRGLSYCHKRKIL 125

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 318
           H DLKP N+L++     KL+DFG++R  S    + +N  +        T  Y  P+  L 
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--------TLWYRPPDVLLG 177

Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
           S E +   D++  G IL  + TGRP
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 69/231 (29%), Positives = 98/231 (42%), Gaps = 71/231 (30%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIK---------MLHPHSLQGPSEFQQEIDILSKIR 191
           KIGEG YG ++K   R+ +    VAIK         ++   +L+       EI +L +++
Sbjct: 8   KIGEGSYGVVFK--CRNRETGQIVAIKKFVESEDDPVIKKIALR-------EIRMLKQLK 58

Query: 192 HPNLVTLVGACPEVWT------LVYEYL-----------PNGSLEDRLSCKDNSPPLSWQ 234
           HPNLV L+    EV+       LV+EY            P G        K     + WQ
Sbjct: 59  HPNLVNLI----EVFRRKRKLHLVFEYCDHTVLNELEKNPRGV--PEHLIKK----IIWQ 108

Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
           T           L  ++ C  H+ +H D+KP NIL+      KL DFG +R L+      
Sbjct: 109 T-----------LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156

Query: 295 NNTTLCCRTDPKGTFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGRP 343
                   TD   T  Y  PE L  G+    P  DV++ G +   LLTG+P
Sbjct: 157 -------YTDYVATRWYRAPELLV-GDTQYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKM--LHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 198
           KIGEG YG +YK   R     +A+K   L       PS   +EI +L +++H N+V L  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 199 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           V    +   LV+EYL +  L+  +   D+SP  +   R+ I T L  +L  +  C  H +
Sbjct: 69  VVHSEKRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRL-IKTYLYQILRGIAYCHSHRV 123

Query: 259 VHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-F 316
           +H DLKP N+L+D      KL+DFG++R             +   T    T  Y  PE  
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFG--------IPVRTFTHEVVTLWYRAPEIL 175

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
           L S   +   D++S G I   ++  +P
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKP 202

Length = 294

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 47/225 (20%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKM-LHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 198
           KIG+G +G ++K   RH +    VA+K  L  +  +G P    +EI IL  ++H N+V L
Sbjct: 19  KIGQGTFGEVFKA--RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 76

Query: 199 VGACPEVWT----------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--------RIA 240
           +  C    T          LV+E+           C+ +   L     +        ++ 
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEF-----------CEHDLAGLLSNKNVKFTLSEIKKVM 125

Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
             L + L ++H  K   I+H D+K ANIL+  + + KL+DFG++R  S ++ S  N    
Sbjct: 126 KMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN---- 178

Query: 301 CRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRP 343
             T+   T  Y  PE L  GE    P  D++  G I+  + T  P
Sbjct: 179 RYTNRVVTLWYRPPELLL-GERDYGPPIDMWGAGCIMAEMWTRSP 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 33/265 (12%)

Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL +    M+VA+KML P +     E    E+ I+S +  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 197 TLVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
            L+GAC    P +  ++ EY   G L + L  K  S  L+ +  +  + ++   + FL S
Sbjct: 103 NLLGACTIGGPIL--VITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFLAS 159

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL--SQNEISSNNTTLCCRTDPKGTFA 310
               + +H DL   N+LL    + K+ DFG++R +    N +   N  L  +        
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-------- 208

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 370
           +M PE + +   T +SDV+S+GI+L  + +    LG        +D+   K + +     
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPGMPVDSKFYKLIKEGYRMA 264

Query: 371 WPFVQAEQLANLAMRCCEMSRKSRP 395
            P     ++ ++   C +     RP
Sbjct: 265 QPEHAPAEIYDIMKTCWDADPLKRP 289

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 13/91 (14%)

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           H ++H D+KP+NILLDA+   KL DFGIS  L  ++          +T   G  AYM PE
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---------AKTRSAGCAAYMAPE 184

Query: 316 FLASGELTPK----SDVYSFGIILLRLLTGR 342
            +   +  PK    +DV+S GI L+ L TG+
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.0 bits (181), Expect = 1e-14
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)

Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 197
           KIG+G  G++Y  +      +VAI+ ++            EI ++ + ++PN+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 198 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           LVG   E+W +V EYL  GSL D ++  C D     +      +  E    L FLHS   
Sbjct: 87  LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 134

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           + ++H D+K  NILL  +   KL+DFG   F +Q  I+   +    R+   GT  +M PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQ--ITPEQSK---RSTMVGTPYWMAPE 186

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +      PK D++S GI+ + ++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 30/211 (14%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNLVTL 198
           KIGEG YG +YK   R       VA+K +      +G PS   +EI +L ++ HPN+V L
Sbjct: 6   KIGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63

Query: 199 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSCK 254
             V        LV+E+L +  L+  +   D+SP       +      +L   + + HS  
Sbjct: 64  LDVVHSENKLYLVFEFL-DLDLKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYCHS-- 117

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
            H ++H DLKP N+L+D     KL+DFG++R        +    +   T    T  Y  P
Sbjct: 118 -HRVLHRDLKPQNLLIDREGALKLADFGLAR--------AFGVPVRTYTHEVVTLWYRAP 168

Query: 315 EFLASGEL--TPKSDVYSFGIILLRLLTGRP 343
           E L       TP  D++S G I   ++  RP
Sbjct: 169 EILLGSRQYSTP-VDIWSIGCIFAEMVNRRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 39/218 (17%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR-HPNLVTL 198
           K+G+G YG ++K + R     VA+K +   + +  ++ Q+   EI  L ++  HPN+V L
Sbjct: 14  KLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQELGDHPNIVKL 72

Query: 199 VGACPEV----WTLVYEYLPN--------GSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           +            LV+EY+            LED               +  I  +L   
Sbjct: 73  LNVIKAENDKDIYLVFEYMETDLHAVIRANILED-------------VHKRYIMYQLLKA 119

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L ++HS    +++H DLKP+NILL+++   KL+DFG++R LS+ E +  N  L   TD  
Sbjct: 120 LKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL---TDYV 173

Query: 307 GTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
            T  Y  PE L  S   T   D++S G IL  +L G+P
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 72/221 (32%), Positives = 105/221 (47%), Gaps = 39/221 (17%)

Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVG 200
           +G G YG +YKG  RH++     AIK++     +   E +QEI++L K   H N+ T  G
Sbjct: 14  VGNGTYGQVYKG--RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 70

Query: 201 AC---------PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFL 250
           A           ++W LV E+   GS+ D + + K N+    W   I    E+   L  L
Sbjct: 71  AFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSHL 127

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           H    H ++H D+K  N+LL  N   KL DFG+S  L +  +   NT +       GT  
Sbjct: 128 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFI-------GTPY 176

Query: 311 YMDPEFLASGELTP------KSDVYSFGIILLRLLTGRPAL 345
           +M PE +A  E  P      KSD++S GI  + +  G P L
Sbjct: 177 WMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 73/264 (27%), Positives = 117/264 (44%), Gaps = 31/264 (11%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G ++ G LR  +  VA+K      P  L+  ++F QE  IL +  HPN+V L+
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLI 59

Query: 200 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G C +     +V E +  G     L  +   P L  +  I++     + + +L S     
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLES---KH 114

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            +H DL   N L+    V K+SDFG+SR   + E     +T   +  P     +  PE L
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIP---VKWTAPEAL 168

Query: 318 ASGELTPKSDVYSFGIILLRL--LTGRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
             G  + +SDV+SFGI+L     L   P   ++ ++ + A++ G     L       P +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPC-----PEL 220

Query: 375 QAEQLANLAMRCCEMSRKSRPELG 398
             + +  L  RC E     RP   
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFS 244

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 52/278 (18%)

Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +GEG +GS+ +G L       ++VA+K +    H+     EF  E   +    HPN++ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 199 VGACPEVWTL--------VYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 247
           +G C E  +L        +  ++ +G L   L           L  QT ++   ++   +
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR------FLSQNEISSNNTTLCC 301
            +L +    + +H DL   N +L  +    ++DFG+S+      +  Q  I+        
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA-------- 175

Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGI----ILLRLLTGRPALGITKEVQYALDT 357
               K    ++  E LA    T KSDV++FG+    I  R  T  P +   +   Y    
Sbjct: 176 ----KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231

Query: 358 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
            +LK   D L         ++L +L   C     K RP
Sbjct: 232 NRLKQPEDCL---------DELYDLMYSCWRADPKDRP 260

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 21/214 (9%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM--QVAIKM--LHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK   +     VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 195 LVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L  V        LV+E+L     +D     D SP       + I + L  +L  L  
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPL-IKSYLFQLLQGLAF 115

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R             +   T    T  Y 
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--------VPVRTYTHEVVTLWYR 167

Query: 313 DPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 345
            PE  L     +   D++S G I   ++T R AL
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 33/228 (14%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQG--PSEFQQEIDILSKIRH 192
            F+   +IGEG YG +Y+   R       VA+K +   + +   P    +EI +L  +RH
Sbjct: 8   EFEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65

Query: 193 PNLVTL----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVL 247
           PN+V L    VG   +   LV EY      +D  S  DN P P S      +  +L   L
Sbjct: 66  PNIVELKEVVVGKHLDSIFLVMEYCE----QDLASLLDNMPTPFSESQVKCLMLQLLRGL 121

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDP 305
            +LH    + I+H DLK +N+LL      K++DFG++R        ++    TL      
Sbjct: 122 QYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW----- 173

Query: 306 KGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
                Y  PE L      T   D+++ G IL  LL  +P L    E++
Sbjct: 174 -----YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 24/235 (10%)

Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           K+GEG Y ++YKG   L    VA+K +   H    P    +E+ +L  ++H N+VTL  +
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +  TLV+EYL +  L+  L    NS  +       +   L  +L  L+ C    ++
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-----NVKLFLFQLLRGLNYCHRRKVL 126

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 318
           H DLKP N+L++     KL+DFG++R  S    + +N  +        T  Y  P+  L 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--------TLWYRPPDILLG 178

Query: 319 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWP 372
           S + + + D++  G I   + TGRP   G T E Q        + L  P    WP
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWP 230

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 72.6 bits (178), Expect = 4e-14
 Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 25/210 (11%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGA 201
           ++G+G YGS+YK L R   V + M         S+F Q   E+DIL K   P +V   GA
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 202 CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              +   VY   EY+  GSL+   +    +  +      RI   +   L FL   + H+I
Sbjct: 68  F-FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNI 124

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+KP N+L++ N   KL DFG+S        S   T + C++       YM PE + 
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQS-------YMAPERIK 174

Query: 319 SGEL------TPKSDVYSFGIILLRLLTGR 342
           SG        T +SDV+S G+ +L +  GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 31/214 (14%)

Query: 140 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
            +  +KIGEG  G +     +H   QVA+KM+     Q       E+ I+   +H N+V 
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 198 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 249
                LVG   E+W L+ E+L  G+L D +S          QTR+   +IAT   SVL  
Sbjct: 83  MYKSYLVGE--ELWVLM-EFLQGGALTDIVS----------QTRLNEEQIATVCESVLQA 129

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L       ++H D+K  +ILL  +   KLSDFG    +S++        +  R    GT 
Sbjct: 130 LCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--------VPKRKSLVGTP 181

Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +M PE ++      + D++S GI+++ ++ G P
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.1 bits (174), Expect = 6e-14
 Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 16/198 (8%)

Query: 144 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 198
           +++G G +G + KG+ +     + VAIK+L   + +    E  +E +I+ ++ +P +V +
Sbjct: 1   VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E   LV E    G L   LS K +   +S      +   +  V + +   +  +
Sbjct: 61  IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLEGKN 115

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L      ++++    R+  K    +  PE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKAL-----GADDSYYKARSAGKWPLKWYAPECI 170

Query: 318 ASGELTPKSDVYSFGIIL 335
              + + +SDV+S+GI +
Sbjct: 171 NFRKFSSRSDVWSYGITM 188

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 36/253 (14%)

Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQ-GPSEFQQ-------------EIDILSK 189
           +GEG YG + K    L    VAIK +    +    ++ +Q             E+ I+++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 190 IRHPNLVTLVGA-CPEVW-TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           I+H N++ LV       +  LV + +    L+  +   D    L+      I  ++ + L
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCILLQILNGL 132

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS---SNNTTLCCR-- 302
             LH       +H DL PANI +++  + K++DFG++R       S   S + T+  R  
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 303 -TDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 360
            T    T  Y  PE L  + +     D++S G I   LLTG+P      E+      G++
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QLGRI 246

Query: 361 KNLL-DPLAGDWP 372
             LL  P   +WP
Sbjct: 247 FELLGTPNEDNWP 259

Length = 335

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 68/239 (28%), Positives = 111/239 (46%), Gaps = 24/239 (10%)

Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           K+GEG Y +++KG   L    VA+K +   H    P    +E+ +L  ++H N+VTL  +
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +  TLV+EYL     +D     D+   +     ++I   L  +L  L  C    ++
Sbjct: 73  VHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRRKVL 126

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 318
           H DLKP N+L++     KL+DFG++R  S    + +N  +        T  Y  P+  L 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--------TLWYRPPDVLLG 178

Query: 319 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQA 376
           S E + + D++  G I   + +GRP   G T E +  L     + L  P    WP + +
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISS 234

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 32/248 (12%)

Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQG-PSEFQQEIDILSKIR---H 192
           ++P  +IG G YG++YK    H    VA+K +    +  G P    +E+ +L ++    H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 193 PNLVTLVGACPEVWT-------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
           PN+V L+  C    T       LV+E++ +  L   L  K   P L  +T   +  +   
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFLR 119

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            L FLH+   + IVH DLKP NIL+ +    KL+DFG++R      I S    L   T  
Sbjct: 120 GLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMAL---TPV 167

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 365
             T  Y  PE L         D++S G I   +   +P      E   A   GK+ +L+ 
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIG 224

Query: 366 -PLAGDWP 372
            P   DWP
Sbjct: 225 LPPEDDWP 232

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 27/210 (12%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKML--HPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +I EG YG +Y+   R  +    VA+K L         P    +EI+IL K++HPN+VT+
Sbjct: 12  RIEEGTYGVVYRA--RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69

Query: 199 ----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
               VG+  +   +V EY+ +  L+  +  +    P        +  +L S +  LH   
Sbjct: 70  KEVVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHD-- 124

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
            + I+H DLK +N+LL+   + K+ DFG++R     E  S        T    T  Y  P
Sbjct: 125 -NWILHRDLKTSNLLLNNRGILKICDFGLAR-----EYGSPLKPY---TQLVVTLWYRAP 175

Query: 315 E-FLASGELTPKSDVYSFGIILLRLLTGRP 343
           E  L + E +   D++S G I   LLT +P
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 40/285 (14%)

Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQG--PSEFQQEIDILSKI 190
             ++   +IGEG YG ++K   R ++     VA+K +   + +   P    +E+ +L  +
Sbjct: 1   QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 191 R---HPNLVTLVGACP-------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 240
               HPN+V L   C           TLV+E++ +  L   L  K   P +  +T   + 
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD-KVPEPGVPTETIKDMM 116

Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            +L   L FLHS   H +VH DLKP NIL+ ++   KL+DFG++R  S     ++     
Sbjct: 117 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 171

Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 360
                  T  Y  PE L         D++S G I   +   +P    + +V      GK+
Sbjct: 172 -------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKI 221

Query: 361 KNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKDV 401
            +++  P   DWP   A        +  +   K      ELGKD+
Sbjct: 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 26/210 (12%)

Query: 145 KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           ++G+G +G +YK   +      A K++   S +   ++  EI+IL+   HP +V L+GA 
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKPHSI 258
               ++W ++ E+ P G+++  +   D       + +I+ I  ++   L +LHS K   I
Sbjct: 79  YWDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHSMK---I 131

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DLK  N+LL  +   KL+DFG+S        + N  TL  R    GT  +M PE + 
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMAPEVVM 183

Query: 319 SGEL--TP---KSDVYSFGIILLRLLTGRP 343
              +  TP   K+D++S GI L+ +    P
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 38/232 (16%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPN 194
           +++   K+GEG +G +YK         VA+K +  H+ +   P    +EI IL K++HPN
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68

Query: 195 LVTLVGACPEVWTLVYEYLPNGSLEDRLS--------CKDNSPPLSWQTRIR-------- 238
           +V L+        +  E  P+ S   R S          D S  L     ++        
Sbjct: 69  VVPLI-------DMAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKC 119

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
              +L   + +LH      I+H D+K ANIL+D   + K++DFG++R       +     
Sbjct: 120 YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 299 LCCRTDPKG---TFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPAL 345
                       T  Y  PE L  GE   T   D++  G +   + T RP L
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRRPIL 227

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)

Query: 146 IGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G+G +G +Y          L   QV      P + +  S  + EI +L  ++H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 199 VGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G   +      T+  EY+P GS++D+L        L+     +   ++   + +LHS  
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHS-- 124

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
            + IVH D+K ANIL D+    KL DFG S+ L    I  + T +   T   GT  +M P
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT--ICMSGTGIRSVT---GTPYWMSP 178

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E ++      K+DV+S G  ++ +LT +P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 145 KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           ++G+G +G +YK   +   V  A K++   S +   ++  EIDIL+   HPN+V L+ A 
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                +W L+ E+   G++ D +  +   P    Q R+ +  +    L +LH  K   I+
Sbjct: 72  YYENNLWILI-EFCAGGAV-DAVMLELERPLTEPQIRV-VCKQTLEALNYLHENK---II 125

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL-- 317
           H DLK  NIL   +   KL+DFG+S        + N  T+  R    GT  +M PE +  
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 318 ASGELTP---KSDVYSFGIILLRLLTGRP 343
            + +  P   K+DV+S GI L+ +    P
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 33/212 (15%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ--EIDILSKI-RHPNLVTLV 199
           ++G+G +GS+Y    +     VAIK +         E     E+  L K+  HPN+V L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 200 GACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHS 252
               EV+        V+EY+  G+L   L       P S ++ IR I  ++   L  +H 
Sbjct: 65  ----EVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFS-ESVIRSIIYQILQGLAHIHK 117

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
              H   H DLKP N+L+    V K++DFG++R     EI S        TD   T  Y 
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPY----TDYVSTRWYR 165

Query: 313 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE  L S   +   D+++ G I+  L T RP
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 73/276 (26%), Positives = 130/276 (47%), Gaps = 43/276 (15%)

Query: 145 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G+ +         +VAIK ++   S++   EF  E  ++ +    ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 197 TLVGACPEVW-TLV-YEYLPNGSLEDRL----SCKDNSP---PLSWQTRIRIATELCSVL 247
            L+G   +   TLV  E +  G L+  L       +N+P   P S +  I++A E+   +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH DL   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 133 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--------RKGGKG 181

Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SDV+SFG++L  +  L  +P  G++ E  +++ ++ G L 
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL- 240

Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
                   D P    + L  L   C + + K RP  
Sbjct: 241 --------DKPDNCPDMLFELMRMCWQYNPKMRPSF 268

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 75/262 (28%), Positives = 117/262 (44%), Gaps = 37/262 (14%)

Query: 146 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVTLV 199
           +G G  G++YK   LL    +A+K++    L    E Q+    E++IL K   P ++   
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVI---PLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 200 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           GA       ++  E++  GSL       D    +      RIA  +   L +L S K   
Sbjct: 66  GAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK--- 115

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H D+KP+N+L++     KL DFG+S  L    ++S   T        GT AYM PE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYV------GTNAYMAPERI 165

Query: 318 ASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLD---PLAGDWPF 373
           +  +    SDV+S GI  + L  GR P   I K     +    L+ ++D   P+     F
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225

Query: 374 VQAEQLANLAMRCCEMSRKSRP 395
             +E+  +   +C     K RP
Sbjct: 226 --SEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRHPN 194
           +F+   +IG G YG +YK   R++      AIK++     +  +  QQEI ++   +H N
Sbjct: 10  DFELIQRIGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 195 LVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           +V   G+     ++W +  E+   GSL+D       + PLS      ++ E    L +LH
Sbjct: 68  IVAYFGSYLRRDKLW-ICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH 123

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           S      +H D+K ANILL  N   KL+DFG+S  ++         T+  R    GT  +
Sbjct: 124 S---KGKMHRDIKGANILLTDNGHVKLADFGVSAQIT--------ATIAKRKSFIGTPYW 172

Query: 312 MDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPAL 345
           M PE  A    G      D+++ GI  + L   +P +
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 25/217 (11%)

Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRHP 193
           H+++   ++G G YG +YK   R++      A+K++        S  QQEI ++ + +H 
Sbjct: 9   HDYELIQRVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC 66

Query: 194 NLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G+    E   +  EY   GSL+D       + PLS      +  E    L +LH
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH 123

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           S      +H D+K ANILL  N   KL+DFG++  ++         T+  R    GT  +
Sbjct: 124 S---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT--------ATIAKRKSFIGTPYW 172

Query: 312 MDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPAL 345
           M PE  A   +G      D+++ GI  + L   +P +
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.6 bits (167), Expect = 9e-13
 Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 201
           KIG+G  G+++    +    +VAIK ++            EI ++ ++++PN+V  + + 
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 202 -CPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              +   +V EYL  GSL D ++  C D +   +      +  E    L FLH+   + +
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA------VCRECLQALEFLHA---NQV 136

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K  N+LL  +   KL+DFG    ++  +  S  +T+       GT  +M PE + 
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPEVVT 188

Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
                PK D++S GI+ + ++ G P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 49/221 (22%)

Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRH-PNLVTLVGA 201
           IG G +G++ K L +     + +    S     E ++   ++D++ +    P +V   GA
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 202 ---------CPEV--------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 244
                    C E+        +  VYE L           K   P       I     + 
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYEVL-----------KSVIP-----EEILGKIAVA 115

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
           +V    +  +   I+H D+KP+NILLD N   KL DFGIS  L  + I+        +T 
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIA--------KTR 166

Query: 305 PKGTFAYMDPEFLASGELTP---KSDVYSFGIILLRLLTGR 342
             G   YM PE +          +SDV+S GI L  + TG+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 22/200 (11%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 197
           ++G G +G++ KG+ +  +    VA+K+L   +   P+   E  +E +++ ++ +P +V 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVR 60

Query: 198 LVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC-SVLIFLHSCKP 255
           ++G C  E W LV E    G L   L    +          +  TEL   V + +   + 
Sbjct: 61  MIGICEAESWMLVMELAELGPLNKFLQKNKH-------VTEKNITELVHQVSMGMKYLEE 113

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
            + VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  PE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE-----NYYKAKTHGKWPVKWYAPE 168

Query: 316 FLASGELTPKSDVYSFGIIL 335
            +   + + KSDV+SFG+++
Sbjct: 169 CMNYYKFSSKSDVWSFGVLM 188

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 51/289 (17%)

Query: 145 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVT 197
           +IG G +G +  G     +   +V +K L   +   P E   F QE+    ++ HPN++ 
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 198 LVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 253
            +G C E   + LV E+ P G L++ L           Q  +  R+A E+ S L++LH  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGI--SRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                +H DL   N  L A+   K+ D+G+   ++     I+ +   +  R        +
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--------W 168

Query: 312 MDPEFLAS-------GELTPKSDVYSFGIILLRLLTGR----PALGITKEVQYALDTGKL 360
           + PE +          + T KS+++S G+ +  L T      P L   + ++  +    +
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228

Query: 361 K----NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 405
           K     L    +  W  V         M+ C +  ++RP   ++V  +L
Sbjct: 229 KLPKPQLDLKYSDRWYEV---------MQFCWLDPETRPTA-EEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 44/225 (19%)

Query: 145 KIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNL 195
           ++GE  +G +YKG L       +   VAIK L   + +GP   EF+ E  + S+++HPN+
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNI 70

Query: 196 VTLVGACP--EVWTLVYEYLPN----------------GSLEDRLSCKDNSPPLSWQTRI 237
           V L+G     +  ++++ Y  +                GS +D  + K    P  +   +
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---V 127

Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS--N 295
            I T++ + + FL S   H +VH DL   N+L+      K+SD G+ R +   +      
Sbjct: 128 HIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184

Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           N+ L  R        +M PE +  G+ +  SD++S+G++L  + +
Sbjct: 185 NSLLPIR--------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 26/206 (12%)

Query: 146 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ----QEIDILSKIRHPNLVTLV 199
           I +G +GS+Y  K        AIK+L    +   ++      +   ++ +   P +  L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 200 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            +    +   LV EYL  G      S       L      +   E+   +  LH      
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCA---SLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RG 117

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H D+KP N+L+D     KL+DFG+SR   +N+               GT  Y+ PE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------------KFVGTPDYLAPETI 165

Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
                   SD +S G ++   L G P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 22/209 (10%)

Query: 146 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 198
           +G+G +G +Y        R + V      P S +   E    + EI +L  + H  +V  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 199 VGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G   +      ++  E++P GS++D+L    +   L+     +   ++   + +LHS  
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHS-- 124

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
            + IVH D+K ANIL D+    KL DFG S+ L    I  + T +   T   GT  +M P
Sbjct: 125 -NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT--ICLSGTGMKSVT---GTPYWMSP 178

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E ++      K+D++S G  ++ +LT +P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 29/214 (13%)

Query: 141 DPSLKIGEGGYGSIYKGLLRHMQVAIKML-HPH--SLQGPSEFQQEIDILSKIRHPNLVT 197
             S+ I E    SIYKG+  + +V I+     H          + EI  L +I   N++ 
Sbjct: 23  YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82

Query: 198 LVG-------ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
           + G         P + +L+ EY   G L + L   D    LS++T++ +A + C  L  L
Sbjct: 83  IYGFIIDIVDDLPRL-SLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNL 138

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           +  K  +  + +L   + L+  N+  K+   G+ + LS     + N              
Sbjct: 139 Y--KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF-----------MV 185

Query: 311 YMDPEFLAS--GELTPKSDVYSFGIILLRLLTGR 342
           Y   + L     E T K D+YS G++L  + TG+
Sbjct: 186 YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 39/245 (15%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL--V 199
           K+GEG Y ++YKG  +     VA+K +     +G P    +E  +L  ++H N+VTL  +
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS------- 252
               +  TLV+EYL            D    +           + +V +FL         
Sbjct: 72  IHTKKTLTLVFEYLD----------TDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLAY 118

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDPKGTFA 310
           C    ++H DLKP N+L+      KL+DFG++R  S      S+   TL           
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW---------- 168

Query: 311 YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 369
           Y  P+  L S E +   D++  G I   + TGRP    + +V+  L     + L  P   
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK-IFRVLGTPTEE 227

Query: 370 DWPFV 374
            WP V
Sbjct: 228 TWPGV 232

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 27/208 (12%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVT 197
           +GEG YG + K   RH +    VAIK       +   E ++    E+ +L  ++  N+V 
Sbjct: 9   VGEGAYGVVLK--CRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVE 64

Query: 198 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           L  A        LV+EY+    LE      +  PP       ++ + +  ++  +H C  
Sbjct: 65  LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP------EKVRSYIYQLIKAIHWCHK 118

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           + IVH D+KP N+L+  N V KL DFG +R LS+   ++        T+   T  Y  PE
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN-------YTEYVATRWYRSPE 171

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L         D++S G IL  L  G+P
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLV 196
           +G G +G+++KG+         + VAIK +   S  G   FQ+  D    +  + H  +V
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIV 72

Query: 197 TLVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
            L+G CP     LV +  P GSL D +  + +   L  Q  +    ++   + +L     
Sbjct: 73  RLLGICPGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEE--- 127

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           H +VH +L   NILL ++ + +++DFG++  L  ++           ++ K    +M  E
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY------FYSEHKTPIKWMALE 181

Query: 316 FLASGELTPKSDVYSFGIILLRLLT 340
            +  G  T +SDV+S+G+ +  +++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 65.3 bits (159), Expect = 6e-12
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 22/201 (10%)

Query: 145 KIGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSEF---QQEIDILSKIRHPNLVT 197
           ++G+G +G++Y    K  +   ++ +    P     P+E     QE  +LSK+ HP +V 
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 198 LVGACPE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
              +  E   + ++ EY     L+ +L   K     LS     ++      +L+ +H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS---ENQVCEWFIQLLLGVHYMH 123

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              I+H DLK  NI L  N + K+ DFG+SR L  +      TT        GT  YM P
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS--CDLATTF------TGTPYYMSP 174

Query: 315 EFLASGELTPKSDVYSFGIIL 335
           E L       KSD++S G IL
Sbjct: 175 EALKHQGYDSKSDIWSLGCIL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL-QG-PSEFQQEIDILSKIRHPN 194
            ++   KIGEG YG+++K   R     VA+K +      +G PS   +EI +L +++H N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 195 LVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L  V    +  TLV+EY      +   SC  +  P   ++      +L   L F HS
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS---FMFQLLKGLAFCHS 117

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
              H+++H DLKP N+L++ N   KL+DFG++R        +    + C +    T  Y 
Sbjct: 118 ---HNVLHRDLKPQNLLINKNGELKLADFGLAR--------AFGIPVRCYSAEVVTLWYR 166

Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLT-GRP 343
            P+ L   +L   S D++S G I   L   GRP
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)

Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
            D  +KIGEG  G +    ++     VA+K +     Q       E+ I+   +H N+V 
Sbjct: 22  LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 198 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 249
                LVG   E+W +V E+L  G+L D ++           TR+   +IA    +VL  
Sbjct: 82  MYNSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLKA 128

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L       ++H D+K  +ILL  +   KLSDFG    +S+ E+    + +       GT 
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLV-------GTP 180

Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +M PE ++     P+ D++S GI+++ ++ G P
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)

Query: 140 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
            D  +KIGEG  G +     +H   QVA+K +     Q       E+ I+    H N+V 
Sbjct: 24  LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 198 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 249
                LVG   E+W +V E+L  G+L D ++           TR+   +IAT   SVL  
Sbjct: 84  MYNSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIATVCLSVLRA 130

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L       ++H D+K  +ILL ++   KLSDFG    +S+ E+    + +       GT 
Sbjct: 131 LSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLV-------GTP 182

Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +M PE ++      + D++S GI+++ ++ G P
Sbjct: 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSK-IRHPNLVT 197
           IG+G +G +   L +H       A+K+L   ++    E +    E ++L K ++HP LV 
Sbjct: 3   IGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 198 LVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCK 254
           L  +    +    V +Y+  G L   L  + + P    + R R  A E+ S L +LHS  
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSLN 116

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              I++ DLKP NILLD+     L+DFG+ +     E S   +T C      GT  Y+ P
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFC------GTPEYLAP 165

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E L         D +  G +L  +L G P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 45/218 (20%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKML--HPHSLQGPSEFQQEIDILSKIR-HPNLVT 197
           KIGEG +  + K   +  +     AIK +  H  SL+  +  + EI  L ++  HPN++ 
Sbjct: 6   KIGEGTFSEVLKA--QSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILR 62

Query: 198 LVGACPEV--------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 249
           L+    EV          LV+E L + +L + +  K    PL  +       +L   L  
Sbjct: 63  LI----EVLFDRKTGRLALVFE-LMDMNLYELI--KGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR---TDPK 306
           +H    + I H D+KP NIL+  + + KL+DFG  R             +  +   T+  
Sbjct: 116 MHR---NGIFHRDIKPENILIKDDIL-KLADFGSCR------------GIYSKPPYTEYI 159

Query: 307 GTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
            T  Y  PE  L  G   PK D+++ G +   +L+  P
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)

Query: 164 VAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLVGACPEVWTL--VYEYLPNGSLE 219
           VA+KML   + +   S+   E++++  I +H N++ L+GAC +   L  + EY   G+L 
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109

Query: 220 DRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 266
           + L  +                  ++++  +    ++   + +L S K    +H DL   
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166

Query: 267 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 326
           N+L+  N V K++DFG++R +  N I     T    T+ +    +M PE L     T +S
Sbjct: 167 NVLVTENNVMKIADFGLARDV--NNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQS 220

Query: 327 DVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           DV+SFG+++  + T  G P  GI  E  + L
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 22/209 (10%)

Query: 146 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 198
           +G G +G +Y        R + V      P S +   E    + EI +L  +RH  +V  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 199 VGAC--PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G    PE    ++  EY+P GS++D+L        L+     R   ++   + +LHS  
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHS-- 124

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
            + IVH D+K ANIL D+    KL DFG S+ +    I  + T +   T   GT  +M P
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT--ICMSGTGIKSVT---GTPYWMSP 178

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E ++      K+DV+S    ++ +LT +P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 52/231 (22%)

Query: 138 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQ----EIDILSK 189
             +     IGEG YG +     +   ++VAIK + P  H       F Q    EI IL +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-----FCQRTLREIKILRR 59

Query: 190 IRHPNLVTL--------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS--------W 233
            +H N++ +          +  +V+ +V E +    L   +     +  LS        +
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVY-IVQELMET-DLYKLIK----TQHLSNDHIQYFLY 113

Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 293
           Q  +R        L ++HS    +++H DLKP+N+LL+ N   K+ DFG++R        
Sbjct: 114 QI-LR-------GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162

Query: 294 SNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
           +        T+   T  Y  PE  L S   T   D++S G IL  +L+ RP
Sbjct: 163 TGFL-----TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 28/206 (13%)

Query: 146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQ---EIDILSKIRHPNLVTLV 199
           +G G  G + K L R   + +A K++H   L+  P+   Q   E+ +L +   P +V   
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIH---LEIKPAIRNQIIRELKVLHECNSPYIVGFY 65

Query: 200 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           GA     E+ ++  E++  GSL D++  K    P +   +I IA  +   L +L   + H
Sbjct: 66  GAFYSDGEI-SICMEHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLR--EKH 119

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +YM PE 
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSYMSPER 169

Query: 317 LASGELTPKSDVYSFGIILLRLLTGR 342
           L     T +SD++S G+ L+ +  GR
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 70/238 (29%), Positives = 105/238 (44%), Gaps = 48/238 (20%)

Query: 140 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNL 195
           FD   +IGEG YG +YK   +     VA+K +   +  +G P    +EI IL ++ H N+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 196 VTLVGACPEVWT----------------LVYEYLPN---GSLEDRLS--CKDNSPPLSWQ 234
           V L     E+ T                LV+EY+ +   G LE  L    +D+       
Sbjct: 69  VNLK----EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH------- 117

Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
               I + +  +L  L+ C   + +H D+K +NILL+     KL+DFG++R  +  E   
Sbjct: 118 ----IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 295 NNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEV 351
                   T+   T  Y  PE L   E   P  DV+S G IL  L T +P     +E+
Sbjct: 174 -------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 29/219 (13%)

Query: 138 HNFDPSLKIGEGGYGSIYKGLLRH---MQV-AIKMLHPHSLQGPSE---FQQEIDILSKI 190
            +FD    IG G +G +   L+RH    QV A+K+L    +   S+   F +E DI++  
Sbjct: 43  EDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
               +V L  A    +   +V EY+P G L + +S  D   P  W  R   A E+   L 
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKW-ARFYTA-EVVLALD 156

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            +HS      +H D+KP N+LLD +   KL+DFG    +  N +   +T +       GT
Sbjct: 157 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-------GT 206

Query: 309 FAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRP 343
             Y+ PE L S    G    + D +S G+ L  +L G  
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 59/276 (21%)

Query: 146 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLV 196
           +G+G YG +   L+RH     Q  IK L   +L+  S       +QE  +LS+++HPN+V
Sbjct: 8   VGKGSYGEV--SLVRHRTDGKQYVIKKL---NLRNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 197 TLVGACPEVWT-------LVYEYLPNGSLEDRLSCKD-----NSPPLSWQTRIRIATELC 244
                  E W        +V  +   G L  +L  +       +  + W  +I +A    
Sbjct: 63  AY----RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA---- 114

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL-SQNEISSNNTTLCCRT 303
             L +LH      I+H DLK  N+ L    + K+ D GI+R L +Q +++S   TL    
Sbjct: 115 --LQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS---TLI--- 163

Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI--TKEVQYALDTGKLK 361
              GT  YM PE  ++     KSDV++ G  +  + T + A        + Y +  GKL 
Sbjct: 164 ---GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220

Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
               P+  D+    + +L  L         + RP +
Sbjct: 221 ----PMPKDY----SPELGELIATMLSKRPEKRPSV 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 41/217 (18%)

Query: 146 IGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
           +G+GGYG ++          G +  M+V  K     + +  +  + E +IL  ++HP +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 197 TLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE------LCSVLI 248
            L+ A        L+ EYL  G L   L             R  I  E      L  + +
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLE------------REGIFMEDTACFYLSEISL 111

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPK 306
            L       I++ DLKP NILLDA    KL+DFG    L +  I       T C      
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFG----LCKESIHEGTVTHTFC------ 161

Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  YM PE L         D +S G ++  +LTG P
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 68/249 (27%), Positives = 113/249 (45%), Gaps = 23/249 (9%)

Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIR 191
           G   +++   K+GEG Y ++YKG   +    VA+K++     +G P    +E  +L  ++
Sbjct: 2   GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK 61

Query: 192 HPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLI 248
           H N+V L  +    E  TLV+EY+      D     D  P       +++   +L   L 
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           ++H      I+H DLKP N+L+      KL+DFG++R  S    + +N  +        T
Sbjct: 118 YIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--------T 166

Query: 309 FAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 367
             Y  P+  L S E +   D++  G I + ++ G  A    K++Q  L+   L  L  P 
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV-LGTPN 225

Query: 368 AGDWPFVQA 376
              WP V +
Sbjct: 226 EDTWPGVHS 234

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 32/212 (15%)

Query: 148 EGGYGSIYKGLLRHM------QVAIKMLHPHSLQGPSEFQ-----QEIDILSKIRHPNLV 196
           EG +G I+ G+L         +V +K +  H+    SE Q     QE  +L  + H N++
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA----SEIQVTLLLQESCLLYGLSHQNIL 71

Query: 197 TLVGACPEVWT---LVYEYLPNGSLED-----RLSCKDNSPPLSWQTRIRIATELCSVLI 248
            ++  C E      ++Y Y+  G+L+      RL   +N   LS Q  + +A ++   + 
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH      ++H D+   N ++D     K++D  +SR L   +        C   +    
Sbjct: 132 YLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH------CLGDNENRP 182

Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M  E L + E +  SDV+SFG++L  L+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 63/270 (23%), Positives = 113/270 (41%), Gaps = 35/270 (12%)

Query: 146 IGEGGYGSIYK-------GLLRHMQVAIKMLHPHSLQGPSEFQQEID--------ILSKI 190
           +G G +G +YK         L  ++  I + +P   +   E  + I         I  ++
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALK-EINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 191 RHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVL 247
           RHPN+V       E   L  V + +    L +   S K+     + +    I  ++   L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +LH  K   IVH DL P NI+L  +    ++DFG+++                 T   G
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---------LTSVVG 175

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 367
           T  Y  PE + +     K+DV++FG IL ++ T +P    T  +  A  T  ++ + +PL
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA--TKIVEAVYEPL 233

Query: 368 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
                 + +E + ++   C     ++RP++
Sbjct: 234 PEG---MYSEDVTDVITSCLTPDAEARPDI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 64/238 (26%), Positives = 94/238 (39%), Gaps = 58/238 (24%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKML-------HPHSLQGPSEFQQEIDILSKIRHPN 194
           IG G +G ++  L+R        A+K+L               +  + E DIL+    P 
Sbjct: 9   IGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQI----AHVRAERDILADADSPW 62

Query: 195 LVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           +V L       ++        LV EY+P G L + L  KD  P      R  IA EL   
Sbjct: 63  IVKLY------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ET-ARFYIA-ELVLA 113

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS----------RFLSQNEISSNN 296
           L  +H       +H D+KP NIL+DA+   KL+DFG+            +L+ +      
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 297 TTLCCRTDPK-----------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             +  R               GT  Y+ PE L       + D +S G+IL  +L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 51/277 (18%)

Query: 146 IGEGGYGSIYKGLLRH----MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +GEG +GS+ +G L      ++VA+K +     +     +F  E   + +  HPN++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 200 GACPEVW--------TLVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVLI 248
           G C +           ++  ++ +G L   L      D    L  Q  ++  T++ S + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR------FLSQNEISSNNTTLCCR 302
           +L S    S +H DL   N +L+ N    ++DFG+S+      +  Q  I+         
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA--------- 174

Query: 303 TDPKGTFAYMDPEFLASGELTPKSDVYSFGI----ILLRLLTGRPALGITKEVQYALDTG 358
              K    ++  E LA    T KSDV+SFG+    I  R  T  P +  ++   Y     
Sbjct: 175 ---KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231

Query: 359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
           +LK   D L G         L +L   C  ++ K RP
Sbjct: 232 RLKQPPDCLDG---------LYSLMSSCWLLNPKDRP 259

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 29/208 (13%)

Query: 146 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQ--QEIDILSKIRHPNLV 196
           +G+G +G ++  L+R +         A+K+L   +L+     +   E DIL+++ HP +V
Sbjct: 4   LGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 197 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSC 253
            L  A        L+ ++L  G L  RLS       +  +  ++    EL   L  LHS 
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL 117

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               I++ DLKP NILLD     KL+DFG+S+    +E      + C      GT  YM 
Sbjct: 118 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC------GTVEYMA 166

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTG 341
           PE +     T  +D +SFG+++  +LTG
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 28/225 (12%)

Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLV----T 197
           IG+G YG +   +  H   +VAIK ++     +   +   +EI +L  +RHP++V     
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 198 LVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           ++      +    +V+E L    L   +   D+  P   Q  +    +L   L ++H+  
Sbjct: 68  MLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL---YQLLRALKYIHTA- 122

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCRTDPKGTFAYMD 313
             ++ H DLKP NIL +A+   K+ DFG++R      ++ N+T T    TD   T  Y  
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLAR------VAFNDTPTAIFWTDYVATRWYRA 174

Query: 314 PEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 356
           PE   S   + TP  D++S G I   +LTG+P L   K V + LD
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKNVVHQLD 218

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 28/211 (13%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 199
           +IG G +G++Y          VAIK +     Q   ++Q   +E+  L ++RHPN +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 200 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G      T  LV EY   GS  D L    +  PL       I       L +LHS   H 
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHS---HE 135

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            +H D+K  NILL      KL+DFG     S + +S  N+ +       GT  +M PE +
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFG-----SASLVSPANSFV-------GTPYWMAPEVI 183

Query: 318 AS---GELTPKSDVYSFGIILLRLLTGRPAL 345
            +   G+   K DV+S GI  + L   +P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 35/214 (16%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ--QEIDILSKIRH-PNLVTL 198
           +G G YG + K  +RH+     +A+K +   ++    + +   ++DI  +    P  VT 
Sbjct: 9   LGRGAYGVVDK--MRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYTVTF 65

Query: 199 VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 253
            GA     +VW  +   + + SL D+   K     L+    I  +IA  +   L +LHS 
Sbjct: 66  YGALFREGDVW--ICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS- 121

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
              S++H D+KP+N+L++ N   KL DFGIS +L  + ++        +T   G   YM 
Sbjct: 122 -KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVA--------KTIDAGCKPYMA 171

Query: 314 PEFLASGELTP-----KSDVYSFGIILLRLLTGR 342
           PE + + EL       KSDV+S GI ++ L TGR
Sbjct: 172 PERI-NPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 36/272 (13%)

Query: 145 KIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL-- 198
           K+GEG Y ++YKG+ R    + VA+K++   + +G P    +E  +L  ++H N+V L  
Sbjct: 12  KLGEGSYATVYKGISRINGQL-VALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 199 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHSCKPHS 257
           +    E  T V+EY+      D        P       +R+   +L   L ++H      
Sbjct: 71  IIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QH 123

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDPKGTFAYMDPE 315
           I+H DLKP N+L+      KL+DFG++R  S      SS   TL           Y  P+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW----------YRPPD 173

Query: 316 -FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGDWPF 373
             L + + +   D++  G I + +L G+PA     +V   L+  K+  +L  P    WP 
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE--KIWTVLGVPTEDTWP- 230

Query: 374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 405
                ++ L     E     +P+  + VW+ L
Sbjct: 231 ----GVSKLPNYKPEWFLPCKPQQLRVVWKRL 258

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 145 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 199
           +IG G +G++Y  + +     VAIK +     Q   ++Q   +E+  L K+RHPN +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 200 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G      T  LV EY   GS  D L    +  PL       +       L +LHS   H+
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HN 135

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           ++H D+K  NILL    + KL DFG     S + ++  N  +       GT  +M PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFG-----SASIMAPANXFV-------GTPYWMAPEVI 183

Query: 318 AS---GELTPKSDVYSFGIILLRLLTGRPAL 345
            +   G+   K DV+S GI  + L   +P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 199
           +IG G +G++Y     H    VA+K +     Q   ++Q   +E+  L +++HPN +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 200 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +  T  LV EY   GS  D L    +  PL       I       L +LHS   H+
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HN 141

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           ++H D+K  NILL      KL+DFG     S ++ S  N+ +       GT  +M PE +
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFV-------GTPYWMAPEVI 189

Query: 318 AS---GELTPKSDVYSFGIILLRLLTGRPAL 345
            +   G+   K DV+S GI  + L   +P L
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.9 bits (154), Expect = 8e-11
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 46/221 (20%)

Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ---------QEIDILSKIRHPN 194
           IG G YG +   +      +VAIK +          F          +EI +L  +RH N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 195 LVTLVGACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCS 245
           ++ L+            +V+ +V E +    L   +       PL+    I+    ++  
Sbjct: 61  IIGLLDILRPPSPEDFNDVY-IVTELMET-DLHKVIKSPQ---PLTDD-HIQYFLYQILR 114

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT--LCCRT 303
            L +LHS     ++H DLKP+NIL+++N   K+ DFG++R +  +E      T  +  R 
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 304 DPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
                  Y  PE  L+S   T   D++S G I   LLT +P
Sbjct: 172 -------YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 34/228 (14%)

Query: 137 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHP 193
           T  ++    IG+G YG +YK   +      A+K+L P S     E + E +IL  +  HP
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHP 79

Query: 194 NLVTLVG--------ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR---IATE 242
           N+V   G           ++W LV E    GS+ + +        L    R+    I+  
Sbjct: 80  NVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQRLDEAMISYI 133

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 302
           L   L+ L     + I+H D+K  NILL      KL DFG+S  L+   +  N +     
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---- 189

Query: 303 TDPKGTFAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPAL 345
               GT  +M PE +A  +        + DV+S GI  + L  G P L
Sbjct: 190 ----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 49/228 (21%)

Query: 145 KIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVT 197
            IG G YG +YK   ++ +     AIK       Q     Q   +EI +L +++H N+V+
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 198 LVGACPE-----VWTLVYEYLPNGSLE----DRLSCKDNSPP-----LSWQTRIRIATEL 243
           LV    E     V+ L+++Y  +   +     R + + + PP     L WQ        +
Sbjct: 67  LVEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------I 117

Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGISRFL---SQNEISSNN 296
            + + +LHS   + ++H DLKPANIL+        V K+ D G++R      +     + 
Sbjct: 118 LNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174

Query: 297 TTLCCRTDPKGTFAYMDPEF-LASGELTPKSDVYSFGIILLRLLTGRP 343
             +        T  Y  PE  L +   T   D+++ G I   LLT  P
Sbjct: 175 VVV--------TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 11/104 (10%)

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+   L FLH      I++ DLK  N+LLD+    K++DFG+ +   +  +    T+ 
Sbjct: 102 AAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            C     GT  Y+ PE L+     P  D ++ G++L  +L G+ 
Sbjct: 156 FC-----GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 30/214 (14%)

Query: 162 MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACPE---VWTLVYEYLPNG 216
           + VA+KML   +  +  S+   E++++  I +H N++ L+GAC +   ++ LV EY   G
Sbjct: 45  VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV-EYASKG 103

Query: 217 SLEDRL-------------SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 263
           +L + L             +CK     L+++  +  A ++   + +L S K    +H DL
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL 160

Query: 264 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 323
              N+L+  + V K++DFG++R +   +     T      + +    +M PE L     T
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT------NGRLPVKWMAPEALFDRVYT 214

Query: 324 PKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
            +SDV+SFG++L  + T  G P  GI  E  + L
Sbjct: 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 41/240 (17%)

Query: 146 IGEGGYGSIYKGLL---------RHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +              R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               LS++  +
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +  + I     
Sbjct: 144 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 198

Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 199 T----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 49/273 (17%)

Query: 146 IGEGGYGSIYKGLLRH------------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP 193
           +G+G + +IYKG+LR             + V +K+L     +    F +   ++S++ H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61

Query: 194 NLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +LV L G C  +   +V EY+  G L+  L  + N+  L W  ++ +A +L S L +L  
Sbjct: 62  HLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 253 CKPHSIVHGDLKPANILL---DAN-----FVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
            K   +VHG++   NIL+     N     F+ KLSD GI              T+  R +
Sbjct: 120 KK---LVHGNVCGKNILVARYGLNEGYVPFI-KLSDPGIPI------------TVLSREE 163

Query: 305 PKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 362
                 ++ PE + +G+  LT  +D +SFG  LL + +       T          + ++
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223

Query: 363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
            L       P     +LANL  +C       RP
Sbjct: 224 RL-------PMPDCAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIR 191
           ++D    IG G +G +   L+RH       A+K+L    +   S+   F +E DI++   
Sbjct: 44  DYDVVKVIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 192 HPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 249
            P +V L  A  +     +V EY+P G L + +S  D   P  W    +  T    V++ 
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---KFYT--AEVVLA 154

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L +     ++H D+KP N+LLD +   KL+DFG    + +  +   +T +       GT 
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-------GTP 207

Query: 310 AYMDPEFLAS----GELTPKSDVYSFGIILLRLLTG 341
            Y+ PE L S    G    + D +S G+ L  +L G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 37/238 (15%)

Query: 146 IGEGGYGSIYK----GLLRHMQ-----VAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPN 194
           +GEG +G + +    G+ +        VA+KML  ++  +  ++   E++++  I +H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCK-----DNSP--------PLSWQTRIRI 239
           ++ L+G C +   L  + EY   G+L + L  +     D +          LS++  +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A ++   + +L S +    +H DL   N+L+  + V K++DFG++R +    I     T 
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHD--IDYYKKTS 194

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
             R   K    +M PE L     T +SDV+SFGI++  + T  G P  GI  E  + L
Sbjct: 195 NGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 145 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 199
           +IG G +G++Y  + +  +  VAIK +     Q   ++Q   +E+  L +I+HPN +   
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 200 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G      T  LV EY   GS  D L    +  PL       I       L +LHS   H+
Sbjct: 92  GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HN 145

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           ++H D+K  NILL      KL+DFG     S +  S  N+ +       GT  +M PE +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFG-----SASIASPANSFV-------GTPYWMAPEVI 193

Query: 318 AS---GELTPKSDVYSFGIILLRLLTGRPAL 345
            +   G+   K DV+S GI  + L   +P L
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 22/225 (9%)

Query: 146 IGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKG+         + VAIK+L  + S +   E   E  +++ +  P +  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C      LV + +P G L D +  ++N   +  Q  +    ++   + +L   +   
Sbjct: 75  LGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           +VH DL   N+L+ +    K++DFG++R L  +E   +          K    +M  E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH------ADGGKVPIKWMALESI 183

Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
                T +SDV+S+G+ +  L+T   +P  GI  +E+   L+ G+
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.2 bits (146), Expect = 6e-10
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 11/104 (10%)

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+   L+FLH    H +++ DLK  NILLDA    KL+DFG+ +   +  ++   TT 
Sbjct: 102 AAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            C     GT  Y+ PE L   E  P  D ++ G+++  ++ G+P
Sbjct: 156 FC-----GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQP 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 198
           IG G +G +   L+RH       A+K+L    +   S+   F +E DI++    P +V L
Sbjct: 51  IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             A  +     +V EY+P G L + +S  D   P  W    R  T    V++ L +    
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---RFYT--AEVVLALDAIHSM 161

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
             +H D+KP N+LLD +   KL+DFG    +++  +   +T +       GT  Y+ PE 
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-------GTPDYISPEV 214

Query: 317 LAS----GELTPKSDVYSFGIILLRLLTG 341
           L S    G    + D +S G+ L  +L G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G + K  ++H    + +A K++H        ++  +E+ +L +   P
Sbjct: 6   DFERISELGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 63

Query: 194 NLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            +V   GA     E+ ++  E++  GSL+  L      P    +   +++  +   L +L
Sbjct: 64  YIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLAYL 119

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +
Sbjct: 120 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRS 167

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           YM PE L     + +SD++S G+ L+ L  GR
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 52/205 (25%), Positives = 80/205 (39%), Gaps = 22/205 (10%)

Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVG 200
           +G+GG+G +    ++      A K L    L   +G      E  IL K+    +V+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 201 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           A    +   LV   +  G L+  +      P       I  A ++   L  LH      I
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLHQ---RRI 116

Query: 259 VHGDLKPANILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           V+ DLKP N+LLD +   ++SD G++       +I              GT  YM PE L
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----------AGTPGYMAPEVL 166

Query: 318 ASGELTPKSDVYSFGIILLRLLTGR 342
                    D ++ G  L  ++ GR
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 19/201 (9%)

Query: 146 IGEGGYGS--IYKGLLRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +GEG +G   + + +    + A+K +  P S     + ++E  +L+K++HPN+V    + 
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 203 PEVWTL--VYEYLPNGSLEDRLSCKDNSPPL-SWQTRIRIATELCSVLIFLHSCKPHSIV 259
                L  V EY   G L  ++  K     L    T ++   ++C  +  +H  +   ++
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VL 122

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H D+K  NI L  N   KL DFG +R L      ++     C     GT  Y+ PE   +
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLL------TSPGAYACTY--VGTPYYVPPEIWEN 174

Query: 320 GELTPKSDVYSFGIILLRLLT 340
                KSD++S G IL  L T
Sbjct: 175 MPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 40/275 (14%)

Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G+G +GS+ +  L+       +VA+KML     S     EF +E   + +  HPN++ L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 199 VGACPE--------VWTLVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 247
           +G            +  ++  ++ +G L   L      +    L  QT +R   ++ S +
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L S    + +H DL   N +L+ N    ++DFG+S+ +   +        C    P  
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG---CASKLPVK 180

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEV-QYALDTGKLKNL 363
             A    E LA    T  SDV++FG+ +  ++T    P  G+   E+  Y +   +LK  
Sbjct: 181 WLAL---ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237

Query: 364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 398
            D L         E +  L  +C     K RP   
Sbjct: 238 PDCL---------EDVYELMCQCWSPEPKCRPSFQ 263

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)

Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP-HSLQGPSEFQQEIDILSKIR-HPNLVTLVG- 200
           IG+G YG ++K L +    + A+K+L P H +    E + E +IL  +  HPN+V   G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID--EEIEAEYNILKALSDHPNVVKFYGM 83

Query: 201 -------ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                     ++W LV E    GS+ D +  K             IA  L   L+ L   
Sbjct: 84  YYKKDVKNGDQLW-LVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
             +  +H D+K  NILL      KL DFG+S  L+   +  N +         GT  +M 
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--------GTPFWMA 192

Query: 314 PEFLASGE-----LTPKSDVYSFGIILLRLLTGRPALG 346
           PE +A  +        + DV+S GI  + L  G P L 
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 22/225 (9%)

Query: 146 IGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C      L+ + +P G L D +  +++   +  Q  +    ++   + +L       
Sbjct: 75  LGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEE---RR 129

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           +VH DL   N+L+      K++DFG+++ L  +E   +          K    +M  E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH------AEGGKVPIKWMALESI 183

Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
                T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 70/239 (29%), Positives = 106/239 (44%), Gaps = 45/239 (18%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR 191
           +F+    I  G YG++Y  L+RH     + A+K ++  +L   ++ QQ   E DIL+   
Sbjct: 2   DFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE 59

Query: 192 HPNLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 244
           +P +V++  +       C     +V EY+  G   D  +   N   L          E  
Sbjct: 60  NPFVVSMFCSFETKRHLC-----MVMEYVEGG---DCATLLKNIGALPVDMARMYFAETV 111

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
             L +LH+   + IVH DLKP N+L+ +    KL+DFG    LS+  + S  T L     
Sbjct: 112 LALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG----LSKIGLMSLTTNLYEGHI 164

Query: 305 PKGTFAYMD------PEFLA------SGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
            K T  ++D      PE++A       G   P  D ++ GIIL   L G  P  G T E
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPE 222

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 42/124 (33%), Positives = 61/124 (49%), Gaps = 12/124 (9%)

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           VL+ +H      ++H D+K ANILL +N + KL DFG S+  +         T C     
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC----- 206

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT-KEVQYALDTGKLKNL 363
            GT  Y+ PE       + K+D++S G++L  LLT  RP  G   +EV +    G+    
Sbjct: 207 -GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR---- 261

Query: 364 LDPL 367
            DPL
Sbjct: 262 YDPL 265

Length = 496

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 57/250 (22%)

Query: 138 HNFDPSLKIGEGGYGSIYKGLLRH--------MQVAIK--MLHPHSLQGPSEFQQEIDIL 187
            +F+    IG G +G +   L++         M+   K  ML    +   +  + E DIL
Sbjct: 1   DDFESIKVIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQV---AHVRAERDIL 55

Query: 188 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSW-QTRIRIATELC 244
           ++  +P +V L  +        L+ EYLP G +   L  KD     +  +TR  IA    
Sbjct: 56  AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYIA---- 108

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS------------RFLSQNEI 292
             ++ + S      +H D+KP N+LLDA    KLSDFG+             R LS    
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168

Query: 293 SSNNTTLCCRTDPK------------------GTFAYMDPE-FLASGELTPKSDVYSFGI 333
           S+    +      K                  GT  Y+ PE FL +G    + D +S G+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGV 227

Query: 334 ILLRLLTGRP 343
           I+  +L G P
Sbjct: 228 IMYEMLVGYP 237

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGP---SEFQQEIDILSKIR 191
           +FD    +G G +G +   ++R        A+K++    L      S F++E DILS   
Sbjct: 2   DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 192 HPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 249
            P +  L  A    +   LV EY P G L   L+  ++      +   +    L  +++ 
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFD-EDMAQFY--LAELVLA 114

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           +HS      VH D+KP N+L+D     KL+DFG     S   +++N         P GT 
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-----SAARLTANKMVNS--KLPVGTP 167

Query: 310 AYMDPEFLASGELTPKS------DVYSFGIILLRLLTGR 342
            Y+ PE L +     K       D +S G+I   ++ GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.6 bits (142), Expect = 5e-09
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)

Query: 145 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 196
            IG+GG G +Y   L +      +VA+K +     + P     F +E  I + + HP +V
Sbjct: 9   LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 197 TLVGACPEVWTLVYE--YLPNGSLEDRL----SCKDNSPPLSWQTRI----RIATELCSV 246
            +   C +   + Y   Y+   +L+  L      +  S  L+ +T +     I  ++C+ 
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE-----ISSNNTTLCC 301
           + ++HS     ++H DLKP NILL       + D+G + F    E     I  +   +C 
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 302 R--TDPK---GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
              T P    GT  YM PE L     +  +D+Y+ G+IL ++LT
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 38/220 (17%)

Query: 138 HNFDPSLKIGEGGYGSI----YKGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKI 190
            +F+    +G G +G +    +KG   +   AIK L    +    + Q   QE  IL ++
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTGEYY--AIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 191 RHPNLVTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
            HP +V ++ +  +   V+  + E++  G L   L      P         +A    + L
Sbjct: 76  SHPFIVNMMCSFQDENRVY-FLLEFVVGGELFTHLRKAGRFPN-------DVAKFYHAEL 127

Query: 248 I----FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           +    +LHS     I++ DLKP N+LLD     K++DFG ++     ++     TLC   
Sbjct: 128 VLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLC--- 176

Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
              GT  Y+ PE + S       D ++ G++L   + G P
Sbjct: 177 ---GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213

Length = 329

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 26/208 (12%)

Query: 146 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQQEID-----ILSKIRHPNLVTL 198
           IG+G +G +   K  L     A+K+L    +    E Q+ I      +L  ++HP LV L
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVGL 61

Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 255
             +    E    V +++  G L   L  ++ S P   + R R  A E+ S L +LHS   
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFP---EPRARFYAAEIASALGYLHSIN- 116

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             IV+ DLKP NILLD+     L+DFG+ +       S   TT C      GT  Y+ PE
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFC------GTPEYLAPE 166

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +         D +  G +L  +L G P
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 29/218 (13%)

Query: 139 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 189
           NF+    +G G YG ++          G L  M+V  K       +     + E  +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 190 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           +R  P LVTL  A        L+ +Y+  G L   L  +++      + R+ IA E+   
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVYIA-EIVLA 117

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDP 305
           L  LH      I++ D+K  NILLD+     L+DFG+S+ FL++ E  +   + C     
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFC----- 167

Query: 306 KGTFAYMDPEFLASGELTPKS--DVYSFGIILLRLLTG 341
            GT  YM PE +  G        D +S G++   LLTG
Sbjct: 168 -GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 195
           +F+   ++G G  G ++K   +   + +A K++H        ++  +E+ +L +   P +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 196 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           V   GA     E+ ++  E++  GSL+  L      P    Q   +++  +   L +L  
Sbjct: 66  VGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLR- 120

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
            + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +YM
Sbjct: 121 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSYM 169

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            PE L     + +SD++S G+ L+ +  GR
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 14/150 (9%)

Query: 145 KIGEGGYGSIYKGL----LRHMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G +  G         QV +K L    S+Q   +F +E      ++H NL+  +
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 200 GACPEV--WTLVYEYLPNGSLEDRL-SCK--DNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           G C EV  + LV E+ P G L+  L SC+  +   P    T  R+A E+   L+ LH   
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLHK-- 118

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGIS 284
            ++ +H DL   N LL A+   K+ D+G+S
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 28/209 (13%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID----ILSKIRHPNLVT 197
           IG+G +G +   L RH       A+K+L   ++    E +  +     +L  ++HP LV 
Sbjct: 3   IGKGSFGKVL--LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 198 LVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCK 254
           L  +      L  V +Y+  G L   L           + R R  A E+ S L +LHS  
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL- 115

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
             +IV+ DLKP NILLD+     L+DFG+ +     E +   +T C      GT  Y+ P
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFC------GTPEYLAP 165

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E L         D +  G +L  +L G P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 36/234 (15%)

Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 200
           IG+G +G + +   R  Q   A+K +    +   SE      E  +L+++  P +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 201 A--CPEVWTLVYEYLPNGSLEDRLS---CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           +   PE   LV  ++  G L   L      D S     + R   A  LC+ L  LH    
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-----RARFYTAELLCA-LENLHK--- 111

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
            ++++ DLKP NILLD      L DFG+ +   +++  +N  T C      GT  Y+ PE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN--TFC------GTPEYLAPE 163

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--KNLLDPL 367
            L     T   D ++ G++L  +LTG P         Y  +  ++  K L +PL
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPF-------YDENVNEMYRKILQEPL 210

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 52/274 (18%)

Query: 146 IGEGGYGSIYKGL---------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
           +G+G +  I+KG+         L   +V +K+L          F +   ++S++ H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
              G C   +   +V EY+  GSL+  L    N   +SW  ++ +A +L   L FL    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED-- 118

Query: 255 PHSIVHGDLKPANILL----DANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              + HG++   N+LL    D    +    KLSD GIS  +   EI      L  R    
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLER---- 167

Query: 307 GTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTG--RP--ALGITKEVQYALDTGKLK 361
               ++ PE +     L+  +D +SFG  L  + +G  +P  AL   K++Q+  D  +L 
Sbjct: 168 --IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP 225

Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                 A  W      +LANL  +C +     RP
Sbjct: 226 ------APKW-----TELANLINQCMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 28/207 (13%)

Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGPSEFQQ-----EIDILSKIRHPNL 195
           +G G +G + +G L     R + VAI  L      G S+ Q+     E   L +  H N+
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLR----AGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 196 VTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           V L G      T+  V EY+ NG+L+  L  + +   L     + +   L S + +L   
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
                VH  L    +L++++ V K+S F   R L +++  +  TT+      K    +  
Sbjct: 127 ---GYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTM----SGKSPVLWAA 176

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT 340
           PE +     +  SDV+SFGI++  +++
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 42/216 (19%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID-----ILSKIRHPNLV 196
           IG+G +G +   L +        A+K+L   ++    E Q  I      +L  ++HP LV
Sbjct: 3   IGKGSFGKVL--LAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLV 59

Query: 197 TLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
            L  +    E    V +Y+  G L      E              + R R  A E+ S +
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL----------EPRARFYAAEVASAI 109

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +LHS    +I++ DLKP NILLD+     L+DFG+ +     E     +T C      G
Sbjct: 110 GYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFC------G 158

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           T  Y+ PE L         D +  G +L  +L G P
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)

Query: 139 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 189
           NF+    +G G YG ++          G L  M+V  K       +     + E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 190 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           IR  P LVTL  A        L+ +Y+  G L   LS ++       Q       E+   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS---GEIVLA 117

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L  LH      I++ D+K  NILLD+N    L+DFG+S+   ++E+     + C      
Sbjct: 118 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFC------ 167

Query: 307 GTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTG 341
           GT  YM P+ +  G+       D +S G+++  LLTG
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 65/246 (26%), Positives = 96/246 (39%), Gaps = 30/246 (12%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
           KIGEG YG +YK   ++    VA+K   L       P    +EI +L  +     +  + 
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 201 ACPEVWT--------LVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
               V          LV+EYL +      D  + +    PL  +T      +L   +   
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDS-NGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 251 HSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           H    H ++H DLKP N+L+D    + K++D G+ R  S          +   T    T 
Sbjct: 127 HK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--------IPVKSYTHEIVTL 175

Query: 310 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 368
            Y  PE  L S   +   D++S G I   +   +P      E+Q  L   KL  L  P  
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL--LGTPTE 233

Query: 369 GDWPFV 374
             WP V
Sbjct: 234 QVWPGV 239

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 45/165 (27%), Positives = 65/165 (39%), Gaps = 31/165 (18%)

Query: 188 SKIRHPNLVTLVGACPEVWTLVY---EYLPNGSL-----EDRLSCKDNSPPLSWQTRIRI 239
           +  RHP LV L  AC +    V    EY   G L      D  S          + R   
Sbjct: 57  NSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----------EPRAVF 105

Query: 240 -ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
            A  +   L +LH    + IV+ DLK  N+LLD     K++DFG+ +           +T
Sbjct: 106 YAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST 160

Query: 299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            C      GT  ++ PE L     T   D +  G+++  +L G  
Sbjct: 161 FC------GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)

Query: 139 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 189
           NF+    +G G YG ++          G L  M+V  K       +     + E ++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 190 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCS 245
           +R  P LVTL  A        L+ +Y+  G +   L  +DN      +  +R  + E+  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEIIL 116

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTD 304
            L  LH      IV+ D+K  NILLD+     L+DFG+S+ FLS+ +      + C    
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--ERTYSFC---- 167

Query: 305 PKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
             GT  YM PE +       K+ D +S GI++  LLTG
Sbjct: 168 --GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 49/145 (33%), Positives = 68/145 (46%), Gaps = 17/145 (11%)

Query: 208 LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 266
            V EYL  G L   + SC     P +       A E+   L FLHS     IV+ DLK  
Sbjct: 73  FVMEYLNGGDLMFHIQSCHKFDLPRA----TFYAAEIICGLQFLHS---KGIVYRDLKLD 125

Query: 267 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 326
           NILLD +   K++DFG+ +   +N +    T   C     GT  Y+ PE L   +     
Sbjct: 126 NILLDTDGHIKIADFGMCK---ENMLGDAKTCTFC-----GTPDYIAPEILLGQKYNTSV 177

Query: 327 DVYSFGIILLRLLTGR-PALGITKE 350
           D +SFG++L  +L G+ P  G  +E
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEE 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 32/246 (13%)

Query: 106 EELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ-- 163
           + L+  +K+ S S+  P+  +   + +      NF  +L  G G +G +     ++    
Sbjct: 5   KNLQLHKKKDSDSTKEPKRKNKMKYEDF-----NFIRTL--GTGSFGRVILATYKNEDFP 57

Query: 164 -VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGS 217
            VAIK      +    +      E  IL+ I HP  V L G+  +     LV E++  G 
Sbjct: 58  PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGE 117

Query: 218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
               L      P          A ++  +  +L S    +IV+ DLKP N+LLD +   K
Sbjct: 118 FFTFLRRNKRFPN---DVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIK 171

Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      + +   TLC      GT  Y+ PE L +      +D ++ GI +  
Sbjct: 172 MTDFGFAKV-----VDTRTYTLC------GTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220

Query: 338 LLTGRP 343
           +L G P
Sbjct: 221 ILVGCP 226

Length = 340

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 52/165 (31%), Positives = 74/165 (44%), Gaps = 22/165 (13%)

Query: 183 EIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRI 239
           E  +L   RHP L  L  +      L  V EY   G L   LS  +  S     + R   
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYG 101

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-- 297
           A E+ S L +LHSC    +V+ DLK  N++LD +   K++DFG    L +  IS   T  
Sbjct: 102 A-EIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFG----LCKEGISDGATMK 153

Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           T C      GT  Y+ PE L   +     D +  G+++  ++ GR
Sbjct: 154 TFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 40/111 (36%), Positives = 54/111 (48%), Gaps = 17/111 (15%)

Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 293
           + +  IA EL   L  LH    + IV+ DLKP NILLDA     L DFG    LS+  ++
Sbjct: 97  RAKFYIA-ELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFG----LSKANLT 148

Query: 294 SNNT--TLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTG 341
            N T  T C      GT  Y+ PE L   +  T   D +S G+++  +  G
Sbjct: 149 DNKTTNTFC------GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 37/211 (17%)

Query: 146 IGEGGYGSI--YKGLLRHMQVAIK-MLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--V 199
           +G G +G +   +  L    VAIK ++ P S    ++   +E+ +L  +RH N+++L  +
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 200 GACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              P E    V E L  G+   RL     S PL  Q       ++   L ++HS     +
Sbjct: 78  FISPLEDIYFVTELL--GTDLHRLL---TSRPLEKQFIQYFLYQILRGLKYVHSA---GV 129

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK-----GTFAYMD 313
           VH DLKP+NIL++ N   K+ DFG++R                  DP+      T  Y  
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARI----------------QDPQMTGYVSTRYYRA 173

Query: 314 PE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE  L   +   + D++S G I   +L G+P
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 12/98 (12%)

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L ++HS    +++H DLKP+N+LL+AN   K+ DFG++R        + +      T+  
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTEYV 169

Query: 307 GTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
            T  Y  PE  L   E T   DV+S G I   LL  +P
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 30/212 (14%)

Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----V 199
           IG G +G +Y+ +      +VAIK +    LQ P    +E+ I+  + H N++ L     
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129

Query: 200 GACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
             C +         +V E++P    +       N+  L        + +LC  L ++HS 
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS- 188

Query: 254 KPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
               I H DLKP N+L+D N    KL DFG ++ L   + S   + +C R        Y 
Sbjct: 189 --KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRF-------YR 237

Query: 313 DPEF-LASGELTPKSDVYSFGIILLRLLTGRP 343
            PE  L +   T   D++S G I+  ++ G P
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYP 269

Length = 440

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 11/103 (10%)

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+   L FLH      I++ DLK  N+LLD +   K++DFG+ +   +N       + 
Sbjct: 102 AAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKAST 155

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            C     GT  Y+ PE L   +     D +SFG++L  +L G+
Sbjct: 156 FC-----GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 32/226 (14%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 198
           K+G G YG +YK   +  +     A+K +    +   +   +EI +L +++HPN+++L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65

Query: 199 ---VGACPEVWTLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
                A  +VW L+++Y  +     ++   + K N  P+    R  + + L  +L  +H 
Sbjct: 66  VFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQL-PRGMVKSLLYQILDGIHY 123

Query: 253 CKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTL--CCRTDP- 305
              + ++H DLKPANIL+          K++D G +R          N+ L      DP 
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--------NSPLKPLADLDPV 175

Query: 306 KGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRPALGITKE 350
             TF Y  PE L       K+ D+++ G I   LLT  P     +E
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 38/232 (16%)

Query: 146 IGEGGYGSIY------KGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRH--- 192
           IG GG+G +Y       G +  M+      IKM      QG +    E  +LS +     
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGDC 56

Query: 193 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
           P +V +  A   P+  + + + +  G L   LS        S       A E+   L  +
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHM 113

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           H+     +V+ DLKPANILLD +   ++SD G++   S+ +  ++           GT  
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----------VGTHG 160

Query: 311 YMDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKL 360
           YM PE L  G     S D +S G +L +LL G  P      + ++ +D   L
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 32/226 (14%)

Query: 145 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 198
           K+G G YG +YK   +      + A+K +    +   +   +EI +L +++HPN++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQK 65

Query: 199 ---VGACPEVWTLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
                +  +VW L+++Y  +     ++   + K N  P+    R  + + L  +L  +H 
Sbjct: 66  VFLSHSDRKVW-LLFDYAEHDLWHIIKFHRASKANKKPMQL-PRSMVKSLLYQILDGIHY 123

Query: 253 CKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTL--CCRTDP- 305
              + ++H DLKPANIL+          K++D G +R          N+ L      DP 
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--------NSPLKPLADLDPV 175

Query: 306 KGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRPALGITKE 350
             TF Y  PE L       K+ D+++ G I   LLT  P     +E
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 50/174 (28%), Positives = 70/174 (40%), Gaps = 33/174 (18%)

Query: 183 EIDILSKIRHPNLVTLVGACPEVW-TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 241
           EIDIL  I H  ++ L+ A    W + V   +P     D  +  D S PL  +  I I  
Sbjct: 136 EIDILKTISHRAIINLIHAYR--WKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQR 192

Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 301
            L   L +LH      I+H D+K  NI LD    + L DFG +                C
Sbjct: 193 RLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA----------------C 233

Query: 302 RTD-----PK-----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
           + D     P+     GT     PE LA      K+D++S G++L  +      L
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 11/102 (10%)

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+ S L+FLH      I++ DLK  N+LLD     KL+DFG+ +    N  ++  +T 
Sbjct: 102 AAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STF 156

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           C      GT  Y+ PE L      P  D ++ G++L  +L G
Sbjct: 157 C------GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+   L FLHS     I++ DLK  N++LD +   K++DFG+ +   +N    N  + 
Sbjct: 102 AAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRAST 155

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            C     GT  Y+ PE L   + T   D +SFG++L  +L G+
Sbjct: 156 FC-----GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 75/239 (31%)

Query: 146 IGEGGYGSIYKGLLRH--MQVAIK---MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
           +G G  G ++  +      +VA+K   +  P S++      +EI I+ ++ H N+V    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDHDNIVK--- 66

Query: 201 ACPEVWTLVYEYL-PNGSLEDRLSCKDNSPPLSWQTRIRIA--------TELCSV----- 246
                   VYE L P+GS        D +  +   T +           T+L +V     
Sbjct: 67  --------VYEVLGPSGS--------DLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP 110

Query: 247 ----------------LIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFL-- 287
                           L ++HS    +++H DLKPAN+ ++  + V K+ DFG++R +  
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167

Query: 288 --SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRP 343
             S     S             T  Y  P  L S    T   D+++ G I   +LTG+P
Sbjct: 168 HYSHKGYLSEGLV---------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 31/209 (14%)

Query: 146 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G+G +G +   L+R        A+K+L    +    E      E  +L   RHP L  L
Sbjct: 3   LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 255
             A    +    V EY   G L   LS       +  + R R    E+ S L +LHS   
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS--- 113

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 313
             +V+ D+K  N++LD +   K++DFG    L +  IS   T  T C      GT  Y+ 
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC------GTPEYLA 163

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGR 342
           PE L   +     D +  G+++  ++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 11/104 (10%)

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+   L FLHS     I++ DLK  N++LDA    K++DFG+ +   +N      T  
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            C     GT  Y+ PE +A        D ++FG++L  +L G+P
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 24/208 (11%)

Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 200
           IG G +G +    ++H +   A+K+L+   +   +E   F++E ++L       + TL  
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68

Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           A  +     LV +Y   G L   LS  ++  P     R  IA     +++ +HS      
Sbjct: 69  AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYIA----EMVLAIHSIHQLHY 123

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           VH D+KP N+LLD N   +L+DFG    ++Q+    ++  +       GT  Y+ PE L 
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-------GTPDYISPEILQ 176

Query: 319 S-----GELTPKSDVYSFGIILLRLLTG 341
           +     G+  P+ D +S G+ +  +L G
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 22/209 (10%)

Query: 145 KIGEGGYG-----SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G      IY        V  ++    S +  +EF Q+ D    ++HPN++  +
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C E   + LV+EY   G L+  LS +     NS  L  Q   R+A E+ + +  +H  
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHK- 117

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGI--SRFLSQNEISSNNTTLCCR-TDPKGTFA 310
             H+ +H DL   N  L ++   K+ D+GI  SR+      + ++  +  R   P+    
Sbjct: 118 --HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLL 339
           +     L + E T  S+V++ G+ L  L 
Sbjct: 176 FHGG--LITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 49/225 (21%)

Query: 145 KIGEGGYGSI----YKGLLRHMQVAIK---------MLHPHSLQGPSEFQQEIDILSKIR 191
           ++G+G YG +             VAIK         +L   +L+       E+ +L   R
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-------ELKLLRHFR 59

Query: 192 -HPNLVTLV-------GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS---WQTRI-RI 239
            H N+  L        G   E++  +YE L    L   +    +  PL+   +Q+ I +I
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELY--LYEELMEADLHQIIR---SGQPLTDAHFQSFIYQI 114

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
              LC  L ++HS    +++H DLKP N+L++A+   K+ DFG++R  S+N   +     
Sbjct: 115 ---LCG-LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM- 166

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 343
              T+   T  Y  PE + S +   K+ DV+S G IL  LL  +P
Sbjct: 167 ---TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 31/209 (14%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G+G +G +   L+R        A+K+L    +    E      E  +L   RHP L +L
Sbjct: 3   LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 255
             +    +    V EY+  G L   LS       +  + R R    E+ S L +LHS K 
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSGK- 115

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 313
             IV+ DLK  N++LD +   K++DFG    L +  I+   T  T C      GT  Y+ 
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFG----LCKEGITDAATMKTFC------GTPEYLA 163

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGR 342
           PE L   +     D +  G+++  ++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 45/140 (32%), Positives = 65/140 (46%), Gaps = 19/140 (13%)

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           +++ L       ++H DLK ANI L    + KL DFG S+  S +      ++ C     
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC----- 232

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG-----ITKEVQYA-LD-- 356
            GT  Y+ PE       + K+D++S G+IL  LLT  RP  G     I ++V Y   D  
Sbjct: 233 -GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291

Query: 357 ----TGKLKNLLDPLAGDWP 372
               +  +K LLDPL    P
Sbjct: 292 PCPVSSGMKALLDPLLSKNP 311

Length = 478

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 11/97 (11%)

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L +LHS     I+H D+KP N+L+++N V K+ DFG++R    +E           T   
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-------SKHMTQEV 165

Query: 307 GTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGR 342
            T  Y  PE L  S   T   D++S G I   LL  R
Sbjct: 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 7e-07
 Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 38/236 (16%)

Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQV-----AIKMLHPHSLQGPSEFQQ---EIDILSK 189
            +F     +G+G  G ++   L  ++      A+K+L    +   ++ ++   E +IL+ 
Sbjct: 1   KHFKKIKLLGKGDVGRVF---LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT 57

Query: 190 IRHPNLVTLVG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           + HP L TL           LV +Y P G L   L  +     LS +     A E+   L
Sbjct: 58  LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLAL 116

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS----------------QNE 291
            +LH      IV+ DLKP NILL  +    LSDF +S+                    + 
Sbjct: 117 EYLH-LL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 292 ISSNNTTLCCRTDPK-----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            S  + T       +     GT  Y+ PE ++        D ++ GI+L  +L G 
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 20/212 (9%)

Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 200
           +G+GG+G +    +R      A K L    ++   G S    E  IL K+    +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 201 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           A    +   LV   +  G L+  +    N P    +  +  A E+   L  LH     + 
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR---ENT 123

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           V+ DLKP NILLD     ++SD G++  + + E               GT  YM PE L 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---------GTVGYMAPEVLN 174

Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 350
           +   T   D +  G ++  ++ G+      KE
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 16/141 (11%)

Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKPHSIVHGDLKPA 266
           LV EY+  G L   +  +   P    +   R  A E+C  L FLH      I++ DLK  
Sbjct: 73  LVIEYVNGGDLMFHMQRQRKLP----EEHARFYAAEICIALNFLHE---RGIIYRDLKLD 125

Query: 267 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 326
           N+LLDA+   KL+D+G+ +   +     + T+  C     GT  Y+ PE L   E     
Sbjct: 126 NVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFC-----GTPNYIAPEILRGEEYGFSV 177

Query: 327 DVYSFGIILLRLLTGRPALGI 347
           D ++ G+++  ++ GR    I
Sbjct: 178 DWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 11/104 (10%)

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+   L FLHS     I++ DLK  N++LD+    K++DFG+ +   +N      T  
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            C     GT  Y+ PE +A        D ++FG++L  +L G+ 
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 60/225 (26%)

Query: 146 IGEGGYGSIYKGLLRH--MQVAIK-MLHPHSLQGPSEFQQEID---------ILSKIRHP 193
           +G G YG +          +VAIK +  P        FQ  I          +L  + H 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYRELRLLKHMDHE 74

Query: 194 NLVTLVGACPEVWTLVYEYLPNGSLED-------------RLSCKDNSPPLSWQTRIR-I 239
           N++ L+    +V+T      P  SLED              L+       LS    I+ +
Sbjct: 75  NVIGLL----DVFT------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFL 123

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
             ++   L ++HS     I+H DLKP+NI ++ +   K+ DFG++R              
Sbjct: 124 VYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--------- 171

Query: 300 CCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
              T    T  Y  PE  L         D++S G I+  LLTG+ 
Sbjct: 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 20/212 (9%)

Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 200
           +G+GG+G +    +R      A K L    ++   G +    E  IL K+    +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 201 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           A    +   LV   +  G L+  +    N P    Q  I  A ELC  L  L       I
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR---ERI 123

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           V+ DLKP NILLD     ++SD G++  + + E               GT  YM PE + 
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---------GTVGYMAPEVIN 174

Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 350
           + + T   D +  G ++  ++ G+      KE
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 27/220 (12%)

Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP 193
            + P   IG G YG +   +      +VAIK + PH+   P+  ++   E+ IL   +H 
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 194 NLVTL-------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           N++ +            +V+ +V + L    L   +       PL+ +       +L   
Sbjct: 65  NIIAIRDILRPPGADFKDVY-VVMD-LMESDLHHIIHSDQ---PLTEEHIRYFLYQLLRG 119

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L ++HS     ++H DLKP+N+L++ +   ++ DFG++R LS +            T+  
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM----TEYV 172

Query: 307 GTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPAL 345
            T  Y  PE L S  E T   D++S G I   +L GR  L
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 29/208 (13%)

Query: 146 IGEGGYGSIY---KGLLRHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRH---PNLV 196
           IG GG+G +Y   K     M  A+K L    +   QG +    E  +LS +     P +V
Sbjct: 2   IGRGGFGEVYGCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 197 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            +  A   P+    + + +  G L   LS        S +     ATE+   L  +H+  
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHN-- 115

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              +V+ DLKPANILLD +   ++SD G++   S+ +  ++           GT  YM P
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----------VGTHGYMAP 164

Query: 315 EFLASGELTPKS-DVYSFGIILLRLLTG 341
           E L  G     S D +S G +L +LL G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 31/105 (29%), Positives = 56/105 (53%)

Query: 11  ESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 70
           +    E  ++R+  +E L   + ELE  +++ D +  EL+    ++  LE +I E ++  
Sbjct: 778 KEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEEEI 837

Query: 71  KELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
           +ELE+K+    E L+  +KE +EL+ E ++   E EEL    KE 
Sbjct: 838 EELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKEL 882

Length = 1163

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 24/208 (11%)

Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 200
           IG G +G +    L++     A+K+L+   +   +E   F++E D+L    +  + TL  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           A  +     LV +Y   G L   LS  ++  P     R  +A     ++I + S      
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA----EMVIAIDSVHQLHY 123

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           VH D+KP NIL+D N   +L+DFG    L ++    ++  +       GT  Y+ PE L 
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-------GTPDYISPEILQ 176

Query: 319 S-----GELTPKSDVYSFGIILLRLLTG 341
           +     G+  P+ D +S G+ +  +L G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 25/121 (20%), Positives = 52/121 (42%), Gaps = 11/121 (9%)

Query: 6   QAKASESLYAEELK----RRKEFEEALANGKLE-------LERMKKQHDEVMEELQIALD 54
             + S +    EL+    R  + E  +     E       +E  +K+ D++ EE     +
Sbjct: 305 SLERSIAEKERELEDAEERLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAELKE 364

Query: 55  QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
           +   L +++ E D+   E   ++    E L+  K+E +EL+ E D+  +E + L +   +
Sbjct: 365 ELEDLRAELEEVDKEFAETRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELAD 424

Query: 115 A 115
            
Sbjct: 425 L 425

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 24/112 (21%), Positives = 49/112 (43%), Gaps = 16/112 (14%)

Query: 180 FQQEIDILSKIRH-----PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQ 234
            ++E+ IL  +       P ++    +    + L+ E++   +L+           +S +
Sbjct: 38  REREVAILQLLARKGLPVPKVLASGESDGWSY-LLMEWIEGETLD----------EVSEE 86

Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 286
            +  IA +L  +L  LH      + HGDL P NIL+D   +  + D+  + +
Sbjct: 87  EKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 20/160 (12%)

Query: 192 HPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           HP LV L  +C         V E++  G L   +  +   P    +   R  + E+   L
Sbjct: 55  HPFLVGL-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 109

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            FLH      I++ DLK  N+LLDA    KL+D+G+ +   +     + T+  C     G
Sbjct: 110 NFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFC-----G 158

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 347
           T  Y+ PE L   +     D ++ G+++  ++ GR    I
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 20/212 (9%)

Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 200
           +G+GG+G +    +R      A K L    ++   G +    E  IL K+    +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 201 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           A    +   LV   +  G L+  +    N P    +  +  A E+   L  LH      I
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR---ERI 123

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           V+ DLKP NILLD     ++SD G++  + + E               GT  YM PE + 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---------GTVGYMAPEVVK 174

Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 350
           +   T   D +  G ++  ++ G+      KE
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 13/123 (10%)

Query: 220 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
            R +  + SP LS+   +  + ++ + + FL S    + VH DL   N+L+    + K+ 
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKIC 281

Query: 280 DFGISRFL--SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           DFG++R +    N IS  +T L           +M PE + +   T  SDV+SFGI+L  
Sbjct: 282 DFGLARDIMRDSNYISKGSTFL--------PLKWMAPESIFNNLYTTLSDVWSFGILLWE 333

Query: 338 LLT 340
           + T
Sbjct: 334 IFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 17/132 (12%)

Query: 209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 268
           +Y ++ + + +     KD   PL  QTR  I  +L   + ++H  K   ++H D+K  NI
Sbjct: 249 LYSFMYDEAFD----WKDR--PLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENI 298

Query: 269 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDV 328
            L+ +    L DFG +    +   + +   +       GT A   PE LA       +D+
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-------GTVATNSPEILAGDGYCEITDI 351

Query: 329 YSFGIILLRLLT 340
           +S G+ILL +L+
Sbjct: 352 WSCGLILLDMLS 363

Length = 501

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 11/104 (10%)

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+   L FLH      I++ DLK  N++LD+    K++DFG+ +   ++ +    T  
Sbjct: 107 AAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT 160

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            C     GT  Y+ PE +A        D +++G++L  +L G+P
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 12/114 (10%)

Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
           I  + ++   ++ LHS     IV+ D+KP N+LLD     +LSD G++      E+    
Sbjct: 98  IHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAV-----ELKDGK 149

Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 350
           T     T   GT  YM PE L     +   D ++ G  +  ++ GR      KE
Sbjct: 150 TI----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 19/136 (13%)

Query: 212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 271
                 +  R+ CK N   +       I  ++ + L ++H    H I HGD+KP NI++D
Sbjct: 110 VENTKEIFKRIKCK-NKKLIK-----NIMKDMLTTLEYIHE---HGISHGDIKPENIMVD 160

Query: 272 ANFVSKLSDFGISRFLSQN----EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 327
            N    + D+GI+     +    E S     L      +GT  Y   +      +T + D
Sbjct: 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL-----HRGTLYYAGLDAHNGACVTRRGD 215

Query: 328 VYSFGIILLRLLTGRP 343
           + S G  +L+   G  
Sbjct: 216 LESLGYCMLK-WAGIK 230

Length = 294

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+C  L  LH      IV+ DLKP NILLD +   ++SD G++  + + +      T+
Sbjct: 108 AAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ------TI 158

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
             R    GT  YM PE + +   T   D ++ G +L  ++ G+
Sbjct: 159 KGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 42/140 (30%), Positives = 62/140 (44%), Gaps = 19/140 (13%)

Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 267
           LV +Y   G L   LS  ++  P     R  +A     +++ + S      VH D+KP N
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA----EMVLAIDSVHQLGYVHRDIKPDN 132

Query: 268 ILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL-----ASGE 321
           +LLD N   +L+DFG   R L+   + SN           GT  Y+ PE L       G 
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--------GTPDYISPEILQAMEDGKGR 184

Query: 322 LTPKSDVYSFGIILLRLLTG 341
             P+ D +S G+ +  +L G
Sbjct: 185 YGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 32/173 (18%)

Query: 183 EIDILSKIRHPNLVTLVGA-------C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLS 232
           E  IL  I HP+++ L G        C   P   T +Y YL   + +  ++  D      
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL---AAKRNIAICD------ 183

Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
               + I   +   + +LH    + I+H D+K  NI ++      L DFG + F    +I
Sbjct: 184 ---ILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDI 235

Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
           ++N           GT A   PE LA     P  D++S GI+L  + T   +L
Sbjct: 236 NANKYY-----GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 9/92 (9%)

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           FL S K    +H DL   NILL  N V K+ DFG++R + ++             D +  
Sbjct: 188 FLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK------GDARLP 238

Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE +     T +SDV+SFG++L  + +
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 21/206 (10%)

Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 200
           +G+GG+G +    +R      A K L+   L+    ++    E  IL+K+    +V+L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 201 ACPEVWT---LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           A  +  T   LV   +  G L   + +  + +P            ++ S L  LH     
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---R 116

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            I++ DLKP N+LLD +   ++SD G++  L   +  +            GT  +M PE 
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--------GTPGFMAPEL 168

Query: 317 LASGELTPKSDVYSFGIILLRLLTGR 342
           L   E     D ++ G+ L  ++  R
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 45.8 bits (109), Expect = 5e-05
 Identities = 26/113 (23%), Positives = 53/113 (46%)

Query: 4   NLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI 63
             + K +E    E     +E EE L   +LE+  ++++ +E+ +EL    ++ S LE Q 
Sbjct: 245 QEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQKELYALANEISRLEQQK 304

Query: 64  AESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 116
               +    LE+++      L+  + + DEL  E  +  ++ EEL++  +   
Sbjct: 305 QILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEELESLE 357

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 33/164 (20%)

Query: 186 ILSKIRHPNLV----TLVG---AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT 235
           +L  + HP+++    TLV     C   P   + +Y YL              S PL    
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK-----------RSRPLPIDQ 158

Query: 236 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
            + I  ++   L +LH+     I+H D+K  NI ++      + D G ++F     ++  
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPA 212

Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
              L       GT     PE LA  +   K+D++S GI+L  +L
Sbjct: 213 FLGLA------GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|224495 COG1579, COG1579, Zn-ribbon protein, possibly nucleic acid-binding [General function prediction only]

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 32/120 (26%), Positives = 52/120 (43%), Gaps = 7/120 (5%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           Q    ES   E  +R K  EE L+  K E E           E+QIA ++ + LE ++AE
Sbjct: 60  QVSQLESEIQEIRERIKRAEEKLSAVKDERELRALNI-----EIQIAKERINSLEDELAE 114

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK--SRKEASSSSHMPQ 123
             +  ++LE++I    E L+  +K   E +   ++ V E  E  +  S K       +  
Sbjct: 115 LMEEIEKLEKEIEDLKERLERLEKNLAEAEARLEEEVAEIREEGQELSSKREELKEKLDP 174

Length = 239

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 26/110 (23%), Positives = 56/110 (50%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +  A E    +   R +E EE L   + ELE ++++ +E+ EEL+   +  + L+ +I E
Sbjct: 724 ELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAKLKEEIEE 783

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
            ++  + L++++    E L+  ++  D L+ E +   +  E L +  +E 
Sbjct: 784 LEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEEL 833

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 25/104 (24%), Positives = 47/104 (45%), Gaps = 1/104 (0%)

Query: 16  EELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELE 74
           E+++  KE  E       ELE++  + +E  EEL+  L      LE       +   ELE
Sbjct: 330 EKIEALKEELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELE 389

Query: 75  QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 118
            ++      L+  K+E + L+   ++  +  E+L++  KE  + 
Sbjct: 390 AELAEIRNELEELKREIESLEERLERLSERLEDLKEELKELEAE 433

Length = 1163

>gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional

 Score = 45.5 bits (107), Expect = 7e-05
 Identities = 28/113 (24%), Positives = 54/113 (47%)

Query: 2    ADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLES 61
            AD  + KA E+  A+E K++ E  +  A+   +     K+  E  +    A   ++    
Sbjct: 1304 ADEAKKKAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAEAAE 1363

Query: 62   QIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
            + AE+ +  KE  +K   A +     KK+ DE + + ++  K+A+EL+K+   
Sbjct: 1364 EKAEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDKKKADELKKAAAA 1416

Length = 2084

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 16/142 (11%)

Query: 210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 269
           Y+   +  +++ LS  D S  L+    +    ++   + FL S    + VH DL   N+L
Sbjct: 214 YKGSNDSEVKNLLS-DDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL 269

Query: 270 LDANFVSKLSDFGISRFL--SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 327
           L    + K+ DFG++R +    N +S  +T L  +        +M PE +     T  SD
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK--------WMAPESIFDNLYTTLSD 321

Query: 328 VYSFGIILLRL--LTGRPALGI 347
           V+S+GI+L  +  L G P  G+
Sbjct: 322 VWSYGILLWEIFSLGGTPYPGM 343

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 21/165 (12%)

Query: 183 EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI- 239
           E  +L   RHP L  L  +    +    V EY   G L   LS       +  + R R  
Sbjct: 45  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFY 100

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-- 297
             E+ S L +LHS K  ++V+ DLK  N++LD +   K++DFG    L +  I    T  
Sbjct: 101 GAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGATMK 154

Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           T C      GT  Y+ PE L   +     D +  G+++  ++ GR
Sbjct: 155 TFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 44.7 bits (106), Expect = 9e-05
 Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 7/112 (6%)

Query: 5   LQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIA 64
           L+A+  E   A  L + KE  + L   + EL R++++ +E+ EEL+ A  +   L+S++ 
Sbjct: 218 LKAELRELELALLLAKLKELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSEL- 276

Query: 65  ESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 116
                 +EL +++    E L   K+E +EL+ E     +  EEL    +E  
Sbjct: 277 ------EELREELEELQEELLELKEEIEELEGEISLLRERLEELENELEELE 322

Length = 1163

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 31/118 (26%), Positives = 58/118 (49%), Gaps = 11/118 (9%)

Query: 220 DRLSCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
           D    +D     PL     +R ++++   + FL S    + +H D+   N+LL    V+K
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAK 252

Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 335
           + DFG++R +       N++    + + +    +M PE +     T +SDV+S+GI+L
Sbjct: 253 ICDFGLARDI------MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 44/163 (26%), Positives = 63/163 (38%), Gaps = 33/163 (20%)

Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 267
           L+ E+LP G +   L  KD       +T+  IA  + ++     S      +H D+KP N
Sbjct: 78  LIMEFLPGGDMMTLLMKKDTLT--EEETQFYIAETVLAI----DSIHQLGFIHRDIKPDN 131

Query: 268 ILLDANFVSKLSDFGI---------------------SRFLSQNEISSNNTTLCCRTDPK 306
           +LLD+    KLSDFG+                     S F  QN  S        R   +
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191

Query: 307 ------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                 GT  Y+ PE           D +S G+I+  +L G P
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 13/113 (11%)

Query: 230 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR--FL 287
           PL+ +  I  + ++   + FL S K    +H DL   NILL  N V K+ DFG++R  + 
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226

Query: 288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             + +   +  L           +M PE +     T +SDV+SFG++L  + +
Sbjct: 227 DPDYVRKGSARL--------PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 12/117 (10%)

Query: 224 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 283
            K     L+ +  I  + ++   + FL S K    +H DL   NILL  N V K+ DFG+
Sbjct: 172 YKK---VLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 225

Query: 284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           +R + +      +     + D +    +M PE +     T +SDV+SFG++L  + +
Sbjct: 226 ARDIYK------DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 23/167 (13%)

Query: 178 SEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLS--CKDNSPPLS 232
              QQEI    +++HPN++  V +     E++ +V   +  GS ED L     +  P   
Sbjct: 44  KLLQQEIITSRQLQHPNILPYVTSFIVDSELY-VVSPLMAYGSCEDLLKTHFPEGLP--- 99

Query: 233 WQTRIR-IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 291
            +  I  I  ++ + L ++HS      +H  +K ++ILL  +    LS    S  +    
Sbjct: 100 -ELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---- 151

Query: 292 ISSNNTTLCCRTDPKGT---FAYMDPEFLASGEL--TPKSDVYSFGI 333
           I            PK +     ++ PE L         KSD+YS GI
Sbjct: 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 27/112 (24%), Positives = 57/112 (50%)

Query: 4   NLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI 63
             +  A E       +RR+  E+ +   + E+E ++++ DE+ EEL+    +   L+ ++
Sbjct: 806 ERRLDALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEEL 865

Query: 64  AESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
            E +   +ELE ++    E  +  ++E  EL+ E  +  +E E+LR+  +E 
Sbjct: 866 EELEAEKEELEDELKELEEEKEELEEELRELESELAELKEEIEKLRERLEEL 917

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 25/112 (22%), Positives = 52/112 (46%), Gaps = 7/112 (6%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +    E    E  +  +E E+ +   K ELE ++++ +E+ EEL    ++   LE +I+ 
Sbjct: 247 ELSRLEEELEELQEELEEAEKEIEELKSELEELREELEELQEELLELKEEIEELEGEISL 306

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 117
             +  +ELE +       L+  ++  +EL+ + +   +E EE     +E   
Sbjct: 307 LRERLEELENE-------LEELEERLEELKEKIEALKEELEERETLLEELEQ 351

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 24/112 (21%), Positives = 57/112 (50%), Gaps = 2/112 (1%)

Query: 1   MADNLQAKASESLYAEELKRRK--EFEEALANGKLELERMKKQHDEVMEELQIALDQKSL 58
           + + L+ + +E        R +  E +  + + +  LER+ ++ +++ EEL+    +   
Sbjct: 377 LFEALREELAELEAELAEIRNELEELKREIESLEERLERLSERLEDLKEELKELEAELEE 436

Query: 59  LESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 110
           L++++ E ++  +ELE+++    + L+  ++E  ELQ E  +  KE   L  
Sbjct: 437 LQTELEELNEELEELEEQLEELRDRLKELERELAELQEELQRLEKELSSLEA 488

Length = 1163

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 25/97 (25%), Positives = 47/97 (48%)

Query: 19  KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 78
           ++ +E EE +A  +  L  ++K+ +E+ EEL+    +   L  QI+   +    LE ++ 
Sbjct: 684 EKIEELEEKIAELEKALAELRKELEELEEELEQLRKELEELSRQISALRKDLARLEAEVE 743

Query: 79  SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
              E +    KE  EL+ E ++  +  EE  +   EA
Sbjct: 744 QLEERIAQLSKELTELEAEIEELEERLEEAEEELAEA 780

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 2e-04
 Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 39/211 (18%)

Query: 142 PSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HP 193
             LK+ +G +G +   +L+H       +Q  IK  + +++        E  +   ++ +P
Sbjct: 20  KKLKLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNP 69

Query: 194 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N + L  +    +   L+ +Y+ +G L D L        LS     +I  +L   L  LH
Sbjct: 70  NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 252 SCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
               H+I+H D+K  N+L D A     L D+G    L +       T  C      GT  
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYG----LCKII----GTPSCYD----GTLD 171

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           Y  PE +         D ++ G++   LLTG
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 41/227 (18%)

Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHP--HSLQGPSEFQQEIDIL 187
           E+     N  P   +G G YGS+         ++VA+K L     S+       +E+ +L
Sbjct: 14  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 188 SKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTR 236
             ++H N++ L+       +L     VY   +L    L + + C+    D+   L +Q  
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-- 128

Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
                 +   L ++HS     I+H DLKP+N+ ++ +   K+ DFG++R           
Sbjct: 129 ------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 173

Query: 297 TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGR 342
                 T    T  Y  PE + +        D++S G I+  LLTGR
Sbjct: 174 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 6/82 (7%)

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   NILL    ++K+ DFG++R +       N++    + + +    +M PE + 
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDI------RNDSNYVVKGNARLPVKWMAPESIF 289

Query: 319 SGELTPKSDVYSFGIILLRLLT 340
           +   T +SDV+S+GI+L  + +
Sbjct: 290 NCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 48/221 (21%)

Query: 144 LKIGEGGYGSIYKGLLRHM--QVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
            ++G G YG++   L R    +VAIK L+    S        +E+ +L  ++H N++ L+
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 200 GACPEVWT------------LVYEYLPN--GSL--EDRLSCKDNSPPLSWQTRIR-IATE 242
               +V+T            LV  ++    G L   ++LS          + RI+ +  +
Sbjct: 81  ----DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----------EDRIQFLVYQ 126

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 302
           +   L ++H+     I+H DLKP N+ ++ +   K+ DFG++R  + +E++    T   R
Sbjct: 127 MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVVTRWYR 182

Query: 303 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             P+    +M          T   D++S G I+  +LTG+P
Sbjct: 183 A-PEVILNWM--------HYTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)

Query: 19  KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQK-- 76
           +R +E E  L   +  LE +K++ + + EEL+        LE  +AE ++  +ELE+K  
Sbjct: 309 ERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEAKEELEEKLS 368

Query: 77  --IISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 118
             +    EL +  ++E  EL+ E  +   E EEL++  +     
Sbjct: 369 ALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEER 412

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 25/114 (21%), Positives = 55/114 (48%), Gaps = 11/114 (9%)

Query: 8   KASESLYAEEL----KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI 63
           +   +L   +L    K  +E EE L+  + ELE ++++ +E  +E++    +   L  ++
Sbjct: 224 ELELALLLAKLKELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREEL 283

Query: 64  AESDQ-------TAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 110
            E  +         +ELE +I    E L+  + E +EL+   ++  ++ E L++
Sbjct: 284 EELQEELLELKEEIEELEGEISLLRERLEELENELEELEERLEELKEKIEALKE 337

Length = 1163

>gnl|CDD|224495 COG1579, COG1579, Zn-ribbon protein, possibly nucleic acid-binding [General function prediction only]

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 10/101 (9%)

Query: 20  RRKEFEEALANGKLELERMKKQHDEVMEELQIALD----QKSLLESQIAESDQTAKELEQ 75
           R KE  +AL   K ELE + K     +E L+I L+    Q S LES+I E  +  K  E+
Sbjct: 25  RIKEIRKALKKAKAELEALNK----ALEALEIELEDLENQVSQLESEIQEIRERIKRAEE 80

Query: 76  KI--ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
           K+  +     L+    E    +   +    E  EL +  ++
Sbjct: 81  KLSAVKDERELRALNIEIQIAKERINSLEDELAELMEEIEK 121

Length = 239

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 43/215 (20%)

Query: 146 IGEGGYGSIYKGLL--------------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR 191
           +G G    IY G+L              + ++V +K+L P        F +   ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 192 HPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 249
           H ++V L G C       +V E++  G L+  L     S  L+   + ++A +L S L +
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 250 LHSCKPHSIVHGDLKPANILL-------DANFVSKLSDFGIS-RFLSQNEISSNNTTLCC 301
           L       +VHG++   NILL       +     KLSD GI    LS+ E        C 
Sbjct: 121 LEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE--------CV 169

Query: 302 RTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIIL 335
              P     ++ PE +  S  L+  +D +SFG  L
Sbjct: 170 ERIP-----WIAPECVEDSKNLSIAADKWSFGTTL 199

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 33/163 (20%)

Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 267
           L+ E+LP G +   L  KD     + Q  I         ++ + +      +H D+KP N
Sbjct: 78  LIMEFLPGGDMMTLLMKKDTLSEEATQFYI------AETVLAIDAIHQLGFIHRDIKPDN 131

Query: 268 ILLDANFVSKLSDFGIS------------RFLSQNEIS-----SNNTTLCCRTDPK---- 306
           +LLDA    KLSDFG+             R L+ N  S     + N+     T  K    
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191

Query: 307 ------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                 GT  Y+ PE           D +S G+I+  +L G P
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 30/126 (23%), Positives = 55/126 (43%), Gaps = 13/126 (10%)

Query: 2   ADNLQAKASESLYAEELKRRKEF---EEALANGKLELERMKKQHDEV-------MEELQI 51
            +   +   E L       R+E    E  LA  + ELE +K++ + +        E L+ 
Sbjct: 363 LEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEERLERLSERLED 422

Query: 52  ALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKS 111
             ++   LE+++ E     +EL +++    E L+  +    EL+ E  +     EEL++ 
Sbjct: 423 LKEELKELEAELEELQTELEELNEELEELEEQLEELRDRLKELERELAEL---QEELQRL 479

Query: 112 RKEASS 117
            KE SS
Sbjct: 480 EKELSS 485

Length = 1163

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 43.1 bits (102), Expect = 4e-04
 Identities = 22/112 (19%), Positives = 52/112 (46%)

Query: 4   NLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI 63
             +   +E+   E   + ++ +E L   +  L+ ++ +   + EE     ++   LE +I
Sbjct: 774 EEELAEAEAEIEELEAQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESLERRI 833

Query: 64  AESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
           A +++  ++LE++I    E +++   E +EL+   ++   E E L   R   
Sbjct: 834 AATERRLEDLEEQIEELSEDIESLAAEIEELEELIEELESELEALLNERASL 885

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 69/310 (22%), Positives = 129/310 (41%), Gaps = 59/310 (19%)

Query: 145 KIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 198
           KIG G +G ++  L++H +       K +    L+    S+   E++++ +++H N+V  
Sbjct: 20  KIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 199 VG-----ACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +      A  +++ L+ E+   G L   +  C      +     + I  +L   L + H+
Sbjct: 78  IDRFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136

Query: 253 CKP----HSIVHGDLKPANILLDANF-----------------VSKLSDFGISRFLSQNE 291
            K       ++H DLKP NI L                     ++K+ DFG+S+ +    
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196

Query: 292 ISSNNTTLCCRTDPKGTFAYMDPEFL--ASGELTPKSDVYSFGIILLRLLTGRPALGITK 349
           ++ +    C      GT  Y  PE L   +     KSD+++ G I+  L +G+      K
Sbjct: 197 MAHS----CV-----GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF--HK 245

Query: 350 EVQYALDTGKLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPE----LGKDVWRV 404
              ++    +LK   D P+ G     ++++L  L      +S K RP     LG  + + 
Sbjct: 246 ANNFSQLISELKRGPDLPIKG-----KSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300

Query: 405 LEPMRASCGG 414
           + P   + GG
Sbjct: 301 VGPPVGAAGG 310

Length = 1021

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 20/160 (12%)

Query: 192 HPNLVTLVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           HP LV L  +C +  +    V EY+  G L   +  +   P    +   R  + E+   L
Sbjct: 55  HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 109

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +LH      I++ DLK  N+LLD+    KL+D+G+ +   +     + T+  C     G
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFC-----G 158

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 347
           T  Y+ PE L   +     D ++ G+++  ++ GR    I
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 42/170 (24%), Positives = 62/170 (36%), Gaps = 41/170 (24%)

Query: 209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 268
           V +Y+P G +   L             R  IA   C++     S      +H D+KP NI
Sbjct: 79  VMDYIPGGDMMSLLIRLGIFE--EDLARFYIAELTCAI----ESVHKMGFIHRDIKPDNI 132

Query: 269 LLDANFVSKLSDFGI---------SRFLSQN------------EISSNNT---------- 297
           L+D +   KL+DFG+         S++  +             E S  +           
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192

Query: 298 ----TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                 C      GT  Y+ PE L     T   D +S G+IL  +L G+P
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|237177 PRK12704, PRK12704, phosphodiesterase; Provisional

 Score = 42.5 bits (101), Expect = 5e-04
 Identities = 22/97 (22%), Positives = 51/97 (52%), Gaps = 3/97 (3%)

Query: 15  AEELKRRKEFE--EALANGKLELERMKKQHDEVMEELQIALDQK-SLLESQIAESDQTAK 71
           AE +K+    E  E +   + E E+  ++    +++L+  L QK   L+ ++   ++  +
Sbjct: 51  AEAIKKEALLEAKEEIHKLRNEFEKELRERRNELQKLEKRLLQKEENLDRKLELLEKREE 110

Query: 72  ELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 108
           ELE+K     +  Q  +K+++EL+   ++ ++E E +
Sbjct: 111 ELEKKEKELEQKQQELEKKEEELEELIEEQLQELERI 147

Length = 520

>gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional

 Score = 42.1 bits (98), Expect = 7e-04
 Identities = 32/133 (24%), Positives = 63/133 (47%), Gaps = 21/133 (15%)

Query: 2    ADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEV---------MEELQIA 52
            A+  + KA E+  A+E K++ E  +     K + E  KK+ DE           +E + A
Sbjct: 1459 AEEAKKKAEEAKKADEAKKKAEEAKKADEAKKKAEEAKKKADEAKKAAEAKKKADEAKKA 1518

Query: 53   LDQKSLLESQIAESDQTAKEL----EQKIISAVELLQNYKKEQDELQME--------RDK 100
             + K   E++ AE  + A E     E+K    ++  +  KK +++ + E        ++ 
Sbjct: 1519 EEAKKADEAKKAEEAKKADEAKKAEEKKKADELKKAEELKKAEEKKKAEEAKKAEEDKNM 1578

Query: 101  AVKEAEELRKSRK 113
            A+++AEE +K+ +
Sbjct: 1579 ALRKAEEAKKAEE 1591

Length = 2084

>gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair]

 Score = 41.7 bits (98), Expect = 8e-04
 Identities = 23/105 (21%), Positives = 44/105 (41%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           + +       E L   +E +E L   K  L  ++    E ++  +  L +   L  ++ E
Sbjct: 229 ELEQEIEALEERLAELEEEKERLEELKARLLEIESLELEALKIREEELRELERLLEELEE 288

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 110
             +  +ELE++I    E L+  +   +EL+   +K     E L K
Sbjct: 289 KIERLEELEREIEELEEELEGLRALLEELEELLEKLKSLEERLEK 333

Length = 908

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 41.6 bits (98), Expect = 9e-04
 Identities = 21/110 (19%), Positives = 55/110 (50%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           + + +E       +  +  E+     + E+E ++++ +E+ E+L    ++   LE ++ E
Sbjct: 801 ELEEAERRLDALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEE 860

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
             +  +ELE +     + L+  ++E++EL+ E  +   E  EL++  ++ 
Sbjct: 861 LKEELEELEAEKEELEDELKELEEEKEELEEELRELESELAELKEEIEKL 910

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 28/104 (26%), Positives = 55/104 (52%), Gaps = 4/104 (3%)

Query: 16  EELK-RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 74
           EELK   +E  E L   + EL  +K++ +E+  E+ +  ++   LE+++ E ++  +EL+
Sbjct: 270 EELKSELEELREELEELQEELLELKEEIEELEGEISLLRERLEELENELEELEERLEELK 329

Query: 75  QKIISAVELLQNYKKEQDELQMERD---KAVKEAEELRKSRKEA 115
           +KI +  E L+  +   +EL+       +A +E EE   +  E 
Sbjct: 330 EKIEALKEELEERETLLEELEQLLAELEEAKEELEEKLSALLEE 373

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 26/108 (24%), Positives = 54/108 (50%), Gaps = 3/108 (2%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           + +        EL   +E  E L +   ELE   ++ +E +EELQ  L++   LE ++  
Sbjct: 713 ELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEE---LEEELES 769

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRK 113
            ++   +L+++I    E  Q  ++E +EL+ E ++A +  + L +  +
Sbjct: 770 LEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELE 817

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 32/123 (26%), Positives = 61/123 (49%), Gaps = 10/123 (8%)

Query: 3   DNLQAKASESLYAEELKRRKEF--------EEALANGKLELERMKKQHDEVMEELQIALD 54
           +    +  E L  EEL+ R E         EEALA  K E+E ++++   + EEL+   +
Sbjct: 743 EEELEELEEEL--EELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEE 800

Query: 55  QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
           +    E ++   ++  + LEQ+     + ++  ++E +EL+ + D+  +E EEL K  +E
Sbjct: 801 ELEEAERRLDALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEE 860

Query: 115 ASS 117
              
Sbjct: 861 LKE 863

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 26/117 (22%), Positives = 55/117 (47%), Gaps = 14/117 (11%)

Query: 8   KASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESD 67
           +  E    E  +R    E  L + +   ER++++    +EEL+   ++   LE ++ E +
Sbjct: 796 EELEEELEEAERRLDALERELESLEQRRERLEQE----IEELE---EEIEELEEKLDELE 848

Query: 68  QTAKELEQKIISAVELLQNYKKEQDEL-------QMERDKAVKEAEELRKSRKEASS 117
           +  +ELE+++    E L+  + E++EL       + E+++  +E  EL     E   
Sbjct: 849 EELEELEKELEELKEELEELEAEKEELEDELKELEEEKEELEEELRELESELAELKE 905

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 24/100 (24%), Positives = 53/100 (53%), Gaps = 1/100 (1%)

Query: 16  EELKRRKEF-EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 74
            EL+ + E  EE L + K EL  ++   +E+  +L+    Q   L+ ++A  ++  ++L+
Sbjct: 677 AELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQ 736

Query: 75  QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
            ++    E L+  ++E +ELQ   ++  +E E L ++  +
Sbjct: 737 SRLEELEEELEELEEELEELQERLEELEEELESLEEALAK 776

Length = 1163

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 8/121 (6%)

Query: 2   ADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLES 61
            +    +    L  E   +  E  E LA  + +LE +K++ + +  EL+    +   LES
Sbjct: 314 LERQLEELEAQL-EELESKLDELAEELAELEEKLEELKEELESLEAELEELEAELEELES 372

Query: 62  QIAESDQTAKELEQKIISAVE-------LLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
           ++ E ++  + L  K+             ++  +   + L+  R++  +E EEL K  +E
Sbjct: 373 RLEELEEQLETLRSKVAQLELQIASLNNEIERLEARLERLEDRRERLQQEIEELLKKLEE 432

Query: 115 A 115
           A
Sbjct: 433 A 433

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional

 Score = 41.7 bits (97), Expect = 0.001
 Identities = 29/119 (24%), Positives = 61/119 (51%), Gaps = 6/119 (5%)

Query: 2    ADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIA------LDQ 55
            A+  +      + AEELK+ +E ++ +   K +    KK+ +E+ +  +          +
Sbjct: 1609 AEEAKKAEEAKIKAEELKKAEEEKKKVEQLKKKEAEEKKKAEELKKAEEENKIKAAEEAK 1668

Query: 56   KSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
            K+  + + AE  + A+E E+K   A++      K+ +EL+ +  +  K+AEEL+K+ +E
Sbjct: 1669 KAEEDKKKAEEAKKAEEDEKKAAEALKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEE 1727

Length = 2084

>gnl|CDD|206034 pfam13863, DUF4200, Domain of unknown function (DUF4200)

 Score = 38.7 bits (91), Expect = 0.001
 Identities = 25/100 (25%), Positives = 47/100 (47%), Gaps = 9/100 (9%)

Query: 19  KRRKEFEEALANGKLELERMKKQHDEVMEELQ---IALDQK-SLLESQIAESDQTAKELE 74
           KRR+  E      +L L+  +++ +   E L+     L++K   L+  + + D+  KE E
Sbjct: 5   KRREMEEV-----QLALDAKREEFERREELLKQREEELEKKEEELQESLIKFDKFLKENE 59

Query: 75  QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
            K   A +  +  KK + E + E  +   E EEL+   ++
Sbjct: 60  AKRRRAEKKAEEEKKLRKEKEEEIKELKAELEELKAEIEK 99

This family is found in eukaryotes. It is a coiled-coil domain of unknwon function. Length = 126

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 6/78 (7%)

Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 267
           LV EYL  G ++  L           +  ++  +E+   L +LH    H I+H DLKP N
Sbjct: 81  LVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDN 134

Query: 268 ILLDANFVSKLSDFGISR 285
           +L+      KL+DFG+S+
Sbjct: 135 MLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 41/135 (30%), Positives = 54/135 (40%), Gaps = 17/135 (12%)

Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 267
           LV ++   G L   +S   N P    +   R A E+   L  LH      IV  DL P N
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDALHR---EGIVCRDLNPNN 115

Query: 268 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 327
           ILLD     +L+ F        +E+  +    C     +    Y  PE     E T   D
Sbjct: 116 ILLDDRGHIQLTYFS-----RWSEVEDS----CDGEAVENM--YCAPEVGGISEETEACD 164

Query: 328 VYSFGIILLRLLTGR 342
            +S G IL  LLTG+
Sbjct: 165 WWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 7/100 (7%)

Query: 15  AEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 74
            E  +  +E EE L   + ELE ++K+ +E+ EEL+    +K  LE ++       KELE
Sbjct: 831 EELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDEL-------KELE 883

Query: 75  QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
           ++     E L+  + E  EL+ E +K  +  EEL    + 
Sbjct: 884 EEKEELEEELRELESELAELKEEIEKLRERLEELEAKLER 923

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 32/101 (31%), Positives = 58/101 (57%), Gaps = 8/101 (7%)

Query: 16  EELKRRKEF-EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 74
           EEL+R+ E  +  LA  + ELE+++ + +E+ EEL+   ++   L+ ++        ELE
Sbjct: 712 EELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLE-------ELE 764

Query: 75  QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
           +++ S  E L   K+E +EL+ +R    +E EEL +  +EA
Sbjct: 765 EELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEA 805

Length = 1163

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 40.4 bits (95), Expect = 0.002
 Identities = 19/95 (20%), Positives = 38/95 (40%), Gaps = 1/95 (1%)

Query: 6   QAKASESLYAEEL-KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIA 64
           +     S   E L    +E EE +   + ELE +  +   + E L +   +   L  ++ 
Sbjct: 845 EQIEELSEDIESLAAEIEELEELIEELESELEALLNERASLEEALALLRSELEELSEELR 904

Query: 65  ESDQTAKELEQKIISAVELLQNYKKEQDELQMERD 99
           E +    EL +++    E L   +   + L++  D
Sbjct: 905 ELESKRSELRRELEELREKLAQLELRLEGLEVRID 939

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 40.4 bits (95), Expect = 0.002
 Identities = 29/120 (24%), Positives = 54/120 (45%), Gaps = 6/120 (5%)

Query: 3   DNLQAKASESLYAEELKRR-KEFEEALANGKL-----ELERMKKQHDEVMEELQIALDQK 56
            +L+ +A ++   +ELK   +E E AL   +L     ELE ++++  E  EEL+    + 
Sbjct: 203 KSLERQAEKAERYKELKAELRELELALLVLRLEELREELEELQEELKEAEEELEELTAEL 262

Query: 57  SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 116
             LE ++ E      ELE++I    + L     E   L+ ++    +    L +  +E  
Sbjct: 263 QELEEKLEELRLEVSELEEEIEELQKELYALANEISRLEQQKQILRERLANLERQLEELE 322

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 12/92 (13%)

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     I+H DLKP+NI++ ++   K+ DFG++R    N + +             T 
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV---------TR 186

Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
            Y  PE +         D++S G I+  L+ G
Sbjct: 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|226513 COG4026, COG4026, Uncharacterized protein containing TOPRIM domain, potential nuclease [General function prediction only]

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 31/132 (23%), Positives = 55/132 (41%), Gaps = 9/132 (6%)

Query: 21  RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQ---KI 77
           RKE + AL    L+  +   ++ ++ E+     + K  LE    E ++  KELE+   + 
Sbjct: 109 RKELKNALVRAGLKTLQRVPEYMDLKEDY---EELKEKLEELQKEKEELLKELEELEAEY 165

Query: 78  ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGAT 137
               E L+  + E   L+    K   E  +L+K   E      +P+   +   S++   T
Sbjct: 166 EEVQERLKRLEVENSRLEEMLKKLPGEVYDLKKRWDELEPGVELPE---EELISDLVKET 222

Query: 138 HNFDPSLKIGEG 149
            N  P    G+G
Sbjct: 223 LNLAPKDIEGQG 234

Length = 290

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 30/114 (26%), Positives = 56/114 (49%), Gaps = 4/114 (3%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD----QKSLLES 61
             +  E L AE  + ++E EE L+    ELE + +   E + EL+  L     +   L+ 
Sbjct: 345 LLEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKR 404

Query: 62  QIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
           +I   ++  + L +++    E L+  + E +ELQ E ++  +E EEL +  +E 
Sbjct: 405 EIESLEERLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEEL 458

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 20/102 (19%), Positives = 49/102 (48%), Gaps = 7/102 (6%)

Query: 19  KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 78
              +  E+ L   + +LE +++Q +E+  EL    ++   L+S++       +ELE+++ 
Sbjct: 695 NELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSRL-------EELEEELE 747

Query: 79  SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH 120
              E L+  ++  +EL+ E +   +   +L++  +E      
Sbjct: 748 ELEEELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQ 789

Length = 1163

>gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional

 Score = 39.7 bits (92), Expect = 0.003
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 16/129 (12%)

Query: 2    ADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEV---MEELQIALDQKSL 58
            AD  + KA E   A+E K++ E ++  A+   +    KK+ DE     EE + A + K  
Sbjct: 1380 ADAAKKKAEEKKKADEAKKKAEEDKKKADELKKAAAAKKKADEAKKKAEEKKKADEAKKK 1439

Query: 59   LES--------QIAESDQTAKELEQKIISAVELLQNYKKEQ-----DELQMERDKAVKEA 105
             E         + AE  + A+E ++K   A +  +  KK +     DE + + ++A K+A
Sbjct: 1440 AEEAKKADEAKKKAEEAKKAEEAKKKAEEAKKADEAKKKAEEAKKADEAKKKAEEAKKKA 1499

Query: 106  EELRKSRKE 114
            +E +K+ + 
Sbjct: 1500 DEAKKAAEA 1508

Length = 2084

>gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair]

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 29/117 (24%), Positives = 61/117 (52%), Gaps = 8/117 (6%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQK----SLLES 61
           + +         L+  +E  E L + +  LE+++++ +++  EL+   ++K     LLE 
Sbjct: 302 ELEEELEGLRALLEELEELLEKLKSLEERLEKLEEKLEKLESELEELAEEKNELAKLLEE 361

Query: 62  QIAESDQTAKELEQKIISAVELLQNYKKEQDEL---QMERDKAVKEA-EELRKSRKE 114
           ++ E ++  +ELE+++  A+E L+  ++   EL     E   A++E  EEL +  KE
Sbjct: 362 RLKELEERLEELEKELEKALERLKQLEEAIQELKEELAELSAALEEIQEELEELEKE 418

Length = 908

>gnl|CDD|224259 COG1340, COG1340, Uncharacterized archaeal coiled-coil protein [Function unknown]

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 6/103 (5%)

Query: 22  KEFEEALANGKLELERMKKQ---HDEVMEELQIALDQKSLLES---QIAESDQTAKELEQ 75
           +E  + +   + ELE  KK    ++++ E      + K        +I E    A+E  +
Sbjct: 134 RELVQKIKELRKELEDAKKALEENEKLKELKAEIDELKKKAREIHEKIQELANEAQEYHE 193

Query: 76  KIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 118
           ++I   E     +KE DEL  E  +  K+ +EL +  +   + 
Sbjct: 194 EMIKLFEEADELRKEADELHEEFVELSKKIDELHEEFRNLQNE 236

Length = 294

>gnl|CDD|234750 PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed

 Score = 39.8 bits (94), Expect = 0.003
 Identities = 21/58 (36%), Positives = 37/58 (63%), Gaps = 1/58 (1%)

Query: 59  LESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE-ELRKSRKEA 115
           LE    E +Q A+E E  +  A +L +  ++++++LQ E DK ++EAE E +++ KEA
Sbjct: 525 LEELERELEQKAEEAEALLKEAEKLKEELEEKKEKLQEEEDKLLEEAEKEAQQAIKEA 582

Length = 782

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLV- 199
           +G G YGS+   Y   LR  +VA+K L     SL       +E+ +L  ++H N++ L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ-KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 200 ----GACPEVWTLVY--EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                   E +  VY    L    L + + C+     LS +    +  +L   L ++HS 
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----LSDEHVQFLIYQLLRGLKYIHSA 137

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               I+H DLKP+N+ ++ +   ++ DFG++R  + +E+          T    T  Y  
Sbjct: 138 ---GIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEM----------TGYVATRWYRA 183

Query: 314 PEFLASG-ELTPKSDVYSFGIILLRLLTGR 342
           PE + +        D++S G I+  LL G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 26/79 (32%), Positives = 35/79 (44%), Gaps = 10/79 (12%)

Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI--VHGDLKP 265
           L+ E+LP G L   L        + + T     T        L     H +  +H D+KP
Sbjct: 78  LIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129

Query: 266 ANILLDANFVSKLSDFGIS 284
            NIL+D     KLSDFG+S
Sbjct: 130 DNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|234501 TIGR04211, SH3_and_anchor, SH3 domain protein

 Score = 38.1 bits (89), Expect = 0.004
 Identities = 24/105 (22%), Positives = 47/105 (44%), Gaps = 4/105 (3%)

Query: 22  KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 81
            E ++ LA  + EL  +++Q  E+ +E Q    + S LE+++    +    ++Q   +A+
Sbjct: 69  PELQQELAELQEELAELQEQLAELQQENQELKQELSTLEAELERLQKELARIKQLSANAI 128

Query: 82  ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFS 126
           EL     +E  EL+ E  +  +E E L    +    +     F  
Sbjct: 129 EL----DEENRELREELAELKQENEALEAENERLQENEQRRWFLY 169

Members of this protein family have a signal peptide, a strongly conserved SH3 domain, a variable region, and then a C-terminal hydrophobic transmembrane alpha helix region. Length = 198

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 38.9 bits (91), Expect = 0.004
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 13/100 (13%)

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 302
           LC +   LHS     I+H DLKP+NI++ ++   K+ DFG++R       +  +  +   
Sbjct: 128 LCGIK-HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMM--- 174

Query: 303 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           T    T  Y  PE +         D++S G I+  ++ G 
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	498
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
PF04564	73	U-box: U-box domain; InterPro: IPR003613 Quality c	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
smart00090	237	RIO RIO-like kinase.	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
smart00504	63	Ubox Modified RING finger domain. Modified RING fi	99.45
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.38
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.34
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
KOG1243	690	consensus Protein kinase [General function predict	99.22
COG4248	637	Uncharacterized protein with protein kinase and he	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.99
KOG4642	284	consensus Chaperone-dependent E3 ubiquitin protein	98.98
PRK09902	216	hypothetical protein; Provisional	98.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.82
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.77
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.58
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.56
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.51
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.49
PF01636	239	APH: Phosphotransferase enzyme family This family	98.44
KOG2042	943	consensus Ubiquitin fusion degradation protein-2 [	98.41
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.36
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.31
COG5113	929	UFD2 Ubiquitin fusion degradation protein 2 [Postt	98.3
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.3
PLN02876	822	acyl-CoA dehydrogenase	98.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.25
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.22
TIGR00599	397	rad18 DNA repair protein rad18. This family is bas	98.19
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.13
PRK10593	297	hypothetical protein; Provisional	98.05
PRK05231	319	homoserine kinase; Provisional	98.04
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.99
PLN03208	193	E3 ubiquitin-protein ligase RMA2; Provisional	97.97
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.95
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.92
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.9
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.83
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.76
PF11789	57	zf-Nse: Zinc-finger of the MIZ type in Nse subunit	97.73
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.71
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.58
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.53
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.49
PLN02756	418	S-methyl-5-thioribose kinase	97.46
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.44
PLN02236	344	choline kinase	97.29
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.28
PF15227	42	zf-C3HC4_4: zinc finger of C3HC4-type, RING; PDB:	96.97
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.87
PRK12396	409	5-methylribose kinase; Reviewed	96.86
KOG0823	230	consensus Predicted E3 ubiquitin ligase [Posttrans	96.84
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.8
KOG2270	520	consensus Serine/threonine protein kinase involved	96.77
COG2334	331	Putative homoserine kinase type II (protein kinase	96.71
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.67
KOG0287	442	consensus Postreplication repair protein RAD18 [Re	96.66

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-53  Score=428.79  Aligned_cols=276  Identities=46%  Similarity=0.798  Sum_probs=236.6

Q ss_pred             cCCCCChHHHHHhhcCCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee
Q 010882          124 FFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC  202 (498)
Q Consensus       124 ~~~~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~  202 (498)
                      ....|++.++..+|++|+....||+||||.||+|...+ ..||||++.........+|.+|+.++++++|||+|+|+|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56779999999999999999999999999999999976 88999988765543144599999999999999999999999


Q ss_pred             c--C-cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEe
Q 010882          203 P--E-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS  279 (498)
Q Consensus       203 ~--~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  279 (498)
                      .  + ..+|||||+++|||.++|+..... +|+|.+|++||.++|+||.|||...+.+||||||||+|||||.++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            4  3 279999999999999999865544 89999999999999999999999877789999999999999999999999


Q ss_pred             eccccccccccccCCCCccceeccCC-CCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCC---------cH
Q 010882          280 DFGISRFLSQNEISSNNTTLCCRTDP-KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI---------TK  349 (498)
Q Consensus       280 DFGla~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~---------~~  349 (498)
                      |||+|+...... ...       ... .||.+|+|||++..+..+.++|||||||+|+||+||++|.+.         ..
T Consensus       220 DFGLa~~~~~~~-~~~-------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~  291 (361)
T KOG1187|consen  220 DFGLAKLGPEGD-TSV-------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE  291 (361)
T ss_pred             CccCcccCCccc-cce-------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence            999997554311 000       011 599999999999999999999999999999999999988863         23


Q ss_pred             HHHHHHHhCccccccCCCC--CCCCH-HHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          350 EVQYALDTGKLKNLLDPLA--GDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      +....+..+.+..++|+..  +.++. .....+..++.+|++.+|..||+|.+ |+..|+.+.
T Consensus       292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~-Vv~~L~~~~  353 (361)
T KOG1187|consen  292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ-VVKELEGIL  353 (361)
T ss_pred             HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH-HHHHHHhhc
Confidence            4455677778999999985  45664 57778999999999999999999999 667775543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-50  Score=402.29  Aligned_cols=255  Identities=35%  Similarity=0.550  Sum_probs=212.1

Q ss_pred             CCCCcccccCceEEEEEEECCeE-EEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceecC---cceEEEeeCC
Q 010882          141 DPSLKIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE---VWTLVYEYLP  214 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~~---~~~lV~E~~~  214 (498)
                      .....||+|+||+||+|.+++.. ||||++.......  .+.|.+|+.+|++++|||||+++|+|.+   ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            44456999999999999999988 9999998654333  4589999999999999999999999955   3789999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cccCCCCCCcEEEcCCC-ceeEeecccccccccccc
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~~~  292 (498)
                      +|+|.++|+.. ....+++..++.|+.|||+|+.|||+   ++ ||||||||+||||+.++ ++||+|||+++.......
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~  199 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT  199 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence            99999999754 45679999999999999999999999   66 99999999999999998 999999999987664321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhc--cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLA--SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      .        .+...||+.|||||++.  ...|+.++|||||||+||||+||+.||.............     .......
T Consensus       200 ~--------~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~-----~~~~Rp~  266 (362)
T KOG0192|consen  200 S--------MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV-----VGGLRPP  266 (362)
T ss_pred             c--------ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----hcCCCCC
Confidence            1        12246999999999999  5689999999999999999999999998776543322111     1111223


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhcC
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG  413 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~~  413 (498)
                      .|..++..+..|+.+||..+|..||++.+ +...|+.+.....
T Consensus       267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~e-i~~~l~~~~~~~~  308 (362)
T KOG0192|consen  267 IPKECPPHLSSLMERCWLVDPSRRPSFLE-IVSRLESIMSHIS  308 (362)
T ss_pred             CCccCCHHHHHHHHHhCCCCCCcCCCHHH-HHHHHHHHHHhhc
Confidence            45557789999999999999999999998 8888888876543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.6e-50  Score=394.96  Aligned_cols=327  Identities=22%  Similarity=0.288  Sum_probs=245.5

Q ss_pred             HHHHHHHHHHHhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 010882           20 RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERD   99 (498)
Q Consensus        20 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (498)
                      -.+...+..++++..|++++...   +.-++...+++..++..++..+- .++.+..+.+                   .
T Consensus        66 ~s~~T~~k~~~~k~~ien~Y~~~---~~~~~~R~er~~~le~~l~~~~~-s~~~~~~~~~-------------------~  122 (550)
T KOG0605|consen   66 VSNKTKRKVAAAKQYIENHYSSQ---IKYLNERKERRKELEEKLASEDV-SEEEQNELLK-------------------S  122 (550)
T ss_pred             cCchhHHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHHHHHhhccc-cHHHHHHHHH-------------------H
Confidence            34455668889999999998887   55566666666666666665421 1111111110                   1


Q ss_pred             HHHHHHHHHHHhhhhcccCCCCCCcCCCCChHHHHHhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC-
Q 010882          100 KAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG-  176 (498)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-  176 (498)
                      -..++.+-+|..|...                    ...+|+.++.||+|+||.||.+.-  +|..+|+|++++..+.. 
T Consensus       123 ~~~kEte~lR~~R~r~--------------------~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~  182 (550)
T KOG0605|consen  123 LLSKETEYLRLRRTRL--------------------SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKK  182 (550)
T ss_pred             HhhHHHHHHHhccccC--------------------CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhh
Confidence            1122444455544321                    235789999999999999999976  57889999999875543 


Q ss_pred             --hhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 010882          177 --PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS  252 (498)
Q Consensus       177 --~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~  252 (498)
                        .+.+..|.++|...++|+||+||.+|++  ++||||||+|||++..+|.   ....|++.....++.+++.|+..||.
T Consensus       183 ~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~  259 (550)
T KOG0605|consen  183 NQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ  259 (550)
T ss_pred             hhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH
Confidence              4568899999999999999999999965  6999999999999999994   45679999999999999999999999


Q ss_pred             cCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC---------------CCccc------------------
Q 010882          253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS---------------NNTTL------------------  299 (498)
Q Consensus       253 ~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~---------------~~~~~------------------  299 (498)
                         .|+|||||||+|+|||..|++||+|||||..+.......               .....                  
T Consensus       260 ---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (550)
T KOG0605|consen  260 ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQT  336 (550)
T ss_pred             ---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHH
Confidence               999999999999999999999999999997553311100               00000                  


Q ss_pred             ------eeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          300 ------CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       300 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                            ......+|||.|||||++.+.+|+..||+|||||||||||.|.|||...+.....-....+...+....   ..
T Consensus       337 w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---~~  413 (550)
T KOG0605|consen  337 WKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---EV  413 (550)
T ss_pred             HHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---cC
Confidence                  011245899999999999999999999999999999999999999998777665544444443332111   11


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+.+..+||.+||. ||.+|-....
T Consensus       414 ~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  414 DLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             cccHHHHHHHHHHhc-CHHHhcCccc
Confidence            234789999999999 9999987433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-48  Score=390.23  Aligned_cols=243  Identities=25%  Similarity=0.395  Sum_probs=207.3

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      ..|...+.||+|||+.||.+.+  .|..||+|++.+....   ..+.+.+||+|.+.|+|||||+++++|++  +.|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4689999999999999999988  5789999999875433   45678999999999999999999999965  689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |+|..|+|..++.   ...++++.+++.+..||+.||.|||+   ++|||||||..|+||+.+.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999994   45679999999999999999999999   89999999999999999999999999999988754


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      +  ....      ...|||.|+|||++...+++..+||||+|||||-||+|+|||...+--.. +..-+..+      ..
T Consensus       172 ~--Erk~------TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-y~~Ik~~~------Y~  236 (592)
T KOG0575|consen  172 G--ERKK------TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-YNKIKLNE------YS  236 (592)
T ss_pred             c--cccc------eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-HHHHHhcC------cc
Confidence            3  1222      33499999999999999999999999999999999999999976533222 11111111      22


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      .|...+.+..+||..+|+.+|.+||++.+++
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL  267 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVL  267 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence            4667788899999999999999999998843

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-49  Score=362.57  Aligned_cols=252  Identities=28%  Similarity=0.430  Sum_probs=207.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeec-eecC---cceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVG-ACPE---VWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g-~~~~---~~~lV  209 (498)
                      .+|.+.++||+|+||+||++.+  .+..||.|.++-.....  ......|+.+|++|+|||||++++ .|.+   ..+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3577788999999999999987  57889999988443322  346789999999999999999999 4532   37899


Q ss_pred             EeeCCCCCHHhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          210 YEYLPNGSLEDRLSC-KDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      ||||.+|+|...+.. +.....+++.++++++.|++.||+.+|+.-++ -|+||||||.||+|+++|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999998864 23456799999999999999999999995443 3899999999999999999999999999988


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~  365 (498)
                      ....+.        ..+.+|||.||+||.+...+|+.+|||||+||++|||+.-++||.+.+-....  +..+...    
T Consensus       179 ~s~~tf--------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~----  246 (375)
T KOG0591|consen  179 SSKTTF--------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP----  246 (375)
T ss_pred             cchhHH--------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC----
Confidence            755322        24557999999999999999999999999999999999999999888554332  2333221    


Q ss_pred             CCCCCCC-HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          366 PLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       366 ~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                          ..| ...+..+..||..|+..||..||+....|.++.
T Consensus       247 ----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  247 ----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             ----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                234 668899999999999999999999655444433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-48  Score=371.93  Aligned_cols=244  Identities=31%  Similarity=0.489  Sum_probs=198.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY  210 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~  210 (498)
                      ..+|...+.||.|+||+||+|.++  +..||||.+.+..  ....+-+..|+.+|+.++|||||.|++++  .+..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888889999999999999984  6889999998763  23455678999999999999999999998  45789999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC------CceeEeecccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN------FVSKLSDFGIS  284 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~------~~~kl~DFGla  284 (498)
                      |||.||+|.++++..   ..+++.+...++.|+|.||++||.   ++||||||||+||||+.+      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999543   469999999999999999999999   899999999999999864      46899999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL  364 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (498)
                      +.+.....   ..      ...|+|.|||||++..++|+.|+|+||+|+|||+|+||++||...+..+......+-...+
T Consensus       163 R~L~~~~~---a~------tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~  233 (429)
T KOG0595|consen  163 RFLQPGSM---AE------TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV  233 (429)
T ss_pred             hhCCchhH---HH------HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc
Confidence            98875432   22      2349999999999999999999999999999999999999998766554443222222221


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       365 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                          ...+...+..+.+|+...+..+|.+|-+..+
T Consensus       234 ----~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~  264 (429)
T KOG0595|consen  234 ----PVLPAELSNPLRELLISLLQRNPKDRISFED  264 (429)
T ss_pred             ----CchhhhccCchhhhhhHHHhcCccccCchHH
Confidence                1123334445667777777777777776655

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-48  Score=369.10  Aligned_cols=240  Identities=25%  Similarity=0.372  Sum_probs=201.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--C-cceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--E-VWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~-~~~lV~E~  212 (498)
                      +.+....||+|..|+||++.++  +.-+|+|++..... ...+++.+|+++++.++|||||.+||+|.  . ..+|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4456678999999999999996  67899999965432 23567899999999999999999999983  3 38899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      |.||||++++.   ..+.+++.....|+.++++||.|||..  +.||||||||+||||+..|.+||+|||.++.+..+. 
T Consensus       160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~-  233 (364)
T KOG0581|consen  160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI-  233 (364)
T ss_pred             cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhhh-
Confidence            99999999994   335699999999999999999999964  679999999999999999999999999998766541 


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCc-----HHHHHHHHhCccccccCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT-----KEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~-----~~~~~~~~~~~~~~~~~~~  367 (498)
                               ..+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||...     .++...      ..+++..
T Consensus       234 ---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------~~Iv~~p  298 (364)
T KOG0581|consen  234 ---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------CAIVDEP  298 (364)
T ss_pred             ---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------HHHhcCC
Confidence                     24457999999999999999999999999999999999999999653     222221      1222322


Q ss_pred             CCCCCHH-HHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFV-QAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~-~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+..|.. .++++..++..||+.||.+||++.+
T Consensus       299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~q  331 (364)
T KOG0581|consen  299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQ  331 (364)
T ss_pred             CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence            3344554 7899999999999999999999988

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-47  Score=379.33  Aligned_cols=251  Identities=30%  Similarity=0.514  Sum_probs=212.1

Q ss_pred             CCCCCCcccccCceEEEEEEECCe-EEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPN  215 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~~  215 (498)
                      .+...+.||+|-||+||.|.+++. .||+|.++... ...+.|.+|+++|++|+|+|||+|+|+|..  ..+|||||++.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            344567899999999999999876 89999998653 456789999999999999999999999954  48999999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.++|.. ..+..+...+.+.++.|||+|++||++   +++|||||...||||++++.+||+|||||+...++.+...
T Consensus       286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            999999965 345678899999999999999999999   8999999999999999999999999999996655543221


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  372 (498)
                             .+..-...|.|||.+..+.++.+||||||||+||||+| |+.|++.....+  ..+..|-        .-..|
T Consensus       362 -------~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy--------Rlp~P  426 (468)
T KOG0197|consen  362 -------EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY--------RLPRP  426 (468)
T ss_pred             -------CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC--------cCCCC
Confidence                   22335678999999999999999999999999999999 999998765433  3344431        22357


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ..++..+.+|+..||..+|++|||+.. +...|+.+..
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~-L~~~l~~~~~  463 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFET-LREVLEDFFT  463 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHH-HHHHHHHhhh
Confidence            778899999999999999999999987 7777776643

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=364.28  Aligned_cols=238  Identities=29%  Similarity=0.374  Sum_probs=201.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      ..+|++.++||+|+||+||.+..+  ++.+|+|++++....   .......|..||.+++||.||.++.+|++  ..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            457999999999999999998764  678999999876433   34568899999999999999999999965  69999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      +||+.||.|..+|.   ....+++.....++.+|+.||.|||+   +|||||||||+|||||.+|+++|+|||||+....
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999994   44569999999999999999999999   9999999999999999999999999999996544


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCccccccCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPL  367 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~~~~~  367 (498)
                      .+..  .      ....||+.|||||++.+.+|+..+||||+||++|||+||.+||...+..  ...+..++.       
T Consensus       178 ~~~~--t------~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-------  242 (357)
T KOG0598|consen  178 DGDA--T------RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-------  242 (357)
T ss_pred             CCCc--c------ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-------
Confidence            3221  1      2245999999999999999999999999999999999999999876543  333333331       


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCC
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                       ...|...+....+++...+..+|++|-.
T Consensus       243 -~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  243 -PLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             -CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence             2234446788999999999999999963

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-47  Score=367.30  Aligned_cols=242  Identities=28%  Similarity=0.429  Sum_probs=195.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC-------hhhHHHHHHHHHcCCCCCeeeeeceec--Ccc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-------PSEFQQEIDILSKIRHPNLVTLVGACP--EVW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~hpniv~l~g~~~--~~~  206 (498)
                      ..|.+.+.||+|+||.|-+|..+  ++.||||++++.....       ...+.+|++||++|+|||||+++++|.  +..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            35677889999999999999874  7899999998753222       123579999999999999999999994  567


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC---CceeEeeccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGI  283 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGl  283 (498)
                      |+||||+.||+|.+.+-   ....+.+..-..++.|++.||.|||+   +||+||||||+|||+..+   ..+||+|||+
T Consensus       252 YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999994   33456777778899999999999999   999999999999999766   7899999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCC---CCccchHhHHHHHHHHHhCCCCCCCcHH---HHHHHHh
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL---TPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDT  357 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~~  357 (498)
                      |+......   ...+.      .|||.|.|||++.+.++   ..++|+||+|||||-+|+|.|||.....   ....+..
T Consensus       326 AK~~g~~s---fm~Tl------CGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~  396 (475)
T KOG0615|consen  326 AKVSGEGS---FMKTL------CGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK  396 (475)
T ss_pred             hhccccce---ehhhh------cCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence            99876432   23333      49999999999988653   3478999999999999999999964321   3344444


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          358 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      |++...  |   ..-...+++..+||.+||..||++||++.+
T Consensus       397 G~y~f~--p---~~w~~Iseea~dlI~~mL~VdP~~R~s~~e  433 (475)
T KOG0615|consen  397 GRYAFG--P---LQWDRISEEALDLINWMLVVDPENRPSADE  433 (475)
T ss_pred             Cccccc--C---hhhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence            443321  1   122357789999999999999999999988

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=365.58  Aligned_cols=253  Identities=28%  Similarity=0.400  Sum_probs=211.9

Q ss_pred             HHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcC-CCCCeeeeeceecC--c
Q 010882          134 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--V  205 (498)
Q Consensus       134 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~  205 (498)
                      +....+|.+++.||.|+|++|++|+..  ++.||||++.+.-   ....+-+..|-++|.+| .||.|++||..|+|  .
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            344568999999999999999999874  6889999997642   22345678899999999 89999999999965  5


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      +|+|+||+++|+|.++|.+   .+.|++.....++.+|+.||.|||+   +|||||||||+|||||.+|++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccc
Confidence            8999999999999999953   3568888999999999999999999   999999999999999999999999999999


Q ss_pred             cccccccCC-----CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc
Q 010882          286 FLSQNEISS-----NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL  360 (498)
Q Consensus       286 ~~~~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (498)
                      .+.......     ...........+||..|.+||++.....++.+|+|+||||||+|+.|.|||.+.++.........+
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence            887654431     111111135689999999999999999999999999999999999999999988775443333222


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                             .-.||...++.+.+|+.+.|-.||.+|++..+
T Consensus       303 -------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~q  334 (604)
T KOG0592|consen  303 -------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQ  334 (604)
T ss_pred             -------cccCCCCCCHHHHHHHHHHHccCccccccHHH
Confidence                   22356666789999999999999999999866

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=338.13  Aligned_cols=231  Identities=28%  Similarity=0.417  Sum_probs=200.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      .+|+..+.||.|+||.|..++.+  +..+|+|++.+....   ..+...+|..+|+.+.||++++|++.|.+  ..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            36888899999999999999874  678999999875433   34567899999999999999999999865  689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||.|..+|+   ...++++.....+|.+|+.||+|||+   ++|++|||||+|||||.+|++||+|||+|+.....
T Consensus       124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999994   44579999999999999999999999   89999999999999999999999999999976543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~  368 (498)
                           ..+.      .|||.|+|||++...+|+.++|+|||||++|||+.|.+||...+....  .+..++         
T Consensus       198 -----T~Tl------CGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~---------  257 (355)
T KOG0616|consen  198 -----TWTL------CGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK---------  257 (355)
T ss_pred             -----EEEe------cCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc---------
Confidence                 2233      399999999999999999999999999999999999999988777442  222222         


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCC
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSR  394 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~R  394 (498)
                      -.+|...+..+.+|+...++.|-..|
T Consensus       258 v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            23677888999999999999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-45  Score=351.57  Aligned_cols=247  Identities=30%  Similarity=0.484  Sum_probs=201.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cC--cceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PE--VWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~--~~~lV~E  211 (498)
                      .++...+.||+|+||.||.+...  +...|||.+........+.+.+|+.+|++|+|||||+++|..  .+  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            35667788999999999999986  588999988765333356689999999999999999999963  33  4889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-CCceeEeecccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~  290 (498)
                      |+++|||.+++.....  .|++..+..++.|++.||.|||+   +|||||||||+||||+. +|.+||+|||+++.....
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999964332  69999999999999999999999   99999999999999999 799999999999876531


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCC-cHHHHHHHHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI-TKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      ...     ........||+.|||||++..+ ...+++|||||||++.||+||.+||.. .......+..+.-.     ..
T Consensus       172 ~~~-----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----~~  241 (313)
T KOG0198|consen  172 GTK-----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----SL  241 (313)
T ss_pred             ccc-----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----CC
Confidence            111     1112345699999999999864 334599999999999999999999976 33334333333222     12


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +.+|...+....+++..|+..+|..||++.+
T Consensus       242 P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~e  272 (313)
T KOG0198|consen  242 PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEE  272 (313)
T ss_pred             CCCCcccCHHHHHHHHHHhhcCcccCcCHHH
Confidence            2567778899999999999999999999988

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.6e-43  Score=345.91  Aligned_cols=243  Identities=22%  Similarity=0.339  Sum_probs=199.8

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceecC------cceEEEeeC
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE------VWTLVYEYL  213 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~~------~~~lV~E~~  213 (498)
                      ...||+|++|.||+|.+++..||||++.......   .+.|.+|+.+|++++||||++++|++.+      ..++||||+
T Consensus        25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            3679999999999999999999999997654333   3567899999999999999999998744      468999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++..   ...+++.....++.+++.||.|||..  .+++||||||+|||++.++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999953   34688999999999999999999973  378899999999999999999999999998654321  


Q ss_pred             CCCccceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLAG  369 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  369 (498)
                               ....||..|+|||++.+  ..++.++|||||||++|||+||+.||...+....  .+..+...       .
T Consensus       178 ---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------~  241 (283)
T PHA02988        178 ---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS-------L  241 (283)
T ss_pred             ---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC-------C
Confidence                     12358999999999976  6899999999999999999999999986543221  11111111       1


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ..|..++..+.+++.+||+.+|.+||++.+ ++..|+.+.
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~e-ll~~l~~~~  280 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKE-ILYNLSLYK  280 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCHHH-HHHHHHHHH
Confidence            233346778999999999999999999998 777777653

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-44  Score=351.52  Aligned_cols=248  Identities=29%  Similarity=0.403  Sum_probs=203.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceec----CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV  209 (498)
                      ..|+...+||+|.||.||+|+.  ++..||+|++....  ...+....+||.||++|+||||++|.+...    ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            3577778899999999999988  46789999988664  344566789999999999999999999762    358999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      +|||+. +|..++.  .....|+..++..++.|++.||.|+|.   +||+|||||.+|||||.+|.+||+|||||+++..
T Consensus       197 FeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             Eecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999976 8888884  345679999999999999999999999   9999999999999999999999999999998876


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      .....       .+..+-|.+|.|||.+.+. .|+.++|+||.||||.||++|+|.|.+.+++.++..+-++-.  .|..
T Consensus       271 ~~~~~-------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG--SP~e  341 (560)
T KOG0600|consen  271 SGSAP-------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG--SPTE  341 (560)
T ss_pred             CCCcc-------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC--CCCh
Confidence            54322       2445679999999999986 799999999999999999999999999988876643321111  1111


Q ss_pred             CCCC------------------------HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          369 GDWP------------------------FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       369 ~~~~------------------------~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..|+                        ...+....+|+..+|..||.+|.++.++
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a  397 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA  397 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH
Confidence            1111                        1123567889999999999999999884

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=361.24  Aligned_cols=265  Identities=26%  Similarity=0.460  Sum_probs=210.0

Q ss_pred             HHHHHhhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeecee-cCcce
Q 010882          131 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC-PEVWT  207 (498)
Q Consensus       131 ~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~-~~~~~  207 (498)
                      .++......+.+...||+|+||+||+|.|.| .||||+++......  .+.|++|+.++++-+|-||+-+.|+| .+...
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A  463 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA  463 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence            4444445556677889999999999999976 49999998765443  46799999999999999999999999 44568


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      ||..+|+|-||+.+|+-.  ...|...+.+.||.|+++|+.|||.   ++|||||||+.||||.+++.|||+||||+..-
T Consensus       464 IiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence            999999999999999743  3568889999999999999999999   99999999999999999999999999999754


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL  364 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (498)
                      ..-.....      .....|...|||||++..   .+|++.+||||||||+|||+||..||.....-+..+..|+-.-..
T Consensus       539 ~~w~g~~q------~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p  612 (678)
T KOG0193|consen  539 TRWSGEQQ------LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP  612 (678)
T ss_pred             eeeccccc------cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc
Confidence            43211111      133458999999999975   469999999999999999999999998444333333333332222


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       365 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      |..  .....++.++.+|+..||..++++||.+.+ ++..|+.+..
T Consensus       613 d~s--~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~-il~~l~~l~~  655 (678)
T KOG0193|consen  613 DLS--KIRSNCPKAMKRLLSDCWKFDREERPLFPQ-LLSKLEELLP  655 (678)
T ss_pred             cch--hhhccCHHHHHHHHHHHHhcCcccCccHHH-HHHHHHHhhh
Confidence            221  122346689999999999999999999999 5555555443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-43  Score=356.37  Aligned_cols=255  Identities=25%  Similarity=0.406  Sum_probs=201.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceecC---
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACPE---  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~~---  204 (498)
                      ..+|.+.+.||+|+||.||+|.+.       +..||||++...... ....+.+|+.++..+ +||||++++|+|..   
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            357888999999999999999752       356999998754322 235688999999999 89999999998843   


Q ss_pred             cceEEEeeCCCCCHHhhhccCCC---------------------------------------------------------
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDN---------------------------------------------------------  227 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  227 (498)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            47899999999999999864211                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCC
Q 010882          228 --SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP  305 (498)
Q Consensus       228 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~  305 (498)
                        ..++++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++.........      .....
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------~~~~~  236 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RKGSA  236 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchh------cccCC
Confidence              2358888999999999999999999   899999999999999999999999999998654322111      11223


Q ss_pred             CCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH---HHHHHHhCccccccCCCCCCCCHHHHHHHHH
Q 010882          306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLAN  381 (498)
Q Consensus       306 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  381 (498)
                      .+++.|+|||++.+..++.++|||||||+||||+| |.+||.....   ....+..+.        ....|...+..+.+
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~  308 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT--------RMRAPENATPEIYR  308 (338)
T ss_pred             CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC--------CCCCCCCCCHHHHH
Confidence            46789999999999999999999999999999997 9999975432   111122111        11123345678999


Q ss_pred             HHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          382 LAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       382 li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ++.+||+.+|.+||++.+ +++.|+.+.
T Consensus       309 li~~cl~~dp~~RPs~~e-l~~~l~~~~  335 (338)
T cd05102         309 IMLACWQGDPKERPTFSA-LVEILGDLL  335 (338)
T ss_pred             HHHHHccCChhhCcCHHH-HHHHHHHHH
Confidence            999999999999999998 778887764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3e-43  Score=320.32  Aligned_cols=245  Identities=26%  Similarity=0.382  Sum_probs=201.5

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .|...+.||+|.||+||+|.+  +++.||||+++.....+  .-...+|+..|+.++||||+.|+++|.  +...||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            466677899999999999998  47899999998754332  345789999999999999999999995  468899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++ .+|...+.  +....|+..++..++.+++.||+|||.   +.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus        83 m~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   83 MP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             cc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            96 58999995  556789999999999999999999999   8999999999999999999999999999998876543


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC-
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD-  370 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  370 (498)
                      ..        ...+-|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.|-|.+.+.+++....  +.-+-.|.... 
T Consensus       157 ~~--------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I--f~~LGTP~~~~W  226 (318)
T KOG0659|consen  157 IQ--------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI--FRALGTPTPDQW  226 (318)
T ss_pred             cc--------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH--HHHcCCCCcccC
Confidence            22        222569999999999875 7999999999999999999999999988877654322  11111111111 


Q ss_pred             ----------------------CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          371 ----------------------WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       371 ----------------------~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                            ....++....+|+..++.+||.+|+++.+
T Consensus       227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q  277 (318)
T KOG0659|consen  227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ  277 (318)
T ss_pred             ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence                                  22234566799999999999999999988

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.5e-44  Score=329.81  Aligned_cols=246  Identities=28%  Similarity=0.398  Sum_probs=197.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-C-hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~-~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .|+...++|+|+||+||+++++  |+-||||++...... . .+-..+|+.+|++|+|||+|.|+.+|.  ..++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            4677788999999999999885  788999999754332 1 345679999999999999999999994  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      |+..-|.+ |.  .....++...+..++.|++.|+.|+|+   +++|||||||+||||+.+|.+||||||+|+.+...+.
T Consensus        83 ~dhTvL~e-Le--~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   83 CDHTVLHE-LE--RYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             cchHHHHH-HH--hccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence            98755554 43  233458888999999999999999999   8999999999999999999999999999998874321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc--------c
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN--------L  363 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~--------~  363 (498)
                      .        .+..+.|.+|.|||.+.+ .+|++.+||||+||++.||+||.|-|.+.+.++.+....+...        +
T Consensus       157 ~--------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  157 N--------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             h--------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence            1        134468999999999988 5899999999999999999999999998888776653321111        0


Q ss_pred             c----------CC-------CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          364 L----------DP-------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       364 ~----------~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +          -|       ....+| ..+..+.+++..||..||.+|++-.+
T Consensus       229 F~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~q  280 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQ  280 (396)
T ss_pred             hccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHH
Confidence            0          01       111122 23457899999999999999998776

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=352.78  Aligned_cols=242  Identities=26%  Similarity=0.408  Sum_probs=207.2

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP  214 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~  214 (498)
                      .|..-.+||+|+.|.||.+..  .+..||||.+........+-+.+|+.+|+..+|+|||.++.+|  .+..+.||||++
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            466667899999999999977  4678999999887777777889999999999999999999987  567899999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      ||+|.|.+.    ...+++.++..|+.+++.||+|||.   +||+|||||.+|||++.+|.+||+|||+|..+.....  
T Consensus       354 ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  354 GGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             CCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence            999999984    3348999999999999999999999   9999999999999999999999999999998776543  


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                            .+...+|||.|||||+.....|++++||||||++++||+-|.|||-..++.........-..   | .-..+..
T Consensus       425 ------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~---P-~lk~~~k  494 (550)
T KOG0578|consen  425 ------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT---P-KLKNPEK  494 (550)
T ss_pred             ------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC---C-CcCCccc
Confidence                  23556799999999999999999999999999999999999999976666544333211100   1 1123556


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+..+.+++.+||..|+..||++.+
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~e  519 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKE  519 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHH
Confidence            7889999999999999999999988

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-43  Score=351.78  Aligned_cols=242  Identities=28%  Similarity=0.383  Sum_probs=201.1

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC----C-CChhhHHHHHHHHHcCC-CCCeeeeecee--cCc
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS----L-QGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEV  205 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~----~-~~~~~~~~E~~il~~l~-hpniv~l~g~~--~~~  205 (498)
                      ..+.|...+.||+|+||+|+.|..  .+..||||++....    . ...+.+.+|+.+++.++ ||||++++.++  ...
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            346889999999999999999987  46899999776641    1 22446778999999999 99999999988  446


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-CceeEeecccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS  284 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla  284 (498)
                      .++||||+.||+|.+++..   ..++.+.....++.|++.|+.|+|+   +||+||||||+|||+|.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            8999999999999999953   5678889999999999999999999   899999999999999999 99999999999


Q ss_pred             cccc-ccccCCCCccceeccCCCCCCCcCChhhhccCC-CC-CccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccc
Q 010882          285 RFLS-QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK  361 (498)
Q Consensus       285 ~~~~-~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (498)
                      .... ....   .      ....||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+........    
T Consensus       169 ~~~~~~~~~---l------~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki----  235 (370)
T KOG0583|consen  169 AISPGEDGL---L------KTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI----  235 (370)
T ss_pred             cccCCCCCc---c------cCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH----
Confidence            9773 2221   1      2335999999999999977 86 7799999999999999999999875543322221    


Q ss_pred             cccCCCCCCCCHHH-HHHHHHHHHHhhhcccCCCCChhH
Q 010882          362 NLLDPLAGDWPFVQ-AEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       362 ~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                         ....-.+|... +..+..|+.+||..+|..|+++.+
T Consensus       236 ---~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~  271 (370)
T KOG0583|consen  236 ---RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLE  271 (370)
T ss_pred             ---hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHH
Confidence               11112245555 889999999999999999999988

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.7e-44  Score=370.12  Aligned_cols=256  Identities=29%  Similarity=0.523  Sum_probs=214.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeecee--cCcc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~  206 (498)
                      ..+....+.||+|+||+||+|...+       ..||||.++..... ...+|++|+++|..|+|||||+|+|+|  .+..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            3455667789999999999998743       56999999876654 567899999999999999999999999  4468


Q ss_pred             eEEEeeCCCCCHHhhhccCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          207 TLVYEYLPNGSLEDRLSCKD-------N----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      ++|+|||..|||.++|....       .    .++|+..+.+.||.|||.|+.||-+   +.+|||||-..|+||+++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence            99999999999999995421       1    3349999999999999999999999   77999999999999999999


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCc--HHHH
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT--KEVQ  352 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~--~~~~  352 (498)
                      |||+||||++-....++....      ....-.+.|||||.+..++||.+||||||||||||++| |+.||.+.  .++.
T Consensus       642 VKIsDfGLsRdiYssDYYk~~------~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVR------GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             EEecccccchhhhhhhhhccc------CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            999999999965544433221      11123679999999999999999999999999999999 88888654  4566


Q ss_pred             HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          353 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ..+..|++..        .|..++..+..|+..||+.+|.+||++.+ |...|..+..
T Consensus       716 e~i~~g~lL~--------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e-I~~~L~~~~~  764 (774)
T KOG1026|consen  716 ECIRAGQLLS--------CPENCPTEVYSLMLECWNENPKRRPSFKE-IHSRLQAWAQ  764 (774)
T ss_pred             HHHHcCCccc--------CCCCCCHHHHHHHHHHhhcCcccCCCHHH-HHHHHHHHHh
Confidence            6667766532        57788899999999999999999999999 8888877654

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=339.21  Aligned_cols=256  Identities=25%  Similarity=0.340  Sum_probs=208.3

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEE
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY  210 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~  210 (498)
                      ...+|+....||.|..++||+|++  ++..||||+++...-. +.+.+.+|+..|+.++||||++++.+|  ...+++||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            345788889999999999999998  4789999999876443 357899999999999999999999988  55789999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      .||.+||+.+++...-. ..+++..+..|+.+++.||.|||.   +|.||||||+.||||+.+|.|||+|||.+..+...
T Consensus       104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            99999999999965433 348999999999999999999999   99999999999999999999999999999877665


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh--CccccccC-
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKNLLD-  365 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~~-  365 (498)
                      +   .+..... ...+||++|||||++..  .+|+.|+||||||++..||.+|..||....+...++..  +....... 
T Consensus       180 G---~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~  255 (516)
T KOG0582|consen  180 G---DRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS  255 (516)
T ss_pred             C---ceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence            4   1222222 66789999999999654  47999999999999999999999999887776655432  11111110 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ....+-....+..+.+++..||..||.+||++.+
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk  289 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASK  289 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence            0001111224568999999999999999999988

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=357.68  Aligned_cols=241  Identities=23%  Similarity=0.300  Sum_probs=201.4

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCC-CCCeeeeeceec--Ccc
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIR-HPNLVTLVGACP--EVW  206 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~-hpniv~l~g~~~--~~~  206 (498)
                      ....+|...++||+|+||+|+++..+  +..+|||++++....   +.+....|..|+...+ ||.++.|+.+|+  +.+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34568999999999999999999985  578999999987543   3556778999988885 999999999995  579


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      |+||||+.||++..+.    ....|++.....++.+++.||.|||.   +||||||||.+|||||.+|++||+|||+|+-
T Consensus       445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999944433    33569999999999999999999999   9999999999999999999999999999985


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      .--.+  ...      +...|||.|||||++.+..|+.++|||||||+|||||+|.+||.++++-+..-..       -.
T Consensus       518 ~m~~g--~~T------sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI-------~~  582 (694)
T KOG0694|consen  518 GMGQG--DRT------STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI-------VN  582 (694)
T ss_pred             cCCCC--Ccc------ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------hc
Confidence            33221  112      3345999999999999999999999999999999999999999987764432111       01


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ....+|...+.+...++.++|..+|++|-.+
T Consensus       583 d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            1233788889999999999999999999877

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-43  Score=351.09  Aligned_cols=239  Identities=30%  Similarity=0.417  Sum_probs=202.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      +|.+...||+|+||.||||+-+  ...||+|.+.+....  ....+.+|++|++.++|||||.++.+|+.  .+++|.||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            5666778999999999999875  478999999865432  34568899999999999999999999954  68899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +.| +|..+|.   ....+++..+..|+.+++.||.|||+   ++|+|||+||.||||+.+|++|++|||+|+.+.....
T Consensus        83 a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   83 AVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             hhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence            976 9999994   44679999999999999999999999   8999999999999999999999999999997765321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                              ..+...|||.|||||...+..|+..+|.||+|||+|||.+|+|||....... ++.      .+-.....||
T Consensus       156 --------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-Lv~------~I~~d~v~~p  220 (808)
T KOG0597|consen  156 --------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-LVK------SILKDPVKPP  220 (808)
T ss_pred             --------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-HHH------HHhcCCCCCc
Confidence                    1355679999999999999999999999999999999999999996544322 211      1112233478


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...+..+..++...|..||..|.+..+
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~  247 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTD  247 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHH
Confidence            888999999999999999999999887

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=350.09  Aligned_cols=237  Identities=28%  Similarity=0.482  Sum_probs=197.8

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCHHh
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED  220 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL~~  220 (498)
                      +.-||.|+.|.||.|.+++..||||+++.-       -..+|.-|++|+||||+.+.|+|.  ..++||||||+.|-|..
T Consensus       129 LeWlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~  201 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE  201 (904)
T ss_pred             hhhhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence            456999999999999999999999987632       235788899999999999999994  46889999999999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccce
Q 010882          221 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC  300 (498)
Q Consensus       221 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  300 (498)
                      +|.   ...+++......+..+||.|+.|||.   +.|||||||+-||||+.+..+||+|||.++-..+..+        
T Consensus       202 VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--------  267 (904)
T KOG4721|consen  202 VLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--------  267 (904)
T ss_pred             HHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhh--------
Confidence            994   45678888899999999999999999   7899999999999999999999999999886654321        


Q ss_pred             eccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHH
Q 010882          301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA  380 (498)
Q Consensus       301 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  380 (498)
                       .....||..|||||++.+.+.+.|+|||||||||||||||..||...+.....+..|.  +.   +.-..|..+++-+.
T Consensus       268 -kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--Ns---L~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  268 -KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--NS---LHLPVPSTCPDGFK  341 (904)
T ss_pred             -hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC--Cc---ccccCcccCchHHH
Confidence             2345699999999999999999999999999999999999999976544322222221  11   11235677888999


Q ss_pred             HHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          381 NLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       381 ~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      -|+.+||+..|.+||++.+ ++.-|+-
T Consensus       342 lL~Kqcw~sKpRNRPSFrq-il~HldI  367 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQ-ILLHLDI  367 (904)
T ss_pred             HHHHHHHhcCCCCCccHHH-HHHHHhh
Confidence            9999999999999999999 5555553

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=335.39  Aligned_cols=248  Identities=28%  Similarity=0.411  Sum_probs=197.5

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC--------------ChhhHHHHHHHHHcCCCCCeeeee
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--------------GPSEFQQEIDILSKIRHPNLVTLV  199 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--------------~~~~~~~E~~il~~l~hpniv~l~  199 (498)
                      ..+.|.+...||+|.||.|-+|..  .+..||||++.+....              ..+...+|+.||++|+|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            346799999999999999999988  4688999999764211              124688999999999999999999


Q ss_pred             ceec----CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          200 GACP----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       200 g~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      .+.+    +.+|||+|||..|.+...=   .....|+..+.+.|+.++..||.|||+   +|||||||||+|+||+.+|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence            9874    4689999999998876542   233349999999999999999999999   89999999999999999999


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCC----CCCccchHhHHHHHHHHHhCCCCCCCcHHH
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEV  351 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~~~~~~  351 (498)
                      +||+|||.+..+..........   +-...+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-.....
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~---~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDD---QLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             EEeeccceeeecccCCccccHH---HHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            9999999998775442222111   123367999999999998743    346789999999999999999999776655


Q ss_pred             HHHHHhCccccccCCCCCCCCH--HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          352 QYALDTGKLKNLLDPLAGDWPF--VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...-.+  ..+   +.  .+|.  ...+.+.+||.++|..||..|.++.+
T Consensus       326 ~l~~KI--vn~---pL--~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~  368 (576)
T KOG0585|consen  326 ELFDKI--VND---PL--EFPENPEINEDLKDLIKRLLEKDPEQRITLPD  368 (576)
T ss_pred             HHHHHH--hcC---cc--cCCCcccccHHHHHHHHHHhhcChhheeehhh
Confidence            432221  111   11  1222  35678999999999999999999987

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.7e-42  Score=338.38  Aligned_cols=259  Identities=26%  Similarity=0.455  Sum_probs=196.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------------------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR------------------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL  198 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l  198 (498)
                      ++|.+.+.||+|+||.||+|.+.                  +..||+|++...... ....|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            46788889999999999999752                  236999998764322 23568899999999999999999


Q ss_pred             eceec--CcceEEEeeCCCCCHHhhhccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCccc
Q 010882          199 VGACP--EVWTLVYEYLPNGSLEDRLSCKD----------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH  260 (498)
Q Consensus       199 ~g~~~--~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  260 (498)
                      +|+|.  +..++||||+++|+|.+++....                ....+++..+..++.|++.||.|||+   .||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            99984  46899999999999999885321                12357888999999999999999999   89999


Q ss_pred             CCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh
Q 010882          261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT  340 (498)
Q Consensus       261 rDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  340 (498)
                      |||||+|||++.++.+||+|||+++........      .......++..|+|||++..+.++.++|||||||++|||++
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCcee------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence            999999999999999999999999865433211      11123346889999999998899999999999999999987


Q ss_pred             --CCCCCCCcHHHHHHHHhCc-cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          341 --GRPALGITKEVQYALDTGK-LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       341 --G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                        |..||...+.......... +...........|..++..+.+++.+||+.+|.+||++.+ +...|+
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~-i~~~l~  303 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD-IHAFLT  303 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH-HHHHHh
Confidence              5577765432221111100 0000000011123345678999999999999999999988 665553

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-42  Score=347.29  Aligned_cols=238  Identities=26%  Similarity=0.401  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      +-|..++.||.|+-|.|..|.+  +|+.+|||++.+....   ....+.+|+-||+.+.||||++||+++.+  .+|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4577888999999999999988  5899999999876322   24568899999999999999999999954  689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||.|.++|.   ..++|++.+..+++.||+.|+.|+|.   .+|+||||||+|+|||..+++||+|||+|.+...+
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999994   45679999999999999999999999   78999999999999999999999999999876554


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~  367 (498)
                      ..-   .      ...|+|.|.|||++.+.+| +.++||||+|||||.||||+.||+.++.-..+  +..|.+       
T Consensus       166 klL---e------TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-------  229 (786)
T KOG0588|consen  166 KLL---E------TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-------  229 (786)
T ss_pred             ccc---c------ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-------
Confidence            321   2      2249999999999999988 47899999999999999999999966543332  233322       


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        ..|...+.+..+|+.+|+..||.+|.++.+
T Consensus       230 --~MPs~Is~eaQdLLr~ml~VDp~~RiT~~e  259 (786)
T KOG0588|consen  230 --EMPSNISSEAQDLLRRMLDVDPSTRITTEE  259 (786)
T ss_pred             --cCCCcCCHHHHHHHHHHhccCccccccHHH
Confidence              256777889999999999999999999988

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=338.55  Aligned_cols=232  Identities=26%  Similarity=0.376  Sum_probs=193.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      +|...+.||+|+||.||+|...  +..||+|++.....   .....+.+|+.+++.++||||+++++++.+  ..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            6788899999999999999985  78899999865322   234568899999999999999999998743  5789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++|+|.+++..   ...+++.....++.|++.||.|||+   +||+||||||+|||++.+|.+||+|||++.......
T Consensus        82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          82 YVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            9999999999853   3468999999999999999999999   899999999999999999999999999988654321


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  369 (498)
                                 ....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+....  .+..+.         .
T Consensus       156 -----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------~  215 (291)
T cd05612         156 -----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---------L  215 (291)
T ss_pred             -----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------c
Confidence                       123489999999999998999999999999999999999999976544322  111111         1


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCC
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                      .+|...+..+.+++.+||+.||.+||+
T Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~R~~  242 (291)
T cd05612         216 EFPRHLDLYAKDLIKKLLVVDRTRRLG  242 (291)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHccC
Confidence            244445678999999999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.1e-42  Score=321.17  Aligned_cols=245  Identities=27%  Similarity=0.333  Sum_probs=197.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeee----ceecCcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLV----GACPEVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~----g~~~~~~~lV~  210 (498)
                      +|+....|++|+||.||+|.++  +.-||+|+++.....  -+-.-.+||.+|.+++|||||.+-    |.--+..|+||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            5777889999999999999985  578999999865432  234567999999999999999985    44456799999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |||+. +|..++...  ..++...+...+..|++.||+|||.   +.|+||||||+|+|++..|.+||+|||+|+.+...
T Consensus       157 e~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  157 EYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            99976 898888633  3679999999999999999999999   89999999999999999999999999999987655


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC-
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA-  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-  368 (498)
                      ..        ..+..+-|.+|.|||.+.+. .|+.++|+||+|||+.||++++|-|.+..++.+....-  ..+-.|.. 
T Consensus       231 ~k--------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If--~llGtPte~  300 (419)
T KOG0663|consen  231 LK--------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF--KLLGTPSEA  300 (419)
T ss_pred             cc--------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH--HHhCCCccc
Confidence            21        12445579999999999885 69999999999999999999999999887765543221  11111111 


Q ss_pred             -------------------------CCCCHH-HHHHHHHHHHHhhhcccCCCCChhH
Q 010882          369 -------------------------GDWPFV-QAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       369 -------------------------~~~~~~-~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                               ..++.. .+..-.+|+...|.+||.+|.|+.+
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~  357 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED  357 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence                                     112211 3467789999999999999999988

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-41  Score=333.74  Aligned_cols=240  Identities=25%  Similarity=0.343  Sum_probs=192.6

Q ss_pred             CCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          140 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      |...+.||+|+||.||+|..  .+..||||.+......   ....+.+|+.+++.++||||+++++++.  +..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66678899999999999987  4788999998754322   2345778999999999999999999874  468899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++... ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            9999999887532 23468999999999999999999999   8999999999999999999999999999986543211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH--HHHHhCccccccCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  370 (498)
                               .....||+.|+|||++.+..++.++|||||||++|+|+||++||...+...  ..+... ..    .....
T Consensus       158 ---------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~----~~~~~  223 (285)
T cd05631         158 ---------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-VK----EDQEE  223 (285)
T ss_pred             ---------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-hh----ccccc
Confidence                     123458999999999999999999999999999999999999997643211  111110 00    01112


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ++...+..+.+|+.+||+.+|.+||+.
T Consensus       224 ~~~~~s~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05631         224 YSEKFSEDAKSICRMLLTKNPKERLGC  250 (285)
T ss_pred             CCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence            344456789999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=339.09  Aligned_cols=233  Identities=23%  Similarity=0.303  Sum_probs=189.5

Q ss_pred             ccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      ||+|+||.||+|...  +..||+|++....   ......+..|+.++.+++||||++++++|.  +..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999984  5789999987532   223456788999999999999999999884  468999999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++..   ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++........     
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-----  149 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-----  149 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc-----
Confidence            999953   3468999999999999999999999   89999999999999999999999999998754322110     


Q ss_pred             ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHH
Q 010882          299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ  378 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (498)
                         .....||+.|+|||++.+..++.++|||||||++|+|+||++||...+........  ...     ...+|...+..
T Consensus       150 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--~~~-----~~~~~~~~~~~  219 (312)
T cd05585         150 ---TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQE-----PLRFPDGFDRD  219 (312)
T ss_pred             ---cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--HcC-----CCCCCCcCCHH
Confidence               12345899999999999999999999999999999999999999765433221111  000     11244456678


Q ss_pred             HHHHHHHhhhcccCCCCChhH
Q 010882          379 LANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       379 l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +.+++.+||..+|.+||++..
T Consensus       220 ~~~li~~~L~~dp~~R~~~~~  240 (312)
T cd05585         220 AKDLLIGLLSRDPTRRLGYNG  240 (312)
T ss_pred             HHHHHHHHcCCCHHHcCCCCC
Confidence            999999999999999997644

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-43  Score=337.95  Aligned_cols=240  Identities=27%  Similarity=0.379  Sum_probs=201.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~  213 (498)
                      .|.....||+|+||.||+|.+.  ++.||+|++...... ..+++++|+.+|..++++||.++||++  ...+.++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            4666678999999999999985  578999999876443 467899999999999999999999987  45688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      .||++.+.|.   ....+.+..+..|+.++..||.|||.   ++.+|||||+.|||+..+|.+||+|||.+..+......
T Consensus        94 ~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   94 GGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             cCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999993   44556788888899999999999999   89999999999999999999999999999876654322


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC-CCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL-AGDWP  372 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~  372 (498)
                              +...+|||.|||||++....|+.++||||||++.+||++|.||+....+....+       ++... .+...
T Consensus       168 --------r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------lIpk~~PP~L~  232 (467)
T KOG0201|consen  168 --------RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------LIPKSAPPRLD  232 (467)
T ss_pred             --------cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------eccCCCCCccc
Confidence                    245679999999999998899999999999999999999999997766533221       11111 11222


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...++.+.+++..||+.+|+.||++.+
T Consensus       233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~  259 (467)
T KOG0201|consen  233 GDFSPPFKEFVEACLDKNPEFRPSAKE  259 (467)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHH
Confidence            346688999999999999999999987

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.9e-41  Score=344.46  Aligned_cols=253  Identities=24%  Similarity=0.395  Sum_probs=198.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeeceec--Cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EV  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~  205 (498)
                      ..+|.+.+.||+|+||.||+|.+.       +..||||+++.... ...+.+.+|+.+|..+ +||||++++|+|.  +.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            447888999999999999999742       35799999875432 2345688999999999 8999999999984  46


Q ss_pred             ceEEEeeCCCCCHHhhhccCCC----------------------------------------------------------
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDN----------------------------------------------------------  227 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  227 (498)
                      .++||||++||+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            8899999999999998853211                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          228 --------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       228 --------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                                    ...+++..+..++.+++.||.|||+   ++|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          1257889999999999999999999   89999999999999999999999999999865433211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH---HHHHHhCccccccCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV---QYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~---~~~~~~~~~~~~~~~~~~  369 (498)
                      .      ......++..|+|||++.+..++.++|||||||++|||+| |.+||......   ...+..+.        ..
T Consensus       271 ~------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~~  336 (375)
T cd05104         271 V------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--------RM  336 (375)
T ss_pred             c------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--------cC
Confidence            0      0122335678999999999999999999999999999998 89999654221   11222111        01


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      ..|...+..+.+|+.+||+.+|.+||++.+ +++.|+.
T Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-il~~l~~  373 (375)
T cd05104         337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQ-IVQLIEQ  373 (375)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHH-HHHHHHh
Confidence            122334568999999999999999999998 6666664

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-42  Score=343.16  Aligned_cols=234  Identities=22%  Similarity=0.337  Sum_probs=194.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      .+|.+.+.||+|+||.||+|.+.  +..||||++.....   .....+.+|+.++++++||||+++++++.  +..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46888889999999999999985  67899999875422   23456889999999999999999999884  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++..   ...+++.....++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++......
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999953   3468889999999999999999999   89999999999999999999999999999865432


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~  368 (498)
                      .           ....||+.|+|||++.+..++.++|||||||++|+|+||++||...+.....  +..+.         
T Consensus       172 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~---------  231 (329)
T PTZ00263        172 T-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR---------  231 (329)
T ss_pred             c-----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---------
Confidence            1           1234899999999999999999999999999999999999999765543221  22211         


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ..+|...+..+.+|+..||+.||.+||+.
T Consensus       232 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~  260 (329)
T PTZ00263        232 LKFPNWFDGRARDLVKGLLQTDHTKRLGT  260 (329)
T ss_pred             cCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            12344456789999999999999999974

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=341.18  Aligned_cols=244  Identities=27%  Similarity=0.357  Sum_probs=197.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|.+.+.||+|+||.||+|.+.  +..||||++.....   .....+..|+.++..++||||+++++++.  +..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            6888899999999999999984  67899999875422   23456889999999999999999999884  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++.   ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++...... 
T Consensus        82 ~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~-  154 (333)
T cd05600          82 YVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-  154 (333)
T ss_pred             CCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc-
Confidence            999999999994   33468899999999999999999999   89999999999999999999999999999765431 


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccC-CCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGD  370 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  370 (498)
                                .....||+.|+|||++.+..++.++|||||||++|||+||.+||...+..............+. +....
T Consensus       155 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  224 (333)
T cd05600         155 ----------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD  224 (333)
T ss_pred             ----------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCc
Confidence                      1234599999999999999999999999999999999999999976554332221111111111 11111


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .....+..+.+++.+||..+|.+||++.+
T Consensus       225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~  253 (333)
T cd05600         225 PRFNLSDEAWDLITKLINDPSRRFGSLED  253 (333)
T ss_pred             cccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence            11234678999999999999999999887

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.6e-42  Score=341.52  Aligned_cols=229  Identities=23%  Similarity=0.297  Sum_probs=187.7

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gs  217 (498)
                      .||+|+||.||++...  +..||||++.....   .....+.+|+.+++.++||||+++++++.  +..++||||++||+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            5999999999999874  67899999875422   22345778999999999999999999884  46889999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      |.+++.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++........    
T Consensus        82 L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~----  151 (323)
T cd05571          82 LFFHLS---RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT----  151 (323)
T ss_pred             HHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc----
Confidence            999984   33568999999999999999999999   89999999999999999999999999998753222110    


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCCCCCCCHHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLAGDWPFVQ  375 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  375 (498)
                          .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+....  .+..+         ...+|...
T Consensus       152 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~---------~~~~p~~~  218 (323)
T cd05571         152 ----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------EIRFPRTL  218 (323)
T ss_pred             ----ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---------CCCCCCCC
Confidence                1233599999999999999999999999999999999999999976543221  11111         11244556


Q ss_pred             HHHHHHHHHHhhhcccCCCCC
Q 010882          376 AEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       376 ~~~l~~li~~cl~~~p~~RP~  396 (498)
                      +..+.+++.+||..||.+||+
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCC
Confidence            788999999999999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-42  Score=308.79  Aligned_cols=243  Identities=26%  Similarity=0.417  Sum_probs=202.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      ..+|+.++.||+|.||.||.|+.+  +.-||+|++.+...   ....++.+|++|-+.|+||||+++||+|-+  ..||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            347899999999999999999985  45699999976532   234678999999999999999999999954  68999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      +||.++|+|...|... ....+++.....++.|+|.||.|+|.   ++||||||||+|+|++..|.+||+|||.+.....
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            9999999999999632 34568888889999999999999999   8999999999999999999999999999875442


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                          ..+.+.      .||..|.+||+..+..++..+|+|++|++.||++.|.+||.....-..-....+       ...
T Consensus       177 ----~kR~tl------cgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k-------~~~  239 (281)
T KOG0580|consen  177 ----NKRKTL------CGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK-------VDL  239 (281)
T ss_pred             ----CCceee------ecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH-------ccc
Confidence                223333      499999999999999999999999999999999999999976542221111111       122


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+|...+....++|.+|+..+|.+|....++
T Consensus       240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v  270 (281)
T KOG0580|consen  240 KFPSTISGGAADLISRLLVKNPIERLALTEV  270 (281)
T ss_pred             cCCcccChhHHHHHHHHhccCccccccHHHH
Confidence            3567778899999999999999999999883

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.6e-41  Score=344.58  Aligned_cols=258  Identities=24%  Similarity=0.398  Sum_probs=200.3

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceec--C
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--E  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~--~  204 (498)
                      ...+|.+.+.||+|+||.||+|...       +..||||++...... ....+.+|+.+++.+ +||||++++|+|.  .
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457889999999999999998852       246999999754322 245688999999999 8999999999984  3


Q ss_pred             cceEEEeeCCCCCHHhhhccCC----------------------------------------------------------
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKD----------------------------------------------------------  226 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------  226 (498)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            5889999999999999885321                                                          


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          227 ---------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       227 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                               ...++++..++.|+.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++........    
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~----  268 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY----  268 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce----
Confidence                     11357888999999999999999999   89999999999999999999999999999765432211    


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                        .......+++.|+|||++.+..++.++|||||||++|+|++ |++||.............  ....   ....|...+
T Consensus       269 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~--~~~~---~~~~~~~~~  341 (374)
T cd05106         269 --VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV--KRGY---QMSRPDFAP  341 (374)
T ss_pred             --eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH--Hccc---CccCCCCCC
Confidence              01122235678999999998899999999999999999998 999996543211111100  0000   111233345


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..+.+++.+||+.+|.+||++.+ +++.|+.+
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~-l~~~l~~~  372 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQ-ISQLIQRQ  372 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHH-HHHHHHHH
Confidence            78999999999999999999998 77888765

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=345.70  Aligned_cols=255  Identities=28%  Similarity=0.442  Sum_probs=204.6

Q ss_pred             cCCCCCCcccccCceEEEEEEECC------eEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeecee--cCcc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~  206 (498)
                      .+....++||+|+||+||+|.++-      ..||||..+...   .....+|.+|+++|+.++|||||++||++  ....
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            344556899999999999998741      238999988533   22356799999999999999999999988  4468


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++|||+|.||+|.++|....  ..++..+++.++.++|+||+|||+   +++|||||-..|+|++.++.+||+||||++.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            99999999999999996433  269999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccC
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLD  365 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (498)
                      ........        ..-.-...|+|||.+..+-|+.++|||||||++||+++ |..||.+....+......     ..
T Consensus       312 ~~~~~~~~--------~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~-----~~  378 (474)
T KOG0194|consen  312 GSQYVMKK--------FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV-----KN  378 (474)
T ss_pred             Ccceeecc--------ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-----hc
Confidence            54211111        01123578999999999999999999999999999999 889998766543322210     01


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ......|...+..+..++.+||..+|.+||+|.+ +.+.|+.+...
T Consensus       379 ~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~-i~~~l~~~~~~  423 (474)
T KOG0194|consen  379 GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMST-IKKKLEALEKK  423 (474)
T ss_pred             CccCCCCCCCHHHHHHHHHHhccCChhhccCHHH-HHHHHHHHHhc
Confidence            1112245567789999999999999999999998 88888877654

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.7e-41  Score=333.55  Aligned_cols=253  Identities=23%  Similarity=0.400  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--C----eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~----~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV  209 (498)
                      .+|+..+.||+|+||.||+|.+.  +    ..||||++..... .....+..|+.+++.++||||++++|+|. +..++|
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v   86 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   86 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence            36888899999999999999863  2    2489999875432 23457889999999999999999999984 457899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      ++|+++|+|.+++...  ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          87 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            9999999999998532  3458889999999999999999999   8999999999999999999999999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~  366 (498)
                      .....      ......++..|+|||++.+..++.++|||||||++|||+| |.+||.......  .....+.       
T Consensus       162 ~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------  228 (316)
T cd05108         162 DEKEY------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------  228 (316)
T ss_pred             CCcce------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-------
Confidence            32111      0112235678999999999999999999999999999998 999997643322  1111111       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                       ....+..++..+..++.+||..+|.+||++.+ +...+..+..
T Consensus       229 -~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~-l~~~l~~~~~  270 (316)
T cd05108         229 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRE-LIIEFSKMAR  270 (316)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHc
Confidence             11123334567999999999999999999998 6666666543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6e-41  Score=325.93  Aligned_cols=249  Identities=23%  Similarity=0.370  Sum_probs=198.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      .+|.+.+.||+|+||.||+|.++     +..||+|+++..... ....|.+|+.++++++||||++++|++.  +..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46788889999999999999763     467999998764322 2346889999999999999999999884  468999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++...  ...+++..++.++.+++.||.|||+   ++++||||||+|||++.++.+|++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999998532  3468999999999999999999999   8999999999999999999999999998765322


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~~~  366 (498)
                      ....       ......++..|+|||.+.+..++.++|||||||++||+++ |.+||........  .+..+.       
T Consensus       160 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------  225 (266)
T cd05064         160 EAIY-------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-------  225 (266)
T ss_pred             cchh-------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-------
Confidence            1110       0112235678999999999999999999999999999875 9999976543322  222211       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                       ....|...+..+.+++.+||+.+|.+||++.+ +.+.|..
T Consensus       226 -~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~-i~~~l~~  264 (266)
T cd05064         226 -RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQ-IHSILSK  264 (266)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHH-HHHHHHh
Confidence             11123345678999999999999999999988 6666654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=335.46  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhh--HHHHHHHHHcCC-CCCeeeeeceecC---cceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSE--FQQEIDILSKIR-HPNLVTLVGACPE---VWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l~-hpniv~l~g~~~~---~~~lV  209 (498)
                      .+|...++||.|.||.||+|..  .+..||||.++..-.. .++  -.+|+.-|++|+ ||||++|..++.+   .+++|
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            3677888999999999999987  4678999998765433 333  358999999999 9999999998843   57999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      ||||. .+|.+++..+  ...|++..+..|+.||++||+|+|.   +|+.|||+||+|||+..+..+||+|||+|+-+..
T Consensus        89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence            99995 5999999643  6789999999999999999999999   9999999999999999999999999999996643


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc------
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN------  362 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~------  362 (498)
                      ..-         .+..+.|.+|.|||++.. +-|+.+.|+||+|||++|+.+-+|-|.+.+++++....-.+..      
T Consensus       163 kpP---------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~  233 (538)
T KOG0661|consen  163 KPP---------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS  233 (538)
T ss_pred             CCC---------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence            321         234467999999999875 5689999999999999999999999999888776543311100      


Q ss_pred             ---------ccC---CC-----CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 ---------LLD---PL-----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 ---------~~~---~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                               .+.   |.     ....-...+.+..+|+.+||..||.+||++.+
T Consensus       234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~  287 (538)
T KOG0661|consen  234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ  287 (538)
T ss_pred             chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence                     000   00     00111125678999999999999999999988

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=363.69  Aligned_cols=254  Identities=29%  Similarity=0.481  Sum_probs=208.1

Q ss_pred             CCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTL  208 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~l  208 (498)
                      +....+.||+|+||.||.|.+.+       ..||||.+.... .....+|.+|..+|+.++|||||+++|+|-+  ..+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            44566789999999999998842       349999998653 3446789999999999999999999999944  5789


Q ss_pred             EEeeCCCCCHHhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          209 VYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ++|||+||+|..+|...+.    ...|+....+.++.|||+|..||++   +++|||||...|+||+....+||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence            9999999999999965421    4568999999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHH---HhCcc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL---DTGKL  360 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~---~~~~~  360 (498)
                      +-+....+....      ...+-...|||||.+..+.++.++|||||||+|||++| |..||+..+..+...   ..|+ 
T Consensus       850 rDiy~~~yyr~~------~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR-  922 (1025)
T KOG1095|consen  850 RDIYDKDYYRKH------GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR-  922 (1025)
T ss_pred             Hhhhhchheecc------CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc-
Confidence            944333322111      11123468999999999999999999999999999999 999998776654332   2332 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                              -+.|..++..+.+|+.+||+.+|.+||++.. +++.+..+...
T Consensus       923 --------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~-i~~q~~~i~~~  964 (1025)
T KOG1095|consen  923 --------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRT-IVEQDPAISNA  964 (1025)
T ss_pred             --------cCCCCCCChHHHHHHHHHccCChhhCccHHH-HHhhhhhhhhh
Confidence                    2247778899999999999999999999998 66666666543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-41  Score=340.85  Aligned_cols=234  Identities=23%  Similarity=0.328  Sum_probs=192.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECC---eEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      .+|...+.||+|+||.||+|.+.+   ..||+|++....   ......+.+|+.+++.++||||+++++++.+  ..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            368888999999999999998642   579999986432   2234568899999999999999999999844  57899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.....
T Consensus       110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999953   3468999999999999999999999   8999999999999999999999999999986532


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ..           ....||+.|+|||++.+..++.++|||||||++|||+||.+||...+..........  .     ..
T Consensus       184 ~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~-----~~  245 (340)
T PTZ00426        184 RT-----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE--G-----II  245 (340)
T ss_pred             Cc-----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--C-----CC
Confidence            21           123589999999999988899999999999999999999999987654322111110  0     11


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCC
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRP  395 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP  395 (498)
                      .+|...+..+.+++.+|++.+|.+|+
T Consensus       246 ~~p~~~~~~~~~li~~~l~~dp~~R~  271 (340)
T PTZ00426        246 YFPKFLDNNCKHLMKKLLSHDLTKRY  271 (340)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHcC
Confidence            23444567789999999999999996

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.6e-41  Score=328.20  Aligned_cols=248  Identities=26%  Similarity=0.325  Sum_probs=194.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|.+.+.||+|+||.||+|.++  +..||||++.....  .....+.+|+.+++.++||||++++++|.  +..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            6888899999999999999985  57899999875432  23456889999999999999999999884  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++++++..+..   ....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          82 VEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            99887766542   23468999999999999999999999   8999999999999999999999999999987643221


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc------------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------------  360 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~------------  360 (498)
                      ..       .....||+.|+|||++.+..++.++|||||||++|+|++|++||...+...........            
T Consensus       156 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         156 AN-------YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             cc-------ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence            11       12345899999999999889999999999999999999999999765433222111000            


Q ss_pred             ------ccccCCCC-------CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 ------KNLLDPLA-------GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 ------~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                            .....+..       ..+....+..+.+++.+||+.+|.+||++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~  280 (287)
T cd07848         229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ  280 (287)
T ss_pred             hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence                  00000000       0111224567999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.4e-41  Score=336.40  Aligned_cols=230  Identities=22%  Similarity=0.276  Sum_probs=186.6

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gs  217 (498)
                      .||+|+||.||++...  +..||+|++.....   .....+.+|+.+++.++||||++++++|.  +..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            5999999999999874  68899999875422   22345778999999999999999999884  46899999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      |..++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.........    
T Consensus        82 L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~----  151 (323)
T cd05595          82 LFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT----  151 (323)
T ss_pred             HHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc----
Confidence            9998843   3468999999999999999999999   89999999999999999999999999998753222110    


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE  377 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (498)
                          .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.........       .....+|...+.
T Consensus       152 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~-------~~~~~~p~~~~~  220 (323)
T cd05595         152 ----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------MEEIRFPRTLSP  220 (323)
T ss_pred             ----cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCCCCCCCCCH
Confidence                123458999999999999999999999999999999999999997554322111110       001123445668


Q ss_pred             HHHHHHHHhhhcccCCCC
Q 010882          378 QLANLAMRCCEMSRKSRP  395 (498)
Q Consensus       378 ~l~~li~~cl~~~p~~RP  395 (498)
                      .+.+++.+||..+|.+||
T Consensus       221 ~~~~li~~~L~~dP~~R~  238 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             HHHHHHHHHccCCHHHhC
Confidence            899999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7e-41  Score=335.62  Aligned_cols=230  Identities=23%  Similarity=0.273  Sum_probs=187.6

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gs  217 (498)
                      .||+|+||.||++...  +..||||++.....   .....+.+|+.+++.++||||+++++++.  +..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            5999999999999874  67899999975422   22356788999999999999999999884  46899999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      |.+++.   ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++........    
T Consensus        82 L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~----  151 (328)
T cd05593          82 LFFHLS---RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT----  151 (328)
T ss_pred             HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc----
Confidence            999884   33468999999999999999999999   89999999999999999999999999998753221110    


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE  377 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (498)
                          .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+.........       .....+|...+.
T Consensus       152 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~-------~~~~~~p~~~~~  220 (328)
T cd05593         152 ----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEDIKFPRTLSA  220 (328)
T ss_pred             ----cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc-------cCCccCCCCCCH
Confidence                123459999999999998899999999999999999999999997654432211110       011124455667


Q ss_pred             HHHHHHHHhhhcccCCCC
Q 010882          378 QLANLAMRCCEMSRKSRP  395 (498)
Q Consensus       378 ~l~~li~~cl~~~p~~RP  395 (498)
                      .+.+++.+||..+|.+||
T Consensus       221 ~~~~li~~~L~~dP~~R~  238 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRL  238 (328)
T ss_pred             HHHHHHHHHcCCCHHHcC
Confidence            899999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.6e-41  Score=352.66  Aligned_cols=246  Identities=21%  Similarity=0.256  Sum_probs=199.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC---CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~  213 (498)
                      .|.+.+.||+|+||.||+|...   +..||+|.+..........+..|+.+|+.++||||++++++|  .+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3788889999999999999863   467899977554433345678899999999999999999998  34689999999


Q ss_pred             CCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          214 PNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       214 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +||+|.++|... ....++++..+..++.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988532 234578999999999999999999999   8999999999999999999999999999987654321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAGD  370 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~  370 (498)
                      ..      ......||+.|+|||++.+..++.++|||||||++|+|+||++||...+.....  +..+..        ..
T Consensus       225 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~--------~~  290 (478)
T PTZ00267        225 LD------VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY--------DP  290 (478)
T ss_pred             cc------cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CC
Confidence            11      113345999999999999999999999999999999999999999765443221  111111        11


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      .|...+..+.+++..||..+|..||++.+++
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l  321 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLL  321 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence            3344567899999999999999999998844

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.5e-41  Score=333.29  Aligned_cols=236  Identities=25%  Similarity=0.301  Sum_probs=188.8

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||.||+|.+.  +..||||++....   ......+..|..++..+ +||||+++++++.  +..++||||++||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999885  5679999987542   12234456677777654 8999999999874  4688999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++..   ...++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........    
T Consensus        82 ~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~----  151 (316)
T cd05592          82 DLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG----  151 (316)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC----
Confidence            99998843   3468999999999999999999999   8999999999999999999999999999975432211    


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..........       .....|...+
T Consensus       152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------~~~~~~~~~~  220 (316)
T cd05592         152 ----KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------DRPHFPRWIS  220 (316)
T ss_pred             ----ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCC
Confidence                11234589999999999998999999999999999999999999976554322211110       1122344566


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ..+.+++.+||+.+|.+||++.+.+
T Consensus       221 ~~~~~ll~~~l~~~P~~R~~~~~~l  245 (316)
T cd05592         221 KEAKDCLSKLFERDPTKRLGVDGDI  245 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHH
Confidence            7899999999999999999986534

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-40  Score=340.70  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=201.7

Q ss_pred             hhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCC-CChhhHHHHHHHHHcCC-CCCeeeeeceecC--
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIR-HPNLVTLVGACPE--  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-hpniv~l~g~~~~--  204 (498)
                      ....|.+.+.||+|+||.||+|.+.+       ..||||++..... ...+.+.+|+.+|+++. ||||++++|+|.+  
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            35678889999999999999998632       3699999975432 22457889999999996 9999999999954  


Q ss_pred             cceEEEeeCCCCCHHhhhccCC----------------------------------------------------------
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKD----------------------------------------------------------  226 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------  226 (498)
                      ..++||||+++|+|.++|....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            5899999999999999885421                                                          


Q ss_pred             -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc
Q 010882          227 -----------------------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD  271 (498)
Q Consensus       227 -----------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~  271 (498)
                                                         ....+++..+..++.|++.||.|||+   .+|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence                                               01347888999999999999999999   8999999999999999


Q ss_pred             CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH
Q 010882          272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE  350 (498)
Q Consensus       272 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~  350 (498)
                      .++.+||+|||+++........      .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~  345 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNY------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV  345 (400)
T ss_pred             CCCEEEEEeCCcceeccccccc------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence            9999999999999865432211      01123347789999999998899999999999999999997 9999865322


Q ss_pred             ---HHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          351 ---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       351 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                         ....+..+        .....+...+..+.+++.+||+.+|.+||++.+ +.+.|+.+
T Consensus       346 ~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~-l~~~l~~l  397 (400)
T cd05105         346 DSTFYNKIKSG--------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLH-LSDIVESL  397 (400)
T ss_pred             hHHHHHHHhcC--------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHH-HHHHHHHH
Confidence               11111111        011123345678999999999999999999988 87888765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-40  Score=326.28  Aligned_cols=251  Identities=27%  Similarity=0.470  Sum_probs=200.2

Q ss_pred             CCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTL  208 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~l  208 (498)
                      +|.+.+.||+|+||.||+|...+       ..||+|.+...... ....|.+|+.+++.++||||+++++++.+  ..++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            57788899999999999998743       46999998754322 23568899999999999999999999843  5789


Q ss_pred             EEeeCCCCCHHhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          209 VYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      +|||+++|+|.+++.....             ...+++..++.++.+++.||.|||+   ++++||||||+||+++.++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence            9999999999999854321             1458889999999999999999999   89999999999999999999


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--  352 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--  352 (498)
                      +||+|||++..........      ......+++.|+|||.+.+..++.++|||||||++|||+| |..||.......  
T Consensus       163 ~~L~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         163 VKISDFGLSRDIYSADYYR------VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             EEECCCcceeecccccccc------ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999998654322111      1123347889999999998899999999999999999998 999997543322  


Q ss_pred             HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          353 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      ..+..+.        ....|..++..+.+|+.+||+.+|.+||++.+ +...|+.
T Consensus       237 ~~i~~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~-i~~~l~~  282 (283)
T cd05048         237 EMIRSRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKD-IHTRLRS  282 (283)
T ss_pred             HHHHcCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHH-HHHHHhc
Confidence            2222211        11234456789999999999999999999998 6666653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-41  Score=334.67  Aligned_cols=246  Identities=25%  Similarity=0.382  Sum_probs=208.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--Cc-ceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EV-WTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~-~~lV~  210 (498)
                      .+|...+.+|+|+||.++....+  +..|++|.+.......  .....+|+.+++++.|||||.+.++|.  +. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            47888999999999999877664  5789999998765444  345789999999999999999999994  34 78999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      +||+||+|.+.+.+.. +..+++..+..++.|++.||.|||+   +.|+|||||+.|||++.++.+||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997554 5679999999999999999999998   88999999999999999999999999999988765


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      ...        ....+||+.|++||++.+.+|+.++|||||||++|||++-+++|...+...........  ...|    
T Consensus       160 ~~~--------a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~--~~~P----  225 (426)
T KOG0589|consen  160 DSL--------ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG--LYSP----  225 (426)
T ss_pred             hhh--------hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc--cCCC----
Confidence            411        13456999999999999999999999999999999999999999877665444333211  1233    


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      .|...+.++..++..|+..+|..||++.+.+
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL  256 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELL  256 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHh
Confidence            4556678999999999999999999999844

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-41  Score=324.12  Aligned_cols=239  Identities=24%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCCh---hhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      ..+|++.+.||+|.||.|-++..  .++.||||.+++....+.   -.+.+|++||+.|+||||+.+|.+|.  +...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            44688888999999999999976  478999999988755543   45789999999999999999999995  468899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||..+|.|.|++.   ....|++.+...++.||..|+.|+|.   ++++|||||.+|||||.|+++||+||||+.++..
T Consensus       132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999994   44569999999999999999999999   8999999999999999999999999999998876


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~  366 (498)
                      ...   ..+      ..|+|.|.+||++++.+| ++.+|-|||||+||-|+.|.-||++.+.-..  .+..|...+    
T Consensus       206 ~kf---LqT------FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE----  272 (668)
T KOG0611|consen  206 KKF---LQT------FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE----  272 (668)
T ss_pred             ccH---HHH------hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC----
Confidence            543   222      349999999999999987 5889999999999999999999998654332  223332222    


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                            ...+....-||++||..+|.+|.++.++
T Consensus       273 ------P~~PSdA~gLIRwmLmVNP~RRATieDi  300 (668)
T KOG0611|consen  273 ------PETPSDASGLIRWMLMVNPERRATIEDI  300 (668)
T ss_pred             ------CCCCchHHHHHHHHHhcCcccchhHHHH
Confidence                  1233457789999999999999998873

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.8e-40  Score=319.09  Aligned_cols=247  Identities=25%  Similarity=0.464  Sum_probs=196.9

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLP  214 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~  214 (498)
                      .+|...+.||+|+||.||+|.++. ..+|+|.+.... .....+.+|+.++++++||||++++++|.+  ..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            357777889999999999998854 579999876432 345678999999999999999999999843  5889999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++...  ...+++..+..++.+++.||.|||+   ++++||||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999998532  2358899999999999999999999   899999999999999999999999999988654322111


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                             .....++..|+|||++.+..++.++|||||||++|+|+| |++||...+..............      ..|.
T Consensus       158 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~------~~~~  224 (256)
T cd05114         158 -------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL------YRPK  224 (256)
T ss_pred             -------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC------CCCC
Confidence                   122235678999999988889999999999999999999 99999765443322111111111      1233


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHHHHHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRV  404 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~  404 (498)
                      ..+..+.+++.+||..+|.+||++.+ ++..
T Consensus       225 ~~~~~~~~li~~c~~~~p~~Rps~~~-l~~~  254 (256)
T cd05114         225 LASMTVYEVMYSCWHEKPEGRPTFAE-LLRA  254 (256)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHH-HHHh
Confidence            34568999999999999999999998 5443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-41  Score=340.77  Aligned_cols=248  Identities=23%  Similarity=0.305  Sum_probs=193.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|.+.+.||+|+||.||+|...  +..||||++.....   .....+.+|+.+|..++||||++++++|.  +..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            6888899999999999999884  67899999975321   22345788999999999999999999984  45889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++..   ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          82 YLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999853   3468999999999999999999999   899999999999999999999999999997654321


Q ss_pred             cCCCCcc------------------------------ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhC
Q 010882          292 ISSNNTT------------------------------LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG  341 (498)
Q Consensus       292 ~~~~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG  341 (498)
                      .......                              .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            1100000                              0001234699999999999999999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCC
Q 010882          342 RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       342 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                      .+||...+..............+.   .......+..+.+++.+|+. +|.+|++
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQ---FPDEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccC---CCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            999987654433222211111110   00111245678899999996 9999998

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-40  Score=324.33  Aligned_cols=248  Identities=27%  Similarity=0.375  Sum_probs=190.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC---CeEEEEEEecCCCCC--ChhhHHHHHHHHHcC---CCCCeeeeeceec-------
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKI---RHPNLVTLVGACP-------  203 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~hpniv~l~g~~~-------  203 (498)
                      +|.+.+.||+|+||.||+|...   +..||||.+......  ....+.+|+.+++.+   +||||++++++|.       
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6888899999999999999873   577999998754322  234566788887766   6999999999872       


Q ss_pred             CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                      ...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            24789999996 68999885432 3458999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccc--
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK--  361 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--  361 (498)
                      +........         .....||+.|+|||.+.+..++.++|||||||++|||+||++||............-...  
T Consensus       157 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~  227 (290)
T cd07862         157 ARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  227 (290)
T ss_pred             eEeccCCcc---------cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            986543211         123458999999999998899999999999999999999999997654432211110000  


Q ss_pred             --------------cccCCCCC----CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 --------------NLLDPLAG----DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 --------------~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                    ..+.+...    ......+..+.+++.+||+.+|++||++.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  284 (290)
T cd07862         228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA  284 (290)
T ss_pred             CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence                          00000000    0111245678899999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.2e-40  Score=318.16  Aligned_cols=242  Identities=25%  Similarity=0.446  Sum_probs=194.1

Q ss_pred             cccccCceEEEEEEE----CCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLL----RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~~gs  217 (498)
                      .||+|+||.||+|.+    .+..||+|++......  ..+.+..|+.+++.++||||++++|++. +..++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            599999999999976    3578999998754322  2457889999999999999999999984 46789999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      |.+++..   ...+++..+..++.|++.||.|||.   ++|+||||||.||+++.++.+||+|||++...........  
T Consensus        82 L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~--  153 (257)
T cd05116          82 LNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--  153 (257)
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee--
Confidence            9999843   3468999999999999999999999   8999999999999999999999999999986643321110  


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCCCCCCCCHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                         ......++..|+|||.+....++.++|||||||++|||+| |.+||...+..  ...+..+.        ....|..
T Consensus       154 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~--------~~~~~~~  222 (257)
T cd05116         154 ---AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE--------RMECPQR  222 (257)
T ss_pred             ---ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--------CCCCCCC
Confidence               0122235689999999988889999999999999999998 99999754332  22222221        1123445


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      .+..+.+++.+||+.+|.+||++.. |...|+
T Consensus       223 ~~~~l~~li~~~~~~~p~~Rp~~~~-i~~~l~  253 (257)
T cd05116         223 CPPEMYDLMKLCWTYGVDERPGFAV-VELRLR  253 (257)
T ss_pred             CCHHHHHHHHHHhccCchhCcCHHH-HHHHHh
Confidence            6688999999999999999999988 655554

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-40  Score=333.04  Aligned_cols=232  Identities=27%  Similarity=0.351  Sum_probs=187.2

Q ss_pred             CcccccCceEEEEEEE-----CCeEEEEEEecCCC----CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          144 LKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +.||+|+||.||++..     .+..||||++....    ......+..|+.+|+.++||||++++++|.  +..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5699999999999875     35789999987532    122345778999999999999999999884  458999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++..   ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999999843   3467888899999999999999999   8999999999999999999999999999875332211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      .        .....||+.|+|||++.+..++.++|||||||++|||+||++||...+...........       ....|
T Consensus       156 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-------~~~~~  220 (323)
T cd05584         156 V--------THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-------KLNLP  220 (323)
T ss_pred             c--------ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------CCCCC
Confidence            1        12235899999999999888999999999999999999999999866543322111100       11234


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCC
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                      ...+..+.+++.+||+.+|.+||+
T Consensus       221 ~~~~~~~~~li~~~l~~~p~~R~~  244 (323)
T cd05584         221 PYLTPEARDLLKKLLKRNPSSRLG  244 (323)
T ss_pred             CCCCHHHHHHHHHHcccCHhHcCC
Confidence            445678999999999999999994

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-40  Score=333.75  Aligned_cols=239  Identities=23%  Similarity=0.304  Sum_probs=191.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCC-Ceeeeeceec--CcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHP-NLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hp-niv~l~g~~~--~~~~lV~  210 (498)
                      +|.+.+.||+|+||.||+|...  +..||||++....   ......+..|+.++..+.|+ +|+.+++++.  +..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4777889999999999999885  4689999987542   22345678899999999765 5778888773  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999984   33468899999999999999999999   89999999999999999999999999998743211


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      ...        .....||+.|+|||++.+..++.++|||||||++|+|+||++||...+..........       ....
T Consensus       155 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-------~~~~  219 (324)
T cd05587         155 GKT--------TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME-------HNVS  219 (324)
T ss_pred             CCc--------eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CCCC
Confidence            100        1223589999999999999999999999999999999999999976554332211111       1122


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                      +|...+..+.+++.+||..+|.+||+..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~  247 (324)
T cd05587         220 YPKSLSKEAVSICKGLLTKHPAKRLGCG  247 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence            4445667899999999999999999874

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-41  Score=325.92  Aligned_cols=243  Identities=40%  Similarity=0.644  Sum_probs=189.2

Q ss_pred             CCcccccCceEEEEEEEC------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          143 SLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .+.||.|+||.||+|.+.      +..|+||++...... ..+.|.+|++++++++||||++++|+|.  +..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            357999999999999997      578999999653322 2568999999999999999999999995  3578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.++|... ....+++..+..|+.|++.||.|||+   ++++||||+|+|||++.++.+||+|||++.........
T Consensus        84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            999999999654 24569999999999999999999999   88999999999999999999999999999876322111


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  370 (498)
                            .......+...|+|||.+....++.++||||||+++|||+| |+.||...+...  ..+..+..        ..
T Consensus       160 ------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------~~  225 (259)
T PF07714_consen  160 ------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------LP  225 (259)
T ss_dssp             ------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------TT
T ss_pred             ------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ce
Confidence                  11223346789999999999989999999999999999999 789987543322  22222211        11


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV  404 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~  404 (498)
                      .+..++..+.+++..||+.+|.+||++.+ +++.
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~-i~~~  258 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQE-ILQE  258 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHH-HHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHH-HHhc
Confidence            23345678999999999999999999998 5443

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-40  Score=333.02  Aligned_cols=239  Identities=22%  Similarity=0.307  Sum_probs=192.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~  210 (498)
                      +|.+.+.||+|+||.||+|...  +..||||++.....   .....+..|..++..+ +||+|+.+++++.  +..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4777889999999999999885  46899999875432   2233566788888877 5899999999874  4688999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.+.+..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999998843   3468899999999999999999999   89999999999999999999999999998754322


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      ...        .....||+.|+|||++.+..++.++|||||||++|||+||++||...+..........       ....
T Consensus       155 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------~~~~  219 (323)
T cd05616         155 GVT--------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------HNVA  219 (323)
T ss_pred             CCc--------cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCC
Confidence            111        1234589999999999999999999999999999999999999986554322211110       1122


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                      +|...+..+.+++.+|++.+|.+|++..
T Consensus       220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05616         220 YPKSMSKEAVAICKGLMTKHPGKRLGCG  247 (323)
T ss_pred             CCCcCCHHHHHHHHHHcccCHHhcCCCC
Confidence            4555678899999999999999999863

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.7e-40  Score=331.78  Aligned_cols=248  Identities=23%  Similarity=0.335  Sum_probs=195.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|+..+.||+|+||.||++...  +..||+|++..... .....+.+|+++|+.++||||+++++++.  +..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            57888999999999999999985  67899999875422 22356889999999999999999999883  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++..   ...+++..+..++.+++.||.|||+.  .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        85 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          85 MDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999999953   34588999999999999999999983  369999999999999999999999999987654321 


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc-cc----------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-LK----------  361 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~----------  361 (498)
                               .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+........+. ..          
T Consensus       159 ---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (331)
T cd06649         159 ---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSI  229 (331)
T ss_pred             ---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcccc
Confidence                     1223589999999999988999999999999999999999999965433221110000 00          


Q ss_pred             -----------------------------cccCCCCCCC-CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 -----------------------------NLLDPLAGDW-PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 -----------------------------~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                                   .+........ ....+..+.+|+.+||..||++||++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el  298 (331)
T cd06649         230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML  298 (331)
T ss_pred             CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH
Confidence                                         0000000001 11245689999999999999999999883

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-41  Score=337.65  Aligned_cols=251  Identities=25%  Similarity=0.309  Sum_probs=198.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|.+.+.||+|+||.||+|...  +..||||++.....   .....+..|+.++..++||||+++++++.  +..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            6888899999999999999986  78999999875422   23456889999999999999999999884  46889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++|+|.+++...   ..+++..+..++.|++.||.|||.   +||+||||||+||||+.++.+||+|||++.......
T Consensus        82 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          82 YMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            99999999999533   568999999999999999999999   899999999999999999999999999998665432


Q ss_pred             cCC---------------------CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH
Q 010882          292 ISS---------------------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE  350 (498)
Q Consensus       292 ~~~---------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~  350 (498)
                      ...                     ............||+.|+|||++.+..++.++|||||||+||||+||+.||...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            000                     00000112345699999999999999999999999999999999999999987654


Q ss_pred             HHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCC-hhH
Q 010882          351 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE-LGK  399 (498)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~-~~~  399 (498)
                      .............+.  .. .....+..+.+++..|+. +|.+||+ +.+
T Consensus       236 ~~~~~~i~~~~~~~~--~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~  281 (350)
T cd05573         236 QETYNKIINWKESLR--FP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEE  281 (350)
T ss_pred             HHHHHHHhccCCccc--CC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHH
Confidence            332222211111111  00 011146789999999997 9999999 776

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-40  Score=330.48  Aligned_cols=236  Identities=25%  Similarity=0.338  Sum_probs=188.4

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHc-CCCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSK-IRHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~-l~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||+||+|...  +..||||++....   ......+..|..++.. ++||||+++++++.  +..++||||++||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            5999999999999985  5789999987542   2233456678888876 48999999999884  4588999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++..   ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.........   
T Consensus        82 ~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---  152 (316)
T cd05619          82 DLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---  152 (316)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc---
Confidence            99999843   3468899999999999999999999   89999999999999999999999999998753221110   


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                           .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+......... ..      ...+|...+
T Consensus       153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-~~------~~~~~~~~~  220 (316)
T cd05619         153 -----TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-MD------NPCYPRWLT  220 (316)
T ss_pred             -----eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hC------CCCCCccCC
Confidence                 122358999999999999899999999999999999999999997654332211111 00      111334456


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ..+.+++.+||..+|.+||++.+.+
T Consensus       221 ~~~~~li~~~l~~~P~~R~~~~~~l  245 (316)
T cd05619         221 REAKDILVKLFVREPERRLGVKGDI  245 (316)
T ss_pred             HHHHHHHHHHhccCHhhcCCChHHH
Confidence            7899999999999999999997434

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-40  Score=320.76  Aligned_cols=251  Identities=26%  Similarity=0.285  Sum_probs=202.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECC--eEEEEEEecCCCCCCh---hhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~---~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      +.|...+.||.|.-|+||++..++  ..+|+|++.+......   .....|.+||+.++||.++.||+.|+  +..|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457778889999999999999976  6899999987655443   35678999999999999999999994  4688999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |||+||+|..++++. ....+++..+..++.+++.||+|||.   .|||+|||||+||||-++|++-|+||.|+......
T Consensus       157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999988644 45679999999999999999999999   99999999999999999999999999998754221


Q ss_pred             ccC-----------------------------CCC-------------------ccceeccCCCCCCCcCChhhhccCCC
Q 010882          291 EIS-----------------------------SNN-------------------TTLCCRTDPKGTFAYMDPEFLASGEL  322 (498)
Q Consensus       291 ~~~-----------------------------~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~~~~  322 (498)
                      .+.                             ...                   .+.......+||-.|+|||++.+.+.
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence            000                             000                   00122345689999999999999999


Q ss_pred             CCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          323 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       323 ~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      +.++|||+|||+||||+.|..||.+.+.-....+.-  .+.  ......| ..+..+.+||+..|..||.+|...
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv--~~~--l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV--GQP--LKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh--cCC--CcCCCCC-cchhHHHHHHHHHhccChhhhhcc
Confidence            999999999999999999999998776544433221  110  1112222 566789999999999999999873

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-40  Score=333.17  Aligned_cols=238  Identities=23%  Similarity=0.284  Sum_probs=189.3

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHH---HcCCCCCeeeeeceec--CcceEE
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDIL---SKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il---~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      |.+.+.||+|+||.||+|.+.  +..||||++.....   ...+.+..|+.++   +.++||||+++++++.  +..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            556778999999999999884  67899999975421   2234566776665   5678999999999884  468999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||++||+|...+.    ...+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999998874    2358999999999999999999999   8999999999999999999999999999874322


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ...        ......||+.|+|||++.+..++.++|||||||++|+|+||++||...+..........       ...
T Consensus       154 ~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------~~~  218 (324)
T cd05589         154 FGD--------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEV  218 (324)
T ss_pred             CCC--------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC
Confidence            111        01234589999999999999999999999999999999999999976544322111100       011


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+|...+..+.+++.+||..+|.+||+..+
T Consensus       219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~  248 (324)
T cd05589         219 RYPRFLSREAISIMRRLLRRNPERRLGSGE  248 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            234445678899999999999999997654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3e-40  Score=322.76  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=197.7

Q ss_pred             hhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--c
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--V  205 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~  205 (498)
                      .+++|+..+.||+|+||.||+|.+.+       ..||||++..... .....+.+|+.+++.++||||+++++++.+  .
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            35678999999999999999998642       5699998864322 223468899999999999999999999853  5


Q ss_pred             ceEEEeeCCCCCHHhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeE
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDN-------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL  278 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  278 (498)
                      .++||||+++|+|.+++.....       ...+++..++.++.+++.||.|||+   .+++||||||+|||++.++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            7899999999999999854221       2346788999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHH--H
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA--L  355 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~--~  355 (498)
                      +|||++...........      .....+++.|+|||++.+..++.++|||||||++|||+| |.+||.........  .
T Consensus       161 ~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRK------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV  234 (277)
T ss_pred             CCCCCccccCCcceeec------CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999876543221110      112346788999999998899999999999999999999 78898755432211  1


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      ..+..        ...+...+..+.+++.+||+.+|.+||++.+ ++..|
T Consensus       235 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-~l~~l  275 (277)
T cd05062         235 MEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-IISSI  275 (277)
T ss_pred             HcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHh
Confidence            11111        1123344578999999999999999999988 55444

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.8e-40  Score=324.15  Aligned_cols=248  Identities=26%  Similarity=0.350  Sum_probs=191.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      .+|...+.||.|+||.||+|...  +..||+|++..... .....+.+|+.+++.++||||+++++++.+  ..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888899999999999999874  67899999875432 234567899999999999999999998843  57899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++ +|.+++...  ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 899888532  3457889999999999999999999   8999999999999999999999999999975432211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----C---------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G---------  358 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~---------  358 (498)
                      .        .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........    +         
T Consensus       159 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07871         159 T--------YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG  230 (288)
T ss_pred             c--------ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence            1        123358999999999876 46899999999999999999999999764432211100    0         


Q ss_pred             -----ccccccCCCCC-----CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 -----KLKNLLDPLAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 -----~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                           .+.....+...     ......+....+|+.+||..||.+||++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~  281 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA  281 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence                 00000000000     001123467889999999999999999988

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-40  Score=333.10  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=190.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceec-------Ccce
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP-------EVWT  207 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~-------~~~~  207 (498)
                      +|.+.+.||+|+||.||+|...  +..||||++....  ......+.+|+.+++.++||||+++++++.       ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            3677789999999999999874  6889999987432  223446889999999999999999999872       1368


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+. ++|.+++.   ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68999884   33468999999999999999999999   89999999999999999999999999999864


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH----------
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL----------  355 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~----------  355 (498)
                      .......     .......||+.|+|||++.+  ..++.++|||||||++|+|+||++||...+......          
T Consensus       154 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  228 (338)
T cd07859         154 FNDTPTA-----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS  228 (338)
T ss_pred             ccccCcc-----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            3322111     11133469999999999876  578999999999999999999999997543321110          


Q ss_pred             -------HhCcccccc----CCCC----CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          356 -------DTGKLKNLL----DPLA----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       356 -------~~~~~~~~~----~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                             ........+    ....    ..++ ..+..+.+++.+||..+|.+||++.++
T Consensus       229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~  287 (338)
T cd07859         229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEA  287 (338)
T ss_pred             HHHHHHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHH
Confidence                   000000000    0000    0011 234568899999999999999999883

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-40  Score=339.06  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=192.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .|...+.||+|+||+||+|...  +..||||++......   ....+..|+.+++.++||||+++++++.  +..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778889999999999999884  578999999754322   2346889999999999999999999984  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++..   ...+++..+..++.|++.||.|||.   .||+||||||+||||+.++++||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999853   3468889999999999999999999   899999999999999999999999999986442111


Q ss_pred             cCCC---------------------------------------CccceeccCCCCCCCcCChhhhccCCCCCccchHhHH
Q 010882          292 ISSN---------------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG  332 (498)
Q Consensus       292 ~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG  332 (498)
                      ....                                       ....+.....+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0000                                       0000011234699999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHH--hhhcccCCCCChhH
Q 010882          333 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMR--CCEMSRKSRPELGK  399 (498)
Q Consensus       333 vil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RP~~~~  399 (498)
                      |++|||+||.+||...+..............+.   .......+..+.+++.+  |+..+|..||++.+
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLH---IPPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHccccccC---CCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            999999999999976554332222111111110   00111245678888887  55566667999887

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.9e-40  Score=318.89  Aligned_cols=249  Identities=26%  Similarity=0.475  Sum_probs=200.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      .+|.+.++||+|+||.||+|... +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.  +..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            46788899999999999999875 4679999876533 24568899999999999999999999874  45789999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++... ....+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++......... 
T Consensus        85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05072          85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-  159 (261)
T ss_pred             CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence            99999998543 23468889999999999999999999   89999999999999999999999999999876432211 


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  371 (498)
                            ......++..|+|||++....++.++|||||||++|+|+| |..||.......  ..+..+.    ..+    .
T Consensus       160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~----~  225 (261)
T cd05072         160 ------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY----RMP----R  225 (261)
T ss_pred             ------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----CCC----C
Confidence                  1122346778999999998889999999999999999999 999997543322  2222110    011    1


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      +...+..+.+++.+|+..+|++||++.+ +.++|+.
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~  260 (261)
T cd05072         226 MENCPDELYDIMKTCWKEKAEERPTFDY-LQSVLDD  260 (261)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHH-HHHHHhc
Confidence            1234567999999999999999999988 7777764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.7e-40  Score=320.06  Aligned_cols=251  Identities=23%  Similarity=0.393  Sum_probs=197.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC--Ce----EEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~  210 (498)
                      +|...+.||+|+||+||+|.+.  +.    .|++|.+...... ....+..|+.+++.++||||++++|++.. ..++|+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~   87 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT   87 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEE
Confidence            5777889999999999999883  33    4788887543221 23467788889999999999999999854 578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus        88 e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          88 QLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            999999999999532  3468999999999999999999999   89999999999999999999999999999866433


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~~  367 (498)
                      .....      .....|+..|+|||.+.++.++.++|||||||++|||+| |..||......  ...+..+...      
T Consensus       163 ~~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------  230 (279)
T cd05111         163 DKKYF------YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL------  230 (279)
T ss_pred             Ccccc------cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC------
Confidence            21111      122347789999999998899999999999999999998 99999765432  2222222111      


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                        ..+..++..+..++.+||..+|..||++.+ +...|..+.
T Consensus       231 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~e-l~~~l~~~~  269 (279)
T cd05111         231 --AQPQICTIDVYMVMVKCWMIDENVRPTFKE-LANEFTRMA  269 (279)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHHH
Confidence              112234467889999999999999999988 666776654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.4e-40  Score=323.01  Aligned_cols=256  Identities=23%  Similarity=0.461  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      .+|.+.+.||+|+||.||++...       +..+|+|.+..........+.+|+.++++++||||++++++|.  +..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46788889999999999999752       3458999887554444567899999999999999999999984  46899


Q ss_pred             EEeeCCCCCHHhhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeE
Q 010882          209 VYEYLPNGSLEDRLSCKD----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL  278 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  278 (498)
                      ||||+++|+|.+++....          ....+++..++.++.|++.||.|||+   +|++||||||+|||++.++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence            999999999999985322          12358999999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHH
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YAL  355 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~  355 (498)
                      +|||++.........      .......+++.|+|||++.+..++.++|||||||++|+|+| |.+||.......  ..+
T Consensus       162 ~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         162 GDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             ccCCccccccCCcee------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999865432211      11123346789999999998899999999999999999999 999997544322  222


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ..+...        ..+...+..+.+++.+||+.+|.+||++.+ +...|+.+...
T Consensus       236 ~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~-v~~~l~~~~~~  282 (288)
T cd05093         236 TQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKE-IHSLLQNLAKA  282 (288)
T ss_pred             HcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHH-HHHHHHHHHHh
Confidence            222211        112234567999999999999999999998 78888887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.5e-40  Score=318.44  Aligned_cols=251  Identities=26%  Similarity=0.472  Sum_probs=200.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      +|...+.||+|+||.||+|.+.  +..||+|.+... ......+.+|+.+++.++||||++++++|.  +..++||||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            4677788999999999999884  678999998743 234567889999999999999999999884  46789999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++.... ...+++..++.++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++..........
T Consensus        86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            999999985432 3458999999999999999999999   899999999999999999999999999998664332111


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                             .....++..|+|||.+.+..++.++|||||||++|||+| |.+||............   ..   ......+.
T Consensus       162 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~~---~~~~~~~~  228 (263)
T cd05052         162 -------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EK---GYRMERPE  228 (263)
T ss_pred             -------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HC---CCCCCCCC
Confidence                   112234678999999998999999999999999999998 99999754332211111   00   01112344


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..+..+.+++.+||..+|.+||++.+ +.+.|+.+
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~-l~~~l~~~  262 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAE-IHQAFETM  262 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHH-HHHHHHhh
Confidence            45688999999999999999999998 77777653

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.8e-40  Score=331.45  Aligned_cols=234  Identities=24%  Similarity=0.281  Sum_probs=188.7

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||.||+|...  +..||||++....   ......+..|..++..+ +||||+++++++.  +..++||||++||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5999999999999885  6789999987532   22345677888888876 6999999999884  4589999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++..   ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.........   
T Consensus        82 ~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~---  152 (320)
T cd05590          82 DLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---  152 (320)
T ss_pred             hHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc---
Confidence            99998843   3468999999999999999999999   89999999999999999999999999998753222111   


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                           .....||+.|+|||++.+..++.++|||||||++|+|+||++||...+.........  .     .....|...+
T Consensus       153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~-----~~~~~~~~~~  220 (320)
T cd05590         153 -----TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--N-----DEVVYPTWLS  220 (320)
T ss_pred             -----ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--c-----CCCCCCCCCC
Confidence                 123459999999999998899999999999999999999999997665433211110  0     0112344456


Q ss_pred             HHHHHHHHHhhhcccCCCCChhH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+.+++.+||+.+|.+||++.+
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         221 QDAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCC
Confidence            78999999999999999999843

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.7e-40  Score=322.32  Aligned_cols=251  Identities=24%  Similarity=0.457  Sum_probs=199.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--Ccce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~  207 (498)
                      .+|.+.+.||+|+||.||+|...       +..||||.+...... ....+.+|+++|+.++||||+++++++.  ...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            35777888999999999999763       357999998765433 3467899999999999999999999984  4689


Q ss_pred             EEEeeCCCCCHHhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          208 LVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                      +||||+++|+|.+++....           ....+++..+..++.+++.||.|||+   ++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            9999999999999996432           13458889999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--H
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--Y  353 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~  353 (498)
                      ||+|||++..........      ......+++.|+|||++.+..++.++|||||||++|||++ |..||.......  .
T Consensus       162 kl~d~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             EECCcccceecccCccee------cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999987543322111      0122346789999999999999999999999999999999 999986543322  2


Q ss_pred             HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      .+..+...        ..+...+..+.+++.+||..+|.+||++.+ +++.|+
T Consensus       236 ~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e-il~~l~  279 (280)
T cd05049         236 CITQGRLL--------QRPRTCPSEVYDIMLGCWKRDPQQRINIKD-IHERLQ  279 (280)
T ss_pred             HHHcCCcC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHhh
Confidence            22222111        123345678999999999999999999988 655553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-40  Score=348.71  Aligned_cols=253  Identities=21%  Similarity=0.274  Sum_probs=202.2

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC----
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE----  204 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~----  204 (498)
                      +.....+|.+.+.||+|+||+||+|..  .+..||||++......  ....+.+|+.++..++|+||+++++.+..    
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344567899999999999999999987  4789999998764332  23467889999999999999999876521    


Q ss_pred             ------cceEEEeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCcee
Q 010882          205 ------VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK  277 (498)
Q Consensus       205 ------~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  277 (498)
                            ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+   ++|+||||||+||||+.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence                  257999999999999998542 234568999999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh
Q 010882          278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT  357 (498)
Q Consensus       278 l~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (498)
                      |+|||+++.+........      .....||+.|+|||++.+..++.++|||||||+||||+||+.||...+........
T Consensus       184 L~DFGls~~~~~~~~~~~------~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~  257 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDV------GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT  257 (496)
T ss_pred             EEecccCeeccccccccc------cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999987643321111      12345999999999999999999999999999999999999999765443221111


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          358 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        .....    ...|...+..+.+++..||..+|.+||++.++
T Consensus       258 --~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~el  294 (496)
T PTZ00283        258 --LAGRY----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKL  294 (496)
T ss_pred             --hcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence              11111    12344556789999999999999999999884

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.8e-40  Score=316.13  Aligned_cols=244  Identities=25%  Similarity=0.468  Sum_probs=195.1

Q ss_pred             cccccCceEEEEEEEC----CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCCCCCH
Q 010882          145 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGSL  218 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~~gsL  218 (498)
                      .||+|+||.||+|.++    +..||+|++...... ..+.+.+|+.++++++||||++++++|. +..++||||+++|+|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            3899999999999874    346999998765332 2356889999999999999999999985 457899999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++..  ....+++..+..++.+++.||.|||+   +|++||||||+|||++.++.+||+|||++...........   
T Consensus        82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---  153 (257)
T cd05115          82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK---  153 (257)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee---
Confidence            999853  23468999999999999999999999   8999999999999999999999999999986543321111   


Q ss_pred             ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCCCCCCCHHH
Q 010882          299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFVQ  375 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  375 (498)
                        ......+++.|+|||++....++.++|||||||++|+|++ |.+||.......  ..+..+.        ....|..+
T Consensus       154 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~  223 (257)
T cd05115         154 --ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--------RLDCPAEC  223 (257)
T ss_pred             --ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------CCCCCCCC
Confidence              1122234678999999988889999999999999999996 999997544322  2222221        12234456


Q ss_pred             HHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          376 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       376 ~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      +.++.+++.+||..+|++||++.+ |.+.|+.
T Consensus       224 ~~~l~~li~~c~~~~~~~Rp~~~~-i~~~l~~  254 (257)
T cd05115         224 PPEMYALMKDCWIYKWEDRPNFAK-VEERMRT  254 (257)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHH-HHHHHhh
Confidence            788999999999999999999998 6666654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-40  Score=323.34  Aligned_cols=238  Identities=23%  Similarity=0.321  Sum_probs=189.0

Q ss_pred             ccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      ||+|+||+||++...  +..||+|.+......   ..+.+..|+.+++.++||||+++++++.  ...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999874  678999998754322   2345778999999999999999999874  358899999999999


Q ss_pred             HhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          219 EDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       219 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      .+.+... .....+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++..+......    
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~----  153 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK----  153 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc----
Confidence            9887432 234568999999999999999999999   89999999999999999999999999999765432211    


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCccccccCCCCCCCCHHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQ  375 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  375 (498)
                          .....||+.|+|||++.+..++.++|||||||++|+|+||+.||......  ...........     ...++...
T Consensus       154 ----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  224 (280)
T cd05608         154 ----TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-----SVTYPDKF  224 (280)
T ss_pred             ----ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-----CCCCcccC
Confidence                12335899999999999999999999999999999999999999754221  11111111111     11234456


Q ss_pred             HHHHHHHHHHhhhcccCCCCChhH
Q 010882          376 AEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       376 ~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +..+.+++.+||+.+|.+||++.+
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~  248 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRD  248 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCC
Confidence            678999999999999999997644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.4e-40  Score=330.79  Aligned_cols=232  Identities=25%  Similarity=0.351  Sum_probs=187.0

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||.||+|...  +..||||++.....   .....+..|..++..+ +||||+++++++.  +..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            5999999999999885  56899999875422   2334577899999876 7999999999984  4589999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+.+.   ....+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++.........   
T Consensus        82 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~---  152 (321)
T cd05591          82 DLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---  152 (321)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc---
Confidence            9999884   33468899999999999999999999   89999999999999999999999999998754322111   


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                           .....||+.|+|||++.+..++.++|||||||++|+|+||++||...+...........       ...+|...+
T Consensus       153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-------~~~~p~~~~  220 (321)
T cd05591         153 -----TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-------DVLYPVWLS  220 (321)
T ss_pred             -----ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------CCCCCCCCC
Confidence                 12335899999999999889999999999999999999999999876543322111100       011333456


Q ss_pred             HHHHHHHHHhhhcccCCCCCh
Q 010882          377 EQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ..+.+++..||+.+|.+||+.
T Consensus       221 ~~~~~ll~~~L~~dp~~R~~~  241 (321)
T cd05591         221 KEAVSILKAFMTKNPNKRLGC  241 (321)
T ss_pred             HHHHHHHHHHhccCHHHcCCC
Confidence            789999999999999999943

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.6e-40  Score=329.72  Aligned_cols=237  Identities=23%  Similarity=0.279  Sum_probs=188.8

Q ss_pred             CcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEeeCCC
Q 010882          144 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      +.||+|+||.||+|...  +..||+|++....   ......+..|..++..+ +||||+++++++.  +..++||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999984  6789999987542   12334567788888764 8999999999884  468899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.+++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++.......   
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---  151 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---  151 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---
Confidence            999998843   3468899999999999999999999   8999999999999999999999999999874321110   


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ  375 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (498)
                           ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+......... .      .....|...
T Consensus       152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~-~------~~~~~~~~~  219 (316)
T cd05620         152 -----RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-V------DTPHYPRWI  219 (316)
T ss_pred             -----ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-h------CCCCCCCCC
Confidence                 0123458999999999999999999999999999999999999997654432211110 0      011234445


Q ss_pred             HHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          376 AEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       376 ~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      +..+.+++.+||+.+|.+||++.+.+
T Consensus       220 ~~~~~~li~~~l~~dP~~R~~~~~~~  245 (316)
T cd05620         220 TKESKDILEKLFERDPTRRLGVVGNI  245 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHH
Confidence            67899999999999999999986534

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.3e-40  Score=324.94  Aligned_cols=249  Identities=26%  Similarity=0.361  Sum_probs=190.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ..+|.+.+.||+|+||.||+|...  +..||||++..... .....+.+|+.+++.++||||+++++++.  +..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            357899999999999999999984  67899999875432 22346788999999999999999999884  46889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++ ++|.+++..  ....++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            995 678877743  23458889999999999999999999   899999999999999999999999999987543221


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh-----Cccc----
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-----GKLK----  361 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-----~~~~----  361 (498)
                      ..        .....||+.|+|||++.+ ..++.++|||||||++|+|+||.+||.........+..     +...    
T Consensus       158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (303)
T cd07869         158 HT--------YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW  229 (303)
T ss_pred             cc--------CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence            10        123458999999999876 45888999999999999999999999764332211110     0000    


Q ss_pred             ----c--ccCCCCC--CCCH---------HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          362 ----N--LLDPLAG--DWPF---------VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       362 ----~--~~~~~~~--~~~~---------~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                          .  ...+...  ..+.         ..+..+.+|+..||+.||.+||++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~  284 (303)
T cd07869         230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA  284 (303)
T ss_pred             cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHH
Confidence                0  0000000  0000         12356789999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.2e-40  Score=319.36  Aligned_cols=252  Identities=26%  Similarity=0.492  Sum_probs=204.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ..+|...+.||.|+||.||+|.+. +..+|+|++..........+..|+.+++.++||||+++++++.  +..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            346888889999999999999985 5789999988766555678999999999999999999999884  4578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++.... ...+++..+..++.+++.||.|||+   +|++||||+|+||+++.++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999996432 3468999999999999999999999   89999999999999999999999999999866433211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      .        ....++..|+|||.+....++.++|||||||++|+|++ |+.||.............      .......+
T Consensus       161 ~--------~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~~~~  226 (261)
T cd05148         161 S--------SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT------AGYRMPCP  226 (261)
T ss_pred             c--------cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH------hCCcCCCC
Confidence            1        12336788999999988889999999999999999998 899997544322111110      01111223


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      ...+..+.+++.+||..+|.+||++.+ +.+.|+.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~-l~~~L~~  260 (261)
T cd05148         227 AKCPQEIYKIMLECWAAEPEDRPSFKA-LREELDN  260 (261)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHH-HHHHHhc
Confidence            455678999999999999999999998 7777664

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-40  Score=313.64  Aligned_cols=248  Identities=28%  Similarity=0.388  Sum_probs=197.9

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCC-eeeeeceecC--------c
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPN-LVTLVGACPE--------V  205 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpn-iv~l~g~~~~--------~  205 (498)
                      .|....+||+|+||+||+|+.  .|..||+|++.....  ..+....+|+.+|+.|+|+| ||+|++++..        .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            455556799999999999988  478899999987644  34667889999999999999 9999999832        5


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      +++|+||+. -+|..++...... ..++...+..++.|++.||.|||+   ++|+||||||+||||+++|.+||+|||+|
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence            789999995 5899998643321 357778899999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      +.+.-...        ..+..++|.+|.|||++.+. .|+...||||+|||++||+++++-|.+..+.........+...
T Consensus       168 ra~~ip~~--------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  168 RAFSIPMR--------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             HHhcCCcc--------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            96543221        12445689999999999987 7999999999999999999999999988887665544222111


Q ss_pred             cCCCCCCCCH------------------HH-------HHHHHHHHHHhhhcccCCCCChhHH
Q 010882          364 LDPLAGDWPF------------------VQ-------AEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       364 ~~~~~~~~~~------------------~~-------~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        |....||.                  ..       .....+++.+|++.+|.+|.++..+
T Consensus       240 --P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a  299 (323)
T KOG0594|consen  240 --PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA  299 (323)
T ss_pred             --CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH
Confidence              11111111                  11       1368899999999999999999873

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.6e-40  Score=321.87  Aligned_cols=250  Identities=27%  Similarity=0.429  Sum_probs=197.2

Q ss_pred             CCCCCCcccccCceEEEEEEE------CCeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      +|++.+.||+|+||.||+|.+      .+..||+|.+...... ....+.+|+.+++.++||||+++++++.  +..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            567778999999999999985      2467999998753322 2356889999999999999999999874  467999


Q ss_pred             EeeCCCCCHHhhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          210 YEYLPNGSLEDRLSCKD--------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      |||+++|+|.+++....              ....+++...+.++.+++.||.|||+   ++++||||||+|||++.++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence            99999999999984221              12357888999999999999999999   89999999999999999999


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH--HH
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQ  352 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~--~~  352 (498)
                      +||+|||+++..........      .....++..|+|||++.+..++.++|||||||++|||+| |.+||.....  +.
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         163 VKISDLGLSREIYSADYYRV------QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             EEeccccccccccCCcceec------ccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999986543321111      122336778999999988889999999999999999999 9999965433  22


Q ss_pred             HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          353 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      ..+......        ..+...+..+.+++.+||+.+|.+||++.+ +.+.|.
T Consensus       237 ~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-i~~~l~  281 (283)
T cd05090         237 EMVRKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKD-IHTRLR  281 (283)
T ss_pred             HHHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHH-HHHHhh
Confidence            222221111        123345678999999999999999999988 665554

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=339.27  Aligned_cols=249  Identities=23%  Similarity=0.298  Sum_probs=190.9

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      +|.+.+.||+|+||.||++..  .+..||||++.....   .....+.+|+.+++.++||||++++++|.+  ..++|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            678889999999999999987  467899999865321   223567889999999999999999999854  5899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++..   ...+++..+..++.|++.||.|||+   .||+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          82 FLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9999999999843   3568899999999999999999999   899999999999999999999999999997432211


Q ss_pred             cCC----------CCcc-----------------------------ceeccCCCCCCCcCChhhhccCCCCCccchHhHH
Q 010882          292 ISS----------NNTT-----------------------------LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG  332 (498)
Q Consensus       292 ~~~----------~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG  332 (498)
                      ...          ....                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            000          0000                             0000124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH--HHHHHHHHHHHHhhhcccCCC---CChhH
Q 010882          333 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF--VQAEQLANLAMRCCEMSRKSR---PELGK  399 (498)
Q Consensus       333 vil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~R---P~~~~  399 (498)
                      |++|||+||.+||..................+     .+|.  ..+..+.+++.+|+. +|.+|   |++.+
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETL-----YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc-----CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            99999999999997654433222111111111     1121  245778999999997 67665   47666

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-40  Score=316.33  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=201.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ..+|.+.+.||+|+||.||+|.+. +..||+|.+.... ...+.+.+|+.++++++||||+++++++.  ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            346888899999999999999874 4679999987543 34567899999999999999999999884  3588999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++.... ...+++..+..++.+++.||.|||+   .|++||||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 3468999999999999999999999   89999999999999999999999999999876532211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      .       .....++..|+|||++.+..++.++|||||||++|+|+| |+.||.................      ...+
T Consensus       160 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------~~~~  226 (261)
T cd05068         160 A-------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------MPCP  226 (261)
T ss_pred             c-------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------CCCC
Confidence            0       111223468999999998899999999999999999999 9999976543322211111100      1123


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      ...+..+.+++.+|++.+|.+||++.+ +...|+.
T Consensus       227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~-l~~~l~~  260 (261)
T cd05068         227 PGCPKELYDIMLDCWKEDPDDRPTFET-LQWKLED  260 (261)
T ss_pred             CcCCHHHHHHHHHHhhcCcccCCCHHH-HHHHHhc
Confidence            345578999999999999999999998 6666653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.9e-40  Score=323.75  Aligned_cols=254  Identities=25%  Similarity=0.498  Sum_probs=203.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      +|.....||+|+||.||+|...       +..+++|.+..........+.+|+.++++++||||+++++++.  +..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            5777788999999999999753       3458999887555444567999999999999999999999984  457999


Q ss_pred             EeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          210 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                      |||+++++|.+++....             ....+++..++.++.+++.||.|||+   ++|+||||||+|||++.++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence            99999999999985432             12348999999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--H
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--Y  353 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~  353 (498)
                      ||+|||++..........      ......|+..|+|||++.+..++.++|||||||++|+|+| |.+||.......  .
T Consensus       163 ~l~dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             EECCCCcccccCCCceee------cCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999997654322110      1123347889999999999899999999999999999999 999986543322  2


Q ss_pred             HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ....+..        ...+...+..+.+++.+||+.+|.+||++.+ |.+.|+.+..
T Consensus       237 ~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~-v~~~l~~~~~  284 (291)
T cd05094         237 CITQGRV--------LERPRVCPKEVYDIMLGCWQREPQQRLNIKE-IYKILHALGK  284 (291)
T ss_pred             HHhCCCC--------CCCCccCCHHHHHHHHHHcccChhhCcCHHH-HHHHHHHHHh
Confidence            2222211        1123334578999999999999999999998 8888888754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.4e-40  Score=331.75  Aligned_cols=254  Identities=26%  Similarity=0.417  Sum_probs=199.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceec---Cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---EV  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~---~~  205 (498)
                      .+|.+.+.||.|+||.||+|...       ++.||+|++...... ....+..|+.++.++ +||||++++++|.   ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            46888899999999999999753       257999998753322 234577899999999 8999999999873   35


Q ss_pred             ceEEEeeCCCCCHHhhhccCCC----------------------------------------------------------
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDN----------------------------------------------------------  227 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  227 (498)
                      .++||||+++|+|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999998853211                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCC
Q 010882          228 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG  307 (498)
Q Consensus       228 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~g  307 (498)
                      ..++++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++..+.......      ......+
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~------~~~~~~~  237 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RKGDARL  237 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh------hccCCCC
Confidence            1368999999999999999999999   899999999999999999999999999998764322111      0122346


Q ss_pred             CCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH---HHHHHHhCccccccCCCCCCCCHHHHHHHHHHH
Q 010882          308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLA  383 (498)
Q Consensus       308 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  383 (498)
                      +..|+|||++.+..++.++|||||||+||||+| |.+||.....   ....+..+..        ...|...+..+.+++
T Consensus       238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~  309 (337)
T cd05054         238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR--------MRAPEYATPEIYSIM  309 (337)
T ss_pred             CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC--------CCCCccCCHHHHHHH
Confidence            788999999999999999999999999999998 9999965322   1111111111        112334457899999


Q ss_pred             HHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          384 MRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       384 ~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      .+||+.+|.+||++.+ +++.|+.+.
T Consensus       310 ~~cl~~~p~~RPs~~e-ll~~l~~~~  334 (337)
T cd05054         310 LDCWHNNPEDRPTFSE-LVEILGDLL  334 (337)
T ss_pred             HHHccCChhhCcCHHH-HHHHHHHHH
Confidence            9999999999999998 878887764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-40  Score=317.22  Aligned_cols=251  Identities=29%  Similarity=0.464  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      .+|...+.||+|+||.||+|.+.     ...||||.+...... ....|..|+.+++.++||||+++++++.  +..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            46888899999999999999874     247999998754322 2456889999999999999999999874  357899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++...  ...+++..++.++.+++.||.|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999998533  2468999999999999999999999   8999999999999999999999999999997752


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~  366 (498)
                      .....  .    .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......  ..+..+.       
T Consensus       159 ~~~~~--~----~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------  225 (266)
T cd05033         159 SEATY--T----TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------  225 (266)
T ss_pred             cccce--e----ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-------
Confidence            11100  0    112235678999999998899999999999999999998 999996543222  1121110       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                       ....+...+..+.+++.+||+.+|.+||++.+ +...|+.+
T Consensus       226 -~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e-i~~~l~~~  265 (266)
T cd05033         226 -RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQ-IVSTLDKM  265 (266)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHhh
Confidence             11123345578999999999999999999998 77776653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-40  Score=317.57  Aligned_cols=246  Identities=26%  Similarity=0.395  Sum_probs=193.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec----C---cceEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----E---VWTLV  209 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~----~---~~~lV  209 (498)
                      .|...+++|.|+||.||+|...  +..||||..-.+..    --.+|+.+|+.++|||||+|..+|.    .   ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            5677789999999999999985  57899998764332    2348999999999999999988772    2   35689


Q ss_pred             EeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-CceeEeeccccccc
Q 010882          210 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFL  287 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~~~  287 (498)
                      |||+|. +|...+... ..+..++.-.+.-+..|+++||.|||+   .||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 888888531 234567777888899999999999999   899999999999999976 99999999999988


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc------
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------  360 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~------  360 (498)
                      ..+...  ....       .|..|.|||.+.+. .|+.+.||||.|||+.||+-|+|-|.+.+.+.++...-++      
T Consensus       177 ~~~epn--iSYi-------cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  177 VKGEPN--ISYI-------CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             ccCCCc--eeEE-------EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence            766422  2222       48899999999885 7999999999999999999999999887766554432111      


Q ss_pred             --------c--cccCCC--CCC----CCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          361 --------K--NLLDPL--AGD----WPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       361 --------~--~~~~~~--~~~----~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                              .  ....+.  ...    +....+.++.+|+.+++.++|..|.++.+.+
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l  304 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL  304 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence                    0  000010  111    2334567899999999999999999988844

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.7e-40  Score=316.71  Aligned_cols=244  Identities=25%  Similarity=0.460  Sum_probs=196.3

Q ss_pred             CCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      +|.+.+.||+|+||.||.|.+.+ ..||||.+.... ...+.|.+|+.++++++||||++++++|.  +..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            56777889999999999998865 459999887443 34567999999999999999999999984  357899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.+++...  ...+++..++.++.+++.||.|||+   .+++|+||||+|||++.++.+||+|||+++........  
T Consensus        84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--  156 (256)
T cd05113          84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT--  156 (256)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee--
Confidence            9999998532  2368999999999999999999999   89999999999999999999999999998865433211  


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCccccccCCCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  372 (498)
                           ......++..|+|||.+.+..++.++|||||||++|+|+| |..||...+....  ....+..        ...+
T Consensus       157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~  223 (256)
T cd05113         157 -----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR--------LYRP  223 (256)
T ss_pred             -----ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC--------CCCC
Confidence                 1122336778999999998889999999999999999999 9999975443221  1111111        1122


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV  404 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~  404 (498)
                      ...+..+.+++.+||..+|.+||++.+ ++..
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~-ll~~  254 (256)
T cd05113         224 HLASEKVYAIMYSCWHEKAEERPTFQQ-LLSS  254 (256)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHH-HHHh
Confidence            334578999999999999999999988 5443

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.5e-40  Score=332.73  Aligned_cols=231  Identities=23%  Similarity=0.266  Sum_probs=186.0

Q ss_pred             cccccCceEEEEEEE--CCeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gs  217 (498)
                      .||+|+||.||++..  .+..||+|++.....   .....+..|+.++..++||||+++++++.  +..++||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            599999999999987  467899999875422   22345778999999999999999999884  46899999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      |.+++.   ....+++..+..++.|++.||.|||+.  .||+||||||+|||++.++.+||+|||+++........    
T Consensus        82 L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~----  152 (325)
T cd05594          82 LFFHLS---RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----  152 (325)
T ss_pred             HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc----
Confidence            999884   334689999999999999999999962  58999999999999999999999999998753322111    


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE  377 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (498)
                          .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+.........       .....+|...+.
T Consensus       153 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~-------~~~~~~p~~~~~  221 (325)
T cd05594         153 ----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEEIRFPRTLSP  221 (325)
T ss_pred             ----cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh-------cCCCCCCCCCCH
Confidence                122359999999999999999999999999999999999999997654322111110       011123444567


Q ss_pred             HHHHHHHHhhhcccCCCC
Q 010882          378 QLANLAMRCCEMSRKSRP  395 (498)
Q Consensus       378 ~l~~li~~cl~~~p~~RP  395 (498)
                      .+.+++.+||+.+|.+|+
T Consensus       222 ~~~~li~~~L~~dP~~R~  239 (325)
T cd05594         222 EAKSLLSGLLKKDPKQRL  239 (325)
T ss_pred             HHHHHHHHHhhcCHHHhC
Confidence            899999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-40  Score=333.62  Aligned_cols=234  Identities=23%  Similarity=0.305  Sum_probs=186.2

Q ss_pred             CcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEeeCCC
Q 010882          144 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      +.||+|+||.||+|...  +..||||++.....   .....+..|..++..+ +||||++++++|.  ...++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999884  67899999976432   2234578899999998 7999999999984  458999999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.+++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++........  
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~--  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc--
Confidence            999998842   3569999999999999999999999   89999999999999999999999999998743221110  


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH--------HHHHHHhCccccccCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--------VQYALDTGKLKNLLDPL  367 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--------~~~~~~~~~~~~~~~~~  367 (498)
                            .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.....        ......     ... ..
T Consensus       153 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-----~~~-~~  220 (329)
T cd05588         153 ------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ-----VIL-EK  220 (329)
T ss_pred             ------cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH-----HHH-cC
Confidence                  1233589999999999999999999999999999999999999963211        000000     000 01


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ....|...+..+.+++.+||+.+|.+||+.
T Consensus       221 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         221 QIRIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            112344456789999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-39  Score=353.47  Aligned_cols=267  Identities=23%  Similarity=0.322  Sum_probs=205.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..||||++.......   ...|.+|+.++++++||||+++++++.  +..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888899999999999999884  6889999987543222   346889999999999999999999984  4578999


Q ss_pred             eeCCCCCHHhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecc
Q 010882          211 EYLPNGSLEDRLSCKD--------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG  282 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  282 (498)
                      ||++||+|.+++....        ....+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        12346677889999999999999999   899999999999999999999999999


Q ss_pred             ccccccccccCCC----------CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH
Q 010882          283 ISRFLSQNEISSN----------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ  352 (498)
Q Consensus       283 la~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~  352 (498)
                      +++..........          ..........+||+.|+|||++.+..++.++|||||||++|||+||++||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987622110000          000011123569999999999999999999999999999999999999997643322


Q ss_pred             HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          353 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .... .   ....+.........+..+.+++.+|++.+|++||+..+++...|+.....
T Consensus       239 i~~~-~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ISYR-D---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhh-h---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            1111 1   11111110011234567899999999999999998888888888877654

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.8e-40  Score=317.48  Aligned_cols=247  Identities=27%  Similarity=0.345  Sum_probs=195.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      ..+|.+.+.||+|+||.||+|..  .+..||+|++..........+.+|+.++++++||||+++++++.  +..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            34788999999999999999997  46789999987654445567889999999999999999999883  467899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++..   ..++++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.+||+|||++........
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            999999999842   3468999999999999999999999   8999999999999999999999999999986543211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      .        .....|++.|+|||.+.   ...++.++|||||||++|+|+||++||..............  ....+...
T Consensus       162 ~--------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~  231 (267)
T cd06646         162 K--------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK--SNFQPPKL  231 (267)
T ss_pred             c--------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--CCCCCCCC
Confidence            1        12235889999999985   34578899999999999999999999864433222111100  00111111


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+...+..+.+++.+||..+|.+||++.+
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~  261 (267)
T cd06646         232 KDKTKWSSTFHNFVKISLTKNPKKRPTAER  261 (267)
T ss_pred             ccccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence            111234578999999999999999999988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.4e-41  Score=333.99  Aligned_cols=235  Identities=28%  Similarity=0.335  Sum_probs=190.9

Q ss_pred             CcccccCceEEEEEEE-----CCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          144 LKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      +.||+|+||.||++..     .+..||+|++.....  .....+..|+.+|++++||||+++++++.  +..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999998865     367899999975432  22345778999999999999999999884  45889999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++..   ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......... 
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-  154 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-  154 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence            9999999843   3468999999999999999999999   89999999999999999999999999998764332111 


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                             .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+..........       .....|..
T Consensus       155 -------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-------~~~~~p~~  220 (318)
T cd05582         155 -------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-------AKLGMPQF  220 (318)
T ss_pred             -------eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-------CCCCCCCC
Confidence                   1234589999999999988899999999999999999999999976554332211110       01123444


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+..+.+++.+||+.+|.+||++.+
T Consensus       221 ~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            5678999999999999999999765

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-39  Score=320.60  Aligned_cols=253  Identities=28%  Similarity=0.429  Sum_probs=199.9

Q ss_pred             CCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      +|.+.+.||+|+||.||+|....       ..+++|.+..... .....+.+|+.+++.++||||+++++.|.  +..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46777889999999999998632       4689998865432 12356889999999999999999999884  46889


Q ss_pred             EEeeCCCCCHHhhhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCc
Q 010882          209 VYEYLPNGSLEDRLSCKD---------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN  267 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N  267 (498)
                      ||||+++|+|.+++....                     ...++++..++.++.+++.||.|||+   ++++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            999999999999885321                     12358899999999999999999999   899999999999


Q ss_pred             EEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 010882          268 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG  346 (498)
Q Consensus       268 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~  346 (498)
                      ||++.++.+||+|||+++..........      .....++..|+|||.+.+..++.++|||||||++|+|+| |..||.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVK------RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhc------ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999986543321110      122236778999999988889999999999999999999 999997


Q ss_pred             CcHHHHH--HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          347 ITKEVQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       347 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      .......  ....+ .       ....+...+..+.+++..||+.+|.+||++.+ +...|+.+.
T Consensus       232 ~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~-i~~~l~~~~  287 (290)
T cd05045         232 GIAPERLFNLLKTG-Y-------RMERPENCSEEMYNLMLTCWKQEPDKRPTFAD-ISKELEKMM  287 (290)
T ss_pred             CCCHHHHHHHHhCC-C-------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHH-HHHHHHHHH
Confidence            6543321  11111 0       11123345678999999999999999999998 778887764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=346.75  Aligned_cols=262  Identities=22%  Similarity=0.305  Sum_probs=204.9

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC-C-eEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeecee-----c----
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR-H-MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC-----P----  203 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~-----~----  203 (498)
                      ...++.+.+.|.+|||+.||.+... + ..||+|++...+......+.+|+++|+.|. |||||.+++++     .    
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            3446677888999999999999884 3 789999988776667778999999999997 99999999954     1    


Q ss_pred             CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                      -.++|.||||.||+|-|++...... .|++.++++|+.++++|+.+||++. .+|||||||-+||||+.+|+.||||||.
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence            1367999999999999999654433 3999999999999999999999987 4899999999999999999999999999


Q ss_pred             cccccccccCCCC-ccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc
Q 010882          284 SRFLSQNEISSNN-TTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK  359 (498)
Q Consensus       284 a~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (498)
                      +............ ..+...-...-|+.|.|||++.   +.+++.|+|||+|||+||-|+....||+......  +..++
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--Ilng~  270 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--ILNGN  270 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--EEecc
Confidence            8754433311110 0011111223599999999985   4679999999999999999999999997653321  22222


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          360 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      +.-      +. ...++..+.+||..||+.+|.+||++.+ |...+..+.
T Consensus       271 Y~~------P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Q-v~~~~~~l~  312 (738)
T KOG1989|consen  271 YSF------PP-FPNYSDRLKDLIRTMLQPNPDERPNIYQ-VLEEIFELA  312 (738)
T ss_pred             ccC------CC-CccHHHHHHHHHHHHhccCcccCCCHHH-HHHHHHHHh
Confidence            221      11 1367889999999999999999999999 444444444

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.8e-40  Score=330.59  Aligned_cols=240  Identities=23%  Similarity=0.294  Sum_probs=187.4

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHH-HHHcCCCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||+||+|...  +..||||++.....   .....+..|.. +++.++||||+++++++.  +..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            6999999999999984  68899999875322   12234455554 567899999999999874  4689999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++........    
T Consensus        82 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~----  151 (323)
T cd05575          82 ELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK----  151 (323)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC----
Confidence            99999853   3468899999999999999999999   8999999999999999999999999999875322111    


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                          ......||+.|+|||++.+..++.++|||||||++|+|+||.+||...+.........  ...     ...+...+
T Consensus       152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~-----~~~~~~~~  220 (323)
T cd05575         152 ----TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKP-----LRLKPNIS  220 (323)
T ss_pred             ----ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCC-----CCCCCCCC
Confidence                0123358999999999999999999999999999999999999997654332211110  000     11223346


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      ..+.+++.+||+.+|.+||++...+.+++
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il  249 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAKDDFLEIK  249 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence            78999999999999999999875333333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-39  Score=313.52  Aligned_cols=250  Identities=29%  Similarity=0.493  Sum_probs=200.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEEeeCCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEYLPN  215 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~E~~~~  215 (498)
                      .+|.+.+.||+|+||.||+|... +..||+|.+..... ....+.+|+.++++++|||++++++++.+ ..++||||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~   84 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK   84 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence            36788889999999999999875 46799999875433 45679999999999999999999998743 57899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      ++|.+++... ....+++..+..++.+++.||.|||+   ++++||||||+||+++.++.++|+|||++..+....... 
T Consensus        85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-  159 (260)
T cd05070          85 GSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-  159 (260)
T ss_pred             CcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-
Confidence            9999998542 23458999999999999999999999   899999999999999999999999999998664432111 


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                            .....++..|+|||++.+..++.++|||||||++|+|++ |.+||...+..........      ......+..
T Consensus       160 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~  227 (260)
T cd05070         160 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER------GYRMPCPQD  227 (260)
T ss_pred             ------ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------CCCCCCCCc
Confidence                  112235678999999988889999999999999999999 8999976443322111110      011123344


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      .+..+.+++.+|+..+|.+||++.+ +...|+
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rpt~~~-l~~~l~  258 (260)
T cd05070         228 CPISLHELMLQCWKKDPEERPTFEY-LQSFLE  258 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHH-HHHHHh
Confidence            5678999999999999999999988 666665

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.4e-40  Score=329.94  Aligned_cols=240  Identities=21%  Similarity=0.309  Sum_probs=191.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCC-CCCeeeeeceec--CcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-hpniv~l~g~~~--~~~~lV~  210 (498)
                      +|+..+.||+|+||.||+|..+  +..||||++....   ......+..|..++..+. ||+|+++++++.  +..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677789999999999999884  6789999987542   222345778999998886 577778888774  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999984   33468999999999999999999999   89999999999999999999999999998754322


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      ...        .....||+.|+|||++.+..++.++|||||||++|+|+||++||..............       ....
T Consensus       155 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-------~~~~  219 (323)
T cd05615         155 GVT--------TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-------HNVS  219 (323)
T ss_pred             Ccc--------ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCC
Confidence            111        1233589999999999998999999999999999999999999986544322111100       1112


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +|...+..+.+++.+||+.+|.+|++..+
T Consensus       220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~~  248 (323)
T cd05615         220 YPKSLSKEAVSICKGLMTKHPSKRLGCGP  248 (323)
T ss_pred             CCccCCHHHHHHHHHHcccCHhhCCCCCC
Confidence            34455678999999999999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=313.70  Aligned_cols=246  Identities=25%  Similarity=0.460  Sum_probs=196.0

Q ss_pred             CCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      +|.+.+.||+|+||.||+|.+.+ ..+|+|++.... .....+.+|+.+++.++||||+++++++.  +..++||||++|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            46778889999999999998854 579999986433 23457889999999999999999999884  357899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      ++|.+++...  ...+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||+++......... 
T Consensus        84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-  157 (256)
T cd05059          84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-  157 (256)
T ss_pred             CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence            9999998533  2368999999999999999999999   899999999999999999999999999988654322111 


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                            .....++..|+|||.+.+..++.++|||||||++|+|+| |.+||...............   .   ....|..
T Consensus       158 ------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~---~~~~~~~  225 (256)
T cd05059         158 ------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG---Y---RLYRPKL  225 (256)
T ss_pred             ------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC---C---cCCCCCC
Confidence                  112234568999999998899999999999999999999 89999755433222111100   0   1122334


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHHHHHH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKDVWRV  404 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~v~~~  404 (498)
                      .+..+.+++.+||..+|.+||++.+ +...
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rpt~~~-~l~~  254 (256)
T cd05059         226 APTEVYTIMYSCWHEKPEDRPAFKK-LLSQ  254 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHH-HHHH
Confidence            5678999999999999999999988 5443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.2e-40  Score=332.52  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=190.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      +|+..+.||+|+||+||++...  +..||||++.....   .....+..|+.++..++||||+++++++.+  ..++|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            6888899999999999999874  67899999875322   223467889999999999999999999854  5889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          82 FLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            9999999999953   3568999999999999999999999   899999999999999999999999999998653221


Q ss_pred             cCCCC---------------------------ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCC
Q 010882          292 ISSNN---------------------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA  344 (498)
Q Consensus       292 ~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p  344 (498)
                      .....                           ..........||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00000                           000001234699999999999999999999999999999999999999


Q ss_pred             CCCcHHHHHHHHhCcccc-ccCCCCCCCCHHHHHHHHHHHHHhhh--cccCCCCChhH
Q 010882          345 LGITKEVQYALDTGKLKN-LLDPLAGDWPFVQAEQLANLAMRCCE--MSRKSRPELGK  399 (498)
Q Consensus       345 f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RP~~~~  399 (498)
                      |................. ...+..    ...+..+.+++.+++.  .++..||++.+
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~----~~~s~~~~~li~~l~~~~~~r~~r~~~~e  289 (363)
T cd05628         236 FCSETPQETYKKVMNWKETLIFPPE----VPISEKAKDLILRFCCEWEHRIGAPGVEE  289 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcccCCCc----CCCCHHHHHHHHHHcCChhhcCCCCCHHH
Confidence            976554332222111111 111110    1134567778877543  23445688777

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.3e-40  Score=337.77  Aligned_cols=248  Identities=22%  Similarity=0.301  Sum_probs=190.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .|...+.||+|+||.||+|...  +..||||++.....   .....+.+|+.+++.++||||++++++|.  +..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788889999999999999884  57899999875432   12346889999999999999999999984  45899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++|+|.+++..   ...+++.....++.|++.||.|||+   ++|+||||||+|||++.+|.+||+|||+|..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999999853   3458888999999999999999999   899999999999999999999999999986432110


Q ss_pred             cCCC---------------------------------------CccceeccCCCCCCCcCChhhhccCCCCCccchHhHH
Q 010882          292 ISSN---------------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG  332 (498)
Q Consensus       292 ~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG  332 (498)
                      ....                                       ..........+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0000                                       0000011234699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCC
Q 010882          333 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       333 vil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                      |+||||+||++||...+..............+.   .......+..+.+++.+++ .+|.+|++
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~p~~~~~s~~~~~li~~l~-~~p~~R~~  295 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLH---IPPQAKLSPEASDLIIKLC-RGPEDRLG  295 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC---CCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence            999999999999987655433322211111110   0011234567788887776 49999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.2e-40  Score=327.91  Aligned_cols=232  Identities=22%  Similarity=0.295  Sum_probs=188.0

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||.||+|.+.  +..||||++....   ......+..|..++..+ +||||+++++++.  +..++||||++||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999885  5789999987542   22345577899999888 6999999999884  4689999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++..   ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........   
T Consensus        82 ~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---  152 (318)
T cd05570          82 DLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---  152 (318)
T ss_pred             CHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc---
Confidence            99998843   3468999999999999999999999   89999999999999999999999999998743222111   


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                           .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+...........       ...+|...+
T Consensus       153 -----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-------~~~~~~~~~  220 (318)
T cd05570         153 -----TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-------EVRYPRWLS  220 (318)
T ss_pred             -----ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------CCCCCCcCC
Confidence                 12235899999999999999999999999999999999999999765443221111100       112344456


Q ss_pred             HHHHHHHHHhhhcccCCCCCh
Q 010882          377 EQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ..+.+++.+||..+|.+||++
T Consensus       221 ~~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         221 KEAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             HHHHHHHHHHccCCHHHcCCC
Confidence            789999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-39  Score=315.57  Aligned_cols=253  Identities=24%  Similarity=0.376  Sum_probs=197.9

Q ss_pred             CCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      |.+.+.||+|+||.||+|...     +..||||.+......  ....+.+|+.+++.++||||+++++++..        
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456778999999999999873     256999998754322  23568899999999999999999998722        


Q ss_pred             cceEEEeeCCCCCHHhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKD---NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                      ..++||||+++|+|..++....   ....+++.....++.|++.||.|||+   .+++||||||+||+++.++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence            2689999999999999885332   23468999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCcc
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL  360 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (498)
                      |+++..........      .....++..|+|||.+.+..++.++|||||||++|||++ |.+||.............  
T Consensus       158 g~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~--  229 (273)
T cd05035         158 GLSKKIYSGDYYRQ------GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR--  229 (273)
T ss_pred             cceeeccccccccc------cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence            99986643322110      111235678999999988889999999999999999999 899997654332211110  


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                          .......|...+..+.+++.+||+.+|.+||++.+ +...|+.+
T Consensus       230 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e-~~~~l~~~  272 (273)
T cd05035         230 ----HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTK-LREVLENI  272 (273)
T ss_pred             ----cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHhh
Confidence                11111234455678999999999999999999988 76666654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-40  Score=321.64  Aligned_cols=243  Identities=23%  Similarity=0.312  Sum_probs=193.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|+..+.||+|+||.||++...  +..||||++......   ....+.+|+.+++.++||||+++++.+.  +..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4677789999999999999874  688999998754322   2245778999999999999999999884  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999888533 23468999999999999999999999   899999999999999999999999999987654322


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      .         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......   +...+......+
T Consensus       157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~  224 (285)
T cd05605         157 T---------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE---VERRVKEDQEEY  224 (285)
T ss_pred             c---------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH---HHHHhhhccccc
Confidence            1         1223589999999999988999999999999999999999999976433111000   000111111223


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      +...+..+.+++..||..||.+||+.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLGC  250 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcCC
Confidence            44566789999999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-39  Score=317.05  Aligned_cols=249  Identities=26%  Similarity=0.396  Sum_probs=194.4

Q ss_pred             CCCCcccccCceEEEEEEECC----eEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--------Ccc
Q 010882          141 DPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVW  206 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--------~~~  206 (498)
                      .+.+.||+|+||.||+|.+..    ..||+|.+.....  .....+..|+.+++.++||||+++++.|.        ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456789999999999998753    3699998875422  22456889999999999999999999762        135


Q ss_pred             eEEEeeCCCCCHHhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          207 TLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                      ++||||+++|+|.+++...   .....+++.....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999887422   123458999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCcc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKL  360 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~  360 (498)
                      ++..........      .....+++.|+|||++.+..++.++|||||||++|+|++ |++||.......  ..+..+..
T Consensus       159 ~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  232 (272)
T cd05075         159 SKKIYNGDYYRQ------GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR  232 (272)
T ss_pred             ccccCcccceec------CCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            987644321110      112236778999999999899999999999999999999 899997543322  11222111


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                              ...+...+..+.+++.+||+.+|.+||++.+ +...|+.
T Consensus       233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-l~~~l~~  270 (272)
T cd05075         233 --------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFET-LRCELEK  270 (272)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHh
Confidence                    1122334567999999999999999999988 6666664

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=313.77  Aligned_cols=245  Identities=27%  Similarity=0.479  Sum_probs=196.1

Q ss_pred             CcccccCceEEEEEEEC--C---eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCCCC
Q 010882          144 LKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG  216 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~~g  216 (498)
                      +.||+|+||.||+|.+.  +   ..||+|.+...... ....+..|+.+++.++||||+++++++. +..++||||+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            36999999999999873  2   57999998765443 3456889999999999999999999884 4578999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++..   ...+++..+..++.+++.||.|||.   .+++||||||+|||++.++.+||+|||+++.........  
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~--  152 (257)
T cd05060          81 PLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY--  152 (257)
T ss_pred             cHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc--
Confidence            99999953   2368999999999999999999999   899999999999999999999999999998664332111  


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCccccccCCCCCCCCH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  373 (498)
                         .......++..|+|||.+.+..++.++|||||||++|+|+| |.+||...+....  .+..+.        ....|.
T Consensus       153 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~  221 (257)
T cd05060         153 ---RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--------RLPRPE  221 (257)
T ss_pred             ---ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--------cCCCCC
Confidence               11112235678999999998899999999999999999998 9999975543221  122211        112334


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..+..+.+++.+||..+|.+||++.+ +...|+.+
T Consensus       222 ~~~~~l~~li~~cl~~~p~~Rp~~~~-l~~~l~~~  255 (257)
T cd05060         222 ECPQEIYSIMLSCWKYRPEDRPTFSE-LESTFRRD  255 (257)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHH-HHHHHHhc
Confidence            45678999999999999999999998 77777653

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.6e-39  Score=313.74  Aligned_cols=252  Identities=31%  Similarity=0.478  Sum_probs=201.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN  215 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~~  215 (498)
                      .+|.+.+.||+|+||.||+|.+.+ ..||+|.+.... ...+.+.+|+.+++.++||||+++++.+. +..++||||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~   84 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK   84 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence            468889999999999999998754 579999987533 34567899999999999999999999774 467899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.+++... ....+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++.......... 
T Consensus        85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~-  159 (262)
T cd05071          85 GSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-  159 (262)
T ss_pred             CcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc-
Confidence            9999999532 23457899999999999999999999   899999999999999999999999999998665432111 


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                            .....++..|+|||+..+..++.++|||||||++|+|+| |.+||...............      .....+..
T Consensus       160 ------~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~  227 (262)
T cd05071         160 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------YRMPCPPE  227 (262)
T ss_pred             ------ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC------CCCCCccc
Confidence                  112346788999999988899999999999999999999 88999754332211111000      00112334


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      .+..+.+++.+|++.+|.+||++.+ +...|+..
T Consensus       228 ~~~~l~~li~~~l~~~p~~Rp~~~~-~~~~l~~~  260 (262)
T cd05071         228 CPESLHDLMCQCWRKEPEERPTFEY-LQAFLEDY  260 (262)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHH-HHHHHHHh
Confidence            5678999999999999999999988 77777653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.9e-40  Score=321.12  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=196.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      +|.+.+.||+|+||.||+|...       +..||||++...... ....+..|+.+++.++||||+++++++.  +..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3556678999999999999863       367999998754322 1356889999999999999999999984  46789


Q ss_pred             EEeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          209 VYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      ++||+++++|.+++....             ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence            999999999999984211             12358888999999999999999999   89999999999999999999


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--  352 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--  352 (498)
                      +||+|||+++........      .......+++.|+|||.+.++.++.++|||||||++|||+| |.+||.......  
T Consensus       163 ~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         163 VKISDLGLFREVYAADYY------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             eEecccccccccccchhe------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999998865433211      11123346789999999988889999999999999999998 888987543322  


Q ss_pred             HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          353 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      ..+..+.        ....+...+..+.+++..||+.+|.+||++.+ +...|+
T Consensus       237 ~~i~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~-i~~~l~  281 (283)
T cd05091         237 EMIRNRQ--------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKD-IHSRLR  281 (283)
T ss_pred             HHHHcCC--------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH-HHHHhh
Confidence            2222211        11234455678999999999999999999988 655554

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-39  Score=319.46  Aligned_cols=260  Identities=26%  Similarity=0.401  Sum_probs=198.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE------CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec----Ccce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~  207 (498)
                      .+|.+.+.||+|+||.||+|.+      .+..||+|.+..........+.+|+.+++.++||||+++++++.    ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677888999999999999875      35789999987655444567899999999999999999999762    2578


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+++|+|.+++...  ...+++..+..++.+++.||.|||+   +|++||||||+||+++.++.+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998532  3458999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH-HHHHHhCcc------
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKL------  360 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~~------  360 (498)
                      .......     .......++..|+|||++.+..++.++|||||||++|||++|..|+...... .........      
T Consensus       159 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05081         159 PQDKEYY-----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY  233 (284)
T ss_pred             cCCCcce-----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence            4332110     0111223455799999999888999999999999999999998776432211 100000000      


Q ss_pred             --ccccC-CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          361 --KNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       361 --~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                        ...+. ......+...+..+.+++.+||..+|.+||++.+ +...|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e-i~~~l~~~  283 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSE-LALQVEAI  283 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHH-HHHHHHhc
Confidence              00000 0011122334578999999999999999999998 77777654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2e-39  Score=312.19  Aligned_cols=242  Identities=29%  Similarity=0.458  Sum_probs=191.2

Q ss_pred             cccccCceEEEEEEE--CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCHH
Q 010882          145 KIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLE  219 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL~  219 (498)
                      .||+|+||.||+|..  .++.||+|.+..... .....+.+|+.+++.++||||++++++|.  ...++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            599999999999987  478899998764322 22356889999999999999999999984  4578999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccc
Q 010882          220 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL  299 (498)
Q Consensus       220 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  299 (498)
                      +++...  ...+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++...........    
T Consensus        82 ~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~----  152 (252)
T cd05084          82 TFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST----  152 (252)
T ss_pred             HHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc----
Confidence            998532  3468999999999999999999999   8999999999999999999999999999875442211100    


Q ss_pred             eeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCCCCCCCHHHH
Q 010882          300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       300 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                        .....++..|+|||.+.++.++.++|||||||++|+|++ |.+||.......  .....+        .....+...+
T Consensus       153 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~  222 (252)
T cd05084         153 --GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG--------VRLPCPELCP  222 (252)
T ss_pred             --CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC--------CCCCCcccCC
Confidence              011123567999999998899999999999999999998 899996543322  111111        0112333456


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      ..+.+++.+||..+|.+||++.+ +.+.|.
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~-~~~~l~  251 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFST-VHQELQ  251 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHH-HHHHHh
Confidence            78999999999999999999998 655553

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-39  Score=319.42  Aligned_cols=251  Identities=24%  Similarity=0.444  Sum_probs=198.4

Q ss_pred             cCCCCCCcccccCceEEEEEEE-------CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      .+|.....||+|+||.||++..       .+..+|+|.+..........+.+|+++++.++||||+++++++.  +..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            3567788999999999999964       24579999887655444567999999999999999999999884  45789


Q ss_pred             EEeeCCCCCHHhhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          209 VYEYLPNGSLEDRLSCKDN------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                      ||||+++|+|.+++.....            ...+++..++.++.|++.||.|||+   ++++||||||+|||++.++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence            9999999999999854321            1358899999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--  353 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--  353 (498)
                      ||+|||++..........      ......+++.|+|||.+.+..++.++|||||||++|||+| |.+||........  
T Consensus       162 kL~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYR------VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE  235 (280)
T ss_pred             EECCCCceeEcCCCceee------cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            999999987554322111      1122335788999999999999999999999999999998 9999965433221  


Q ss_pred             HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      ....+.        ....+...+..+.+++.+||..+|.+||++.+ |...|+
T Consensus       236 ~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~-l~~~l~  279 (280)
T cd05092         236 CITQGR--------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKD-IHSRLQ  279 (280)
T ss_pred             HHHcCc--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHH-HHHHHh
Confidence            111111        11123345578999999999999999999988 655543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.9e-40  Score=332.88  Aligned_cols=240  Identities=25%  Similarity=0.383  Sum_probs=187.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|+..+.||+|+||.||+|.+.  +..||||++...... ....+.+|+.+++.++||||+++++++.  +..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45677788999999999999884  688999998654322 2356889999999999999999999984  358899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+..       .++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986543       24567788999999999999999   8999999999999999999999999999986643221


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCccccccC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLD  365 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~~~  365 (498)
                      .        .....||..|+|||++..     ...+.++|||||||++|||++|+.||......  ..........    
T Consensus       224 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~----  291 (353)
T PLN00034        224 P--------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS----  291 (353)
T ss_pred             c--------ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc----
Confidence            1        123459999999998853     23456899999999999999999999732211  1111110000    


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       .....+...+..+.+|+.+||..+|.+||++.++
T Consensus       292 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~el  325 (353)
T PLN00034        292 -QPPEAPATASREFRHFISCCLQREPAKRWSAMQL  325 (353)
T ss_pred             -CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence             1111233456789999999999999999999883

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.9e-40  Score=332.57  Aligned_cols=234  Identities=22%  Similarity=0.302  Sum_probs=185.9

Q ss_pred             CcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEeeCCC
Q 010882          144 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      +.||+|+||.||+|...  +..||+|++......   ....+..|+.++.++ +||||+++++++.  +..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999884  578999999764322   234577899988877 7999999999884  468999999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|..++.   ....+++..+..++.+++.||.|||+   ++|+||||||+|||++.++.+||+|||+++........  
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~--  152 (329)
T cd05618          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--
Confidence            99998884   33468999999999999999999999   89999999999999999999999999998753222110  


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH--------HHHHHHHhCccccccCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--------EVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~--------~~~~~~~~~~~~~~~~~~  367 (498)
                            .....||+.|+|||++.+..++.++|||||||++|+|+||++||....        ........      +...
T Consensus       153 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------i~~~  220 (329)
T cd05618         153 ------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV------ILEK  220 (329)
T ss_pred             ------cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH------HhcC
Confidence                  123458999999999999999999999999999999999999995211        00111100      0011


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ....|...+..+.+++.+||+.+|.+||+.
T Consensus       221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         221 QIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            122455566789999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-39  Score=333.26  Aligned_cols=256  Identities=25%  Similarity=0.421  Sum_probs=202.0

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCCCC-hhhHHHHHHHHHcCC-CCCeeeeeceec--
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKIR-HPNLVTLVGACP--  203 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~-~~~~~~E~~il~~l~-hpniv~l~g~~~--  203 (498)
                      ....+|.+.+.||+|+||.||+|.+++       ..||||++....... ...+.+|+.+|.++. ||||++++|+|.  
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            344568888999999999999998643       579999997543222 346889999999997 999999999984  


Q ss_pred             CcceEEEeeCCCCCHHhhhccCC---------------------------------------------------------
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKD---------------------------------------------------------  226 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------  226 (498)
                      ...++||||+++|+|.+++....                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            35799999999999999986421                                                         


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcE
Q 010882          227 --------------------------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI  268 (498)
Q Consensus       227 --------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Ni  268 (498)
                                                            ....+++..++.|+.+++.||.|||+   .+++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence                                                  11247788889999999999999999   8999999999999


Q ss_pred             EEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 010882          269 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGI  347 (498)
Q Consensus       269 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~  347 (498)
                      |++.++.+||+|||+++..........      .....|++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYIS------KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             EEeCCCEEEEEecCcceeccccccccc------CCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999986533221100      122347889999999998889999999999999999998 8999965


Q ss_pred             cHHHHH---HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          348 TKEVQY---ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       348 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ......   .+..+.        ....|...+..+.+++.+||..+|..||++.+ ++..|+.+
T Consensus       345 ~~~~~~~~~~~~~~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~e-ll~~L~~~  399 (401)
T cd05107         345 LPMNEQFYNAIKRGY--------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ-LVHLVGDL  399 (401)
T ss_pred             CCchHHHHHHHHcCC--------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHH
Confidence            432221   111110        11123345678999999999999999999998 77777765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.9e-39  Score=313.67  Aligned_cols=255  Identities=25%  Similarity=0.397  Sum_probs=200.9

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|..  .+..||||.+.......   ...+.+|+.+++.++||||+++++++.  +..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688889999999999999987  46889999886533322   345789999999999999999999874  4688999


Q ss_pred             eeCCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          211 EYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      ||+++|+|.+++.... ....++...+..++.+++.||.|||+   ++++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885322 23458889999999999999999999   8999999999999999999999999999887643


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH-HHHHHhCccccccCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLDPLA  368 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~~  368 (498)
                      ....        .....|++.|+|||.+.+..++.++|+||||+++|+|+||+.||...... ......  +.....+  
T Consensus       159 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~--  226 (267)
T cd08228         159 KTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK--IEQCDYP--  226 (267)
T ss_pred             hhHH--------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH--HhcCCCC--
Confidence            3211        12235889999999999888999999999999999999999998543211 111111  0110000  


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ...+...+..+.+++.+||..+|.+||++.+ +.+.++.+
T Consensus       227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-vl~~~~~~  265 (267)
T cd08228         227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGY-VHQIAKQM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHCCCCcccCcCHHH-HHHHHHHh
Confidence            1112235578999999999999999999998 77777654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.7e-40  Score=321.72  Aligned_cols=255  Identities=26%  Similarity=0.431  Sum_probs=202.1

Q ss_pred             hhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeeceecC--
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACPE--  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--  204 (498)
                      ...+|...+.||+|+||.||+|...+       ..||+|.+..... .....+.+|+.++.++ +||||++++++|..  
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34568888899999999999998642       5799999875422 2234688999999999 89999999999843  


Q ss_pred             cceEEEeeCCCCCHHhhhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD  271 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~  271 (498)
                      ..++||||+++|+|.+++...             .....+++..++.++.|++.||.|||+   ++|+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence            588999999999999998532             224568999999999999999999999   8999999999999999


Q ss_pred             CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH
Q 010882          272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE  350 (498)
Q Consensus       272 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~  350 (498)
                      .++.+||+|||+++.+........      .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             CCCeEEeCccccccccccccceec------cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            999999999999987654321111      122235678999999988899999999999999999998 9999976543


Q ss_pred             HH--HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          351 VQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       351 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..  .....+.        ....+...+..+.+|+.+||..+|.+||++.+ ++..|+.+
T Consensus       241 ~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-il~~l~~~  291 (293)
T cd05053         241 EELFKLLKEGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ-LVEDLDRM  291 (293)
T ss_pred             HHHHHHHHcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHH-HHHHHHHh
Confidence            22  1111111        11234445678999999999999999999988 77777665

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.7e-39  Score=312.19  Aligned_cols=244  Identities=27%  Similarity=0.455  Sum_probs=198.3

Q ss_pred             cCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee---cCcceEEEeeCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLP  214 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~---~~~~~lV~E~~~  214 (498)
                      .+|...+.||+|+||.||+|...+..||+|.+....  ..+.+.+|+.++++++|||++++++++   ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            367788899999999999999999999999986432  345788999999999999999999975   235789999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++.... ...+++..+..++.+++.||.|||+   +|++||||||+||+++.++.+||+|||++.......   
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          84 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            999999985432 3358899999999999999999999   899999999999999999999999999987543221   


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  371 (498)
                              ....++..|+|||++.+..++.++|||||||++|+|++ |++||.......  ..+..+.        ....
T Consensus       157 --------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~  220 (256)
T cd05082         157 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------KMDA  220 (256)
T ss_pred             --------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------CCCC
Confidence                    11124678999999998889999999999999999998 999997543322  1121110        1122


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      +...+..+.+++.+||..+|.+||++.+ +.+.|+.
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~-l~~~l~~  255 (256)
T cd05082         221 PDGCPPVVYDVMKQCWHLDAATRPSFLQ-LREQLEH  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHH-HHHHHhc
Confidence            3345678999999999999999999998 6666653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.5e-40  Score=330.16  Aligned_cols=239  Identities=24%  Similarity=0.282  Sum_probs=187.1

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHH-HHHcCCCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||.||+|...  +..||||++.....   .....+..|.. +++.++||||+++++++.  +..++||||++||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            5999999999999874  67899999875422   12234555655 467799999999999884  4689999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|..++.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++.......    
T Consensus        82 ~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~----  151 (325)
T cd05604          82 ELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD----  151 (325)
T ss_pred             CHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC----
Confidence            9998884   34568999999999999999999999   8999999999999999999999999999875322111    


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.........  ...     ...+...+
T Consensus       152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--~~~-----~~~~~~~~  220 (325)
T cd05604         152 ----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKP-----LVLRPGAS  220 (325)
T ss_pred             ----CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--cCC-----ccCCCCCC
Confidence                0123458999999999999999999999999999999999999997654332211110  000     01122345


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHHHHH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDVWRV  404 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v~~~  404 (498)
                      ..+.+++..|+..+|.+||++.+.+.++
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence            6788999999999999999987534333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.3e-40  Score=336.23  Aligned_cols=251  Identities=23%  Similarity=0.302  Sum_probs=192.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|.+.+.||+|+||.||++...  +..||||++.....   .....+.+|+.+|+.++||||+++++.+.  +..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888899999999999999874  67899999865321   23456889999999999999999999884  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++..   ...++......++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+|..+....
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999953   3468888899999999999999999   899999999999999999999999999986432100


Q ss_pred             cCC---------------------C--------------CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHH
Q 010882          292 ISS---------------------N--------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL  336 (498)
Q Consensus       292 ~~~---------------------~--------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~  336 (498)
                      ...                     .              ....+......||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            000                     0              00000112346999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCC---ChhH
Q 010882          337 RLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGK  399 (498)
Q Consensus       337 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---~~~~  399 (498)
                      ||+||++||..................+.   .......+..+.+++.+|+ .+|.+|+   ++.+
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLH---IPSQAKLSREASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCcccc---CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            99999999987654433222211111111   0111234567888888876 5999999   5555

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.5e-39  Score=316.56  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=199.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--Ce----EEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV  209 (498)
                      .+|...+.||+|+||+||+|.+.  +.    .||+|++...... ....+.+|+.+++.++||||++++|+|. ...+++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~   86 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV   86 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence            46778889999999999999863  32    5899998754322 2456889999999999999999999984 357899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |+|+++|+|.+++...  ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          87 TQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            9999999999998532  3468999999999999999999999   8999999999999999999999999999987653


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~  366 (498)
                      .....      ......+++.|+|||.+.+..++.++|||||||++|||+| |.+||......  ...+..+..      
T Consensus       162 ~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------  229 (279)
T cd05109         162 DETEY------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER------  229 (279)
T ss_pred             cccee------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc------
Confidence            32110      0112235778999999998899999999999999999998 99999754322  222222111      


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                        ...+...+..+.+++..||..+|..||++.+ ++..|..+.
T Consensus       230 --~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~-l~~~l~~~~  269 (279)
T cd05109         230 --LPQPPICTIDVYMIMVKCWMIDSECRPRFRE-LVDEFSRMA  269 (279)
T ss_pred             --CCCCccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHhh
Confidence              1112335578999999999999999999998 666666654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.7e-40  Score=334.93  Aligned_cols=244  Identities=25%  Similarity=0.307  Sum_probs=193.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      ..+|...+.||+|+||.||++...  +..||+|++....   ......+..|+.+++.++||||+++++++.+  ..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            457888899999999999999884  6789999986432   1223457889999999999999999998844  57899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||++||+|.+++..    ..++...+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999842    247888899999999999999999   8999999999999999999999999999986543


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccC----CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD  365 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (498)
                      .....       .....||+.|+|||++.+.    .++.++|||||||++|||+||++||...+.............   
T Consensus       195 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---  264 (370)
T cd05596         195 NGMVR-------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN---  264 (370)
T ss_pred             CCccc-------CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---
Confidence            32111       1234599999999998653    378899999999999999999999987654332211111000   


Q ss_pred             CCCCCCCH--HHHHHHHHHHHHhhhcccCC--CCChhH
Q 010882          366 PLAGDWPF--VQAEQLANLAMRCCEMSRKS--RPELGK  399 (498)
Q Consensus       366 ~~~~~~~~--~~~~~l~~li~~cl~~~p~~--RP~~~~  399 (498)
                        ...+|.  ..+..+.+++..||..+|.+  ||++.+
T Consensus       265 --~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~e  300 (370)
T cd05596         265 --SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDE  300 (370)
T ss_pred             --cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHH
Confidence              011222  34678999999999988987  999877

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.8e-40  Score=330.84  Aligned_cols=242  Identities=26%  Similarity=0.337  Sum_probs=189.4

Q ss_pred             CCCCCCcccccCceEEEEEEE-----CCeEEEEEEecCCC----CCChhhHHHHHHHHHcC-CCCCeeeeeceec--Ccc
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW  206 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~  206 (498)
                      +|.+.+.||+|+||.||++..     .+..||+|++....    ....+.+..|+.++..+ +||||+++++++.  +..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477788999999999999876     35789999986532    12245678899999999 5999999999884  357


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            899999999999999843   3468999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCccccc
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNL  363 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~  363 (498)
                      +.......       .....||+.|+|||++.+. .++.++|||||||++|||+||..||......  ...+... +.. 
T Consensus       155 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~-  225 (332)
T cd05614         155 FLSEEKER-------TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR-ILK-  225 (332)
T ss_pred             ccccCCCc-------cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH-Hhc-
Confidence            54322111       1234599999999999865 4788999999999999999999999642210  0011100 000 


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                         .....|...+..+.+++.+||+.+|.+||++.
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  257 (332)
T cd05614         226 ---CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG  257 (332)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence               11123444567899999999999999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-39  Score=325.47  Aligned_cols=248  Identities=24%  Similarity=0.367  Sum_probs=193.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|+..+.||+|+||.||++.+.  +..+|+|.+..... .....+.+|+++++.++||||++++++|.  +..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            57899999999999999999985  67899998875422 22356889999999999999999999984  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++..   ...+++.....++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||++....... 
T Consensus        85 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          85 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            999999999953   34588899999999999999999972  369999999999999999999999999987553321 


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC-----cccc-----
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-----KLKN-----  362 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~-----~~~~-----  362 (498)
                               .....||..|+|||++.+..++.++|||||||++|+|++|+.||............+     ....     
T Consensus       159 ---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         159 ---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             ---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence                     122358999999999998889999999999999999999999997543321110000     0000     


Q ss_pred             ----------------------------ccCCCCCCCC-HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 ----------------------------LLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 ----------------------------~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                                  .........+ ...+.++.+|+.+||+.||.+||++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el  296 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL  296 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH
Confidence                                        0000000000 1134678999999999999999999883

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.6e-40  Score=328.09  Aligned_cols=239  Identities=25%  Similarity=0.327  Sum_probs=187.0

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHH-HHHcCCCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||.||+|...  +..||+|++.....   .....+..|.. +++.++||||+++++++.  +..++||||++||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            6999999999999984  67899999875322   12234555554 678899999999999884  4689999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|...+.   ....++...+..++.|++.||.|||+   .+|+||||||+||||+.++.+||+|||+++........   
T Consensus        82 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~---  152 (321)
T cd05603          82 ELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---  152 (321)
T ss_pred             CHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc---
Confidence            9998884   23468888999999999999999999   89999999999999999999999999998753221110   


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                           .....||+.|+|||++.+..++.++|||||||++|||+||.+||...+........  ...     ....|...+
T Consensus       153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~-----~~~~~~~~~  220 (321)
T cd05603         153 -----TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI--LHK-----PLQLPGGKT  220 (321)
T ss_pred             -----cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH--hcC-----CCCCCCCCC
Confidence                 12335899999999999889999999999999999999999999765432211111  001     112344456


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHHHHH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDVWRV  404 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v~~~  404 (498)
                      ..+.+++.+||+.+|.+||+....+.+.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~  248 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAKADFLEI  248 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCCCCHHHH
Confidence            7899999999999999999876434333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.5e-39  Score=312.14  Aligned_cols=249  Identities=31%  Similarity=0.518  Sum_probs=201.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN  215 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~~  215 (498)
                      .+|.+.++||+|+||.||+|... +..||+|.+.... .....+.+|+.++++++||||+++++++. +..++||||+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN   84 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence            46888899999999999999874 5789999987543 34568999999999999999999999874 468999999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.+++.... ...+++..+..++.+++.||.|||+   .+++||||||+||+++.++.++|+|||++.........  
T Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--  158 (260)
T cd05067          85 GSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT--  158 (260)
T ss_pred             CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc--
Confidence            99999985432 3468999999999999999999999   89999999999999999999999999999866532211  


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCccccccCCCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  372 (498)
                           ......++..|+|||++....++.++|||||||++|+|+| |++||...+....  .+..+.        ....+
T Consensus       159 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~  225 (260)
T cd05067         159 -----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY--------RMPRP  225 (260)
T ss_pred             -----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC--------CCCCC
Confidence                 1122346789999999998899999999999999999999 9999975443222  111110        01122


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      ...+..+.+++.+|++.+|.+||++.+ +...|+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~-l~~~l~~  259 (260)
T cd05067         226 DNCPEELYELMRLCWKEKPEERPTFEY-LRSVLED  259 (260)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHH-HHHHhhc
Confidence            334578999999999999999999988 7666653

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.8e-39  Score=318.79  Aligned_cols=260  Identities=27%  Similarity=0.441  Sum_probs=199.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC------------------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH------------------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVT  197 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~------------------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~  197 (498)
                      ..+|.+.+.||+|+||.||+|....                  ..||+|.+...... ..+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3478889999999999999987632                  45899998754322 3457889999999999999999


Q ss_pred             eeceec--CcceEEEeeCCCCCHHhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCc
Q 010882          198 LVGACP--EVWTLVYEYLPNGSLEDRLSCKD--------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN  267 (498)
Q Consensus       198 l~g~~~--~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N  267 (498)
                      ++++|.  +..++||||+++++|.+++....        ....+++..++.++.+++.||.|||+   .+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            999884  46899999999999999985432        12368999999999999999999999   899999999999


Q ss_pred             EEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh--CCCCC
Q 010882          268 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPAL  345 (498)
Q Consensus       268 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf  345 (498)
                      |+++.++.++|+|||+++.........      ......+++.|+|||++.+..++.++|||||||++|||++  |..||
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             eeecCCCceEEccccceeecccCccee------ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            999999999999999987654332111      1123346789999999988889999999999999999998  67888


Q ss_pred             CCcHHHHHHHHhCccccccC-CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          346 GITKEVQYALDTGKLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      .................... ......+...+..+.+++.+||+.+|.+||++.+ +...|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e-l~~~L~  295 (296)
T cd05051         235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE-IHLFLQ  295 (296)
T ss_pred             CCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHH-HHHHhc
Confidence            65433222111111100000 0011123345578999999999999999999998 655553

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=317.00  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=198.7

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--Ccce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~  207 (498)
                      ++|.+...||+|+||.||+|...+       ..||+|.+..... .....+.+|+.+++.++||||++++|++.  ...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            467888899999999999998743       5799999865432 22346889999999999999999999874  4689


Q ss_pred             EEEeeCCCCCHHhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEee
Q 010882          208 LVYEYLPNGSLEDRLSCKDN-------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD  280 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  280 (498)
                      +||||+++|+|.+++.....       ...+++..++.++.+++.||.|||+   .+++||||||+|||++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence            99999999999999864321       2347889999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCc
Q 010882          281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGK  359 (498)
Q Consensus       281 FGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~  359 (498)
                      ||+++..........      .....++..|+|||.+.+..++.++|||||||++|||+| |.+||...+......... 
T Consensus       163 fg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-  235 (277)
T cd05032         163 FGMTRDIYETDYYRK------GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-  235 (277)
T ss_pred             cccchhhccCccccc------CCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-
Confidence            999986544321111      122346889999999988889999999999999999998 999996544322111110 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          360 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                           .......|...+..+.+++.+||..+|.+||++.+ +...|
T Consensus       236 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-l~~~l  275 (277)
T cd05032         236 -----DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLE-IVSSL  275 (277)
T ss_pred             -----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHH-HHHHh
Confidence                 11111223344678999999999999999999988 55544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4e-39  Score=315.11  Aligned_cols=239  Identities=24%  Similarity=0.326  Sum_probs=187.7

Q ss_pred             ccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      ||+|+||.||++...  +..||+|.+......   ....+..|++++++++||||+++++++.  ...++||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999874  788999998653221   2234567999999999999999999884  358899999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++... ....+++..+..++.|++.||.|||+   .||+||||||+|||++.++.++|+|||++........      
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------  150 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------  150 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------
Confidence            9888533 23458899999999999999999999   8999999999999999999999999999876543211      


Q ss_pred             ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCccccccCCCCCCCCHHHH
Q 010882          299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                         .....||..|+|||++.+..++.++|||||||++|+|+||++||......  ...+........+..    .....+
T Consensus       151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  223 (277)
T cd05607         151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFT  223 (277)
T ss_pred             ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCC
Confidence               12235899999999999888999999999999999999999999653221  111111111111110    112345


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ..+.+++..||+.+|.+||++.+.+
T Consensus       224 ~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         224 EESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             HHHHHHHHHHhccCHhhCCCCccch
Confidence            7799999999999999999997743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.6e-40  Score=331.33  Aligned_cols=234  Identities=24%  Similarity=0.323  Sum_probs=186.4

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||.||+|...  +..||+|++.....   .....+..|+.++.++ +||||+.+++++.  ...++||||++||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            6999999999999874  57899999976432   2234578899999888 6999999999884  4688999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|..++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.........   
T Consensus        82 ~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---  152 (327)
T cd05617          82 DLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---  152 (327)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc---
Confidence            99998842   3469999999999999999999999   89999999999999999999999999998743221110   


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH------HHHHHHHhCccccccCCCCCC
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK------EVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~  370 (498)
                           .....||+.|+|||++.+..++.++|||||||+||+|+||++||....      .........     . .....
T Consensus       153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----~-~~~~~  221 (327)
T cd05617         153 -----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-----L-EKPIR  221 (327)
T ss_pred             -----eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-----H-hCCCC
Confidence                 123458999999999999999999999999999999999999995321      111111100     0 01112


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                      .|...+..+.+++.+||..+|.+||++.
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            3445567889999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-39  Score=317.99  Aligned_cols=256  Identities=28%  Similarity=0.431  Sum_probs=196.9

Q ss_pred             CCCCCcccccCceEEEEEEE------CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC----cceE
Q 010882          140 FDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTL  208 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~~l  208 (498)
                      |...+.||+|+||+||.+.+      .+..||+|.+..... .....|.+|+.+|+.++||||++++++|..    ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37778899999999988754      346799999875432 234578899999999999999999998732    4789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+++|+|.+++..    ..+++..++.++.+++.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999843    348999999999999999999999   899999999999999999999999999998665


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH-HHHHHHh-------Ccc
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDT-------GKL  360 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~~-------~~~  360 (498)
                      .......     ......++..|+|||.+....++.++|||||||++|+|+||..||..... .......       ..+
T Consensus       159 ~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05080         159 EGHEYYR-----VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL  233 (283)
T ss_pred             Ccchhhc-----cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence            3321100     01122356789999999888899999999999999999999999864321 1111100       001


Q ss_pred             ccccCCC-CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          361 KNLLDPL-AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       361 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ...++.. ....+...+..+.+++.+||+.+|++||++.+ ++..|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~-i~~~l~~~  281 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRS-LIPILKEM  281 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHH-HHHHHHHh
Confidence            1111110 11123445678999999999999999999998 77777765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.8e-40  Score=328.06  Aligned_cols=238  Identities=24%  Similarity=0.302  Sum_probs=186.2

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHH-HHHcCCCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|+||+||+|...  +..||+|++.....   .....+..|.. +++.++||||+++++++.  +..++||||++||
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            5999999999999885  56799999875321   11223444444 567899999999999884  4689999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++..   ...++......++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++........   
T Consensus        82 ~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~---  152 (325)
T cd05602          82 ELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC---
Confidence            99999853   3457888888999999999999999   89999999999999999999999999998753322110   


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.........  ..     ....+...+
T Consensus       153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~-----~~~~~~~~~  220 (325)
T cd05602         153 -----TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NK-----PLQLKPNIT  220 (325)
T ss_pred             -----cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hC-----CcCCCCCCC
Confidence                 123459999999999999999999999999999999999999997655433211110  00     011233456


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHHHH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDVWR  403 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v~~  403 (498)
                      ..+.+++.+||+.+|.+||++.+.+.+
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            789999999999999999998764433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=314.47  Aligned_cols=250  Identities=25%  Similarity=0.337  Sum_probs=197.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecC--CCCCChhhHHHHHHHHHcCCCCCeeeeeceecC-------c
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------V  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-------~  205 (498)
                      ...|...+.||+|+||.|..+.++  +..||||++..  ......+...+|+.+|+.++|+||+.+++++..       .
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            445666788999999999999884  68899999873  333445678899999999999999999998732       4


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .|+|+|+| +.+|...+.   .+..|+......++.|+++||.|+|+   .+|+||||||+|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccccee
Confidence            79999999 679999994   44559999999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC------
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG------  358 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~------  358 (498)
                      .......      ....+..+-|.+|.|||++.. ..|+.+.||||.||||.||++|++-|.+.+.+.+.....      
T Consensus       174 ~~~~~~~------~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  174 YLDKFFE------DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             eccccCc------ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            8765310      111245568999999999865 579999999999999999999999998765543321110      


Q ss_pred             -----------ccccccCCC--C------CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 -----------KLKNLLDPL--A------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 -----------~~~~~~~~~--~------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                 +....+...  .      .-+| ...+...+|+.+||..||.+|+|+.+.
T Consensus       248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eA  307 (359)
T KOG0660|consen  248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEA  307 (359)
T ss_pred             CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHH
Confidence                       011111100  0      1122 455678999999999999999999883

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.2e-39  Score=317.12  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=203.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC------eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec---Ccc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~---~~~  206 (498)
                      ..+|.+...||+|+||.||+|.+..      ..|++|++..... .....+.+|+.++++++||||+++++++.   ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4578888999999999999998753      6799998864322 22456889999999999999999999873   457


Q ss_pred             eEEEeeCCCCCHHhhhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNS-----PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                      +++++|+++|+|.+++......     ..+++..+..++.+++.||.|||+   ++++||||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence            8999999999999998543222     568999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCcc
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL  360 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (498)
                      |+++.+........      .....++..|+|||++.+..++.++|||||||++||+++ |++||...+...........
T Consensus       162 g~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  235 (280)
T cd05043         162 ALSRDLFPMDYHCL------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG  235 (280)
T ss_pred             CCcccccCCceEEe------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence            99986543321110      112236778999999988889999999999999999999 99999765443322111100


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      .      ....+...+..+.+++.+||..+|++||++.+ +...|..+.
T Consensus       236 ~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-~~~~l~~~~  277 (280)
T cd05043         236 Y------RLAQPINCPDELFAVMACCWALDPEERPSFSQ-LVQCLTDFH  277 (280)
T ss_pred             C------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHH-HHHHHHHHH
Confidence            0      11122334578999999999999999999998 777777664

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-39  Score=310.34  Aligned_cols=244  Identities=28%  Similarity=0.486  Sum_probs=201.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      .+|.+.+.||.|+||.||+|...++.||||.+..... ....+.+|+.+++.++||||+++++++.  +..++||||+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            4678889999999999999999999999999976543 4567899999999999999999999884  468899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      ++|.+++.... ...+++..+..++.+++.||.|||+   ++++||||||+||+++.++.+||+|||+++.......   
T Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          85 GSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            99999985432 2368999999999999999999999   8999999999999999999999999999986632211   


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCccccccCCCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  372 (498)
                              ...++..|+|||++....++.++||||||+++|+|++ |..||........  .+..+ .       ....+
T Consensus       158 --------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~-------~~~~~  221 (256)
T cd05039         158 --------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-Y-------RMEAP  221 (256)
T ss_pred             --------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-C-------CCCCc
Confidence                    1225678999999988889999999999999999998 9999976543322  11111 0       11123


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      ...+..+.+++.+||..+|.+||++.+ +...|.
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~-l~~~l~  254 (256)
T cd05039         222 EGCPPEVYKVMKDCWELDPAKRPTFKQ-LREQLA  254 (256)
T ss_pred             cCCCHHHHHHHHHHhccChhhCcCHHH-HHHHHh
Confidence            334678999999999999999999988 666554

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.6e-40  Score=340.37  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=188.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC----------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~----------  204 (498)
                      ..+|.+.+.||+|+||.||+|..  .+..||||++...    .....+|+.+|+.++||||+++++++..          
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45789999999999999999988  4678999988542    2345689999999999999999886511          


Q ss_pred             cceEEEeeCCCCCHHhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-ceeEeecc
Q 010882          205 VWTLVYEYLPNGSLEDRLSC-KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFG  282 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFG  282 (498)
                      ..++||||+++ +|.+++.. ......+++..+..++.|++.||.|||+   ++|+||||||+||||+.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            25689999975 67666632 2334578999999999999999999999   8999999999999999654 79999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc--
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK--  359 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~--  359 (498)
                      +|+.+.....         .....||+.|+|||++.+. .++.++|||||||+||||+||.+||..............  
T Consensus       217 la~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  287 (440)
T PTZ00036        217 SAKNLLAGQR---------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL  287 (440)
T ss_pred             cchhccCCCC---------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9986543221         1223589999999998764 689999999999999999999999976544322211100  


Q ss_pred             --------------cccccCCC------CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 --------------LKNLLDPL------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 --------------~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                    +....-+.      ...+|...+..+.+|+.+||..+|.+||++.++
T Consensus       288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~  348 (440)
T PTZ00036        288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA  348 (440)
T ss_pred             CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence                          00000000      011233345789999999999999999999883

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3e-39  Score=319.15  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=196.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC----eEEEEEEecCCC-CCChhhHHHHHHHHHcC-CCCCeeeeeceecC--cceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~lV  209 (498)
                      ++|.+.+.||+|+||.||+|....    ..+++|.++... ......+.+|+.++.++ +||||+++++++.+  ..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            367888899999999999998743    347888876432 22345688999999999 79999999999843  57899


Q ss_pred             EeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          210 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                      |||+++|+|.+++....             ....+++..++.++.|++.||.|||+   +||+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999999985422             12358899999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHH
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL  355 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~  355 (498)
                      ||+|||++........         .....++..|+|||++....++.++|||||||++|||+| |.+||..........
T Consensus       159 kl~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVYVK---------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE  229 (297)
T ss_pred             EECCcCCCccccceec---------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999864321100         011123567999999988889999999999999999998 999997554322111


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ..      ........|...+..+.+++.+||+.+|.+||++.+ +.+.|+.+..
T Consensus       230 ~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~~~~  277 (297)
T cd05089         230 KL------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQ-ISVQLSRMLE  277 (297)
T ss_pred             HH------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHH
Confidence            11      000111123345678999999999999999999999 6666776654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.1e-39  Score=317.63  Aligned_cols=255  Identities=24%  Similarity=0.408  Sum_probs=198.5

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--Cc
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EV  205 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~  205 (498)
                      ...+|.+.+.||+|+||.||+|..+       +..||+|.+...... ....+.+|+.+++.++||||+++++++.  +.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3457888999999999999999753       347999987644321 2345788999999999999999999884  45


Q ss_pred             ceEEEeeCCCCCHHhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeE
Q 010882          206 WTLVYEYLPNGSLEDRLSCKD-------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL  278 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  278 (498)
                      .++||||+++|+|.+++....       ....+++..+..++.+++.||.|||+   ++|+||||||+|||++.++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence            799999999999999996422       13456778889999999999999999   89999999999999999999999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HH
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--AL  355 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~  355 (498)
                      +|||+++..........      .....++..|+|||.+.++.++.++|||||||++|||++ |.+||........  .+
T Consensus       161 ~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRK------GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV  234 (288)
T ss_pred             CcCCccccccccccccc------cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999986543321111      122235778999999998899999999999999999999 7889975443221  11


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..+.        ....+...+..+.+++.+||+.+|.+||++.+ +.+.|+..
T Consensus       235 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-ll~~l~~~  278 (288)
T cd05061         235 MDGG--------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE-IVNLLKDD  278 (288)
T ss_pred             HcCC--------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHhh
Confidence            1111        11123334578999999999999999999988 65555543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.4e-39  Score=310.17  Aligned_cols=254  Identities=28%  Similarity=0.409  Sum_probs=202.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|...  +..||+|.++....   .....+.+|+.++++++|+||+++++++.  +..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            46888899999999999999985  78899998864322   22457889999999999999999999884  4578999


Q ss_pred             eeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          211 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       211 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      ||+++|+|.+++... .....+++..+..++.+++.||.|||+   .|++||||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988542 234568999999999999999999999   8999999999999999999999999999886543


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH-HHHHHhCccccccCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLDPLA  368 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~~  368 (498)
                      ....        .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ....... ....    .
T Consensus       159 ~~~~--------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~----~  225 (267)
T cd08224         159 KTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EKCD----Y  225 (267)
T ss_pred             CCcc--------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhh-hcCC----C
Confidence            3211        12234889999999999888999999999999999999999999543211 1111100 0000    1


Q ss_pred             CCCCH-HHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          369 GDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       369 ~~~~~-~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ...|. ..+..+.+++.+||..+|.+||++.+ +.+.|..+
T Consensus       226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~-il~~~~~~  265 (267)
T cd08224         226 PPLPADHYSEELRDLVSRCINPDPEKRPDISY-VLQVAKEM  265 (267)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCcccCCCHHH-HHHHHHHh
Confidence            11222 45568999999999999999999988 77777655

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.2e-39  Score=309.67  Aligned_cols=244  Identities=25%  Similarity=0.394  Sum_probs=198.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|...+.||+|+||.||+|...  +..|++|.+.....  .....+.+|+.+++.++||||+++++++.  ...++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4667788999999999999884  68899999865432  23457889999999999999999999984  358999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++|++|.+++... ....+++..+..++.+++.||.|||+   .|++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998643 23568999999999999999999999   8999999999999999999999999999886654321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      .        .....|++.|+|||++.+..++.++|||||||++|+|+||+.||...+........  ....    ....+
T Consensus       157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~----~~~~~  222 (256)
T cd08529         157 F--------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI--IRGV----FPPVS  222 (256)
T ss_pred             h--------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HcCC----CCCCc
Confidence            1        12234889999999999989999999999999999999999999766543221111  0111    11123


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ...+..+.+++.+||+.+|++||++.++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l  250 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQL  250 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHH
Confidence            3456789999999999999999999883

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.1e-40  Score=333.10  Aligned_cols=250  Identities=23%  Similarity=0.302  Sum_probs=191.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      +|+..+.||+|+||.||++...  +..||||++....   ......+..|+.++..++||||+++++++.+  ..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5788889999999999999884  6789999987532   2234567889999999999999999998843  5799999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.+|.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          82 FLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999984   33568999999999999999999999   899999999999999999999999999987553221


Q ss_pred             cCCCC---------------------------ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCC
Q 010882          292 ISSNN---------------------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA  344 (498)
Q Consensus       292 ~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p  344 (498)
                      .....                           ..........||+.|+|||++.+..++.++|||||||++|||+||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00000                           000001234699999999999999999999999999999999999999


Q ss_pred             CCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          345 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       345 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                      |..................+..  . .....+..+.+++.+|+. +|.+|++..
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~--p-~~~~~s~~~~~li~~l~~-~p~~R~~~~  285 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVF--P-PEVPISEKAKDLILRFCT-DSENRIGSN  285 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceec--C-CCCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence            9765543322211111111110  0 011245678889988774 999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.7e-39  Score=321.05  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=203.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECC---------eEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeeceec--C
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E  204 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~  204 (498)
                      .+|.+.+.||+|+||.||++...+         ..+|+|.+..... .....+..|+.+++.+ +||||++++++|.  +
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            468889999999999999997632         4699999875422 2345688899999999 7999999999984  4


Q ss_pred             cceEEEeeCCCCCHHhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD  271 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~  271 (498)
                      ..++||||+++|+|.+++.....             ...+++.+++.++.+++.||.|||+   +|++||||||+|||++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence            68899999999999999964321             2358899999999999999999999   8999999999999999


Q ss_pred             CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH
Q 010882          272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE  350 (498)
Q Consensus       272 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~  350 (498)
                      .++.+||+|||++...........      .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.....
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             CCCcEEECCCcccccccccchhhc------cccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            999999999999876543221110      111235678999999998889999999999999999998 8899975443


Q ss_pred             HH--HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          351 VQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       351 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ..  ..+..+.        ....|...+..+.+++.+||..+|.+||++.+ ++..|+.+....
T Consensus       249 ~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-vl~~l~~~~~~~  303 (307)
T cd05098         249 EELFKLLKEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ-LVEDLDRILALT  303 (307)
T ss_pred             HHHHHHHHcCC--------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHH-HHHHHHHHHHHh
Confidence            22  1111111        11234445678999999999999999999998 888888877653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.6e-39  Score=312.30  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=200.8

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|...+.||+|+||.||+|..  .+..||||.+.......   ...+.+|+.+++.++||||+++++++.  +..++|||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            577778899999999999986  47889999886543322   346889999999999999999999873  46889999


Q ss_pred             eCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          212 YLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       212 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |+++++|.+++... .....+++..++.++.+++.||.|||+   +|++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            99999999988532 234568999999999999999999999   89999999999999999999999999998865433


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      ...        .....|+..|+|||++.+..++.++||||||+++|+|++|..||............ .+.....+  ..
T Consensus       160 ~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~--~~  228 (267)
T cd08229         160 TTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEQCDYP--PL  228 (267)
T ss_pred             Ccc--------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh-hhhcCCCC--CC
Confidence            211        12234899999999999888999999999999999999999999643321111100 01111000  00


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      .+...+..+.+++.+||..+|.+||++.+ |+++++.+
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-i~~~~~~~  265 (267)
T cd08229         229 PSDHYSEELRQLVNMCINPDPEKRPDITY-VYDVAKRM  265 (267)
T ss_pred             CcccccHHHHHHHHHhcCCCcccCCCHHH-HHHHHhhh
Confidence            12245678999999999999999999998 77777654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-39  Score=319.40  Aligned_cols=259  Identities=27%  Similarity=0.462  Sum_probs=195.9

Q ss_pred             cCCCCCCcccccCceEEEEEEECC----------------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeec
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH----------------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVG  200 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~----------------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g  200 (498)
                      .+|.+.+.||+|+||.||++...+                ..||+|.+...... ....|.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468888999999999999987632                24899998754322 2356889999999999999999999


Q ss_pred             eec--CcceEEEeeCCCCCHHhhhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEE
Q 010882          201 ACP--EVWTLVYEYLPNGSLEDRLSCKD---------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL  269 (498)
Q Consensus       201 ~~~--~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiL  269 (498)
                      ++.  ...++||||+++++|.+++....         ....+++..++.++.+++.||.|||+   .+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            983  46889999999999999985322         11347889999999999999999999   89999999999999


Q ss_pred             EcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh--CCCCCCC
Q 010882          270 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI  347 (498)
Q Consensus       270 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf~~  347 (498)
                      ++.++.+||+|||++.........      .......++..|+|||++.++.++.++|||||||++|+|+|  |..||..
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             EcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999999999999765432211      11123346789999999998899999999999999999998  6678865


Q ss_pred             cHHHHHHHHhCcc-ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          348 TKEVQYALDTGKL-KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       348 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      ............. ...........+...+..+.+++.+||+.+|.+||++.+ |.+.|.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~-i~~~l~  294 (295)
T cd05097         236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK-IHHFLR  294 (295)
T ss_pred             cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH-HHHHHh
Confidence            4322111111000 000000001112234578999999999999999999988 666553

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.2e-39  Score=319.97  Aligned_cols=254  Identities=26%  Similarity=0.431  Sum_probs=196.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--C--eEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--H--MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV  209 (498)
                      ++|++.+.||+|+||.||+|.++  +  ..+|+|.+..... .....+.+|+.++.++ +||||+++++++.  +..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46788889999999999999874  3  3468887664322 2235688999999999 8999999999984  468999


Q ss_pred             EeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          210 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                      |||+++|+|.+++....             ....+++..++.++.|++.||.|||+   +|++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence            99999999999986432             12368899999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHH
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL  355 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~  355 (498)
                      ||+|||++.......         ......++..|+|||++.+..++.++|||||||++|+|+| |.+||...+......
T Consensus       164 kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  234 (303)
T cd05088         164 KIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  234 (303)
T ss_pred             EeCccccCcccchhh---------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence            999999986322111         0111224678999999988889999999999999999998 999996544322111


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ..   .   .......+...+..+.+++.+||..+|.+||++.+ ++..|..+..
T Consensus       235 ~~---~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-il~~l~~~~~  282 (303)
T cd05088         235 KL---P---QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRMLE  282 (303)
T ss_pred             HH---h---cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHH
Confidence            11   0   01111123334567899999999999999999998 6566666543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.8e-39  Score=309.81  Aligned_cols=246  Identities=28%  Similarity=0.410  Sum_probs=195.9

Q ss_pred             cccccCceEEEEEEECC-----eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~E~~~~gs  217 (498)
                      .||+|+||.||+|.+..     ..||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ..++||||+++|+
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~   81 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS   81 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence            58999999999998732     3699999987655 345678999999999999999999998744 5789999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      |.+++..... ..+++..+..++.|++.||.|||.   ++++||||+|+||+++.++.+||+|||++..+.......   
T Consensus        82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~---  154 (257)
T cd05040          82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY---  154 (257)
T ss_pred             HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence            9999964432 468999999999999999999999   899999999999999999999999999998765432110   


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                        .......++..|+|||++.+..++.++|||||||++|+|+| |.+||...+............     .....+...+
T Consensus       155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~  227 (257)
T cd05040         155 --VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-----ERLERPEACP  227 (257)
T ss_pred             --ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----CcCCCCccCC
Confidence              11123457889999999998899999999999999999999 999996544333221111100     1111233345


Q ss_pred             HHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          377 EQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      ..+.+++.+||..+|.+||++.+ +...|
T Consensus       228 ~~~~~li~~~l~~~p~~Rps~~~-~~~~l  255 (257)
T cd05040         228 QDIYNVMLQCWAHNPADRPTFAA-LREFL  255 (257)
T ss_pred             HHHHHHHHHHCCCCcccCCCHHH-HHHHh
Confidence            78999999999999999999998 54443

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-39  Score=331.45  Aligned_cols=244  Identities=25%  Similarity=0.320  Sum_probs=190.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      ..+|.+.+.||+|+||.||++...  +..||+|++....   ......+..|+.+++.++||||+++++++.+  ..++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            457888999999999999999985  5789999986432   1223457899999999999999999998843  58999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||++||+|.+++..    ..++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+|.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999842    247888999999999999999999   8999999999999999999999999999986543


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccC----CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD  365 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (498)
                      ....       ......||+.|+|||++.+.    .++.++|||||||+||+|+||++||...+.............   
T Consensus       195 ~~~~-------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~---  264 (370)
T cd05621         195 TGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN---  264 (370)
T ss_pred             CCce-------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---
Confidence            2211       11234699999999999764    378899999999999999999999976554322211110000   


Q ss_pred             CCCCCCCH--HHHHHHHHHHHHhhhcccC--CCCChhH
Q 010882          366 PLAGDWPF--VQAEQLANLAMRCCEMSRK--SRPELGK  399 (498)
Q Consensus       366 ~~~~~~~~--~~~~~l~~li~~cl~~~p~--~RP~~~~  399 (498)
                        ...+|.  ..+..+.+++..|+..++.  .||++.+
T Consensus       265 --~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e  300 (370)
T cd05621         265 --SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEE  300 (370)
T ss_pred             --ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence              011222  3467789999999975443  3778776

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-39  Score=308.55  Aligned_cols=246  Identities=31%  Similarity=0.507  Sum_probs=199.5

Q ss_pred             CcccccCceEEEEEEEC-----CeEEEEEEecCCCCCC-hhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCCC
Q 010882          144 LKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPN  215 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~~  215 (498)
                      +.||+|+||.||+|...     +..|++|.+....... ...+..|+.+++.++||||+++++++.+  ..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            36999999999999885     6789999998654433 5678899999999999999999998844  68899999999


Q ss_pred             CCHHhhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          216 GSLEDRLSCKDN------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       216 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |+|.+++.....      ...+++..+..++.+++.||.|||+   ++++||||+|+||+++.++.+||+|||++.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999964321      3679999999999999999999999   8999999999999999999999999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      ....      .......+++.|+|||.+....++.++|||||||++|+|++ |.+||..............      ...
T Consensus       158 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------~~~  225 (262)
T cd00192         158 DDYY------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK------GYR  225 (262)
T ss_pred             cccc------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------CCC
Confidence            4311      11133457899999999998899999999999999999999 6999976643322111111      111


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      ...|...+..+.+++.+||..+|.+||++.+ +...|
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-l~~~l  261 (262)
T cd00192         226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSE-LVERL  261 (262)
T ss_pred             CCCCccCChHHHHHHHHHccCCcccCcCHHH-HHHhh
Confidence            2234455788999999999999999999988 55443

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.5e-39  Score=316.69  Aligned_cols=244  Identities=25%  Similarity=0.387  Sum_probs=198.8

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .+|...+.||+|+||.||+|..  .+..||+|.+........+.+.+|+.+++.++||||+++++.|.  ...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4788888999999999999987  46789999988765555677899999999999999999999873  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++..    ..+++.++..++.+++.||.|||+   .||+||||||+|||++.++.+||+|||++.........
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999842    357889999999999999999999   89999999999999999999999999998765432211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              .....|++.|+|||.+.+..++.++|||||||++|+|+||++||................   .+ ....+.
T Consensus       173 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~---~~-~~~~~~  240 (296)
T cd06654         173 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TP-ELQNPE  240 (296)
T ss_pred             --------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC---CC-CCCCcc
Confidence                    122358999999999998889999999999999999999999997655433222111100   00 011233


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+..+.+++.+||..+|.+||++.++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~ei  267 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKEL  267 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence            455779999999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.6e-39  Score=314.63  Aligned_cols=243  Identities=25%  Similarity=0.358  Sum_probs=193.6

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      |++.+.||.|+||.||+|...  +..+++|.+..........+.+|+.+++.++||||++++++|.  ...++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            456677999999999999985  5678999986554444567889999999999999999999873  467899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|..++..  ...++++..+..++.+++.||.|||+   .|++||||||+|||++.++.+||+|||++........   
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---  158 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ---  158 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc---
Confidence            999988753  23568999999999999999999999   8999999999999999999999999999876533211   


Q ss_pred             CccceeccCCCCCCCcCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                           ......||+.|+|||++.     +..++.++|||||||++|+|++|++||...+..............    ...
T Consensus       159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~  229 (282)
T cd06643         159 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP----TLA  229 (282)
T ss_pred             -----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC----CCC
Confidence                 112335899999999984     345788999999999999999999999765544332222111110    011


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .|...+..+.+++.+||+.+|.+||++.+
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  258 (282)
T cd06643         230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQ  258 (282)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence            23334578999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-39  Score=310.26  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=197.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC-----ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      .+|...+.||+|+||.||.|..  .+..||+|.+......     ....+.+|+.++++++||||+++++++.  +..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688889999999999999987  4688999998754322     1246888999999999999999999984  46899


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+++++|.+++..   ...++...+..++.+++.||.|||.   .+++||||+|+||+++.++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999999853   3468889999999999999999999   899999999999999999999999999987654


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      .......     ......|+..|+|||++.+..++.++|||||||++|+|++|++||...+...........     ...
T Consensus       156 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----~~~  225 (263)
T cd06625         156 TICSSGT-----GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-----PTN  225 (263)
T ss_pred             ccccccc-----cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-----CCC
Confidence            3211100     012334788999999999988999999999999999999999999754433222221111     111


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...|...+..+.+++.+||..+|.+||++.+
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  256 (263)
T cd06625         226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEE  256 (263)
T ss_pred             CCCCccCCHHHHHHHHHHhhcCcccCCCHHH
Confidence            2244456678999999999999999999988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.8e-39  Score=318.10  Aligned_cols=284  Identities=24%  Similarity=0.425  Sum_probs=212.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--C----eEEEEEEecCCCCCC-hhhHHHHHHHHHcCCCCCeeeeeceec-CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV  209 (498)
                      .+|...+.||+|+||.||+|.+.  +    ..||+|.+....... ...+.+|+.+++.++||||++++|.|. ...++|
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v   86 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV   86 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence            35777889999999999999873  3    257999887543222 336889999999999999999999884 456799


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      +||+++|+|.+++...  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          87 TQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             ehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence            9999999999998532  3458899999999999999999999   8999999999999999999999999999986643


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH--HHHHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK--EVQYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~--~~~~~~~~~~~~~~~~~  366 (498)
                      ......      .....++..|+|||++.+..++.++|||||||++|||+| |..||....  ........+..      
T Consensus       162 ~~~~~~------~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------  229 (303)
T cd05110         162 DEKEYN------ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER------  229 (303)
T ss_pred             cccccc------cCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------
Confidence            221100      122346789999999998899999999999999999998 899996542  22222222111      


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhcCCCCCCCCCCCCCCCCCCCcCCCccccccCC
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQD  443 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~~~~~~~~~~~~~~~~~P~~~~cpi~~e~~~d  443 (498)
                        ...+...+..+.+++..||..+|.+||++.+ +...|..+.....  ......+..+...|.....|.+++.+.+
T Consensus       230 --~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~-l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (303)
T cd05110         230 --LPQPPICTIDVYMVMVKCWMIDADSRPKFKE-LAAEFSRMARDPQ--RYLVIQGDDRMKLPSPNDSKFFQNLLDE  301 (303)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHhchh--hheeeccCCcCCCCCCchhhHHhccccc
Confidence              0112234567899999999999999999988 7777777643322  1122233333445666666666665543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.7e-39  Score=315.14  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=196.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--Ccc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~  206 (498)
                      +.+|.+.+.||+|+||.||+|.+.+       ..||+|.+...... ....|.+|+.+++.++||||+++++++.  +..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4578888999999999999998843       57899987644322 2346889999999999999999999874  357


Q ss_pred             eEEEeeCCCCCHHhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC---ceeEe
Q 010882          207 TLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLS  279 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~  279 (498)
                      ++||||++||+|.+++.....    ...+++..++.++.+++.||.|||+   ++++||||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence            899999999999999864321    2358999999999999999999999   8999999999999998654   69999


Q ss_pred             eccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhC
Q 010882          280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTG  358 (498)
Q Consensus       280 DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~  358 (498)
                      |||+++.........      ......++..|+|||++.+..++.++|||||||++|+|+| |..||.............
T Consensus       162 dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~  235 (277)
T cd05036         162 DFGMARDIYRASYYR------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT  235 (277)
T ss_pred             cCccccccCCcccee------cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999998763322111      0112234578999999998899999999999999999997 999997643222111100


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                            ......+|...+..+.+++.+|++.+|.+||++.+ |++.|
T Consensus       236 ------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~-vl~~l  275 (277)
T cd05036         236 ------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT-ILERI  275 (277)
T ss_pred             ------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHh
Confidence                  00112234455678999999999999999999998 55444

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.5e-40  Score=330.01  Aligned_cols=245  Identities=25%  Similarity=0.310  Sum_probs=194.6

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|.+...||+|+||.||++...  +..||||++.....   .....+..|+.+++.++||||+++++++.  +..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            6788889999999999999874  67899999975432   23456889999999999999999999884  35889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++|+|.+++...  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          82 YQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            99999999999533  2468999999999999999999999   899999999999999999999999999998664332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhc------cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD  365 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (498)
                      ..       ......||+.|+|||++.      ...++.++|||||||++|+|+||+.||............-.....+.
T Consensus       157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~  229 (330)
T cd05601         157 MV-------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK  229 (330)
T ss_pred             ce-------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence            11       112345899999999987      45678999999999999999999999976544332221111111111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                         .......+..+.+|+..|+. +|.+||++.+
T Consensus       230 ---~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~  259 (330)
T cd05601         230 ---FPEDPKVSSDFLDLIQSLLC-GQKERLGYEG  259 (330)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHH
Confidence               00111345778999999997 9999999987

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=333.05  Aligned_cols=238  Identities=29%  Similarity=0.470  Sum_probs=198.7

Q ss_pred             cccccCceEEEEEEECC--eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCCCCCHHh
Q 010882          145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLED  220 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~~gsL~~  220 (498)
                      +||+|.||+||.|++..  ..+|||-+..........+..|+.+-+.|+|.|||+++|+|.+  .+-|.||-+|||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            59999999999999864  4579999887766666779999999999999999999999955  3568999999999999


Q ss_pred             hhccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc-CCCceeEeeccccccccccccCCCCc
Q 010882          221 RLSCKDNSPPL--SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       221 ~l~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      +|..+  -+|+  .+.++-.+..||++||.|||.   +.|||||||-+||||+ -.|.+||+|||.++.+..-.      
T Consensus       662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------  730 (1226)
T KOG4279|consen  662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------  730 (1226)
T ss_pred             HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC------
Confidence            99643  3456  788889999999999999999   7899999999999996 57999999999998765322      


Q ss_pred             cceeccCCCCCCCcCChhhhccC--CCCCccchHhHHHHHHHHHhCCCCCCCcHHH-HHHHHhCccccccCCCCCCCCHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                        .+.....||..|||||++..+  +|+.++|||||||++.||.||+|||...... ...+.-|.+..     .+..|..
T Consensus       731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKv-----HP~iPee  803 (1226)
T KOG4279|consen  731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKV-----HPPIPEE  803 (1226)
T ss_pred             --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceec-----CCCCcHH
Confidence              223445699999999999876  6999999999999999999999999644332 23334443322     2446888


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+.+...+|.+|+.++|.+||++.+.
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~L  829 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDL  829 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHh
Confidence            89999999999999999999999883

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.6e-39  Score=313.19  Aligned_cols=248  Identities=28%  Similarity=0.371  Sum_probs=195.8

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceec--------
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--------  203 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--------  203 (498)
                      .+++.|+..+.||+|+||.||+|...  +..||+|.+.... .....+..|+.++.++ +||||++++++|.        
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35667888889999999999999884  6789999986543 3456788999999998 7999999999873        


Q ss_pred             CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                      ...++||||+++|+|.+++... ....+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence            2468999999999999998642 23468999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG  358 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (498)
                      +........        ......|++.|+|||++..     ..++.++|||||||++|||++|.+||.............
T Consensus       158 ~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~  229 (272)
T cd06637         158 SAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  229 (272)
T ss_pred             ceecccccc--------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence            886543211        1123458999999999863     358889999999999999999999996544332222111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..     +.....+...+..+.+|+.+||..+|.+||++.++
T Consensus       230 ~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  266 (272)
T cd06637         230 RN-----PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL  266 (272)
T ss_pred             cC-----CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            10     00011112345679999999999999999999873

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-39  Score=329.97  Aligned_cols=242  Identities=22%  Similarity=0.299  Sum_probs=186.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ..|.+.+.||+|+||.||++...  +..||+|...      ...+.+|+.+|++++||||++++++|.  ...++|||++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999884  6789999753      235789999999999999999999884  4678999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      . ++|..++..   ...+++..++.|+.|++.||.|||+   ++||||||||+|||++.++.+||+|||++.........
T Consensus       166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            4 788888843   3468899999999999999999999   89999999999999999999999999999754322110


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH----------HHHHHHH-hCcc--
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK----------EVQYALD-TGKL--  360 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~----------~~~~~~~-~~~~--  360 (498)
                             ......||+.|+|||++.+..++.++|||||||++|||+||++||....          .....+. .+..  
T Consensus       239 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        239 -------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             -------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence                   1123469999999999999999999999999999999999997763211          0000000 0000  


Q ss_pred             ----------cc---------ccCCC-CCCCC--HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 ----------KN---------LLDPL-AGDWP--FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 ----------~~---------~~~~~-~~~~~--~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                ..         ...+. ...|.  ...+..+.+|+.+||+.||.+||++.+
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e  372 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA  372 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence                      00         00000 00111  123567899999999999999999988

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.7e-39  Score=313.03  Aligned_cols=254  Identities=26%  Similarity=0.402  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-----eEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~  210 (498)
                      .+|.+.+.||+|+||.||+|.+..     ..||||...... ....+.+.+|+.+++.++||||++++++|.+ ..++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~   85 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM   85 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence            357778899999999999998743     368999887554 2234578999999999999999999998854 578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.+++...  ...+++..+..++.+++.||.|||+   .+++||||||+|||++.++.+||+|||++......
T Consensus        86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          86 ELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            999999999999532  3358999999999999999999999   89999999999999999999999999999865443


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ....       .....++..|+|||.+....++.++|||||||++|||++ |.+||..................      
T Consensus       161 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------  227 (270)
T cd05056         161 SYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------  227 (270)
T ss_pred             ccee-------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------
Confidence            2111       112235678999999988889999999999999999996 99999765443322211111111      


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ..+...+..+.+++.+|+..+|.+||++.+ +...|+.+..
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~-~~~~l~~~~~  267 (270)
T cd05056         228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTE-LKAQLSDILQ  267 (270)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHh
Confidence            123345678999999999999999999988 7777777653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-38  Score=309.41  Aligned_cols=246  Identities=26%  Similarity=0.455  Sum_probs=197.6

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCCh---------hhHHHHHHHHHcCCCCCeeeeeceec--Ccc
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---------SEFQQEIDILSKIRHPNLVTLVGACP--EVW  206 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~---------~~~~~E~~il~~l~hpniv~l~g~~~--~~~  206 (498)
                      |.+...||.|+||.||+|...  +..||+|.+........         +.+.+|+.++++++||||+++++++.  +..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            566788999999999999873  57899998876543322         45788999999999999999999874  467


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+++++|.+++..   ...+++..+..++.+++.||.|||+   .+++||||+|+||+++.++.+||+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            899999999999999943   3568889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      ...........  .......|+..|+|||.+.+..++.++|||||||++|+|+||+.||...+..........      .
T Consensus       156 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~  227 (267)
T cd06628         156 LEANSLSTKTN--GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------N  227 (267)
T ss_pred             cccccccCCcc--ccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc------c
Confidence            65322111111  111233588999999999988899999999999999999999999976554433222211      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .....|...+..+.+++.+||+.+|.+||++.+
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (267)
T cd06628         228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAE  260 (267)
T ss_pred             CCCcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence            112234455688999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-40  Score=327.40  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=208.1

Q ss_pred             CCCCcccccCceEEEEEEECC------eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEEee
Q 010882          141 DPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEY  212 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~E~  212 (498)
                      .+.++||.|-||.||+|++..      -.||||.-+.+.. .+.+.|..|.-+|+.++||||++|+|+|.+ ...||||.
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL  471 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMEL  471 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEec
Confidence            345679999999999999842      3599999887543 446789999999999999999999999965 57899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++-|.|..+|..  +...|+..+...++.|++.||.|||+   ..+|||||...|||+.....+||+|||+++.+....+
T Consensus       472 ~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  472 APLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             ccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            999999999964  44568888999999999999999999   8899999999999999999999999999999877654


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      ....       ...-.+-|||||.++-..++.+||||.|||+|||++. |..||.+....+.      +..+-.......
T Consensus       547 YkaS-------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------I~~iEnGeRlP~  613 (974)
T KOG4257|consen  547 YKAS-------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------IGHIENGERLPC  613 (974)
T ss_pred             hhcc-------ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce------EEEecCCCCCCC
Confidence            3222       1224568999999999999999999999999999987 9999966543221      112222334457


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      |..+++.+..|+.+||+++|.+||.+.+ +...|..+..
T Consensus       614 P~nCPp~LYslmskcWayeP~kRPrfte-i~~~lsdv~q  651 (974)
T KOG4257|consen  614 PPNCPPALYSLMSKCWAYEPSKRPRFTE-IKAILSDVLQ  651 (974)
T ss_pred             CCCCChHHHHHHHHHhccCcccCCcHHH-HHHHHHHHHH
Confidence            8889999999999999999999999998 6667766553

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-38  Score=308.86  Aligned_cols=250  Identities=30%  Similarity=0.475  Sum_probs=199.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN  215 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~~  215 (498)
                      .+|.+...||+|+||.||+|.+.+ ..+|+|.+.... .....+.+|+.+++.++|||++++++++. +..++||||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence            357788899999999999998854 579999876543 23467889999999999999999999874 357899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.+++... ....+++..+..++.+++.||.|||+   .|++|+||||+||+++.++.++|+|||++.......... 
T Consensus        85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~-  159 (260)
T cd05069          85 GSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA-  159 (260)
T ss_pred             CCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc-
Confidence            9999999643 23458899999999999999999999   899999999999999999999999999998664332111 


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                            .....++..|+|||.+.+..++.++|||||||++|+|+| |.+||..............   ..   ....+..
T Consensus       160 ------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~---~~~~~~~  227 (260)
T cd05069         160 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER---GY---RMPCPQG  227 (260)
T ss_pred             ------cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CC---CCCCCcc
Confidence                  112236788999999988889999999999999999999 9999976543222111100   00   1112334


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      .+..+.+++.+||..+|.+||++.+ +.+.|+
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~  258 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEY-IQSFLE  258 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHH-HHHHHh
Confidence            5678999999999999999999988 766665

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.9e-39  Score=319.37  Aligned_cols=258  Identities=23%  Similarity=0.409  Sum_probs=203.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC---------CeEEEEEEecCCC-CCChhhHHHHHHHHHcC-CCCCeeeeeceec--
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--  203 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--  203 (498)
                      ..+|.+.+.||+|+||.||+|...         +..||+|.+.... ......+.+|+.+++.+ +||||+++++++.  
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            346788899999999999999752         2469999887542 22345788999999999 8999999999884  


Q ss_pred             CcceEEEeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL  270 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl  270 (498)
                      ...++||||+++|+|.+++....             ....+++.++..++.|++.||.|||+   +|++||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence            35789999999999999986432             12358889999999999999999999   899999999999999


Q ss_pred             cCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH
Q 010882          271 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK  349 (498)
Q Consensus       271 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  349 (498)
                      +.++.+||+|||+++..........      .....+++.|+|||++.+..++.++|||||||++|+|+| |..||....
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             cCCCcEEECCCccceeccccccccc------ccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999986643321110      122346788999999988889999999999999999999 888886543


Q ss_pred             HHHH--HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          350 EVQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       350 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ....  .+..+.        ....+...+..+.+++.+||..+|.+||++.+ ++..|+.+....
T Consensus       245 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e-~l~~l~~~~~~~  300 (304)
T cd05101         245 VEELFKLLKEGH--------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQ-LVEDLDRILTLT  300 (304)
T ss_pred             HHHHHHHHHcCC--------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHH-HHHHHHHHHHhh
Confidence            3221  111111        11123345678999999999999999999988 778888876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.2e-39  Score=312.27  Aligned_cols=254  Identities=25%  Similarity=0.438  Sum_probs=198.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--C---eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      .+|+..+.||+|+||.||+|...  +   ..+|+|.+..... .....+..|+.+++.++||||+++++++.  +..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46788889999999999999874  2   3699998865422 22456889999999999999999999984  457899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++++|.+++..  ....+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999853  23568999999999999999999999   8999999999999999999999999999986643


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      ......     ......+++.|+|||++....++.++|||||||++|||+| |+.||...+...........      ..
T Consensus       160 ~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~------~~  228 (268)
T cd05063         160 DPEGTY-----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG------FR  228 (268)
T ss_pred             ccccce-----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC------CC
Confidence            321110     0111224567999999998889999999999999999998 99999654332211111100      01


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ...+...+..+.+++.+||..+|.+||++.+ |...|+.+
T Consensus       229 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~-i~~~l~~~  267 (268)
T cd05063         229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVD-IVNLLDKL  267 (268)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHhh
Confidence            1122334578999999999999999999998 77776654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.6e-39  Score=324.46  Aligned_cols=254  Identities=25%  Similarity=0.386  Sum_probs=197.9

Q ss_pred             cCCCCCCcccccCceEEEEEEE-------CCeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceec---Cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---EV  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~---~~  205 (498)
                      .+|.+.+.||+|+||.||+|.+       .++.||||++...... ....+.+|+.++.++ +||||++++++|.   ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            4788999999999999999974       2468999999754322 234678999999999 6899999999873   24


Q ss_pred             ceEEEeeCCCCCHHhhhccCCC----------------------------------------------------------
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDN----------------------------------------------------------  227 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  227 (498)
                      .++||||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999853210                                                          


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcccee
Q 010882          228 ------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC  301 (498)
Q Consensus       228 ------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~  301 (498)
                            ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..........      .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~------~  237 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------R  237 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh------h
Confidence                  1247888899999999999999999   899999999999999999999999999998653322110      0


Q ss_pred             ccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH---HHHHHHhCccccccCCCCCCCCHHHHH
Q 010882          302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAE  377 (498)
Q Consensus       302 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (498)
                      .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.....   .......+..        ...|...+.
T Consensus       238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~  309 (343)
T cd05103         238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--------MRAPDYTTP  309 (343)
T ss_pred             cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC--------CCCCCCCCH
Confidence            122336778999999988899999999999999999997 9999965322   1111212111        111223456


Q ss_pred             HHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          378 QLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       378 ~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      .+.+++..||+.+|.+||++.+ ++..|+.+.
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~e-il~~l~~~~  340 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSE-LVEHLGNLL  340 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHH-HHHHHHHHH
Confidence            7999999999999999999998 777777664

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=340.41  Aligned_cols=253  Identities=28%  Similarity=0.466  Sum_probs=209.7

Q ss_pred             CCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ..+.++||.|.||+||+|.++     ...||||.++.... ....+|..|+.||.+++||||++|.|+..  ...+||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            345678999999999999984     35799999986533 34568999999999999999999999874  35789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      ||++|+|+.+|..++  ..|++.+...+++.||.|+.||-.   +++|||||...|||++.+..+|++||||++.+.++.
T Consensus       711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            999999999997554  459999999999999999999999   999999999999999999999999999999876554


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH--HHHHHHhCccccccCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~--~~~~~~~~~~~~~~~~~~  368 (498)
                      . ....+    .+..-...|.|||.+...+++.+||||||||||||.++ |..||.....  +..+++.|        ..
T Consensus       786 ~-~~ytt----~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g--------yR  852 (996)
T KOG0196|consen  786 E-AAYTT----LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG--------YR  852 (996)
T ss_pred             C-ccccc----cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc--------cC
Confidence            1 11111    22234579999999999999999999999999999887 8888865443  33344443        12


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      -.-|.+++..|.+|+..||++|..+||.+.+ ++..|+.+.+.
T Consensus       853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~q-iV~~lDklIrn  894 (996)
T KOG0196|consen  853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQ-IVSTLDKLIRN  894 (996)
T ss_pred             CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHH-HHHHHHHHhcC
Confidence            2247778899999999999999999999999 78888887654

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.9e-39  Score=309.42  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=190.3

Q ss_pred             cccccCceEEEEEEEC-----CeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceec---CcceEEEeeCCC
Q 010882          145 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYLPN  215 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~---~~~~lV~E~~~~  215 (498)
                      .||+|+||.||+|.+.     ...||||.+.... ......+.+|+.+++.++||||++++++|.   ...++||||+++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            5899999999999863     2569999875432 223457889999999999999999999763   247899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.+++...  ...+++..+..++.+++.||.|||+   .+++||||||+|||++.++.+||+|||+++..........
T Consensus        82 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          82 GDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            9999998532  2346778889999999999999999   8999999999999999999999999999986543221110


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                      .    ......++..|+|||.+.+..++.++|||||||++|||+| |.+||...+.........      .......+..
T Consensus       157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~  226 (262)
T cd05058         157 H----NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL------QGRRLLQPEY  226 (262)
T ss_pred             c----ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh------cCCCCCCCCc
Confidence            0    0122346788999999988899999999999999999999 567776544332211110      0011112223


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      .+..+.+++..||..+|.+||++.+ ++..|+.+
T Consensus       227 ~~~~~~~li~~cl~~~p~~Rp~~~~-il~~l~~~  259 (262)
T cd05058         227 CPDPLYEVMLSCWHPKPEMRPTFSE-LVSRIEQI  259 (262)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHH-HHHHHHHH
Confidence            4568999999999999999999988 77777665

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=350.95  Aligned_cols=243  Identities=27%  Similarity=0.317  Sum_probs=202.3

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceecC--cce
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWT  207 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~  207 (498)
                      -...+|.+.++||+|+||.|..++.+  +..||+|++++..+   ....-|..|.+||.--+.++|+.|+.+|++  ++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            34458999999999999999999885  56799999987433   234468899999999999999999999965  689


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||++||+|..+|...   .++++.....++.+++.||.-||+   .|+|||||||+|||||..|++||+|||.|-.+
T Consensus       152 lVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             EEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhc
Confidence            999999999999999533   379999999999999999999999   89999999999999999999999999999988


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      ..++....       ...+|||.|++||++..     +.|++.|||||+||++|||+.|..||...+-+..--.+.....
T Consensus       226 ~~dG~V~s-------~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~  298 (1317)
T KOG0612|consen  226 DADGTVRS-------SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE  298 (1317)
T ss_pred             CCCCcEEe-------ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence            86654322       44579999999999953     5699999999999999999999999988777665444444433


Q ss_pred             ccCCCCCCCC--HHHHHHHHHHHHHhhhcccCCCCC
Q 010882          363 LLDPLAGDWP--FVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       363 ~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                      .+.     +|  ...+....+||...+. +|..|..
T Consensus       299 ~l~-----FP~~~~VSeeakdLI~~ll~-~~e~RLg  328 (1317)
T KOG0612|consen  299 SLS-----FPDETDVSEEAKDLIEALLC-DREVRLG  328 (1317)
T ss_pred             hcC-----CCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence            332     44  3478889999988774 6667766

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-39  Score=321.90  Aligned_cols=242  Identities=29%  Similarity=0.466  Sum_probs=205.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCC-CCCeeeeeceecC--cceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIR-HPNLVTLVGACPE--VWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~-hpniv~l~g~~~~--~~~l  208 (498)
                      ...|.+.+.||+|.||.||++..+  +..+|+|++.+.....   ...+.+|+.+|+++. |||||.++++|.+  ..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            346888899999999999999884  6889999998765543   458999999999998 9999999999954  5799


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC----CCceeEeecccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDFGIS  284 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~----~~~~kl~DFGla  284 (498)
                      |||+|.||.|.+.+...    .+++.....++.+++.|+.|||+   .||+||||||+|+|+..    ++.+|++|||++
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999999654    39999999999999999999999   89999999999999963    357999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCcccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKN  362 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~  362 (498)
                      .......         .....+||+.|+|||++....|+..+||||+||++|.|++|.+||...+....  .+..+.+  
T Consensus       187 ~~~~~~~---------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--  255 (382)
T KOG0032|consen  187 KFIKPGE---------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--  255 (382)
T ss_pred             eEccCCc---------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--
Confidence            9876521         12445699999999999999999999999999999999999999987764433  3334333  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        +...+.|+ ..+..+.+++..|+..||..|+++.+
T Consensus       256 --~f~~~~w~-~is~~akd~i~~ll~~dp~~R~ta~~  289 (382)
T KOG0032|consen  256 --DFTSEPWD-DISESAKDFIRKLLEFDPRKRLTAAQ  289 (382)
T ss_pred             --CCCCCCcc-ccCHHHHHHHHHhcccCcccCCCHHH
Confidence              22334454 45888999999999999999999988

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.9e-39  Score=311.42  Aligned_cols=252  Identities=27%  Similarity=0.459  Sum_probs=198.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      .+|.+.+.||+|+||.||+|.+.     +..+|+|.+..... .....+.+|+.++++++||||+++++++.  +..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778889999999999999873     24699999865432 22357889999999999999999999883  468899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++...  ...+++.++..++.+++.||.|||+   .+++||||||+|||++.++.++|+|||++..+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999533  3468999999999999999999999   8999999999999999999999999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~  366 (498)
                      ......     ......++..|+|||.+.+..++.++|||||||++|++++ |..||.......  ..+..+  .     
T Consensus       159 ~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~--~-----  226 (267)
T cd05066         159 DPEAAY-----TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG--Y-----  226 (267)
T ss_pred             ccceee-----ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC--C-----
Confidence            321110     0112234678999999998899999999999999999887 999996543222  112111  0     


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                       ....+...+..+.+++.+|++.+|.+||++.+ +.+.|+.+
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~~  266 (267)
T cd05066         227 -RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQ-IVSILDKL  266 (267)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcccCchhCCCHHH-HHHHHHhh
Confidence             01122334578899999999999999999998 77777653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-38  Score=320.33  Aligned_cols=247  Identities=24%  Similarity=0.270  Sum_probs=188.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|.+.+.||+|+||.||++..+  +..||+|++....   ......+..|+.++..++||||+++++++.  +..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            6788889999999999999985  5679999986422   122345788999999999999999999884  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++|+|.+++...  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        82 y~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          82 YYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            99999999999532  3468899999999999999999999   899999999999999999999999999987553322


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      ..       ......||+.|+|||++.     ...++.++|||||||++|||++|++||...+...............  
T Consensus       157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--  227 (332)
T cd05623         157 TV-------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--  227 (332)
T ss_pred             cc-------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc--
Confidence            11       012345999999999986     3468899999999999999999999997655433221111000000  


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCC--CCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RP~~~~  399 (498)
                      .....+...+..+.+++.+|+..++..  ||++.+
T Consensus       228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~  262 (332)
T cd05623         228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIED  262 (332)
T ss_pred             cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHH
Confidence            001111234678899999988654433  567665

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-40  Score=295.53  Aligned_cols=266  Identities=24%  Similarity=0.299  Sum_probs=206.7

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee-------cCcc
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-------PEVW  206 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~-------~~~~  206 (498)
                      ..++|.+.+.||+|||+.||.+..  .+..||+|++......+.+...+|++..++++||||+++++++       ....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            346789999999999999998874  5788999999888777888899999999999999999999876       2247


Q ss_pred             eEEEeeCCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      ||++.|...|||.+.+.... .+..+++.+++.|+.++++||.+||...+ +++||||||.|||++..+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999986543 44479999999999999999999999663 69999999999999999999999999988


Q ss_pred             cccccccCCC-CccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccc
Q 010882          286 FLSQNEISSN-NTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK  361 (498)
Q Consensus       286 ~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (498)
                      ...-...... ............|..|.|||.+.-   ...+.++|||||||+||+|+.|..||+..-.     .-+.+.
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~GgSla  252 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----QGGSLA  252 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----cCCeEE
Confidence            6543221111 111111233357999999999964   4578899999999999999999999953211     111221


Q ss_pred             cccCCCCCCCCH--HHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          362 NLLDPLAGDWPF--VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       362 ~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      -.+-.....+|.  ..++.+.+++..|++.||..||++.+ ++..++.+
T Consensus       253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~-ll~~~d~L  300 (302)
T KOG2345|consen  253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE-LLSKLDDL  300 (302)
T ss_pred             EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH-HHHHHHhh
Confidence            111111111221  26789999999999999999999998 65555543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=326.76  Aligned_cols=258  Identities=28%  Similarity=0.481  Sum_probs=215.5

Q ss_pred             HHHHHhhcCCCCCCcccccCceEEEEEEECC--eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--Ccc
Q 010882          131 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW  206 (498)
Q Consensus       131 ~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~  206 (498)
                      ++++-...+.....+||.|.||.||.|+|+.  -.||||.++.+. ...++|..|+.+|+.++|||+|+|+|+|.  ..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4455555566777899999999999999964  679999998554 35789999999999999999999999994  469


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      |||.|||..|+|.++|...+ ...++.-..+.++.||+.|+.||..   +++|||||...|.|++++..+|++||||+++
T Consensus       339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999999997543 3446666788999999999999999   8999999999999999999999999999999


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH--HHHHHHhCccccc
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNL  363 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~--~~~~~~~~~~~~~  363 (498)
                      +..+.+...       .+..-.+-|.|||-+....++.++|||+|||+|||+.| |..||.+.+.  +..+++.|     
T Consensus       415 MtgDTYTAH-------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-----  482 (1157)
T KOG4278|consen  415 MTGDTYTAH-------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-----  482 (1157)
T ss_pred             hcCCceecc-------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-----
Confidence            876654332       22234678999999999999999999999999999998 8899987543  33333333     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                         ...+-|..|++.+.+|++.||+-+|.+||++.+ +.+.++.+-
T Consensus       483 ---yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFae-iHqafEtmf  524 (1157)
T KOG4278|consen  483 ---YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAE-IHQAFETMF  524 (1157)
T ss_pred             ---ccccCCCCCCHHHHHHHHHHhcCCcccCccHHH-HHHHHHHHh
Confidence               123357778899999999999999999999998 888887653

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7e-39  Score=317.41  Aligned_cols=253  Identities=23%  Similarity=0.402  Sum_probs=199.7

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceec--C
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--E  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~--~  204 (498)
                      ..++|...+.||+|+||.||+|...       +..||||++...... ..+.+.+|+.+++++ +||||++++++|.  +
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3457888999999999999999752       347999998754322 235688999999999 7999999999884  4


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||+++|+|.+++.... ...+++.++..++.+++.||.|||+   ++++|+||||+|||++.++.+||+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence            5899999999999999986432 2348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH---HHHHhCcc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ---YALDTGKL  360 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~---~~~~~~~~  360 (498)
                      .........      .......++..|+|||.+.+..++.++|||||||++|+|+| |.+||.......   .....+. 
T Consensus       189 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~-  261 (302)
T cd05055         189 RDIMNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY-  261 (302)
T ss_pred             ccccCCCce------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC-
Confidence            865433211      01122346789999999999899999999999999999998 999986543221   1111110 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                             ....+...+..+.+++.+||..+|.+||++.+ +...|+.
T Consensus       262 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e-ll~~l~~  300 (302)
T cd05055         262 -------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQ-IVQLIGK  300 (302)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH-HHHHHHh
Confidence                   11122334578999999999999999999998 6666654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.2e-39  Score=310.98  Aligned_cols=250  Identities=28%  Similarity=0.421  Sum_probs=197.0

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      ++.++.++.....||+|+||.||+|.+.  +..||+|.+..........+.+|+.+++.++||||++++|++.  +..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3445667777788999999999999874  5679999987655445567899999999999999999999884  46889


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-CCceeEeeccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPL--SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISR  285 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~  285 (498)
                      ||||+++++|.+++....  .++  +...+..++.|++.||.|||+   .+|+||||||+||+++. ++.++|+|||++.
T Consensus        83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            999999999999986432  234  778889999999999999999   89999999999999986 6799999999987


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC--CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH-HHhCcccc
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-LDTGKLKN  362 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~-~~~~~~~~  362 (498)
                      ........        .....|++.|+|||++...  .++.++|||||||++|+|++|++||......... ...+    
T Consensus       158 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~----  225 (268)
T cd06624         158 RLAGINPC--------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG----  225 (268)
T ss_pred             ecccCCCc--------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh----
Confidence            65432211        1123489999999998764  3788999999999999999999999643221111 1111    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       ........|...+..+.+++.+||+.+|.+||++.++
T Consensus       226 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  262 (268)
T cd06624         226 -MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL  262 (268)
T ss_pred             -hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence             0011123455566789999999999999999999883

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1e-38  Score=312.97  Aligned_cols=249  Identities=27%  Similarity=0.348  Sum_probs=192.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|...+.||.|+||.||+|...  +..||||.+......  ....+.+|+.+++.++||||+++++++.  ...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677788999999999999884  678999998754322  2356889999999999999999999984  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++ ++|.+++........+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 6898888654444678999999999999999999999   8999999999999999999999999999875532211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC----cc-------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG----KL-------  360 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~----~~-------  360 (498)
                              ......|++.|+|||++.+. .++.++|||||||++|+|+||++||.............    ..       
T Consensus       157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         157 --------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             --------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence                    11233578999999998764 57889999999999999999999997654432221110    00       


Q ss_pred             -------cccc----CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 -------KNLL----DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 -------~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                             ....    ...........+.++.+++.+||..||.+||++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~  278 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK  278 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence                   0000    00000011124567889999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.1e-39  Score=324.76  Aligned_cols=246  Identities=21%  Similarity=0.278  Sum_probs=189.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      ..+|...+.||+|+||.||++...  +..||||++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999874  6889999986542  2234567899999999999999999998732        


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||+.+ +|.+.+.     ..++...+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            36899999965 5666653     247888899999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH---H-----
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---D-----  356 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~---~-----  356 (498)
                      +.......         .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+......   .     
T Consensus       171 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         171 RTACTNFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             cccccCcc---------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            75432211         123458999999999999999999999999999999999999997543221100   0     


Q ss_pred             -----------------h-Cccc-----c----ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          357 -----------------T-GKLK-----N----LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       357 -----------------~-~~~~-----~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                       . ....     .    ...+.....+...+..+.+|+.+||..||.+||++.++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  312 (359)
T cd07876         242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA  312 (359)
T ss_pred             cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence                             0 0000     0    00000000111234678999999999999999999883

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.9e-39  Score=327.31  Aligned_cols=248  Identities=23%  Similarity=0.302  Sum_probs=191.1

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceecC-------cce
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT  207 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~~-------~~~  207 (498)
                      +|++.+.||+|+||.||+|..  .+..||||++.....  .....+.+|+.+++.++||||+++++++..       ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477888999999999999987  478899999865322  234568899999999999999999998842       468


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+. ++|.+.+.   ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 57888773   34568999999999999999999999   89999999999999999999999999999865


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc------
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------  360 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~------  360 (498)
                      ......       ......||+.|+|||++.+. .++.++|||||||++|||+||++||...+...........      
T Consensus       154 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~  226 (372)
T cd07853         154 EPDESK-------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL  226 (372)
T ss_pred             ccCccc-------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            432211       11234589999999999874 5789999999999999999999999765433211100000      


Q ss_pred             ---------------ccccCCC----CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          361 ---------------KNLLDPL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       361 ---------------~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                     .....+.    ........+..+.+|+.+||+.||.+||++.++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  285 (372)
T cd07853         227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA  285 (372)
T ss_pred             HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH
Confidence                           0000000    001112235678999999999999999999883

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.4e-39  Score=308.38  Aligned_cols=241  Identities=27%  Similarity=0.421  Sum_probs=196.7

Q ss_pred             CCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCCCCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGS  217 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~~gs  217 (498)
                      +|.+.+.||+|+||.||+|...+..||+|.+....  ....+.+|+.+++.++||||+++++++. +..++||||+++|+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~   84 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGN   84 (254)
T ss_pred             HceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCC
Confidence            57888899999999999999889999999986432  3467899999999999999999999873 46789999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      |.+++.... ...+++..++.++.+++.||.|||+   .|++||||||+||+++.++.+||+|||++.......      
T Consensus        85 L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------  154 (254)
T cd05083          85 LVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------  154 (254)
T ss_pred             HHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC------
Confidence            999996432 3458899999999999999999999   899999999999999999999999999987543221      


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCCCCCCCHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                           .....+..|+|||++.+..++.++|||||||++|+|++ |++||...+...  .....+.        ....+..
T Consensus       155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  221 (254)
T cd05083         155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY--------RMEPPEG  221 (254)
T ss_pred             -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC--------CCCCCCc
Confidence                 11124678999999988899999999999999999998 999997554322  2222211        1112334


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      .+..+.+++.+||+.+|..||++.+ +...|
T Consensus       222 ~~~~~~~li~~~l~~~p~~Rp~~~~-l~~~l  251 (254)
T cd05083         222 CPADVYVLMTSCWETEPKKRPSFHK-LREKL  251 (254)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHH-HHHHH
Confidence            5578999999999999999999988 55444

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.2e-39  Score=312.08  Aligned_cols=246  Identities=27%  Similarity=0.351  Sum_probs=193.3

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~  213 (498)
                      .+|...+.||+|+||.||+|..  .+..||+|++..........+.+|+.+++.++||||+++++++  .+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            3667777899999999999987  4688999998765544455688999999999999999999987  44688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++..   ...+++.++..++.+++.||.|||+   .|++|+||||+||+++.++.+||+|||++........ 
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence            99999999843   3468999999999999999999999   8999999999999999999999999999876543211 


Q ss_pred             CCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                             ......|++.|+|||++.   ...++.++|||||||++|+|++|.+||..............  ....+....
T Consensus       162 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~~~~~~~~  232 (267)
T cd06645         162 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SNFQPPKLK  232 (267)
T ss_pred             -------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cCCCCCccc
Confidence                   112345899999999985   45688899999999999999999999864433221111100  001110000


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .....+..+.+++.+||..+|.+||++.+
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~  261 (267)
T cd06645         233 DKMKWSNSFHHFVKMALTKNPKKRPTAEK  261 (267)
T ss_pred             ccCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence            11123467899999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-38  Score=314.19  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .+|...+.||.|+||.||+|..  .+..||+|.+........+.+.+|+.+++.++||||+++++++.  +..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688888999999999999986  46889999987655555677889999999999999999999884  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|..++..    ..+++.++..++.+++.||.|||+   .|++||||||+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999998842    358999999999999999999999   89999999999999999999999999998865433211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              .....|++.|+|||.+.+..++.++|||||||++|+|+||++||...+.............    .....+.
T Consensus       172 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~----~~~~~~~  239 (296)
T cd06655         172 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT----PELQNPE  239 (296)
T ss_pred             --------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----cccCCcc
Confidence                    1223489999999999988899999999999999999999999987655433222111000    0011233


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ..+..+.+++.+||..+|.+||++.+++
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il  267 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELL  267 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence            4556799999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.6e-39  Score=314.26  Aligned_cols=252  Identities=27%  Similarity=0.493  Sum_probs=198.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~  206 (498)
                      ..+|...+.||+|+||.||+|...       +..||+|++..... .....+.+|+.++++++||||++++++|.+  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999863       46799999875432 223568899999999999999999999843  57


Q ss_pred             eEEEeeCCCCCHHhhhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCc
Q 010882          207 TLVYEYLPNGSLEDRLSCKD-------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN  267 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N  267 (498)
                      ++||||+++|+|.+++....                   ....+++..++.++.+++.||.|||.   ++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            99999999999999985321                   12357889999999999999999999   899999999999


Q ss_pred             EEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 010882          268 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG  346 (498)
Q Consensus       268 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~  346 (498)
                      ||++.++.+||+|||++...........      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKA------SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             eEecCCCceEECccccceecccCccccc------cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999875543221110      112235678999999998899999999999999999998 888885


Q ss_pred             CcHHHH--HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          347 ITKEVQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       347 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      ......  ..+..+..        ...+...+..+.+++.+||+.+|.+||++.+ +...|+
T Consensus       235 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e-l~~~l~  287 (288)
T cd05050         235 GMAHEEVIYYVRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFAS-INRILQ  287 (288)
T ss_pred             CCCHHHHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHH-HHHHhh
Confidence            433222  22222211        1123345678999999999999999999998 666554

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-41  Score=301.29  Aligned_cols=241  Identities=25%  Similarity=0.418  Sum_probs=195.0

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCC--CCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      .|++...||+|.|+.||++..  .|+.+|+|+++..  +..+.+.+.+|+.|.+.|+||||++|.....+  ..|+|+|+
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~   91 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   91 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence            566667899999999999877  4778999988654  33356788999999999999999999998743  57899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc---CCCceeEeeccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~~~~  289 (498)
                      +.||+|..-+-..   -.+++...-..+.||+.||.|+|.   ++|||||+||.|+||.   .+--+||+|||+|..+..
T Consensus        92 m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   92 VTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             ccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            9999997655322   346777888899999999999999   9999999999999995   345789999999997762


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCccccccCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPL  367 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~~~~~  367 (498)
                      ..         ...+.+|||.|||||++...+|+..+||||.|||||-|+.|++||.+.+..  ...+..    ..+|..
T Consensus       166 g~---------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~----g~yd~~  232 (355)
T KOG0033|consen  166 GE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA----GAYDYP  232 (355)
T ss_pred             cc---------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc----cccCCC
Confidence            21         124567999999999999999999999999999999999999999874332  222222    223333


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...|+ ..++...+|+++||..||.+|.++.+
T Consensus       233 ~~~w~-~is~~Ak~LvrrML~~dP~kRIta~E  263 (355)
T KOG0033|consen  233 SPEWD-TVTPEAKSLIRRMLTVNPKKRITADE  263 (355)
T ss_pred             CcccC-cCCHHHHHHHHHHhccChhhhccHHH
Confidence            33454 56678999999999999999999877

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-38  Score=312.61  Aligned_cols=256  Identities=26%  Similarity=0.391  Sum_probs=201.0

Q ss_pred             ChHHHHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceec--
Q 010882          129 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--  203 (498)
Q Consensus       129 ~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--  203 (498)
                      .++.+.....+|++.+.||+|+||.||+|...  +..+|+|++.... .....+..|+.+++.+ +||||++++++|.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34556667889999999999999999999884  6789999876432 2245688999999999 6999999999872  


Q ss_pred             -----CcceEEEeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCcee
Q 010882          204 -----EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK  277 (498)
Q Consensus       204 -----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  277 (498)
                           +..++||||++||+|.+++... .....+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence                 2479999999999999987532 234568889999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH
Q 010882          278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQ  352 (498)
Q Consensus       278 l~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~  352 (498)
                      |+|||++.........        .....|++.|+|||++..     ..++.++|||||||++|+|+||++||.......
T Consensus       165 l~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~  236 (286)
T cd06638         165 LVDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR  236 (286)
T ss_pred             EccCCceeecccCCCc--------cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence            9999998865432211        123358999999999853     457889999999999999999999997665443


Q ss_pred             HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          353 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .........   .+. ...|...+..+.+++.+||+.+|.+||++.++
T Consensus       237 ~~~~~~~~~---~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el  280 (286)
T cd06638         237 ALFKIPRNP---PPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL  280 (286)
T ss_pred             HHhhccccC---CCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence            322211111   000 01122345679999999999999999999883

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.3e-39  Score=315.46  Aligned_cols=259  Identities=27%  Similarity=0.438  Sum_probs=195.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC------------------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR------------------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL  198 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l  198 (498)
                      ++|++.+.||+|+||.||++...                  ...||+|++...... ....+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888899999999999998542                  235899998754322 24578999999999999999999


Q ss_pred             eceec--CcceEEEeeCCCCCHHhhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcE
Q 010882          199 VGACP--EVWTLVYEYLPNGSLEDRLSCKDN--------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI  268 (498)
Q Consensus       199 ~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Ni  268 (498)
                      ++++.  +..++||||+++|+|.+++.....        ...+++.++..++.+++.||.|||+   .|++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            99883  468999999999999999864321        1347788999999999999999999   8999999999999


Q ss_pred             EEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh--CCCCCC
Q 010882          269 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALG  346 (498)
Q Consensus       269 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf~  346 (498)
                      |++.++.++|+|||++..+.......      ......+++.|+|||....+.++.++|||||||++|||+|  |..||.
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYR------IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCccee------ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            99999999999999998654322110      1122235678999999988899999999999999999998  778886


Q ss_pred             CcHHHHHHHHhCccc-cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          347 ITKEVQYALDTGKLK-NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       347 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      ...........+... ..........+..++..+.+++.+||+.+|.+||++.+ +.+.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-i~~~l~  295 (296)
T cd05095         236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE-IHATLL  295 (296)
T ss_pred             ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHHh
Confidence            543322111111100 00000001112234578999999999999999999998 655553

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=310.18  Aligned_cols=245  Identities=27%  Similarity=0.460  Sum_probs=189.8

Q ss_pred             cccccCceEEEEEEECC----eEEEEEEecCCC-CCChhhHHHHHHHHHcC-CCCCeeeeeceecC--cceEEEeeCCCC
Q 010882          145 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~lV~E~~~~g  216 (498)
                      .||+|+||.||+|...+    ..+++|.+.... ......+.+|+.++.++ +||||++++++|..  ..++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            59999999999998743    357888887432 22345788999999999 89999999999843  578999999999


Q ss_pred             CHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          217 SLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       217 sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                      +|.+++....             ....+++..+..++.+++.||.|||+   .+++||||||+|||++.++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999985422             12358899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCcccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      +.......  .       .....++..|+|||++....++.++|||||||++|||+| |..||...+........     
T Consensus       159 ~~~~~~~~--~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-----  224 (270)
T cd05047         159 SRGQEVYV--K-------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----  224 (270)
T ss_pred             ccccchhh--h-------ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-----
Confidence            86322110  0       011124667999999988889999999999999999997 99999654332211111     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                       ........+...+..+.+++.+||..+|.+||++.+ ++..|..+
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-il~~l~~~  268 (270)
T cd05047         225 -PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRM  268 (270)
T ss_pred             -hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHH-HHHHHHHh
Confidence             000011123335568999999999999999999998 66666654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1e-38  Score=320.31  Aligned_cols=247  Identities=23%  Similarity=0.287  Sum_probs=188.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|.+.+.||+|+||.||++...  +..||+|++.....   .....+..|+.++..++||||+.+++++.  +..++|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            6888899999999999999884  57899999865321   12345788999999999999999999884  46889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++...  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        82 y~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          82 YYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             CCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999532  3468899999999999999999999   899999999999999999999999999998654332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      ...       .....||+.|+|||++.+     +.++.++|||||||+||+|+||+.||...+..............+. 
T Consensus       157 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-  228 (331)
T cd05624         157 TVQ-------SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ-  228 (331)
T ss_pred             cee-------eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc-
Confidence            111       122359999999999876     4678899999999999999999999976544332211110000000 


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCC--CCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RP~~~~  399 (498)
                       ........+..+.+++.+|+...+.+  |+++.+
T Consensus       229 -~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~  262 (331)
T cd05624         229 -FPSHITDVSEEAKDLIQRLICSRERRLGQNGIED  262 (331)
T ss_pred             -CCCccccCCHHHHHHHHHHccCchhhcCCCCHHH
Confidence             00111124578999999999865433  345544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.6e-39  Score=318.49  Aligned_cols=256  Identities=24%  Similarity=0.415  Sum_probs=201.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC---------CeEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeeceec--C
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E  204 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~  204 (498)
                      .+|.+.+.||+|+||.||+|...         ...||+|.+..... .....+..|+.+++.+ +||||++++++|.  .
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46788899999999999999752         34699999875432 2235688999999999 6999999999884  3


Q ss_pred             cceEEEeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD  271 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~  271 (498)
                      ..++||||+++|+|.+++....             ....+++..+..++.|++.||.|||+   +|++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence            5789999999999999985432             12458999999999999999999999   8999999999999999


Q ss_pred             CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH
Q 010882          272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE  350 (498)
Q Consensus       272 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~  350 (498)
                      .++.+||+|||+++..........      .....++..|+|||++.+..++.++|||||||++|+|+| |..||.....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKK------TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             CCCcEEEccccccccccccccccc------cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999986543221110      011224568999999998899999999999999999999 8999976533


Q ss_pred             H--HHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          351 V--QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       351 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .  ......+.        ....+...+..+.+++.+||..+|.+||++.+ +...|..+...
T Consensus       243 ~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~-ll~~l~~~~~~  296 (314)
T cd05099         243 EELFKLLREGH--------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQ-LVEALDKVLAA  296 (314)
T ss_pred             HHHHHHHHcCC--------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHHHHH
Confidence            2  22222111        11223345678999999999999999999988 77888877653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-38  Score=312.77  Aligned_cols=247  Identities=27%  Similarity=0.369  Sum_probs=189.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcC---CCCCeeeeeceecC-------
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKI---RHPNLVTLVGACPE-------  204 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~hpniv~l~g~~~~-------  204 (498)
                      +|++.+.||+|+||.||+|...  +..||+|.+......  ....+.+|+.+++.+   +||||+++++++..       
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4777889999999999999884  678999998754322  233566788887766   79999999998732       


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+   .||+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            3689999997 48888885332 3458999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc-----
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-----  359 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-----  359 (498)
                      ........         .....||+.|+|||++.+..++.++|||||||++|+|++|++||..............     
T Consensus       156 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07863         156 RIYSCQMA---------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  226 (288)
T ss_pred             ccccCccc---------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC
Confidence            86543221         1223589999999999988999999999999999999999999975543322111000     


Q ss_pred             ----ccc-------ccCCCCC----CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          360 ----LKN-------LLDPLAG----DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       360 ----~~~-------~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                          +..       ...+...    ......+..+.+++.+||+.||.+||++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~  281 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR  281 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence                000       0000000    011134567899999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-38  Score=308.32  Aligned_cols=232  Identities=25%  Similarity=0.410  Sum_probs=182.8

Q ss_pred             cccccCceEEEEEEEC--------------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          145 KIGEGGYGSIYKGLLR--------------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      .||+|+||.||+|...              ...|++|++..........|..|+.+++.++||||++++++|.  ...++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            5899999999999752              2358999887654444557889999999999999999999984  35789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc-------eeEeec
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-------SKLSDF  281 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~-------~kl~DF  281 (498)
                      ||||+++|+|..++..  ....+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.       +|++||
T Consensus        82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          82 VEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999988853  23468999999999999999999999   89999999999999987664       899999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhc-cCCCCCccchHhHHHHHHHHH-hCCCCCCCcHHHHHH-HHhC
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLL-TGRPALGITKEVQYA-LDTG  358 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~~~-~~~~  358 (498)
                      |++......            ....|+..|+|||++. +..++.++|||||||++|||+ +|..||......... ...+
T Consensus       157 g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  224 (262)
T cd05077         157 GIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG  224 (262)
T ss_pred             CCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhc
Confidence            998654321            1224788999999987 456899999999999999998 588888654322211 1111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHH
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR  403 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~  403 (498)
                      ...         ........+.+|+.+||+.+|.+||++.+ ++.
T Consensus       225 ~~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~-il~  259 (262)
T cd05077         225 QCM---------LVTPSCKELADLMTHCMNYDPNQRPFFRA-IMR  259 (262)
T ss_pred             Ccc---------CCCCChHHHHHHHHHHcCCChhhCcCHHH-HHH
Confidence            110         11123467899999999999999999988 443

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.2e-38  Score=306.19  Aligned_cols=249  Identities=24%  Similarity=0.446  Sum_probs=196.7

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCeEEEEEEecCCCCCC------hhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQG------PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~------~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      +|...+.||.|+||.||+|.. .+..+|||.+.......      ...+.+|+.+++.++||||++++++|.+  ..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            366778899999999999987 46789999887543211      2458899999999999999999999843  58899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++++|.+++..   ..++++..+..++.+++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999943   2458889999999999999999999   8999999999999999999999999999986533


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      .......  ........|+..|+|||++.+..++.++|||||||++|+|+||..||...+...............    .
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~  228 (265)
T cd06631         155 VGLHGTH--SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----P  228 (265)
T ss_pred             ccccccc--cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC----C
Confidence            2111100  011123458999999999998889999999999999999999999997655443322221111111    1


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+...+..+.+++.+||..+|.+||++.+
T Consensus       229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  258 (265)
T cd06631         229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQ  258 (265)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence            123345678999999999999999999987

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-38  Score=305.23  Aligned_cols=244  Identities=27%  Similarity=0.386  Sum_probs=199.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ++|+..+.||.|+||.||+|...  +..|++|.+.....  .+.+.+|+++++.++||||+++++++.  ...+++|||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            46888889999999999999985  57899999875432  678999999999999999999999884  4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++..  ....+++..+..++.+++.||.|||+   .+++||||+|+||+++.++.+||+|||++.........
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            99999999853  23568999999999999999999999   89999999999999999999999999998866433211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              .....|+..|+|||++.+..++.++|||||||++|+|+||++||................    ......+.
T Consensus       156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~  223 (256)
T cd06612         156 --------RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP----PPTLSDPE  223 (256)
T ss_pred             --------cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC----CCCCCchh
Confidence                    122348899999999998899999999999999999999999997655433322221110    00111233


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+..+.+++.+||+.+|.+||++.++
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~i  250 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQL  250 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHH
Confidence            455789999999999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.5e-38  Score=307.86  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=186.0

Q ss_pred             cccccCceEEEEEEEC----CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~~gs  217 (498)
                      .||+|+||.||+|...    +..+|+|.+...... ....+.+|+.++++++||||++++|+|.+  ..++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            5999999999999864    256999988754322 23468899999999999999999998853  5789999999999


Q ss_pred             HHhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          218 LEDRLSCKD--NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       218 L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |.+++....  ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++++||+|||++.........  
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~--  156 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY--  156 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence            999986432  22346777888999999999999999   89999999999999999999999999998754332211  


Q ss_pred             CccceeccCCCCCCCcCChhhhccC-------CCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHH--hCccccccC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASG-------ELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALD--TGKLKNLLD  365 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~--~~~~~~~~~  365 (498)
                          .......|+..|+|||++...       .++.++|||||||++|||++ |.+||...........  .+......+
T Consensus       157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05087         157 ----VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK  232 (269)
T ss_pred             ----ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence                111233478899999998642       35789999999999999996 9999975443322111  111111111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                         .......+..+.+++..|+ .+|.+||++.+ |+..|
T Consensus       233 ---~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~-l~~~l  267 (269)
T cd05087         233 ---PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEE-VHLLL  267 (269)
T ss_pred             ---CccCCCCChHHHHHHHHHh-cCcccCCCHHH-HHHHh
Confidence               1122234567889999998 68999999998 55444

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8e-39  Score=311.21  Aligned_cols=255  Identities=25%  Similarity=0.429  Sum_probs=197.4

Q ss_pred             CCCCCCcccccCceEEEEEEECC-----eEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      +|.+.+.||+|+||.||+|....     ..||||++.... ......|..|+.+++.++||||+++++++.+  ..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778889999999999998742     369999987542 2234578999999999999999999998843  578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.+++...  ...+++..++.++.+++.||.|||+   +|++||||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999998533  3468999999999999999999999   89999999999999999999999999998865433


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ......   .......++..|+|||++.+..++.++|||||||++|||++ |.+||...+............      ..
T Consensus       160 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~------~~  230 (269)
T cd05065         160 TSDPTY---TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY------RL  230 (269)
T ss_pred             cccccc---ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC------cC
Confidence            211100   00111123457999999998899999999999999999987 999997554332211111000      11


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..+...+..+.+++.+||..+|.+||++.+ +...|+.+
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~~  268 (269)
T cd05065         231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQ-IVSTLDKM  268 (269)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHhh
Confidence            123345577899999999999999999988 66666543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.2e-39  Score=327.94  Aligned_cols=248  Identities=24%  Similarity=0.295  Sum_probs=191.1

Q ss_pred             HHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceecC--cc
Q 010882          134 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VW  206 (498)
Q Consensus       134 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~  206 (498)
                      .....+|.+.+.||+|+||.||++...  +..||+|++.....   .....+.+|+.+++.++||||+++++++.+  ..
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            334568999999999999999999885  57899999864221   223457889999999999999999998843  58


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||++||+|.+++..    ..++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       119 ~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            899999999999999842    247888899999999999999999   8999999999999999999999999999986


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccC----CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      ........       .....||+.|+|||++...    .++.++|||||||++|||++|.+||...+.............
T Consensus       192 ~~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~  264 (371)
T cd05622         192 MNKEGMVR-------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN  264 (371)
T ss_pred             cCcCCccc-------ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            64322111       1234599999999999754    378899999999999999999999987654332211111111


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCC---CCChhH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKS---RPELGK  399 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~---RP~~~~  399 (498)
                      .+.   ...+...+..+.+++..|+. +|..   ||++.+
T Consensus       265 ~~~---~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~e  300 (371)
T cd05622         265 SLT---FPDDNDISKEAKNLICAFLT-DREVRLGRNGVEE  300 (371)
T ss_pred             ccc---CCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHH
Confidence            110   00112356788999999997 4444   566655

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-38  Score=304.53  Aligned_cols=242  Identities=28%  Similarity=0.430  Sum_probs=191.1

Q ss_pred             cccccCceEEEEEEEC-CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCHHh
Q 010882          145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED  220 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL~~  220 (498)
                      +||+|+||.||+|... +..||+|.+...... ....+.+|+.+++.++||||++++++|.  +..++||||+++|+|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            5999999999999874 577999998754322 1346889999999999999999999984  35889999999999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccce
Q 010882          221 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC  300 (498)
Q Consensus       221 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  300 (498)
                      ++...  ...+++..+..++.+++.||.|||.   ++++||||||+||+++.++.+||+|||++..........      
T Consensus        82 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------  150 (250)
T cd05085          82 FLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------  150 (250)
T ss_pred             HHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc------
Confidence            88532  3458899999999999999999999   899999999999999999999999999987543322111      


Q ss_pred             eccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHH
Q 010882          301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL  379 (498)
Q Consensus       301 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  379 (498)
                       .....+++.|+|||++.+..++.++|||||||++|++++ |..||...............      .....+...+..+
T Consensus       151 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~  223 (250)
T cd05085         151 -SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG------YRMSCPQKCPDDV  223 (250)
T ss_pred             -CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCCHHH
Confidence             111234678999999998889999999999999999999 99999755433221111111      0111233456789


Q ss_pred             HHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          380 ANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       380 ~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      .+++.+|+..+|.+||++.+ +.+.|
T Consensus       224 ~~li~~~l~~~p~~Rp~~~~-l~~~l  248 (250)
T cd05085         224 YKVMQRCWDYKPENRPKFSE-LQKEL  248 (250)
T ss_pred             HHHHHHHcccCcccCCCHHH-HHHHh
Confidence            99999999999999999988 54443

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-38  Score=313.57  Aligned_cols=243  Identities=24%  Similarity=0.313  Sum_probs=192.3

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      |...+.||+|+||+||+|.+.  +..||+|.+......   ....+.+|+.+++.++|+||+.+++++.  +..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556678999999999999884  678999998754322   2345778999999999999999998873  468899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++... ....+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999999888533 23469999999999999999999999   8999999999999999999999999999875432211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH-hCccccccCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-TGKLKNLLDPLAGDW  371 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~  371 (498)
                               .....|+..|+|||++.+..++.++|+|||||++|+|+||.+||........... .......    ...+
T Consensus       158 ---------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~----~~~~  224 (285)
T cd05632         158 ---------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET----EEVY  224 (285)
T ss_pred             ---------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc----cccc
Confidence                     1223589999999999988999999999999999999999999976443211111 1111111    1123


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +...+..+.+|+..||+.+|.+||++.+
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~  252 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQE  252 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence            3345567899999999999999999543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=318.86  Aligned_cols=247  Identities=24%  Similarity=0.271  Sum_probs=188.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|.+.+.||+|+||.||++...  +..||||++....   ......+..|+.++..++||||++++++|.  +..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            6888899999999999999884  6789999987422   122345889999999999999999999884  45899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++...  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          82 YYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             cCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            99999999999532  3468899999999999999999999   899999999999999999999999999987654332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      ...       .....||+.|+|||++..     ..++.++|||||||++|+|++|+.||...+..............+. 
T Consensus       157 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-  228 (331)
T cd05597         157 TVQ-------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ-  228 (331)
T ss_pred             Ccc-------ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc-
Confidence            111       112358999999999973     4578899999999999999999999976543322111111111111 


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcc--cCCCCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMS--RKSRPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~--p~~RP~~~~  399 (498)
                       ........+..+.+++.+|+..+  +..||++.+
T Consensus       229 -~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~  262 (331)
T cd05597         229 -FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQD  262 (331)
T ss_pred             -CCCccCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence             00111124567889999877543  333677766

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-38  Score=307.21  Aligned_cols=243  Identities=24%  Similarity=0.341  Sum_probs=197.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      +|.+.+.||.|+||.||++...  +..||+|.+.... ....+.+..|+.+++.++||||+++++++.  +..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677789999999999999874  6789999986432 233467889999999999999999999884  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++... ....++......++.+++.||.|||+   ++++|+||||+||+++.++.++|+|||++.........
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999988532 23458899999999999999999999   89999999999999999999999999998765432211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH--HhCccccccCCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGDW  371 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~  371 (498)
                              .....|++.|+|||++.+..++.++||||||+++|+|++|.+||...+......  ..+...        ..
T Consensus       157 --------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~  220 (255)
T cd08219         157 --------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--------PL  220 (255)
T ss_pred             --------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--------CC
Confidence                    122358999999999998889999999999999999999999998655433221  111111        12


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      |...+..+.+++.+||+.+|.+||++.+++
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il  250 (255)
T cd08219         221 PSHYSYELRSLIKQMFKRNPRSRPSATTIL  250 (255)
T ss_pred             CcccCHHHHHHHHHHHhCCcccCCCHHHHh
Confidence            334556789999999999999999998843

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-38  Score=324.04  Aligned_cols=245  Identities=21%  Similarity=0.281  Sum_probs=190.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      ..+|...+.||+|+||.||++...  +..||||++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999874  6789999987542  2234567899999999999999999998732        


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            36899999965 6777763     247888999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----C--
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G--  358 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~--  358 (498)
                      +.......         .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+........    +  
T Consensus       174 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  244 (364)
T cd07875         174 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  244 (364)
T ss_pred             cccCCCCc---------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            86543211         12345899999999999999999999999999999999999999765432211100    0  


Q ss_pred             --------------------cc---------ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 --------------------KL---------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 --------------------~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                          ..         .....+.....+......+.+|+.+||..||.+||++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e  314 (364)
T cd07875         245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE  314 (364)
T ss_pred             CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence                                00         000000001111123457899999999999999999988

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.9e-39  Score=312.55  Aligned_cols=233  Identities=26%  Similarity=0.407  Sum_probs=180.7

Q ss_pred             cccccCceEEEEEEEC--------------------------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeee
Q 010882          145 KIGEGGYGSIYKGLLR--------------------------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL  198 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l  198 (498)
                      .||+|+||.||+|...                          ...|++|++..........|..|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999742                          13589998865433334568889999999999999999


Q ss_pred             eceec--CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC--
Q 010882          199 VGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF--  274 (498)
Q Consensus       199 ~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~--  274 (498)
                      +|+|.  ...++||||+++|+|..++..  ....+++..+..++.|++.||.|||+   ++|+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence            99984  457899999999999999853  23468899999999999999999999   8999999999999997644  


Q ss_pred             -----ceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHH-hCCCCCCC
Q 010882          275 -----VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLL-TGRPALGI  347 (498)
Q Consensus       275 -----~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tG~~pf~~  347 (498)
                           .+|++|||++......            ....++..|+|||.+.+ ..++.++|||||||++|||+ +|.+||..
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             cCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence                 4799999987643221            12247889999998876 56899999999999999995 79999975


Q ss_pred             cHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHH
Q 010882          348 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR  403 (498)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~  403 (498)
                      .............        ...|......+.+++.+||+.+|.+||++.+ ++.
T Consensus       225 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~-il~  271 (274)
T cd05076         225 RTPSEKERFYEKK--------HRLPEPSCKELATLISQCLTYEPTQRPSFRT-ILR  271 (274)
T ss_pred             cChHHHHHHHHhc--------cCCCCCCChHHHHHHHHHcccChhhCcCHHH-HHH
Confidence            4332211100000        0112223357899999999999999999988 443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.3e-38  Score=311.95  Aligned_cols=245  Identities=24%  Similarity=0.367  Sum_probs=194.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~  213 (498)
                      +.|.+.+.||.|+||.||+|...  +..|++|++..........+.+|+.+++.++||||+++++++  ....++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            46888889999999999999884  578999998765444456788999999999999999999987  34689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|..++...  ...+++..+..++.|++.||.|||.   .+++||||||+||+++.++.+||+|||++.........
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            999998887432  3468999999999999999999999   89999999999999999999999999998754322111


Q ss_pred             CCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                              .....|++.|+|||++.+     ..++.++|||||||++|+|+||.+||...+............   .+. 
T Consensus       167 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~-  234 (292)
T cd06644         167 --------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPT-  234 (292)
T ss_pred             --------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC---Ccc-
Confidence                    122348899999999853     456789999999999999999999997654433222211110   010 


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...+...+..+.+++.+||..+|++||++.+
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  265 (292)
T cd06644         235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQ  265 (292)
T ss_pred             CCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence            1112334567899999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.2e-38  Score=308.06  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=184.3

Q ss_pred             cccccCceEEEEEEEC----CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gs  217 (498)
                      .||+|+||.||+|...    ...+|+|.+...... ....|.+|+.+++.++||||++++|+|.  ...++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            5999999999999753    246888887643322 2346789999999999999999999884  45899999999999


Q ss_pred             HHhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          218 LEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       218 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |.+++.....  ...+++.....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-  157 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI-  157 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence            9999964322  2335677888999999999999999   899999999999999999999999999987543221110 


Q ss_pred             CccceeccCCCCCCCcCChhhhcc-------CCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                           ......+++.|+|||++..       ..++.++|||||||++|||++ |.+||............. .....+..
T Consensus       158 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~  231 (269)
T cd05042         158 -----TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV-REQDIKLP  231 (269)
T ss_pred             -----ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-hccCccCC
Confidence                 0122346778999999753       356789999999999999999 788987554322111110 00111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      ....+...+..+.+++..|+ .+|.+||++.+ |.+.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~-v~~~l  267 (269)
T cd05042         232 KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE-VHELL  267 (269)
T ss_pred             CCcccccCCHHHHHHHHHHh-cCcccccCHHH-HHHHh
Confidence            12233345677888999998 59999999988 65554

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-38  Score=312.29  Aligned_cols=260  Identities=26%  Similarity=0.425  Sum_probs=196.8

Q ss_pred             cCCCCCCcccccCceEEEEEEE------CCeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceecC----cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~  206 (498)
                      ..|...+.||+|+||.||.+.+      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+    ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3567788999999999999875      25679999987543 2234578999999999999999999998843    47


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||++|++|.+++...  ...+++..+..++.+++.||.|||+   +|++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998532  2358999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH-HHHH--hC--c--
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALD--TG--K--  359 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~-~~~~--~~--~--  359 (498)
                      +.......     .......|+..|+|||++.+..++.++|||||||++|+|+||+.|+....... ....  .+  .  
T Consensus       159 ~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05079         159 IETDKEYY-----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT  233 (284)
T ss_pred             cccCccce-----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence            64332110     11123447788999999988889999999999999999999887653211000 0000  00  0  


Q ss_pred             -c-ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          360 -L-KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       360 -~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                       . ....+......+...+..+.+++.+||+.+|.+||++.+ ++..|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-il~~l~~~  283 (284)
T cd05079         234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQN-LIEGFEAI  283 (284)
T ss_pred             HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHH-HHHHHHhh
Confidence             0 000000011122335678999999999999999999988 66666543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=306.34  Aligned_cols=248  Identities=29%  Similarity=0.364  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .+|...+.||.|+||.||+|...  +..+++|++..........+.+|+.++++++||||++++|++.  ...+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            46888889999999999999874  5789999998665555678999999999999999999999873  4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++...  ...++...+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++.........
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            999999988532  2568999999999999999999999   89999999999999999999999999998765432211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccC---CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                              .....|+..|+|||.+.+.   .++.++|||||||++|+|+||.+||...+..........  ..+.+....
T Consensus       158 --------~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~  227 (262)
T cd06613         158 --------RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK--SNFPPPKLK  227 (262)
T ss_pred             --------cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCcccc
Confidence                    1223588999999999876   788999999999999999999999976543332221111  001111111


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+...+..+.+++.+||..+|..||++.++
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  257 (262)
T cd06613         228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKL  257 (262)
T ss_pred             chhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence            233456789999999999999999999883

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-38  Score=314.15  Aligned_cols=244  Identities=25%  Similarity=0.371  Sum_probs=198.8

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .+|...+.||.|+||.||+|..  .+..||+|.+........+.+.+|+.+++.++||||++++++|.  +..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5788889999999999999987  47889999997665555667889999999999999999999884  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++..    ..+++..+..++.+++.||.|||+   .+++||||||+|||++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999999842    357889999999999999999999   89999999999999999999999999998765433211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              .....|++.|+|||.+.+..++.++|||||||++|+|+||.+||...+............    ......|.
T Consensus       172 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~----~~~~~~~~  239 (297)
T cd06656         172 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG----TPELQNPE  239 (297)
T ss_pred             --------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC----CCCCCCcc
Confidence                    122348899999999998889999999999999999999999997654332211111000    00111234


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+..+.+++.+||..+|.+||++.++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKEL  266 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            455778999999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-38  Score=312.90  Aligned_cols=242  Identities=24%  Similarity=0.326  Sum_probs=190.5

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      |+..+.||+|+||.||++...  +..||||.+.......   ...+..|+.+++.++|+||+.+++.+.  +..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566778999999999999885  6789999987543322   235778999999999999999999874  468899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++||+|.+++.... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999885332 2458999999999999999999999   8999999999999999999999999999876543221


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                               .....||+.|+|||++.+..++.++|||||||++|+|++|++||...........   ...........++
T Consensus       158 ---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~  225 (285)
T cd05630         158 ---------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEVQEEYS  225 (285)
T ss_pred             ---------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhhhhhhcC
Confidence                     1223589999999999998999999999999999999999999975321100000   0000010111123


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ...+..+.+|+..||+.+|.+||+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~R~s~  250 (285)
T cd05630         226 EKFSPDARSLCKMLLCKDPKERLGC  250 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHccCC
Confidence            3455678999999999999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-39  Score=296.09  Aligned_cols=245  Identities=27%  Similarity=0.443  Sum_probs=199.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC----Ch----hhHHHHHHHHHcC-CCCCeeeeeceecC-
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ----GP----SEFQQEIDILSKI-RHPNLVTLVGACPE-  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~----~~----~~~~~E~~il~~l-~hpniv~l~g~~~~-  204 (498)
                      -.+|.+.+.||+|..++|.++..+  +..+|+|++......    ..    +.-.+|+.||+++ .||||+.+.+++.. 
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            346788888999999999988774  678999988654321    12    2356899999998 59999999999854 


Q ss_pred             -cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          205 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       205 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                       ..++|+|.|+.|.|.|+|   .....+++....+|+.++..|+.|||.   ++||||||||+|||+|.+.++||+|||+
T Consensus        96 sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             chhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence             478999999999999999   455679999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhcc------CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--H
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--L  355 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~  355 (498)
                      |..+..+..-         ....|||+|+|||.+.-      .+|+..+|+||+|||||.|+.|.|||........+  +
T Consensus       170 a~~l~~GekL---------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I  240 (411)
T KOG0599|consen  170 ACQLEPGEKL---------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI  240 (411)
T ss_pred             eeccCCchhH---------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence            9987765421         22349999999998842      46899999999999999999999999766554332  3


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ..|+..    ...+.|. +.+....+||.+||+.||.+|.+..+.+
T Consensus       241 meGkyq----F~speWa-dis~~~KdLIsrlLqVdp~~Ritake~L  281 (411)
T KOG0599|consen  241 MEGKYQ----FRSPEWA-DISATVKDLISRLLQVDPTKRITAKEAL  281 (411)
T ss_pred             Hhcccc----cCCcchh-hccccHHHHHHHHHeeCchhcccHHHHh
Confidence            333332    2233343 4667899999999999999999998843

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-38  Score=315.69  Aligned_cols=249  Identities=23%  Similarity=0.343  Sum_probs=190.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|...+.||+|+||.||+|...  +..||+|.+...... ....+.+|+.++++++||||+++++++.  +..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888889999999999999874  578999998754332 2346789999999999999999999984  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++ +|.+++...  ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 888877432  3458889999999999999999999   8999999999999999999999999999875433221


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc---------ccc
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------LKN  362 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~---------~~~  362 (498)
                      .        .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+..........         +..
T Consensus       160 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07872         160 T--------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG  231 (309)
T ss_pred             c--------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence            1        122357999999999865 4688999999999999999999999975443221110000         000


Q ss_pred             c--------cC-CCCC-----CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 L--------LD-PLAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 ~--------~~-~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .        .+ +...     ......+..+.+++.+||..+|.+||++.++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  283 (309)
T cd07872         232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA  283 (309)
T ss_pred             hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence            0        00 0000     0011235678899999999999999999883

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-38  Score=322.97  Aligned_cols=247  Identities=20%  Similarity=0.276  Sum_probs=190.6

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC-------
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~-------  204 (498)
                      ..++|...+.||+|+||.||++...  +..||||++......  ....+.+|+.+++.++||||+++++++..       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468999999999999999999874  678999998754322  23567789999999999999999998732       


Q ss_pred             -cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          205 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       205 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                       ..++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence             36899999965 6766663     247888999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----C-
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G-  358 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~-  358 (498)
                      ++.......         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........    + 
T Consensus       166 ~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (355)
T cd07874         166 ARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_pred             cccCCCccc---------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            986533211         12335899999999999989999999999999999999999999764432211000    0 


Q ss_pred             -----------ccccccC-------------------CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 -----------KLKNLLD-------------------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 -----------~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                 .....++                   +.....+...+..+.+|+.+||..||.+||++.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el  308 (355)
T cd07874         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA  308 (355)
T ss_pred             CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence                       0000000                   00011122234678999999999999999999883

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=325.92  Aligned_cols=246  Identities=26%  Similarity=0.394  Sum_probs=207.3

Q ss_pred             CCCCcccccCceEEEEEEECC-----eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEEeeC
Q 010882          141 DPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEYL  213 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~E~~  213 (498)
                      ...++||+|.||+|++|.|+.     -.||||.+...... ...+|.+|+.+|.+|+|||+++|||+.-+ ...+|||++
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELa  192 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELA  192 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhc
Confidence            345679999999999999952     46999999877655 56789999999999999999999999864 578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      +.|||.+.|+. .....|.......++.|||.|+.||.+   +++|||||...|+||.....+||+||||.+.+..+...
T Consensus       193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999986 566778888999999999999999999   89999999999999999999999999999987765422


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      -     .......-.+.|+|||.+....++.+||||+|||++|||+| |..||.+....+.+....      +...-.-|
T Consensus       269 Y-----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD------~~erLpRP  337 (1039)
T KOG0199|consen  269 Y-----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID------AGERLPRP  337 (1039)
T ss_pred             e-----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc------ccccCCCC
Confidence            1     11223335679999999999999999999999999999999 789998877665443322      11222357


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ..+++.+++++..||..+|.+||++..++
T Consensus       338 k~csedIY~imk~cWah~paDRptFsair  366 (1039)
T KOG0199|consen  338 KYCSEDIYQIMKNCWAHNPADRPTFSAIR  366 (1039)
T ss_pred             CCChHHHHHHHHHhccCCccccccHHHHH
Confidence            77899999999999999999999999844

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-38  Score=316.97  Aligned_cols=257  Identities=24%  Similarity=0.405  Sum_probs=202.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC---------CeEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeeceec--C
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E  204 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~  204 (498)
                      .+|.+.+.||+|+||.||++...         ...||+|.+..... .....+.+|+.+++++ +||||++++++|.  +
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            36888899999999999999752         13689998875322 2245788999999999 7999999999984  3


Q ss_pred             cceEEEeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD  271 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~  271 (498)
                      ..++||||+++|+|.+++....             ....+++.+++.++.|++.||.|||.   +|++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence            5789999999999999986432             22358889999999999999999999   8999999999999999


Q ss_pred             CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH
Q 010882          272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE  350 (498)
Q Consensus       272 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~  350 (498)
                      .++.+||+|||+++.........      ......++..|+|||++.+..++.++|||||||++|||++ |.+||.....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             CCCcEEECCcccceecccccccc------cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999998654322110      0122235678999999999899999999999999999999 8899975443


Q ss_pred             HHH--HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          351 VQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       351 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ...  .+..+        .....+...+..+.+++.+||+.+|.+||++.+ ++..|+.+....
T Consensus       243 ~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e-ll~~l~~~~~~~  297 (334)
T cd05100         243 EELFKLLKEG--------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQ-LVEDLDRVLTVT  297 (334)
T ss_pred             HHHHHHHHcC--------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHH-HHHHHHHHhhhc
Confidence            222  11111        111123344578999999999999999999988 777888776544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=310.35  Aligned_cols=246  Identities=28%  Similarity=0.382  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .+|.+.+.||.|+||.||+|.+.  +..||+|.+........+.+..|+.++++++||||+++++.+.  ...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46788889999999999999884  6789999987654444567889999999999999999999884  4678999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++...  ..++++..+..++.+++.||.|||+   .+|+||||||+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            999999998532  3468999999999999999999999   8999999999999999999999999999875433211 


Q ss_pred             CCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                             ......||+.|+|||.+..     ..++.++|||||||++|+|++|++||...+............   .+ .
T Consensus       159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-~  227 (280)
T cd06611         159 -------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PP-T  227 (280)
T ss_pred             -------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC---CC-C
Confidence                   1123358999999999853     346789999999999999999999997665433222211110   00 0


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ...+...+..+.+++..||+.+|.+||++.++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  259 (280)
T cd06611         228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL  259 (280)
T ss_pred             cCCcccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            11233345689999999999999999999883

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.4e-38  Score=307.60  Aligned_cols=246  Identities=25%  Similarity=0.454  Sum_probs=193.3

Q ss_pred             cccccCceEEEEEEECC--------eEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          145 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~--------~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .||+|+||.||+|....        ..||||.+.... ......+.+|+.+++.++||||++++++|.  +..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            59999999999998742        569999876543 233567889999999999999999999884  4689999999


Q ss_pred             CCCCHHhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-----ceeEeecccc
Q 010882          214 PNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-----VSKLSDFGIS  284 (498)
Q Consensus       214 ~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-----~~kl~DFGla  284 (498)
                      ++|+|.+++....    ....+++..++.++.+++.||.|||+   .+++|+||||+||+++.++     .+||+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999986422    23458889999999999999999998   8899999999999999877     8999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      ...........      .....++..|+|||++.++.++.++|||||||++|+|+| |..||...+..........    
T Consensus       159 ~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----  228 (269)
T cd05044         159 RDIYKSDYYRK------EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA----  228 (269)
T ss_pred             ccccccccccc------CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc----
Confidence            86543321111      122346789999999999999999999999999999998 9999975543322211110    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                        ......+...+..+.+++.+||..+|.+||++.+ +.+.|.
T Consensus       229 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~  268 (269)
T cd05044         229 --GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDR-IQEILQ  268 (269)
T ss_pred             --CCccCCcccchHHHHHHHHHHcCCCcccCCCHHH-HHHHHh
Confidence              0111223445678999999999999999999988 655553

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8e-39  Score=348.33  Aligned_cols=251  Identities=22%  Similarity=0.348  Sum_probs=195.2

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec----Ccce
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT  207 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~  207 (498)
                      ...+|.+...||+|+||+||++.+.  +..||+|++......  ....|..|+.+|+.|+|||||+++++|.    ..++
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4457999999999999999999884  577999998754332  2456889999999999999999999872    3478


Q ss_pred             EEEeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCcccCCCCCCcEEEcC----------
Q 010882          208 LVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKP----HSIVHGDLKPANILLDA----------  272 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivHrDlkp~NiLl~~----------  272 (498)
                      |||||+++|+|.++|... .....+++..++.|+.||+.||.|||...+    .+||||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999998542 223569999999999999999999998432    45999999999999964          


Q ss_pred             -------CCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHHHHHHhCCC
Q 010882          273 -------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRP  343 (498)
Q Consensus       273 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~  343 (498)
                             .+.+||+|||++..+.....         .....||+.|+|||++.+  ..++.++||||||||||+|+||.+
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESM---------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccccc---------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                   23589999999986543221         122358999999999864  458899999999999999999999


Q ss_pred             CCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          344 ALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ||.........+...  .......    ....+..+.+||..||..+|.+||++.+++
T Consensus       242 PF~~~~~~~qli~~l--k~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL  293 (1021)
T PTZ00266        242 PFHKANNFSQLISEL--KRGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQCL  293 (1021)
T ss_pred             CCCcCCcHHHHHHHH--hcCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence            997554433222211  0000000    112357899999999999999999998843

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-38  Score=304.24  Aligned_cols=252  Identities=30%  Similarity=0.508  Sum_probs=200.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ..+|.+.+.||+|+||.||+|... +..||||.+.... .....+..|+.++++++||||+++++++.  ...++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            357888899999999999999875 4679999987543 34567999999999999999999999884  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++... ....+++..+..++.+++.||.|||.   ++++|+||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            999999999643 23468999999999999999999999   89999999999999999999999999998866432111


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      .       .....++..|+|||.+.+..++.++|||||||++|+|+| |+.||...............      .....+
T Consensus       160 ~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~------~~~~~~  226 (261)
T cd05034         160 A-------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG------YRMPRP  226 (261)
T ss_pred             h-------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------CCCCCC
Confidence            0       112235678999999998889999999999999999999 99999654432211111100      001122


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      ...+..+.+++.+|+..+|.+||++.+ +...|+.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~-l~~~l~~  260 (261)
T cd05034         227 PNCPEELYDLMLQCWDKDPEERPTFEY-LQSFLED  260 (261)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHH-HHHHHhc
Confidence            334578999999999999999999988 7666653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.6e-38  Score=305.16  Aligned_cols=249  Identities=29%  Similarity=0.500  Sum_probs=199.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEEeeCCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEYLPN  215 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~E~~~~  215 (498)
                      .+|.+.+.||+|+||.||+|... +..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.+ ..++||||+++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK   84 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence            46888899999999999999874 5679999887532 234678899999999999999999998744 57899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.+++... ....+++..+..++.+++.||.|||+   .|++||||||+||+++.++.+||+|||++.........  
T Consensus        85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  158 (260)
T cd05073          85 GSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT--  158 (260)
T ss_pred             CcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc--
Confidence            9999999643 23458888999999999999999999   89999999999999999999999999999765432211  


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCCCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  372 (498)
                           ......++..|+|||++....++.++|+|||||++|+++| |.+||...+..  ...+..+..        ...+
T Consensus       159 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~~  225 (260)
T cd05073         159 -----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------MPRP  225 (260)
T ss_pred             -----cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC--------CCCc
Confidence                 1122346778999999998889999999999999999999 99999764432  222222110        1112


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      ...+..+.+++.+|++.+|.+||++.+ +...|+.
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~-l~~~L~~  259 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEY-IQSVLDD  259 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHH-HHHHHhc
Confidence            234578999999999999999999988 7666653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-38  Score=311.75  Aligned_cols=241  Identities=26%  Similarity=0.355  Sum_probs=188.1

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      +|...+.||+|+||.||+|.+  .+..||+|++..... .....+.+|+.++++++||||++++++|.  +..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            567778999999999999987  467899999865422 22356889999999999999999999884  4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|..+.       .+++..+..++.+++.||.|||+   .||+|+||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            999996543       36788899999999999999999   899999999999999999999999999997654321  


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH-HHhCccccccCCCCCCC-
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-LDTGKLKNLLDPLAGDW-  371 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~-  371 (498)
                              .....||..|+|||++.+..++.++|||||||++|+|+||+.||......... ..........+...... 
T Consensus       150 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (279)
T cd06619         150 --------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP  221 (279)
T ss_pred             --------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC
Confidence                    12335899999999999889999999999999999999999999642210000 00000000001111111 


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ....+..+.+++.+|++.+|..||++.+
T Consensus       222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~e  249 (279)
T cd06619         222 VGQFSEKFVHFITQCMRKQPKERPAPEN  249 (279)
T ss_pred             CCcCCHHHHHHHHHHhhCChhhCCCHHH
Confidence            1124567899999999999999999987

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=306.86  Aligned_cols=241  Identities=28%  Similarity=0.363  Sum_probs=196.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      +|+..+.||.|+||.||+|...  +..||+|++.... ......+.+|+.+++.++||||+++++++.  ...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5777888999999999999884  6889999987543 223456889999999999999999999874  3578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++...    ++++..+..++.+++.||.|||+   ++++||||+|+||+++.++.++|+|||++.........
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence            999999998532    78999999999999999999999   89999999999999999999999999999876543211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              .....|++.|+|||++.+..++.++|||||||++|+|+||++||...+.........   ....+   ..+.
T Consensus       155 --------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~---~~~~  220 (274)
T cd06609         155 --------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP---KNNPP---SLEG  220 (274)
T ss_pred             --------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh---hcCCC---CCcc
Confidence                    123458899999999998889999999999999999999999997654332221111   10111   1111


Q ss_pred             H-HHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          374 V-QAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       374 ~-~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      . .+..+.+++.+||..+|.+||++.++
T Consensus       221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~i  248 (274)
T cd06609         221 NKFSKPFKDFVSLCLNKDPKERPSAKEL  248 (274)
T ss_pred             cccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence            2 45679999999999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=318.91  Aligned_cols=257  Identities=28%  Similarity=0.481  Sum_probs=203.6

Q ss_pred             CCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCC-hhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP  214 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~  214 (498)
                      ...+.++||+|-||+|..+...+ ..||||+++...... ...|.+|+.+|.+|+||||+.|+|+|  ++..++|+||++
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            44567789999999999998876 899999999876555 47899999999999999999999999  567899999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|..+|..... +.+....-.+|+.||+.|++||.+   .++|||||.+.|+|+|.++++||+|||+++.+....+..
T Consensus       619 nGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  619 NGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             cCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            9999999965432 223455667899999999999999   789999999999999999999999999999655443221


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh--CCCCCCCcHHHHHHHHhCccccccCC-CCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYALDTGKLKNLLDP-LAGDW  371 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  371 (498)
                            .....+-.+.|||||.+..++++.+||||+|||+|||+++  ...||.....-+..-+.+.+..--.. .....
T Consensus       695 ------vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  695 ------VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             ------eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence                  1123345689999999999999999999999999999876  67888654433322222221111000 11234


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      |..++..+.+++.+||..+-.+||++.+ +...|.
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~-lh~~lq  802 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQ-LHLFLQ  802 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHH-HHHHHH
Confidence            6678889999999999999999999998 444443

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.5e-38  Score=304.41  Aligned_cols=246  Identities=26%  Similarity=0.397  Sum_probs=194.7

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC-----ChhhHHHHHHHHHcCCCCCeeeeeceec----Ccc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP----EVW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~  206 (498)
                      .+|...+.||+|+||.||+|..  .+..||+|.+......     ....+.+|+.+++.++||||+++++++.    ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3788889999999999999987  4678999988654321     1245788999999999999999999873    346


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      +++|||+++++|.+++..   ...+++..+..++.+++.||.|||+   .+|+||||+|+||+++.++.+||+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999843   3458899999999999999999998   8999999999999999999999999999876


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      .........     ......|+..|+|||++.+..++.++|||||||++|+|+||++||.............     ..+
T Consensus       156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-----~~~  225 (266)
T cd06651         156 LQTICMSGT-----GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-----TQP  225 (266)
T ss_pred             cccccccCC-----ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-----cCC
Confidence            532211110     0122348899999999998889999999999999999999999997554333222111     111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .....|...+..+..++ .||..+|.+||++.++
T Consensus       226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~ei  258 (266)
T cd06651         226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEEL  258 (266)
T ss_pred             CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHH
Confidence            12334555667788888 7888999999999883

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.7e-38  Score=303.29  Aligned_cols=247  Identities=26%  Similarity=0.493  Sum_probs=195.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      .+|.+.+.||.|+||.||+|.+. +..+|+|.+.... .....|..|++++++++||||+++++++.  ...++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35677788999999999999875 6789999886443 33467899999999999999999999984  36789999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++...  ...+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            99999998532  3468899999999999999999999   899999999999999999999999999987654322110


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                             .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...................      .|.
T Consensus       158 -------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~  224 (256)
T cd05112         158 -------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY------KPR  224 (256)
T ss_pred             -------cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC------CCC
Confidence                   112235678999999998889999999999999999998 999997544322111111111111      122


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHHHHHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRV  404 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~  404 (498)
                      ..+..+.+++.+||+.+|.+||++.+ +.+.
T Consensus       225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~-~l~~  254 (256)
T cd05112         225 LASQSVYELMQHCWKERPEDRPSFSL-LLHQ  254 (256)
T ss_pred             CCCHHHHHHHHHHcccChhhCCCHHH-HHHh
Confidence            24578999999999999999999988 5443

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-38  Score=307.85  Aligned_cols=253  Identities=24%  Similarity=0.413  Sum_probs=201.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--C----eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV  209 (498)
                      .+|...+.||+|+||.||+|.+.  +    ..||+|.+...... ....+.+|+.++++++||||++++++|. ...++|
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v   86 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI   86 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence            46778889999999999999873  2    35899988755432 2356889999999999999999999884 468899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++...  ...+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++....
T Consensus        87 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          87 TQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            9999999999999532  3458999999999999999999999   8999999999999999999999999999987653


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~  366 (498)
                      .....      ......++..|+|||.+....++.++|||||||++||++| |++||.......  ..+..+.       
T Consensus       162 ~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------  228 (279)
T cd05057         162 DEKEY------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-------  228 (279)
T ss_pred             cccce------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-------
Confidence            22110      0112234678999999988889999999999999999999 999997654322  2222111       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                       ....|...+..+.+++.+||..+|..||++.+ +...|+.+..
T Consensus       229 -~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~-l~~~l~~~~~  270 (279)
T cd05057         229 -RLPQPPICTIDVYMVLVKCWMIDAESRPTFKE-LINEFSKMAR  270 (279)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHH-HHHHHHHHHh
Confidence             11123334567899999999999999999998 7777777643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.2e-38  Score=314.61  Aligned_cols=194  Identities=25%  Similarity=0.394  Sum_probs=157.3

Q ss_pred             CCcccccCceEEEEEEEC----CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec----CcceEEEeeCC
Q 010882          143 SLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYEYLP  214 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV~E~~~  214 (498)
                      ..+||+|+||+||+|...    +..||+|.+....  ....+.+|+.+|++++||||+++++++.    ...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            457999999999999863    3679999986542  2346789999999999999999999873    34789999985


Q ss_pred             CCCHHhhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE----cCCCceeEeecccc
Q 010882          215 NGSLEDRLSCKD------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGIS  284 (498)
Q Consensus       215 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGla  284 (498)
                       ++|.+++....      ....+++..+..++.|++.||.|||+   +||+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58887764221      22358899999999999999999999   899999999999999    45679999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                      +.+.......     .......||+.|+|||++.+. .++.++|||||||++|+|+||++||..
T Consensus       160 ~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccc-----cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            8764332111     111334689999999999774 589999999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-38  Score=310.29  Aligned_cols=246  Identities=28%  Similarity=0.407  Sum_probs=194.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~  213 (498)
                      +|++.+.||+|+||.||++...  +..||+|.+..... .....+.+|+.++++++||||+++++++  ....++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5777889999999999999985  68899998865322 2235788999999999999999999987  34688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|..++........+++..+..++.+++.||.|||+.  .+|+||||||+||+++.++.+||+|||++..+....  
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            9999999886433344789999999999999999999962  489999999999999999999999999987653221  


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccC------CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                              .....|++.|+|||.+.+.      .++.++|||||||++|+|+||+.||...........   +.......
T Consensus       158 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~  226 (286)
T cd06622         158 --------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---LSAIVDGD  226 (286)
T ss_pred             --------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---HHHHhhcC
Confidence                    1223488899999998654      357899999999999999999999965332111100   11111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ....+...+..+.+++.+||+.+|.+||++.+
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  258 (286)
T cd06622         227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQ  258 (286)
T ss_pred             CCCCCcccCHHHHHHHHHHcccCcccCCCHHH
Confidence            22234456788999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=327.59  Aligned_cols=246  Identities=23%  Similarity=0.314  Sum_probs=189.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC----CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ..+|.+.+.||.|+||.||++...    +..||+|.+...     ..+.+|+.+|+.++||||+++++++.  ...++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            346999999999999999998763    367999987542     34578999999999999999999884  4688999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+. ++|.+++   .....+++..++.|+.|++.||.|||+   +||+||||||+|||++.++.+||+|||++......
T Consensus       166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9995 6888888   334579999999999999999999999   89999999999999999999999999999765443


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH------HHHHHHh-C--cc-
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDT-G--KL-  360 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~------~~~~~~~-~--~~-  360 (498)
                      .....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ....+.. +  .. 
T Consensus       239 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        239 PDTPQ------CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             ccccc------ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence            21111      1234699999999999999999999999999999999999999854221      1110000 0  00 


Q ss_pred             -------------ccccCCCCCCC--C-----HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          361 -------------KNLLDPLAGDW--P-----FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       361 -------------~~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                   ..........+  |     ...+..+.+++.+||..+|.+||++.++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~  372 (392)
T PHA03207        313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI  372 (392)
T ss_pred             cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH
Confidence                         00000000001  1     1134578899999999999999999883

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.7e-39  Score=309.60  Aligned_cols=235  Identities=26%  Similarity=0.391  Sum_probs=184.5

Q ss_pred             cccccCceEEEEEEECC---------eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          145 KIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .||.|+||.||+|....         ..||+|.+........+.+..|+.+++.++||||+++++++.  +..++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            59999999999998632         348888876544344567889999999999999999999884  4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc--------eeEeeccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--------SKLSDFGISR  285 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~--------~kl~DFGla~  285 (498)
                      ++|+|.+++...  ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.        ++++|||++.
T Consensus        82 ~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          82 KFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999533  2368899999999999999999999   89999999999999987765        6999999876


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhC-CCCCCCcHHHHHHHHhCccccc
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      .....            ....|++.|+|||++.+. .++.++|||||||++|+|++| .+||..............    
T Consensus       157 ~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~----  220 (258)
T cd05078         157 TVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED----  220 (258)
T ss_pred             ccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc----
Confidence            54321            122478899999999874 578999999999999999998 467655433221111110    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                          ....|......+.+++.+||+.+|.+||++.+ +++.|
T Consensus       221 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-il~~l  257 (258)
T cd05078         221 ----RHQLPAPKWTELANLINQCMDYEPDFRPSFRA-IIRDL  257 (258)
T ss_pred             ----cccCCCCCcHHHHHHHHHHhccChhhCCCHHH-HHHhc
Confidence                11123334467999999999999999999998 54443

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.8e-38  Score=308.87  Aligned_cols=257  Identities=27%  Similarity=0.353  Sum_probs=202.0

Q ss_pred             CChHHHHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceec-
Q 010882          128 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP-  203 (498)
Q Consensus       128 ~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~-  203 (498)
                      +.+.++..++++|.....||+|+||.||++...  +..+|+|++.... .....+..|+.++.++ +|||+++++++|. 
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            445666777889999999999999999999884  6789999986532 2345678899999999 8999999999873 


Q ss_pred             ------CcceEEEeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          204 ------EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       204 ------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                            ...++||||+++|+|.+++... .....+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence                  2478999999999999988532 234568999999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-----CCCCccchHhHHHHHHHHHhCCCCCCCcHHH
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKEV  351 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~~  351 (498)
                      ||+|||++.........        .....|+..|+|||.+...     .++.++|||||||++|+|++|++||......
T Consensus       168 kl~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             EEeecccchhccccccc--------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            99999998865432211        1223589999999998653     3688999999999999999999999765543


Q ss_pred             HHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          352 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..........   .+. ...+......+.+++.+||+.+|.+||++.++
T Consensus       240 ~~~~~~~~~~---~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i  284 (291)
T cd06639         240 KTLFKIPRNP---PPT-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHL  284 (291)
T ss_pred             HHHHHHhcCC---CCC-CCcccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence            3322211100   000 01122344679999999999999999999883

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-39  Score=323.65  Aligned_cols=237  Identities=26%  Similarity=0.333  Sum_probs=183.9

Q ss_pred             ccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcC---CCCCeeeeeceec--CcceEEEeeCCC
Q 010882          146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI---RHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l---~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      ||+|+||+||+|...  +..||||++......   ....+..|..++..+   +||||+.+++++.  +..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999884  688999998643221   123355677777665   6999999999884  458999999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|.+++.   ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.........  
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence            99999884   34568999999999999999999999   89999999999999999999999999998753322111  


Q ss_pred             CccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  372 (498)
                            .....||+.|+|||++.+. .++.++|||||||++|+|+||+.||...+....  .+..+..         .+|
T Consensus       153 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------~~~  217 (330)
T cd05586         153 ------TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV---------RFP  217 (330)
T ss_pred             ------ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC---------CCC
Confidence                  1234599999999998764 589999999999999999999999976543322  1111111         111


Q ss_pred             -HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          373 -FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       373 -~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                       ...+..+.+++.+||..+|.+||+....+.+++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll  251 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELK  251 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHh
Confidence             124577899999999999999997654333333

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-38  Score=304.00  Aligned_cols=233  Identities=28%  Similarity=0.459  Sum_probs=184.6

Q ss_pred             cccccCceEEEEEEECCe------------EEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEe
Q 010882          145 KIGEGGYGSIYKGLLRHM------------QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE  211 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E  211 (498)
                      .||+|+||.||+|.+...            .|++|.+...... ...|.+|+.+++.++||||++++|+|. ...++|||
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e   80 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE   80 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence            599999999999998532            3788887654332 578899999999999999999999874 46789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-------ceeEeecccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-------VSKLSDFGIS  284 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-------~~kl~DFGla  284 (498)
                      |+++|+|.+++....  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++       .+||+|||++
T Consensus        81 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          81 YVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             cCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999995332  268999999999999999999999   8999999999999999887       7999999998


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccC--CCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLK  361 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~  361 (498)
                      ......            ....++..|+|||++...  .++.++|||||||++|+|++ |..||...+.........   
T Consensus       156 ~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---  220 (259)
T cd05037         156 ITVLSR------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---  220 (259)
T ss_pred             cccccc------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---
Confidence            865431            122367889999999876  78999999999999999999 578886543221111000   


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHH
Q 010882          362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV  404 (498)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~  404 (498)
                         ..  ...+......+.+++.+||..+|.+||++.+ +++.
T Consensus       221 ---~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-il~~  257 (259)
T cd05037         221 ---DQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRA-ILRD  257 (259)
T ss_pred             ---cC--CCCCCCCchHHHHHHHHHhccChhhCCCHHH-HHHh
Confidence               00  0111122378999999999999999999988 5443

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.6e-38  Score=302.80  Aligned_cols=242  Identities=24%  Similarity=0.351  Sum_probs=196.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--C-cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--E-VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~-~~~lV~E  211 (498)
                      +|.+.+.||+|+||.||++...  +..||+|.+.....  .....+.+|+.++++++|||++++++.+.  + ..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4777889999999999999874  57899999865432  23456889999999999999999998874  2 3689999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++++|.+++... ....+++.++..++.+++.||.+||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998542 23468999999999999999999999   899999999999999999999999999998664322


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  369 (498)
                      ..        .....|++.|+|||++.+..++.++|||||||++|+|+||+.||...+....  ....+..        .
T Consensus       157 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~  220 (257)
T cd08223         157 DM--------ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--------P  220 (257)
T ss_pred             Cc--------cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------C
Confidence            11        1233589999999999999999999999999999999999999976543222  1222211        1


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+...+..+.+++.+|++.+|.+||++.++
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~  251 (257)
T cd08223         221 PMPKDYSPELGELIATMLSKRPEKRPSVKSI  251 (257)
T ss_pred             CCccccCHHHHHHHHHHhccCcccCCCHHHH
Confidence            2234456789999999999999999999883

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=311.15  Aligned_cols=299  Identities=25%  Similarity=0.389  Sum_probs=222.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHH----HHHHhhhhcccCCCCCCcCCCCChHHHHHhhcCCCCCCcccccCceEEEEEEE
Q 010882           84 LQNYKKEQDELQMERDKAVKEAE----ELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL  159 (498)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~  159 (498)
                      +..++++..++++++++..++..    ++++...+..+           .|.+-.....+|-...+||+|||+.||++.+
T Consensus       416 lgHLkKEEaeiqaElERLErvrnlHiRELKRi~NEdnS-----------QFkDHptLn~RYLlLhLLGrGGFSEVyKAFD  484 (775)
T KOG1151|consen  416 LGHLKKEEAEIQAELERLERVRNLHIRELKRIHNEDNS-----------QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFD  484 (775)
T ss_pred             HhhhhhhHHHHHHHHHHHHHHHHHHHHHHHhhcccchh-----------hhccCcchHHHHHHHHHhccccHHHHHHhcc
Confidence            34555666666666666554432    22222111111           2223333445677888999999999999987


Q ss_pred             --CCeEEEEEEecCCCCCC-------hhhHHHHHHHHHcCCCCCeeeeecee---cCcceEEEeeCCCCCHHhhhccCCC
Q 010882          160 --RHMQVAIKMLHPHSLQG-------PSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDN  227 (498)
Q Consensus       160 --~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~hpniv~l~g~~---~~~~~lV~E~~~~gsL~~~l~~~~~  227 (498)
                        ..+.||||+-.......       .+...+|.+|-+.|+||.||++|++|   .+.+|-|+|||+|-+|+.+|.   .
T Consensus       485 l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK---Q  561 (775)
T KOG1151|consen  485 LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK---Q  561 (775)
T ss_pred             cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHH---h
Confidence              46789999866443211       23466899999999999999999998   457899999999999999994   3


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc---CCCceeEeeccccccccccccCCCCccceeccC
Q 010882          228 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD  304 (498)
Q Consensus       228 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~  304 (498)
                      ...+++.+...|+.||+.||.||.... .+|||-||||.||||-   .-|.+||+||||++.+..+....... ......
T Consensus       562 hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdG-meLTSQ  639 (775)
T KOG1151|consen  562 HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDG-MELTSQ  639 (775)
T ss_pred             hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccc-eeeecc
Confidence            456889999999999999999999877 5899999999999995   44789999999999987765433222 223456


Q ss_pred             CCCCCCcCChhhhccC----CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHH
Q 010882          305 PKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA  380 (498)
Q Consensus       305 ~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  380 (498)
                      ..||++|++||++.-+    .++.++||||+|||+|.++.|+.||+.....+..+....+...-+...+.- +.++.+..
T Consensus       640 gAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K-PvVsseAk  718 (775)
T KOG1151|consen  640 GAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK-PVVSSEAK  718 (775)
T ss_pred             cCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC-CccCHHHH
Confidence            6799999999998654    478899999999999999999999997765555555444433322222222 34667889


Q ss_pred             HHHHHhhhcccCCCCChhH
Q 010882          381 NLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       381 ~li~~cl~~~p~~RP~~~~  399 (498)
                      .+|++||++.-++|.+..+
T Consensus       719 aFIRRCLaYRKeDR~DV~q  737 (775)
T KOG1151|consen  719 AFIRRCLAYRKEDRIDVQQ  737 (775)
T ss_pred             HHHHHHHHhhhhhhhhHHH
Confidence            9999999999999987665

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-38  Score=300.99  Aligned_cols=244  Identities=29%  Similarity=0.455  Sum_probs=193.0

Q ss_pred             cccccCceEEEEEEEC-CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCCCCCHHh
Q 010882          145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLED  220 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~~gsL~~  220 (498)
                      +||.|+||.||++.+. +..||+|.+...... ....+.+|++++++++||||+++++++.+  ..++||||+++++|.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            6999999999999885 788999988765433 34578999999999999999999998843  5789999999999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccce
Q 010882          221 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC  300 (498)
Q Consensus       221 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  300 (498)
                      ++...  ...+++..+..++.+++.||.|||+   ++++||||+|+|||++.++.+||+|||++...........     
T Consensus        82 ~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-----  151 (251)
T cd05041          82 FLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-----  151 (251)
T ss_pred             HHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-----
Confidence            98533  3468889999999999999999999   8999999999999999999999999999986542211111     


Q ss_pred             eccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHH
Q 010882          301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL  379 (498)
Q Consensus       301 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  379 (498)
                       .....++..|+|||.+.++.++.++|||||||++|+|+| |..||................      ....|...+..+
T Consensus       152 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~  224 (251)
T cd05041         152 -DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------RMPAPQLCPEEI  224 (251)
T ss_pred             -cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC------CCCCCccCCHHH
Confidence             011224667999999988899999999999999999999 889997654322211111000      111233456789


Q ss_pred             HHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          380 ANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       380 ~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      .+++.+|+..+|.+||++.+ ++..|+
T Consensus       225 ~~li~~~l~~~p~~Rp~~~e-ll~~l~  250 (251)
T cd05041         225 YRLMLQCWAYDPENRPSFSE-IYNELQ  250 (251)
T ss_pred             HHHHHHHhccChhhCcCHHH-HHHHhh
Confidence            99999999999999999988 655543

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.2e-38  Score=312.03  Aligned_cols=246  Identities=25%  Similarity=0.356  Sum_probs=192.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      +|...+.||+|+||.||++.+.  +..||+|.+...... ....+.+|++++++++||||++++++|.  +..++||||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            6888899999999999999884  577899988754221 2345889999999999999999999883  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++..   ...+++..+..++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          82 DGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999953   35688999999999999999999972  479999999999999999999999999987543221  


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc-ccC-------
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN-LLD-------  365 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-~~~-------  365 (498)
                              .....|+..|+|||.+.+..++.++|||||||++|+|+||+.||...+........+.... ...       
T Consensus       155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence                    1223589999999999888899999999999999999999999965432211111100000 000       


Q ss_pred             ----------------------CCCCCCC-HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 ----------------------PLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 ----------------------~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                            ......| ...+..+.+++.+||..+|++||++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  283 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE  283 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence                                  0000001 124567999999999999999999988

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-38  Score=319.21  Aligned_cols=244  Identities=20%  Similarity=0.310  Sum_probs=188.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--------C
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------E  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--------~  204 (498)
                      ..+|...+.||+|+||.||+|...  +..||||++.....  .....+.+|+.+|+.++||||+++++++.        .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            457888899999999999999874  57899999875322  22345778999999999999999998773        2


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..+++|+++ +++|.+++.    ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence            358999988 789988873    2358999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Cc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK  359 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~  359 (498)
                      +......           ....||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+........    +.
T Consensus       166 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         166 RQADDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             eecCCCc-----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            8654321           22358999999999977 46889999999999999999999999754432211110    00


Q ss_pred             -------------cccccCCCCCCCC--------HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 -------------LKNLLDPLAGDWP--------FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 -------------~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                   ....+.. ....+        ...++.+.+|+.+||..||.+||++.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el  295 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA  295 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                         0000000 00001        1123457899999999999999999883

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-38  Score=310.29  Aligned_cols=259  Identities=25%  Similarity=0.438  Sum_probs=199.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC----cce
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE----VWT  207 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~~  207 (498)
                      .|...+.||+|+||.||+|.+.      +..||||++...... ....|.+|+.+++.+.||||+++++++..    ..+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            5667788999999999999864      568999999765443 35679999999999999999999998744    578


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+++|+|.+++...  ...+++..+..++.+++.||.|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        85 lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            999999999999999533  2358999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--------HHhCc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--------LDTGK  359 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--------~~~~~  359 (498)
                      .......     .......++..|+|||.+.+..++.++|||||||++|||+||..||.........        .....
T Consensus       160 ~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05038         160 PEDKDYY-----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR  234 (284)
T ss_pred             ccCCcce-----eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence            5332110     1111223567799999998889999999999999999999999988543211000        00000


Q ss_pred             cccccC-CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          360 LKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       360 ~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      +...+. ......+...+..+.+++.+||..+|.+||++.+ +...|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e-i~~~l~~i  283 (284)
T cd05038         235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFAD-LILIVDRL  283 (284)
T ss_pred             HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHH-HHHHHhhc
Confidence            000000 0011122334578999999999999999999998 77777654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.9e-38  Score=310.60  Aligned_cols=240  Identities=25%  Similarity=0.341  Sum_probs=193.1

Q ss_pred             CCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCCCCC
Q 010882          142 PSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS  217 (498)
Q Consensus       142 ~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~~gs  217 (498)
                      ....||.|+||.||+|..  .+..||+|.+........+.+.+|+.++..++||||++++++|  .+..++||||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            344699999999999987  4688999998765555566788999999999999999999987  456899999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT  297 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  297 (498)
                      |.+++..    ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.........    
T Consensus       105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~----  173 (297)
T cd06659         105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----  173 (297)
T ss_pred             HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc----
Confidence            9998732    458899999999999999999999   89999999999999999999999999998755432211    


Q ss_pred             cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHH
Q 010882          298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE  377 (498)
Q Consensus       298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (498)
                          .....|+..|+|||++.+..++.++|||||||++|||++|++||................   .+.. ..+...+.
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~  245 (297)
T cd06659         174 ----RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKL-KNAHKISP  245 (297)
T ss_pred             ----ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---CCCc-cccCCCCH
Confidence                122348999999999998889999999999999999999999997654433222111100   0000 11123456


Q ss_pred             HHHHHHHHhhhcccCCCCChhHH
Q 010882          378 QLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       378 ~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+.+++.+||+.+|.+||++.++
T Consensus       246 ~l~~~i~~~l~~~P~~Rps~~~l  268 (297)
T cd06659         246 VLRDFLERMLTREPQERATAQEL  268 (297)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHH
Confidence            78999999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=310.58  Aligned_cols=252  Identities=24%  Similarity=0.283  Sum_probs=197.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|...+.||+|+||.||+|...  +..||+|.+......   ....+..|+.+++.++||||+++++.+.  ...++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5778889999999999999884  588999998765433   3356889999999999999999999884  35789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+.|++|.+++... ....+++..+..++.|++.||.|||+   .|++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          82 YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             ecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            99999999998532 33568999999999999999999999   899999999999999999999999999988654322


Q ss_pred             cCCCCc---------------------cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH
Q 010882          292 ISSNNT---------------------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE  350 (498)
Q Consensus       292 ~~~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~  350 (498)
                      ......                     .........||..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            110000                     00011234689999999999988899999999999999999999999976554


Q ss_pred             HHHHHHhCccccccCCCCCCCCH--HHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          351 VQYALDTGKLKNLLDPLAGDWPF--VQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ........  ..     ...++.  ..+..+.+++.+||..+|.+||+....+
T Consensus       238 ~~~~~~~~--~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~  283 (316)
T cd05574         238 DETFSNIL--KK-----EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGA  283 (316)
T ss_pred             HHHHHHHh--cC-----CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence            33222111  00     001111  1568899999999999999999955433

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.3e-38  Score=307.59  Aligned_cols=253  Identities=27%  Similarity=0.371  Sum_probs=198.6

Q ss_pred             ChHHHHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceec--
Q 010882          129 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--  203 (498)
Q Consensus       129 ~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--  203 (498)
                      +..++..+.+.|++...||.|+||.||+|...  +..||+|++.... .....+..|+.+++++ +||||+++++++.  
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            45556667788999999999999999999984  5789999986543 2345688999999998 7999999999872  


Q ss_pred             ------CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCcee
Q 010882          204 ------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK  277 (498)
Q Consensus       204 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  277 (498)
                            +..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence                  35789999999999999885432 3458888899999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccccccCCCCccceeccCCCCCCCcCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH
Q 010882          278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ  352 (498)
Q Consensus       278 l~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~  352 (498)
                      |+|||++........        ......|++.|+|||.+.     ...++.++|||||||++|+|+||.+||.......
T Consensus       162 l~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~  233 (282)
T cd06636         162 LVDFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR  233 (282)
T ss_pred             EeeCcchhhhhcccc--------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence            999999876532211        012345899999999986     3467889999999999999999999996544332


Q ss_pred             HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          353 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ........   ..+  ...+...+..+.+++.+||..+|.+||++.+
T Consensus       234 ~~~~~~~~---~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e  275 (282)
T cd06636         234 ALFLIPRN---PPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ  275 (282)
T ss_pred             hhhhHhhC---CCC--CCcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence            22211110   000  0011234578999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=306.55  Aligned_cols=242  Identities=26%  Similarity=0.378  Sum_probs=202.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP  214 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~  214 (498)
                      -|.+..+||+|+||.||++.++  |..||||.+...  .+..++.+|+.||.++++|+||++||++  ...+++|||||-
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            4777888999999999999885  788999998654  3567899999999999999999999976  346899999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      .||..|.+.  ..+.+|++.++..|+...+.||.|||.   ..-||||||..||||+.+|++||+|||.|..+.+.... 
T Consensus       112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-  185 (502)
T KOG0574|consen  112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-  185 (502)
T ss_pred             CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence            999999996  345689999999999999999999999   67899999999999999999999999999877655422 


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                             +....|||.|||||++..-+|+.++||||||+...||..|+|||....+....+-.    ..-.|..-.-|..
T Consensus       186 -------RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT~PPPTF~KPE~  254 (502)
T KOG0574|consen  186 -------RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PTKPPPTFKKPEE  254 (502)
T ss_pred             -------hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cCCCCCCCCChHh
Confidence                   34556999999999999999999999999999999999999999766554321111    0001111123556


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+..+.++++.||-.+|++|-++.+
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~  279 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALR  279 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHH
Confidence            6788999999999999999998776

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=333.88  Aligned_cols=250  Identities=22%  Similarity=0.297  Sum_probs=186.8

Q ss_pred             HHHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCC------CCeeeeeceec
Q 010882          132 EIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH------PNLVTLVGACP  203 (498)
Q Consensus       132 ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h------pniv~l~g~~~  203 (498)
                      ++...+++|.+.+.||+|+||+||+|.+.  +..||||++.... .....+..|+.++..++|      ++++.++++|.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445678999999999999999999874  6789999986432 223456678888877754      45888888874


Q ss_pred             ---CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC------
Q 010882          204 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF------  274 (498)
Q Consensus       204 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~------  274 (498)
                         ...++||+++ |++|.+++..   ...+++..+..|+.|++.||.|||+.  .|||||||||+|||++.++      
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccc
Confidence               3578999988 7889988843   34689999999999999999999971  3899999999999998765      


Q ss_pred             ----------ceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCC
Q 010882          275 ----------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA  344 (498)
Q Consensus       275 ----------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p  344 (498)
                                .+||+|||++......           .....||+.|+|||++.+..++.++|||||||+||||+||++|
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~~-----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERHS-----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             cccccCCCCceEEECCCCccccCccc-----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence                      4999999987543211           1234699999999999999999999999999999999999999


Q ss_pred             CCCcHHHHHHHHh----Cccc-------------cccC------CCC-----------CCC-CHHHHHHHHHHHHHhhhc
Q 010882          345 LGITKEVQYALDT----GKLK-------------NLLD------PLA-----------GDW-PFVQAEQLANLAMRCCEM  389 (498)
Q Consensus       345 f~~~~~~~~~~~~----~~~~-------------~~~~------~~~-----------~~~-~~~~~~~l~~li~~cl~~  389 (498)
                      |...+........    +.+.             .+.+      +..           ..+ .......+.+|+.+||..
T Consensus       345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            9765433221110    0000             0000      000           000 001235678999999999


Q ss_pred             ccCCCCChhH
Q 010882          390 SRKSRPELGK  399 (498)
Q Consensus       390 ~p~~RP~~~~  399 (498)
                      ||.+||++.+
T Consensus       425 dP~~R~ta~e  434 (467)
T PTZ00284        425 DRQKRLNARQ  434 (467)
T ss_pred             ChhhCCCHHH
Confidence            9999999988

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.8e-38  Score=308.89  Aligned_cols=241  Identities=27%  Similarity=0.394  Sum_probs=193.3

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      |...+.||+|+||.||+|.+.  +..||+|.+..... .....+.+|+.++++++||||++++++|.  ...++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            444567999999999999874  67899999875432 22456889999999999999999999884  45899999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +++|.+++.    ...+++..+..++.+++.||.|||+   ++++|+||+|+||+++.++.++|+|||++..+.....  
T Consensus        86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06642          86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence            999999884    2458899999999999999999999   8999999999999999999999999999876543221  


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                            ......|+..|+|||++.+..++.++|||||||++|||+||++||............      ........+..
T Consensus       157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~~  224 (277)
T cd06642         157 ------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------PKNSPPTLEGQ  224 (277)
T ss_pred             ------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh------hcCCCCCCCcc
Confidence                  112235889999999999888999999999999999999999999654332211111      00111122334


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      .+..+.+++.+||..+|.+||++.+++
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il  251 (277)
T cd06642         225 YSKPFKEFVEACLNKDPRFRPTAKELL  251 (277)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            567899999999999999999999844

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.4e-38  Score=301.78  Aligned_cols=241  Identities=27%  Similarity=0.420  Sum_probs=196.5

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-----ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      |...+.||+|+||.||+|...  +..|++|.+......     ....+.+|+.+++.++||||+++++++.  ...++||
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            566778999999999999984  688999988654321     2356889999999999999999999884  4688999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++++|.+++..   ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999843   3468899999999999999999999   89999999999999999999999999998865433


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      .         ......|++.|+|||.+.... ++.++|+|||||++|+|++|++||............+....     ..
T Consensus       156 ~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~  221 (258)
T cd06632         156 S---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----LP  221 (258)
T ss_pred             c---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----CC
Confidence            2         012335899999999998776 89999999999999999999999976654443333222111     11


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+...+..+.+++.+||+.+|.+||++.++
T Consensus       222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~  252 (258)
T cd06632         222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAEL  252 (258)
T ss_pred             CcCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence            2334456789999999999999999999883

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-37  Score=302.42  Aligned_cols=245  Identities=24%  Similarity=0.365  Sum_probs=194.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-----ChhhHHHHHHHHHcCCCCCeeeeeceecC----cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACPE----VW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~  206 (498)
                      .+|...+.||+|+||.||+|...  +..||||.+......     ....+.+|+.++++++||||+++++++.+    ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            36888899999999999999874  678999988643211     12467889999999999999999998743    46


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+++|+|.+++..   ...+++.....++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            799999999999999853   2457888999999999999999999   8999999999999999999999999999886


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      .........     ......|+..|+|||.+.+..++.++|||||||++|+|++|++||............     ...+
T Consensus       156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~~  225 (265)
T cd06652         156 LQTICLSGT-----GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-----ATQP  225 (265)
T ss_pred             ccccccccc-----ccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH-----hcCC
Confidence            543211110     112234899999999998888999999999999999999999999765433222111     1111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .....|...+..+.+++.+|+. +|..||++.+
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~  257 (265)
T cd06652         226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADE  257 (265)
T ss_pred             CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence            2233455667788999999994 9999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-37  Score=304.43  Aligned_cols=241  Identities=26%  Similarity=0.384  Sum_probs=196.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .|+..+.||.|+||.||+|.+.  +..||||++..... .....+.+|+.+++.++||||+++++++.  ...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667778999999999999874  68899999875432 23456889999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      +||+|.+++..    .++++.....++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            99999999842    358889999999999999999999   89999999999999999999999999999765432211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              .....|+..|+|||++.+..++.++|||||||++|+|+||.+||.............      .......+.
T Consensus       158 --------~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------~~~~~~~~~  223 (277)
T cd06640         158 --------RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP------KNNPPTLTG  223 (277)
T ss_pred             --------cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh------cCCCCCCch
Confidence                    122358889999999988889999999999999999999999997554332211110      001122344


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+..+.+++..||+.+|.+||++.++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~i  250 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKEL  250 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHH
Confidence            567889999999999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-38  Score=309.14  Aligned_cols=249  Identities=26%  Similarity=0.360  Sum_probs=194.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|...+.||+|+||+||+|...  +..||+|++..... .....+.+|+++++.++||||+++++++.  ...++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            35677788999999999999885  78899998865432 23467889999999999999999999984  468899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++..   ..++++.....++.+++.||.|||+.  .+++||||+|+||+++.++.++|+|||++....... 
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999998843   34689999999999999999999973  479999999999999999999999999987543221 


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH-----HHHHhCccccccCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-----YALDTGKLKNLLDPL  367 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~-----~~~~~~~~~~~~~~~  367 (498)
                               .....|+..|+|||++.+..++.++|||||||++|+|+||+.||.......     ...-...+.......
T Consensus       159 ---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd06620         159 ---------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP  229 (284)
T ss_pred             ---------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence                     122358999999999988899999999999999999999999997533210     000000001111111


Q ss_pred             CCCCCH-HHHHHHHHHHHHhhhcccCCCCChhHHHH
Q 010882          368 AGDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVW  402 (498)
Q Consensus       368 ~~~~~~-~~~~~l~~li~~cl~~~p~~RP~~~~~v~  402 (498)
                      ....+. ..+..+.+++.+|+..+|.+||++.+ +.
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e-~~  264 (284)
T cd06620         230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ-LC  264 (284)
T ss_pred             CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHH-Hh
Confidence            111122 25567999999999999999999988 43

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.4e-38  Score=310.77  Aligned_cols=249  Identities=24%  Similarity=0.323  Sum_probs=191.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|...+.||.|+||.||+|...  +..||+|.+..... .....+.+|+.+++.++||||+++++++.  ...++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            36888889999999999999874  67899999875432 23456789999999999999999999984  467899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++ ++|.+.+...  ...+++..+..++.+++.||.|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5898888532  3458899999999999999999999   8999999999999999999999999999875432211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC---------cccc
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG---------KLKN  362 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~---------~~~~  362 (498)
                      .        .....+++.|+|||.+.+. .++.++|||||||++|+|+||++||...+.........         .+..
T Consensus       160 ~--------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (301)
T cd07873         160 T--------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  231 (301)
T ss_pred             c--------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence            1        1223478999999998764 57889999999999999999999997654322111000         0000


Q ss_pred             ccC------CCCCC--------CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 LLD------PLAGD--------WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 ~~~------~~~~~--------~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ...      .....        .....+..+.+|+.+||..+|.+||++.++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei  283 (301)
T cd07873         232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA  283 (301)
T ss_pred             hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            000      00000        111245678999999999999999999883

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-37  Score=300.58  Aligned_cols=241  Identities=24%  Similarity=0.342  Sum_probs=196.5

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|+..+.||.|+||.||.+..  .+..+++|.+....  ......+.+|+.++++++||||+++++++.  +..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477888999999998888776  46789999886543  233456889999999999999999999984  357899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++.... ...+++..+..++.+++.||.|||+   .+++||||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999986432 3568999999999999999999999   8999999999999999999999999999986644321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAGD  370 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~  370 (498)
                              ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.........  +..+...        .
T Consensus       157 --------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~  220 (256)
T cd08221         157 --------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT--------P  220 (256)
T ss_pred             --------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------C
Confidence                    112345899999999998888899999999999999999999999765433222  1122111        1


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+...+..+.+++.+||..+|.+||++.+
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~  249 (256)
T cd08221         221 VVSVYSSELISLVHSLLQQDPEKRPTADE  249 (256)
T ss_pred             CccccCHHHHHHHHHHcccCcccCCCHHH
Confidence            22345678999999999999999999988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.3e-38  Score=304.62  Aligned_cols=250  Identities=26%  Similarity=0.437  Sum_probs=197.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC--cce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~  207 (498)
                      .+|.....||.|+||.||+|...       ...|++|.+...... ....+.+|+.++++++||||++++++|.+  ..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46788889999999999999863       356999988654433 24578999999999999999999999854  689


Q ss_pred             EEEeeCCCCCHHhhhccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          208 LVYEYLPNGSLEDRLSCKDNS------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                      +||||+++|+|.+++......      ..+++..+..++.+++.||.|||+   .+|+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999644322      268999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhC
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTG  358 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~  358 (498)
                      |++.........       ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  .....+
T Consensus       162 ~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYY-------KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG  234 (275)
T ss_pred             ccccccCccccc-------ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence            998754322111       1122346788999999988888999999999999999999 888996533222  111211


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      .+..       ..+...+..+.+++.+||..+|.+||++.+ +...|
T Consensus       235 ~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~-~l~~l  273 (275)
T cd05046         235 KLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSE-LVSAL  273 (275)
T ss_pred             CcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHh
Confidence            1111       112234578999999999999999999988 54443

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.7e-38  Score=311.31  Aligned_cols=193  Identities=25%  Similarity=0.398  Sum_probs=156.5

Q ss_pred             CcccccCceEEEEEEEC----CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec----CcceEEEeeCCC
Q 010882          144 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYEYLPN  215 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV~E~~~~  215 (498)
                      .+||+|+||.||+|...    +..||+|.+....  ....+.+|+.+++.++||||+++++++.    ...++||||+. 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            57999999999999864    3679999886543  2346789999999999999999999872    35789999986 


Q ss_pred             CCHHhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE----cCCCceeEeeccccc
Q 010882          216 GSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISR  285 (498)
Q Consensus       216 gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGla~  285 (498)
                      ++|.+++...      .....+++..+..++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            4777776321      122358899999999999999999999   899999999999999    566899999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                      .........     .......||+.|+|||++.+. .++.++|||||||++|||+||++||..
T Consensus       161 ~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         161 LFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccCCCcccc-----cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            765432111     111334589999999999764 588999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-37  Score=312.03  Aligned_cols=253  Identities=18%  Similarity=0.239  Sum_probs=188.0

Q ss_pred             CCccccc--CceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCC
Q 010882          143 SLKIGEG--GYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP  214 (498)
Q Consensus       143 ~~~lG~G--~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~  214 (498)
                      ..+||+|  +||+||++..+  +..||||.+.......  ...+..|+.+++.++||||++++++|  .+..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4579999  78999999874  6889999987543222  34577899999999999999999988  446899999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++.... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++++|||.+..........
T Consensus        83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999985332 2358999999999999999999999   899999999999999999999999998765433221110


Q ss_pred             CCccceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH--hCccccccCCC---
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLDPL---  367 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~--~~~~~~~~~~~---  367 (498)
                      . ..........++..|+|||++.+  ..++.++|||||||++|||+||++||...........  .+.....++..   
T Consensus       159 ~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 R-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             c-ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence            0 00001122347888999999976  4689999999999999999999999975432221111  11111111000   


Q ss_pred             ----------------------------------CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          368 ----------------------------------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       368 ----------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                                        ...+....+..+.+++.+||+.||.+||++.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el  304 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL  304 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH
Confidence                                              000112245678999999999999999999883

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-37  Score=299.57  Aligned_cols=243  Identities=32%  Similarity=0.526  Sum_probs=195.7

Q ss_pred             CCCCcccccCceEEEEEEECC------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          141 DPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .+.+.||.|+||.||++....      ..||+|++...... ....+..|+.++..++||||+++++++.  ...++|||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456789999999999999864      77999999765443 4568899999999999999999999885  46889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++++|.+++..... ..+++..+..++.+++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999853221 128999999999999999999999   899999999999999999999999999998765442


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCccccccCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLA  368 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~~~~~  368 (498)
                      ....       ....+++.|+|||.+.+..++.++|||||||++|+|++ |++||...+....  ....+..        
T Consensus       158 ~~~~-------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------  222 (258)
T smart00219      158 YYKK-------KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------  222 (258)
T ss_pred             cccc-------ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------
Confidence            2111       12237889999999988889999999999999999999 8899975433222  1222111        


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR  403 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~  403 (498)
                      ...+...+..+.+++.+|+..+|.+||++.+ +..
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~-ll~  256 (258)
T smart00219      223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSE-LVE  256 (258)
T ss_pred             CCCCCcCCHHHHHHHHHHCcCChhhCcCHHH-HHh
Confidence            1123335678999999999999999999988 443

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-37  Score=302.37  Aligned_cols=253  Identities=24%  Similarity=0.394  Sum_probs=195.4

Q ss_pred             CCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      |.+.+.||+|+||.||+|.+.     +..||||++......  ..+.+.+|+.+++.++||||+++++++..        
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455678999999999999863     478999998754322  24568899999999999999999998732        


Q ss_pred             cceEEEeeCCCCCHHhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          205 VWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                      ..+++++|+++|+|.+++...   .....+++.....++.+++.||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence            236899999999999887432   122357889999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCcc
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL  360 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (498)
                      |+++..........      .....+++.|++||.+....++.++|||||||++|+|++ |++||...............
T Consensus       158 g~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQ------GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG  231 (273)
T ss_pred             cccccccCCcceec------CCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence            99986543221111      112235678999999998889999999999999999999 89999765443221111001


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..      ...+...+..+.+++.+||+.+|.+||++.+ +...|+.+
T Consensus       232 ~~------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~-~~~~l~~~  272 (273)
T cd05074         232 NR------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQH-LRDQLELI  272 (273)
T ss_pred             Cc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHhh
Confidence            11      1122334578999999999999999999988 77776653

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-37  Score=302.40  Aligned_cols=249  Identities=25%  Similarity=0.397  Sum_probs=193.3

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC--C--------hhhHHHHHHHHHcCCCCCeeeeeceec--C
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--G--------PSEFQQEIDILSKIRHPNLVTLVGACP--E  204 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~--------~~~~~~E~~il~~l~hpniv~l~g~~~--~  204 (498)
                      +|...+.||.|+||.||+|..  .+..||+|.+......  .        .+.+..|+.+++.++||||+++++++.  +
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            356677899999999999987  4678999987642111  1        235788999999999999999999884  4


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||+++|+|.+++...   ..+++..+..++.+++.||.|||+   ++++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccc
Confidence            688999999999999999533   568999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCC--CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      ..........      ......|+..|+|||.+....  ++.++||||||+++|++++|..||.................
T Consensus       156 ~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  229 (272)
T cd06629         156 KKSDDIYDND------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS  229 (272)
T ss_pred             cccccccccc------ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc
Confidence            7643221110      112335899999999987654  88999999999999999999999975544433322211110


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      . ...........+..+.+++.+||..+|..||++.++
T Consensus       230 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (272)
T cd06629         230 A-PPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL  266 (272)
T ss_pred             C-CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            0 000111112346789999999999999999998883

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-37  Score=305.04  Aligned_cols=247  Identities=29%  Similarity=0.378  Sum_probs=192.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|+....||+|+||.||+|...  +..||+|++.....  ...+.+.+|+.+++.++||||+++++++.  ...++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            5788889999999999999985  68899998865422  22356789999999999999999999884  357899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++++|..++.   ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          82 CDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             cCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99998888763   33458999999999999999999999   8999999999999999999999999999987654321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc-ccc--------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-LKN--------  362 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~~--------  362 (498)
                      .        .....|+..|+|||++.+ ..++.++|||||||++|+|+||.+||.............. ...        
T Consensus       156 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07847         156 D--------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI  227 (286)
T ss_pred             c--------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            1        122347889999999876 4578899999999999999999999976544322211100 000        


Q ss_pred             ---------ccCCCCC-CCC-----HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 ---------LLDPLAG-DWP-----FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 ---------~~~~~~~-~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                               ...+... ..+     ...+..+.+++.+||+.+|.+||++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e  279 (286)
T cd07847         228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE  279 (286)
T ss_pred             cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence                     0000000 000     123567899999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-38  Score=314.89  Aligned_cols=221  Identities=24%  Similarity=0.308  Sum_probs=177.0

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      -|..++.||-|+||+|.++.-  +...||+|.+.+.+...   ...++.|.+||...+.++||+||.+|.+  .+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            355667899999999998754  45679999998765433   3457889999999999999999999954  6999999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||++..+|-+   ..-|.+.....++.++.+|+++.|.   .|+|||||||+|||||.+|++||+|||||.-+.-..
T Consensus       710 YIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             ccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence            9999999999943   3458888888899999999999999   999999999999999999999999999997552111


Q ss_pred             cC---CC-------------------------------CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHH
Q 010882          292 IS---SN-------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR  337 (498)
Q Consensus       292 ~~---~~-------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~e  337 (498)
                      .+   ..                               ....+.....+||+.|+|||++...+|+..|||||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence            00   00                               000011234589999999999999999999999999999999


Q ss_pred             HHhCCCCCCCcHHHHHHHHhCccccccC
Q 010882          338 LLTGRPALGITKEVQYALDTGKLKNLLD  365 (498)
Q Consensus       338 lltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (498)
                      |+.|++||.............++...++
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~  891 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNFLH  891 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhccc
Confidence            9999999976655444444444555544

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=302.84  Aligned_cols=250  Identities=30%  Similarity=0.395  Sum_probs=197.0

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceecC-------
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE-------  204 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~-------  204 (498)
                      .++++|+..+.||.|+||.||+|...  +..|++|++..... ....+.+|+.+++++ +||||++++++|.+       
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35678999999999999999999984  57899999875432 346789999999999 79999999999832       


Q ss_pred             -cceEEEeeCCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecc
Q 010882          205 -VWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG  282 (498)
Q Consensus       205 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  282 (498)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence             3689999999999999885422 23568999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT  357 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (498)
                      ++.........        .....|+..|+|||++..     ..++.++|||||||+||+|+||++||............
T Consensus       159 ~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  230 (275)
T cd06608         159 VSAQLDSTLGR--------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI  230 (275)
T ss_pred             cceecccchhh--------hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence            98765432211        123458999999999854     34678899999999999999999999754332222211


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          358 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..  . ..+ ....+...+..+.+++.+||..+|.+||++.++
T Consensus       231 ~~--~-~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l  269 (275)
T cd06608         231 PR--N-PPP-TLKSPENWSKKFNDFISECLIKNYEQRPFMEEL  269 (275)
T ss_pred             hc--c-CCC-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence            10  0 000 111222345789999999999999999999883

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.9e-38  Score=309.26  Aligned_cols=243  Identities=23%  Similarity=0.323  Sum_probs=193.4

Q ss_pred             CCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN  215 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~~  215 (498)
                      |.....||.|+||.||++..  .+..||||.+........+.+.+|+.+++.++||||+++++.+  .+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            34446799999999999987  4678999998755444456788999999999999999999987  4568999999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      ++|.+++..    ..+++..+..++.+++.||.|||+   ++|+||||||+||+++.++.+||+|||++.........  
T Consensus       104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--  174 (292)
T cd06658         104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--  174 (292)
T ss_pred             CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--
Confidence            999998842    358899999999999999999999   89999999999999999999999999998755332211  


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ  375 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (498)
                            .....|+..|+|||.+.+..++.++|||||||++|||++|+.||............   ...+.+... .....
T Consensus       175 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~-~~~~~  244 (292)
T cd06658         175 ------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNLPPRVK-DSHKV  244 (292)
T ss_pred             ------CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCccc-ccccc
Confidence                  12234899999999998888999999999999999999999999765443221111   111111111 11234


Q ss_pred             HHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          376 AEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       376 ~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      +..+.+++..||..+|.+||++.+++
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il  270 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELL  270 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHh
Confidence            56789999999999999999998833

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=317.95  Aligned_cols=238  Identities=28%  Similarity=0.389  Sum_probs=195.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCCh---hhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E  211 (498)
                      -|...+.||.|+||.||-+.+.  ...||||.+.-...++.   .++.+|+..|.+++|||++.+-|+|  ....+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4667778999999999999883  57899999876655543   4688999999999999999999998  345789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      || -||-.|+|.  -...+|.+-.+..|+.+++.||.|||+   ++.||||||..||||+..|.|||+|||.|....+. 
T Consensus       107 YC-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  107 YC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             HH-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            99 467777774  234678888999999999999999999   89999999999999999999999999998765543 


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                                 .+.+|||.|||||++.   .+.|+-++||||||++..||.-.+||+-..+.+..++-+..-.   .|..
T Consensus       180 -----------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe---sPtL  245 (948)
T KOG0577|consen  180 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPTL  245 (948)
T ss_pred             -----------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC---CCCC
Confidence                       3457999999999985   4789999999999999999999999987776655443321110   1111


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        -....+..+..++..||+.-|.+||+..+
T Consensus       246 --qs~eWS~~F~~Fvd~CLqKipqeRptse~  274 (948)
T KOG0577|consen  246 --QSNEWSDYFRNFVDSCLQKIPQERPTSEE  274 (948)
T ss_pred             --CCchhHHHHHHHHHHHHhhCcccCCcHHH
Confidence              12345688999999999999999999765

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-37  Score=299.77  Aligned_cols=251  Identities=25%  Similarity=0.331  Sum_probs=199.6

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~  213 (498)
                      +|++.+.||.|+||+||+|..  .+..+|+|++..... .....+.+|+.+++.++||||+++++.+  .+..++||||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            688889999999999999987  457899999875432 2456789999999999999999999987  34688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++........+++.....++.+++.||.|||+   .|++||||+|+||+++.++.++|+|||++..+......
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999654333568999999999999999999999   89999999999999999999999999999876544321


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC-
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW-  371 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  371 (498)
                      ..    .......|+..|+|||++... .++.++|||||||++|+|+||+.||...+...........   ..+..... 
T Consensus       159 ~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (267)
T cd06610         159 TR----KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGA  231 (267)
T ss_pred             cc----cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcc
Confidence            10    111333589999999999877 7889999999999999999999999765543322211110   00111100 


Q ss_pred             -CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          372 -PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       372 -~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       ....+..+.+++..||..+|..||++.+
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (267)
T cd06610         232 DYKKYSKSFRKMISLCLQKDPSKRPTAEE  260 (267)
T ss_pred             ccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence             1244678999999999999999999988

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=308.68  Aligned_cols=242  Identities=23%  Similarity=0.342  Sum_probs=201.7

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +-|.+.+.||+|.|++|-.+.+  .|..||||++.+.....  ...+.+|+..|+.+.|||||+||.+.+  ..+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3578888999999999988764  79999999998765543  457889999999999999999999874  57999999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc-CCCceeEeecccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~  290 (498)
                      +-.+|+|.|++.+..  ..+.+....+++.||+.|+.|+|+.   .+|||||||+||.+- +-|-+||.|||++..+...
T Consensus        98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999996544  4588889999999999999999994   599999999998875 5689999999999877654


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCC-CccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ..   ..      ...|+..|.|||++.+..|+ +++||||||||||-|++|++||...+..+.+-.+      +| ...
T Consensus       173 ~k---L~------TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI------mD-CKY  236 (864)
T KOG4717|consen  173 KK---LT------TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI------MD-CKY  236 (864)
T ss_pred             ch---hh------cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh------hc-ccc
Confidence            32   22      23499999999999999987 5789999999999999999999765544332111      11 122


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..|...+.+..+||..||..||++|.+..++
T Consensus       237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI  267 (864)
T KOG4717|consen  237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEI  267 (864)
T ss_pred             cCchhhhHHHHHHHHHHHhcCchhhccHHHH
Confidence            3688899999999999999999999998773

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-38  Score=308.23  Aligned_cols=245  Identities=35%  Similarity=0.517  Sum_probs=191.2

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChh--hHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL  213 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~--~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~  213 (498)
                      |+..+.||+|+||+||++...  +..||+|++.........  ....|+.++++++||||+++++++  ....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            445678999999999999995  467999999865433222  234599999999999999999988  44678999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++.   ....+++..+..++.+++.||.+||+   .+++|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred             cccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc--
Confidence            9999999995   34568999999999999999999999   899999999999999999999999999987641111  


Q ss_pred             CCCccceeccCCCCCCCcCChhhhc-cCCCCCccchHhHHHHHHHHHhCCCCCCCcH--HHHHHHHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~  370 (498)
                            .......||..|+|||++. +..++.++||||||+++|+|++|..||....  ...................  
T Consensus       153 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  224 (260)
T PF00069_consen  153 ------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ--  224 (260)
T ss_dssp             ------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--
T ss_pred             ------cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--
Confidence                  1123345899999999998 7789999999999999999999999998652  1111111110000000000  


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ........+.+++..||+.+|.+||++.++
T Consensus       225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l  254 (260)
T PF00069_consen  225 QSREKSEELRDLIKKMLSKDPEQRPSAEEL  254 (260)
T ss_dssp             SHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred             ccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence            001123789999999999999999999883

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-39  Score=310.82  Aligned_cols=244  Identities=25%  Similarity=0.348  Sum_probs=201.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV  209 (498)
                      .+.|..-++||+||||.||-+..  +|+.+|.|.+.+....   ......+|-.||.+++.|.||.|-.+|  .+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            34678889999999999998766  5778999988654332   233467899999999999999998888  4679999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |..|.||+|.-+|....+ +.+++...+.++.+|++||.+||.   .+||+|||||+|||||+.|+++|+|.|||.-+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999975543 679999999999999999999999   8999999999999999999999999999997766


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPL  367 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~  367 (498)
                      ...         ..+.+||.+|||||++.++.|+...|||||||+||||+.|+.||....+-..  .++...+..     
T Consensus       340 g~~---------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-----  405 (591)
T KOG0986|consen  340 GKP---------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-----  405 (591)
T ss_pred             CCc---------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-----
Confidence            542         1345799999999999999999999999999999999999999965433111  122211111     


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                      ...+|...+++...+....|..||.+|-.-.
T Consensus       406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            2336667788999999999999999997544

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.8e-37  Score=299.91  Aligned_cols=246  Identities=25%  Similarity=0.384  Sum_probs=197.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec----CcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV~  210 (498)
                      +|+..+.||.|+||.||++...  +..||+|.+......  ..+.+..|+.+++.++||||+++++.+.    ...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4677788999999999999874  578999998754332  2346888999999999999999998762    2468999


Q ss_pred             eeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          211 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       211 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      ||+++++|.+++... ....++++..++.++.+++.||.|||..+  ..+++||||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998542 23457899999999999999999999321  289999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH--HHHHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~  365 (498)
                      ......        .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+...  ..+..+       
T Consensus       161 ~~~~~~--------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------  225 (265)
T cd08217         161 GHDSSF--------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-------  225 (265)
T ss_pred             cCCccc--------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-------
Confidence            543210        122358999999999998889999999999999999999999997654222  111111       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       .....+...+..+.+++.+|++.+|.+||++.++
T Consensus       226 -~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~i  259 (265)
T cd08217         226 -KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL  259 (265)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence             1122344556789999999999999999999883

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.5e-37  Score=306.62  Aligned_cols=257  Identities=23%  Similarity=0.272  Sum_probs=195.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      +|...+.||+|+||.||++...  +..||+|.+......   ....+.+|+.+++.++||||+++++++..  ..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6788889999999999999885  578999998764321   23467899999999999999999998843  5689999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++..   ...+++..+..++.+++.||.|||+   ++++||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          82 YVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999943   3468999999999999999999999   899999999999999999999999999987422111


Q ss_pred             cCC-------CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccccc
Q 010882          292 ISS-------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL  364 (498)
Q Consensus       292 ~~~-------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (498)
                      ...       ............|+..|+|||.+....++.++|+|||||++|+|+||..||............. .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~-~~~~~  234 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-SDDIE  234 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcccC
Confidence            000       0000011123457889999999988889999999999999999999999997554322111110 00111


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       365 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      .+.   .+...+..+.+++.+||+.+|.+||+... +.++|+
T Consensus       235 ~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~-~~~ll~  272 (305)
T cd05609         235 WPE---GDEALPADAQDLISRLLRQNPLERLGTGG-AFEVKQ  272 (305)
T ss_pred             CCC---ccccCCHHHHHHHHHHhccChhhccCccC-HHHHHh
Confidence            111   11134577899999999999999999765 444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-37  Score=302.38  Aligned_cols=246  Identities=23%  Similarity=0.410  Sum_probs=195.9

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC------ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      +|+..+.||+|+||.||+|..  .+..||+|++......      ....+..|+.++++++||||+++++++.  +..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999987  4688999998754321      1356889999999999999999999984  35789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-ceeEeeccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL  287 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~  287 (498)
                      ||||+++++|.+++..   ..++++..+..++.|++.||.|||+   +|++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   3468899999999999999999999   8999999999999998775 6999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH---HHHHHhCcccccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV---QYALDTGKLKNLL  364 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~---~~~~~~~~~~~~~  364 (498)
                      .........    ......||..|+|||.+.+..++.++|||||||++|+|++|..||......   ........     
T Consensus       155 ~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----  225 (268)
T cd06630         155 AAKGTGAGE----FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-----  225 (268)
T ss_pred             ccccccCCc----cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc-----
Confidence            543211111    112345899999999998888999999999999999999999999643221   11111100     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       365 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .......|...+..+.+++.+|+..+|..||++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  260 (268)
T cd06630         226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRE  260 (268)
T ss_pred             cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence            01123345566788999999999999999999988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-37  Score=300.76  Aligned_cols=247  Identities=23%  Similarity=0.405  Sum_probs=183.5

Q ss_pred             cccccCceEEEEEEEC-C---eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLLR-H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~~gs  217 (498)
                      .||+|+||.||+|... +   ..+++|.+..... .....|.+|+.+++.++||||+++++.|.+  ..++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999999753 2   3466777664432 234678999999999999999999999853  5799999999999


Q ss_pred             HHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          218 LEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       218 L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      |.+++.... ....++...+..++.+++.||.|||+   .+++||||||+|||++.++.+||+|||++.........   
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~---  155 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI---  155 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhh---
Confidence            999996432 22346777788999999999999999   89999999999999999999999999998643221110   


Q ss_pred             ccceeccCCCCCCCcCChhhhcc-------CCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHH--HHhCccccccCC
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA--LDTGKLKNLLDP  366 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~--~~~~~~~~~~~~  366 (498)
                         .......|+..|+|||++..       ..++.++|||||||++|||++ |.+||.........  ...+......++
T Consensus       156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (268)
T cd05086         156 ---ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP  232 (268)
T ss_pred             ---hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCC
Confidence               01123457899999999853       245788999999999999997 57788654332211  111112222222


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                         ..+...+..+.+++..|| .+|.+||++.+ +.+.|
T Consensus       233 ---~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~-i~~~l  266 (268)
T cd05086         233 ---QLELPYSERWYEVLQFCW-LSPEKRATAEE-VHRLL  266 (268)
T ss_pred             ---ccCCCCcHHHHHHHHHHh-hCcccCCCHHH-HHHHh
Confidence               223335577889999999 68999999998 55544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-37  Score=305.88  Aligned_cols=245  Identities=26%  Similarity=0.395  Sum_probs=197.9

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ++|...+.||+|+||.||+|..  .+..||+|.+........+.+.+|+.+++.++||||++++++|.  +..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788889999999999999986  46789999987555445567889999999999999999999883  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++..    ..+++..+..++.+++.||.|||+   +|++||||+|+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999842    347889999999999999999999   89999999999999999999999999998765433211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              .....|++.|+|||.+....++.++|||||||++|++++|++||...+........+....   + ....+.
T Consensus       172 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~---~-~~~~~~  239 (293)
T cd06647         172 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT---P-ELQNPE  239 (293)
T ss_pred             --------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC---C-CCCCcc
Confidence                    1223588999999999888899999999999999999999999976544322111110000   0 011123


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ..+..+.+++.+||..+|.+||++.+++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il  267 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELL  267 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            3456799999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.9e-38  Score=306.77  Aligned_cols=248  Identities=26%  Similarity=0.356  Sum_probs=192.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|+..+.||+|+||.||+|.+.  +..||+|++......  ..+.+.+|+.+++.++||||++++++|.  ...++||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5778889999999999999984  688999988654322  2456889999999999999999999984  358999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++++|..+...   ...+++..+..++.+++.||.|||+   .+++||||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          82 VDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             CCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            999999887632   2358999999999999999999999   8999999999999999999999999999886543321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC----ccc------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG----KLK------  361 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~----~~~------  361 (498)
                      .        .....|+..|+|||++.+. .++.++|||||||++|+|+||++||.............    .+.      
T Consensus       156 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07846         156 V--------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI  227 (286)
T ss_pred             c--------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence            1        1223578999999998764 57889999999999999999999997554332211110    000      


Q ss_pred             --------cccCCCCC------CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 --------NLLDPLAG------DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 --------~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                              ....+...      ......+..+.+++.+||..+|.+||++.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  280 (286)
T cd07846         228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL  280 (286)
T ss_pred             hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence                    00000000      0011345779999999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.1e-37  Score=302.01  Aligned_cols=247  Identities=26%  Similarity=0.388  Sum_probs=200.1

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEe
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE  211 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E  211 (498)
                      .+..|+....||.|+||.||+|.+.  +..|++|++..... ....+..|+.+++.++||||+++++++  .+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4456888889999999999999986  78899999876543 456788999999999999999999987  456899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++++|.+++....  ..+++..+..++.+++.||.|||.   .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999996432  379999999999999999999999   899999999999999999999999999987554322


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      ..        .....|+..|+|||++.+..++.++|||||||++|+|+||+.||...+..........  .....  ...
T Consensus       171 ~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~--~~~  238 (286)
T cd06614         171 SK--------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT--KGIPP--LKN  238 (286)
T ss_pred             hh--------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCC--Ccc
Confidence            11        1223478999999999888899999999999999999999999986554432222111  00000  111


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      +...+..+.+++.+|++.+|..||++.++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i  267 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEEL  267 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            22245789999999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-37  Score=301.86  Aligned_cols=247  Identities=26%  Similarity=0.334  Sum_probs=193.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC----cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~~lV~E  211 (498)
                      +|...+.||.|++|.||+|...  +..||+|.+..... .....+.+|++++++++||||++++++|.+    ..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5677789999999999999984  68899999875433 234568899999999999999999998732    4789999


Q ss_pred             eCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          212 YLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       212 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |+++++|.+++... .....++...+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            99999999887532 234568889999999999999999999   89999999999999999999999999998754322


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH-----HH--HHHHhCccccc
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQ--YALDTGKLKNL  363 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-----~~--~~~~~~~~~~~  363 (498)
                      ..          ....++..|+|||.+.+..++.++|||||||++|+|+||..||.....     ..  ...........
T Consensus       159 ~~----------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd06621         159 LA----------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL  228 (287)
T ss_pred             cc----------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence            11          122478899999999988999999999999999999999999975411     11  11111111111


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+...  .....+..+.+++.+||..+|.+||++.++
T Consensus       229 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei  263 (287)
T cd06621         229 KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDM  263 (287)
T ss_pred             ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHH
Confidence            00000  001235789999999999999999999883

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.1e-37  Score=302.14  Aligned_cols=241  Identities=24%  Similarity=0.346  Sum_probs=193.6

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN  215 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~~  215 (498)
                      |...+.||+|++|.||+|...  +..|++|.+........+.+.+|+.+++.++||||+++++++  .+..++|+||++|
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444568999999999999874  578999998755444456788999999999999999999987  4568999999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      ++|.+++..    ..+++..+..++.+++.||.|||+   ++++||||+|+||+++.++.++|+|||++........   
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~---  170 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP---  170 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence            999999853    458899999999999999999999   8999999999999999999999999998875433211   


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ  375 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (498)
                           ......|++.|+|||.+.+..++.++|||||||++|+|++|++||...+.........   ....+. ...+...
T Consensus       171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~---~~~~~~-~~~~~~~  241 (285)
T cd06648         171 -----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR---DNLPPK-LKNLHKV  241 (285)
T ss_pred             -----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH---hcCCCC-CcccccC
Confidence                 1122358999999999988889999999999999999999999997654432221111   111111 1112234


Q ss_pred             HHHHHHHHHHhhhcccCCCCChhH
Q 010882          376 AEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       376 ~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +..+.+++.+||..+|.+||++.+
T Consensus       242 ~~~l~~li~~~l~~~p~~Rpt~~~  265 (285)
T cd06648         242 SPRLRSFLDRMLVRDPAQRATAAE  265 (285)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHH
Confidence            578999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.9e-37  Score=300.12  Aligned_cols=248  Identities=23%  Similarity=0.406  Sum_probs=194.1

Q ss_pred             CCCCCCcccccCceEEEEEEECC---eEEEEEEecCCCC----------CChhhHHHHHHHHHc-CCCCCeeeeeceec-
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHSL----------QGPSEFQQEIDILSK-IRHPNLVTLVGACP-  203 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~~~----------~~~~~~~~E~~il~~-l~hpniv~l~g~~~-  203 (498)
                      +|.+...||+|+||.||+|...+   ..+|+|.+.....          .....+..|+.++.+ ++||||++++++|. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36777889999999999999854   7799998764321          112346778888875 79999999999884 


Q ss_pred             -CcceEEEeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          204 -EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       204 -~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                       +..++||||++|++|.+++... .....+++..++.++.+++.||.|||+.  .+++||||+|.|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence             4688999999999999987432 2345689999999999999999999952  57999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH--HhCc
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGK  359 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~  359 (498)
                      |++.......         ......|+..|+|||++.+..++.++||||||+++|+|++|++||..........  ..+.
T Consensus       159 g~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (269)
T cd08528         159 GLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV  229 (269)
T ss_pred             cceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence            9998654432         1123458999999999998889999999999999999999999997654432221  1111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          360 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      ..    +..   ....+..+.+++.+||+.+|.+||++.+ +...+
T Consensus       230 ~~----~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e-~~~~~  267 (269)
T cd08528         230 YE----PLP---EGMYSEDVTDVITSCLTPDAEARPDIIQ-VSAMI  267 (269)
T ss_pred             CC----cCC---cccCCHHHHHHHHHHCCCCCccCCCHHH-HHHHh
Confidence            11    111   1124578999999999999999999998 54443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-39  Score=319.72  Aligned_cols=244  Identities=24%  Similarity=0.362  Sum_probs=202.5

Q ss_pred             CCCCCcccccCceEEEEEEECCe--EEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN  215 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~~  215 (498)
                      |++...||.|+||.||++..+..  ..|.|++...+....++|.-|++||..++||+||+|++.|  ...+.|..|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            44556799999999999998754  3577888776666778899999999999999999999854  6778999999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |-.+.++-  .-..+|++.++..++.+++.||.|||+   ++|||||||..|||++-+|.++|+|||.+.....      
T Consensus       114 GAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~------  182 (1187)
T KOG0579|consen  114 GAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS------  182 (1187)
T ss_pred             chHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh------
Confidence            99988774  334679999999999999999999999   8999999999999999999999999998764322      


Q ss_pred             CccceeccCCCCCCCcCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                        +...+....|||.|||||+..     ..+|+.++||||||++|.||.-+.||....+.+...+...+...    ..--
T Consensus       183 --t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP----PTLl  256 (1187)
T KOG0579|consen  183 --TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP----PTLL  256 (1187)
T ss_pred             --HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC----Cccc
Confidence              222345678999999999875     35799999999999999999999999988888776665433221    1111


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      -|...+..+.+++.+||..||..||++.+.
T Consensus       257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql  286 (1187)
T KOG0579|consen  257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQL  286 (1187)
T ss_pred             CcchhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence            355567889999999999999999998873

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-37  Score=298.14  Aligned_cols=245  Identities=23%  Similarity=0.349  Sum_probs=196.4

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|+..+.||+|+||.||++..  .+..||+|.+.....  .....+.+|+.++++++||||+++++++.  +..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            467788999999999999987  467899999875322  23457889999999999999999999884  358899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++++|.+++... ....+++..+..++.+++.||.|||+   ++++|+||+|+|||++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988532 22357899999999999999999999   8999999999999999999999999999986543321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      .        .....|++.|+|||++.+..++.++|+|||||++|+|+||+.||...+........  ..    ......+
T Consensus       157 ~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~~----~~~~~~~  222 (256)
T cd08218         157 L--------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI--IR----GSYPPVS  222 (256)
T ss_pred             h--------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH--hc----CCCCCCc
Confidence            1        11234889999999999888999999999999999999999999755432221111  00    1111123


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ...+..+.+++.+||+.+|.+||++.+++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl  251 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSIL  251 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence            34567899999999999999999999843

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.3e-37  Score=304.55  Aligned_cols=235  Identities=26%  Similarity=0.356  Sum_probs=192.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|...+.||+|+||.||++.+.  +..||+|++.....   ...+.+.+|+.++++++||||+++++++.  ...++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            5778889999999999999884  68899999875432   23456889999999999999999999874  45789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++|+|.+++..   ...++...+..++.+++.||.|||+   .|++||||+|+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  155 (290)
T cd05580          82 YVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT  155 (290)
T ss_pred             cCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence            9999999999853   3568999999999999999999999   899999999999999999999999999988654331


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                                 ....|++.|+|||.+.+..++.++||||||+++|+|+||+.||...............       ....
T Consensus       156 -----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~~  217 (290)
T cd05580         156 -----------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-------KVRF  217 (290)
T ss_pred             -----------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------CccC
Confidence                       2234899999999998888899999999999999999999999765532211111000       1113


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      |...+..+.+++.+||..+|.+||+.
T Consensus       218 ~~~~~~~l~~li~~~l~~~p~~R~~~  243 (290)
T cd05580         218 PSFFSPDAKDLIRNLLQVDLTKRLGN  243 (290)
T ss_pred             CccCCHHHHHHHHHHccCCHHHccCc
Confidence            33446789999999999999999943

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.1e-37  Score=297.27  Aligned_cols=243  Identities=24%  Similarity=0.371  Sum_probs=195.3

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~  212 (498)
                      +|+..+.||+|+||.||++..  .+..+|||.+......  ....+.+|+.+++.++||||+++++.+  .+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477788999999999999887  4678999998754322  345788999999999999999999987  3468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-CceeEeeccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~~~~~~~  291 (498)
                      +++++|.+++.... ...+++..+..++.+++.||.|||+   ++++||||+|+||+++.+ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999995432 3458999999999999999999999   899999999999999854 568999999998764332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      ..         ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.........      .......
T Consensus       157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~------~~~~~~~  221 (256)
T cd08220         157 KA---------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM------SGTFAPI  221 (256)
T ss_pred             cc---------cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH------hcCCCCC
Confidence            11         12348999999999998889999999999999999999999997654432222111      0011112


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      +...+..+.+++.+||..+|.+||++.++
T Consensus       222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  250 (256)
T cd08220         222 SDRYSPDLRQLILSMLNLDPSKRPQLSQI  250 (256)
T ss_pred             CCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence            33356789999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=299.79  Aligned_cols=241  Identities=26%  Similarity=0.410  Sum_probs=193.5

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC-CCChhhHHHHHHHHHcCC---CCCeeeeeceec--CcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIR---HPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~---hpniv~l~g~~~--~~~~lV~  210 (498)
                      .|+..+.||.|+||.||+|.+  .+..||+|.+.... ......+.+|+.+++.++   |||+++++++|.  +..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466778899999999999997  46889999987543 233467889999999997   999999999884  3578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++++|.+++..    ..+++.....++.+++.||.|||+   .|++||||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999999842    268999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ...        .....|+..|+|||.+.++ .++.++|||||||++|+|++|.+||..............   ..   ..
T Consensus       155 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~---~~  220 (277)
T cd06917         155 SSK--------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---SK---PP  220 (277)
T ss_pred             ccc--------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---CC---CC
Confidence            211        1223589999999998754 578899999999999999999999976654332211111   10   11


Q ss_pred             CCCH-HHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPF-VQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~-~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .++. ..+..+.+++.+||+.+|.+||++.++
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~i  252 (277)
T cd06917         221 RLEDNGYSKLLREFVAACLDEEPKERLSAEEL  252 (277)
T ss_pred             CCCcccCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            1111 145689999999999999999999883

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=300.21  Aligned_cols=239  Identities=25%  Similarity=0.304  Sum_probs=197.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChh---hHHHHHHHHHcCCCCCeeeeecee--cCcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~---~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV  209 (498)
                      -.+|+..++||+|.||+|..+.-+  ++.+|||++++......+   .-..|-.+|...+||.+..|-.+|  .+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            457899999999999999988764  688999999986544433   345789999999999999998888  4579999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||..||.|..+|.+   ...+++.....+..+|+.||.|||+   ++||.||||.+|+|||.+|++||+|||||+--..
T Consensus       247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            999999999999953   4568888888899999999999999   8999999999999999999999999999985433


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      .+  ...      ....|||.|+|||++....|+.++|||.+|||||||++|+.||...+.-       ++-.++-....
T Consensus       321 ~g--~t~------kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-------kLFeLIl~ed~  385 (516)
T KOG0690|consen  321 YG--DTT------KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-------KLFELILMEDL  385 (516)
T ss_pred             cc--cee------ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-------HHHHHHHhhhc
Confidence            22  222      2345999999999999999999999999999999999999999654321       11122222223


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCC
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                      .+|...+++...|+.-.|..||.+|..
T Consensus       386 kFPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  386 KFPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence            477778889999999999999999964

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-37  Score=323.74  Aligned_cols=246  Identities=20%  Similarity=0.305  Sum_probs=187.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY  212 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~  212 (498)
                      ...|.+.+.||+|+||.||+|.+.  +..||||...      ...+.+|+.+|++|+|||||++++++  ....++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            346888999999999999999985  5789999632      23467899999999999999999987  3467899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +. ++|.+++...  ...+++..++.|+.|++.||.|||+   +|||||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            94 7888887432  3469999999999999999999999   8999999999999999999999999999986543221


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCC-CCc---------HHHHHHHHhCcccc
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL-GIT---------KEVQYALDTGKLKN  362 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf-~~~---------~~~~~~~~~~~~~~  362 (498)
                      ..      ......||+.|+|||++.+..++.++|||||||+||||++|..|+ ...         ..+...+.......
T Consensus       316 ~~------~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        316 TP------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             cc------cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence            11      112346999999999999999999999999999999999987654 211         11111111111100


Q ss_pred             -ccC--------------------C--CCCCCCH--HHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 -LLD--------------------P--LAGDWPF--VQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 -~~~--------------------~--~~~~~~~--~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       .+.                    +  ....|..  ..+..+.+|+.+||+.||.+||++.++
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el  452 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL  452 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence             000                    0  0011111  123468899999999999999999883

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.5e-37  Score=299.76  Aligned_cols=240  Identities=28%  Similarity=0.406  Sum_probs=193.9

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      |...+.||.|+||.||+|...  +..||||.+..... .....+.+|+.++++++||||+++++++.  +..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            667778999999999999874  67899998764332 22356889999999999999999999884  46889999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++.    ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+.....  
T Consensus        86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence            999999884    2358899999999999999999999   8999999999999999999999999999876543221  


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                            ......|+..|+|||.+.+..++.++|||||||++|+|+||.+||..............      ......+..
T Consensus       157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~  224 (277)
T cd06641         157 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK------NNPPTLEGN  224 (277)
T ss_pred             ------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc------CCCCCCCcc
Confidence                  11223588999999999888889999999999999999999999976543322211110      011112334


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+..+.+++.+||..+|..||++.++
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~  250 (277)
T cd06641         225 YSKPLKEFVEACLNKEPSFRPTAKEL  250 (277)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHH
Confidence            56789999999999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=303.19  Aligned_cols=248  Identities=28%  Similarity=0.374  Sum_probs=195.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|+..+.||+|+||.||+|.+.  +..||||+++....  ...+.+.+|+++++.++||||+++++++.  +..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5788889999999999999885  57899998875422  23467899999999999999999999984  458999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++++.+..++.   ....+++..+..++.+++.||.|||.   .+++||||+|+||+++.++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99877776653   23458999999999999999999999   8999999999999999999999999999887654331


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc----cc------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----LK------  361 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~----~~------  361 (498)
                      ..       .....|+..|+|||++.+. .++.++||||||+++|+|++|++||..............    +.      
T Consensus       156 ~~-------~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07833         156 SP-------LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL  228 (288)
T ss_pred             cc-------ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence            01       1234578999999999888 789999999999999999999999976544322211100    00      


Q ss_pred             ----------cccCCC-----CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          362 ----------NLLDPL-----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       362 ----------~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                ...+..     ...++...+..+.+++.+||..+|++||++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  281 (288)
T cd07833         229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE  281 (288)
T ss_pred             cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence                      000000     00123334688999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-36  Score=294.56  Aligned_cols=245  Identities=31%  Similarity=0.445  Sum_probs=195.7

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|...+.||+|+||.||+|..  .+..|++|.+......  ....+..|+.+++.++||||+++++.+.  +..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            367778999999999999987  4688999998765543  4567889999999999999999999873  468899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++++|.+++..   ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999853   3458889999999999999999999   8999999999999999999999999999987654432


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCC---CCCccchHhHHHHHHHHHhCCCCCCCcH-HHHHHHHhCccccccCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~~~~~~~~~~~~~  368 (498)
                      .....    .....|++.|+|||++.+..   ++.++||||||+++|+|++|+.||.... ...........   .   .
T Consensus       155 ~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~---~  224 (264)
T cd06626         155 TMGEE----VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG---H---K  224 (264)
T ss_pred             ccccc----ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC---C---C
Confidence            11110    12245889999999998766   8899999999999999999999996542 22222111110   0   1


Q ss_pred             CCCCH--HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          369 GDWPF--VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       369 ~~~~~--~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...|.  ..+..+.+++.+||+.+|.+||++.+
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  257 (264)
T cd06626         225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASE  257 (264)
T ss_pred             CCCCcccccCHHHHHHHHHHccCCcccCCCHHH
Confidence            11222  23677899999999999999999988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4e-37  Score=303.83  Aligned_cols=248  Identities=25%  Similarity=0.308  Sum_probs=191.6

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-----ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      +|...+.||+|+||.||+|...  +..||||.+......     ....+..|+.+++.++||||+++++++.+  ..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3667788999999999999974  688999999765432     13456789999999999999999999854  67899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+ +|+|.+++....  ..+++..+..++.|++.||.|||.   ++++||||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999995322  369999999999999999999999   8999999999999999999999999999986644


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc---------
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------  359 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~---------  359 (498)
                      ....        .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||..............         
T Consensus       155 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (298)
T cd07841         155 PNRK--------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN  226 (298)
T ss_pred             CCcc--------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence            3211        122347889999999865 4578899999999999999999998865443221111000         


Q ss_pred             ------cccccCCC-CC-----CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 ------LKNLLDPL-AG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 ------~~~~~~~~-~~-----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                            ........ ..     ......+..+.+++.+||..+|.+||++.++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~  279 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA  279 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH
Confidence                  00000000 00     0112335778999999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-37  Score=314.67  Aligned_cols=188  Identities=22%  Similarity=0.327  Sum_probs=158.4

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ...+|.+.+.||+|+||.||+|...  +..||+|+....      ....|+.++++++||||+++++++.  ...++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999985  468999975432      3457999999999999999999884  45789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+. |+|.+++..  ...++++..+..|+.|++.||.|||.   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            995 688888853  34568999999999999999999999   899999999999999999999999999987533221


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA  344 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p  344 (498)
                      .         .....||+.|+|||++.+..++.++|||||||++|||+++..|
T Consensus       212 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        212 A---------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             c---------cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence            0         1233589999999999999999999999999999999985544

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.5e-37  Score=302.01  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=193.6

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|.+.+.||.|+||.||+|.+  .+..||+|++.....  .....+.+|+.++++++||||+++++++.  ...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            467788899999999999987  468899999876542  23467899999999999999999999874  457899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      + +++|.+++...  ..++++..+..++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 99999998533  2569999999999999999999999   8999999999999999999999999999987654321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Cc--------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK--------  359 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~--------  359 (498)
                      .       ......|+..|+|||++.+. .++.++|||||||++|+|+||.+||............    +.        
T Consensus       155 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07832         155 R-------LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG  227 (286)
T ss_pred             C-------ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence            0       01234589999999998764 4688999999999999999999998755432211100    00        


Q ss_pred             ------cccccCCCCC-----CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 ------LKNLLDPLAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 ------~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                            ......+...     ......+..+.+++.+|+..+|.+||++.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  279 (286)
T cd07832         228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA  279 (286)
T ss_pred             ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH
Confidence                  0000000000     0011235789999999999999999999883

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.6e-37  Score=301.13  Aligned_cols=248  Identities=26%  Similarity=0.344  Sum_probs=190.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|+..+.||.|+||.||+|...  +..||||.+......  ....+.+|++++++++||||+++++++.  +..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4777889999999999999884  678999988754322  2356889999999999999999999884  468899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +. ++|.+++.... ...+++..+..++.+++.||.|||.   .+++||||+|+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            95 68988885432 3568999999999999999999999   8999999999999999999999999999876543211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc-----------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-----------  360 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-----------  360 (498)
                      .        .....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...+...........           
T Consensus       156 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         156 T--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             c--------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence            1        12234788999999887654 688999999999999999999999765443222111000           


Q ss_pred             -----------ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 -----------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 -----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                 ...............+..+.+++.+||+.||.+||++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  277 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA  277 (284)
T ss_pred             hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHH
Confidence                       000000000011123466889999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.6e-37  Score=299.93  Aligned_cols=249  Identities=26%  Similarity=0.359  Sum_probs=192.6

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      +|+..+.||.|++|.||+|...  +..||||.+...... ....+.+|+.++++++||||++++++|.  +..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778889999999999999984  688999998765332 3456778999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++ +|.+++........+++..+..++.+++.||.|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            75 888888654444579999999999999999999999   8999999999999999999999999999976543211 


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC--------------
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG--------------  358 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~--------------  358 (498)
                             ......+|+.|+|||++.+. .++.++|||||||++|+|+||++||...+.........              
T Consensus       156 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07836         156 -------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI  228 (284)
T ss_pred             -------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence                   11223478999999998664 57889999999999999999999997544322111000              


Q ss_pred             -ccccccCC-------CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 -KLKNLLDP-------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 -~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       ........       .........+..+.+++..|++.+|.+||++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  277 (284)
T cd07836         229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD  277 (284)
T ss_pred             hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence             00000000       000011233567889999999999999999987

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.6e-36  Score=290.67  Aligned_cols=243  Identities=30%  Similarity=0.474  Sum_probs=198.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      +|...+.||+|+||.||++...  +..|++|++..........+.+|+.+++.++||||+++++.+.  ...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677788999999999999985  6889999998765545678999999999999999999999873  46889999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +++|.+++....  ..+++..+..++.+++.||.+||.   .+++||||+|+||+++.++.++|+|||++........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999985332  568999999999999999999999   8999999999999999999999999999886654321  


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                             .....|+..|+|||.+.+..++.++||||||+++|+|++|++||...+..........    ........+..
T Consensus       154 -------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~  222 (253)
T cd05122         154 -------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNPEK  222 (253)
T ss_pred             -------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cCCCCcCcccc
Confidence                   1223488999999999888899999999999999999999999976643332222211    00111111222


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+..+.+++.+||..+|..||++.+
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~  247 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQ  247 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHH
Confidence            3578999999999999999999987

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-37  Score=300.35  Aligned_cols=248  Identities=26%  Similarity=0.389  Sum_probs=188.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|+..+.||.|+||.||+|..+  +..||||.+...... ....+.+|+.+++.++||||+++++++.  +..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            46888889999999999999874  688999998754322 2345778999999999999999999984  458899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++ +|.+++...  ...+++.....++.+++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            974 899988533  2368899999999999999999999   8999999999999999999999999999875432111


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH-hC---------ccc
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-TG---------KLK  361 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~-~~---------~~~  361 (498)
                      .        .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.........+. ..         .+.
T Consensus       159 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         159 T--------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP  230 (291)
T ss_pred             c--------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence            0        112246889999999876 4588999999999999999999999965431111100 00         000


Q ss_pred             cc------cC---CCC------CCCC-HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          362 NL------LD---PLA------GDWP-FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       362 ~~------~~---~~~------~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..      ..   +..      ...+ ......+.+++.+||+.+|.+||++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e  284 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE  284 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence            00      00   000      0000 001267789999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.4e-37  Score=300.24  Aligned_cols=251  Identities=27%  Similarity=0.387  Sum_probs=189.7

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC-hhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      ++.+|...+.||+|+||.||+|...  +..||+|++....... ...+.+|+.+++.++|+||+++++++.+  ..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4567888999999999999999874  6889999987543322 3467899999999999999999998843  578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+. ++|.+.+..  ....+++..+..++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9995 677766642  23457888889999999999999999   89999999999999999999999999998754322


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh-----C------
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-----G------  358 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-----~------  358 (498)
                      ...        .....+++.|+|||++.+. .++.++|||||||++|+|+||.+||.........+..     +      
T Consensus       157 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  228 (291)
T cd07870         157 SQT--------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT  228 (291)
T ss_pred             CCC--------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence            111        1223478999999998764 5788999999999999999999999755432111110     0      


Q ss_pred             -----ccccccCCCC-CCCC---------HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 -----KLKNLLDPLA-GDWP---------FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 -----~~~~~~~~~~-~~~~---------~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                           .+........ ...+         ...+..+.+++.+|+..+|.+||++.++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~  285 (291)
T cd07870         229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA  285 (291)
T ss_pred             hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence                 0000000000 0000         0124578899999999999999999883

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.5e-37  Score=301.98  Aligned_cols=247  Identities=26%  Similarity=0.305  Sum_probs=186.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|...+.||+|+||.||+|.+.  +..||+|.+.....  .....+.+|+.++++++||||+++++++.  ...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            3677788999999999999984  68899999875422  22356788999999999999999999884  458899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +. ++|.+++...  ...+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            96 5788877432  3468999999999999999999999   8999999999999999999999999999986543211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCC-CcHHHHHHHHh----C--------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALG-ITKEVQYALDT----G--------  358 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~-~~~~~~~~~~~----~--------  358 (498)
                      .        .....+++.|+|||++.+. .++.++|||||||++|+|+||..||. ..+........    +        
T Consensus       155 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd07839         155 C--------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP  226 (284)
T ss_pred             C--------cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence            1        1233578999999998775 47899999999999999999987753 22211110000    0        


Q ss_pred             ccccccCC-----CCC-----CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 KLKNLLDP-----LAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 ~~~~~~~~-----~~~-----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+....+.     ...     ......+..+.+++.+||+.+|.+||++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~  277 (284)
T cd07839         227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE  277 (284)
T ss_pred             HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence            00000000     000     001124567899999999999999999988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=302.42  Aligned_cols=240  Identities=23%  Similarity=0.299  Sum_probs=194.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC--eEEEEEEecCCCCCC---hhhHHHHHHHHHcC-CCCCeeeeeceec--CcceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG---PSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~---~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~l  208 (498)
                      ..+|....+||+|+||.|..+..++  ..+|||++++.....   .+--..|-.+|... +-|.+++|..+|+  +.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            3478999999999999999998876  469999998864322   23344677777766 4678888888874  68999


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+.||+|.-+++.   -..+.+.....+|.+||-||-|||+   +|||.||||.+||+||.+|++||+|||+|+--.
T Consensus       428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc
Confidence            9999999999999953   3457778899999999999999999   999999999999999999999999999998322


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      -..   ..+     ....|||.|+|||++...+|+.++|||||||+||||+.|++||++.++-.........       .
T Consensus       502 ~~~---~TT-----kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------n  566 (683)
T KOG0696|consen  502 FDG---VTT-----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------N  566 (683)
T ss_pred             cCC---cce-----eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------c
Confidence            211   111     2335999999999999999999999999999999999999999987664432222111       1


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ..+|...+.+...+....+...|.+|...
T Consensus       567 vsyPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  567 VSYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence            23788888999999999999999999543

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-36  Score=301.33  Aligned_cols=240  Identities=28%  Similarity=0.374  Sum_probs=190.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ..|...+.||+|+||.||+|..  .+..||+|.+.......   ...+.+|+.+++.++||||++++++|.  +..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            3588888999999999999987  46889999986543332   245889999999999999999999984  4678999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++ |+|.+.+...  ..++++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9996 5777776422  3468999999999999999999999   89999999999999999999999999998754322


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                                  ....|++.|+|||++.   ...++.++|||||||++|||+||++||...+........... .  .+.
T Consensus       169 ------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~--~~~  233 (307)
T cd06607         169 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-D--SPT  233 (307)
T ss_pred             ------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-C--CCC
Confidence                        1224788999999884   356889999999999999999999999765543322221100 0  000


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        ..+...+..+.+++.+||..+|.+||++.++
T Consensus       234 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  264 (307)
T cd06607         234 --LSSNDWSDYFRNFVDSCLQKIPQDRPSSEEL  264 (307)
T ss_pred             --CCchhhCHHHHHHHHHHhcCChhhCcCHHHH
Confidence              0122345689999999999999999999883

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.9e-37  Score=303.76  Aligned_cols=257  Identities=16%  Similarity=0.187  Sum_probs=181.2

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-----eEEEEEEecCCCCCCh-h----------hHHHHHHHHHcCCCCCeeeeece
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGP-S----------EFQQEIDILSKIRHPNLVTLVGA  201 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~-~----------~~~~E~~il~~l~hpniv~l~g~  201 (498)
                      ..|.+.+.||+|+||.||+|.+.+     ..+|+|+......... +          ....+...+..++|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            478889999999999999998754     3567776443222110 0          11233345566789999999987


Q ss_pred             ecC------cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          202 CPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       202 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      +..      ..+++|+++. .++.+.+..   ....++..+..|+.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence            632      2367888774 467666632   2335778889999999999999999   89999999999999999999


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH-
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-  354 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~-  354 (498)
                      ++|+|||+|+.+........ ..........||+.|+|||++.+..++.++|||||||+||||+||.+||......... 
T Consensus       165 ~~l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIE-YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccc-cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            99999999987643321110 0001122346999999999999999999999999999999999999999754211110 


Q ss_pred             --HHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          355 --LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       355 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                        ...+-+..+..+. . .+...+..+.+++..|+..+|.+||++.+ +.+.+
T Consensus       244 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~-l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEGK-I-KIKNANKFIYDFIECVTKLSYEEKPDYDA-LIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhhh-h-ccCCCCHHHHHHHHHHHhCCCCCCCCHHH-HHHhh
Confidence              0000011111100 0 11223578999999999999999999988 55443

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-37  Score=298.49  Aligned_cols=238  Identities=25%  Similarity=0.310  Sum_probs=195.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      +|...+.||.|+||.||+|...  +..||+|.+.....   ...+.+.+|+.++++++||||+++++++.  ...++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777889999999999999985  68899999875432   23467889999999999999999999884  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+.|++|.+++..   ..+++...+..++.+++.||.|||.   ++++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999943   2578999999999999999999999   899999999999999999999999999988654332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH--HHHHHHhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~  369 (498)
                      .         .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.....  ..........      ...
T Consensus       155 ~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~  219 (258)
T cd05578         155 L---------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------ADV  219 (258)
T ss_pred             c---------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------ccc
Confidence            1         1223488999999999988899999999999999999999999976542  1111111110      112


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ..|...+..+.+++.+||..+|.+||+.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~  247 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGD  247 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCc
Confidence            2344456889999999999999999999

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.6e-37  Score=299.31  Aligned_cols=242  Identities=26%  Similarity=0.384  Sum_probs=186.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHH-HHcCCCCCeeeeecee--cCcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDI-LSKIRHPNLVTLVGAC--PEVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~i-l~~l~hpniv~l~g~~--~~~~~lV~E~  212 (498)
                      +|++...||+|+||.||+|.+.  +..||||.+...... ....+..|+.+ ++.++||||+++++++  ....++||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            6788889999999999999984  688999998754322 23345566665 5667899999999988  3468999999


Q ss_pred             CCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          213 LPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       213 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ++ |+|.+++... .....+++..+..++.|++.||.|||+   + +++||||||+|||++.++.+||+|||++......
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            96 6888877532 234579999999999999999999998   6 8999999999999999999999999998865432


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhcc----CCCCCccchHhHHHHHHHHHhCCCCCCCcHH-HHHHHHhCccccccC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDTGKLKNLLD  365 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~~~~~~~~~~  365 (498)
                      ..         .....|+..|+|||.+.+    ..++.++|+|||||++|+|++|+.||..... .......      ..
T Consensus       158 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~  222 (283)
T cd06617         158 VA---------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV------VE  222 (283)
T ss_pred             cc---------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH------Hh
Confidence            11         122348899999999865    4578899999999999999999999964321 1111110      00


Q ss_pred             CCCCCCC-HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 PLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 ~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ......+ ...+..+.+++.+||..+|.+||++.+
T Consensus       223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~  257 (283)
T cd06617         223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPE  257 (283)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence            0011111 124578999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-37  Score=299.35  Aligned_cols=247  Identities=25%  Similarity=0.335  Sum_probs=190.2

Q ss_pred             CCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          140 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      |+..+.||.|++|.||+|.+  .+..||+|++......  ....+.+|+.+++.++|||++++++++.  +..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            55677899999999999987  4788999998754322  2356889999999999999999999984  4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      + ++|.+++.... ...+++..+..++.+++.||.|||+   ++++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 68999885332 1368999999999999999999999   89999999999999999999999999999755332111


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc-------------
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-------------  359 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-------------  359 (498)
                              .....+++.|+|||++.+. .++.++|||||||++|+|+||++||...+..........             
T Consensus       156 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07835         156 --------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV  227 (283)
T ss_pred             --------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence                    1223478999999988764 578899999999999999999999976544322211100             


Q ss_pred             ---------cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          360 ---------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       360 ---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                               +...............+..+.+++.+|++.+|.+||++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  276 (283)
T cd07835         228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA  276 (283)
T ss_pred             hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence                     0000000001111223467899999999999999999988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.5e-37  Score=298.83  Aligned_cols=236  Identities=25%  Similarity=0.341  Sum_probs=188.0

Q ss_pred             ccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      ||+|+||+||++...  +..||+|.+.....   .....+..|+.+++.++||||+++++++.  +..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999874  68899999875432   22345678999999999999999999874  468999999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++..... ..+++..+..++.+++.||.|||+   .+++||||+|+||+++.++.+||+|||++........      
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------  150 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------  150 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------
Confidence            999864322 468999999999999999999999   8999999999999999999999999999876543211      


Q ss_pred             ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCccccccCCCCCCCCHHHH
Q 010882          299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                         .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......  ...+......     .....+...+
T Consensus       151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~  222 (277)
T cd05577         151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----MAVEYPDKFS  222 (277)
T ss_pred             ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----ccccCCccCC
Confidence               12234788999999998888999999999999999999999999654321  1111111111     1122334456


Q ss_pred             HHHHHHHHHhhhcccCCCCChhH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+.+++.+||+.+|.+||+..+
T Consensus       223 ~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         223 PEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             HHHHHHHHHHccCChhHccCCCc
Confidence            78999999999999999996655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-36  Score=293.60  Aligned_cols=244  Identities=24%  Similarity=0.349  Sum_probs=198.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      +|+..+.||.|+||.||+|...  +..|+||++..... .....+.+|+.++.+++||||+++++++.  ...++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5778889999999999999885  68899999876544 33567899999999999999999999884  4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++..   ..+++...+..++.+++.||.|||+.  .+++||||+|+||+++.++.++|+|||++.........
T Consensus        82 ~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          82 DGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            99999999953   25689999999999999999999973  57999999999999999999999999999876543221


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH--HHHHHHHhCccccccCCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      .        ....|+..|+|||.+.+..++.++||||||+++|+|+||.+||....  .........     ........
T Consensus       157 ~--------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~  223 (264)
T cd06623         157 C--------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-----CDGPPPSL  223 (264)
T ss_pred             c--------cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-----hcCCCCCC
Confidence            1        12347899999999998899999999999999999999999997653  211111111     11111223


Q ss_pred             CHH-HHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          372 PFV-QAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       372 ~~~-~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      +.. .+..+.+++..||..+|..||++.++
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l  253 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAEL  253 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            333 56789999999999999999999883

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-36  Score=294.76  Aligned_cols=234  Identities=26%  Similarity=0.327  Sum_probs=190.7

Q ss_pred             ccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      ||.|+||.||+|...  +..||+|++......   ..+.+.+|+.+++.++||||+++++.+.  ...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999996  789999998764332   2456889999999999999999999874  458899999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++..   ...++...+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~------  148 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK------  148 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc------
Confidence            999953   3458899999999999999999999   8999999999999999999999999999986643320      


Q ss_pred             ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH--HHHHHHHhCccccccCCCCCCCCHHHH
Q 010882          299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGDWPFVQA  376 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (498)
                         .....|++.|+|||.+....++.++|+||||+++|+|++|..||....  ..........     ......+|...+
T Consensus       149 ---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~  220 (262)
T cd05572         149 ---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK-----GNGKLEFPNYID  220 (262)
T ss_pred             ---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc-----cCCCCCCCcccC
Confidence               122348899999999988889999999999999999999999997655  2221111100     011223444457


Q ss_pred             HHHHHHHHHhhhcccCCCCChhH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+.+++.+||..+|.+||++.+
T Consensus       221 ~~~~~~i~~~l~~~p~~R~~~~~  243 (262)
T cd05572         221 KAAKDLIKQLLRRNPEERLGNLK  243 (262)
T ss_pred             HHHHHHHHHHccCChhhCcCCcc
Confidence            78999999999999999999544

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-36  Score=299.78  Aligned_cols=248  Identities=25%  Similarity=0.300  Sum_probs=190.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCC-CCCeeeeeceecC--c-----c
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIR-HPNLVTLVGACPE--V-----W  206 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-hpniv~l~g~~~~--~-----~  206 (498)
                      +|+..+.||+|+||.||+|.+.  +..||||.+.....  .....+.+|+.+++.+. ||||+++++++..  .     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6788889999999999999984  67899998765432  22356888999999995 6999999998732  2     6


Q ss_pred             eEEEeeCCCCCHHhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-CCceeEeeccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGI  283 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGl  283 (498)
                      ++||||+++ +|.+++.....  ...+++..+..++.|++.||.|||.   ++|+||||+|+||+++. ++.+||+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence            899999985 78888754322  3468999999999999999999999   89999999999999998 89999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      +..+......        .....+++.|+|||++.+ ..++.++|||||||++|+|+||.+||...+............ 
T Consensus       158 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~-  228 (295)
T cd07837         158 GRAFSIPVKS--------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL-  228 (295)
T ss_pred             ceecCCCccc--------cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh-
Confidence            8865332111        112247889999998865 457899999999999999999999997655443322110000 


Q ss_pred             ccCCCC---------------C--------CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 LLDPLA---------------G--------DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 ~~~~~~---------------~--------~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       ..+..               .        ......+..+.+++.+||..+|.+||++.++
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei  288 (295)
T cd07837         229 -GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA  288 (295)
T ss_pred             -CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence             00000               0        0001245678999999999999999999873

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=294.21  Aligned_cols=245  Identities=24%  Similarity=0.363  Sum_probs=195.4

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC-----CChhhHHHHHHHHHcCCCCCeeeeeceecC----cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVTLVGACPE----VW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~  206 (498)
                      .+|.+.+.||+|+||.||+|..  .+..||+|.+.....     .....+.+|+.++++++||||+++++++.+    ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3688899999999999999987  467899998754321     123468899999999999999999998743    36


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+++++|.+++..   ...+++.....++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999843   3458889999999999999999999   8999999999999999999999999999986


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      .........     ......|+..|+|||++.+..++.++|||||||++|+|++|++||.............     ..+
T Consensus       156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~  225 (264)
T cd06653         156 IQTICMSGT-----GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-----TQP  225 (264)
T ss_pred             cccccccCc-----cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-----cCC
Confidence            532111000     0123358999999999998889999999999999999999999997654433322211     111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .....|...+..+.+++.+||. +|..||+..+
T Consensus       226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~  257 (264)
T cd06653         226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEF  257 (264)
T ss_pred             CCCCCCcccCHHHHHHHHHHhc-CcccCccHHH
Confidence            1223456677889999999999 5799999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-36  Score=299.48  Aligned_cols=249  Identities=26%  Similarity=0.349  Sum_probs=192.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec----CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV  209 (498)
                      .+|...+.||.|+||.||+|.+.  +..||+|.+......  ....+.+|+.++.+++||||+++++++.    ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            36778889999999999999985  678999998754322  2235678999999999999999999873    568999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+. ++|.+++....  ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.....
T Consensus        85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 59999885432  368999999999999999999999   8999999999999999999999999999986654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC----------
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG----------  358 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~----------  358 (498)
                      ....        .....+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.............          
T Consensus       159 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
T cd07843         159 PLKP--------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI  230 (293)
T ss_pred             Cccc--------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence            3211        1223478999999998764 46889999999999999999999997543322111000          


Q ss_pred             -------------ccccc-cCCCCCCCCHH-HHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 -------------KLKNL-LDPLAGDWPFV-QAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 -------------~~~~~-~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                   .+... .......++.. .+..+.+++.+||+.+|++||++.++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el  287 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA  287 (293)
T ss_pred             HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH
Confidence                         00000 00001112222 46778999999999999999999883

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.8e-37  Score=299.87  Aligned_cols=248  Identities=25%  Similarity=0.297  Sum_probs=187.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCC-CCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|.....||+|+||.||++...  +..||+|.+...... ....+.+|+.++.++. ||||++++|++.  ...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3455567999999999999884  688999998754332 3456889999999996 999999999873  457899999


Q ss_pred             CCCCCHHhhhcc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          213 LPNGSLEDRLSC--KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       213 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      +. ++|.++...  ......+++..+..++.+++.||.|||+.  .+++||||||+||+++.++.+||+|||++......
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            85 466554321  11235689999999999999999999972  48999999999999999999999999999765432


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccC---CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                      ...         ....|++.|+|||.+.+.   .++.++|||||||++|+|++|++||.............  .....+.
T Consensus       162 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~  230 (288)
T cd06616         162 IAK---------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV--VKGDPPI  230 (288)
T ss_pred             Ccc---------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh--cCCCCCc
Confidence            211         122489999999999876   68999999999999999999999997654322221111  0000011


Q ss_pred             -CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          368 -AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       368 -~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       ....+...+..+.+|+.+||+.+|.+||++.++
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i  264 (288)
T cd06616         231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKEL  264 (288)
T ss_pred             CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence             111223356789999999999999999999883

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9e-37  Score=295.03  Aligned_cols=241  Identities=27%  Similarity=0.351  Sum_probs=190.5

Q ss_pred             ccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      ||.|+||.||++...  +..|++|++.....   .....+.+|++++++++||||+++++.+.  ...++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999985  78899999876543   23456889999999999999999998874  457899999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++...   ..+++..+..++.|++.||.|||.   .+++||||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9999532   368999999999999999999999   8999999999999999999999999999886543321100000


Q ss_pred             ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHH--H
Q 010882          299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ--A  376 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  376 (498)
                      ........++..|+|||.+....++.++||||||+++|+|+||..||..............  .     ...++...  +
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~  227 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--G-----KIEWPEDVEVS  227 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C-----CcCCCccccCC
Confidence            0112334588899999999888899999999999999999999999976543322211110  0     01123222  6


Q ss_pred             HHHHHHHHHhhhcccCCCCChhH
Q 010882          377 EQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       377 ~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+.+++.+||+.+|..||++..
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~  250 (265)
T cd05579         228 DEAIDLISKLLVPDPEKRLGAKS  250 (265)
T ss_pred             HHHHHHHHHHhcCCHhhcCCCcc
Confidence            78999999999999999999955

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-36  Score=293.82  Aligned_cols=244  Identities=27%  Similarity=0.396  Sum_probs=194.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      +|...+.||.|+||.||+|..+  +..||+|.+.....  ...+.+.+|+.+++.++||||+++++.+.+  ..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677788999999999999984  57899999875422  234568899999999999999999998843  57899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-ceeEeeccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNE  291 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~~  291 (498)
                      +++++|.+++... ....+++..+..++.+++.||.|||+   .+++|+||||+||+++.++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999998533 23458999999999999999999999   8999999999999999875 56999999988654322


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      ..        .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+........  ......+    .
T Consensus       157 ~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~----~  222 (257)
T cd08225         157 EL--------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI--CQGYFAP----I  222 (257)
T ss_pred             cc--------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--hcccCCC----C
Confidence            11        11234899999999998888999999999999999999999999765433222211  1111111    1


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      +...+..+.+++.+||..+|.+||++.++
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l  251 (257)
T cd08225         223 SPNFSRDLRSLISQLFKVSPRDRPSITSI  251 (257)
T ss_pred             CCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            22345689999999999999999999883

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.1e-36  Score=298.23  Aligned_cols=238  Identities=23%  Similarity=0.327  Sum_probs=190.0

Q ss_pred             CCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCCCCCH
Q 010882          143 SLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL  218 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~~gsL  218 (498)
                      ...||+|+||.||+|..  .+..||||.+..........+.+|+.+++.++||||+++++.+  .+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            35699999999999988  4688999998654444456788999999999999999999987  4568999999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++.    ...+++..+..++.+++.||.|||+   .|++||||+|+||+++.++.++|+|||++.........     
T Consensus       105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-----  172 (292)
T cd06657         105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-----  172 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-----
Confidence            99873    2358899999999999999999999   89999999999999999999999999998755432110     


Q ss_pred             ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHH
Q 010882          299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ  378 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (498)
                         .....|++.|+|||.+.+..++.++|||||||++|+|++|.+||.............   ..+.+... .....+..
T Consensus       173 ---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~  245 (292)
T cd06657         173 ---RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNLPPKLK-NLHKVSPS  245 (292)
T ss_pred             ---ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhCCcccC-CcccCCHH
Confidence               122348899999999988889999999999999999999999997654332211110   00111100 11224567


Q ss_pred             HHHHHHHhhhcccCCCCChhH
Q 010882          379 LANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       379 l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +.+++.+||..+|.+||++.+
T Consensus       246 l~~li~~~l~~~P~~R~~~~~  266 (292)
T cd06657         246 LKGFLDRLLVRDPAQRATAAE  266 (292)
T ss_pred             HHHHHHHHHhCCcccCcCHHH
Confidence            899999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.3e-36  Score=289.65  Aligned_cols=245  Identities=27%  Similarity=0.416  Sum_probs=199.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec----CcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV~  210 (498)
                      +|...+.||+|++|.||+|...  +..|++|++.....  ...+.+.+|+.++++++||||+++++.+.    ...++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667788999999999999986  78899999876543  23567889999999999999999999884    3578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++++|.+++...   ..+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998533   379999999999999999999999   89999999999999999999999999999876654


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH-HHHHHHHhCccccccCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ...      .......++..|+|||.+....++.++||||||+++|+|++|..||.... ..........     .....
T Consensus       155 ~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~  223 (260)
T cd06606         155 ETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-----SGEPP  223 (260)
T ss_pred             ccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-----cCCCc
Confidence            321      01123458999999999988889999999999999999999999997654 2222211111     01112


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..|...+..+.+++.+|++.+|.+||++.++
T Consensus       224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~l  254 (260)
T cd06606         224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADEL  254 (260)
T ss_pred             CCCcccCHHHHHHHHHhCcCChhhCCCHHHH
Confidence            2344557889999999999999999999883

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=289.40  Aligned_cols=241  Identities=28%  Similarity=0.435  Sum_probs=198.5

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|...+.||+|+||.||+|...  +..|++|.+.....  .....+.+|++++++++|||++++++++.  ...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677889999999999999874  57899999987654  23467899999999999999999999874  457899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++++|.+++..   ...+++..+..++.+++.||.|||+   .|++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999999853   3568999999999999999999999   8999999999999999999999999999987654332


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      .        .....|+..|+|||.+.+..++.++||||||+++|+|++|++||..............      ......+
T Consensus       155 ~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~  220 (254)
T cd06627         155 D--------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------DDHPPLP  220 (254)
T ss_pred             c--------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------cCCCCCC
Confidence            1        1223489999999999888889999999999999999999999976544332222110      1112234


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...+..+.+++.+||..+|++||++.+
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~  247 (254)
T cd06627         221 EGISPELKDFLMQCFQKDPNLRPTAKQ  247 (254)
T ss_pred             CCCCHHHHHHHHHHHhCChhhCcCHHH
Confidence            455678999999999999999999988

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.9e-37  Score=296.57  Aligned_cols=243  Identities=27%  Similarity=0.372  Sum_probs=194.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      +|+..+.||.|+||.||++.+.  +..||+|.+..... .....+.+|++++++++||||+++++.+.  ...++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5667778999999999999985  68899999876533 23456889999999999999999999873  4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++++|.+++....  .+++...+..++.+++.||.|||+.  .+++||||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            9999999985332  5788999999999999999999982  58999999999999999999999999998765432211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH----HHHHHHHhCccccccCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK----EVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~----~~~~~~~~~~~~~~~~~~~~  369 (498)
                                ...|+..|+|||++.+..++.++|||||||++|+|++|..||....    ........     .......
T Consensus       158 ----------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~  222 (265)
T cd06605         158 ----------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-----IVNEPPP  222 (265)
T ss_pred             ----------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-----HhcCCCC
Confidence                      1348899999999998899999999999999999999999996542    11111111     1111111


Q ss_pred             CCCHH-HHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFV-QAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~-~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+.. .+..+.+++.+||..+|.+||++.++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  254 (265)
T cd06605         223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL  254 (265)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            12222 56789999999999999999999883

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.8e-36  Score=300.19  Aligned_cols=252  Identities=22%  Similarity=0.267  Sum_probs=190.3

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCC--CCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      .+.+|.|+++.||++...+..||||++...  .......+.+|+.+++.++||||+++++++.  +..+++|||+++|+|
T Consensus         7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            344666677777777778899999998764  2233467899999999999999999999884  467899999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++.... ...+++..+..++.+++.||.|||+   ++|+||||||+||+++.++.+||+|||.+.......... ...
T Consensus        87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~-~~~  161 (314)
T cd08216          87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ-RVV  161 (314)
T ss_pred             HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc-ccc
Confidence            99986432 2358889999999999999999999   899999999999999999999999999987654332111 111


Q ss_pred             ceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh--CccccccC---------
Q 010882          299 LCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKNLLD---------  365 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~~---------  365 (498)
                      ........++..|+|||++..  ..++.++|||||||++|||++|..||............  +.....++         
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            111233457889999999976  35889999999999999999999999755433322211  11111110         


Q ss_pred             -----------C-----CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 -----------P-----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 -----------~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                 +     .....+...+..+.+++.+||..+|.+||++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  291 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ  291 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence                       0     001112234567899999999999999999988

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=337.72  Aligned_cols=246  Identities=26%  Similarity=0.354  Sum_probs=196.6

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEE
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV  209 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV  209 (498)
                      .+-++.....||.|.||.||.|..  +|...|+|-+....  ......+.+|+.++..++|||+|++||+=  .+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            345677788899999999999987  46778999776433  23345688999999999999999999975  5678999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      ||||.+|+|.+.+.   .+.-.++.....+..|++.||.|||+   +|||||||||.||||+.+|.+|++|||.|..+..
T Consensus      1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999994   33345666677788999999999999   8999999999999999999999999999998765


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCCc-HHHHHH--HHhCccccc
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGIT-KEVQYA--LDTGKLKNL  363 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~--~~~~~~~~~  363 (498)
                      .....    ...-...+||+.|||||++.+   .+..-+.||||+|||++||+||+.||... ++....  +..|..   
T Consensus      1387 ~~~~~----~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~--- 1459 (1509)
T KOG4645|consen 1387 NAQTM----PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK--- 1459 (1509)
T ss_pred             chhcC----CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC---
Confidence            42111    112245679999999999976   35677899999999999999999999643 333322  223322   


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                           +..|...+.+-.+++.+||+.||+.|-++.+
T Consensus      1460 -----Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1460 -----PQIPERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred             -----CCCchhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence                 2356668889999999999999999965544

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=301.34  Aligned_cols=199  Identities=26%  Similarity=0.356  Sum_probs=163.3

Q ss_pred             CCCCCcccccCceEEEEEEE----CCeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceec----CcceE
Q 010882          140 FDPSLKIGEGGYGSIYKGLL----RHMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTL  208 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~l  208 (498)
                      |.....||+|+||.||+|..    .+..||+|.+....   ......+.+|+.+++.++||||++++++|.    ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            67778899999999999998    35789999998643   233456788999999999999999999984    34899


Q ss_pred             EEeeCCCCCHHhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC----CCceeEeecc
Q 010882          209 VYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDFG  282 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~----~~~~kl~DFG  282 (498)
                      ||||+++ +|.+.+...  .....++...+..++.|++.||.|||+   .+|+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 676666322  122368999999999999999999999   89999999999999999    8999999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                      ++..........     .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||..
T Consensus       158 ~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  218 (316)
T cd07842         158 LARLFNAPLKPL-----ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG  218 (316)
T ss_pred             cccccCCCcccc-----cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            998764432210     111234589999999988764 588999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-37  Score=305.71  Aligned_cols=246  Identities=27%  Similarity=0.358  Sum_probs=193.1

Q ss_pred             hhcCCCCCCcccccCceEEEEEEECC-eEEEEEEecCC--CCCChhhHHHHHHHHHcCC-CCCeeeeecee--cCcceEE
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPH--SLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLV  209 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~g~~--~~~~~lV  209 (498)
                      ....|++.++||+||.+.||++...+ +-||+|.+...  +.....-|.+|+..|.+|. |.+||+||++-  ++..|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34568999999999999999998854 56788766543  3334567999999999995 99999999875  5679999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||- ..+|..+|.....  .++...+..+..|++.|+.++|.   +||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus       439 mE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             eecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            9987 4699999964433  23323778899999999999999   89999999999999965 5999999999998766


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccC-----------CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG  358 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (498)
                      +.++-      .+...+||+.||+||.+...           +.+.++||||||||||+|+.|++||+.......     
T Consensus       512 DTTsI------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a-----  580 (677)
T KOG0596|consen  512 DTTSI------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA-----  580 (677)
T ss_pred             cccce------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH-----
Confidence            54332      23556799999999998542           256789999999999999999999975543322     


Q ss_pred             ccccccCCC-CCCCCHHHH-HHHHHHHHHhhhcccCCCCChhH
Q 010882          359 KLKNLLDPL-AGDWPFVQA-EQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 ~~~~~~~~~-~~~~~~~~~-~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ++..+.+|. ...||.... .++.+++..||+.||++||+..+
T Consensus       581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e  623 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPE  623 (677)
T ss_pred             HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHH
Confidence            344555553 223443322 23999999999999999999988

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=304.89  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=189.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC-------cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~-------~~  206 (498)
                      +++|.+.+.||+|+||.||+|..  .+..||||.+..... .....+..|+.++++++||||+++++++..       ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            35788999999999999999987  468899999864322 234567889999999999999999987632       36


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+. ++|.+++.    ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            89999996 58888773    2458999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh------C-
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT------G-  358 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~------~-  358 (498)
                      .........     ......||+.|+|||.+.+ ..++.++|||||||++|+|+||++||...+........      . 
T Consensus       156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~  230 (336)
T cd07849         156 ADPEHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS  230 (336)
T ss_pred             ccccccccC-----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            543221111     1123458999999998755 46889999999999999999999999654322111000      0 


Q ss_pred             --ccccccC----------CCCCCCC-----HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 --KLKNLLD----------PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 --~~~~~~~----------~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        .+..+.+          +.....+     ...+..+.+++.+||+.+|.+||++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e  288 (336)
T cd07849         231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE  288 (336)
T ss_pred             HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence              0000000          0000000     123567899999999999999999988

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-36  Score=305.52  Aligned_cols=252  Identities=22%  Similarity=0.327  Sum_probs=193.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec------Ccce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~------~~~~  207 (498)
                      .+|+..+.||.|+||.||+|...  +..||+|++.....  .....+.+|+.+|+.++||||+++++++.      ...+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            57888899999999999999874  78899999875432  23456778999999999999999998773      2478


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+. |+|.+++.   ....+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++...
T Consensus        85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999995 68999884   33458999999999999999999999   89999999999999999999999999999865


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH---H-hC----
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---D-TG----  358 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~---~-~~----  358 (498)
                      ........    .......|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...+......   . .|    
T Consensus       158 ~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~  233 (334)
T cd07855         158 SSSPTEHK----YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE  233 (334)
T ss_pred             cccCcCCC----cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence            44321110    11123468999999999866 468899999999999999999999996543221100   0 00    


Q ss_pred             ---------ccccccC--CCCCCC-----CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 ---------KLKNLLD--PLAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 ---------~~~~~~~--~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                               .+....+  +.....     ....+..+.+++.+||+.+|.+||++.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~  291 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA  291 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                     0000000  000111     12246789999999999999999999873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8e-36  Score=297.56  Aligned_cols=235  Identities=28%  Similarity=0.381  Sum_probs=187.5

Q ss_pred             CCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          140 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      |...+.||+|+||.||+|..  .+..||+|.+.......   ...+.+|+.+++.++|||+++++++|.  +..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            67778899999999999987  46789999987543322   346888999999999999999999884  457899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++ |+|.+.+..  ...++++..+..++.+++.||.|||+   ++++||||+|+||+++.++.+||+|||++......  
T Consensus       107 ~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         107 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            97 478777742  23568999999999999999999999   89999999999999999999999999998754321  


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH--HhCccccccCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPL  367 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~~~~  367 (498)
                                ....|++.|+|||++.   .+.++.++|||||||++|+|++|++||..........  ..+...      
T Consensus       179 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------  242 (317)
T cd06635         179 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP------  242 (317)
T ss_pred             ----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC------
Confidence                      1234889999999984   4568899999999999999999999986543322211  111110      


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       ...+...+..+.+++.+||+.+|.+||++.+
T Consensus       243 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  273 (317)
T cd06635         243 -TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEE  273 (317)
T ss_pred             -CCCCccccHHHHHHHHHHccCCcccCcCHHH
Confidence             0012234567999999999999999999988

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.6e-36  Score=304.64  Aligned_cols=246  Identities=21%  Similarity=0.288  Sum_probs=190.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      ..+|...+.||+|+||.||+|..  .+..||||.+....  ......+.+|+.++++++||||++++++|..        
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            45788899999999999999987  46889999986432  2233567789999999999999999998732        


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||+. ++|.+.+..     .++...+..++.|++.||.|||+   .||+||||||+||+++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            3589999995 588887732     28888999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----C--
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G--  358 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~--  358 (498)
                      ........         .....||..|+|||.+.+..++.++|||||||++|+|++|+.||...+........    +  
T Consensus       166 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         166 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             eeCCCCCC---------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            86543221         12234889999999999999999999999999999999999999754322110000    0  


Q ss_pred             -------------------c------cccccC----CC-CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 -------------------K------LKNLLD----PL-AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 -------------------~------~~~~~~----~~-~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                         .      +.....    +. ....+...+..+.+++.+||..||.+||++.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei  308 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA  308 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence                               0      000000    00 000022345678999999999999999999884

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.1e-36  Score=295.04  Aligned_cols=231  Identities=26%  Similarity=0.329  Sum_probs=177.7

Q ss_pred             cccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHH---cCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILS---KIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~---~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      .||+|+||.||++...  +..||+|.+.......   ...+..|..++.   ..+||||+.+++++.  +..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999874  6889999887543221   123445544443   347999999998874  46889999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++..   ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||++........  
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--  152 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence            9999998843   3469999999999999999999999   8999999999999999999999999999875432211  


Q ss_pred             CCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHH-HHHHHhCccccccCCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  372 (498)
                              ....||+.|+|||.+.+ ..++.++|||||||++|+|+||..||...... ..........     .....|
T Consensus       153 --------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~  219 (279)
T cd05633         153 --------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----VNVELP  219 (279)
T ss_pred             --------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-----CCcCCc
Confidence                    12348999999999874 56889999999999999999999999643211 1111111110     111234


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCC
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                      ...+..+.+++.+||..+|.+||+
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~R~~  243 (279)
T cd05633         220 DSFSPELKSLLEGLLQRDVSKRLG  243 (279)
T ss_pred             cccCHHHHHHHHHHhcCCHHHhcC
Confidence            456678999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.9e-36  Score=297.87  Aligned_cols=249  Identities=27%  Similarity=0.305  Sum_probs=191.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec----CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV  209 (498)
                      .+|...+.||.|+||.||+|.+.  +..||+|.+......  ....+.+|+.++++++||||+++++++.    +..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            47888899999999999999984  688999998754322  2335678999999999999999999873    347899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+. ++|.+++...  ...+++..+..++.|++.||.|||+   .|++||||||+||+++.++.+||+|||++.....
T Consensus        87 ~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          87 MEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            99996 5888888532  3568999999999999999999999   8999999999999999999999999999987653


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccc-----c-
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK-----N-  362 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-----~-  362 (498)
                      ....        .....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+............     . 
T Consensus       161 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07845         161 PAKP--------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI  232 (309)
T ss_pred             ccCC--------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            3211        122236889999999876 457899999999999999999999997655433221110000     0 


Q ss_pred             -----------ccCCCCCCC------CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 -----------LLDPLAGDW------PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 -----------~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                 ........+      ....+..+.+++.+||..||++||++.++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i  287 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA  287 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence                       000000000      01135678899999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.6e-36  Score=341.25  Aligned_cols=249  Identities=29%  Similarity=0.476  Sum_probs=196.3

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ..|.....||+|+||.||+|..  .+..||||.+.....    ....|+.++++++|||||+++|+|.  +..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            4577788999999999999997  468899999864332    2235689999999999999999994  4578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++.      .++|..+..|+.+++.||.|||..+..+|+||||||+||+++.++..++. ||........   
T Consensus       766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            9999999993      38899999999999999999996555799999999999999999888875 6655432211   


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCc--------HHHHHHHHhCccccccC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT--------KEVQYALDTGKLKNLLD  365 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~--------~~~~~~~~~~~~~~~~~  365 (498)
                               ....||+.|+|||++.+..++.++|||||||++|||+||++||+..        .+.............++
T Consensus       836 ---------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  906 (968)
T PLN00113        836 ---------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID  906 (968)
T ss_pred             ---------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence                     1225899999999999999999999999999999999999998532        11122222222333344


Q ss_pred             CCCC---CCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          366 PLAG---DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       366 ~~~~---~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      +...   ..+......+.+++.+||+.+|.+||+|.+ |++.|+.+.+
T Consensus       907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e-vl~~L~~~~~  953 (968)
T PLN00113        907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND-VLKTLESASR  953 (968)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHH-HHHHHHHhhc
Confidence            4321   233455667889999999999999999999 7778887754

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.8e-36  Score=291.18  Aligned_cols=242  Identities=20%  Similarity=0.281  Sum_probs=183.9

Q ss_pred             HHHHhhcCCCCCCcc--cccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeecee--cC
Q 010882          132 EIEGATHNFDPSLKI--GEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PE  204 (498)
Q Consensus       132 ei~~~~~~~~~~~~l--G~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~--~~  204 (498)
                      ++....++|.+.+.+  |.|+||.||++...  +..+|+|.+.......     .|+.+...+ +||||++++++|  .+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            333334566666665  99999999999874  6789999986543221     123233222 799999999988  44


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-ceeEeeccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGI  283 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGl  283 (498)
                      ..++||||+++|+|.+++...   .++++..+..++.|++.||.|||+   .+++||||||+||+++.++ .++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            689999999999999999532   379999999999999999999999   8999999999999999988 999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      +.......            ...|+..|+|||++.+..++.++|||||||++|+|+||+.||...........  .+...
T Consensus       157 ~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~  222 (267)
T PHA03390        157 CKIIGTPS------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE--SLLKR  222 (267)
T ss_pred             ceecCCCc------------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH--HHHHh
Confidence            87654221            12489999999999998999999999999999999999999974322110000  00000


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCCh-hH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL-GK  399 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~-~~  399 (498)
                      .. .....+...+..+.+++.+||+.+|.+||+. .+
T Consensus       223 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  258 (267)
T PHA03390        223 QQ-KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNE  258 (267)
T ss_pred             hc-ccCCcccccCHHHHHHHHHHhccChhhCCchHHH
Confidence            10 1112233567889999999999999999964 44

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.3e-36  Score=295.35  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=188.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ++|+....||+|+||.||+|...  +..||+|.+.....  .....+.+|+.++++++||||+++++++.  ...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            36788889999999999999874  67899998865432  22356889999999999999999999984  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-CCceeEeecccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~  290 (498)
                      |++ ++|.+++.... ...+++.....++.+++.||.|||+   ++++||||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            995 57888774322 2346788888999999999999999   89999999999999985 567999999999755332


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc-----cccc-
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-----LKNL-  363 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-----~~~~-  363 (498)
                      ...        .....|++.|+|||++.+. .++.++|||||||++|+|+||++||..............     .... 
T Consensus       157 ~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (294)
T PLN00009        157 VRT--------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW  228 (294)
T ss_pred             ccc--------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            110        1223478999999998764 578899999999999999999999976543322111100     0000 


Q ss_pred             ------cC--CCCCC--------CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          364 ------LD--PLAGD--------WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       364 ------~~--~~~~~--------~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                            .+  .....        .....+..+.+++.+|++.+|.+||++.++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~  281 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA  281 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence                  00  00000        011235678999999999999999999883

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.8e-36  Score=288.58  Aligned_cols=244  Identities=27%  Similarity=0.437  Sum_probs=199.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|...+.||.|+||.||++.+.  +..|++|++.....  .....+..|+++++.++|||++++++.+.  +..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677788999999999999986  78899999876543  34567889999999999999999998873  467899999


Q ss_pred             CCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          213 LPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       213 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      +++++|.+++.... ....+++..+..++.+++.||.|||.   .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986432 23679999999999999999999999   899999999999999999999999999998664432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      .        ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+........  ....    ....
T Consensus       158 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~~----~~~~  223 (258)
T cd08215         158 D--------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LKGQ----YPPI  223 (258)
T ss_pred             c--------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH--hcCC----CCCC
Confidence            1        112235899999999998888999999999999999999999999765433222111  1111    1223


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      |...+..+.+++.+||..+|..||++.+
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  251 (258)
T cd08215         224 PSQYSSELRNLVSSLLQKDPEERPSIAQ  251 (258)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            3345678999999999999999999988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=289.61  Aligned_cols=233  Identities=24%  Similarity=0.281  Sum_probs=182.9

Q ss_pred             CcccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHHHH-HcCCCCCeeeeeceec--CcceEEEeeCCC
Q 010882          144 LKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDIL-SKIRHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~il-~~l~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      +.||.|+||.||+|..  .+..||||++.......   ...+..|..++ ...+||||+++++++.  +..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4699999999999988  46789999987543222   12344555444 4558999999999984  468999999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      ++|.+++..   ..++++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++......     
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  150 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----  150 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence            999999843   3468899999999999999999999   89999999999999999999999999998754321     


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCCCCCCH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  373 (498)
                             ....|++.|+|||.+.+..++.++||||||+++|+|+||.+||...+.....  ...+....     ....+.
T Consensus       151 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~  218 (260)
T cd05611         151 -------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW-----PEEVKE  218 (260)
T ss_pred             -------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC-----CCcccc
Confidence                   2234889999999998888899999999999999999999999765432221  11111110     011122


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+..+.+++.+||+.+|.+||++..
T Consensus       219 ~~~~~~~~~i~~~l~~~p~~R~~~~~  244 (260)
T cd05611         219 FCSPEAVDLINRLLCMDPAKRLGANG  244 (260)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCCCc
Confidence            34678999999999999999998865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.7e-36  Score=291.91  Aligned_cols=244  Identities=25%  Similarity=0.306  Sum_probs=185.0

Q ss_pred             CCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC-ChhhHHHHHHHHHcCC-CCCeeeeeceec----CcceEEEe
Q 010882          140 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP----EVWTLVYE  211 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-hpniv~l~g~~~----~~~~lV~E  211 (498)
                      |.+.+.||+|+||.||+|..  .+..||+|.+...... ......+|+.++.++. ||||+++++++.    +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            45667899999999999987  4678999998754222 2234457899999985 999999999874    45799999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++ |+|.+.+...  ...+++..+..++.+++.||.|||+   .+++||||+|+||+++. +.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            996 5788877432  3468999999999999999999999   89999999999999999 999999999998654322


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC----c-------
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG----K-------  359 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~----~-------  359 (498)
                      ..         ....++..|+|||.+.. ..++.++|||||||++|||++|.+||...+.........    .       
T Consensus       154 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07831         154 PY---------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK  224 (282)
T ss_pred             Cc---------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            11         12347899999997754 457889999999999999999999997654322111100    0       


Q ss_pred             ------cccccCCC-CC----CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          360 ------LKNLLDPL-AG----DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       360 ------~~~~~~~~-~~----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                            ......+. .+    ......+..+.+++.+||..+|.+||++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~  275 (282)
T cd07831         225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ  275 (282)
T ss_pred             hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH
Confidence                  00000000 00    001234678999999999999999999988

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=313.71  Aligned_cols=196  Identities=34%  Similarity=0.540  Sum_probs=169.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceecC--------cce
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------VWT  207 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------~~~  207 (498)
                      .+.....||+||||.||+|+++  |..||||.++... ....+...+|+++|++|+|||||+++++-.+        ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3455667999999999999974  7899999998754 3445678899999999999999999987532        357


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc--CCC--ceeEeeccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANF--VSKLSDFGI  283 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~--~~~--~~kl~DFGl  283 (498)
                      +|||||.||||...|..-.+...|++.+.+.+..+++.||.|||.   +||+||||||.||++-  .+|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            999999999999999887788889999999999999999999998   8999999999999984  334  459999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCC
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALG  346 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~  346 (498)
                      |+-+.++..         ..+.+||..|++||.+.. +.|+..+|.|||||++|+++||..||-
T Consensus       171 Arel~d~s~---------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~  225 (732)
T KOG4250|consen  171 ARELDDNSL---------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI  225 (732)
T ss_pred             cccCCCCCe---------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence            998776541         255679999999999985 788999999999999999999999984

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.4e-36  Score=296.53  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=189.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC---------
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE---------  204 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~---------  204 (498)
                      ++|...+.||+|+||.||+|...  +..||||.+......  ....+.+|+.++++++||||++++++|..         
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46888999999999999999884  688999988654322  23356789999999999999999998732         


Q ss_pred             -cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          205 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       205 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                       ..++||||+. ++|.+.+..  ....+++.++..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence             3489999996 588888743  23468999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH----hC
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD----TG  358 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~----~~  358 (498)
                      +...........    .......++..|+|||++.+. .++.++||||||+++|+|+||++||...+.......    .+
T Consensus       166 ~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         166 ARAFSLSKNSKP----NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cccccCCcccCC----CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            987654322110    111234578999999998764 478899999999999999999999976543221110    00


Q ss_pred             ccccccC--------------CCC--C-----CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 KLKNLLD--------------PLA--G-----DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 ~~~~~~~--------------~~~--~-----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+....-              +..  .     -.+...+..+.+++.+||..+|.+||++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e  303 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT  303 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence            0000000              000  0     001112456789999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-36  Score=292.87  Aligned_cols=248  Identities=27%  Similarity=0.389  Sum_probs=190.8

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceec----CcceEEEe
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE  211 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV~E  211 (498)
                      |.+.+.||.|+||.||+|...  +..||+|.+....  ......+.+|+.+++.++|||++++++++.    ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556778999999999999985  5889999998653  223456889999999999999999999884    45899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++ +|.+++...  ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9974 898888532  2468999999999999999999999   899999999999999999999999999998665432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc---------c
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---------K  361 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~---------~  361 (498)
                      ..       ......++..|+|||.+.+ ..++.++||||||+++|+|+||++||...+...........         .
T Consensus       155 ~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07840         155 SA-------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP  227 (287)
T ss_pred             cc-------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence            10       0122347889999998765 45789999999999999999999999765433221111000         0


Q ss_pred             cccC--------CCC-------CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 NLLD--------PLA-------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 ~~~~--------~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ...+        +..       ..+....+..+.+++.+||..+|.+||++.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  281 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA  281 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            0000        000       00011126788999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.6e-36  Score=296.99  Aligned_cols=241  Identities=26%  Similarity=0.355  Sum_probs=188.4

Q ss_pred             CCCCCCcccccCceEEEEEEE-----CCeEEEEEEecCCCC----CChhhHHHHHHHHHcC-CCCCeeeeeceecC--cc
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VW  206 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~  206 (498)
                      +|++.+.||.|+||.||.+..     .+..||+|++.....    ...+.+.+|+.++.++ +||||+.+++++..  ..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999876     467899999875322    2235688899999999 59999999988843  57


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+++++|.+++..   ..++++..+..++.+++.||.|||+   .+++||||+|+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            899999999999999853   3468889999999999999999999   8999999999999999999999999999986


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccC--CCCCccchHhHHHHHHHHHhCCCCCCCcHHHH--HHHHhCcccc
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKN  362 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~  362 (498)
                      ........       .....|+..|+|||.+...  .++.++||||||+++|+|+||..||.......  ..+..     
T Consensus       155 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-----  222 (290)
T cd05613         155 FHEDEVER-------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-----  222 (290)
T ss_pred             cccccccc-------cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----
Confidence            54332111       1223589999999998753  46789999999999999999999996432110  00100     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      .+......+|...+..+.+++.+||+.+|.+||+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~  257 (290)
T cd05613         223 RILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC  257 (290)
T ss_pred             HhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence            00001122344566789999999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-36  Score=302.53  Aligned_cols=248  Identities=25%  Similarity=0.316  Sum_probs=190.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceecC-------cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-------~~  206 (498)
                      ..|...+.||+|+||.||+|...  +..||||.+....  ......+..|+.+++.++||||+++++++..       ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            46888889999999999999874  6889999987532  2234567789999999999999999998732       36


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+. ++|.+++.   ....+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          85 YIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            89999995 68988884   33569999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH---H------
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---D------  356 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~---~------  356 (498)
                      .......        .....|+..|+|||.+.. ..++.++|||||||++|+|++|++||...+......   .      
T Consensus       158 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  229 (337)
T cd07858         158 TSEKGDF--------MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS  229 (337)
T ss_pred             cCCCccc--------ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            5433211        122347899999998875 468899999999999999999999997543211100   0      


Q ss_pred             --------hCcccccc-------CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          357 --------TGKLKNLL-------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       357 --------~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                              .......+       .+.........+..+.+++.+||+.+|.+||++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el  288 (337)
T cd07858         230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA  288 (337)
T ss_pred             hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence                    00000000       000001112345778999999999999999999883

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.7e-36  Score=294.75  Aligned_cols=252  Identities=27%  Similarity=0.352  Sum_probs=192.7

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceecC-------
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE-------  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~~-------  204 (498)
                      ...+|++.+.||.|+||.||+|...  +..||||.+.....  .....+.+|+.+++.++||||+++++++.+       
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3457888999999999999999984  67899999875432  223567789999999999999999998732       


Q ss_pred             -----cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEe
Q 010882          205 -----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS  279 (498)
Q Consensus       205 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  279 (498)
                           ..++||||+++ +|.+.+...  ...+++..+..++.+++.||.|||+   .+|+||||||+||+++.++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence                 47899999976 777776432  3468999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC
Q 010882          280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG  358 (498)
Q Consensus       280 DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (498)
                      |||++..........       .....++..|+|||.+.+. .++.++|||||||++|+|++|++||...+.........
T Consensus       159 dfg~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~  231 (302)
T cd07864         159 DFGLARLYNSEESRP-------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS  231 (302)
T ss_pred             cccccccccCCcccc-------cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999998765432111       1122468899999988654 57889999999999999999999997654433221110


Q ss_pred             cc---------cccc--------CCCC------CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 KL---------KNLL--------DPLA------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 ~~---------~~~~--------~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..         ..+.        ++..      .......+..+.+++.+||..+|.+||++.++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  296 (302)
T cd07864         232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA  296 (302)
T ss_pred             HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            00         0000        0000      00011235789999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.8e-36  Score=293.46  Aligned_cols=247  Identities=27%  Similarity=0.398  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC---CChhhHHHHHHHHHcCC-CCCeeeeeceec--CcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-hpniv~l~g~~~--~~~~lV~  210 (498)
                      +|...+.||+|+||.||+|..  .+..||+|++.....   .....+..|+.++++++ ||||+++++++.  +..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            678888999999999999988  468899999876432   22356788999999998 999999999874  4688999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++++|.+++..   ...+++..+..|+.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          82 EYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999953   3469999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCC------------ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC
Q 010882          291 EISSNN------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG  358 (498)
Q Consensus       291 ~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (498)
                      ......            ..........|+..|+|||.+....++.++||||||++++++++|+.||.............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            321000            00112234468899999999988889999999999999999999999998665433221111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                             .....+|...+..+.+++.+||+.+|.+||++.
T Consensus       236 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  268 (280)
T cd05581         236 -------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN  268 (280)
T ss_pred             -------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcc
Confidence                   111123444567899999999999999999993

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.3e-35  Score=290.33  Aligned_cols=234  Identities=26%  Similarity=0.338  Sum_probs=180.4

Q ss_pred             cccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHH---HHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          145 KIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEID---ILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~---il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      .||+|+||.||++..  .+..||+|.+.......   ...+..|..   .++..+||||+.+++++.  +..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999987  46789999987643221   122344443   344467999999999874  46889999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      ||+|.+++.   ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..+.....  
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--  152 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence            999999884   33569999999999999999999999   8999999999999999999999999999875532211  


Q ss_pred             CCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHH-HHHHhCccccccCCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  372 (498)
                              ....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||....... ........     .....+|
T Consensus       153 --------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~  219 (278)
T cd05606         153 --------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TMAVELP  219 (278)
T ss_pred             --------cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-----ccCCCCC
Confidence                    123589999999999755 68999999999999999999999997542111 00111000     0112234


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCC-----ChhH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRP-----ELGK  399 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP-----~~~~  399 (498)
                      ...+..+.+++.+|+..+|.+||     ++.+
T Consensus       220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~  251 (278)
T cd05606         220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE  251 (278)
T ss_pred             CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHH
Confidence            44578899999999999999999     6655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.7e-36  Score=295.58  Aligned_cols=249  Identities=25%  Similarity=0.330  Sum_probs=192.5

Q ss_pred             CCCCCCcccccCceEEEEEEE-----CCeEEEEEEecCCCC----CChhhHHHHHHHHHcC-CCCCeeeeeceec--Ccc
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW  206 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~  206 (498)
                      +|...+.||+|+||.||++..     .+..||||++.....    .....+..|+.++.++ +||||+++++++.  ...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778899999999999875     346799999875321    2345688999999999 5999999998874  357


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+   .+++||||+|.||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            899999999999999843   3468899999999999999999999   8999999999999999999999999999876


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCC--CCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCcccc
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKN  362 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~  362 (498)
                      +......       ......|+..|+|||.+.+..  .+.++||||||+++|+|+||..||......  ...+...... 
T Consensus       155 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-  226 (288)
T cd05583         155 FLAEEEE-------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-  226 (288)
T ss_pred             ccccccc-------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-
Confidence            5433211       112235899999999987654  788999999999999999999999643211  1111111001 


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                          .....|...+..+.+++.+||+.+|++||++.+ +...|+
T Consensus       227 ----~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~-~~~~l~  265 (288)
T cd05583         227 ----SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANG-ADEIKN  265 (288)
T ss_pred             ----cCCCCCcccCHHHHHHHHHHhcCCHhhccCcch-HHHHhc
Confidence                111233445577899999999999999999877 544443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.3e-36  Score=300.84  Aligned_cols=254  Identities=28%  Similarity=0.395  Sum_probs=191.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC--CCCChhhHHHHHHHHHcC-CCCCeeeeeceecC----cce
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE----VWT  207 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~----~~~  207 (498)
                      ..+|...+.||+|+||.||+|.+.  +..||||++...  .......+.+|+.+++++ +||||++++++|..    ..+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            346788889999999999999884  688999988643  222334577899999999 99999999998732    468


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||++ ++|..++..   . .+++..+..++.+++.||.|||+   .||+||||||+||+++.++.+||+|||++...
T Consensus        86 lv~e~~~-~~L~~~~~~---~-~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRA---N-ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhc---C-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 599988842   2 68889999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Cc---
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK---  359 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~---  359 (498)
                      .........   .......||..|+|||.+.+ ..++.++|||||||++|+|+||++||............    +.   
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         158 SELEENPEN---PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             ccccccccC---cchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            543321100   11223468999999998765 45788999999999999999999999754332211000    00   


Q ss_pred             ----------cccccC----CC---CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          360 ----------LKNLLD----PL---AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       360 ----------~~~~~~----~~---~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                                ....++    ..   ........+..+.+++.+||+.+|.+||++.+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il  293 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL  293 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh
Confidence                      000000    00   0001111457899999999999999999998843

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=290.98  Aligned_cols=247  Identities=27%  Similarity=0.347  Sum_probs=192.6

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      |...+.||.|++|.||+|...  +..+++|.+......  ....+..|+.++++++||||+++++++.  +..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456678999999999999884  678999998754332  3457889999999999999999999874  4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++ +|.+++...  ...+++..+..++.+++.||.|||.   .+|+|+||+|+||+++.++.+||+|||.+.........
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence            75 888888532  2578999999999999999999999   89999999999999999999999999999876543210


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc---------cccc
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------LKNL  363 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~---------~~~~  363 (498)
                              .....++..|+|||.+.+. .++.++||||||+++|+|+||++||...+..........         +...
T Consensus       155 --------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd05118         155 --------YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF  226 (283)
T ss_pred             --------ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence                    1223478899999999876 788999999999999999999999976554332111100         0000


Q ss_pred             cC---------C-----CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          364 LD---------P-----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       364 ~~---------~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+         +     .........+..+.+++.+||+.+|.+||++.++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l  277 (283)
T cd05118         227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA  277 (283)
T ss_pred             hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence            00         0     0000112356789999999999999999999883

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-36  Score=301.47  Aligned_cols=254  Identities=21%  Similarity=0.296  Sum_probs=193.3

Q ss_pred             CCChHHHHHhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeecee
Q 010882          127 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC  202 (498)
Q Consensus       127 ~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~  202 (498)
                      .....++...+.+|...+.||+|+||.||+|..  .+..||+|++.....  .....+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            334455666778999999999999999999986  468899999875322  2235678899999999999999999887


Q ss_pred             c--------CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC
Q 010882          203 P--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF  274 (498)
Q Consensus       203 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  274 (498)
                      .        ...+++++++ +++|.+++..    ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCC
Confidence            3        1356788776 8899888742    358999999999999999999999   8999999999999999999


Q ss_pred             ceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH
Q 010882          275 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY  353 (498)
Q Consensus       275 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~  353 (498)
                      .+||+|||++.......           ....||..|+|||.+.+ ..++.++|||||||++|+|++|++||...+....
T Consensus       158 ~~kl~dfg~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~  226 (345)
T cd07877         158 ELKILDFGLARHTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ  226 (345)
T ss_pred             CEEEecccccccccccc-----------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999987543211           22347899999999876 5688999999999999999999999965433211


Q ss_pred             HHHh----Cc--------------------cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          354 ALDT----GK--------------------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       354 ~~~~----~~--------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ....    +.                    +.........+.....+..+.+++.+|++.+|.+||++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  296 (345)
T cd07877         227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ  296 (345)
T ss_pred             HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence            1000    00                    0000000000011123567899999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-36  Score=300.75  Aligned_cols=243  Identities=23%  Similarity=0.341  Sum_probs=186.7

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceecC--------c
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE--------V  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------~  205 (498)
                      .+|.....||+|+||.||+|..  .+..||||++.....  .....+.+|+.+++.++||||++++++|..        .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            5788889999999999999987  478899999875322  223467899999999999999999998742        3


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .++|+||+. ++|..++.     ..+++..+..++.+++.||.|||+   ++++||||||+|||++.++.+||+|||+++
T Consensus        95 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             EEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            589999996 47777651     358899999999999999999999   899999999999999999999999999987


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc-----
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-----  359 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-----  359 (498)
                      ......           ....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..........     
T Consensus       166 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (342)
T cd07879         166 HADAEM-----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  234 (342)
T ss_pred             CCCCCC-----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            543211           22347889999999876 4688999999999999999999999976543221111000     


Q ss_pred             ------------cccccC--CC--CCCC---CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 ------------LKNLLD--PL--AGDW---PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 ------------~~~~~~--~~--~~~~---~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                  ......  +.  ...+   ....+..+.+++.+||+.+|.+||++.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~  294 (342)
T cd07879         235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA  294 (342)
T ss_pred             CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                        000000  00  0000   01234568899999999999999999883

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.2e-36  Score=306.27  Aligned_cols=199  Identities=30%  Similarity=0.384  Sum_probs=168.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-C-----CCeeeeecee--cCcce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-H-----PNLVTLVGAC--PEVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-----pniv~l~g~~--~~~~~  207 (498)
                      .+|.+...||+|+||.|-+|.+.  +..||||+++.... -..+-..|+.+|..|+ |     -|+|+++++|  ....|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            36788999999999999999985  67899999985432 2345667999999997 3     4899999987  56799


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC--CceeEeeccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSKLSDFGISR  285 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~DFGla~  285 (498)
                      ||+|.+ ..+|.++|..+. ..+|+...+..|+.||+.||.+||.   .+|||+||||+||||..-  ..+||+|||.|.
T Consensus       265 iVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            999999 569999996543 4469999999999999999999999   899999999999999643  379999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY  353 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~  353 (498)
                      .......           ...-+..|.|||++.+.+|+.+.||||||||++||+||.|-|.+.++.+.
T Consensus       340 ~~~q~vy-----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ  396 (586)
T KOG0667|consen  340 FESQRVY-----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ  396 (586)
T ss_pred             ccCCcce-----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence            7765432           12357899999999999999999999999999999999999987776543

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-35  Score=293.09  Aligned_cols=246  Identities=25%  Similarity=0.339  Sum_probs=187.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCC-CCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .+|...+.||+|+||.||+|.+.  +..||||.+...... ....+..|+.++.++. ||||++++++|.  ...++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            46788899999999999999986  789999998754322 2345667887777764 999999999984  36889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+. ++|.+++...  ..++++..+..++.+++.||.|||+.  .+|+||||+|+||+++.++.+||+|||++..+....
T Consensus        95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            985 5777776432  23789999999999999999999972  489999999999999999999999999987654322


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCC----CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                      ..         ....|+..|+|||.+.+..    ++.++||||||+++|+|++|+.||............. +... .+.
T Consensus       170 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~-~~~  238 (296)
T cd06618         170 AK---------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI-LQEE-PPS  238 (296)
T ss_pred             cc---------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-hcCC-CCC
Confidence            11         1224788999999987553    7889999999999999999999997533211111110 0000 000


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       .......+..+.+++.+||..+|.+||++.++
T Consensus       239 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i  270 (296)
T cd06618         239 -LPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL  270 (296)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence             01111245789999999999999999999883

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.4e-35  Score=295.55  Aligned_cols=252  Identities=21%  Similarity=0.240  Sum_probs=186.6

Q ss_pred             ccccc--CceEEEEEEE--CCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCC
Q 010882          145 KIGEG--GYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG  216 (498)
Q Consensus       145 ~lG~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~g  216 (498)
                      .||+|  +||+||++.+  .++.||||++......  ..+.+.+|+.+++.++||||++++++|.  +..++||||+++|
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46766  9999999988  5789999998754322  2356889999999999999999999984  4678999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++.... ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.++++|||.+........... 
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (328)
T cd08226          85 SANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK-  159 (328)
T ss_pred             CHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc-
Confidence            9999886432 2358899999999999999999999   8999999999999999999999999987654332211110 


Q ss_pred             ccceeccCCCCCCCcCChhhhccC--CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccc-------------
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK-------------  361 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-------------  361 (498)
                      ..........++..|+|||++.+.  .++.++|||||||++|+|++|++||............-...             
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence            000001112356789999999763  57899999999999999999999997543322211110000             


Q ss_pred             --------------------------cccC-CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          362 --------------------------NLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       362 --------------------------~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                                                ...+ ......+...+..+.+|+.+||..+|.+||++.+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l  306 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL  306 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence                                      0000 000111233567899999999999999999999843

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=307.12  Aligned_cols=235  Identities=20%  Similarity=0.366  Sum_probs=183.8

Q ss_pred             CCcccccCceEEEEEEECCe--EEE---EEEecCC-CCCChhhHHHHHHHHHcCCCCCeeeeeceecC----cceEEEee
Q 010882          143 SLKIGEGGYGSIYKGLLRHM--QVA---IKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEY  212 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~--~va---vK~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~~lV~E~  212 (498)
                      ..+||+|+|-+||+|.+...  .||   ||.-... .....+.|..|+.+|+.|+||||+++|.++.+    ...+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            45699999999999998543  343   2221111 12234679999999999999999999999843    36789999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-CCceeEeeccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~~  291 (498)
                      +..|+|..++.+   ...++...+..|+.||+.||.|||+.. .+|||||||.+||||+. -|.|||+|.|||.......
T Consensus       125 ~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999953   345778899999999999999999977 49999999999999975 4899999999999876543


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH---HHHHHHhCccccccCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~~~~~~~~~~~~~  368 (498)
                      .          ...+|||.|||||++. ..|+..+||||||++|+||+|+..||.--..   +...+-.|.....     
T Consensus       201 a----------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s-----  264 (632)
T KOG0584|consen  201 A----------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA-----  264 (632)
T ss_pred             c----------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH-----
Confidence            1          2346999999999986 8899999999999999999999999953221   2222222221111     


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        +.....+++.++|..|+.. .+.||++.+.
T Consensus       265 --l~kV~dPevr~fIekCl~~-~~~R~sa~eL  293 (632)
T KOG0584|consen  265 --LSKVKDPEVREFIEKCLAT-KSERLSAKEL  293 (632)
T ss_pred             --hhccCCHHHHHHHHHHhcC-chhccCHHHH
Confidence              1222357899999999999 9999999883

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.4e-35  Score=286.79  Aligned_cols=244  Identities=24%  Similarity=0.342  Sum_probs=191.7

Q ss_pred             CCCCCCcccccCceEEEEEEECC--eEEEEEEecCCCC-----CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      +|.+.+.||+|+||.||++.+..  ..+++|+++....     .....+..|+.+++.++||||+++++++.  +..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36777889999999999998753  4466666654322     12335678999999999999999999884  457899


Q ss_pred             EeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          210 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      |||+++++|.+++... .....+++..+..++.+++.||.|||+   .|++|+||+|+||+++. +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988532 234579999999999999999999999   89999999999999975 569999999987654


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      .....        .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||............      .....
T Consensus       157 ~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~  222 (260)
T cd08222         157 GSCDL--------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------VEGPT  222 (260)
T ss_pred             CCccc--------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HcCCC
Confidence            33211        12234889999999998888899999999999999999999999765443322221      11111


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ...+...+..+.+++.+||..+|.+||++.++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  254 (260)
T cd08222         223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEI  254 (260)
T ss_pred             CCCcchhcHHHHHHHHHHhcCChhhCcCHHHH
Confidence            22345566789999999999999999999883

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-35  Score=294.94  Aligned_cols=257  Identities=25%  Similarity=0.310  Sum_probs=191.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      ..+|.+.+.||.|+||.||+|...  +..||||.+......  ....+.+|+.+++.++||||+++++.+.+        
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            357889999999999999999984  678999988654322  23467889999999999999999987621        


Q ss_pred             --cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecc
Q 010882          205 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG  282 (498)
Q Consensus       205 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  282 (498)
                        ..++||+|+.+ +|...+..  ....+++..+..++.+++.||.|||+   .||+||||||+||+++.++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCc
Confidence              36899999964 67776642  34569999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccccccCCCCc---cceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC
Q 010882          283 ISRFLSQNEISSNNT---TLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG  358 (498)
Q Consensus       283 la~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (498)
                      ++.............   .........|++.|+|||.+.+. .++.++|||||||++|+|++|++||...+.........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998665432211110   01112334678999999988654 58899999999999999999999997654432111100


Q ss_pred             c---------------cccccC-CCCCCCC-------HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 K---------------LKNLLD-PLAGDWP-------FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 ~---------------~~~~~~-~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .               +....+ ......+       ......+.+++.+||+.+|.+||++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e  304 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD  304 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence            0               000000 0000011       112356889999999999999999887

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.9e-35  Score=284.57  Aligned_cols=240  Identities=32%  Similarity=0.439  Sum_probs=196.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +|+....||.|+||.||++...  +..+|+|.+......  ....+..|+.+++.++||||+++++++.  ...++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677788999999999999874  578999998754322  2446778999999999999999998873  468899999


Q ss_pred             CCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          213 LPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       213 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+   .|++||||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            99999999885421 23568999999999999999999999   899999999999999999999999999998765431


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  369 (498)
                      .          ....|++.|+|||.+.+..++.++|+||||+++|+|++|++||...+.....  +..+..        .
T Consensus       158 ~----------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~  219 (256)
T cd08530         158 A----------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY--------P  219 (256)
T ss_pred             c----------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------C
Confidence            1          1234789999999999888999999999999999999999999765543221  111111        1


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+...+..+.+++.+|+..+|.+||++.+
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  249 (256)
T cd08530         220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDK  249 (256)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCCCHHH
Confidence            223355678999999999999999999988

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=289.94  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=188.8

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCC-CCCeeeeeceec--CcceEEEeeC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      |.+.+.||.|+||+||+|...  +..|+||.+...... ......+|+..+++++ ||||+++++++.  +..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            456778999999999999984  578999998754322 2234567999999999 999999999884  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                       +|+|.+++.... ...+++..+..++.+++.||.|||+   ++++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence             889999885432 3468999999999999999999999   89999999999999999999999999999865432211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc-------------
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-------------  359 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-------------  359 (498)
                               ....|+..|+|||++.. ..++.++|+||||+++|+|+||++||..............             
T Consensus       156 ---------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd07830         156 ---------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG  226 (283)
T ss_pred             ---------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence                     22347899999998854 4578999999999999999999999975543322211100             


Q ss_pred             ------cccccCCC----CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 ------LKNLLDPL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 ------~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                            +...+...    ........+..+.+++.+||..+|.+||++.++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  277 (283)
T cd07830         227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA  277 (283)
T ss_pred             hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence                  00000000    000111124679999999999999999999873

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=287.50  Aligned_cols=247  Identities=29%  Similarity=0.382  Sum_probs=188.5

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcC---CCCCeeeeeceec--Cc-----
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI---RHPNLVTLVGACP--EV-----  205 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l---~hpniv~l~g~~~--~~-----  205 (498)
                      |.+.+.||+|+||.||+|.++  +..||+|++.......  ...+.+|+.+++++   +||||++++++|.  +.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456678999999999999985  6889999997543221  34566788877666   5999999999983  23     


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .+++|||+. ++|.+++.... ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence            789999996 48988885432 2358999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc---c--
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---L--  360 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~---~--  360 (498)
                      ........         ....++..|+|||++.+..++.++|||||||++|+|+||.+||............-.   .  
T Consensus       156 ~~~~~~~~---------~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07838         156 IYSFEMAL---------TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS  226 (287)
T ss_pred             eccCCccc---------ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCC
Confidence            76433211         122478899999999988899999999999999999999999976544322111100   0  


Q ss_pred             ----c-------cccCCCC----CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          361 ----K-------NLLDPLA----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       361 ----~-------~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                          .       .......    .......+..+.+++.+||+.+|.+||++.++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i  281 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA  281 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH
Confidence                0       0000000    00112345678899999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-36  Score=318.22  Aligned_cols=253  Identities=19%  Similarity=0.229  Sum_probs=177.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC---eEEEEEEec--------------C---CCCCChhhHHHHHHHHHcCCCCCee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLH--------------P---HSLQGPSEFQQEIDILSKIRHPNLV  196 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~--------------~---~~~~~~~~~~~E~~il~~l~hpniv  196 (498)
                      ..+|.+.+.||+|+||+||++..+.   ..+++|.+.              +   ........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4679999999999999999987642   112222111              0   0111234578999999999999999


Q ss_pred             eeeceec--CcceEEEeeCCCCCHHhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC
Q 010882          197 TLVGACP--EVWTLVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA  272 (498)
Q Consensus       197 ~l~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~  272 (498)
                      ++++++.  +..++|++++. ++|.+++.....  ...........|+.|++.||.|||+   ++||||||||+||||+.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence            9999984  46789999984 577776643211  1223456677899999999999999   89999999999999999


Q ss_pred             CCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCC-CCCCc--H
Q 010882          273 NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP-ALGIT--K  349 (498)
Q Consensus       273 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~-pf~~~--~  349 (498)
                      ++.+||+|||+++.+.......       .....||+.|+|||++.+..++.++|||||||+||||++|.. ||...  .
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~  375 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAF-------DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK  375 (501)
T ss_pred             CCCEEEEeCCCceecCcccccc-------cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence            9999999999998764332111       123469999999999999999999999999999999999874 45321  1


Q ss_pred             HHHHHHHhCc--------c-------ccccCC-----CCCCCC-----HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          350 EVQYALDTGK--------L-------KNLLDP-----LAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       350 ~~~~~~~~~~--------~-------~~~~~~-----~~~~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ........-.        +       ...++.     .....+     ...+..+.+++.+||..||.+||++.++
T Consensus       376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el  451 (501)
T PHA03210        376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL  451 (501)
T ss_pred             HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence            1111110000        0       000000     000000     0123456778999999999999999883

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-35  Score=298.53  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=190.2

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC-------
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~-------  204 (498)
                      ...+|...+.||+|+||.||+|...  +..||||++......  ....+.+|+.+|+.++||||+++++++..       
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3457888999999999999999874  688999998643222  23467899999999999999999998732       


Q ss_pred             -cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          205 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       205 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                       .+++||+|+ +++|.+++.    ...+++..+..++.|++.||.|||+   .||+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence             248999999 789998874    2458999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc--
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--  360 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--  360 (498)
                      +.......           ....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+...........  
T Consensus       165 ~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~  233 (343)
T cd07880         165 ARQTDSEM-----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG  233 (343)
T ss_pred             ccccccCc-----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            87543221           22347899999999876 45888999999999999999999999765432211110000  


Q ss_pred             ---------------ccccCCC-------CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          361 ---------------KNLLDPL-------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       361 ---------------~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                     .......       ........+..+.+++.+|++.+|.+||++.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~  295 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA  295 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence                           0000000       000112244568999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-35  Score=299.74  Aligned_cols=250  Identities=22%  Similarity=0.292  Sum_probs=189.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC-----------
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-----------  204 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-----------  204 (498)
                      .+|...+.||.|+||.||+|...  +..||+|.+........+.+.+|+.+++.++||||+++++++..           
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888999999999999999884  67899999876655556778899999999999999999987632           


Q ss_pred             -----cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc-CCCceeE
Q 010882          205 -----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKL  278 (498)
Q Consensus       205 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl  278 (498)
                           ..++||||++ ++|.+++.    ...+++..+..++.|++.||.|||+   .||+||||||+||+++ .++.+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence                 3589999996 58988873    2358899999999999999999999   8999999999999997 4567899


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT  357 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (498)
                      +|||++...........     ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...+........
T Consensus       157 ~dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         157 GDFGLARIVDPHYSHKG-----YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             CCcccceecCCcccccc-----ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999976543211100     0122357899999998755 46888999999999999999999999755433221110


Q ss_pred             Cccc----------------c-cc-CCCCCCC-----CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          358 GKLK----------------N-LL-DPLAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       358 ~~~~----------------~-~~-~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ....                . .. .......     ....+..+.+++.+||..+|.+||++.++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  297 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA  297 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHH
Confidence            0000                0 00 0000001     11234678899999999999999999883

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-36  Score=303.44  Aligned_cols=241  Identities=26%  Similarity=0.395  Sum_probs=200.2

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeecee--cCcceEE
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV  209 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV  209 (498)
                      ....|.+...||+|.|++|..|.+  ++..||||.+.+.....  ...+.+|+++|+.|+|||||+++.+.  ...+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            456789999999999999999987  57899999998765443  34588999999999999999999986  4579999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+.+|.+.++|...   ..+.......++.|+..|++|||+   ++|||||||++||||+.+.++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999999543   345567888999999999999999   8999999999999999999999999999998875


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHH--HHHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~  366 (498)
                      ...   .      ....|++.|.|||++.+.+| ++.+|+||+|++||-|+.|..||++.+-  ....+..+++.     
T Consensus       208 ~~~---l------qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-----  273 (596)
T KOG0586|consen  208 GLM---L------QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR-----  273 (596)
T ss_pred             ccc---c------cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec-----
Confidence            432   2      23349999999999999876 5789999999999999999999986432  12222222221     


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                          .|.-.+.+..+++++++-.+|.+|+++.++
T Consensus       274 ----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqi  303 (596)
T KOG0586|consen  274 ----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQI  303 (596)
T ss_pred             ----ccceeechhHHHHHHhhccCccccCCHHHh
Confidence                344456778999999999999999998873

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.7e-35  Score=292.50  Aligned_cols=236  Identities=28%  Similarity=0.375  Sum_probs=186.7

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .|...+.||.|+||.||+|...  +..||+|.+......   ....+.+|+.+++.++|||++++++++.  ...++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666678999999999999984  578999988643222   2346778999999999999999999873  45789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+. |+|.+.+..  ...++++..+..++.+++.||.|||+   .+++||||+|+||+++.++.+||+|||++...... 
T Consensus        96 ~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          96 YCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             ccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            996 588777742  23458899999999999999999999   89999999999999999999999999998765322 


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP  366 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~  366 (498)
                                 ....|++.|+|||.+.   ...++.++|||||||++|+|+||..||...+.....  ...+....    
T Consensus       169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----  233 (308)
T cd06634         169 -----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----  233 (308)
T ss_pred             -----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC----
Confidence                       1234889999999985   346788999999999999999999998654433221  11111110    


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                         ..+...+..+.+++.+||..+|.+||++.+
T Consensus       234 ---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~  263 (308)
T cd06634         234 ---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  263 (308)
T ss_pred             ---cCcccccHHHHHHHHHHhhCCcccCCCHHH
Confidence               012235577999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=276.00  Aligned_cols=239  Identities=25%  Similarity=0.372  Sum_probs=185.2

Q ss_pred             CCCcccccCceEEEEEEECC--eEEEEEEecCCCCC-ChhhHHHHHHHHHcCC-CCCeeeeecee--cCcceEEEeeCCC
Q 010882          142 PSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPN  215 (498)
Q Consensus       142 ~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-hpniv~l~g~~--~~~~~lV~E~~~~  215 (498)
                      ....||.|+.|.|++..++.  ...|||.+...... ..+.+...++++...+ .|+||+.+|+|  .....+.||.| +
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence            34569999999999999864  88999998765432 3456777788776664 89999999998  34577889987 3


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      .-++.+|.  ....++++...-++...+..||.||...  ++|||||+||+|||+|..|++||+|||++..+.+....  
T Consensus       175 ~C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--  248 (391)
T KOG0983|consen  175 TCAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--  248 (391)
T ss_pred             HHHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence            34566664  3345688888889999999999999986  58999999999999999999999999999887665422  


Q ss_pred             CccceeccCCCCCCCcCChhhhccC---CCCCccchHhHHHHHHHHHhCCCCCCCcH-HHHHHHHh-CccccccCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDT-GKLKNLLDPLAGD  370 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~~-~~~~~~~~~~~~~  370 (498)
                             +...|.+.|||||.+...   .|+..+||||||+.|+||.||+.||.+-+ ++..+-.. ......+++    
T Consensus       249 -------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~----  317 (391)
T KOG0983|consen  249 -------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG----  317 (391)
T ss_pred             -------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc----
Confidence                   333599999999999754   68899999999999999999999997633 22222111 011111111    


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       ....+..+.+++..||..|+.+||.+.+
T Consensus       318 -~~gFSp~F~~fv~~CL~kd~r~RP~Y~~  345 (391)
T KOG0983|consen  318 -HMGFSPDFQSFVKDCLTKDHRKRPKYNK  345 (391)
T ss_pred             -ccCcCHHHHHHHHHHhhcCcccCcchHH
Confidence             1125688999999999999999999987

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=287.39  Aligned_cols=247  Identities=28%  Similarity=0.403  Sum_probs=192.0

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      |+....||+|+||.||+|...  +..||+|++....  ....+.+..|+.+++.++||||+++++++.  +..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999984  6889999998653  233467889999999999999999999874  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      + ++|.+++....  ..+++..+..++.+++.||.|||.   ++|+||||+|+||+++.++.+||+|||++.........
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            7 58999995332  468999999999999999999999   89999999999999999999999999999866433211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc------------
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------------  360 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~------------  360 (498)
                              .....++..|+|||.+.+. .++.++|||||||++|||++|++||...............            
T Consensus       155 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07829         155 --------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV  226 (282)
T ss_pred             --------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence                    1122367889999999776 7899999999999999999999999765543221111000            


Q ss_pred             ccc--cCCCCCCC--------CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          361 KNL--LDPLAGDW--------PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       361 ~~~--~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ...  .+.....+        ....+..+.+++.+||..+|.+||++.++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  276 (282)
T cd07829         227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA  276 (282)
T ss_pred             cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence            000  00000000        01125679999999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.6e-35  Score=295.08  Aligned_cols=255  Identities=22%  Similarity=0.292  Sum_probs=188.7

Q ss_pred             CCC-CCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--------------hhhHHHHHHHHHcCCCCCeeeeece
Q 010882          139 NFD-PSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--------------PSEFQQEIDILSKIRHPNLVTLVGA  201 (498)
Q Consensus       139 ~~~-~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l~hpniv~l~g~  201 (498)
                      +|. ..+.||.|+||.||+|...  +..||||.+.......              ...+.+|+.+++.++||||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            454 3467999999999999874  6889999986543221              1247789999999999999999998


Q ss_pred             e--cCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEe
Q 010882          202 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS  279 (498)
Q Consensus       202 ~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  279 (498)
                      +  .+..++||||+. |+|.+++.   ....+++.....++.|++.||.|||.   .|++||||+|+||+++.++.+||+
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence            7  346889999996 68999884   33468999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccccccCCC-----C-ccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHH
Q 010882          280 DFGISRFLSQNEISSN-----N-TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ  352 (498)
Q Consensus       280 DFGla~~~~~~~~~~~-----~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~  352 (498)
                      |||++...........     . ..........+++.|+|||.+.+. .++.++|||||||++|+|+||.+||...+...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999986652211100     0 000111233578899999998764 47889999999999999999999997655432


Q ss_pred             HHHHh----Cc-----ccccc-----CCCCC-------CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          353 YALDT----GK-----LKNLL-----DPLAG-------DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       353 ~~~~~----~~-----~~~~~-----~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .....    +.     +....     .+...       ......+..+.+++.+||+.+|.+||++.++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            21110    00     00000     00000       0011235678999999999999999999883

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.6e-36  Score=321.21  Aligned_cols=255  Identities=26%  Similarity=0.384  Sum_probs=187.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeecee-----------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC-----------  202 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~-----------  202 (498)
                      ..+|+....||+||||.||+++.  .|..||||++.... ......+.+|+.+|++|+|||||++|.++           
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            34678888999999999999987  58999999998654 22234678999999999999999997543           


Q ss_pred             ----------------------------------------------c---------------------------------
Q 010882          203 ----------------------------------------------P---------------------------------  203 (498)
Q Consensus       203 ----------------------------------------------~---------------------------------  203 (498)
                                                                    .                                 
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                          0                                 


Q ss_pred             -------------------------------CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 010882          204 -------------------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS  252 (498)
Q Consensus       204 -------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~  252 (498)
                                                     -..||=||||+..+|.+++..+....  .....++++.+|++||.|+|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence                                           00245678888777777774332111  345778999999999999999


Q ss_pred             cCCCCcccCCCCCCcEEEcCCCceeEeecccccccc------ccccC----CCCccceeccCCCCCCCcCChhhhccC--
Q 010882          253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS------QNEIS----SNNTTLCCRTDPKGTFAYMDPEFLASG--  320 (498)
Q Consensus       253 ~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~------~~~~~----~~~~~~~~~~~~~gt~~y~aPE~~~~~--  320 (498)
                         +|||||||||.||+||.++.|||+|||+|....      .....    .......-.++.+||.-|+|||++.+.  
T Consensus       716 ---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 ---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             ---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence               899999999999999999999999999998722      11000    001111123677899999999999775  


Q ss_pred             -CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          321 -ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       321 -~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       .|+.|+|+|||||||+||+.   ||+..-+-...+..  +....-|...++.......-+.+|.++++.||.+||++.+
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~--LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN--LRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh--cccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence             49999999999999999975   47654332222211  2222222223445555667789999999999999999988


Q ss_pred             HH
Q 010882          400 DV  401 (498)
Q Consensus       400 ~v  401 (498)
                      .+
T Consensus       868 LL  869 (1351)
T KOG1035|consen  868 LL  869 (1351)
T ss_pred             Hh
Confidence            43

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-35  Score=296.72  Aligned_cols=249  Identities=26%  Similarity=0.340  Sum_probs=193.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceecC-------cce
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT  207 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-------~~~  207 (498)
                      +|.+.+.||.|+||.||+|...  +..||||.+....  ....+.+.+|+.+++.++||||+++++++..       ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4777889999999999999984  6889999987643  2334678899999999999999999998733       468


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||+|++ ++|.+++..   ..++++..+..++.+++.||.|||+   +||+||||||.|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 589888842   3479999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Cc---
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK---  359 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~---  359 (498)
                      .......     .......||+.|+|||.+.+. .++.++|||||||++|+|+||++||...+........    +.   
T Consensus       154 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  228 (330)
T cd07834         154 DPDEDEK-----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE  228 (330)
T ss_pred             ccccccc-----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence            5432100     011234589999999999887 7899999999999999999999999765432211100    00   


Q ss_pred             ----------cccccCCC--C-----CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          360 ----------LKNLLDPL--A-----GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       360 ----------~~~~~~~~--~-----~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                ....+...  .     .......+..+.+++.+||+.+|.+||++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  285 (330)
T cd07834         229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE  285 (330)
T ss_pred             hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence                      00000000  0     0001123567899999999999999999988

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.2e-35  Score=294.26  Aligned_cols=251  Identities=23%  Similarity=0.268  Sum_probs=187.3

Q ss_pred             CCCCCCcccccCceEEEEEEEC----CeEEEEEEecCCCC--CChhhHHHHHHHHHcC-CCCCeeeeeceec------Cc
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSL--QGPSEFQQEIDILSKI-RHPNLVTLVGACP------EV  205 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~hpniv~l~g~~~------~~  205 (498)
                      +|...+.||+|+||.||++...    +..||||.+.....  .....+.+|+.++.++ +||||+++++.+.      ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3667788999999999999985    45899999864321  1245678899999999 5999999998641      23


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .+++++|+. ++|.+.+.   ....+++..+..++.|++.||.|||+   .|++||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888885 68999884   34568999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH---H-----
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---D-----  356 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~---~-----  356 (498)
                      .+........    .......||+.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+......   .     
T Consensus       154 ~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (332)
T cd07857         154 GFSENPGENA----GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP  229 (332)
T ss_pred             eccccccccc----ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence            6654322111    11133468999999998766 468999999999999999999999997543211100   0     


Q ss_pred             ---------hCcccc---ccC----CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          357 ---------TGKLKN---LLD----PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       357 ---------~~~~~~---~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                               ......   ...    ..........+..+.+++.+|++.+|.+||++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l  289 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA  289 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence                     000000   000    00000001135679999999999999999999883

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.3e-35  Score=289.36  Aligned_cols=238  Identities=27%  Similarity=0.364  Sum_probs=186.4

Q ss_pred             CCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          140 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      |.....||+|+||.||+|..  .+..|++|.+.......   ...+.+|+.+++.++|||++++++++.  +..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55566799999999999987  46889999987543322   245788999999999999999999984  357899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +. |+|.+.+..  ...++++..+..++.+++.||.|||+   .|++||||+|+||+++.++.+||+|||++......  
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            96 578777743  23468999999999999999999999   89999999999999999999999999988642211  


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                                ....|+..|+|||++.   ...++.++|||||||++|+|++|.+||...+............ .  +.. 
T Consensus       175 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~--~~~-  240 (313)
T cd06633         175 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-S--PTL-  240 (313)
T ss_pred             ----------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C--CCC-
Confidence                      2235899999999984   3568889999999999999999999997654433222211110 0  000 


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       .....+..+.+++.+||+.+|.+||++.++
T Consensus       241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~  270 (313)
T cd06633         241 -QSNEWTDSFRGFVDYCLQKIPQERPASAEL  270 (313)
T ss_pred             -CccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence             111234568999999999999999999883

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.4e-35  Score=294.46  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=190.2

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceec---Ccce
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWT  207 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~---~~~~  207 (498)
                      ..+++|...+.||.|+||.||+|...  +..||||.+....  ......+..|+.+++.++||||++++++|.   ...+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            35678999999999999999999874  6789999886432  223456889999999999999999999873   3578


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+ +++|.+++.    ..+++......++.+++.||.|||+   .+|+||||+|+||+++.++.+||+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 678988874    2357888888999999999999999   89999999999999999999999999998754


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH----------
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD----------  356 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~----------  356 (498)
                      ....           ....++..|+|||.+.+ ..++.++|||||||++|+|+||++||...........          
T Consensus       159 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  227 (328)
T cd07856         159 DPQM-----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD  227 (328)
T ss_pred             CCCc-----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            3211           12347889999998866 5689999999999999999999999965433211100          


Q ss_pred             -------hCccccccCC--CCCCCC-----HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          357 -------TGKLKNLLDP--LAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       357 -------~~~~~~~~~~--~~~~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                             .+.....+..  .....|     ...+..+.+++.+||+.+|.+||++.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el  285 (328)
T cd07856         228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA  285 (328)
T ss_pred             HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                   0000000000  000111     1235789999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=287.90  Aligned_cols=257  Identities=23%  Similarity=0.345  Sum_probs=196.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHc--CCCCCeeeeeceec------CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACP------EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~g~~~------~~~~lV  209 (498)
                      +.....+.||+|.||+||+|.|+|..||||++....   ...+.+|.+|...  |+|+||+.++++-.      ..++||
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            455677789999999999999999999999997543   3467889999876  59999999998751      247899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS-----CKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      .+|.+.|||.|+|.+    ..++....++++..+|+||++||.     .....|.|||||+.|||+.++|..-|+|+|||
T Consensus       288 TdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             eecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999943    568899999999999999999995     22346999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccC----CC-C-CccchHhHHHHHHHHHhC----------CCCCCCc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----EL-T-PKSDVYSFGIILLRLLTG----------RPALGIT  348 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~-~-~~~DvwSlGvil~elltG----------~~pf~~~  348 (498)
                      -........    .-...+..+||-.|||||++...    .+ + ..+||||||.||||++..          ++||...
T Consensus       364 v~h~~~t~~----idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  364 VRHDSDTDT----IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             EEecccCCc----ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            876554211    11223567899999999999653    12 1 347999999999999763          3677533


Q ss_pred             HHHHHH-------HHhCccccccCCCCCCCC-HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          349 KEVQYA-------LDTGKLKNLLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       349 ~~~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      -+.+..       +...++...+..   .|. ......+.+++..||..+|.-|-++-. +-+.|..+.
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALr-iKKtl~~l~  504 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALR-IKKTLAKLS  504 (513)
T ss_pred             CCCCCCHHHHhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHH-HHHHHHHHh
Confidence            222211       222222222222   122 335678999999999999999999877 766666664

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=278.68  Aligned_cols=233  Identities=30%  Similarity=0.370  Sum_probs=190.3

Q ss_pred             ccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      ||.|+||.||++...  +..||+|++......   ....+..|+.+++.++||||+++++.+.  ...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999885  688999998765432   3457889999999999999999999874  357999999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++..   ...+++..+..++.+++.||.|||.   .+++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------  148 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------  148 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence            999943   3468999999999999999999999   8999999999999999999999999999886543321      


Q ss_pred             ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHH
Q 010882          299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ  378 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (498)
                        ......|+..|+|||.+.+...+.++|+||||+++|+|++|..||.............  .     ....+|...+..
T Consensus       149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~  219 (250)
T cd05123         149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL--K-----DPLRFPEFLSPE  219 (250)
T ss_pred             --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh--c-----CCCCCCCCCCHH
Confidence              0123358899999999988888999999999999999999999997655322111110  0     112234445678


Q ss_pred             HHHHHHHhhhcccCCCCChhH
Q 010882          379 LANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       379 l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +.+++.+||..+|.+||++.+
T Consensus       220 l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         220 ARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHhcCCHhhCCCccc
Confidence            999999999999999999953

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.8e-36  Score=279.06  Aligned_cols=201  Identities=27%  Similarity=0.413  Sum_probs=165.7

Q ss_pred             cCCCCCCcccccCceEEEEEEECC------eEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeecee---cCcc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC---PEVW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~---~~~~  206 (498)
                      ..|+....||+|.||.||++.-++      ..+|||.++.....+  .....+|+.+++.++||||+.|..+|   +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            357888899999999999996532      368999998653322  34578999999999999999999887   3368


Q ss_pred             eEEEeeCCCCCHHhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC----CceeEee
Q 010882          207 TLVYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN----FVSKLSD  280 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~D  280 (498)
                      ++++||.+. +|...++..  .....++......|++||+.|+.|||+   +-|+||||||.||||..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence            899999976 788877432  233578899999999999999999999   889999999999999877    8999999


Q ss_pred             ccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       281 FGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                      ||+++.+...-..     .......+-|++|.|||.+.+. .|+++.||||.|||+.||+|-.|-|.+
T Consensus       180 lGlaR~~~~plkp-----l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKP-----LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccc-----cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999988654211     1122445679999999999885 699999999999999999999988854

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=301.48  Aligned_cols=248  Identities=25%  Similarity=0.441  Sum_probs=204.3

Q ss_pred             CCCCcccccCceEEEEEEE--C----CeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEee
Q 010882          141 DPSLKIGEGGYGSIYKGLL--R----HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEY  212 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~--~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~  212 (498)
                      ...++||+|+||+||+|.+  .    +-+||||++.... .....++..|+-+|.+|+|||+++|+|+|. +...||++|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~  778 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL  778 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence            3456899999999999998  2    2579999987653 334568999999999999999999999995 457899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +|+|+|.|+++.  .+.++..+..+.|..|||+|+.|||.   +.+|||||-..|||+..-.++||.|||+++.+..+..
T Consensus       779 mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  779 MPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             cccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999964  45668888999999999999999998   8999999999999999999999999999998876653


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCc--HHHHHHHHhCccccccCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT--KEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~--~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      .-..      ....-.+.|||-|.+....|+.++|||||||++||++| |..|+.+.  .++...++.|.        .-
T Consensus       854 ey~~------~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--------RL  919 (1177)
T KOG1025|consen  854 EYSA------PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--------RL  919 (1177)
T ss_pred             cccc------cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc--------cC
Confidence            2211      12223568999999999999999999999999999999 88888754  34444444432        22


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..|..++..+..++.+||..|+..||.+.+ +...+..+
T Consensus       920 sqPpiCtiDVy~~mvkCwmid~~~rp~fke-l~~~fs~~  957 (1177)
T KOG1025|consen  920 SQPPICTIDVYMVMVKCWMIDADSRPTFKE-LAEEFSRM  957 (1177)
T ss_pred             CCCCCccHHHHHHHHHHhccCcccCccHHH-HHHHHHHH
Confidence            357788899999999999999999999988 44444443

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=274.31  Aligned_cols=243  Identities=23%  Similarity=0.371  Sum_probs=192.6

Q ss_pred             cccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceecC--cceEEEeeCCCCCHH
Q 010882          145 KIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE--VWTLVYEYLPNGSLE  219 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~--~~~lV~E~~~~gsL~  219 (498)
                      .||+|+||.|-.++.  ++..||||++.+........+.+|++++.... |+||+.|+.+|.+  .+|||||-+.||+|.
T Consensus        85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL  164 (463)
T KOG0607|consen   85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL  164 (463)
T ss_pred             HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence            599999999988765  68899999999887777888999999999984 9999999999954  699999999999999


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC---ceeEeeccccccccccccCCCC
Q 010882          220 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       220 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      .++.   ....+++.+..++..+|+.||.|||.   +||.||||||+|||.....   -+||+||.|..........+ .
T Consensus       165 shI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s-p  237 (463)
T KOG0607|consen  165 SHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS-P  237 (463)
T ss_pred             HHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC-C
Confidence            9995   34568999999999999999999999   9999999999999996543   57999999987654433222 2


Q ss_pred             ccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcHHH-----------------HHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEV-----------------QYA  354 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-----------------~~~  354 (498)
                      .....-..++|+..|||||+..-     ..|+.++|.||||||||-||.|.+||.+.--.                 ...
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence            22233456789999999998742     35889999999999999999999999532111                 111


Q ss_pred             HHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          355 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +..|+..-    ...+| ...+.+..+++...+-.++.+|-++.+
T Consensus       318 IQEGkYeF----PdkdW-ahIS~eakdlisnLlvrda~~rlsa~~  357 (463)
T KOG0607|consen  318 IQEGKYEF----PDKDW-AHISSEAKDLISNLLVRDAKQRLSAAQ  357 (463)
T ss_pred             HhccCCcC----Chhhh-HHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence            22222211    11122 246678899999999999999988776

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-35  Score=295.66  Aligned_cols=244  Identities=22%  Similarity=0.308  Sum_probs=189.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      .++|.....||+|+||.||+|...  +..||||++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            457888999999999999999984  6789999986532  1223567789999999999999999887632        


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++|+||+ +++|.+++..    ..+++..+..++.+++.||.|||+   .||+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccc
Confidence            278999998 6799998842    468999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc-
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN-  362 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-  362 (498)
                      .......           ....++..|+|||.+.+. .++.++|||||||++|+|+||++||................. 
T Consensus       166 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~  234 (343)
T cd07851         166 RHTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT  234 (343)
T ss_pred             ccccccc-----------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence            8654321           223478899999998653 678899999999999999999999975543322111000000 


Q ss_pred             ----------------ccC---C-CCCCC---CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 ----------------LLD---P-LAGDW---PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 ----------------~~~---~-~~~~~---~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                      .+.   . ....+   ....+..+.+++.+||+.+|.+||++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e  294 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE  294 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence                            000   0 00000   0123578999999999999999999988

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=274.56  Aligned_cols=241  Identities=22%  Similarity=0.376  Sum_probs=190.5

Q ss_pred             hhcCCCC-CCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceecC------c
Q 010882          136 ATHNFDP-SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE------V  205 (498)
Q Consensus       136 ~~~~~~~-~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~------~  205 (498)
                      .+.+|.+ ..+||-|-.|.|..+..+  +..+|+|++.     +.....+|++.--.. .|||||.+++++..      .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            3556765 467999999999988875  6789999985     334667888876655 59999999998843      4


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---CCceeEeecc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFG  282 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFG  282 (498)
                      +.+|||.++||.|...+... ....+++.+...|..+|+.|+.|||+   .+|.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence            67899999999999999644 34569999999999999999999999   89999999999999964   5679999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH------HHHHHH
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALD  356 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~------~~~~~~  356 (498)
                      +|+.-.....   .      ..+.-||.|.|||++....|+..+|+||+||+||-|+.|.|||....-      ....+.
T Consensus       210 FAK~t~~~~~---L------~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~  280 (400)
T KOG0604|consen  210 FAKETQEPGD---L------MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR  280 (400)
T ss_pred             cccccCCCcc---c------cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh
Confidence            9986543221   1      223479999999999999999999999999999999999999953221      122222


Q ss_pred             hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          357 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .|.+    +....+| ...++...++|+.+|..+|.+|.++.+
T Consensus       281 ~gqy----~FP~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~  318 (400)
T KOG0604|consen  281 TGQY----EFPEPEW-SCVSEAAKDLIRKLLKTEPTERLTIEE  318 (400)
T ss_pred             ccCc----cCCChhH-hHHHHHHHHHHHHHhcCCchhheeHHH
Confidence            2211    1112223 246788999999999999999999988

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=296.35  Aligned_cols=238  Identities=22%  Similarity=0.302  Sum_probs=199.9

Q ss_pred             CCCCCcccccCceEEEEEEECCeE--EEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          140 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~~~~--vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      +.....||-||||.|=.+..++..  +|+|++++...   ...+.+..|-+||..+++|.||+||-.|.+  +.|+.||-
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            445567999999999988887655  78888876533   335678899999999999999999999955  68899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      |-||.|...|.   ..+.|...+...++..+.+|+.|||.   +|||+|||||+|++||.+|-+||.|||+|+.+..+. 
T Consensus       502 ClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-  574 (732)
T KOG0614|consen  502 CLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-  574 (732)
T ss_pred             hcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence            99999999994   45568888889999999999999999   999999999999999999999999999999876543 


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                        ...+.      .|||.|.|||++.+.+++.++|.||||+++|||+||.|||.+.+++..-...-+-.+     ...||
T Consensus       575 --KTwTF------cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----~i~~P  641 (732)
T KOG0614|consen  575 --KTWTF------CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----KIEFP  641 (732)
T ss_pred             --ceeee------cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----hhhcc
Confidence              23333      499999999999999999999999999999999999999998887653221111111     23478


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ...+....+|+++.|..+|.+|-..
T Consensus       642 r~I~k~a~~Lik~LCr~~P~ERLG~  666 (732)
T KOG0614|consen  642 RRITKTATDLIKKLCRDNPTERLGY  666 (732)
T ss_pred             cccchhHHHHHHHHHhcCcHhhhcc
Confidence            8888999999999999999999863

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-37  Score=278.34  Aligned_cols=242  Identities=26%  Similarity=0.310  Sum_probs=188.2

Q ss_pred             CCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeecee--cCcceEEEeeCCCC
Q 010882          143 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNG  216 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~--~~~~~lV~E~~~~g  216 (498)
                      ...||.|+||+|++-.++  +...|||.+..... ....++..|.++..+- +.||||++||++  +...++.||+| ..
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence            346999999999998875  67899999986554 4456788888866554 789999999986  34577999998 45


Q ss_pred             CHHhhhcc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          217 SLEDRLSC--KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       217 sL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      ||+.+...  ......+++...-.|....+.||.||...  ..||||||||+|||||..|.+||+|||+|..+..+..  
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence            77665422  12234688888888999999999999875  5699999999999999999999999999987654432  


Q ss_pred             CCccceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH---hCccccccCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD---TGKLKNLLDPLAG  369 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~---~~~~~~~~~~~~~  369 (498)
                             .+...|...|||||.+..  .+|+.+|||||||++|||+.||..|+...+.+...+.   .|....+..+.  
T Consensus       224 -------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~--  294 (361)
T KOG1006|consen  224 -------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK--  294 (361)
T ss_pred             -------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc--
Confidence                   133458899999999975  3599999999999999999999999988776543332   22222221110  


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       -....+..+..+|..|+..|.++||.+.+
T Consensus       295 -~~~~~s~~~~~fintCl~Kd~~~Rpky~~  323 (361)
T KOG1006|consen  295 -ECVHYSFSMVRFINTCLIKDRSDRPKYDD  323 (361)
T ss_pred             -cccccCHHHHHHHHHHhhcccccCcchhh
Confidence             11236788999999999999999999987

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=283.47  Aligned_cols=256  Identities=27%  Similarity=0.434  Sum_probs=196.1

Q ss_pred             CCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcC--CCCCeeeeeceec------CcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGACP------EVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~hpniv~l~g~~~------~~~~lV~  210 (498)
                      ......+||+|+||.||+|.+.++.||||++..   .....|..|-+|.+..  .|+||++++++-.      ..+.||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            344556799999999999999999999999874   3456789999998874  7999999998752      2578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC------CCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP------HSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~------~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      +|.+.|||.++|..    ..++|....+|+..+++||+|||.-.+      .+|+|||||+.||||.++++.-|+|||||
T Consensus       288 ~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999953    459999999999999999999997543      47999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCC-----CccchHhHHHHHHHHHhCCCCC------------C
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELT-----PKSDVYSFGIILLRLLTGRPAL------------G  346 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwSlGvil~elltG~~pf------------~  346 (498)
                      ..+..+.....      ..+.+||..|||||++.+. .+.     .+.||||+|.|||||++.-..+            .
T Consensus       364 l~~~p~~~~~d------~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  364 LRLEPGKPQGD------THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             EEecCCCCCcc------hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            98875432221      1236799999999999764 222     3589999999999999965322            1


Q ss_pred             -------CcHHHHHHHHhCccccccCCCCCCCC-HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          347 -------ITKEVQYALDTGKLKNLLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       347 -------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                             ..++++..+...+....+..   .|- .....-+.+.+..||+.|++-|.|+.- |.+.+..+...
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~---~W~~h~~~~~l~et~EeCWDhDaeARLTA~C-v~eR~~~l~~~  506 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPD---AWRKHAGMAVLCETIEECWDHDAEARLTAGC-VEERMAELMML  506 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChh---hhhcCccHHHHHHHHHHHcCCchhhhhhhHH-HHHHHHHHhcc
Confidence                   11223333333222222111   111 124567899999999999999999988 66666666544

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.5e-34  Score=312.86  Aligned_cols=143  Identities=29%  Similarity=0.433  Sum_probs=126.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      .+|.+.+.||+|+||.||+|.+.  +..||||++.......   ...+..|+.++..++||||+++++++.  +..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            46888899999999999999986  7899999997644322   256889999999999999999998874  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ||++||+|.+++..   ...+++..++.|+.|++.||.|||.   ++||||||||+||||+.++.+||+|||+++.
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~  153 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV  153 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence            99999999999843   3458889999999999999999999   8999999999999999999999999999873

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=308.84  Aligned_cols=254  Identities=28%  Similarity=0.478  Sum_probs=203.6

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC---------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceecC
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACPE  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~~  204 (498)
                      ...+..+.+.||.|.||.|++|...         ...||||+++..... ..+.+..|+.+|+.+ .||||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3344455668999999999999753         346999999865433 456799999999998 59999999999954


Q ss_pred             --cceEEEeeCCCCCHHhhhccCC-----CC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEE
Q 010882          205 --VWTLVYEYLPNGSLEDRLSCKD-----NS--------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL  269 (498)
Q Consensus       205 --~~~lV~E~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiL  269 (498)
                        ..++|+||+..|+|.++|....     ..        ..|+....+.++.|||.|++||++   .++|||||-..|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEE
Confidence              6889999999999999997544     00        238899999999999999999999   88999999999999


Q ss_pred             EcCCCceeEeeccccccccccccCCCCccceeccCCCC--CCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 010882          270 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG--TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG  346 (498)
Q Consensus       270 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~  346 (498)
                      ++.+..+||+|||+|+...........       ...|  ...|||||.+....|+.++|||||||+||||+| |..||.
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~-------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTK-------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEec-------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            999999999999999965443322111       1112  235999999999999999999999999999999 889998


Q ss_pred             CcH---HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          347 ITK---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       347 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      +..   .+...+..|.        ....|..++.++.+++..||+.+|.+||++.+ +.+.++..
T Consensus       524 ~~~~~~~l~~~l~~G~--------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~-~~~~~~~~  579 (609)
T KOG0200|consen  524 GIPPTEELLEFLKEGN--------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE-CVEFFEKH  579 (609)
T ss_pred             CCCcHHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH-HHHHHHHH
Confidence            632   2322233332        23357778899999999999999999999999 66777664

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.7e-34  Score=275.74  Aligned_cols=218  Identities=24%  Similarity=0.210  Sum_probs=175.7

Q ss_pred             cCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCHHhhhcc
Q 010882          149 GGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSC  224 (498)
Q Consensus       149 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL~~~l~~  224 (498)
                      |.||.||++.+  .+..||+|.+....     .+..|...+....||||+++++++.  +..++||||++||+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999988  46789999987543     3445666666678999999999874  468899999999999999853


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccC
Q 010882          225 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD  304 (498)
Q Consensus       225 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~  304 (498)
                         ...+++..+..++.+++.||.|||.   ++|+||||||+||+++.++.++++|||++.......           ..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----------~~  141 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----------DG  141 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----------cc
Confidence               2458999999999999999999999   899999999999999999999999999876554321           12


Q ss_pred             CCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHH
Q 010882          305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAM  384 (498)
Q Consensus       305 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  384 (498)
                      ..++..|+|||.+.+..++.++||||+||++|+|++|++||.......   .        .......|...+..+.+++.
T Consensus       142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---~--------~~~~~~~~~~~~~~~~~li~  210 (237)
T cd05576         142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---N--------THTTLNIPEWVSEEARSLLQ  210 (237)
T ss_pred             CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---c--------cccccCCcccCCHHHHHHHH
Confidence            236778999999988889999999999999999999998875332110   0        00011234445678999999


Q ss_pred             HhhhcccCCCCChhH
Q 010882          385 RCCEMSRKSRPELGK  399 (498)
Q Consensus       385 ~cl~~~p~~RP~~~~  399 (498)
                      +|++.||.+||++..
T Consensus       211 ~~l~~dp~~R~~~~~  225 (237)
T cd05576         211 QLLQFNPTERLGAGV  225 (237)
T ss_pred             HHccCCHHHhcCCCc
Confidence            999999999999855

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-36  Score=270.54  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=195.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC--CCCChhhHHHHHHHHHcCCCCCeeeeeceec----------
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP----------  203 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~g~~~----------  203 (498)
                      +.|....+||+|.||+||++..+  ++.||+|++-..  ...-+....+|+++|..|.|+|++.++..|.          
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666678999999999999874  567898865432  2334567789999999999999999999882          


Q ss_pred             CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                      ..+|+||.+|+. +|..+|.  +....++..++.+++.++..||.|+|.   ..|+|||+||.|+||+.+|.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence            137999999975 7888884  344679999999999999999999999   7899999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----C
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G  358 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~  358 (498)
                      ++.++........    ..+..+-|.+|.+||.+.+. .|+++.|||.-||||.||+||.|-|.+..+.+.....    |
T Consensus       171 ar~fs~~~n~~kp----rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  171 ARAFSTSKNVVKP----RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccceecccccCCC----CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            9877655432222    23455679999999999875 7999999999999999999999999876664433211    2


Q ss_pred             ccccccCCCCCCC------------------------CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 KLKNLLDPLAGDW------------------------PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 ~~~~~~~~~~~~~------------------------~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+..-+=|.....                        |..-.+...+|+..++..||.+||++.+
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~  311 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ  311 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence            2211111111111                        1112246789999999999999999887

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=299.23  Aligned_cols=252  Identities=27%  Similarity=0.380  Sum_probs=208.3

Q ss_pred             HHHHHhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeecee-----
Q 010882          131 SEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC-----  202 (498)
Q Consensus       131 ~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~-----  202 (498)
                      +.+...+..|++...||.|.||.||++..  .++.+|+|+...... ..+++..|.+||+.+ +|||++.+||++     
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            33444566788889999999999999876  478899999876543 356788899999888 699999999987     


Q ss_pred             --cCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEee
Q 010882          203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD  280 (498)
Q Consensus       203 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  280 (498)
                        .+.+.||||||.|||..|++.... +..+.|..+..|+..++.||.+||.   +-++|||||-.|||++.++.|||.|
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEee
Confidence              457899999999999999996554 6779999999999999999999999   7799999999999999999999999


Q ss_pred             ccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-----CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH
Q 010882          281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL  355 (498)
Q Consensus       281 FGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  355 (498)
                      ||++..+..+..        .+...+|||.|||||++.-.     .|+..+|+||||++..||.-|.||+-...++..++
T Consensus       167 FGvSaQldsT~g--------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF  238 (953)
T KOG0587|consen  167 FGVSAQLDSTVG--------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF  238 (953)
T ss_pred             eeeeeeeecccc--------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence            999987654432        23445699999999999753     47788999999999999999999998888777665


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+.+-...    .-.-|..-+.++.++|..||..|...||++.+
T Consensus       239 ~IpRNPPP----kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~  278 (953)
T KOG0587|consen  239 LIPRNPPP----KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEE  278 (953)
T ss_pred             cCCCCCCc----cccchhhHHHHHHHHHHHHHhhccccCcchhh
Confidence            54321111    11124556789999999999999999999877

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-35  Score=286.61  Aligned_cols=238  Identities=27%  Similarity=0.435  Sum_probs=195.8

Q ss_pred             CCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEeeCCCC
Q 010882          143 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG  216 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~~~~g  216 (498)
                      .++||+|.||+||-|.++  |+.||||++.+...  ...+.+.+|+.||..++||.||.|.-.|  .+..+.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            467999999999999885  78999999987543  2346789999999999999999998888  46789999999665


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC---CceeEeeccccccccccccC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla~~~~~~~~~  293 (498)
                      =|.-.|.  .....|++.....+..||+.||.|||.   ++|+|+||||+||||...   -.+||+|||+|+.+.+... 
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            5555554  334568888888899999999999999   899999999999999643   4799999999999876542 


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              +...+|||.|+|||++...+|...-|+||.|||+|--++|.-||..+..+...+....+...-.    .| .
T Consensus       723 --------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~----PW-~  789 (888)
T KOG4236|consen  723 --------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPN----PW-S  789 (888)
T ss_pred             --------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCC----ch-h
Confidence                    2456799999999999999999999999999999999999999987777665555443332211    12 2


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+....+||...|+..-++|-+..+
T Consensus       790 eis~~AidlIn~LLqVkm~kRysvdk  815 (888)
T KOG4236|consen  790 EISPEAIDLINNLLQVKMRKRYSVDK  815 (888)
T ss_pred             hcCHHHHHHHHHHHHHHHHHhcchHh
Confidence            45677889999999999999987655

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-35  Score=273.65  Aligned_cols=239  Identities=24%  Similarity=0.328  Sum_probs=191.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~l  208 (498)
                      ..+|...++||+|+|++|..+.+.  .+-+|+|++++.-   ..+.+-++.|-.+..+. +||.+|.|..+|+  ..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            347899999999999999988874  5679999998753   33445577888888776 7999999999885  46899


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      |.||++||+|..+++   ....|++.....+..+|..||.|||+   +|||.||||.+|||||..|++||+|+|+|+--.
T Consensus       329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999998884   44569999999999999999999999   999999999999999999999999999998543


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH-------HHHHHHHhCccc
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK-------EVQYALDTGKLK  361 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~-------~~~~~~~~~~~~  361 (498)
                      ..+.  ..      ....|||.|+|||++.+..|+..+|||+|||+|+||+.|+.||+...       .-.+++.     
T Consensus       403 ~~gd--~t------stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq-----  469 (593)
T KOG0695|consen  403 GPGD--TT------STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ-----  469 (593)
T ss_pred             CCCc--cc------ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH-----
Confidence            3321  11      23459999999999999999999999999999999999999997422       1122211     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCC
Q 010882          362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP  395 (498)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  395 (498)
                      .+++ .....|...+-....++...|+.||.+|.
T Consensus       470 vile-kqiriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  470 VILE-KQIRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHhh-hcccccceeehhhHHHHHHhhcCCcHHhc
Confidence            1111 11124555566778889999999999885

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=246.11  Aligned_cols=201  Identities=31%  Similarity=0.448  Sum_probs=167.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~  212 (498)
                      +|....+||+|.||+||+|..+  +.-||+|.+.....  .-+....+|+.+|+.+.|.|||++++..  +....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3455567999999999999875  56799998876533  3467889999999999999999999986  3468899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      |. -+|..+...  -++.++......++.|+++||.|+|+   ++++||||||.|+||+.+|.+||+|||+++-+.-.  
T Consensus        83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip--  154 (292)
T KOG0662|consen   83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--  154 (292)
T ss_pred             hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence            95 478877753  34568889999999999999999999   88999999999999999999999999999976543  


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCC-CCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLT-GRPALGITKEVQY  353 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~  353 (498)
                            ..|....+-|.+|.+|.++.+.+ |+...|+||-|||+.|+.. |+|-|.+.+-..+
T Consensus       155 ------vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq  211 (292)
T KOG0662|consen  155 ------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ  211 (292)
T ss_pred             ------eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence                  23344456799999999998865 8889999999999999976 8888876554333

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=289.41  Aligned_cols=230  Identities=27%  Similarity=0.411  Sum_probs=186.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceecC--cceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      +..|.+...+|.|+||.|-.+...  ++..++|++....    .+..+|+.++... +||||+++.+.+.+  ..++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            556888888999999999998874  6789999987652    2345677777666 69999999999965  5789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE-cCCCceeEeecccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL-DANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl-~~~~~~kl~DFGla~~~~~~  290 (498)
                      ++.||-|.+.+...   ..+. ..+..|+.+++.|+.|||.   +|+|||||||+|||+ +..|+++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999888877432   2233 6788899999999999999   899999999999999 68999999999999876544


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH---HHHHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~~~~~~~~~~~~  367 (498)
                      .           ..+.-|..|.|||++...+|+.+|||||||++||+||+|+.||.....   +...+..          
T Consensus       470 ~-----------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~----------  528 (612)
T KOG0603|consen  470 C-----------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM----------  528 (612)
T ss_pred             h-----------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC----------
Confidence            1           122358899999999999999999999999999999999999964321   1111111          


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       +.+....+....+|+.+||+.+|.+||++.+
T Consensus       529 -~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~  559 (612)
T KOG0603|consen  529 -PKFSECVSDEAKDLLQQLLQVDPALRLGADE  559 (612)
T ss_pred             -CccccccCHHHHHHHHHhccCChhhCcChhh
Confidence             2223567789999999999999999999988

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.2e-32  Score=257.37  Aligned_cols=233  Identities=31%  Similarity=0.408  Sum_probs=186.7

Q ss_pred             CceEEEEEEEC--CeEEEEEEecCCCCCC-hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCHHhhhcc
Q 010882          150 GYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSC  224 (498)
Q Consensus       150 ~~g~Vy~~~~~--~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL~~~l~~  224 (498)
                      +||.||+|...  +..+|+|++....... .+.+.+|+.++++++|+||+++++.+.  ...++||||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            68999999985  5889999998765544 678999999999999999999999884  468899999999999999853


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccC
Q 010882          225 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD  304 (498)
Q Consensus       225 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~  304 (498)
                      .   ..+++..+..++.+++.+|.+||.   .+++|+||+|+||+++.++.++|+|||++........         ...
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---------~~~  145 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---------LTT  145 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeeccccc---------ccc
Confidence            2   238899999999999999999999   8999999999999999999999999999987654321         123


Q ss_pred             CCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHH
Q 010882          305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAM  384 (498)
Q Consensus       305 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  384 (498)
                      ..|+..|++||.+....++.++||||||+++++|++|.+||............-. ......  .......+..+.+++.
T Consensus       146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~i~  222 (244)
T smart00220      146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG-KPKPPF--PPPEWKISPEAKDLIR  222 (244)
T ss_pred             ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-ccCCCC--ccccccCCHHHHHHHH
Confidence            3488999999999988899999999999999999999999976222221111100 000000  0000004578999999


Q ss_pred             HhhhcccCCCCChhHH
Q 010882          385 RCCEMSRKSRPELGKD  400 (498)
Q Consensus       385 ~cl~~~p~~RP~~~~~  400 (498)
                      +|+..+|.+||++.++
T Consensus       223 ~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      223 KLLVKDPEKRLTAEEA  238 (244)
T ss_pred             HHccCCchhccCHHHH
Confidence            9999999999999883

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=290.22  Aligned_cols=244  Identities=28%  Similarity=0.385  Sum_probs=188.4

Q ss_pred             CCCCCcccccCce-EEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceecC--cceEEEeeCCC
Q 010882          140 FDPSLKIGEGGYG-SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYEYLPN  215 (498)
Q Consensus       140 ~~~~~~lG~G~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~lV~E~~~~  215 (498)
                      |...+.+|.|+-| .||+|.+.++.||||.+-..   ...-..+|+..|..- +|||||++|+.-.+  ..||..|.|. 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence            5566679999987 57999999999999987543   234567999999988 59999999987644  5789999994 


Q ss_pred             CCHHhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---C--CceeEeeccccccccc
Q 010882          216 GSLEDRLSCKDN-SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---N--FVSKLSDFGISRFLSQ  289 (498)
Q Consensus       216 gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~--~~~kl~DFGla~~~~~  289 (498)
                      .+|.+++..... .....-...+.+..|++.||++||+   .+||||||||.||||+.   +  ..++|+|||+|+.+..
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            699999965311 1111113446788999999999999   78999999999999975   3  4789999999998876


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhC-CCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      +..+...     ..+..||.+|+|||++.....+.++||||+|||+|+.++| .+||+..-..+..+..+......  ..
T Consensus       664 ~~sS~~r-----~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~--L~  736 (903)
T KOG1027|consen  664 GKSSFSR-----LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVH--LE  736 (903)
T ss_pred             Ccchhhc-----ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceee--ec
Confidence            6543332     3456799999999999998888899999999999999996 89998766655444444322111  10


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                       ..+. +  ...+||.+|++++|..||++.+++
T Consensus       737 -~~~d-~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  737 -PLPD-C--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             -cCch-H--HHHHHHHHhcCCCcccCCCHHHHh
Confidence             0111 1  789999999999999999999843

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=4.2e-32  Score=288.67  Aligned_cols=250  Identities=21%  Similarity=0.217  Sum_probs=162.6

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeece--------
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA--------  201 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~--------  201 (498)
                      ...+|...+.||+|+||.||+|.+.      +..||||++.....  .+.+..+  .+....+.+++.++..        
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5668999999999999999999984      56899998764321  1111111  1222223333333222        


Q ss_pred             ecCcceEEEeeCCCCCHHhhhccCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 010882          202 CPEVWTLVYEYLPNGSLEDRLSCKDNS-----------------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK  264 (498)
Q Consensus       202 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk  264 (498)
                      .....++||||+.+++|.+++......                 .......+..|+.|++.||.|||+   ++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence            134578999999999999988533210                 011223456799999999999999   899999999


Q ss_pred             CCcEEEcC-CCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccC----------------------C
Q 010882          265 PANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----------------------E  321 (498)
Q Consensus       265 p~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~  321 (498)
                      |+|||++. ++.+||+|||+|+.+.......       .....||+.|+|||.+...                      .
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-------~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~  355 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYI-------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN  355 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccC-------CcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence            99999985 6899999999998654322111       1234589999999976432                      2


Q ss_pred             CCCccchHhHHHHHHHHHhCCCCCCCcHH-HHHHHHhC-----ccccccCCCCC-C------CCHHHHHHHHHHHHHhhh
Q 010882          322 LTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDTG-----KLKNLLDPLAG-D------WPFVQAEQLANLAMRCCE  388 (498)
Q Consensus       322 ~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~~~-----~~~~~~~~~~~-~------~~~~~~~~l~~li~~cl~  388 (498)
                      ++.++|||||||+||||+++..|++.... ....+...     .+...+.+... +      ..........+|+.+||+
T Consensus       356 ~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        356 LPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             CCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            33456999999999999997766543211 11111110     01111111100 0      000112345689999999


Q ss_pred             cccCCCCChhH
Q 010882          389 MSRKSRPELGK  399 (498)
Q Consensus       389 ~~p~~RP~~~~  399 (498)
                      .||.+||++.+
T Consensus       436 ~dP~kR~ta~e  446 (566)
T PLN03225        436 FKGRQRISAKA  446 (566)
T ss_pred             CCcccCCCHHH
Confidence            99999999988

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.5e-31  Score=278.02  Aligned_cols=254  Identities=19%  Similarity=0.235  Sum_probs=177.0

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE------------------CCeEEEEEEecCCCCCChhh--------------HHHH
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL------------------RHMQVAIKMLHPHSLQGPSE--------------FQQE  183 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~--------------~~~E  183 (498)
                      ..++|.+.++||+|+||+||+|..                  .+..||||.+........+.              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999964                  23569999987543322222              3457


Q ss_pred             HHHHHcCCCCCe-----eeeeceec----------CcceEEEeeCCCCCHHhhhccCCC---------------------
Q 010882          184 IDILSKIRHPNL-----VTLVGACP----------EVWTLVYEYLPNGSLEDRLSCKDN---------------------  227 (498)
Q Consensus       184 ~~il~~l~hpni-----v~l~g~~~----------~~~~lV~E~~~~gsL~~~l~~~~~---------------------  227 (498)
                      +.++.+++|.++     +.++|+|.          ...++||||+++|+|.++|+....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     66777662          246899999999999999864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCC
Q 010882          228 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG  307 (498)
Q Consensus       228 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~g  307 (498)
                      ...+++..+..++.+++.||.|||.   .+|+||||||+|||++.++.+||+|||++.........   .    .....+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~---~----~~~g~~  372 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF---N----PLYGML  372 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---C----ccccCC
Confidence            1234677888999999999999999   89999999999999999999999999999755332111   0    112235


Q ss_pred             CCCcCChhhhccCC--------------------C--CCccchHhHHHHHHHHHhCCC-CCCCcHHHHHHHHh-----Cc
Q 010882          308 TFAYMDPEFLASGE--------------------L--TPKSDVYSFGIILLRLLTGRP-ALGITKEVQYALDT-----GK  359 (498)
Q Consensus       308 t~~y~aPE~~~~~~--------------------~--~~~~DvwSlGvil~elltG~~-pf~~~~~~~~~~~~-----~~  359 (498)
                      |+.|+|||.+....                    +  ..+.||||+||++|+|++|.. ||............     ..
T Consensus       373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~  452 (507)
T PLN03224        373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR  452 (507)
T ss_pred             CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence            89999999886432                    1  124799999999999999874 77543222111110     00


Q ss_pred             cccccCCCCCCCC--HHHHHHHHHHHHHhhhccc---CCCCChhHH
Q 010882          360 LKNLLDPLAGDWP--FVQAEQLANLAMRCCEMSR---KSRPELGKD  400 (498)
Q Consensus       360 ~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p---~~RP~~~~~  400 (498)
                      +... .....+++  ...+....+|+.+++..+|   .+|+|+.++
T Consensus       453 ~r~~-~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ea  497 (507)
T PLN03224        453 WRMY-KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQA  497 (507)
T ss_pred             HHhh-cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHH
Confidence            0000 00011111  2346788999999999766   689999883

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=4e-32  Score=239.11  Aligned_cols=198  Identities=27%  Similarity=0.348  Sum_probs=159.0

Q ss_pred             CCCCCCcccccCceEEEEEE--ECCeEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      +......||+|+||.|-+-+  ..|.-.|+|.+...-. +.......|+++..+. ..|.+|.+||...  ....+.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            44455679999999885544  4688999999876433 2345677888887665 6999999999763  357899999


Q ss_pred             CCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          213 LPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       213 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      | ..||+.+.... ..+..+++..+-+|+..+..||.|||+.  ..+||||+||+||||+.+|++|++|||++..+.++.
T Consensus       127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            8 45887665321 3456789999999999999999999996  579999999999999999999999999998876543


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhcc----CCCCCccchHhHHHHHHHHHhCCCCCCCc
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRPALGIT  348 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~pf~~~  348 (498)
                      ..         +-..|.-.|||||.+..    .+|+.+|||||||+.++||.+++.||+..
T Consensus       204 Ak---------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  204 AK---------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             HH---------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            21         12347889999999865    36999999999999999999999999754

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=259.98  Aligned_cols=248  Identities=26%  Similarity=0.356  Sum_probs=187.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCC--CCC----eeeeeceec--Ccc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR--HPN----LVTLVGACP--EVW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--hpn----iv~l~g~~~--~~~  206 (498)
                      +.+|.+...+|+|.||.|-.+.++  +..||||+++... .-.+...-|+++|.++.  -|+    +|.+.++|+  ...
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            668999999999999999998875  4689999987533 22455678999999994  233    677777773  467


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC--------------
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--------------  272 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~--------------  272 (498)
                      +||+|.+ |-|+.++|..+ +-.+++..++..|+.|++.+++|||+   .+++|-||||+|||+..              
T Consensus       167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence            8999998 66999999643 45679999999999999999999999   89999999999999932              


Q ss_pred             ------CCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCC
Q 010882          273 ------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG  346 (498)
Q Consensus       273 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~  346 (498)
                            +..++|+|||.|..-....           ...+.|-.|.|||++.+-+++..|||||+||||+|+.||..-|.
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                  2358999999998765443           23457999999999999999999999999999999999998885


Q ss_pred             CcHHHHHH-----------------------HHhCccc-----------cccCCCCC-----CCCHHHHHHHHHHHHHhh
Q 010882          347 ITKEVQYA-----------------------LDTGKLK-----------NLLDPLAG-----DWPFVQAEQLANLAMRCC  387 (498)
Q Consensus       347 ~~~~~~~~-----------------------~~~~~~~-----------~~~~~~~~-----~~~~~~~~~l~~li~~cl  387 (498)
                      ..+..+.+                       +..+++.           ...++...     ........+|.+|+..||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            43311100                       0111110           00000000     001123456999999999


Q ss_pred             hcccCCCCChhHHH
Q 010882          388 EMSRKSRPELGKDV  401 (498)
Q Consensus       388 ~~~p~~RP~~~~~v  401 (498)
                      ..||.+|+++.+++
T Consensus       391 ~fDP~~RiTl~EAL  404 (415)
T KOG0671|consen  391 EFDPARRITLREAL  404 (415)
T ss_pred             ccCccccccHHHHh
Confidence            99999999999843

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=254.81  Aligned_cols=262  Identities=24%  Similarity=0.378  Sum_probs=206.0

Q ss_pred             HHHHHhhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeecee
Q 010882          131 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC  202 (498)
Q Consensus       131 ~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~  202 (498)
                      .++.....++....++-+|.||.||+|.++.       +.|-+|.++.... .....+..|.-.+..+.|||+..+.|++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            4444556678888889999999999998753       3467777765432 2345688899999999999999999988


Q ss_pred             c---CcceEEEeeCCCCCHHhhhc-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC
Q 010882          203 P---EVWTLVYEYLPNGSLEDRLS-----CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF  274 (498)
Q Consensus       203 ~---~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  274 (498)
                      -   +..+.+|.+..-|+|..+|.     .......++..+...++.|++.|+.|||.   +++||.||...|.+||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence            3   34678899998999999996     22334567778889999999999999999   9999999999999999999


Q ss_pred             ceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH
Q 010882          275 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY  353 (498)
Q Consensus       275 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~  353 (498)
                      .+||+|=.+++-+-+..+.      |.....-....||+||.+....|+.++|||||||+||||+| |+.|+...++.+.
T Consensus       434 qVkltDsaLSRDLFP~DYh------cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm  507 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYH------CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM  507 (563)
T ss_pred             eEEeccchhccccCccccc------ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence            9999999999865443321      11122224668999999999999999999999999999999 8999977666543


Q ss_pred             HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..      -+.|..+-.-|..+++++..++.-||...|++||++.+ +..-|..+
T Consensus       508 ~~------ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q-lv~cLseF  555 (563)
T KOG1024|consen  508 EH------YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQ-LVICLSEF  555 (563)
T ss_pred             HH------HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH-HHHHHHHH
Confidence            21      11222222347788999999999999999999999999 55555544

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.9e-31  Score=238.23  Aligned_cols=244  Identities=22%  Similarity=0.396  Sum_probs=189.2

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceecC----cce
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE----VWT  207 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~----~~~  207 (498)
                      +...+|++.+++|+|.|++||.|..  ++..++||++++..   .+.+.+|+.||..|. ||||++|+++..+    ...
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            3456899999999999999999985  57889999998643   357899999999997 9999999998744    367


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-CceeEeecccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRF  286 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~~  286 (498)
                      ||+||+.+.+...+.      +.|+...+..++.+++.||.|+|+   +||+|||+||.|++||.. -.++|+|+|+|.+
T Consensus       112 LiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             hHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhh
Confidence            999999998887766      457778899999999999999999   999999999999999954 5799999999998


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCC-CcHHHHHHHHhC------
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALG-ITKEVQYALDTG------  358 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~-~~~~~~~~~~~~------  358 (498)
                      +.......         -.+.+..|--||.+..- .|+.+-|+|||||+|..|+..+.||- +.+..++++...      
T Consensus       183 YHp~~eYn---------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~  253 (338)
T KOG0668|consen  183 YHPGKEYN---------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD  253 (338)
T ss_pred             cCCCceee---------eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence            87664322         22457788999999764 57888899999999999999998873 222222211110      


Q ss_pred             -------ccccccCCC---------CCCCC--------HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 -------KLKNLLDPL---------AGDWP--------FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 -------~~~~~~~~~---------~~~~~--------~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                             +..-.++|.         ...|.        .-.+++..+++...|..|-.+||++.+
T Consensus       254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE  318 (338)
T KOG0668|consen  254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE  318 (338)
T ss_pred             HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence                   111112221         01111        113467888999999999999999877

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=270.30  Aligned_cols=248  Identities=28%  Similarity=0.361  Sum_probs=205.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee--cCcceEEEee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY  212 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~~lV~E~  212 (498)
                      ..+|+....+|.|.||.|||+++.  +...|+|+++.....+..-+++|+-+++..+|||||.++|.+  .+...++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            457889999999999999999884  688999999988777778889999999999999999999998  5678999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      |.||+|.+..+   ...++++.++..++++...||+|||+   .|-+|||||-.|||++..|.+|++|||.+..+...  
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh--
Confidence            99999999874   45679999999999999999999999   89999999999999999999999999998755433  


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                            ...+....||+.|||||+..   .+.|...||||++|+...|+---+||.....+.+..+...  ...++|..-
T Consensus       166 ------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--kS~~qpp~l  237 (829)
T KOG0576|consen  166 ------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--KSGFQPPTL  237 (829)
T ss_pred             ------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--ccCCCCCcc
Confidence                  23345667999999999874   4679999999999999999999999876555554433221  112222222


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .-+..-+..+.++++.|+..+|++||++...
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaekl  268 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKL  268 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhh
Confidence            2233346789999999999999999998763

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.4e-29  Score=230.65  Aligned_cols=203  Identities=38%  Similarity=0.594  Sum_probs=176.3

Q ss_pred             ccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCCCCCHHh
Q 010882          146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLED  220 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~~gsL~~  220 (498)
                      ||+|++|.||++...  +..+++|++...... ....+.+|+.+++.+.|++|+++++++..  ..+++|||++|++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999997  789999998865432 24679999999999999999999999854  7899999999999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-CCceeEeeccccccccccccCCCCccc
Q 010882          221 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTL  299 (498)
Q Consensus       221 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~  299 (498)
                      ++....  ..+++..+..++.+++.+|.+||.   .+++|+||+|.||+++. ++.++|+|||.+........       
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------  148 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------  148 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------
Confidence            985321  468899999999999999999999   89999999999999999 89999999999986654321       


Q ss_pred             eeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHH
Q 010882          300 CCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ  378 (498)
Q Consensus       300 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (498)
                       ......++..|++||.+... .++.++|+||+|+++++|                                      ..
T Consensus       149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~  189 (215)
T cd00180         149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PE  189 (215)
T ss_pred             -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HH
Confidence             01223478899999999887 788999999999999999                                      56


Q ss_pred             HHHHHHHhhhcccCCCCChhH
Q 010882          379 LANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       379 l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +.+++..|+..+|.+||++.+
T Consensus       190 ~~~~l~~~l~~~p~~R~~~~~  210 (215)
T cd00180         190 LKDLIRKMLQKDPEKRPSAKE  210 (215)
T ss_pred             HHHHHHHHhhCCcccCcCHHH
Confidence            899999999999999999987

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=244.65  Aligned_cols=247  Identities=23%  Similarity=0.333  Sum_probs=186.7

Q ss_pred             CCCCCCcccccCceEEEEEEE--CCeEEEEEEecCC--CCCChhhHHHHHHHHHcCCCCCeeeeeceecC-------cce
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT  207 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-------~~~  207 (498)
                      +.++.+.||-|+||+||-..+  .++.||+|++...  +..+-+.+.+|+.+|.-++|.|++..+++...       ..|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            567788999999999999887  4788999987643  22234678899999999999999999887632       357


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      .|.|.+. .+|+..+   -...+|+...+.-+..||++||+|||+   .+|+||||||.|+|++.|..+||+|||+++..
T Consensus       134 V~TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence            8888884 5888888   455678888999999999999999999   89999999999999999999999999999987


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh---------
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT---------  357 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~---------  357 (498)
                      ..+.....       +..+-|-.|.|||++.+. .|+.+.||||.|||+.|++..+.-|...++++.+-..         
T Consensus       207 e~d~~~hM-------TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~  279 (449)
T KOG0664|consen  207 DQRDRLNM-------THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ  279 (449)
T ss_pred             chhhhhhh-------HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence            65542221       222358899999999985 6999999999999999999999888655544332111         


Q ss_pred             --------C-ccccccCC-CCCC--------CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          358 --------G-KLKNLLDP-LAGD--------WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       358 --------~-~~~~~~~~-~~~~--------~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                              | +..-+-.+ ...+        .+.........+...++..+|+.|.+..+
T Consensus       280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~  339 (449)
T KOG0664|consen  280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEE  339 (449)
T ss_pred             HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhh
Confidence                    1 00000000 0011        12223345667778888889999888766

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=8e-29  Score=233.19  Aligned_cols=196  Identities=37%  Similarity=0.553  Sum_probs=167.0

Q ss_pred             CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      |.....||.|++|.||+|...  +..+|+|.+...... ..+.+.+|+..+.+++|+|++++++++.  +..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            455678999999999999985  588999999876554 5678899999999999999999999874  56889999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +++|.+++.....  .+++..+..++.+++.+|.+||.   .+++|+||+|.||+++.++.++|+|||++......... 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            9999999853321  18889999999999999999999   79999999999999999999999999999876543200 


Q ss_pred             CCccceeccCCCCCCCcCChhhh-ccCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                            ......++..|++||.+ ....++.++||||||+++++|++|++||..
T Consensus       155 ------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 ------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                  01223478899999998 666788899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-30  Score=255.27  Aligned_cols=193  Identities=24%  Similarity=0.405  Sum_probs=165.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--------ChhhHHHHHHHHHcCC---CCCeeeeeceecC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIR---HPNLVTLVGACPE  204 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~---hpniv~l~g~~~~  204 (498)
                      .+|...+.+|.|+||.|+.++++  ...|+||.+.+....        ....+-.|+.||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888999999999999999995  467999998875432        1234567999999997   9999999999954


Q ss_pred             --cceEEEeeC-CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          205 --VWTLVYEYL-PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       205 --~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                        ++||+||-- +|.+|.+++   ...+.+++.....|+.|++.|+++||.   .||||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeec
Confidence              688999864 667999999   556779999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCC
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALG  346 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~  346 (498)
                      |.|........          ...+||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus       715 gsaa~~ksgpf----------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGPF----------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCCc----------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99876554332          34469999999999999887 556799999999999999988884

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.4e-29  Score=249.28  Aligned_cols=199  Identities=25%  Similarity=0.331  Sum_probs=167.2

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCC------CCCeeeeecee--cCc
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR------HPNLVTLVGAC--PEV  205 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~------hpniv~l~g~~--~~~  205 (498)
                      ....|.+....|+|-||+|.+|.+  ++..||||++..+.. -.+.=..|++||++|+      --|+++|+-.|  ...
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            345677778899999999999988  467999999986532 2234568999999995      34789998877  457


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-CceeEeecccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS  284 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla  284 (498)
                      +|||+|-+ ..+|.++|...+....|....+..++.|+..||..|..   .||+|.||||+|||++++ ..+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCccc
Confidence            89999988 56999999877777789999999999999999999999   689999999999999865 57899999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK  349 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~  349 (498)
                      .....+...+..          -+-.|.|||++.+.+|+...|+||.||+||||.||+.-|.+..
T Consensus       585 ~~~~eneitPYL----------VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  585 SFASENEITPYL----------VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             cccccccccHHH----------HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            887766532221          2557999999999999999999999999999999999987543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.2e-28  Score=238.57  Aligned_cols=200  Identities=28%  Similarity=0.425  Sum_probs=163.0

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeecee--cCcce
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWT  207 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~--~~~~~  207 (498)
                      ....|....+||.|.|++||++++.     +..||+|.+...  ..+..+..|+++|..+. +.||+++.+++  .+...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3456788889999999999999763     467999998754  35677999999999995 89999999987  56789


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-CCceeEeecccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRF  286 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~  286 (498)
                      +||||++..+..+++.      .++...+..++..++.||.++|.   +|||||||||+|+|.+. -+.-.|.|||+|..
T Consensus       112 ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             EEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999999883      36678999999999999999999   99999999999999985 46778999999983


Q ss_pred             ccccc------c------CC------------------------CCccceeccCCCCCCCcCChhhhccC-CCCCccchH
Q 010882          287 LSQNE------I------SS------------------------NNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVY  329 (498)
Q Consensus       287 ~~~~~------~------~~------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw  329 (498)
                      .....      .      ..                        +...........||++|.|||++... ..++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            21110      0      00                        00011123455799999999999875 578999999


Q ss_pred             hHHHHHHHHHhCCCCCC
Q 010882          330 SFGIILLRLLTGRPALG  346 (498)
Q Consensus       330 SlGvil~elltG~~pf~  346 (498)
                      |.|||++.+++++.||-
T Consensus       263 s~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFF  279 (418)
T ss_pred             eccceeehhhccccccc
Confidence            99999999999999984

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1e-28  Score=231.00  Aligned_cols=241  Identities=21%  Similarity=0.265  Sum_probs=184.2

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceecC--------c
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------V  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------~  205 (498)
                      .+|.-.+.+|.|.- .|.-+.+  .+++||+|.+...-  ........+|..++..++|+||++++.+|..        .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46667778999988 5555554  57899999876442  2234567899999999999999999999832        4


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      +|+||||+ .++|...+.     ..++-.++..|+.|+++|+.|||+   .||+||||||+||++..++.+||.|||+|+
T Consensus        96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence            79999999 568888774     336667888999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH---------
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD---------  356 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~---------  356 (498)
                      ....+.         ..+..+.|..|.|||++.+.+|...+||||+||++.||++|..-|.+.+.+.....         
T Consensus       167 ~e~~~~---------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd  237 (369)
T KOG0665|consen  167 TEDTDF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD  237 (369)
T ss_pred             ccCccc---------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence            654431         12344679999999999998899999999999999999999988865433221110         


Q ss_pred             ---------hC-------------ccccccCCCCCCCC------HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          357 ---------TG-------------KLKNLLDPLAGDWP------FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       357 ---------~~-------------~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                               .+             .+...+.  ...|+      .-.+..+.+++.+||-.+|++|.+..+
T Consensus       238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fp--D~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d  306 (369)
T KOG0665|consen  238 PSFMKQLQPTVRNYVENRPQYQAISFSELFP--DSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD  306 (369)
T ss_pred             HHHHHHhhHHHHHHhhcChHhhccchhhhCC--cccccccccCCccchHHHHHHHHHhhccChhhcccHHH
Confidence                     00             0000000  01122      123456889999999999999999887

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3e-27  Score=231.80  Aligned_cols=129  Identities=23%  Similarity=0.350  Sum_probs=107.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-----C---CCeeeeeceec----
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----H---PNLVTLVGACP----  203 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h---pniv~l~g~~~----  203 (498)
                      .+|-+.++||.|.|++||++.+.  .+.||+|+.+... .-.+....||.+|++++     |   .+||+|++.|.    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            56888899999999999999885  5789999987432 22355678999999983     3   36999999983    


Q ss_pred             --CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc
Q 010882          204 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD  271 (498)
Q Consensus       204 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~  271 (498)
                        ...++|+|++ |.+|..++..... ..++...+..|+.|++.||.|||..  .||||-||||+|||+.
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence              2589999999 7899998865443 4589999999999999999999995  5899999999999993

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=6.4e-28  Score=268.55  Aligned_cols=198  Identities=16%  Similarity=0.171  Sum_probs=138.3

Q ss_pred             cCCC-CCeeeeecee---------cCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 010882          189 KIRH-PNLVTLVGAC---------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI  258 (498)
Q Consensus       189 ~l~h-pniv~l~g~~---------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  258 (498)
                      .++| +||++++++|         .+.++++|||+ +++|.++|..  ....+++.++..|+.||+.||.|||+   +||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            4556 6888888877         12466788887 6699999952  23569999999999999999999999   899


Q ss_pred             ccCCCCCCcEEEcCCCc-------------------eeEeeccccccccccccCC--C------CccceeccCCCCCCCc
Q 010882          259 VHGDLKPANILLDANFV-------------------SKLSDFGISRFLSQNEISS--N------NTTLCCRTDPKGTFAY  311 (498)
Q Consensus       259 vHrDlkp~NiLl~~~~~-------------------~kl~DFGla~~~~~~~~~~--~------~~~~~~~~~~~gt~~y  311 (498)
                      |||||||+||||+..|.                   +||+|||+++.........  .      ..........+||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999965444                   4555555554321100000  0      0000001224689999


Q ss_pred             CChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhccc
Q 010882          312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR  391 (498)
Q Consensus       312 ~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p  391 (498)
                      +|||++.+..++.++|||||||+||||++|.+|+.........+...    .+.+    ...........++.+||+.+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~~~L~~~P  253 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR----VLPP----QILLNWPKEASFCLWLLHPEP  253 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh----hcCh----hhhhcCHHHHHHHHHhCCCCh
Confidence            99999999999999999999999999999999986433222222111    1111    011123346788899999999


Q ss_pred             CCCCChhHH
Q 010882          392 KSRPELGKD  400 (498)
Q Consensus       392 ~~RP~~~~~  400 (498)
                      .+||++.++
T Consensus       254 ~~Rps~~ei  262 (793)
T PLN00181        254 SCRPSMSEL  262 (793)
T ss_pred             hhCcChHHH
Confidence            999999984

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.6e-28  Score=220.18  Aligned_cols=238  Identities=21%  Similarity=0.309  Sum_probs=176.7

Q ss_pred             cCCCCCCcccccCceEEEEEEECC--eEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeece-e--cCcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA-C--PEVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~-~--~~~~~lV~E  211 (498)
                      ..|.+.+.||+|.||.+-.+.+++  +.+++|-++... ....+|.+|...--.| .|.||+.-|.+ |  .+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            468888999999999999999974  679999887543 3567899998876666 48999988865 4  346778999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc--CCCceeEeeccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~DFGla~~~~~  289 (498)
                      |+|.|+|.+-+..    ..+.+.....++.|++.|+.|+|+   +++||||||.+||||-  ...++||+|||+++..+.
T Consensus       103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999999987732    346777888999999999999999   8999999999999993  345899999999875443


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccC-----CCCCccchHhHHHHHHHHHhCCCCCCCcHH------HHHHHHhC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDTG  358 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~------~~~~~~~~  358 (498)
                      ..           .....+..|.+||.....     ...+.+|||.||+++|.++||.+||.....      ....+..+
T Consensus       176 tV-----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  176 TV-----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR  244 (378)
T ss_pred             ee-----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence            21           111246789999987543     246789999999999999999999963211      11122222


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +..     ..++.....++.+..+..+-+..+|++|=-..+
T Consensus       245 k~~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~  280 (378)
T KOG1345|consen  245 KNP-----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT  280 (378)
T ss_pred             cCc-----cCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence            222     112222234567788888899999988844433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=7.5e-26  Score=225.90  Aligned_cols=264  Identities=23%  Similarity=0.284  Sum_probs=196.5

Q ss_pred             CCCCCCcccccCceEEEEEEECC---eEEEEEEecCCCCCChhhHHHHHHHHHcCCC----CCeeeeecee---cCcceE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH----PNLVTLVGAC---PEVWTL  208 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~E~~il~~l~h----pniv~l~g~~---~~~~~l  208 (498)
                      +|.+.+.||+|+||.||.|....   ..+|+|............+..|+.++..+..    +++..+++..   ....++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            78999999999999999999854   4699998876544444478899999999972    5788887766   235789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-----CceeEeeccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-----FVSKLSDFGI  283 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-----~~~kl~DFGl  283 (498)
                      ||+.+ |.||.++..... ...++..+.+.|+.|++.+|.+||+   .|+|||||||+|++++..     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 889999875443 5679999999999999999999999   899999999999999865     4699999999


Q ss_pred             cc--cccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCc
Q 010882          284 SR--FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGK  359 (498)
Q Consensus       284 a~--~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~  359 (498)
                      |+  .+...................||..|+++..+.+...+.+.|+||++.++.+++.|..||......  ...+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            99  332222111011111123456999999999999999999999999999999999999999543321  11111111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          360 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      .......    .....+..+..+...+-..+...+|++.. +...|.......
T Consensus       254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~-~~~~l~~~~~~~  301 (322)
T KOG1164|consen  254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEK-LAELLKDVFDSE  301 (322)
T ss_pred             hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHH-HHHHHHHHHHhc
Confidence            1111111    12223456777777777799999999988 777776665443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=2.5e-26  Score=208.82  Aligned_cols=166  Identities=22%  Similarity=0.229  Sum_probs=124.3

Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |||.+++..  ...++++.+++.|+.|++.||.|||+   ++      ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence            789999953  24569999999999999999999999   55      999999999999999  99988654321    


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC-ccccccCCCCCCCCHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-KLKNLLDPLAGDWPFV  374 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  374 (498)
                               ..||+.|+|||++.+..++.++|||||||++|||+||++||............- .......+.....+..
T Consensus        64 ---------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (176)
T smart00750       64 ---------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLES  134 (176)
T ss_pred             ---------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHH
Confidence                     148999999999999999999999999999999999999997543322111110 0000111111112223


Q ss_pred             HHH--HHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          375 QAE--QLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       375 ~~~--~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ...  .+.+++.+||..+|.+||++.+ ++..+..+
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~-ll~~~~~~  169 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANH-YLAHCRAL  169 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHH-HHHHHHHH
Confidence            333  6999999999999999999988 55554433

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3.8e-26  Score=228.13  Aligned_cols=173  Identities=16%  Similarity=0.124  Sum_probs=131.3

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEEC---CeEEEEEEecCCCC-----CChhhHHHHHHHHHcCCCCCeee-eeceec
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVT-LVGACP  203 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~hpniv~-l~g~~~  203 (498)
                      +.....+|.....||+|+||+||+|.++   +..||||++.....     .....|.+|+.+|+.++|+|+++ +++ + 
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~-   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T-   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c-
Confidence            3344567999999999999999999873   56789998753311     12346899999999999999985 444 3 


Q ss_pred             CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCC-CCCcEEEcCCCceeEeecc
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL-KPANILLDANFVSKLSDFG  282 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~NiLl~~~~~~kl~DFG  282 (498)
                      ...++||||++|++|....    .   ..   ...++.+++.||.|||+   +||+|||| ||+|||++.++.+||+|||
T Consensus        91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            4579999999999997321    1   11   14678899999999999   89999999 9999999999999999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhccC
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG  320 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  320 (498)
                      +|+.+..............-....|++.|+|||++...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99987654322211111111345689999999999754

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=7.4e-26  Score=207.15  Aligned_cols=246  Identities=23%  Similarity=0.384  Sum_probs=195.1

Q ss_pred             CCCCCcccccCceEEEEEEECCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN  215 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~  215 (498)
                      ..+..+|.....|+.|+|.+.+..+++|+++.....  ...+|..|.-.|+.+.||||+.++|+|.  ....++..|+|.
T Consensus       192 lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            345567899999999999999999999998765332  2357999999999999999999999994  467899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEe--eccccccccccccC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS--DFGISRFLSQNEIS  293 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~--DFGla~~~~~~~~~  293 (498)
                      |||...|+... +...+..+..+++.++++|+.|||+..+ -|.---|++..++||++.+++|+  |--++.  .     
T Consensus       272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf--q-----  342 (448)
T KOG0195|consen  272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q-----  342 (448)
T ss_pred             hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee--e-----
Confidence            99999997542 3346667899999999999999999864 24444689999999999888775  211111  0     


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCC---CccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELT---PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                              ..+..-.|.||+||.+...+-+   .++|+|||++++||+.|...||....+.+....     -.++.....
T Consensus       343 --------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----ialeglrv~  409 (448)
T KOG0195|consen  343 --------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----IALEGLRVH  409 (448)
T ss_pred             --------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----hhhcccccc
Confidence                    1223458899999999876533   468999999999999999999987766654332     234445556


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      .|+..+..+.+|+.-|++.||.+||.+.. ++.+|+.+
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdm-ivpilekm  446 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDM-IVPILEKM  446 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcce-ehhhHHHh
Confidence            78888999999999999999999999987 77777765

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=6.8e-24  Score=199.46  Aligned_cols=262  Identities=19%  Similarity=0.256  Sum_probs=201.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceec--CcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .-+|.++++||+|+||+++.|..  ++.+||||.-...+  ..-++..|....+.|. .++|...|.+-+  -+..||||
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            34799999999999999999975  78999999865433  3357888999999885 688888765544  45679999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-----CceeEeecccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-----FVSKLSDFGISRF  286 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-----~~~kl~DFGla~~  286 (498)
                      ++ |.||.|++.-.+  ..|+..++..||.|++.-++|+|+   +.+|.|||||+|+||+..     ..+.|+|||+|+.
T Consensus       105 LL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            99 889999885333  458999999999999999999999   889999999999999743     3689999999998


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH---HHHHHhCc--cc
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV---QYALDTGK--LK  361 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~---~~~~~~~~--~~  361 (498)
                      +.+..+... .......+..||..||+-..+.+...+...|+-|||-|+++.|-|..||.+....   +.-..+|.  -.
T Consensus       179 YrDp~TkqH-IPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  179 YRDPKTKQH-IPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS  257 (449)
T ss_pred             hcCcccccc-CccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence            877765433 3334456677999999999999999999999999999999999999999653321   11111221  11


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ..++.+...    .+.++...+.-.-..+..+-|++.- +..++..+....
T Consensus       258 T~i~~Lc~g----~P~efa~Yl~yvR~L~F~E~PDYdy-lr~Lf~dvldr~  303 (449)
T KOG1165|consen  258 TPIEVLCEG----FPEEFATYLRYVRRLDFFETPDYDY-LRKLFDDVLDRL  303 (449)
T ss_pred             CCHHHHHhc----CHHHHHHHHHHHHhcCcccCCCHHH-HHHHHHHHHHhc
Confidence            111111222    3467888888888889999999876 666666665443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4.1e-24  Score=192.74  Aligned_cols=259  Identities=20%  Similarity=0.289  Sum_probs=198.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCC-CCeeeeecee--cCcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~g~~--~~~~~lV~E  211 (498)
                      .++|.+.++||.|+||.+|.|..  .|..||||+-....  ...++..|..+...|++ ..|..+..+.  .+...+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            45789999999999999999987  57899999865433  23467889999999975 5566655554  346789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC---CceeEeecccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLS  288 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla~~~~  288 (498)
                      .+ |.||.+++.-.  ...++..+.+-++-|++.-++|+|.   +++|||||||+|+|.+-+   ..+.|+|||+|+.+-
T Consensus        92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            99 88999988532  2358888999999999999999999   899999999999999744   468999999999876


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH-----HHHhCccccc
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-----ALDTGKLKNL  363 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-----~~~~~~~~~~  363 (498)
                      +..+... ..........||..|.+-..+.+...+...|+-|+|.+|..+..|..||.+......     .+.+.++...
T Consensus       166 d~~t~~H-Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  166 DIRTRQH-IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccc-CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            6543322 222334556799999999988888899999999999999999999999976543321     2233334443


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      +......+|    .++.-.+.-|-..-..+-|+..- +.++..-+.
T Consensus       245 ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~y-lrqlFriLf  285 (341)
T KOG1163|consen  245 IEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMY-LRQLFRILF  285 (341)
T ss_pred             HHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHH-HHHHHHHHH
Confidence            333444454    56777888999999999999866 555555443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.1e-22  Score=200.75  Aligned_cols=257  Identities=33%  Similarity=0.463  Sum_probs=193.0

Q ss_pred             CCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCC-CeeeeeceecCc--ceEEEeeC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHP-NLVTLVGACPEV--WTLVYEYL  213 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hp-niv~l~g~~~~~--~~lV~E~~  213 (498)
                      |.....||.|+||.||++... ..+++|.+.......   ...+.+|+.++..+.|+ +|+++++.+...  .+++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            556678999999999999888 778999988654433   56799999999999988 799999988443  58999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-ceeEeecccccccccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~~~  292 (498)
                      .++++.+++........++......++.+++.++.|+|.   .+++|||+||+||+++..+ .++++|||+++.+.....
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999999776322111268889999999999999999999   8899999999999999988 799999999985554332


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCCcHH------HHHHHHhCccccc
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDTGKLKNL  363 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~------~~~~~~~~~~~~~  363 (498)
                      .....  .......||..|+|||.+.+   ..++...|+||+|++++++++|..||.....      ....+........
T Consensus       158 ~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         158 TSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             ccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            11100  11244569999999999987   5788899999999999999999999876542      1111111111100


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW  402 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~  402 (498)
                      ........+......+.+++..|+..+|..|.+......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            000011111122357899999999999999999887443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=3.4e-23  Score=192.86  Aligned_cols=169  Identities=16%  Similarity=0.175  Sum_probs=132.8

Q ss_pred             hhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhh---------HHHHHHHHHcCCCCCeeeeeceec---
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHPNLVTLVGACP---  203 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~hpniv~l~g~~~---  203 (498)
                      ..++|...++||.|+||.||.....+..+|||++.+........         +.+|+..+.++.||+|..+..++.   
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            46789999999999999999977777789999998654433322         679999999999999998877642   


Q ss_pred             -------CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          204 -------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       204 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                             ...++||||++|.+|.++..       ++.    ....+++.+|..+|.   .|++|||++|+||+++.+| +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence                   24789999999999988741       222    245689999999999   8999999999999999988 9


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHH
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL  339 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  339 (498)
                      +|+|||.+........                    ..-+.....|+.++|+|||||.+.-+.
T Consensus       174 ~liDfg~~~~~~e~~a--------------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKA--------------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhh--------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            9999998764432210                    011344556778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.6e-22  Score=185.89  Aligned_cols=137  Identities=18%  Similarity=0.164  Sum_probs=106.1

Q ss_pred             CcccccCceEEEEEEE-CCeEEEEEEecCCCCCC---------hhh-----------------HHHHHHHHHcCCCCCee
Q 010882          144 LKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQG---------PSE-----------------FQQEIDILSKIRHPNLV  196 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~---------~~~-----------------~~~E~~il~~l~hpniv  196 (498)
                      ..||+|+||.||+|.. .|..||||+++......         ...                 ...|+.++.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            5799999999999987 47899999997642211         011                 23499999999877764


Q ss_pred             eeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          197 TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL-HSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       197 ~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      ..........++||||++|+++.....   ...+++......++.+++.+|.+| |.   .||+||||||+|||++ ++.
T Consensus        83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          83 CPEPILLKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCcEEEecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence            332222234589999999887765431   224688899999999999999999 67   7999999999999998 478


Q ss_pred             eeEeeccccccc
Q 010882          276 SKLSDFGISRFL  287 (498)
Q Consensus       276 ~kl~DFGla~~~  287 (498)
                      ++|+|||+|...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=3.6e-23  Score=219.97  Aligned_cols=247  Identities=22%  Similarity=0.316  Sum_probs=179.6

Q ss_pred             CCCCCCcccccCceEEEEEEECCeEEEEEEecCCC-CCChhhHHHHHHH--HHcCCCCCeeeeecee--cCcceEEEeeC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHS-LQGPSEFQQEIDI--LSKIRHPNLVTLVGAC--PEVWTLVYEYL  213 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~i--l~~l~hpniv~l~g~~--~~~~~lV~E~~  213 (498)
                      +|...+.||++.|=+|.+|.++...|+||++-+.. ..+...|.+.+.-  ...++|||++++.-.-  ....|||-+|+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv  103 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV  103 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence            56777889999999999999988889999987654 3344455544333  4445899999986653  33578899998


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      .. +|.|.|   ..++-|..-+...|+.|++.||.-+|.   .||+|||||.+||||+.-.-+.|+||..-+..--....
T Consensus       104 kh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  104 KH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             hh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            54 899999   455667888999999999999999999   89999999999999999889999999876533222211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccC----------C-CCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccc
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASG----------E-LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLK  361 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~  361 (498)
                      +..-.... .....-.+|+|||.+...          . .+++.||||+||+++||++ |+|||....-..+.  .|. .
T Consensus       177 Padf~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr--~~~-~  252 (1431)
T KOG1240|consen  177 PADFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR--SGN-A  252 (1431)
T ss_pred             cccceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh--ccC-c
Confidence            22222222 222345689999988542          1 5788999999999999988 89999765544332  111 0


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ........   ......+.+|+..|++.||..|-++.+
T Consensus       253 ~~~e~~Le---~Ied~~~Rnlil~Mi~rdPs~RlSAed  287 (1431)
T KOG1240|consen  253 DDPEQLLE---KIEDVSLRNLILSMIQRDPSKRLSAED  287 (1431)
T ss_pred             cCHHHHHH---hCcCccHHHHHHHHHccCchhccCHHH
Confidence            00000000   011236899999999999999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.9e-22  Score=183.98  Aligned_cols=192  Identities=15%  Similarity=0.063  Sum_probs=142.2

Q ss_pred             CCCCcccccCceEEEEEEECCeEEEEEEecCCCCCCh----hhHHHHHHHHHcCC-CCCeeeeeceecCcceEEEeeCCC
Q 010882          141 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP----SEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYLPN  215 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~----~~~~~E~~il~~l~-hpniv~l~g~~~~~~~lV~E~~~~  215 (498)
                      .+...|++|+||+||.+...+.+++.+.+........    ..|.+|+++|++|. |++|++++++  +..+++|+|+.|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G   82 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG   82 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence            4556799999999998777788888887765433111    24789999999995 5889999886  456899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCC-CCCcEEEcCCCceeEeeccccccccccccC-
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL-KPANILLDANFVSKLSDFGISRFLSQNEIS-  293 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~NiLl~~~~~~kl~DFGla~~~~~~~~~-  293 (498)
                      .+|...+.   .       ....++.+++.+|.++|.   +||+|||| ||+|||++.++.++|+|||+|......... 
T Consensus        83 ~~L~~~~~---~-------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         83 AAMYQRPP---R-------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ccHHhhhh---h-------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            99876541   0       113577899999999999   89999999 799999999999999999999865433210 


Q ss_pred             ---C-CCccceeccCCCCCCCcCChhhhccC-CCC-CccchHhHHHHHHHHHhCCCCCCC
Q 010882          294 ---S-NNTTLCCRTDPKGTFAYMDPEFLASG-ELT-PKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       294 ---~-~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltG~~pf~~  347 (498)
                         . .........-...++.|++|+...-- ..+ ...++++-|+-+|.++||+.++..
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence               0 00000001112378899999865432 333 567999999999999999987743

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=4.1e-23  Score=219.41  Aligned_cols=248  Identities=22%  Similarity=0.305  Sum_probs=177.4

Q ss_pred             CCCCcccccCceEEEEEEEC--CeEEEEEEecCC--CCCCh----hhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          141 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGP----SEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~----~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      ....++|.|+||.|+.....  ...++.|.....  .....    ..+..|+.+-..|.|||++..+..+.+  ..+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977766542  222333332211  11111    125668888888999999877665532  233449


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |||++ +|..++...   ..++...+-.++.|+..||.|+|.   .||.||||||+|++++.+|.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 999998432   457778889999999999999999   89999999999999999999999999999876544


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCc-cchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK-SDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ...    ......+.+|+-.|+|||++.+..|++. .||||.|++++.|++|+.||-.....+................+
T Consensus       474 ~e~----~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~  549 (601)
T KOG0590|consen  474 WEK----NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG  549 (601)
T ss_pred             cch----hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence            321    1223466789999999999999999875 69999999999999999999643322111000000000000111


Q ss_pred             CC--CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DW--PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~--~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+  -...+.....++.++|+.+|.+|.++.+
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~  581 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQ  581 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHH
Confidence            11  1234567889999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.8e-23  Score=209.43  Aligned_cols=223  Identities=27%  Similarity=0.327  Sum_probs=179.3

Q ss_pred             cccccCceEEEEE-----EECCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCC-CCCeeeeeceec--CcceEEEeeCC
Q 010882          145 KIGEGGYGSIYKG-----LLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       145 ~lG~G~~g~Vy~~-----~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~-hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      .+|.|+||.|+.+     ...+..+|+|++++.....  ......|..++..++ ||.+|++...+.  ...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            3799999999863     3456779999988754322  225667889999997 999999998884  46899999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      ||.|...+.   ....+.......+...++-++.++|.   .+++|||+|++||+++.+|++++.|||+++........ 
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999998884   44556777777788899999999999   89999999999999999999999999999876544321 


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (498)
                                 .||..|||||++.  .+..++|+||||++++||+||..||.......  +.         ......|..
T Consensus       154 -----------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~--Il---------~~~~~~p~~  209 (612)
T KOG0603|consen  154 -----------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKR--IL---------KAELEMPRE  209 (612)
T ss_pred             -----------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHH--Hh---------hhccCCchh
Confidence                       3899999999998  67788999999999999999999998711111  11         111235777


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChh
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                      .+.....++..++..+|.+|-...
T Consensus       210 l~~~a~~~~~~l~~r~p~nrLg~~  233 (612)
T KOG0603|consen  210 LSAEARSLFRQLFKRNPENRLGAG  233 (612)
T ss_pred             hhHHHHHHHHHHHhhCHHHHhccC
Confidence            788899999999999999997664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=4.2e-21  Score=176.81  Aligned_cols=140  Identities=17%  Similarity=0.164  Sum_probs=108.8

Q ss_pred             CCcccccCceEEEEEEEC-CeEEEEEEecCCCCC---------------------C-----hhhHHHHHHHHHcCCCCCe
Q 010882          143 SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ---------------------G-----PSEFQQEIDILSKIRHPNL  195 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~il~~l~hpni  195 (498)
                      ...||+|+||.||+|... |..||||++......                     .     ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            357999999999999875 899999999865321                     0     0123578999999999987


Q ss_pred             eeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          196 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       196 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      .....+.....++||||++|+++.....   ...+++......++.+++.+|.++|+.  .||+||||||+|||++ ++.
T Consensus        82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLKKNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEecCCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCC
Confidence            4433332234589999999886543321   123577888999999999999999983  5899999999999999 889


Q ss_pred             eeEeecccccccc
Q 010882          276 SKLSDFGISRFLS  288 (498)
Q Consensus       276 ~kl~DFGla~~~~  288 (498)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=4.8e-20  Score=176.84  Aligned_cols=228  Identities=21%  Similarity=0.277  Sum_probs=146.4

Q ss_pred             CCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCC-----------CC-----eeeee
Q 010882          141 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRH-----------PN-----LVTLV  199 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h-----------pn-----iv~l~  199 (498)
                      .....||.|+||.||.+.+.  +..+|||++......   ..+.+.+|.-....+.+           .-     ++++-
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            44567999999999999995  599999988654422   23456666544444322           11     22221


Q ss_pred             ce---e---c-------CcceEEEeeCCCCCHHhhhcc---CC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCC
Q 010882          200 GA---C---P-------EVWTLVYEYLPNGSLEDRLSC---KD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD  262 (498)
Q Consensus       200 g~---~---~-------~~~~lV~E~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD  262 (498)
                      +-   +   .       -+.+++|.-+ .+||.+++..   .. ....+....++.+..|++..+++||.   .|+||+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecc
Confidence            10   0   0       0235677776 5688877532   11 12234556677888999999999999   9999999


Q ss_pred             CCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccC--------CCCCccchHhHHHH
Q 010882          263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--------ELTPKSDVYSFGII  334 (498)
Q Consensus       263 lkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlGvi  334 (498)
                      |+|+|+|++.+|.++|+||+...........           ...+..|.+||.....        .++.+.|.|+||++
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec-----------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            9999999999999999999987655433211           1246789999977542        47888999999999


Q ss_pred             HHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCC
Q 010882          335 LLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR  394 (498)
Q Consensus       335 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  394 (498)
                      +|.|++|..||+.......          .+.....+. ..++.+..||..+|+.+|.+|
T Consensus       240 ly~lWC~~lPf~~~~~~~~----------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEAD----------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGST----------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCcccc----------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999986532110          000122345 678999999999999999887

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=5.8e-20  Score=170.57  Aligned_cols=133  Identities=17%  Similarity=0.204  Sum_probs=103.2

Q ss_pred             CCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcC-----CCCCeeeeeceecCc-----ce-EE
Q 010882          141 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-----RHPNLVTLVGACPEV-----WT-LV  209 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~hpniv~l~g~~~~~-----~~-lV  209 (498)
                      .....||+|+||.||.....+. .+||++........+.+.+|+.+++.+     +||||++++|++.+.     .+ +|
T Consensus         5 ~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          5 SEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CCcceecCCCceEEEECCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            3456799999999996222233 479988765545567899999999999     579999999998543     23 78


Q ss_pred             Eee--CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcccCCCCCCcEEEcC----CCceeEeecc
Q 010882          210 YEY--LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL-IFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDFG  282 (498)
Q Consensus       210 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivHrDlkp~NiLl~~----~~~~kl~DFG  282 (498)
                      |||  +++|+|.+++...    .+++.  ..++.+++.++ .|||+   ++||||||||+|||++.    ++.++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  6689999999432    35544  35677888777 89999   89999999999999974    3489999955


Q ss_pred             c
Q 010882          283 I  283 (498)
Q Consensus       283 l  283 (498)
                      -
T Consensus       155 G  155 (210)
T PRK10345        155 G  155 (210)
T ss_pred             C
Confidence            3

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=6.5e-20  Score=186.73  Aligned_cols=209  Identities=28%  Similarity=0.473  Sum_probs=153.8

Q ss_pred             HHcCCCCCeeeeecee--cCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-ccCCC
Q 010882          187 LSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI-VHGDL  263 (498)
Q Consensus       187 l~~l~hpniv~l~g~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vHrDl  263 (498)
                      |+.+.|.|+.+++|.+  ....++|.+||..|+|.|.+..  ....+++.....+..+++.||.|||+.   +| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            4578999999999998  3457889999999999999964  456788999999999999999999994   44 99999


Q ss_pred             CCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccC---C----CCCccchHhHHHHHH
Q 010882          264 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG---E----LTPKSDVYSFGIILL  336 (498)
Q Consensus       264 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DvwSlGvil~  336 (498)
                      ++.|.++|..+.+||+|||+.............      ....-..-|.|||.+...   .    .+.+.||||||++++
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~------~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~  149 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAH------HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY  149 (484)
T ss_pred             ccccceeeeeEEEEechhhhccccccccccccc------chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence            999999999999999999998876431100000      111135689999999763   1    466799999999999


Q ss_pred             HHHhCCCCCCCcH------HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          337 RLLTGRPALGITK------EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       337 elltG~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      |+++...||+...      ++...+..+ ....+-|...... ...+.+..++.+||..+|..||++.+ +...++.+.
T Consensus       150 ei~~r~~~~~~~~~~~~~~eii~~~~~~-~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~-i~~~~~~~~  225 (484)
T KOG1023|consen  150 EILFRSGPFDLRNLVEDPDEIILRVKKG-GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQ-IRSKLLTIN  225 (484)
T ss_pred             HHHhccCccccccccCChHHHHHHHHhc-CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHH-HHhhhhhhc
Confidence            9999999997522      122222220 1111111111111 33447999999999999999999988 665555543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=3.4e-20  Score=197.49  Aligned_cols=217  Identities=24%  Similarity=0.317  Sum_probs=148.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecCcceEEEeeCC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLP  214 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~~~~lV~E~~~  214 (498)
                      ..+|+.++.|..|+||-||...++  .+++|+|+-+ ...     +.+-  ++.....|.             .|     
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----ilRn--ilt~a~npf-------------vv-----  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----ILRN--ILTFAGNPF-------------VV-----  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----hhhc--cccccCCcc-------------ee-----
Confidence            458999999999999999999876  6789985432 211     1110  222223333             33     


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                       |+-.+.+   .+.++++..        ++.+++|||+   .||+|||+||+|.+|+.-|++|++|||+++.........
T Consensus       136 -gDc~tll---k~~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 -GDCATLL---KNIGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             -chhhhhc---ccCCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence             5555555   233344433        2779999999   899999999999999999999999999998643322111


Q ss_pred             C-------CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          295 N-------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       295 ~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                      .       ...........||+.|+|||++...+|+..+|||++|+|+||.+.|..||.++..-... .. -+.+.+...
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf-g~-visd~i~wp  278 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-GQ-VISDDIEWP  278 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-hh-hhhhhcccc
Confidence            0       00111234557999999999999999999999999999999999999999877443211 00 011111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                      .++  ...+.+.++++.+.|+.+|..|--..
T Consensus       279 E~d--ea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  279 EED--EALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             ccC--cCCCHHHHHHHHHHHHhChHhhcccc
Confidence            111  12457899999999999999996433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=3.9e-19  Score=192.96  Aligned_cols=248  Identities=23%  Similarity=0.293  Sum_probs=176.5

Q ss_pred             HHHHhhcCCCCCCcccccCceEEEEEEE-CCeEEEEEEecCCCCCChhhHHHHHHHHHcCC---CCCeeeeece--ecCc
Q 010882          132 EIEGATHNFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR---HPNLVTLVGA--CPEV  205 (498)
Q Consensus       132 ei~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~g~--~~~~  205 (498)
                      +++.....|.+.+.||+|+||.||+|.. ++..||+|+-++....   +|.--.+++.+|+   -+.|..+..+  |.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            4444556788889999999999999987 4788999997765433   4444556666666   1223333332  4678


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-------CCceeE
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------NFVSKL  278 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-------~~~~kl  278 (498)
                      .+||+||.+.|||.+++.   ....+++...+.++.+++..+..||.   .+||||||||+|+||..       +.-++|
T Consensus       769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence            899999999999999994   66679999999999999999999999   88999999999999942       346899


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG  358 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (498)
                      +|||.+--+.--..   ..   ......+|-.+-.+|+..+.+++..+|.|.|+.+++-||.|+.       ++  +..|
T Consensus       843 IDfG~siDm~lfp~---~~---~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y-------~q--~~~g  907 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPD---GT---KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY-------ME--VKNG  907 (974)
T ss_pred             EecccceeeeEcCC---Cc---EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH-------HH--hcCC
Confidence            99998864332111   11   1234568999999999999999999999999999999999962       22  1111


Q ss_pred             ccccccCCCCCCCCHH-HHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          359 KLKNLLDPLAGDWPFV-QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      .. ..+...   ++.. .-..+.+++..+|+.+-..=|.+.+ +...++.+
T Consensus       908 ~~-~~~~~~---~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~-lr~~~~~~  953 (974)
T KOG1166|consen  908 SS-WMVKTN---FPRYWKRDMWNKFFDLLLNPDCDTLPNLQE-LRTELEEV  953 (974)
T ss_pred             cc-eecccc---chhhhhHHHHHHHHHHHhCcCcccchhHHH-HHHHHHHH
Confidence            11 111111   1111 1234567777788766655566655 44444444

>PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis

Probab=99.79  E-value=5.3e-20  Score=140.57  Aligned_cols=71  Identities=44%  Similarity=0.843  Sum_probs=63.0

Q ss_pred             CCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          428 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       428 ~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      +|++|.|||+.++|.|||++++|+|||+.+|..|+..++.+||+|+++++..+|+||.+||++|++|+.+|
T Consensus         1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~~~   71 (73)
T PF04564_consen    1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCAEN   71 (73)
T ss_dssp             SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHHHC
T ss_pred             CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHHHc
Confidence            58999999999999999999999999999999999998999999999999999999999999999999876

Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A ....

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=4.6e-19  Score=164.49  Aligned_cols=128  Identities=27%  Similarity=0.399  Sum_probs=105.5

Q ss_pred             cccccCceEEEEEEECCeEEEEEEecCCCCCC--------hhhHHHHHHHHHcCCCCC--eeeeeceecCcceEEEeeCC
Q 010882          145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPN--LVTLVGACPEVWTLVYEYLP  214 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l~hpn--iv~l~g~~~~~~~lV~E~~~  214 (498)
                      .||+|+||.||+|.+.+..|++|+........        ...+.+|+.++..+.|++  ++.+++...+..++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            38999999999999999999999866433211        145678999999998775  44555555667799999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      |++|.+.+...   .       ..++.+++.+|.+||+   .|++|||++|.||+++ ++.++++|||++..
T Consensus        81 g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEG---N-------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhc---H-------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999987321   1       0789999999999999   8999999999999999 88999999998875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=6.7e-19  Score=164.91  Aligned_cols=132  Identities=27%  Similarity=0.417  Sum_probs=109.8

Q ss_pred             CcccccCceEEEEEEECCeEEEEEEecCCCCCC--------hhhHHHHHHHHHcCCCCCeeeeece--ecCcceEEEeeC
Q 010882          144 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYL  213 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l~hpniv~l~g~--~~~~~~lV~E~~  213 (498)
                      +.||+|++|.||+|.+.+..|++|+........        ...+.+|+.++..+.|+||+....+  ..+..++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            469999999999999999999999876543322        1347789999999999887655444  456788999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      +|++|.+++...      .. .+..++.+++.+|.++|.   .+++|||++|.|||++ ++.++|+|||++..
T Consensus        82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998421      12 788999999999999999   8999999999999999 78999999998764

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=3.6e-19  Score=169.17  Aligned_cols=140  Identities=18%  Similarity=0.173  Sum_probs=109.5

Q ss_pred             CCCCCCcccccCceEEEEEE-E--CCeEEEEEEecCCCCC-------------------C-----hhhHHHHHHHHHcCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGL-L--RHMQVAIKMLHPHSLQ-------------------G-----PSEFQQEIDILSKIR  191 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~-~--~~~~vavK~~~~~~~~-------------------~-----~~~~~~E~~il~~l~  191 (498)
                      -|.+...||+|+||.||+|. .  .+..||||++......                   .     ...+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            36677889999999999998 3  5789999998754211                   0     012568999999997


Q ss_pred             CC--CeeeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cccCCCCCCcE
Q 010882          192 HP--NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANI  268 (498)
Q Consensus       192 hp--niv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivHrDlkp~Ni  268 (498)
                      +.  .++.+++.  ...++||||++|++|...+.   ....+.......++.+++.+|.+||.   .| ++||||||+||
T Consensus       109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe--cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence            53  34555543  24589999999988876542   22345666778999999999999999   88 99999999999


Q ss_pred             EEcCCCceeEeeccccccc
Q 010882          269 LLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       269 Ll~~~~~~kl~DFGla~~~  287 (498)
                      +++ ++.++|+|||++...
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 889999999988754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=6.8e-19  Score=169.48  Aligned_cols=200  Identities=21%  Similarity=0.229  Sum_probs=141.6

Q ss_pred             CCCCeeeeeceec-----------------------------CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHH
Q 010882          191 RHPNLVTLVGACP-----------------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT  241 (498)
Q Consensus       191 ~hpniv~l~g~~~-----------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  241 (498)
                      .|||||+++++|-                             ...|+||...+ .+|+.+|...    ..+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence            5999999998761                             12578988775 4899998533    355667888999


Q ss_pred             HHHHHHHHHHhcCCCCcccCCCCCCcEEE--cCCC--ceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhh
Q 010882          242 ELCSVLIFLHSCKPHSIVHGDLKPANILL--DANF--VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL  317 (498)
Q Consensus       242 ~i~~~L~~LH~~~~~~ivHrDlkp~NiLl--~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  317 (498)
                      |+++|+.|||.   +||.|||+|++||||  |.++  .+.|+|||+|---...+..  ..........-|...-||||+.
T Consensus       349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlq--lpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQ--LPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccc--cccccccccCCCcceecchhhh
Confidence            99999999999   999999999999999  3444  5789999988532221111  1111112334488899999998


Q ss_pred             ccCC------CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhccc
Q 010882          318 ASGE------LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR  391 (498)
Q Consensus       318 ~~~~------~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p  391 (498)
                      ...+      --.++|.|+.|.+.||+++...||....+......  .   .-+...+..|..+++.+.+|+...|+.||
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r--~---Yqe~qLPalp~~vpp~~rqlV~~lL~r~p  498 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR--T---YQESQLPALPSRVPPVARQLVFDLLKRDP  498 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh--h---hhhhhCCCCcccCChHHHHHHHHHhcCCc
Confidence            6532      12478999999999999999999976443221111  1   11112333566677889999999999999


Q ss_pred             CCCCChhHHHHHHhH
Q 010882          392 KSRPELGKDVWRVLE  406 (498)
Q Consensus       392 ~~RP~~~~~v~~~L~  406 (498)
                      ++||+..- ...+|.
T Consensus       499 skRvsp~i-AANvl~  512 (598)
T KOG4158|consen  499 SKRVSPNI-AANVLN  512 (598)
T ss_pred             cccCCccH-HHhHHH
Confidence            99998743 444443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=4.9e-18  Score=157.54  Aligned_cols=136  Identities=20%  Similarity=0.181  Sum_probs=107.7

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCeEEEEEEecCCCCC----------------------ChhhHHHHHHHHHcCCCC--
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQ----------------------GPSEFQQEIDILSKIRHP--  193 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~----------------------~~~~~~~E~~il~~l~hp--  193 (498)
                      .|...+.||+|+||.||+|.. .+..||||++......                      ....+..|..++..+.|+  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            467778899999999999988 4789999987653210                      011356789999999877  


Q ss_pred             CeeeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC
Q 010882          194 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN  273 (498)
Q Consensus       194 niv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~  273 (498)
                      +++..++.  ...++||||++|++|......         .....++.+++.++.++|.   .||+||||+|.||+++.+
T Consensus        96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          96 PVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCC
Confidence            44555543  345899999999999776420         2345788999999999999   899999999999999999


Q ss_pred             CceeEeecccccccc
Q 010882          274 FVSKLSDFGISRFLS  288 (498)
Q Consensus       274 ~~~kl~DFGla~~~~  288 (498)
                      +.++|+|||++....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=3.1e-18  Score=182.49  Aligned_cols=135  Identities=28%  Similarity=0.380  Sum_probs=110.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCC--------ChhhHHHHHHHHHcCCCCCeeeeecee--cCcc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~hpniv~l~g~~--~~~~  206 (498)
                      ...|...+.||+|+||+||+|.+.+..+++|+.......        ..+.+.+|+.++..++|+|++..+.++  ....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            445567889999999999999998777766654322111        124578999999999999988765544  4468


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||++|++|.+++.           ....++.+++.+|.+||+   .+++||||||+|||+ .++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            89999999999999883           456789999999999999   899999999999999 577999999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=2.9e-19  Score=178.78  Aligned_cols=174  Identities=23%  Similarity=0.329  Sum_probs=134.4

Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ++||.|++|...+|.++|.+.......++.....++.|++.|+.|      ++.+|+|+||.||++..+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999776666778888999999999999999      58999999999999999999999999998


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      .......+.  .......+..+||..||+||.+.+..|+.++||||||+||+|+++ -.-+|.....         +.+ 
T Consensus       404 ts~~~~~~~--~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---------~~d-  471 (516)
T KOG1033|consen  404 TSQDKDETV--APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---------LTD-  471 (516)
T ss_pred             eecccCCcc--cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---------hhh-
Confidence            876654411  112223466789999999999999999999999999999999998 3333321111         111 


Q ss_pred             cCCCCCCCCHH---HHHHHHHHHHHhhhcccCCCCChh
Q 010882          364 LDPLAGDWPFV---QAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       364 ~~~~~~~~~~~---~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                        ...+.+|..   ..+.-..|+.+++.+.|..||+..
T Consensus       472 --~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  472 --IRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             --hhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence              112223321   123456899999999999999543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.1e-16  Score=140.57  Aligned_cols=132  Identities=20%  Similarity=0.278  Sum_probs=112.0

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCC--CCeeeeeceecC--cceEEEeeCCCCCH
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGACPE--VWTLVYEYLPNGSL  218 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~g~~~~--~~~lV~E~~~~gsL  218 (498)
                      .+.||.|+++.||++...+..+++|.......  ...+..|+.++..+.|  ++++++++++..  ..+++|||++|+++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            45799999999999999888899999865433  4578999999999976  588888887743  68999999998876


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ..+          +......++.+++.+|.+||.....+++|+|++|.||+++.++.++++|||++..
T Consensus        81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            543          4567778899999999999997656899999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=3.7e-16  Score=143.41  Aligned_cols=136  Identities=19%  Similarity=0.213  Sum_probs=96.5

Q ss_pred             CCcccccCceEEEEEEEC-CeEEEEEEecCCCCCC--hhh----------------------HHHHHHHHHcCCCCC--e
Q 010882          143 SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--PSE----------------------FQQEIDILSKIRHPN--L  195 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~--~~~----------------------~~~E~~il~~l~hpn--i  195 (498)
                      .+.||+|+||.||+|... +..||||++.......  ...                      ...|...+..+.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            457999999999999886 7899999987543211  111                      134566666664432  4


Q ss_pred             eeeeceecCcceEEEeeCCCCCHHhh-hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC
Q 010882          196 VTLVGACPEVWTLVYEYLPNGSLEDR-LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF  274 (498)
Q Consensus       196 v~l~g~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  274 (498)
                      .+.++.  ...++||||++|+++... +....    .. .....++.+++.++.++|..  .+|+||||||+||+++ ++
T Consensus        82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec--CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CC
Confidence            444443  246899999999544321 11000    11 46778999999999999973  5799999999999999 89


Q ss_pred             ceeEeecccccccc
Q 010882          275 VSKLSDFGISRFLS  288 (498)
Q Consensus       275 ~~kl~DFGla~~~~  288 (498)
                      .++|+|||.+....
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            99999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=9.3e-16  Score=146.07  Aligned_cols=132  Identities=20%  Similarity=0.218  Sum_probs=103.3

Q ss_pred             Cccc-ccCceEEEEEEECCeEEEEEEecCCCC-------------CChhhHHHHHHHHHcCCCCCe--eeeeceecC---
Q 010882          144 LKIG-EGGYGSIYKGLLRHMQVAIKMLHPHSL-------------QGPSEFQQEIDILSKIRHPNL--VTLVGACPE---  204 (498)
Q Consensus       144 ~~lG-~G~~g~Vy~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~hpni--v~l~g~~~~---  204 (498)
                      ..|| .||.|+||.+...+..++||.+.....             .....+.+|+.++..|.|++|  +..++++..   
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            4688 899999999888888999998853210             122457889999999998775  566665421   


Q ss_pred             ---cceEEEeeCCC-CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEee
Q 010882          205 ---VWTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD  280 (498)
Q Consensus       205 ---~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  280 (498)
                         ..++||||++| .+|.+++..    .+++..    .+.+++.+|.+||.   .||+||||||.|||++.++.++|+|
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence               13599999997 699988842    235543    35689999999999   8999999999999999999999999


Q ss_pred             cccccc
Q 010882          281 FGISRF  286 (498)
Q Consensus       281 FGla~~  286 (498)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=1e-16  Score=170.74  Aligned_cols=247  Identities=25%  Similarity=0.334  Sum_probs=179.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC---CeEEEEEEecCCC--CCChhhHHHHHHHHHcCC-CCCeeeeecee--cCcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-hpniv~l~g~~--~~~~~lV  209 (498)
                      ..|.+.+.||+|+|+.|-.....   ...+|+|.+....  .........|..+-..+. |+|++.+++..  .+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45777788999999999776552   3456777665433  222344556888888887 99999999987  3467899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcccCCCCCCcEEEcCCC-ceeEeeccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH-SCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL  287 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~  287 (498)
                      ++|..||++.+-+.. ......+....-.++.++..+|.|+| .   .++.|+|+||+|.+++..+ .+|++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999888731 11113444566788999999999999 6   7899999999999999999 9999999999977


Q ss_pred             cc-cccCCCCccceeccCCCC-CCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccccc
Q 010882          288 SQ-NEISSNNTTLCCRTDPKG-TFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL  364 (498)
Q Consensus       288 ~~-~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (498)
                      .. .+...      ......| ++.|+|||.+.+. ...+..|+||.|+++.-+++|..|+.......     +......
T Consensus       176 ~~~~g~~~------~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~  244 (601)
T KOG0590|consen  176 RNKNGAER------SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWK  244 (601)
T ss_pred             cccCCcce------eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeec
Confidence            66 32211      1233457 9999999999885 45677899999999999999999986543322     1111111


Q ss_pred             CCC---CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          365 DPL---AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       365 ~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +..   .............++...++..+|..|.+..+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~  282 (601)
T KOG0590|consen  245 SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEE  282 (601)
T ss_pred             ccccccccCccccCChhhhhcccccccCCchhcccccc
Confidence            110   01111234456788888999999999998877

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=3.9e-14  Score=146.42  Aligned_cols=137  Identities=23%  Similarity=0.288  Sum_probs=97.4

Q ss_pred             CcccccCceEEEEEEE-CCeEEEEEEecCCCCCC--------------------------h--------------hhHHH
Q 010882          144 LKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQG--------------------------P--------------SEFQQ  182 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~--------------------------~--------------~~~~~  182 (498)
                      ..||.|++|.||+|+. .|+.||||+.++.....                          .              -.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999998 58999999987642110                          0              02445


Q ss_pred             HHHHHHcCC-----CCCe--eeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 010882          183 EIDILSKIR-----HPNL--VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS-VLIFLHSCK  254 (498)
Q Consensus       183 E~~il~~l~-----hpni--v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~  254 (498)
                      |+..+.++.     +++|  .+++..+....+|||||++|++|.+.......  .+   .+..++..++. .+..+|.  
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~--  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLR--  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHh--
Confidence            666555552     3332  23343334467899999999999887642111  12   23456666655 4677887  


Q ss_pred             CCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       255 ~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                       .|++|+|++|.||+++.++.++++|||++..++
T Consensus       276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             899999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.5e-13  Score=123.83  Aligned_cols=129  Identities=18%  Similarity=0.125  Sum_probs=98.9

Q ss_pred             CcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC-eeeeeceecCcceEEEeeCCCCCHHhhh
Q 010882          144 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEYLPNGSLEDRL  222 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~g~~~~~~~lV~E~~~~gsL~~~l  222 (498)
                      +.|+.|.++.||++...+..|++|+...... ....+..|+.++..+.+.+ ++++++...+..++||||++|.++.+..
T Consensus         4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~   82 (170)
T cd05151           4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED   82 (170)
T ss_pred             eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence            4588999999999999899999999765432 2235788999999986544 3456666655678999999998875431


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          223 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       223 ~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                              .   ....++.+++.+|..||...  +.+++|||++|.||+++ ++.++++|||.+.
T Consensus        83 --------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          83 --------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             --------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence                    1   11345678999999999943  23469999999999999 6689999999865

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>smart00504 Ubox Modified RING finger domain

Probab=99.45  E-value=1.1e-13  Score=103.06  Aligned_cols=63  Identities=57%  Similarity=0.993  Sum_probs=60.7

Q ss_pred             CcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHH
Q 010882          431 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW  494 (498)
Q Consensus       431 ~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~  494 (498)
                      +|.||++.++|.||+++++|++|++.+|..|+.. +.+||+|+.+++..+++||.+||++|++|
T Consensus         1 ~~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~-~~~cP~~~~~~~~~~l~~~~~l~~~i~~~   63 (63)
T smart00504        1 EFLCPISLEVMKDPVILPSGQTYERRAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAIQEW   63 (63)
T ss_pred             CcCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHH-CCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence            5789999999999999999999999999999988 78999999999999999999999999998

Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=6.7e-14  Score=132.42  Aligned_cols=202  Identities=23%  Similarity=0.304  Sum_probs=138.9

Q ss_pred             HHHcCCCCCeeeeeceecC-------cceEEEeeCCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 010882          186 ILSKIRHPNLVTLVGACPE-------VWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHS  257 (498)
Q Consensus       186 il~~l~hpniv~l~g~~~~-------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  257 (498)
                      -|-.+.|.|||+++.++.+       ...++.||+..|+|..+|.+.. ....+......+|+.||..||.|||++. .+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence            3445679999999988743       3568999999999999996533 3345777777899999999999999988 48


Q ss_pred             cccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHH
Q 010882          258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR  337 (498)
Q Consensus       258 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~e  337 (498)
                      |+|+++..+-|++..+|-+|++--.-..    ...+.+......+....|-++|.|||+=.....+.++|||+||...++
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s----~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS----THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccc----cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence            9999999999999999988876322111    000111111122334457899999998777777889999999999999


Q ss_pred             HHhCCCC-CCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHH
Q 010882          338 LLTGRPA-LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW  402 (498)
Q Consensus       338 lltG~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~  402 (498)
                      |..|..- -.....+......   ...+-...       ...-+.++..|++..|..||+|...+.
T Consensus       275 mailEiq~tnseS~~~~ee~i---a~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENI---ANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHheeccCCCcceeehhhhh---hhheeecc-------CccccCcCcccccCCCCCCcchhhhhc
Confidence            9888643 2221111111111   11110000       012345678999999999999998543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.38  E-value=2.7e-13  Score=145.43  Aligned_cols=253  Identities=22%  Similarity=0.211  Sum_probs=170.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeece--ecCcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGA--CPEVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~--~~~~~~lV  209 (498)
                      ...|.+.+-+-+|++|.++...-.  +...++|+.....   ....+....+-.++-..+||-+++.+..  |....+||
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            345666667889999999865443  2223333332211   1122233344444444456777777666  46678999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      ++|+.|++|...|+..   +..+..........+..++++||.   ..++|+|++|.|+|+..+|+.+++|||+......
T Consensus       883 ~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999988533   344444455566778899999999   5699999999999999999999999994433211


Q ss_pred             c----cc----C-------------CCCc--cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCC
Q 010882          290 N----EI----S-------------SNNT--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG  346 (498)
Q Consensus       290 ~----~~----~-------------~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~  346 (498)
                      .    ..    .             ....  ........+||+.|.+||.+.+...+..+|+|++|++++|.++|.+||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            1    00    0             0000  0012345689999999999999999999999999999999999999998


Q ss_pred             CcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          347 ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .....+..-..   ... +.....-+...+....+++...+..+|.+|-.+..
T Consensus      1037 a~tpq~~f~ni---~~~-~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1037 AETPQQIFENI---LNR-DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred             Ccchhhhhhcc---ccC-CCCCCCCccccChhhhhhhhhhhccCchhccCccc
Confidence            76554332111   111 11112223445677889999999999999987763

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=1.1e-11  Score=109.48  Aligned_cols=128  Identities=28%  Similarity=0.392  Sum_probs=101.7

Q ss_pred             cccccCceEEEEEEECCeEEEEEEecCCCCCCh--------hhHHHHHHHHHcCC--CCCeeeeeceecCcceEEEeeCC
Q 010882          145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP--------SEFQQEIDILSKIR--HPNLVTLVGACPEVWTLVYEYLP  214 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~il~~l~--hpniv~l~g~~~~~~~lV~E~~~  214 (498)
                      .+++|+-+.+|.+.+.+.++++|.-.+.....+        ..-.+|+.+++++.  --+++.++.+.++...|+|||++
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~   82 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE   82 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence            588999999999988888888886554433222        23567999998885  34555667777778889999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      |..|.+.+...          ...++..+-.-+.-||.   .|||||||.++||+++.++ +.++||||+..
T Consensus        83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          83 GELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             ChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999888422          35677788888899999   8999999999999998765 89999999863

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=2.6e-12  Score=134.54  Aligned_cols=144  Identities=19%  Similarity=0.250  Sum_probs=92.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--------------------------Ch--------h---
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------------------GP--------S---  178 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--------------------------~~--------~---  178 (498)
                      ..|+. ..||+|++|.||+|..+  |+.||||+.++....                          +.        +   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35666 68999999999999984  789999999864210                          00        0   


Q ss_pred             ---hHHHHHHHHHcCC----CCC---eeeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHH-H
Q 010882          179 ---EFQQEIDILSKIR----HPN---LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV-L  247 (498)
Q Consensus       179 ---~~~~E~~il~~l~----hpn---iv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~-L  247 (498)
                         +|.+|+..+.++.    +.+   |.++|.-+....+|||||+.|+++.+.-.-...  ..+.   ..++...+.. +
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~---~~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDM---KLLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCH---HHHHHHHHHHHH
Confidence               1344555555542    332   223343334467899999999999874211111  1111   1122222211 1


Q ss_pred             HHHHhcCCCCcccCCCCCCcEEEcCCC----ceeEeecccccccccc
Q 010882          248 IFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGISRFLSQN  290 (498)
Q Consensus       248 ~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFGla~~~~~~  290 (498)
                      .-+..   .|++|+|++|.||+++.+|    .+++.|||++..++..
T Consensus       274 ~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        274 TQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            22223   7899999999999999888    9999999999877553

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.34  E-value=1.3e-11  Score=112.82  Aligned_cols=134  Identities=16%  Similarity=0.137  Sum_probs=97.0

Q ss_pred             CcccccCceEEEEEEEC--------CeEEEEEEecCCCC--C-------------------C-hhhHH----HHHHHHHc
Q 010882          144 LKIGEGGYGSIYKGLLR--------HMQVAIKMLHPHSL--Q-------------------G-PSEFQ----QEIDILSK  189 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~--------~~~vavK~~~~~~~--~-------------------~-~~~~~----~E~~il~~  189 (498)
                      ..||.|--+.||.|...        +..+|||+.+....  .                   + ...+.    +|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46999999999999764        26899998864211  0                   0 11223    79999999


Q ss_pred             CC--CCCeeeeeceecCcceEEEeeCCCCCHHh-hhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcccCCCCC
Q 010882          190 IR--HPNLVTLVGACPEVWTLVYEYLPNGSLED-RLSCKDNSPPLSWQTRIRIATELCSVLIFL-HSCKPHSIVHGDLKP  265 (498)
Q Consensus       190 l~--hpniv~l~g~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrDlkp  265 (498)
                      +.  .-+++..+++  ...+|||||+.++.+.. .|.    ...++......+..+++.+|..| |.   .|+|||||++
T Consensus        83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence            85  2456666654  56789999997653322 221    12344556677889999999998 77   7999999999


Q ss_pred             CcEEEcCCCceeEeeccccccc
Q 010882          266 ANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       266 ~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      .|||++ ++.+.|+|||.+...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999987644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1.6e-12  Score=132.98  Aligned_cols=244  Identities=25%  Similarity=0.281  Sum_probs=171.6

Q ss_pred             CCCCCCcccc--cCceEEEEEEE--C--CeEEEEEEecCC--CCCChhhHHHHHHHHHcCC-CCCeeeeeceecC--cce
Q 010882          139 NFDPSLKIGE--GGYGSIYKGLL--R--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE--VWT  207 (498)
Q Consensus       139 ~~~~~~~lG~--G~~g~Vy~~~~--~--~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~--~~~  207 (498)
                      .|.....+|.  |.+|.||.+..  .  +..+|+|.-+..  .......=.+|+....+++ |+|.++.+..+.+  ..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4667778999  99999999887  3  467898874332  2222333346666666674 9999997777743  466


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcccCCCCCCcEEEcCC-CceeEeecc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS----VLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFG  282 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFG  282 (498)
                      +-+|+| +.+|..+.+..  ..-++....+.+..+...    ||..+|.   .+++|-|+||.||++..+ ...+++|||
T Consensus       195 iqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence            777777 57888877532  223566677777777777    9999999   899999999999999998 889999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCc-HHHHHHHHhCccc
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT-KEVQYALDTGKLK  361 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~~~~~~~~  361 (498)
                      +...+..........   ......|...|++||... +-++..+|+||+|.++.+..+|..++... ...+...+.+-  
T Consensus       269 ~v~~i~~~~~~~~~~---~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--  342 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFK---VSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--  342 (524)
T ss_pred             eeEEccCCcccccee---eeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--
Confidence            999887765433222   223446899999999874 56778899999999999999987665322 11111111111  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                         .+.  ++-...+..+..++.++++.+|..|++...
T Consensus       343 ---ip~--e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~  375 (524)
T KOG0601|consen  343 ---IPL--EFCEGGSSSLRSVTSQMLDEDPRLRLTAQI  375 (524)
T ss_pred             ---Cch--hhhcCcchhhhhHHHHhcCcchhhhhHHHH
Confidence               111  111123445666899999999999987754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=3.5e-11  Score=113.16  Aligned_cols=139  Identities=22%  Similarity=0.324  Sum_probs=108.9

Q ss_pred             CcccccCceEEEEEEECC-eEEEEEEecCCCC-CChhhHHHHHHHHHcCCC--CCeeeeeceecC-----cceEEEeeCC
Q 010882          144 LKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRH--PNLVTLVGACPE-----VWTLVYEYLP  214 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h--pniv~l~g~~~~-----~~~lV~E~~~  214 (498)
                      +.||.|.++.||++...+ ..+++|....... .....+..|+.++..+.+  .++.++++++..     ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            458999999999998875 7899999765432 235578999999999975  345667777644     4589999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK----------------------------------------  254 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  254 (498)
                      |+++.+.+..    ..++...+..++.+++.+|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776521    34677788888899999999998531                                        


Q ss_pred             -------------CCCcccCCCCCCcEEEcC--CCceeEeecccccc
Q 010882          255 -------------PHSIVHGDLKPANILLDA--NFVSKLSDFGISRF  286 (498)
Q Consensus       255 -------------~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~  286 (498)
                                   +..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245799999999999998  66789999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=5.6e-12  Score=129.12  Aligned_cols=236  Identities=24%  Similarity=0.242  Sum_probs=165.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC---CeEEEEEEecCCCCCChhhH--HHHHHHHHcC-CCCCeeeeecee--cCcceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEF--QQEIDILSKI-RHPNLVTLVGAC--PEVWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~--~~E~~il~~l-~hpniv~l~g~~--~~~~~l  208 (498)
                      +.+|.....||.|.|+.|+....+   +..|++|.+.........++  ..|+-+...+ -|.++++.+..+  .+..|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            457888999999999999987654   46789988766544333222  2456555555 488888877766  346788


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-CceeEeeccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFL  287 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~~~  287 (498)
                      =-|||.++++...+   .....+....++++..+++.++.++|+   +.++|+|++|+||++..+ +..+++|||+...+
T Consensus       344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccc
Confidence            99999999887666   223456677888999999999999998   899999999999999886 78899999998643


Q ss_pred             cccccCCCCccceeccCCCCCCCcC--ChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYM--DPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (498)
                      .-...           ...++-.+.  +|.......+..+.|++|||.-+.+.+||.+--......         ..+..
T Consensus       418 ~~~~~-----------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---------~~i~~  477 (524)
T KOG0601|consen  418 AFSSG-----------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---------LTIRS  477 (524)
T ss_pred             ceecc-----------cccccccccccchhhccccccccccccccccccccccccCcccCcccccc---------eeeec
Confidence            21110           011233344  555555567889999999999999999997532211110         11111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ......+... ..+..+...+...++..||.+.+
T Consensus       478 ~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~  510 (524)
T KOG0601|consen  478 GDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVE  510 (524)
T ss_pred             ccccCCCchH-HhhhhhhhhhcCCccccchhhhh
Confidence            1111122223 77888888899999999998866

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=1.5e-10  Score=102.02  Aligned_cols=141  Identities=21%  Similarity=0.242  Sum_probs=102.1

Q ss_pred             CCCcccccCceEEEEEEECCeEEEEEEecCCCCCC--------hhhHHHHHHHHHcCCC--CCeeeeeceecCcceEEEe
Q 010882          142 PSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRH--PNLVTLVGACPEVWTLVYE  211 (498)
Q Consensus       142 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l~h--pniv~l~g~~~~~~~lV~E  211 (498)
                      ....|-+|+-+.|++|.+.|+.+.||.-.......        .....+|+.+|.++.-  -.++.++-+-.....|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            45578999999999999999999998654332221        2346789999998752  2233444333446789999


Q ss_pred             eCCC-CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC---ceeEeecccccc
Q 010882          212 YLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRF  286 (498)
Q Consensus       212 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~  286 (498)
                      |++| .++.+++....... ........++..+-..+.-||.   ++||||||..+||+|..++   .+.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9987 46777775433322 2223336788899999999999   8999999999999996544   458999999753

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.22  E-value=1.1e-10  Score=120.98  Aligned_cols=162  Identities=19%  Similarity=0.232  Sum_probs=119.5

Q ss_pred             CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHH
Q 010882          160 RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI  237 (498)
Q Consensus       160 ~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~  237 (498)
                      .+.+|.|...........+...+-+..|+.++||||++++..+..  ..|||+|.+.  .|..++..      ++.....
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHH
Confidence            367788887765544334557788999999999999999998844  5799999983  56666632      2244556


Q ss_pred             HHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhh
Q 010882          238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL  317 (498)
Q Consensus       238 ~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  317 (498)
                      ..+.||+.||.|||.-  .+++|++|.-+.|+|+..|..||++|.++..........        ....--..|..|+.+
T Consensus       108 ~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--------~~~~~~~s~~~P~~~  177 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--------KSLYLIESFDDPEEI  177 (690)
T ss_pred             HHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--------ccchhhhcccChhhc
Confidence            6789999999999863  579999999999999999999999999987543322100        000112346667655


Q ss_pred             ccCCCCCccchHhHHHHHHHHHhC
Q 010882          318 ASGELTPKSDVYSFGIILLRLLTG  341 (498)
Q Consensus       318 ~~~~~~~~~DvwSlGvil~elltG  341 (498)
                      ....  ...|.|-|||+++|++.|
T Consensus       178 ~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  178 DPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             Cccc--cchhhhhHHHHHHHHhCc
Confidence            4333  456999999999999999

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.18  E-value=1.9e-09  Score=106.01  Aligned_cols=254  Identities=20%  Similarity=0.289  Sum_probs=165.6

Q ss_pred             CCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeee--------eeceecC-cceEEE
Q 010882          141 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVT--------LVGACPE-VWTLVY  210 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~--------l~g~~~~-~~~lV~  210 (498)
                      .+++.||+|+-+.+|..-.-+. .+.|+.+....-..   .+-+..|... .||-+-.        |+|.-.. ...+.|
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCCccccCCccceeeecchhhc-hhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4567799999999995322222 34477765432211   1223333333 4654332        2332222 255777


Q ss_pred             eeCCCC-CHHhhhc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          211 EYLPNG-SLEDRLS---CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       211 E~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ..+.|. ...+++.   +....+...|...++.+..++.+.+-||.   .|.+-||++++|+|++.++.+.|.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence            777664 2344442   23345668999999999999999999999   8999999999999999999999987432211


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhC-CCCCCCc-------HHHHH
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTG-RPALGIT-------KEVQY  353 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG-~~pf~~~-------~~~~~  353 (498)
                      - .+     ..   .....+|...|++||...-     ..-+..+|.|.|||++++++.| ++||.+.       +..+.
T Consensus       167 ~-~n-----g~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         167 N-AN-----GT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             c-cC-----Cc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            1 11     11   1245679999999998752     3456789999999999999886 9999642       22333


Q ss_pred             HHHhCccccccC------CCCCCCCHH-HHHHHHHHHHHhhhc--ccCCCCChhHHHHHHhHHHHhh
Q 010882          354 ALDTGKLKNLLD------PLAGDWPFV-QAEQLANLAMRCCEM--SRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       354 ~~~~~~~~~~~~------~~~~~~~~~-~~~~l~~li~~cl~~--~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .+..|.+...-+      +....||.. .++.+..|..+|+..  ++.-||+... .+..|..+.+.
T Consensus       238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a-W~aAl~al~~~  303 (637)
T COG4248         238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA-WVAALDALRQQ  303 (637)
T ss_pred             hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH-HHHHHHHHHHh
Confidence            444444443333      223445554 456788899999975  3568999876 66777776643

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.02  E-value=2e-08  Score=101.34  Aligned_cols=165  Identities=23%  Similarity=0.296  Sum_probs=128.5

Q ss_pred             ceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec------CcceEEEeeCCC-CCHHhh
Q 010882          151 YGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTLVYEYLPN-GSLEDR  221 (498)
Q Consensus       151 ~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~------~~~~lV~E~~~~-gsL~~~  221 (498)
                      -.+.|++..  .|..|++|+++............-+++++++.|+|||++..+|.      ...++||+|.|+ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357788876  57889999997766666656667799999999999999988763      247899999986 578776


Q ss_pred             hccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          222 LSCKD------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       222 l~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      .....            .+...++...+.++.|+..||.++|+   .|+..+-|.|.+||++.+.+++|+..|+...+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            64321            23356788999999999999999999   8999999999999999988999998887765543


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP  343 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~  343 (498)
                      +..                      +-+..   -.+-|.=.||.+++.|.||..
T Consensus       446 d~~----------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  446 DPT----------------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCC----------------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            320                      00111   125688899999999999964

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=2.2e-09  Score=97.77  Aligned_cols=124  Identities=23%  Similarity=0.250  Sum_probs=80.0

Q ss_pred             EEEEEEE-CCeEEEEEEecCCCCCC--------------------------hhhHHHHHHHHHcCCCC--Ceeeeeceec
Q 010882          153 SIYKGLL-RHMQVAIKMLHPHSLQG--------------------------PSEFQQEIDILSKIRHP--NLVTLVGACP  203 (498)
Q Consensus       153 ~Vy~~~~-~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~il~~l~hp--niv~l~g~~~  203 (498)
                      .||.|.. .+..+|||+.......-                          .....+|...|.++..-  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899987 57899999986532110                          01256899999999754  566776553 


Q ss_pred             CcceEEEeeCC--CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCcccCCCCCCcEEEcCCCceeEee
Q 010882          204 EVWTLVYEYLP--NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF-LHSCKPHSIVHGDLKPANILLDANFVSKLSD  280 (498)
Q Consensus       204 ~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  280 (498)
                       ...|||||++  |..+..+....     ++......++.+++..+.. +|.   .||+||||++.|||++.+ .+.|+|
T Consensus        80 -~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 -RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             -TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred             -CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence             5679999998  65554433211     1123455677778775555 567   899999999999999988 999999


Q ss_pred             ccccccc
Q 010882          281 FGISRFL  287 (498)
Q Consensus       281 FGla~~~  287 (498)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.99  E-value=7.5e-09  Score=99.87  Aligned_cols=136  Identities=15%  Similarity=0.063  Sum_probs=97.0

Q ss_pred             ccccCceEEEEEEECCeEEEEEEecCCCCC----------C-hhhHHHHHHHHHcCCCCC--eeeeecee-------cCc
Q 010882          146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ----------G-PSEFQQEIDILSKIRHPN--LVTLVGAC-------PEV  205 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~----------~-~~~~~~E~~il~~l~hpn--iv~l~g~~-------~~~  205 (498)
                      +-......|+++.+.|..|.||........          . ...+.+|...+.+|..-+  ++..+++.       ...
T Consensus        30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~  109 (268)
T PRK15123         30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT  109 (268)
T ss_pred             EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence            444444457778888899999977543210          1 114778999888874222  22333332       123


Q ss_pred             ceEEEeeCCCC-CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-------CCcee
Q 010882          206 WTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------NFVSK  277 (498)
Q Consensus       206 ~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-------~~~~k  277 (498)
                      .+||||++++. +|.+++.... ..+.+...+..++.+++..+.-||.   .||+|+|+++.|||++.       ++.+.
T Consensus       110 s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        110 SFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEE
Confidence            67999999886 8999884221 2345566778899999999999999   99999999999999975       46899


Q ss_pred             Eeeccccc
Q 010882          278 LSDFGISR  285 (498)
Q Consensus       278 l~DFGla~  285 (498)
                      |+||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99999775

>KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones]

Probab=98.98  E-value=3.2e-10  Score=103.03  Aligned_cols=73  Identities=32%  Similarity=0.587  Sum_probs=69.8

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      ..+|++++|.|+.++|.+|+++++|.||+|..|..++..-+..+|+|+.+|+..+++||++|+.+|..|+..+
T Consensus       206 rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~~n  278 (284)
T KOG4642|consen  206 REVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLKEN  278 (284)
T ss_pred             ccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHHhc
Confidence            4689999999999999999999999999999999999998889999999999999999999999999998764

>PRK09902 hypothetical protein; Provisional

Probab=98.82  E-value=9.1e-08  Score=87.82  Aligned_cols=137  Identities=16%  Similarity=0.110  Sum_probs=103.1

Q ss_pred             ccccCceEEEEEEECCeEEEEEEecCCC------CCChhhHHHHHHHHHcCCC--CCeeeeecee------cCcceEEEe
Q 010882          146 IGEGGYGSIYKGLLRHMQVAIKMLHPHS------LQGPSEFQQEIDILSKIRH--PNLVTLVGAC------PEVWTLVYE  211 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h--pniv~l~g~~------~~~~~lV~E  211 (498)
                      -|+||.+.|++-.+.|..+-+|.-...-      ......|.+|...|.+|..  -.+++.+.+.      .-..+||+|
T Consensus        26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            4779999999988888888899765221      2234679999999999853  2244444221      113579999


Q ss_pred             eCCC-CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc--eeEeecccccc
Q 010882          212 YLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGISRF  286 (498)
Q Consensus       212 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~DFGla~~  286 (498)
                      -+.| -||.+++... ...+.+...+..++.+++.++.-||.   .|+.|+|+.+.|||++.+|.  ++++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            8864 4898888432 22356777888999999999999999   89999999999999986666  99999996653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.82  E-value=2.6e-08  Score=93.54  Aligned_cols=133  Identities=20%  Similarity=0.186  Sum_probs=92.5

Q ss_pred             CCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCC----------------------ChhhHHHHHHHHHcCCCC--C
Q 010882          140 FDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ----------------------GPSEFQQEIDILSKIRHP--N  194 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~----------------------~~~~~~~E~~il~~l~hp--n  194 (498)
                      ..++..||-|.-|.||.|... +.++|||.-......                      +.....+|..+|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            356678999999999999985 899999965432111                      012356899999998654  5


Q ss_pred             eeeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC
Q 010882          195 LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF  274 (498)
Q Consensus       195 iv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  274 (498)
                      |++-++.  +...+||||+.|-.|...-        ++....-.|+..|++-+.-+-.   .||||||+++-||+++++|
T Consensus       173 VP~P~~~--nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW--NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc--ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence            5555553  4568999999986665432        1122223334444444443334   6999999999999999999


Q ss_pred             ceeEeeccccc
Q 010882          275 VSKLSDFGISR  285 (498)
Q Consensus       275 ~~kl~DFGla~  285 (498)
                      .+.++||--+.
T Consensus       240 ~~~vIDwPQ~v  250 (304)
T COG0478         240 DIVVIDWPQAV  250 (304)
T ss_pred             CEEEEeCcccc
Confidence            99999998654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=4.4e-08  Score=91.27  Aligned_cols=104  Identities=30%  Similarity=0.342  Sum_probs=79.5

Q ss_pred             hhhHHHHHHHHHcCCCCC--eeeeeceec------CcceEEEeeCCCC-CHHhhhccCCCCCCCCHHHHHHHHHHHHHHH
Q 010882          177 PSEFQQEIDILSKIRHPN--LVTLVGACP------EVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVL  247 (498)
Q Consensus       177 ~~~~~~E~~il~~l~hpn--iv~l~g~~~------~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L  247 (498)
                      .....+|...+..|..-.  ++..+++..      ...++|+|++++. +|.+++....   .++......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence            446778888887774222  333344332      2357999999885 8999885321   255567888999999999


Q ss_pred             HHHHhcCCCCcccCCCCCCcEEEcCCC---ceeEeecccccc
Q 010882          248 IFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRF  286 (498)
Q Consensus       248 ~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~  286 (498)
                      .-||.   .||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999   9999999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.77  E-value=2.1e-09  Score=111.86  Aligned_cols=152  Identities=22%  Similarity=0.330  Sum_probs=102.6

Q ss_pred             HHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC-ccceeccCCCCCCCcCChhhhccC
Q 010882          242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN-TTLCCRTDPKGTFAYMDPEFLASG  320 (498)
Q Consensus       242 ~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~  320 (498)
                      +++.||.|+|..  .++||++|.|++|.+++++..||+.|+.+............ ..........-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            455899999986  57999999999999999999999999998754431111100 000000111246789999999998


Q ss_pred             CCCCccchHhHHHHHHHHH-hCCCCCCCcHH-HHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          321 ELTPKSDVYSFGIILLRLL-TGRPALGITKE-VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       321 ~~~~~~DvwSlGvil~ell-tG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                      ..++++|+||+||++|-+. .|++-+...+. ..+....+    ..+.....++...+.++.+=+.+.+..+..-||++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence            8899999999999999998 45544432211 11111111    111111223445667888889999999999999654


Q ss_pred             H
Q 010882          399 K  399 (498)
Q Consensus       399 ~  399 (498)
                      .
T Consensus       261 ~  261 (700)
T KOG2137|consen  261 L  261 (700)
T ss_pred             h
Confidence            4

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=2.2e-07  Score=97.12  Aligned_cols=139  Identities=21%  Similarity=0.297  Sum_probs=93.0

Q ss_pred             CcccccCceEEEEEEEC-CeEEEEEEecCCCCCCh------------------------------h----------hHHH
Q 010882          144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP------------------------------S----------EFQQ  182 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~------------------------------~----------~~~~  182 (498)
                      ..|+.++-|.||+|++. |+.||||+.++.-....                              +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57999999999999997 89999999987532211                              0          1345


Q ss_pred             HHHHHHcCC-----CCC--eeeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 010882          183 EIDILSKIR-----HPN--LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV-LIFLHSCK  254 (498)
Q Consensus       183 E~~il~~l~-----hpn--iv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~  254 (498)
                      |..-+.+++     .|+  |.++|--+.....|+|||++|..+.+...-..  ..++..   .|+..++.+ +.-+=.  
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~--  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLR--  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHh--
Confidence            555555552     333  23334333456789999999999888742222  224322   333333332 122222  


Q ss_pred             CCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       255 ~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                       .|++|.|..|.||+++.+|.+-+.|||+...++..
T Consensus       284 -dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         284 -DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             -cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence             68999999999999999999999999998876543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.56  E-value=1.4e-06  Score=79.59  Aligned_cols=107  Identities=22%  Similarity=0.231  Sum_probs=85.7

Q ss_pred             HHHHHHHHcCCC-CCeeeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcc
Q 010882          181 QQEIDILSKIRH-PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV  259 (498)
Q Consensus       181 ~~E~~il~~l~h-pniv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  259 (498)
                      ..|.-+|..+.+ +++++++|+|..  ++|.||+..+++...-.....-..-+|..|.+||.+++..+.+|++.....+.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~   84 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY   84 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence            358888999976 699999999964  68999998776643210001123468999999999999999999987766788


Q ss_pred             cCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          260 HGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       260 HrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      -.|++|+|+-++.+|++|++|...+.....
T Consensus        85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~~  114 (188)
T PF12260_consen   85 LCDVSPDNFGVNDDGRLKLIDLDDVFVEDK  114 (188)
T ss_pred             EeecchHHeEEeCCCcEEEEechhcchhHH
Confidence            899999999999999999999998765543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.56  E-value=6.5e-07  Score=84.57  Aligned_cols=130  Identities=18%  Similarity=0.245  Sum_probs=81.2

Q ss_pred             CcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC--eeeeecee--cCcceEEEeeCCCCC-H
Q 010882          144 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGAC--PEVWTLVYEYLPNGS-L  218 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~g~~--~~~~~lV~E~~~~gs-L  218 (498)
                      ..||+|..+.||+.  .+..+++|......  ......+|.++++.+..-.  +.+.++++  .+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            56999999999984  35567888876422  3456789999998885332  34555554  335678999999863 2


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHH---------------------------------------HHHhcC-CCCc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLI---------------------------------------FLHSCK-PHSI  258 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~---------------------------------------~LH~~~-~~~i  258 (498)
                      ...+.       .+......++..++..+.                                       +|.... ...+
T Consensus        83 ~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        83 SRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             hhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            21110       001111112222222222                                       222111 2356


Q ss_pred             ccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          259 VHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       259 vHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      +|+|+.|.||+++.++ +.|+||+.+.
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcC
Confidence            8999999999999888 9999999765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.51  E-value=5.9e-07  Score=82.84  Aligned_cols=135  Identities=19%  Similarity=0.213  Sum_probs=90.8

Q ss_pred             hhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhh---------HHHHHHHHHcCCC---CCeeeeecee-
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRH---PNLVTLVGAC-  202 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~h---pniv~l~g~~-  202 (498)
                      ...+|...+++-......|.+-...+..+.+|............         ..+.+..+.++..   -..+.++.+. 
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            34567777778777888888888889999999877543222111         2234444444422   1222222221 


Q ss_pred             ------cCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          203 ------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       203 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                            ....++||||++|..|.+...       ++.    .++..+..++.-||.   .|++|||..|.|++++.++ +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-E
Confidence                  234568999999988876541       222    345567788999999   8999999999999999665 8


Q ss_pred             eEeeccccc
Q 010882          277 KLSDFGISR  285 (498)
Q Consensus       277 kl~DFGla~  285 (498)
                      ++.||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=9.6e-07  Score=77.92  Aligned_cols=130  Identities=19%  Similarity=0.181  Sum_probs=92.6

Q ss_pred             CCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecCcceEEEeeCCCCCHHh
Q 010882          141 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLED  220 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~~~~lV~E~~~~gsL~~  220 (498)
                      ...+.||+|++|.||+|.+++..+|+|+-..++  ....+..|+++|..+.--++.+=+..+. ..++.|||+.|-+|.+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg-~~~i~me~i~G~~L~~  101 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG-EDFIRMEYIDGRPLGK  101 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec-hhhhhhhhhcCcchhh
Confidence            345679999999999999999999999876443  4567999999999998766554333222 2345599999988877


Q ss_pred             hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC-CCcEEEcCCCceeEeecccccc
Q 010882          221 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK-PANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       221 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk-p~NiLl~~~~~~kl~DFGla~~  286 (498)
                      .-...      +-.+    ...+++.-.-|..   .||-|+.|. |...+|.+++.+.|+||.-|+.
T Consensus       102 ~~~~~------~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         102 LEIGG------DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhcc------cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            65211      1222    3345555455666   799999995 6555555566999999998763

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.44  E-value=9.1e-07  Score=83.53  Aligned_cols=140  Identities=21%  Similarity=0.298  Sum_probs=83.9

Q ss_pred             CcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCC--Ceeeeecee-----cCcceEEEeeCCCC
Q 010882          144 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC-----PEVWTLVYEYLPNG  216 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~g~~-----~~~~~lV~E~~~~g  216 (498)
                      +.|+.|..+.||+....+..+++|.....  .....+..|..+++.+...  .+.++++.+     ....+++|++++|.
T Consensus         3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            46899999999999998889999997643  3346788999999888532  355666633     22358999999998


Q ss_pred             CHHh----------------hh---ccC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh--
Q 010882          217 SLED----------------RL---SCK-DNSPPLSWQTR---------IRI------------ATELCS-VLIFLHS--  252 (498)
Q Consensus       217 sL~~----------------~l---~~~-~~~~~l~~~~~---------~~i------------~~~i~~-~L~~LH~--  252 (498)
                      ++..                .+   +.. ....++.....         ...            ...+.. .+..++.  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            8877                11   111 11111111110         000            011222 3333332  


Q ss_pred             --cCCCCcccCCCCCCcEEEc-CCCceeEeeccccc
Q 010882          253 --CKPHSIVHGDLKPANILLD-ANFVSKLSDFGISR  285 (498)
Q Consensus       253 --~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~  285 (498)
                        ..+..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              1346799999999999999 66667899999764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG2042 consensus Ubiquitin fusion degradation protein-2 [Posttranslational modification, protein turnover, chaperones]

Probab=98.41  E-value=2.7e-07  Score=99.95  Aligned_cols=72  Identities=26%  Similarity=0.481  Sum_probs=68.7

Q ss_pred             CCCCCCcCCCccccccCCceecc-CCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~-~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      .++|++|..|++..+|.|||+.+ +|.+.+|+.|.+++-+ ..+||++|.+|+..+++||-+||..|+.|.+++
T Consensus       865 ~dvpdef~DPlm~Tlm~dPV~LP~Srv~vDRsti~rhlLs-~~tdPFNR~pLt~d~v~pn~eLK~kI~~~~~ek  937 (943)
T KOG2042|consen  865 GDVPDEFLDPLMSTLMSDPVVLPSSRVTVDRSTIERHLLS-DCTDPFNREPLTEDMVSPNEELKAKIRCWIKEK  937 (943)
T ss_pred             ccCchhhhCccccccCCCCccCCcccccccHHHHHHHHhc-CCCCccccccCchhhcCCCHHHHHHHHHHHHHh
Confidence            56999999999999999999999 9999999999999998 789999999999999999999999999998763

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.36  E-value=4.2e-06  Score=80.07  Aligned_cols=137  Identities=16%  Similarity=0.164  Sum_probs=83.1

Q ss_pred             ccccCc-eEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceecC--cceEEEeeCCCCCHHhh
Q 010882          146 IGEGGY-GSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE--VWTLVYEYLPNGSLEDR  221 (498)
Q Consensus       146 lG~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~--~~~lV~E~~~~gsL~~~  221 (498)
                      |-.|.+ ..||+....+..+.||+.....   ...+.+|+.+++.+. +--+.+++++...  ..++||++++|.+|...
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            445555 7899987766788888876443   346778999998884 3345566766643  46899999999877643


Q ss_pred             h-------------------ccCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cCC
Q 010882          222 L-------------------SCKDN-SPPLSW--QTRIRIAT--------------------ELCSVLIFLHS----CKP  255 (498)
Q Consensus       222 l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~i~~~L~~LH~----~~~  255 (498)
                      .                   +.... ..++..  ........                    .+...+..|-.    ..+
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            2                   11100 111110  01110000                    01111222211    112


Q ss_pred             CCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          256 HSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       256 ~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      ..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            458999999999999998888999999664

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.31  E-value=2.7e-06  Score=88.76  Aligned_cols=139  Identities=19%  Similarity=0.247  Sum_probs=93.4

Q ss_pred             CcccccCceEEEEEEEC-CeEEEEEEecCCCCCCh---------------------------h----------hHHHHHH
Q 010882          144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP---------------------------S----------EFQQEID  185 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~---------------------------~----------~~~~E~~  185 (498)
                      ..||.-+.|.||+|+.+ |..||||+-++.-....                           +          +|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            46999999999999986 67899999876432210                           0          1445555


Q ss_pred             HHHcC----CCCC------eeeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 010882          186 ILSKI----RHPN------LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP  255 (498)
Q Consensus       186 il~~l----~hpn------iv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  255 (498)
                      -..++    .|-+      |+++|-.+.....|+||||+|..+.|...-..  ..++...   |+..+.++  |++..-.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~--~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEA--YLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHH--HHHHHHh
Confidence            44333    3555      66677667777899999999987776543111  2244443   33333332  2222222


Q ss_pred             CCcccCCCCCCcEEEcC----CCceeEeeccccccccc
Q 010882          256 HSIVHGDLKPANILLDA----NFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       256 ~~ivHrDlkp~NiLl~~----~~~~kl~DFGla~~~~~  289 (498)
                      .|++|+|-.|.||++..    ++.+.+.|||+...++.
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            68999999999999983    67899999999876654

>COG5113 UFD2 Ubiquitin fusion degradation protein 2 [Posttranslational modification, protein turnover, chaperones]

Probab=98.30  E-value=1.2e-06  Score=89.50  Aligned_cols=74  Identities=27%  Similarity=0.478  Sum_probs=68.8

Q ss_pred             CCCCCCCCCcCCCccccccCCceecc-CCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHh
Q 010882          423 EERCEPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ  497 (498)
Q Consensus       423 ~~~~~~P~~~~cpi~~e~~~dp~~~~-~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~  497 (498)
                      +...++|++|..|.+..+|+|||+.+ ++.+.+|+.|..++-+ ..|||..|-||+..+.+||-.||..|..|.+.
T Consensus       846 ED~GDvPDeFlDPLmftimkdPV~Lp~S~i~IDRSTikahlls-d~tDPFNRmPLtlddVtpn~eLrekIn~f~k~  920 (929)
T COG5113         846 EDMGDVPDEFLDPLMFTIMKDPVKLPTSRITIDRSTIKAHLLS-DGTDPFNRMPLTLDDVTPNAELREKINRFYKC  920 (929)
T ss_pred             hhccCCchhhhCchhhhcccCCeecccccccccHHHHHHHHhc-CCCCccccCCCchhhcCCCHHHHHHHHHHHhc
Confidence            34578999999999999999999998 8899999999999999 67999999999999999999999999988764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.30  E-value=1e-07  Score=98.45  Aligned_cols=184  Identities=18%  Similarity=0.149  Sum_probs=127.8

Q ss_pred             CCCCCcccccCceEEEEEEECCe-EEEEEEecCCCCCChhhHHHHHHHHHcCCCCC-eeeeecee--cCcceEEEeeCCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGAC--PEVWTLVYEYLPN  215 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~g~~--~~~~~lV~E~~~~  215 (498)
                      +..-.-+++|+++++||.+.... ....+.+.     ......-++++|.+++||| .+..++.+  ++...++|+|+.+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs-----~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVS-----QTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeec-----cchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            33344589999999998765432 22234332     2245667899999999999 66666666  3457789999977


Q ss_pred             C-CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          216 G-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       216 g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      | +-.....  .....+...+...+....+++|++||+   -.-+|+|    ||+..+ +..|.+||+....+.....  
T Consensus       319 ~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~--  386 (829)
T KOG0576|consen  319 GRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK--  386 (829)
T ss_pred             CccccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcccc--
Confidence            6 2211110  111122233444566677888999998   3358998    777765 5789999998877665431  


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                             .....+|+.++|||+.....+....|+||+|+--.+|.-|-+|-..
T Consensus       387 -------~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  387 -------PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             -------cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence                   1334589999999999999999999999999988888888877643

>PLN02876 acyl-CoA dehydrogenase

Probab=98.27  E-value=9.5e-06  Score=91.14  Aligned_cols=146  Identities=19%  Similarity=0.318  Sum_probs=90.8

Q ss_pred             CCcccccCceEEEEEEECC----eEEEEEEecCCCC-CChhhHHHHHHHHHcCC-CCCe--eeeeceecC-----cceEE
Q 010882          143 SLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIR-HPNL--VTLVGACPE-----VWTLV  209 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-hpni--v~l~g~~~~-----~~~lV  209 (498)
                      ...|+.|.++.+|+....+    ..+++|+...... .....+.+|+.+|+.+. |+++  ++++++|.+     ..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            3568899999999877654    4677887654322 23457889999999995 6664  778888754     47899


Q ss_pred             EeeCCCCCHHh--------------------h---hccCCC--------CCCCCH--HHHHHHH---------------H
Q 010882          210 YEYLPNGSLED--------------------R---LSCKDN--------SPPLSW--QTRIRIA---------------T  241 (498)
Q Consensus       210 ~E~~~~gsL~~--------------------~---l~~~~~--------~~~l~~--~~~~~i~---------------~  241 (498)
                      |||++|..+.+                    .   |+....        ..+..+  .++..+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998865322                    1   111110        001111  1111111               1


Q ss_pred             HHHHHHHHHHhcCC--------CCcccCCCCCCcEEEcCC-C-ceeEeecccccccc
Q 010882          242 ELCSVLIFLHSCKP--------HSIVHGDLKPANILLDAN-F-VSKLSDFGISRFLS  288 (498)
Q Consensus       242 ~i~~~L~~LH~~~~--------~~ivHrDlkp~NiLl~~~-~-~~kl~DFGla~~~~  288 (498)
                      .+...+.+|....|        ..+||+|+++.||+++.+ + .+-|.||+++..-+
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence            12334556644333        249999999999999853 3 35799999987543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.25  E-value=7.9e-06  Score=76.29  Aligned_cols=135  Identities=19%  Similarity=0.203  Sum_probs=85.7

Q ss_pred             cccccCceEEEEEEE-CCeEEEEEEecCCCCCCh-------------------hh-----HHHHHHHHHcCC--CCCeee
Q 010882          145 KIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGP-------------------SE-----FQQEIDILSKIR--HPNLVT  197 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~-------------------~~-----~~~E~~il~~l~--hpniv~  197 (498)
                      .|+.|.-+.||+|.. .+..||||++........                   ..     ..+|..-|+++.  +-.+++
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            477788889999886 478899999975432111                   00     235666666663  223333


Q ss_pred             eeceecCcceEEEeeCCCCC-HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          198 LVGACPEVWTLVYEYLPNGS-LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       198 l~g~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                      -+++.  ...|||||+.... -.-.|    ...++.......+..++++.+.-|-..  .++||+||+.-|||+. ++.+
T Consensus       135 Pi~~~--~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         135 PIAFR--NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             ceeec--CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeE
Confidence            33332  3569999985431 11111    111233334556666777776666442  5799999999999999 8899


Q ss_pred             eEeecccccccc
Q 010882          277 KLSDFGISRFLS  288 (498)
Q Consensus       277 kl~DFGla~~~~  288 (498)
                      .|+|||-|....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999776443

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.22  E-value=9.6e-06  Score=77.17  Aligned_cols=71  Identities=11%  Similarity=0.165  Sum_probs=45.4

Q ss_pred             CcccccCce-EEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCC---CeeeeeceecC-----cceEEEeeCC
Q 010882          144 LKIGEGGYG-SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP---NLVTLVGACPE-----VWTLVYEYLP  214 (498)
Q Consensus       144 ~~lG~G~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp---niv~l~g~~~~-----~~~lV~E~~~  214 (498)
                      ..|+.||.. .||+.   +..+++|.....  .....+.+|..+|..+...   -+...++....     ..++||++++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            457877776 58864   345777865432  2345788999999887531   24444444322     3478999999


Q ss_pred             CCCHH
Q 010882          215 NGSLE  219 (498)
Q Consensus       215 ~gsL~  219 (498)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            97764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00599 rad18 DNA repair protein rad18

Probab=98.19  E-value=3e-06  Score=84.87  Aligned_cols=70  Identities=11%  Similarity=0.245  Sum_probs=64.6

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHH
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQ  496 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~  496 (498)
                      ......|.|||+.+.+.+|+++++||+||..||..|+.. ...||+|+..+....|.+|..|.++|+.|..
T Consensus        21 ~~Le~~l~C~IC~d~~~~PvitpCgH~FCs~CI~~~l~~-~~~CP~Cr~~~~~~~Lr~N~~L~~iVe~~~~   90 (397)
T TIGR00599        21 YPLDTSLRCHICKDFFDVPVLTSCSHTFCSLCIRRCLSN-QPKCPLCRAEDQESKLRSNWLVSEIVESFKN   90 (397)
T ss_pred             cccccccCCCcCchhhhCccCCCCCCchhHHHHHHHHhC-CCCCCCCCCccccccCccchHHHHHHHHHHH
Confidence            356788999999999999999999999999999999987 5689999999988899999999999999875

This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University).

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.13  E-value=1.3e-05  Score=77.22  Aligned_cols=137  Identities=18%  Similarity=0.150  Sum_probs=81.0

Q ss_pred             ccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCe-eeeeceecCcceEEEeeCCCCCHHhh---
Q 010882          146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSLEDR---  221 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~g~~~~~~~lV~E~~~~gsL~~~---  221 (498)
                      +..|-.+.+|+....+..+++|........-.-...+|..+++.+..-.+ .++++.+.  .++||||++|.++...   
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~~~v~e~i~G~~~~~~~~~   81 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--HWLLVEWLEGEVITLDQFV   81 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--CEEEEEeccCccccccccc
Confidence            56677889999887788899997654322211246789999998864322 34455443  4689999998765421   


Q ss_pred             --------------hccCC-CCCCCCHHHHH-HHHHH---------HHHHHHHHHhc-----CCCCcccCCCCCCcEEEc
Q 010882          222 --------------LSCKD-NSPPLSWQTRI-RIATE---------LCSVLIFLHSC-----KPHSIVHGDLKPANILLD  271 (498)
Q Consensus       222 --------------l~~~~-~~~~l~~~~~~-~i~~~---------i~~~L~~LH~~-----~~~~ivHrDlkp~NiLl~  271 (498)
                                    |+... ...+++....+ .+..+         +...+..+-..     .+..++|+|+.|.||+++
T Consensus        82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~  161 (256)
T TIGR02721        82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT  161 (256)
T ss_pred             CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence                          11111 11122222111 11111         11112222111     123589999999999999


Q ss_pred             CCCceeEeeccccc
Q 010882          272 ANFVSKLSDFGISR  285 (498)
Q Consensus       272 ~~~~~kl~DFGla~  285 (498)
                      .++ +.|+||+.|.
T Consensus       162 ~~~-~~lIDwE~a~  174 (256)
T TIGR02721       162 PQG-LKLIDWEYAS  174 (256)
T ss_pred             CCC-CEEEeccccC
Confidence            877 7899999765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=98.05  E-value=5.1e-05  Score=74.82  Aligned_cols=73  Identities=22%  Similarity=0.132  Sum_probs=55.0

Q ss_pred             CcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCC---CCeeeeeceec-----CcceEEEeeCCC
Q 010882          144 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH---PNLVTLVGACP-----EVWTLVYEYLPN  215 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---pniv~l~g~~~-----~~~~lV~E~~~~  215 (498)
                      +.||.|..+.||+....+..+.+|..+.  ......|..|...|+.|.-   -.++++++.|.     +..+||||+++|
T Consensus        20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            4599999999999876555677787532  1234589999999998853   36778888763     347999999998


Q ss_pred             CCH
Q 010882          216 GSL  218 (498)
Q Consensus       216 gsL  218 (498)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>PRK05231 homoserine kinase; Provisional

Probab=98.04  E-value=7.8e-05  Score=74.34  Aligned_cols=139  Identities=19%  Similarity=0.267  Sum_probs=77.4

Q ss_pred             CcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-----CCCeeee-----eceecCcceEEEeeC
Q 010882          144 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----HPNLVTL-----VGACPEVWTLVYEYL  213 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----hpniv~l-----~g~~~~~~~lV~E~~  213 (498)
                      +.|+.|....+|+....+..+++|++..   ...+.+..|+.++..|.     .|.++.-     +....+..+++++|+
T Consensus        28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQGEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             chhccccccceEEEEeCCCcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            4466777789999877666899998762   22344455666666553     3333321     111234568999999


Q ss_pred             CCCCHH-----------hhh---ccCCC--------CCCCCH-HHHHH------------HH-HHHHHHHHHHHhc----
Q 010882          214 PNGSLE-----------DRL---SCKDN--------SPPLSW-QTRIR------------IA-TELCSVLIFLHSC----  253 (498)
Q Consensus       214 ~~gsL~-----------~~l---~~~~~--------~~~l~~-~~~~~------------i~-~~i~~~L~~LH~~----  253 (498)
                      +|..+.           ..|   +....        ...+.| .....            .. ..+...+..+...    
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            987431           111   11100        001112 11111            01 1111222333211    


Q ss_pred             CCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          254 KPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       254 ~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      -+.++||+|+.|.||+++.+...-|+||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            35689999999999999977666899999764

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.99  E-value=8.3e-05  Score=75.69  Aligned_cols=74  Identities=16%  Similarity=0.096  Sum_probs=55.8

Q ss_pred             CcccccCceEEEEEEECC--eEEEEEEecCCC-------CCChhhHHHHHHHHHcCC---CCCeeeeeceecCcceEEEe
Q 010882          144 LKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS-------LQGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVYE  211 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~---hpniv~l~g~~~~~~~lV~E  211 (498)
                      +.||.|.+..||++...+  +.|+||.-.+..       ....+.+..|.+.|..+.   ..++++++.+..+..++|||
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME  111 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME  111 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence            469999999999998864  389999854221       124566788999888863   35678888887777899999


Q ss_pred             eCCCCC
Q 010882          212 YLPNGS  217 (498)
Q Consensus       212 ~~~~gs  217 (498)
                      |+++..
T Consensus       112 ~L~~~~  117 (401)
T PRK09550        112 DLSDHK  117 (401)
T ss_pred             cCCCcc
Confidence            998743

>PLN03208 E3 ubiquitin-protein ligase RMA2; Provisional

Probab=97.97  E-value=6.2e-06  Score=73.71  Aligned_cols=60  Identities=20%  Similarity=0.381  Sum_probs=52.8

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhc---------------CCCCCCCCCCCCCCCCCCccHH
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS---------------GHETSPMTNLPLAHKNLVPNLA  486 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~---------------~~~~~p~~~~~~~~~~~~pn~~  486 (498)
                      ...+.|.|||+.+.+.||+++.+||.|+..+|..|+..               +..+||+|+.+++...++|.+.
T Consensus        14 ~~~~~~~CpICld~~~dPVvT~CGH~FC~~CI~~wl~~s~~s~~~~~~~~~~k~~~~CPvCR~~Is~~~LvPiyg   88 (193)
T PLN03208         14 DSGGDFDCNICLDQVRDPVVTLCGHLFCWPCIHKWTYASNNSRQRVDQYDHKREPPKCPVCKSDVSEATLVPIYG   88 (193)
T ss_pred             cCCCccCCccCCCcCCCcEEcCCCchhHHHHHHHHHHhccccccccccccccCCCCcCCCCCCcCChhcEEEeec
Confidence            45578999999999999999999999999999999852               2458999999999999999763

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.95  E-value=5.6e-05  Score=71.78  Aligned_cols=139  Identities=20%  Similarity=0.260  Sum_probs=81.1

Q ss_pred             CcccccCceEEEEEEEC---CeEEEEEEecCCCCCChhhHHHHHHHHHcCCC-CCeeeeeceecCcceEEEeeCCCCCHH
Q 010882          144 LKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGACPEVWTLVYEYLPNGSLE  219 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~g~~~~~~~lV~E~~~~gsL~  219 (498)
                      +.|..|-...||+....   +..|++|+...... ..-...+|+.+++.+.. .-.+++++.+.  ..+||||++|.++.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l~   80 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTLE   80 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcCC
Confidence            34777888899998765   46788997654322 11234579999988853 33445555544  34899999987653


Q ss_pred             hh-----------------hccCCCC--------CCCC-HHHHHHHHH----------------------HHH---HHHH
Q 010882          220 DR-----------------LSCKDNS--------PPLS-WQTRIRIAT----------------------ELC---SVLI  248 (498)
Q Consensus       220 ~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~i~---~~L~  248 (498)
                      ..                 ++.....        .... +..+..+..                      .+.   ..|.
T Consensus        81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  160 (235)
T cd05157          81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK  160 (235)
T ss_pred             HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence            21                 1111111        1111 122112111                      111   1111


Q ss_pred             -HHHhc-CCCCcccCCCCCCcEEEcC-CCceeEeeccccc
Q 010882          249 -FLHSC-KPHSIVHGDLKPANILLDA-NFVSKLSDFGISR  285 (498)
Q Consensus       249 -~LH~~-~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~  285 (498)
                       .+... .+..++|+|+.+.|||++. ++.+.|+||..|.
T Consensus       161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence             11111 2356999999999999998 5789999999765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.92  E-value=6.7e-05  Score=73.95  Aligned_cols=140  Identities=16%  Similarity=0.190  Sum_probs=85.6

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCC--Ceeeeecee--------cCcceEEEee
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC--------PEVWTLVYEY  212 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~g~~--------~~~~~lV~E~  212 (498)
                      ...|..|....+|+....+..+++|+...   .....+..|+.++..|.+-  .+++++...        .+..++||+|
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            34577787789999877777899998764   2345677788888887432  244544432        3345789999


Q ss_pred             CCCCCHHh-----------h---hccC----CCC----CCCCHHHHH----------HHHHHHHHHHHHHHh----cCCC
Q 010882          213 LPNGSLED-----------R---LSCK----DNS----PPLSWQTRI----------RIATELCSVLIFLHS----CKPH  256 (498)
Q Consensus       213 ~~~gsL~~-----------~---l~~~----~~~----~~l~~~~~~----------~i~~~i~~~L~~LH~----~~~~  256 (498)
                      ++|.++..           .   |+..    ...    ....|....          .....+..++.++..    ..+.
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            99876532           0   0100    000    011221111          011112334444443    2246


Q ss_pred             CcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          257 SIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       257 ~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      +++|+|+.|.||+++.++.+.|.||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            79999999999999998778999999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.90  E-value=0.00018  Score=71.34  Aligned_cols=141  Identities=18%  Similarity=0.209  Sum_probs=83.2

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCC--Ceeeeecee--------cCcceEEEee
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC--------PEVWTLVYEY  212 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~g~~--------~~~~~lV~E~  212 (498)
                      ...++.|....+|+....+..+++|+.+...  ....+..|..++..|...  .+++++...        .+..++||+|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            3457777778999877666678889875422  244566777887777422  244444432        2346799999


Q ss_pred             CCCCCHHh-----------h---hccCCCC--C------C-CCHHHHH------------HHHHHHHHHHHHHHh----c
Q 010882          213 LPNGSLED-----------R---LSCKDNS--P------P-LSWQTRI------------RIATELCSVLIFLHS----C  253 (498)
Q Consensus       213 ~~~gsL~~-----------~---l~~~~~~--~------~-l~~~~~~------------~i~~~i~~~L~~LH~----~  253 (498)
                      ++|.++..           .   ++.....  .      . -.|....            .....+...+.++..    .
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99854321           1   1110000  0      0 0111100            001122334554532    2


Q ss_pred             CCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          254 KPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       254 ~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .+.+++|+|+.+.||+++.++.+.|.||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            35789999999999999998877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.83  E-value=0.00017  Score=65.96  Aligned_cols=123  Identities=24%  Similarity=0.357  Sum_probs=89.0

Q ss_pred             cCCCCCCcccccCc-eEEEEEEECCeEEEEEEecC---CCC------------------CChhhHHHHHHHHHcCC---C
Q 010882          138 HNFDPSLKIGEGGY-GSIYKGLLRHMQVAIKMLHP---HSL------------------QGPSEFQQEIDILSKIR---H  192 (498)
Q Consensus       138 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~il~~l~---h  192 (498)
                      .+++....||.|.- |.||++...+..+|+|++..   ...                  .-...|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            67888899999999 99999999999999999322   111                  01134888999888884   4


Q ss_pred             CCe--eeeecee--c------------------CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 010882          193 PNL--VTLVGAC--P------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL  250 (498)
Q Consensus       193 pni--v~l~g~~--~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L  250 (498)
                      .++  |+.+|+.  .                  ..+.||.||++...            .++.    .-+.++.+-+..+
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHHH
Confidence            455  8888876  1                  01457888876543            1222    2244566667778


Q ss_pred             HhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       251 H~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      |.   .||+-+|+++.|..     .-||+|||.+
T Consensus       181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HH---CCeeeccCcccccc-----CCEEEecccC
Confidence            88   89999999999987     3489999964

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.76  E-value=0.00046  Score=63.49  Aligned_cols=128  Identities=24%  Similarity=0.292  Sum_probs=85.6

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCC----------------CCChhhHHHHHHHHHcCC------CCCeeeeec
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHS----------------LQGPSEFQQEIDILSKIR------HPNLVTLVG  200 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~------hpniv~l~g  200 (498)
                      ...||+|+.=.||.-- .+....||+.....                .....++.+|+.....+.      +.+|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            4579999999999421 24557889887765                122456777877766665      888999999


Q ss_pred             eecC--cceEEEeeCCC------CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC
Q 010882          201 ACPE--VWTLVYEYLPN------GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA  272 (498)
Q Consensus       201 ~~~~--~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~  272 (498)
                      ....  ...+|+|.+.+      -||.+++..    ..++. .....   +-.-..||-.   +.|+.+|++|.||++..
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEEEEe
Confidence            9855  46788887543      367787732    23444 33333   3333445555   67999999999999963


Q ss_pred             C---C-ceeEee-cc
Q 010882          273 N---F-VSKLSD-FG  282 (498)
Q Consensus       273 ~---~-~~kl~D-FG  282 (498)
                      .   . .+.|+| ||
T Consensus       154 ~~~~~~~lvlIDG~G  168 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLG  168 (199)
T ss_pred             cCCCceEEEEEeCCC
Confidence            3   2 577777 44

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF11789 zf-Nse: Zinc-finger of the MIZ type in Nse subunit; PDB: 2YU4_A 3HTK_C

Probab=97.73  E-value=1.9e-05  Score=56.62  Aligned_cols=44  Identities=27%  Similarity=0.564  Sum_probs=31.2

Q ss_pred             CCcCCCccccccCCceec-cCCceecHHHHHHHH-hcCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWL-DSGHETSPMTN  473 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~-~~~~~~~p~~~  473 (498)
                      -.+.|||+...+.|||.+ .+||+|++++|..|+ ..+.-.||+++
T Consensus        10 ~~~~CPiT~~~~~~PV~s~~C~H~fek~aI~~~i~~~~~~~CPv~G   55 (57)
T PF11789_consen   10 ISLKCPITLQPFEDPVKSKKCGHTFEKEAILQYIQRNGSKRCPVAG   55 (57)
T ss_dssp             --SB-TTTSSB-SSEEEESSS--EEEHHHHHHHCTTTS-EE-SCCC
T ss_pred             eccCCCCcCChhhCCcCcCCCCCeecHHHHHHHHHhcCCCCCCCCC
Confidence            457899999999999998 589999999999999 33455899864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.71  E-value=7.8e-05  Score=84.43  Aligned_cols=174  Identities=16%  Similarity=0.046  Sum_probs=120.9

Q ss_pred             EEEEEecCCCCCChhh-----HHHHHHHHHcCCCCCeeeeeceec----CcceEEEeeCCCCCHHhhhccC-CCCCCCCH
Q 010882          164 VAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLVTLVGACP----EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSW  233 (498)
Q Consensus       164 vavK~~~~~~~~~~~~-----~~~E~~il~~l~hpniv~l~g~~~----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~  233 (498)
                      +.+|+.+....+...+     ...|.+-++...|+++...+.--+    ..-+.+++|+.+|.+.+.+-+. ...+++..
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            4556655433332222     334555556678999887665442    3467899999999999988543 23344444


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCC--CCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCc
Q 010882          234 QTRIRIATELCSVLIFLHSCKP--HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY  311 (498)
Q Consensus       234 ~~~~~i~~~i~~~L~~LH~~~~--~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y  311 (498)
                      .-......+......-+|....  +--+|+++|+.|.+|..++.+|++++|+.+......        ...+...+++.|
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--------sf~Gl~l~sp~~ 1406 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--------SFFGLELCSPIY 1406 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH--------hhhhhhhCCHHH
Confidence            3333333333555555555433  236899999999999999999999999998332221        122444688899


Q ss_pred             CChhhhccCCCCCccchHhHHHHHHHHHhCCCCC
Q 010882          312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL  345 (498)
Q Consensus       312 ~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf  345 (498)
                      ++|++...-.++.++|+|+.|+-+|+...|.++|
T Consensus      1407 v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1407 VLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            9999998889999999999999999999999887

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.58  E-value=0.0004  Score=68.67  Aligned_cols=138  Identities=22%  Similarity=0.293  Sum_probs=81.6

Q ss_pred             cccccCceEEEEEEEC--------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC-eeeeeceecCcceEEEeeCCC
Q 010882          145 KIGEGGYGSIYKGLLR--------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEYLPN  215 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~g~~~~~~~lV~E~~~~  215 (498)
                      .|..|-...||+....        +..+++|+..... .......+|..++..+...+ ..++++++.+  .+|++|++|
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--~~v~e~i~G   81 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN--GRIEEFIPS   81 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC--CchhheeCC
Confidence            3555666788987764        3678999866433 22345678888888885322 3456666643  468999998


Q ss_pred             CCHHhh-----------------hccCCCCC------CCC--HHHHHH--------------------------HHHHHH
Q 010882          216 GSLEDR-----------------LSCKDNSP------PLS--WQTRIR--------------------------IATELC  244 (498)
Q Consensus       216 gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~~i~  244 (498)
                      .++...                 |+......      ..+  +.....                          +...+.
T Consensus        82 ~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (302)
T cd05156          82 RTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEA  161 (302)
T ss_pred             CcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHH
Confidence            766431                 11111110      111  111100                          011122


Q ss_pred             HHHHHHHh------cCCCCcccCCCCCCcEEEcCC----CceeEeeccccc
Q 010882          245 SVLIFLHS------CKPHSIVHGDLKPANILLDAN----FVSKLSDFGISR  285 (498)
Q Consensus       245 ~~L~~LH~------~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~  285 (498)
                      ..+..|-.      ..+..++|+|+.|.|||++.+    +.+.++||+.|.
T Consensus       162 ~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         162 KYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22333432      134578999999999999974    889999999765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.53  E-value=0.00045  Score=76.83  Aligned_cols=190  Identities=23%  Similarity=0.222  Sum_probs=129.7

Q ss_pred             HHHHHHHHHcCCCCCeeeeeceecC------cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 010882          180 FQQEIDILSKIRHPNLVTLVGACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC  253 (498)
Q Consensus       180 ~~~E~~il~~l~hpniv~l~g~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  253 (498)
                      ...|...+.++.|+|++.++++.-.      ...+.-+||..-++...+.   .-..++..+.+.+..++.+||.|+|. 
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH-
Confidence            3457777888899999999887622      1234567888888888884   34567788888899999999999999 


Q ss_pred             CCCCcccCCCCCC---cEEEcCCCceeEe--eccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCc--c
Q 010882          254 KPHSIVHGDLKPA---NILLDANFVSKLS--DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK--S  326 (498)
Q Consensus       254 ~~~~ivHrDlkp~---NiLl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~  326 (498)
                        ....|.-+..+   +...+..+.+.++  ||+.+..+.........         .-+..|.+||......+..+  .
T Consensus       305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~---------~~~~~~~~~e~~~~~~~~~~r~~  373 (1351)
T KOG1035|consen  305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD---------LLAEIRNADEDLKENTAKKSRLT  373 (1351)
T ss_pred             --hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh---------cCccccccccccccccchhhhhh
Confidence              33444444433   4444556677777  89888776654432221         23556778887766655544  7


Q ss_pred             chHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          327 DVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       327 DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      |+|.+|..+..+..|..+-.........         +       +......+.+....|+..++++|++..++
T Consensus       374 dL~~lgll~~~~~~~~~i~~~~~~~~~~---------l-------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  374 DLWCLGLLLLQLSQGEDISEKSAVPVSL---------L-------DVLSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHHHHHhhhhhcCcccccccchhhh---------h-------ccccchhhhhhhhhhcchhhhhccchhhh
Confidence            9999999999999987654322211111         0       11111257788889999999999998873

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.49  E-value=0.001  Score=65.43  Aligned_cols=128  Identities=19%  Similarity=0.320  Sum_probs=79.5

Q ss_pred             eEEEEEEECCeEEEEEEecC--CCCCChhhHHHHHHHHHcCCC--CCeeeeeceecCcc----eEEEeeCCCCCHHhhhc
Q 010882          152 GSIYKGLLRHMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRH--PNLVTLVGACPEVW----TLVYEYLPNGSLEDRLS  223 (498)
Q Consensus       152 g~Vy~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h--pniv~l~g~~~~~~----~lV~E~~~~gsL~~~l~  223 (498)
                      -.+|.....++++++. ...  ..........+|..+++.+.-  .-+...++.|.+..    +.||+|++|..+.+.+.
T Consensus        39 n~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          39 NDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             cceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            3445555557778887 332  122234456788888888753  33556688886655    89999999854433221


Q ss_pred             cCCCCCCCCHHHHHHHH-HHHHHHHHHHHh--------------------------------------------------
Q 010882          224 CKDNSPPLSWQTRIRIA-TELCSVLIFLHS--------------------------------------------------  252 (498)
Q Consensus       224 ~~~~~~~l~~~~~~~i~-~~i~~~L~~LH~--------------------------------------------------  252 (498)
                      .      .+..  .+++ ..++..|.-||+                                                  
T Consensus       118 ~------~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~  189 (321)
T COG3173         118 P------ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA  189 (321)
T ss_pred             c------ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence            0      0000  1111 234444444443                                                  


Q ss_pred             cC-----CCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          253 CK-----PHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       253 ~~-----~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ..     +..++|||+.+.||+++.++-+=|.||+++..-.
T Consensus       190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            21     2468999999999999998889999999987644

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.46  E-value=0.0019  Score=65.77  Aligned_cols=80  Identities=15%  Similarity=0.069  Sum_probs=57.1

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCCC-------CChhhHHHHHHHHHcCC---CCCeeeeeceecCcceEEEee
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL-------QGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVYEY  212 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~---hpniv~l~g~~~~~~~lV~E~  212 (498)
                      .+.||.|....||+....+..|+||.-.....       .+...-..|...|..+.   ..++++++++|.+..++||||
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~  116 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY  116 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence            34689999999999887777799997652211       13344455677776664   357889999999989999999


Q ss_pred             CCC--CCHHhhh
Q 010882          213 LPN--GSLEDRL  222 (498)
Q Consensus       213 ~~~--gsL~~~l  222 (498)
                      +++  ..+.+-|
T Consensus       117 L~~~~~ilr~~L  128 (418)
T PLN02756        117 LEPPHIILRKGL  128 (418)
T ss_pred             cCCcceehhhhh
Confidence            977  2454433

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.44  E-value=6e-05  Score=72.84  Aligned_cols=148  Identities=14%  Similarity=0.169  Sum_probs=94.9

Q ss_pred             CCCChHHHHHhhc---CCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCC--C--------------------hhh
Q 010882          126 SDFSFSEIEGATH---NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ--G--------------------PSE  179 (498)
Q Consensus       126 ~~~~~~ei~~~~~---~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~--------------------~~~  179 (498)
                      .-|.+--|+....   -++++..||-|.-+.||.+.+. |.+.++|.-......  +                    .-.
T Consensus        77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla  156 (465)
T KOG2268|consen   77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA  156 (465)
T ss_pred             ccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence            3344444444333   3577889999999999999885 788888854321110  0                    012


Q ss_pred             HHHHHHHHHcCCC-C-CeeeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 010882          180 FQQEIDILSKIRH-P-NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS  257 (498)
Q Consensus       180 ~~~E~~il~~l~h-p-niv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  257 (498)
                      ..+|...|+.|.. - -|++.++.  ...++|||++.|-.|...-+-      ....+   +...+..-+--|-.   +|
T Consensus       157 a~kEfafmkaL~e~gfpVPkpiD~--~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~---~G  222 (465)
T KOG2268|consen  157 ATKEFAFMKALYERGFPVPKPIDH--NRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLAN---HG  222 (465)
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccc--cceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHH---cC
Confidence            4468888887742 1 23344443  356799999998877654321      11122   22333333344444   89


Q ss_pred             cccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          258 IVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       258 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||+|.+-=||+++.++.++++||--+...
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhhcc
Confidence            999999999999999999999999866533

>PLN02236 choline kinase

Probab=97.29  E-value=0.0016  Score=65.56  Aligned_cols=138  Identities=17%  Similarity=0.202  Sum_probs=80.0

Q ss_pred             cccccCceEEEEEEEC------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC-eeeeeceecCcceEEEeeCCCCC
Q 010882          145 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEYLPNGS  217 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~g~~~~~~~lV~E~~~~gs  217 (498)
                      .|-.|-...+|+....      +..|++|+......... .-.+|..++..+..-+ -.++++.+...  .|++|+++.+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~~  119 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHART  119 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCCC
Confidence            3545777889987653      25789998765432222 2367999988885333 33556666443  6899998876


Q ss_pred             HHhh-----------------hccCCC-CC--CCCHHHHHHHHHH-----------------HHHHHHHH----Hh-cCC
Q 010882          218 LEDR-----------------LSCKDN-SP--PLSWQTRIRIATE-----------------LCSVLIFL----HS-CKP  255 (498)
Q Consensus       218 L~~~-----------------l~~~~~-~~--~l~~~~~~~i~~~-----------------i~~~L~~L----H~-~~~  255 (498)
                      |...                 ++.... ..  +..+..+..+..+                 +...+..|    .. ..+
T Consensus       120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~  199 (344)
T PLN02236        120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE  199 (344)
T ss_pred             CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence            6421                 111110 11  1122222222211                 11112222    21 223


Q ss_pred             CCcccCCCCCCcEEEcC-CCceeEeeccccc
Q 010882          256 HSIVHGDLKPANILLDA-NFVSKLSDFGISR  285 (498)
Q Consensus       256 ~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~  285 (498)
                      ..++|+|+++.|||++. ++.+.|+||..|.
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            46899999999999986 4789999999775

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.28  E-value=0.0028  Score=63.31  Aligned_cols=78  Identities=15%  Similarity=0.114  Sum_probs=53.2

Q ss_pred             cccccCceEEEEEEECC--eEEEEEEecCC-------CCCChhhHHHHHHHHHcCC--CC-CeeeeeceecCcceEEEee
Q 010882          145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPH-------SLQGPSEFQQEIDILSKIR--HP-NLVTLVGACPEVWTLVYEY  212 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~--~~vavK~~~~~-------~~~~~~~~~~E~~il~~l~--hp-niv~l~g~~~~~~~lV~E~  212 (498)
                      .||.|....||++...+  ..|+||.-.+.       -..+.+...-|...|+...  -| .++++|.+-++...+|||+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd   81 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED   81 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence            48999999999998864  57999964321       1223456667888887764  34 4666776667777899999


Q ss_pred             CCCC-CHHhhh
Q 010882          213 LPNG-SLEDRL  222 (498)
Q Consensus       213 ~~~g-sL~~~l  222 (498)
                      ++.. .|.+.|
T Consensus        82 L~~~~ilR~~L   92 (370)
T TIGR01767        82 LSHHKIARKGL   92 (370)
T ss_pred             CccchHHHHHH
Confidence            9553 343444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF15227 zf-C3HC4_4: zinc finger of C3HC4-type, RING; PDB: 2EGP_A 2ECV_A 2ECJ_A 2YSL_A 2YSJ_A

Probab=96.97  E-value=0.00087  Score=44.89  Aligned_cols=38  Identities=21%  Similarity=0.455  Sum_probs=29.5

Q ss_pred             CCccccccCCceeccCCceecHHHHHHHHhcCCC---CCCC
Q 010882          434 CPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHE---TSPM  471 (498)
Q Consensus       434 cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~---~~p~  471 (498)
                      |||..+++.||+..+.||+|.+.+|.+|....+.   .||.
T Consensus         1 CpiC~~~~~~Pv~l~CGH~FC~~Cl~~~~~~~~~~~~~CP~   41 (42)
T PF15227_consen    1 CPICLDLFKDPVSLPCGHSFCRSCLERLWKEPSGSGFSCPE   41 (42)
T ss_dssp             ETTTTSB-SSEEE-SSSSEEEHHHHHHHHCCSSSST---SS
T ss_pred             CCccchhhCCccccCCcCHHHHHHHHHHHHccCCcCCCCcC
Confidence            7899999999999999999999999998766443   3554

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.87  E-value=0.0047  Score=56.90  Aligned_cols=151  Identities=17%  Similarity=0.159  Sum_probs=90.4

Q ss_pred             CceEEEEEEECCeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecCcceEEEeeCCCCCHHhhhccCCCC
Q 010882          150 GYGSIYKGLLRHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNS  228 (498)
Q Consensus       150 ~~g~Vy~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~  228 (498)
                      |-++.-.|..+-.+..+|++...... ...-|..+.+++.+++-  |++|..--.-.+.++.|+|-....          
T Consensus        74 gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~ArmhG--ilrL~NDn~~~yGvIlE~Cy~~~i----------  141 (308)
T PF07387_consen   74 GNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMHG--ILRLKNDNNYKYGVILERCYKIKI----------  141 (308)
T ss_pred             CceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhhh--eeEeecCCCceeEEEEeeccCccc----------
Confidence            33444444333344556666544333 44567888999888753  677764322245689999843211          


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCC
Q 010882          229 PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT  308 (498)
Q Consensus       229 ~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt  308 (498)
                        ++    ..++.-=..+|.-.|+.+ .+.+|||..|+||+-|+.|.+||.|-+..-  ..                  +
T Consensus       142 --~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~------------------~  194 (308)
T PF07387_consen  142 --NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN------------------Q  194 (308)
T ss_pred             --ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--hh------------------e
Confidence              00    111111245677788755 589999999999999999999999987432  11                  1


Q ss_pred             CCcCChhhhccCCCCCccchHhHHHHHHHHHhCC
Q 010882          309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR  342 (498)
Q Consensus       309 ~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~  342 (498)
                      ..|.--   .....+.++.+-+|-.-++++....
T Consensus       195 V~~vN~---~Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  195 VNMVNI---EYESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             eeEEee---eccccChHHHHHHHHHHHHHHHHHH
Confidence            122221   1234566777777777777776643

The function of this family is unknown.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.86  E-value=0.0043  Score=62.82  Aligned_cols=73  Identities=16%  Similarity=0.160  Sum_probs=52.1

Q ss_pred             CCcccccCceEEEEEEEC--CeEEEEEEecCC------CCCChhhHHHHHHHHHcCC--CC-CeeeeeceecCcceEEEe
Q 010882          143 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH------SLQGPSEFQQEIDILSKIR--HP-NLVTLVGACPEVWTLVYE  211 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~~~~E~~il~~l~--hp-niv~l~g~~~~~~~lV~E  211 (498)
                      ...||.|.-..||++...  +..|+||.-.+.      -..+.+...-|..+|+.+.  .| +++++|.+-++...+|||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME  113 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME  113 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence            346899999999999874  567999864321      1223456777888888774  34 566677766677789999


Q ss_pred             eCCC
Q 010882          212 YLPN  215 (498)
Q Consensus       212 ~~~~  215 (498)
                      +++.
T Consensus       114 dL~~  117 (409)
T PRK12396        114 DLSD  117 (409)
T ss_pred             hCcc
Confidence            9864

>KOG0823 consensus Predicted E3 ubiquitin ligase [Posttranslational modification, protein turnover, chaperones]

Probab=96.84  E-value=0.00075  Score=61.64  Aligned_cols=58  Identities=22%  Similarity=0.469  Sum_probs=51.4

Q ss_pred             CCCCcCCCccccccCCceeccCCceecHHHHHHHHhc--CCCCCCCCCCCCCCCCCCccH
Q 010882          428 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS--GHETSPMTNLPLAHKNLVPNL  485 (498)
Q Consensus       428 ~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~--~~~~~p~~~~~~~~~~~~pn~  485 (498)
                      .-..|.|.|+.+.-+||||+-+||=||=.||-+|++.  +...||+|+...+.+.++|=|
T Consensus        44 ~~~~FdCNICLd~akdPVvTlCGHLFCWpClyqWl~~~~~~~~cPVCK~~Vs~~~vvPlY  103 (230)
T KOG0823|consen   44 DGGFFDCNICLDLAKDPVVTLCGHLFCWPCLYQWLQTRPNSKECPVCKAEVSIDTVVPLY  103 (230)
T ss_pred             CCCceeeeeeccccCCCEEeecccceehHHHHHHHhhcCCCeeCCccccccccceEEeee
Confidence            3468999999999999999999999999999999865  455789999999998888854

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.80  E-value=0.0088  Score=58.27  Aligned_cols=30  Identities=37%  Similarity=0.676  Sum_probs=24.9

Q ss_pred             CcccCCCCCCcEEEcCCCc-eeEeecccccc
Q 010882          257 SIVHGDLKPANILLDANFV-SKLSDFGISRF  286 (498)
Q Consensus       257 ~ivHrDlkp~NiLl~~~~~-~kl~DFGla~~  286 (498)
                      .++|+|+.|.|||++.++. .-|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997554 56999997753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.77  E-value=0.0068  Score=59.99  Aligned_cols=137  Identities=18%  Similarity=0.160  Sum_probs=88.4

Q ss_pred             CCcccccCceEEEEEEE-CCeEEEEEEecCCCC--CCh--------------------h----hHHHHHHHHHcCCCCCe
Q 010882          143 SLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSL--QGP--------------------S----EFQQEIDILSKIRHPNL  195 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~--------------------~----~~~~E~~il~~l~hpni  195 (498)
                      -..|..|.-+.||.+.- .|..+|||+++..-.  .+.                    +    -..+|+.-|.+++.-.|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34688899999999887 477899999864311  111                    0    13467777877765443


Q ss_pred             eeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          196 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       196 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      .----+.-....|||+|+-+...   -.-.-....++......+-.+++.-+.-|-+.  .++||.||+--|+|+. +|.
T Consensus       229 P~PePIlLk~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-dG~  302 (520)
T KOG2270|consen  229 PCPEPILLKNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-DGK  302 (520)
T ss_pred             CCCCceeeecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-CCE
Confidence            31111112245799999843211   11111233566667777777777777777554  4699999999999996 468


Q ss_pred             eeEeeccccc
Q 010882          276 SKLSDFGISR  285 (498)
Q Consensus       276 ~kl~DFGla~  285 (498)
                      +.|+|-+-+.
T Consensus       303 lyiIDVSQSV  312 (520)
T KOG2270|consen  303 LYIIDVSQSV  312 (520)
T ss_pred             EEEEEccccc
Confidence            9999988654

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.71  E-value=0.015  Score=57.95  Aligned_cols=137  Identities=27%  Similarity=0.402  Sum_probs=82.0

Q ss_pred             ccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC---CCC---eeeeec----eecC--cceEEEeeC
Q 010882          146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR---HPN---LVTLVG----ACPE--VWTLVYEYL  213 (498)
Q Consensus       146 lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---hpn---iv~l~g----~~~~--~~~lV~E~~  213 (498)
                      |.+ .-..||+....+..+++|+....  ....++.-|...|..|.   .|=   +..+=|    ....  ..+-|++|+
T Consensus        34 l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             ccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            444 45678888777777799988765  45567777888887773   111   233322    2244  677899999


Q ss_pred             CCCCHHh-h-----------h---cc--CC----C---CCCCCHH-----------------HHHHHHHHHHHHHHHHHh
Q 010882          214 PNGSLED-R-----------L---SC--KD----N---SPPLSWQ-----------------TRIRIATELCSVLIFLHS  252 (498)
Q Consensus       214 ~~gsL~~-~-----------l---~~--~~----~---~~~l~~~-----------------~~~~i~~~i~~~L~~LH~  252 (498)
                      +|..+.. .           |   +.  .+    .   .....|.                 .+..+...+...+..+-.
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9987762 1           0   10  00    0   0112332                 222222222233333333


Q ss_pred             cCCCC---cccCCCCCCcEEEcCCCc-eeEeeccccc
Q 010882          253 CKPHS---IVHGDLKPANILLDANFV-SKLSDFGISR  285 (498)
Q Consensus       253 ~~~~~---ivHrDlkp~NiLl~~~~~-~kl~DFGla~  285 (498)
                      ..+.+   +||+|+.|.|||++.+.. +-+.|||-|.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            33445   999999999999998874 8999999764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.67  E-value=0.0099  Score=58.86  Aligned_cols=30  Identities=27%  Similarity=0.265  Sum_probs=25.8

Q ss_pred             CCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          255 PHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       255 ~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      +.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            368999999999999988 568899999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG0287 consensus Postreplication repair protein RAD18 [Replication, recombination and repair]

Probab=96.66  E-value=0.0011  Score=63.43  Aligned_cols=65  Identities=15%  Similarity=0.268  Sum_probs=60.3

Q ss_pred             CCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHH
Q 010882          430 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWL  495 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~  495 (498)
                      +-+.|-|+.+-+.-|+++++|||||.-||+.++.. ++.||.|..+.....|.-|..|-.+|+.+.
T Consensus        22 ~lLRC~IC~eyf~ip~itpCsHtfCSlCIR~~L~~-~p~CP~C~~~~~Es~Lr~n~il~Eiv~S~~   86 (442)
T KOG0287|consen   22 DLLRCGICFEYFNIPMITPCSHTFCSLCIRKFLSY-KPQCPTCCVTVTESDLRNNRILDEIVKSLN   86 (442)
T ss_pred             HHHHHhHHHHHhcCceeccccchHHHHHHHHHhcc-CCCCCceecccchhhhhhhhHHHHHHHHHH
Confidence            45679999999999999999999999999999988 999999999999999999999999988764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	498
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-49
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-49
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-48
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-46
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-43
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-43
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-37
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-24
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-23
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-23
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-22
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1t1h_A	78	Nmr Solution Structure Of The U Box Domain From Atp		2e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-06
2oxq_C	80	Structure Of The Ubch5 :chip U-Box Complex Length =		9e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
2f42_A	179	Dimerization And U-Box Domains Of Zebrafish C-Termi		2e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-05
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		3e-05
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		3e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-04
2c2l_A	281	Crystal Structure Of The Chip U-Box E3 Ubiquitin Li		1e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  192 bits (488), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 119/307 (38%), Positives = 173/307 (56%), Gaps = 31/307 (10%)
Query: 125 FSDFSFSEIEGATHNFDP------SLKIGEGGYGSIYKGLLRHMQVAIK----MLHPHSL 174
           F  FSF E++  T+NFD         K+GEGG+G +YKG + +  VA+K    M+   + 
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 175 QGPSEFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLS 232
           +   +F QEI +++K +H NLV L+G   +     LVY Y+PNGSL DRLSC D +PPLS
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
           W  R +IA    + + FLH  + H I H D+K ANILLD  F +K+SDFG++R       
Sbjct: 132 WHMRCKIAQGAANGINFLH--ENHHI-HRDIKSANILLDEAFTAKISDFGLAR------A 182
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           S         +   GT AYM PE L  GE+TPKSD+YSFG++LL ++TG PA+   +E Q
Sbjct: 183 SEKFAQTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
Query: 353 YAL--------DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
             L        +   +++ +D    D      E + ++A +C    +  RP++ K V ++
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI-KKVQQL 300
Query: 405 LEPMRAS 411
           L+ M AS
Sbjct: 301 LQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  191 bits (486), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 120/307 (39%), Positives = 175/307 (57%), Gaps = 31/307 (10%)
Query: 125 FSDFSFSEIEGATHNFDP------SLKIGEGGYGSIYKGLLRHMQVAIK----MLHPHSL 174
           F  FSF E++  T+NFD         K+GEGG+G +YKG + +  VA+K    M+   + 
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 175 QGPSEFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLS 232
           +   +F QEI +++K +H NLV L+G   +     LVY Y+PNGSL DRLSC D +PPLS
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
           W  R +IA    + + FLH  + H I H D+K ANILLD  F +K+SDFG++R   +   
Sbjct: 132 WHMRCKIAQGAANGINFLH--ENHHI-HRDIKSANILLDEAFTAKISDFGLARASEKFA- 187
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
               T +  R    GT AYM PE L  GE+TPKSD+YSFG++LL ++TG PA+   +E Q
Sbjct: 188 ---QTVMXXRI--VGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
Query: 353 YAL--------DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
             L        +   +++ +D    D      E + ++A +C    +  RP++ K V ++
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI-KKVQQL 300
Query: 405 LEPMRAS 411
           L+ M AS
Sbjct: 301 LQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 119/307 (38%), Positives = 172/307 (56%), Gaps = 31/307 (10%)
Query: 125 FSDFSFSEIEGATHNFDP------SLKIGEGGYGSIYKGLLRHMQVAIK----MLHPHSL 174
           F  FSF E++  T+NFD         K+GEGG+G +YKG + +  VA+K    M+   + 
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 65
Query: 175 QGPSEFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLS 232
           +   +F QEI +++K +H NLV L+G   +     LVY Y+PNGSL DRLSC D +PPLS
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 125
Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
           W  R +IA    + + FLH  + H I H D+K ANILLD  F +K+SDFG++R       
Sbjct: 126 WHMRCKIAQGAANGINFLH--ENHHI-HRDIKSANILLDEAFTAKISDFGLAR------A 176
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           S             GT AYM PE L  GE+TPKSD+YSFG++LL ++TG PA+   +E Q
Sbjct: 177 SEKFAQXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 235
Query: 353 YAL--------DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
             L        +   +++ +D    D      E + ++A +C    +  RP++ K V ++
Sbjct: 236 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI-KKVQQL 294
Query: 405 LEPMRAS 411
           L+ M AS
Sbjct: 295 LQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  181 bits (459), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 117/307 (38%), Positives = 167/307 (54%), Gaps = 31/307 (10%)
Query: 125 FSDFSFSEIEGATHNFDP------SLKIGEGGYGSIYKGLLRHMQVAIK----MLHPHSL 174
           F  FSF E++  T+NFD         K GEGG+G +YKG + +  VA+K    M+   + 
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 62
Query: 175 QGPSEFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLS 232
           +   +F QEI + +K +H NLV L+G   +     LVY Y PNGSL DRLSC D +PPLS
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLS 122
Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
           W  R +IA    + + FLH  + H I H D+K ANILLD  F +K+SDFG++R       
Sbjct: 123 WHXRCKIAQGAANGINFLH--ENHHI-HRDIKSANILLDEAFTAKISDFGLAR------A 173
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           S         +   GT AY  PE L  GE+TPKSD+YSFG++LL ++TG PA+   +E Q
Sbjct: 174 SEKFAQXVXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 232
Query: 353 YAL--------DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
             L        +   +++ +D    D      E   ++A +C    +  RP++ K V ++
Sbjct: 233 LLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDI-KKVQQL 291
Query: 405 LEPMRAS 411
           L+   AS
Sbjct: 292 LQEXTAS 298

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 116/314 (36%), Positives = 180/314 (57%), Gaps = 24/314 (7%)
Query: 111 SRKEASSSSHMPQFFS-DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKM 168
           S  +A SSS++  F S      ++E AT+NFD    IG G +G +YKG+LR   +VA+K 
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 169 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKD 226
             P S QG  EF+ EI+ LS  RHP+LV+L+G C E     L+Y+Y+ NG+L+  L   D
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 227 -NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 285
             +  +SW+ R+ I       L +LH+    +I+H D+K  NILLD NFV K++DFGIS+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
                E+   +         KGT  Y+DPE+   G LT KSDVYSFG++L  +L  R A+
Sbjct: 188 --KGTELDQTHLXXVV----KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 346 --GITKEV----QYALDT---GKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
              + +E+    ++A+++   G+L+ ++DP LA         +  + A++C  +S + RP
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 396 ELGKDVWRVLEPMR 409
            +G  +W++   +R
Sbjct: 302 SMGDVLWKLEYALR 315

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 116/314 (36%), Positives = 180/314 (57%), Gaps = 24/314 (7%)
Query: 111 SRKEASSSSHMPQFFS-DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKM 168
           S  +A SSS++  F S      ++E AT+NFD    IG G +G +YKG+LR   +VA+K 
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 169 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKD 226
             P S QG  EF+ EI+ LS  RHP+LV+L+G C E     L+Y+Y+ NG+L+  L   D
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 227 -NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 285
             +  +SW+ R+ I       L +LH+    +I+H D+K  NILLD NFV K++DFGIS+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
                E+   +         KGT  Y+DPE+   G LT KSDVYSFG++L  +L  R A+
Sbjct: 188 --KGTELGQTHLXXVV----KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 346 --GITKEV----QYALDT---GKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
              + +E+    ++A+++   G+L+ ++DP LA         +  + A++C  +S + RP
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 396 ELGKDVWRVLEPMR 409
            +G  +W++   +R
Sbjct: 302 SMGDVLWKLEYALR 315

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 105/311 (33%), Positives = 164/311 (52%), Gaps = 28/311 (9%)
Query: 114 EASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPH 172
           E     H+ Q    FS  E++ A+ NF     +G GG+G +YKG L     VA+K L   
Sbjct: 15  EEDPEVHLGQL-KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 73
Query: 173 SLQGPS-EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK-DNS 228
             QG   +FQ E++++S   H NL+ L G C  P    LVY Y+ NGS+   L  + ++ 
Sbjct: 74  RXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 133
Query: 229 PPLSWQTRIRIATELCSVLIFLHS-CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 287
           PPL W  R RIA      L +LH  C P  I+H D+K ANILLD  F + + DFG+++ +
Sbjct: 134 PPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLM 192
Query: 288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 347
              +              +GT  ++ PE+L++G+ + K+DV+ +G++LL L+TG+ A  +
Sbjct: 193 DYKDXHVXXAV-------RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 245
Query: 348 TK-----------EVQYALDTGKLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
            +            V+  L   KL+ L+D  L G++   + EQL  +A+ C + S   RP
Sbjct: 246 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 305
Query: 396 ELGKDVWRVLE 406
           ++  +V R+LE
Sbjct: 306 KM-SEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 163/311 (52%), Gaps = 28/311 (9%)
Query: 114 EASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ-VAIKMLHPH 172
           E     H+ Q    FS  E++ A+ NF     +G GG+G +YKG L     VA+K L   
Sbjct: 7   EEDPEVHLGQL-KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEE 65
Query: 173 SLQGPS-EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK-DNS 228
             QG   +FQ E++++S   H NL+ L G C  P    LVY Y+ NGS+   L  + ++ 
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 229 PPLSWQTRIRIATELCSVLIFLHS-CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 287
           PPL W  R RIA      L +LH  C P  I+H D+K ANILLD  F + + DFG+++ +
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 347
              +              +G   ++ PE+L++G+ + K+DV+ +G++LL L+TG+ A  +
Sbjct: 185 DYKDXHVXXAV-------RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237
Query: 348 TK-----------EVQYALDTGKLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
            +            V+  L   KL+ L+D  L G++   + EQL  +A+ C + S   RP
Sbjct: 238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297
Query: 396 ELGKDVWRVLE 406
           ++  +V R+LE
Sbjct: 298 KM-SEVVRMLE 307

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 109/218 (50%), Gaps = 13/218 (5%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTLVGAC 202
           KIG G +G++++       VA+K+L          +EF +E+ I+ ++RHPN+V  +GA 
Sbjct: 44  KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P   ++V EYL  GSL   L        L  + R+ +A ++   + +LH+  P  IVH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVH 162
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            +LK  N+L+D  +  K+ DFG+SR  +   +SS +          GT  +M PE L   
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--------GTPEWMAPEVLRDE 214
Query: 321 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 358
               KSDVYSFG+IL  L T +   G     Q     G
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 252

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTLVGAC 202
           KIG G +G++++       VA+K+L          +EF +E+ I+ ++RHPN+V  +GA 
Sbjct: 44  KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P   ++V EYL  GSL   L        L  + R+ +A ++   + +LH+  P  IVH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVH 162
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLK  N+L+D  +  K+ DFG+SR  +   + S            GT  +M PE L   
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA--------GTPEWMAPEVLRDE 214
Query: 321 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 358
               KSDVYSFG+IL  L T +   G     Q     G
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 252

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 138/310 (44%), Gaps = 42/310 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV 205
           +G G +G + K   R   VAIK +   S +    F  E+  LS++ HPN+V L GAC   
Sbjct: 16  VGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKP 265
             LV EY   GSL + L   +  P  +    +    +    + +LHS +P +++H DLKP
Sbjct: 74  VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133
Query: 266 ANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTP 324
            N+LL A   V K+ DFG +  + Q  +++N          KG+ A+M PE       + 
Sbjct: 134 PNLLLVAGGTVLKICDFGTACDI-QTHMTNN----------KGSAAWMAPEVFEGSNYSE 182
Query: 325 KSDVYSFGIILLRLLT--------GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 376
           K DV+S+GIIL  ++T        G PA  I   V        +KNL  P          
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP---------- 232
Query: 377 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPI 436
             + +L  RC       RP + + V  +   MR        Y  G++E  + P   + P 
Sbjct: 233 --IESLMTRCWSKDPSQRPSMEEIVKIMTHLMR--------YFPGADEPLQYPCQHSLPP 282
Query: 437 FQEVMQDPHV 446
            ++   +P+V
Sbjct: 283 GEDGRVEPYV 292

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 138/310 (44%), Gaps = 42/310 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV 205
           +G G +G + K   R   VAIK +   S +    F  E+  LS++ HPN+V L GAC   
Sbjct: 17  VGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLNP 74
Query: 206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKP 265
             LV EY   GSL + L   +  P  +    +    +    + +LHS +P +++H DLKP
Sbjct: 75  VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 134
Query: 266 ANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTP 324
            N+LL A   V K+ DFG +  + Q  +++N          KG+ A+M PE       + 
Sbjct: 135 PNLLLVAGGTVLKICDFGTACDI-QTHMTNN----------KGSAAWMAPEVFEGSNYSE 183
Query: 325 KSDVYSFGIILLRLLT--------GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 376
           K DV+S+GIIL  ++T        G PA  I   V        +KNL  P          
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP---------- 233
Query: 377 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPI 436
             + +L  RC       RP + + V  +   MR        Y  G++E  + P   + P 
Sbjct: 234 --IESLMTRCWSKDPSQRPSMEEIVKIMTHLMR--------YFPGADEPLQYPCQHSLPP 283
Query: 437 FQEVMQDPHV 446
            ++   +P+V
Sbjct: 284 GEDGRVEPYV 293

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 139/281 (49%), Gaps = 32/281 (11%)
Query: 145 KIGEGGYGSIY--KGLLRHMQVAIKMLH--PHSLQGP-SEFQQEIDILSKIRHPNLVTLV 199
           K+G GG  ++Y  +  + +++VAIK +   P   +     F++E+   S++ H N+V+++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
               E   + LV EY+   +L + +   ++  PLS  T I    ++   +   H  +   
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           IVH D+KP NIL+D+N   K+ DFGI++ LS+  ++  N  L       GT  Y  PE  
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-------GTVQYFSPE-Q 183
Query: 318 ASGELTPK-SDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLDPLAGDWPFV 374
           A GE T + +D+YS GI+L  +L G P       V  A+      + N+   +  D P  
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP-- 241
Query: 375 QAEQLANLAMRCCEMSRKSR----PELGKDVWRVLEPMRAS 411
             + L+N+ +R  E  + +R     E+  D+  VL   RA+
Sbjct: 242 --QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 31/258 (12%)
Query: 145 KIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G ++     +H +VA+K + P S+   + F  E +++  ++H  LV L     
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 80
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E   ++ E++  GSL D L   + S  PL     I  + ++   + F+      + +H 
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHR 135
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+ A+ V K++DFG++R +  NE ++       R   K    +  PE +  G 
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 188
Query: 322 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQ 378
            T KSDV+SFGI+L+ ++T GR P  G++  EV  AL+ G       P   + P    E+
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----PRPENCP----EE 240
Query: 379 LANLAMRCCEMSRKSRPE 396
           L N+ MRC     K+RPE
Sbjct: 241 LYNIMMRCW----KNRPE 254

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ KIRH  LV L    
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 191
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 192 FTIKSDVWSFGILLTELTT 210

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/213 (34%), Positives = 113/213 (53%), Gaps = 30/213 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-------FQQEIDILSKIRHPNL 195
           +IG+GG+G ++KG L   +  VAIK L     +G +E       FQ+E+ I+S + HPN+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 196 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           V L G       +V E++P G L  RL   D + P+ W  ++R+  ++   + ++ +  P
Sbjct: 86  VKLYGLMHNPPRMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 256 HSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
             IVH DL+  NI L     +A   +K++DFG    LSQ  + S +  L       G F 
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFG----LSQQSVHSVSGLL-------GNFQ 191
Query: 311 YMDPEFLASGE--LTPKSDVYSFGIILLRLLTG 341
           +M PE + + E   T K+D YSF +IL  +LTG
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 17  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 131
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 184
Query: 322 LTPKSDVYSFGIILLRLLT-GR 342
            T KSDV+SFGI+L  L T GR
Sbjct: 185 FTIKSDVWSFGILLTELTTKGR 206

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 31/258 (12%)
Query: 145 KIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G ++     +H +VA+K + P S+   + F  E +++  ++H  LV L     
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 253
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E   ++ E++  GSL D L   + S  PL     I  + ++   + F+      + +H 
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHR 308
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+ A+ V K++DFG++R +  NE ++       R   K    +  PE +  G 
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 361
Query: 322 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQ 378
            T KSDV+SFGI+L+ ++T GR P  G++  EV  AL+ G       P   + P    E+
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----PRPENCP----EE 413
Query: 379 LANLAMRCCEMSRKSRPE 396
           L N+ MRC     K+RPE
Sbjct: 414 LYNIMMRCW----KNRPE 427

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 14  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 128
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTA-------RQGAKFPIKWTAPEAALYGR 181
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 182 FTIKSDVWSFGILLTELTT 200

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 357
Query: 322 LTPKSDVYSFGIILLRLLT-GR 342
            T KSDV+SFGI+L  L T GR
Sbjct: 358 FTIKSDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 357
Query: 322 LTPKSDVYSFGIILLRLLT-GR 342
            T KSDV+SFGI+L  L T GR
Sbjct: 358 FTIKSDVWSFGILLTELTTKGR 379

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 440
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 441 FTIKSDVWSFGILLTELTT 459

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 357
Query: 322 LTPKSDVYSFGIILLRLLT-GR 342
            T KSDV+SFGI+L  L T GR
Sbjct: 358 FTIKSDVWSFGILLTELTTKGR 379

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTA-------RQGAKFPIKWTAPEAALYGR 191
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 192 FTIKSDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 191
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 192 FTIKSDVWSFGILLTELTT 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 191
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 192 FTIKSDVWSFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 15  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 129
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 182
Query: 322 LTPKSDVYSFGIILLRLLT-GR 342
            T KSDV+SFGI+L  L T GR
Sbjct: 183 FTIKSDVWSFGILLTELTTKGR 204

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 13  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 127
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 180
Query: 322 LTPKSDVYSFGIILLRLLT-GR 342
            T KSDV+SFGI+L  L T GR
Sbjct: 181 FTIKSDVWSFGILLTELTTKGR 202

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 191
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 192 FTIKSDVWSFGILLTELTT 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P  + +V EY+P G+L D L  + N   ++    + +AT++ S + +L   +  + +
Sbjct: 98  TLEPPFY-IVTEYMPYGNLLDYLR-ECNREEVTAVVLLYMATQISSAMEYL---EKKNFI 152
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N V K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 205
Query: 320 GELTPKSDVYSFGIILLRLLT 340
              + KSDV++FG++L  + T
Sbjct: 206 NTFSIKSDVWAFGVLLWEIAT 226

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 21  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + ++ ++ S + ++      + VH 
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLK-GETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 188
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 189 FTIKSDVWSFGILLTELTT 207

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 37/271 (13%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-------FQQEIDILSKIRHPNL 195
           +IG+GG+G ++KG L   +  VAIK L     +G +E       FQ+E+ I+S + HPN+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 196 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           V L G       +V E++P G L  RL   D + P+ W  ++R+  ++   + ++ +  P
Sbjct: 86  VKLYGLMHNPPRMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 256 HSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
             IVH DL+  NI L     +A   +K++DFG     SQ  + S +  L       G F 
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGT----SQQSVHSVSGLL-------GNFQ 191
Query: 311 YMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL--DP 366
           +M PE + + E   T K+D YSF +IL  +LTG          +Y+    K  N++  + 
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EYSYGKIKFINMIREEG 246
Query: 367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
           L    P     +L N+   C     K RP  
Sbjct: 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHF 277

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 21  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + ++ ++ S + ++      + VH 
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLK-GETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTA-------RQGAKFPIKWTAPEAALYGR 188
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 189 FTIKSDVWSFGILLTELTT 207

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 191 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 305
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG+ R +  NE ++       R   K    +  PE    G 
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 358
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 359 FTIKSDVWSFGILLTELTT 377

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL  ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 191
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 192 FTIKSDVWSFGILLTELTT 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 112/213 (52%), Gaps = 30/213 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-------FQQEIDILSKIRHPNL 195
           +IG+GG+G ++KG L   +  VAIK L     +G +E       FQ+E+ I+S + HPN+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 196 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           V L G       +V E++P G L  RL   D + P+ W  ++R+  ++   + ++ +  P
Sbjct: 86  VKLYGLMHNPPRMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 256 HSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
             IVH DL+  NI L     +A   +K++DF     LSQ  + S +  L       G F 
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFS----LSQQSVHSVSGLL-------GNFQ 191
Query: 311 YMDPEFLASGE--LTPKSDVYSFGIILLRLLTG 341
           +M PE + + E   T K+D YSF +IL  +LTG
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  G L D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 191
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 192 FTIKSDVWSFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 144 LKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L    
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 203 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E    +V EY+  G L D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 191
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  L T
Sbjct: 192 FTIKSDVWSFGILLTELTT 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 203 PEV--WTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   +S    + +AT++ S + +L      + +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---KNFI 131
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TFTAHAGAKFPIKWTAPESLAY 184
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 20/202 (9%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 203 ---PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              P  + ++ E++  G+L D L  C  N   +S    + +AT++ S + +L   +  + 
Sbjct: 79  TREPPFYIII-EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLA 185
Query: 319 SGELTPKSDVYSFGIILLRLLT 340
             + + KSDV++FG++L  + T
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 20/202 (9%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 203 ---PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              P  + ++ E++  G+L D L  C  N   +S    + +AT++ S + +L   +  + 
Sbjct: 79  TREPPFYIII-EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLA 185
Query: 319 SGELTPKSDVYSFGIILLRLLT 340
             + + KSDV++FG++L  + T
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 203 PE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   +S    + +AT++ S + +L      + +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---KNFI 138
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 191
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 203 PEV--WTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   +S    + +AT++ S + +L   +  + +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 186
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 203 PEV--WTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   +S    + +AT++ S + +L   +  + +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 186
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P  + ++ E++  G+L D L  + N   +S    + +AT++ S + +L   +  + +
Sbjct: 77  TREPPFYIII-EFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TXTAHAGAKFPIKWTAPESLAY 184
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 203 PEV--WTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   ++    + +AT++ S + +L   +  + +
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYL---EKKNFI 146
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 199
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 200 NKFSIKSDVWAFGVLLWEIAT 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 203 PEV--WTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   ++    + +AT++ S + +L   +  + +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 188
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 203 PE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   ++    + +AT++ S + +L      + +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK---KNFI 138
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 191
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 203 PEV--WTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   ++    + +AT++ S + +L   +  + +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 188
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 20/202 (9%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 203 ---PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              P  + ++ E++  G+L D L  C  N   ++    + +AT++ S + +L      + 
Sbjct: 80  TREPPFYIII-EFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK---KNF 133
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TXTAHAGAKFPIKWTAPESLA 186
Query: 319 SGELTPKSDVYSFGIILLRLLT 340
             + + KSDV++FG++L  + T
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G +G +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 203 PEV--WTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   +S    + +AT++ S + +L      + +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---KNFI 131
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TXTAHAGAKFPIKWTAPESLAY 184
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 20/202 (9%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 203 ---PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              P  + ++ E++  G+L D L  C  N   ++    + +AT++ S + +L      + 
Sbjct: 84  TREPPFYIII-EFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK---KNF 137
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLA 190
Query: 319 SGELTPKSDVYSFGIILLRLLT 340
             + + KSDV++FG++L  + T
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 109/200 (54%), Gaps = 16/200 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 203 PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                + ++ E++  G+L D L  + N   ++    + +AT++ S + +L   +  + +H
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA  
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAYN 187
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSDV++FG++L  + T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 16/200 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 203 PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                + ++ E++  G+L D L  + N   ++    + +AT++ S + +L      + +H
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 138
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA  
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAYN 191
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSDV++FG++L  + T
Sbjct: 192 KFSIKSDVWAFGVLLWEIAT 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 16/200 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 203 PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                + ++ E++  G+L D L  + N   ++    + +AT++ S + +L      + +H
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA  
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAYN 192
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSDV++FG++L  + T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 16/200 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 203 PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                + ++ E++  G+L D L  + N   ++    + +AT++ S + +L      + +H
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA  
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-------TXTAHAGAKFPIKWTAPESLAYN 192
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSDV++FG++L  + T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 203 PE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   ++    + +AT++ S + +L      + +
Sbjct: 80  TREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK---KNFI 134
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAPAGAKFPIKWTAPESLAY 187
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 188 NKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 16/200 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 203 PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                + ++ E++  G+L D L  + N   ++    + +AT++ S + +L      + +H
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA  
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAYN 187
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSDV++FG++L  + T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 203 PE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   ++    + +AT++ S + +L      + +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK---KNFI 135
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DL   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAPAGAKFPIKWTAPESLAY 188
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 203 PE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   +S    + +AT++ S + +L   +  + +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H +L   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 393
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    + +VAIK L P ++  P  F +E  I+ K++H  LV L     
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS-PESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 204 E-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
           E    +V EY+  GSL D L   +    L     + +A ++ + + ++      + +H D
Sbjct: 75  EEPIYIVTEYMNKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIHRD 130
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+    + K++DFG++R +  NE ++       R   K    +  PE    G  
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTA-------RQGAKFPIKWTAPEAALYGRF 183
Query: 323 TPKSDVYSFGIILLRLLT-GR 342
           T KSDV+SFGI+L  L+T GR
Sbjct: 184 TIKSDVWSFGILLTELVTKGR 204

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 84  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 139
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 192
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 193 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 231

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 140
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 193
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 232

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 140
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXTA-------REGAKFPIKWTAPEAINYGTF 193
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 232

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L        L+    + +A ++   + F+      + +H D
Sbjct: 87  QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE---RNYIHRD 142
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXTA-------REGAKFPIKWTAPEAINYGTF 195
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 196 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 234

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 80  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 135
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTA-------REGAKFPIKWTAPEAINYGTF 188
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 189 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 227

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 89  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 144
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 197
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 198 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 236

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTA-------REGAKFPIKWTAPEAINYGTF 187
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 74  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 129
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 182
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 183 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L        L+    + +A ++   + F+      + +H D
Sbjct: 88  QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE---RNYIHRD 143
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXTA-------REGAKFPIKWTAPEAINYGTF 196
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 197 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 235

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 81  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 136
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTA-------REGAKFPIKWTAPEAINYGTF 189
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 190 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 228

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTA-------REGAKFPIKWTAPEAINYGTF 187
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 203 PE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                + ++ E++  G+L D L  C  N   ++    + +AT++ S + +L   +  + +
Sbjct: 325 TREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYL---EKKNFI 379
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H +L   N L+  N + K++DFG+SR ++ +       T       K    +  PE LA 
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLAY 432
Query: 320 GELTPKSDVYSFGIILLRLLT 340
            + + KSDV++FG++L  + T
Sbjct: 433 NKFSIKSDVWAFGVLLWEIAT 453

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 187
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 33/266 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 31  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 86
Query: 200 G--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +       +  I IA +    + +LH+    S
Sbjct: 87  GYSTAPQL-AIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KS 140
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS------GSILWMAPEVI 194
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITKEVQY--ALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    Q    +  G L   L  +  + 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 372 PFVQAEQLANLAMRCCEMSRKSRPEL 397
           P    +++  L   C +  R  RP  
Sbjct: 255 P----KRMKRLMAECLKKKRDERPSF 276

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 129/282 (45%), Gaps = 33/282 (11%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 19  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 74
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +       +  I IA +    + +LH+    S
Sbjct: 75  GYSTKPQL-AIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KS 128
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVI 182
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITKEVQY--ALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    Q    +  G L   L  +  + 
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 242
Query: 372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 413
           P    +++  L   C +  R  RP   + +  + E  R   G
Sbjct: 243 P----KRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG 280

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 16/199 (8%)
Query: 145 KIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           +IG G +G ++ G  L   +VAIK +   ++    +F +E +++ K+ HP LV L G C 
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           E     LV+E++ +G L D L  +      + +T + +  ++C  + +L      S++H 
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---SVIHR 127
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N L+  N V K+SDFG++RF+  ++ +S+  T       K    +  PE  +   
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 180
Query: 322 LTPKSDVYSFGIILLRLLT 340
            + KSDV+SFG+++  + +
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 128/258 (49%), Gaps = 41/258 (15%)
Query: 145 KIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G ++     +H +VA+K + P S+   + F  E +++  ++H  LV L     
Sbjct: 189 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 247
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
            E   ++ E++  GSL D L   + S  PL     I  + ++   + F+      + +H 
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHR 302
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+ A+ V K++DFG++R  ++  I                  +  PE +  G 
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKFPIK-----------------WTAPEAINFGS 345
Query: 322 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQ 378
            T KSDV+SFGI+L+ ++T GR P  G++  EV  AL+ G       P   + P    E+
Sbjct: 346 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----PRPENCP----EE 397
Query: 379 LANLAMRCCEMSRKSRPE 396
           L N+ MRC     K+RPE
Sbjct: 398 LYNIMMRCW----KNRPE 411

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 132/275 (48%), Gaps = 31/275 (11%)
Query: 146 IGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 198
           IG G +G +YKG+L+       + VAIK L   ++ +   +F  E  I+ +  H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 199 VGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
            G   +     ++ EY+ NG+L+  L  KD    +     +++   L  +   +      
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSV-----LQLVGMLRGIAAGMKYLANM 166
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           + VH DL   NIL+++N V K+SDFG+SR L  +  ++  T     +  K    +  PE 
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT-----SGGKIPIRWTAPEA 221
Query: 317 LASGELTPKSDVYSFGIILLRLLTG--RPALGITK-EVQYALDTGKLKNLLDPLAGDWPF 373
           ++  + T  SDV+SFGI++  ++T   RP   ++  EV  A++ G       P   D P 
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG----FRLPTPMDCP- 276
Query: 374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
                +  L M+C +  R  RP+   D+  +L+ +
Sbjct: 277 ---SAIYQLMMQCWQQERARRPKFA-DIVSILDKL 307

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 129/282 (45%), Gaps = 33/282 (11%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 31  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 86
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +       +  I IA +    + +LH+    S
Sbjct: 87  GYSTKPQL-AIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KS 140
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS------GSILWMAPEVI 194
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITKEVQY--ALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    Q    +  G L   L  +  + 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 413
           P    +++  L   C +  R  RP   + +  + E  R   G
Sbjct: 255 P----KRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG 292

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H +
Sbjct: 75  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRN 130
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G  
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 183
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 184 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 222

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 15  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 70
Query: 200 G--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 71  GYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 124
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVI 178
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 239 P----KAMKRLMAECLKKKRDERP 258

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 42  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 97
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 98  GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 151
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVI 205
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 265
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 266 P----KAMKRLMAECLKKKRDERP 285

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 43  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 98
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 99  GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 152
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVI 206
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 266
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 267 P----KAMKRLMAECLKKKRDERP 286

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 20  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 75
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 76  GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 129
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVI 183
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 244 P----KAMKRLMAECLKKKRDERP 263

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 145 KIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           +IG G +G ++ G  L   +VAIK +   S+    +F +E +++ K+ HP LV L G C 
Sbjct: 34  EIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS-EDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           E     LV+E++ +G L D L  +      + +T + +  ++C  + +L       ++H 
Sbjct: 93  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 147
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N L+  N V K+SDFG++RF+  ++ +S+  T       K    +  PE  +   
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 200
Query: 322 LTPKSDVYSFGIILLRLLT 340
            + KSDV+SFG+++  + +
Sbjct: 201 YSSKSDVWSFGVLMWEVFS 219

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 145 KIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           +IG G +G ++ G  L   +VAIK +   ++    +F +E +++ K+ HP LV L G C 
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           E     LV+E++ +G L D L  +      + +T + +  ++C  + +L       ++H 
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 127
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N L+  N V K+SDFG++RF+  ++ +S+  T       K    +  PE  +   
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 180
Query: 322 LTPKSDVYSFGIILLRLLT 340
            + KSDV+SFG+++  + +
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 110/240 (45%), Gaps = 39/240 (16%)
Query: 119 SHM--PQFFSD-FSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHS 173
           SHM  P   SD +   EI            +G GG   ++  + L  H  VA+K+L    
Sbjct: 2   SHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRADL 49
Query: 174 LQGPS---EFQQEIDILSKIRHPNLVTLVGACPEVWT-------LVYEYLPNGSLEDRLS 223
            + PS    F++E    + + HP +V  V A  E  T       +V EY+   +L D + 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVA-VYATGEAETPAGPLPYIVMEYVDGVTLRDIVH 108
Query: 224 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 283
            +    P++ +  I +  + C  L F H    + I+H D+KPANI++ A    K+ DFGI
Sbjct: 109 TEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           +R ++ +  S   T         GT  Y+ PE      +  +SDVYS G +L  +LTG P
Sbjct: 163 ARAIADSGNSVTQTAAVI-----GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 17  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 72
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 73  GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 126
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVI 180
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 240
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 241 P----KAMKRLMAECLKKKRDERP 260

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 20  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 75
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 76  GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 129
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVI 183
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 244 P----KAMKRLMAECLKKKRDERP 263

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 145 KIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           +IG G +G ++ G  L   +VAIK +   ++    +F +E +++ K+ HP LV L G C 
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           E     LV+E++ +G L D L  +      + +T + +  ++C  + +L       ++H 
Sbjct: 76  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 130
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N L+  N V K+SDFG++RF+  ++ +S+  T       K    +  PE  +   
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 183
Query: 322 LTPKSDVYSFGIILLRLLT 340
            + KSDV+SFG+++  + +
Sbjct: 184 YSSKSDVWSFGVLMWEVFS 202

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 15  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 70
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 71  GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 124
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVI 178
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 239 P----KAMKRLMAECLKKKRDERP 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 145 KIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           +IG G +G ++ G  L   +VAIK +   ++    +F +E +++ K+ HP LV L G C 
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           E     LV+E++ +G L D L  +      + +T + +  ++C  + +L       ++H 
Sbjct: 71  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 125
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N L+  N V K+SDFG++RF+  ++ +S+  T       K    +  PE  +   
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 178
Query: 322 LTPKSDVYSFGIILLRLLT 340
            + KSDV+SFG+++  + +
Sbjct: 179 YSSKSDVWSFGVLMWEVFS 197

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 119 SHM--PQFFSD-FSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHS 173
           SHM  P   SD +   EI            +G GG   ++  + L  H  VA+K+L    
Sbjct: 2   SHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRADL 49
Query: 174 LQGPS---EFQQEIDILSKIRHPNLV---------TLVGACPEVWTLVYEYLPNGSLEDR 221
            + PS    F++E    + + HP +V         T  G  P +   V EY+   +L D 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI---VMEYVDGVTLRDI 106
Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 281
           +  +    P++ +  I +  + C  L F H    + I+H D+KPANIL+ A    K+ DF
Sbjct: 107 VHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANILISATNAVKVVDF 160
Query: 282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           GI+R ++ +  S   T         GT  Y+ PE      +  +SDVYS G +L  +LTG
Sbjct: 161 GIARAIADSGNSVXQTAAVI-----GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
Query: 342 RP 343
            P
Sbjct: 216 EP 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 119 SHM--PQFFSD-FSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHS 173
           SHM  P   SD +   EI            +G GG   ++  + L  H  VA+K+L    
Sbjct: 2   SHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRADL 49
Query: 174 LQGPS---EFQQEIDILSKIRHPNLV---------TLVGACPEVWTLVYEYLPNGSLEDR 221
            + PS    F++E    + + HP +V         T  G  P +   V EY+   +L D 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI---VMEYVDGVTLRDI 106
Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 281
           +  +    P++ +  I +  + C  L F H    + I+H D+KPANI++ A    K+ DF
Sbjct: 107 VHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDF 160
Query: 282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           GI+R ++ +  S   T         GT  Y+ PE      +  +SDVYS G +L  +LTG
Sbjct: 161 GIARAIADSGNSVTQTAAVI-----GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
Query: 342 RP 343
            P
Sbjct: 216 EP 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 119 SHM--PQFFSD-FSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHS 173
           SHM  P   SD +   EI            +G GG   ++  + L  H  VA+K+L    
Sbjct: 2   SHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRADL 49
Query: 174 LQGPS---EFQQEIDILSKIRHPNLV---------TLVGACPEVWTLVYEYLPNGSLEDR 221
            + PS    F++E    + + HP +V         T  G  P +   V EY+   +L D 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI---VMEYVDGVTLRDI 106
Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 281
           +  +    P++ +  I +  + C  L F H    + I+H D+KPANI++ A    K+ DF
Sbjct: 107 VHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDF 160
Query: 282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           GI+R ++ +  S   T         GT  Y+ PE      +  +SDVYS G +L  +LTG
Sbjct: 161 GIARAIADSGNSVTQTAAVI-----GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
Query: 342 RP 343
            P
Sbjct: 216 EP 217

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 35  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 90
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 91  GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 144
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS------GSILWMAPEVI 198
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 258
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 259 P----KAMKRLMAECLKKKRDERP 278

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 43  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 98
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 99  GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 152
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS------GSILWMAPEVI 206
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 266
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 267 P----KAMKRLMAECLKKKRDERP 286

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 119 SHM--PQFFSD-FSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHS 173
           SHM  P   SD +   EI            +G GG   ++  + L  H  VA+K+L    
Sbjct: 2   SHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRADL 49
Query: 174 LQGPS---EFQQEIDILSKIRHPNLV---------TLVGACPEVWTLVYEYLPNGSLEDR 221
            + PS    F++E    + + HP +V         T  G  P +   V EY+   +L D 
Sbjct: 50  ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI---VMEYVDGVTLRDI 106
Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 281
           +  +    P++ +  I +  + C  L F H    + I+H D+KPANI++ A    K+ DF
Sbjct: 107 VHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDF 160
Query: 282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           GI+R ++ +  S   T         GT  Y+ PE      +  +SDVYS G +L  +LTG
Sbjct: 161 GIARAIADSGNSVTQTAAVI-----GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
Query: 342 RP 343
            P
Sbjct: 216 EP 217

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 42/304 (13%)
Query: 121 MPQFFSDFSFSEIEGATHNFDPSLKI---------GEGGYGSIYKGLL-----RHMQVAI 166
           M  F   F+F +   A   F   + I         G G +G +  G L     R + VAI
Sbjct: 7   MKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAI 66
Query: 167 KMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLS 223
           K L   ++ +   +F  E  I+ +  HPN++ L G   +     ++ E++ NGSL+  L 
Sbjct: 67  KTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR 126
Query: 224 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 283
             D        T I++   L  +   +      + VH DL   NIL+++N V K+SDFG+
Sbjct: 127 QNDGQ-----FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL 181
Query: 284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-- 341
           SRFL   E  +++ T       K    +  PE +   + T  SDV+S+GI++  +++   
Sbjct: 182 SRFL---EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 238
Query: 342 RPALGITKEVQYALDTGKLKNLLDPLAGDW----PFVQAEQLANLAMRCCEMSRKSRPEL 397
           RP   +T +           ++++ +  D+    P      L  L + C +  R  RP+ 
Sbjct: 239 RPYWDMTNQ-----------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 287
Query: 398 GKDV 401
           G+ V
Sbjct: 288 GQIV 291

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 120/269 (44%), Gaps = 39/269 (14%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE----FQQEIDILSKIRHPNLVTLVGA 201
           IG GG+G +Y+      +VA+K       +  S+     +QE  + + ++HPN++ L G 
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           C   P +  LV E+   G L   LS K   P       +  A ++   + +LH      I
Sbjct: 75  CLKEPNL-CLVMEFARGGPLNRVLSGKRIPP----DILVNWAVQIARGMNYLHDEAIVPI 129
Query: 259 VHGDLKPANILLD--------ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           +H DLK +NIL+         +N + K++DFG++R         + TT   +    G +A
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-------EWHRTT---KMSAAGAYA 179
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITK-EVQYALDTGKLKNLLDPLA 368
           +M PE + +   +  SDV+S+G++L  LLTG  P  GI    V Y +   K       LA
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-------LA 232
Query: 369 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
              P    E  A L   C      SRP  
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSF 261

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++YKG   H  VA+KML+     P  LQ    F+ E+ +L K RH N++  +
Sbjct: 15  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNILLFM 70
Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G    P++  +V ++    SL   L   +    +     I IA +    + +LH+    S
Sbjct: 71  GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KS 124
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS------GSILWMAPEVI 178
Query: 318 ASGELTP---KSDVYSFGIILLRLLTGR-PALGITK--EVQYALDTGKLKNLLDPLAGDW 371
              +  P   +SDVY+FGI+L  L+TG+ P   I    ++ + +  G L   L  +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    + +  L   C +  R  RP
Sbjct: 239 P----KAMKRLMAECLKKKRDERP 258

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 138/301 (45%), Gaps = 44/301 (14%)
Query: 124 FFSDFSFSEIEGATHNFDPSLK---------IGEGGYGSIYKGLL-----RHMQVAIKML 169
           F   F+F +   A   F   +          IG G +G +  G L     R + VAIK L
Sbjct: 6   FVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL 65
Query: 170 HP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGA---CPEVWTLVYEYLPNGSLEDRLSCK 225
              ++ +   +F  E  I+ +  HPN++ L G    C  V  ++ EY+ NGSL+  L   
Sbjct: 66  KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPV-MIITEYMENGSLDAFLRKN 124
Query: 226 DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 285
           D        T I++   L  +   +      S VH DL   NIL+++N V K+SDFG+SR
Sbjct: 125 DGR-----FTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSR 179
Query: 286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRP 343
            L  +  ++  T        K    +  PE +A  + T  SDV+S+GI++  +++   RP
Sbjct: 180 VLEDDPEAAYTT-----RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234
Query: 344 ALGIT-KEVQYALDTG-KLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 400
              ++ ++V  A++ G +L   +D P+A          L  L + C +  R  RP+ G+ 
Sbjct: 235 YWDMSNQDVIKAIEEGYRLPPPMDCPIA----------LHQLMLDCWQKERSDRPKFGQI 284
Query: 401 V 401
           V
Sbjct: 285 V 285

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G  G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 204 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +   E ++       R   K    +  PE +  G  
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTA-------REGAKFPIKWTAPEAINYGTF 187
Query: 323 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 358
           T KSDV+SFGI+L  ++T GR P  G+T  EV   L+ G
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 109/243 (44%), Gaps = 43/243 (17%)
Query: 118 SSHM--PQFFSD-FSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPH 172
            SHM  P   SD +   EI            +G GG   ++  + L  H  VA+K+L   
Sbjct: 18  GSHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRAD 65
Query: 173 SLQGPS---EFQQEIDILSKIRHPNLV---------TLVGACPEVWTLVYEYLPNGSLED 220
             + PS    F++E    + + HP +V         T  G  P +   V EY+   +L D
Sbjct: 66  LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI---VMEYVDGVTLRD 122
Query: 221 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 280
            +  +    P++ +  I +  + C  L F H    + I+H D+KPANI++ A    K+ D
Sbjct: 123 IVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMD 176
Query: 281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           FGI+R ++ +  S   T         GT  Y+ PE      +  +SDVYS G +L  +LT
Sbjct: 177 FGIARAIADSGNSVTQTAAVI-----GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 231
Query: 341 GRP 343
           G P
Sbjct: 232 GEP 234

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 16/199 (8%)
Query: 145 KIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           +IG G +G ++ G  L   +VAIK +   ++    +F +E +++ K+ HP LV L G C 
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           E     LV E++ +G L D L  +      + +T + +  ++C  + +L       ++H 
Sbjct: 74  EQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 128
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N L+  N V K+SDFG++RF+  ++ +S+  T       K    +  PE  +   
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 181
Query: 322 LTPKSDVYSFGIILLRLLT 340
            + KSDV+SFG+++  + +
Sbjct: 182 YSSKSDVWSFGVLMWEVFS 200

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 193
           +FD    +G+G +G++Y    R  +  +A+K+L    L+      + ++E++I S +RHP
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 194 NLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N++ L G   +     L+ EY P G++   L        LS     R AT +  +   L 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSRFDEQRTATYITELANALS 126
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
            C    ++H D+KP N+LL +N   K++DFG     S +  SS  TTLC      GT  Y
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLC------GTLDY 176
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           + PE +       K D++S G++    L G P
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 27/263 (10%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G + +G L+        VAIK L   ++ +   EF  E  I+ +  HPN++ L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 200 GACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G         ++ E++ NG+L+  L   D        T I++   L  +   +      S
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQ-----FTVIQLVGMLRGIASGMRYLAEMS 136
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SRFL +N   S++ T       K    +  PE +
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN---SSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SD +S+GI++  +++   RP   ++ ++V  A++    ++   P   D P  
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----QDYRLPPPPDCP-- 247
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP  
Sbjct: 248 --TSLHQLMLDCWQKDRNARPRF 268

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G +   L        LS     R AT +  +
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ------KLSKFDEQRTATYITEL 122
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------ 172
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 128/268 (47%), Gaps = 31/268 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +  G L     R + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 200 GA---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           G    C  V  ++ EY+ NGSL+  L   D        T I++   L  +   +      
Sbjct: 82  GVVTKCKPV-MIITEYMENGSLDAFLRKNDGR-----FTVIQLVGMLRGIGSGMKYLSDM 135
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           S VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT-----RGGKIPIRWTAPEA 190
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 373
           +A  + T  SDV+S+GI++  +++   RP   ++ ++V  A++ G    L  P+  D P 
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG--YRLPPPM--DCPI 246
Query: 374 VQAEQLANLAMRCCEMSRKSRPELGKDV 401
                L  L + C +  R  RP+ G+ V
Sbjct: 247 A----LHQLMLDCWQKERSDRPKFGQIV 270

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 23  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 134
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      
Sbjct: 135 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------ 184
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 221

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 128/268 (47%), Gaps = 31/268 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +  G L     R + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 200 GA---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           G    C  V  ++ EY+ NGSL+  L   D        T I++   L  +   +      
Sbjct: 76  GVVTKCKPV-MIITEYMENGSLDAFLRKNDGR-----FTVIQLVGMLRGIGSGMKYLSDM 129
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           S VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE 
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT-----RGGKIPIRWTAPEA 184
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 373
           +A  + T  SDV+S+GI++  +++   RP   ++ ++V  A++ G    L  P+  D P 
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG--YRLPPPM--DCPI 240
Query: 374 VQAEQLANLAMRCCEMSRKSRPELGKDV 401
                L  L + C +  R  RP+ G+ V
Sbjct: 241 A----LHQLMLDCWQKERSDRPKFGQIV 264

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 127/268 (47%), Gaps = 31/268 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +  G L     R + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ-----FTVIQLVGMLRGISAGMKYLSDMG 144
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTAPEAI 199
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLLDPLAGDWPF 373
           A  + T  SDV+S+GI++  +++   RP   +T ++V  A++ G +L + +D  A     
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAA---- 255
Query: 374 VQAEQLANLAMRCCEMSRKSRPELGKDV 401
                L  L + C +  R SRP+  + V
Sbjct: 256 -----LYQLMLDCWQKERNSRPKFDEIV 278

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 143
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------ 193
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 27/263 (10%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G + +G L+        VAIK L   ++ +   EF  E  I+ +  HPN++ L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 200 GACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G         ++ E++ NG+L+  L   D        T I++   L  +   +      S
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQ-----FTVIQLVGMLRGIASGMRYLAEMS 138
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SRFL +N   S++ T       K    +  PE +
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN---SSDPTETSSLGGKIPIRWTAPEAI 195
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SD +S+GI++  +++   RP   ++ ++V  A++    ++   P   D P  
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----QDYRLPPPPDCP-- 249
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP  
Sbjct: 250 --TSLHQLMLDCWQKDRNARPRF 270

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 35/220 (15%)
Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           ++GEG +G ++     +       M VA+K L   +L    +FQ+E ++L+ ++H ++V 
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 198 LVGACPEV--WTLVYEYLPNGSLE--------DRLSCKDNSP-----PLSWQTRIRIATE 242
             G C +     +V+EY+ +G L         D +   D  P      L     + IA++
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLC 300
           + S +++L S      VH DL   N L+ AN + K+ DFG+SR +   +      +T L 
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            R        +M PE +   + T +SDV+SFG+IL  + T
Sbjct: 199 IR--------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 120
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------ 170
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 122
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------ 172
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 18/231 (7%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  +    VA+KM+   S+    EF QE   + K+ HP LV   G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 204 EVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           + +   +V EY+ NG L + L  + +   L     + +  ++C  + FL S   H  +H 
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHR 128
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N L+D +   K+SDFG++R++  ++  S+  T       K    +  PE     +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT-------KFPVKWSAPEVFHYFK 181
Query: 322 LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDP-LAGD 370
            + KSDV++FGI++  + + G+    +    +  L   +   L  P LA D
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD 232

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 122
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------ 172
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 117
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------ 167
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 120
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------ 170
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 193
           +FD    +G+G +G++Y    R  +  +A+K+L    L+      + ++E++I S +RHP
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 194 NLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N++ L G   +     L+ EY P G++   L        LS     R AT +  +   L 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSRFDEQRTATYITELANALS 126
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
            C    ++H D+KP N+LL +N   K++DFG     S +  SS   TLC      GT  Y
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLC------GTLDY 176
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           + PE +       K D++S G++    L G P
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 112/242 (46%), Gaps = 36/242 (14%)
Query: 122 PQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL 174
           PQ+FSD     I+    +     ++GEG +G ++     +       M VA+K L   S 
Sbjct: 27  PQYFSDACVHHIK--RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE 84
Query: 175 QGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRL---------- 222
               +FQ+E ++L+ ++H ++V   G C E   L  V+EY+ +G L   L          
Sbjct: 85  SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 223 -SCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 280
              +D +P PL     + +A+++ + +++L        VH DL   N L+    V K+ D
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGD 201
Query: 281 FGISRFLSQNEI--SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL 338
           FG+SR +   +       T L  R        +M PE +   + T +SDV+SFG++L  +
Sbjct: 202 FGMSRDIYSTDYYRVGGRTMLPIR--------WMPPESILYRKFTTESDVWSFGVVLWEI 253
Query: 339 LT 340
            T
Sbjct: 254 FT 255

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 131 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQE 183
           S+ + A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 62
Query: 184 IDILSKIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 241
           ++I S +RHPN++ L G   +     L+ EY P G++   L        LS     R AT
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTAT 116
Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 301
            +  +   L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC 
Sbjct: 117 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC- 171
Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 172 -----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 136 ATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKI 190
           A  +F+    +G+G +G++Y  +   R   +A+K+L    L+      + ++E++I S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 191 RHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
           RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +  
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITELAN 116
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      GT
Sbjct: 117 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------GT 166
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             Y+ PE +       K D++S G++    L G+P
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 201

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 5   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 116
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTLC      
Sbjct: 117 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLC------ 166
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 203

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 33/270 (12%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +  G L     R + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 200 GACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     ++ E++ NGSL+  L   D        T I++   L  +   +      +
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYLADMN 129
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH  L   NIL+++N V K+SDFG+SRFL   E  +++ T       K    +  PE +
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALDTGKLKNLLDPLAGDW---- 371
              + T  SDV+S+GI++  +++   RP   +T +           ++++ +  D+    
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----------DVINAIEQDYRLPP 235
Query: 372 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 401
           P      L  L + C +  R  RP+ G+ V
Sbjct: 236 PMDCPSALHQLMLDCWQKDRNHRPKFGQIV 265

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 125/285 (43%), Gaps = 23/285 (8%)
Query: 139 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHP 193
           NF    KIG G +  +Y+   LL  + VA+K +    L   +  ++  +EID+L ++ HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFL 250
           N++    +  E     +V E    G L   +   K     +  +T  +   +LCS L  +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     ++H D+KPAN+ + A  V KL D G+ RF S    ++++          GT  
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GTPY 201
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 370
           YM PE +       KSD++S G +L  +   +      K   Y+L     +    PL  D
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 415
                +E+L  L   C     + RP++   V+ V + M A    S
Sbjct: 262 H---YSEELRQLVNMCINPDPEKRPDVTY-VYDVAKRMHACTASS 302

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 222
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 274
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKF 297

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 119
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K+++FG     S +  SS  TTLC      
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLC------ 169
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTL- 198
           +L +G  G   + K  L   +VA+K+L+     SL    + ++EI  L   RHP+++ L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V + P    +V EY+  G L D + CK+    L  +   R+  ++ S + +   C  H 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI-CKNGR--LDEKESRRLFQQILSGVDY---CHRHM 136
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           +VH DLKP N+LLDA+  +K++DFG+S  +S  E    +          G+  Y  PE +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---------GSPNYAAPEVI 187
Query: 318 ASGELT--PKSDVYSFGIILLRLLTG 341
            SG L   P+ D++S G+IL  LL G
Sbjct: 188 -SGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 39/301 (12%)
Query: 122 PQFFSD-FSFSEIEGATHNFDPSLK---------IGEGGYGSIYKGLLR-----HMQVAI 166
           PQF+++  ++ E   A  +F   ++         IG G  G +  G LR      + VAI
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 167 KMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLS 223
           K L   ++ +   +F  E  I+ +  HPN++ L G      +  +V EY+ NGSL+  L 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 224 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 283
             D        T +++   L  V   +        VH DL   N+L+D+N V K+SDFG+
Sbjct: 143 THDGQ-----FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-- 341
           SR L  +  ++  T     T  K    +  PE +A    +  SDV+SFG+++  +L    
Sbjct: 198 SRVLEDDPDAAXTT-----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 342 RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 400
           RP   +T ++V  +++ G    L  P+           L  L + C    R  RP   + 
Sbjct: 253 RPYWNMTNRDVISSVEEG--YRLPAPMG------CPHALHQLMLDCWHKDRAQRPRFSQI 304
Query: 401 V 401
           V
Sbjct: 305 V 305

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 143 SLKIGEGGYGSIYKGLLRHMQVAIKMLH-----PHSLQGPSEFQQEIDILSKIRHPNLVT 197
           S +IG G +G++YKG   H  VA+K+L      P   Q    F+ E+ +L K RH N++ 
Sbjct: 41  STRIGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQA---FRNEVAVLRKTRHVNILL 96
Query: 198 LVG-ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
            +G    +   +V ++    SL   L  ++    +     I IA +    + +LH+    
Sbjct: 97  FMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHA---K 151
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           +I+H D+K  NI L      K+ DFG++   S+   S           P G+  +M PE 
Sbjct: 152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ------VEQPTGSVLWMAPEV 205
Query: 317 LASGELTP---KSDVYSFGIILLRLLTG 341
           +   +  P   +SDVYS+GI+L  L+TG
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 120
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 171
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 228
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 229 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 122
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 173
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 230
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE- 204
           IG+G +G +  G  R  +VA+K +   +      F  E  +++++RH NLV L+G   E 
Sbjct: 29  IGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 205 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
                +V EY+  GSL D L  +  S  L     ++ + ++C  + +L     ++ VH D
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHRD 142
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L   N+L+  + V+K+SDFG+++     E SS   T       K    +  PE L   + 
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT------GKLPVKWTAPEALREKKF 191
Query: 323 TPKSDVYSFGIILLRLLT-GR 342
           + KSDV+SFGI+L  + + GR
Sbjct: 192 STKSDVWSFGILLWEIYSFGR 212

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 39/301 (12%)
Query: 122 PQFFSD-FSFSEIEGATHNFDPSLK---------IGEGGYGSIYKGLLR-----HMQVAI 166
           PQF+++  ++ E   A  +F   ++         IG G  G +  G LR      + VAI
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 167 KMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLS 223
           K L   ++ +   +F  E  I+ +  HPN++ L G      +  +V EY+ NGSL+  L 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 224 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 283
             D        T +++   L  V   +        VH DL   N+L+D+N V K+SDFG+
Sbjct: 143 THDGQ-----FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-- 341
           SR L  +  ++  T     T  K    +  PE +A    +  SDV+SFG+++  +L    
Sbjct: 198 SRVLEDDPDAAYTT-----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 342 RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 400
           RP   +T ++V  +++ G    L  P+           L  L + C    R  RP   + 
Sbjct: 253 RPYWNMTNRDVISSVEEG--YRLPAPMG------CPHALHQLMLDCWHKDRAQRPRFSQI 304
Query: 401 V 401
           V
Sbjct: 305 V 305

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 122
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 173
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 230
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 222
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 274
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 222
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 274
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKF 297

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 165
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 166 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 220
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 272
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 273 CPAALYQLMLDCWQKDRNNRPKF 295

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 122
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 173
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 230
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 122
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 173
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 230
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 122
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 173
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 230
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 222
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 274
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 222
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 274
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 138
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 193
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 245
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 246 CPAALYQLMLDCWQKDRNNRPKF 268

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 122
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 173
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 230
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 118
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS   TLC      
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLC------ 168
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 118
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  T LC      
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLC------ 168
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE- 204
           IG+G +G +  G  R  +VA+K +   +      F  E  +++++RH NLV L+G   E 
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 205 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
                +V EY+  GSL D L  +  S  L     ++ + ++C  + +L     ++ VH D
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHRD 127
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L   N+L+  + V+K+SDFG+++     E SS   T       K    +  PE L   + 
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT------GKLPVKWTAPEALREKKF 176
Query: 323 TPKSDVYSFGIILLRLLT-GR 342
           + KSDV+SFGI+L  + + GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 117
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  T LC      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLC------ 167
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 122
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  T LC      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLC------ 172
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 155
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 210
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 262
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 263 CPAALYQLMLDCWQKDRNNRPKF 285

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE- 204
           IG+G +G +  G  R  +VA+K +   +      F  E  +++++RH NLV L+G   E 
Sbjct: 20  IGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 205 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
                +V EY+  GSL D L  +  S  L     ++ + ++C  + +L     ++ VH D
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHRD 133
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L   N+L+  + V+K+SDFG+++     E SS   T       K    +  PE L     
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT------GKLPVKWTAPEALREAAF 182
Query: 323 TPKSDVYSFGIILLRLLT 340
           + KSDV+SFGI+L  + +
Sbjct: 183 STKSDVWSFGILLWEIYS 200

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE- 204
           IG+G +G +  G  R  +VA+K +   +      F  E  +++++RH NLV L+G   E 
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 205 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
                +V EY+  GSL D L  +  S  L     ++ + ++C  + +L     ++ VH D
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHRD 314
Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L   N+L+  + V+K+SDFG+++     E SS   T       K    +  PE L   + 
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT------GKLPVKWTAPEALREKKF 363
Query: 323 TPKSDVYSFGIILLRLLT-GR 342
           + KSDV+SFGI+L  + + GR
Sbjct: 364 STKSDVWSFGILLWEIYSFGR 384

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 120
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K+++FG     S +  SS  TTLC      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLC------ 170
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 145 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G   +  +VA+K L P ++   + F +E +++  ++H  LV L     
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 78
Query: 204 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
             E   ++ EY+  GSL D L   +    L     I  + ++   + ++      + +H 
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIER---KNYIHR 134
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ AN+L+  + + K++DFG++R +  NE ++       R   K    +  PE +  G 
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGC 187
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KSDV+SFGI+L  ++T
Sbjct: 188 FTIKSDVWSFGILLYEIVT 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 25/273 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNL 195
           ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 196 VTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGI 124
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y+ 
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVA 175
Query: 314 PEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDW 371
           PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P    W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----W 231
Query: 372 PFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
             + +  LA L     E   +R + P++ KD W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 25/273 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNL 195
           ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 196 VTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLHGI 123
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y+ 
Sbjct: 124 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVA 174
Query: 314 PEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDW 371
           PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P    W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----W 230
Query: 372 PFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
             + +  LA L     E   +R + P++ KD W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 117
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  T LC      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLC------ 167
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 117
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  T LC      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELC------ 167
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           KIG+G +G ++KG+    Q  VAIK++    +     + QQEI +LS+   P +    G+
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                ++W ++ EYL  GS  D L       PL       I  E+   L +LHS K    
Sbjct: 74  YLKDTKLW-IIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 125
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K AN+LL  +   KL+DFG++  L+  +I  N           GT  +M PE + 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 177
Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
                 K+D++S GI  + L  G P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEP 202

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N    N   L  +    GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN----NRERLLNKM--XGTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 122
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N    N   L  +    GT  Y
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN----NRERLLNKM--XGTLPY 173
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 230
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           KIG+G +G ++KG+    Q  VAIK++    +     + QQEI +LS+   P +    G+
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                ++W ++ EYL  GS  D L       PL       I  E+   L +LHS K    
Sbjct: 89  YLKDTKLW-IIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 140
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K AN+LL  +   KL+DFG++  L+  +I  N           GT  +M PE + 
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV--------GTPFWMAPEVIK 192
Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
                 K+D++S GI  + L  G P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEP 217

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 25/205 (12%)
Query: 146 IGEGGYGSIYKG--LLRHMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTL-- 198
           +G G +G +  G   L   +VA+K+L+     SL    + ++EI  L   RHP+++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 199 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           V + P  + +V EY+  G L D + CK        + R R+  ++ S + +   C  H +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI-CKHGRVE-EMEAR-RLFQQILSAVDY---CHRHMV 132
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           VH DLKP N+LLDA+  +K++DFG+S  +S  E            D  G+  Y  PE + 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---------DSCGSPNYAAPEVI- 182
Query: 319 SGELT--PKSDVYSFGIILLRLLTG 341
           SG L   P+ D++S G+IL  LL G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 117
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  T LC      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLC------ 167
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG++R L  +  ++  T        K    +  PE +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 222
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 274
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKF 297

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           KIG+G +G ++KG+    Q  VAIK++    +     + QQEI +LS+   P +    G+
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                ++W ++ EYL  GS  D L       PL       I  E+   L +LHS K    
Sbjct: 74  YLKDTKLW-IIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 125
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K AN+LL  +   KL+DFG++  L+  +I  N           GT  +M PE + 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV--------GTPFWMAPEVIK 177
Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
                 K+D++S GI  + L  G P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEP 202

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +IG+G +G +YKG+  H +  VAIK++    +     + QQEI +LS+   P +    G+
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 202 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                ++W ++ EYL  GS  D L       PL       I  E+   L +LHS +    
Sbjct: 86  YLKSTKLW-IIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 137
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K AN+LL      KL+DFG++  L+  +I  N           GT  +M PE + 
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV--------GTPFWMAPEVIK 189
Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
                 K+D++S GI  + L  G P
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEP 214

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 146 IGEGGYGSIY------KGLLRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTL 198
           +GEG +G +       +G     QVA+K L P S     ++ ++EI+IL  + H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 199 VGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C E       L+ E+LP+GSL++ L    N   ++ + +++ A ++C  + +L S  
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLP--KNKNKINLKQQLKYAVQICKGMDYLGS-- 144
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               VH DL   N+L+++    K+ DFG+++      I ++      + D      +  P
Sbjct: 145 -RQYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEXXTVKDDRDSPVFWYAP 198
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   +    SDV+SFG+ L  LLT
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 118/229 (51%), Gaps = 30/229 (13%)
Query: 146 IGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 196
           +G G +G++YKG+         + VAIK+L+  +  GP    EF  E  I++ + HP+LV
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLV 80
Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
            L+G C  P +  LV + +P+G L + +   KDN   +  Q  +    ++   +++L   
Sbjct: 81  RLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE- 135
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               +VH DL   N+L+ +    K++DFG++R L  +E   N          K    +M 
Sbjct: 136 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA------DGGKMPIKWMA 187
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
            E +   + T +SDV+S+G+ +  L+T  G+P  GI T+E+   L+ G+
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 236

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           KIG+G +G ++KG+    Q  VAIK++    +     + QQEI +LS+   P +    G+
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 93
Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                ++W ++ EYL  GS  D L       PL       I  E+   L +LHS K    
Sbjct: 94  YLKDTKLW-IIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 145
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K AN+LL  +   KL+DFG++  L+  +I  N           GT  +M PE + 
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 197
Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
                 K+D++S GI  + L  G P
Sbjct: 198 QSAYDSKADIWSLGITAIELARGEP 222

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 146 IGEGGYGSIYKGLLR----HMQVAIKMLHPH-SLQGPSEFQQEIDILSKI-RHPNLVTLV 199
           IGEG +G + K  ++     M  AIK +  + S     +F  E+++L K+  HPN++ L+
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLS-------------CKDNSPPLSWQTRIRIATELC 244
           GAC       L  EY P+G+L D L                  +  LS Q  +  A ++ 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
             + +L        +H DL   NIL+  N+V+K++DFG+SR                +T 
Sbjct: 153 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 200
Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 348
            +    +M  E L     T  SDV+S+G++L  +  L G P  G+T
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 107/205 (52%), Gaps = 25/205 (12%)
Query: 146 IGEGGYGSIYKG--LLRHMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTL-- 198
           +G G +G +  G   L   +VA+K+L+     SL    + ++EI  L   RHP+++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 199 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           V + P  + +V EY+  G L D + CK        + R R+  ++ S + +   C  H +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI-CKHGRVE-EMEAR-RLFQQILSAVDY---CHRHMV 132
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           VH DLKP N+LLDA+  +K++DFG+S  +S  E      T C      G+  Y  PE + 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC------GSPNYAAPEVI- 182
Query: 319 SGELT--PKSDVYSFGIILLRLLTG 341
           SG L   P+ D++S G+IL  LL G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + FL S 
Sbjct: 98  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 152
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 153 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMA 205
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRP 343
            E L + + T KSDV+SFG++L  L+T G P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 121/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V EY+ NGSL+  L   D        T I++   L  +   +       
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+ R L  +  ++  T        K    +  PE +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 222
Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 274
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKF 297

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + FL S 
Sbjct: 103 GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 157
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 158 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMA 210
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 270
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 271 ------LYEVMLKCWHPKAEMRPSFSELVSRI 296

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + FL S 
Sbjct: 96  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 150
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 151 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMA 203
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 263
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 264 ------LYEVMLKCWHPKAEMRPSFSELVSRI 289

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 146 IGEGGYGSIY------KGLLRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTL 198
           +GEG +G +       +G     QVA+K L P S     ++ ++EI+IL  + H N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 199 VGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C E       L+ E+LP+GSL++ L    N   ++ + +++ A ++C  + +L S  
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLP--KNKNKINLKQQLKYAVQICKGMDYLGS-- 132
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               VH DL   N+L+++    K+ DFG+++      I ++      + D      +  P
Sbjct: 133 -RQYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEXXTVKDDRDSPVFWYAP 186
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   +    SDV+SFG+ L  LLT
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + FL S 
Sbjct: 99  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 153
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 154 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMA 206
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRP 343
            E L + + T KSDV+SFG++L  L+T G P
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + FL S 
Sbjct: 98  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 152
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 153 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMA 205
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 265
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 266 ------LYEVMLKCWHPKAEMRPSFSELVSRI 291

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 118/229 (51%), Gaps = 30/229 (13%)
Query: 146 IGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 196
           +G G +G++YKG+         + VAIK+L+  +  GP    EF  E  I++ + HP+LV
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLV 103
Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
            L+G C  P +  LV + +P+G L + +   KDN   +  Q  +    ++   +++L   
Sbjct: 104 RLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE- 158
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               +VH DL   N+L+ +    K++DFG++R L  +E   N          K    +M 
Sbjct: 159 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA------DGGKMPIKWMA 210
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
            E +   + T +SDV+S+G+ +  L+T  G+P  GI T+E+   L+ G+
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 259

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N    N   L  +    GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN----NRERLLNKM--XGTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 120
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS    LC      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALC------ 170
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 146 IGEGGYGSIYKGLLR----HMQVAIKMLHPH-SLQGPSEFQQEIDILSKI-RHPNLVTLV 199
           IGEG +G + K  ++     M  AIK +  + S     +F  E+++L K+  HPN++ L+
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLS-------------CKDNSPPLSWQTRIRIATELC 244
           GAC       L  EY P+G+L D L                  +  LS Q  +  A ++ 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
             + +L        +H DL   NIL+  N+V+K++DFG+SR                +T 
Sbjct: 143 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 190
Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 348
            +    +M  E L     T  SDV+S+G++L  +  L G P  G+T
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 236

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G  R +       +VA+K ++   SL+   EF  E  ++      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 197 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 247
            L+G     +   +V E + +G L+  L             PP + Q  I++A E+   +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH DL   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 141 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX--------RKGGKG 189
Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SD++SFG++L  +  L  +P  G++ E  +++ +D G L 
Sbjct: 190 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 248
Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   D P    E++ +L   C + + K RP
Sbjct: 249 --------DQPDNCPERVTDLMRMCWQFNPKMRP 274

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 143
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS    LC      
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLC------ 193
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N    N   L  +    GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN----NRERLLNKM--XGTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + FL S 
Sbjct: 99  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 153
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 154 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHN----KTGAKLPVKWMA 206
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRP 343
            E L + + T KSDV+SFG++L  L+T G P
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 119
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS    LC      
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLC------ 169
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG YG +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N    N   L  +    GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN----NRERLLNKM--XGTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G  R +       +VA+K ++   SL+   EF  E  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 197 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 247
            L+G     +   +V E + +G L+  L             PP + Q  I++A E+   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH DL   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 144 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX--------RKGGKG 192
Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SD++SFG++L  +  L  +P  G++ E  +++ +D G L 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 251
Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   D P    E++ +L   C + + K RP
Sbjct: 252 --------DQPDNCPERVTDLMRMCWQFNPKMRP 277

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + FL S 
Sbjct: 157 GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 211
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 212 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMA 264
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRP 343
            E L + + T KSDV+SFG++L  L+T G P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 118
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS  TTL       
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLS------ 168
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 117
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS    LC      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALC------ 167
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 47/259 (18%)
Query: 138 HNFDPSLKIGEGGYGSIYK----GLLRH---MQVAIKMLHPH-SLQGPSEFQQEIDILSK 189
           +N +    IGEG +G +++    GLL +     VA+KML    S    ++FQ+E  ++++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 190 IRHPNLVTLVGACP--EVWTLVYEYLPNGSLED-----------RLSCKDNS-------- 228
             +PN+V L+G C   +   L++EY+  G L +            LS  D S        
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 229 --PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 286
             PPLS   ++ IA ++ + + +L   K    VH DL   N L+  N V K++DFG+SR 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 287 LSQNEI--SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--R 342
           +   +   +  N  +  R        +M PE +     T +SDV+++G++L  + +   +
Sbjct: 224 IYSADYYKADGNDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 343 PALGIT-KEVQYALDTGKL 360
           P  G+  +EV Y +  G +
Sbjct: 276 PYYGMAHEEVIYYVRDGNI 294

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G  R +       +VA+K ++   SL+   EF  E  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 197 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 247
            L+G     +   +V E + +G L+  L             PP + Q  I++A E+   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH DL   N ++  +F  K+ DFG++R + +        T   R   KG
Sbjct: 144 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--------TAYYRKGGKG 192
Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SD++SFG++L  +  L  +P  G++ E  +++ +D G L 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 251
Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   D P    E++ +L   C + + K RP
Sbjct: 252 --------DQPDNCPERVTDLMRMCWQFNPKMRP 277

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 120
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS    LC      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLC------ 170
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 119/253 (47%), Gaps = 30/253 (11%)
Query: 133 IEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG-----PSEFQQEIDIL 187
            +G    +    K+GEG YG +YK   +  Q  I  L    L       PS   +EI +L
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKA--KDSQGRIVALKRIRLDAEDEGIPSTAIREISLL 73
Query: 188 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
            ++ HPN+V+L+         TLV+E++     +D     D +      ++I+I   L  
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIY--LYQ 127
Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           +L  +  C  H I+H DLKP N+L++++   KL+DFG++R       S  +  +      
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV------ 181
Query: 306 KGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNL 363
             T  Y  P+ L  S + +   D++S G I   ++TG+P   G+T + Q      K+ ++
Sbjct: 182 --TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP----KIFSI 235
Query: 364 L-DPLAGDWPFVQ 375
           L  P   +WP VQ
Sbjct: 236 LGTPNPREWPQVQ 248

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 119/253 (47%), Gaps = 30/253 (11%)
Query: 133 IEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG-----PSEFQQEIDIL 187
            +G    +    K+GEG YG +YK   +  Q  I  L    L       PS   +EI +L
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKA--KDSQGRIVALKRIRLDAEDEGIPSTAIREISLL 73
Query: 188 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
            ++ HPN+V+L+         TLV+E++     +D     D +      ++I+I   L  
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIY--LYQ 127
Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           +L  +  C  H I+H DLKP N+L++++   KL+DFG++R       S  +  +      
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV------ 181
Query: 306 KGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNL 363
             T  Y  P+ L  S + +   D++S G I   ++TG+P   G+T + Q      K+ ++
Sbjct: 182 --TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP----KIFSI 235
Query: 364 L-DPLAGDWPFVQ 375
           L  P   +WP VQ
Sbjct: 236 LGTPNPREWPQVQ 248

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G  R +       +VA+K ++   SL+   EF  E  ++      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 197 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 247
            L+G     +   +V E + +G L+  L             PP + Q  I++A E+   +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH DL   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 143 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------RKGGKG 191
Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SD++SFG++L  +  L  +P  G++ E  +++ +D G L 
Sbjct: 192 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 250
Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   D P    E++ +L   C + + K RP
Sbjct: 251 --------DQPDNCPERVTDLMRMCWQFNPKMRP 276

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 135 GATHNFDPS----LK-IGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILS 188
           G +   DP     LK +G G +G +  G  R    VAIKM+   S+    EF +E  ++ 
Sbjct: 1   GGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMM 59
Query: 189 KIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            + H  LV L G C +     ++ EY+ NG L + L  ++       Q  + +  ++C  
Sbjct: 60  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEA 117
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDP 305
           + +L S      +H DL   N L++   V K+SDFG+SR++  +E  SS  +    R  P
Sbjct: 118 MEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSP 174
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
                   PE L   + + KSD+++FG+++  + +
Sbjct: 175 --------PEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 145 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G ++ G   +  +VA+K L P ++   + F +E +++  ++H  LV L     
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 77
Query: 204 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
             E   ++ E++  GSL D L   +    L     I  + ++   + ++      + +H 
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIER---KNYIHR 133
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ AN+L+  + + K++DFG++R +  NE ++       R   K    +  PE +  G 
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGC 186
Query: 322 LTPKSDVYSFGIILLRLLT 340
            T KS+V+SFGI+L  ++T
Sbjct: 187 FTIKSNVWSFGILLYEIVT 205

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G  R +       +VA+K ++   SL+   EF  E  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 197 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 247
            L+G     +   +V E + +G L+  L             PP + Q  I++A E+   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH DL   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 144 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------RKGGKG 192
Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SD++SFG++L  +  L  +P  G++ E  +++ +D G L 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 251
Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   D P    E++ +L   C + + K RP
Sbjct: 252 --------DQPDNCPERVTDLMRMCWQFNPKMRP 277

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQGPSEFQQEIDILSKI 190
           HN     ++GEG +G ++     ++        VA+K L   S     +F +E ++L+ +
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 191 RHPNLVTLVGACPEV--WTLVYEYLPNGSLE--------DRLSCKDNSPP--LSWQTRIR 238
           +H ++V   G C E     +V+EY+ +G L         D +   + +PP  L+    + 
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNN 296
           IA ++ + +++L S      VH DL   N L+  N + K+ DFG+SR +   +      +
Sbjct: 133 IAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           T L  R        +M PE +   + T +SDV+S G++L  + T
Sbjct: 190 TMLPIR--------WMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 118/255 (46%), Gaps = 38/255 (14%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQG-PSEFQQEIDILSKIR 191
           AT  ++P  +IG G YG++YK    H    VA+K +  P+  +G P    +E+ +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 192 ---HPNLVTLVGACPEV-------WTLVYEYLPNGSLEDRLSCKDNSPP--LSWQTRIRI 239
              HPN+V L+  C           TLV+E++     +D  +  D +PP  L  +T   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDL 117
Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS-QNEISSNNTT 298
             +    L FLH+   + IVH DLKP NIL+ +    KL+DFG++R  S Q  ++    T
Sbjct: 118 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVT 174
Query: 299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 358
           L  R           PE L         D++S G I   +   +P      E   A   G
Sbjct: 175 LWYRA----------PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLG 221
Query: 359 KLKNLLD-PLAGDWP 372
           K+ +L+  P   DWP
Sbjct: 222 KIFDLIGLPPEDDWP 236

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 97  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 151
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 152 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHN----KTGAKLPVKWMA 204
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRP 343
            E L + + T KSDV+SFG++L  L+T G P
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 117
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS    LC      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLC------ 167
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 120/275 (43%), Gaps = 25/275 (9%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHP 193
             ++D    +GEG  G +   + R  +  VA+K++    ++  P   ++EI I   + H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V   G   E  +  L  EY   G L DR+      P    Q   R   +L + +++LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVVYLH 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y
Sbjct: 122 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPY 172
Query: 312 MDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           + PE L   E   +  DV+S GI+L  +L G  P    +   Q   D  + K  L+P   
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--- 229
Query: 370 DWPFVQAEQLANLAMRCCE--MSRKSRPELGKDVW 402
            W  + +  LA L     E   +R + P++ KD W
Sbjct: 230 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 96  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 150
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 151 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----KTGAKLPVKWMA 203
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 263
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 264 ------LYEVMLKCWHPKAEMRPSFSELVSRI 289

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 123/264 (46%), Gaps = 31/264 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +  G L     R + VAIK L   ++ +   +F  E  I+ +  HPN+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 200 GACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G     +   +V E++ NG+L+  L   D        T I++   L  +   +       
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQ-----FTVIQLVGMLRGIAAGMRYLADMG 165
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR +  +  +   T     T  K    +  PE +
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT-----TGGKIPVRWTAPEAI 220
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLLDPLAGDWPF 373
              + T  SDV+S+GI++  +++   RP   ++ ++V  A++ G +L   +D  AG    
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAG---- 276
Query: 374 VQAEQLANLAMRCCEMSRKSRPEL 397
                L  L + C +  R  RP+ 
Sbjct: 277 -----LHQLMLDCWQKERAERPKF 295

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 197
           KIG+G  G++Y  +      +VAI+ ++            EI ++ + ++PN+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 198 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           LVG   E+W +V EYL  GSL D ++  C D     +      +  E    L FLHS   
Sbjct: 87  LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 134
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           + ++H D+K  NILL  +   KL+DFG   F +Q  I+   +    R++  GT  +M PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQ--ITPEQSK---RSEMVGTPYWMAPE 186
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +      PK D++S GI+ + ++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 93  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 147
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 148 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----KTGAKLPVKWMA 200
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 261 ------LYEVMLKCWHPKAEMRPSFSELVSRI 286

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  R    VAIKM+   S+    EF +E  ++  + H  LV L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +     ++ EY+ NG L + L  ++       Q  + +  ++C  + +L S      +H 
Sbjct: 90  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 144
Query: 262 DLKPANILLDANFVSKLSDFGISRF-LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
           DL   N L++   V K+SDFG+SR+ L   E SS  +    R  P        PE L   
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSP--------PEVLMYS 196
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSD+++FG+++  + +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 98  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 152
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 153 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----KTGAKLPVKWMA 205
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 265
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 266 ------LYEVMLKCWHPKAEMRPSFSELVSRI 291

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 121/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V E + NGSL+  L   D        T I++   L  +   +       
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 222
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 274
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 121/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V E + NGSL+  L   D        T I++   L  +   +       
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG 138
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 193
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 245
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 246 CPAALYQLMLDCWQKDRNNRPKF 268

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 98  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 152
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 153 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----KTGAKLPVKWMA 205
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 265
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 266 ------LYEVMLKCWHPKAEMRPSFSELVSRI 291

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 119/254 (46%), Gaps = 36/254 (14%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQG-PSEFQQEIDILSKIR 191
           AT  ++P  +IG G YG++YK    H    VA+K +  P+  +G P    +E+ +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 192 ---HPNLVTLVGACPEV-------WTLVYEYLPNGSLEDRLSCKDNSPP--LSWQTRIRI 239
              HPN+V L+  C           TLV+E++     +D  +  D +PP  L  +T   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDL 117
Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
             +    L FLH+   + IVH DLKP NIL+ +    KL+DFG++R  S  +++ +   +
Sbjct: 118 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALDPVVV 173
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 359
                   T  Y  PE L         D++S G I   +   +P      E   A   GK
Sbjct: 174 --------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGK 222
Query: 360 LKNLLD-PLAGDWP 372
           + +L+  P   DWP
Sbjct: 223 IFDLIGLPPEDDWP 236

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 146 IGEGGYGSIYKGLLR----HMQVAIKMLHPH-SLQGPSEFQQEIDILSKI-RHPNLVTLV 199
           IGEG +G + K  ++     M  AIK +  + S     +F  E+++L K+  HPN++ L+
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLS-------------CKDNSPPLSWQTRIRIATELC 244
           GAC       L  EY P+G+L D L                  +  LS Q  +  A ++ 
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
             + +L        +H +L   NIL+  N+V+K++DFG+SR                +T 
Sbjct: 150 RGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 197
Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 348
            +    +M  E L     T  SDV+S+G++L  +  L G P  G+T
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 243

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 90  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 144
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 145 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----KTGAKLPVKWMA 197
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 257
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 258 ------LYEVMLKCWHPKAEMRPSFSELVSRI 283

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +G G +G +  G L+      + VAIK L   ++ +   +F  E  I+ +  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   +     +V E + NGSL+  L   D     +  T I++   L  +   +       
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   NIL+++N V K+SDFG+SR L  +  ++  T        K    +  PE +
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTSPEAI 222
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
           A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G     L P     P  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP-----PMD 274
Query: 375 QAEQLANLAMRCCEMSRKSRPEL 397
               L  L + C +  R +RP+ 
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKF 297

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 97  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 151
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 152 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----KTGAKLPVKWMA 204
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 264
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 265 ------LYEVMLKCWHPKAEMRPSFSELVSRI 290

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 95  GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 149
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 150 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----KTGAKLPVKWMA 202
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 263 ------LYEVMLKCWHPKAEMRPSFSELVSRI 288

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G++   L        LS     R AT +  +
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITEL 120
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS    LC      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLC------ 170
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 197
           KIG+G  G++Y  +      +VAI+ ++            EI ++ + ++PN+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 198 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           LVG   E+W +V EYL  GSL D ++  C D     +      +  E    L FLHS   
Sbjct: 87  LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 134
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           + ++H D+K  NILL  +   KL+DFG    ++  +  S  +T+       GT  +M PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPE 186
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +      PK D++S GI+ + ++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  R    VAIKM+   S+    EF +E  ++  + H  LV L G C 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +     ++ EY+ NG L + L  ++       Q  + +  ++C  + +L S      +H 
Sbjct: 74  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 128
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSN-NTTLCCRTDPKGTFAYMDPEFLASG 320
           DL   N L++   V K+SDFG+SR++  +E +S+  +    R  P        PE L   
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--------PEVLMYS 180
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSD+++FG+++  + +
Sbjct: 181 KFSSKSDIWAFGVLMWEIYS 200

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS---EFQQEIDILSKI 190
           A  +F+    +G+G +G++Y    ++ +  +A+K+L    L+      + ++E++I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 191 RHPNLVTLVGA---CPEVWTLVYEYLPNGSLE---DRLSCKDNSPPLSWQTRIRIATELC 244
           RHPN++ L G       V+ L+ EY P G++     +LS  D       Q      TEL 
Sbjct: 66  RHPNILRLYGYFHDSTRVY-LILEYAPLGTVYRELQKLSKFDE------QRTATYITELA 118
Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
           + L + HS K   ++H D+KP N+LL +    K++DFG     S +  SS    LC    
Sbjct: 119 NALSYCHSKK---VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALC---- 167
Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 168 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 127/274 (46%), Gaps = 43/274 (15%)
Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G  R +       +VA+K ++   SL+   EF  E  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 197 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 247
            L+G     +   +V E + +G L+  L             PP + Q  I++A E+   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH DL   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 144 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX--------RKGGKG 192
Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SD++SFG++L  +  L  +P  G++ E  +++ +D G L 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 251
Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   D P    E++ +L   C + +   RP
Sbjct: 252 --------DQPDNCPERVTDLMRMCWQFNPNMRP 277

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 117 GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 171
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 172 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----KTGAKLPVKWMA 224
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
            E L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 284
Query: 373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
                 L  + ++C     + RP   + V R+
Sbjct: 285 ------LYEVMLKCWHPKAEMRPSFSELVSRI 310

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 146 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV 199
           IG G +G +Y G L     + +  A+K L+  +  G  S+F  E  I+    HPN+++L+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           G C      P V   V  Y+ +G L + +  + ++P +  +  I    ++   + +L S 
Sbjct: 116 GICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 170
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K    VH DL   N +LD  F  K++DFG++R +   E  S +     +T  K    +M 
Sbjct: 171 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN----KTGAKLPVKWMA 223
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT-GRP 343
            E L + + T KSDV+SFG++L  L+T G P
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  R    VAIKM+   S+    EF +E  ++  + H  LV L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +     ++ EY+ NG L + L  ++       Q  + +  ++C  + +L S      +H 
Sbjct: 70  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 124
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSN-NTTLCCRTDPKGTFAYMDPEFLASG 320
           DL   N L++   V K+SDFG+SR++  +E +S+  +    R  P        PE L   
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--------PEVLMYS 176
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSD+++FG+++  + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYS 196

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 86/339 (25%), Positives = 153/339 (45%), Gaps = 48/339 (14%)
Query: 118 SSHMPQFFSD---FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIK 167
           +S  P++FS    +   E E A      S ++G+G +G +Y+G+ + +       +VAIK
Sbjct: 2   ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 168 MLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSC 224
            ++   S++   EF  E  ++ +    ++V L+G   +     ++ E +  G L+  L  
Sbjct: 62  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 225 ----KDNSP---PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
                +N+P   P S    I++A E+   + +L++ K    VH DL   N ++  +F  K
Sbjct: 122 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 335
           + DFG++R + + +          R   KG     +M PE L  G  T  SDV+SFG++L
Sbjct: 179 IGDFGMTRDIYETDY--------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
Query: 336 LRL--LTGRPALGITKE--VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 391
             +  L  +P  G++ E  +++ ++ G L         D P    + L  L   C + + 
Sbjct: 231 WEIATLAEQPYQGLSNEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNP 281
Query: 392 KSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPP 430
           K RP   + +  + E M       + Y   SEE   P P
Sbjct: 282 KMRPSFLEIISSIKEEMEPGFREVSFYY--SEENKLPEP 318

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           ++GEG +G ++     +       M VA+K L   S     +FQ+E ++L+ ++H ++V 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 198 LVGACPEVWTL--VYEYLPNGSLEDRL-----------SCKDNSP-PLSWQTRIRIATEL 243
             G C E   L  V+EY+ +G L   L             +D +P PL     + +A+++
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCC 301
            + +++L        VH DL   N L+    V K+ DFG+SR +   +       T L  
Sbjct: 145 AAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           R        +M PE +   + T +SDV+SFG++L  + T
Sbjct: 202 R--------WMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  R    VAIKM+   S+    EF +E  ++  + H  LV L G C 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +     ++ EY+ NG L + L  ++       Q  + +  ++C  + +L S      +H 
Sbjct: 81  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 135
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSN-NTTLCCRTDPKGTFAYMDPEFLASG 320
           DL   N L++   V K+SDFG+SR++  +E +S+  +    R  P        PE L   
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--------PEVLMYS 187
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSD+++FG+++  + +
Sbjct: 188 KFSSKSDIWAFGVLMWEIYS 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  R    VAIKM+   S+    EF +E  ++  + H  LV L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +     ++ EY+ NG L + L  ++       Q  + +  ++C  + +L S      +H 
Sbjct: 75  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 129
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSN-NTTLCCRTDPKGTFAYMDPEFLASG 320
           DL   N L++   V K+SDFG+SR++  +E +S+  +    R  P        PE L   
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--------PEVLMYS 181
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSD+++FG+++  + +
Sbjct: 182 KFSSKSDIWAFGVLMWEIYS 201

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 197
           KIG+G  G++Y  +      +VAI+ ++            EI ++ + ++PN+V      
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 198 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           LVG   E+W +V EYL  GSL D ++  C D     +      +  E    L FLHS   
Sbjct: 88  LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 135
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           + ++H D+K  NILL  +   KL+DFG   F +Q  I+   +    R+   GT  +M PE
Sbjct: 136 NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQ--ITPEQSK---RSXMVGTPYWMAPE 187
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +      PK D++S GI+ + ++ G P
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           ++GEG +G ++     +       M VA+K L   S     +FQ+E ++L+ ++H ++V 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 198 LVGACPEVWTL--VYEYLPNGSLEDRL-----------SCKDNSP-PLSWQTRIRIATEL 243
             G C E   L  V+EY+ +G L   L             +D +P PL     + +A+++
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCC 301
            + +++L        VH DL   N L+    V K+ DFG+SR +   +       T L  
Sbjct: 139 AAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           R        +M PE +   + T +SDV+SFG++L  + T
Sbjct: 196 R--------WMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 104/220 (47%), Gaps = 37/220 (16%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVG 200
           +G G YG +YKG  RH++     AIK++     +   E +QEI++L K   H N+ T  G
Sbjct: 32  VGNGTYGQVYKG--RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 88
Query: 201 AC---------PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFL 250
           A           ++W LV E+   GS+ D + + K N+    W   I    E+   L  L
Sbjct: 89  AFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSHL 145
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           H    H ++H D+K  N+LL  N   KL DFG+S  L +  +   NT +       GT  
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFI-------GTPY 194
Query: 311 YMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPAL 345
           +M PE +A  E        KSD++S GI  + +  G P L
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 197
           KIG+G  G++Y  +      +VAI+ ++            EI ++ + ++PN+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 198 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           LVG   E+W +V EYL  GSL D ++  C D     +      +  E    L FLHS   
Sbjct: 87  LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 134
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           + ++H D+K  NILL  +   KL+DFG   F +Q  I+   +    R+   GT  +M PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQ--ITPEQSK---RSXMVGTPYWMAPE 186
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +      PK D++S GI+ + ++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  R    VAIKM+   S+    EF +E  ++  + H  LV L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 204 EV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +     ++ EY+ NG L + L  ++       Q  + +  ++C  + +L S      +H 
Sbjct: 90  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 144
Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSN-NTTLCCRTDPKGTFAYMDPEFLASG 320
           DL   N L++   V K+SDFG+SR++  +E +S+  +    R  P        PE L   
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--------PEVLMYS 196
Query: 321 ELTPKSDVYSFGIILLRLLT 340
           + + KSD+++FG+++  + +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 117/255 (45%), Gaps = 38/255 (14%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQG-PSEFQQEIDILSKIR 191
           AT  ++P  +IG G YG++YK    H    VA+K +  P+  +G P    +E+ +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 192 ---HPNLVTLVGACPEV-------WTLVYEYLPNGSLEDRLSCKDNSPP--LSWQTRIRI 239
              HPN+V L+  C           TLV+E++     +D  +  D +PP  L  +T   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDL 117
Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS-QNEISSNNTT 298
             +    L FLH+   + IVH DLKP NIL+ +    KL+DFG++R  S Q  +     T
Sbjct: 118 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVT 174
Query: 299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 358
           L  R           PE L         D++S G I   +   +P      E   A   G
Sbjct: 175 LWYRA----------PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLG 221
Query: 359 KLKNLLD-PLAGDWP 372
           K+ +L+  P   DWP
Sbjct: 222 KIFDLIGLPPEDDWP 236

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L    ++  +     ++  +++C  + +L + +
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQA--HAERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 138 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 189
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 34/238 (14%)
Query: 146 IGEGGYGSIYK--GLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGA 201
           +G+G +G + K    +   + A+K+++  S +    S   +E+++L K+ HPN++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 202 CPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
             +   + +V E    G L D +  +      S     RI  ++ S + ++H    H+IV
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH---KHNIV 143
Query: 260 HGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           H DLKP NILL++   +   K+ DFG+S    QN             D  GT  Y+ PE 
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---------TKMKDRIGTAYYIAPEV 194
Query: 317 LASGELTPKSDVYSFGIILLRLLTGRPAL------GITKEVQ---YALDTGKLKNLLD 365
           L  G    K DV+S G+IL  LL+G P         I K V+   YA D  + + + D
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILS 188
           A  +F+    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++E++I S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 189 KIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
            +RHPN++ L G   +     L+ EY P G +   L        LS     R AT +  +
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ------KLSKFDEQRTATYITEL 122
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
              L  C    ++H D+KP N+LL +    K++DFG     S +  SS    L       
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXL------X 172
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE +       K D++S G++    L G+P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 79/319 (24%), Positives = 137/319 (42%), Gaps = 48/319 (15%)
Query: 114 EASSSSHMPQFFSDFSFSEI----EGATHNFDPSLKIGEGGYGSIYK----GLLR---HM 162
           + + SS    F+ DF   E     E    N +    +G G +G +      G+ +    +
Sbjct: 17  QVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI 76
Query: 163 QVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLVTLVGACPEV--WTLVYEYLPNGSL 218
           QVA+KML   +     E    E+ +++++  H N+V L+GAC       L++EY   G L
Sbjct: 77  QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
Query: 219 --------------------EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                               + RL  +++   L+++  +  A ++   + FL      S 
Sbjct: 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSC 193
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           VH DL   N+L+    V K+ DFG++R    + +S +N  +  R + +    +M PE L 
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDSNYVV--RGNARLPVKWMAPESLF 247
Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 378
            G  T KSDV+S+GI+L  + +    LG+       +D    K + +    D PF   E+
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFS----LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEE 303
Query: 379 LANLAMRCCEMSRKSRPEL 397
           +  +   C     + RP  
Sbjct: 304 IYIIMQSCWAFDSRKRPSF 322

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 144 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 198
           +++G G +GS+ +G+ R     + VAIK+L   + +  +E   +E  I+ ++ +P +V L
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E   LV E    G L   L  K    P+S      +A  L  V + +   +  +
Sbjct: 76  IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS-----NVAELLHQVSMGMKYLEEKN 130
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L      ++++    R+  K    +  PE +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKAL-----GADDSYYTARSAGKWPLKWYAPECI 185
Query: 318 ASGELTPKSDVYSFGIILLRLLT 340
              + + +SDV+S+G+ +   L+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 138 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 189
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/339 (25%), Positives = 152/339 (44%), Gaps = 48/339 (14%)
Query: 118 SSHMPQFFSD---FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIK 167
           +S  P++FS    +   E E A      S ++G+G +G +Y+G+ + +       +VAIK
Sbjct: 2   ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 168 MLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLS- 223
            ++   S++   EF  E  ++ +    ++V L+G   +     ++ E +  G L+  L  
Sbjct: 62  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 224 ---CKDNSP---PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
                 N+P   P S    I++A E+   + +L++ K    VH DL   N ++  +F  K
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 335
           + DFG++R + + +          R   KG     +M PE L  G  T  SDV+SFG++L
Sbjct: 179 IGDFGMTRDIYETDY--------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
Query: 336 LRL--LTGRPALGITKE--VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 391
             +  L  +P  G++ E  +++ ++ G L         D P    + L  L   C + + 
Sbjct: 231 WEIATLAEQPYQGLSNEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNP 281
Query: 392 KSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPP 430
           K RP   + +  + E M       + Y   SEE   P P
Sbjct: 282 KMRPSFLEIISSIKEEMEPGFREVSFYY--SEENKLPEP 318

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 141/306 (46%), Gaps = 46/306 (15%)
Query: 118 SSHMPQFFSD---FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIK 167
           +S  P++FS    +   E E A      S ++G+G +G +Y+G+ + +       +VAIK
Sbjct: 24  ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 83
Query: 168 MLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSC 224
            ++   S++   EF  E  ++ +    ++V L+G   +     ++ E +  G L+  L  
Sbjct: 84  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 143
Query: 225 ----KDNSP---PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
                +N+P   P S    I++A E+   + +L++ K    VH DL   N ++  +F  K
Sbjct: 144 LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 200
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 335
           + DFG++R + + +          R   KG     +M PE L  G  T  SDV+SFG++L
Sbjct: 201 IGDFGMTRDIYETDY--------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 252
Query: 336 LRL--LTGRPALGITKE--VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 391
             +  L  +P  G++ E  +++ ++ G L         D P    + L  L   C + + 
Sbjct: 253 WEIATLAEQPYQGLSNEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNP 303
Query: 392 KSRPEL 397
           K RP  
Sbjct: 304 KMRPSF 309

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EFFKVKEPGESPIFWYAP 186
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 139
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 140 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 191
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 140
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 141 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 192
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 138
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 139 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 190
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 141
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 142 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 193
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 217
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 133
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 134 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 185
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 132
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 133 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 184
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 186
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLV 196
           FD   K+GEG YGS+YK + +     VAIK +   S LQ   E  +EI I+ +   P++V
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSPHVV 87
Query: 197 TLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
              G+     ++W +V EY   GS+ D +  ++ +      T   IAT L S L  L   
Sbjct: 88  KYYGSYFKNTDLW-IVMEYCGAGSVSDIIRLRNKT-----LTEDEIATILQSTLKGLEYL 141
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
                +H D+K  NILL+    +KL+DFG++  L+ + ++  N  +       GT  +M 
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVI-------GTPFWMA 193
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE +        +D++S GI  + +  G+P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKP 223

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 186
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 43/289 (14%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQE 183
           E E A      S ++G+G +G +Y+G+ + +       +VAIK ++   S++   EF  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 184 IDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSC----KDNSP---PLSWQ 234
             ++ +    ++V L+G   +     ++ E +  G L+  L       +N+P   P S  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
             I++A E+   + +L++ K    VH DL   N ++  +F  K+ DFG++R + + +   
Sbjct: 133 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX- 188
Query: 295 NNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE 350
                  R   KG     +M PE L  G  T  SDV+SFG++L  +  L  +P  G++ E
Sbjct: 189 -------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 241
Query: 351 --VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
             +++ ++ G L         D P    + L  L   C + + K RP  
Sbjct: 242 QVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSF 281

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 30/230 (13%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVG 200
           +G+G +  +Y+    H  ++VAIKM+   ++         Q E+ I  +++HP+++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              +     LV E   NG +   L  K+   P S         ++ + +++LHS   H I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLHS---HGI 133
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL  +N+LL  N   K++DFG++  L        + TLC      GT  Y+ PE   
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLC------GTPNYISPEIAT 185
Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 368
                 +SDV+S G +   LL GRP            DT  +KN L+ + 
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRP----------PFDTDTVKNTLNKVV 225

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 43/287 (14%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQE 183
           E E A      S ++G+G +G +Y+G+ + +       +VAIK ++   S++   EF  E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 184 IDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSC----KDNSP---PLSWQ 234
             ++ +    ++V L+G   +     ++ E +  G L+  L       +N+P   P S  
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
             I++A E+   + +L++ K    VH DL   N ++  +F  K+ DFG++R + + +   
Sbjct: 124 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX- 179
Query: 295 NNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE 350
                  R   KG     +M PE L  G  T  SDV+SFG++L  +  L  +P  G++ E
Sbjct: 180 -------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 232
Query: 351 --VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
             +++ ++ G L         D P    + L  L   C + + K RP
Sbjct: 233 QVLRFVMEGGLL---------DKPDNCPDMLLELMRMCWQYNPKMRP 270

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 197
           KIG+G  G++Y  +      +VAI+ ++            EI ++ + ++PN+V      
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 198 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           LVG   E+W +V EYL  GSL D ++  C D     +      +  E    L FLHS   
Sbjct: 88  LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 135
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           + ++H ++K  NILL  +   KL+DFG    ++  +  S  +T+       GT  +M PE
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPE 187
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +      PK D++S GI+ + ++ G P
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 115/237 (48%), Gaps = 34/237 (14%)
Query: 145 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVG 200
           K+G G YG +   +  + H++ AIK++   S+     S+  +E+ +L  + HPN++ L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 201 ACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              +   + LV E    G L D +  +     +     I+   ++ S + +LH    H+I
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK---QVLSGVTYLH---KHNI 157
Query: 259 VHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH DLKP N+LL++   + + K+ DFG+S       +  N   +  R    GT  Y+ PE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLS------AVFENQKKMKERL---GTAYYIAPE 208
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALG------ITKEVQ---YALDTGKLKNL 363
            L   +   K DV+S G+IL  LL G P  G      I ++V+   Y  D+ + KN+
Sbjct: 209 VLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 152
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 153 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 204
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 152
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 153 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 204
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 134/293 (45%), Gaps = 43/293 (14%)
Query: 128 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSE 179
           F   E E A      S ++G+G +G +Y+G+ + +       +VAIK ++   S++   E
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 180 FQQEIDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSC----KDNSP---P 230
           F  E  ++ +    ++V L+G   +     ++ E +  G L+  L       +N+P   P
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 231 LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 290
            S    I++A E+   + +L++ K    VH DL   N ++  +F  K+ DFG++R + + 
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 182
Query: 291 EISSNNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALG 346
           +          R   KG     +M PE L  G  T  SDV+SFG++L  +  L  +P  G
Sbjct: 183 DYY--------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 234
Query: 347 ITKE--VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
           ++ E  +++ ++ G L         D P    + L  L   C + + K RP  
Sbjct: 235 LSNEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSF 278

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 125/286 (43%), Gaps = 34/286 (11%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE----FQQEIDILSKIRHPNLVTLVGA 201
           +G+G +G   K  + H +    M+    ++   E    F +E+ ++  + HPN++  +G 
Sbjct: 18  LGKGCFGQAIK--VTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 202 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +    + EY+  G+L   +   D+  P  W  R+  A ++ S + +LHS    +I+
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYLHSM---NII 130
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK------GTFAYMD 313
           H DL   N L+  N    ++DFG++R +   +          + D K      G   +M 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY---ALDTG-KLKNLLDPLAG 369
           PE +       K DV+SFGI+L  ++ GR    +  +  Y    +D G  ++  LD    
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII-GR----VNADPDYLPRTMDFGLNVRGFLDRYC- 244
Query: 370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK-DVWRVLEPMRASCGG 414
             P         + +RCC++  + RP   K + W  LE +R    G
Sbjct: 245 --PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW--LETLRMHLAG 286

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 43/289 (14%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQE 183
           E E A      S ++G+G +G +Y+G+ + +       +VAIK ++   S++   EF  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 184 IDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSC----KDNSP---PLSWQ 234
             ++ +    ++V L+G   +     ++ E +  G L+  L       +N+P   P S  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
             I++A E+   + +L++ K    VH DL   N ++  +F  K+ DFG++R + + +   
Sbjct: 126 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY- 181
Query: 295 NNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE 350
                  R   KG     +M PE L  G  T  SDV+SFG++L  +  L  +P  G++ E
Sbjct: 182 -------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 234
Query: 351 --VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
             +++ ++ G L         D P    + L  L   C + + K RP  
Sbjct: 235 QVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSF 274

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 43/289 (14%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQE 183
           E E A      S ++G+G +G +Y+G+ + +       +VAIK ++   S++   EF  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 184 IDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSC----KDNSP---PLSWQ 234
             ++ +    ++V L+G   +     ++ E +  G L+  L       +N+P   P S  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
             I++A E+   + +L++ K    VH DL   N ++  +F  K+ DFG++R + + +   
Sbjct: 132 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY- 187
Query: 295 NNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE 350
                  R   KG     +M PE L  G  T  SDV+SFG++L  +  L  +P  G++ E
Sbjct: 188 -------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 240
Query: 351 --VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
             +++ ++ G L         D P    + L  L   C + + K RP  
Sbjct: 241 QVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSF 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 114/238 (47%), Gaps = 34/238 (14%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGA 201
           +G+G +G + K   R  Q   A+K+++  S +    S   +E+++L K+ HPN++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 202 CPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
             +   + +V E    G L D +  +      S     RI  ++ S + ++H    H+IV
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNIV 143
Query: 260 HGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           H DLKP NILL++   +   K+ DFG+S    Q      NT +    D  GT  Y+ PE 
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKM---KDRIGTAYYIAPEV 194
Query: 317 LASGELTPKSDVYSFGIILLRLLTGRPAL------GITKEVQ---YALDTGKLKNLLD 365
           L  G    K DV+S G+IL  LL+G P         I K V+   YA D  + + + D
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 145 KIGEGGYGSIYKGLLRHM--QVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT---- 197
           ++G GG+G + + + +    QVAIK      S +    +  EI I+ K+ HPN+V+    
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 198 ---LVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
              L    P ++  L  EY   G L   L+  +N   L       + +++ S L +LH  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 140
Query: 254 KPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
             + I+H DLKP NI+L       + K+ D G ++ L Q E       LC  T+  GT  
Sbjct: 141 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-------LC--TEFVGTLQ 189
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQY 353
           Y+ PE L   + T   D +SFG +    +TG RP L   + VQ+
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 233

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 121/275 (44%), Gaps = 48/275 (17%)
Query: 146 IGEGGYGSIYKGLLRHM----QVAIKM-----LHPHSLQGPSEFQQEIDILSKIRHPNLV 196
           IG+G +  +   L RH+    +VAIK+     L+P SLQ   +  +E+ I+  + HPN+V
Sbjct: 20  IGKGNFAKV--KLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIV 74
Query: 197 TL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L  V    +   L+ EY   G + D L           +++ R       ++  +  C 
Sbjct: 75  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR------QIVSAVQYCH 128
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              IVH DLK  N+LLDA+   K++DFG S   ++  +     T C      G+  Y  P
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDTFC------GSPPYAAP 179
Query: 315 EFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGDW- 371
           E     +   P+ DV+S G+IL  L++G              D   LK L +  L G + 
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVSG----------SLPFDGQNLKELRERVLRGKYR 229
Query: 372 -PFVQAEQLANLAMRCCEMS---RKSRPELGKDVW 402
            PF  +    NL  R   ++   R +  ++ KD W
Sbjct: 230 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 264

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 43/289 (14%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQE 183
           E E A      S ++G+G +G +Y+G+ + +       +VAIK ++   S++   EF  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 184 IDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSC----KDNSP---PLSWQ 234
             ++ +    ++V L+G   +     ++ E +  G L+  L       +N+P   P S  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
             I++A E+   + +L++ K    VH DL   N ++  +F  K+ DFG++R + + +   
Sbjct: 132 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY- 187
Query: 295 NNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE 350
                  R   KG     +M PE L  G  T  SDV+SFG++L  +  L  +P  G++ E
Sbjct: 188 -------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 240
Query: 351 --VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
             +++ ++ G L         D P    + L  L   C + + K RP  
Sbjct: 241 QVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSF 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 114/238 (47%), Gaps = 34/238 (14%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGA 201
           +G+G +G + K   R  Q   A+K+++  S +    S   +E+++L K+ HPN++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 202 CPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
             +   + +V E    G L D +  +      S     RI  ++ S + ++H    H+IV
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNIV 143
Query: 260 HGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           H DLKP NILL++   +   K+ DFG+S    Q      NT +    D  GT  Y+ PE 
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKM---KDRIGTAYYIAPEV 194
Query: 317 LASGELTPKSDVYSFGIILLRLLTGRPAL------GITKEVQ---YALDTGKLKNLLD 365
           L  G    K DV+S G+IL  LL+G P         I K V+   YA D  + + + D
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 43/289 (14%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQE 183
           E E A      S ++G+G +G +Y+G+ + +       +VAIK ++   S++   EF  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 184 IDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSC----KDNSP---PLSWQ 234
             ++ +    ++V L+G   +     ++ E +  G L+  L       +N+P   P S  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
             I++A E+   + +L++ K    VH DL   N ++  +F  K+ DFG++R + + +   
Sbjct: 133 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-- 187
Query: 295 NNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE 350
                  R   KG     +M PE L  G  T  SDV+SFG++L  +  L  +P  G++ E
Sbjct: 188 ------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 241
Query: 351 --VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
             +++ ++ G L         D P    + L  L   C + + K RP  
Sbjct: 242 QVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSF 281

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 21/184 (11%)
Query: 164 VAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPEVWT----LVYEYLPNG 216
           VA+K L   +  GP   S ++QEIDIL  + H +++   G C +       LV EY+P G
Sbjct: 63  VAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLG 120
Query: 217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
           SL D L        +     +  A ++C  + +LH+      +H DL   N+LLD + + 
Sbjct: 121 SLRDYLP----RHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLV 173
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG+++      +   +     R D      +  PE L   +    SDV+SFG+ L 
Sbjct: 174 KIGDFGLAK-----AVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 337 RLLT 340
            LLT
Sbjct: 229 ELLT 232

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 106/250 (42%), Gaps = 45/250 (18%)
Query: 145 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGP-------------SEFQQEIDILSK 189
           K+G G YG +   K    H + AIK++                      E   EI +L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 190 IRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           + HPN++ L     +   + LV E+   G L +++    N           I  ++ S +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGI 159
Query: 248 IFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
            +LH    H+IVH D+KP NILL+        K+ DFG+S F S++             D
Sbjct: 160 CYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---------YKLRD 207
Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG------ITKEVQ---YAL 355
             GT  Y+ PE L   +   K DV+S G+I+  LL G P  G      I K+V+   Y  
Sbjct: 208 RLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266
Query: 356 DTGKLKNLLD 365
           D    KN+ D
Sbjct: 267 DFNDWKNISD 276

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 145 KIGEGGYGSIYKGLLRHM--QVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT---- 197
           ++G GG+G + + + +    QVAIK      S +    +  EI I+ K+ HPN+V+    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 198 ---LVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
              L    P ++  L  EY   G L   L+  +N   L       + +++ S L +LH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 254 KPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
             + I+H DLKP NI+L       + K+ D G ++ L Q E       LC  T+  GT  
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-------LC--TEFVGTLQ 188
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQY 353
           Y+ PE L   + T   D +SFG +    +TG RP L   + VQ+
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 127/274 (46%), Gaps = 43/274 (15%)
Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G  R +       +VA+K ++   SL+   EF  E  ++      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 197 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 247
            L+G     +   +V E + +G L+  L             PP + Q  I++A E+   +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH +L   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 145 AYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY--------YRKGGKG 193
Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SD++SFG++L  +  L  +P  G++ E  +++ +D G L 
Sbjct: 194 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 252
Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   D P    E++ +L   C + +   RP
Sbjct: 253 --------DQPDNCPERVTDLMRMCWQFNPNMRP 278

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 127/274 (46%), Gaps = 43/274 (15%)
Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G  R +       +VA+K ++   SL+   EF  E  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 197 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 247
            L+G     +   +V E + +G L+  L             PP + Q  I++A E+   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++ K    VH +L   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 144 AYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------RKGGKG 192
Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 361
                +M PE L  G  T  SD++SFG++L  +  L  +P  G++ E  +++ +D G L 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 251
Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   D P    E++ +L   C + +   RP
Sbjct: 252 --------DQPDNCPERVTDLMRMCWQFNPNMRP 277

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 29/211 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGACP 203
           IG G YG++YKG L    VA+K+    S      F  E +I  +  + H N+   +    
Sbjct: 21  IGRGRYGAVYKGSLDERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 204 EV-------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
            V       + LV EY PNGSL   LS   +     W +  R+A  +   L +LH+  P 
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 257 ------SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
                 +I H DL   N+L+  +    +SDFG+S  L+ N +              GT  
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 311 YMDPEFLASG-------ELTPKSDVYSFGII 334
           YM PE L              + D+Y+ G+I
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLI 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +IG+G +G ++KG+    Q  VAIK++    +     + QQEI +LS+     +    G+
Sbjct: 30  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGS 89
Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKP 255
                ++W ++ EYL  GS  D L     + P       +IAT   E+   L +LHS K 
Sbjct: 90  YLKGSKLW-IIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYLHSEKK 141
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
              +H D+K AN+LL      KL+DFG++  L+  +I  N           GT  +M PE
Sbjct: 142 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPE 190
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +       K+D++S GI  + L  G P
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEP 218

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L + +
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 135
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H +L   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 136 ---YIHRNLATRNILVENENRVKIGDFGLTKVLPQDK-----EYYKVKEPGESPIFWYAP 187
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 132/289 (45%), Gaps = 43/289 (14%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQE 183
           E E A      S ++G+G +G +Y+G+ + +       +VAIK ++   S++   EF  E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 184 IDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLS----CKDNSP---PLSWQ 234
             ++ +    ++V L+G   +     ++ E +  G L+  L        N+P   P S  
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
             I++A E+   + +L++ K    VH DL   N ++  +F  K+ DFG++R + + +   
Sbjct: 129 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY- 184
Query: 295 NNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE 350
                  R   KG     +M PE L  G  T  SDV+SFG++L  +  L  +P  G++ E
Sbjct: 185 -------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 237
Query: 351 --VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
             +++ ++ G L         D P    + L  L   C + + K RP  
Sbjct: 238 QVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSF 277

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 30/231 (12%)
Query: 129 SFSEIEGATHNFDPS------LKIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEF 180
           S  + E  T + +P        ++G+G +G +YK   +   V  A K++   S +   ++
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 181 QQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI 237
             EIDIL+   HPN+V L+ A      +W L+ E+   G++ D +  +   P    Q ++
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAV-DAVMLELERPLTESQIQV 139
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
            +  +    L +LH  K   I+H DLK  NIL   +   KL+DFG+S        + N  
Sbjct: 140 -VCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTR 187
Query: 298 TLCCRTDPKGTFAYMDPEFLA--SGELTP---KSDVYSFGIILLRLLTGRP 343
           T+  R    GT  +M PE +   + +  P   K+DV+S GI L+ +    P
Sbjct: 188 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 132/289 (45%), Gaps = 43/289 (14%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLH-PHSLQGPSEFQQE 183
           E E A      S ++G+G +G +Y+G+ + +       +VAIK ++   S++   EF  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 184 IDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSC----KDNSP---PLSWQ 234
             ++ +    ++V L+G   +     ++ E +  G L+  L       +N+P   P S  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
             I++A E+   + +L++ K    VH DL   N  +  +F  K+ DFG++R + + +   
Sbjct: 126 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY- 181
Query: 295 NNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE 350
                  R   KG     +M PE L  G  T  SDV+SFG++L  +  L  +P  G++ E
Sbjct: 182 -------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 234
Query: 351 --VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
             +++ ++ G L         D P    + L  L   C + + K RP  
Sbjct: 235 QVLRFVMEGGLL---------DKPDNCPDMLLELMRMCWQYNPKMRPSF 274

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSE-FQQEIDILSK 189
           +DP   IG G    + + + R          M+V  + L P  L+   E  ++E  IL +
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 190 IR-HPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           +  HP+++TL+ +        LV++ +  G L D L+ K     LS +    I   L   
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEA 212
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           + FLH+   ++IVH DLKP NILLD N   +LSDFG S  L   E       LC      
Sbjct: 213 VSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELC------ 260
Query: 307 GTFAYMDPEFL--ASGELTP----KSDVYSFGIILLRLLTGRPALGITKEV 351
           GT  Y+ PE L  +  E  P    + D+++ G+IL  LL G P     +++
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL- 198
           IG+G +  +   L RH+    +VA+K++    L   S  +  +E+ I+  + HPN+V L 
Sbjct: 15  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V    +   LV EY   G + D L          W        +   ++  +  C    
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYLVAH------GWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMDPE 315
           IVH DLK  N+LLDA+   K++DFG S     NE +  N   T C      G+  Y  PE
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDTFC------GSPPYAAPE 175
Query: 316 FLASGELT-PKSDVYSFGIILLRLLTG 341
                +   P+ DV+S G+IL  L++G
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 117/258 (45%), Gaps = 41/258 (15%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQG----PSEFQQEIDILS 188
           AT  ++P  +IG G YG++YK    H    VA+K +  P+   G    P    +E+ +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 189 KIR---HPNLVTLVGACPEV-------WTLVYEYLPNGSLEDRLSCKDNSPP--LSWQTR 236
           ++    HPN+V L+  C           TLV+E++     +D  +  D +PP  L  +T 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETI 122
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS-QNEISSN 295
             +  +    L FLH+   + IVH DLKP NIL+ +    KL+DFG++R  S Q  ++  
Sbjct: 123 KDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179
Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 355
             TL  R           PE L         D++S G I   +   +P      E   A 
Sbjct: 180 VVTLWYRA----------PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---AD 226
Query: 356 DTGKLKNLLD-PLAGDWP 372
             GK+ +L+  P   DWP
Sbjct: 227 QLGKIFDLIGLPPEDDWP 244

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 25/224 (11%)
Query: 183 EIDILSKIRHPNLVT----LVGACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRI 237
           E+++L +++HPN+V     ++        +V EY   G L   ++        L  +  +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 238 RIATELCSVLIFLH--SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
           R+ T+L   L   H  S   H+++H DLKPAN+ LD     KL DFG++R L+ +E  + 
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK 174
Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI--TKEVQY 353
                      GT  YM PE +       KSD++S G +L  L    P       KE+  
Sbjct: 175 EFV--------GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226
Query: 354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
            +  GK + +        P+  +++L  +  R   +    RP +
Sbjct: 227 KIREGKFRRI--------PYRYSDELNEIITRMLNLKDYHRPSV 262

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        M VAIK     +     E F QE   + +  HP++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L   + I  A +L + L +L S +   
Sbjct: 458 GVITENPVW-IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLESKR--- 511
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-------DSTYYKASKGKLPIKWMAPESI 564
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 145 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 196
           K+G+G +G + +G       + + VA+K L P  L  P    +F +E++ +  + H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L G    P +  +V E  P GSL DRL        L   T  R A ++   + +L S +
Sbjct: 79  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKR 135
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   N+LL    + K+ DFG+ R L QN+          +   K  FA+  P
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHRKVPFAWCAP 187
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L +   +  SD + FG+ L  + T
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 120/264 (45%), Gaps = 34/264 (12%)
Query: 135 GATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSK 189
           G +  +    K+G G YG +   K  L   + AIK++   S+   S       E+ +L +
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 190 IRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           + HPN++ L     +   + LV E    G L D +  +     +       I  ++ S  
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGT 117
Query: 248 IFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
            +LH    H+IVH DLKP N+LL++   + + K+ DFG+S   +  E+           +
Sbjct: 118 TYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGK------MKE 165
Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG--ITKEVQYALDTGKLKN 362
             GT  Y+ PE L   +   K DV+S G+IL  LL G P  G    +E+   ++ GK   
Sbjct: 166 RLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFS- 223
Query: 363 LLDPLAGDWPFV--QAEQLANLAM 384
             DP   DW  V  +A+QL  L +
Sbjct: 224 -FDP--PDWTQVSDEAKQLVKLML 244

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 145 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 196
           K+G+G +G + +G       + + VA+K L P  L  P    +F +E++ +  + H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L G    P +  +V E  P GSL DRL        L   T  R A ++   + +L S +
Sbjct: 85  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKR 141
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   N+LL    + K+ DFG+ R L Q     N+     +   K  FA+  P
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-----NDDHYVMQEHRKVPFAWCAP 193
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L +   +  SD + FG+ L  + T
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 146 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           +G+G YG +Y G  L   +++AIK +     +      +EI +   ++H N+V  +G+  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 204 E--VWTLVYEYLPNGSLEDRLSC-----KDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           E     +  E +P GSL   L       KDN   + + T+     ++   L +LH    +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHD---N 141
Query: 257 SIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
            IVH D+K  N+L++  + V K+SDFG S+ L+           C  T   GT  YM PE
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-------GINPCTETF-TGTLQYMAPE 193
Query: 316 FLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 355
            +  G       +D++S G  ++ + TG+P      E Q A+
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 145 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 196
           K+G+G +G + +G       + + VA+K L P  L  P    +F +E++ +  + H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L G    P +  +V E  P GSL DRL        L   T  R A ++   + +L S +
Sbjct: 79  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKR 135
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   N+LL    + K+ DFG+ R L Q     N+     +   K  FA+  P
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-----NDDHYVMQEHRKVPFAWCAP 187
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L +   +  SD + FG+ L  + T
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 145 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 196
           K+G+G +G + +G       + + VA+K L P  L  P    +F +E++ +  + H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L G    P +  +V E  P GSL DRL        L   T  R A ++   + +L S +
Sbjct: 85  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKR 141
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   N+LL    + K+ DFG+ R L Q     N+     +   K  FA+  P
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-----NDDHXVMQEHRKVPFAWCAP 193
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L +   +  SD + FG+ L  + T
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+       +Q      VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 199 VGACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ E+LP GSL + L  + +   +     ++  +++C  + +L + +
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 138 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESPIFWYAP 189
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 145 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 196
           K+G+G +G + +G       + + VA+K L P  L  P    +F +E++ +  + H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L G    P +  +V E  P GSL DRL        L   T  R A ++   + +L S +
Sbjct: 75  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKR 131
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   N+LL    + K+ DFG+ R L Q     N+     +   K  FA+  P
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-----NDDHYVMQEHRKVPFAWCAP 183
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L +   +  SD + FG+ L  + T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 121/266 (45%), Gaps = 34/266 (12%)
Query: 133 IEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDIL 187
            +G +  +    K+G G YG +   K  L   + AIK++   S+   S       E+ +L
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 188 SKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
            ++ HPN++ L     +   + LV E    G L D +  +     +       I  ++ S
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLS 132
Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCR 302
              +LH    H+IVH DLKP N+LL++   + + K+ DFG+S   +  E+          
Sbjct: 133 GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGK------M 180
Query: 303 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG--ITKEVQYALDTGKL 360
            +  GT  Y+ PE L   +   K DV+S G+IL  LL G P  G    +E+   ++ GK 
Sbjct: 181 KERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKF 239
Query: 361 KNLLDPLAGDWPFV--QAEQLANLAM 384
               DP   DW  V  +A+QL  L +
Sbjct: 240 S--FDP--PDWTQVSDEAKQLVKLML 261

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 145 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 196
           K+G+G +G + +G       + + VA+K L P  L  P    +F +E++ +  + H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L G    P +  +V E  P GSL DRL        L   T  R A ++   + +L S +
Sbjct: 75  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKR 131
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   N+LL    + K+ DFG+ R L Q     N+     +   K  FA+  P
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-----NDDHXVMQEHRKVPFAWCAP 183
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L +   +  SD + FG+ L  + T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKM-----LHPHSLQGPSEFQQEIDILSK 189
           N+     IG+G +  +   L RH+    +VA+K+     L+P SLQ   +  +E+ I+  
Sbjct: 16  NYRLQKTIGKGNFAKV--KLARHVLTGREVAVKIIDKTQLNPTSLQ---KLFREVRIMKI 70
Query: 190 IRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           + HPN+V L  V    +   LV EY   G + D L           + + R       ++
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR------QIV 124
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDP 305
             +  C    IVH DLK  N+LLD +   K++DFG S     NE +  N   T C     
Sbjct: 125 SAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFS-----NEFTVGNKLDTFC----- 174
Query: 306 KGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTG 341
            G+  Y  PE     +   P+ DV+S G+IL  L++G
Sbjct: 175 -GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 145 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 196
           K+G+G +G + +G       + + VA+K L P  L  P    +F +E++ +  + H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L G    P +  +V E  P GSL DRL        L   T  R A ++   + +L S +
Sbjct: 75  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLESKR 131
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   N+LL    + K+ DFG+ R L Q     N+     +   K  FA+  P
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-----NDDHYVMQEHRKVPFAWCAP 183
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L +   +  SD + FG+ L  + T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL- 198
           IG+G +  +   L RH+    +VA+K++    L   S  +  +E+ I+  + HPN+V L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V    +   LV EY   G + D L           + + R       ++  +  C    
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR------QIVSAVQYCHQKF 133
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMDPE 315
           IVH DLK  N+LLDA+   K++DFG S     NE +  N   T C      G+  Y  PE
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDTFC------GSPPYAAPE 182
Query: 316 FLASGELT-PKSDVYSFGIILLRLLTG 341
                +   P+ DV+S G+IL  L++G
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +GEG +G +Y+G+  +     + VA+K      +L    +F  E  I+  + HP++V L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E   W ++ E  P G L   L    NS  L   T +  + ++C  + +L S    +
Sbjct: 76  GIIEEEPTW-IIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESI---N 129
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   NIL+ +    KL DFG+SR++   +    + T       +    +M PE +
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT-------RLPIKWMSPESI 182
Query: 318 ASGELTPKSDVYSFGIILLRLLT 340
                T  SDV+ F + +  +L+
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILS 205

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        M VAIK     +     E F QE   + +  HP++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L+  + I  A +L + L +L S     
Sbjct: 78  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLES---KR 131
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------EDSTYYKASKGKLPIKWMAPESI 184
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL- 198
           IG+G +  +   L RH+    +VA+K++    L   S  +  +E+ I+  + HPN+V L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V    +   LV EY   G + D L           + + R       ++  +  C    
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR------QIVSAVQYCHQKF 133
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMDPE 315
           IVH DLK  N+LLDA+   K++DFG S     NE +  N   T C      G+  Y  PE
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDTFC------GSPPYAAPE 182
Query: 316 FLASGELT-PKSDVYSFGIILLRLLTG 341
                +   P+ DV+S G+IL  L++G
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 120/276 (43%), Gaps = 50/276 (18%)
Query: 146 IGEGGYGSIYKGLLRHM----QVAIKM-----LHPHSLQGPSEFQQEIDILSKIRHPNLV 196
           IG+G +  +   L RH+    +VAIK+     L+P SLQ   +  +E+ I+  + HPN+V
Sbjct: 23  IGKGNFAKV--KLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIV 77
Query: 197 TL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L  V    +   L+ EY   G + D L           +++ R       ++  +  C 
Sbjct: 78  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR------QIVSAVQYCH 131
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK-GTFAYMD 313
              IVH DLK  N+LLDA+   K++DFG           SN  T+  + D   G   Y  
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGF----------SNEFTVGGKLDAFCGAPPYAA 181
Query: 314 PEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGDW 371
           PE     +   P+ DV+S G+IL  L++G              D   LK L +  L G +
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSG----------SLPFDGQNLKELRERVLRGKY 231
Query: 372 --PFVQAEQLANLAMRCCEMS---RKSRPELGKDVW 402
             PF  +    NL  R   ++   R +  ++ KD W
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 109/240 (45%), Gaps = 39/240 (16%)
Query: 145 KIGEGGYGS--IYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 200
           KIGEG +G   + K      Q  IK ++   +      E ++E+ +L+ ++HPN+V    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 201 ACPEVWTL--VYEYLPNGSLEDRLSCKDN-----SPPLSWQTRIRIATELCSVLIFLHSC 253
           +  E  +L  V +Y   G L  R++ +          L W  +I      C  L  +H  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHDR 144
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           K   I+H D+K  NI L  +   +L DFGI+R L        N+T+       GT  Y+ 
Sbjct: 145 K---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL--------NSTVELARACIGTPYYLS 193
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL-LDPLAGDWP 372
           PE   +     KSD+++ G +L  L T          +++A + G +KNL L  ++G +P
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCT----------LKHAFEAGSMKNLVLKIISGSFP 243

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +GEG +G +Y+G+  +     + VA+K      +L    +F  E  I+  + HP++V L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E   W ++ E  P G L   L    NS  L   T +  + ++C  + +L S    +
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESI---N 133
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   NIL+ +    KL DFG+SR++   +    + T       +    +M PE +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT-------RLPIKWMSPESI 186
Query: 318 ASGELTPKSDVYSFGIILLRLLT 340
                T  SDV+ F + +  +L+
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 129 SFSEIEGATHNFDPS------LKIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEF 180
           S  + E  T + +P        ++G+G +G +YK   +   V  A K++   S +   ++
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 181 QQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI 237
             EIDIL+   HPN+V L+ A      +W L+ E+   G++ D +  +   P    Q ++
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAV-DAVMLELERPLTESQIQV 139
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
            +  +    L +LH  K   I+H DLK  NIL   +   KL+DFG         +S+ NT
Sbjct: 140 -VCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFG---------VSAKNT 186
Query: 298 TLCCRTDP-KGTFAYMDPEFLA--SGELTP---KSDVYSFGIILLRLLTGRP 343
               R D   GT  +M PE +   + +  P   K+DV+S GI L+ +    P
Sbjct: 187 RXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +GEG +G +Y+G+  +     + VA+K      +L    +F  E  I+  + HP++V L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E   W ++ E  P G L   L    NS  L   T +  + ++C  + +L S    +
Sbjct: 92  GIIEEEPTW-IIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESI---N 145
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   NIL+ +    KL DFG+SR++   +    + T       +    +M PE +
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT-------RLPIKWMSPESI 198
Query: 318 ASGELTPKSDVYSFGIILLRLLT 340
                T  SDV+ F + +  +L+
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILS 221

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        M VAIK     +     E F QE   + +  HP++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L   + I  A +L + L +L S +   
Sbjct: 458 GVITENPVW-IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLESKR--- 511
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ A    KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYME-------DSTYYKASKGKLPIKWMAPESI 564
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 144 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 198
           +++G G +GS+ +G+ R     + VAIK+L   + +  +E   +E  I+ ++ +P +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E   LV E    G L   L  K    P+S      +A  L  V + +   +  +
Sbjct: 402 IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS-----NVAELLHQVSMGMKYLEEKN 456
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH +L   N+LL     +K+SDFG+S+ L      ++++    R+  K    +  PE +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKAL-----GADDSYYTARSAGKWPLKWYAPECI 511
Query: 318 ASGELTPKSDVYSFGIILLRLLT 340
              + + +SDV+S+G+ +   L+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 183 EIDILSKIRHPNLVT----LVGACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRI 237
           E+++L +++HPN+V     ++        +V EY   G L   ++        L  +  +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 238 RIATELCSVLIFLH--SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
           R+ T+L   L   H  S   H+++H DLKPAN+ LD     KL DFG++R L+ +  +S 
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSF 172
Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI--TKEVQY 353
             T        GT  YM PE +       KSD++S G +L  L    P       KE+  
Sbjct: 173 AKTFV------GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226
Query: 354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
            +  GK + +        P+  +++L  +  R   +    RP +
Sbjct: 227 KIREGKFRRI--------PYRYSDELNEIITRMLNLKDYHRPSV 262

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        M VAIK     +     E F QE   + +  HP++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L+  + I  A +L + L +L S     
Sbjct: 78  GVITENPVW-IIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLES---KR 131
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------EDSTXXKASKGKLPIKWMAPESI 184
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 129 SFSEIEGATHNFDPS------LKIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEF 180
           S  + E  T + +P        ++G+G +G +YK   +   V  A K++   S +   ++
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 181 QQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI 237
             EIDIL+   HPN+V L+ A      +W L+ E+   G++ D +  +   P    Q ++
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAV-DAVMLELERPLTESQIQV 139
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
            +  +    L +LH  K   I+H DLK  NIL   +   KL+DFG         +S+ NT
Sbjct: 140 -VCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFG---------VSAKNT 186
Query: 298 TLCCRTDP-KGTFAYMDPEFLA--SGELTP---KSDVYSFGIILLRLLTGRP 343
               R D   GT  +M PE +   + +  P   K+DV+S GI L+ +    P
Sbjct: 187 RXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 87/185 (47%), Gaps = 21/185 (11%)
Query: 165 AIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDR 221
           A+K +   +L+G  S  + EI +L KI+H N+V L  +   P    LV + +  G L DR
Sbjct: 51  AVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDR 110
Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKL 278
           +  K         T IR   ++   + +LH      IVH DLKP N+L    D      +
Sbjct: 111 IVEKGFYTEKDASTLIR---QVLDAVYYLHRM---GIVHRDLKPENLLYYSQDEESKIMI 164
Query: 279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL 338
           SDFG+S+   + ++ S   T C      GT  Y+ PE LA    +   D +S G+I   L
Sbjct: 165 SDFGLSKMEGKGDVMS---TAC------GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYIL 215
Query: 339 LTGRP 343
           L G P
Sbjct: 216 LCGYP 220

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 164 VAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEYLPNG 216
           VA+K L      GP   S ++QEIDIL  + H +++   G C +       LV EY+P G
Sbjct: 46  VAVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLG 103
Query: 217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
           SL D L        +     +  A ++C  + +LHS      +H +L   N+LLD + + 
Sbjct: 104 SLRDYLP----RHSIGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDRLV 156
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG+++      +   +     R D      +  PE L   +    SDV+SFG+ L 
Sbjct: 157 KIGDFGLAK-----AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 337 RLLT 340
            LLT
Sbjct: 212 ELLT 215

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 146 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           +G+G YG +Y G  L   +++AIK +     +      +EI +   ++H N+V  +G+  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 204 E--VWTLVYEYLPNGSLEDRLSC-----KDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           E     +  E +P GSL   L       KDN   + + T+     ++   L +LH    +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHD---N 127
Query: 257 SIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
            IVH D+K  N+L++  + V K+SDFG S+ L+           C  T   GT  YM PE
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-------GINPCTETF-TGTLQYMAPE 179
Query: 316 FLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 355
            +  G       +D++S G  ++ + TG+P      E Q A+
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 221

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 132/301 (43%), Gaps = 60/301 (19%)
Query: 146 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNL 195
           +GEG +G + K    H++       VA+KML  ++   PSE +    E ++L ++ HP++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHV 88
Query: 196 VTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPP---------------------LS 232
           + L GAC +     L+ EY   GSL   L       P                     L+
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
               I  A ++   + +L   K   +VH DL   NIL+      K+SDFG+SR + + + 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED- 204
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE 350
                +   R+  +    +M  E L     T +SDV+SFG++L  ++T  G P  GI  E
Sbjct: 205 -----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 351 VQYALDTGKLKNLLDPLAG---DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 407
                   +L NLL    G   + P   +E++  L ++C +     RP    D+ + LE 
Sbjct: 260 --------RLFNLLK--TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA-DISKDLEK 308
Query: 408 M 408
           M
Sbjct: 309 M 309

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 146 IGEGGYGSI-----YKGLLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 197
           +GEG +G +     YK      +VA+K +    L+        ++EI  L  +RHP+++ 
Sbjct: 17  LGEGSFGKVKLATHYKT---QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 198 L--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           L  V   P    +V EY   G L D +  K        + R      +C++      C  
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMT--EDEGRRFFQQIICAI----EYCHR 126
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           H IVH DLKP N+LLD N   K++DFG+S  ++      N     C     G+  Y  PE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT----DGNFLKTSC-----GSPNYAAPE 177
Query: 316 FLASGELT--PKSDVYSFGIILLRLLTGR 342
            + +G+L   P+ DV+S GI+L  +L GR
Sbjct: 178 VI-NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 132/301 (43%), Gaps = 60/301 (19%)
Query: 146 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNL 195
           +GEG +G + K    H++       VA+KML  ++   PSE +    E ++L ++ HP++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHV 88
Query: 196 VTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPP---------------------LS 232
           + L GAC +     L+ EY   GSL   L       P                     L+
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
               I  A ++   + +L   K   +VH DL   NIL+      K+SDFG+SR + + + 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED- 204
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE 350
                +   R+  +    +M  E L     T +SDV+SFG++L  ++T  G P  GI  E
Sbjct: 205 -----SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 351 VQYALDTGKLKNLLDPLAG---DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 407
                   +L NLL    G   + P   +E++  L ++C +     RP    D+ + LE 
Sbjct: 260 --------RLFNLLK--TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA-DISKDLEK 308
Query: 408 M 408
           M
Sbjct: 309 M 309

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL- 198
           IG+G +  +   L RH+    +VA++++    L   S  +  +E+ I+  + HPN+V L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V    +   LV EY   G + D L           + + R       ++  +  C    
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR------QIVSAVQYCHQKF 133
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMDPE 315
           IVH DLK  N+LLDA+   K++DFG S     NE +  N   T C      G+  Y  PE
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDTFC------GSPPYAAPE 182
Query: 316 FLASGELT-PKSDVYSFGIILLRLLTG 341
                +   P+ DV+S G+IL  L++G
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        + VAIK     +     E F QE   + +  HP++V L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L+  + I  A +L + L +L S     
Sbjct: 75  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLES---KR 128
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------EDSTYYKASKGKLPIKWMAPESI 181
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 182 NFRRFTSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        + VAIK     +     E F QE   + +  HP++V L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L+  + I  A +L + L +L S     
Sbjct: 80  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLES---KR 133
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------EDSTYYKASKGKLPIKWMAPESI 186
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 187 NFRRFTSASDVWMFGVCMWEIL 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 132/301 (43%), Gaps = 60/301 (19%)
Query: 146 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNL 195
           +GEG +G + K    H++       VA+KML  ++   PSE +    E ++L ++ HP++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHV 88
Query: 196 VTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPP---------------------LS 232
           + L GAC +     L+ EY   GSL   L       P                     L+
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
               I  A ++   + +L      S+VH DL   NIL+      K+SDFG+SR + + + 
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED- 204
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE 350
                +   R+  +    +M  E L     T +SDV+SFG++L  ++T  G P  GI  E
Sbjct: 205 -----SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 351 VQYALDTGKLKNLLDPLAG---DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 407
                   +L NLL    G   + P   +E++  L ++C +     RP    D+ + LE 
Sbjct: 260 --------RLFNLLK--TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA-DISKDLEK 308
Query: 408 M 408
           M
Sbjct: 309 M 309

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        + VAIK     +     E F QE   + +  HP++V L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L+  + I  A +L + L +L S     
Sbjct: 81  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLES---KR 134
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------EDSTYYKASKGKLPIKWMAPESI 187
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 188 NFRRFTSASDVWMFGVCMWEIL 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        M VAIK     +     E F QE   + +  HP++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L+  + I  A +L + L +L S     
Sbjct: 78  GVITENPVW-IIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLES---KR 131
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ A    KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYM-------EDSTYYKASKGKLPIKWMAPESI 184
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        + VAIK     +     E F QE   + +  HP++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L+  + I  A +L + L +L S     
Sbjct: 78  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLES---KR 131
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------EDSTYYKASKGKLPIKWMAPESI 184
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL--V 199
           K+G G Y ++YKGL +   + VA+K +   S +G PS   +EI ++ +++H N+V L  V
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 200 GACPEVWTLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
                  TLV+E++ N      D  +  +    L          +L   L F H  K   
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDPKGTFAYMDPE 315
           I+H DLKP N+L++     KL DFG++R      N  SS   TL  R           P+
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA----------PD 178
Query: 316 FLASGELTPKS-DVYSFGIILLRLLTGRPAL-GITKEVQYAL 355
            L        S D++S G IL  ++TG+P   G   E Q  L
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 25/224 (11%)
Query: 183 EIDILSKIRHPNLVT----LVGACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRI 237
           E+++L +++HPN+V     ++        +V EY   G L   ++        L  +  +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 238 RIATELCSVLIFLH--SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
           R+ T+L   L   H  S   H+++H DLKPAN+ LD     KL DFG++R L+ +   + 
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI--TKEVQY 353
                      GT  YM PE +       KSD++S G +L  L    P       KE+  
Sbjct: 175 AFV--------GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226
Query: 354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
            +  GK + +        P+  +++L  +  R   +    RP +
Sbjct: 227 KIREGKFRRI--------PYRYSDELNEIITRMLNLKDYHRPSV 262

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIK-MLHPHSLQGPSEF-QQEIDILSKIRHPNLVTLVGA 201
           +GEG YG + K   +     VAIK  L     +   +   +EI +L ++RH NLV L+  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 202 CPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
           C +   W LV+E++ +  L+D L    N   L +Q   +   ++ + + F HS   H+I+
Sbjct: 93  CKKKKRWYLVFEFVDHTILDD-LELFPNG--LDYQVVQKYLFQIINGIGFCHS---HNII 146
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQ-NEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           H D+KP NIL+  + V KL DFG +R L+   E+           D   T  Y  PE L 
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD---------DEVATRWYRAPELLV 197
Query: 319 SGELTPKS-DVYSFGIILLRLLTGRP 343
                 K+ DV++ G ++  +  G P
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEP 223

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 164 VAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEYLPNG 216
           VA+K L      GP   S ++QEIDIL  + H +++   G C +       LV EY+P G
Sbjct: 46  VAVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLG 103
Query: 217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
           SL D L        +     +  A ++C  + +LH+      +H +L   N+LLD + + 
Sbjct: 104 SLRDYLP----RHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDRLV 156
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG+++      +   +     R D      +  PE L   +    SDV+SFG+ L 
Sbjct: 157 KIGDFGLAK-----AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 337 RLLT 340
            LLT
Sbjct: 212 ELLT 215

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL- 198
           IG+G +  +   L RH+    +VA+K++    L   S  +  +E+ I+  + HPN+V L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V    +   LV EY   G + D L           + + R       ++  +  C    
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR------QIVSAVQYCHQKF 133
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS-SNNTTLCCRTDPKGTFAYMDPEF 316
           IVH DLK  N+LLDA+   K++DFG S     NE +  N     C   P     Y  PE 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDAFCGAPP-----YAAPEL 183
Query: 317 LASGELT-PKSDVYSFGIILLRLLTG 341
               +   P+ DV+S G+IL  L++G
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        + VAIK     +     E F QE   + +  HP++V L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L   + I  A +L + L +L S +   
Sbjct: 106 GVITENPVW-IIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESKR--- 159
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------EDSTYYKASKGKLPIKWMAPESI 212
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 213 NFRRFTSASDVWMFGVCMWEIL 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 145 KIGEGGYGSIY------KGLLRHMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVT 197
           K+G G +G ++       GL R     IK ++    Q P E  + EI++L  + HPN++ 
Sbjct: 29  KLGSGAFGDVHLVEERSSGLER----VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 198 LVGACPEVWTL--VYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           +     +   +  V E    G L +R+ S +     LS      +  ++ + L + HS  
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-- 142
Query: 255 PHSIVHGDLKPANILL-DANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
              +VH DLKP NIL  D +  S  K+ DFG++     +E S+N           GT  Y
Sbjct: 143 -QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---------GTALY 192
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           M PE     ++T K D++S G+++  LLTG
Sbjct: 193 MAPEVFKR-DVTFKCDIWSAGVVMYFLLTG 221

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           IGEG +G +++G+        + VAIK     +     E F QE   + +  HP++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 200 GACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G   E  VW ++ E    G L   L  +  S  L+  + I  A +L + L +L S +   
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLESKR--- 136
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++        ++T    +  K    +M PE +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------EDSTYYKASKGKLPIKWMAPESI 189
Query: 318 ASGELTPKSDVYSFGIILLRLL 339
                T  SDV+ FG+ +  +L
Sbjct: 190 NFRRFTSASDVWMFGVCMWEIL 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           K+GEG Y ++YKG   L    VA+K +   H    P    +E+ +L  ++H N+VTL  +
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +  TLV+EYL     +D     D+   +     +++   L  +L  L  C    ++
Sbjct: 69  IHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQKVL 122
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 318
           H DLKP N+L++     KL+DFG++R  S    + +N  +        T  Y  P+  L 
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--------TLWYRPPDILLG 174
Query: 319 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 377
           S + + + D++  G I   + TGRP   G T E Q        + L  P    WP + + 
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSN 231
Query: 378 Q 378
           +
Sbjct: 232 E 232

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 115/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++TL+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 216 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 111/228 (48%), Gaps = 30/228 (13%)
Query: 132 EIEGATHNFDPSL------KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQE 183
           E E    + DP+       ++G+G +G +YK   +      A K++   S +   ++  E
Sbjct: 7   EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE 66
Query: 184 IDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 240
           I+IL+   HP +V L+GA     ++W ++ E+ P G++ D +  + +      Q ++ + 
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIMI-EFCPGGAV-DAIMLELDRGLTEPQIQV-VC 123
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            ++   L FLHS +   I+H DLK  N+L+      +L+DFG+S        + N  TL 
Sbjct: 124 RQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS--------AKNLKTLQ 172
Query: 301 CRTDPKGTFAYMDPEFLASGEL--TP---KSDVYSFGIILLRLLTGRP 343
            R    GT  +M PE +    +  TP   K+D++S GI L+ +    P
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 41/216 (18%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 199
           KIGEG YG ++K   R     VAIK     S   P   +   +EI +L +++HPNLV L+
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 200 GACPEVWT------LVYEYLPNGSLEDRLSCKDNSP-----PLSWQTRIRIATELCSVLI 248
               EV+       LV+EY  +  L +    +   P      ++WQT           L 
Sbjct: 69  ----EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT-----------LQ 113
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            ++ C  H+ +H D+KP NIL+  + V KL DFG +R L+      +        D   T
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD--------DEVAT 165
Query: 309 FAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRP 343
             Y  PE L    +  P  DV++ G +   LL+G P
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV- 196
            D  +KIGEG  G +     +H   QVA+KM+     Q       E+ I+   +H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 197 ----TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 249
                LVG   E+W L+ E+L  G+L D +S          Q R+   +IAT   +VL  
Sbjct: 107 MYKSYLVGE--ELWVLM-EFLQGGALTDIVS----------QVRLNEEQIATVCEAVLQA 153
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L       ++H D+K  +ILL  +   KLSDFG    +S++        +  R    GT 
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--------VPKRKXLVGTP 205
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +M PE ++      + D++S GI+++ ++ G P
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R ++  +   N  
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT- 216
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
                T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 217 -----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL- 198
           IG+G +  +   L RH+    +VA++++    L   S  +  +E+ I+  + HPN+V L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V    +   LV EY   G + D L           + + R       ++  +  C    
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR------QIVSAVQYCHQKF 133
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS-SNNTTLCCRTDPKGTFAYMDPEF 316
           IVH DLK  N+LLDA+   K++DFG S     NE +  N     C + P     Y  PE 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDEFCGSPP-----YAAPEL 183
Query: 317 LASGELT-PKSDVYSFGIILLRLLTG 341
               +   P+ DV+S G+IL  L++G
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDXXKK 215
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 216 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 24/209 (11%)
Query: 145 KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           ++G+G +G +YK   +      A K++   S +   ++  EI+IL+   HP +V L+GA 
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               ++W ++ E+ P G++ D +  + +      Q ++ +  ++   L FLHS +   I+
Sbjct: 78  YHDGKLWIMI-EFCPGGAV-DAIMLELDRGLTEPQIQV-VCRQMLEALNFLHSKR---II 131
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DLK  N+L+      +L+DFG+S        + N  TL  R    GT  +M PE +  
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVS--------AKNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 320 GEL--TP---KSDVYSFGIILLRLLTGRP 343
             +  TP   K+D++S GI L+ +    P
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 116/256 (45%), Gaps = 39/256 (15%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQ--GPSEFQQEIDILS 188
           A   ++   +IGEG YG ++K   R ++     VA+K +   + +   P    +E+ +L 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 189 KIR---HPNLVTLVGACP-------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
            +    HPN+V L   C           TLV+E++ +  L   L  K   P +  +T   
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD-KVPEPGVPTETIKD 124
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS-QNEISSNNT 297
           +  +L   L FLHS   H +VH DLKP NIL+ ++   KL+DFG++R  S Q  ++S   
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 357
           TL           Y  PE L         D++S G I   +   +P    + +V      
Sbjct: 182 TLW----------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QL 228
Query: 358 GKLKNLLD-PLAGDWP 372
           GK+ +++  P   DWP
Sbjct: 229 GKILDVIGLPGEEDWP 244

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDXXKK 215
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 216 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 115/273 (42%), Gaps = 44/273 (16%)
Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL- 198
           IG+G +  +   L RH+    +VA+K++    L   S  +  +E+ I   + HPN+V L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V    +   LV EY   G + D L           + + R       ++  +  C    
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR------QIVSAVQYCHQKF 133
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS-SNNTTLCCRTDPKGTFAYMDPEF 316
           IVH DLK  N+LLDA+   K++DFG S     NE +  N     C   P     Y  PE 
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFS-----NEFTFGNKLDAFCGAPP-----YAAPEL 183
Query: 317 LASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGDW--P 372
               +   P+ DV+S G+IL  L++G              D   LK L +  L G +  P
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG----------SLPFDGQNLKELRERVLRGKYRIP 233
Query: 373 FVQAEQLANLAMRCCEMS---RKSRPELGKDVW 402
           F  +    NL  +   ++   R +  ++ KD W
Sbjct: 234 FYXSTDCENLLKKFLILNPSKRGTLEQIXKDRW 266

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 116/256 (45%), Gaps = 39/256 (15%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQ--GPSEFQQEIDILS 188
           A   ++   +IGEG YG ++K   R ++     VA+K +   + +   P    +E+ +L 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 189 KIR---HPNLVTLVGACP-------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
            +    HPN+V L   C           TLV+E++ +  L   L  K   P +  +T   
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD-KVPEPGVPTETIKD 124
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS-QNEISSNNT 297
           +  +L   L FLHS   H +VH DLKP NIL+ ++   KL+DFG++R  S Q  ++S   
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 357
           TL           Y  PE L         D++S G I   +   +P    + +V      
Sbjct: 182 TLW----------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QL 228
Query: 358 GKLKNLLD-PLAGDWP 372
           GK+ +++  P   DWP
Sbjct: 229 GKILDVIGLPGEEDWP 244

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 139 NFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNL 195
           +F+P   +G GG+G ++  K  +     AIK +  P+      +  +E+  L+K+ HP +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 196 VTLVGACPEVWTL---------VYEYLP-----NGSLEDRLSCKDNSPPLSWQTRIRIAT 241
           V    A  E  T          VY Y+        +L+D ++ +           + I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT--- 298
           ++   + FLHS     ++H DLKP+NI    + V K+ DFG+   + Q+E      T   
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 299 -LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
                T   GT  YM PE +     + K D++S G+IL  LL
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTL--VG 200
           +G G +  +     +  Q  VAIK +   +L+G     + EI +L KI+HPN+V L  + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                  L+ + +  G L DR+  K      + +   R+  ++   + +LH      IVH
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDL---GIVH 139
Query: 261 GDLKPANIL---LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP N+L   LD +    +SDFG+S+      + S   T C      GT  Y+ PE L
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TAC------GTPGYVAPEVL 190
Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
           A    +   D +S G+I   LL G P
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTL--VG 200
           +G G +  +     +  Q  VAIK +   +L+G     + EI +L KI+HPN+V L  + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                  L+ + +  G L DR+  K      + +   R+  ++   + +LH      IVH
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDL---GIVH 139
Query: 261 GDLKPANIL---LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP N+L   LD +    +SDFG+S+      + S   T C      GT  Y+ PE L
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TAC------GTPGYVAPEVL 190
Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
           A    +   D +S G+I   LL G P
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTL--VG 200
           +G G +  +     +  Q  VAIK +   +L+G     + EI +L KI+HPN+V L  + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                  L+ + +  G L DR+  K      + +   R+  ++   + +LH      IVH
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDL---GIVH 139
Query: 261 GDLKPANIL---LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP N+L   LD +    +SDFG+S+      + S   T C      GT  Y+ PE L
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TAC------GTPGYVAPEVL 190
Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
           A    +   D +S G+I   LL G P
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 116/256 (45%), Gaps = 39/256 (15%)
Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQ--GPSEFQQEIDILS 188
           A   ++   +IGEG YG ++K   R ++     VA+K +   + +   P    +E+ +L 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 189 KIR---HPNLVTLVGACP-------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
            +    HPN+V L   C           TLV+E++ +  L   L  K   P +  +T   
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD-KVPEPGVPTETIKD 124
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS-QNEISSNNT 297
           +  +L   L FLHS   H +VH DLKP NIL+ ++   KL+DFG++R  S Q  ++S   
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 357
           TL           Y  PE L         D++S G I   +   +P    + +V      
Sbjct: 182 TLW----------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QL 228
Query: 358 GKLKNLLD-PLAGDWP 372
           GK+ +++  P   DWP
Sbjct: 229 GKILDVIGLPGEEDWP 244

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 35/226 (15%)
Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSKIR-HPNLVTL 198
           K+G+G YG ++K + R     VA+K +   + Q  ++ Q+   EI IL+++  H N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 199 VGACP-----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           +         +V+ LV++Y+     E  L     +  L    +  +  +L  V+ +LHS 
Sbjct: 75  LNVLRADNDRDVY-LVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR----------- 302
               ++H D+KP+NILL+A    K++DFG+SR        +NN  L              
Sbjct: 129 ---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 303 --TDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 345
             TD   T  Y  PE  L S + T   D++S G IL  +L G+P  
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTL--VG 200
           +G G +  +     +  Q  VAIK +   +L+G     + EI +L KI+HPN+V L  + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                  L+ + +  G L DR+  K      + +   R+  ++   + +LH      IVH
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDL---GIVH 139
Query: 261 GDLKPANIL---LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP N+L   LD +    +SDFG+S+      + S   T C      GT  Y+ PE L
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TAC------GTPGYVAPEVL 190
Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
           A    +   D +S G+I   LL G P
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 216 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 31/72 (43%), Positives = 44/72 (61%)
Query: 427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 486
           E P YF CPI  E+M+DP + + G TYE  +++ WLD+GH+T P +   L H  L PN  
Sbjct: 4   EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYV 63
Query: 487 LRSAIQEWLQQH 498
           L+S I  W + +
Sbjct: 64  LKSLIALWCESN 75

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSL-----QGPSEFQQEIDILSK 189
           N+     +GEG +G +   L  H     +VA+K+++   L     QG    ++EI  L  
Sbjct: 15  NYQIVKTLGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRL 70
Query: 190 IRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           +RHP+++ L  V    +   +V EY  N  L D +  +D    +S Q   R   ++ S +
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK---MSEQEARRFFQQIISAV 126
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +   C  H IVH DLKP N+LLD +   K++DFG+S  ++      N     C     G
Sbjct: 127 EY---CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSC-----G 174
Query: 308 TFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGR 342
           +  Y  PE + SG+L   P+ DV+S G+IL  +L  R
Sbjct: 175 SPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L +  L+D +    ++  L+      I + L  +L 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM----DASALTGIPLPLIKSYLFQLLQ 116
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 168
Query: 309 FAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGR 342
             Y  PE L   +  +   D++S G I   ++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 26/224 (11%)
Query: 134 EGATHNFDPSLK---IGEGGYGSIYK--GLLRHMQVAIKMLHPHSLQGPSEFQQEIDILS 188
           +GA ++F    K   +G G +G ++K       +++A K++    ++   E + EI +++
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 189 KIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           ++ H NL+ L  A        LV EY+  G L DR+   D S  L+    I    ++C  
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQICEG 199
Query: 247 LIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           +  +H      I+H DLKP NIL    DA  + K+ DFG++R     E    N       
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF------ 249
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALG 346
              GT  ++ PE +    ++  +D++S G+I   LL+G  P LG
Sbjct: 250 ---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSL-----QGPSEFQQEIDILSK 189
           N+     +GEG +G +   L  H     +VA+K+++   L     QG    ++EI  L  
Sbjct: 5   NYQIVKTLGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRL 60
Query: 190 IRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           +RHP+++ L  V    +   +V EY  N  L D +  +D    +S Q   R   ++ S +
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK---MSEQEARRFFQQIISAV 116
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +   C  H IVH DLKP N+LLD +   K++DFG+S  ++      N     C     G
Sbjct: 117 EY---CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSC-----G 164
Query: 308 TFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGR 342
           +  Y  PE + SG+L   P+ DV+S G+IL  +L  R
Sbjct: 165 SPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 110/229 (48%), Gaps = 34/229 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ-EIDILSKIRHPNLVTLVGA-- 201
           +IG+G YG ++ G  R  +VA+K+    + +  S F++ EI     +RH N++  + A  
Sbjct: 44  QIGKGRYGEVWMGKWRGEKVAVKVF--FTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 202 -CPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS----- 252
                WT   L+ +Y  NGSL D L     S  L  ++ +++A    S L  LH+     
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 253 -CKPHSIVHGDLKPANILLDANFVSKLSDFGIS-RFLSQ-NEISSNNTTLCCRTDPKGTF 309
             KP +I H DLK  NIL+  N    ++D G++ +F+S  NE+     T        GT 
Sbjct: 158 QGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV------GTK 210
Query: 310 AYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            YM PE L         +    +D+YSFG+IL  +     + GI +E Q
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 115
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVT 167
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSL-----QGPSEFQQEIDILSK 189
           N+     +GEG +G +   L  H     +VA+K+++   L     QG    ++EI  L  
Sbjct: 14  NYQIVKTLGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRL 69
Query: 190 IRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           +RHP+++ L  V    +   +V EY  N  L D +  +D    +S Q   R   ++ S +
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK---MSEQEARRFFQQIISAV 125
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +   C  H IVH DLKP N+LLD +   K++DFG+S  ++      N     C     G
Sbjct: 126 EY---CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSC-----G 173
Query: 308 TFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGR 342
           +  Y  PE + SG+L   P+ DV+S G+IL  +L  R
Sbjct: 174 SPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L +  L+D +    ++  L+      I + L  +L 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM----DASALTGIPLPLIKSYLFQLLQ 117
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 169
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 193
           +F+    +G+G +G++Y    +  H  VA+K+L    ++      + ++EI+I + + HP
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 194 NLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N++ L     +     L+ EY P G L   L     S     Q    I  EL   L++ H
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQ---KSCTFDEQRTATIMEELADALMYCH 140
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             K   ++H D+KP N+LL      K++DFG     S +  S    T+C      GT  Y
Sbjct: 141 GKK---VIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMC------GTLDY 187
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           + PE +       K D++  G++   LL G P
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVGNP 219

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 216 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V +++DFG++R +  N I     
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMRIADFGLARDI--NNIDYYKK 215
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 216 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 164 VAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEYLPNG 216
           VA+K L      GP   S +Q+EI+IL  + H ++V   G C +       LV EY+P G
Sbjct: 41  VAVKALKEGC--GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLG 98
Query: 217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
           SL D L        +     +  A ++C  + +LH+      +H  L   N+LLD + + 
Sbjct: 99  SLRDYLP----RHCVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLV 151
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG+++      +   +     R D      +  PE L   +    SDV+SFG+ L 
Sbjct: 152 KIGDFGLAK-----AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLY 206
Query: 337 RLLT 340
            LLT
Sbjct: 207 ELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 164 VAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEYLPNG 216
           VA+K L      GP   S +Q+EI+IL  + H ++V   G C +       LV EY+P G
Sbjct: 40  VAVKALKEGC--GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLG 97
Query: 217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
           SL D L        +     +  A ++C  + +LH+      +H  L   N+LLD + + 
Sbjct: 98  SLRDYLP----RHCVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLV 150
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG+++      +   +     R D      +  PE L   +    SDV+SFG+ L 
Sbjct: 151 KIGDFGLAK-----AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLY 205
Query: 337 RLLT 340
            LLT
Sbjct: 206 ELLT 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSL-----QGPSEFQQEIDILSK 189
           N+     +GEG +G +   L  H     +VA+K+++   L     QG    ++EI  L  
Sbjct: 9   NYQIVKTLGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRL 64
Query: 190 IRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           +RHP+++ L  V    +   +V EY  N  L D +  +D    +S Q   R   ++ S +
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK---MSEQEARRFFQQIISAV 120
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +   C  H IVH DLKP N+LLD +   K++DFG+S  ++      N     C     G
Sbjct: 121 EY---CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSC-----G 168
Query: 308 TFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGR 342
           +  Y  PE + SG+L   P+ DV+S G+IL  +L  R
Sbjct: 169 SPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D  +  D S  L+      I + L  +L 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKTFMDASA-LTGIPLPLIKSYLFQLLQ 117
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 169
Query: 309 FAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGR 342
             Y  PE L   +  +   D++S G I   ++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 150 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 204
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 205 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 153 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 207
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 208 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 263

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 148 SCTYQLARGMEYLASQK---CIHRDLTARNVLVTENNVMKIADFGLARDI--NNIDYYKK 202
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 203 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 258

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G ++ G LR  +  VA+K      P  L+  ++F QE  IL +  HPN+V L+
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLI 178
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G C +     +V E +  G     L  +     L  +T +++  +  + + +L S     
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            +H DL   N L+    V K+SDFG+SR  +    +++      R  P     +  PE L
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL---RQVP---VKWTAPEAL 287
Query: 318 ASGELTPKSDVYSFGIIL 335
             G  + +SDV+SFGI+L
Sbjct: 288 NYGRYSSESDVWSFGILL 305

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G ++ G LR  +  VA+K      P  L+  ++F QE  IL +  HPN+V L+
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLI 178
Query: 200 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G C +     +V E +  G     L  +     L  +T +++  +  + + +L S     
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            +H DL   N L+    V K+SDFG+SR  +    +++      R  P     +  PE L
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGL---RQVP---VKWTAPEAL 287
Query: 318 ASGELTPKSDVYSFGIIL 335
             G  + +SDV+SFGI+L
Sbjct: 288 NYGRYSSESDVWSFGILL 305

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 134 EGATHNFDPSLK-IGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQEIDILSK 189
           +G+ +++   L+ +G G +G +++ + +    + VA  +  P+ L   +  + EI I+++
Sbjct: 46  QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT-VKNEISIMNQ 104
Query: 190 IRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           + HP L+ L  A  + +   L+ E+L  G L DR++ +D    +S    I    + C  L
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGL 162
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDP 305
             +H    HSIVH D+KP NI+ +    S  K+ DFG++  L+ +EI    T        
Sbjct: 163 KHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-------- 211
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
             T  +  PE +    +   +D+++ G++   LL+G
Sbjct: 212 -ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               ++++  +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 207 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 261
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 262 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 115
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 167
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 116
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 168
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 115
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 167
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 116
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 117 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 168
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 117
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 169
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 117
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 169
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 116
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 168
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIY----KGL-----LRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      GL      R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  ++  PP               LS +  +
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARE--PPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +   +      
Sbjct: 154 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 209
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
                T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 210 -----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 118
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 170
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 146 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--VGA 201
           +G G +  ++  K  L     A+K +        S  + EI +L KI+H N+VTL  +  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 202 CPEVWTLVYEYLPNGSLEDRL------SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
               + LV + +  G L DR+      + KD S          +  ++ S + +LH    
Sbjct: 77  STTHYYLVMQLVSGGELFDRILERGVYTEKDAS---------LVIQQVLSAVKYLHE--- 124
Query: 256 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           + IVH DLKP N+L    + N    ++DFG+S+ + QN I S   T C      GT  Y+
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMS---TAC------GTPGYV 174
Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE LA    +   D +S G+I   LL G P
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYP 205

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 114/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIY----KGL-----LRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      GL      R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               LS +  +
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +  + I     
Sbjct: 154 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDXXKK 208
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 209 T----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +   +      PL       I + L  +L 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-----IKSYLFQLLQ 115
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 167
Query: 309 FAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGR 342
             Y  PE L   +  +   D++S G I   ++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  +  Y   G+L + L  +   PP               ++++  +
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 216 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 170
Query: 313 DPEFLASGE-LTPKSDVYSFGIILLRLLTGR 342
            PE L   +  +   D++S G I   ++T R
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +   +      PL       I + L  +L 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-----IKSYLFQLLQ 117
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 118 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 169
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L +  L+D +    ++  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKDFM----DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T  Y 
Sbjct: 119 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------TLWYR 170
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 145 KIGEGGYGSI----YKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+    Y  L  +    VA+K L         +FQ+EI IL  +    +V  
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 199 VGAC-----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
            G       PE+  LV EYLP+G L D L  + +   L     +  ++++C  + +L S 
Sbjct: 74  RGVSYGPGRPEL-RLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 129
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
                VH DL   NIL+++    K++DFG+++ L  ++          R   +    +  
Sbjct: 130 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DXXVVREPGQSPIFWYA 182
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT 340
           PE L+    + +SDV+SFG++L  L T
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 125
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 126 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 177
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIR 191
           +FD    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++EI+I S +R
Sbjct: 16  DFDIGRPLGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 192 HPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 249
           HPN++ +     +     L+ E+ P G L   L               R AT +  +   
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF------DEQRSATFMEELADA 127
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LH C    ++H D+KP N+L+      K++DFG     S +  S     +C      GT 
Sbjct: 128 LHYCHERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMC------GTL 177
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
            Y+ PE +       K D++  G++    L G P  
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIY----KGL-----LRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      GL      R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               LS +  +
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +   +      
Sbjct: 143 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 198
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
                T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 199 -----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 253

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIY----KGL-----LRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      GL      R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               LS +  +
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +   +      
Sbjct: 154 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 209
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
                T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 210 -----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 141 DPS----LKI-GEGGYGSIY-----KGLLRHMQVAIKMLHPHSLQGPSEFQQEI--DILS 188
           DPS    LK+ G+G +G ++      G       A+K+L   +L+     + ++  DIL 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 189 KIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           ++ HP +V L  A        L+ ++L  G L  RLS        + +       EL   
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALA 138
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L  LHS     I++ DLKP NILLD     KL+DFG+S+    +E      + C      
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC------ 187
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           GT  YM PE +     T  +D +SFG+++  +LTG
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIY----KGL-----LRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      GL      R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               LS +  +
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +   +      
Sbjct: 147 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 202
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
                T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 203 -----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 257

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 141 DPS----LKI-GEGGYGSIY-----KGLLRHMQVAIKMLHPHSLQGPSEFQQEI--DILS 188
           DPS    LK+ G+G +G ++      G       A+K+L   +L+     + ++  DIL 
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 82
Query: 189 KIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           ++ HP +V L  A        L+ ++L  G L  RLS        + +       EL   
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALA 139
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L  LHS     I++ DLKP NILLD     KL+DFG+S+    +E      + C      
Sbjct: 140 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC------ 188
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           GT  YM PE +     T  +D +SFG+++  +LTG
Sbjct: 189 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIY----KGL-----LRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      GL      R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               LS +  +
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +   +      
Sbjct: 139 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 194
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
                T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 195 -----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIYK----GLLRH-----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      G+ +      + VA+KML   + +   S+   E++++  I +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  +  Y   G+L + L  +   PP               ++++  +
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRAR--RPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
               +L   + +L S K    +H DL   N+L+  N V K++DFG++R +  N I     
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
           T    T+ +    +M PE L     T +SDV+SFG+++  + T  G P  GI  E  + L
Sbjct: 216 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIY----KGL-----LRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      GL      R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               LS +  +
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +   +      
Sbjct: 146 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 201
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
                T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 202 -----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 256

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G+  NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 191 RHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            HPN+V L+     + T    YL    ++  L    ++  L+      I + L  +L  L
Sbjct: 63  NHPNIVKLLDV---IHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
             C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T  
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------TLW 171
Query: 311 YMDPEFLASGE-LTPKSDVYSFGIILLRLLTGR 342
           Y  PE L   +  +   D++S G I   ++T R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLSF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 170
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 33  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 80
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET-----CTR 135
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 136 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +        GT  Y+ PE L     +  SD+++ G I+ +L+ G P
Sbjct: 192 NSFV------GTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLP 232

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 170
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 170
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIR 191
           +FD    +G+G +G++Y  L R  Q    +A+K+L    L+      + ++EI+I S +R
Sbjct: 15  DFDIVRPLGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 192 HPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 249
           HPN++ +     +     L+ E+ P G L   L               R AT +  +   
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF------DEQRSATFMEELADA 126
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LH C    ++H D+KP N+L+      K++DFG     S +  S     +C      GT 
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMC------GTL 176
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
            Y+ PE +       K D++  G++    L G P  
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 141 DPS----LKI-GEGGYGSIY-----KGLLRHMQVAIKMLHPHSLQGPSEFQQEI--DILS 188
           DPS    LK+ G+G +G ++      G       A+K+L   +L+     + ++  DIL 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 189 KIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           ++ HP +V L  A        L+ ++L  G L  RLS        + +       EL   
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALA 138
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L  LHS     I++ DLKP NILLD     KL+DFG+S+    +E      + C      
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC------ 187
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           GT  YM PE +     T  +D +SFG+++  +LTG
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 117
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 169
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIY----KGL-----LRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      GL      R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               LS +  +
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +   +      
Sbjct: 154 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 209
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
                T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 210 -----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL++    M VA+KML P + L        E+ +LS +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 197 TLVGAC----PEVWTLVYEYLPNGSL-------EDRLSCKDNSPPL--------SWQTRI 237
            L+GAC    P +  ++ EY   G L        D   C   SP +          +  +
Sbjct: 114 NLLGACTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             + ++   + FL S    + +H DL   NILL    ++K+ DFG++R +       N++
Sbjct: 172 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARHI------KNDS 222
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
               + + +    +M PE + +   T +SDV+S+GI L  L +
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 117
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 169
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 122
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 174
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 135 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKI 190
           G   NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++
Sbjct: 1   GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
            HPN+V L+          LV+E+L     +D     D S  L+      I + L  +L 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQ 115
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            L  C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------T 167
Query: 309 FAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
             Y  PE L   +    + D++S G I   ++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 146 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLVG 200
           +G+G +G +   K  +   + A+K++    ++  ++ +   +E+ +L ++ HPN++ L  
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              +   + LV E    G L D +  +      S     RI  ++ S + ++H  K   I
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---I 170
Query: 259 VHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           VH DLKP N+LL     DAN   ++ DFG+S     ++            D  GT  Y+ 
Sbjct: 171 VHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---------KMKDKIGTAYYIA 219
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE L  G    K DV+S G+IL  LL+G P
Sbjct: 220 PEVL-HGTYDEKCDVWSTGVILYILLSGCP 248

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL +    ++VA+KML   +     E    E+ I+S + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 197 TLVGACPEVW--TLVYEYLPNGSLEDRLSCK-------DNSPPLSWQTRIRIATELCSVL 247
            L+GAC       ++ EY   G L + L  K       ++  PL  +  +  ++++   +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            FL S    + +H D+   N+LL    V+K+ DFG++R +       N++    + + + 
Sbjct: 174 AFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDI------MNDSNYIVKGNARL 224
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
              +M PE +     T +SDV+S+GI+L  + +
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 125
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 126 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 177
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 178 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 34  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 81
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 136
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 137 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 192
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +        GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 193 NSFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 146 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLVG 200
           +G+G +G +   K  +   + A+K++    ++  ++ +   +E+ +L ++ HPN++ L  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              +   + LV E    G L D +  +      S     RI  ++ S + ++H  K   I
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---I 171
Query: 259 VHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           VH DLKP N+LL     DAN   ++ DFG+S     ++            D  GT  Y+ 
Sbjct: 172 VHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---------KMKDKIGTAYYIA 220
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE L  G    K DV+S G+IL  LL+G P
Sbjct: 221 PEVL-HGTYDEKCDVWSTGVILYILLSGCP 249

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 146 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLVG 200
           +G+G +G +   K  +   + A+K++    ++  ++ +   +E+ +L ++ HPN++ L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              +   + LV E    G L D +  +      S     RI  ++ S + ++H  K   I
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---I 147
Query: 259 VHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           VH DLKP N+LL     DAN   ++ DFG+S     ++            D  GT  Y+ 
Sbjct: 148 VHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---------KMKDKIGTAYYIA 196
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE L  G    K DV+S G+IL  LL+G P
Sbjct: 197 PEVL-HGTYDEKCDVWSTGVILYILLSGCP 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 146 IGEGGYGSIYK---------GLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
           +G+GGYG +++         G +  M+V  K +   + +  +  + E +IL +++HP +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 197 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L+ A        L+ EYL  G L  +L   +        T      E+   L  LH   
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLHQ-- 139
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              I++ DLKP NI+L+     KL+DFG+ +    +   ++  T C      GT  YM P
Sbjct: 140 -KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH--TFC------GTIEYMAP 190
Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E L         D +S G ++  +LTG P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 146 IGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLV 196
           +G G +G+++KG+         + V IK++   S  G   FQ   D    +  + H ++V
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 197 TLVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
            L+G CP     LV +YLP GSL D +  + +   L  Q  +    ++   + +L     
Sbjct: 97  RLLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEE--- 151
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           H +VH +L   N+LL +    +++DFG++  L  ++           ++ K    +M  E
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ------LLYSEAKTPIKWMALE 205
Query: 316 FLASGELTPKSDVYSFGIILLRLLT 340
            +  G+ T +SDV+S+G+ +  L+T
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL++    M VA+KML P + L        E+ +LS +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 197 TLVGAC----PEVWTLVYEYLPNGSL-------EDRLSCKDNSPPL--------SWQTRI 237
            L+GAC    P +  ++ EY   G L        D   C   SP +          +  +
Sbjct: 107 NLLGACTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             + ++   + FL S    + +H DL   NILL    ++K+ DFG++R +       N++
Sbjct: 165 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI------KNDS 215
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
               + + +    +M PE + +   T +SDV+S+GI L  L +
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 95/179 (53%), Gaps = 22/179 (12%)
Query: 179 EFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E ++E++IL +IRHPN++TL  +        L+ E +  G L D L+ K++   L+    
Sbjct: 61  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEA 117
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEI 292
            +   ++   + +LHS +   I H DLKP NI LLD N  +   KL DFGI+     ++I
Sbjct: 118 TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKI 169
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
            + N       +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 170 EAGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 224

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 31  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 78
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 133
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 134 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 190 NAFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 30  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 77
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TR 132
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 133 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 188
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +        GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 189 NSFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL++    M VA+KML P + L        E+ +LS +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 197 TLVGAC----PEVWTLVYEYLPNGSL-------EDRLSCKDNSPPL--------SWQTRI 237
            L+GAC    P +  ++ EY   G L        D   C   SP +          +  +
Sbjct: 109 NLLGACTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             + ++   + FL S    + +H DL   NILL    ++K+ DFG++R +       N++
Sbjct: 167 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI------KNDS 217
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
               + + +    +M PE + +   T +SDV+S+GI L  L +
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 95/179 (53%), Gaps = 22/179 (12%)
Query: 179 EFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E ++E++IL +IRHPN++TL  +        L+ E +  G L D L+ K++   L+    
Sbjct: 54  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEA 110
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEI 292
            +   ++   + +LHS +   I H DLKP NI LLD N  +   KL DFGI+     ++I
Sbjct: 111 TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKI 162
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
            + N       +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 163 EAGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 217

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL +    ++VA+KML   +     E    E+ I+S + +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 197 TLVGACPEVW--TLVYEYLPNGSLEDRLSCK-------DNSPPLSWQTRIRIATELCSVL 247
            L+GAC       ++ EY   G L + L  K       ++  PL  +  +  ++++   +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            FL S    + +H D+   N+LL    V+K+ DFG++R +       N++    + + + 
Sbjct: 166 AFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDI------MNDSNYIVKGNARL 216
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
              +M PE +     T +SDV+S+GI+L  + +
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 33  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 80
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 135
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 136 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 192 NXFV------GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLP 232

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 146 IGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLV 196
           +G G +G+++KG+         + V IK++   S  G   FQ   D    +  + H ++V
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 197 TLVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
            L+G CP     LV +YLP GSL D +  + +   L  Q  +    ++   + +L     
Sbjct: 79  RLLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEE--- 133
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           H +VH +L   N+LL +    +++DFG++  L  ++           ++ K    +M  E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ------LLYSEAKTPIKWMALE 187
Query: 316 FLASGELTPKSDVYSFGIILLRLLT 340
            +  G+ T +SDV+S+G+ +  L+T
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           +V L+     + T    YL    +   L    ++  L+      I + L  +L  L  C 
Sbjct: 63  IVKLLDV---IHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
            H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y  P
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYRAP 171
Query: 315 EFLASGELTPKS-DVYSFGIILLRLLTGR 342
           E L   +    + D++S G I   ++T R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 9   DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 56
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 111
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 112 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 168 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 11  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 58
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 113
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 114 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 169
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 170 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 210

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L   +    K+      +G PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 170
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L   +    K+      +G PS   +EI +L ++ HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 117
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R        +    +   T    T  Y 
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYR 169
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 95/179 (53%), Gaps = 22/179 (12%)
Query: 179 EFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E ++E++IL +IRHPN++TL  +        L+ E +  G L D L+ K++   L+    
Sbjct: 75  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEA 131
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEI 292
            +   ++   + +LHS +   I H DLKP NI LLD N  +   KL DFGI+     ++I
Sbjct: 132 TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKI 183
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
            + N       +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 184 EAGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 238

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 10  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 57
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 112
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 113 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 168
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 169 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 8   DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 55
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 56  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 110
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 111 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 166
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 167 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 207

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 33/246 (13%)
Query: 109 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNF-DPSLKIGEGGYGSIYKGLLRHMQ--VA 165
           R  ++E    SH  QF +        G   ++ D  +KIGEG  G +    +R     VA
Sbjct: 122 RSPQREPQRVSHE-QFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVA 180
Query: 166 IKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT-----LVGACPEVWTLVYEYLPNGSLED 220
           +K +     Q       E+ I+   +H N+V      LVG   E+W +V E+L  G+L D
Sbjct: 181 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW-VVMEFLEGGALTD 237
Query: 221 RLSCKDNSPPLSWQTRI---RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
            ++           TR+   +IA    +VL  L       ++H D+K  +ILL  +   K
Sbjct: 238 IVT----------HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 287
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           LSDFG    +S+ E+      +       GT  +M PE ++     P+ D++S GI+++ 
Sbjct: 288 LSDFGFCAQVSK-EVPRRKXLV-------GTPYWMAPELISRLPYGPEVDIWSLGIMVIE 339
Query: 338 LLTGRP 343
           ++ G P
Sbjct: 340 MVDGEP 345

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 31  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 78
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 133
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 134 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 190 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL++    M VA+KML P + L        E+ +LS +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 197 TLVGAC----PEVWTLVYEYLPNGSL-------EDRLSCKDNSPPL--------SWQTRI 237
            L+GAC    P +  ++ EY   G L        D   C   SP +          +  +
Sbjct: 114 NLLGACTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             + ++   + FL S    + +H DL   NILL    ++K+ DFG++R +       N++
Sbjct: 172 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI------KNDS 222
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
               + + +    +M PE + +   T +SDV+S+GI L  L +
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T  Y 
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------TLWYR 170
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T  Y 
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------TLWYR 170
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 33  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 80
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 135
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 136 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 192 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 31  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 78
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 133
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 134 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 190 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 33  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 80
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 135
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 136 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 192 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSI----YKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+    Y  L  +    VA+K L         +FQ+EI IL  +    +V  
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 199 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G       +   LV EYLP+G L D L  + +   L     +  ++++C  + +L S  
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 132
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               VH DL   NIL+++    K++DFG+++ L  ++          R   +    +  P
Sbjct: 133 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DYYVVREPGQSPIFWYAP 186
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L+    + +SDV+SFG++L  L T
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 33  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 80
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 135
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 136 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 192 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 117
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T  Y 
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------TLWYR 169
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T  Y 
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------TLWYR 170
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 38  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 85
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 86  RERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 140
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 141 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 196
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 197 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 237

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 117
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T  Y 
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------TLWYR 169
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 30  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 77
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TR 132
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 133 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 188
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 189 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSI----YKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+    Y  L  +    VA+K L         +FQ+EI IL  +    +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 199 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G       +   LV EYLP+G L D L  + +   L     +  ++++C  + +L S  
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               VH DL   NIL+++    K++DFG+++ L  ++          R   +    +  P
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DYYVVREPGQSPIFWYAP 199
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L+    + +SDV+SFG++L  L T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 146 IGEGGYGSIYK---------GLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
           +G+GGYG +++         G +  M+V  K +   + +  +  + E +IL +++HP +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 197 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L+ A        L+ EYL  G L  +L   +        T      E+   L  LH   
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLHQ-- 139
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT--LCCRTDPKGTFAYM 312
              I++ DLKP NI+L+     KL+DFG    L +  I     T   C      GT  YM
Sbjct: 140 -KGIIYRDLKPENIMLNHQGHVKLTDFG----LCKESIHDGTVTHXFC------GTIEYM 188
Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE L         D +S G ++  +LTG P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 144 LKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +KIGEG  G +     +H   QVA+K +     Q       E+ I+    H N+V +  +
Sbjct: 51  IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 202 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIFLHSCKP 255
                E+W +V E+L  G+L D ++           TR+   +IAT   SVL  L     
Sbjct: 111 YLVGDELW-VVMEFLEGGALTDIVT----------HTRMNEEQIATVCLSVLRALSYLHN 159
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             ++H D+K  +ILL ++   KLSDFG    +S+ E+      +       GT  +M PE
Sbjct: 160 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKXLV-------GTPYWMAPE 211
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            ++      + D++S GI+++ ++ G P
Sbjct: 212 VISRLPYGTEVDIWSLGIMVIEMIDGEP 239

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 15  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 62
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 63  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TR 117
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 118 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 173
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 174 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVG 200
           +G G +G ++    RH     A+K+L    +    + +   D   +LS + HP ++ + G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 201 ACPEVWT--LVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHS 257
              +     ++ +Y+  G L   L      P P++       A E+C  L +LHS     
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA----KFYAAEVCLALEYLHS---KD 126
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I++ DLKP NILLD N   K++DFG +++     +      LC      GT  Y+ PE +
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLC------GTPDYIAPEVV 175
Query: 318 ASGELTPKSDVYSFGIILLRLLTG 341
           ++       D +SFGI++  +L G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 34  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 81
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 136
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 137 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 192
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 193 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 146 IGEGGYGSIY----KGL-----LRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 194
           +GEG +G +      GL      R  +VA+KML   + +   S+   E++++  I +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 195 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 237
           ++ L+GAC +   L  + EY   G+L + L  +   PP               LS +  +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +   +      
Sbjct: 195 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 250
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 355
                T+ +    +M PE L     T +SDV+SFG++L  + T  G P  G+  E  + L
Sbjct: 251 -----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 33  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 80
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 135
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 136 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 192 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ-EIDILSKIRHPNLVTLV----- 199
           IG+G +G +++G  R  +VA+K+    S +  S F++ EI     +RH N++  +     
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 200 --GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH------ 251
             G   ++W LV +Y  +GSL D L    N   ++ +  I++A    S L  LH      
Sbjct: 70  DNGTWTQLW-LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             KP +I H DLK  NIL+  N    ++D G    L+    S+ +T         GT  Y
Sbjct: 125 QGKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 312 MDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           M PE L         E   ++D+Y+ G++   +       GI ++ Q
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 226

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL++    M VA+KML P + L        E+ +LS +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 197 TLVGAC----PEVWTLVYEYLPNGSL-------EDRLSCKDNSPPL--------SWQTRI 237
            L+GAC    P +  ++ EY   G L        D   C   SP +          +  +
Sbjct: 91  NLLGACTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
             + ++   + FL S    + +H DL   NILL    ++K+ DFG++R +       N++
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI------KNDS 199
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
               + + +    +M PE + +   T +SDV+S+GI L  L +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 139 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK    L    VA+K   L   +   PS   +EI +L ++ HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L     +D     D S  L+      I + L  +L  L  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAF 118
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           C  H ++H DLKP N+L++     KL+DFG++R       +  +  +        T  Y 
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--------TLWYR 170
Query: 313 DPEFLASGELTPKS-DVYSFGIILLRLLTGR 342
            PE L   +    + D++S G I   ++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 33/246 (13%)
Query: 109 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNF-DPSLKIGEGGYGSIYKGLLRHMQ--VA 165
           R  ++E    SH  QF +        G   ++ D  +KIGEG  G +    +R     VA
Sbjct: 45  RSPQREPQRVSH-EQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVA 103
Query: 166 IKMLHPHSLQGPSEFQQEIDILSKIRHPNLV-----TLVGACPEVWTLVYEYLPNGSLED 220
           +K +     Q       E+ I+   +H N+V      LVG   E+W +V E+L  G+L D
Sbjct: 104 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW-VVMEFLEGGALTD 160
Query: 221 RLSCKDNSPPLSWQTRI---RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
            ++           TR+   +IA    +VL  L       ++H D+K  +ILL  +   K
Sbjct: 161 IVT----------HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 210
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           LSDFG    +S+ E+      +       GT  +M PE ++     P+ D++S GI+++ 
Sbjct: 211 LSDFGFCAQVSK-EVPRRKXLV-------GTPYWMAPELISRLPYGPEVDIWSLGIMVIE 262
Query: 338 LLTGRP 343
           ++ G P
Sbjct: 263 MVDGEP 268

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ-EIDILSKIRHPNLVTLV----- 199
           IG+G +G +++G  R  +VA+K+    S +  S F++ EI     +RH N++  +     
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 200 --GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH------ 251
             G   ++W LV +Y  +GSL D L    N   ++ +  I++A    S L  LH      
Sbjct: 69  DNGTWTQLW-LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             KP +I H DLK  NIL+  N    ++D G    L+    S+ +T         GT  Y
Sbjct: 124 QGKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 312 MDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           M PE L         E   ++D+Y+ G++   +       GI ++ Q
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 133 IEGATHNFDPS----LKI-GEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEF 180
           ++  +   DPS    LK+ G+G +G ++  L+R +         A+K+L   +L+     
Sbjct: 18  VKAGSEKADPSHFELLKVLGQGSFGKVF--LVRKVTRPDSGHLYAMKVLKKATLKVRDRV 75
Query: 181 QQEI--DILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           + ++  DIL+ + HP +V L  A        L+ ++L  G L  RLS        + +  
Sbjct: 76  RTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDV 132
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
                EL   L  LHS     I++ DLKP NILLD     KL+DFG+S+    +E     
Sbjct: 133 KFYLAELALGLDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHE--KKA 187
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
            + C      GT  YM PE +     +  +D +S+G+++  +LTG
Sbjct: 188 YSFC------GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 92/190 (48%), Gaps = 19/190 (10%)
Query: 163 QVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSL 218
           +VAIK ++    Q    E  +EI  +S+  HPN+V+   +     E+W LV + L  GS+
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW-LVMKLLSGGSV 100
Query: 219 EDRLS-----CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 273
            D +       +  S  L   T   I  E+   L +LH    +  +H D+K  NILL  +
Sbjct: 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGED 157
Query: 274 FVSKLSDFGISRFLSQ-NEISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSF 331
              +++DFG+S FL+   +I+ N      R    GT  +M PE +        K+D++SF
Sbjct: 158 GSVQIADFGVSAFLATGGDITRNKV----RKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213
Query: 332 GIILLRLLTG 341
           GI  + L TG
Sbjct: 214 GITAIELATG 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 145 KIGEGGYGSI----YKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+    Y  L  +    VA+K L         +FQ+EI IL  +    +V  
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 199 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G       +   LV EYLP+G L D L  + +   L     +  ++++C  + +L S  
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 133
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               VH DL   NIL+++    K++DFG+++ L  ++          R   +    +  P
Sbjct: 134 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DYYVVREPGQSPIFWYAP 187
Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L+    + +SDV+SFG++L  L T
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ-EIDILSKIRHPNLVTLV----- 199
           IG+G +G +++G  R  +VA+K+    S +  S F++ EI     +RH N++  +     
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 200 --GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH------ 251
             G   ++W LV +Y  +GSL D L    N   ++ +  I++A    S L  LH      
Sbjct: 72  DNGTWTQLW-LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             KP +I H DLK  NIL+  N    ++D G    L+    S+ +T         GT  Y
Sbjct: 127 QGKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 312 MDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           M PE L         E   ++D+Y+ G++   +       GI ++ Q
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 228

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 146 IGEGGYGSIYKG-----LLRHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLV 199
           IG+G +G +Y G         +Q AIK L   + +Q    F +E  ++  + HPN++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 200 GAC--PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           G    PE +  ++  Y+ +G L   +     +P +  +  I    ++   + +L   K  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYLAEQK-- 144
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
             VH DL   N +LD +F  K++DFG++R +   E  S       R   K T      E 
Sbjct: 145 -FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL----ES 199
Query: 317 LASGELTPKSDVYSFGIILLRLLT 340
           L +   T KSDV+SFG++L  LLT
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ-EIDILSKIRHPNLVTLV----- 199
           IG+G +G +++G  R  +VA+K+    S +  S F++ EI     +RH N++  +     
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAADNK 74
Query: 200 --GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH------ 251
             G   ++W LV +Y  +GSL D L    N   ++ +  I++A    S L  LH      
Sbjct: 75  DNGTWTQLW-LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             KP +I H DLK  NIL+  N    ++D G    L+    S+ +T         GT  Y
Sbjct: 130 QGKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 312 MDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           M PE L         E   ++D+Y+ G++   +       GI ++ Q
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + ++   + L    + AIK+L    +   ++     
Sbjct: 36  DFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 83
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 84  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 138
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 139 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 194
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 195 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 235

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 82/178 (46%), Gaps = 38/178 (21%)
Query: 182 QEIDILSKIR-HPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
           +E+DIL K+  HPN++ L         + LV++ +  G L D L+ K     LS +   +
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRK 128
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
           I   L  V+  LH     +IVH DLKP NILLD +   KL+DFG S              
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS-------------- 171
Query: 299 LCCRTDPK-------GTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRP 343
             C+ DP        GT +Y+ PE +             + D++S G+I+  LL G P
Sbjct: 172 --CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKG+         + VAIK+L  + S +   E   E  +++ +  P +  L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C      LV + +P G L D +  ++N   L  Q  +    ++   + +L   +   
Sbjct: 85  LGICLTSTVQLVTQLMPYGCLLDHV--RENRGRLGSQDLLNWCMQIAKGMSYLEDVR--- 139
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           +VH DL   N+L+ +    K++DFG++R L  +E   +          K    +M  E +
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA------DGGKVPIKWMALESI 193
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
                T +SDV+S+G+ +  L+T   +P  GI  +E+   L+ G+
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 238

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 82/178 (46%), Gaps = 38/178 (21%)
Query: 182 QEIDILSKIR-HPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
           +E+DIL K+  HPN++ L         + LV++ +  G L D L+ K     LS +   +
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRK 128
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
           I   L  V+  LH     +IVH DLKP NILLD +   KL+DFG S              
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS-------------- 171
Query: 299 LCCRTDPK-------GTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRP 343
             C+ DP        GT +Y+ PE +             + D++S G+I+  LL G P
Sbjct: 172 --CQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 82/178 (46%), Gaps = 38/178 (21%)
Query: 182 QEIDILSKIR-HPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
           +E+DIL K+  HPN++ L         + LV++ +  G L D L+ K     LS +   +
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRK 115
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
           I   L  V+  LH     +IVH DLKP NILLD +   KL+DFG S              
Sbjct: 116 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS-------------- 158
Query: 299 LCCRTDPK-------GTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRP 343
             C+ DP        GT +Y+ PE +             + D++S G+I+  LL G P
Sbjct: 159 --CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 146 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 200
           +G+G +G +   K  +   + A+K++    ++  ++     +E+ +L ++ HPN++ L  
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              +   + LV E    G L D +  +      S     RI  ++ S + ++H  K   I
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKNK---I 153
Query: 259 VHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           VH DLKP N+LL     DAN   ++ DFG+S   +  E S          D  GT  Y+ 
Sbjct: 154 VHRDLKPENLLLESKSKDANI--RIIDFGLS---THFEASKK------MKDKIGTAYYIA 202
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE L  G    K DV+S G+IL  LL+G P
Sbjct: 203 PEVL-HGTYDEKCDVWSTGVILYILLSGCP 231

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 146 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLVG 200
           +G+G +G +   K  +   + A+K++    ++  ++ +   +E+ +L ++ HPN+  L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              +   + LV E    G L D +  +      S     RI  ++ S + + H  K   I
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYXHKNK---I 147
Query: 259 VHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           VH DLKP N+LL     DAN   ++ DFG+S     ++            D  GT  Y+ 
Sbjct: 148 VHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKKXK---------DKIGTAYYIA 196
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE L  G    K DV+S G+IL  LL+G P
Sbjct: 197 PEVL-HGTYDEKCDVWSTGVILYILLSGCP 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 92/190 (48%), Gaps = 19/190 (10%)
Query: 163 QVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSL 218
           +VAIK ++    Q    E  +EI  +S+  HPN+V+   +     E+W LV + L  GS+
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW-LVMKLLSGGSV 95
Query: 219 EDRLS-----CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 273
            D +       +  S  L   T   I  E+   L +LH    +  +H D+K  NILL  +
Sbjct: 96  LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGED 152
Query: 274 FVSKLSDFGISRFLSQ-NEISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSF 331
              +++DFG+S FL+   +I+ N      R    GT  +M PE +        K+D++SF
Sbjct: 153 GSVQIADFGVSAFLATGGDITRNKV----RKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 208
Query: 332 GIILLRLLTG 341
           GI  + L TG
Sbjct: 209 GITAIELATG 218

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ-EIDILSKIRHPNLVTLV----- 199
           IG+G +G +++G  R  +VA+K+    S +  S F++ EI     +RH N++  +     
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAADNK 94
Query: 200 --GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH------ 251
             G   ++W LV +Y  +GSL D L    N   ++ +  I++A    S L  LH      
Sbjct: 95  DNGTWTQLW-LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             KP +I H DLK  NIL+  N    ++D G    L+    S+ +T         GT  Y
Sbjct: 150 QGKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 312 MDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           M PE L         E   ++D+Y+ G++   +       GI ++ Q
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 251

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGS--IYKGLLRHMQVAIKMLHPHSLQGPSEF---Q 181
           DF F +I            +GEG + +  + + L    + AIK+L    +   ++     
Sbjct: 31  DFKFGKI------------LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVT 78
Query: 182 QEIDILSKIRHPNLVTLVGACPEVWTLVY--EYLPNGSLED---RLSCKDNSPPLSWQTR 236
           +E D++S++ HP  V L     +   L +   Y  NG L     ++   D +      TR
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTR 133
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
              A E+ S L +LH      I+H DLKP NILL+ +   +++DFG ++ LS     +  
Sbjct: 134 FYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                     GT  Y+ PE L        SD+++ G I+ +L+ G P
Sbjct: 190 NXFV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 112/232 (48%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT A++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 30/226 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ-EIDILSKIRHPNLVTLVGACPE 204
           IG+G +G +++G  R  +VA+K+    S +  S F++ EI     +RH N++  + A  +
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 205 ---VWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH------S 252
               WT   LV +Y  +GSL D L    N   ++ +  I++A    S L  LH       
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
            KP +I H DLK  NIL+  N    ++D G    L+    S+ +T         GT  YM
Sbjct: 164 GKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 313 DPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            PE L         E   ++D+Y+ G++   +       GI ++ Q
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 206
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 206
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 46/226 (20%)
Query: 145 KIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNL 195
           ++GE  +G +YKG L       +   VAIK L   + +GP   EF+ E  + ++++HPN+
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNV 91
Query: 196 VTLVGACP--EVWTLVYEYLPNGSL-----------------EDRLSCKDNSPPLSWQTR 236
           V L+G     +  ++++ Y  +G L                 +DR       PP      
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP----DF 147
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS-- 294
           + +  ++ + + +L S   H +VH DL   N+L+      K+SD G+ R +   +     
Sbjct: 148 VHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 204
Query: 295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            N+ L  R        +M PE +  G+ +  SD++S+G++L  + +
Sbjct: 205 GNSLLPIR--------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV- 196
            D  +KIGEG  G +    +R     VA+K +     Q       E+ I+   +H N+V 
Sbjct: 33  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 197 ----TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 249
                LVG   E+W +V E+L  G+L D ++           TR+   +IA    +VL  
Sbjct: 93  MYNSYLVGD--ELW-VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLQA 139
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L       ++H D+K  +ILL  +   KLSDFG    +S+ E+      +       GT 
Sbjct: 140 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLV-------GTP 191
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +M PE ++     P+ D++S GI+++ ++ G P
Sbjct: 192 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 225

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 198
           IG G +G +   L+RH       A+K+L    +   S+   F +E DI++    P +V L
Sbjct: 77  IGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             A  +     +V EY+P G L + +S  D   P  W    R  T    V++ L +    
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---RFYT--AEVVLALDAIHSM 187
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
             +H D+KP N+LLD +   KL+DFG    +++  +   +T +       GT  Y+ PE 
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-------GTPDYISPEV 240
Query: 317 LAS----GELTPKSDVYSFGIILLRLLTG 341
           L S    G    + D +S G+ L  +L G
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV- 196
            D  +KIGEG  G +    +R     VA+K +     Q       E+ I+   +H N+V 
Sbjct: 31  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 197 ----TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 249
                LVG   E+W +V E+L  G+L D ++           TR+   +IA    +VL  
Sbjct: 91  MYNSYLVGD--ELW-VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLQA 137
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L       ++H D+K  +ILL  +   KLSDFG    +S+ E+      +       GT 
Sbjct: 138 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLV-------GTP 189
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +M PE ++     P+ D++S GI+++ ++ G P
Sbjct: 190 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 223

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 46/226 (20%)
Query: 145 KIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNL 195
           ++GE  +G +YKG L       +   VAIK L   + +GP   EF+ E  + ++++HPN+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNV 74
Query: 196 VTLVGACP--EVWTLVYEYLPNGSL-----------------EDRLSCKDNSPPLSWQTR 236
           V L+G     +  ++++ Y  +G L                 +DR       PP      
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP----DF 130
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS-- 294
           + +  ++ + + +L S   H +VH DL   N+L+      K+SD G+ R +   +     
Sbjct: 131 VHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            N+ L  R        +M PE +  G+ +  SD++S+G++L  + +
Sbjct: 188 GNSLLPIR--------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV- 196
            D  +KIGEG  G +    +R     VA+K +     Q       E+ I+   +H N+V 
Sbjct: 22  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 197 ----TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 249
                LVG   E+W +V E+L  G+L D ++           TR+   +IA    +VL  
Sbjct: 82  MYNSYLVGD--ELW-VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLQA 128
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L       ++H D+K  +ILL  +   KLSDFG    +S+ E+      +       GT 
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLV-------GTP 180
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +M PE ++     P+ D++S GI+++ ++ G P
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 198
           IG G +G +   L+RH       A+K+L    +   S+   F +E DI++    P +V L
Sbjct: 82  IGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             A  +     +V EY+P G L + +S  D   P  W    R  T    V++ L +    
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---RFYT--AEVVLALDAIHSM 192
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
             +H D+KP N+LLD +   KL+DFG    +++  +   +T +       GT  Y+ PE 
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-------GTPDYISPEV 245
Query: 317 LAS----GELTPKSDVYSFGIILLRLLTG 341
           L S    G    + D +S G+ L  +L G
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 145
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 200
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV- 196
            D  +KIGEG  G +    +R     VA+K +     Q       E+ I+   +H N+V 
Sbjct: 26  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 197 ----TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 249
                LVG   E+W +V E+L  G+L D ++           TR+   +IA    +VL  
Sbjct: 86  MYNSYLVGD--ELW-VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLQA 132
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L       ++H D+K  +ILL  +   KLSDFG    +S+ E+      +       GT 
Sbjct: 133 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLV-------GTP 184
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +M PE ++     P+ D++S GI+++ ++ G P
Sbjct: 185 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 218

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 198
           IG G +G +   L+RH       A+K+L    +   S+   F +E DI++    P +V L
Sbjct: 82  IGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             A  +     +V EY+P G L + +S  D   P  W    R  T    V++ L +    
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---RFYT--AEVVLALDAIHSM 192
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
             +H D+KP N+LLD +   KL+DFG    +++  +   +T +       GT  Y+ PE 
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-------GTPDYISPEV 245
Query: 317 LAS----GELTPKSDVYSFGIILLRLLTG 341
           L S    G    + D +S G+ L  +L G
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 152
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 207
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 153
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 208
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 144
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 199
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 206
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 145
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 200
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 145 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 199
           +IG G +G++Y  + +     VAIK +     Q   ++Q   +E+  L K+RHPN +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 200 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G      T  LV EY   GS  D L    +  PL       +       L +LHS   H+
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           ++H D+K  NILL    + KL DFG     S + ++  N  +       GT  +M PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFG-----SASIMAPANXFV-------GTPYWMAPEVI 183
Query: 318 AS---GELTPKSDVYSFGIILLRLLTGRPAL 345
            +   G+   K DV+S GI  + L   +P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIR 191
           ++D    IG G +G +   L+RH       A+K+L    +   S+   F +E DI++   
Sbjct: 76  DYDVVKVIGRGAFGEVQ--LVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 192 HPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 249
            P +V L  A  +     +V EY+P G L + +S  D   P  W    +  T    V++ 
Sbjct: 134 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---KFYT--AEVVLA 186
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           L +     ++H D+KP N+LLD +   KL+DFG    + +  +   +T +       GT 
Sbjct: 187 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-------GTP 239
Query: 310 AYMDPEFLAS----GELTPKSDVYSFGIILLRLLTG 341
            Y+ PE L S    G    + D +S G+ L  +L G
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 145 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 199
           +IG G +G++Y  + +     VAIK +     Q   ++Q   +E+  L K+RHPN +   
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 200 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G      T  LV EY   GS  D L    +  PL       +       L +LHS   H+
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HN 174
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           ++H D+K  NILL    + KL DFG     S + ++  N  +       GT  +M PE +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFG-----SASIMAPANXFV-------GTPYWMAPEVI 222
Query: 318 AS---GELTPKSDVYSFGIILLRLLTGRPAL 345
            +   G+   K DV+S GI  + L   +P L
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 202
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 202
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 202
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ-EIDILSKIRHPNLVTLVG---- 200
           +G+G YG +++GL     VA+K+      Q  S F++ EI     +RH N++  +     
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFSSRDEQ--SWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 201 ---ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC--SVLIFLHSCKP 255
              +  ++W L+  Y  +GSL D L  +   P L+ +  +  A  L    V IF    KP
Sbjct: 74  SRNSSTQLW-LITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKP 132
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK-GTFAYMDP 314
            +I H D K  N+L+ +N    ++D G++   SQ      +  L    +P+ GT  YM P
Sbjct: 133 -AIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQ-----GSDYLDIGNNPRVGTKRYMAP 186
Query: 315 EFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKE 350
           E L         E    +D+++FG++L  +       GI ++
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVED 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAI+ + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 206
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L        LS         ++   L ++HS    +++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 206
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKM--LHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 198
           KIGEG YG+++K   R  H  VA+K   L       PS   +EI +L +++H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 199 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           V    +  TLV+E+      +   SC  +  P        + + L  +L  L  C   ++
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI------VKSFLFQLLKGLGFCHSRNV 122
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DLKP N+L++ N   KL++FG++R        +    + C +    T  Y  P+ L 
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR--------AFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 319 SGELTPKS-DVYSFGIILLRLLT-GRP 343
             +L   S D++S G I   L   GRP
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 202
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 155
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 210
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 211 KGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 202
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKM--LHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 198
           KIGEG YG+++K   R  H  VA+K   L       PS   +EI +L +++H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 199 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           V    +  TLV+E+      +   SC  +  P        + + L  +L  L  C   ++
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI------VKSFLFQLLKGLGFCHSRNV 122
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DLKP N+L++ N   KL+DFG++R        +    + C +    T  Y  P+ L 
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLAR--------AFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 319 SGELTPKS-DVYSFGIILLRL 338
             +L   S D++S G I   L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAEL 195

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 149
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 204
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 30/235 (12%)
Query: 116 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHS 173
            ++S +P ++ D S    +  +  F+   ++G G    +Y+   +  Q   A+K+L    
Sbjct: 33  GTASLVPDYWIDGS--NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK--K 88
Query: 174 LQGPSEFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPL 231
                  + EI +L ++ HPN++ L  +   P   +LV E +  G L DR+  K      
Sbjct: 89  TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---Y 145
Query: 232 SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL-----DANFVSKLSDFGISRF 286
           S +       ++   + +LH    + IVH DLKP N+L      DA    K++DFG+S+ 
Sbjct: 146 SERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPL--KIADFGLSKI 200
Query: 287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           +    +     T+C      GT  Y  PE L      P+ D++S GII   LL G
Sbjct: 201 VEHQVLMK---TVC------GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTLVG 200
           +G+G   ++++G  RH +     AIK+ +  S   P + Q +E ++L K+ H N+V L  
Sbjct: 17  LGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 201 ACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
              E  T    L+ E+ P GSL   L    N+  L     + +   L  V+  ++  + +
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV---LRDVVGGMNHLREN 131
Query: 257 SIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
            IVH ++KP NI+     D   V KL+DFG +R L  +E               GT  Y+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---------QFVSLYGTEEYL 182
Query: 313 DPEFLASGEL--------TPKSDVYSFGIILLRLLTG----RPALG--ITKEVQYALDTG 358
            P+      L            D++S G+      TG    RP  G    KEV Y + TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 359 K 359
           K
Sbjct: 243 K 243

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 167
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 222
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 123 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 173
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 174 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 123 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 173
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 174 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 106/241 (43%), Gaps = 41/241 (17%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTLVG 200
           +G+G   ++++G  RH +     AIK+ +  S   P + Q +E ++L K+ H N+V L  
Sbjct: 17  LGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 201 ACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
              E  T    L+ E+ P GSL   L    N+  L  ++   I   L  V+  ++  + +
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP-ESEFLIV--LRDVVGGMNHLREN 131
Query: 257 SIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
            IVH ++KP NI+     D   V KL+DFG +R L  +E               GT  Y+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---------QFVXLYGTEEYL 182
Query: 313 DPEFLASGEL--------TPKSDVYSFGIILLRLLTG----RPALG--ITKEVQYALDTG 358
            P+      L            D++S G+      TG    RP  G    KEV Y + TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 359 K 359
           K
Sbjct: 243 K 243

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 48/218 (22%)
Query: 179 EFQQEIDILSKIRHPNLVT---LVGACPEVWTLVYEYLPNGS----------LEDRLSCK 225
           +F+ E+ I++ I++   +T   ++    EV+ ++YEY+ N S          L+   +C 
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVY-IIYEYMENDSILKFDEYFFVLDKNYTC- 146
Query: 226 DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 285
                +  Q    I   + +   ++H+ K  +I H D+KP+NIL+D N   KLSDFG S 
Sbjct: 147 ----FIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA--SGELTPKSDVYSFGIILLRLLTGRP 343
           ++   +I             +GT+ +M PEF +  S     K D++S GI L  +     
Sbjct: 201 YMVDKKIKG----------SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 344 ALGI------------TKEVQYALDTGKLKNLLDPLAG 369
              +            TK ++Y LD     + L PL  
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYPLDRN---HFLYPLTN 285

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T      +   T  Y  PE + + 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--XEXVATRWYRAPEIMLNS 206
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      L  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 152
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T      +   T  Y  PE + + 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--XEXVATRWYRAPEIMLNS 207
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G ++K  + H    + +A K++H        ++  +E+ +L +   P
Sbjct: 26  DFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 83
Query: 194 NLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            +V   GA     E+ ++  E++  GSL+  L      P    Q   +++  +   L +L
Sbjct: 84  YIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYL 139
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +
Sbjct: 140 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRS 187
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 346
           YM PE L     + +SD++S G+ L+ +  GR  +G
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL +    ++VA+KML   +     E    E+ I+S + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 197 TLVGACPEVW--TLVYEYLPNGSLEDRLSCKDN-----------SPPLSWQTRIRIATEL 243
            L+GAC       ++ EY   G L + L  K             +  LS +  +  ++++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
              + FL S    + +H D+   N+LL    V+K+ DFG++R +       N++    + 
Sbjct: 174 AQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDI------MNDSNYIVKG 224
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           + +    +M PE +     T +SDV+S+GI+L  + +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL   RH N++ +  + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 149
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 204
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYK------GLLRHMQVAIKMLHPHSLQGPS--EFQQEID 185
           E     +D   ++G G +  + K      GL    +   K     S +G S  + ++E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 186 ILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           IL +I+HPN++TL  V        L+ E +  G L D L+ K++   L+ +       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEISSNNTTL 299
            + + +LHS +   I H DLKP NI LLD N      K+ DFG++     ++I   N   
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEF- 174
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
               +  GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL   RH N++ +  + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   Y+    +E  L     +  LS         ++   L ++HS    +++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 149
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 204
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 107/248 (43%), Gaps = 46/248 (18%)
Query: 139 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
           +F+    +G+G +G + K    L     AIK +  H+ +  S    E+ +L+ + H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 197 TLVGACPEVWTLV---------------YEYLPNGSLEDRLSCKDNSPPLS--WQTRIRI 239
               A  E    V                EY  NG+L D +  ++ +      W    R+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RL 121
Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL----------SQ 289
             ++   L ++HS     I+H DLKP NI +D +   K+ DFG+++ +          SQ
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 290 NEISSNNTTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLL----TGRPA 344
           N   S++      T   GT  Y+  E L  +G    K D+YS GII   ++    TG   
Sbjct: 179 NLPGSSDNL----TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER 234
Query: 345 LGITKEVQ 352
           + I K+++
Sbjct: 235 VNILKKLR 242

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 143 SLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPS--------EFQQEIDILSKIRH 192
           S  +G G  G +     R    +VAIK++        S          + EI+IL K+ H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 193 PNLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLI 248
           P ++ +      E + +V E +  G L D++             R++ AT       +L+
Sbjct: 75  PCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYFYQMLL 125
Query: 249 FLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            +     + I+H DLKP N+LL +   + + K++DFG S+ L +   +S   TLC     
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLC----- 177
Query: 306 KGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRP 343
            GT  Y+ PE L S          D +S G+IL   L+G P
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 143 SLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPS--------EFQQEIDILSKIRH 192
           S  +G G  G +     R    +VAIK++        S          + EI+IL K+ H
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 193 PNLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLI 248
           P ++ +      E + +V E +  G L D++             R++ AT       +L+
Sbjct: 74  PCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYFYQMLL 124
Query: 249 FLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            +     + I+H DLKP N+LL +   + + K++DFG S+ L +   +S   TLC     
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLC----- 176
Query: 306 KGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRP 343
            GT  Y+ PE L S          D +S G+IL   L+G P
Sbjct: 177 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 107/228 (46%), Gaps = 26/228 (11%)
Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ- 182
           S+F  +     + N+D   ++G+G +  + + + +   ++ A K+++   L    +FQ+ 
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKL 75
Query: 183 --EIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
             E  I  K++HPN+V L  +  E     LV++ +  G L + +  ++      + +   
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE------FYSEAD 129
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSN 295
            +  +  +L  +  C  + IVH +LKP N+LL +       KL+DFG++  ++ +E    
Sbjct: 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189
Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                      GT  Y+ PE L     +   D+++ G+IL  LL G P
Sbjct: 190 FA---------GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 143 SLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPS--------EFQQEIDILSKIRH 192
           S  +G G  G +     R    +VAIK++        S          + EI+IL K+ H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 193 PNLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLI 248
           P ++ +      E + +V E +  G L D++             R++ AT       +L+
Sbjct: 75  PCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYFYQMLL 125
Query: 249 FLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            +     + I+H DLKP N+LL +   + + K++DFG S+ L +   +S   TLC     
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLC----- 177
Query: 306 KGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRP 343
            GT  Y+ PE L S          D +S G+IL   L+G P
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +R  +VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
               +  +   Y+    +E  L     S  LS         ++   L ++HS    +++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA---NVLH 167
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+L++     K+ DFG++R         ++T     T+   T  Y  PE + + 
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEH---DHTGFL--TEXVATRWYRAPEIMLNS 222
Query: 321 ELTPKS-DVYSFGIILLRLLTGRP 343
           +   KS D++S G IL  +L+ RP
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 149 GGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILS--KIRHPNLVTLVGACP--- 203
           G +G ++K  L +  VA+K+     +Q    +Q E ++ S   ++H N++  +GA     
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 204 ----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH--- 256
               ++W L+  +   GSL D L     +  +SW     IA  +   L +LH   P    
Sbjct: 92  SVDVDLW-LITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 257 ----SIVHGDLKPANILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFAY 311
               +I H D+K  N+LL  N  + ++DFG++ +F +       +  +       GT  Y
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV-------GTRRY 199
Query: 312 MDPEFLASG-----ELTPKSDVYSFGIILLRL 338
           M PE L        +   + D+Y+ G++L  L
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 122/278 (43%), Gaps = 41/278 (14%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL +    ++VA+KML   +     E    E+ I+S + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 197 TLVGACPEVW--TLVYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRIRI 239
            L+GAC       ++ EY   G L + L  K   PP               LS +  +  
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRK--RPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           ++++   + FL S    + +H D+   N+LL    V+K+ DFG++R +       N++  
Sbjct: 172 SSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDI------MNDSNY 222
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 359
             + + +    +M PE +     T +SDV+S+GI+L  + +    LG+       +++  
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGLNPYPGILVNSKF 278
Query: 360 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
            K + D      P    + + ++   C  +    RP  
Sbjct: 279 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 316

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 143 SLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPS--------EFQQEIDILSKIRH 192
           S  +G G  G +     R    +VAIK++        S          + EI+IL K+ H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 193 PNLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLI 248
           P ++ +      E + +V E +  G L D++             R++ AT       +L+
Sbjct: 75  PCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYFYQMLL 125
Query: 249 FLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            +     + I+H DLKP N+LL +   + + K++DFG S+ L +   +S   TLC     
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLC----- 177
Query: 306 KGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRP 343
            GT  Y+ PE L S          D +S G+IL   L+G P
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G ++K  + H    + +A K++H        ++  +E+ +L +   P
Sbjct: 34  DFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 194 NLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
            +V   GA       ++  E++  GSL+  L      P    Q   +++  +   L +L 
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLR 148
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +Y
Sbjct: 149 --EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSY 196
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           M PE L     + +SD++S G+ L+ +  GR
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 145 KIGEGGYGSIYKGLLRHM--QVAIK-MLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV- 199
           KIG+G +G ++K   R    +VA+K +L  +  +G P    +EI IL  ++H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 200 ---------GACPEVWTLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
                      C     LV+++  +   G L + L         +     R+   L + L
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGL 138
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            ++H  K   I+H D+K AN+L+  + V KL+DFG++R  S  + S  N       +   
Sbjct: 139 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY----XNRVV 191
Query: 308 TFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYAL 355
           T  Y  PE  L   +  P  D++  G I+  + T  P + G T++ Q AL
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 241

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 143 SLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPS--------EFQQEIDILSKIRH 192
           S  +G G  G +     R    +VAIK++        S          + EI+IL K+ H
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 193 PNLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLI 248
           P ++ +      E + +V E +  G L D++             R++ AT       +L+
Sbjct: 81  PCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYFYQMLL 131
Query: 249 FLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            +     + I+H DLKP N+LL +   + + K++DFG S+ L +   +S   TLC     
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLC----- 183
Query: 306 KGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRP 343
            GT  Y+ PE L S          D +S G+IL   L+G P
Sbjct: 184 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 223

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 145 KIGEGGYGSIYKGLLRHM--QVAIK-MLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV- 199
           KIG+G +G ++K   R    +VA+K +L  +  +G P    +EI IL  ++H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 200 ---------GACPEVWTLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
                      C     LV+++  +   G L + L         +     R+   L + L
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGL 138
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            ++H  K   I+H D+K AN+L+  + V KL+DFG++R  S  + S  N       +   
Sbjct: 139 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY----XNRVV 191
Query: 308 TFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYAL 355
           T  Y  PE  L   +  P  D++  G I+  + T  P + G T++ Q AL
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 241

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--VG 200
           IGEG YG +      +  ++VAIK + P   Q   +   +EI IL + RH N++ +  + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P +  +   YL    +   L     +  LS         ++   L ++HS    +++H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 167
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP+N+LL+     K+ DFG++R    +    ++T     T+   T  Y  PE + + 
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDH---DHTGFL--TEYVATRWYRAPEIMLNS 222
Query: 321 ELTPKS-DVYSFGIILLRLLTGRPAL 345
           +   KS D++S G IL  +L+ RP  
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L    +      +  I +  ++   + +L      +
Sbjct: 94  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 147
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  PE +
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYAPECI 202
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
              + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 247

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L    +      +  I +  ++   + +L      +
Sbjct: 94  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 147
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  PE +
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYAPECI 202
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
              + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 247

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL +    ++VA+KML   +     E    E+ I+S + +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 197 TLVGACPEVW--TLVYEYLPNGSLEDRLSCK--------------------DNSPPLSWQ 234
            L+GAC       ++ EY   G L + L  K                    ++  PL  +
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 235 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
             +  ++++   + FL S    + +H D+   N+LL    V+K+ DFG++R +       
Sbjct: 159 DLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDI------M 209
Query: 295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           N++    + + +    +M PE +     T +SDV+S+GI+L  + +
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L    +      +  I +  ++   + +L      +
Sbjct: 92  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 145
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  PE +
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYAPECI 200
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
              + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 245

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L    +      +  I +  ++   + +L      +
Sbjct: 84  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 137
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  PE +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYAPECI 192
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
              + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 237

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 145 KIGEGGYGSIYKGLLRHM--QVAIK-MLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV- 199
           KIG+G +G ++K   R    +VA+K +L  +  +G P    +EI IL  ++H N+V L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 200 ---------GACPEVWTLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
                      C     LV+++  +   G L + L         +     R+   L + L
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGL 137
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            ++H  K   I+H D+K AN+L+  + V KL+DFG++R  S  + S  N       +   
Sbjct: 138 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY----XNRVV 190
Query: 308 TFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYAL 355
           T  Y  PE  L   +  P  D++  G I+  + T  P + G T++ Q AL
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 145 KIGEGGYGSIYKGLLRHM--QVAIK-MLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLV- 199
           KIG+G +G ++K   R    +VA+K +L  +  +G P    +EI IL  ++H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 200 ---------GACPEVWTLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
                      C     LV+++  +   G L + L         +     R+   L + L
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGL 138
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            ++H  K   I+H D+K AN+L+  + V KL+DFG++R  S  + S  N       +   
Sbjct: 139 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY----XNRVV 191
Query: 308 TFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYAL 355
           T  Y  PE  L   +  P  D++  G I+  + T  P + G T++ Q AL
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 241

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPN 194
           N+D   ++G+G +  + + + +   ++ A K+++   L      + ++E  I  K++HPN
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 195 LVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L  +  E     LV++ +  G L + +  ++      + +    +  +  +L  +  
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAY 119
Query: 253 CKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           C  + IVH +LKP N+LL +       KL+DFG++  ++ +E               GT 
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---------GTP 170
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            Y+ PE L     +   D+++ G+IL  LL G P
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 204

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPN 194
           N+D   ++G+G +  + + + +   ++ A K+++   L      + ++E  I  K++HPN
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 195 LVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L  +  E     LV++ +  G L + +  ++      + +    +  +  +L  +  
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAY 120
Query: 253 CKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           C  + IVH +LKP N+LL +       KL+DFG++  ++ +E               GT 
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---------GTP 171
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            Y+ PE L     +   D+++ G+IL  LL G P
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQ----EIDILSKIRHPNLVTL 198
           +GEG + ++YK   ++    VAIK +   H  +      +    EI +L ++ HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 199 VGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           + A       +LV++++    LE  +  KDNS  L   T   I   +   L  L     H
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLE--VIIKDNSLVL---TPSHIKAYMLMTLQGLEYLHQH 131
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
            I+H DLKP N+LLD N V KL+DFG+++ F S N    +            T  Y  PE
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV---------TRWYRAPE 182
Query: 316 FLASGELTPKS-DVYSFGIILLRLLTGRPAL 345
            L    +     D+++ G IL  LL   P L
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRVPFL 213

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ---VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 195
           ++D   ++G G +G +++   R       A  ++ PH     +  ++EI  +S +RHP L
Sbjct: 52  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVLRHPTL 110
Query: 196 VTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           V L  A  +     ++YE++  G L ++++ + N   +S    +    ++C  L  +H  
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE- 167
Query: 254 KPHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             ++ VH DLKP NI+      +  KL DFG++  L   + S   TT        GT  +
Sbjct: 168 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTT--------GTAEF 216
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 346
             PE      +   +D++S G++   LL+G    G
Sbjct: 217 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 251

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L    +      +  I +  ++   + +L      +
Sbjct: 78  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 131
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  PE +
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NXYKAQTHGKWPVKWYAPECI 186
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
              + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 231

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L    +      +  I +  ++   + +L      +
Sbjct: 72  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 125
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  PE +
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYAPECI 180
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
              + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 225

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 38/215 (17%)
Query: 149 GGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACP--- 203
           G +G ++K  L +  VA+K+     LQ    +Q E +I S   ++H NL+  + A     
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIF---PLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 204 ----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH--- 256
               E+W L+  +   GSL D L  K N   ++W     +A  +   L +LH   P    
Sbjct: 83  NLEVELW-LITAFHDKGSLTDYL--KGNI--ITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 257 -----SIVHGDLKPANILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFA 310
                SI H D K  N+LL ++  + L+DFG++ RF         +  +       GT  
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV-------GTRR 190
Query: 311 YMDPEFLASG-----ELTPKSDVYSFGIILLRLLT 340
           YM PE L        +   + D+Y+ G++L  L++
Sbjct: 191 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G ++K  + H    + +A K++H        ++  +E+ +L +   P
Sbjct: 69  DFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 126
Query: 194 NLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
            +V   GA       ++  E++  GSL+  L      P    Q   +++  +   L +L 
Sbjct: 127 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTYLR 183
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +Y
Sbjct: 184 --EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSY 231
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           M PE L     + +SD++S G+ L+ +  GR
Sbjct: 232 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 146 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    GL +    ++VA+KML   +     E    E+ I+S + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 197 TLVGACPEVW--TLVYEYLPNGSLEDRLSCK----DNSPPL-------SWQTRIRIATEL 243
            L+GAC       ++ EY   G L + L  K    +  P         S +  +  ++++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
              + FL S    + +H D+   N+LL    V+K+ DFG++R +       N++    + 
Sbjct: 174 AQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDI------MNDSNYIVKG 224
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           + +    +M PE +     T +SDV+S+GI+L  + +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L    +      +  I +  ++   + +L      +
Sbjct: 78  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 131
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  PE +
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYAPECI 186
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
              + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 231

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 22/179 (12%)
Query: 179 EFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E ++E+ IL ++ HPN++TL  V        L+ E +  G L D L+ K++   LS +  
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEA 117
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANI-LLDANF---VSKLSDFGISRFLSQNEI 292
                ++   + +LH+ K   I H DLKP NI LLD N      KL DFG++  + ++ +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGV 173
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
              N          GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 174 EFKNIF--------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQ 181
           SDF F ++            IG+G +G +   L RH    +  A+K+L   ++    E +
Sbjct: 38  SDFHFLKV------------IGKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEK 83
Query: 182 QEID----ILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT 235
             +     +L  ++HP LV L  +    +    V +Y+  G L   L  +        + 
Sbjct: 84  HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEP 139
Query: 236 RIRI-ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
           R R  A E+ S L +LHS    +IV+ DLKP NILLD+     L+DFG+ +     E +S
Sbjct: 140 RARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNS 194
Query: 295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
             +T C      GT  Y+ PE L         D +  G +L  +L G P  
Sbjct: 195 TTSTFC------GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L    +      +  I +  ++   + +L      +
Sbjct: 74  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 127
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  PE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYAPECI 182
Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
              + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 227

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP 193
           N+D   ++G+G +  + + + +   ++ A K+++   L    +FQ+   E  I  K++HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHP 65
Query: 194 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N+V L  +  E     LV++ +  G L + +  ++      + +    +  +  +L  + 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIA 119
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            C  + IVH +LKP N+LL +       KL+DFG++  ++ +E               GT
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---------GT 170
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             Y+ PE L     +   D+++ G+IL  LL G P
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 113/229 (49%), Gaps = 29/229 (12%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G ++K  + H    + +A K++H        ++  +E+ +L +   P
Sbjct: 10  DFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 67
Query: 194 NLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            +V   GA     E+ ++  E++  GSL+  L      P    Q   +++  +   L +L
Sbjct: 68  YIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYL 123
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              + H I+H D+KP+NIL+++    KL DFG+S  L  +E+++            GT +
Sbjct: 124 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DEMANEFV---------GTRS 171
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTG---RPALGITKEVQYALD 356
           YM PE L     + +SD++S G+ L+ +  G   RP + I + + Y ++
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVN 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 38/221 (17%)
Query: 143 SLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPS--------EFQQEIDILSKIRH 192
           S  +G G  G +     R    +VAI+++        S          + EI+IL K+ H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 193 PNLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLI 248
           P ++ +      E + +V E +  G L D++             R++ AT       +L+
Sbjct: 200 PCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG---------NKRLKEATCKLYFYQMLL 250
Query: 249 FLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            +     + I+H DLKP N+LL +   + + K++DFG S+ L +  +     TLC     
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLC----- 302
Query: 306 KGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRP 343
            GT  Y+ PE L S          D +S G+IL   L+G P
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 146 IGEGGYGSIYKG-LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 202
           IG G +G +++  L+   +VAIK +    LQ      +E+ I+  ++HPN+V L      
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 203 -----PEVW-TLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                 EV+  LV EY+P     +       K   P L  +  +    +L   L ++HS 
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM---YQLLRSLAYIHSI 160
Query: 254 KPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
               I H D+KP N+LLD  + V KL DFG ++ L   E   N + +C R        Y 
Sbjct: 161 ---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSR-------YYR 208
Query: 313 DPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
            PE +  +   T   D++S G ++  L+ G+P
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQP 240

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ---VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 195
           ++D   ++G G +G +++   R       A  ++ PH     +  ++EI  +S +RHP L
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVLRHPTL 216
Query: 196 VTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           V L  A  +     ++YE++  G L ++++ + N   +S    +    ++C  L  +H  
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE- 273
Query: 254 KPHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             ++ VH DLKP NI+      +  KL DFG++  L   + S   TT        GT  +
Sbjct: 274 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTT--------GTAEF 322
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 346
             PE      +   +D++S G++   LL+G    G
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 145 KIGEGG--YGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+GEGG  Y  + +GL      A+K +  H  Q   E Q+E D+     HPN++ LV  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 203 -------PEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
                   E W L+  +   G+L + +   KD    L+    + +   +C  L  +H+  
Sbjct: 96  LRERGAKHEAWLLL-PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFG-ISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
                H DLKP NILL       L D G +++     E S    TL      + T +Y  
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 314 PEFLASGE---LTPKSDVYSFGIILLRLLTG 341
           PE  +      +  ++DV+S G +L  ++ G
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G ++K  + H    + +A K++H        ++  +E+ +L +   P
Sbjct: 7   DFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 194 NLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            +V   GA     E+ ++  E++  GSL+  L      P    Q   +++  +   L +L
Sbjct: 65  YIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYL 120
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRS 168
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           YM PE L     + +SD++S G+ L+ +  GR
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 38/221 (17%)
Query: 143 SLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPS--------EFQQEIDILSKIRH 192
           S  +G G  G +     R    +VAI+++        S          + EI+IL K+ H
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
Query: 193 PNLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLI 248
           P ++ +      E + +V E +  G L D++             R++ AT       +L+
Sbjct: 214 PCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG---------NKRLKEATCKLYFYQMLL 264
Query: 249 FLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            +     + I+H DLKP N+LL +   + + K++DFG S+ L +  +     TLC     
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLC----- 316
Query: 306 KGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRP 343
            GT  Y+ PE L S          D +S G+IL   L+G P
Sbjct: 317 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 356

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G ++K  + H    + +A K++H        ++  +E+ +L +   P
Sbjct: 7   DFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 194 NLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            +V   GA     E+ ++  E++  GSL+  L      P    Q   +++  +   L +L
Sbjct: 65  YIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYL 120
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRS 168
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           YM PE L     + +SD++S G+ L+ +  GR
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 128/293 (43%), Gaps = 56/293 (19%)
Query: 130 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM---------QVAIKMLHPHSLQGPSEF 180
           F +I      F+ SL  G+G +  I+KG+ R +         +V +K+L          F
Sbjct: 2   FHKIRNEDLIFNESL--GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 181 QQEIDILSKIRHPNLVTLVG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
            +   ++SK+ H +LV   G   C +   LV E++  GSL+  L    N   + W  ++ 
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLE 117
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILL---------DANFVSKLSDFGISRFLSQ 289
           +A +L + + FL     ++++HG++   NILL         +  F+ KLSD GIS     
Sbjct: 118 VAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGIS----- 168
Query: 290 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTG--RP--A 344
                   T+  +   +    ++ PE + +   L   +D +SFG  L  + +G  +P  A
Sbjct: 169 -------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
Query: 345 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
           L   +++Q+  D  +L           P  +A +LANL   C +     RP  
Sbjct: 222 LDSQRKLQFYEDRHQL-----------PAPKAAELANLINNCMDYEPDHRPSF 263

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G ++K  + H    + +A K++H        ++  +E+ +L +   P
Sbjct: 7   DFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 194 NLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
            +V   GA       ++  E++  GSL+  L      P    Q   +++  +   L +L 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLR 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +Y
Sbjct: 122 --EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSY 169
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           M PE L     + +SD++S G+ L+ +  GR
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLS----CKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           +G C  E W LV E    G L   L      KD       +  I +  ++   + +L   
Sbjct: 436 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-------KNIIELVHQVSMGMKYLEES 488
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
              + VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  
Sbjct: 489 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYA 540
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
           PE +   + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 541 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 589

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G ++K  + H    + +A K++H        ++  +E+ +L +   P
Sbjct: 7   DFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 194 NLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
            +V   GA       ++  E++  GSL+  L      P    Q   +++  +   L +L 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLR 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +Y
Sbjct: 122 --EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSY 169
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           M PE L     + +SD++S G+ L+ +  GR
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 56/230 (24%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV 205
           IG GG+G ++K   +H       +         + ++E+  L+K+ H N+V   G     
Sbjct: 20  IGSGGFGQVFKA--KHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGC---- 73
Query: 206 WTLVYEYLPNGSLEDRLSCKDNSPPLS-------------------------WQTRIR-- 238
           W   ++Y P  S +D L   D  P  S                         W  + R  
Sbjct: 74  WD-GFDYDPETS-DDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 239 -----IATELCSVLI----FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 289
                +A EL   +     ++HS K   ++H DLKP+NI L      K+ DFG+   L  
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKK---LIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           +           RT  KGT  YM PE ++S +   + D+Y+ G+IL  LL
Sbjct: 189 D---------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 145 KIGEGGYGSIYKG---LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG   + + ++     +  +    P+   E   E +++ ++ +P +V +
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLS----CKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           +G C  E W LV E    G L   L      KD       +  I +  ++   + +L   
Sbjct: 437 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD-------KNIIELVHQVSMGMKYLEES 489
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
              + VH DL   N+LL     +K+SDFG+S+ L  +E          +T  K    +  
Sbjct: 490 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYA 541
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
           PE +   + + KSDV+SFG+++    +   +P  G+   EV   L+ G+
Sbjct: 542 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 590

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           IG G +G +   L++HM+     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 49  IGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY+P G +   L      S P     R   A ++     +LHS   
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 160
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     K++DFG ++      +      LC      GT  Y+ PE
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLC------GTPEYLAPE 208
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 193
           +F+   ++G G  G ++K  + H    + +A K++H        ++  +E+ +L +   P
Sbjct: 7   DFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 194 NLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
            +V   GA       ++  E++  GSL+  L      P    Q   +++  +   L +L 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLR 121
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
             + H I+H D+KP+NIL+++    KL DFG+S  L    I S   +        GT +Y
Sbjct: 122 --EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSY 169
Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           M PE L     + +SD++S G+ L+ +  GR
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    IG G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTIGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM 128
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+L+D     K
Sbjct: 129 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIK 181
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 182 VADFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 231 MAAGYPPFFADQPIQ 245

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 94/226 (41%), Gaps = 27/226 (11%)
Query: 139 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 189
           NF+    +G G YG ++          G L  M+V  K       +     + E  +L  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 190 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           IR  P LVTL  A        L+ +Y+  G L   LS ++       Q  +    E+   
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV---GEIVLA 171
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L  LH      I++ D+K  NILLD+N    L+DFG+S+    +E +      C      
Sbjct: 172 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFC------ 221
Query: 307 GTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKE 350
           GT  YM P+ +  G+       D +S G+++  LLTG     +  E
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    IG G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTIGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+L+D     K
Sbjct: 129 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIK 181
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 182 VADFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 231 MAAGYPPFFADQPIQ 245

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 56/293 (19%)
Query: 130 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM---------QVAIKMLHPHSLQGPSEF 180
           F +I      F+ SL  G+G +  I+KG+ R +         +V +K+L          F
Sbjct: 2   FHKIRNEDLIFNESL--GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 181 QQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
            +   ++SK+ H +LV   G   C +   LV E++  GSL+  L    N   + W  ++ 
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLE 117
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILL---------DANFVSKLSDFGISRFLSQ 289
           +A +L   + FL     ++++HG++   NILL         +  F+ KLSD GIS     
Sbjct: 118 VAKQLAWAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGIS----- 168
Query: 290 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTG--RP--A 344
                   T+  +   +    ++ PE + +   L   +D +SFG  L  + +G  +P  A
Sbjct: 169 -------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
Query: 345 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
           L   +++Q+  D  +L           P  +A +LANL   C +     RP  
Sbjct: 222 LDSQRKLQFYEDRHQL-----------PAPKAAELANLINNCMDYEPDHRPSF 263

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--- 202
           IG GG+G ++K   +H       +         + ++E+  L+K+ H N+V   G     
Sbjct: 19  IGSGGFGQVFKA--KHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 203 ---PEVWT------------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
              PE  +            +  E+   G+LE  +  K     L     + +  ++   +
Sbjct: 77  DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLALELFEQITKGV 135
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            ++HS K   +++ DLKP+NI L      K+ DFG+   L  +           R   KG
Sbjct: 136 DYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---------GKRXRSKG 183
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           T  YM PE ++S +   + D+Y+ G+IL  LL
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 139 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
           +F+    +G+G +G + K    L     AIK +  H+ +  S    E+ +L+ + H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 197 TLVGACPEVWTLV---------------YEYLPNGSLEDRLSCKDNSPPLS--WQTRIRI 239
               A  E    V                EY  N +L D +  ++ +      W    R+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW----RL 121
Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL----------SQ 289
             ++   L ++HS     I+H DLKP NI +D +   K+ DFG+++ +          SQ
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 290 NEISSNNTTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLL----TGRPA 344
           N   S++      T   GT  Y+  E L  +G    K D+YS GII   ++    TG   
Sbjct: 179 NLPGSSDNL----TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER 234
Query: 345 LGITKEVQ 352
           + I K+++
Sbjct: 235 VNILKKLR 242

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 107/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 28  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 69
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+L+D     +
Sbjct: 130 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 182
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +     TLC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 183 VTDFGFAK-----RVKGRTWTLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 232 MAAGYPPFFADQPIQ 246

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQG +   +E+ I+ K+ H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                  EV+  LV +Y+P     +    S    + P+ +        +L   L ++HS 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK--LYMYQLFRSLAYIHS- 140
Query: 254 KPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
               I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y 
Sbjct: 141 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YYR 189
Query: 313 DPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
            PE +  + + T   DV+S G +L  LL G+P
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQG +   +E+ I+ K+ H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                  EV+  LV +Y+P     +    S    + P+ +        +L   L ++HS 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK--LYMYQLFRSLAYIHS- 140
Query: 254 KPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
               I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y 
Sbjct: 141 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YYR 189
Query: 313 DPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 345
            PE +  + + T   DV+S G +L  LL G+P  
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQG +   +E+ I+ K+ H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 84  SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YY 188
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 107/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 13  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 54
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 55  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 114
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+L+D     +
Sbjct: 115 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 167
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +     TLC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 168 VTDFGFAK-----RVKGRTWTLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 216
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 217 MAAGYPPFFADQPIQ 231

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 93  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 146
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 200
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 201 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 246

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 22/236 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           KIGEG YG +YK    + +  A+K   L       PS   +EI IL +++H N+V L  V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +   LV+E+L +  L+  L   +          +   + L  +L  +  C    ++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL-A 318
           H DLKP N+L++     K++DFG++R        +    +   T    T  Y  P+ L  
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR--------AFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 374
           S + +   D++S G I   ++ G P      E    +   ++  L  P + +WP V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI--LGTPNSKNWPNV 228

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 23/176 (13%)
Query: 175 QGPSE-FQQEIDILSKIRHPNLVTLVGACPEV----WTLVYEYLPNGSLEDRLSCKDNSP 229
           +GP E   QEI IL K+ HPN+V LV    +       +V+E +  G + +  + K    
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---- 132
Query: 230 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 289
           PLS         +L   + +LH  K   I+H D+KP+N+L+  +   K++DFG+S     
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS----- 184
Query: 290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKS-DVYSFGIILLRLLTGR 342
           NE   ++  L   ++  GT A+M PE L+      + K+ DV++ G+ L   + G+
Sbjct: 185 NEFKGSDALL---SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 84  LGICLTSTVQLIMQLMPFGXLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 137
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 191
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 237

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 22/236 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           KIGEG YG +YK    + +  A+K   L       PS   +EI IL +++H N+V L  V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +   LV+E+L     +    C+     ++ ++       L  +L  +  C    ++
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSF------LLQLLNGIAYCHDRRVL 122
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL-A 318
           H DLKP N+L++     K++DFG++R        +    +   T    T  Y  P+ L  
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR--------AFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 374
           S + +   D++S G I   ++ G P      E    +   ++  L  P + +WP V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRI--LGTPNSKNWPNV 228

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 133 IEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPH-SLQGPSEFQQEIDI- 186
            E    + +P +++G G YG + K  +RH+     +A+K +    + Q       ++DI 
Sbjct: 46  FEVKADDLEPIMELGRGAYGVVEK--MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 103
Query: 187 LSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           +  +  P  VT  GA     +VW +  E +     +      D    +      +IA  +
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVW-ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 162
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
              L  LHS    S++H D+KP+N+L++A    K+ DFGIS +L    + S   T+    
Sbjct: 163 VKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDSVAKTIDAGC 216
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            P      ++PE    G  + KSD++S GI ++ L   R
Sbjct: 217 KPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILR 254

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 30/275 (10%)
Query: 87  YKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEI----EGATHNFDP 142
           Y+++  ELQ  + +      +L K R     + + P +      S I    E    N   
Sbjct: 2   YRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITL 61
Query: 143 SLKIGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPN 194
              +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N
Sbjct: 62  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 121
Query: 195 LVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLI 248
           +V  +G   +     ++ E +  G L+  L      P     L+    + +A ++     
Sbjct: 122 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 249 FLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           +L     +  +H D+   N LL       V+K+ DFG++R + +   +S      C   P
Sbjct: 182 YLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---ASYYRKGGCAMLP 235
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
                +M PE    G  T K+D +SFG++L  + +
Sbjct: 236 ---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 85  LGICLTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 138
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 192
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 238

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 22/236 (9%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           KIGEG YG +YK    + +  A+K   L       PS   +EI IL +++H N+V L  V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +   LV+E+L +  L+  L   +          +   + L  +L  +  C    ++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL-A 318
           H DLKP N+L++     K++DFG++R        +    +   T    T  Y  P+ L  
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR--------AFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 374
           S + +   D++S G I   ++ G P      E    +   ++  L  P + +WP V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI--LGTPNSKNWPNV 228

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 83  LGICLTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 136
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 190
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 84  LGICLTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 137
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 191
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 237

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++HM+     A+K+L    +    E +  ++   IL  +  P LV L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY P G +   L      S P     R   A ++     +LHS   
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 160
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+++D     K++DFG+++      +      LC      GT  Y+ PE
Sbjct: 161 -DLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLC------GTPEYLAPE 208
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 87  LGICLTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 140
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 194
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 240

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 86  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 139
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 193
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 239

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 29/244 (11%)
Query: 145 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNLVTLVG 200
           K+GEG YG +YK +  + +  VAIK +   H  +G P    +E+ +L +++H N++ L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                    L++EY  N    D     D +P +S +       +L + + F HS +    
Sbjct: 101 VIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---C 153
Query: 259 VHGDLKPANILLDANFVS-----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           +H DLKP N+LL  +  S     K+ DFG++R        +    +   T    T  Y  
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--------AFGIPIRQFTHEIITLWYRP 205
Query: 314 PE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 372
           PE  L S   +   D++S   I   +L   P      E+       ++  L D     WP
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT--WP 263
Query: 373 FVQA 376
            V A
Sbjct: 264 GVTA 267

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 83  LGICLTSTVQLITQLMPFGXLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 136
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 190
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 86  LGICLTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 139
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 193
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 239

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 136
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 190
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 89  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 142
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 196
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 197 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 242

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 86  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 139
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 193
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 239

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 85  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 138
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 192
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 238

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 86  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 139
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 193
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 136
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 190
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 90  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 143
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 197
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 243

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 40/274 (14%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL 198
           +G+G +GS+ +  L+      ++VA+KML    +      EF +E   + +  HP++  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 199 VGACPE--------VWTLVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 247
           VG            +  ++  ++ +G L   L      +N   L  QT +R   ++   +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L S    + +H DL   N +L  +    ++DFG+SR +   +        C    P  
Sbjct: 151 EYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG---CASKLP-- 202
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE--VQYALDTGKLKNL 363
              ++  E LA    T  SDV++FG+ +  ++T    P  GI       Y +   +LK  
Sbjct: 203 -VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ- 260
Query: 364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 397
                   P    E++ +L  +C     K RP  
Sbjct: 261 --------PPECMEEVYDLMYQCWSADPKQRPSF 286

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 178 SEFQQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT 235
           ++  +E+ +L +   P +V   GA       ++  E++  GSL+  L      P    + 
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE---EI 115
Query: 236 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
             +++  +   L +L   + H I+H D+KP+NIL+++    KL DFG+S  L    I S 
Sbjct: 116 LGKVSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSM 169
Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
             +        GT +YM PE L     + +SD++S G+ L+ L  GR
Sbjct: 170 ANSFV------GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 77  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 130
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 184
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 230

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 22/179 (12%)
Query: 179 EFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E ++E+ IL ++ H N++TL  V        L+ E +  G L D L+ K++   LS +  
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEA 117
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANI-LLDANFVS---KLSDFGISRFLSQNEI 292
                ++   + +LH+ K   I H DLKP NI LLD N      KL DFG++  + ++ +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGV 173
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
              N          GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 174 EFKNIF--------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 108 LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 161
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 215
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 216 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 261

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 40/229 (17%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGA-- 201
           +G+G YG +++G  +   VA+K+    S +    + +E ++ + +  RH N++  + +  
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 202 -----CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH----- 251
                  ++W L+  Y   GSL D L        L   + +RI   + S L  LH     
Sbjct: 73  TSRHSSTQLW-LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 252 -SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ--NEISSNNTTLCCRTDPK-G 307
              KP +I H DLK  NIL+  N    ++D G++   SQ  N++   N       +P+ G
Sbjct: 128 TQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN-------NPRVG 179
Query: 308 TFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKE 350
           T  YM PE L         +   + D+++FG++L  +     + GI ++
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 80  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAEGMNYLED---R 133
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 187
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 188 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 233

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 40/231 (17%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGA-- 201
           +G+G YG +++G  +   VA+K+    S +    + +E ++ + +  RH N++  + +  
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 202 -----CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH----- 251
                  ++W L+  Y   GSL D L        L   + +RI   + S L  LH     
Sbjct: 73  TSRHSSTQLW-LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 252 -SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ--NEISSNNTTLCCRTDPK-G 307
              KP +I H DLK  NIL+  N    ++D G++   SQ  N++   N       +P+ G
Sbjct: 128 TQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN-------NPRVG 179
Query: 308 TFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           T  YM PE L         +   + D+++FG++L  +     + GI ++ +
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 22/179 (12%)
Query: 179 EFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E ++E+ IL ++ H N++TL  V        L+ E +  G L D L+ K++   LS +  
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEA 117
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANI-LLDANF---VSKLSDFGISRFLSQNEI 292
                ++   + +LH+ K   I H DLKP NI LLD N      KL DFG++  + ++ +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGV 173
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
              N          GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 174 EFKNIF--------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 22/179 (12%)
Query: 179 EFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E ++E+ IL ++ H N++TL  V        L+ E +  G L D L+ K++   LS +  
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEA 117
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANI-LLDANF---VSKLSDFGISRFLSQNEI 292
                ++   + +LH+ K   I H DLKP NI LLD N      KL DFG++  + ++ +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGV 173
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
              N          GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 174 EFKNIF--------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 22/179 (12%)
Query: 179 EFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E ++E+ IL ++ H N++TL  V        L+ E +  G L D L+ K++   LS +  
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEA 117
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANI-LLDANF---VSKLSDFGISRFLSQNEI 292
                ++   + +LH+ K   I H DLKP NI LLD N      KL DFG++  + ++ +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGV 173
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
              N          GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 174 EFKNIF--------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 133 IEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPH-SLQGPSEFQQEIDI- 186
           +E    + +P +++G G YG + K  +RH+     +A+K +    + Q       ++DI 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEK--MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 187 LSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 243
           +  +  P  VT  GA     +VW +  E +     +      D    +      +IA  +
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVW-ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
              L  LHS    S++H D+KP+N+L++A    K+ DFGIS +L  +   + +    C+ 
Sbjct: 119 VKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDIDAGCK- 173
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            P      ++PE    G  + KSD++S GI ++ L   R
Sbjct: 174 -PYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILR 210

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 22/179 (12%)
Query: 179 EFQQEIDILSKIRHPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           E ++E+ IL ++ H N++TL  V        L+ E +  G L D L+ K++   LS +  
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEA 117
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANI-LLDANF---VSKLSDFGISRFLSQNEI 292
                ++   + +LH+ K   I H DLKP NI LLD N      KL DFG++  + ++ +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGV 173
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE 350
              N          GT  ++ PE +    L  ++D++S G+I   LL+G  P LG TK+
Sbjct: 174 EFKNIF--------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 28  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 69
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+L+D     +
Sbjct: 130 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 182
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 183 VTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 232 MAAGYPPFFADQPIQ 246

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 146 IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +   + +  ++  A K +  + ++    F+QEI+I+  + HPN++ L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
              +++ LV E    G L +R+  K            RI  ++ S + + H     ++ H
Sbjct: 77  DNTDIY-LVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKL---NVAH 129
Query: 261 GDLKPANILLDANFVS---KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP N L   +      KL DFG++      ++              GT  Y+ P+ L
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---------GTPYYVSPQVL 180
Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
             G   P+ D +S G+++  LL G P
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLCGYP 205

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 118/276 (42%), Gaps = 49/276 (17%)
Query: 181 QQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 238
           ++EI IL+  RH N++ L  +    E   +++E++    + +R++   ++  L+ +  + 
Sbjct: 49  KKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVS 106
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNN 296
              ++C  L FLHS   H+I H D++P NI+      S  K+ +FG +R L       +N
Sbjct: 107 YVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDN 159
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKE----- 350
             L   T P+    Y  PE      ++  +D++S G ++  LL+G  P L  T +     
Sbjct: 160 FRLLF-TAPE----YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN 214
Query: 351 ---VQYALDTGKLKNLL----------------------DPLAGDWPFVQAEQLANLAMR 385
               +Y  D    K +                       + L   W   + E+++   +R
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274
Query: 386 CCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLG 421
             +  R     + KD+  V+   R SCGG+   + G
Sbjct: 275 TLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKG 310

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+L+D     +
Sbjct: 129 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 182 VTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 231 MAAGYPPFFADQPIQ 245

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 34/238 (14%)
Query: 146 IGEGGYGSIYKG-------LLRHMQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +              VA+KML   +          E+ IL  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDN---------SPPLSWQTRIRIATELC 244
            L+GAC +      ++ E+   G+L   L  K N            L+ +  I  + ++ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
             + FL S K    +H DL   NILL    V K+ DFG++R + +      +     + D
Sbjct: 155 KGMEFLASRK---XIHRDLAARNILLSEKNVVKIXDFGLARDIYK------DPDYVRKGD 205
Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL----TGRPALGITKEVQYALDTG 358
            +    +M PE +     T +SDV+SFG++L  +     +  P + I +E    L  G
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEG 263

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+L+D     +
Sbjct: 129 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 182 VTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 231 MAAGYPPFFADQPIQ 245

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 40/231 (17%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGA-- 201
           +G+G YG +++G  +   VA+K+    S +    + +E ++ + +  RH N++  + +  
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASDM 101
Query: 202 -----CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH----- 251
                  ++W L+  Y   GSL D L        L   + +RI   + S L  LH     
Sbjct: 102 TSRHSSTQLW-LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 156
Query: 252 -SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ--NEISSNNTTLCCRTDPK-G 307
              KP +I H DLK  NIL+  N    ++D G++   SQ  N++   N       +P+ G
Sbjct: 157 TQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN-------NPRVG 208
Query: 308 TFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           T  YM PE L         +   + D+++FG++L  +     + GI ++ +
Sbjct: 209 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 259

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL----RHMQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G++YKGL       +++ + ++       P   ++ +D   +++ + +P++  L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 117 LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 170
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 171 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 224
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 225 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 270

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 146 IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +   + +  ++  A K +  + ++    F+QEI+I+  + HPN++ L     
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 93
Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
              +++ LV E    G L +R+  K            RI  ++ S + + H     ++ H
Sbjct: 94  DNTDIY-LVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAH 146
Query: 261 GDLKPANILLDANFVS---KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP N L   +      KL DFG++      ++              GT  Y+ P+ L
Sbjct: 147 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---------GTPYYVSPQVL 197
Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
             G   P+ D +S G+++  LL G P
Sbjct: 198 -EGLYGPECDEWSAGVMMYVLLCGYP 222

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 34/239 (14%)
Query: 146 IGEGGYGSIYKGLLRH-----MQVAIKM--LHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +GEG +GS+ +G L+      ++VA+K   L   S +   EF  E   +    HPN++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 199 VGACPEVWT-------LVYEYLPNGSLE-----DRLSCKDNSPPLSWQTRIRIATELCSV 246
           +G C E+ +       ++  ++  G L       RL       PL  QT ++   ++   
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QTLLKFMVDIALG 159
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           + +L +    + +H DL   N +L  +    ++DFG+S+ +   +              K
Sbjct: 160 MEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI------AK 210
Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGI----ILLRLLTGRPALGITKEVQYALDTGKLK 361
               ++  E LA    T KSDV++FG+    I  R +T  P +   +   Y L   +LK
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK 269

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    E +  ++   IL  +  P LV L  +  +   L  V EY P G +
Sbjct: 69  YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+++D     +
Sbjct: 129 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQ 181
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG+++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 182 VTDFGLAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 231 MAAGYPPFFADQPIQ 245

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+L+D     +
Sbjct: 129 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 182 VTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 231 MAAGYPPFFADQPIQ 245

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++HM+     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY P G +   L      S P     R   A ++     +LHS   
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 160
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+++D     K++DFG ++      +      LC      GT  Y+ PE
Sbjct: 161 -DLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 208
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 193
           NF+    +G+G +G +    ++      A+K+L    +    + +    E  ILS  R+ 
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 194 NLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIF 249
             +T +  C   P+    V E++  G L   +           + R R  A E+ S L+F
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----EARARFYAAEIISALMF 139
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LH      I++ DLK  N+LLD     KL+DFG+ +    N +++   T C      GT 
Sbjct: 140 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC------GTP 188
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
            Y+ PE L      P  D ++ G++L  +L G
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 85  LGICLTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 138
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG ++ L   E   +          K    +M  E 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA------EGGKVPIKWMALES 192
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 238

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 87  LGICLTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 140
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG ++ L   E   +          K    +M  E 
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA------EGGKVPIKWMALES 194
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 240

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE----I 292
           + I  ++   + FLHS     ++H DLKP+NI    + V K+ DFG+   + Q+E    +
Sbjct: 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
            +            GT  YM PE +     + K D++S G+IL  LL
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 174
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 175 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YY 222
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 105/249 (42%), Gaps = 48/249 (19%)
Query: 139 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
           +F+    +G+G +G + K    L     AIK +  H+ +  S    E+ +L+ + H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVV 65
Query: 197 TLVGACPEVWTLV---------------YEYLPNGSLEDRLSCKDNSPPLS--WQTRIRI 239
               A  E    V                EY  N +L D +  ++ +      W    R+
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW----RL 121
Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL----------SQ 289
             ++   L ++HS     I+H +LKP NI +D +   K+ DFG+++ +          SQ
Sbjct: 122 FRQILEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 290 N-EISSNNTTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLL----TGRP 343
           N   SS+N T        GT  Y+  E L  +G    K D YS GII    +    TG  
Sbjct: 179 NLPGSSDNLTSAI-----GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXE 233
Query: 344 ALGITKEVQ 352
            + I K+++
Sbjct: 234 RVNILKKLR 242

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 42/243 (17%)
Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQE 183
           SDF    +E           + EGG+  +Y+   +    + A+K L  +  +      QE
Sbjct: 16  SDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE 75
Query: 184 IDILSKIR-HPNLVTLVGACP---------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSW 233
           +  + K+  HPN+V    A           +   L+   L  G L + L   ++  PLS 
Sbjct: 76  VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS--------- 284
            T ++I  + C  +  +H  KP  I+H DLK  N+LL      KL DFG +         
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 285 ------RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL---ASGELTPKSDVYSFGIIL 335
                 R L + EI+ N T +           Y  PE +   ++  +  K D+++ G IL
Sbjct: 195 SWSAQRRALVEEEITRNTTPM-----------YRTPEIIDLYSNFPIGEKQDIWALGCIL 243
Query: 336 LRL 338
             L
Sbjct: 244 YLL 246

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKI 190
           ++FD    +G+G +G +   L+R        A+K+L    +    E    +    +L   
Sbjct: 8   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 191 RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           RHP L  L  A    +    V EY   G L   LS       +  + R R    E+ S L
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSAL 121
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDP 305
            +LHS     +V+ D+K  N++LD +   K++DFG    L +  IS   T  T C     
Sbjct: 122 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC----- 169
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            GT  Y+ PE L   +     D +  G+++  ++ GR
Sbjct: 170 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 85  LGICLTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 138
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG ++ L   E   +          K    +M  E 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA------EGGKVPIKWMALES 192
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 238

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L   +S Q   +F  E  I+SK  H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +   +S      C   P   
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---ASYYRKGGCAMLP--- 223
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 106/256 (41%), Gaps = 48/256 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 28  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 69
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 219 EDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
              L    +   P   +      A ++     +LHS     +++ DLKP N+L+D     
Sbjct: 130 FSHLRRIGRFXEPHARF-----YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI 181
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           +++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++ 
Sbjct: 182 QVTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 337 RLLTGRPALGITKEVQ 352
            +  G P     + +Q
Sbjct: 231 EMAAGYPPFFADQPIQ 246

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 85  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 138
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG ++ L   E   +          K    +M  E 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA------EGGKVPIKWMALES 192
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 238

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKI 190
           ++FD    +G+G +G +   L+R        A+K+L    +    E    +    +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 191 RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           RHP L  L  A    +    V EY   G L   LS       +  + R R    E+ S L
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSAL 118
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDP 305
            +LHS     +V+ D+K  N++LD +   K++DFG    L +  IS   T  T C     
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC----- 166
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            GT  Y+ PE L   +     D +  G+++  ++ GR
Sbjct: 167 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 152
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 153 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YY 200
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 106/256 (41%), Gaps = 48/256 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 219 EDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
              L    +   P   +      A ++     +LHS     +++ DLKP N+L+D     
Sbjct: 129 FSHLRRIGRFXEPHARF-----YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI 180
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           +++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++ 
Sbjct: 181 QVTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 337 RLLTGRPALGITKEVQ 352
            +  G P     + +Q
Sbjct: 230 EMAAGYPPFFADQPIQ 245

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 136
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG ++ L   E   +          K    +M  E 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA------EGGKVPIKWMALES 190
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 168
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 169 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YY 216
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 249

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIKM--LHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVG 200
           +IG GG   +++ L    Q+ AIK   L     Q    ++ EI  L+K++ H + +  + 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                   +Y  +  G+++     K       W+ +    +   ++L  +H+   H IVH
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 178
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKPAN L+  + + KL DFGI+  +        +TT   +    GT  YM PE +   
Sbjct: 179 SDLKPANFLI-VDGMLKLIDFGIANQMQP------DTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 321 ELTPKS-----------DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLA 368
             + ++           DV+S G IL  +  G+ P   I  ++       KL  ++DP  
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNH 285
Query: 369 G-DWPFVQAEQLANLAMRCC----EMSRKSRPEL 397
             ++P +  + L ++ ++CC       R S PEL
Sbjct: 286 EIEFPDIPEKDLQDV-LKCCLKRDPKQRISIPEL 318

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 106/256 (41%), Gaps = 48/256 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+P G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 219 EDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
              L    +   P   +      A ++     +LHS     +++ DLKP N+L+D     
Sbjct: 129 FSHLRRIGRFXEPHARF-----YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI 180
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           +++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++ 
Sbjct: 181 QVTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 337 RLLTGRPALGITKEVQ 352
            +  G P     + +Q
Sbjct: 230 EMAAGYPPFFADQPIQ 245

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 90  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 143
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG ++ L   E   +          K    +M  E 
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA------EGGKVPIKWMALES 197
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 243

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 146 IGEGGYGSIYKGL------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +GEG YG + + L       R +++  K        G +  ++EI +L ++RH N++ LV
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 200 GAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
                   +   +V EY   G  E   S  +   P+          +L   L +LHS   
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY--FCQLIDGLEYLHS--- 127
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             IVH D+KP N+LL      K+S  G++  L  +  ++++T   CRT  +G+ A+  PE
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL--HPFAADDT---CRTS-QGSPAFQPPE 181
Query: 316 FLASGELT---PKSDVYSFGIILLRLLTG 341
            +A+G  T    K D++S G+ L  + TG
Sbjct: 182 -IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 16/108 (14%)
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSN 295
           I  ++ + + FLHS   H+I H D+KP N+L    + + V KL+DFG ++  +QN + + 
Sbjct: 114 IMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT- 169
Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                    P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 170 ---------PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 208

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 146 IGEGGYGSIYKG-------LLRHMQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +              VA+KML   +          E+ IL  I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDN-----------SPPLSWQTRIRIATE 242
            L+GAC +      ++ E+   G+L   L  K N              L+ +  I  + +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 302
           +   + FL S K    +H DL   NILL    V K+ DFG++R + ++           +
Sbjct: 157 VAKGMEFLASRK---XIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR------K 207
Query: 303 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            D +    +M PE +     T +SDV+SFG++L  + +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKI 190
           ++FD    +G+G +G +   L+R        A+K+L    +    E    +    +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 191 RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           RHP L  L  A    +    V EY   G L   LS       +  + R R    E+ S L
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSAL 118
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDP 305
            +LHS     +V+ D+K  N++LD +   K++DFG    L +  IS   T  T C     
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC----- 166
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            GT  Y+ PE L   +     D +  G+++  ++ GR
Sbjct: 167 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 148
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 149 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YY 196
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 102
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 159
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 160 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YY 207
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 240

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YY 188
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 345
             PE +  + + T   DV+S G +L  LL G+P  
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----- 198
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 199 -VGACPEV--WTLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
             G   +V    LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YY 188
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 345
             PE +  + + T   DV+S G +L  LL G+P  
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 16/108 (14%)
Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSN 295
           I  ++ + + FLHS   H+I H D+KP N+L    + + V KL+DFG ++  +QN + + 
Sbjct: 133 IMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT- 188
Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                    P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 189 ---------PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 174
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 175 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YY 222
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 152
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 153 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YY 200
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDI 186
           +I+    +F+    +G+G +G ++    +      AIK L    +    + +    E  +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 187 LS-KIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATE 242
           LS    HP L  +       E    V EYL  G L   + SC  +   LS  T    A E
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFY--AAE 127
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 302
           +   L FLHS     IV+ DLK  NILLD +   K++DFG+ +   +N +    T   C 
Sbjct: 128 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEFC- 180
Query: 303 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
               GT  Y+ PE L   +     D +SFG++L  +L G+
Sbjct: 181 ----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 105/256 (41%), Gaps = 48/256 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY P G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 219 EDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
              L    +   P   +      A ++     +LHS     +++ DLKP N+++D     
Sbjct: 129 FSHLRRIGRFXEPHARF-----YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYI 180
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++ 
Sbjct: 181 KVTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 337 RLLTGRPALGITKEVQ 352
            +  G P     + +Q
Sbjct: 230 EMAAGYPPFFADQPIQ 245

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 176
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 177 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YY 224
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIKM--LHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVG 200
           +IG GG   +++ L    Q+ AIK   L     Q    ++ EI  L+K++ H + +  + 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                   +Y  +  G+++     K       W+ +    +   ++L  +H+   H IVH
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 178
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKPAN L+  + + KL DFGI+  +        +TT   +    GT  YM PE +   
Sbjct: 179 SDLKPANFLI-VDGMLKLIDFGIANQMQP------DTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 321 ELTPKS-----------DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLA 368
             + ++           DV+S G IL  +  G+ P   I  ++       KL  ++DP  
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNH 285
Query: 369 G-DWPFVQAEQLANLAMRCC----EMSRKSRPEL 397
             ++P +  + L ++ ++CC       R S PEL
Sbjct: 286 EIEFPDIPEKDLQDV-LKCCLKRDPKQRISIPEL 318

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 39/274 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIKM--LHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVG 200
           +IG GG   +++ L    Q+ AIK   L     Q    ++ EI  L+K++ H + +  + 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                   +Y  +  G+++     K       W+ +      L +V    H+   H IVH
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV----HTIHQHGIVH 150
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKPAN L+  + + KL DFGI+  +        +TT   +    GT  YM PE +   
Sbjct: 151 SDLKPANFLI-VDGMLKLIDFGIANQMQP------DTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 321 ELTPKS-----------DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLA 368
             + ++           DV+S G IL  +  G+ P   I  ++       KL  ++DP  
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNH 257
Query: 369 G-DWPFVQAEQLANLAMRCC----EMSRKSRPEL 397
             ++P +  + L ++ ++CC       R S PEL
Sbjct: 258 EIEFPDIPEKDLQDV-LKCCLKRDPKQRISIPEL 290

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 84
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                  EV+  LV +Y+P     +    S    + P+ +        +L   L ++HS 
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIHS- 141
Query: 254 KPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
               I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y 
Sbjct: 142 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YYR 190
Query: 313 DPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 345
            PE +  + + T   DV+S G +L  LL G+P  
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 96
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 153
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 154 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YY 201
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 234

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 88
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 145
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 146 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YY 193
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 87
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                  EV+  LV +Y+P     +    S    + P+ +        +L   L ++HS 
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIHS- 144
Query: 254 KPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
               I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y 
Sbjct: 145 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YYR 193
Query: 313 DPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 345
            PE +  + + T   DV+S G +L  LL G+P  
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR-------YY 188
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 345
             PE +  + + T   DV+S G +L  LL G+P  
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 178
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 179 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YY 226
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +  G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 90  LGICLTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 143
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 197
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 243

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 219
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 220 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YY 267
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
             PE +  + + T   DV+S G +L  LL G+P
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILS-KIRHPNLVTLV 199
           +G+G +G ++    +      AIK L    +    + +    E  +LS    HP L  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 200 GA--CPEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
                 E    V EYL  G L   + SC  +   LS  T    A E+   L FLHS    
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFY--AAEIILGLQFLHS---K 137
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            IV+ DLK  NILLD +   K++DFG+ +   +N +    T   C     GT  Y+ PE 
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNXFC-----GTPDYIAPEI 189
Query: 317 LASGELTPKSDVYSFGIILLRLLTGR 342
           L   +     D +SFG++L  +L G+
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +  G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 136
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 190
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/255 (22%), Positives = 105/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY P G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+++D     +
Sbjct: 129 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQ 181
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 182 VTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 231 MAAGYPPFFADQPIQ 245

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 39/274 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIKM--LHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVG 200
           +IG GG   +++ L    Q+ AIK   L     Q    ++ EI  L+K++ H + +  + 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                   +Y  +  G+++     K       W+ +      L +V    H+   H IVH
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV----HTIHQHGIVH 131
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKPAN L+  + + KL DFGI+  +        +TT   +    GT  YM PE +   
Sbjct: 132 SDLKPANFLI-VDGMLKLIDFGIANQMQP------DTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 321 ELTPKS-----------DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLA 368
             + ++           DV+S G IL  +  G+ P   I  ++       KL  ++DP  
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNH 238
Query: 369 G-DWPFVQAEQLANLAMRCC----EMSRKSRPEL 397
             ++P +  + L ++ ++CC       R S PEL
Sbjct: 239 EIEFPDIPEKDLQDV-LKCCLKRDPKQRISIPEL 271

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           IG G +G +Y+  L      VAIK +    LQ      +E+ I+ K+ H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 203 ------PEVW-TLVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHS 252
                  EV+  LV +Y+P     +    S    + P+ +   +++   +L   L ++HS
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 253 CKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                I H D+KP N+LLD +  V KL DFG ++ L + E   N + +C R        Y
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR-------YY 188
Query: 312 MDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 345
             PE +  + + T   DV+S G +L  LL G+P  
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 146 IGEGGYGSIYKGLL------RHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +  G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C      L+ + +P G L D +   KDN   +  Q  +    ++   + +L      
Sbjct: 90  LGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED---R 143
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DL   N+L+      K++DFG+++ L   E   +          K    +M  E 
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------EGGKVPIKWMALES 197
Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 359
           +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G+
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 243

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/240 (22%), Positives = 107/240 (44%), Gaps = 31/240 (12%)
Query: 110 KSRKEASSSSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAI 166
           ++R     ++H P+ + D++   +E G   ++    K+G G Y  +++ +    + +V +
Sbjct: 8   RARVYTDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67
Query: 167 KMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGACPEVWT----LVYEYLPNGSLEDR 221
           K+L P      ++ ++EI IL  +R  PN++TL     +  +    LV+E++ N   +  
Sbjct: 68  KILKP---VKKNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 124
Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSD 280
                        T   I   +  +L  L  C    I+H D+KP N+++D      +L D
Sbjct: 125 YQT---------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLID 175
Query: 281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLL 339
           +G++ F    +    N  +  R        +  PE L   ++   S D++S G +L  ++
Sbjct: 176 WGLAEFYHPGQ--EYNVRVASR-------YFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 146 IGEGGYGSIYK----GLLRHMQ---VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    G+ +      VA+KML   +          E+ IL  I  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDN------SPP------LSWQTRIRIAT 241
            L+GAC +      ++ E+   G+L   L  K N      +P       L+ +  I  + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 301
           ++   + FL S K    +H DL   NILL    V K+ DFG++R + ++           
Sbjct: 156 QVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR------ 206
Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
           + D +    +M PE +     T +SDV+SFG++L  + +
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK+ H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +           C   P   
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG---CAMLP--- 209
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++HM+     A+K+L    +    + +  ++   IL  +  P L  L
Sbjct: 50  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY P G +   L      S P     R   A ++     +LHS   
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 161
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+++D     K++DFG ++      +      LC      GT  Y+ PE
Sbjct: 162 -DLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 209
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/255 (22%), Positives = 104/255 (40%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 28  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 69
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P L  L  +  +   L  V EY P G +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+++D     K
Sbjct: 130 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIK 182
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 183 VTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 232 MAAGYPPFFADQPIQ 246

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 146 IGEGGYGSIYKG-------LLRHMQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +              VA+KML   +          E+ IL  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDN---------SPPLSWQTRIRIATELC 244
            L+GAC +      ++ E+   G+L   L  K N            L+ +  I  + ++ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
             + FL S K    +H DL   NILL    V K+ DFG++R + +      +     + D
Sbjct: 155 KGMEFLASRK---XIHRDLAARNILLSEKNVVKICDFGLARDIYK------DPDYVRKGD 205
Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            +    +M PE +     T +SDV+SFG++L  + +
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK+ H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +           C   P   
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG---CAMLP--- 223
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 146 IGEGGYGSIYK----GLLRHMQ---VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    G+ +      VA+KML   +          E+ IL  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDN-------SPP------LSWQTRIRIA 240
            L+GAC +      ++ E+   G+L   L  K N       +P       L+ +  I  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            ++   + FL S K    +H DL   NILL    V K+ DFG++R + ++          
Sbjct: 146 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR----- 197
Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            + D +    +M PE +     T +SDV+SFG++L  + +
Sbjct: 198 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +           C   P   
Sbjct: 175 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG---CAMLP--- 225
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +           C   P   
Sbjct: 158 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG---CAMLP--- 208
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 200
           IG G YG +     R    QVAIK + P++    +  ++   E+ IL   +H N++    
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDNIIA--- 117
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIF 249
               +  ++   +P G  +      D           +S PL+ +       +L   L +
Sbjct: 118 ----IKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           +HS +   ++H DLKP+N+L++ N   K+ DFG++R L     +S        T+   T 
Sbjct: 174 MHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC----TSPAEHQYFMTEYVATR 226
Query: 310 AYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGR 342
            Y  PE + S  E T   D++S G I   +L  R
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 146 IGEGGYGSIYK----GLLRHMQ---VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    G+ +      VA+KML   +          E+ IL  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDN-------SPP------LSWQTRIRIA 240
            L+GAC +      ++ E+   G+L   L  K N       +P       L+ +  I  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            ++   + FL S K    +H DL   NILL    V K+ DFG++R + ++          
Sbjct: 146 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR----- 197
Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            + D +    +M PE +     T +SDV+SFG++L  + +
Sbjct: 198 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKI 190
           ++FD    +G+G +G +   L+R        A+K+L    +    E    +    +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 191 RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           RHP L  L  A    +    V EY   G L   LS       +  + R R    E+ S L
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSAL 118
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDP 305
            +LHS     +V+ D+K  N++LD +   K++DFG    L +  IS   T    C     
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKXFC----- 166
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            GT  Y+ PE L   +     D +  G+++  ++ GR
Sbjct: 167 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +           C   P   
Sbjct: 158 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG---CAMLP--- 208
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 146 IGEGGYGSIYK----GLLRHMQ---VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    G+ +      VA+KML   +          E+ IL  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDN-------SPP------LSWQTRIRIA 240
            L+GAC +      ++ E+   G+L   L  K N       +P       L+ +  I  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            ++   + FL S K    +H DL   NILL    V K+ DFG++R + ++          
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR----- 206
Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            + D +    +M PE +     T +SDV+SFG++L  + +
Sbjct: 207 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +   +S      C   P   
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---ASYYRKGGCAMLP--- 209
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +   +S      C   P   
Sbjct: 165 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---ASYYRKGGCAMLP--- 215
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 200
           IG G YG +     R    QVAIK + P++    +  ++   E+ IL   +H N++    
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDNIIA--- 118
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIF 249
               +  ++   +P G  +      D           +S PL+ +       +L   L +
Sbjct: 119 ----IKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           +HS +   ++H DLKP+N+L++ N   K+ DFG++R L     +S        T+   T 
Sbjct: 175 MHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC----TSPAEHQYFMTEYVATR 227
Query: 310 AYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGR 342
            Y  PE + S  E T   D++S G I   +L  R
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +           C   P   
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG---CAMLP--- 223
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKI 190
           ++FD    +G+G +G +   L+R        A+K+L    +    E    +    +L   
Sbjct: 10  NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 191 RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           RHP L  L  A    +    V EY   G L   LS       +  + R R    E+ S L
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSAL 123
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDP 305
            +LHS     +V+ D+K  N++LD +   K++DFG    L +  IS   T    C     
Sbjct: 124 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKXFC----- 171
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            GT  Y+ PE L   +     D +  G+++  ++ GR
Sbjct: 172 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 39/274 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIKM--LHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVG 200
           +IG GG   +++ L    Q+ AIK   L     Q    ++ EI  L+K++ H + +  + 
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                   +Y  +  G+++     K       W+ +      L +V    H+   H IVH
Sbjct: 79  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV----HTIHQHGIVH 134
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKPAN L+  + + KL DFGI+  +        +TT   +    GT  YM PE +   
Sbjct: 135 SDLKPANFLI-VDGMLKLIDFGIANQMQP------DTTSVVKDSQVGTVNYMPPEAIKDM 187
Query: 321 ELTPKS-----------DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDP-L 367
             + ++           DV+S G IL  +  G+ P   I  ++       KL  ++DP  
Sbjct: 188 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNH 241
Query: 368 AGDWPFVQAEQLANLAMRCC----EMSRKSRPEL 397
             ++P +  + L ++ ++CC       R S PEL
Sbjct: 242 EIEFPDIPEKDLQDV-LKCCLKRDPKQRISIPEL 274

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +           C   P   
Sbjct: 176 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG---CAMLP--- 226
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 39/274 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIKM--LHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVG 200
           +IG GG   +++ L    Q+ AIK   L     Q    ++ EI  L+K++ H + +  + 
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                   +Y  +  G+++     K       W+ +      L +V    H+   H IVH
Sbjct: 75  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV----HTIHQHGIVH 130
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKPAN L+  + + KL DFGI+  +        +TT   +    GT  YM PE +   
Sbjct: 131 SDLKPANFLI-VDGMLKLIDFGIANQMQP------DTTSVVKDSQVGTVNYMPPEAIKDM 183
Query: 321 ELTPKS-----------DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDP-L 367
             + ++           DV+S G IL  +  G+ P   I  ++       KL  ++DP  
Sbjct: 184 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNH 237
Query: 368 AGDWPFVQAEQLANLAMRCC----EMSRKSRPEL 397
             ++P +  + L ++ ++CC       R S PEL
Sbjct: 238 EIEFPDIPEKDLQDV-LKCCLKRDPKQRISIPEL 270

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHS------LQGP--SEFQQEIDILSKIRHPNL 195
           +G G +G ++  +   ++ +V +K +          ++ P   +   EI ILS++ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 196 VTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           + ++        + LV E   +GS  D  +  D  P L       I  +L S + +L   
Sbjct: 92  IKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL--- 146
Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           +   I+H D+K  NI++  +F  KL DFG + +L + ++     T C      GT  Y  
Sbjct: 147 RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFC------GTIEYCA 197
Query: 314 PEFLASGEL-TPKSDVYSFGIILLRLL 339
           PE L       P+ +++S G+ L  L+
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/256 (21%), Positives = 104/256 (40%), Gaps = 48/256 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 28  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 69
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P L  L  +  +   L  V EY P G +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 219 EDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
              L    +   P   +      A ++     +LHS     +++ DLKP N+++D     
Sbjct: 130 FSHLRRIGRFXEPHARF-----YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYI 181
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++ 
Sbjct: 182 KVTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 337 RLLTGRPALGITKEVQ 352
            +  G P     + +Q
Sbjct: 231 EMAAGYPPFFADQPIQ 246

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +           C   P   
Sbjct: 150 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG---CAMLP--- 200
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 201 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 146 IGEGGYGSIYK----GLLRHMQ---VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    G+ +      VA+KML   +          E+ IL  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDN-------SPP------LSWQTRIRIA 240
            L+GAC +      ++ E+   G+L   L  K N       +P       L+ +  I  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            ++   + FL S K    +H DL   NILL    V K+ DFG++R + ++          
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR----- 206
Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            + D +    +M PE +     T +SDV+SFG++L  + +
Sbjct: 207 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 49  LGTGSFGRVM--LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY+P G +   L      S P     R   A ++     +LHS   
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 160
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     +++DFG ++      +      LC      GT  Y+ PE
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 208
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG++R + +           C   P   
Sbjct: 199 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG---CAMLP--- 249
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 146 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G+G +G +     K   R+   A+K+L    +    E      E  +L   RHP L  L
Sbjct: 159 LGKGTFGKVILVKEKATGRYY--AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 255
             +    +    V EY   G L   LS       +  + R R    E+ S L +LHS K 
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK- 271
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
            ++V+ DLK  N++LD +   K++DFG+ +   ++   +   T C      GT  Y+ PE
Sbjct: 272 -NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFC------GTPEYLAPE 322
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGR 342
            L   +     D +  G+++  ++ GR
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 49  LGTGSFGRVM--LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY+P G +   L      S P     R   A ++     +LHS   
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 160
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     +++DFG ++      +      LC      GT  Y+ PE
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 208
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 50  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY+P G +   L      S P     R   A ++     +LHS   
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 161
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     +++DFG ++      +      LC      GT  Y+ PE
Sbjct: 162 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 209
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 49  LGTGSFGRVM--LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY+P G +   L      S P     R   A ++     +LHS   
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 160
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     +++DFG ++      +      LC      GT  Y+ PE
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 208
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKI 190
           ++FD    +G+G +G +   L+R        A+K+L    +    E    +    +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 191 RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           RHP L  L  A    +    V EY   G L   LS       +  + R R    E+ S L
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSAL 118
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDP 305
            +LHS     +V+ D+K  N++LD +   K++DFG    L +  IS   T    C     
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKXFC----- 166
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            GT  Y+ PE L   +     D +  G+++  ++ GR
Sbjct: 167 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 50  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY+P G +   L      S P     R   A ++     +LHS   
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 161
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     +++DFG ++      +      LC      GT  Y+ PE
Sbjct: 162 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 209
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 50  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY+P G +   L      S P     R   A ++     +LHS   
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 161
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     +++DFG ++      +      LC      GT  Y+ PE
Sbjct: 162 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 209
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 16/110 (14%)
Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
           ++   +   L +L   + H ++H D+KP+NILLD     KL DFGIS  L  ++    + 
Sbjct: 128 KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTP-----KSDVYSFGIILLRLLTGR 342
                    G  AYM PE +   + T      ++DV+S GI L+ L TG+
Sbjct: 186 ---------GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 146 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G+G +G +     K   R+   A+K+L    +    E      E  +L   RHP L  L
Sbjct: 156 LGKGTFGKVILVKEKATGRYY--AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 255
             +    +    V EY   G L   LS       +  + R R    E+ S L +LHS K 
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK- 268
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 313
            ++V+ DLK  N++LD +   K++DFG    L +  I    T  T C      GT  Y+ 
Sbjct: 269 -NVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGATMKTFC------GTPEYLA 317
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGR 342
           PE L   +     D +  G+++  ++ GR
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 27/195 (13%)
Query: 164 VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLVTLVGACPEV---WTLVYEYLPNGSL 218
           VA+KML   +          E+ IL  I  H N+V L+GAC +      ++ E+   G+L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 219 EDRLSCKDN-------SPP------LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKP 265
              L  K N       +P       L+ +  I  + ++   + FL S K    +H DL  
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 178
Query: 266 ANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK 325
            NILL    V K+ DFG++R + ++           + D +    +M PE +     T +
Sbjct: 179 RNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAPETIFDRVYTIQ 232
Query: 326 SDVYSFGIILLRLLT 340
           SDV+SFG++L  + +
Sbjct: 233 SDVWSFGVLLWEIFS 247

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 27/195 (13%)
Query: 164 VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLVTLVGACPEV---WTLVYEYLPNGSL 218
           VA+KML   +          E+ IL  I  H N+V L+GAC +      ++ E+   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 219 EDRLSCKDN-------SPP------LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKP 265
              L  K N       +P       L+ +  I  + ++   + FL S K    +H DL  
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 167
Query: 266 ANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK 325
            NILL    V K+ DFG++R + ++           + D +    +M PE +     T +
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAPETIFDRVYTIQ 221
Query: 326 SDVYSFGIILLRLLT 340
           SDV+SFG++L  + +
Sbjct: 222 SDVWSFGVLLWEIFS 236

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKI 190
           ++FD    +G+G +G +   L+R        A+K+L    +    E    +    +L   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 191 RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           RHP L  L  A    +    V EY   G L   LS       +  + R R    E+ S L
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSAL 118
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDP 305
            +LHS     +V+ D+K  N++LD +   K++DFG    L +  IS   T    C     
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKXFC----- 166
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            GT  Y+ PE L   +     D +  G+++  ++ GR
Sbjct: 167 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/255 (22%), Positives = 105/255 (41%), Gaps = 46/255 (18%)
Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV--- 164
           L+K    A +++H+ QF                +    +G G +G +   L++HM+    
Sbjct: 27  LKKWENPAQNTAHLDQF----------------ERIKTLGTGSFGRVM--LVKHMETGNH 68
Query: 165 -AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSL 218
            A+K+L    +    + +  ++   IL  +  P LV L  +  +   L  V EY+  G +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 219 EDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
              L      S P     R   A ++     +LHS     +++ DLKP N+L+D     +
Sbjct: 129 FSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           ++DFG ++      +      LC      GT  Y+ PE + S       D ++ G+++  
Sbjct: 182 VTDFGFAK-----RVKGRTWXLC------GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 338 LLTGRPALGITKEVQ 352
           +  G P     + +Q
Sbjct: 231 MAAGYPPFFADQPIQ 245

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 50  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY P G +   L      S P     R   A ++     +LHS   
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 161
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+++D     K++DFG ++      +      LC      GT  Y+ PE
Sbjct: 162 -DLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 209
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 27/195 (13%)
Query: 164 VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLVTLVGACPEV---WTLVYEYLPNGSL 218
           VA+KML   +          E+ IL  I  H N+V L+GAC +      ++ E+   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 219 EDRLSCKDN-------SPP------LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKP 265
              L  K N       +P       L+ +  I  + ++   + FL S K    +H DL  
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 167
Query: 266 ANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK 325
            NILL    V K+ DFG++R + ++           + D +    +M PE +     T +
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAPETIFDRVYTIQ 221
Query: 326 SDVYSFGIILLRLLT 340
           SDV+SFG++L  + +
Sbjct: 222 SDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 146 IGEGGYGSIYK----GLLRHMQ---VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 196
           +G G +G + +    G+ +      VA+KML   +          E+ IL  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDN-------SPP------LSWQTRIRIA 240
            L+GAC +      ++ E+   G+L   L  K N       +P       L+ +  I  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            ++   + FL S K    +H DL   NILL    V K+ DFG++R + ++          
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR----- 206
Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
            + D +    +M PE +     T +SDV+SFG++L  + +
Sbjct: 207 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 39/274 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIKM--LHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVG 200
           +IG GG   +++ L    Q+ AIK   L     Q    ++ EI  L+K++ H + +  + 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                   +Y  +  G+++     K       W+ +    +   ++L  +H+   H IVH
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 178
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKPAN L+  + + KL DFGI+  +        +TT   +    G   YM PE +   
Sbjct: 179 SDLKPANFLI-VDGMLKLIDFGIANQMQP------DTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 321 ELTPKS-----------DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLA 368
             + ++           DV+S G IL  +  G+ P   I  ++       KL  ++DP  
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNH 285
Query: 369 G-DWPFVQAEQLANLAMRCC----EMSRKSRPEL 397
             ++P +  + L ++ ++CC       R S PEL
Sbjct: 286 EIEFPDIPEKDLQDV-LKCCLKRDPKQRISIPEL 318

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 70  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY+P G +   L      S P     R   A ++     +LHS   
Sbjct: 128 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 181
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     +++DFG ++      +      LC      GT  Y+ PE
Sbjct: 182 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 229
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 27/195 (13%)
Query: 164 VAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLVTLVGACPEV---WTLVYEYLPNGSL 218
           VA+KML   +          E+ IL  I  H N+V L+GAC +      ++ E+   G+L
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 219 EDRLSCKDN-------SPP------LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKP 265
              L  K N       +P       L+ +  I  + ++   + FL S K    +H DL  
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213
Query: 266 ANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK 325
            NILL    V K+ DFG++R + ++           + D +    +M PE +     T +
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAPETIFDRVYTIQ 267
Query: 326 SDVYSFGIILLRLLT 340
           SDV+SFG++L  + +
Sbjct: 268 SDVWSFGVLLWEIFS 282

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 42  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             +  +   L  V EY+P G +   L      S P     R   A ++     +LHS   
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL-- 153
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     +++DFG ++      +      LC      GT  Y+ PE
Sbjct: 154 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTPEYLAPE 201
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            + S       D ++ G+++  +  G P     + +Q
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 64  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 177
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +     TLC      GT 
Sbjct: 178 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLC------GTP 223
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 116/284 (40%), Gaps = 67/284 (23%)
Query: 146 IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQ--GPSEFQQ---EIDILSKIRHPNLVTL 198
           IG+G YG +   +    +   AIK+++ + ++   P + ++   E+ ++ K+ HPN+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 199 --VGACPEVWTLVYEYLPNGSLEDRLS------------------------CKDNS---- 228
             V    +   LV E    G L D+L+                        C + +    
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 229 -----PPLSWQTRIR----IATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSK 277
                  L +  R +    I  ++ S L +LH+     I H D+KP N L   N  F  K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIIL 335
           L DFG+S+   +     NN      T   GT  ++ PE L +      PK D +S G++L
Sbjct: 211 LVDFGLSKEFYK----LNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 336 LRLLTGR---PALGITKEVQYALDTGKL------KNLLDPLAGD 370
             LL G    P +     +   L+  KL       N+L PLA D
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNK-KLCFENPNYNVLSPLARD 309

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 146 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC 202
           +GEG Y  +     L    + A+K++   +    S   +E++ L + + + N++ L+   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 203 PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
            +   + LV+E L  GS+   L+        + +   R+  ++ + L FLH+     I H
Sbjct: 81  EDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHT---KGIAH 134
Query: 261 GDLKPANILLDA-NFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP NIL ++   VS  K+ DF +   +  N  S    T    T P G+  YM PE +
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNN-SCTPITTPELTTPCGSAEYMAPEVV 193
Query: 318 -----ASGELTPKSDVYSFGIILLRLLTGRP 343
                 +     + D++S G++L  +L+G P
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYP 224

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 42/233 (18%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 199
           IG+G +G +    K   + M  A+K ++       +E +   +E+ I+  + HP LV L 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKM-YAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 200 GACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE-----LCSVLIFLHS 252
            +    E   +V + L  G L   L           Q  +    E     +C +++ L  
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHL-----------QQNVHFKEETVKLFICELVMALDY 130
Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
            +   I+H D+KP NILLD +    ++DF I+  L +    +  TT+       GT  YM
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMA------GTKPYM 181
Query: 313 DPEFLASGELTPKS---DVYSFGIILLRLLTGRPALGI-----TKEVQYALDT 357
            PE  +S +    S   D +S G+    LL GR    I     +KE+ +  +T
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET 234

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 23/209 (11%)
Query: 140 FDPSLKIGEGGYG--SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +D    IG G +G   + +  L    VA+K +           Q+EI     +RHPN+V 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVR 80
Query: 198 L--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
              V   P    ++ EY   G L +R+    N+   S         +L S + + HS + 
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ- 136
Query: 256 HSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
             I H DLK  N LLD +     K+ DFG S+  S    S   +T+       GT AY+ 
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTV-------GTPAYIA 185
Query: 314 PEFLASGELTPK-SDVYSFGIILLRLLTG 341
           PE L   E   K +DV+S G+ L  +L G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 230 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 289
           P++ +  I  + ++   + FL S K    +H DL   NILL  N V K+ DFG++R + +
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGI 347
                 N     + D +    +M PE +     + KSDV+S+G++L  +  L G P  G+
Sbjct: 252 ------NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGV 305
Query: 348 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 401
                  +D      L + +    P     ++  + + C     K RP   + V
Sbjct: 306 Q------MDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELV 353

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 127
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 128 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 175
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           +P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 176 EPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++ ++  G P     + +Q
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQ 245

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 115/278 (41%), Gaps = 50/278 (17%)
Query: 146 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLVTLVG 200
           IG+G +G +Y G   H +VAI+++    ++  +E     F++E+    + RH N+V  +G
Sbjct: 41  IGKGRFGQVYHGRW-HGEVAIRLI---DIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           AC  P    ++       +L      +D    L      +IA E+   + +LH+     I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYS--VVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DLK  N+  D   V  ++DFG+       +       L  +    G   ++ PE + 
Sbjct: 152 LHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN---GWLCHLAPEIIR 207
Query: 319 SGELTP-----------KSDVYSFGIILLRL------LTGRPALGITKEVQYALDTGKLK 361
             +L+P            SDV++ G I   L         +PA  I     + + TG   
Sbjct: 208 --QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----WQMGTGMKP 261
Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 399
           NL     G       ++++++ + C    ++ RP   K
Sbjct: 262 NLSQIGMG-------KEISDILLFCWAFEQEERPTFTK 292

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 104/230 (45%), Gaps = 25/230 (10%)
Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTL 198
           IG+G +  + + + R    Q A+K++              + ++E  I   ++HP++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE-LCSVLIFLHSCKP 255
           +       +  +V+E++    L   +  + ++  +  +    +A+  +  +L  L  C  
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA---VASHYMRQILEALRYCHD 148
Query: 256 HSIVHGDLKPANILLDANFVS---KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           ++I+H D+KP N+LL +   S   KL DFG++  L ++ + +            GT  +M
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV--------GTPHFM 200
Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLK 361
            PE +         DV+  G+IL  LL+G  P  G  + +   +  GK K
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK 250

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 198
           K+G G YG +YK   +  +     A+K +    +   +   +EI +L +++HPN+++L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 85
Query: 199 ---VGACPEVWTLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
                A  +VW L+++Y  +     ++   + K N  P+    R  + + L  +L  +H 
Sbjct: 86  VFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQL-PRGMVKSLLYQILDGIHY 143
Query: 253 CKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTL--CCRTDP- 305
              + ++H DLKPANIL+          K++D G +R          N+ L      DP 
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--------NSPLKPLADLDPV 195
Query: 306 KGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 350
             TF Y  PE  L +   T   D+++ G I   LLT  P     +E
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  P LV L
Sbjct: 42  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
             +  +   L  V EY+P G +   L    +   P   +      A ++     +LHS  
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLHSL- 153
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              +++ DLKP N+L+D     +++DFG ++      +      LC      GT  Y+ P
Sbjct: 154 --DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTPEYLAP 200
Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           E + S       D ++ G+++  +  G P     + +Q
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 146 IGEGGYGSIYKGLLRHM-------QVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +G G +G +Y+G +  M       QVA+K L    S Q   +F  E  I+SK  H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 198 LVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLH 251
            +G   +     ++ E +  G L+  L      P     L+    + +A ++     +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 252 SCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
               +  +H D+   N LL       V+K+ DFG+++ + +   +S      C   P   
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYR---ASYYRKGGCAMLP--- 209
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
             +M PE    G  T K+D +SFG++L  + +
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 179
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 180 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 227
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 228 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 267

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 173
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 221
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 195 LVTLVGACPEVWTL------------VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           ++ L  +CP V  L            + EY   G +   L   + +  +S    IR+  +
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS-LCLPELAEMVSENDVIRLIKQ 139
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGISRFLSQNEISSNNTTL 299
           +   + +LH    ++IVH DLKP NILL + +     K+ DFG+SR +            
Sbjct: 140 ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---------A 187
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG 346
           C   +  GT  Y+ PE L    +T  +D+++ GII   LLT   P +G
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 44  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 157
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 158 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 203
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 129
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 177
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVG 200
           +GEG YG +     +     VAIK + P     P       +EI IL   +H N++T+  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 201 AC-PEVWTLVYE-YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              P+ +    E Y+    ++  L    ++  LS         +    +  LH     ++
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NV 133
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT--LCCRTDPKGTFAYMDPE- 315
           +H DLKP+N+L+++N   K+ DFG++R + ++   ++  T      T+   T  Y  PE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEV 193
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPAL 345
            L S + +   DV+S G IL  L   RP  
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 85  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 143
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 144 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 191
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 192 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 231

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 179 EFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           + ++E  I   ++HPN+V L  +  E     LV++ +  G L + +  ++      + + 
Sbjct: 49  KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE------YYSE 102
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEIS 293
              +  +  +L  ++ C  + IVH DLKP N+LL +       KL+DFG++  +  ++ +
Sbjct: 103 ADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQA 162
Query: 294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                        GT  Y+ PE L         D+++ G+IL  LL G P
Sbjct: 163 WFGFA--------GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYP 204

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQ 245

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 129
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 177
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 33/208 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           IG G +G     L+R  Q    VA+K +     +     ++EI     +RHPN+V    V
Sbjct: 27  IGAGNFG--VARLMRDKQANELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P    +V EY   G L +R+ C  N+   S         +L S + + H+ +   + 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERI-C--NAGRFSEDEARFFFQQLISGVSYAHAMQ---VA 137
Query: 260 HGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPK---GTFAYMDP 314
           H DLK  N LLD +     K++DFG S+                 + PK   GT AY+ P
Sbjct: 138 HRDLKLENTLLDGSPAPRLKIADFGYSK------------ASVLHSQPKSAVGTPAYIAP 185
Query: 315 EFLASGELTPK-SDVYSFGIILLRLLTG 341
           E L   E   K +DV+S G+ L  +L G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 76  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 134
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 135 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 182
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 183 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 222

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 179 EFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           + ++E  I   ++HPN+V L  +  E     LV++ +  G L + +  ++      + + 
Sbjct: 49  KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE------YYSE 102
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEIS 293
              +  +  +L  ++ C  + IVH DLKP N+LL +       KL+DFG++  +  ++ +
Sbjct: 103 ADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQA 162
Query: 294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                        GT  Y+ PE L         D+++ G+IL  LL G P
Sbjct: 163 WFGFA--------GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYP 204

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRH-PNLVTLVG 200
           +IG G YGS+ K + +     + +    S     E +Q   ++D++ +    P +V   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 201 A---------CPEVWTL----VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           A         C E+ +      Y+Y+         S  D+  P     +I +AT    V 
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYV--------YSVLDDVIPEEILGKITLAT----VK 136
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
              H  +   I+H D+KP+NILLD +   KL DFGIS  L  +           +T   G
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---------IAKTRDAG 187
Query: 308 TFAYMDPEFL---ASGE-LTPKSDVYSFGIILLRLLTGR 342
              YM PE +   AS +    +SDV+S GI L  L TGR
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 77  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 135
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 136 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 183
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 184 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 223

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVG 200
           +GEG YG +     +     VAIK + P     P       +EI IL   +H N++T+  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 201 AC-PEVWTLVYE-YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              P+ +    E Y+    ++  L    ++  LS         +    +  LH     ++
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NV 133
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT--LCCRTDPKGTFAYMDPE- 315
           +H DLKP+N+L+++N   K+ DFG++R + ++   ++  T      T+   T  Y  PE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEV 193
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPAL 345
            L S + +   DV+S G IL  L   RP  
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 75  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 133
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 134 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 181
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 182 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 221

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 133 IEGATHNFD-------PSLKIGEGGYGSIYKGLLRHM---QV-AIKMLHPH-SLQGPSEF 180
            +GA  NF+       P  ++G G YG + K   RH+   Q+ A+K +    + Q     
Sbjct: 22  FQGAXENFEVKADDLEPIXELGRGAYGVVEK--XRHVPSGQIXAVKRIRATVNSQEQKRL 79
Query: 181 QQEIDILSK-IRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQT 235
             ++DI  + +  P  VT  GA     +VW  +   L + SL+       D    +    
Sbjct: 80  LXDLDISXRTVDCPFTVTFYGALFREGDVW--ICXELXDTSLDKFYKQVIDKGQTIPEDI 137
Query: 236 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
             +IA  +   L  LHS    S++H D+KP+N+L++A    K  DFGIS +L  +   + 
Sbjct: 138 LGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD--VAK 193
Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +    C+  P      ++PE    G  + KSD++S GI  + L   R
Sbjct: 194 DIDAGCK--PYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILR 237

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 128
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 129 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 176
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 177 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 216

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 127
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 128 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 175
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D++S G+I+  LL G P
Sbjct: 176 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 30  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 143
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 144 LHSL---DLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 189
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 190 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 232

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 39/274 (14%)
Query: 145 KIGEGGYGSIYKGLLRHMQV-AIKM--LHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVG 200
           +IG GG   +++ L    Q+ AIK   L     Q    ++ EI  L+K++ H + +  + 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 201 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                   +Y  +  G+++     K       W+ +      L +V    H+   H IVH
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV----HTIHQHGIVH 150
Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKPAN L+  + + KL DFGI+     N++  +   +  +    GT  YM PE +   
Sbjct: 151 SDLKPANFLI-VDGMLKLIDFGIA-----NQMQPDXXXV-VKDSQVGTVNYMPPEAIKDM 203
Query: 321 ELTPKS-----------DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLA 368
             + ++           DV+S G IL  +  G+ P   I  ++       KL  ++DP  
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNH 257
Query: 369 G-DWPFVQAEQLANLAMRCC----EMSRKSRPEL 397
             ++P +  + L ++ ++CC       R S PEL
Sbjct: 258 EIEFPDIPEKDLQDV-LKCCLKRDPKQRISIPEL 290

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           F+    +G G +G +   L++H +     A+K+L    +    + +  ++   I   +  
Sbjct: 44  FERIRTLGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY P G +   L      S P     R   A ++     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 157
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     K++DFG ++      +      LC      GT 
Sbjct: 158 LHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLC------GTP 203
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 200
           IG G +G +    L++     A+K+L+   +   +E   F++E D+L       + TL  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           A  +     LV +Y   G L   LS  ++  P     R  +A     ++I + S      
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE-MARFYLA----EMVIAIDSVHQLHY 196
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL- 317
           VH D+KP NIL+D N   +L+DFG    L ++    ++  +       GT  Y+ PE L 
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-------GTPDYISPEILQ 249
Query: 318 ----ASGELTPKSDVYSFGIILLRLLTG 341
                 G   P+ D +S G+ +  +L G
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 33/208 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           IG G +G     L+R  Q    VA+K +     +  +  ++EI     +RHPN+V    V
Sbjct: 27  IGSGNFG--VARLMRDKQSNELVAVKYIE-RGEKIAANVKREIINHRSLRHPNIVRFKEV 83
Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P    +V EY   G L +R+    N+   S         +L S + + H+ +   + 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQ---VC 137
Query: 260 HGDLKPANILLDANFVSKLS--DFGISRFLSQNEISSNNTTLCCRTDPK---GTFAYMDP 314
           H DLK  N LLD +   +L   DFG S+            +    + PK   GT AY+ P
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSK------------SSVLHSQPKSTVGTPAYIAP 185
Query: 315 EFLASGELTPK-SDVYSFGIILLRLLTG 341
           E L   E   K +DV+S G+ L  +L G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+++D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 111/277 (40%), Gaps = 37/277 (13%)
Query: 109 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSI---YKGLLRHMQVA 165
           RK    +  ++ MP+  SD+   +     H       IG G YG +   Y  L + +   
Sbjct: 30  RKQHHSSKPTASMPRPHSDWQIPDRYEIRH------LIGTGSYGHVCEAYDKLEKRVVAI 83
Query: 166 IKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVG-ACPEVWTLVYEYLPNGSLEDRLS 223
            K+L     L       +EI IL+++ H ++V ++    P+      E      + D   
Sbjct: 84  KKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDF 143
Query: 224 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 283
            K    P+ + T + I T L ++L+ +       I+H DLKPAN L++ +   K+ DFG+
Sbjct: 144 KKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202
Query: 284 SRFLSQNEISSNNTTLCCRTDPKG--TFA-----------------YMDPEFLASGE-LT 323
           +R +   E  ++   +  R D     TF                  Y  PE +   E  T
Sbjct: 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262
Query: 324 PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 360
              DV+S G I   LL       I + V Y  D G L
Sbjct: 263 EAIDVWSIGCIFAELLN-----MIKENVAYHADRGPL 294

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLI 248
           P LV L  +  +   L  V EY+  G +   L    +   P   +      A ++     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFE 155
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GT 201
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
             Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLI 248
           P LV L  +  +   L  V EY+  G +   L    +   P   +      A ++     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFE 155
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GT 201
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
             Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 139 NFDPSLK---IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-H 192
           ++D  LK   +GEG +    K + +  +   A+K++   S +  +  Q+EI  L     H
Sbjct: 9   HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGH 65
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           PN+V L     EV+       LV E L  G L +R+  K +    S      I  +L S 
Sbjct: 66  PNIVKL----HEVFHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSA 118
Query: 247 LIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           +  +H      +VH DLKP N+L    + N   K+ DFG +R         +N  L    
Sbjct: 119 VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-----PDNQPL---K 167
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            P  T  Y  PE L         D++S G+IL  +L+G+
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 200
           ++G+G +  + + + +    + A K+++   L      + ++E  I   ++HPN+V L  
Sbjct: 38  ELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 97
Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           +  E     LV++ +  G L + +  ++      + +    +  +  +L  ++    H I
Sbjct: 98  SISEEGFHYLVFDLVTGGELFEDIVARE------YYSEADASHCIHQILESVNHIHQHDI 151
Query: 259 VHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH DLKP N+LL +       KL+DFG++  +   + +             GT  Y+ PE
Sbjct: 152 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA--------GTPGYLSPE 203
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L         D+++ G+IL  LL G P
Sbjct: 204 VLRKDPYGKPVDIWACGVILYILLVGYP 231

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 38  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLI 248
           P LV L  +  +   L  V EY+  G +   L    +   P   +      A ++     
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFE 150
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT
Sbjct: 151 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GT 196
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
             Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 197 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 240

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      + P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 146 IGEGGYGSIYK--GLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC 202
           +GEG +  +     L+   + A+K++        S   +E+++L + + H N++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 203 P--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
              + + LV+E +  GS+   +  + +   L       +  ++ S L FLH+     I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHN---KGIAH 134
Query: 261 GDLKPANILLD-ANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP NIL +  N VS  K+ DFG+   +  N   S  +T    T P G+  YM PE +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLT-PCGSAEYMAPEVV 193
Query: 318 ASGE-----LTPKSDVYSFGIILLRLLTGRP 343
            +          + D++S G+IL  LL+G P
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 146 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ------EIDILSKIR----HP 193
           +G+GG+G+++ G  L   +QVAIK++  + + G S          E+ +L K+     HP
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 194 NLVTLVG--ACPEVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            ++ L+      E + LV E  LP   L D ++  +  P     +R         V+  +
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT--EKGPLGEGPSRCFFG----QVVAAI 152
Query: 251 HSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
             C    +VH D+K  NIL+D     +KL DFG    L               TD  GT 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----------TDFDGTR 202
Query: 310 AYMDPEFLASGELTP-KSDVYSFGIILLRLLTG 341
            Y  PE+++  +     + V+S GI+L  ++ G
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLI 248
           P LV L  +  +   L  V EY+  G +   L    +   P   +      A ++     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFE 155
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GT 201
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
             Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           IG G +G     L+R  Q    VA+K +     +     ++EI     +RHPN+V    V
Sbjct: 26  IGSGNFG--VARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEV 82
Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P    +V EY   G L +R+    N+   S         +L S + + H+ +   + 
Sbjct: 83  ILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQ---VC 136
Query: 260 HGDLKPANILLDANFVSKLS--DFGISRFLSQNEISSNNTTLCCRTDPK---GTFAYMDP 314
           H DLK  N LLD +   +L   DFG S+            +    + PK   GT AY+ P
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSK------------SSVLHSQPKSTVGTPAYIAP 184
Query: 315 EFLASGELTPK-SDVYSFGIILLRLLTG 341
           E L   E   K +DV+S G+ L  +L G
Sbjct: 185 EVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 64  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLI 248
           P LV L  +  +   L  V EY+  G +   L    +   P   +      A ++     
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFE 176
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT
Sbjct: 177 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GT 222
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
             Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 133 IEGATHNFDPSLKIGEGGYGSIY------KGLLRHMQV----AIKMLHPHSLQGPSEFQQ 182
           I    ++F     IG GG+G +Y       G +  M+      IKM    +L        
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM- 242
Query: 183 EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 240
            + ++S    P +V +  A   P+  + + + +  G L   LS        S       A
Sbjct: 243 -LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYA 298
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            E+   L  +H+     +V+ DLKPANILLD +   ++SD G++   S+ +  ++     
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 351
Query: 301 CRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTG 341
                 GT  YM PE L  G      +D +S G +L +LL G
Sbjct: 352 ------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 133 IEGATHNFDPSLKIGEGGYGSIY------KGLLRHMQV----AIKMLHPHSLQGPSEFQQ 182
           I    ++F     IG GG+G +Y       G +  M+      IKM    +L        
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM- 242
Query: 183 EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 240
            + ++S    P +V +  A   P+  + + + +  G L   LS        S       A
Sbjct: 243 -LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYA 298
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            E+   L  +H+     +V+ DLKPANILLD +   ++SD G++   S+ +  ++     
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 351
Query: 301 CRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTG 341
                 GT  YM PE L  G      +D +S G +L +LL G
Sbjct: 352 ------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 133 IEGATHNFDPSLKIGEGGYGSIY------KGLLRHMQV----AIKMLHPHSLQGPSEFQQ 182
           I    ++F     IG GG+G +Y       G +  M+      IKM    +L        
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM- 241
Query: 183 EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 240
            + ++S    P +V +  A   P+  + + + +  G L   LS        S       A
Sbjct: 242 -LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYA 297
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            E+   L  +H+     +V+ DLKPANILLD +   ++SD G++   S+ +  ++     
Sbjct: 298 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----- 349
Query: 301 CRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTG 341
                 GT  YM PE L  G      +D +S G +L +LL G
Sbjct: 350 -----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 133 IEGATHNFDPSLKIGEGGYGSIY------KGLLRHMQV----AIKMLHPHSLQGPSEFQQ 182
           I    ++F     IG GG+G +Y       G +  M+      IKM    +L        
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM- 242
Query: 183 EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 240
            + ++S    P +V +  A   P+  + + + +  G L   LS        S       A
Sbjct: 243 -LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYA 298
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            E+   L  +H+     +V+ DLKPANILLD +   ++SD G++   S+ +  ++     
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----- 350
Query: 301 CRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTG 341
                 GT  YM PE L  G      +D +S G +L +LL G
Sbjct: 351 -----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 146 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G+G +G +     K   R+   A+K+L    +    E      E  +L   RHP L  L
Sbjct: 18  LGKGTFGKVILVKEKATGRY--YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 255
             +    +    V EY   G L   LS       +  + R R    E+ S L +LHS K 
Sbjct: 76  KYSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK- 130
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 313
            ++V+ DLK  N++LD +   K++DFG    L +  I    T    C      GT  Y+ 
Sbjct: 131 -NVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGATMKXFC------GTPEYLA 179
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGR 342
           PE L   +     D +  G+++  ++ GR
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/279 (22%), Positives = 116/279 (41%), Gaps = 27/279 (9%)
Query: 145 KIGEGGYGSIYK--GLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 200
           ++G+G +  + +   +L   + A K+++   L      + ++E  I   ++HPN+V L  
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 201 ACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           +  E     L+++ +  G L + +  ++      + +    +  +  +L  +  C    +
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQMGV 142
Query: 259 VHGDLKPANILLDANF---VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH DLKP N+LL +       KL+DFG++  +   + +             GT  Y+ PE
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--------GTPGYLSPE 194
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV- 374
            L         D+++ G+IL  LL G P      E Q+ L         D  + +W  V 
Sbjct: 195 VLRKDPYGKPVDLWACGVILYILLVGYPPF--WDEDQHRLYQQIKAGAYDFPSPEWDTVT 252
Query: 375 -QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 412
            +A+ L N  +      R +  E  K  W       ASC
Sbjct: 253 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASC 291

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 146 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G+G +G +     K   R+   A+K+L    +    E    +    +L   RHP L  L
Sbjct: 17  LGKGTFGKVILVKEKATGRY--YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 255
             +    +    V EY   G L   LS       +  + R R    E+ S L +LHS K 
Sbjct: 75  KYSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK- 129
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 313
            ++V+ DLK  N++LD +   K++DFG    L +  I    T    C      GT  Y+ 
Sbjct: 130 -NVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGATMKXFC------GTPEYLA 178
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGR 342
           PE L   +     D +  G+++  ++ GR
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 146 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLVTL 198
           +G+G +G +     K   R+   A+K+L    +    E    +    +L   RHP L  L
Sbjct: 16  LGKGTFGKVILVKEKATGRY--YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 199 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 255
             +    +    V EY   G L   LS       +  + R R    E+ S L +LHS K 
Sbjct: 74  KYSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK- 128
Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 313
            ++V+ DLK  N++LD +   K++DFG    L +  I    T    C      GT  Y+ 
Sbjct: 129 -NVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGATMKXFC------GTPEYLA 177
Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGR 342
           PE L   +     D +  G+++  ++ GR
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 193
           +F+  + +G+G +G +     +  +   AIK+L    +    + +    E  +L+ +  P
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 194 NLVTLVGACPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
             +T + +C +    +Y   EY+  G L   +              +  A E+   L FL
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISIGLFFL 136
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           H      I++ DLK  N++LD+    K++DFG+ +   ++ +    T   C     GT  
Sbjct: 137 HK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFC-----GTPD 185
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
           Y+ PE +A        D +++G++L  +L G+P  
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 42/246 (17%)
Query: 115 ASSSSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML 169
            S S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L
Sbjct: 11  GSMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKL 67
Query: 170 HP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
                S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 68  SKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 127
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 128 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 176
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 177 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 226
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 227 ELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 42/246 (17%)
Query: 115 ASSSSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML 169
            S S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L
Sbjct: 1   GSHSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKL 57
Query: 170 HP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
                S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 58  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 118 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 166
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 167 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 216
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 217 ELLTGR 222

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   IG G YGS+         ++VA+K L   
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRP 63
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 124 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKIL 172
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 173 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 222
Query: 340 TGR 342
           TGR
Sbjct: 223 TGR 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 42/246 (17%)
Query: 115 ASSSSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML 169
            S S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L
Sbjct: 1   GSMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKL 57
Query: 170 HP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
                S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 58  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 118 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSEL 166
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 167 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 216
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 217 ELLTGR 222

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 12/103 (11%)
Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+C  L  LH      IV+ DLKP NILLD +   ++SD G++  + + +        
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-- 346
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
                  GT  YM PE + +   T   D ++ G +L  ++ G+
Sbjct: 347 -------GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 42/246 (17%)
Query: 115 ASSSSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML 169
            S S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L
Sbjct: 11  GSMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKL 67
Query: 170 HP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
                S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 68  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 127
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 128 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 176
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 177 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 226
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 227 ELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 42/246 (17%)
Query: 115 ASSSSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML 169
            S S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L
Sbjct: 11  GSMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKL 67
Query: 170 HP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
                S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 68  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 127
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 128 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 176
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 177 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 226
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 227 ELLTGR 232

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV-- 199
           +G G YGS+   Y   LR      K+  P  SL       +E+ +L  ++H N++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 200 ---GACPEVWTLVY--EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
                  E ++ VY    L    L + + C+     LS +    +  +L   L ++HS  
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQ----ALSDEHVQFLVYQLLRGLKYIHSA- 150
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              I+H DLKP+N+ ++ +   ++ DFG++R  +  E++    T   R  P+    +M  
Sbjct: 151 --GIIHRDLKPSNVAVNEDSELRILDFGLAR-QADEEMTGYVATRWYRA-PEIMLNWM-- 204
Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGR 342
                       D++S G I+  LL G+
Sbjct: 205 ------HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 42/246 (17%)
Query: 115 ASSSSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML 169
            S S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L
Sbjct: 1   GSMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKL 57
Query: 170 HP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
                S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 58  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 118 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 166
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 167 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 216
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 217 ELLTGR 222

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 22/160 (13%)
Query: 193 PNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           P++V +V     ++       +V E L  G L  R+  + +    + +    I   +   
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQA-FTEREASEIXKSIGEA 173
Query: 247 LIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
           + +LHS    +I H D+KP N+L  +   N + KL+DFG ++     E +S+N+     T
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSL----T 221
Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            P  T  Y+ PE L   +     D +S G+I   LL G P
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYP 261

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+   Y   LR      K+  P  SL       +E+ +L  ++H N++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 202 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                 +      YL    +   L+    S  LS +    +  +L   L ++HS     I
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA---GI 152
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DLKP+N+ ++ +   ++ DFG++R  +  E++    T   R  P+    +M      
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLAR-QADEEMTGYVATRWYRA-PEIMLNWM------ 204
Query: 319 SGELTPKSDVYSFGIILLRLLTGR 342
                   D++S G I+  LL G+
Sbjct: 205 --HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV-- 199
           +G G YGS+   Y   LR      K+  P  SL       +E+ +L  ++H N++ L+  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 200 ---GACPEVWTLVY--EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
                  E ++ VY    L    L + + C+     LS +    +  +L   L ++HS  
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQ----ALSDEHVQFLVYQLLRGLKYIHSA- 142
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              I+H DLKP+N+ ++ +   ++ DFG++R  +  E++    T   R  P+    +M  
Sbjct: 143 --GIIHRDLKPSNVAVNEDCELRILDFGLAR-QADEEMTGYVATRWYRA-PEIMLNWM-- 196
Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGR 342
                       D++S G I+  LL G+
Sbjct: 197 ------HYNQTVDIWSVGCIMAELLQGK 218

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 7/84 (8%)
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H D+KP NIL+ A+  + L DFGI+   +  +++    T+       GT  Y  PE  + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-------GTLYYXAPERFSE 209
Query: 320 GELTPKSDVYSFGIILLRLLTGRP 343
              T ++D+Y+   +L   LTG P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSP 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 12/103 (11%)
Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           A E+C  L  LH      IV+ DLKP NILLD +   ++SD G++  + + +        
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-- 346
Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
                  GT  YM PE + +   T   D ++ G +L  ++ G+
Sbjct: 347 -------GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ P  + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 108/247 (43%), Gaps = 42/247 (17%)
Query: 114 EASSSSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKM 168
           ++++S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K 
Sbjct: 21  QSNASQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKK 77
Query: 169 LHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLE 219
           L     S+       +E+ +L  ++H N++ L+       +L     VY   +L    L 
Sbjct: 78  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 137
Query: 220 DRLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 275
           + + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +  
Sbjct: 138 NIVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 186
Query: 276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 335
            K+ DFG++R  + +E+     T   R  P+    +M              D++S G I+
Sbjct: 187 LKILDFGLARH-TDDEMXGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIM 236
Query: 336 LRLLTGR 342
             LLTGR
Sbjct: 237 AELLTGR 243

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 63
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 124 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKIL 172
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 173 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 222
Query: 340 TGR 342
           TGR
Sbjct: 223 TGR 225

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 146 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVG 200
           +GEG YG +     +     VAIK + P     P       +EI IL   +H N++T+  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 201 AC-PEVWTLVYE-YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
              P+ +    E Y+    ++  L    ++  LS         +    +  LH     ++
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NV 133
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT--LCCRTDPKGTFAYMDPE- 315
           +H DLKP+N+L+++N   K+ DFG++R + ++   ++  T       +   T  Y  PE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193
Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPAL 345
            L S + +   DV+S G IL  L   RP  
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 38/213 (17%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 141
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R        
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA------- 190
Query: 311 YMDPEFLASG-ELTPKSDVYSFGIILLRLLTGR 342
              PE + +        D++S G I+  LLTGR
Sbjct: 191 ---PEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 13  SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 69
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 70  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 129
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 130 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKIL 178
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 179 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 228
Query: 340 TGR 342
           TGR
Sbjct: 229 TGR 231

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 46/246 (18%)
Query: 119 SHM----PQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKML 169
           SHM    P F+    + +  E+     N  P   +G G YGS+         ++VA+K L
Sbjct: 18  SHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKL 74
Query: 170 HP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
                S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 75  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 134
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 135 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 183
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 184 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 233
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 234 ELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 46/246 (18%)
Query: 119 SHM----PQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKML 169
           SHM    P F+    + +  E+     N  P   +G G YGS+         ++VA+K L
Sbjct: 19  SHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKL 75
Query: 170 HP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
                S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 76  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 135
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 136 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 184
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 185 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 234
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 235 ELLTGR 240

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 146 IGEGGYGSIYK--GLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGA 201
           IG+G +  + +   L    + A K+++   L      + ++E  I   ++H N+V L  +
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 202 CPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
             E     LV++ +  G L + +  ++      + +    +  +  +L  +  C    +V
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQMGVV 125
Query: 260 HGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           H DLKP N+LL +       KL+DFG++  +  ++ +             GT  Y+ PE 
Sbjct: 126 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--------GTPGYLSPEV 177
Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
           L         D+++ G+IL  LL G P
Sbjct: 178 LRKEAYGKPVDIWACGVILYILLVGYP 204

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 193
           +F+    IG G +G +    +++ +   A+K+L+   +   +E   F++E D+L      
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 194 NLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
            +  L  A  +     LV +Y   G L   LS  ++  P     R  I      +++ + 
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED-MARFYIG----EMVLAID 189
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           S      VH D+KP N+LLD N   +L+DFG    L  N+  +  +++       GT  Y
Sbjct: 190 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC--LKMNDDGTVQSSVAV-----GTPDY 242
Query: 312 MDPEFLAS-----GELTPKSDVYSFGIILLRLLTG 341
           + PE L +     G+  P+ D +S G+ +  +L G
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHP 193
           T  ++    IG G Y    + + +  +M+ A+K++   S + P+E   EI+IL +  +HP
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPTE---EIEILLRYGQHP 76
Query: 194 NLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N++TL  V    +   +V E +  G L D++         S +    +   +   + +LH
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLH 133
Query: 252 SCKPHSIVHGDLKPANILL---DANFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
           +     +VH DLKP+NIL      N  S ++ DFG ++     ++ + N  L     P  
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLRAENGLLMT---PCY 182
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           T  ++ PE L         D++S G++L  +LTG
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 147
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 148 HSA---DIIHRDLKPSNLAVNEDSELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 202
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 203 WM--------HYNQTVDIWSVGCIMAELLTGR 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 126 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 174
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 175 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 224
Query: 340 TGR 342
           TGR
Sbjct: 225 TGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 193
           +F+    IG G +G +    +++ +   A+K+L+   +   +E   F++E D+L      
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 194 NLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
            +  L  A  +     LV +Y   G L   LS  ++  P     R  I      +++ + 
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED-MARFYIG----EMVLAID 205
Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           S      VH D+KP N+LLD N   +L+DFG    L  N+  +  +++       GT  Y
Sbjct: 206 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC--LKMNDDGTVQSSVAV-----GTPDY 258
Query: 312 MDPEFLAS-----GELTPKSDVYSFGIILLRLLTG 341
           + PE L +     G+  P+ D +S G+ +  +L G
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 63
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 124 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 172
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 173 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 222
Query: 340 TGR 342
           TGR
Sbjct: 223 TGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 1   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 57
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 58  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 117
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 118 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 166
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 167 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 216
Query: 340 TGR 342
           TGR
Sbjct: 217 TGR 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 147
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 148 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 202
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 203 WM--------HYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 141
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 196
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 197 WM--------HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 13  SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 69
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 70  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 129
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 130 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 178
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 179 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 228
Query: 340 TGR 342
           TGR
Sbjct: 229 TGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 126 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 174
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 175 DFGLARH-TADEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 224
Query: 340 TGR 342
           TGR
Sbjct: 225 TGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 126 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 174
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 175 DFGLARH-TADEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 224
Query: 340 TGR 342
           TGR
Sbjct: 225 TGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 126 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 174
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 175 DFGLARH-TADEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 224
Query: 340 TGR 342
           TGR
Sbjct: 225 TGR 227

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DFGLARH-TDDEMTGXVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 147
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 148 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 202
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 203 WM--------HYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 4   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 60
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 61  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 121 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 169
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 170 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 219
Query: 340 TGR 342
           TGR
Sbjct: 220 TGR 222

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 123
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 124 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 170
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 171 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 25  SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 81
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 82  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 141
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 142 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 190
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 191 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 240
Query: 340 TGR 342
           TGR
Sbjct: 241 TGR 243

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 118
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 119 ---VLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 165
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      L       GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLA------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
           +G GG+G ++   ++     +    +        +G      E  IL+K+    +V+L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 201 ACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTR-IRIATELCSVLIFLHSCKPH 256
           A  E  T   LV   +  G +   +   D   P   + R I    ++ S L  LH     
Sbjct: 253 AF-ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           +I++ DLKP N+LLD +   ++SD G++  L   +  +            GT  +M PE 
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--------GTPGFMAPEL 360
Query: 317 LASGELTPKSDVYSFGIILLRLLTGR 342
           L   E     D ++ G+ L  ++  R
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 137
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 138 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 184
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 185 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 137
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 138 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 184
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 185 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
           +G GG+G ++   ++     +    +        +G      E  IL+K+    +V+L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 201 ACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTR-IRIATELCSVLIFLHSCKPH 256
           A  E  T   LV   +  G +   +   D   P   + R I    ++ S L  LH     
Sbjct: 253 AF-ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           +I++ DLKP N+LLD +   ++SD G++  L   +  +            GT  +M PE 
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--------GTPGFMAPEL 360
Query: 317 LASGELTPKSDVYSFGIILLRLLTGR 342
           L   E     D ++ G+ L  ++  R
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
           +G GG+G ++   ++     +    +        +G      E  IL+K+    +V+L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 201 ACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTR-IRIATELCSVLIFLHSCKPH 256
           A  E  T   LV   +  G +   +   D   P   + R I    ++ S L  LH     
Sbjct: 253 AF-ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           +I++ DLKP N+LLD +   ++SD G++  L   +  +            GT  +M PE 
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--------GTPGFMAPEL 360
Query: 317 LASGELTPKSDVYSFGIILLRLLTGR 342
           L   E     D ++ G+ L  ++  R
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 146
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 147 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 201
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 202 WM--------HYNQTVDIWSVGCIMAELLTGR 225

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 33/227 (14%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----- 198
           +G GG G ++  +      +VAIK +     Q      +EI I+ ++ H N+V +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 199 ---------VGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
                    VG+  E+ +  +V EY+      D  +  +  P L    R+    +L   L
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHARL-FMYQLLRGL 133
Query: 248 IFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
            ++HS    +++H DLKPAN+ ++  + V K+ DFG++R +  +     + +    T   
Sbjct: 134 KYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK-- 188
Query: 307 GTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
               Y  P  L S    T   D+++ G I   +LTG+       E++
Sbjct: 189 ---WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 46/246 (18%)
Query: 119 SHM----PQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSI---YKGLLRHMQVAIKM 168
           SHM    P F+    + +  E+     N  P   +G G YGS+   +     H     K+
Sbjct: 19  SHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKL 75
Query: 169 LHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
             P  S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 76  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 135
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 136 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 184
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 185 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 234
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 235 ELLTGR 240

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 76  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 122
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 123 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 169
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 150
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 151 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 197
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 198 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      LC      GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
             + PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 138
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 139 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 193
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 194 WM--------HYNQTVDIWSVGCIMAELLTGR 217

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 123
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 124 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 170
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 171 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 123
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 124 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 170
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 171 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 138
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 139 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 185
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 186 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 138
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 139 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 185
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 186 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 138
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 139 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 185
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 186 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 146 IGEGGYGSIYK--GLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC 202
           +GEG +  +     L+   + A+K++        S   +E+++L + + H N++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 203 P--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
              + + LV+E +  GS+   +  + +   L       +  ++ S L FLH+     I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHN---KGIAH 134
Query: 261 GDLKPANILLD-ANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP NIL +  N VS  K+ DF +   +  N   S  +T    T P G+  YM PE +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT-PCGSAEYMAPEVV 193
Query: 318 ASGE-----LTPKSDVYSFGIILLRLLTGRP 343
            +          + D++S G+IL  LL+G P
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 46/246 (18%)
Query: 119 SHM----PQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSI---YKGLLRHMQVAIKM 168
           SHM    P F+    + +  E+     N  P   +G G YGS+   +     H     K+
Sbjct: 18  SHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKL 74
Query: 169 LHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLED 220
             P  S+       +E+ +L  ++H N++ L+       +L     VY   +L    L +
Sbjct: 75  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 134
Query: 221 RLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
            + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   
Sbjct: 135 IVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 183
Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           K+ DFG++R  + +E++    T   R  P+    +M              D++S G I+ 
Sbjct: 184 KILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMA 233
Query: 337 RLLTGR 342
            LLTGR
Sbjct: 234 ELLTGR 239

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 138
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 139 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 193
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 194 WM--------HYNQTVDIWSVGCIMAELLTGR 217

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 75  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 121
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 122 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 168
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 169 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 150
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 151 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 197
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 198 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 151
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 152 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 198
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 199 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 151
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 152 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 198
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 199 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 151
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 152 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 198
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 199 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 146 IGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
           +G GG+G ++   ++     +    +        +G      E  IL+K+    +V+L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 201 ACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTR-IRIATELCSVLIFLHSCKPH 256
           A  E  T   LV   +  G +   +   D   P   + R I    ++ S L  LH     
Sbjct: 253 AF-ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           +I++ DLKP N+LLD +   ++SD G++  L   +  +            GT  +M PE 
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--------GTPGFMAPEL 360
Query: 317 LASGELTPKSDVYSFGIILLRLLTGR 342
           L   E     D ++ G+ L  ++  R
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 165
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 166 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 212
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 213 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+   +     H     K+  P  S+       +E+ +L  ++H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 147
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 148 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 202
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 203 WM--------HYNQTVDIWSVGCIMAELLTGR 226

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 165
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 166 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 212
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 213 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+   +     H     K+  P  S+       +E+ +L  ++H N++ L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 151
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 152 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 206
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 207 WM--------HYNQTVDIWSVGCIMAELLTGR 230

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 137
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 192
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 193 WM--------HYNQTVDIWSVGCIMAELLTGR 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSI---YKGLLRHMQVAIKMLHP 171
           S   P F+    + +  E+     N  P   +G G YGS+   +     H     K+  P
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DFG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 139
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 140 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 194
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 195 WM--------HYNQTVDIWSVGCIMAELLTGR 218

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 150
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 151 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 197
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 198 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 46/247 (18%)
Query: 118 SSHM----PQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSI---YKGLLRHMQVAIK 167
            SHM    P F+    + +  E+     N  P   +G G YGS+   +     H     K
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKK 74
Query: 168 MLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLE 219
           +  P  S+       +E+ +L  ++H N++ L+       +L     VY   +L    L 
Sbjct: 75  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 134
Query: 220 DRLSCK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 275
           + + C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +  
Sbjct: 135 NIVKCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 183
Query: 276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 335
            K+ DFG++R  + +E+     T   R  P+    +M              D++S G I+
Sbjct: 184 LKILDFGLARH-TDDEMXGXVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIM 233
Query: 336 LRLLTGR 342
             LLTGR
Sbjct: 234 AELLTGR 240

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 146 IGEGGYGSIYKG--LLRHMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+     +   +++A+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
                +L     VY   +L    L + + C+     L+      +  ++   L ++HS  
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIHSA- 173
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    +M  
Sbjct: 174 --DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWMHY 229
Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGR 342
                       D++S G I+  LLTGR
Sbjct: 230 NMTV--------DIWSVGCIMAELLTGR 249

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 151
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 152 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 198
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 199 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 118
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 119 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 165
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 150
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 151 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 197
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 198 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 30/223 (13%)
Query: 140 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID---ILSKIRH 192
           FD    +G G +G +   L++H +     A+K+L    +    + +  ++   IL  +  
Sbjct: 43  FDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 193 PNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           P LV L  +  +   L  V EY+  G +   L      S P     R   A ++     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEY 156
Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           LHS     +++ DLKP N+L+D     +++DFG ++      +      L       GT 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLX------GTP 202
Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            Y+ PE + S       D ++ G+++  +  G P     + +Q
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 46/221 (20%)
Query: 147 GEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDI---LSKIRHPNLVTLVGA 201
           G+G +G++  G  +   M VAIK +    +Q P    +E+ I   L+ + HPN+V L   
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 202 CPEV---------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF--- 249
              +           +V EY+P+        C++      ++ ++     L  V +F   
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPDTL---HRCCRN-----YYRRQVAPPPILIKVFLFQLI 139
Query: 250 -----LHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
                LH     ++ H D+KP N+L++ A+   KL DFG ++ LS +E   N   +C R 
Sbjct: 140 RSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRY 196
Query: 304 DPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRP 343
                  Y  PE +   +  T   D++S G I   ++ G P
Sbjct: 197 -------YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           D+G++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DYGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 124 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 170
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 171 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 217
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 218 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 157
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 158 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 204
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 40/234 (17%)
Query: 118 SSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ 175
            SHM   FSD            +     IG G Y    + + +  +M+ A+K++   S +
Sbjct: 18  GSHMNLVFSD-----------GYVVKETIGVGSYSECKRCVHKATNMEYAVKVID-KSKR 65
Query: 176 GPSEFQQEIDILSKI-RHPNLVTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPL 231
            PSE   EI+IL +  +HPN++TL     +   V+ LV E +  G L D++  +      
Sbjct: 66  DPSE---EIEILLRYGQHPNIITLKDVYDDGKHVY-LVTELMRGGELLDKILRQKF---F 118
Query: 232 SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL-LDANF---VSKLSDFGISRFL 287
           S +    +   +   + +LHS     +VH DLKP+NIL +D +      ++ DFG ++  
Sbjct: 119 SEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAK-- 173
Query: 288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
              ++ + N  L     P  T  ++ PE L         D++S GI+L  +L G
Sbjct: 174 ---QLRAENGLLMT---PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 99  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 145
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 146 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 192
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 193 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2OXQ|C Chain C, Structure Of The Ubch5 :chip U-Box Complex Length = 80

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 43/79 (54%), Gaps = 1/79 (1%)
Query: 420 LGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHK 479
           +GS++R E P Y    I  E+M +P +   G TY+ + ++  L       P+T  PL   
Sbjct: 3   MGSKKR-EIPDYLCGKISFELMAEPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQD 61
Query: 480 NLVPNLALRSAIQEWLQQH 498
            L+PNLA++  I  ++Q++
Sbjct: 62  QLIPNLAMKEVIDAFIQEN 80

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+   PE    +++++   G+L++ L+         WQ        
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS-----FFWQ-------- 118
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 119 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 165
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH    + ++H DLK  N+ L+ +   K+ DFG++  +  +       TLC      GT
Sbjct: 136 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKTLC------GT 184
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             Y+ PE L+    + + DV+S G I+  LL G+P
Sbjct: 185 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 219

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+   +     H     K+  P  S+       +E+ +L  ++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 141
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMAGFVATRWYRA-PEIMLN 196
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 197 WM--------HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH    + ++H DLK  N+ L+ +   K+ DFG++  +  +       TLC      GT
Sbjct: 132 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKTLC------GT 180
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             Y+ PE L+    + + DV+S G I+  LL G+P
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 215

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
           +  A E+   L FL S     I++ DLK  N++LD+    K++DFG+ +   +N      
Sbjct: 124 VFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVT 177
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           T   C     GT  Y+ PE +A        D ++FG++L  +L G+
Sbjct: 178 TKXFC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 127 DFSF-SEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQE 183
           D+ +  E+  ATH     L++G G +G +++   +    Q A+K +     +      +E
Sbjct: 66  DYEYREEVHWATHQ----LRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA-----EE 116
Query: 184 IDILSKIRHPNLVTLVGACPE-VWTLVY-EYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 241
           +   + +  P +V L GA  E  W  ++ E L  GSL   +  +   P       +  A 
Sbjct: 117 LMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQAL 176
Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-SKLSDFGISRFLSQNEISSNNTTLC 300
           E    L +LHS     I+HGD+K  N+LL ++   + L DFG +  L  + +  +   L 
Sbjct: 177 E---GLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKD---LL 227
Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
                 GT  +M PE +       K DV+S   ++L +L G
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 139 NFDPSLKIGEGGYGSI-YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLV 196
           +F P   +G G  G+I Y+G+  +  VA+K + P      S   +E+ +L +   HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVI 81
Query: 197 TLVGACPEV---WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                C E    +  +   L   +L++ +  KD +  L  +  I +  +  S L  LHS 
Sbjct: 82  RYF--CTEKDRQFQYIAIELCAATLQEYVEQKDFAH-LGLEP-ITLLQQTTSGLAHLHSL 137
Query: 254 KPHSIVHGDLKPANILLD-----ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
              +IVH DLKP NIL+          + +SDFG+ + L+    S +      R+   GT
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR-----RSGVPGT 189
Query: 309 FAYMDPEFLASG---ELTPKSDVYSFGIILLRLLT 340
             ++ PE L+       T   D++S G +   +++
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH    + ++H DLK  N+ L+ +   K+ DFG++  +  +       TLC      GT
Sbjct: 132 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKTLC------GT 180
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             Y+ PE L+    + + DV+S G I+  LL G+P
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 215

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
           +  A E+   L FL S     I++ DLK  N++LD+    K++DFG+ +   +N      
Sbjct: 445 VFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVT 498
Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           T   C     GT  Y+ PE +A        D ++FG++L  +L G+
Sbjct: 499 TKXFC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+   +     H     K+  P  S+       +E+ +L  ++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 141
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 142 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMAGFVATRWYRA-PEIMLN 196
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 197 WM--------HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 27/205 (13%)
Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           IG G +G     L+R  Q    VA+K +     +     ++EI     +RHPN+V    V
Sbjct: 27  IGSGNFG--VARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P    +V EY   G L +R+    N+   S         +L S + + H+ +   + 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQ---VC 137
Query: 260 HGDLKPANILLDANFVSKLS--DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           H DLK  N LLD +   +L    FG S+         ++       D  GT AY+ PE L
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSK---------SSVLHSQPKDTVGTPAYIAPEVL 188
Query: 318 ASGELTPK-SDVYSFGIILLRLLTG 341
              E   K +DV+S G+ L  +L G
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH+   + ++H DLK  N+ L+ +   K+ DFG++  +  +       TLC      GT
Sbjct: 157 YLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD--GERKKTLC------GT 205
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
             Y+ PE L     + + D++S G IL  LL G+P  
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           IG G +G     L+R  Q    VA+K +     +     ++EI     +RHPN+V    V
Sbjct: 27  IGSGNFG--VARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P    +V EY   G L +R+    N+   S         +L S + + H+ +   + 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQ---VC 137
Query: 260 HGDLKPANILLDANFVSKLS--DFGISRFLSQNEISSNNTTLCCRTDPK---GTFAYMDP 314
           H DLK  N LLD +   +L    FG S+            +    + PK   GT AY+ P
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSK------------SSVLHSQPKSTVGTPAYIAP 185
Query: 315 EFLASGELTPK-SDVYSFGIILLRLLTG 341
           E L   E   K +DV+S G+ L  +L G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 127 DFSF-SEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQE 183
           D+ +  E+  ATH     L++G G +G +++   +    Q A+K +     +      +E
Sbjct: 85  DYEYREEVHWATHQ----LRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA-----EE 135
Query: 184 IDILSKIRHPNLVTLVGACPE-VWTLVY-EYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 241
           +   + +  P +V L GA  E  W  ++ E L  GSL   +  +   P       +  A 
Sbjct: 136 LMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQAL 195
Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-SKLSDFGISRFLSQNEISSNNTTLC 300
           E    L +LHS     I+HGD+K  N+LL ++   + L DFG +  L  + +     +L 
Sbjct: 196 E---GLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGL---GKSLL 246
Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
                 GT  +M PE +       K DV+S   ++L +L G
Sbjct: 247 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+   +     H     K+  P  S+       +E+ +L  ++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 137
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 192
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 193 WM--------HYNQTVDIWSVGCIMAELLTGR 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 146 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 202
           IG G Y    + + +  +M+ A+K++   S + PSE   EI+IL +  +HPN++TL    
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVID-KSKRDPSE---EIEILLRYGQHPNIITLKDVY 90
Query: 203 PE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
            +   V+ LV E +  G L D++         S +    +   +   + +LHS     +V
Sbjct: 91  DDGKHVY-LVTELMRGGELLDKIL---RQKFFSEREASFVLHTIGKTVEYLHS---QGVV 143
Query: 260 HGDLKPANIL-LDANF---VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           H DLKP+NIL +D +      ++ DFG ++     ++ + N  L     P  T  ++ PE
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAK-----QLRAENGLLMT---PCYTANFVAPE 195
Query: 316 FLASGELTPKSDVYSFGIILLRLLTG 341
            L         D++S GI+L  +L G
Sbjct: 196 VLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           ++H DLK  N+ L+ +   K+ DFG++   ++ E       + C     GT  Y+ PE L
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLC-----GTPNYIAPEVL 187
Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
           +    + + DV+S G I+  LL G+P
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKP 213

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH    + ++H DLK  N+ L+ +   K+ DFG++   ++ E       + C     GT
Sbjct: 154 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLC-----GT 202
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
             Y+ PE L+    + + DV+S G I+  LL G+P  
Sbjct: 203 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 100/225 (44%), Gaps = 44/225 (19%)
Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+ E   G ++KG  +   + +K+L     S +   +F +E   L    HPN++ ++GAC
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 203 -----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
                P   TL+  ++P GSL + L    N   +     ++ A ++   + FLH+ +P  
Sbjct: 77  QSPPAPHP-TLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
             H  L   ++++D +  +++S   + +F  Q+              P   +A   P ++
Sbjct: 135 PRHA-LNSRSVMIDEDMTARISMADV-KFSFQS--------------PGRMYA---PAWV 175
Query: 318 ASGELTPK--------SDVYSFGIILLRLLTGRPALGITKEVQYA 354
           A   L  K        +D++SF ++L  L        +T+EV +A
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWEL--------VTREVPFA 212

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH    + ++H DLK  N+ L+ +   K+ DFG++   ++ E       + C     GT
Sbjct: 156 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLC-----GT 204
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
             Y+ PE L+    + + DV+S G I+  LL G+P  
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 202 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQ--TRIRIATELCSVLIFLHSCKPHSIV 259
                +L  E   +  L   L   D +  +  Q  T   +   +  +L  L       I+
Sbjct: 90  FTPARSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    +M       
Sbjct: 148 HRDLKPSNLAVNEDXELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM------- 198
Query: 320 GELTPKSDVYSFGIILLRLLTGR 342
                  D++S G I+  LLTGR
Sbjct: 199 -HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 23/241 (9%)
Query: 179 EFQQEIDILSKIRHPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
           + ++E  I   ++HPN+V L  +  E     L+++ +  G L + +  ++      + + 
Sbjct: 56  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE------YYSE 109
Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRFLSQNEIS 293
              +  +  +L  +  C    +VH +LKP N+LL +       KL+DFG++  +   + +
Sbjct: 110 ADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 353
                        GT  Y+ PE L         D+++ G+IL  LL G P      E Q+
Sbjct: 170 WFGFA--------GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW--DEDQH 219
Query: 354 ALDTGKLKNLLDPLAGDWPFV--QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 411
            L         D  + +W  V  +A+ L N  +      R +  E  K  W       AS
Sbjct: 220 RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVAS 279
Query: 412 C 412
           C
Sbjct: 280 C 280

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+   +     H     K+  P  S+       +E+ +L  ++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C+    D+   L +Q        +   L ++
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 137
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMAGFVATRWYRA-PEIMLN 192
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 193 WM--------HYNQTVDIWSVGCIMAELLTGR 216

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 36/212 (16%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+   +     H     K+  P  S+       +E+ +L  ++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 202 CPEVWTL-----VY--EYLPNGSLEDRLSC----KDNSPPLSWQTRIRIATELCSVLIFL 250
                +L     VY   +L    L + + C     D+   L +Q        +   L ++
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQ--------ILRGLKYI 137
Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     I+H DLKP+N+ ++ +   K+ DFG++R  + +E++    T   R  P+    
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRA-PEIMLN 192
Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           +M              D++S G I+  LLTGR
Sbjct: 193 WM--------HYNQTVDIWSVGCIMAELLTGR 216

>pdb|2F42|A Chain A, Dimerization And U-Box Domains Of Zebrafish C-Terminal Of Hsp70 Interacting Protein Length = 179

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/72 (30%), Positives = 38/72 (52%)
Query: 427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 486
           E P Y    I  E+M++P +   G TY+ + ++  L       P+T  PL    L+PNLA
Sbjct: 102 EIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQDQLIPNLA 161
Query: 487 LRSAIQEWLQQH 498
           ++  I  ++Q++
Sbjct: 162 MKEVIDAFIQEN 173

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH+   + ++H DLK  N+ L+ +   K+ DFG++   ++ E         C     GT
Sbjct: 157 YLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGERKKXLC-----GT 205
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
             Y+ PE L     + + D++S G IL  LL G+P  
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 24/234 (10%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPP 230
             S+       +E+ +L  ++H N++ L+       +L  E   +  L   L   D +  
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL--EEFNDVYLVTHLMGADLNNI 116
Query: 231 LSWQ--TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 288
           +  Q  T   +   +  +L  L       I+H DLKP+N+ ++ +   K+ DFG++R  +
Sbjct: 117 VKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-T 175
Query: 289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            +E++    T   R  P+    +M              D++S G I+  LLTGR
Sbjct: 176 DDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 63/146 (43%), Gaps = 16/146 (10%)
Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 267
           LV+E L + +L D L    N   +S     + A ++C+ L+FL +    SI+H DLKP N
Sbjct: 133 LVFEML-SYNLYDLLR-NTNFRGVSLNLTRKFAQQMCTALLFL-ATPELSIIHCDLKPEN 189
Query: 268 ILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK 325
           ILL        K+ DFG S  L Q       +             Y  PE L        
Sbjct: 190 ILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRF-----------YRSPEVLLGMPYDLA 238
Query: 326 SDVYSFGIILLRLLTGRPALGITKEV 351
            D++S G IL+ + TG P      EV
Sbjct: 239 IDMWSLGCILVEMHTGEPLFSGANEV 264

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 33/214 (15%)
Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +IGEG +G I++G  LL + QVAIK   P     P        +  + R   L+      
Sbjct: 16  RIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQ-------LRDEYRTYKLLAGCTGI 67
Query: 203 PEVWTLVYEYLPNG--------SLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           P V+    E L N         SLED L  C       S +T   +A     +L  + S 
Sbjct: 68  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKT---VAMAAKQMLARVQSI 121
Query: 254 KPHSIVHGDLKPANILL------DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
              S+V+ D+KP N L+      +AN +  + DFG+ +F  ++ ++  +     + +  G
Sbjct: 122 HEKSLVYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFY-RDPVTKQHIPYREKKNLSG 179
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           T  YM        E + + D+ + G + +  L G
Sbjct: 180 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 213

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 33/214 (15%)
Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +IGEG +G I++G  LL + QVAIK   P     P        +  + R   L+      
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQ-------LRDEYRTYKLLAGCTGI 68
Query: 203 PEVWTLVYEYLPNG--------SLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           P V+    E L N         SLED L  C       S +T   +A     +L  + S 
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKT---VAMAAKQMLARVQSI 122
Query: 254 KPHSIVHGDLKPANILL------DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
              S+V+ D+KP N L+      +AN +  + DFG+ +F  ++ ++  +     + +  G
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFY-RDPVTKQHIPYREKKNLSG 180
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           T  YM        E + + D+ + G + +  L G
Sbjct: 181 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
            FG++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 GFGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 43/93 (46%), Gaps = 13/93 (13%)
Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            L  LHS     +VH D+KPANI L      KL DFG+       E+ +         DP
Sbjct: 169 ALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL-----LVELGTAGAGEVQEGDP 220
Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRL 338
           +    YM PE L  G     +DV+S G+ +L +
Sbjct: 221 R----YMAPELL-QGSYGTAADVFSLGLTILEV 248

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH+   + ++H DLK  N+ L+ +   K+ DFG++   ++ E         C     GT
Sbjct: 141 YLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGERKKDLC-----GT 189
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
             Y+ PE L     + + D++S G IL  LL G+P  
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           D G++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DAGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 63/146 (43%), Gaps = 16/146 (10%)
Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 267
           LV+E L + +L D L    N   +S     + A ++C+ L+FL +    SI+H DLKP N
Sbjct: 133 LVFEML-SYNLYDLLR-NTNFRGVSLNLTRKFAQQMCTALLFL-ATPELSIIHCDLKPEN 189
Query: 268 ILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK 325
           ILL        K+ DFG S  L Q       +             Y  PE L        
Sbjct: 190 ILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF-----------YRSPEVLLGMPYDLA 238
Query: 326 SDVYSFGIILLRLLTGRPALGITKEV 351
            D++S G IL+ + TG P      EV
Sbjct: 239 IDMWSLGCILVEMHTGEPLFSGANEV 264

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 93/228 (40%), Gaps = 41/228 (17%)
Query: 145 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           KIGEG + S+Y    +       ++A+K L P S   P     E+  L+     + V  V
Sbjct: 28  KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGV 85
Query: 200 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             C    +   +   YL + S  D L+       LS+Q        L   L  +H     
Sbjct: 86  KYCFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---F 136
Query: 257 SIVHGDLKPANILLDANFVS-KLSDFGIS-----------RFLS----QNEISSNNTTLC 300
            IVH D+KP+N L +       L DFG++           +F+     Q   S N  ++C
Sbjct: 137 GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSIC 196
Query: 301 C----RTDPK-GTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGR 342
                +  P+ GT  +  PE L      T   D++S G+I L LL+GR
Sbjct: 197 LSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 63/146 (43%), Gaps = 16/146 (10%)
Query: 208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 267
           LV+E L + +L D L    N   +S     + A ++C+ L+FL +    SI+H DLKP N
Sbjct: 114 LVFEML-SYNLYDLLR-NTNFRGVSLNLTRKFAQQMCTALLFL-ATPELSIIHCDLKPEN 170
Query: 268 ILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK 325
           ILL        K+ DFG S  L Q       +             Y  PE L        
Sbjct: 171 ILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF-----------YRSPEVLLGMPYDLA 219
Query: 326 SDVYSFGIILLRLLTGRPALGITKEV 351
            D++S G IL+ + TG P      EV
Sbjct: 220 IDMWSLGCILVEMHTGEPLFSGANEV 245

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
           +LH+   + ++H DLK  N+ L+ +   K+ DFG++   ++ E         C     GT
Sbjct: 157 YLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGERKKDLC-----GT 205
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 345
             Y+ PE L     + + D++S G IL  LL G+P  
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 26/235 (11%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLEDRLSCKDN 227
             S+       +E+ +L  ++H N++ L+       +L      YL    +   L+    
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 228 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 287
           S  L+      +  ++   L ++HS     I+H DLKP+N+ ++ +   K+ DFG+ R  
Sbjct: 119 SQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRH- 174
Query: 288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
           + +E++    T   R  P+    +M              D++S G I+  LLTGR
Sbjct: 175 TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           D G++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DRGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 97/228 (42%), Gaps = 43/228 (18%)
Query: 132 EIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHP--HSLQGPSEFQQEIDIL 187
           E+     +  P   +G G YG++   +      +VAIK L+    S        +E+ +L
Sbjct: 22  EVRAVYRDLQP---VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78
Query: 188 SKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS------------WQT 235
             +RH N++ L+            + P+ +L+D        P +              + 
Sbjct: 79  KHMRHENVIGLLDV----------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128
Query: 236 RIR-IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 294
           RI+ +  ++   L ++H+     I+H DLKP N+ ++ +   K+ DFG++R  + +E+  
Sbjct: 129 RIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMXG 184
Query: 295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
              T   R  P+    +M          T   D++S G I+  ++TG+
Sbjct: 185 XVVTRWYRA-PEVILNWM--------RYTQTVDIWSVGCIMAEMITGK 223

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 138 HNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEF---QQEIDILSKI-R 191
            +FD    IG G Y  +    L+      A+K++    +    +    Q E  +  +   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 192 HPNLVTLVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           HP LV L  +C +  +    V EY+  G L   +  +   P    +   R  + E+   L
Sbjct: 80  HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 134
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +LH      I++ DLK  N+LLD+    KL+D+G+ +   +     + T+  C     G
Sbjct: 135 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFC-----G 183
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 348
           T  Y+ PE L   +     D ++ G+++  ++ GR    I 
Sbjct: 184 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 224

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP- 171
           S   P F+    + +  E+     N  P   +G G YGS+         ++VA+K L   
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           D G++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DGGLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 40/213 (18%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKML-HPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 200
           IG G  G +   Y  +L    VAIK L  P   Q  ++   +E+ ++  + H N++ L+ 
Sbjct: 32  IGSGAQGIVVAAYDAILER-NVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 201 ACPEVWTLVYEYLPNGSLED----RLSCKDNSPPLSWQTRIRIATELCSVLIF------- 249
                      + P  SLE+     +  +     LS   ++ +  E  S L++       
Sbjct: 91  V----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 250 -LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            LHS     I+H DLKP+NI++ ++   K+ DFG++R            T    T    T
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR---------TAGTSFMMTPYVVT 188
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
             Y  PE +         D++S G+I+  ++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 40/213 (18%)
Query: 146 IGEGGYGSI---YKGLLRHMQVAIKML-HPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 200
           IG G  G +   Y  +L    VAIK L  P   Q  ++   +E+ ++  + H N++ L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILER-NVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 201 ACPEVWTLVYEYLPNGSLED----RLSCKDNSPPLSWQTRIRIATELCSVLIF------- 249
                      + P  SLE+     +  +     LS   ++ +  E  S L++       
Sbjct: 91  V----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 250 -LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            LHS     I+H DLKP+NI++ ++   K+ DFG++R            T    T    T
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR---------TAGTSFMMTPYVVT 188
Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
             Y  PE +         D++S G+I+  ++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 192 HPNLVTLVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           HP LV L  +C +  +    V EY+  G L   +  +   P    +   R  + E+   L
Sbjct: 112 HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 166
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +LH      I++ DLK  N+LLD+    KL+D+G+ +   +     + T+  C     G
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFC-----G 215
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 348
           T  Y+ PE L   +     D ++ G+++  ++ GR    I 
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 103/230 (44%), Gaps = 25/230 (10%)
Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTL 198
           IG+G +  + + + R    Q A+K++              + ++E  I   ++HP++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 199 V--GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE-LCSVLIFLHSCKP 255
           +   +   +  +V+E++    L   +  + ++  +  +    +A+  +  +L  L  C  
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA---VASHYMRQILEALRYCHD 148
Query: 256 HSIVHGDLKPANILLDANFVS---KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           ++I+H D+KP  +LL +   S   KL  FG++  L ++ + +            GT  +M
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV--------GTPHFM 200
Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLK 361
            PE +         DV+  G+IL  LL+G  P  G  + +   +  GK K
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK 250

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 192 HPNLVTLVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           HP LV L  +C +  +    V EY+  G L   +  +   P    +   R  + E+   L
Sbjct: 69  HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 123
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +LH      I++ DLK  N+LLD+    KL+D+G+ +   +     + T+  C     G
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFC-----G 172
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 348
           T  Y+ PE L   +     D ++ G+++  ++ GR    I 
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 192 HPNLVTLVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           HP LV L  +C +  +    V EY+  G L   +  +   P    +   R  + E+   L
Sbjct: 65  HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 119
Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +LH      I++ DLK  N+LLD+    KL+D+G+ +   +     + T+  C     G
Sbjct: 120 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFC-----G 168
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 348
           T  Y+ PE L   +     D ++ G+++  ++ GR    I 
Sbjct: 169 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 209

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 102/230 (44%), Gaps = 25/230 (10%)
Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTL 198
           IG+G +  + + + R    Q A+K++              + ++E  I   ++HP++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE-LCSVLIFLHSCKP 255
           +       +  +V+E++    L   +  + ++  +  +    +A+  +  +L  L  C  
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA---VASHYMRQILEALRYCHD 150
Query: 256 HSIVHGDLKPANILLDANFVS---KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           ++I+H D+KP  +LL +   S   KL  FG++  L ++ + +            GT  +M
Sbjct: 151 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV--------GTPHFM 202
Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLK 361
            PE +         DV+  G+IL  LL+G  P  G  + +   +  GK K
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK 252

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 90/228 (39%), Gaps = 48/228 (21%)
Query: 134 EGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGP--SEFQQEIDILSK 189
           +G    FD  ++IG G + ++YKGL     ++VA   L    L       F++E + L  
Sbjct: 24  DGRFLKFD--IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKG 81
Query: 190 IRHPNLVTLVGA------CPEVWTLVYEYLPNGSLE---DRLSCKDNSPPLSWQTRIRIA 240
           ++HPN+V    +        +   LV E   +G+L+    R          SW       
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------C 135
Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTL 299
            ++   L FLH+  P  I+H DLK  NI +     S K+ D G++               
Sbjct: 136 RQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA--------------- 179
Query: 300 CCRTDPKGTFAYM---DPEFLASGELTPK----SDVYSFGIILLRLLT 340
              T  + +FA      PEF A      K     DVY+FG   L   T
Sbjct: 180 ---TLKRASFAKAVIGTPEFXAPEXYEEKYDESVDVYAFGXCXLEXAT 224

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 51/221 (23%)
Query: 146 IGEGGYGSIYKGLL--RHMQVAIKMLH----------PHSLQGPSE----------FQQE 183
           +G GG+GS+Y G+    ++ VAIK +           P+  + P E          F   
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 184 IDILSKIRHPNLVTLVGACPEVWTLVYEYLP-NGSLEDRLSCKDNSPPLSWQTRIRIATE 242
           I +L     P+   L+    E    +++++   G+L++ L+         WQ        
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARS-----FFWQ-------- 122
Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCC 301
              VL  +  C    ++H D+K  NIL+D N    KL DFG    L              
Sbjct: 123 ---VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------V 169
Query: 302 RTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 341
            TD  GT  Y  PE++       +S  V+S GI+L  ++ G
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 42/243 (17%)
Query: 118 SSHMPQFFS---DFSFSEIEGATHNFDPSLKIGEGGYGSI---YKGLLRHMQVAIKMLHP 171
           S   P F+    + +  E+     N  P   +G G YGS+   +     H     K+  P
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP 58
Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLS 223
             S+       +E+ +L  ++H N++ L+       +L     VY   +L    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 224 CK----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           C+    D+   L +Q        +   L ++HS     I+H DLKP+N+ ++ +   K+ 
Sbjct: 119 CQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 339
           DF ++R  + +E++    T   R  P+    +M              D++S G I+  LL
Sbjct: 168 DFYLARH-TDDEMTGYVATRWYRA-PEIMLNWM--------HYNQTVDIWSVGCIMAELL 217
Query: 340 TGR 342
           TGR
Sbjct: 218 TGR 220

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 33/237 (13%)
Query: 119 SHM-PQFFS----DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKML-H 170
           SHM  QF+S    D +F+ ++     +     IG G  G +      +  + VA+K L  
Sbjct: 2   SHMDSQFYSVQVADSTFTVLK----RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR 57
Query: 171 PHSLQGPSE-FQQEIDILSKIRHPNLVTLVGACPEVWTL-----VYEYLPNGSLEDRLSC 224
           P   Q  ++   +E+ +L  + H N+++L+       TL     VY  +    L D   C
Sbjct: 58  PFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM---ELMDANLC 114
Query: 225 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 284
           +     L  +    +  ++   +  LHS     I+H DLKP+NI++ ++   K+ DFG++
Sbjct: 115 QVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 171
Query: 285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           R  S N + +             T  Y  PE +         D++S G I+  L+ G
Sbjct: 172 RTASTNFMMTPYVV---------TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 146 IGEGGYGSIYKGLLRHM--QVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +G G YGS+   + +    +VAIK L     S        +E+ +L  ++H N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 202 CPEVWTL-----VYEYLP--NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
                +L      Y  +P     L+  +  K +   + +     +  ++   L ++HS  
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIHSA- 145
Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              +VH DLKP N+ ++ +   K+ DFG++R  +  E++    T   R  P+   ++M  
Sbjct: 146 --GVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMTGYVVTRWYRA-PEVILSWM-- 199
Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGR 342
                       D++S G I+  +LTG+
Sbjct: 200 ------HYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 32/209 (15%)
Query: 146 IGEGGYGSIYKGL--LRHMQVAIKML-HPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 201
           IG G  G +      +  + VA+K L  P   Q  ++   +E+ +L  + H N+++L+  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 202 CPEVWTLVYEYLPNGSLED----RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC---K 254
                     + P  +LE+     L  +     L     + +  E  S L++   C    
Sbjct: 92  ----------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKH 141
Query: 255 PHS--IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
            HS  I+H DLKP+NI++ ++   K+ DFG++R    N + +             T  Y 
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV---------TRYYR 192
Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTG 341
            PE +         D++S G I+  L+ G
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 50/246 (20%)
Query: 139 NFDPSLK---IGEG--GYGS----IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 189
           NF+ SLK   + E   GYGS    +++G  +   VA+K +    +        EI +L++
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTE 64
Query: 190 IR-HPNLVTLVGACPEV---WTLVYEYLPNGSLEDRLSCKDNSPP-LSWQTR---IRIAT 241
              HPN++     C E    +  +   L N +L+D +  K+ S   L  Q     I +  
Sbjct: 65  SDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------------NFVSKLSDFGISRFLS 288
           ++ S +  LHS K   I+H DLKP NIL+               N    +SDFG+ + L 
Sbjct: 123 QIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 289 QNEISSNNTTLCCRTDPKGTFAYMDPEFL-------ASGELTPKSDVYSFGIILLRLLT- 340
             + SS  T L    +P GT  +  PE L           LT   D++S G +   +L+ 
Sbjct: 180 SGQ-SSFRTNL---NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 341 GRPALG 346
           G+   G
Sbjct: 236 GKHPFG 241

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHP 193
           T  ++    IG G Y    + + +  + + A+K++   S + P+E   EI+IL +  +HP
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDK-SKRDPTE---EIEILLRYGQHP 76
Query: 194 NLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N++TL  V    +   +V E    G L D++         S +    +   +   + +LH
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLH 133
Query: 252 SCKPHSIVHGDLKPANILL---DANFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
           +     +VH DLKP+NIL      N  S ++ DFG ++     ++ + N  L     P  
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLRAENGLLXT---PCY 182
Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           T  ++ PE L         D++S G++L   LTG
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 14/104 (13%)
Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLC 300
           +L   + F+HS     I H D+KP N+L+++ +   KL DFG ++ L  +E S     +C
Sbjct: 149 QLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV--AXIC 203
Query: 301 CRTDPKGTFAYMDPEF-LASGELTPKSDVYSFGIILLRLLTGRP 343
            R        Y  PE  L + E TP  D++S G +   L+ G+P
Sbjct: 204 SR-------FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240

>pdb|2C2L|A Chain A, Crystal Structure Of The Chip U-Box E3 Ubiquitin Ligase Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/70 (28%), Positives = 38/70 (54%)
Query: 429 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALR 488
           P Y    I  E+M++P +   G TY+ + ++  L      +P+T  PL  + L+PNLA++
Sbjct: 206 PDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMK 265
Query: 489 SAIQEWLQQH 498
             I  ++ ++
Sbjct: 266 EVIDAFISEN 275

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   NILL    V K+ DFG++R + +      +     + D +    +M PE + 
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYK------DPDYVRKGDARLPLKWMAPETIF 273
Query: 319 SGELTPKSDVYSFGIILLRLLT 340
               T +SDV+SFG++L  + +
Sbjct: 274 DRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   NILL    V K+ DFG++R + +      +     + D +    +M PE + 
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYK------DPDYVRKGDARLPLKWMAPETIF 275
Query: 319 SGELTPKSDVYSFGIILLRLLT 340
               T +SDV+SFG++L  + +
Sbjct: 276 DRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   NILL    V K+ DFG++R + ++           + D +    +M PE + 
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAPETIF 268
Query: 319 SGELTPKSDVYSFGIILLRLLT 340
               T +SDV+SFG++L  + +
Sbjct: 269 DRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DL   NILL    V K+ DFG++R + ++           + D +    +M PE + 
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAPETIF 266
Query: 319 SGELTPKSDVYSFGIILLRLLT 340
               T +SDV+SFG++L  + +
Sbjct: 267 DRVYTIQSDVWSFGVLLWEIFS 288
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	498
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-103
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-102
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-89
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-70
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-69
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-60
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-49
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-40
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-38
1t1h_A	78	Gspef-atpub14, armadillo repeat containing protein	7e-38
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-35
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-34
2f42_A	179	STIP1 homology and U-box containing protein 1; cha	6e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-30
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-28
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-28
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-28
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-27
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-26
2kr4_A	85	Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ri	3e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-26
2kre_A	100	Ubiquitin conjugation factor E4 B; U-box domain, E	7e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-24
1wgm_A	98	Ubiquitin conjugation factor E4A; ubiquitinating e	2e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-21
2c2l_A	281	CHIP, carboxy terminus of HSP70-interacting protei	5e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-19
3m62_A	968	Ubiquitin conjugation factor E4; armadillo-like re	2e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-15
2yu4_A	94	E3 SUMO-protein ligase NSE2; SP-ring domain, struc	6e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-07
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	2e-07
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	1e-06
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	8e-06
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	1e-05
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	2e-05
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	7e-05
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	7e-05
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	2e-04
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	3e-04
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	7e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-07
2bay_A	61	PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin l	6e-07
3lvg_D	190	LCB, clathrin light chain B; SELF assembly, coated	8e-07
2dfs_A	1080	Myosin-5A; myosin-V, inhibited state, cryoelectron	2e-06
2dfs_A	1080	Myosin-5A; myosin-V, inhibited state, cryoelectron	1e-05
2dfs_A	1080	Myosin-5A; myosin-V, inhibited state, cryoelectron	2e-05
2dfs_A	1080	Myosin-5A; myosin-V, inhibited state, cryoelectron	2e-05
2dfs_A	1080	Myosin-5A; myosin-V, inhibited state, cryoelectron	6e-05
2dfs_A	1080	Myosin-5A; myosin-V, inhibited state, cryoelectron	8e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	5e-05
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	7e-05
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	8e-05
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	2e-04
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	4e-04
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	5e-04
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	5e-04
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	7e-04
3htk_C	267	E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-	6e-05
1w1w_A	430	Structural maintenance of chromosome 1; cohesin, c	2e-04
3na7_A	256	HP0958; flagellar biogenesis, flagellum export, C4	4e-04
3haj_A	486	Human pacsin2 F-BAR; pacsin,syndapin,FAP52,F-BAR,	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  311 bits (799), Expect = e-103
 Identities = 118/314 (37%), Positives = 176/314 (56%), Gaps = 31/314 (9%)

Query: 111 SRKEASSSSHMPQFFS-DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKM 168
           S  +A SSS++  F S      ++E AT+NFD    IG G +G +YKG+LR   +VA+K 
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70

Query: 169 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKD 226
             P S QG  EF+ EI+ LS  RHP+LV+L+G C E     L+Y+Y+ NG+L+  L   D
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130

Query: 227 N-SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 285
             +  +SW+ R+ I       L +LH+    +I+H D+K  NILLD NFV K++DFGIS+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 286 FLSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
             ++ +   +S         T  KGT  Y+DPE+   G LT KSDVYSFG++L  +L  R
Sbjct: 188 KGTELDQTHLS---------TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 343 PALGITKE------VQYA---LDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRK 392
            A+  +         ++A    + G+L+ ++DP LA         +  + A++C  +S +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298

Query: 393 SRPELGKDVWRVLE 406
            RP +G DV   LE
Sbjct: 299 DRPSMG-DVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  307 bits (790), Expect = e-102
 Identities = 114/304 (37%), Positives = 171/304 (56%), Gaps = 31/304 (10%)

Query: 128 FSFSEIEGATHNFDPSL------KIGEGGYGSIYKGLLRHMQVAIKMLHPH----SLQGP 177
           FSF E++  T+NFD         K+GEGG+G +YKG + +  VA+K L       + +  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74

Query: 178 SEFQQEIDILSKIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQT 235
            +F QEI +++K +H NLV L+G   +     LVY Y+PNGSL DRLSC D +PPLSW  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134

Query: 236 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
           R +IA    + + FLH    +  +H D+K ANILLD  F +K+SDFG++R   +   +  
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191

Query: 296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 355
            + +       GT AYM PE L  GE+TPKSD+YSFG++LL ++TG PA+   +E Q  L
Sbjct: 192 TSRI------VGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

Query: 356 --------DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 407
                   +   +++ +D    D      E + ++A +C    +  RP++   V ++L+ 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK-KVQQLLQE 303

Query: 408 MRAS 411
           M AS
Sbjct: 304 MTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  276 bits (707), Expect = 2e-89
 Identities = 101/299 (33%), Positives = 161/299 (53%), Gaps = 31/299 (10%)

Query: 128 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGP-SEFQQEID 185
           FS  E++ A+ NF     +G GG+G +YKG L     VA+K L     QG   +FQ E++
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 186 ILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATE 242
           ++S   H NL+ L G C       LVY Y+ NGS+   L    ++ PPL W  R RIA  
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 243 LCSVLIFLH-SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTL 299
               L +LH  C P  I+H D+K ANILLD  F + + DFG+++ +   +  ++      
Sbjct: 140 SARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT------ 192

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--------V 351
              T  +GT  ++ PE+L++G+ + K+DV+ +G++LL L+TG+ A  + +         +
Sbjct: 193 ---TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249

Query: 352 QYA---LDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 406
            +    L   KL+ L+D  L G++   + EQL  +A+ C + S   RP++  +V R+LE
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLE 307

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  225 bits (575), Expect = 4e-70
 Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 21/273 (7%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 204
            +G G +G + K   R   VAIK +   S +    F  E+  LS++ HPN+V L GAC  
Sbjct: 15  VVGRGAFGVVCKAKWRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 264
              LV EY   GSL + L   +  P  +    +    +    + +LHS +P +++H DLK
Sbjct: 73  PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132

Query: 265 PANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 323
           P N+LL A   V K+ DFG +  +  +            T+ KG+ A+M PE       +
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTH-----------MTNNKGSAAWMAPEVFEGSNYS 181

Query: 324 PKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 382
            K DV+S+GIIL  ++T R P   I       +          PL  + P    + + +L
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLP----KPIESL 236

Query: 383 AMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 415
             RC       RP + +++ +++  +     G+
Sbjct: 237 MTRCWSKDPSQRPSM-EEIVKIMTHLMRYFPGA 268

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  222 bits (569), Expect = 3e-69
 Identities = 83/315 (26%), Positives = 134/315 (42%), Gaps = 21/315 (6%)

Query: 102 VKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH 161
           +K              ++    F       +++    + +   KIG G +G++++     
Sbjct: 1   MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60

Query: 162 MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS 217
             VA+K+L           EF +E+ I+ ++RHPN+V  +GA   P   ++V EYL  GS
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120

Query: 218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
           L   L        L  + R+ +A ++   + +LH+  P  IVH +LK  N+L+D  +  K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVK 179

Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           + DFG+SR  +   +SS            GT  +M PE L       KSDVYSFG+IL  
Sbjct: 180 VCDFGLSRLKASTFLSS--------KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231

Query: 338 LLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 396
           L T + P   +    Q     G  K     +  +       Q+A +   C       RP 
Sbjct: 232 LATLQQPWGNLN-PAQVVAAVGF-KCKRLEIPRNLN----PQVAAIIEGCWTNEPWKRPS 285

Query: 397 LGKDVWRVLEPMRAS 411
               +  +L P+  S
Sbjct: 286 F-ATIMDLLRPLIKS 299

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  214 bits (547), Expect = 6e-66
 Identities = 67/319 (21%), Positives = 115/319 (36%), Gaps = 53/319 (16%)

Query: 111 SRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLH 170
                 SS        D     +   +           G +G ++K  L +  VA+K+  
Sbjct: 3   HHHHHHSSG------VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFP 56

Query: 171 PHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWT---LVYEYLPNGSLEDRLSC 224
               Q   + + E+  L  ++H N++  +GA      V     L+  +   GSL D L  
Sbjct: 57  IQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-- 113

Query: 225 KDNSPPLSWQTRIRIATELCSVLIFLHS--------CKPHSIVHGDLKPANILLDANFVS 276
              +  +SW     IA  +   L +LH          KP  I H D+K  N+LL  N  +
Sbjct: 114 --KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-ISHRDIKSKNVLLKNNLTA 170

Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSF 331
            ++DFG++      + + +           GT  YM PE L        +   + D+Y+ 
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQV------GTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224

Query: 332 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 391
           G++L  L +   A     + +Y L         + +                M+   + +
Sbjct: 225 GLVLWELASRCTAADGPVD-EYML------PFEEEIGQHPSLED--------MQEVVVHK 269

Query: 392 KSRPELGKDVWRVLEPMRA 410
           K RP L +D W+    M  
Sbjct: 270 KKRPVL-RDYWQKHAGMAM 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  207 bits (529), Expect = 7e-64
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 36/279 (12%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS----EFQQEIDILSKIRHPNLVTLVG 200
            IG GG+G +Y+      +VA+K       +  S      +QE  + + ++HPN++ L G
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
            C       LV E+   G L   LS K     +     +  A ++   + +LH      I
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 259 VHGDLKPANILLD--------ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           +H DLK +NIL+         +N + K++DFG++R   +    S            G +A
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----------AGAYA 179

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           +M PE + +   +  SDV+S+G++L  LLTG  P  GI   +  A        L  P+  
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAM-NKLALPIPS 237

Query: 370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
             P    E  A L   C      SRP    ++   L  +
Sbjct: 238 TCP----EPFAKLMEDCWNPDPHSRPSF-TNILDQLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  206 bits (527), Expect = 3e-63
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 26/273 (9%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 202
           +IG G +G++YKG   H  VA+KML+  +        F+ E+ +L K RH N++  +G  
Sbjct: 31  RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 203 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
                 +V ++    SL   L    +      +  I IA +    + +LH+     I+H 
Sbjct: 90  TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DLK  NI L  +   K+ DFG++   S+   S             G+  +M PE +   +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ------LSGSILWMAPEVIRMQD 198

Query: 322 LTP---KSDVYSFGIILLRLLTGR-PALGIT--KEVQYALDTGKLKNLLDPLAGDWPFVQ 375
             P   +SDVY+FGI+L  L+TG+ P   I    ++   +  G L   L  +  + P   
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP--- 255

Query: 376 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
            +++  L   C +  R  RP     +   +E +
Sbjct: 256 -KRMKRLMAECLKKKRDERPSF-PRILAEIEEL 286

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  204 bits (521), Expect = 2e-62
 Identities = 80/282 (28%), Positives = 135/282 (47%), Gaps = 38/282 (13%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS-------EFQQEIDILSKIRHPNL 195
           +IG+GG+G ++KG  +     VAIK L     +G +       EFQ+E+ I+S + HPN+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 196 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           V L G       +V E++P G L  RL   D + P+ W  ++R+  ++   + ++ +  P
Sbjct: 86  VKLYGLMHNPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143

Query: 256 HSIVHGDLKPANILLD-----ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
             IVH DL+  NI L      A   +K++DFG+S+        S ++     +   G F 
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSV----SGLLGNFQ 191

Query: 311 YMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR-PALGIT-KEVQYALDTGKLKNLLDP 366
           +M PE + + E   T K+D YSF +IL  +LTG  P    +  ++++     + + L   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLRPT 250

Query: 367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
           +  D P     +L N+   C     K RP     + + L  +
Sbjct: 251 IPEDCP----PRLRNVIELCWSGDPKKRPHF-SYIVKELSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  204 bits (522), Expect = 3e-62
 Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 20/281 (7%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
            +G+G +G   K   R     + +K L     +    F +E+ ++  + HPN++  +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
              +    + EY+  G+L   +  K       W  R+  A ++ S + +LHS     I+H
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIH 131

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK------GTFAYMDP 314
            DL   N L+  N    ++DFG++R +   +          + D K      G   +M P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 374
           E +       K DV+SFGI+L  ++    A                  L      + P  
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP-- 249

Query: 375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 415
                  + +RCC++  + RP     +   LE +R    G 
Sbjct: 250 --PSFFPITVRCCDLDPEKRPSF-VKLEHWLETLRMHLAGH 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  201 bits (512), Expect = 1e-60
 Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 33/279 (11%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 202
            IG+G +G +Y G   H +VAI+++            F++E+    + RH N+V  +GAC
Sbjct: 40  LIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
             P    ++       +L   +  +D    L      +IA E+   + +LH+     I+H
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILH 153

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLK  N+  D   V  ++DFG+       +       L       G   ++ PE +   
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKL---RIQNGWLCHLAPEIIRQL 209

Query: 321 EL---------TPKSDVYSFGIILLRLLTGR-PALGITKE-VQYALDTGKLKNLLDPLAG 369
                      +  SDV++ G I   L     P      E + + + TG      +    
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM---KPNLSQI 266

Query: 370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
                  ++++++ + C    ++ RP     +  +LE +
Sbjct: 267 GMG----KEISDILLFCWAFEQEERPTF-TKLMDMLEKL 300

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  196 bits (501), Expect = 1e-59
 Identities = 51/275 (18%), Positives = 108/275 (39%), Gaps = 32/275 (11%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 202
           K+ E   G ++KG  +   + +K+L           +F +E   L    HPN++ ++GAC
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 203 --PEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
             P       +  ++P GSL + L  +  +  +     ++ A ++   + FLH+ +P  I
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL- 317
               L   ++++D +  +++S   +                          A++ PE L 
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQS-------------PGRMYAPAWVAPEALQ 181

Query: 318 --ASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFV 374
                     +D++SF ++L  L+T   P   ++  ++  +    L+ L   +       
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVA-LEGLRPTIPPGIS-- 237

Query: 375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 409
               ++ L   C       RP+    +  +LE M+
Sbjct: 238 --PHVSKLMKICMNEDPAKRPKF-DMIVPILEKMQ 269

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  189 bits (482), Expect = 3e-56
 Identities = 65/248 (26%), Positives = 96/248 (38%), Gaps = 31/248 (12%)

Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI 186
           + + SE      N      IG G YG++YKG L    VA+K+    + Q    F  E +I
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNI 58

Query: 187 --LSKIRHPNLVTLVGAC--------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 236
             +  + H N+   +            E   LV EY PNGSL   L    +     W + 
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYL-LVMEYYPNGSLXKYL----SLHTSDWVSS 113

Query: 237 IRIATELCSVLIFLHSCKPHS------IVHGDLKPANILLDANFVSKLSDFGISRFLSQN 290
            R+A  +   L +LH+  P        I H DL   N+L+  +    +SDFG+S  L+ N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 291 EISSNNTTLCCRTDPKGTFAYMDPEFL-------ASGELTPKSDVYSFGIILLRLLTGRP 343
            +              GT  YM PE L              + D+Y+ G+I   +     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 344 ALGITKEV 351
            L   + V
Sbjct: 234 DLFPGESV 241

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  181 bits (461), Expect = 2e-53
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 34/229 (14%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC 202
            +G+G YG +++G  +   VA+K+      +    + +E ++     +RH N++  + + 
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASD 71

Query: 203 -------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS--- 252
                   ++W L+  Y   GSL D L        L   + +RI   + S L  LH    
Sbjct: 72  MTSRHSSTQLW-LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 253 ---CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
               KP +I H DLK  NIL+  N    ++D G++   SQ+     N          GT 
Sbjct: 127 GTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST----NQLDVGNNPRVGTK 181

Query: 310 AYMDPEFL------ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            YM PE L         +   + D+++FG++L  +     + GI ++ +
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  177 bits (450), Expect = 2e-51
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 34/229 (14%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC 202
           +IG+G YG ++ G  R  +VA+K+           + +E +I     +RH N++  + A 
Sbjct: 44  QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAAD 100

Query: 203 -------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS--- 252
                   +++ L+ +Y  NGSL D L     S  L  ++ +++A    S L  LH+   
Sbjct: 101 IKGTGSWTQLY-LITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 253 ---CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
               KP +I H DLK  NIL+  N    ++D G++     +     N          GT 
Sbjct: 156 STQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT----NEVDIPPNTRVGTK 210

Query: 310 AYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
            YM PE L         +    +D+YSFG+IL  +     + GI +E Q
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  172 bits (438), Expect = 1e-49
 Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 41/284 (14%)

Query: 90  EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEG 149
           E   L           ++L      + S S +P          I            IG+G
Sbjct: 1   EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQE-------SIGKG 53

Query: 150 GYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC----- 202
            +G +++G  R  +VA+K+      +    + +E +I     +RH N++  + A      
Sbjct: 54  RFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNG 110

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS------CK 254
              ++W LV +Y  +GSL D L    N   ++ +  I++A    S L  LH        K
Sbjct: 111 TWTQLW-LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
           P +I H DLK  NIL+  N    ++D G++           +T         GT  YM P
Sbjct: 166 P-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA----TDTIDIAPNHRVGTKRYMAP 220

Query: 315 EFL------ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 352
           E L         E   ++D+Y+ G++   +       GI ++ Q
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  145 bits (368), Expect = 8e-40
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)

Query: 145 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
            +G+G   ++++G  RH       AIK+ +  S   P +   +E ++L K+ H N+V L 
Sbjct: 16  ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 200 GACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            A  E  T     L+ E+ P GSL   L    N+  L     + +  ++   +  L    
Sbjct: 74  -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130

Query: 255 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
            + IVH ++KP NI+     D   V KL+DFG +R L  +E      +L       GT  
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLY------GTEE 180

Query: 311 YMDPEFLASGEL--------TPKSDVYSFGIILLRLLTGRP 343
           Y+ P+      L            D++S G+      TG  
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  144 bits (365), Expect = 1e-39
 Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 40/285 (14%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL- 198
           K+G GG  ++Y     + +++VAIK +     +       F++E+   S++ H N+V++ 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V    + + LV EY+   +L + +   ++  PLS  T I    ++   +   H      
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           IVH D+KP NIL+D+N   K+ DFGI++ LS+  ++  N  L       GT  Y  PE  
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-------GTVQYFSPEQA 184

Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP------ALGI-TKEVQYALDTGKLKNLLDPLAGD 370
                   +D+YS GI+L  +L G P      A+ I  K +Q       +   +     D
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVPNVTTDVRK---D 239

Query: 371 WPFVQAEQLANLAMRCCEMSRKSRP----ELGKDVWRVLEPMRAS 411
            P    + L+N+ +R  E  + +R     E+  D+  VL   RA+
Sbjct: 240 IP----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  143 bits (362), Expect = 2e-38
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 33/262 (12%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
           +IG G +G ++ G LR  +  VA+K           ++F QE  IL +  HPN+V L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 202 CPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           C +   ++ +V E +  G     L  +     L  +T +++  +  + + +L S      
Sbjct: 181 CTQKQPIY-IVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCC 234

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEF 316
           +H DL   N L+    V K+SDFG+SR  +    +         +            PE 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA--------ASGGLRQVPVKWTAPEA 286

Query: 317 LASGELTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 373
           L  G  + +SDV+SFGI+L    + G  P   ++ ++ +  ++ G     L       P 
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRLPC-----PE 338

Query: 374 VQAEQLANLAMRCCEMSRKSRP 395
           +  + +  L  +C       RP
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRP 360

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  140 bits (355), Expect = 4e-38
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 20/206 (9%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL- 198
            +G GG G +Y+    +R   VA+K++       P      Q+E     +++ P++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
             G       +    +    L   L       PL+    + I  ++ S L   H+     
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA---AG 154

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
             H D+KP NIL+ A+  + L DFGI+   +  +++    T+       GT  YM PE  
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-------GTLYYMAPERF 207

Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
           +    T ++D+Y+   +L   LTG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSP 233

>1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78

 Score =  132 bits (334), Expect = 7e-38
 Identities = 31/72 (43%), Positives = 44/72 (61%)

Query: 427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 486
           E P YF CPI  E+M+DP + + G TYE  +++ WLD+GH+T P +   L H  L PN  
Sbjct: 4   EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYV 63

Query: 487 LRSAIQEWLQQH 498
           L+S I  W + +
Sbjct: 64  LKSLIALWCESN 75

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  141 bits (358), Expect = 8e-38
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)

Query: 145 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
            +G+G   ++++G  RH       AIK+ +  S   P +   +E ++L K+ H N+V L 
Sbjct: 16  ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 200 GACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            A  E  T     L+ E+ P GSL   L    N+  L     + +  ++   +  L    
Sbjct: 74  -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130

Query: 255 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
            + IVH ++KP NI+     D   V KL+DFG +R L  +E      +L       GT  
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLY------GTEE 180

Query: 311 YMDPEFLASGEL--------TPKSDVYSFGIILLRLLTGRP 343
           Y+ P+      L            D++S G+      TG  
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  137 bits (348), Expect = 6e-37
 Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 197
            +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 198 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           L+G C    V  L+ + +P G L D +  +++   +  Q  +    ++   + +L     
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 313
             +VH DL   N+L+      K++DFG+++ L   E               G     +M 
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            E +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  136 bits (344), Expect = 2e-36
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)

Query: 145 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNL--VTLV 199
           +IG GG   +++ L    Q  AIK ++       +   ++ EI  L+K++  +   + L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
                 +   +V E   N  L   L  K     +    R      +   +  +H    H 
Sbjct: 95  DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HG 147

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           IVH DLKPAN L+    + KL DFGI+  +  +  S    +        GT  YM PE +
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GTVNYMPPEAI 200

Query: 318 -----------ASGELTPKSDVYSFGIILLRLLTGRP 343
                      +  +++PKSDV+S G IL  +  G+ 
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  142 bits (359), Expect = 2e-36
 Identities = 65/286 (22%), Positives = 99/286 (34%), Gaps = 52/286 (18%)

Query: 145 KIGEGGYGSIYKGL---LRHMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL-- 198
            I  GG G IY  L   +    V +K L              E   L+++ HP++V +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 199 VGACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                +        +V EY+   SL+           L     I    E+   L +LHS 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHS- 200

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               +V+ DLKP NI+L    + KL D G         I+S            GT  +  
Sbjct: 201 --IGLVYNDLKPENIMLTEEQL-KLIDLGAVS-----RINSFGYLY-------GTPGFQA 245

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 373
           PE +     T  +D+Y+ G  L  L    P              G+    +D L  D P 
Sbjct: 246 PE-IVRTGPTVATDIYTVGRTLAALTLDLPT-----------RNGR---YVDGLPEDDPV 290

Query: 374 VQA-EQLANLAMRCCEMSRKSRP----ELGKDVWRVLEPMRASCGG 414
           ++  +    L  R  +   + R     E+   +  VL  + A   G
Sbjct: 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (343), Expect = 2e-36
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 19/208 (9%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLV 199
           KIG G +  +Y+       + VA+K +    L          +EID+L ++ HPN++   
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 200 GACPEVWTL--VYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
            +  E   L  V E    G L   +   K     +  +T  +   +LCS L  +HS    
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---R 155

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            ++H D+KPAN+ + A  V KL D G+ RF         ++         GT  YM PE 
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF--------SSKTTAAHSLVGTPYYMSPER 207

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRPA 344
           +       KSD++S G +L  +   +  
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  134 bits (340), Expect = 2e-36
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 25/214 (11%)

Query: 145 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVT 197
            IG G YG   K   R       +  K L   S+   +E Q    E+++L +++HPN+V 
Sbjct: 13  TIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVR 69

Query: 198 LVGACPEVWT----LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
                 +       +V EY   G L   +         L  +  +R+ T+L   L   H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 253 CK--PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
                H+++H DLKPAN+ LD     KL DFG++R L+ +  +S   T        GT  
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFV------GTPY 181

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 344
           YM PE +       KSD++S G +L  L    P 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (343), Expect = 3e-36
 Identities = 59/252 (23%), Positives = 97/252 (38%), Gaps = 22/252 (8%)

Query: 108 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVA 165
           +  S      SS   +    F    +     ++    K+GEGG+  +   +GL      A
Sbjct: 1   MGSSHHHHHHSS--GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYA 58

Query: 166 IKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-------PEVWTLVYEYLPNGSL 218
           +K +  H  Q   E Q+E D+     HPN++ LV  C        E W L+  +   G+L
Sbjct: 59  LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW-LLLPFFKRGTL 117

Query: 219 EDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
            + +   KD    L+    + +   +C  L  +H+       H DLKP NILL       
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPV 174

Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPK--GTFAYMDPEFLAS---GELTPKSDVYSFG 332
           L D G         +  +   L  +       T +Y  PE  +      +  ++DV+S G
Sbjct: 175 LMDLGSMNQAC-IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233

Query: 333 IILLRLLTGRPA 344
            +L  ++ G   
Sbjct: 234 CVLYAMMFGEGP 245

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  135 bits (343), Expect = 4e-36
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)

Query: 145 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNL--VTLV 199
           +IG GG   +++ L    Q  AIK ++       +   ++ EI  L+K++  +   + L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
                 +   +V E   N  L   L  K     +    R      +   +  +H    H 
Sbjct: 76  DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HG 128

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           IVH DLKPAN L+    + KL DFGI+  +  +  S    +        GT  YM PE +
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GTVNYMPPEAI 181

Query: 318 -----------ASGELTPKSDVYSFGIILLRLLTGRP 343
                      +  +++PKSDV+S G IL  +  G+ 
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  134 bits (339), Expect = 6e-36
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 21/207 (10%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVT 197
            +GEG +G +              QVA+K L P S     ++ ++EI+IL  + H N+V 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 198 LVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
             G C         L+ E+LP+GSL++ L    N   ++ + +++ A ++C  + +L S 
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS- 144

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
                VH DL   N+L+++    K+ DFG+++ +  ++          + D      +  
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-----EYYTVKDDRDSPVFWYA 197

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT 340
           PE L   +    SDV+SFG+ L  LLT
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  133 bits (338), Expect = 9e-36
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+               VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 199 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L +  
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EFFKVKEPGESPIFWYAP 186

Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  135 bits (341), Expect = 9e-36
 Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 24/235 (10%)

Query: 117 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL 174
            SS +     +  F  +E     +    KIGEG +G            Q  IK +   S 
Sbjct: 7   HSSGVDLGTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI-NISR 61

Query: 175 QGPSEFQ---QEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP 229
               E +   +E+ +L+ ++HPN+V    +  E  +L  V +Y   G L  R++      
Sbjct: 62  MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGV 120

Query: 230 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 289
                  +    ++C  L  +H  K   I+H D+K  NI L  +   +L DFGI+R L+ 
Sbjct: 121 LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177

Query: 290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 344
                            GT  Y+ PE   +     KSD+++ G +L  L T + A
Sbjct: 178 T--VELARACI------GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  134 bits (338), Expect = 9e-36
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 24/223 (10%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNL 195
           +F+P   +G GG+G +++   +      AIK +  P+      +  +E+  L+K+ HP +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 196 VTLVGACPEVWT--------------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 241
           V    A  E  T              +  +     +L+D ++ +           + I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125

Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE----ISSNNT 297
           ++   + FLHS     ++H DLKP+NI    + V K+ DFG+   + Q+E    + +   
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 340
                T   GT  YM PE +     + K D++S G+IL  LL 
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  134 bits (339), Expect = 1e-35
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+               VA+K L   + +   +F++EI+IL  ++H N+V  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 199 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G C         L+ EYLP GSL D L  + +   +     ++  +++C  + +L +  
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 163

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   NIL++     K+ DFG+++ L Q++          +   +    +  P
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EYYKVKEPGESPIFWYAP 217

Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L   + +  SDV+SFG++L  L T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  135 bits (342), Expect = 1e-35
 Identities = 64/281 (22%), Positives = 103/281 (36%), Gaps = 41/281 (14%)

Query: 87  YKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHN---FDPS 143
           +        + R   +KE    +  R+   S           S S  E  +     +   
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61

Query: 144 LKIGEGGYGSIYKGLLRHMQ-VAIKM-----LHPHSLQGPSEFQQEIDILSKIRHPNL-- 195
            +IG GG   +++ L    Q  AIK          +L     ++ EI  L+K++  +   
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKI 118

Query: 196 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           + L       +   +V E   N  L   L  K     +    R      +   +  +H  
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ- 173

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
             H IVH DLKPAN L+    + KL DFGI+  +  +  S    +        G   YM 
Sbjct: 174 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GAVNYMP 224

Query: 314 PEFL-----------ASGELTPKSDVYSFGIILLRLLTGRP 343
           PE +           +  +++PKSDV+S G IL  +  G+ 
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  134 bits (339), Expect = 1e-35
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 198
           ++G+G +GS+               VA+K L         +FQ+EI IL  +    +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 199 VGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            G           LV EYLP+G L D L  + +   L     +  ++++C  + +L S  
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               VH DL   NIL+++    K++DFG+++ L  ++          R   +    +  P
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DYYVVREPGQSPIFWYAP 199

Query: 315 EFLASGELTPKSDVYSFGIILLRLLT 340
           E L+    + +SDV+SFG++L  L T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  131 bits (333), Expect = 2e-35
 Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 23/222 (10%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           +IG G +G ++ G      +VAIK +   ++    +F +E +++ K+ HP LV L G C 
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 204 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
           E   +  LV E++ +G L D L  +      + +T + +  ++C  + +L       ++H
Sbjct: 74  EQAPIC-LVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIH 127

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
            DL   N L+  N V K+SDFG++RF+  ++  SS  T    +        +  PE  + 
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--------WASPEVFSF 179

Query: 320 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
              + KSDV+SFG+++  + +    P    +  EV   + TG
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  136 bits (343), Expect = 2e-35
 Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 17/219 (7%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249

Query: 204 EV-WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
           E    +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH D
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305

Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G  
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRF 358

Query: 323 TPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
           T KSDV+SFGI+L  L T    P  G+  +EV   ++ G
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  136 bits (344), Expect = 4e-35
 Identities = 63/222 (28%), Positives = 116/222 (52%), Gaps = 21/222 (9%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 203 PE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                 + ++ E++  G+L D L  + N   +S    + +AT++ S + +L      + +
Sbjct: 286 TREPPFY-IITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 340

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H +L   N L+  N + K++DFG+SR ++ +  ++           K    +  PE LA 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-------HAGAKFPIKWTAPESLAY 393

Query: 320 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            + + KSDV++FG++L  + T    P  GI   +V   L+  
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  130 bits (330), Expect = 5e-35
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 23/222 (10%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  +    VA+KM+   S+    EF QE   + K+ HP LV   G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 204 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
           +   ++ +V EY+ NG L + L  + +   L     + +  ++C  + FL S   H  +H
Sbjct: 74  KEYPIY-IVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIH 127

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
            DL   N L+D +   K+SDFG++R++  ++ +SS  T    +        +  PE    
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--------WSAPEVFHY 179

Query: 320 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            + + KSDV++FGI++  + +    P    T  EV   +  G
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  137 bits (346), Expect = 6e-35
 Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 32/216 (14%)

Query: 145 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 199
           ++G GG+G + +    H     QVAIK           E +  EI I+ K+ HPN+V+  
Sbjct: 21  RLGTGGFGYVLRW--IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 200 GACPEVWT---------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
              P+            L  EY   G L   L+  +N   L       + +++ S L +L
Sbjct: 79  -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 251 HSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
           H    + I+H DLKP NI+L       + K+ D G ++ L Q E+    T         G
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFV------G 185

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           T  Y+ PE L   + T   D +SFG +    +TG  
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  130 bits (330), Expect = 8e-35
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 26/210 (12%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 200
           +IG G + ++YKGL     ++VA         +      F++E ++L  ++HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 201 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           +            LV E + +G+L+  L        +  +       ++   L FLH+  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 255 PHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           P  I+H DLK  NI +       K+ D G++     +   +            GT  +M 
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----------IGTPEFMA 198

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE           DVY+FG+ +L + T   
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEY 227

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (340), Expect = 8e-35
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 27/222 (12%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 204
            IG+G +G +  G  R  +VA+K +   +      F  E  +++++RH NLV L+G   E
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 205 VWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
               +Y   EY+  GSL D L        L     ++ + ++C  + +L     ++ VH 
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 313

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFLAS 319
           DL   N+L+  + V+K+SDFG+++  S              T   G        PE L  
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEAS-------------STQDTGKLPVKWTAPEALRE 360

Query: 320 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            + + KSDV+SFGI+L  + +    P   I  K+V   ++ G
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  136 bits (343), Expect = 8e-35
 Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 19/220 (8%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G+G +G ++ G      +VAIK L P ++  P  F QE  ++ K+RH  LV L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 204 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           E  ++ +V EY+  GSL D L   +    L     + +A ++ S + ++      + VH 
Sbjct: 333 EEPIY-IVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G 
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 440

Query: 322 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            T KSDV+SFGI+L  L T    P  G+  +EV   ++ G
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  134 bits (339), Expect = 1e-34
 Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 21/221 (9%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           K+G G +G ++      H +VA+K + P S+     F  E +++  ++H  LV L     
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 204 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +  ++ ++ E++  GSL D L   D          I  + ++   + F+      + +H 
Sbjct: 254 KEPIY-IITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
           DL+ ANIL+ A+ V K++DFG++R +  NE  +        +        +  PE +  G
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAINFG 360

Query: 321 ELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
             T KSDV+SFGI+L+ ++T    P  G++  EV  AL+ G
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  131 bits (331), Expect = 2e-34
 Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 197
            +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 198 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           L+G C    V  L+ + +P G L D +  +++   +  Q  +    ++   + +L     
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 313
             +VH DL   N+L+      K++DFG+++ L   E               G     +M 
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            E +     T +SDV+S+G+ +  L+T   +P  GI   E+   L+ G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (328), Expect = 2e-34
 Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 25/227 (11%)

Query: 144 LKIGEGGYGSIYKGLLRH----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 198
           +++G G +GS+ +G+ R     + VAIK+L          E  +E  I+ ++ +P +V L
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G C    +  LV E    G L   L        +       +  ++   + +L      
Sbjct: 76  IGVCQAEALM-LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE---K 129

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMDP 314
           + VH DL   N+LL     +K+SDFG+S+ L  ++               G +   +  P
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-------SYYTARSAGKWPLKWYAP 182

Query: 315 EFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
           E +   + + +SDV+S+G+ +   L+   +P   +   EV   ++ G
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  130 bits (328), Expect = 2e-34
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 19/220 (8%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G ++ G    H +VA+K L   S+  P  F  E +++ +++H  LV L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 204 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
           +  ++ ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H 
Sbjct: 79  QEPIY-IITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL+ ANIL+      K++DFG++R +  NE ++       R   K    +  PE +  G 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGT 186

Query: 322 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            T KSDV+SFGI+L  ++T    P  G+T  EV   L+ G
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (329), Expect = 2e-34
 Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 34/231 (14%)

Query: 137 THNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH 192
             +F+    +G+G +G + K   R+       AIK +  H+ +  S    E+ +L+ + H
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKA--RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNH 61

Query: 193 PNLVTLVGA------------CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRI 237
             +V    A              +  + ++   EY  NG+L D +     +         
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYW 119

Query: 238 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 297
           R+  ++   L ++HS     I+H DLKP NI +D +   K+ DFG+++ + ++       
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 298 TLCCRTDPK------GTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTG 341
           +              GT  Y+  E L  +G    K D+YS GII   ++  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  129 bits (326), Expect = 2e-34
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 202
            IG+G +G +  G  R  +VA+K +   +      F  E  +++++RH NLV L+G    
Sbjct: 28  TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
               ++ +V EY+  GSL D L        L     ++ + ++C  + +L     ++ VH
Sbjct: 86  EKGGLY-IVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFLA 318
            DL   N+L+  + V+K+SDFG+++  S              T   G        PE L 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------------STQDTGKLPVKWTAPEALR 187

Query: 319 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
             + + KSDV+SFGI+L  + +    P   I  K+V   ++ G
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  129 bits (327), Expect = 2e-34
 Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 23/222 (10%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 203
           ++G G +G +  G  R    VAIKM+   S+    EF +E  ++  + H  LV L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 204 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
           +   ++ ++ EY+ NG L + L  ++       Q  + +  ++C  + +L S      +H
Sbjct: 90  KQRPIF-IITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
            DL   N L++   V K+SDFG+SR++  +E  SS  +    R        +  PE L  
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR--------WSPPEVLMY 195

Query: 320 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            + + KSD+++FG+++  + +    P    T  E    +  G
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  129 bits (326), Expect = 3e-34
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 41/227 (18%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN 194
           +F     IG GG+G ++K   +H        IK +  ++ +   + ++E+  L+K+ H N
Sbjct: 12  DFKEIELIGSGGFGQVFKA--KHRIDGKTYVIKRV-KYNNE---KAEREVKALAKLDHVN 65

Query: 195 LVTLVGA---------------CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTR 236
           +V   G                       ++   E+   G+LE  +  K     L     
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLA 124

Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
           + +  ++   + ++HS K   +++ DLKP+NI L      K+ DFG+   L  +      
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKR 178

Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           T         GT  YM PE ++S +   + D+Y+ G+IL  LL    
Sbjct: 179 TRSK------GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  129 bits (326), Expect = 3e-34
 Identities = 64/224 (28%), Positives = 116/224 (51%), Gaps = 25/224 (11%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G YG +Y+G+ +   + VA+K L   +++   EF +E  ++ +I+HPNLV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 203 PE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                 + ++ E++  G+L D L  + N   +S    + +AT++ S + +L      + +
Sbjct: 79  TREPPFY-IITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 133

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFL 317
           H DL   N L+  N + K++DFG+SR ++ +  +++             F      PE L
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA---------GAKFPIKWTAPESL 184

Query: 318 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
           A  + + KSDV++FG++L  + T    P  GI   +V   L+  
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  128 bits (325), Expect = 4e-34
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 21/201 (10%)

Query: 145 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 196
           K+G+G +G + +G         + VA+K L P  L  P    +F +E++ +  + H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 197 TLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L G      +  +V E  P GSL DRL  + +       T  R A ++   + +L S  
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
               +H DL   N+LL    + K+ DFG+ R L QN+          +   K  FA+  P
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHRKVPFAWCAP 193

Query: 315 EFLASGELTPKSDVYSFGIIL 335
           E L +   +  SD + FG+ L
Sbjct: 194 ESLKTRTFSHASDTWMFGVTL 214

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  128 bits (325), Expect = 5e-34
 Identities = 70/308 (22%), Positives = 125/308 (40%), Gaps = 32/308 (10%)

Query: 116 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLH 170
             S+  P+         I  ++     +  IG G +G +Y G L       +  A+K L+
Sbjct: 3   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62

Query: 171 P-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLEDRLSCKD 226
               +   S+F  E  I+    HPN+++L+G C            Y+ +G L + +  ++
Sbjct: 63  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RN 120

Query: 227 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 286
            +   + +  I    ++   + +L S      VH DL   N +LD  F  K++DFG++R 
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177

Query: 287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPA 344
           +   E  S +     +   K    +M  E L + + T KSDV+SFG++L  L+T    P 
Sbjct: 178 MYDKEYYSVHNKTGAKLPVK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

Query: 345 LGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKD 400
             +   ++   L  G     L       P    + L  + ++C     + RP   EL   
Sbjct: 234 PDVNTFDITVYLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285

Query: 401 VWRVLEPM 408
           +  +    
Sbjct: 286 ISAIFSTF 293

>2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179

 Score =  125 bits (315), Expect = 6e-34
 Identities = 22/77 (28%), Positives = 40/77 (51%)

Query: 422 SEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL 481
             ++ E P Y    I  E+M++P +   G TY+ + ++  L       P+T  PL    L
Sbjct: 97  KRKKREIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQDQL 156

Query: 482 VPNLALRSAIQEWLQQH 498
           +PNLA++  I  ++Q++
Sbjct: 157 IPNLAMKEVIDAFIQEN 173

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (324), Expect = 7e-34
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 27/229 (11%)

Query: 145 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 198
            IG+G +G +Y G         +Q AIK L     +Q    F +E  ++  + HPN++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 199 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           +G           ++  Y+ +G L   +  +      + +  I    ++   + +L    
Sbjct: 88  IGIMLPPEGLPH-VLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAE-- 142

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYM 312
               VH DL   N +LD +F  K++DFG++R +   E  S       +          + 
Sbjct: 143 -QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS------VQQHRHARLPVKWT 195

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
             E L +   T KSDV+SFG++L  LLT    P   I   ++ + L  G
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  128 bits (325), Expect = 9e-34
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 30/214 (14%)

Query: 145 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 197
            +G GG   ++        R   VA+K+L     + PS    F++E    + + HP +V 
Sbjct: 19  ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 198 L------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           +            +  +V EY+   +L D +       P++ +  I +  + C  L F H
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTF 309
               + I+H D+KPANI++ A    K+ DFGI+R ++ +   ++     +       GT 
Sbjct: 134 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-------GTA 183

Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            Y+ PE      +  +SDVYS G +L  +LTG P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  129 bits (326), Expect = 9e-34
 Identities = 50/229 (21%), Positives = 90/229 (39%), Gaps = 46/229 (20%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEF-----------------QQEIDIL 187
            + +G +  I      +   A+K      L+   +F                 + E+ I+
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 188 SKIRHPNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSC-----KDNSPPLSWQTR 236
           + I++   +T       + T      ++YEY+ N S+           K+ +  +  Q  
Sbjct: 98  TDIKNEYCLTCE----GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153

Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
             I   + +   ++H+ K  +I H D+KP+NIL+D N   KLSDFG     S+  +    
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFG----ESEYMVDKKI 207

Query: 297 TTLCCRTDPKGTFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGRP 343
                     GT+ +M PEF ++       K D++S GI L  +     
Sbjct: 208 KGSR------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  128 bits (324), Expect = 1e-33
 Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 24/226 (10%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 197
            +G G +G+++KG+         + V IK++      Q        +  +  + H ++V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 198 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           L+G CP   +  LV +YLP GSL D +  + +   L  Q  +    ++   + +L     
Sbjct: 80  LLGLCPGSSLQ-LVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEE--- 133

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           H +VH +L   N+LL +    +++DFG++  L  ++           ++ K    +M  E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL------YSEAKTPIKWMALE 187

Query: 316 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            +  G+ T +SDV+S+G+ +  L+T    P  G+   EV   L+ G
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (323), Expect = 1e-33
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 23/207 (11%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 197
            +GEG +G +               VA+K L      Q  S ++QEIDIL  + H +++ 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 198 LVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
             G C         LV EY+P GSL D L    +S  L+    +  A ++C  + +LH+ 
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQL--LLFAQQICEGMAYLHAQ 153

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
                +H DL   N+LLD + + K+ DFG+++ + +            R D      +  
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-----EYYRVREDGDSPVFWYA 205

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT 340
           PE L   +    SDV+SFG+ L  LLT
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  127 bits (321), Expect = 1e-33
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 27/207 (13%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G+G +G++Y  L R  Q    +A+K+L    L+      Q   E++I S +RHPN++ L
Sbjct: 17  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 199 VG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
            G         L+ EY P G++   L           Q      TEL + L + HS    
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHS---K 128

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            ++H D+KP N+LL +    K++DFG     S +  SS  T LC      GT  Y+ PE 
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLC------GTLDYLPPEM 178

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
           +       K D++S G++    L G+P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  127 bits (321), Expect = 2e-33
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 24/225 (10%)

Query: 145 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 198
            IGEG +G +++G+        + VAIK      S     +F QE   + +  HP++V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G   E  VW ++ E    G L   L  +     L   + I  A +L + L +L S    
Sbjct: 82  IGVITENPVW-IIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES---K 135

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
             VH D+   N+L+ +N   KL DFG+SR++  +            +  K    +M PE 
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPES 188

Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
           +     T  SDV+ FG+ +  +L    +P  G+   +V   ++ G
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  127 bits (321), Expect = 2e-33
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 24/225 (10%)

Query: 145 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 198
            +GEG +G +Y+G+  +     + VA+K      +L    +F  E  I+  + HP++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G   E   W ++ E  P G L   L  + N   L   T +  + ++C  + +L S    
Sbjct: 79  IGIIEEEPTW-IIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---I 132

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           + VH D+   NIL+ +    KL DFG+SR++   +    + T       +    +M PE 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT-------RLPIKWMSPES 185

Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
           +     T  SDV+ F + +  +L+   +P   +  K+V   L+ G
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  128 bits (323), Expect = 2e-33
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 24/202 (11%)

Query: 145 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTL 198
            IG G  G +  G LR      + VAIK L    + +   +F  E  I+ +  HPN++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 199 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
            G          +V EY+ NGSL+  L  + +    +    + +   + + + +L     
Sbjct: 116 EGVVTRGRLAM-IVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSD--- 169

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MD 313
              VH DL   N+L+D+N V K+SDFG+SR L  +  ++  TT        G        
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-------GGKIPIRWTA 222

Query: 314 PEFLASGELTPKSDVYSFGIIL 335
           PE +A    +  SDV+SFG+++
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVM 244

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (320), Expect = 2e-33
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 39/212 (18%)

Query: 145 KIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 195
            +G+G +  I+KG+ R           +V +K+L          F +   ++SK+ H +L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 196 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           V   G C    E   LV E++  GSL+  L  K N   ++   ++ +A +L + + FL  
Sbjct: 75  VLNYGVCVCGDENI-LVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 253 CKPHSIVHGDLKPANILLDA--------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
              ++++HG++   NILL              KLSD GIS  +   +I            
Sbjct: 132 ---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL----------- 177

Query: 305 PKGTFAYMDPE-FLASGELTPKSDVYSFGIIL 335
            +    ++ PE       L   +D +SFG  L
Sbjct: 178 -QERIPWVPPECIENPKNLNLATDKWSFGTTL 208

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  127 bits (322), Expect = 6e-33
 Identities = 68/301 (22%), Positives = 119/301 (39%), Gaps = 33/301 (10%)

Query: 109 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQ 163
             +      S+  P+         I  ++     +  IG G +G +Y G L       + 
Sbjct: 60  GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119

Query: 164 VAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLE 219
            A+K L+    +   S+F  E  I+    HPN+++L+G C            Y+ +G L 
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 220 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 279
           + +  ++ +   + +  I    ++   + FL S      VH DL   N +LD  F  K++
Sbjct: 180 NFI--RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 234

Query: 280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLR 337
           DFG++R +   E  S                  +M  E L + + T KSDV+SFG++L  
Sbjct: 235 DFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288

Query: 338 LLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 394
           L+T    P   +   ++   L  G     L       P    + L  + ++C     + R
Sbjct: 289 LMTRGAPPYPDVNTFDITVYLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMR 340

Query: 395 P 395
           P
Sbjct: 341 P 341

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  127 bits (322), Expect = 7e-33
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)

Query: 145 KIGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 198
            +G G +G +  G L     + + VAIK L   ++ +   +F  E  I+ +  HPN++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 199 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
            G   +   V  +V EY+ NGSL+  L  + +    +    + +   + S + +L     
Sbjct: 112 EGVVTKSKPVM-IVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSD--- 165

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MD 313
              VH DL   NIL+++N V K+SDFG+ R L  +  ++  T         G        
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-------GGKIPIRWTS 218

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
           PE +A  + T  SDV+S+GI+L  +++   RP   ++ ++V  A+D G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  126 bits (318), Expect = 9e-33
 Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 20/219 (9%)

Query: 145 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGA 201
            + EGG+  +Y  + +    + A+K L  +  +      QE+  + K+  HPN+V    A
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 202 CPEVWT---------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
                          L+   L  G L + L   ++  PLS  T ++I  + C  +  +H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK----GT 308
            KP  I+H DLK  N+LL      KL DFG +  +S     S +       + +     T
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 309 FAYMDPE---FLASGELTPKSDVYSFGIILLRLLTGRPA 344
             Y  PE     ++  +  K D+++ G IL  L   +  
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  127 bits (319), Expect = 1e-32
 Identities = 46/262 (17%), Positives = 87/262 (33%), Gaps = 35/262 (13%)

Query: 108 LRKSRKEASSSSHMPQFFSDFS----FSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-- 161
           L    K  SS  +  ++          +E +  +        +GEG +  +Y+       
Sbjct: 31  LSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90

Query: 162 -----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 214
                 +  +K+  P +        Q ++ L        +    A        LV E   
Sbjct: 91  DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150

Query: 215 NGSLEDRLSCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 272
            G+L + ++   N+P   +     I  A  +  ++  +H C+   I+HGD+KP N +L  
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGN 207

Query: 273 NFVS-----------KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
            F+             L D G S  +      +  T  C       T  +   E L++  
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC------ETSGFQCVEMLSNKP 261

Query: 322 LTPKSDVYSFGIILLRLLTGRP 343
              + D +     +  +L G  
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTY 283

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  126 bits (318), Expect = 1e-32
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 25/203 (12%)

Query: 145 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 197
            IG G +G +YKG+L+       + VAIK L    + +   +F  E  I+ +  H N++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 198 LVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           L G   +   +  ++ EY+ NG+L+  L  ++     S    + +   + + + +L +  
Sbjct: 111 LEGVISKYKPMM-IITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLAN-- 165

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--M 312
             + VH DL   NIL+++N V K+SDFG+SR L  +  ++  T+        G       
Sbjct: 166 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-------GGKIPIRWT 217

Query: 313 DPEFLASGELTPKSDVYSFGIIL 335
            PE ++  + T  SDV+SFGI++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVM 240

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (315), Expect = 1e-32
 Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 18/234 (7%)

Query: 117 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL 174
           S     +   +    E +         + +G+G YG +Y G     Q  +AIK +     
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 175 QGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLS 232
           +      +EI +   ++H N+V  +G+  E   +    E +P GSL   L  K      +
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120

Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNE 291
            QT      ++   L +LH  +   IVH D+K  N+L++  + V K+SDFG S+ L+   
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--G 175

Query: 292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 343
           I+    T        GT  YM PE +  G       +D++S G  ++ + TG+P
Sbjct: 176 INPCTETF------TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  130 bits (329), Expect = 1e-32
 Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 32/262 (12%)

Query: 145 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 198
            IGEG +G +++G+        M VAIK      S     +F QE   + +  HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +G   E  VW ++ E    G L   L  +     L   + I  A +L + L +L S    
Sbjct: 457 IGVITENPVW-IIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES---K 510

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
             VH D+   N+L+ +N   KL DFG+SR++  +            +  K    +M PE 
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPES 563

Query: 317 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 373
           +     T  SDV+ FG+ +  +L    +P  G+   +V   ++ G     L       P 
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPM-----PP 615

Query: 374 VQAEQLANLAMRCCEMSRKSRP 395
                L +L  +C       RP
Sbjct: 616 NCPPTLYSLMTKCWAYDPSRRP 637

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (327), Expect = 2e-32
 Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 19/224 (8%)

Query: 145 KIGEGGYGSIYKGLLR----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           ++G G +GS+ +G+ R     + VAIK+L          E  +E  I+ ++ +P +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 200 GAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           G C  E   LV E    G L   L        +       +  ++   + +L      + 
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 457

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           VH +L   N+LL     +K+SDFG+S+ L  ++     +    R+  K    +  PE + 
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPECIN 512

Query: 319 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 359
             + + +SDV+S+G+ +   L+   +P   +   EV   ++ GK
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  123 bits (312), Expect = 3e-32
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)

Query: 145 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           ++GEG +G ++             M VA+K L   +L    +FQ+E ++L+ ++H ++V 
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 198 LVGACPEV--WTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRIATE 242
             G C +     +V+EY+ +G L   L               +     L     + IA++
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 302
           + S +++L S      VH DL   N L+ AN + K+ DFG+SR +   +          R
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY--------YR 190

Query: 303 TDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 335
                     +M PE +   + T +SDV+SFG+IL
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  123 bits (311), Expect = 4e-32
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 32/211 (15%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G+G +  +Y      +     VAIKM+   ++      Q+   E+ I  +++HP+++ L
Sbjct: 19  LGKGSFAGVY--RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 199 VGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
                  +       LV E   NG +   L  K+   P S         ++ + +++LHS
Sbjct: 77  Y----NYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
              H I+H DL  +N+LL  N   K++DFG++  L        + TLC      GT  Y+
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLC------GTPNYI 179

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE         +SDV+S G +   LL GRP
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  123 bits (312), Expect = 6e-32
 Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 45/277 (16%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           ++GEG +G ++     +       M VA+K L   S     +FQ+E ++L+ ++H ++V 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 198 LVGACPEV--WTLVYEYLPNGSLEDRL------------SCKDNSPPLSWQTRIRIATEL 243
             G C E     +V+EY+ +G L   L                   PL     + +A+++
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
            + +++L        VH DL   N L+    V K+ DFG+SR     +I S +     R 
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYY---RV 216

Query: 304 DPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
             +      +M PE +   + T +SDV+SFG++L  + T   +P   ++  E    +  G
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276

Query: 359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                L+      P     ++  +   C +   + R 
Sbjct: 277 ---RELER-----PRACPPEVYAIMRGCWQREPQQRH 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (312), Expect = 7e-32
 Identities = 52/252 (20%), Positives = 95/252 (37%), Gaps = 24/252 (9%)

Query: 98  RDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKG 157
              + K      ++               D+ + E     H      ++G G +G +++ 
Sbjct: 21  SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRM 77

Query: 158 LLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEY 212
             +    Q A+K +     +      +E+   + +  P +V L GA    P V  +  E 
Sbjct: 78  KDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVN-IFMEL 131

Query: 213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 272
           L  GSL   +        L     +    +    L +LH+ +   I+HGD+K  N+LL +
Sbjct: 132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSS 185

Query: 273 NFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 331
           +     L DFG +  L  + +     +L       GT  +M PE +       K D++S 
Sbjct: 186 DGSRAALCDFGHALCLQPDGLG---KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242

Query: 332 GIILLRLLTGRP 343
             ++L +L G  
Sbjct: 243 CCMMLHMLNGCH 254

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  123 bits (310), Expect = 1e-31
 Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 33/236 (13%)

Query: 145 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVT 197
            +GEG +GS+ +G L+      ++VA+K +     S +   EF  E   +    HPN++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 198 LVGAC----PEVWTLVY---EYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 247
           L+G C     +          ++  G L   L     +     +  QT ++   ++   +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L +    + +H DL   N +L  +    ++DFG+S+ +   +                
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR--------IA 209

Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
                ++  E LA    T KSDV++FG+ +  + T    P  G+   E+   L  G
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  121 bits (307), Expect = 1e-31
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 27/207 (13%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G+G +G++Y  L R  Q    +A+K+L    L+      Q   EI+I S +RHPN++ +
Sbjct: 22  LGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 199 VG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
                  +   L+ E+ P G L   L           Q       EL   L + H     
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHE---R 133

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            ++H D+KP N+L+      K++DFG     S +  S    T+C      GT  Y+ PE 
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRTMC------GTLDYLPPEM 183

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
           +       K D++  G++    L G P
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMP 210

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  124 bits (314), Expect = 2e-31
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 27/218 (12%)

Query: 139 NFDPSLKIGEGGYGSI-YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLV 196
           +F P   +G G  G+I Y+G+  +  VA+K + P          +E+ +L +   HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81

Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
                    +   +  E     +L++ +  KD +        I +  +  S L  LHS  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHS-- 136

Query: 255 PHSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
             +IVH DLKP NIL+          + +SDFG+ + L+    S +  +        GT 
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-----GTE 190

Query: 310 AYMDPEFL---ASGELTPKSDVYSFGIILLRLLT-GRP 343
            ++ PE L        T   D++S G +   +++ G  
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  121 bits (306), Expect = 2e-31
 Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 25/226 (11%)

Query: 145 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG  +       VA+K+L   +       E   E +++ ++ +P +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 199 VGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L    +   +  +  I +  ++   + +L      +
Sbjct: 84  IGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---SN 137

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMDPE 315
            VH DL   N+LL     +K+SDFG+S+ L  +E          +    G +   +  PE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-------NYYKAQTHGKWPVKWYAPE 190

Query: 316 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
            +   + + KSDV+SFG+++    +   +P  G+   EV   L+ G
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  122 bits (307), Expect = 3e-31
 Identities = 70/310 (22%), Positives = 133/310 (42%), Gaps = 42/310 (13%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 196
           ++G+G +G +Y+G+ +         +VAIK ++   S++   EF  E  ++ +    ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 197 TLVGACPEV--WTLVYEYLPNGSLED-------RLSCKDNSPPLSWQTRIRIATELCSVL 247
            L+G   +     ++ E +  G L+         ++      P S    I++A E+   +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L++   +  VH DL   N ++  +F  K+ DFG++R + + +          R   KG
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--------YRKGGKG 200

Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 362
                +M PE L  G  T  SDV+SFG++L  + T   +P  G++ ++V   +  G    
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG---G 257

Query: 363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 422
           LLD      P    + L  L   C + + K RP    ++   ++          S+    
Sbjct: 258 LLDK-----PDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEEMEPGFREVSFYYSE 311

Query: 423 EERCEPPPYF 432
           E +   P   
Sbjct: 312 ENKLPEPEEL 321

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  121 bits (305), Expect = 5e-31
 Identities = 59/264 (22%), Positives = 89/264 (33%), Gaps = 43/264 (16%)

Query: 92  DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGY 151
             +   + + V    E  ++ +        P+ F   SF  +           ++G G Y
Sbjct: 21  QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLS----------RLGHGSY 70

Query: 152 GSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQ---QEIDILSKI-RHPNLVTLVGACPEV 205
           G ++K   +      A+K       +GP +      E+    K+ +HP  V L  A    
Sbjct: 71  GEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA---- 125

Query: 206 WT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
           W       L  E     SL+    C+     L          +    L  LHS     +V
Sbjct: 126 WEEGGILYLQTELC-GPSLQQH--CEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLV 179

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H D+KPANI L      KL DFG+   L                   G   YM PE L  
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQE------GDPRYMAPELLQG 230

Query: 320 GELTPKSDVYSFGIILLRLLTGRP 343
                 +DV+S G+ +L +     
Sbjct: 231 S-YGTAADVFSLGLTILEVACNME 253

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  121 bits (305), Expect = 5e-31
 Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 34/237 (14%)

Query: 145 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVT 197
            +G+G +GS+ +  L+      ++VA+KML     +     EF +E   + +  HP++  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 198 LVGAC----PEVWT----LVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSV 246
           LVG       +       ++  ++ +G L   L      +N   L  QT +R   ++   
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           + +L S    + +H DL   N +L  +    ++DFG+SR +   +          R    
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY--------YRQGCA 198

Query: 307 GTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
                 ++  E LA    T  SDV++FG+ +  ++T    P  GI   E+   L  G
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  122 bits (307), Expect = 5e-31
 Identities = 43/345 (12%), Positives = 87/345 (25%), Gaps = 60/345 (17%)

Query: 94  LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 153
            +       +EA +   +  EA +++  PQ       S +            +  G    
Sbjct: 18  EEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSV 77

Query: 154 IYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGACPEVWT- 207
           ++           A+K+    +    SE     +     +++   +          +   
Sbjct: 78  VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137

Query: 208 ---------------------------LVYEYLPNGSLEDRLSCKDNSP----PLSWQTR 236
                                      L+     +  LE   S  D              
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFRGDEGILAL 196

Query: 237 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
             +  +L  +   L S     +VHG   P N+ +  +    L D          ++ +  
Sbjct: 197 HILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRG 248

Query: 297 TTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRPALGITKEVQYA 354
                         Y   EFL +     T   + +  G+ + R+       G+       
Sbjct: 249 PASS------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-- 300

Query: 355 LDTGKLKNLLDPLAGDWPFVQA----EQLANLAMRCCEMSRKSRP 395
             + K  +L  P      F       + +  L  R     R+ R 
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  120 bits (304), Expect = 9e-31
 Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 41/273 (15%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 196
            +G G +G +Y+G +         +QVA+K L    S Q   +F  E  I+SK  H N+V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 197 TLVGACPEV--WTLVYEYLPNGSLED----RLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
             +G   +     ++ E +  G L+               L+    + +A ++     +L
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 251 HSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
                +  +H D+   N LL       V+K+ DFG++R + +            R     
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------YYRKGGCA 205

Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 362
                +M PE    G  T K+D +SFG++L  + +    P    + +EV   + +G    
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---G 262

Query: 363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
            +DP     P      +  +  +C +   + RP
Sbjct: 263 RMDP-----PKNCPGPVYRIMTQCWQHQPEDRP 290

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  119 bits (301), Expect = 1e-30
 Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 27/208 (12%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 198
           +G+GG+   +   +         A K++    L  P    +   EI I   + H ++V  
Sbjct: 23  LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 199 VGACPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
            G   E    V+   E     SL +    +     L+         ++     +LH    
Sbjct: 81  HG-FFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR--- 133

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           + ++H DLK  N+ L+ +   K+ DFG++  +  +        LC      GT  Y+ PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLC------GTPNYIAPE 185

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L+    + + DV+S G I+  LL G+P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKP 213

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  120 bits (302), Expect = 2e-30
 Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 35/246 (14%)

Query: 109 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----V 164
             +   A  +  +P+   D        +   +     +G+GG+   +   +         
Sbjct: 18  PGAPAAAPPAKEIPEVLVD------PRSRRRYVRGRFLGKGGFAKCF--EISDADTKEVF 69

Query: 165 AIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSL 218
           A K++    L  P    +   EI I   + H ++V   G   E    V+   E     SL
Sbjct: 70  AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSL 128

Query: 219 EDRLSCKDNSPPLS-WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
            +    +     L+  + R     ++     +LH    + ++H DLK  N+ L+ +   K
Sbjct: 129 LELHKRRK---ALTEPEAR-YYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVK 181

Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           + DFG++  +  +        LC      GT  Y+ PE L+    + + DV+S G I+  
Sbjct: 182 IGDFGLATKVEYD--GERKKVLC------GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233

Query: 338 LLTGRP 343
           LL G+P
Sbjct: 234 LLVGKP 239

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (301), Expect = 4e-30
 Identities = 71/321 (22%), Positives = 125/321 (38%), Gaps = 43/321 (13%)

Query: 100 KAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL 159
           K ++E E   + RK   +     Q   +    + E  +       ++G G  G ++K   
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKIS-------ELGAGNGGVVFKVSH 54

Query: 160 RHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGAC---PEVWTLVYE 211
           +     +A K++H      P+   Q   E+ +L +   P +V   GA     E+  +  E
Sbjct: 55  KPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-ICME 111

Query: 212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 271
           ++  GSL+  L     +  +  Q   +++  +   L +L     H I+H D+KP+NIL++
Sbjct: 112 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 166

Query: 272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 331
           +    KL DFG+S  L     S  N+ +       GT +YM PE L     + +SD++S 
Sbjct: 167 SRGEIKLCDFGVSGQLID---SMANSFV-------GTRSYMSPERLQGTHYSVQSDIWSM 216

Query: 332 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMS- 390
           G+ L+ +  GR  +      +  L  G             P      L    M       
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276

Query: 391 ---------RKSRPELGKDVW 402
                     +  P+L   V+
Sbjct: 277 IFELLDYIVNEPPPKLPSGVF 297

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  118 bits (298), Expect = 4e-30
 Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 39/219 (17%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 195
            +G G +G + +            M VA+KML P   L        E+ +LS +  H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 196 VTLVGAC--PEVWTLVYEYLPNGSLEDRL---------------SCKDNSPPLSWQTRIR 238
           V L+GAC       ++ EY   G L + L                 +D+   L  +  + 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
            + ++   + FL S      +H DL   NILL    ++K+ DFG++R +  +        
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG- 205

Query: 299 LCCRTDPKGTFAY--MDPEFLASGELTPKSDVYSFGIIL 335
                          M PE + +   T +SDV+S+GI L
Sbjct: 206 -------NARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  120 bits (302), Expect = 5e-30
 Identities = 32/295 (10%), Positives = 78/295 (26%), Gaps = 53/295 (17%)

Query: 92  DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSF-SEIEGATHNFDPSLKIGEGG 150
           +         V+   E  +S  ++  S+ +      F   SE+            +G+  
Sbjct: 31  ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 90

Query: 151 YGSIYKG--LLRHMQVAIKML----------------------------HPHSLQGPSEF 180
             +  +           + +                             +    +    F
Sbjct: 91  PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150

Query: 181 QQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLEDRL----SCKDNSPPLSW 233
               D++   +   ++ +     ++W L           +L+       S       L  
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210

Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 293
             R+++  ++  +L  LH    + +VH  L+P +I+LD      L+ F            
Sbjct: 211 HARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-------R 260

Query: 294 SNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRP 343
              + +                 L         +T   D ++ G+ +  +     
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  119 bits (299), Expect = 7e-30
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 41/273 (15%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 196
            +G G +G +Y+G +         +QVA+K L    S Q   +F  E  I+SK  H N+V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 197 TLVGACPEV--WTLVYEYLPNGSLEDRL----SCKDNSPPLSWQTRIRIATELCSVLIFL 250
             +G   +     ++ E +  G L+  L            L+    + +A ++     +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 251 HSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
                +  +H D+   N LL       V+K+ DFG++R + +            R     
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------YYRKGGCA 246

Query: 308 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 362
                +M PE    G  T K+D +SFG++L  + +    P    + +EV   + +G    
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---G 303

Query: 363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
            +DP     P      +  +  +C +   + RP
Sbjct: 304 RMDP-----PKNCPGPVYRIMTQCWQHQPEDRP 331

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  116 bits (294), Expect = 1e-29
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 40/218 (18%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 196
           ++GE  +G +YKG L           VAIK L          EF+ E  + ++++HPN+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 197 TLVGAC----PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRI 239
            L+G      P   ++++ Y  +G L + L               +     L     + +
Sbjct: 76  CLLGVVTKDQP--LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
             ++ + + +L S   H +VH DL   N+L+      K+SD G+ R +   +        
Sbjct: 134 VAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY------- 183

Query: 300 CCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 335
             +          +M PE +  G+ +  SD++S+G++L
Sbjct: 184 -YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  116 bits (293), Expect = 2e-29
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           KIG+G  G++Y  +      +VAI+ ++            EI ++ + ++PN+V  + + 
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               E+W +V EYL  GSL D ++       +       +  E    L FLHS   + ++
Sbjct: 87  LVGDELW-VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 138

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H D+K  NILL  +   KL+DFG    ++  E S  +T +       GT  +M PE +  
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-------GTPYWMAPEVVTR 190

Query: 320 GELTPKSDVYSFGIILLRLLTGRP 343
               PK D++S GI+ + ++ G P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEP 214

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (295), Expect = 2e-29
 Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 39/219 (17%)

Query: 145 KIGEGGYGSIYKGLLRH---------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 193
            +GEG +G +                + VA+KML    + +  S+   E++++  I +H 
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 194 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 238
           N++ L+GAC       ++ EY   G+L + L               +     ++++  + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
              +L   + +L S K    +H DL   N+L+  N V K++DFG++R ++  +     T 
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT- 217

Query: 299 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 335
                   G     +M PE L     T +SDV+SFG+++
Sbjct: 218 -------NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  116 bits (293), Expect = 2e-29
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           KIGEG  G +     +H   QVA+KM+     Q       E+ I+   +H N+V +  + 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111

Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               E+W ++ E+L  G+L D +S       L+ +    +   +   L +LH+     ++
Sbjct: 112 LVGEELW-VLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHA---QGVI 163

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H D+K  +ILL  +   KLSDFG    +S  ++    + +       GT  +M PE ++ 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLV-------GTPYWMAPEVISR 215

Query: 320 GELTPKSDVYSFGIILLRLLTGRP 343
                + D++S GI+++ ++ G P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEP 239

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  116 bits (293), Expect = 2e-29
 Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 36/238 (15%)

Query: 145 KIGEGGYGSIYKGLLR----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNLVTL 198
            IGEG +G + K  ++     M  AIK +    S     +F  E+++L K+  HPN++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 199 VGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRIATEL 243
           +GAC       L  EY P+G+L D L                  +  LS Q  +  A ++
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
              + +L        +H DL   NIL+  N+V+K++DFG+SR   +  +      L  R 
Sbjct: 152 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGRLPVR- 206

Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 358
                  +M  E L     T  SDV+S+G++L  +++  G P  G+T  E+   L  G
Sbjct: 207 -------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  116 bits (292), Expect = 3e-29
 Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 42/245 (17%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 195
            +G G +G + +              VA+KML    +         E+ IL  I  H N+
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 196 VTLVGACPEV---WTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRI 239
           V L+GAC +      ++ E+   G+L   L                     L+ +  I  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           + ++   + FL S K    +H DL   NILL    V K+ DFG++R + ++         
Sbjct: 154 SFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-- 208

Query: 300 CCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT-GR---PALGITKEVQY 353
                        +M PE +     T +SDV+SFG++L  + + G    P + I +E   
Sbjct: 209 ------DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262

Query: 354 ALDTG 358
            L  G
Sbjct: 263 RLKEG 267

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  117 bits (294), Expect = 3e-29
 Identities = 33/288 (11%), Positives = 79/288 (27%), Gaps = 63/288 (21%)

Query: 104 EAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-- 161
            +E ++ +     S+S           SE+            +G+    +  +   +   
Sbjct: 39  TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98

Query: 162 MQVAIKML----------------------------HPHSLQGPSEFQQEIDILSKIRHP 193
               + +                             +    +    F    D++   +  
Sbjct: 99  ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158

Query: 194 NLVTLVGACPEVWTLVY---EYLPNGSLEDRL----SCKDNSPPLSWQTRIRIATELCSV 246
            ++ +     ++W L           +L+       S       L    R+++  ++  +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L  LH    + +VH  L+P +I+LD      L+ F                    R    
Sbjct: 219 LASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------------RVVSS 263

Query: 307 GTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRP 343
            +  +  PE  A              +T   D ++ G+++  +     
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  117 bits (294), Expect = 5e-29
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 39/219 (17%)

Query: 145 KIGEGGYGSIYKGLLR---------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 193
            +GEG +G +                 +VA+KML    + +  S+   E++++  I +H 
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 194 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 238
           N++ L+GAC       ++ EY   G+L + L                +    LS +  + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
            A ++   + +L S K    +H DL   N+L+  + V K++DFG++R +   +       
Sbjct: 196 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY------ 246

Query: 299 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 335
              +    G     +M PE L     T +SDV+SFG++L
Sbjct: 247 --YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  117 bits (296), Expect = 6e-29
 Identities = 58/262 (22%), Positives = 98/262 (37%), Gaps = 41/262 (15%)

Query: 145 KIGEGGYGSI-YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 202
            +G G  G++ ++G  +   VA+K +             EI +L++   HPN++    + 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSE 78

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL----CSVLIFLHSCKPH 256
                  +  E   N +L+D +  K+ S       +      L     S +  LHS    
Sbjct: 79  TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134

Query: 257 SIVHGDLKPANILLD-------------ANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
            I+H DLKP NIL+               N    +SDFG+ + L   + S          
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL----N 190

Query: 304 DPKGTFAYMDPEFLASGE-------LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 355
           +P GT  +  PE L           LT   D++S G +   +L+ G+   G     +  +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250

Query: 356 DTGKLKNLLDPLAGDWPFVQAE 377
             G   +L +        + AE
Sbjct: 251 IRGIF-SLDEMKCLHDRSLIAE 271

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  115 bits (289), Expect = 6e-29
 Identities = 57/230 (24%), Positives = 109/230 (47%), Gaps = 32/230 (13%)

Query: 131 SEIEGATHNFDPSL------KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ 182
            E E    + DP+       ++G+G +G +YK   +      A K++   S +   ++  
Sbjct: 6   REYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV 65

Query: 183 EIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR- 238
           EI+IL+   HP +V L+GA     ++W ++ E+ P G+++  +   +    L+ + +I+ 
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLW-IMIEFCPGGAVDAIM--LELDRGLT-EPQIQV 121

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
           +  ++   L FLHS     I+H DLK  N+L+      +L+DFG+S       +   ++ 
Sbjct: 122 VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSF 177

Query: 299 LCCRTDPKGTFAYMDPEFLASGELT-----PKSDVYSFGIILLRLLTGRP 343
           +       GT  +M PE +    +       K+D++S GI L+ +    P
Sbjct: 178 I-------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  114 bits (288), Expect = 7e-29
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 201
           K+G G +G ++    R   ++  IK ++    Q P E  + EI++L  + HPN++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 202 C--PEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                   +V E    G L +R+         LS      +  ++ + L + HS     +
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145

Query: 259 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH DLKP NIL      +   K+ DFG++     +E S   T         GT  YM PE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAA------GTALYMAPE 196

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
                ++T K D++S G+++  LLTG  
Sbjct: 197 VF-KRDVTFKCDIWSAGVVMYFLLTGCL 223

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  116 bits (293), Expect = 7e-29
 Identities = 56/262 (21%), Positives = 104/262 (39%), Gaps = 32/262 (12%)

Query: 88  KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 147
           K        + +   K  E++ K              +  +   E            ++G
Sbjct: 13  KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILE------------ELG 60

Query: 148 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--P 203
            G +G +++ + +        K ++          + EI I++++ HP L+ L  A    
Sbjct: 61  SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120

Query: 204 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 263
               L+ E+L  G L DR++ +D    +S    I    + C  L  +H    HSIVH D+
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHE---HSIVHLDI 175

Query: 264 KPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           KP NI+ +    S  K+ DFG++  L+ +EI               T  +  PE +    
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTT------ATAEFAAPEIVDREP 226

Query: 322 LTPKSDVYSFGIILLRLLTGRP 343
           +   +D+++ G++   LL+G  
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLS 248

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  115 bits (290), Expect = 7e-29
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 35/215 (16%)

Query: 145 KIGEGGYGSIYKGLLR-------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 195
            +G G +G + +            ++VA+KML              E+ I+S + +H N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 196 VTLVGAC--PEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATE 242
           V L+GAC       ++ EY   G L           E   +    +   S +  +  +++
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLC 300
           +   + FL S    + +H D+   N+LL    V+K+ DFG++R +  +   I   N  L 
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 335
            +        +M PE +     T +SDV+S+GI+L
Sbjct: 230 VK--------WMAPESIFDCVYTVQSDVWSYGILL 256

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  117 bits (296), Expect = 8e-29
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 26/209 (12%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLV 199
            +G+G +G +     +    + A+K++    ++  ++     +E+ +L ++ HPN++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
                   + LV E    G L D +  +      S     RI  ++ S + ++H    + 
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHK---NK 146

Query: 258 IVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
           IVH DLKP N+LL     +   ++ DFG+S     ++            D  GT  Y+ P
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---------MKDKIGTAYYIAP 197

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E L  G    K DV+S G+IL  LL+G P
Sbjct: 198 EVL-HGTYDEKCDVWSTGVILYILLSGCP 225

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  114 bits (288), Expect = 9e-29
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 23/206 (11%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 201
            +G G +  ++    R      A+K +        S  + EI +L KI+H N+VTL    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 202 -CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                + LV + +  G L DR+  +      + +    +  ++ S + +LH    + IVH
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHE---NGIVH 129

Query: 261 GDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP N+L    + N    ++DFG+S+      +    +T C      GT  Y+ PE L
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STAC------GTPGYVAPEVL 179

Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
           A    +   D +S G+I   LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYP 205

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  114 bits (288), Expect = 1e-28
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 44/224 (19%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 196
            +GEG +G + K    H         VA+KML    S     +   E ++L ++ HP+++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRL---------------------SCKDNSPPLSW 233
            L GAC       L+ EY   GSL   L                         +   L+ 
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 293
              I  A ++   + +L   K   +VH DL   NIL+      K+SDFG+SR + + +  
Sbjct: 150 GDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206

Query: 294 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 335
              +        +G     +M  E L     T +SDV+SFG++L
Sbjct: 207 VKRS--------QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  118 bits (297), Expect = 1e-28
 Identities = 53/262 (20%), Positives = 106/262 (40%), Gaps = 20/262 (7%)

Query: 88  KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 147
           +K +    ++    +   +    S  +        Q++      + +    ++D   ++G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166

Query: 148 EGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--P 203
            G +G +++   R      A K +           ++EI  +S +RHP LV L  A    
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226

Query: 204 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 263
               ++YE++  G L ++++ + N   +S    +    ++C  L  +H    ++ VH DL
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE---NNYVHLDL 281

Query: 264 KPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           KP NI+      +  KL DFG++  L   +               GT  +  PE      
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTT------GTAEFAAPEVAEGKP 332

Query: 322 LTPKSDVYSFGIILLRLLTGRP 343
           +   +D++S G++   LL+G  
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLS 354

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  115 bits (290), Expect = 1e-28
 Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 26/271 (9%)

Query: 85  QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF---- 140
           Q+ +   +E +     A        KS++ ++ +  +P   + F    +           
Sbjct: 30  QDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFY 89

Query: 141 --DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 196
               +  +G G +G ++K       +++A K++    ++   E + EI +++++ H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 197 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            L  A        LV EY+  G L DR+  +  +  L+    I    ++C  +  +H   
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ-- 205

Query: 255 PHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
              I+H DLKP NIL         K+ DFG++R     E               GT  ++
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNF------GTPEFL 255

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE +    ++  +D++S G+I   LL+G  
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  113 bits (286), Expect = 1e-28
 Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 19/211 (9%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGA 201
            IG G    +       +  +VAIK ++    Q    E  +EI  +S+  HPN+V+   +
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 202 ---CPEVWTLVYEYLPNGSLED--RLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSC 253
                E+W LV + L  GS+ D  +                 IAT   E+   L +LH  
Sbjct: 82  FVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
             +  +H D+K  NILL  +   +++DFG+S FL+      + T    R    GT  +M 
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT---GGDITRNKVRKTFVGTPCWMA 194

Query: 314 PEFLASGEL-TPKSDVYSFGIILLRLLTGRP 343
           PE +        K+D++SFGI  + L TG  
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAA 225

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  114 bits (287), Expect = 1e-28
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+GEG YGS+YK + +     VAIK +         E  +EI I+ +   P++V   G+ 
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               ++W +V EY   GS+ D +  +  +  L+      I       L +LH       +
Sbjct: 94  FKNTDLW-IVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF---MRKI 147

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H D+K  NILL+    +KL+DFG++  L+ + ++  NT +       GT  +M PE +  
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLT-DTMAKRNTVI-------GTPFWMAPEVIQE 199

Query: 320 GELTPKSDVYSFGIILLRLLTGRP 343
                 +D++S GI  + +  G+P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKP 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (295), Expect = 2e-28
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 25/208 (12%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 200
           K+G G YG +     +  H++ AIK++   S+   S     +E+ +L  + HPN++ L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103

Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                  + LV E    G L D +  +      +      I  ++ S + +LH    H+I
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHK---HNI 157

Query: 259 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH DLKP N+LL   + + + K+ DFG+S      +            +  GT  Y+ PE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---------MKERLGTAYYIAPE 208

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L   +   K DV+S G+IL  LL G P
Sbjct: 209 VL-RKKYDEKCDVWSIGVILFILLAGYP 235

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  115 bits (291), Expect = 2e-28
 Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 38/241 (15%)

Query: 125 FSDFSFSEIEGATHNF----DPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS 178
           F D +  +              S  +G G  G +     R    +VAI+++        S
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177

Query: 179 E--------FQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNS 228
                     + EI+IL K+ HP ++ +       + + +V E +  G L D++      
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR- 235

Query: 229 PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISR 285
             L   T      ++   + +LH    + I+H DLKP N+LL   + + + K++DFG S+
Sbjct: 236 --LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290

Query: 286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL---TPKSDVYSFGIILLRLLTGR 342
            L +  +     TLC      GT  Y+ PE L S          D +S G+IL   L+G 
Sbjct: 291 ILGETSLM---RTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341

Query: 343 P 343
           P
Sbjct: 342 P 342

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  113 bits (286), Expect = 2e-28
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGA 201
           KIG+G +G ++KG+    Q  VAIK++     +    + QQEI +LS+   P +    G+
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 202 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                ++W ++ EYL  GS  D L       PL       I  E+   L +LHS      
Sbjct: 89  YLKDTKLW-IIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHS---EKK 140

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H D+K AN+LL  +   KL+DFG++  L+       NT +       GT  +M PE + 
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFV-------GTPFWMAPEVIK 192

Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
                 K+D++S GI  + L  G P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEP 217

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  114 bits (287), Expect = 2e-28
 Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 44/224 (19%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 195
            +G G +G +              +QVA+KML              E+ +++++  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 196 VTLVGAC--PEVWTLVYEYLPNGSL--------------------EDRLSCKDNSPPLSW 233
           V L+GAC       L++EY   G L                    + RL  +++   L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 293
           +  +  A ++   + FL        VH DL   N+L+    V K+ DFG++R +  +   
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228

Query: 294 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 335
                              +M PE L  G  T KSDV+S+GI+L
Sbjct: 229 VVRG--------NARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  114 bits (288), Expect = 2e-28
 Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 39/219 (17%)

Query: 145 KIGEGGYGSIYKGLLRH---------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 193
            +GEG +G +                + VA+KML    + +  S+   E++++  I +H 
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 194 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 238
           N++ L+GAC       ++ EY   G+L + L               +     ++++  + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
              +L   + +L S K    +H DL   N+L+  N V K++DFG++R ++  +       
Sbjct: 208 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY------ 258

Query: 299 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 335
              +    G     +M PE L     T +SDV+SFG+++
Sbjct: 259 --YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (287), Expect = 4e-28
 Identities = 46/243 (18%), Positives = 80/243 (32%), Gaps = 23/243 (9%)

Query: 115 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEG--GYGSIYKGLLRHMQ--VAIKM-- 168
           A    H  +       S        ++    IG+G     ++     +     V ++   
Sbjct: 2   AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61

Query: 169 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA---CPEVWTLVYEYLPNGSLEDRLSCK 225
           L   S +  +  Q E+ +     HPN+V          E+W +V  ++  GS +D +   
Sbjct: 62  LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW-VVTSFMAYGSAKDLICTH 120

Query: 226 DNSPPLSWQTRIRIATELCSVLI---FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 282
                      + IA  L  VL    ++H       VH  +K ++IL+  +    LS   
Sbjct: 121 FMDG----MNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLR 173

Query: 283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLT 340
            +  +  +                    ++ PE L         KSD+YS GI    L  
Sbjct: 174 SNLSMI-SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232

Query: 341 GRP 343
           G  
Sbjct: 233 GHV 235

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  113 bits (284), Expect = 5e-28
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 28/207 (13%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTL- 198
           IG+G +  +     RH+    +VAIK++    L   S     +E+ I+  + HPN+V L 
Sbjct: 23  IGKGNFAKVKLA--RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 199 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            V    +   L+ EY   G + D L        +  +       ++ S + + H      
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---KR 134

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           IVH DLK  N+LLDA+   K++DFG S   +           C      G   Y  PE  
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---AFC------GAPPYAAPELF 185

Query: 318 ASGEL--TPKSDVYSFGIILLRLLTGR 342
             G+    P+ DV+S G+IL  L++G 
Sbjct: 186 -QGKKYDGPEVDVWSLGVILYTLVSGS 211

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  111 bits (279), Expect = 8e-28
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
            IG G +G +   + +   ++ A K +  + ++    F+QEI+I+  + HPN++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                  LV E    G L +R+  K            RI  ++ S + + H     ++ H
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHK---LNVAH 129

Query: 261 GDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            DLKP N L      +   KL DFG++      ++     T        GT  Y+ P+ L
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKV------GTPYYVSPQVL 180

Query: 318 ASGELTPKSDVYSFGIILLRLLTGRP 343
             G   P+ D +S G+++  LL G P
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLCGYP 205

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  111 bits (280), Expect = 8e-28
 Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 66/240 (27%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEF--------------------- 180
           IG+G YG +      +       A+K+L    L   + F                     
Sbjct: 21  IGKGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 181 -----QQEIDILSKIRHPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDN 227
                 QEI IL K+ HPN+V LV    EV          +V+E +  G + +  + K  
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLK-- 132

Query: 228 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 287
             PLS         +L   + +LH      I+H D+KP+N+L+  +   K++DFG+S   
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS--- 184

Query: 288 SQNEISSNNTTL--CCRTDPKGTFAYMDPEFLASGELT---PKSDVYSFGIILLRLLTGR 342
             NE   ++  L         GT A+M PE L+           DV++ G+ L   + G+
Sbjct: 185 --NEFKGSDALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  114 bits (288), Expect = 1e-27
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTLVG 200
            +G+G +G + K   R    + A+K+++  S +    S   +E+++L K+ HPN++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                  + +V E    G L D +  +      S     RI  ++ S + ++H    H+I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNI 142

Query: 259 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH DLKP NILL   + +   K+ DFG+S    QN                GT  Y+ PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI------GTAYYIAPE 193

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L  G    K DV+S G+IL  LL+G P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTP 220

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  114 bits (288), Expect = 1e-27
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS-------------EFQQEIDILSK 189
           K+G G YG +     +  H + AIK++                      E   EI +L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 190 IRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           + HPN++ L       + + LV E+   G L +++  +             I  ++ S +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGI 159

Query: 248 IFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
            +LH    H+IVH D+KP NILL   ++    K+ DFG+S F S++              
Sbjct: 160 CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRL---- 209

Query: 305 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             GT  Y+ PE L   +   K DV+S G+I+  LL G P
Sbjct: 210 --GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  112 bits (281), Expect = 2e-27
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 44/224 (19%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 196
            IGEG +G +++              VA+KML    S    ++FQ+E  ++++  +PN+V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 197 TLVGACPEV--WTLVYEYLPNGSLEDRL---------------------SCKDNSPPLSW 233
            L+G C       L++EY+  G L + L                           PPLS 
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 293
             ++ IA ++ + + +L        VH DL   N L+  N V K++DFG+SR +   +  
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY- 229

Query: 294 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 335
                   + D        +M PE +     T +SDV+++G++L
Sbjct: 230 -------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  110 bits (278), Expect = 2e-27
 Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 41/218 (18%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVT 197
           +GEG YG + +          + A+K+L    L+     +     EI +L ++RH N++ 
Sbjct: 13  LGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 198 LVGACPEVWT--------LVYEYLPNGSLE--DRLSCKDNSPPLS-WQTRIRIATELCSV 246
           LV    +V          +V EY   G  E  D +  K         Q       +L   
Sbjct: 71  LV----DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAH-GYFCQLIDG 121

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           L +LHS     IVH D+KP N+LL      K+S  G++  L          T        
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ------ 172

Query: 307 GTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR 342
           G+ A+  PE     +     K D++S G+ L  + TG 
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  111 bits (279), Expect = 2e-27
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 34/217 (15%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--------FQQEIDILSKIRHPN 194
            +G G  G +     R    +VAIK++        S          + EI+IL K+ HP 
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 195 LVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           ++ +       + + +V E +  G L D++        L   T      ++   + +LH 
Sbjct: 77  IIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHE 132

Query: 253 CKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
              + I+H DLKP N+LL   + + + K++DFG S+ L +  +     TLC      GT 
Sbjct: 133 ---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLC------GTP 180

Query: 310 AYMDPEFLASGEL---TPKSDVYSFGIILLRLLTGRP 343
            Y+ PE L S          D +S G+IL   L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (276), Expect = 5e-27
 Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 35/246 (14%)

Query: 117 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPH 172
           +S    +   +   S +      F+    +G G YG +YKG  RH++     AIK++   
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVT 60

Query: 173 SLQGPSEFQQEIDILSKI-RHPNLVTLVGA---------CPEVWTLVYEYLPNGSLEDRL 222
                 E +QEI++L K   H N+ T  GA           ++W LV E+   GS+ D +
Sbjct: 61  G-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLI 118

Query: 223 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 282
                +          I  E+   L  LH    H ++H D+K  N+LL  N   KL DFG
Sbjct: 119 KNTKGNTLKEEWIAY-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174

Query: 283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-----PKSDVYSFGIILLR 337
           +S  L    +   NT +       GT  +M PE +A  E        KSD++S GI  + 
Sbjct: 175 VSAQLD-RTVGRRNTFI-------GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

Query: 338 LLTGRP 343
           +  G P
Sbjct: 227 MAEGAP 232

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  108 bits (273), Expect = 5e-27
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G G +G +  G   H     +VA+K+L+   ++      +   EI  L   RHP+++ L
Sbjct: 19  LGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 199 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             V + P  + +V EY+  G L D +        +      R+  ++ S + + H    H
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---H 130

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            +VH DLKP N+LLDA+  +K++DFG+S  +S  E      T C      G+  Y  PE 
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC------GSPNYAAPEV 181

Query: 317 LASGEL--TPKSDVYSFGIILLRLLTGR 342
           + SG L   P+ D++S G+IL  LL G 
Sbjct: 182 I-SGRLYAGPEVDIWSCGVILYALLCGT 208

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (273), Expect = 6e-27
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 200
            +G+G +G + K   R    + A+K+++  S +        +E+++L K+ HPN++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                  + +V E    G L D +  +      S     RI  ++ S + ++H    H+I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNI 142

Query: 259 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH DLKP NILL   + +   K+ DFG+S    QN                GT  Y+ PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI------GTAYYIAPE 193

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L  G    K DV+S G+IL  LL+G P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTP 220

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  109 bits (275), Expect = 7e-27
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 196
           ++G G +  + K   +   ++ A K +     +         E ++E+ IL ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 197 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           TL           L+ E +  G L D L+ K++   LS +       ++   + +LH+  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT-- 133

Query: 255 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              I H DLKP NI+L          KL DFG++  +           +       GT  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF------GTPE 183

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           ++ PE +    L  ++D++S G+I   LL+G  
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  108 bits (272), Expect = 8e-27
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 29/213 (13%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 196
           ++G G +  + K   +    + A K +    L          E ++E++IL +IRHPN++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           TL           L+ E +  G L D L+ K++   L+     +   ++   + +LHS  
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHS-- 126

Query: 255 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              I H DLKP NI+L      N   KL DFGI+  +           +       GT  
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF------GTPE 176

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           ++ PE +    L  ++D++S G+I   LL+G  
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  109 bits (274), Expect = 9e-27
 Identities = 57/214 (26%), Positives = 85/214 (39%), Gaps = 30/214 (14%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHP-HSLQGPSEFQQEIDI-LSKIRHPNLVTL 198
           +IG G YGS+ K    H      +A+K +      +   +   ++D+ +     P +V  
Sbjct: 29  EIGRGAYGSVNKM--VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86

Query: 199 VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 253
            GA     + W +  E + + S +       +         I  +I       L  L   
Sbjct: 87  YGALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE- 143

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               I+H D+KP+NILLD +   KL DFGIS  L  + I+             G   YM 
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDA--------GCRPYMA 193

Query: 314 PEFLASGELTP----KSDVYSFGIILLRLLTGRP 343
           PE +           +SDV+S GI L  L TGR 
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  107 bits (270), Expect = 2e-26
 Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 32/210 (15%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 200
           +GEG YG +   L  +      VA+K++         E  ++EI I   + H N+V    
Sbjct: 15  LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY- 71

Query: 201 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
                        L  EY   G L DR+        +      R   +L + +++LH   
Sbjct: 72  ---GHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 123

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y+ P
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVAP 176

Query: 315 EFLASGEL--TPKSDVYSFGIILLRLLTGR 342
           E L           DV+S GI+L  +L G 
Sbjct: 177 ELL-KRREFHAEPVDVWSCGIVLTAMLAGE 205

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  108 bits (272), Expect = 2e-26
 Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 9/175 (5%)

Query: 173 SLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP 230
           S         +I  +      N V  +        L    +     +L+D ++ + +   
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 231 LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 290
                 + I  ++   + FLHS     ++H DLKP+NI    + V K+ DFG+   + Q+
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 291 E----ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           E    + +        T   GT  YM PE +     + K D++S G+IL  LL  
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  107 bits (270), Expect = 2e-26
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 29/213 (13%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHP-HSLQGPSEFQQEIDI-LSKIRHPNLVTL 198
           ++G G YG + K   RH+     +A+K +    + Q       ++DI +  +  P  VT 
Sbjct: 14  ELGRGAYGVVEKM--RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71

Query: 199 VGAC---PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
            GA     +VW +  E + + SL+       D    +      +IA  +   L  LHS  
Sbjct: 72  YGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-- 127

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
             S++H D+KP+N+L++A    K+ DFGIS +L           +    D  G   YM P
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--------DDVAKDID-AGCKPYMAP 178

Query: 315 EFLASGELTP----KSDVYSFGIILLRLLTGRP 343
           E +           KSD++S GI ++ L   R 
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRF 211

>2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85

 Score =  100 bits (252), Expect = 3e-26
 Identities = 17/76 (22%), Positives = 28/76 (36%), Gaps = 1/76 (1%)

Query: 423 EERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV 482
            +  + P  F  P+   +M DP     G   +   +   L +   T P     L    L 
Sbjct: 6   IDYSDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSP-TDPFNRQMLTESMLE 64

Query: 483 PNLALRSAIQEWLQQH 498
           P   L+  IQ W+++ 
Sbjct: 65  PVPELKEQIQAWMREK 80

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  106 bits (267), Expect = 4e-26
 Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 200
           ++G+G +  + + + +   ++ A K+++   L        ++E  I  K++HPN+V L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           +        LV++ +  G L + +  ++     S         ++   + + HS   + I
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHS---NGI 126

Query: 259 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH +LKP N+LL         KL+DFG++  ++ +E               GT  Y+ PE
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFA------GTPGYLSPE 177

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L     +   D+++ G+IL  LL G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYP 205

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (268), Expect = 5e-26
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 27/211 (12%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHP-HSLQGPSEFQQEIDILSK-IRHPNLVTLVG 200
           ++G G  G ++K   R     +A+K +    + +       ++D++ K    P +V   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 201 AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
                 +V+ +  E +     E     K    P+  +   ++   +   L +L     H 
Sbjct: 92  TFITNTDVF-IAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           ++H D+KP+NILLD     KL DFGIS  L  ++ + + +         G  AYM PE +
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSA--------GCAAYMAPERI 196

Query: 318 ASGEL-----TPKSDVYSFGIILLRLLTGRP 343
              +        ++DV+S GI L+ L TG+ 
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQF 227

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  106 bits (268), Expect = 7e-26
 Identities = 44/207 (21%), Positives = 88/207 (42%), Gaps = 25/207 (12%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
            +G G +G +++ +          K +           ++EI IL+  RH N++ L  + 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
              E   +++E++    + +R++       L+ +  +    ++C  L FLHS   H+I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 261 GDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            D++P NI+      +    K+ +FG +R L   +       L           Y  PE 
Sbjct: 126 FDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNF---RLLF------TAPEYYAPEV 174

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
                ++  +D++S G ++  LL+G  
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGIN 201

>2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100

 Score =  100 bits (251), Expect = 7e-26
 Identities = 17/82 (20%), Positives = 28/82 (34%), Gaps = 1/82 (1%)

Query: 417 SYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPL 476
                  +  + P  F  P+   +M DP     G   +   +   L +   T P     L
Sbjct: 15  KNARAEIDYSDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSP-TDPFNRQTL 73

Query: 477 AHKNLVPNLALRSAIQEWLQQH 498
               L P   L+  IQ W+++ 
Sbjct: 74  TESMLEPVPELKEQIQAWMREK 95

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  107 bits (269), Expect = 8e-26
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 29/213 (13%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 196
           ++G G +  + K   +   ++ A K +     +         E ++E+ IL ++ HPN++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 197 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           TL           L+ E +  G L D L+ K++   LS +       ++   + +LH+  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT-- 133

Query: 255 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              I H DLKP NI+L          KL DFG++  +           +       GT  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF------GTPE 183

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           ++ PE +    L  ++D++S G+I   LL+G  
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (268), Expect = 8e-26
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 29/213 (13%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 196
           ++G G +  + K   +   +Q A K +     +         + ++E+ IL +I+HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 197 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           TL           L+ E +  G L D L+ K++   L+ +       ++ + + +LHS  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHS-- 132

Query: 255 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              I H DLKP NI+L          K+ DFG++  +           +       GT  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF------GTPE 182

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           ++ PE +    L  ++D++S G+I   LL+G  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  106 bits (267), Expect = 8e-26
 Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 32/210 (15%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 200
           +GEG YG +   L  +      VA+K++         E  ++EI I   + H N+V    
Sbjct: 15  LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY- 71

Query: 201 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
                        L  EY   G L DR+        +      R   +L + +++LH   
Sbjct: 72  ---GHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 123

Query: 255 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
              I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y+ P
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVAP 176

Query: 315 EFLASGEL--TPKSDVYSFGIILLRLLTGR 342
           E L           DV+S GI+L  +L G 
Sbjct: 177 ELL-KRREFHAEPVDVWSCGIVLTAMLAGE 205

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  107 bits (268), Expect = 9e-26
 Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 64/283 (22%)

Query: 113 KEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLH 170
               SS     +F   S  E+      +     IG+G YG +   +        AIK+++
Sbjct: 4   HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 171 PHSLQGPSE-----FQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLS 223
            + ++  +       + E+ ++ K+ HPN+  L       +   LV E    G L D+L+
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120

Query: 224 CKDNSPPLSWQTRI-------------------------------------RIATELCSV 246
              +         +                                      I  ++ S 
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 247 LIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNN--TTLCCR 302
           L +LH+     I H D+KP N L   + +F  KL DFG+S+   +         TT    
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-- 235

Query: 303 TDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 343
               GT  ++ PE L +      PK D +S G++L  LL G  
Sbjct: 236 ----GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  107 bits (269), Expect = 9e-26
 Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 200
           ++G+G +  + + + +   ++ A K+++   L        ++E  I  K++HPN+V L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           +        LV++ +  G L + +  ++     S         ++   + + HS   + I
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHS---NGI 149

Query: 259 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH +LKP N+LL         KL+DFG++  ++ +E               GT  Y+ PE
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFA------GTPGYLSPE 200

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L     +   D+++ G+IL  LL G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYP 228

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (264), Expect = 1e-25
 Identities = 49/229 (21%), Positives = 85/229 (37%), Gaps = 45/229 (19%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQ---QEIDILSKI-RHPNLVTL 198
           KIG G +GS++K + R      AIK      L G  + Q   +E+   + + +H ++V  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 199 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
             A  E   +    EY   GSL D +S                +  ++   L ++HS   
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135

Query: 256 HSIVHGDLKPANILLDAN-------------------FVSKLSDFGISRFLSQNEISSNN 296
             +VH D+KP+NI +                       + K+ D G         ISS  
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-----RISSPQ 188

Query: 297 TTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTGRPA 344
                    +G   ++  E L  +    PK+D+++  + ++      P 
Sbjct: 189 VE-------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (263), Expect = 2e-25
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 35/219 (15%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---------FQQEIDILSKI-RH 192
            +G G    + + + +    + A+K++        S            +E+DIL K+  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 193 PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
           PN++ L         + LV++ +  G L D L+ K     LS +   +I   L  V+  L
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICAL 140

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           H     +IVH DLKP NILLD +   KL+DFG S  L   E       +C      GT +
Sbjct: 141 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVC------GTPS 188

Query: 311 YMDPEFLASGEL------TPKSDVYSFGIILLRLLTGRP 343
           Y+ PE +             + D++S G+I+  LL G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  104 bits (262), Expect = 3e-25
 Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 29/231 (12%)

Query: 135 GATHNFDPSLK---------IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQE 183
           G+T +F    +         +GEG +  +   +      + A+K++        S   +E
Sbjct: 1   GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60

Query: 184 IDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 240
           +++L + + H N++ L+      + + LV+E +  GS+   +  + +    +      + 
Sbjct: 61  VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---FNELEASVVV 117

Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNT 297
            ++ S L FLH+     I H DLKP NIL    +     K+ DF +   +  N   S  +
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174

Query: 298 TLCCRTDPKGTFAYMDPEFLASGELTPKS-----DVYSFGIILLRLLTGRP 343
           T    T P G+  YM PE + +            D++S G+IL  LL+G P
Sbjct: 175 TPELLT-PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (263), Expect = 5e-25
 Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 34/309 (11%)

Query: 54  DQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRK 113
              +    +   + +  + L               ++            K+  + +    
Sbjct: 10  GVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGT 69

Query: 114 EASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP 171
           E      M        ++  +     +DP   IG G    + + + R    + A+K++  
Sbjct: 70  ENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129

Query: 172 HSLQGPSE--------FQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSLED 220
            + +   E         ++E  IL ++  HP+++TL+ +        LV++ +  G L D
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD 189

Query: 221 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 280
            L+ K     LS +    I   L   + FLH+   ++IVH DLKP NILLD N   +LSD
Sbjct: 190 YLTEKVA---LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243

Query: 281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL------TPKSDVYSFGII 334
           FG S  L   E       LC      GT  Y+ PE L             + D+++ G+I
Sbjct: 244 FGFSCHLEPGEKL---RELC------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

Query: 335 LLRLLTGRP 343
           L  LL G P
Sbjct: 295 LFTLLAGSP 303

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  106 bits (266), Expect = 6e-25
 Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 23/208 (11%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 200
           ++G+G +  + + +      + A  +++   L        ++E  I   ++HPN+V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           +        L+++ +  G L + +  ++     S         ++   ++  H      +
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQ---MGV 131

Query: 259 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           VH +LKP N+LL         KL+DFG++  +   +               GT  Y+ PE
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFA------GTPGYLSPE 183

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            L         D+++ G+IL  LL G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYP 211

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  104 bits (261), Expect = 6e-25
 Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 23/209 (11%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRH-PNLVTLV 199
           ++G G +  + + + +    + A K L          +E   EI +L   +  P ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 200 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
                     L+ EY   G +       + +  +S    IR+  ++   + +LH    ++
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQ---NN 151

Query: 258 IVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
           IVH DLKP NILL         K+ DFG+SR +           +       GT  Y+ P
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIM------GTPEYLAP 202

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E L    +T  +D+++ GII   LLT   
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTS 231

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  104 bits (261), Expect = 7e-25
 Identities = 46/247 (18%), Positives = 94/247 (38%), Gaps = 30/247 (12%)

Query: 110 KSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIK 167
                      +     D  F ++      ++    IG+G +  + + + R    Q A+K
Sbjct: 2   SPGISGGGGGILDMADDDVLFEDV------YELCEVIGKGPFSVVRRCINRETGQQFAVK 55

Query: 168 M-----LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLED 220
           +               + ++E  I   ++HP++V L+       +  +V+E++    L  
Sbjct: 56  IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115

Query: 221 RLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVS 276
            +  + ++    S         ++   L + H    ++I+H D+KP  +LL   + +   
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPV 172

Query: 277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 336
           KL  FG++  L ++                GT  +M PE +         DV+  G+IL 
Sbjct: 173 KLGGFGVAIQLGES--GLVAGGRV------GTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

Query: 337 RLLTGRP 343
            LL+G  
Sbjct: 225 ILLSGCL 231

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  103 bits (260), Expect = 8e-25
 Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 35/214 (16%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKML------HPHSLQGPSEFQQEIDILSKIRH--P 193
           +G GG+GS+Y G    +     VAIK +          L   +    E+ +L K+     
Sbjct: 51  LGSGGFGSVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 194 NLVTL--VGACPEVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            ++ L      P+ + L+ E   P   L D ++ +     L  +       ++   +   
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 165

Query: 251 HSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 309
           H+     ++H D+K  NIL+D N    KL DFG    L         T         GT 
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFD------GTR 212

Query: 310 AYMDPEFLASGELT-PKSDVYSFGIILLRLLTGR 342
            Y  PE++         + V+S GI+L  ++ G 
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  103 bits (258), Expect = 2e-24
 Identities = 61/267 (22%), Positives = 112/267 (41%), Gaps = 26/267 (9%)

Query: 84  LQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPS 143
           + ++      + +  +    ++     +     ++S +P ++ D S    +  +  F+  
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGS--NRDALSDFFEVE 58

Query: 144 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 201
            ++G G    +Y+   +      A+K+L           + EI +L ++ HPN++ L   
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 202 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P   +LV E +  G L DR+  K      S +       ++   + +LH    + IV
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHE---NGIV 170

Query: 260 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           H DLKP N+L      +   K++DFG+S+ +    +     T+C      GT  Y  PE 
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVC------GTPGYCAPEI 221

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
           L      P+ D++S GII   LL G  
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFE 248

>1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98

 Score = 96.0 bits (239), Expect = 2e-24
 Identities = 22/77 (28%), Positives = 29/77 (37%), Gaps = 2/77 (2%)

Query: 423 EERCEPPPYFTCPIFQEVMQDPHVAADG-FTYEAEALKGWLDSGHETSPMTNLPLAHKNL 481
           E   +    F  PI   +M DP V      T +   +   L S   T P    PL    +
Sbjct: 14  ETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQ-TDPFNRSPLTMDQI 72

Query: 482 VPNLALRSAIQEWLQQH 498
            PN  L+  IQ WL + 
Sbjct: 73  RPNTELKEKIQRWLAER 89

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  101 bits (253), Expect = 3e-24
 Identities = 34/208 (16%), Positives = 56/208 (26%), Gaps = 54/208 (25%)

Query: 145 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 197
             G       ++     L R  QVA+  + P  +       E       LS+I  P +  
Sbjct: 38  FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 198 L--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           +  V        +V E++  GSL++       + P      IR    L +     H    
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGA-IRAMQSLAAAADAAHR--- 147

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +      P+ + +  +    L                               A M   
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVL----------------------------AYPATMPDA 179

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
                   P+ D+   G  L  LL  R 
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRW 200

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  104 bits (261), Expect = 3e-24
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 37/212 (17%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +G G +G +  G  +H     +VA+K+L+   ++      +   EI  L   RHP+++ L
Sbjct: 24  LGVGTFGKVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 199 VGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
                +V +      +V EY+  G L D +        L  +   R+  ++ S + + H 
Sbjct: 82  Y----QVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHR 134

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
              H +VH DLKP N+LLDA+  +K++DFG+S  +S  E      T C      G+  Y 
Sbjct: 135 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC------GSPNYA 182

Query: 313 DPEFLASGEL--TPKSDVYSFGIILLRLLTGR 342
            PE + SG L   P+ D++S G+IL  LL G 
Sbjct: 183 APEVI-SGRLYAGPEVDIWSSGVILYALLCGT 213

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  102 bits (255), Expect = 4e-24
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 31/211 (14%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 201
            +G G  G + +   R    + A+K+L+          +QE+D   +    P++V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDV 90

Query: 202 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
              +        ++ E +  G L  R+  + +    + +    I  ++ + + FLHS   
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHS--- 146

Query: 256 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
           H+I H D+KP N+L    + + V KL+DFG ++  +QN +     T C       T  Y+
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPC------YTPYYV 196

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE L   +     D++S G+I+  LL G P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (255), Expect = 5e-24
 Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 36/213 (16%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKML---HPHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++Y          VAIK +      S +   +  +E+  L K+RHPN +   
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 200 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSC 253
           G        W LV EY   GS  D L  + +  PL     + IA         L +LHS 
Sbjct: 121 GCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPL---QEVEIAAVTHGALQGLAYLHS- 172

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
             H+++H D+K  NILL    + KL DFG +            + +       GT  +M 
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA------------SIMAPANSFVGTPYWMA 218

Query: 314 PEFLAS---GELTPKSDVYSFGIILLRLLTGRP 343
           PE + +   G+   K DV+S GI  + L   +P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  101 bits (254), Expect = 6e-24
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 30/208 (14%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +GEG +G +      H     +VA+K +    L+      +   EI  L  +RHP+++ L
Sbjct: 17  LGEGSFGKVKLA--THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 199 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             V   P    +V EY   G L D +  K     ++     R   ++   + + H    H
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHR---H 127

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            IVH DLKP N+LLD N   K++DFG+S  ++         T C      G+  Y  PE 
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK---TSC------GSPNYAAPEV 178

Query: 317 LASGEL--TPKSDVYSFGIILLRLLTGR 342
           + +G+L   P+ DV+S GI+L  +L GR
Sbjct: 179 I-NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  101 bits (253), Expect = 8e-24
 Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 35/214 (16%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKM-----LHPHSLQGPSEFQQ---EIDILSKIRHP 193
           +G G +G ++           +V +K      +         +  +   EI ILS++ H 
Sbjct: 32  LGSGAFGFVWTA--VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 194 NLVTL--VGACPEVWTLVYEYLPNGS-LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
           N++ +  +      + LV E   +G  L   +        L       I  +L S + +L
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYL 146

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
                  I+H D+K  NI++  +F  KL DFG + +L + ++     T C      GT  
Sbjct: 147 RL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY---TFC------GTIE 194

Query: 311 YMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR 342
           Y  PE L  G     P+ +++S G+ L  L+   
Sbjct: 195 YCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEE 227

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =   99 bits (250), Expect = 1e-23
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 198
           +GEG + ++   L R +      AIK+L    +   ++      E D++S++ HP  V L
Sbjct: 38  LGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 199 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
                  E       Y  NG L   +  K  S   +  TR   A E+ S L +LH     
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDET-CTRFYTA-EIVSALEYLHG---K 149

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
            I+H DLKP NILL+ +   +++DFG ++ LS     +   +        GT  Y+ PE 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTAQYVSPEL 203

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
           L        SD+++ G I+ +L+ G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 37/216 (17%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKML------HPHSLQGPSEFQQEIDILSKIR---- 191
           +G+GG+G+++ G    +    QVAIK++          L        E+ +L K+     
Sbjct: 39  LGKGGFGTVFAG--HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 192 HPNLVTL--VGACPEVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
           HP ++ L       E + LV E  LP   L D ++ K     L          ++ + + 
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQ 153

Query: 249 FLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
             HS     +VH D+K  NIL+D     +KL DFG    L         T         G
Sbjct: 154 HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFD------G 200

Query: 308 TFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGR 342
           T  Y  PE+++  +     + V+S GI+L  ++ G 
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 25/207 (12%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGA 201
            +GEG +    K + +  +   A+K++           Q+EI  L     HPN+V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74

Query: 202 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                   LV E L  G L +R+  K +    S      I  +L S +  +H      +V
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHMHD---VGVV 128

Query: 260 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           H DLKP N+L    + N   K+ DFG +R         +N  L     P  T  Y  PE 
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARL-----KPPDNQPL---KTPCFTLHYAAPEL 180

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRP 343
           L         D++S G+IL  +L+G+ 
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQV 207

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 29/209 (13%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSK-IRHPNLVTLVGA 201
            IG G Y    + + +  +M+ A+K++            +EI+IL +  +HPN++TL   
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84

Query: 202 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +   +V E +  G L D++  +      S +    +   +   + +LH+     +V
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA---QGVV 138

Query: 260 HGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
           H DLKP+NIL      +   + ++ DFG ++ L          T C       T  ++ P
Sbjct: 139 HRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAEN--GLLMTPC------YTANFVAP 189

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRP 343
           E L         D++S G++L  +LTG  
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYT 218

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 30/211 (14%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 201
            +G G  G + +   +    + A+KML           ++E+++  +  + P++V +V  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123

Query: 202 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
              ++       +V E L  G L  R+  + +    + +    I   +   + +LHS   
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS--- 179

Query: 256 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
            +I H D+KP N+L      N + KL+DFG ++  + +      TT C       T  Y+
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPC------YTPYYV 230

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE L   +     D++S G+I+  LL G P
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 57/207 (27%), Positives = 83/207 (40%), Gaps = 29/207 (14%)

Query: 146 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 199
           IG G +G     L+R       VA+K +   +       Q+EI     +RHPN+V    V
Sbjct: 28  IGSGNFGVAR--LMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEV 84

Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P    ++ EY   G L +R+         S         +L S + + HS     I 
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHS---MQIC 138

Query: 260 HGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           H DLK  N LLD +     K+ DFG S+    +       +        GT AY+ PE L
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STV------GTPAYIAPEVL 189

Query: 318 ASGEL--TPKSDVYSFGIILLRLLTGR 342
              +      +DV+S G+ L  +L G 
Sbjct: 190 -LRQEYDGKIADVWSCGVTLYVMLVGA 215

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 63/280 (22%), Positives = 103/280 (36%), Gaps = 46/280 (16%)

Query: 81  VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF 140
           ++LL    +E    ++ +DK V  A+ L+ +         +     DF            
Sbjct: 18  LDLLLGVHQELGASELAQDKYV--ADFLQWAEPIVVRLKEVRLQRDDFEI---------- 65

Query: 141 DPSLK-IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIRH 192
              LK IG G +  +   +++  Q     A+K+++   +    E   F++E D+L     
Sbjct: 66  ---LKVIGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 193 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
             +  L  A        LV EY   G L   LS      P     R  +A E+   +  +
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSV 178

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           H       VH D+KP NILLD     +L+DFG    L  +    +           GT  
Sbjct: 179 HR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL-VAV------GTPD 228

Query: 311 YMDPEFLASGELTPKSDVY-------SFGIILLRLLTGRP 343
           Y+ PE L +    P +  Y       + G+    +  G+ 
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 198
            +GEG YG + K   R+      VAIK                +EI +L ++RH NLV L
Sbjct: 32  LVGEGSYGMVMKC--RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89

Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +  C +   W LV+E++ + ++ D L  +     L +Q   +   ++ + + F HS   H
Sbjct: 90  LEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHS---H 143

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           +I+H D+KP NIL+  + V KL DFG +R      +++         D   T  Y  PE 
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVY---DDEVATRWYRAPEL 195

Query: 317 L-ASGELTPKSDVYSFGIILLRLLTGRP 343
           L    +     DV++ G ++  +  G P
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEP 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.8 bits (236), Expect = 4e-21
 Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 46/303 (15%)

Query: 57  SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 116
             LE  I +           + + +++L     E +   + R+K +   E L  ++   S
Sbjct: 7   RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNI--LEYLEWAKPFTS 64

Query: 117 SSSHMPQFFSDFSFSEIEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQ----VAIKMLHP 171
               M     DF               LK IG G +G +   +++        A+K+L+ 
Sbjct: 65  KVKQMRLHREDFEI-------------LKVIGRGAFGEVA--VVKLKNADKVFAMKILNK 109

Query: 172 HSLQGPSE---FQQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKD 226
             +   +E   F++E D+L       + TL  A        LV +Y   G L   LS  +
Sbjct: 110 WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169

Query: 227 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS-R 285
           +  P     R  +A E+   +  +H       VH D+KP NIL+D N   +L+DFG   +
Sbjct: 170 DRLPEEM-ARFYLA-EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224

Query: 286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS-----DVYSFGIILLRLLT 340
            +    + S+           GT  Y+ PE L + E          D +S G+ +  +L 
Sbjct: 225 LMEDGTVQSS--VAV------GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

Query: 341 GRP 343
           G  
Sbjct: 277 GET 279

>2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281

 Score = 92.3 bits (229), Expect = 5e-21
 Identities = 20/77 (25%), Positives = 41/77 (53%)

Query: 422 SEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL 481
             ++ + P Y    I  E+M++P +   G TY+ + ++  L      +P+T  PL  + L
Sbjct: 199 KRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQL 258

Query: 482 VPNLALRSAIQEWLQQH 498
           +PNLA++  I  ++ ++
Sbjct: 259 IPNLAMKEVIDAFISEN 275

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL- 198
           K+G G Y ++YKG   +      VA+K +   S +G PS   +EI ++ +++H N+V L 
Sbjct: 12  KLGNGTYATVYKG--LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69

Query: 199 -VGACPEVWTLVYEYLPN--GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
            V       TLV+E++ N      D  +  +    L          +L   L F H    
Sbjct: 70  DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--- 126

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA----- 310
           + I+H DLKP N+L++     KL DFG++R                   P  TF+     
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG---------------IPVNTFSSEVVT 171

Query: 311 --YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
             Y  P+  + S   +   D++S G IL  ++TG+P
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 91.0 bits (226), Expect = 5e-20
 Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 50/229 (21%)

Query: 144 LKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 199
            K+G G YG +YK   +  +     A+K +    +       +EI +L +++HPN+++L 
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQ 84

Query: 200 GACPE-----VWTLVYEYLPN---GSLEDRLSCKDNSP--PLSWQTRIRIATELCSVLIF 249
                     VW L+++Y  +     ++   + K N     L       +  ++   + +
Sbjct: 85  KVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDP 305
           LH+   + ++H DLKPANIL+          K++D G +R  +                P
Sbjct: 144 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN---------------SP 185

Query: 306 KGTFAYMDPE-----------FLASGELTPKSDVYSFGIILLRLLTGRP 343
               A +DP             L +   T   D+++ G I   LLT  P
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 25/208 (12%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 198
           KIGEG YG ++K   R+      VAIK                +EI +L +++HPNLV L
Sbjct: 10  KIGEGSYGVVFKC--RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 199 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
           +          LV+EY  + ++   L        +       I  +    + F H    H
Sbjct: 68  LEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHK---H 121

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           + +H D+KP NIL+  + V KL DFG +R      ++  +       D   T  Y  PE 
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFAR-----LLTGPSDYY---DDEVATRWYRSPEL 173

Query: 317 LASGEL-TPKSDVYSFGIILLRLLTGRP 343
           L       P  DV++ G +   LL+G P
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVP 201

>3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968

 Score = 91.0 bits (225), Expect = 2e-19
 Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 8/123 (6%)

Query: 377 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPI 436
            +  ++  R   ++     E   +     E  R +            E  + P  F  P+
Sbjct: 843 VRAVDILGRKTGLASPEFIEKLLNFANKAEEQRKAD------EEEDLEYGDVPDEFLDPL 896

Query: 437 FQEVMQDPHV-AADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWL 495
              +M+DP +  A     +   +K  L S   T P   +PL  +++ PN  LR  I  + 
Sbjct: 897 MYTIMKDPVILPASKMNIDRSTIKAHLLS-DSTDPFNRMPLKLEDVTPNEELRQKILCFK 955

Query: 496 QQH 498
           +Q 
Sbjct: 956 KQK 958

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.8 bits (216), Expect = 3e-19
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)

Query: 145 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL--V 199
           KIGEG YG +YK    + +  A+K +       G PS   +EI IL +++H N+V L  V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +   LV+E+L    L+  L        L   T      +L + + + H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA-------YM 312
           H DLKP N+L++     K++DFG++R                   P   +        Y 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFG---------------IPVRKYTHEIVTLWYR 167

Query: 313 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
            P+  + S + +   D++S G I   ++ G P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 195
            +    K+GEG Y ++YKG  +     VA+K +     +G P    +E+ +L  ++H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 196 VTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           VTL  +    +  TLV+EYL    L+  L   D    ++         +L   L + H  
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR- 118

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA--- 310
               ++H DLKP N+L++     KL+DFG++R  S                P  T+    
Sbjct: 119 --QKVLHRDLKPQNLLINERGELKLADFGLARAKS---------------IPTKTYDNEV 161

Query: 311 ----YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
               Y  P+  L S + + + D++  G I   + TGRP
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.8 bits (216), Expect = 4e-19
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 34/212 (16%)

Query: 145 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL--V 199
           K+GEG YG +YK      + VA+K +   +   G PS   +EI +L ++ HPN+V+L  V
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 200 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                  TLV+E++    L+  L   +N   L          +L   +   H    H I+
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRIL 141

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA-------YM 312
           H DLKP N+L++++   KL+DFG++R                   P  ++        Y 
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFG---------------IPVRSYTHEVVTLWYR 186

Query: 313 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
            P+  + S + +   D++S G I   ++TG+P
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 88.2 bits (219), Expect = 5e-19
 Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 45/268 (16%)

Query: 90  EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLK-IGE 148
           + D   + ++K +     L + +   +    +     D+               +K IG 
Sbjct: 35  DLDFPALRKNKNI--DNFLSRYKDTINKIRDLRMKAEDYEV-------------VKVIGR 79

Query: 149 GGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGA 201
           G +G +   L+RH       A+K+L    +   S+   F +E DI++    P +V L  A
Sbjct: 80  GAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137

Query: 202 --CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                   +V EY+P G L + +S  D         R   A E+   L  +HS      +
Sbjct: 138 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA-EVVLALDAIHS---MGFI 190

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H D+KP N+LLD +   KL+DFG    +++  +   + T        GT  Y+ PE L S
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD-TAV------GTPDYISPEVLKS 243

Query: 320 ----GELTPKSDVYSFGIILLRLLTGRP 343
               G    + D +S G+ L  +L G  
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 51/221 (23%)

Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTL 198
           IG+G +G +   +++        A+K ++       +E +   +E+ I+  + HP LV L
Sbjct: 23  IGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 199 VGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATELCS 245
             +    E   +V + L  G L           E+               ++ I  EL  
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------------VKLFIC-ELVM 126

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 305
            L +L +     I+H D+KP NILLD +    ++DF I+  L +       TT+      
Sbjct: 127 ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMA----- 175

Query: 306 KGTFAYMDPEFLASGELTPKS---DVYSFGIILLRLLTGRP 343
            GT  YM PE  +S +    S   D +S G+    LL GR 
Sbjct: 176 -GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 45/220 (20%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL 198
           K+GEG YG +YK           VAIK +     + G P    +E+ +L +++H N++ L
Sbjct: 41  KLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 199 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             V        L++EY  N    D     D +P +S +       +L + + F HS    
Sbjct: 99  KSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---R 151

Query: 257 SIVHGDLKPANILLDANFVS-----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA- 310
             +H DLKP N+LL  +  S     K+ DFG++R                   P   F  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG---------------IPIRQFTH 196

Query: 311 ------YMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 343
                 Y  PE L  S   +   D++S   I   +L   P
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.4 bits (219), Expect = 1e-18
 Identities = 78/344 (22%), Positives = 131/344 (38%), Gaps = 47/344 (13%)

Query: 16  EELKRRKEFEEALAN-GKLEL-ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKEL 73
           EE K   EF E +    KLE  E       E+ +   +            +  +     L
Sbjct: 77  EEAKPLVEFYEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHL 136

Query: 74  EQKIISAVELLQNYKKEQ-DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSE 132
            +K +   +L Q Y +E    L+ +  +   E+++  +  +  +   ++    +DFS   
Sbjct: 137 VKKQVPP-DLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSV-- 193

Query: 133 IEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQ---QEIDI 186
                       + IG GG+G +Y           A+K L    ++          E  +
Sbjct: 194 -----------HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242

Query: 187 LSKI---RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-A 240
           LS +     P +V +  A   P+  + + + +  G L   LS          +  +R  A
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYA 298

Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            E+   L  +H+     +V+ DLKPANILLD +   ++SD G++      + S       
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHAS 350

Query: 301 CRTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 343
                 GT  YM PE L  G     S D +S G +L +LL G  
Sbjct: 351 V-----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 39/217 (17%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL 198
           KIGEG YG+++K   ++ +    VA+K +       G PS   +EI +L +++H N+V L
Sbjct: 9   KIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 199 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             V    +  TLV+E+     L+        +  L  +       +L   L F HS    
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHS---R 120

Query: 257 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA------ 310
           +++H DLKP N+L++ N   KL++FG++R                   P   ++      
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFG---------------IPVRCYSAEVVTL 165

Query: 311 -YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 345
            Y  P+    +   +   D++S G I   L      L
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 45/289 (15%)

Query: 68  QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSD 127
           +T +E  ++  +A++ + +  K+Q   +M+            +  + + +        ++
Sbjct: 91  ETPEE-REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149

Query: 128 FSFSEIEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQ 182
           F +             LK +G+G +G +   L++        A+K+L    +    E   
Sbjct: 150 FEY-------------LKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAH 194

Query: 183 ---EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI 237
              E  +L   RHP L  L  +    +    V EY   G L   LS +        + R 
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRA 250

Query: 238 RI-ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 296
           R    E+ S L +LHS    ++V+ DLK  N++LD +   K++DFG    L +  I    
Sbjct: 251 RFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGA 304

Query: 297 T--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           T  T C      GT  Y+ PE L   +     D +  G+++  ++ GR 
Sbjct: 305 TMKTFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 48/221 (21%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ--------EIDILSKIRH 192
            +GEG + ++YK   R       VAIK +    L   SE +         EI +L ++ H
Sbjct: 17  FLGEGQFATVYKA--RDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQELSH 71

Query: 193 PNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
           PN++ L+ A       +LV++++    LE  +  KDNS  L+              L +L
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           H    H I+H DLKP N+LLD N V KL+DFG+++                   P   + 
Sbjct: 129 HQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG---------------SPNRAYT 170

Query: 311 -------YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
                  Y  PE    +       D+++ G IL  LL   P
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 43/218 (19%)

Query: 145 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----- 198
            IG G +G +++  L    +VAIK +    LQ      +E+ I+  ++HPN+V L     
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102

Query: 199 --VGACPEVW-TLVYEYLP---NGSLEDRLSCKDNSPPL-----SWQTRIRIATELCSVL 247
                  EV+  LV EY+P     +       K   P L      +Q        L   L
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ--------LLRSL 154

Query: 248 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
            ++HS     I H D+KP N+LLD    V KL DFG ++ L   E    N +  C     
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYIC----- 203

Query: 307 GTFAYMDPEF-LASGELTPKSDVYSFGIILLRLLTGRP 343
            +  Y  PE    +   T   D++S G ++  L+ G+P
Sbjct: 204 -SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 66/265 (24%), Positives = 103/265 (38%), Gaps = 54/265 (20%)

Query: 99  DKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL 158
              V   ++  K     ++    P    + S+++ +           IG G +G +Y+  
Sbjct: 25  SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAK 74

Query: 159 LRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT--------L 208
           L      VAIK +    LQ      +E+ I+ K+ H N+V L                 L
Sbjct: 75  LCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130

Query: 209 VYEYLP---NGSLEDRLSCKDNSPPL-----SWQTRIRIATELCSVLIFLHSCKPHSIVH 260
           V +Y+P             K   P +      +Q        L   L ++HS     I H
Sbjct: 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICH 179

Query: 261 GDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 318
            D+KP N+LLD +  V KL DFG ++ L + E    N +  C      +  Y  PE    
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYIC------SRYYRAPELIFG 230

Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
           + + T   DV+S G +L  LL G+P
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQP 255

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.5 bits (209), Expect = 1e-17
 Identities = 71/335 (21%), Positives = 120/335 (35%), Gaps = 27/335 (8%)

Query: 21  RKEFEEALANGKLELERMKKQHDEVME-ELQIALDQKSLLESQIAESDQTAKELEQKIIS 79
           R  F E  A  + EL R     D V E E+     +K+   +                + 
Sbjct: 64  RLLFREFCAT-RPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVP 122

Query: 80  --AVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGAT 137
              V       ++     + ++      E L  +       S     F  + + E +  T
Sbjct: 123 RQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVT 182

Query: 138 -HNFDPSLKIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQ---EIDILSKIR 191
            + F     +G+GG+G +    +R      A K L    ++          E  IL K+ 
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 192 HPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLI 248
              +V+L  A    +   LV   +  G L+  +           + R    A E+C  L 
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFP-EARAVFYAAEICCGLE 300

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            LH      IV+ DLKP NILLD +   ++SD G++  + + +               GT
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRV------GT 348

Query: 309 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             YM PE + +   T   D ++ G +L  ++ G+ 
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 55/230 (23%)

Query: 139 NFDPSLK-IGEGGYGSIYKGLLRHMQV-------AIKMLHPHSLQGPSEFQ--QEIDILS 188
            F+  LK +G+G +G ++  L++ +         A+K+L   +L+     +   E DIL 
Sbjct: 25  QFEL-LKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81

Query: 189 KIRHPNLVTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQT 235
           ++ HP +V L  A        L+ ++L  G L           E+               
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-------------V 128

Query: 236 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 295
           +  +A EL   L  LHS     I++ DLKP NILLD     KL+DFG    LS+  I   
Sbjct: 129 KFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG----LSKESIDHE 180

Query: 296 NT--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
               + C      GT  YM PE +     T  +D +SFG+++  +LTG  
Sbjct: 181 KKAYSFC------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 64/340 (18%), Positives = 120/340 (35%), Gaps = 42/340 (12%)

Query: 15  AEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 74
            E+     +  + + +           +D   + L+    Q         ++      L+
Sbjct: 79  HEQHGPALQLWKDIED-----------YDTADDALRPQKAQALRAAYLEPQAQLFCSFLD 127

Query: 75  QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIE 134
            + ++            D L     +AV     L ++  +    S     F  + + E +
Sbjct: 128 AETVARAR-----AGAGDGLFQPLLRAVLA--HLGQAPFQEFLDSLYFLRFLQWKWLEAQ 180

Query: 135 GAT-HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDI 186
                 F     +G GG+G ++    +        A K L+   L+    +Q    E  I
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVF--ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238

Query: 187 LSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATEL 243
           L+K+    +V+L  A        LV   +  G +   +   D   P   + R      ++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
            S L  LH     +I++ DLKP N+LLD +   ++SD G++  L   +  +         
Sbjct: 299 VSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYA--- 350

Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
              GT  +M PE L   E     D ++ G+ L  ++  R 
Sbjct: 351 ---GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 48/249 (19%)

Query: 121 MPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ- 175
           M + +        +  +  ++   KIG+G +G ++K   RH +    VA+K +   + + 
Sbjct: 1   MAKQYDSVECPFCDEVS-KYEKLAKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEKE 57

Query: 176 G-PSEFQQEIDILSKIRHPNLVTLVGACPEVWT----------LVYEYLPN---GSLEDR 221
           G P    +EI IL  ++H N+V L+  C    +          LV+++  +   G L + 
Sbjct: 58  GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 117

Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 281
                     +     R+   L + L ++H    + I+H D+K AN+L+  + V KL+DF
Sbjct: 118 ------LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168

Query: 282 GISRFLSQNEISSNNT------TLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGII 334
           G++R  S  + S  N       TL           Y  PE  L   +  P  D++  G I
Sbjct: 169 GLARAFSLAKNSQPNRYTNRVVTLW----------YRPPELLLGERDYGPPIDLWGAGCI 218

Query: 335 LLRLLTGRP 343
           +  + T  P
Sbjct: 219 MAEMWTRSP 227

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 43/222 (19%)

Query: 145 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG-----PSEFQQEIDIL---SKIRH 192
           +IG G YG++YK   R       VA+K +   +  G     P    +E+ +L       H
Sbjct: 16  EIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73

Query: 193 PNLVTLV-------GACPEVWTLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATE 242
           PN+V L+              TLV+E++       L+         P L  +T   +  +
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-----PPPGLPAETIKDLMRQ 128

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCC 301
               L FLH+   + IVH DLKP NIL+ +    KL+DFG++R +  Q  ++    TL  
Sbjct: 129 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW- 184

Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                    Y  PE L         D++S G I   +   +P
Sbjct: 185 ---------YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 51/246 (20%), Positives = 104/246 (42%), Gaps = 31/246 (12%)

Query: 110 KSRKEASSSSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAI 166
           ++R     ++H P+ + D+    +E G   ++    K+G G Y  +++ +    + +V +
Sbjct: 7   RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 66

Query: 167 KMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTL--VGACPEVWTLVY--EYLPNGSLEDR 221
           K+L P   +   + ++EI IL  +R  PN++TL  +   P   T     E++ N      
Sbjct: 67  KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--- 120

Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSD 280
              K     L+         E+   L + HS     I+H D+KP N+++D  +   +L D
Sbjct: 121 ---KQLYQTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLID 174

Query: 281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLL 339
           +G++ F    +                +  +  PE L   ++     D++S G +L  ++
Sbjct: 175 WGLAEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225

Query: 340 TGRPAL 345
             +   
Sbjct: 226 FRKEPF 231

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 53/268 (19%), Positives = 104/268 (38%), Gaps = 50/268 (18%)

Query: 88  KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 147
           KK  ++  ++   A  + + L+K    + +++ +      F   +             +G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKT------------LG 50

Query: 148 EGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLVG 200
            G +G +   L++H +     A+K+L    +    + +    E  IL  +  P LV L  
Sbjct: 51  TGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 201 AC--PEVWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           +        +V EY+  G +   L                R   A ++     +LHS   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-----HARFYAA-QIVLTFEYLHS--- 159

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
             +++ DLKP N+L+D     +++DFG ++      +     TLC      GT   + PE
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLC------GTPEALAPE 208

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRP 343
            + S       D ++ G+++  +  G P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYP 236

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.0 bits (201), Expect = 5e-17
 Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 57/232 (24%)

Query: 139 NFDPSLK-IGEGGYGSIYKGLLRHMQV-------AIKMLH-PHSLQGPSEFQQ---EIDI 186
            F+  L+ +G+GGYG ++   +R +         A+K+L     ++   +      E +I
Sbjct: 18  CFEL-LRVLGKGGYGKVF--QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74

Query: 187 LSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSW 233
           L +++HP +V L+ A        L+ EYL  G L           ED             
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT------------ 122

Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 293
                +A E+   L  LH      I++ DLKP NI+L+     KL+DFG    L +  I 
Sbjct: 123 -ACFYLA-EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFG----LCKESIH 173

Query: 294 SNNT--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                 T C      GT  YM PE L         D +S G ++  +LTG P
Sbjct: 174 DGTVTHTFC------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 80.7 bits (198), Expect = 7e-17
 Identities = 50/265 (18%), Positives = 79/265 (29%), Gaps = 59/265 (22%)

Query: 118 SSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--- 174
           S   P  FS          T       KIGEG +G +++ +  H  VAIK++        
Sbjct: 6   SQKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLV 59

Query: 175 -----QGPSEFQQEIDILSKI---------RHPNLVTLV------GACPEVWTLVYEYLP 214
                +   E   EI I  ++         R    + L       G+ P +    +++  
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 215 --NGSLEDRLS--------------------CKDNSPPLSWQTRIRIATELCSVLIFLHS 252
              GS  DR                       +  +   S  T   I  +L + L     
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE- 178

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISR---FLSQNEISSNNTTLCCRTDPKGTF 309
                  H DL   N+LL    + KL      +     S     S       R +  G  
Sbjct: 179 -ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237

Query: 310 AYMDPEF---LASGELTPKSDVYSF 331
            + D      L +G+   + D+Y  
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRL 262

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 80.7 bits (200), Expect = 7e-17
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 41/220 (18%)

Query: 145 KIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQG--PSEFQQEIDIL---SKIRHPN 194
           +IGEG YG ++K   R ++     VA+K +   + +   P    +E+ +L       HPN
Sbjct: 18  EIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75

Query: 195 LVTLVGACPEVW-------TLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATELC 244
           +V L   C           TLV+E++       L+         P +  +T   +  +L 
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-----PEPGVPTETIKDMMFQLL 130

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRT 303
             L FLHS   H +VH DLKP NIL+ ++   KL+DFG++R +  Q  ++S   TL    
Sbjct: 131 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW--- 184

Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                  Y  PE L         D++S G I   +   +P
Sbjct: 185 -------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 34/210 (16%)

Query: 146 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTL 198
           +G G +G ++  L+R        A+K+L    +    + +    E  +LS + HP ++ +
Sbjct: 14  LGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 199 VGAC--PEVWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSC 253
            G     +   ++ +Y+  G L   L       N        +   A E+C  L +LHS 
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAA-EVCLALEYLHS- 124

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               I++ DLKP NILLD N   K++DFG ++      +     TLC      GT  Y+ 
Sbjct: 125 --KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLC------GTPDYIA 171

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           PE +++       D +SFGI++  +L G  
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 77.6 bits (192), Expect = 7e-16
 Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 53/221 (23%)

Query: 146 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKIRHP 193
           +G+G +G +       + V         A+K+L    +    E      E  +L   RHP
Sbjct: 13  LGKGTFGKV-------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 194 NLVTLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELC 244
            L  L  A    +    V EY   G L      E   +          + R R    E+ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT----------EERARFYGAEIV 115

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCR 302
           S L +LHS     +V+ D+K  N++LD +   K++DFG    L +  IS   T  T C  
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC-- 166

Query: 303 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
               GT  Y+ PE L   +     D +  G+++  ++ GR 
Sbjct: 167 ----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.9 bits (190), Expect = 8e-16
 Identities = 43/211 (20%), Positives = 80/211 (37%), Gaps = 51/211 (24%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 201
            +G G  G + +   +    + A+KML           ++E+++  +  + P++V +V  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 79

Query: 202 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
              ++       +V E L  G L  R+  + +    + +    I   +   + +LHS   
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS--- 135

Query: 256 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
            +I H D+KP N+L      N + KL+DFG +                            
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------------------- 167

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             E           D++S G+I+  LL G P
Sbjct: 168 -KETTGEK-YDKSCDMWSLGVIMYILLCGYP 196

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 52/246 (21%), Positives = 91/246 (36%), Gaps = 40/246 (16%)

Query: 115 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH 172
            S S     F+S             +     IG G  G +           VAIK L   
Sbjct: 2   GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SR 60

Query: 173 SLQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLP---NGS 217
             Q  +  ++   E+ ++  + H N++ L         +    +V+ +V E +       
Sbjct: 61  PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQV 119

Query: 218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
           ++  L   +    L +Q        LC  +  LHS     I+H DLKP+NI++ ++   K
Sbjct: 120 IQMELD-HERMSYLLYQM-------LCG-IKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167

Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           + DFG++R    + +          T    T  Y  PE +         D++S G I+  
Sbjct: 168 ILDFGLARTAGTSFMM---------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218

Query: 338 LLTGRP 343
           ++ G  
Sbjct: 219 MIKGGV 224

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 49/242 (20%), Positives = 81/242 (33%), Gaps = 39/242 (16%)

Query: 126 SDFSFSEIEGATHN----FDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSE- 179
            + +  ++    H     +     I  G YG++  G+    + VAIK +      G +  
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65

Query: 180 -FQQ---------EIDILSKIRHPNLVTLVGA-CPEVWT------LVYEYLPNGSLEDRL 222
                        EI +L+   HPN++ L                LV E +    L   +
Sbjct: 66  ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI 124

Query: 223 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 282
              D    +S Q        +   L  LH      +VH DL P NILL  N    + DF 
Sbjct: 125 --HDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN 179

Query: 283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTG 341
           ++R  + +            T       Y  PE  +     T   D++S G ++  +   
Sbjct: 180 LAREDTADANK---------THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

Query: 342 RP 343
           + 
Sbjct: 231 KA 232

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.0 bits (187), Expect = 6e-15
 Identities = 60/320 (18%), Positives = 108/320 (33%), Gaps = 78/320 (24%)

Query: 88  KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 147
            ++ +          ++  + RK    +  ++ MP+  SD+   +       ++    IG
Sbjct: 9   AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD------RYEIRHLIG 62

Query: 148 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLV 196
            G YG + +   +     VAIK +          F+          EI IL+++ H ++V
Sbjct: 63  TGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVV 115

Query: 197 TLVGACP--------EVWTLVYEYLP---------NGSLEDRLSCKDNSPPLSWQTRIRI 239
            ++            E++ +V E               L +          L +      
Sbjct: 116 KVLDIVIPKDVEKFDELY-VVLEIADSDFKKLFRTPVYLTELHIKT-----LLYNL---- 165

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
              L   + ++HS     I+H DLKPAN L++ +   K+ DFG++R +   E  ++   +
Sbjct: 166 ---LVG-VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

Query: 300 CCRTDPKGTFAYMD-------------------PE-FLASGELTPKSDVYSFGIILLRLL 339
             R D      +                     PE  L     T   DV+S G I   LL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

Query: 340 TGRPALGITKEVQYALDTGK 359
                       +  L  G 
Sbjct: 279 NMIKENVAYHADRGPLFPGS 298

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 46/255 (18%)

Query: 109 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAI 166
                 A++++  P+      F ++      +     IGEG YG +      L  ++VAI
Sbjct: 2   HHHHHMAAAAAAGPEMVRGQVF-DV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAI 57

Query: 167 KMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLVTLVGACP--------EVWTLV 209
           K + P        F+          EI IL + RH N++ +             +V+ +V
Sbjct: 58  KKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY-IV 108

Query: 210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 269
            + +     E  L     +  LS         ++   L ++HS    +++H DLKP+N+L
Sbjct: 109 QDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLL 160

Query: 270 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDV 328
           L+     K+ DFG++R    +   +        T+   T  Y  PE  L S   T   D+
Sbjct: 161 LNTTCDLKICDFGLARVADPDHDHTGFL-----TEYVATRWYRAPEIMLNSKGYTKSIDI 215

Query: 329 YSFGIILLRLLTGRP 343
           +S G IL  +L+ RP
Sbjct: 216 WSVGCILAEMLSNRP 230

>2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94

 Score = 69.2 bits (169), Expect = 6e-15
 Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 9/76 (11%)

Query: 432 FTCPIFQEVMQDPHVAAD-GFTYEAEALKGWLDSGHETS-----PMT---NLPLAHKNLV 482
           FTCPI +E M+ P      G TYE +A+   ++S  +       P     +  +   +L+
Sbjct: 8   FTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLI 67

Query: 483 PNLALRSAIQEWLQQH 498
            + ALR AI+   ++ 
Sbjct: 68  QDEALRRAIENHNKKR 83

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 40/220 (18%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS----EFQQEIDILSKIRHPNLVTL 198
             G+G +G++  G  +   M VAIK +    +Q P     E Q  +  L+ + HPN+V L
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQ-IMQDLAVLHHPNIVQL 84

Query: 199 --------VGACPEVW-TLVYEYLPNGSLED--RL--SCKDNSPPLSWQTRIRIATELCS 245
                        +++  +V EY+P    +   R   +                  +L  
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
            +  LH     ++ H D+KP N+L++ A+   KL DFG ++ LS +E    N    C   
Sbjct: 141 SIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYIC--- 193

Query: 305 PKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
              +  Y  PE    +   T   D++S G I   ++ G P
Sbjct: 194 ---SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 74/286 (25%)

Query: 90  EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPSLK-IG 147
                  +     ++   ++   + A+ + H  +    +F               LK +G
Sbjct: 17  GAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFEL-------------LKVLG 63

Query: 148 EGGYGSIYKGLLRHMQV-------AIKMLHPHSLQGPSEFQQ----EIDILSKIRH-PNL 195
            G YG ++  L+R +         A+K+L   ++   ++  +    E  +L  IR  P L
Sbjct: 64  TGAYGKVF--LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 196 VTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATE 242
           VTL  A        L+ +Y+  G L           E                +I +  E
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-------------VQIYVG-E 167

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT---TL 299
           +   L  LH      I++ D+K  NILLD+N    L+DFG    LS+  ++         
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG----LSKEFVADETERAYDF 220

Query: 300 CCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 343
           C      GT  YM P+ +  G+       D +S G+++  LLTG  
Sbjct: 221 C------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.3 bits (185), Expect = 9e-15
 Identities = 49/236 (20%), Positives = 86/236 (36%), Gaps = 22/236 (9%)

Query: 116 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 173
           S S    QF+S             +     IG G  G +           VAIK L    
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRP 98

Query: 174 LQGPSEFQQ---EIDILSKIRHPNLVTL---VGACPEVWTLVYEYLPNGSLEDRLSCKDN 227
            Q  +  ++   E+ ++  + H N+++L         +      YL    ++  L     
Sbjct: 99  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158

Query: 228 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 287
                 +    +   LC  +  LHS     I+H DLKP+NI++ ++   K+ DFG++R  
Sbjct: 159 MELDHERMSYLLYQMLCG-IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214

Query: 288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             + +          T    T  Y  PE +         D++S G I+  ++  + 
Sbjct: 215 GTSFMM---------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 60/243 (24%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL---- 198
            +G G +G + +        + A+K +       P    +E+DI+  + H N++ L    
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYF 69

Query: 199 -----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE----------- 242
                    P      +  L   +       K      S    + +  E           
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129

Query: 243 --------------------LCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDF 281
                               L   + F+HS     I H D+KP N+L+++     KL DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLT 340
           G ++ L  +E    +    C      +  Y  PE  L + E TP  D++S G +   L+ 
Sbjct: 187 GSAKKLIPSE---PSVAYIC------SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 341 GRP 343
           G+P
Sbjct: 238 GKP 240

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 60/274 (21%), Positives = 102/274 (37%), Gaps = 47/274 (17%)

Query: 85  QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPS 143
            +Y     E    +       EE +++     S          DF               
Sbjct: 10  HDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDL------------- 56

Query: 144 LK-IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEF---QQEIDILSKI-RHPN 194
           L+ IG G Y  +   L+R  +     A++++    +    +    Q E  +  +   HP 
Sbjct: 57  LRVIGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114

Query: 195 LVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           LV L  +C         V EY+  G L   +  +    P     R   A E+   L +LH
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEE-HARFYSA-EISLALNYLH 170

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTF 309
                 I++ DLK  N+LLD+    KL+D+G    + +  +   +T  T C      GT 
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFC------GTP 217

Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            Y+ PE L   +     D ++ G+++  ++ GR 
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 55/234 (23%)

Query: 140 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EIDILS 188
           F     +GEG YG +     +     VAIK + P        F +         EI IL 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILK 64

Query: 189 KIRHPNLVTLVGACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLS-------- 232
             +H N++T+             EV+ ++ E +    L   +S    +  LS        
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVY-IIQELMQT-DLHRVIS----TQMLSDDHIQYFI 118

Query: 233 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 292
           +QT       L + +  LH     +++H DLKP+N+L+++N   K+ DFG++R + ++  
Sbjct: 119 YQT-------LRA-VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167

Query: 293 SSNNTTLCCR--TDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
            ++  T       +   T  Y  PE  L S + +   DV+S G IL  L   RP
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 78/276 (28%), Positives = 113/276 (40%), Gaps = 61/276 (22%)

Query: 88  KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLK-I 146
            + Q+   M  + A   A   + +   +S+    P   SDF F             LK I
Sbjct: 3   SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKP---SDFHF-------------LKVI 46

Query: 147 GEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEF---QQEIDILSK-IRHPNLVTL 198
           G+G +G +   L RH       A+K+L   ++    E      E ++L K ++HP LV L
Sbjct: 47  GKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 199 VGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELCSVLIF 249
             +    +    V +Y+  G L      E              + R R  A E+ S L +
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFL----------EPRARFYAAEIASALGY 154

Query: 250 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKG 307
           LHS    +IV+ DLKP NILLD+     L+DFG    L +  I  N+T  T C      G
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQGHIVLTDFG----LCKENIEHNSTTSTFC------G 201

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           T  Y+ PE L         D +  G +L  +L G P
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 57/217 (26%), Positives = 84/217 (38%), Gaps = 44/217 (20%)

Query: 146 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSK-IRH 192
           +G+G +G +                   AIK L    +    +      E  +LS    H
Sbjct: 25  LGKGSFGKV-------FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77

Query: 193 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIF 249
           P L  +       E    V EYL  G L   +            +R    A E+   L F
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----LSRATFYAAEIILGLQF 133

Query: 250 LHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPK 306
           LHS     IV+ DLK  NILLD +  + K++DFG    + +  +  +    T C      
Sbjct: 134 LHS---KGIVYRDLKLDNILLDKDGHI-KIADFG----MCKENMLGDAKTNTFC------ 179

Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           GT  Y+ PE L   +     D +SFG++L  +L G+ 
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 51/222 (22%), Positives = 83/222 (37%), Gaps = 54/222 (24%)

Query: 146 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 192
           +G+G +G +       M           A+K+L    +    +      E  +L+   + 
Sbjct: 28  LGKGSFGKV-------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80

Query: 193 PNLVTLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATEL 243
           P L  L       +    V EY+  G L        R            +      A E+
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----------EPHAVFYAAEI 130

Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCC 301
              L FL S     I++ DLK  N++LD+    K++DFG    + +  I    T  T C 
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTFC- 182

Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                GT  Y+ PE +A        D ++FG++L  +L G+ 
Sbjct: 183 -----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 72.6 bits (179), Expect = 4e-14
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 46/218 (21%)

Query: 146 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEF---QQEIDILSKI-RHPNLVT 197
           IG G Y  +   L+R  +     A+K++    +    +    Q E  +  +   HP LV 
Sbjct: 17  IGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 198 LVGAC---PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELCSVL 247
           L  +C         V EY+  G L      + +L           +   R  + E+   L
Sbjct: 75  LH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----------EEHARFYSAEISLAL 123

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDP 305
            +LH      I++ DLK  N+LLD+    KL+D+G    + +  +   +T  T C     
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFC----- 171

Query: 306 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            GT  Y+ PE L   +     D ++ G+++  ++ GR 
Sbjct: 172 -GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 59/222 (26%), Positives = 86/222 (38%), Gaps = 54/222 (24%)

Query: 146 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 192
           +G+G +G +       M           A+K+L    +    +      E  ILS    H
Sbjct: 31  LGKGSFGKV-------MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83

Query: 193 PNLVTLVGAC--PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATEL 243
           P L  L      P+    V E++  G L        R            + R R  A E+
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----------EARARFYAAEI 133

Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCC 301
            S L+FLH      I++ DLK  N+LLD     KL+DFG    + +  I +  T  T C 
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGICNGVTTATFC- 185

Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                GT  Y+ PE L      P  D ++ G++L  +L G  
Sbjct: 186 -----GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 53/290 (18%), Positives = 97/290 (33%), Gaps = 73/290 (25%)

Query: 109 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM--QVAI 166
                 +   +   Q   +    +      N+     IG G YG +Y    ++    VAI
Sbjct: 3   HHHHHSSGRENLYFQGIKNVHVPD------NYIIKHLIGRGSYGYVYLAYDKNTEKNVAI 56

Query: 167 KMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLVTLVGACP--------EVWTLV 209
           K ++         F+          EI IL++++   ++ L             E++ +V
Sbjct: 57  KKVN-------RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY-IV 108

Query: 210 YEYLP---------NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
            E               L +     ++   + +         L     F+H      I+H
Sbjct: 109 LEIADSDLKKLFKTPIFLTE-----EHIKTILYNL-------LLG-ENFIHES---GIIH 152

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD------- 313
            DLKPAN LL+ +   K+ DFG++R ++  + ++    L    +P      +        
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212

Query: 314 -------PE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 355
                  PE  L     T   D++S G I   LL    +       ++ L
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 29/225 (12%)

Query: 137 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR 191
              +     +G GG G ++  +      +VAIK +    L  P   +    EI I+ ++ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALREIKIIRRLD 66

Query: 192 HPNLVTLVGA-CPEVWTLVYEYLPNGSLED-----RLSCKD-----NSPPLSWQTRIRIA 240
           H N+V +     P    L  +      L            D        PL  +      
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126

Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTL 299
            +L   L ++HS    +++H DLKPAN+ ++  + V K+ DFG++R +  +   S+   L
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY--SHKGHL 181

Query: 300 CCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
              ++   T  Y  P   L+    T   D+++ G I   +LTG+ 
Sbjct: 182 ---SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 42/223 (18%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEFQQ---EIDI 186
           +F+  + +G+G +G +       M           A+K+L    +    + +    E  +
Sbjct: 342 DFNFLMVLGKGSFGKV-------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 394

Query: 187 LSKI-RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATE 242
           L+   + P L  L       +    V EY+  G L   +           +      A E
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHAVFYAAE 450

Query: 243 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLC 300
           +   L FL S     I++ DLK  N++LD+    K++DFG    + +  I    T  T C
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTFC 503

Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                 GT  Y+ PE +A        D ++FG++L  +L G+ 
Sbjct: 504 ------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 52/247 (21%), Positives = 96/247 (38%), Gaps = 43/247 (17%)

Query: 115 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH 172
           + S      F+              +     +G G YGS+   + +    +VAIK L   
Sbjct: 1   SLSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SR 59

Query: 173 SLQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLP---NGS 217
             Q     ++   E+ +L  ++H N++ L         +    + + LV  ++       
Sbjct: 60  PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY-LVMPFMQTDLQKI 118

Query: 218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 277
           +  + S ++    L +Q        L   L ++HS     +VH DLKP N+ ++ +   K
Sbjct: 119 MGLKFS-EEKIQYLVYQM-------LKG-LKYIHSA---GVVHRDLKPGNLAVNEDCELK 166

Query: 278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILL 336
           + DFG++R          +  +   T    T  Y  PE  L+        D++S G I+ 
Sbjct: 167 ILDFGLAR--------HADAEM---TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215

Query: 337 RLLTGRP 343
            +LTG+ 
Sbjct: 216 EMLTGKT 222

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 62/221 (28%), Positives = 88/221 (39%), Gaps = 51/221 (23%)

Query: 146 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRH------PN 194
           IG+G +G + K      H  VA+KM+           +Q   EI IL  +R        N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMN 160

Query: 195 LVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
           ++ ++         C     + +E L + +L + L  K+     S     + A  +   L
Sbjct: 161 VIHMLENFTFRNHIC-----MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQN---EISSNNTTLCCR 302
             LH  +   I+H DLKP NILL     S  K+ DFG S +  Q     I S       R
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS-------R 263

Query: 303 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                 F Y  PE +         D++S G IL  LLTG P
Sbjct: 264 ------F-YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 51/241 (21%), Positives = 90/241 (37%), Gaps = 40/241 (16%)

Query: 122 PQFFSDFSFSEIEGA----THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ 175
           P   S F   E+          +     +G G YG++   +      +VAIK L     Q
Sbjct: 5   PPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQ 63

Query: 176 GPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLPNGSLEDRLS 223
                ++   E+ +L  +RH N++ L         +    + + LV  ++        L 
Sbjct: 64  SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY-LVMPFM-----GTDLG 117

Query: 224 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 283
                  L       +  ++   L ++H+     I+H DLKP N+ ++ +   K+ DFG+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174

Query: 284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGR 342
           +R                 T    T  Y  PE  L     T   D++S G I+  ++TG+
Sbjct: 175 ARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

Query: 343 P 343
            
Sbjct: 224 T 224

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 36/243 (14%)

Query: 116 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 173
             S   P F+       I      +     +G G YGS+         ++VA+K L    
Sbjct: 7   HHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRP 65

Query: 174 LQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLPNGSLEDR 221
            Q     ++   E+ +L  ++H N++ L         +    +V+ LV   +        
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-LVTHLM-----GAD 119

Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 281
           L+       L+      +  ++   L ++HS     I+H DLKP+N+ ++ +   K+ DF
Sbjct: 120 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176

Query: 282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLT 340
           G++R  +              T    T  Y  PE  L         D++S G I+  LLT
Sbjct: 177 GLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

Query: 341 GRP 343
           GR 
Sbjct: 226 GRT 228

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 63/246 (25%)

Query: 137 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EID 185
              ++   K+G+G YG ++K + R     VA+K +          FQ          EI 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60

Query: 186 ILSKIR-HPNLVTLVGACP-----EVWTLVYEYLPNGSLEDRLSCKDNSPPLS------- 232
           IL+++  H N+V L+         +V+ LV++Y+     E  L     +  L        
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVY-LVFDYM-----ETDLHAVIRANILEPVHKQYV 114

Query: 233 -WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 291
            +Q        +   + +LHS     ++H D+KP+NILL+A    K++DFG+SR      
Sbjct: 115 VYQL-------IKV-IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163

Query: 292 ISSNNTTLCCRTDPKGTFAYMD-------------PE-FLASGELTPKSDVYSFGIILLR 337
             +NN  L    + +                    PE  L S + T   D++S G IL  
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223

Query: 338 LLTGRP 343
           +L G+P
Sbjct: 224 ILCGKP 229

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 56/268 (20%), Positives = 101/268 (37%), Gaps = 32/268 (11%)

Query: 110 KSRKEASSSSHMPQFFSDFSF----------SEIEGA-THNFDPSLKIGE-GGYGSIYKG 157
           K  KE ++ S      S+               + GA T    P + I E   +G++   
Sbjct: 58  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 117

Query: 158 LLRHMQVAIK-MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNG 216
           L       +         +   ++   I +  K R  ++ +   +       V E   + 
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS--GFVEEKSLSD 175

Query: 217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 276
             E+          L+ +  I  + ++   + FL S K    +H DL   NILL    V 
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVV 232

Query: 277 KLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGII 334
           K+ DFG++R + ++   +   +  L  +        +M PE +     T +SDV+SFG++
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLK--------WMAPETIFDRVYTIQSDVWSFGVL 284

Query: 335 LLRLLT-GR---PALGITKEVQYALDTG 358
           L  + + G    P + I +E    L  G
Sbjct: 285 LWEIFSLGASPYPGVKIDEEFCRRLKEG 312

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 43/195 (22%), Positives = 65/195 (33%), Gaps = 32/195 (16%)

Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 195
            +G G +G + +     +        VA+KML    +         E+ IL  I  H N+
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 196 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           V L+GAC        ++ E+   G+L   L  K N          R       V      
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV------ 142

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG---TF 309
                 +  DLK     + ++  S  S F   + LS  E       L            +
Sbjct: 143 ----GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198

Query: 310 AY-----MDPEFLAS 319
           ++     M  EFLAS
Sbjct: 199 SFQVAKGM--EFLAS 211

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 41/239 (17%), Positives = 91/239 (38%), Gaps = 71/239 (29%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKML------HPHSLQGPSEFQQEIDILSKIR----- 191
           K+G G + +++    ++ +  VA+K++         +       + EI +L ++      
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA-------EDEIKLLQRVNDADNT 78

Query: 192 ------HPNLVTLVGA-----------CPEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSW 233
                   +++ L+                   +V+E L   +L   +   ++   PL  
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVV-----MVFEVL-GENLLALIKKYEHRGIPLI- 131

Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS------KLSDFGISRFL 287
             + +I+ +L   L ++H  +   I+H D+KP N+L++           K++D G + + 
Sbjct: 132 YVK-QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188

Query: 288 SQ---NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            +   N I +                Y  PE L        +D++S   ++  L+TG  
Sbjct: 189 DEHYTNSIQTR--------------EYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 45/220 (20%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP------ 193
            IG+G +G + K    +    VAIK++        +   Q   E+ +L  +         
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 194 NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIRIATELCS 245
            +V L          C     LV+E L + +L D L  ++ +   +S     + A ++C+
Sbjct: 117 YIVHLKRHFMFRNHLC-----LVFEML-SYNLYDLL--RNTNFRGVSLNLTRKFAQQMCT 168

Query: 246 VLIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 303
            L+FL + +   I+H DLKP NILL        K+ DFG S  L Q         +  R 
Sbjct: 169 ALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSR- 222

Query: 304 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
                F Y  PE L         D++S G IL+ + TG P
Sbjct: 223 -----F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 27/211 (12%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 199
           KIG G +G IY G  +    +VAIK+    +     +   E  I   ++    +  +   
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 200 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           GA  +   +V E L  G SLED  +        S +T + +A ++ S + ++HS    + 
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS---KNF 126

Query: 259 VHGDLKPANILL----DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTFAY 311
           +H D+KP N L+      N V  + DFG++ ++      +  +  +  R +    GT  Y
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRD----ARTHQHIPYRENKNLTGTARY 181

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
                    E + + D+ S G +L+    G 
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 43/245 (17%), Positives = 90/245 (36%), Gaps = 47/245 (19%)

Query: 145 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQ-----QEIDILSKIRH 192
            IG+GG+G IY   +             +K+    +    +E +      + + + K   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 193 PNLVTLVGACPEVWT------------LVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRI 239
              +  +G      +            ++ +    G  L+     + N+   S +T +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY--EANAKRFSRKTVLQL 157

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNT 297
           +  +  +L ++H    H  VHGD+K +N+LL+     +  L D+G++             
Sbjct: 158 SLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY-----RYCPEGV 209

Query: 298 TLCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGI---TK 349
                 DPK    GT  +   +       + + D+   G  +++ LTG  P        K
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269

Query: 350 EVQYA 354
            V+ +
Sbjct: 270 YVRDS 274

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 40/244 (16%), Positives = 78/244 (31%), Gaps = 45/244 (18%)

Query: 145 KIGEGGYGSIYKG----------LLRHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHP 193
                  G +Y+             +  + ++K+      L     F Q      ++   
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 194 NLVTLVGAC--PEVWT----------LVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIA 240
             +        P              LV   L  G SL+           LS ++ +++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQVA 165

Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNTT 298
             L   L FLH    +  VHG++   NI +D    S+  L+ +G +          +   
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF-----RYCPSGKH 217

Query: 299 LCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGI---TKE 350
           +      +    G   ++  +       + +SD+ S G  +L+ L G  P       T++
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277

Query: 351 VQYA 354
           +   
Sbjct: 278 IMKQ 281

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 44/228 (19%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           KIG GG+G IY      +  + A  ++     +    F  E+    ++   + +      
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102

Query: 203 --------PEVW-------------TLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIA 240
                   P  +              +V E L  G  L+        +      T +++ 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQ---NGTFKKSTVLQLG 157

Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNTT 298
             +  VL ++H    +  VHGD+K AN+LL      +  L+D+G+S          N   
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY-----RYCPNGNH 209

Query: 299 LCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
              + +P+    GT  +   +      L+ +SDV   G  +LR L G+
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 199
           KIG G +G IY G  +  + +VAIK+ +  +     +   E  I   ++    +  V   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 200 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           G   +   LV + L  G SLED       S  LS +T + +A ++ + + F+HS    S 
Sbjct: 72  GVEGDYNVLVMDLL--GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHS---KSF 124

Query: 259 VHGDLKPANILL----DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTFAY 311
           +H D+KP N L+     AN V  + DFG++ ++   +     +  +  R +    GT  Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTS----THQHIPYRENKNLTGTARY 179

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
                    E + + D+ S G +L+  L G 
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 29/213 (13%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 199
           +IGEG +G I++G  LL + QVAIK     S     + + E      +     +  V   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 200 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
           G       LV + L  G SLED L         S +T    A ++ + +  +H     S+
Sbjct: 75  GQEGLHNVLVIDLL--GPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 127

Query: 259 VHGDLKPANILL------DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTF 309
           V+ D+KP N L+      +AN +  + DFG+   +            +  R      GT 
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRD----PVTKQHIPYREKKNLSGTA 182

Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            YM        E + + D+ + G + +  L G 
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 29/213 (13%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH----PNLVTL 198
           KIG G +G +  G  L  +  VAIK+    S     +   E     ++      P +   
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 199 VGACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
            G C +   +V E L  G SLED     D +   S +T + IA +L S + ++HS    +
Sbjct: 74  -GPCGKYNAMVLELL--GPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVHS---KN 125

Query: 258 IVHGDLKPANILLDANFVSK-----LSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTF 309
           +++ D+KP N L+            + DF ++  ++           +  R      GT 
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE----TKKHIPYREHKSLTGTA 181

Query: 310 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 342
            YM        E + + D+ + G + +  L G 
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 57/246 (23%), Positives = 90/246 (36%), Gaps = 77/246 (31%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKML---HPHSLQGPSEFQQEIDILSKIRH-----PN 194
           K+G+G +G +     +      A+K++     ++       + E DIL KI++      N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 195 LVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIR-IATELCS 245
           +V   G        C     L++E L   SL + +    N+      +  I+    E+  
Sbjct: 98  IVKYHGKFMYYDHMC-----LIFEPL-GPSLYEII--TRNNYNGFHIE-DIKLYCIEILK 148

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------------KLSD 280
            L +L       + H DLKP NILLD  +                           KL D
Sbjct: 149 ALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 281 FGISRFLSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 337
           FG + F S      I++       R        Y  PE + +      SD++SFG +L  
Sbjct: 206 FGCATFKSDYHGSIINT-------RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAE 251

Query: 338 LLTGRP 343
           L TG  
Sbjct: 252 LYTGSL 257

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 51/271 (18%), Positives = 86/271 (31%), Gaps = 95/271 (35%)

Query: 145 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF-QQEIDILSKIR-----HPN-- 194
           K+G G + +++    +     VA+K++   S +  +E    EI +L  +R      PN  
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 195 -LVTLVGA-----------CPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIAT 241
            +V L+             C     +V+E L  G  L      K N   L      +I  
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-----MVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQ 153

Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILL------------------------------- 270
           ++   L +LH+     I+H D+KP NILL                               
Sbjct: 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 271 ------------------DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
                                   K++D G + ++ +             T+   T  Y 
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----------HFTEDIQTRQYR 260

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             E L        +D++S   +   L TG  
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDY 291

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 21/109 (19%), Positives = 45/109 (41%)

Query: 6    QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
                 E       K + + E  ++  ++ L++ +K   E+ +  +    + S L  QIAE
Sbjct: 1019 NLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAE 1078

Query: 66   SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
                  EL+ ++    E LQ      ++   +++ A+K+  EL     +
Sbjct: 1079 LQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESHISD 1127

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 21/106 (19%), Positives = 44/106 (41%)

Query: 11   ESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 70
            E +  E   R +E EE     + E ++M++Q  ++ E+L+     +  L+ +   +D   
Sbjct: 926  EEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEEEAARQKLQLEKVTADGKI 985

Query: 71   KELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 116
            K++E  I+   +      KE+  L+           E  +  K  +
Sbjct: 986  KKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLT 1031

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 25/110 (22%), Positives = 52/110 (47%), Gaps = 14/110 (12%)

Query: 16   EELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD-----------QKSLLESQIA 64
             +L+ + E EE  A  KL+LE  K   D  +++++  +            ++ LLE +++
Sbjct: 958  LDLEEQLE-EEEAARQKLQLE--KVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVS 1014

Query: 65   ESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
            +      E E+K  +  +L   ++    EL++   K  K  +EL K +++
Sbjct: 1015 DLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRK 1064

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 17/116 (14%), Positives = 50/116 (43%), Gaps = 7/116 (6%)

Query: 11   ESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI------- 63
            E    E  K +++ E   ++   ++  ++ Q  E+  +L    ++     +++       
Sbjct: 1052 EKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQK 1111

Query: 64   AESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSS 119
              + +  +ELE  I    E L++ K  +++ + ++    +E E L+   ++   ++
Sbjct: 1112 NNALKKIRELESHISDLQEDLESEKAARNKAEKQKRDLSEELEALKTELEDTLDTT 1167

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 15/110 (13%), Positives = 40/110 (36%)

Query: 11   ESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 70
            +        + K+ E+ +   + +  ++ K+   + E +       +  E +     +  
Sbjct: 975  QLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLK 1034

Query: 71   KELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH 120
             + E  I      L+  +K + EL+  + K   E+ +L +   E  +   
Sbjct: 1035 NKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIA 1084

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 15/113 (13%), Positives = 43/113 (38%), Gaps = 3/113 (2%)

Query: 2    ADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLES 61
             + + A        +++   ++    L     E + ++++  ++   L    ++   L  
Sbjct: 976  LEKVTADGKIKKMEDDILIMEDQNNKLTK---ERKLLEERVSDLTTNLAEEEEKAKNLTK 1032

Query: 62   QIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
               + +    ELE ++    +  Q  +K + +L+ E     ++  EL+    E
Sbjct: 1033 LKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAE 1085

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 18/110 (16%), Positives = 46/110 (41%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           + + ++    +     KE E+       E   ++++     E    A + +  L ++  E
Sbjct: 865 ELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAKKQE 924

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
            ++   E+E +I    E  Q  + E+ ++Q +     ++ EE   +R++ 
Sbjct: 925 LEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEEEAARQKL 974

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 24/109 (22%), Positives = 48/109 (44%), Gaps = 4/109 (3%)

Query: 14  YAEELKRRKEFEEALANGKLELERMKKQHDE----VMEELQIALDQKSLLESQIAESDQT 69
             EEL+R KE ++       ELE+   Q  E    + E+LQ   +  +  E         
Sbjct: 862 KDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAK 921

Query: 70  AKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 118
            +ELE+ +      ++  ++   +LQ E+ K  ++  +L +  +E  ++
Sbjct: 922 KQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEEEAA 970

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 20/111 (18%), Positives = 42/111 (37%), Gaps = 7/111 (6%)

Query: 6    QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
            ++       AE   +  E +  LA  + EL+    + ++   +   AL +   LES I  
Sbjct: 1068 ESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESHI-- 1125

Query: 66   SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 116
                  +L++ + S        +K++ +L  E +    E E+   +     
Sbjct: 1126 -----SDLQEDLESEKAARNKAEKQKRDLSEELEALKTELEDTLDTTATQQ 1171

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 20/120 (16%), Positives = 52/120 (43%), Gaps = 7/120 (5%)

Query: 6    QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIA- 64
            + +A   LYAE  + R          +  L  M+ + +E  E  Q    +K  ++ Q+  
Sbjct: 900  KLQAETELYAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLD 959

Query: 65   ------ESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 118
                  E +   ++L+ + ++A   ++  + +   ++ + +K  KE + L +   + +++
Sbjct: 960  LEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTN 1019

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 57/240 (23%), Positives = 89/240 (37%), Gaps = 69/240 (28%)

Query: 145 KIGEGGYGSIYKGLLRHMQ---VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP----- 193
            +GEG +G + + +        VA+K++           +    EI +L  +        
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNST 76

Query: 194 -NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIR-IATEL 243
              V ++         C     +V+E L   S  D +  K+N   P      IR +A ++
Sbjct: 77  FRCVQMLEWFEHHGHIC-----IVFELL-GLSTYDFI--KENGFLPFRLD-HIRKMAYQI 127

Query: 244 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------KLSDFGIS 284
           C  + FLHS K   + H DLKP NIL   +  +                   K+ DFG +
Sbjct: 128 CKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 343
            +  ++      T +  R        Y  PE  LA G   P  DV+S G IL+    G  
Sbjct: 185 TYDDEHHS----TLVSTR------H-YRAPEVILALGWSQP-CDVWSIGCILIEYYLGFT 232

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 50/240 (20%), Positives = 84/240 (35%), Gaps = 69/240 (28%)

Query: 145 KIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP----- 193
            +GEG +G + + L       QVA+K++           +    EI++L KI+       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81

Query: 194 -NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 245
              V +          C     + +E L   +  +    ++N  P        +A +LC 
Sbjct: 82  FLCVLMSDWFNFHGHMC-----IAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCH 134

Query: 246 VLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------KLSDFGISRF 286
            L FLH  +   + H DLKP NIL   +                      +++DFG + F
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191

Query: 287 LSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
             ++    +++       R        Y  PE +         DV+S G IL     G  
Sbjct: 192 DHEHHTTIVAT-------R------H-YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237

>2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61

 Score = 45.4 bits (108), Expect = 6e-07
 Identities = 12/54 (22%), Positives = 25/54 (46%), Gaps = 2/54 (3%)

Query: 431 YFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVP 483
           +  C I  +V + P ++      +E   L+ ++       P+TN PL+ + +V 
Sbjct: 3   HMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVE 55

>3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190

 Score = 48.6 bits (115), Expect = 8e-07
 Identities = 15/77 (19%), Positives = 33/77 (42%), Gaps = 4/77 (5%)

Query: 41  QHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIIS-AVELLQNYKKEQDELQMERD 99
           Q D + +E +     +     ++ E D  +K +EQ+    A + L+ + + Q E Q+E++
Sbjct: 76  QADRLTQEPESIRKWREEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSE-QVEKN 134

Query: 100 KAV--KEAEELRKSRKE 114
           K       +   +    
Sbjct: 135 KINNRIADKAFYQQPDA 151

>2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 17/104 (16%), Positives = 46/104 (44%), Gaps = 1/104 (0%)

Query: 16   EELKRR-KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 74
             +L+R+  E  +   +   ++  ++  +    E+L+  +++  + E +   +      L+
Sbjct: 931  MQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQ 990

Query: 75   QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 118
            ++I    + L   + E+  ++   DK   E E+L    KE ++ 
Sbjct: 991  EEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTL 1034

>2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 23/117 (19%), Positives = 50/117 (42%), Gaps = 7/117 (5%)

Query: 5    LQAKASESLYAEELKRRKEFEEAL-----ANGKLE--LERMKKQHDEVMEELQIALDQKS 57
            LQ      +   ELK+ K    ++      +  LE  + +++++ DE  +E +  L++ +
Sbjct: 893  LQCCYRRMMAKRELKKLKIEARSVERYKKLHIGLENKIMQLQRKIDEQNKEYKSLLEKMN 952

Query: 58   LLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
             LE   +   +  +   +++  + E  +N       LQ E  K  KE  + +  +K 
Sbjct: 953  NLEITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKT 1009

>2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 20/114 (17%), Positives = 41/114 (35%), Gaps = 4/114 (3%)

Query: 6    QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI-- 63
            +    E  Y+ E ++ +   E L   + E +    +   + EE+     +    +++   
Sbjct: 950  KMNNLEITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKT 1009

Query: 64   --AESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
                +D+   E EQ +    E     K E++EL        KE  E  + +   
Sbjct: 1010 IEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEITETMEKKLVE 1063

>2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 22/119 (18%), Positives = 47/119 (39%), Gaps = 8/119 (6%)

Query: 6    QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
            Q K  +SL  +       +       + ++ER++       EE + A ++   L+ +IA+
Sbjct: 940  QNKEYKSLLEKMNNLEITYSTETEKLRSDVERLRMS----EEEAKNATNRVLSLQEEIAK 995

Query: 66   SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAV----KEAEELRKSRKEASSSSH 120
              +   + + +  +  E    YK E ++L  E  +       E EEL +   + +    
Sbjct: 996  LRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEIT 1054

>2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 21/116 (18%), Positives = 46/116 (39%), Gaps = 9/116 (7%)

Query: 5   LQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIA 64
           L            +  +  +   +A  K EL+++K +   V    ++       LE++I 
Sbjct: 878 LARVHYHRTLKAIVYLQCCYRRMMA--KRELKKLKIEARSVERYKKL----HIGLENKIM 931

Query: 65  ESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH 120
           +  +   E  ++      LL+     +     E +K   + E LR S +EA ++++
Sbjct: 932 QLQRKIDEQNKEY---KSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATN 984

>2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 16/107 (14%), Positives = 43/107 (40%), Gaps = 3/107 (2%)

Query: 1    MADNLQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD-QKSLL 59
              +   A        EE+ + ++        K  +E    ++    E+L   L  Q +LL
Sbjct: 976  EEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLL 1035

Query: 60   ESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE 106
            +++  E ++   +  ++I   +E  +   +E  +L+++ +      +
Sbjct: 1036 KTEKEELNRRIHDQAKEITETME--KKLVEETKQLELDLNDERLRYQ 1080

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 1e-05
 Identities = 72/553 (13%), Positives = 147/553 (26%), Gaps = 171/553 (30%)

Query: 1   MADNLQA--KASESLYAEELKR----RKEFEEALANGKLELERM--------KKQHDEVM 46
           ++    A     +    +++ +    ++E +  + +    +            KQ + V 
Sbjct: 22  LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKD-AVSGTLRLFWTLLSKQEEMVQ 80

Query: 47  EELQIALDQK-SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEA 105
           + ++  L      L S I    +    + +  I   + L N  +   +  + R +     
Sbjct: 81  KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL-- 138

Query: 106 EELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVA 165
            +LR++  E   + ++                         G  G G   K  +     A
Sbjct: 139 -KLRQALLELRPAKNV--------------LID--------GVLGSG---KTWV-----A 167

Query: 166 IKMLHPHSLQGPSEFQQEIDI----LSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDR 221
           + +   + +Q   +F+    I    L     P  V  +     +  L+Y+  PN +    
Sbjct: 168 LDVCLSYKVQCKMDFK----IFWLNLKNCNSPETVLEM-----LQKLLYQIDPNWTSRSD 218

Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANILLDANFVSKLSD 280
            S        S Q  +R         +       +  +V  +++ A    +A F     +
Sbjct: 219 HSSNIKLRIHSIQAELRR--------LLKSKPYENCLLVLLNVQNAKA-WNA-F-----N 263

Query: 281 FG-----ISRFLS-QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGII 334
                   +RF    + +S+  TT         T      E      L  K         
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT--PDEVK---SLLLK----YLDCR 314

Query: 335 LLRL----LTGRP-ALG-ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCE 388
              L    LT  P  L  I + ++  L T    N        W  V  ++L  +      
Sbjct: 315 PQDLPREVLTTNPRRLSIIAESIRDGLAT--WDN--------WKHVNCDKLTTIIESSLN 364

Query: 389 MSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAA 448
                          VLEP              +E R     +    +F       H+  
Sbjct: 365 ---------------VLEP--------------AEYR---KMFDRLSVFPP---SAHIPT 389

Query: 449 --------DGFTYEAE----------ALKGWLDSG----H-----ETSPMTNLPLAHKNL 481
                   D    +             ++                    + N    H+++
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449

Query: 482 VPNLALRSAIQEW 494
           V +  +       
Sbjct: 450 VDHYNIPKTFDSD 462

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 4e-04
 Identities = 34/237 (14%), Positives = 74/237 (31%), Gaps = 72/237 (30%)

Query: 8   KAS-ESLYAEELKRRKEFEEALA----NGKLE---LERM--KKQHDEVMEELQIALDQKS 57
           ++S   L   E ++   F+  L+    +  +    L  +       +VM  +   L + S
Sbjct: 360 ESSLNVLEPAEYRKM--FDR-LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVN-KLHKYS 415

Query: 58  LLESQIAES---------DQTAK-----ELEQKIISAVELLQNYKKEQDELQMERD---- 99
           L+E Q  ES         +   K      L + I+    + + +  + D +    D    
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQYFY 474

Query: 100 -------KAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYG 152
                  K ++  E +          +     F DF F  +E          KI      
Sbjct: 475 SHIGHHLKNIEHPERM----------TLFRMVFLDFRF--LEQ---------KIRHDSTA 513

Query: 153 SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK---------IRHP--NLVTL 198
               G + +    +K   P+      ++++ ++ +           I     +L+ +
Sbjct: 514 WNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRI 570

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 17/83 (20%), Positives = 41/83 (49%)

Query: 35  LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDEL 94
           ++ +KK+   +  + + ALD+    E+    ++  +K+LE +++S  + L+  + E D+ 
Sbjct: 1   MDAIKKKMQMLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKY 60

Query: 95  QMERDKAVKEAEELRKSRKEASS 117
                 A ++ E   K   +A +
Sbjct: 61  SEALKDAQEKLELAEKKATDAEA 83

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 43.9 bits (103), Expect = 7e-05
 Identities = 17/109 (15%), Positives = 40/109 (36%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           + +  E    E     ++ +        +L  ++   +   E  +++  + + LE +I  
Sbjct: 140 KMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKT 199

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
                K LE +     +    Y++E   L  +  +A   AE   +S  +
Sbjct: 200 VTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTK 248

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 14/112 (12%), Positives = 49/112 (43%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +         +  ++ +  E+   + + ++  + ++     EEL  A ++ +    ++ E
Sbjct: 56  ELDKYSEALKDAQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEE 115

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 117
           +++ A E E+ +       Q  +++ +  +++  +A   AE+  +  +E + 
Sbjct: 116 AEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVAR 167

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 19/97 (19%), Positives = 44/97 (45%)

Query: 19  KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 78
             +K  E+     + EL  ++K+     +EL    +     + ++  +++ A + E  + 
Sbjct: 27  ADKKAAEDRSKQLEDELVSLQKKLKATEDELDKYSEALKDAQEKLELAEKKATDAEADVA 86

Query: 79  SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
           S    +Q +++E D  Q     A+++ EE  K+  E+
Sbjct: 87  SLNRRIQLFEEELDRAQERLATALQKLEEAEKAADES 123

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 19/110 (17%), Positives = 45/110 (40%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
             K ++       K+  + E  +A+    ++  +++ D   E L  AL +    E    E
Sbjct: 63  ALKDAQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADE 122

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
           S++  K +E +     E ++  + +  E +   + A ++ EE+ +     
Sbjct: 123 SERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVII 172

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 17/110 (15%), Positives = 39/110 (35%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           +    ES      +R +  E   A  + E++ +      +  + +    ++   E +I  
Sbjct: 168 KLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKV 227

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
                KE E +   A   +   +K  D+L+ E      + + + +    A
Sbjct: 228 LSDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLKYKAISEELDHA 277

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 14/111 (12%), Positives = 35/111 (31%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
           + +             +  EE     + +   ++++   V   L+    Q      +  +
Sbjct: 161 KYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDK 220

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 116
            ++  K L  K+  A    +  ++   +L+   D    E    +   K  S
Sbjct: 221 YEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLKYKAIS 271

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 19/110 (17%), Positives = 43/110 (39%)

Query: 6   QAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 65
            A+ ++  Y E  ++    E  L   +   E  + +  E+ EE++   +    LE+Q  +
Sbjct: 154 IAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEK 213

Query: 66  SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
             Q   + E++I    + L+  +   +  +    K  K  ++L       
Sbjct: 214 YSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQ 263

>3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} Length = 267

 Score = 43.8 bits (102), Expect = 6e-05
 Identities = 8/71 (11%), Positives = 27/71 (38%), Gaps = 4/71 (5%)

Query: 432 FTCPIFQEVMQDPHVAAD-GFTYEAEALKGWLDSGHETS-PMT--NLPLAHKNLVPNLAL 487
            TCPI  +  + P ++      ++ + ++ +L        P    +  ++ ++ V +  +
Sbjct: 182 LTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIM 241

Query: 488 RSAIQEWLQQH 498
               +    + 
Sbjct: 242 ELRCKIAKMKE 252

>1w1w_A Structural maintenance of chromosome 1; cohesin, chromosome segregation, cell adhesion, kleisin, MIT cell cycle; HET: ATG; 2.90A {Saccharomyces cerevisiae} SCOP: c.37.1.12 Length = 430

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 17/118 (14%), Positives = 45/118 (38%), Gaps = 8/118 (6%)

Query: 5   LQAKASESLYAEELKRRKEFEEA--LANGKLELERMKKQHDEVMEELQIALDQKSLLESQ 62
            Q    +      ++  + FEE       K E E +K++ +++ +    ++  +  +  +
Sbjct: 150 FQGDVEQIAAQSPVELSRMFEEVSGSIQYKKEYEELKEKIEKLSKSATESIKNRRRIHGE 209

Query: 63  IAESDQTAKELEQKIISAVEL------LQNYKKEQDELQMERDKAVKEAEELRKSRKE 114
           +        E+  +              +    E ++L+ E  K + +  +++K RKE
Sbjct: 210 LKTYKSPGLEVLFQGPRGSRYDEAEGRFEVINNETEQLKAEEKKILNQFLKIKKKRKE 267

>3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} Length = 256

 Score = 41.3 bits (96), Expect = 4e-04
 Identities = 15/97 (15%), Positives = 35/97 (36%), Gaps = 5/97 (5%)

Query: 19  KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 78
              +E  + L     + E   K    + EE      Q S  E  + +++     +++K+ 
Sbjct: 25  PLIREKRKDLDKALNDKEAKNKAILNLEEEKLALKLQVSKNEQTLQDTNAKIASIQKKMS 84

Query: 79  SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 115
                    ++E   L +E D A + + +  +  +  
Sbjct: 85  EIKS-----ERELRSLNIEEDIAKERSNQANREIENL 116

>3haj_A Human pacsin2 F-BAR; pacsin,syndapin,FAP52,F-BAR, alternative splicing, coiled coil, cytoplasmic vesicle, endocytosis, phosphoprotein, polymorphism; 2.78A {Homo sapiens} Length = 486

 Score = 41.3 bits (95), Expect = 7e-04
 Identities = 22/107 (20%), Positives = 34/107 (31%), Gaps = 6/107 (5%)

Query: 23  EFEEALANGKLELERMKKQHDEVMEELQ------IALDQKSLLESQIAESDQTAKELEQK 76
             E+A      E ER+ + H EV   L       I   QK     Q+    +  KE E  
Sbjct: 78  TVEKAWMAFMSEAERVSELHLEVKASLMNDDFEKIKNWQKEAFHKQMMGGFKETKEAEDG 137

Query: 77  IISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 123
              A +      KE +  +     A KE +        + +   +  
Sbjct: 138 FRKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNP 184

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	498
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
1wgm_A	98	Ubiquitin conjugation factor E4A; ubiquitinating e	99.7
2kr4_A	85	Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ri	99.69
2kre_A	100	Ubiquitin conjugation factor E4 B; U-box domain, E	99.69
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
2f42_A	179	STIP1 homology and U-box containing protein 1; cha	99.65
3m62_A	968	Ubiquitin conjugation factor E4; armadillo-like re	99.53
2yu4_A	94	E3 SUMO-protein ligase NSE2; SP-ring domain, struc	99.52
1t1h_A	78	Gspef-atpub14, armadillo repeat containing protein	99.49
2c2l_A	281	CHIP, carboxy terminus of HSP70-interacting protei	99.48
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
2bay_A	61	PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin l	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3ztg_A	92	E3 ubiquitin-protein ligase RBBP6; PACT, U-BOX, mR	99.02
3htk_C	267	E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-	98.89
3fl2_A	124	E3 ubiquitin-protein ligase UHRF1; cell cycle, DNA	98.83
1z6u_A	150	NP95-like ring finger protein isoform B; structura	98.8
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
2y43_A	99	E3 ubiquitin-protein ligase RAD18; DNA repair, met	98.69
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.66
2ecw_A	85	Tripartite motif-containing protein 30; metal bind	98.57
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.55
2ckl_A	108	Polycomb group ring finger protein 4; BMI1, RING1B	98.54
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.54
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.51
2ecv_A	85	Tripartite motif-containing protein 5; metal bindi	98.5
1jm7_B	117	BARD1, BRCA1-associated ring domain protein 1; rin	98.49
3hct_A	118	TNF receptor-associated factor 6; cross-brace, bet	98.48
2ckl_B	165	Ubiquitin ligase protein RING2; BMI1, RING1B, poly	98.47
2egp_A	79	Tripartite motif-containing protein 34; ZF-C3HC4 d	98.46
3lrq_A	100	E3 ubiquitin-protein ligase TRIM37; structural gen	98.42
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.4
2csy_A	81	Zinc finger protein 183-like 1; ring finger protei	98.4
3l11_A	115	E3 ubiquitin-protein ligase RNF168; E3 ligase, rin	98.38
1jm7_A	112	BRCA1, breast cancer type 1 susceptibility protein	98.33
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.32
2djb_A	72	Polycomb group ring finger protein 6; PCGF6, ring	98.28
2yur_A	74	Retinoblastoma-binding protein 6; P53-associated c	98.28
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.27
4ayc_A	138	E3 ubiquitin-protein ligase RNF8; DNA damage, K63	98.24
3hcs_A	170	TNF receptor-associated factor 6; cross-brace, bet	98.24
2ecy_A	66	TNF receptor-associated factor 3; metal binding pr	98.23
1rmd_A	116	RAG1; V(D)J recombination, antibody, MAD, ring fin	98.13
2ysl_A	73	Tripartite motif-containing protein 31; ring-type	98.1
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.1
3knv_A	141	TNF receptor-associated factor 2; cross-brace, alt	98.08
1g25_A	65	CDK-activating kinase assembly factor MAT1; ring f	98.03
3ng2_A	71	RNF4, snurf, ring finger protein 4; ring domain, E	98.0
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.9
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.89
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.84
2ysj_A	63	Tripartite motif-containing protein 31; ring-type	97.83
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.83
2xeu_A	64	Ring finger protein 4; transcription, zinc-finger,	97.79
2ct2_A	88	Tripartite motif protein 32; zinc-finger protein H	97.79
2ect_A	78	Ring finger protein 126; metal binding protein, st	97.71
2d8t_A	71	Dactylidin, ring finger protein 146; RNF146, ring	97.71
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.64
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.63
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.62
2ea6_A	69	Ring finger protein 4; RNF4, RES4-26, ring domain,	97.61
2ecj_A	58	Tripartite motif-containing protein 39; TRIM39, ri	97.56
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.54
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.3
4ap4_A	133	E3 ubiquitin ligase RNF4; ligase-signalling protei	97.28
2ep4_A	74	Ring finger protein 24; zinc binding, ubiquitin, E	97.22
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.19
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.12
1chc_A	68	Equine herpes virus-1 ring domain; viral protein;	97.08
2ecn_A	70	Ring finger protein 141; RNF141, ring domain, zinc	97.05
2y1n_A	389	E3 ubiquitin-protein ligase; ligase-transferase co	97.02
2kiz_A	69	E3 ubiquitin-protein ligase arkadia; ring-H2 finge	97.01
1e4u_A	78	Transcriptional repressor NOT4; gene regulation, t	96.98
2ecm_A	55	Ring finger and CHY zinc finger domain- containing	96.97
1iym_A	55	EL5; ring-H2 finger, ubiquitin ligase, DNA binding	96.92
2l0b_A	91	E3 ubiquitin-protein ligase praja-1; zinc finger,	96.86
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.85
1v87_A	114	Deltex protein 2; ring-H2 domain, zinc-binding dom	96.74
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.74
4ap4_A	133	E3 ubiquitin ligase RNF4; ligase-signalling protei	96.69
1x4j_A	75	Ring finger protein 38; structural genomics, NPPSF	96.65
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.64
1bor_A	56	Transcription factor PML; proto-oncogene, nuclear	96.04
2ecl_A	81	Ring-box protein 2; RNF7, ring domian, zinc-bindin	95.97
4ic3_A	74	E3 ubiquitin-protein ligase XIAP; ring domain, zin	95.56
3dpl_R	106	Ring-box protein 1; ubiquitin, NEDD8, cullin, HOST	95.17
1wim_A	94	KIAA0161 protein; ring finger domain, UBCM4-intera	94.82
2vje_A	64	E3 ubiquitin-protein ligase MDM2; proto-oncogene,	94.49
2ecg_A	75	Baculoviral IAP repeat-containing protein 4; BIRC4	94.16
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.71
2d8s_A	80	Cellular modulator of immune recognition; C-MIR, m	93.6
2vje_B	63	MDM4 protein; proto-oncogene, phosphorylation, alt	93.59
3t6p_A	345	Baculoviral IAP repeat-containing protein 2; ring,	93.42
2yho_A	79	E3 ubiquitin-protein ligase mylip; ligase, E2 liga	91.93
4a0k_B	117	E3 ubiquitin-protein ligase RBX1; ligase-DNA-bindi	91.9
2kkx_A	102	Uncharacterized protein ECS2156; methods developme	91.89
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.96
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.56
2ea5_A	68	Cell growth regulator with ring finger domain prot	88.93
2ct0_A	74	Non-SMC element 1 homolog; ring domain, structural	87.47
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.26
3ghg_A	562	Fibrinogen alpha chain; triple-stranded coiled coi	82.02

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-57  Score=446.42  Aligned_cols=257  Identities=25%  Similarity=0.452  Sum_probs=205.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYL  213 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~  213 (498)
                      ..+|.+.+.||+|+||+||+|.+++ .||||+++.....  ..+.|.+|+.+|++++|||||+++|+|. +..+||||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~  113 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWC  113 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcC
Confidence            3467778899999999999998765 5999998754332  2357999999999999999999999984 4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      +||||.++|...  ..++++.+++.|+.|++.||.|||+   ++||||||||+||||+.++++||+|||+|+........
T Consensus       114 ~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          114 EGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             SSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            999999999633  3569999999999999999999999   89999999999999999999999999999876543221


Q ss_pred             CCCccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCCcHH---HHHHHHhCccccccCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDTGKLKNLLDPL  367 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~~~~~~~~~~~~  367 (498)
                      ..      .....||+.|||||++.+   +.|+.++|||||||+||||+||++||...+.   +...+..+    ...|.
T Consensus       189 ~~------~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~----~~~p~  258 (307)
T 3omv_A          189 QQ------VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG----YASPD  258 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT----CCCCC
T ss_pred             ee------ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC----CCCCC
Confidence            11      134569999999999964   4589999999999999999999999975432   22222222    12222


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ....+..++..+.+|+.+||+.+|.+||++.+ |+..|+.+..
T Consensus       259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-i~~~Le~l~~  300 (307)
T 3omv_A          259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQ-ILSSIELLQH  300 (307)
T ss_dssp             STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHH-HHHHHHHHHT
T ss_pred             cccccccchHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHhc
Confidence            33345566788999999999999999999998 7788887754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.5e-58  Score=448.67  Aligned_cols=256  Identities=23%  Similarity=0.460  Sum_probs=211.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      .+|.+.+.||+|+||+||+|.+.       +..||||+++.......+.|.+|+.+|++|+|||||+++|+|.  +..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            36777889999999999999874       4679999998655444567999999999999999999999994  46899


Q ss_pred             EEeeCCCCCHHhhhccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeE
Q 010882          209 VYEYLPNGSLEDRLSCK----------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL  278 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  278 (498)
                      |||||+||||.++|...          .....+++.+++.|+.|++.||.|||+   ++||||||||+||||+.++++||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence            99999999999999643          234579999999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHH
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YAL  355 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~  355 (498)
                      +|||+|+.........      ......||+.|||||++.+..|+.++|||||||+||||+| |++||...+..+  ..+
T Consensus       170 ~DFGla~~~~~~~~~~------~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEE------ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CCcccceecCCCCcee------ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999998665433211      1123358999999999999999999999999999999999 899998654432  233


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ..+..        ...|..++..+.+|+.+||+.||.+||++.+ |...|+.+...
T Consensus       244 ~~~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~-i~~~L~~~~~~  290 (299)
T 4asz_A          244 TQGRV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKG-IHTLLQNLAKA  290 (299)
T ss_dssp             HHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             HcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHHHhc
Confidence            33321        2245566788999999999999999999998 78888887654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.6e-57  Score=449.42  Aligned_cols=255  Identities=24%  Similarity=0.450  Sum_probs=205.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~l  208 (498)
                      .+|.+.++||+|+||+||+|.++       +..||||+++.......+.|.+|+.+|++|+|||||+++|+|.+  ..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            35667788999999999999874       46799999986554445779999999999999999999999954  6899


Q ss_pred             EEeeCCCCCHHhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          209 VYEYLPNGSLEDRLSCKD------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                      |||||++|+|.++|....            ...++++.+++.|+.|++.||.|||+   ++||||||||+||||+.++++
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence            999999999999996532            13469999999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--H
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--Y  353 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~  353 (498)
                      ||+|||+|+..........      .+...||+.|||||++.+..|+.++|||||||+||||+| |++||...+...  .
T Consensus       198 Ki~DFGla~~~~~~~~~~~------~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRV------GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             EECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             EEcccccceeccCCCccee------cCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999987654332111      133469999999999999999999999999999999999 899997654432  2


Q ss_pred             HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      .+..+.        ....|..+++.+.+|+.+||+.||.+||++.+ |...|+.+..
T Consensus       272 ~i~~g~--------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~e-i~~~L~~l~~  319 (329)
T 4aoj_A          272 CITQGR--------ELERPRACPPEVYAIMRGCWQREPQQRHSIKD-VHARLQALAQ  319 (329)
T ss_dssp             HHHHTC--------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHH-HHHHHHHHHH
T ss_pred             HHHcCC--------CCCCcccccHHHHHHHHHHcCcChhHCcCHHH-HHHHHHHHhh
Confidence            222221        12245566788999999999999999999998 7888888764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.1e-57  Score=443.97  Aligned_cols=252  Identities=22%  Similarity=0.378  Sum_probs=207.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      ++.+.+.||+|+||+||+|.+.       +..||||+++.... ...+.|.+|+.+|++++|||||+++|+|.  +..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3455678999999999999873       46799999976533 33568999999999999999999999994  46899


Q ss_pred             EEeeCCCCCHHhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          209 VYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      |||||++|||.++|.....             ...+++..++.|+.|++.||.|||+   ++||||||||+||||+.+++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence            9999999999999964321             2469999999999999999999999   89999999999999999999


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--  352 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--  352 (498)
                      +||+|||+|+..........      .+...||+.|||||++.++.|+.++|||||||+||||+| |++||...+...  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~------~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKL------LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCS------SSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             EEECCcccceeccCCCceeE------ecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999987654332111      234469999999999999999999999999999999999 899998655433  


Q ss_pred             HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          353 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ..+..+.        ....|..++..+.+|+.+||+.+|.+||++.+ |.+.|+++
T Consensus       258 ~~i~~~~--------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~e-i~~~L~a~  304 (308)
T 4gt4_A          258 EMIRNRQ--------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKD-IHSRLRAW  304 (308)
T ss_dssp             HHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHTS
T ss_pred             HHHHcCC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHH-HHHHHHhc
Confidence            2222221        12245566788999999999999999999998 76777654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.4e-55  Score=434.08  Aligned_cols=243  Identities=23%  Similarity=0.333  Sum_probs=205.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ..|+..+.||+|+||+||+|.++  +..||||++........+.+.+|+.+|+.++|||||+++++|.  +..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            35888889999999999999985  7899999998766666778999999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      +||+|.+++..    ..+++..+..|+.|++.||.|||+   +|||||||||+||||+.+|++||+|||+|+.+......
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999953    359999999999999999999999   89999999999999999999999999999876543211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              ....+||+.|||||++.+..|+.++|||||||+||||+||++||...+........   .....+. ...+.
T Consensus       227 --------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~~~~-~~~~~  294 (346)
T 4fih_A          227 --------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPR-LKNLH  294 (346)
T ss_dssp             --------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSSCCC-CSCGG
T ss_pred             --------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCCCCC-CCccc
Confidence                    13456999999999999999999999999999999999999999876554432211   1111111 11234


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+..+.+|+.+||..||.+||++.+
T Consensus       295 ~~s~~~~dli~~~L~~dP~~R~ta~e  320 (346)
T 4fih_A          295 KVSPSLKGFLDRLLVRDPAQRATAAE  320 (346)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            56788999999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.3e-55  Score=431.05  Aligned_cols=241  Identities=24%  Similarity=0.347  Sum_probs=204.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      .+|.+.+.||+|+||+||+|.+.  ++.||||++.+.   .......+.+|+++|++|+|||||++++++.+  ..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999984  688999999753   23345679999999999999999999999854  689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |||+||+|.+++..   ...+++..+..|+.|++.||.|||+   ++||||||||+||||+.+|++||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999953   3469999999999999999999999   89999999999999999999999999999977543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~  368 (498)
                      .....      ....+||+.|||||++.+..|+.++|||||||+||||+||++||...+.....  +..+.         
T Consensus       186 ~~~~~------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---------  250 (311)
T 4aw0_A          186 SKQAR------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE---------  250 (311)
T ss_dssp             TTCCC------BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred             CCccc------ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------
Confidence            32111      23456999999999999999999999999999999999999999876544322  22221         


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+|...+..+.+|+.+||..||.+||++.+
T Consensus       251 ~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e  281 (311)
T 4aw0_A          251 YDFPEKFFPKARDLVEKLLVLDATKRLGCEE  281 (311)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGG
T ss_pred             CCCCcccCHHHHHHHHHHccCCHhHCcChHH
Confidence            1245556788999999999999999999987

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.9e-55  Score=437.18  Aligned_cols=243  Identities=23%  Similarity=0.358  Sum_probs=198.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ++|.+.+.||+|+||+||+|.+.  ++.||||++.......  .+.|.+|+.+|++|+|||||++++++.  +..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            47889999999999999999985  7899999997654332  456899999999999999999999984  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      ||+||+|.++|... ....+++..+..|+.|++.||.|||+   +|||||||||+||||+.+|++||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999999643 33568899999999999999999999   899999999999999999999999999998765432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  369 (498)
                      ..        ....+||+.|||||++.+..|+.++|||||||+||||+||++||...+.....  +..+..        .
T Consensus       180 ~~--------~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------~  243 (350)
T 4b9d_A          180 EL--------ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--------P  243 (350)
T ss_dssp             HH--------HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------C
T ss_pred             cc--------ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--------C
Confidence            11        11234999999999999999999999999999999999999999876554332  222221        1


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+...+..+.+|+.+||+.||.+||++.++
T Consensus       244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~  274 (350)
T 4b9d_A          244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI  274 (350)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            2334456789999999999999999999883

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-54  Score=435.86  Aligned_cols=266  Identities=25%  Similarity=0.366  Sum_probs=216.2

Q ss_pred             CChHHHHHhhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCC-CCeeee
Q 010882          128 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRH-PNLVTL  198 (498)
Q Consensus       128 ~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h-pniv~l  198 (498)
                      +..++++...++|.+.+.||+|+||+||+|.+.+       +.||||++...... ....|.+|+.+|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3445555666789999999999999999998753       57999999765432 24568999999999965 999999


Q ss_pred             eceec---CcceEEEeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCC
Q 010882          199 VGACP---EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD  262 (498)
Q Consensus       199 ~g~~~---~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD  262 (498)
                      +|+|.   ..++||||||++|+|.++|....             ....+++..++.|+.|++.||.|||+   ++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCc
Confidence            99983   24799999999999999996432             13468999999999999999999999   8999999


Q ss_pred             CCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-C
Q 010882          263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-G  341 (498)
Q Consensus       263 lkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G  341 (498)
                      |||+||||+.++++||+|||+|+.+.......      ..+...||+.|||||++.+..|+.++|||||||+||||+| |
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~------~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G  284 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG  284 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCce------eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence            99999999999999999999998765433211      1233458999999999999999999999999999999998 9


Q ss_pred             CCCCCCcH---HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          342 RPALGITK---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       342 ~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ++||...+   .+...+..+.        ....|..+++.+.+++.+||+.||.+||++.+ +++.|+.+...
T Consensus       285 ~~Pf~~~~~~~~~~~~i~~g~--------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~e-il~~L~~llq~  348 (353)
T 4ase_A          285 ASPYPGVKIDEEFCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE-LVEHLGNLLQA  348 (353)
T ss_dssp             CCSSTTCCCSHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCC--------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHH-HHHHHHHHHHH
Confidence            99997543   2333333331        12245556788999999999999999999998 77888887654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-54  Score=430.26  Aligned_cols=253  Identities=21%  Similarity=0.237  Sum_probs=201.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ..|...++||+|+||+||+|.++  +..||||+++....     +.+|+.+|+.|+|||||+++++|.  +..|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45677788999999999999985  78999999975432     247999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-ceeEeecccccccccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~~~  292 (498)
                      +||+|.++|...   ..+++..+..|+.|++.||.|||+   ++||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus       133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            999999999533   469999999999999999999999   8999999999999999887 699999999997765432


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCccccccCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  370 (498)
                      ...   .......+||+.|||||++.+..|+.++|||||||+||||+||++||...+..  ...+..+..      ....
T Consensus       207 ~~~---~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------~~~~  277 (336)
T 4g3f_A          207 GKS---LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP------PIRE  277 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC------GGGG
T ss_pred             ccc---eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC------Cchh
Confidence            211   11123456999999999999999999999999999999999999999754321  111222111      1112


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .|...+..+.+++.+||+.||.+||++.+ +.+.|......
T Consensus       278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~e-l~~~l~~~l~~  317 (336)
T 4g3f_A          278 IPPSCAPLTAQAIQEGLRKEPVHRASAME-LRRKVGKALQE  317 (336)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHH-HHHHHHHHHhh
Confidence            34556788999999999999999999988 66666655543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-54  Score=421.72  Aligned_cols=238  Identities=22%  Similarity=0.386  Sum_probs=190.6

Q ss_pred             CCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC------cceEEE
Q 010882          141 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE------VWTLVY  210 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~------~~~lV~  210 (498)
                      .+..+||+|+||+||+|.++  +..||||++......  ..+.|.+|+.+|++|+|||||+++++|.+      ..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            44567999999999999985  678999998754332  24568999999999999999999998832      478999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cccCCCCCCcEEEc-CCCceeEeeccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD-ANFVSKLSDFGISRFL  287 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~  287 (498)
                      |||+||+|.++|..   ...+++..+..|+.|++.||.|||+   ++  ||||||||+||||+ .+|.+||+|||+|+..
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            99999999999953   3569999999999999999999999   56  99999999999998 4799999999999854


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                      ....          ....+||+.|||||++.+ .|+.++|||||||+||||+||++||............  +.....  
T Consensus       183 ~~~~----------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~--i~~~~~--  247 (290)
T 3fpq_A          183 RASF----------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVK--  247 (290)
T ss_dssp             CTTS----------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HTTTCC--
T ss_pred             CCCc----------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH--HHcCCC--
Confidence            3221          123469999999999864 6999999999999999999999999654332222111  000000  


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...++...++.+.+|+.+||+.||.+|||+.+
T Consensus       248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e  279 (290)
T 3fpq_A          248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  279 (290)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            11123334568999999999999999999988

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=435.47  Aligned_cols=243  Identities=23%  Similarity=0.338  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ..|...+.||+|+||.||+|.++  +..||||++........+.+.+|+.+|+.++|||||+++++|.  +.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46888999999999999999985  7899999998777667788999999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      +||+|.+++..    ..+++..+..|+.|++.||.|||+   +|||||||||+||||+.+|.+||+|||+|+.+......
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            99999999953    359999999999999999999999   89999999999999999999999999999876543211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              ....+||+.|||||++.+..|+.++|||||||+||||+||++||...+........   .....+.. ..+.
T Consensus       304 --------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~~~~~-~~~~  371 (423)
T 4fie_A          304 --------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL-KNLH  371 (423)
T ss_dssp             --------BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCC-SCTT
T ss_pred             --------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCCCCCC-cccc
Confidence                    13346999999999999999999999999999999999999999876554432211   11111111 1223


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+..+.+|+.+||..||.+||++.+
T Consensus       372 ~~s~~~~dli~~~L~~dP~~R~ta~e  397 (423)
T 4fie_A          372 KVSPSLKGFLDRLLVRDPAQRATAAE  397 (423)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            45678999999999999999999987

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.3e-54  Score=425.22  Aligned_cols=257  Identities=24%  Similarity=0.338  Sum_probs=196.0

Q ss_pred             CCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHH--HHHHHHHcCCCCCeeeeeceecC------cceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQ--QEIDILSKIRHPNLVTLVGACPE------VWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~il~~l~hpniv~l~g~~~~------~~~lV~  210 (498)
                      +|.+.+.||+|+||+||+|.++++.||||++....   ...+.  .|+..+.+++|||||+++|+|.+      ..+|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            45667789999999999999999999999986432   23343  45556678899999999999842      368999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      |||+||||.++|..    .++++..+..|+.|++.||.|||+.     +..+||||||||+||||+.++++||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999953    3589999999999999999999973     22489999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC------CCCCccchHhHHHHHHHHHhCCCCCCCcH----------
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITK----------  349 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~pf~~~~----------  349 (498)
                      ..........    ......+||+.|||||++.+.      .++.++|||||||+||||+||.+||+...          
T Consensus       157 ~~~~~~~~~~----~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          157 RHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             EEETTTTEES----CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             cccCCCCcee----eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            7654321111    112345699999999999764      36779999999999999999988764211          


Q ss_pred             -------HHHHHHHhCccccccCCCCCC--CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          350 -------EVQYALDTGKLKNLLDPLAGD--WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       350 -------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                             .....+..+.    +.|....  .+...+..+.+|+.+||+.||.+|||+.+ |.+.|+.+...
T Consensus       233 ~~~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-i~~~L~~l~~~  298 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR-IKKTLSQLSQQ  298 (303)
T ss_dssp             CSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH-HHHHHHHHHHC
T ss_pred             cccchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHH-HHHHHHHHHHH
Confidence                   1111111111    1121111  12345678999999999999999999998 88888888654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-53  Score=412.23  Aligned_cols=237  Identities=26%  Similarity=0.412  Sum_probs=187.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|.+.+.||+|+||+||+|.+.  ++.||||++.+...   .....+.+|+.+|++++|||||++++++.  +..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999984  78999999976532   23457899999999999999999999984  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||| +|+|.+++..   ..++++..+..++.|++.||.|||+   +||+||||||+||||+.++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 7899999853   3569999999999999999999999   89999999999999999999999999999865443


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~  367 (498)
                      ..         .....||+.|||||++.+..| +.++|||||||+||+|+||++||...+....  .+..+.        
T Consensus       166 ~~---------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--------  228 (275)
T 3hyh_A          166 NF---------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--------  228 (275)
T ss_dssp             ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred             Cc---------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--------
Confidence            21         123469999999999998876 5799999999999999999999987554332  222221        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       ..+|...+..+.+|+.+||+.||.+|||+.+
T Consensus       229 -~~~p~~~s~~~~~li~~~L~~dP~~R~s~~e  259 (275)
T 3hyh_A          229 -YTLPKFLSPGAAGLIKRMLIVNPLNRISIHE  259 (275)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence             1244556788999999999999999999988

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.8e-54  Score=424.41  Aligned_cols=240  Identities=28%  Similarity=0.337  Sum_probs=193.5

Q ss_pred             cCCCCCCcccccCceEEEEEEE-----CCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      ++|++.+.||+|+||+||+|..     .++.||||++.....  .....+.+|+.+|++++|||||++++++.  +..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4799999999999999999987     256899999975432  22346889999999999999999999984  46899


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      |||||+||+|.++|..   ...+++..+..++.|++.||.|||+   +|||||||||+|||++.+|++||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999953   3469999999999999999999999   899999999999999999999999999998654


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      .....        .....||+.|||||++.+..|+.++|||||||+||||+||++||...+.........+  .     .
T Consensus       178 ~~~~~--------~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~-----~  242 (304)
T 3ubd_A          178 DHEKK--------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--A-----K  242 (304)
T ss_dssp             ---CC--------CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--C-----C
T ss_pred             CCCcc--------ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--C-----C
Confidence            33211        1334699999999999999999999999999999999999999987655433222110  0     1


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                      ..+|...+..+.+|+.+||+.||.+||++.
T Consensus       243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta~  272 (304)
T 3ubd_A          243 LGMPQFLSPEAQSLLRMLFKRNPANRLGAG  272 (304)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred             CCCCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence            124555678899999999999999999974

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-52  Score=410.37  Aligned_cols=247  Identities=24%  Similarity=0.387  Sum_probs=185.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC-----------
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE-----------  204 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~-----------  204 (498)
                      +|++.+.||+|+||+||+|.++  +..||||++...... ..+.+.+|+.+|++|+|||||+++++|.+           
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5888899999999999999985  789999998754322 23568899999999999999999998732           


Q ss_pred             ---cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          205 ---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       205 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                         ..|+|||||+||+|.+++.........++..++.|+.|++.||.|||+   +|||||||||+||||+.+|.+||+||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence               258999999999999999755444456777889999999999999999   89999999999999999999999999


Q ss_pred             cccccccccccCCCC----ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh
Q 010882          282 GISRFLSQNEISSNN----TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT  357 (498)
Q Consensus       282 Gla~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (498)
                      |+|+.+.........    ......+..+||+.|||||++.+..|+.++|||||||+||||++   ||.........+..
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~  239 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD  239 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence            999977654322111    01112244579999999999999999999999999999999997   77654332221111


Q ss_pred             CccccccCCCCCCCCH---HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          358 GKLKNLLDPLAGDWPF---VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       358 ~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        ..      ...+|.   ..++.+.+|+.+||+.||.+||++.+
T Consensus       240 --~~------~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  276 (299)
T 4g31_A          240 --VR------NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAIN  276 (299)
T ss_dssp             --HH------TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --Hh------cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence              00      111232   23456788999999999999999988

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-50  Score=407.00  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=196.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--------Cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--------EV  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--------~~  205 (498)
                      .+|.+.+.||+|+||+||+|.++  +..||||++......  ....+.+|+.+|+.|+|||||++++++.        ..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            46888999999999999999985  789999999764332  2346789999999999999999999863        34


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .|||||||. |+|.+++.   ...++++..+..|+.|++.||.|||+   +|||||||||+|||++.+|.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence            799999995 68999994   34579999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Ccc
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GKL  360 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~~  360 (498)
                      .+........    ......+||+.|+|||++.+. .++.++||||+||++|||+||++||.+.+........    +..
T Consensus       207 ~~~~~~~~~~----~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          207 GLCTSPAEHQ----YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             CC-------C----CCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ecccCccccc----cccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            7654321111    112345799999999998875 5689999999999999999999999876654433221    110


Q ss_pred             cccc-------------C--CCCCCCC-----HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 KNLL-------------D--PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 ~~~~-------------~--~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ....             .  +.....+     ...+..+.+|+.+||..||.+|||+.+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e  341 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA  341 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence            0000             0  0000001     123567899999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.7e-48  Score=390.57  Aligned_cols=200  Identities=28%  Similarity=0.383  Sum_probs=166.1

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceec--Ccce
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWT  207 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~  207 (498)
                      ..+.|.+.+.||+|+||+||+|..+     +..||||++...  .....+.+|+++|+.+ +|||||+++++|.  +..|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4567999999999999999999863     468999998654  3456788999999998 6999999999984  4689


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-CceeEeecccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRF  286 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~~  286 (498)
                      +|||||+||+|.+++.      .+++.++..++.|++.||.|||+   +|||||||||+||||+.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999982      48999999999999999999999   899999999999999876 8999999999986


Q ss_pred             ccccccCCCC--------------------ccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCC
Q 010882          287 LSQNEISSNN--------------------TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPAL  345 (498)
Q Consensus       287 ~~~~~~~~~~--------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf  345 (498)
                      ..........                    .........+||+.|+|||++.+. .|+.++||||+||++|||+||++||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            5443211000                    000112345799999999999876 5899999999999999999999999


Q ss_pred             C
Q 010882          346 G  346 (498)
Q Consensus       346 ~  346 (498)
                      .
T Consensus       248 ~  248 (361)
T 4f9c_A          248 Y  248 (361)
T ss_dssp             S
T ss_pred             C
Confidence            4

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.8e-48  Score=410.08  Aligned_cols=239  Identities=26%  Similarity=0.337  Sum_probs=192.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHH---HHHHHcCCCCCeeeeeceec--Ccce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQE---IDILSKIRHPNLVTLVGACP--EVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E---~~il~~l~hpniv~l~g~~~--~~~~  207 (498)
                      ++|.+.++||+|+||+||+|..+  +..||||++.+..   ......+..|   +.+++.++|||||+++++|.  +.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            46899999999999999999984  7889999997532   1223334444   66677889999999999995  4689


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      ||||||+||+|.++|..   ...+++..+..|+.||+.||.|||+   +|||||||||+||||+.+|++||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999954   3469999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHH-HHHHHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~~~~~~~  365 (498)
                      .....          ...+||+.|||||++.. ..|+.++|||||||+||||+||++||...+.. ...+.......   
T Consensus       343 ~~~~~----------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---  409 (689)
T 3v5w_A          343 SKKKP----------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---  409 (689)
T ss_dssp             SSCCC----------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---
T ss_pred             CCCCC----------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---
Confidence            54321          23469999999999975 57999999999999999999999999653211 00011000111   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                        ...+|...+..+.+|+.+||..||.+|++.
T Consensus       410 --~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          410 --AVELPDSFSPELRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred             --CCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence              122455677889999999999999999984

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.2e-48  Score=410.66  Aligned_cols=245  Identities=22%  Similarity=0.344  Sum_probs=202.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~  213 (498)
                      ++|.+.+.||+|+||+||+|..+  +..||||++........+.+.+|+.+|+.|+|||||+++++|.+  ..|||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            47889999999999999999985  68899999976554456678999999999999999999999844  689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC--CceeEeeccccccccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~DFGla~~~~~~~  291 (498)
                      +||+|.++|..  ....+++..+..|+.||+.||.|||+   ++|+||||||+|||++.+  +.+||+|||+|+.+....
T Consensus       237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            99999999852  33569999999999999999999999   899999999999999854  899999999999775432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      ..         ...+||+.|||||++.+..|+.++|||||||+||||++|++||...+..............+.   ...
T Consensus       312 ~~---------~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~  379 (573)
T 3uto_A          312 SV---------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---DSA  379 (573)
T ss_dssp             EE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---SGG
T ss_pred             ce---------eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC---ccc
Confidence            11         123599999999999999999999999999999999999999987665443322211111111   111


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +...+..+.+|+.+||..||.+||++.+
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e  407 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQ  407 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            1235678999999999999999999988

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.4e-46  Score=372.29  Aligned_cols=276  Identities=38%  Similarity=0.655  Sum_probs=225.7

Q ss_pred             CCCChHHHHHhhcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-
Q 010882          126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-  203 (498)
Q Consensus       126 ~~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-  203 (498)
                      ..+.+.++...+++|...+.||+|+||.||+|.+. +..||||++........+.+.+|+.+++.++||||++++++|. 
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34555667778899999999999999999999985 6889999988766555678999999999999999999999984 


Q ss_pred             -CcceEEEeeCCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          204 -EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       204 -~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                       +..++||||+++|+|.+++.... ....+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence             46899999999999999996433 23469999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH---------HH
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE---------VQ  352 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---------~~  352 (498)
                      |++...........      .....||+.|+|||++.+..++.++|||||||++|+|+||++||.....         ..
T Consensus       184 g~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~  257 (321)
T 2qkw_B          184 GISKKGTELDQTHL------STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV  257 (321)
T ss_dssp             TTCEECSSSSCCCC------BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred             cccccccccccccc------ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence            99986543221111      1233489999999999999999999999999999999999999964221         11


Q ss_pred             HHHHhCccccccCCC-CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          353 YALDTGKLKNLLDPL-AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .....+.+...+++. ....+...+..+.+++.+||+.+|.+||++.+ +++.|+.+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e-ll~~L~~~l~~  316 (321)
T 2qkw_B          258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD-VLWKLEYALRL  316 (321)
T ss_dssp             HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHS
T ss_pred             hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHHhhc
Confidence            223334445555543 23456778899999999999999999999998 88888877654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.4e-47  Score=375.31  Aligned_cols=263  Identities=30%  Similarity=0.480  Sum_probs=206.4

Q ss_pred             HHHHhhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceecC--cce
Q 010882          132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE--VWT  207 (498)
Q Consensus       132 ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~  207 (498)
                      ++.....+|.+.+.||+|+||+||+|.+.+..||||++.......  ...+.+|+.++++++||||+++++++.+  ..+
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            333445678889999999999999999999999999997654322  3468899999999999999999999844  579


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      +||||+++|+|.+++........+++..++.++.|++.||.|||+   +|  |+||||||+|||++.++.+||+|||+++
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            999999999999999644333348999999999999999999999   77  9999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccC
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD  365 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (498)
                      ........        .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+..........     .
T Consensus       188 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~-----~  254 (309)
T 3p86_A          188 LKASTFLS--------SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-----K  254 (309)
T ss_dssp             ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH-----S
T ss_pred             cccccccc--------cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----c
Confidence            54433211        1234599999999999999999999999999999999999999987654433222110     0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ......|...+..+.+++.+||+.+|.+||++.+ +++.|+.+...
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~-ll~~L~~~~~~  299 (309)
T 3p86_A          255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFAT-IMDLLRPLIKS  299 (309)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHC-
T ss_pred             CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHHh
Confidence            1112244556688999999999999999999998 88888888654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.5e-46  Score=366.46  Aligned_cols=276  Identities=41%  Similarity=0.701  Sum_probs=227.3

Q ss_pred             cCCCCChHHHHHhhcCCCCC------CcccccCceEEEEEEECCeEEEEEEecCCCC----CChhhHHHHHHHHHcCCCC
Q 010882          124 FFSDFSFSEIEGATHNFDPS------LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL----QGPSEFQQEIDILSKIRHP  193 (498)
Q Consensus       124 ~~~~~~~~ei~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~hp  193 (498)
                      ....|++.++..++.+|...      +.||+|+||.||+|.+.+..||||++.....    .....+.+|+.+++.++||
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            34678999999999999887      8899999999999999999999999875432    1245688999999999999


Q ss_pred             Ceeeeeceec--CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc
Q 010882          194 NLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD  271 (498)
Q Consensus       194 niv~l~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~  271 (498)
                      ||+++++++.  +..++||||+++|+|.+++.......++++..+..++.+++.||.|||+   +||+||||||+|||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence            9999999984  4689999999999999999755556679999999999999999999999   8999999999999999


Q ss_pred             CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH-
Q 010882          272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-  350 (498)
Q Consensus       272 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-  350 (498)
                      .++.+||+|||++.........      .......||+.|+|||.+.+ .++.++|||||||++|+|+||.+||..... 
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQT------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSC------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             CCCcEEEeeccccccccccccc------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence            9999999999999865433211      11233469999999998864 588999999999999999999999975321 


Q ss_pred             -----HHHHHH--hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          351 -----VQYALD--TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       351 -----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                           +.....  ...+...++......+...+..+.+++.+||+.+|.+||++.+ +++.|+.+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~-l~~~L~~l~~  306 (307)
T 2nru_A          241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK-VQQLLQEMTA  306 (307)
T ss_dssp             SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHHC-
T ss_pred             HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHHhc
Confidence                 111111  1123344455555677788899999999999999999999988 8888887754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.5e-46  Score=365.93  Aligned_cols=252  Identities=28%  Similarity=0.476  Sum_probs=204.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecCcceEEEeeCCCCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGS  217 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~~~~lV~E~~~~gs  217 (498)
                      ++|.+.+.||+|+||.||+|.+.+..||||++...  ...+.|.+|+.++++++||||++++|++.+..++||||+++|+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~   85 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS   85 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred             hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence            46778889999999999999999999999998643  3456789999999999999999999999888999999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc-eeEeeccccccccccccCCCC
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-SKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~-~kl~DFGla~~~~~~~~~~~~  296 (498)
                      |.+++........+++..++.++.+++.||.|||+.+++||+||||||+|||++.++. +||+|||++.......     
T Consensus        86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----  160 (307)
T 2eva_A           86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----  160 (307)
T ss_dssp             HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred             HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----
Confidence            9999975544456889999999999999999999977678999999999999998886 7999999997553321     


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH--H--HHHHHHhCccccccCCCCCCCC
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--E--VQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~--~--~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                            ....||+.|+|||++.+..++.++|||||||++|+|+||+.||....  .  .......+.        ....+
T Consensus       161 ------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~  226 (307)
T 2eva_A          161 ------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--------RPPLI  226 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC--------CCCCB
T ss_pred             ------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC--------CCCcc
Confidence                  12348999999999999999999999999999999999999997432  1  111111111        11123


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ...+..+.+++.+||+.+|.+||++.+ +++.|+.+...
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~~  264 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEE-IVKIMTHLMRY  264 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHGGG
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHH-HHHHHHHHHHh
Confidence            344578999999999999999999988 88888887654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.2e-46  Score=370.47  Aligned_cols=277  Identities=36%  Similarity=0.623  Sum_probs=223.3

Q ss_pred             CcCCCCChHHHHHhhcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeec
Q 010882          123 QFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVG  200 (498)
Q Consensus       123 ~~~~~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g  200 (498)
                      .....|++.++....++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34567899999999999999999999999999999874 688999999765432 3347899999999999999999999


Q ss_pred             eec--CcceEEEeeCCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCcee
Q 010882          201 ACP--EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK  277 (498)
Q Consensus       201 ~~~--~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  277 (498)
                      +|.  +..++||||+++|+|.+++.... ...++++..+..|+.+++.||.|||+.+..||+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            984  46789999999999999996543 345699999999999999999999993323999999999999999999999


Q ss_pred             EeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH-------
Q 010882          278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-------  350 (498)
Q Consensus       278 l~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-------  350 (498)
                      |+|||++.........       ......||+.|+|||++.+..++.++|||||||++|+|+||++||.....       
T Consensus       175 l~Dfg~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTH-------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM  247 (326)
T ss_dssp             ECCCSSCEECCSSSSC-------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred             eccCccccccCccccc-------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence            9999999876533211       12334599999999999998999999999999999999999999963221       


Q ss_pred             ----HHHHHHhCccccccCCC-CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          351 ----VQYALDTGKLKNLLDPL-AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       351 ----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                          ..............+.. ...++...+..+.+++.+||+.+|.+||++.+ +++.|+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-ll~~L~~  308 (326)
T 3uim_A          248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE-VVRMLEG  308 (326)
T ss_dssp             HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHH-HHHHHHT
T ss_pred             HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHH-HHHHhcC
Confidence                11111122223333322 33567778899999999999999999999998 7677764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.1e-45  Score=360.57  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=204.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      ..+|...+.||+|+||+||+|.+  .+..||||++........+.+.+|+.+++.++||||++++++|.  +..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35799999999999999999987  46889999998766666778999999999999999999999884  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++||+|.+++...    .+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999532    58999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      .        .....||+.|+|||++.+..++.++|||||||++|+|+||++||...+.............    .....+
T Consensus       172 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~  239 (297)
T 3fxz_A          172 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----PELQNP  239 (297)
T ss_dssp             C--------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS----CCCSCG
T ss_pred             c--------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----CCCCCc
Confidence            1        1334699999999999999999999999999999999999999976654433221110000    011134


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...+..+.+++.+||+.||.+||++.+
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~e  266 (297)
T 3fxz_A          240 EKLSAIFRDFLNRCLEMDVEKRGSAKE  266 (297)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHH
Confidence            456678999999999999999999988

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.9e-46  Score=371.30  Aligned_cols=292  Identities=22%  Similarity=0.359  Sum_probs=215.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--C----eEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~----~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV  209 (498)
                      .+|...+.||+|+||.||+|.+.  +    .+||+|.+.... ......|.+|+.++++++||||++++++|. ...++|
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v   94 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   94 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            46888899999999999999874  3    246888886433 234567999999999999999999999984 457899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |+|+++|+|.+++...  ...+++..++.|+.+++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           95 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            9999999999999643  3569999999999999999999999   8999999999999999999999999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH--HHHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~--~~~~~~~~~~~~~~~~  366 (498)
                      ......      .....||+.|+|||++.+..++.++|||||||++|||+| |++||.....  ....+..+.       
T Consensus       170 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------  236 (327)
T 3poz_A          170 EEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------  236 (327)
T ss_dssp             TCC-------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred             Cccccc------ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-------
Confidence            332111      123357889999999999999999999999999999999 9999975432  222222221       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc----CCCCCCCCCCCCCCCCCCCcCCCccccccC
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC----GGSTSYRLGSEERCEPPPYFTCPIFQEVMQ  442 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~----~~~~~~~~~~~~~~~~P~~~~cpi~~e~~~  442 (498)
                       ....+...+..+.+++.+||+.+|.+||++.+ ++..|+.+....    .......  .......++.|.+++..+.+.
T Consensus       237 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-ll~~l~~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~~  312 (327)
T 3poz_A          237 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRE-LIIEFSKMARDPQRYLVIQGDER--MHLPSPTDSNFYRALMDEEDM  312 (327)
T ss_dssp             -CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHH-HHHHHHHHHTSHHHHBCCTTGGG--CCCCCTTTCHHHHHHHC----
T ss_pred             -CCCCCccCCHHHHHHHHHHcCCChhhCCCHHH-HHHHHHHHHhhhhhhhhhcCCCc--cCCCCCCchHHHHhccccccc
Confidence             11234455678999999999999999999998 777777765421    0001100  011122345566777777777


Q ss_pred             CceeccCCc
Q 010882          443 DPHVAADGF  451 (498)
Q Consensus       443 dp~~~~~g~  451 (498)
                      |+++.+|++
T Consensus       313 ~~~~~~d~~  321 (327)
T 3poz_A          313 DDVVDADEY  321 (327)
T ss_dssp             --CCCHHHH
T ss_pred             ccccCHHHc
Confidence            888777654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=366.34  Aligned_cols=257  Identities=27%  Similarity=0.440  Sum_probs=207.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~l  208 (498)
                      ..+|.+.+.||+|+||.||+|.+.     +..||||++..... .....|.+|+.+++.++||||++++++|.+  ..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            346788899999999999999983     35699999975432 224568999999999999999999999854  5789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||++||+|.+++..  ....+++..+..|+.+++.||.|||+   .||+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999953  33569999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHH--HHhCccccccC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA--LDTGKLKNLLD  365 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~--~~~~~~~~~~~  365 (498)
                      ......     .......||+.|+|||++.+..++.++|||||||++|+|+| |..||.........  +..+       
T Consensus       203 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-------  270 (325)
T 3kul_A          203 DDPDAA-----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-------  270 (325)
T ss_dssp             ----CC-----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-------
T ss_pred             cCccce-----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-------
Confidence            432111     11233457889999999999999999999999999999999 99999765443322  2221       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                       .....+...+..+.+++..||..+|.+||++.+ +++.|+.+....
T Consensus       271 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-il~~L~~l~~~~  315 (325)
T 3kul_A          271 -YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ-IVSVLDALIRSP  315 (325)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHSC
T ss_pred             -CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHhCc
Confidence             111234455688999999999999999999998 888999887653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.8e-44  Score=359.18  Aligned_cols=255  Identities=24%  Similarity=0.334  Sum_probs=208.1

Q ss_pred             CCCChHHHHHhhcC----------CCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCC
Q 010882          126 SDFSFSEIEGATHN----------FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP  193 (498)
Q Consensus       126 ~~~~~~ei~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp  193 (498)
                      ..+++.+++.++..          |.....||+|+||.||+|...  +..||||++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34566777766653          566678999999999999984  789999999877666677899999999999999


Q ss_pred             Ceeeeeceec--CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc
Q 010882          194 NLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD  271 (498)
Q Consensus       194 niv~l~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~  271 (498)
                      ||++++++|.  +..++||||++||+|.+++..    ..+++..+..++.+++.||.|||+   .||+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence            9999999883  468999999999999999842    359999999999999999999999   8999999999999999


Q ss_pred             CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH
Q 010882          272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV  351 (498)
Q Consensus       272 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~  351 (498)
                      .++.+||+|||++.........        .....||+.|+|||++.+..++.++|||||||++|+|+||++||......
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~  247 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVPK--------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV  247 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             CCCcEEEeeeeeeeecccCccc--------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999876543211        13346999999999999999999999999999999999999999765543


Q ss_pred             HHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          352 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ......   .....+. ...+...+..+.+++.+||+.+|.+||++.+
T Consensus       248 ~~~~~~---~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  291 (321)
T 2c30_A          248 QAMKRL---RDSPPPK-LKNSHKVSPVLRDFLERMLVRDPQERATAQE  291 (321)
T ss_dssp             HHHHHH---HHSSCCC-CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHHH---hcCCCCC-cCccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            322111   1111111 1122345678999999999999999999988

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.1e-45  Score=359.69  Aligned_cols=264  Identities=23%  Similarity=0.385  Sum_probs=205.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEE------CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec----Ccc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~  206 (498)
                      .++|.+.+.||+|+||.||+|.+      .+..||||++..........+.+|+.++++++||||++++++|.    ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788889999999999999985      46889999998654444567899999999999999999999883    347


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            8999999999999999643  2358999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH-HHhCc------
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-LDTGK------  359 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~-~~~~~------  359 (498)
                      ........     .......||+.|+|||.+.+..++.++|||||||++|+|+||..||......... .....      
T Consensus       164 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          164 LPQDKEFF-----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             -----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             ccCCccee-----eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            65432111     1122345788899999999999999999999999999999999998754322111 00000      


Q ss_pred             ---cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          360 ---LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       360 ---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                         ............|..++..+.+++.+||+.+|.+||++.+ +.+.|+.+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-l~~~L~~l~~~  292 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD-LALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH-HHHHHHHHHHC
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHH-HHHHHHHHHHh
Confidence               0001111122234556788999999999999999999998 88888888654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.5e-45  Score=370.64  Aligned_cols=257  Identities=24%  Similarity=0.416  Sum_probs=208.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC---------CeEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeeceec--
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--  203 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~~--  203 (498)
                      ..+|.+.+.||+|+||.||+|.+.         +..||||++..... .....+.+|+.+|+.+ +||||++++++|.  
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            357888899999999999999863         24699999975432 1235688999999999 8999999999984  


Q ss_pred             CcceEEEeeCCCCCHHhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL  270 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl  270 (498)
                      +..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+   +||+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence            468999999999999999965431             2458999999999999999999999   899999999999999


Q ss_pred             cCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH
Q 010882          271 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK  349 (498)
Q Consensus       271 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  349 (498)
                      +.++.+||+|||+++..........      .....||+.|+|||++.+..++.++|||||||++|||+| |.+||....
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCT------TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCCCEEEccccCCcccCcccceec------ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999999999986654322111      123457899999999999999999999999999999999 999997543


Q ss_pred             H--HHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          350 E--VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       350 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .  ....+..+.        ....|..++..+.+++.+||+.+|.+||++.+ +++.|+.+...
T Consensus       311 ~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e-ll~~L~~il~~  365 (370)
T 2psq_A          311 VEELFKLLKEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ-LVEDLDRILTL  365 (370)
T ss_dssp             GGGHHHHHHTTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             HHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHHH
Confidence            2  222222221        12234456678999999999999999999998 88888887654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5e-45  Score=358.54  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..||+|++.......   ...+.+|+.++++++||||+++++++.+  ..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            46888999999999999999974  6889999986554333   3568899999999999999999999854  578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++...   .++++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++......
T Consensus        91 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           91 EYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            999999999999533   469999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      ....       .....||+.|+|||.+.+..++.++|||||||++|+|+||++||.............  ..........
T Consensus       165 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~  235 (294)
T 4eqm_A          165 SLTQ-------TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI--QDSVPNVTTD  235 (294)
T ss_dssp             -----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH--SSCCCCHHHH
T ss_pred             cccc-------cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--hccCCCcchh
Confidence            2111       123459999999999999999999999999999999999999998766544332211  1111111111


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      .+...+..+.+++.+||+.+|.+||+..+++...|..+.
T Consensus       236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            233355789999999999999999966665777776554

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-45  Score=366.13  Aligned_cols=257  Identities=23%  Similarity=0.364  Sum_probs=203.4

Q ss_pred             hhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC------cceEE
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE------VWTLV  209 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~------~~~lV  209 (498)
                      ...+|.+.+.||+|+||+||+|.+.+..||||++.... .....+..|+.++++++||||+++++++.+      ..++|
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            44678899999999999999999999999999986432 123346678999999999999999999843      25899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CcccCCCCCCcEEEcCCCceeEe
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH----------SIVHGDLKPANILLDANFVSKLS  279 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~----------~ivHrDlkp~NiLl~~~~~~kl~  279 (498)
                      |||+++|+|.+++..    ..+++..+..++.|++.||.|||+   .          +|+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            999999999999953    348999999999999999999999   6          99999999999999999999999


Q ss_pred             eccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-----CCCCccchHhHHHHHHHHHhCCCCCCCcH-----
Q 010882          280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITK-----  349 (498)
Q Consensus       280 DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~-----  349 (498)
                      |||+++..........      .....||+.|+|||++.+.     .++.++|||||||++|||+||++||....     
T Consensus       174 DFg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          174 DFGLALKFEAGKSAGD------THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCTTCEEECTTSCCCC------CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             cCCcccccccccCccc------cccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            9999987654432111      1334699999999999873     45668899999999999999999996421     


Q ss_pred             -------------HHHHHHHhCccccccCCCCCC--CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          350 -------------EVQYALDTGKLKNLLDPLAGD--WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       350 -------------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                                   ...........    .+....  .+...+..+.+|+.+||+.||.+||++.+ +++.|+.+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-ll~~L~~l~~~  319 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC-VGERITQMQRL  319 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHHH
Confidence                         11111111111    111111  12245677999999999999999999998 88888888754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.6e-45  Score=365.15  Aligned_cols=239  Identities=26%  Similarity=0.394  Sum_probs=200.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      .++|.+.+.||+|+||.||+|.+  .+..||||++......  ....+.+|+.+|+.++||||+++++++.  ...++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45789999999999999999998  4789999999754322  2346889999999999999999999984  4589999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++...   ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999999533   458999999999999999999999   89999999999999999999999999999865433


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCC-CccchHhHHHHHHHHHhCCCCCCCcHHHH--HHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~  367 (498)
                      ..         .....||+.|+|||++.+..++ .++|||||||++|+|+||++||...+...  ..+..+..       
T Consensus       168 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------  231 (328)
T 3fe3_A          168 GK---------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-------  231 (328)
T ss_dssp             CG---------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred             Cc---------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Confidence            21         1234599999999999988775 78999999999999999999998765432  22222221       


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        ..|...+..+.+|+.+||..||.+||++.+
T Consensus       232 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e  261 (328)
T 3fe3_A          232 --RIPFYMSTDCENLLKRFLVLNPIKRGTLEQ  261 (328)
T ss_dssp             --CCCTTSCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             --CCCCCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence              234456678999999999999999999988

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=362.27  Aligned_cols=265  Identities=23%  Similarity=0.403  Sum_probs=206.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ++|...+.||+|+||+||+|.+.  +..||+|++..........|.+|+.++++++||||++++++|.  ...++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            46788889999999999999985  6889999987654445567999999999999999999999984  4588999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++...  ...+++..+..|+.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.........
T Consensus        90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999643  3569999999999999999999999   89999999999999999999999999999876544322


Q ss_pred             CCCc------cceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          294 SNNT------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       294 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                      ....      .........||+.|+|||++.+..++.++|||||||++|+|++|.+||............ ......   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-~~~~~~---  240 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-NVRGFL---  240 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-CHHHHH---
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-hhhccc---
Confidence            1100      001112456999999999999999999999999999999999999998532110000000 000000   


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ....|...+..+.+++.+||+.+|.+||++.+ +.+.|+.+....
T Consensus       241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~-l~~~L~~l~~~~  284 (310)
T 3s95_A          241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVK-LEHWLETLRMHL  284 (310)
T ss_dssp             HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHHH
T ss_pred             cccCCCCCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHHhc
Confidence            00123334567999999999999999999988 888898887543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-44  Score=349.26  Aligned_cols=254  Identities=26%  Similarity=0.472  Sum_probs=209.4

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLP  214 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~~  214 (498)
                      .+|...+.||+|+||.||+|.+ .+..||||++.... ...+.+.+|+.++++++||||+++++++.+  ..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            4678888999999999999998 56789999997543 345679999999999999999999999854  5789999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++..  ....+++..+..++.+++.||.|||+   ++|+||||||+|||++.++.+||+|||++..........
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            9999999953  33568999999999999999999999   899999999999999999999999999998665432111


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                             .....||+.|+|||.+.+..++.++|||||||++|+|+| |++||...............      .....|.
T Consensus       164 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~  230 (269)
T 4hcu_A          164 -------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------FRLYKPR  230 (269)
T ss_dssp             -------TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------CCCCCCT
T ss_pred             -------ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC------ccCCCCC
Confidence                   123347889999999999999999999999999999999 99999865543322211111      1112233


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ..+..+.+++..||+.+|.+||++.+ +++.|+.+...
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~~~-ll~~l~~l~~~  267 (269)
T 4hcu_A          231 LASTHVYQIMNHCWRERPEDRPAFSR-LLRQLAEIAES  267 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHC
T ss_pred             cCCHHHHHHHHHHccCCcccCcCHHH-HHHHHHHHHHc
Confidence            45678999999999999999999988 88888887653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.2e-45  Score=359.34  Aligned_cols=255  Identities=22%  Similarity=0.343  Sum_probs=198.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHc--CCCCCeeeeeceec------CcceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACP------EVWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~g~~~------~~~~l  208 (498)
                      .++|.+.+.||+|+||+||+|.+++..||||++...   ....+..|.+++..  ++||||+++++++.      ...++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            357888999999999999999999999999998643   34566777777776  79999999999862      24789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcccCCCCCCcEEEcCCCceeEee
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH--------SCKPHSIVHGDLKPANILLDANFVSKLSD  280 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  280 (498)
                      ||||+++|+|.+++.    ...+++..++.++.+++.||.|||        +   ++|+||||||+|||++.++.+||+|
T Consensus        84 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred             ehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence            999999999999994    246999999999999999999999        6   8999999999999999999999999


Q ss_pred             ccccccccccccCCCCccceeccCCCCCCCcCChhhhccC------CCCCccchHhHHHHHHHHHhC----------CCC
Q 010882          281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTG----------RPA  344 (498)
Q Consensus       281 FGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG----------~~p  344 (498)
                      ||+++.........    ........||+.|+|||++.+.      .++.++|||||||++|||+||          .+|
T Consensus       157 fg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          157 LGLAVMHSQSTNQL----DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             CTTCEEEETTTTEE----ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             CCCeeecccccccc----cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            99998655432111    1112334699999999999876      445789999999999999999          888


Q ss_pred             CCCc-------HHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          345 LGIT-------KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       345 f~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      |...       ...............+  .....+...+..+.+++.+||+.+|.+||++.+ +++.|+.+
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~-i~~~L~~i  300 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQRPNI--PNRWFSDPTLTSLAKLMKECWYQNPSARLTALR-IKKTLTKI  300 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCC--CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH-HHHHHHHH
T ss_pred             ccccCCCCcchhhhhHHHhccCCCCCC--ChhhccCccHHHHHHHHHHHhhcChhhCCCHHH-HHHHHhcc
Confidence            8532       1111111111110000  001122346788999999999999999999988 77777764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.6e-45  Score=366.11  Aligned_cols=267  Identities=25%  Similarity=0.376  Sum_probs=213.9

Q ss_pred             CCChHHHHHhhcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeee
Q 010882          127 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVT  197 (498)
Q Consensus       127 ~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~  197 (498)
                      .+...++....++|.+.+.||+|+||.||+|.+.       +..||||++...... ....+.+|+.++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            3455666677789999999999999999999853       378999999754322 234689999999999 7999999


Q ss_pred             eeceecC---cceEEEeeCCCCCHHhhhccCCC-----------------------------------------------
Q 010882          198 LVGACPE---VWTLVYEYLPNGSLEDRLSCKDN-----------------------------------------------  227 (498)
Q Consensus       198 l~g~~~~---~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------  227 (498)
                      ++++|.+   ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999843   37899999999999999965432                                               


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          228 ----------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       228 ----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                                      ...+++..++.|+.+++.||.|||+   +||+||||||+||||+.++.+||+|||++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            1228999999999999999999999   899999999999999999999999999998664432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH---HHHHHHHhCccccccCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK---EVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~---~~~~~~~~~~~~~~~~~~  367 (498)
                      ..      .......||+.|+|||++.+..++.++|||||||++|||+| |.+||....   .....+..+.        
T Consensus       248 ~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------  313 (359)
T 3vhe_A          248 DY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------  313 (359)
T ss_dssp             TC------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--------
T ss_pred             cc------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC--------
Confidence            11      11233458999999999999999999999999999999999 999997543   2222222221        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ....|...+..+.+++..||+.+|.+||++.+ +++.|+.+...
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e-ll~~L~~~~~~  356 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE-LVEHLGNLLQA  356 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHH-HHHHHHHHHHH
Confidence            11234445678999999999999999999988 88888877653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-44  Score=362.26  Aligned_cols=239  Identities=22%  Similarity=0.298  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|...+.||+|+||.||+|...  +..||||++.+.   .......+.+|+.+|+.++||||+++++++.  +..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            46888899999999999999984  788999999753   2334567889999999999999999999984  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++..   ...+++..+..++.+++.||.|||+   +||+||||||+|||++.+|++||+|||+|+.....
T Consensus        85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999999953   3468999999999999999999999   89999999999999999999999999999854332


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~  368 (498)
                      ...        .....||+.|+|||++.+..++.++|||||||++|||+||++||...+....  .+..+.         
T Consensus       159 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  221 (337)
T 1o6l_A          159 GAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------  221 (337)
T ss_dssp             TCC--------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             CCc--------ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence            211        1234599999999999999999999999999999999999999976543322  222211         


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCC-----ChhH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRP-----ELGK  399 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----~~~~  399 (498)
                      ..+|...+..+.+++.+||..+|.+||     ++.+
T Consensus       222 ~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~e  257 (337)
T 1o6l_A          222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE  257 (337)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHH
Confidence            124555678899999999999999999     5655

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.5e-44  Score=363.53  Aligned_cols=245  Identities=22%  Similarity=0.320  Sum_probs=200.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC------ChhhHHHHHHHHHcCCCCCeeeeeceecC--cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACPE--VW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~  206 (498)
                      ...|.+.+.||+|+||.||+|...  +..||||++......      ..+.+.+|+.+|+.++||||++++++|.+  ..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            347889999999999999999985  788999999865432      24678999999999999999999999854  58


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC----ceeEeecc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFG  282 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFG  282 (498)
                      ++||||++||+|.+++.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999994   34579999999999999999999999   8999999999999998776    79999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      ++........         .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.............
T Consensus       165 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~  235 (361)
T 2yab_A          165 LAHEIEDGVE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY  235 (361)
T ss_dssp             SCEECCTTCC---------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred             CceEcCCCCc---------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence            9987654321         1234599999999999999999999999999999999999999976654332221111110


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .++   ..++...+..+.+|+.+||..||.+||++.+
T Consensus       236 ~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e  269 (361)
T 2yab_A          236 DFD---EEFFSQTSELAKDFIRKLLVKETRKRLTIQE  269 (361)
T ss_dssp             CCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCC---chhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            000   0011234578999999999999999999988

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-44  Score=367.37  Aligned_cols=256  Identities=27%  Similarity=0.459  Sum_probs=196.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~l  208 (498)
                      ..+|.+.+.||+|+||.||+|.+.     +..||||+++.... .....|.+|+.++++++||||++++|+|.+  ..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999874     46799999975432 223568999999999999999999999854  5799


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+++|+|.+++..  ....+++..++.|+.+++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999963  33569999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLD  365 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~  365 (498)
                      ........     .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  ..+..+.      
T Consensus       199 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~------  267 (373)
T 2qol_A          199 DDPEAAYT-----TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY------  267 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE------
T ss_pred             cCCcccee-----ccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            43211111     122346789999999999999999999999999999998 999997554322  2222211      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                        ....+...+..+.+++.+||+.+|.+||++.+ +++.|+.+...
T Consensus       268 --~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~-i~~~L~~~~~~  310 (373)
T 2qol_A          268 --RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ-IVSILDKLIRN  310 (373)
T ss_dssp             --ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHC
T ss_pred             --CCCCCccccHHHHHHHHHHhCcChhhCcCHHH-HHHHHHHHHhC
Confidence              11123345678999999999999999999998 88888888654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.4e-45  Score=371.71  Aligned_cols=255  Identities=25%  Similarity=0.420  Sum_probs=207.1

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ...+|.+.+.||+|+||.||+|.+.  +..||||++...... ....|.+|+.+|++++||||++++|+|.  +..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3457888899999999999999995  788999998754221 2346889999999999999999999985  4589999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            999999999999632  3458999999999999999999999   89999999999999999999999999999865433


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~  367 (498)
                      .....      .....+++.|+|||++.++.++.++|||||||++|||+| |.+||.......  ..+..+.        
T Consensus       267 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------  332 (377)
T 3cbl_A          267 VYAAS------GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG--------  332 (377)
T ss_dssp             EEECC------SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC--------
T ss_pred             ceeec------CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            21111      111235778999999999999999999999999999999 999997654332  2222221        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ....|..++..+.+|+.+||+.+|.+||++.+ +.+.|+.+..
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~-i~~~L~~i~~  374 (377)
T 3cbl_A          333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFST-IYQELQSIRK  374 (377)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH-HHHHHHHHHh
Confidence            11234445678999999999999999999998 8888888764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.5e-44  Score=374.56  Aligned_cols=249  Identities=27%  Similarity=0.456  Sum_probs=207.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec---CcceEEEeeC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYL  213 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~---~~~~lV~E~~  213 (498)
                      ..+|.+.+.||+|+||.||+|.+++..||||+++...  ..+.|.+|+.+|++++||||++++++|.   ...++||||+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            4568888999999999999999999999999998643  4578999999999999999999999873   2579999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++.... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......  
T Consensus       270 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          270 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             TTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence            9999999996432 2347899999999999999999999   899999999999999999999999999998543221  


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH--HHHHHHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  370 (498)
                               ....+|+.|+|||++.+..++.++|||||||+||||+| |+.||.....  +...+..+.        ...
T Consensus       344 ---------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~~~  406 (450)
T 1k9a_A          344 ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------KMD  406 (450)
T ss_dssp             ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC--------CCC
T ss_pred             ---------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCC
Confidence                     11247899999999999999999999999999999999 9999975432  222222221        122


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .|..++..+.+|+.+||+.+|.+||++.+ +...|+.+...
T Consensus       407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~-l~~~L~~i~~~  446 (450)
T 1k9a_A          407 APDGCPPAVYDVMKNCWHLDAATRPTFLQ-LREQLEHIRTH  446 (450)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHT
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHHHHh
Confidence            34556789999999999999999999998 88888887653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-44  Score=362.26  Aligned_cols=259  Identities=27%  Similarity=0.481  Sum_probs=210.5

Q ss_pred             HHhhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--
Q 010882          134 EGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--  203 (498)
Q Consensus       134 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--  203 (498)
                      ....++|.+.+.||+|+||.||+|.+.+       ..||||++...... ....+.+|+.++++++||||++++++|.  
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            3446789999999999999999999864       78999999754322 2456889999999999999999999984  


Q ss_pred             CcceEEEeeCCCCCHHhhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCC
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKDN---------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD  262 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD  262 (498)
                      +..++||||+++|+|.+++.....                     ...+++..++.|+.|++.||.|||+   +||+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence            468999999999999999965321                     2579999999999999999999999   8999999


Q ss_pred             CCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-C
Q 010882          263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-G  341 (498)
Q Consensus       263 lkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G  341 (498)
                      |||+|||++.++.+||+|||++..........      ......||+.|+|||++.+..++.++|||||||++|+|+| |
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  273 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYK------ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  273 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCcccc------ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence            99999999999999999999998664432111      1133458999999999999999999999999999999999 9


Q ss_pred             CCCCCCcHHHH--HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          342 RPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       342 ~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ..||.......  ..+..+..        ...|...+..+.+++.+||+.+|.+||++.+ +.+.|+.+..
T Consensus       274 ~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~-~~~~L~~~~~  335 (343)
T 1luf_A          274 LQPYYGMAHEEVIYYVRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCS-IHRILQRMCE  335 (343)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHTTC
T ss_pred             CCcCCCCChHHHHHHHhCCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHH-HHHHHHHHHh
Confidence            99997654332  22222221        1234455678999999999999999999988 8888887643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.3e-44  Score=355.15  Aligned_cols=261  Identities=20%  Similarity=0.252  Sum_probs=205.7

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|.+.+.||+|+||.||+|..  .+..||||++....  ....+.+|+.+++.+ +||||+++++++.  +..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            5788889999999999999997  47899999987543  235789999999999 9999999999874  457899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc-----eeEeeccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-----SKLSDFGISRFL  287 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~-----~kl~DFGla~~~  287 (498)
                      + +|+|.+++...  ...+++..++.|+.|++.||.|||+   .||+||||||+|||++.++.     +||+|||+++.+
T Consensus        87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            9 99999999643  3569999999999999999999999   89999999999999998887     999999999976


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH---HHH--HHHHhCcccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK---EVQ--YALDTGKLKN  362 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~~~--~~~~~~~~~~  362 (498)
                      ........ ..........||+.|+|||++.+..++.++|||||||++|||+||++||...+   ...  ..+.......
T Consensus       161 ~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          161 IDPETKKH-IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             BCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             ecCCCCcc-ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            54432211 11111245579999999999999999999999999999999999999997521   111  1111111111


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhcC
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG  413 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~~  413 (498)
                      ..+...    ...+ .+.+++..||+.+|.+||++.+ +.+.|+.+....+
T Consensus       240 ~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~-l~~~l~~~~~~~~  284 (330)
T 2izr_A          240 PIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDY-LRKLFTDLFDRKG  284 (330)
T ss_dssp             CHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHH-HHHHHHHHHHHTT
T ss_pred             CHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHH-HHHHHHHHHHHcC
Confidence            000000    1123 8999999999999999999988 8888888776544

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4e-44  Score=350.22  Aligned_cols=247  Identities=30%  Similarity=0.499  Sum_probs=201.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCCh-------hhHHHHHHHHHcCCCCCeeeeeceecCcce
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGP-------SEFQQEIDILSKIRHPNLVTLVGACPEVWT  207 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-------~~~~~E~~il~~l~hpniv~l~g~~~~~~~  207 (498)
                      .++|...+.||+|+||.||+|.+  .+..||||++........       ..+.+|+.++++++||||+++++++.+..+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR   97 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence            35788889999999999999998  478899999876543322       568899999999999999999999988889


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cccCCCCCCcEEEcCCCc-----eeEee
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANFV-----SKLSD  280 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NiLl~~~~~-----~kl~D  280 (498)
                      +||||+++|+|.+.+..  ...++++..+..++.+++.||.|||+   ++  |+||||||+|||++.++.     +||+|
T Consensus        98 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             EEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             EEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            99999999999998853  34579999999999999999999999   77  999999999999988776     99999


Q ss_pred             ccccccccccccCCCCccceeccCCCCCCCcCChhhhc--cCCCCCccchHhHHHHHHHHHhCCCCCCCcHH--H--HHH
Q 010882          281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA--SGELTPKSDVYSFGIILLRLLTGRPALGITKE--V--QYA  354 (498)
Q Consensus       281 FGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--~--~~~  354 (498)
                      ||+++.....           .....||+.|+|||++.  ...++.++|||||||++|+|+||+.||.....  .  ...
T Consensus       173 fg~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  241 (287)
T 4f0f_A          173 FGLSQQSVHS-----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM  241 (287)
T ss_dssp             CTTCBCCSSC-----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred             CCcccccccc-----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence            9998744322           12345999999999984  45678899999999999999999999975321  1  111


Q ss_pred             HHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          355 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      ......       ....+...+..+.+++.+||+.+|.+||++.+ +++.|+.
T Consensus       242 ~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-ll~~L~~  286 (287)
T 4f0f_A          242 IREEGL-------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSY-IVKELSE  286 (287)
T ss_dssp             HHHSCC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHT
T ss_pred             HhccCC-------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHH-HHHHHHh
Confidence            111111       12234456688999999999999999999988 6666654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.6e-44  Score=347.43  Aligned_cols=247  Identities=28%  Similarity=0.469  Sum_probs=194.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCC----ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .+|...+.||+|+||.||+|.+.+..||||++......    ..+.+.+|+.+++.++||||++++++|.  +..++|||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            46888889999999999999999999999998764322    2467889999999999999999999984  35799999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---cccCCCCCCcEEEcC--------CCceeEee
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS---IVHGDLKPANILLDA--------NFVSKLSD  280 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---ivHrDlkp~NiLl~~--------~~~~kl~D  280 (498)
                      |+++|+|.+++.    ...+++..+..++.+++.||.|||+   ++   |+||||||+|||++.        ++.+||+|
T Consensus        87 ~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           87 FARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             CCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             cCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999984    3469999999999999999999999   66   999999999999986        77899999


Q ss_pred             ccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc
Q 010882          281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL  360 (498)
Q Consensus       281 FGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (498)
                      ||++........          ....||+.|+|||.+.+..++.++||||||+++|+|+||++||...+.......... 
T Consensus       160 fg~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-  228 (271)
T 3dtc_A          160 FGLAREWHRTTK----------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-  228 (271)
T ss_dssp             CCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT-
T ss_pred             CCcccccccccc----------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc-
Confidence            999986543321          123589999999999999999999999999999999999999986554332221110 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                          .......+...+..+.+++.+||+.+|.+||++.+ +++.|+.
T Consensus       229 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-~l~~L~~  270 (271)
T 3dtc_A          229 ----NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTN-ILDQLTT  270 (271)
T ss_dssp             ----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHC
T ss_pred             ----CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHH-HHHHHhc
Confidence                01112234455678999999999999999999988 7666653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-44  Score=361.18  Aligned_cols=253  Identities=24%  Similarity=0.414  Sum_probs=203.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--Ce----EEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV  209 (498)
                      .+|...+.||+|+||.||+|.+.  +.    +||+|.+.... ......+.+|+.+++.++||||++++++|. +..++|
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v   92 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV   92 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence            46788889999999999999984  33    48888886543 233456889999999999999999999985 468899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++...  ...+++..+..|+.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            9999999999999633  3468889999999999999999999   8999999999999999999999999999997654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH--HHHHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK--EVQYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~--~~~~~~~~~~~~~~~~~  366 (498)
                      ......      .....||+.|+|||++.+..++.++|||||||++|+|+| |++||....  .....+..+..      
T Consensus       168 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------  235 (325)
T 3kex_A          168 DDKQLL------YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER------  235 (325)
T ss_dssp             CTTCCC-----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB------
T ss_pred             cccccc------ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC------
Confidence            432111      123458889999999999999999999999999999999 999997543  22222322211      


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                        ...|...+..+.+++.+||..+|.+||++.+ +++.|+.+..
T Consensus       236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e-l~~~l~~~~~  276 (325)
T 3kex_A          236 --LAQPQICTIDVYMVMVKCWMIDENIRPTFKE-LANEFTRMAR  276 (325)
T ss_dssp             --CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHH-HHHHHHHHTT
T ss_pred             --CCCCCcCcHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHh
Confidence              1123334567899999999999999999998 7778877653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-43  Score=347.84  Aligned_cols=257  Identities=27%  Similarity=0.449  Sum_probs=197.1

Q ss_pred             hhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEEee
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEY  212 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~E~  212 (498)
                      ..++|.+.+.||+|+||.||+|.+.+ .||||++.......  ...|.+|+.+++.++||||+++++++.. ..++||||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~  100 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW  100 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence            34578999999999999999998765 59999997654322  3568899999999999999999998744 57899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++++|.+++..  ....+++..++.++.+++.||.|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus       101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          101 CEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             cCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            999999999953  34569999999999999999999999   8999999999999999999999999999986543221


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHH---HHHHHHhCccccccCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDTGKLKNLLDP  366 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~~~~~~~~~~~  366 (498)
                      ...      .....||+.|+|||++.   +..++.++|||||||++|+|+||+.||.....   ....+..+.....+  
T Consensus       176 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  247 (289)
T 3og7_A          176 SHQ------FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL--  247 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT--
T ss_pred             ccc------ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch--
Confidence            111      12345899999999997   56788899999999999999999999975332   23333333332222  


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                        ...+..++..+.+++.+||+.+|.+||++.+ +++.|+.+.
T Consensus       248 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e-ll~~L~~l~  287 (289)
T 3og7_A          248 --SKVRSNCPKRMKRLMAECLKKKRDERPSFPR-ILAEIEELA  287 (289)
T ss_dssp             --TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHTT
T ss_pred             --hhccccCCHHHHHHHHHHccCChhhCCCHHH-HHHHHHHHh
Confidence              2233345678999999999999999999988 777777653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-44  Score=375.84  Aligned_cols=259  Identities=29%  Similarity=0.491  Sum_probs=212.1

Q ss_pred             HHHHHhhcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceE
Q 010882          131 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL  208 (498)
Q Consensus       131 ~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~l  208 (498)
                      .++.....+|.+.+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|+.++||||+++++++. +..++
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~l  259 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYI  259 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEE
Confidence            334455667888999999999999999996 6789999998644 35678999999999999999999999985 46899


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+++...
T Consensus       260 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            999999999999995321 2358889999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLD  365 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~  365 (498)
                      ......       .....+|+.|+|||++....++.++|||||||+||||+| |++||.......  ..+..+.      
T Consensus       336 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------  402 (454)
T 1qcf_A          336 DNEYTA-------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------  402 (454)
T ss_dssp             CHHHHT-------TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC------
T ss_pred             CCceec-------cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            432111       122346889999999999999999999999999999999 999997654332  2222221      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                        ....|..++..+.+++.+||..+|.+||++.+ +...|+.+..
T Consensus       403 --~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~-i~~~L~~~~~  444 (454)
T 1qcf_A          403 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEY-IQSVLDDFYT  444 (454)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHTSSS
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhHCcCHHH-HHHHHHHHHh
Confidence              11124455688999999999999999999988 7788877643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=366.15  Aligned_cols=257  Identities=23%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~  206 (498)
                      ..+|.+.+.||+|+||.||+|.+.       +..||||++..... .....+.+|+.++++++||||++++++|.+  ..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357888999999999999999853       45799999875422 223468899999999999999999999844  57


Q ss_pred             eEEEeeCCCCCHHhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC---ceeEe
Q 010882          207 TLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLS  279 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~  279 (498)
                      ++||||++||+|.+++....    ....+++..++.++.|++.||.|||+   +||+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996532    22468999999999999999999999   8999999999999999554   59999


Q ss_pred             eccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHH
Q 010882          280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALD  356 (498)
Q Consensus       280 DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~  356 (498)
                      |||+++...........      ....||+.|+|||++.+..++.++|||||||++|||+| |.+||........  .+.
T Consensus       227 DFG~a~~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKG------GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             CCHHHHHHHHHSSCTTC------CGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CCccccccccccccccC------CCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999865433221111      22347999999999999999999999999999999998 9999976544322  222


Q ss_pred             hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          357 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .+.        ....+...+..+.+|+.+||+.+|.+||++.+ +++.|+.+...
T Consensus       301 ~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e-il~~l~~~~~~  346 (367)
T 3l9p_A          301 SGG--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI-ILERIEYCTQD  346 (367)
T ss_dssp             TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHC
T ss_pred             cCC--------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHhhC
Confidence            211        11234445678999999999999999999988 87888877643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=362.82  Aligned_cols=259  Identities=25%  Similarity=0.406  Sum_probs=211.2

Q ss_pred             hhcCCCCCCcccccCceEEEEEEECC---------eEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceecC
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACPE  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~~  204 (498)
                      ..++|.+.+.||+|+||.||+|.+.+         ..||||++...... ....+.+|+.+++++ +||||++++++|.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            34578889999999999999998632         57999999765322 235688999999999 89999999999843


Q ss_pred             --cceEEEeeCCCCCHHhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEE
Q 010882          205 --VWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL  269 (498)
Q Consensus       205 --~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiL  269 (498)
                        ..++||||+++|+|.+++.....             ...+++..++.|+.|++.||.|||+   ++|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence              58999999999999999965431             2469999999999999999999999   89999999999999


Q ss_pred             EcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCc
Q 010882          270 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT  348 (498)
Q Consensus       270 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~  348 (498)
                      |+.++.+||+|||+++..........      .....||+.|+|||++.+..++.++|||||||++|+|+| |..||...
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCC------CTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EcCCCcEEEcccCccccccccccccc------ccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999986654322111      133457899999999999999999999999999999999 99999765


Q ss_pred             HHHH--HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          349 KEVQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       349 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ....  ..+..+.        ....+...+..+.+++.+||+.+|.+||++.+ +++.|+.+.+..
T Consensus       298 ~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e-ll~~L~~~~~~~  354 (382)
T 3tt0_A          298 PVEELFKLLKEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ-LVEDLDRIVALT  354 (382)
T ss_dssp             CHHHHHHHHHTTC--------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHHS
T ss_pred             CHHHHHHHHHcCC--------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHHHH
Confidence            4322  2222221        11233445678999999999999999999998 888899887664

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-44  Score=360.72  Aligned_cols=259  Identities=24%  Similarity=0.392  Sum_probs=195.7

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEECC-----eEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceecC--c
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE--V  205 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~  205 (498)
                      ....+|.+.+.||+|+||.||+|.+..     ..||||++.....  .....+.+|+.++++++||||+++++++..  .
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999998753     2799999976532  234678999999999999999999998843  2


Q ss_pred             ------ceEEEeeCCCCCHHhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          206 ------WTLVYEYLPNGSLEDRLSCKD---NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       206 ------~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                            .++||||+++|+|.+++....   ....+++..+..|+.|++.||.|||+   +||+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence                  289999999999999985432   22369999999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--H
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--Y  353 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~  353 (498)
                      ||+|||++...........      .....||+.|+|||.+.+..++.++|||||||++|+|+| |.+||.......  .
T Consensus       177 kl~Dfg~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQ------GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             EECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             EEeeccccccccccccccc------cccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            9999999987654332111      123347889999999999999999999999999999999 999997543321  1


Q ss_pred             HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .+..+.        ....+...+..+.+++.+||+.+|.+||++.+ +.+.|+.+...
T Consensus       251 ~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-l~~~l~~~l~~  299 (323)
T 3qup_A          251 YLIGGN--------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTC-LRMELENILGH  299 (323)
T ss_dssp             HHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHHHC
T ss_pred             HHhcCC--------CCCCCCccCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHHH
Confidence            111111        11234445678999999999999999999988 88888888764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.3e-44  Score=356.66  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=197.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC----------
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE----------  204 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~----------  204 (498)
                      .+|.+.+.||+|+||.||+|.+.  +..||||++...... ..+.+.+|+.+|++++||||++++++|.+          
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            46888899999999999999985  788999999754432 34679999999999999999999998722          


Q ss_pred             -------------------------------------------------cceEEEeeCCCCCHHhhhccCCCCCCCCHHH
Q 010882          205 -------------------------------------------------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT  235 (498)
Q Consensus       205 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~  235 (498)
                                                                       ..++||||++||+|.+++.........++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             2689999999999999997665556677888


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCc----cceeccCCCCCCCc
Q 010882          236 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT----TLCCRTDPKGTFAY  311 (498)
Q Consensus       236 ~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~----~~~~~~~~~gt~~y  311 (498)
                      ++.++.|++.||.|||+   +||+||||||+||||+.++.+||+|||+++............    .........||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            99999999999999999   899999999999999999999999999998776543211100    01112345699999


Q ss_pred             CChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhccc
Q 010882          312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR  391 (498)
Q Consensus       312 ~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p  391 (498)
                      +|||++.+..++.++|||||||++|+|+||..|+................        ..+...+..+.+++.+||+.+|
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p  314 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFP--------LLFTQKYPQEHMMVQDMLSPSP  314 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCC--------HHHHHHCHHHHHHHHHHHCSSG
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCC--------cccccCChhHHHHHHHHccCCC
Confidence            99999999999999999999999999999988864333222222221111        1122345678999999999999


Q ss_pred             CCCCChhHH
Q 010882          392 KSRPELGKD  400 (498)
Q Consensus       392 ~~RP~~~~~  400 (498)
                      .+||++.++
T Consensus       315 ~~Rps~~~~  323 (332)
T 3qd2_B          315 TERPEATDI  323 (332)
T ss_dssp             GGSCCHHHH
T ss_pred             CcCCCHHHH
Confidence            999999883

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.3e-44  Score=358.69  Aligned_cols=243  Identities=26%  Similarity=0.378  Sum_probs=194.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      ++|.+.+.||+|+||+||+|.+.  +..||||++..... ...+.+.+|+.+++.++||||+++++++.+  ..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            47888899999999999999985  68899999875433 234678999999999999999999999854  57899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++||+|.+++.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++..+.....
T Consensus        87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999994   34569999999999999999999999   8999999999999999999999999999986643321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHH---HHHHhCccccccCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQ---YALDTGKLKNLLDPLA  368 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~---~~~~~~~~~~~~~~~~  368 (498)
                      ..      ......||+.|+|||++.+..+ +.++|||||||++|+|+||++||.......   ......  ....    
T Consensus       161 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~----  228 (323)
T 3tki_A          161 ER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYL----  228 (323)
T ss_dssp             EC------CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT--CTTS----
T ss_pred             cc------ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc--cccC----
Confidence            11      1133469999999999988775 778999999999999999999997543211   111111  0000    


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       ......+..+.+|+.+||..||.+||++.+
T Consensus       229 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  258 (323)
T 3tki_A          229 -NPWKKIDSAPLALLHKILVENPSARITIPD  258 (323)
T ss_dssp             -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             -CccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence             111335678899999999999999999988

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=364.67  Aligned_cols=238  Identities=24%  Similarity=0.305  Sum_probs=195.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~l  208 (498)
                      ..+|.+.+.||+|+||.||+|...  +..||||++...   .......+..|..+++.+ +||||+++++++.  +..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            457899999999999999999985  688999998753   223445688999999988 7999999999984  46899


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||++||+|.+++...   ..+++..+..++.+++.||.|||+   +||+||||||+||||+.+|++||+|||+|+...
T Consensus       102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999999543   459999999999999999999999   899999999999999999999999999998543


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP  366 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~  366 (498)
                      .....        .....||+.|+|||++.+..++.++|||||||++|||+||++||...+.....  +..+.       
T Consensus       176 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------  240 (353)
T 3txo_A          176 CNGVT--------TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-------  240 (353)
T ss_dssp             C-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             cCCcc--------ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------
Confidence            22211        12345999999999999989999999999999999999999999876543322  22211       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                        ..+|...+..+.+++.+||..+|.+||++
T Consensus       241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          241 --VVYPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             --CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence              12445566789999999999999999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.2e-44  Score=346.52  Aligned_cols=253  Identities=25%  Similarity=0.485  Sum_probs=207.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYL  213 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~  213 (498)
                      ..+|.+.+.||+|+||.||+|.+.+ ..||||++.... .....+.+|+.++.+++||||++++++|.+  ..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            4578888999999999999998864 579999997544 345679999999999999999999999854  578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++...  ...+++..+..++.+++.||.|||+   .||+||||||+|||++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999999543  2458999999999999999999999   89999999999999999999999999999866543211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                             ......||+.|+|||.+.+..++.++||||||+++|+|+| |.+||.................      ...|
T Consensus       161 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------~~~~  227 (268)
T 3sxs_A          161 -------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------LYRP  227 (268)
T ss_dssp             -------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------CCCC
T ss_pred             -------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC------CCCC
Confidence                   1233457888999999999899999999999999999999 9999986554433222111111      1123


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ...+..+.+++..||+.+|.+||++.+ +++.|+.+.
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~-ll~~L~~l~  263 (268)
T 3sxs_A          228 HLASDTIYQIMYSCWHELPEKRPTFQQ-LLSSIEPLR  263 (268)
T ss_dssp             TTSCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHGGGC
T ss_pred             CcChHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHhh
Confidence            334578999999999999999999998 777887764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-44  Score=355.68  Aligned_cols=245  Identities=22%  Similarity=0.330  Sum_probs=199.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC------ChhhHHHHHHHHHcCCCCCeeeeeceecC--cce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~  207 (498)
                      ..|.+.+.||+|+||.||+|...  +..||||++......      ..+.+.+|+.+|+.++||||+++++++.+  ..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46888899999999999999985  688999998765332      34679999999999999999999999843  589


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC----ceeEeeccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI  283 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFGl  283 (498)
                      +||||+++|+|.+++.   ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999994   34569999999999999999999999   8999999999999999877    899999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      +........         .....||+.|+|||++.+..++.++|||||||++|+|+||.+||..................
T Consensus       165 a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  235 (326)
T 2y0a_A          165 AHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE  235 (326)
T ss_dssp             CEECCTTSC---------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred             CeECCCCCc---------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence            987653321         12345999999999999999999999999999999999999999765443322111111000


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .   ....+...+..+.+++.+||..+|.+||++.++
T Consensus       236 ~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  269 (326)
T 2y0a_A          236 F---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS  269 (326)
T ss_dssp             C---CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             c---CccccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            0   000112245678999999999999999999883

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-44  Score=356.28  Aligned_cols=258  Identities=24%  Similarity=0.395  Sum_probs=198.8

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCCh---hhHHHHHHHHHcCCCCCeeeeeceecC--c----c
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE--V----W  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~hpniv~l~g~~~~--~----~  206 (498)
                      ++|.+.+.||+|+||.||+|.+  .+..||||++........   ..+.+|+.++++++||||+++++++..  .    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            4788899999999999999997  468999999987544432   368899999999999999999998743  2    3


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||++||+|.+++...   .++++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus        92 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            8999999999999999533   468999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      ........     .......||+.|+|||++.+..++.++|||||||++|+|+||++||.................. .+
T Consensus       166 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~  239 (311)
T 3ork_A          166 IADSGNSV-----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PP  239 (311)
T ss_dssp             ---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-CH
T ss_pred             cccccccc-----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-Cc
Confidence            65432211     1123345899999999999999999999999999999999999999876554332221100000 00


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                        ...+...+..+.+++.+||+.||.+||+..+++...+..+.
T Consensus       240 --~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          240 --SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             --HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence              00111245789999999999999999999887766665553

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-44  Score=354.53  Aligned_cols=232  Identities=25%  Similarity=0.385  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      .+|.+.+.||+|+||.||++...  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+  ..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            46888899999999999999984  788999998753   22345678899999999999999999999854  588999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++..   ...+++..+..++.+++.||.|||+   +||+||||||+|||++.+|.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            99999999999953   3468999999999999999999999   89999999999999999999999999999865432


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~  368 (498)
                      .           ....||+.|+|||++.+..++.++|||||||++|||+||++||...+.....  +..+.         
T Consensus       160 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------  219 (318)
T 1fot_A          160 T-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---------  219 (318)
T ss_dssp             B-----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC---------
T ss_pred             c-----------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence            1           2345999999999999999999999999999999999999999765543322  11111         


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCC
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRP  395 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP  395 (498)
                      ..+|...+..+.+++.+||..+|.+||
T Consensus       220 ~~~p~~~~~~~~~li~~lL~~dp~~R~  246 (318)
T 1fot_A          220 LRFPPFFNEDVKDLLSRLITRDLSQRL  246 (318)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence            124455668899999999999999999

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.8e-44  Score=361.00  Aligned_cols=240  Identities=25%  Similarity=0.319  Sum_probs=199.9

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcC-CCCCeeeeeceec--Ccce
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWT  207 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~  207 (498)
                      ...+|.+.+.||+|+||.||+|..+  +..||||+++...   ......+..|..++..+ +||||+++++++.  +..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4567889999999999999999985  6889999997532   23456688999999887 8999999999984  4689


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||++||+|.+++...   ..+++..+..++.|++.||.|||+   +||+||||||+|||++.+|++||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999532   458999999999999999999999   89999999999999999999999999999854


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~  365 (498)
                      ......        .....||+.|+|||++.+..++.++|||||||++|||+||++||...+.....  +..+       
T Consensus       169 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------  233 (345)
T 1xjd_A          169 MLGDAK--------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------  233 (345)
T ss_dssp             CCTTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------
T ss_pred             ccCCCc--------ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-------
Confidence            322111        13346999999999999999999999999999999999999999865543222  2211       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                        ...+|...+..+.+++.+||..+|.+||++.
T Consensus       234 --~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~  264 (345)
T 1xjd_A          234 --NPFYPRWLEKEAKDLLVKLFVREPEKRLGVR  264 (345)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred             --CCCCCcccCHHHHHHHHHHhcCCHhHcCCCh
Confidence              1124455678899999999999999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-44  Score=359.92  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=211.3

Q ss_pred             CChHHHHHhhcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeee
Q 010882          128 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLV  199 (498)
Q Consensus       128 ~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~  199 (498)
                      +...++....++|.+.+.||+|+||.||+|.+.       +..||||++...... ....+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344555666778999999999999999999865       467999998754321 234688999999999999999999


Q ss_pred             ceec--CcceEEEeeCCCCCHHhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE
Q 010882          200 GACP--EVWTLVYEYLPNGSLEDRLSCKD-------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL  270 (498)
Q Consensus       200 g~~~--~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl  270 (498)
                      +++.  +..++||||+++|+|.+++....       ...++++..++.++.+++.||.|||+   +||+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence            9984  45899999999999999985421       12467899999999999999999999   899999999999999


Q ss_pred             cCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH
Q 010882          271 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK  349 (498)
Q Consensus       271 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  349 (498)
                      +.++.+||+|||++..........      ......||+.|+|||++.+..++.++|||||||++|+|+| |.+||....
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  245 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  245 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEE------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             cCCCeEEECcCccccccccccccc------cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence            999999999999998654432111      1123347899999999999999999999999999999999 899997654


Q ss_pred             HHHH--HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          350 EVQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       350 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ....  .+..+..        ...+...+..+.+++.+||+.+|.+||++.+ +++.|+.+.
T Consensus       246 ~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-~l~~L~~~~  298 (322)
T 1p4o_A          246 NEQVLRFVMEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-IISSIKEEM  298 (322)
T ss_dssp             HHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHGGGS
T ss_pred             HHHHHHHHHcCCc--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHhh
Confidence            3322  2222211        1234445678999999999999999999998 777776653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-43  Score=342.61  Aligned_cols=249  Identities=20%  Similarity=0.361  Sum_probs=203.1

Q ss_pred             cCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec----CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV~E  211 (498)
                      .+|...+.||+|+||.||+|.+++..||||++.......  ...+.+|+.++++++||||++++++|.    ...++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            468888899999999999999999999999998654322  356899999999999999999999984    35689999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||+   ++  |+||||||+|||++.++.++|+|||++.....
T Consensus        90 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           90 WMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             CCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            99999999999643 23369999999999999999999999   67  99999999999999999999999998754222


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCC---ccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTP---KSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                                   ....||+.|+|||.+.+..++.   ++|||||||++|+|+||+.||...+.........     ...
T Consensus       166 -------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~  227 (271)
T 3kmu_A          166 -------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA-----LEG  227 (271)
T ss_dssp             -------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH-----HSC
T ss_pred             -------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH-----hcC
Confidence                         1234899999999998765544   7999999999999999999997654433221110     011


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      .....|...+..+.+++..||+.+|.+||++.+ +++.|+.+.
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-il~~L~~l~  269 (271)
T 3kmu_A          228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDM-IVPILEKMQ  269 (271)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHhh
Confidence            112234456688999999999999999999988 778887763

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.4e-44  Score=363.82  Aligned_cols=237  Identities=22%  Similarity=0.299  Sum_probs=195.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcC-CCCCeeeeeceecC--cceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~lV  209 (498)
                      .+|.+.+.||+|+||.||+|...  +..||||++.+...   .....+..|..+|.++ +||||++++++|.+  ..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            46888999999999999999985  67899999976432   2345688999999887 89999999999844  58999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||++||+|.+++...   ..+++..+..++.+++.||.|||+   +||+||||||+||||+.+|++||+|||+|+....
T Consensus       132 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999999543   469999999999999999999999   8999999999999999999999999999985332


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH-----------HHHHHHhC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----------VQYALDTG  358 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-----------~~~~~~~~  358 (498)
                      ....        .....||+.|+|||++.+..++.++|||||||++|||+||++||.....           ....+..+
T Consensus       206 ~~~~--------~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~  277 (396)
T 4dc2_A          206 PGDT--------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  277 (396)
T ss_dssp             TTCC--------BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred             CCCc--------cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence            2111        1334699999999999999999999999999999999999999963211           11111111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                               ...+|...+..+.+|+.+||+.||.+||++
T Consensus       278 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          278 ---------QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ---------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                     122455567889999999999999999997

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.8e-44  Score=349.56  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=196.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV  209 (498)
                      ..+|.+.+.||+|+||.||+|.+.     +..||||++...... ..+.+.+|+.++++++||||+++++++.+ ..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv   93 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII   93 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence            457888899999999999999884     346999998754322 24568899999999999999999999854 67899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++...  ...+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           94 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            9999999999999633  3468999999999999999999999   8999999999999999999999999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~  366 (498)
                      .....       .....||+.|+|||++.+..++.++|||||||++|+|+| |.+||......  ...+..+.       
T Consensus       169 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-------  234 (281)
T 1mp8_A          169 STYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------  234 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred             ccccc-------cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-------
Confidence            32111       122347889999999999999999999999999999997 99999754322  22222211       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                       ....+...+..+.+++.+||+.+|.+||++.+ +.+.|+.+..
T Consensus       235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~-l~~~l~~~~~  276 (281)
T 1mp8_A          235 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE-LKAQLSTILE  276 (281)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHH
Confidence             11234455688999999999999999999988 8888887754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.1e-44  Score=347.33  Aligned_cols=255  Identities=24%  Similarity=0.435  Sum_probs=205.3

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      ...+|...+.||+|+||.||+|.+. +..||||++.... .....+.+|+.++..++||||++++++|.+  ..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3457888899999999999999986 4689999997543 345679999999999999999999999854  57899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++...  ...+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++........
T Consensus       101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999999999532  3469999999999999999999999   8999999999999999999999999999986654321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      ..       .....||+.|+|||++.+..++.++|||||||++|+|+| |++||...............      .....
T Consensus       176 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~------~~~~~  242 (283)
T 3gen_A          176 TS-------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG------LRLYR  242 (283)
T ss_dssp             HS-------TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT------CCCCC
T ss_pred             cc-------ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc------cCCCC
Confidence            11       123347889999999999999999999999999999999 99999865443322221111      11112


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      |...+..+.+++.+||+.+|.+||++.+ ++..|..+..
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~-ll~~L~~~~~  280 (283)
T 3gen_A          243 PHLASEKVYTIMYSCWHEKADERPTFKI-LLSNILDVMD  280 (283)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHccCChhHCcCHHH-HHHHHHHHhh
Confidence            3344578999999999999999999998 7777776653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-44  Score=356.82  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=206.7

Q ss_pred             HHhhcCCCCCCcccccCceEEEEEEE-------CCeEEEEEEecCCC-CCChhhHHHHHHHHHcC-CCCCeeeeeceec-
Q 010882          134 EGATHNFDPSLKIGEGGYGSIYKGLL-------RHMQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP-  203 (498)
Q Consensus       134 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~g~~~-  203 (498)
                      .....+|.+.+.||+|+||.||+|.+       .+..||||++.... ......+.+|+.+++++ +||||++++++|. 
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34456888999999999999999997       23579999997543 23456799999999999 8999999999984 


Q ss_pred             -CcceEEEeeCCCCCHHhhhccCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCC
Q 010882          204 -EVWTLVYEYLPNGSLEDRLSCKDNS--------------------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD  262 (498)
Q Consensus       204 -~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD  262 (498)
                       +..++||||+++|+|.+++......                    ..+++..++.++.+++.||.|||+   +||+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence             4689999999999999999654321                    348999999999999999999999   8999999


Q ss_pred             CCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-C
Q 010882          263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-G  341 (498)
Q Consensus       263 lkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G  341 (498)
                      |||+|||++.++.+||+|||++.........      .......||+.|+|||++.+..++.++|||||||++|+|+| |
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  271 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  271 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccc------eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence            9999999999999999999999866543211      11223347889999999999999999999999999999998 9


Q ss_pred             CCCCCCcH---HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          342 RPALGITK---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       342 ~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      .+||....   .....+..+        .....|...+..+.+|+.+||..+|.+||++.+ +.+.|+.+.+
T Consensus       272 ~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-l~~~l~~~~~  334 (344)
T 1rjb_A          272 VNPYPGIPVDANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN-LTSFLGCQLA  334 (344)
T ss_dssp             CCSSTTCCCSHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHC-
T ss_pred             CCCcccCCcHHHHHHHHhcC--------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH-HHHHHHHHHH
Confidence            99997542   222222221        111234445688999999999999999999988 8788887654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=348.58  Aligned_cols=251  Identities=25%  Similarity=0.327  Sum_probs=202.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceecC----cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..||||++.... ....+.+.+|+.++++++||||+++++++..    ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            46888899999999999999996  7899999997543 2345678899999999999999999998732    568999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE----cCCCceeEeecccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISRF  286 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGla~~  286 (498)
                      ||+++|+|.+++........+++..+..|+.|++.||.|||+   +||+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            999999999999765555569999999999999999999999   899999999999999    7888999999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhc--------cCCCCCccchHhHHHHHHHHHhCCCCCCCc------HHHH
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA--------SGELTPKSDVYSFGIILLRLLTGRPALGIT------KEVQ  352 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltG~~pf~~~------~~~~  352 (498)
                      ......         .....||+.|+|||++.        +..++.++|||||||++|||+||++||...      ....
T Consensus       166 ~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          166 LEDDEQ---------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             CCTTCC---------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             cCCCCc---------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            654321         12345999999999986        467899999999999999999999999521      1122


Q ss_pred             HHHHhCccccc----------------cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          353 YALDTGKLKNL----------------LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       353 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+..+.....                .-+.....+...+..+.+++.+||+.||.+||++.++
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~el  300 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF  300 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHh
Confidence            22211111000                0011223456788899999999999999999999883

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.8e-43  Score=344.12  Aligned_cols=256  Identities=29%  Similarity=0.486  Sum_probs=210.2

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeC
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYL  213 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~  213 (498)
                      ...+|.+.+.||+|+||.||+|.+. +..||||++.... ...+.+.+|+.+++.++||||+++++++. +..++||||+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~   89 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM   89 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecC
Confidence            3457888999999999999999986 4689999997543 35678999999999999999999999985 4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++.... ...+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++.........
T Consensus        90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            9999999995321 1268999999999999999999999   89999999999999999999999999999876543211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~  370 (498)
                             ......||+.|+|||.+.+..++.++|||||||++|+|+| |++||........  .+..+        ....
T Consensus       166 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--------~~~~  230 (279)
T 1qpc_A          166 -------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------YRMV  230 (279)
T ss_dssp             -------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCC
T ss_pred             -------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc--------cCCC
Confidence                   1123457889999999998899999999999999999999 9999976543322  12211        1112


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      .+...+..+.+++..||..+|.+||++.+ +...|+.+....
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~-l~~~l~~~~~~~  271 (279)
T 1qpc_A          231 RPDNCPEELYQLMRLCWKERPEDRPTFDY-LRSVLEDFFTAT  271 (279)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHHC
T ss_pred             CcccccHHHHHHHHHHhccChhhCCCHHH-HHHHHHHHHHhc
Confidence            23445678999999999999999999988 888888887653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.3e-44  Score=370.48  Aligned_cols=257  Identities=31%  Similarity=0.483  Sum_probs=206.0

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEE
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY  210 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~  210 (498)
                      +.....+|.+.+.||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|++++||||+++++++. +..++||
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~  257 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT  257 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEe
Confidence            33445678888999999999999999975 679999998644 34678999999999999999999999985 4688999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.+++... ....+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            999999999999532 12458999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~  367 (498)
                      ....       .....+|+.|+|||++.+..++.++|||||||+||||+| |++||.......  ..+..+.        
T Consensus       334 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------  398 (452)
T 1fmk_A          334 EYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------  398 (452)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------
T ss_pred             ceec-------ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            2111       123347889999999999999999999999999999999 999997654332  2222221        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ....|..++..+.+++.+||+.+|.+||++.+ +...|+.+..
T Consensus       399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~-l~~~L~~~~~  440 (452)
T 1fmk_A          399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEY-LQAFLEDYFT  440 (452)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHTTTS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHhc
Confidence            11234456688999999999999999999988 7777777643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.1e-44  Score=353.70  Aligned_cols=257  Identities=27%  Similarity=0.408  Sum_probs=207.8

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--Cc
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV  205 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~  205 (498)
                      ...+|.+.+.||+|+||.||+|.+.       +..||||++..... .....+.+|+.+++.++||||+++++++.  +.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            4567888899999999999999872       37899999975432 12356889999999999999999999984  46


Q ss_pred             ceEEEeeCCCCCHHhhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDN---------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK  264 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk  264 (498)
                      .++||||+++|+|.+++.....                     ...+++..++.++.|++.||.|||+   +||+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence            8999999999999999965432                     2348999999999999999999999   899999999


Q ss_pred             CCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCC
Q 010882          265 PANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP  343 (498)
Q Consensus       265 p~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~  343 (498)
                      |+|||++.++.+||+|||++.........      .......||+.|+|||.+.+..++.++|||||||++|+|+| |.+
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSY------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCE------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccc------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999866543211      11233457899999999999899999999999999999999 999


Q ss_pred             CCCCcHH--HHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          344 ALGITKE--VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       344 pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ||.....  ....+..+.        ....+...+..+.+++.+||+.+|.+||++.+ +.+.|+.+..
T Consensus       252 p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~-l~~~l~~~~~  311 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTGH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD-ISKDLEKMMV  311 (314)
T ss_dssp             SSTTCCGGGHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHhhcCC--------cCCCCccCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHh
Confidence            9975432  222222221        11234455688999999999999999999988 7788877654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9e-44  Score=358.43  Aligned_cols=238  Identities=21%  Similarity=0.291  Sum_probs=198.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~l  208 (498)
                      ..+|.+.+.||+|+||.||+|...  +..||||++...   .......+..|..+|..+ +||||+++++++.  +..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            357888999999999999999996  467999998753   223456788999999988 7999999999985  46899


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||++||+|.+++...   ..+++..+..++.+++.||.|||+   +||+||||||+||||+.+|++||+|||+|+...
T Consensus        99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999533   458999999999999999999999   899999999999999999999999999998543


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDP  366 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~  366 (498)
                      .....        .....||+.|+|||++.+..++.++|||||||++|||++|++||...+....  .+..+.       
T Consensus       173 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------  237 (353)
T 2i0e_A          173 WDGVT--------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------  237 (353)
T ss_dssp             CTTCC--------BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             cCCcc--------cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-------
Confidence            22211        1334699999999999999999999999999999999999999986554322  122211       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                        ..+|...+..+.+|+.+||..+|.+||+.
T Consensus       238 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          238 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              12455567889999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3e-43  Score=356.07  Aligned_cols=244  Identities=23%  Similarity=0.409  Sum_probs=199.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      ..+|.+.+.||+|+||.||+|...  +..||||++......  ....+.+|+.+++.++||||+++++++.+  ..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457899999999999999999985  688999999765432  23568899999999999999999999854  578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC---CceeEeeccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFL  287 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla~~~  287 (498)
                      ||++||+|.+.+.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.+   +.+||+|||++...
T Consensus       108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999984   34569999999999999999999999   899999999999999864   46999999999866


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH--HHHHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~  365 (498)
                      .....         .....||+.|+|||++.+..++.++|||||||++|+|+||.+||...+...  ..+..+....   
T Consensus       182 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---  249 (362)
T 2bdw_A          182 NDSEA---------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY---  249 (362)
T ss_dssp             TTCCS---------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---
T ss_pred             cCCcc---------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---
Confidence            53321         123459999999999999999999999999999999999999997654432  2222222111   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       ....| ...+..+.+|+.+||..||.+||++.++
T Consensus       250 -~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~  282 (362)
T 2bdw_A          250 -PSPEW-DTVTPEAKSLIDSMLTVNPKKRITADQA  282 (362)
T ss_dssp             -CTTGG-GGSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             -Ccccc-cCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence             00111 2346789999999999999999999883

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.8e-44  Score=361.64  Aligned_cols=240  Identities=26%  Similarity=0.368  Sum_probs=197.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      .+|.+.+.||+|+||.||+|...  +..||||++....   ......+.+|+.+|+.++||||++++++|.  +..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46888999999999999999985  5789999986532   234567889999999999999999999984  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++.   ....+++..+..++.+++.||.|||+   +||+||||||+||||+.+|.+||+|||++......
T Consensus        95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999995   34569999999999999999999999   89999999999999999999999999999876433


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCCcHH-----HHHHHHhCcccc
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKN  362 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~-----~~~~~~~~~~~~  362 (498)
                      ..         .....||+.|+|||++..   ..++.++|||||||++|+|+||++||.....     ....+..     
T Consensus       169 ~~---------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-----  234 (384)
T 4fr4_A          169 TQ---------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-----  234 (384)
T ss_dssp             CC---------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-----
T ss_pred             Cc---------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-----
Confidence            21         133459999999999974   4589999999999999999999999964321     1111111     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                          ....+|...+..+.+|+.+||+.+|.+||+..+.+
T Consensus       235 ----~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l  269 (384)
T 4fr4_A          235 ----TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV  269 (384)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred             ----cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence                11224555668899999999999999999954433

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-43  Score=354.69  Aligned_cols=237  Identities=22%  Similarity=0.295  Sum_probs=195.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV  209 (498)
                      .+|.+.+.||+|+||.||+|..+  +..||||++.......   ...+.+|+.++.++ +||||++++++|.  +..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46888899999999999999985  6889999998654333   34578899999988 8999999999984  468999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||++||+|.+++...   ..+++..+..++.+++.||.|||+   +||+||||||+|||++.+|++||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999999533   468999999999999999999999   8999999999999999999999999999985432


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH-----------HHHHHHHhC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK-----------EVQYALDTG  358 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~-----------~~~~~~~~~  358 (498)
                      ....        .....||+.|+|||++.+..++.++|||||||++|||+||++||....           .....+..+
T Consensus       163 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  234 (345)
T 3a8x_A          163 PGDT--------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  234 (345)
T ss_dssp             TTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred             CCCc--------ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence            2111        133469999999999999999999999999999999999999996421           111111111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                               ...+|...+..+.+|+.+||..||.+||++
T Consensus       235 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          235 ---------QIRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                     112455567889999999999999999997

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=347.65  Aligned_cols=240  Identities=26%  Similarity=0.372  Sum_probs=191.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--------------------------ChhhHHHHHHHHHc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------------------GPSEFQQEIDILSK  189 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--------------------------~~~~~~~E~~il~~  189 (498)
                      ++|.+.+.||+|+||.||+|...  +..||||++......                          ..+.+.+|+.+|++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            47888899999999999999884  688999998754321                          13568899999999


Q ss_pred             CCCCCeeeeeceecC----cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCC
Q 010882          190 IRHPNLVTLVGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKP  265 (498)
Q Consensus       190 l~hpniv~l~g~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp  265 (498)
                      ++||||+++++++.+    ..++||||+++|+|.+++.    ..++++..+..++.|++.||.|||+   +||+||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence            999999999999843    4789999999999988652    3469999999999999999999999   8999999999


Q ss_pred             CcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCC---CCCccchHhHHHHHHHHHhCC
Q 010882          266 ANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGR  342 (498)
Q Consensus       266 ~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~  342 (498)
                      +|||++.++.+||+|||++.........        .....||+.|+|||++.+..   ++.++|||||||++|+|+||+
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  237 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDAL--------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ  237 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCE--------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             HHEEECCCCCEEEecCCCcccccccccc--------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence            9999999999999999999876533211        12346999999999998765   377899999999999999999


Q ss_pred             CCCCCcHHHHH--HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          343 PALGITKEVQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       343 ~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +||........  .+......   .+.    +...+..+.+++.+||+.||.+||++.+
T Consensus       238 ~pf~~~~~~~~~~~~~~~~~~---~~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e  289 (298)
T 2zv2_A          238 CPFMDERIMCLHSKIKSQALE---FPD----QPDIAEDLKDLITRMLDKNPESRIVVPE  289 (298)
T ss_dssp             CSSCCSSHHHHHHHHHHCCCC---CCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             CCCCCccHHHHHHHHhcccCC---CCC----ccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence            99976543322  12221111   011    1234578999999999999999999988

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.3e-44  Score=358.08  Aligned_cols=233  Identities=22%  Similarity=0.329  Sum_probs=197.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      .+|...+.||+|+||.||+|...  +..||||++....   ......+.+|+.+|+.++||||+++++++.+  ..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            46888899999999999999984  7889999986532   2345678899999999999999999999854  589999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++...   ..+++..+..++.|++.||.|||+   +||+||||||+|||++.+|.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999543   458999999999999999999999   89999999999999999999999999999865432


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~  368 (498)
                      .           ....||+.|+|||++.+..++.++|||||||++|||+||++||...+....  .+..+.         
T Consensus       195 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  254 (350)
T 1rdq_E          195 T-----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------  254 (350)
T ss_dssp             B-----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             c-----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------
Confidence            1           223489999999999999999999999999999999999999976654332  222221         


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCC
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                      ..+|...+..+.+++.+||+.||.+||+
T Consensus       255 ~~~p~~~~~~~~~li~~lL~~dp~~R~~  282 (350)
T 1rdq_E          255 VRFPSHFSSDLKDLLRNLLQVDLTKRFG  282 (350)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHhccC
Confidence            1234456688999999999999999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-42  Score=341.61  Aligned_cols=262  Identities=19%  Similarity=0.230  Sum_probs=206.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .++|.+.+.||+|+||.||+|..  .+..||||++....  ....+.+|+.+++.+ +|||++++++++.  ...++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            34788899999999999999996  57899999986443  345789999999999 7999999999884  35789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc-----eeEeecccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-----SKLSDFGISRF  286 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~-----~kl~DFGla~~  286 (498)
                      |+ +|+|.+++...  ..++++..+..++.|++.||.|||+   +||+||||||+|||++.++.     +||+|||++..
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999643  3469999999999999999999999   89999999999999987765     99999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH---H--HHHHHHhCccc
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK---E--VQYALDTGKLK  361 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~--~~~~~~~~~~~  361 (498)
                      .......... .........||+.|+|||++.+..++.++|||||||++|+|+||+.||....   .  ....+..+...
T Consensus       161 ~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccccccccc-cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            7654322111 1112345569999999999999999999999999999999999999997521   1  11111111111


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      .....    .....+..+.+++.+||+.+|.+||++.+ +.+.|+.+....
T Consensus       240 ~~~~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~-l~~~l~~~~~~~  285 (298)
T 1csn_A          240 TPLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDY-LQGLFSKVLERL  285 (298)
T ss_dssp             SCHHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHH-HHHHHHHHHHHT
T ss_pred             ccHHH----HHhhCcHHHHHHHHHHhcCCcccCCCHHH-HHHHHHHHHHhc
Confidence            10000    11124578999999999999999999988 888888887654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=352.67  Aligned_cols=243  Identities=21%  Similarity=0.306  Sum_probs=198.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ++|.+.+.||+|+||.||+|...  +..||+|++.... .....+.+|+.+++.++||||+++++++.  +..++||||+
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            57888899999999999999985  6889999987432 23456889999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC--CCceeEeeccccccccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--NFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~~~  291 (498)
                      +||+|.+++..  ....+++..+..++.|++.||.|||+   +||+||||||+|||++.  ++.+||+|||++.......
T Consensus        84 ~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            99999999953  23469999999999999999999999   89999999999999987  7899999999998765432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  369 (498)
                      ..         ....||+.|+|||++.+..++.++|||||||++|+|+||.+||.........  +..+....  .  ..
T Consensus       159 ~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~--~~  225 (321)
T 1tki_A          159 NF---------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--D--EE  225 (321)
T ss_dssp             EE---------EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--C--HH
T ss_pred             cc---------ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC--C--hh
Confidence            11         1224899999999999888999999999999999999999999765443222  22211110  0  00


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       .....+..+.+++.+||..||.+||++.++
T Consensus       226 -~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~  255 (321)
T 1tki_A          226 -AFKEISIEAMDFVDRLLVKERKSRMTASEA  255 (321)
T ss_dssp             -HHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             -hhccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence             001245789999999999999999999883

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.3e-44  Score=367.70  Aligned_cols=255  Identities=23%  Similarity=0.264  Sum_probs=202.3

Q ss_pred             HHHHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceecC-
Q 010882          131 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-  204 (498)
Q Consensus       131 ~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-  204 (498)
                      .++.....+|.+.++||+|+||+||+|.+.  +..||||++.+.   .......+..|+.++..++||||++++++|.+ 
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344455678999999999999999999985  588999998752   12233458999999999999999999999854 


Q ss_pred             -cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          205 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       205 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                       ..++||||++||+|.+++..  ....+++..+..++.+++.||.|||+   ++||||||||+||||+.+|++||+|||+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhh
Confidence             58999999999999999963  23569999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG  358 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (498)
                      |+........       ......||+.|+|||++.     ...++.++|||||||++|||+||++||...+.........
T Consensus       222 a~~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  294 (437)
T 4aw2_A          222 CLKLMEDGTV-------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  294 (437)
T ss_dssp             CEECCTTSCE-------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             hhhcccCCCc-------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence            9866543211       113346999999999997     4568999999999999999999999998765443322211


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCC--CCChhH
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGK  399 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RP~~~~  399 (498)
                      .....+.  ........+..+.+|+.+||..+|.+  ||++.+
T Consensus       295 ~~~~~~~--~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~e  335 (437)
T 4aw2_A          295 NHKERFQ--FPTQVTDVSENAKDLIRRLICSREHRLGQNGIED  335 (437)
T ss_dssp             THHHHCC--CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHH
T ss_pred             hcccccc--CCcccccCCHHHHHHHHHHhcccccccCCCCHHH
Confidence            1110000  01111235678999999999888877  999877

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-43  Score=340.21  Aligned_cols=251  Identities=25%  Similarity=0.480  Sum_probs=207.7

Q ss_pred             cCCCCCCcccccCceEEEEEEE-CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      .+|...+.||+|+||.||+|.+ .+..||+|++..... ..+.+.+|+.+++.++||||+++++++.  +..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            4678888999999999999998 467899999986442 4568999999999999999999999984  46899999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++...  ...+++..+..++.+++.||.|||+   +|++||||||+||+++.++.+||+|||++..........
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            99999999643  3468999999999999999999999   899999999999999999999999999998664332111


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHH--HHhCccccccCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA--LDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~  371 (498)
                             .....||+.|+|||++.+..++.++||||||+++|+|+| |++||.........  +..+.        ....
T Consensus       162 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~--------~~~~  226 (267)
T 3t9t_A          162 -------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--------RLYK  226 (267)
T ss_dssp             -------TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------CCCC
T ss_pred             -------cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC--------cCCC
Confidence                   123357889999999999999999999999999999999 89999765443222  22211        1112


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      |...+..+.+++.+||+.+|.+||++.+ +++.|+.+..
T Consensus       227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~-ll~~L~~l~~  264 (267)
T 3t9t_A          227 PRLASTHVYQIMNHCWRERPEDRPAFSR-LLRQLAEIAE  264 (267)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             CccCcHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHh
Confidence            3345678999999999999999999998 8888888765

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.5e-43  Score=345.43  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=204.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-----eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeecee---cCcce
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWT  207 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~---~~~~~  207 (498)
                      ...|.+.+.||+|+||.||+|.+..     ..||+|.+...... ....+.+|+.++++++||||++++++|   ....+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3467888899999999999998742     35899998754322 235688999999999999999999986   23578


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+++|+|.+++..  ....+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++...
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999953  34568999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCcccccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLL  364 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~  364 (498)
                      ........    .......||+.|+|||.+.+..++.++|||||||++|+|+| |.+||...+....  ....+.     
T Consensus       179 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----  249 (298)
T 3f66_A          179 YDKEYYSV----HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-----  249 (298)
T ss_dssp             SCGGGCBC---------CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-----
T ss_pred             cccchhcc----ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-----
Confidence            54432111    11234468899999999999999999999999999999999 6777765433221  112211     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       365 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                         ....|...+..+.+++.+||+.+|.+||++.+ +++.|+.+...
T Consensus       250 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e-ll~~L~~~~~~  292 (298)
T 3f66_A          250 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE-LVSRISAIFST  292 (298)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHT
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHHh
Confidence               11123344578999999999999999999998 88888887654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-43  Score=349.93  Aligned_cols=258  Identities=24%  Similarity=0.404  Sum_probs=208.4

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE-------CCeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceec--C
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--E  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~--~  204 (498)
                      ..++|.+.+.||+|+||.||+|.+       .+..||||++...... ..+.+.+|+.+++++ +||||++++++|.  +
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            446788899999999999999986       2468999999755332 245788999999999 9999999999984  4


Q ss_pred             cceEEEeeCCCCCHHhhhccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEE
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDN---------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL  269 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiL  269 (498)
                      ..++||||+++|+|.+++.....               ...+++..++.++.+++.||.|||+   +||+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence            68999999999999999965432               2358999999999999999999999   89999999999999


Q ss_pred             EcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCc
Q 010882          270 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT  348 (498)
Q Consensus       270 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~  348 (498)
                      ++.++.+||+|||++.........      .......||+.|+|||++.+..++.++|||||||++|+|+| |.+||...
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             EcCCCCEEEccccccccccccccc------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999876543211      11123347889999999999999999999999999999999 99999754


Q ss_pred             H---HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          349 K---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       349 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .   ........+ ..       ...+...+..+.+++.+||+.+|.+||++.+ +++.|+.+...
T Consensus       252 ~~~~~~~~~~~~~-~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~~  308 (313)
T 1t46_A          252 PVDSKFYKMIKEG-FR-------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ-IVQLIEKQISE  308 (313)
T ss_dssp             CSSHHHHHHHHHT-CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             cchhHHHHHhccC-CC-------CCCcccCCHHHHHHHHHHcCCCchhCcCHHH-HHHHHHHHHHH
Confidence            2   222222221 11       1123345678999999999999999999998 77888877654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-43  Score=357.66  Aligned_cols=267  Identities=16%  Similarity=0.232  Sum_probs=202.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCCC-----------hhhHHHHHHHHHcCCCCCeeee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQG-----------PSEFQQEIDILSKIRHPNLVTL  198 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~-----------~~~~~~E~~il~~l~hpniv~l  198 (498)
                      .++|.+.+.||+|+||.||+|.+.       +..||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            457999999999999999999884       3679999987543110           1123345566777889999999


Q ss_pred             eceecC------cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc-
Q 010882          199 VGACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-  271 (498)
Q Consensus       199 ~g~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~-  271 (498)
                      ++++..      ..++||||+ ||+|.+++..  ....+++..++.|+.|++.||.|||+   +||+||||||+||||+ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence            999843      378999999 9999999964  23569999999999999999999999   8999999999999999 


Q ss_pred             -CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH
Q 010882          272 -ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE  350 (498)
Q Consensus       272 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~  350 (498)
                       .++.+||+|||+++.+.......... ........||+.|+|||++.+..++.++|||||||+||||+||+.||.....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYA-ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSS-CCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCeEEEEECCcceecccCCcccccc-cCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence             88999999999998776543221111 1112345699999999999999999999999999999999999999974211


Q ss_pred             --H-HHHHH---hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhcC
Q 010882          351 --V-QYALD---TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG  413 (498)
Q Consensus       351 --~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~~  413 (498)
                        . .....   ...+...+++...  +...+..+.+++..||..+|.+||++.+ +.+.|+.+....+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~-l~~~l~~~~~~~~  332 (364)
T 3op5_A          267 DPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYEN-LRDILLQGLKAIG  332 (364)
T ss_dssp             CHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHH-HHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHcC
Confidence              1 10000   0111121111110  1123578999999999999999999988 8888888876544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-43  Score=352.39  Aligned_cols=239  Identities=26%  Similarity=0.362  Sum_probs=188.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-----CCeEEEEEEecCCCC----CChhhHHHHHHHHHcCCCCCeeeeeceec--Cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~  205 (498)
                      ..+|.+.+.||+|+||.||++..     .+..||||++.....    .....+.+|+.+|+.++||||+++++++.  +.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            34788899999999999999987     468899999986532    23456789999999999999999999984  46


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .++||||++||+|.+++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            8999999999999999953   2458899999999999999999999   899999999999999999999999999997


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccc
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNL  363 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~  363 (498)
                      ........        .....||+.|+|||++.+..++.++|||||||++|+|++|++||...+.....  +..+.    
T Consensus       170 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----  237 (327)
T 3a62_A          170 ESIHDGTV--------THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK----  237 (327)
T ss_dssp             -----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----
T ss_pred             ccccCCcc--------ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----
Confidence            54332211        12345999999999999999999999999999999999999999865443221  11111    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                           ..+|...+..+.+++.+||..+|.+||++.
T Consensus       238 -----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~  267 (327)
T 3a62_A          238 -----LNLPPYLTQEARDLLKKLLKRNAASRLGAG  267 (327)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred             -----CCCCCCCCHHHHHHHHHHHhcCHhhccCCC
Confidence                 123445568899999999999999999543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=365.35  Aligned_cols=245  Identities=20%  Similarity=0.351  Sum_probs=198.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      ..+|.+.+.||+|+||.||+|..  .+..||+|++......  ....+.+|+.+++.++||||+++++++.+  ..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            34788899999999999999988  4789999999765432  23568899999999999999999999854  589999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc---CCCceeEeeccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFL  287 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~~  287 (498)
                      ||++||+|.+.+..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++   .++.+||+|||++...
T Consensus        90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999999853   3469999999999999999999999   8999999999999998   4678999999999866


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH--HHHHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~  365 (498)
                      ......        .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...  ..+..+....   
T Consensus       164 ~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---  232 (444)
T 3soa_A          164 EGEQQA--------WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF---  232 (444)
T ss_dssp             CTTCCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---
T ss_pred             cCCCce--------eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC---
Confidence            543211        123469999999999999999999999999999999999999997654432  2223322211   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       ....| ...+..+.+|+..||+.||.+||++.++
T Consensus       233 -~~~~~-~~~s~~~~~li~~~L~~dP~~Rpta~e~  265 (444)
T 3soa_A          233 -PSPEW-DTVTPEAKDLINKMLTINPSKRITAAEA  265 (444)
T ss_dssp             -CTTTT-TTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             -Ccccc-ccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence             11111 2346789999999999999999999884

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.3e-44  Score=356.24  Aligned_cols=239  Identities=25%  Similarity=0.378  Sum_probs=197.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|.+  .+..||||++...   .......+.+|+.+++.++||||+++++++.  ...++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4788889999999999999998  4689999998643   1223457899999999999999999999984  4579999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+ +|+|.+++...   ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 78999988533   469999999999999999999999   89999999999999999999999999999866543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ..         .....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||......       .+...+.....
T Consensus       162 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~  225 (336)
T 3h4j_B          162 NF---------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------NLFKKVNSCVY  225 (336)
T ss_dssp             BT---------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-------TCBCCCCSSCC
T ss_pred             cc---------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCCC
Confidence            21         123359999999999988776 68999999999999999999999653211       11111222223


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..|...+..+.+|+.+||..||.+||++.+
T Consensus       226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~e  255 (336)
T 3h4j_B          226 VMPDFLSPGAQSLIRRMIVADPMQRITIQE  255 (336)
T ss_dssp             CCCTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            345566788999999999999999999988

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.3e-44  Score=366.18  Aligned_cols=250  Identities=24%  Similarity=0.279  Sum_probs=200.4

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceecC--c
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--V  205 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~  205 (498)
                      +.....+|.+.+.||+|+||.||+|...  +..||+|++.+.   .......+.+|+.+++.++||||++++++|.+  .
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3345568999999999999999999985  678999998652   22334568899999999999999999999854  5


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .++||||++||+|.+++..    ..+++..+..++.+++.||.|||+   +||+||||||+||||+.+|++||+|||+|+
T Consensus       144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            8999999999999999853    258999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCC----CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccc
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK  361 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (498)
                      ........       ......||+.|+|||++.+..    ++.++|||||||+||||+||++||...+............
T Consensus       217 ~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  289 (410)
T 3v8s_A          217 KMNKEGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK  289 (410)
T ss_dssp             ECCTTSEE-------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             eeccCCcc-------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence            76543211       123456999999999998765    7889999999999999999999998765443322211111


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhhhcccCC--CCChhH
Q 010882          362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGK  399 (498)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RP~~~~  399 (498)
                      ..+.  .. .+...+..+.+|+.+||..+|.+  ||++.+
T Consensus       290 ~~~~--~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~e  326 (410)
T 3v8s_A          290 NSLT--FP-DDNDISKEAKNLICAFLTDREVRLGRNGVEE  326 (410)
T ss_dssp             HHCC--CC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHH
T ss_pred             cccc--CC-CcccccHHHHHHHHHHccChhhhCCCCCHHH
Confidence            0010  00 01134578999999999999988  999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.1e-44  Score=351.19  Aligned_cols=249  Identities=25%  Similarity=0.378  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECC---------eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--Ccc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~  206 (498)
                      .+|.+.+.||+|+||.||+|.+..         ..||+|++........+.+.+|+.+++.++||||++++++|.  +..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            468888899999999999998753         569999997655555678999999999999999999999984  467


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc--------eeE
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--------SKL  278 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~--------~kl  278 (498)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.        +||
T Consensus        88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence            8999999999999999643  2348999999999999999999999   89999999999999998887        999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhC-CCCCCCcHHHHHHHH
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALD  356 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~  356 (498)
                      +|||++.......            ...||+.|+|||++.+ ..++.++|||||||++|+|+|| .+||...........
T Consensus       163 ~Dfg~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~  230 (289)
T 4fvq_A          163 SDPGISITVLPKD------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF  230 (289)
T ss_dssp             CCCCSCTTTSCHH------------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             ccCcccccccCcc------------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence            9999987553321            1127899999999987 6789999999999999999994 566654433222111


Q ss_pred             hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          357 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ....        ...|...+..+.+++.+||+.+|.+||++.+ +++.|+.+....
T Consensus       231 ~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-ll~~l~~l~~p~  277 (289)
T 4fvq_A          231 YEDR--------HQLPAPKAAELANLINNCMDYEPDHRPSFRA-IIRDLNSLFTPD  277 (289)
T ss_dssp             HHTT--------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHH-HHHHHHTCC---
T ss_pred             hhcc--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHhcCCC
Confidence            1100        1122223456899999999999999999988 778887775543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-43  Score=360.58  Aligned_cols=246  Identities=22%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      ...|.+.+.||+|+||.||+|...  +..||+|++..........+.+|+.+|+.++||||++++++|.+  ..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357888999999999999999984  67899999876543345578899999999999999999999843  58999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC--CCceeEeecccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--NFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~~  290 (498)
                      ++||+|.+++..  ....+++..+..++.|++.||.|||+   +||+||||||+|||++.  ++.+||+|||++......
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999853  23469999999999999999999999   89999999999999974  578999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      ...         ....||+.|+|||++.+..++.++|||||||++|+|+||.+||...+...............+   ..
T Consensus       205 ~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---~~  272 (387)
T 1kob_A          205 EIV---------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---ED  272 (387)
T ss_dssp             SCE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---SS
T ss_pred             cce---------eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---cc
Confidence            211         112489999999999999999999999999999999999999987654433222111111111   11


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .....+..+.+++.+||..||.+||++.+
T Consensus       273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  301 (387)
T 1kob_A          273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHD  301 (387)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            12245678999999999999999999988

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-43  Score=373.84  Aligned_cols=252  Identities=27%  Similarity=0.497  Sum_probs=208.3

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ...+|.+.+.||+|+||.||+|.+.  +..||||++.... ...+.|.+|+.+|++++||||++++|+|.  +..++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            4456888889999999999999996  6889999997543 35678999999999999999999999994  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++|+|.+++... ....+++..++.|+.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999999643 23468999999999999999999999   899999999999999999999999999998764332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH--HHHHHHhCccccccCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~--~~~~~~~~~~~~~~~~~~  368 (498)
                      ..       ......+|+.|+|||++....++.++|||||||+||||+| |.+||...+.  +...+..+        ..
T Consensus       373 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------~~  437 (495)
T 1opk_A          373 YT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YR  437 (495)
T ss_dssp             EE-------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------CC
T ss_pred             ee-------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------CC
Confidence            11       1123447889999999999999999999999999999999 9999975432  22222221        11


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ...|..++..+.+|+.+||+.+|.+||++.+ +++.|+.+
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-l~~~L~~~  476 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAE-IHQAFETM  476 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHTS
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHH-HHHHHHHH
Confidence            2234456688999999999999999999998 77777654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.2e-43  Score=352.37  Aligned_cols=247  Identities=23%  Similarity=0.324  Sum_probs=198.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC-----CCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH-----SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      ..|.+.+.||+|+||.||+|...  +..||||++...     .....+.+.+|+.+++.++||||+++++++.  +..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46888999999999999999984  689999998632     1224567999999999999999999999984  46899


Q ss_pred             EEeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc---eeEeecccc
Q 010882          209 VYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGIS  284 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGla  284 (498)
                      ||||++||+|.+.+... .....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998887533 233468999999999999999999999   89999999999999986654   999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH-HHHHHhCccccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNL  363 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~~~~~  363 (498)
                      .........        .....||+.|+|||++.+..++.++|||||||++|+|+||++||...... ...+..+.... 
T Consensus       181 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~-  251 (351)
T 3c0i_A          181 IQLGESGLV--------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM-  251 (351)
T ss_dssp             EECCTTSCB--------CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCC-
T ss_pred             eEecCCCee--------ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCC-
Confidence            876543211        13346999999999999999999999999999999999999999875432 11222221110 


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       .+  . .....+..+.+|+.+||..||.+||++.++
T Consensus       252 -~~--~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~  284 (351)
T 3c0i_A          252 -NP--R-QWSHISESAKDLVRRMLMLDPAERITVYEA  284 (351)
T ss_dssp             -CH--H-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             -Cc--c-ccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence             00  0 001245789999999999999999999884

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=344.64  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=208.6

Q ss_pred             cCCCCCC-cccccCceEEEEEEE----CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEE
Q 010882          138 HNFDPSL-KIGEGGYGSIYKGLL----RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~-~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~  210 (498)
                      .+|.+.. .||+|+||.||+|.+    .+..||||++..... .....+.+|+.+++.++||||+++++++. +..++||
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~   88 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM   88 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence            3455555 899999999999986    357799999986432 23456889999999999999999999984 4588999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.+++..  ....+++..+..++.+++.||.|||+   .||+||||||+|||++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           89 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999953  34569999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~~  367 (498)
                      ....     .......||+.|+|||++.+..++.++|||||||++|+|+| |++||......  ...+..+.        
T Consensus       164 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--------  230 (287)
T 1u59_A          164 DSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------  230 (287)
T ss_dssp             SCEE-----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--------
T ss_pred             ccee-----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--------
Confidence            2111     11233457899999999998899999999999999999999 99999754332  22222221        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhcC
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG  413 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~~  413 (498)
                      ....|...+..+.+++..||..+|.+||++.+ +.+.|+.+..+..
T Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~-l~~~l~~~~~~~~  275 (287)
T 1u59_A          231 RMECPPECPPELYALMSDCWIYKWEDRPDFLT-VEQRMRACYYSLA  275 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHHHHHH
T ss_pred             cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHHhcC
Confidence            12234456688999999999999999999998 8888888877653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=354.72  Aligned_cols=242  Identities=24%  Similarity=0.356  Sum_probs=184.2

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ....|.+.+.||+|+||.||+|.+.  +..||||++....  ..+.+.+|+.+|++++||||++++++|.  +..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567889999999999999999995  5789999997543  3456889999999999999999999984  35789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---CCceeEeecccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLS  288 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla~~~~  288 (498)
                      |+++|+|.+++.   ....+++..+..++.|++.||.|||+   .||+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999994   34569999999999999999999999   89999999999999975   8899999999998654


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH---HHHHhCccccccC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ---YALDTGKLKNLLD  365 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~---~~~~~~~~~~~~~  365 (498)
                      ....         .....||+.|+|||++.+..++.++|||||||++|+|+||..||.......   ..+..+... .  
T Consensus       203 ~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-~--  270 (349)
T 2w4o_A          203 HQVL---------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-F--  270 (349)
T ss_dssp             -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-C--
T ss_pred             cccc---------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-c--
Confidence            3221         123458999999999999999999999999999999999999996543222   112221111 1  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        ...+....+..+.+|+.+||..||.+||++.+
T Consensus       271 --~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  302 (349)
T 2w4o_A          271 --ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ  302 (349)
T ss_dssp             --CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             --CCchhhhCCHHHHHHHHHHccCChhhCcCHHH
Confidence              11122345678999999999999999999988

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3e-43  Score=348.49  Aligned_cols=266  Identities=25%  Similarity=0.368  Sum_probs=212.5

Q ss_pred             ChHHHHHhhcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeee
Q 010882          129 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLV  199 (498)
Q Consensus       129 ~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~  199 (498)
                      ...+.....++|.+.+.||+|+||.||+|.+.       +..||||++...... ....+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            44555566778999999999999999999852       378999999764322 234688999999999 799999999


Q ss_pred             ceecC---cceEEEeeCCCCCHHhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCC
Q 010882          200 GACPE---VWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL  263 (498)
Q Consensus       200 g~~~~---~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl  263 (498)
                      ++|..   ..++||||+++|+|.+++.....             ...+++..+..++.+++.||.|||+   +||+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence            99843   48999999999999999964432             1238899999999999999999999   89999999


Q ss_pred             CCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CC
Q 010882          264 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GR  342 (498)
Q Consensus       264 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~  342 (498)
                      ||+|||++.++.+||+|||++.........      .......||+.|+|||++.+..++.++|||||||++|+|+| |.
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~  248 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  248 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccc------eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence            999999999999999999999866443211      11123347899999999999999999999999999999998 99


Q ss_pred             CCCCCcH---HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          343 PALGITK---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       343 ~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      +||....   .....+..+..        ...+...+..+.+++.+||+.+|.+||++.+ +++.|+.+....
T Consensus       249 ~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~~~  312 (316)
T 2xir_A          249 SPYPGVKIDEEFCRRLKEGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE-LVEHLGNLLQAN  312 (316)
T ss_dssp             CSSTTCCCSHHHHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHHH
T ss_pred             CCCcccchhHHHHHHhccCcc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHhhh
Confidence            9997532   22222222211        1123345678999999999999999999998 888888876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-43  Score=360.43  Aligned_cols=242  Identities=24%  Similarity=0.307  Sum_probs=191.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHH-HHcCCCCCeeeeeceec--CcceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDI-LSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~i-l~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      ..+|.+.+.||+|+||.||+|..+  +..||||++.+....   ....+..|..+ ++.++||||++++++|.  +..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999985  578999999764322   23456677776 57789999999999984  46899


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||++||+|.+++..   ...+++..+..++.+++.||.|||+   +||+||||||+||||+.+|++||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999954   2458899999999999999999999   899999999999999999999999999998643


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP  366 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~  366 (498)
                      .....        .....||+.|+|||++.+..++.++|||||||++|||+||.+||...+.....  +..+.       
T Consensus       191 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------  255 (373)
T 2r5t_A          191 EHNST--------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------  255 (373)
T ss_dssp             CCCCC--------CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-------
T ss_pred             cCCCc--------cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------
Confidence            22211        12345999999999999999999999999999999999999999765443221  21211       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                        ..++...+..+.+|+.+||..||.+||++.+.+
T Consensus       256 --~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          256 --LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             --CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             --cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence              113444567899999999999999999986533

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.7e-43  Score=342.58  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=193.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|...+.||+|+||.||+|... +..||||++.....  .....+.+|+.+++.++||||+++++++.  +..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            36778889999999999999985 78899999875432  23467889999999999999999999984  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++ +|.+++...  ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            975 899988532  3568999999999999999999999   8999999999999999999999999999986543211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Ccc-----c-
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GKL-----K-  361 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~~-----~-  361 (498)
                      .        .....||+.|+|||++.+. .++.++|||||||++|+|+||++||...+........    +..     . 
T Consensus       156 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          156 K--------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             c--------cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence            1        1233589999999999764 5899999999999999999999999865543322211    000     0 


Q ss_pred             --c--ccCCCC--------CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 --N--LLDPLA--------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 --~--~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        .  ..++..        ..+....+..+.+|+.+||..||.+||++.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  278 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA  278 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence              0  000000        01112346788999999999999999999883

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=375.27  Aligned_cols=249  Identities=25%  Similarity=0.430  Sum_probs=201.3

Q ss_pred             cccccCceEEEEEEEC----CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCCCCCH
Q 010882          145 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGSL  218 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~~gsL  218 (498)
                      .||+|+||.||+|.++    +..||||+++.... ...+.|.+|+.+|++++|||||+++|+|. +..++||||+++|+|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L  422 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL  422 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence            6999999999999873    35699999986533 34678999999999999999999999984 468899999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCcc
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT  298 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  298 (498)
                      .+++..  ....+++..+..|+.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+++.........    
T Consensus       423 ~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~----  493 (613)
T 2ozo_A          423 HKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY----  493 (613)
T ss_dssp             HHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee----
Confidence            999953  34569999999999999999999999   899999999999999999999999999998765432111    


Q ss_pred             ceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH--HHHHHHhCccccccCCCCCCCCHHH
Q 010882          299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPLAGDWPFVQ  375 (498)
Q Consensus       299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  375 (498)
                       .......+|+.|+|||++.+..++.++|||||||+||||+| |+.||...+.  +...+..+.        ....|..+
T Consensus       494 -~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------~~~~p~~~  564 (613)
T 2ozo_A          494 -TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------RMECPPEC  564 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC--------CCCCCTTC
T ss_pred             -eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------CCCCCCcC
Confidence             11122346789999999999999999999999999999998 9999976433  223333321        12244556


Q ss_pred             HHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          376 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       376 ~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      +..+.+|+..||+.+|.+||++.+ +.+.|+.+....
T Consensus       565 ~~~l~~li~~cl~~dP~~RPs~~~-l~~~L~~~~~~~  600 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRPDFLT-VEQRMRACYYSL  600 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHH-HHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHHHHHh
Confidence            789999999999999999999998 788888776554

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-43  Score=354.06  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=207.4

Q ss_pred             cCCCCCCcccccCceEEEEEEE------CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec----Ccce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~  207 (498)
                      .+|.+.+.||+|+||.||+|.+      .+..||||++..........+.+|+.++++++||||+++++++.    ...+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4688889999999999999985      36789999998665444567899999999999999999999873    2478


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+++|+|.+++...  ...+++..++.|+.+++.||.|||+   +||+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999999642  2358999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh--------Cc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--------GK  359 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--------~~  359 (498)
                      ......     ........||+.|+|||++.+..++.++|||||||++|+|+||..||............        ..
T Consensus       178 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3lxl_A          178 PLDKDY-----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR  252 (327)
T ss_dssp             CTTCSE-----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred             ccCCcc-----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence            543211     11123445899999999999999999999999999999999999999654332110000        00


Q ss_pred             -cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          360 -LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       360 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                       ............+...+..+.+++..||+.+|.+||++.+ +++.|+.+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e-ll~~L~~~~~~  304 (327)
T 3lxl_A          253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSA-LGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHC---
T ss_pred             HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHhh
Confidence             0000111122234556788999999999999999999998 77888877543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=350.31  Aligned_cols=253  Identities=23%  Similarity=0.394  Sum_probs=199.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--Ce----EEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV  209 (498)
                      .+|...+.||+|+||.||+|.+.  +.    +||+|.+.... ......+.+|+.+++.++||||++++++|. +..++|
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v   94 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   94 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence            47888999999999999999984  33    46888876443 334678999999999999999999999984 457899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |+|+++|+|.+++...  ...+++..++.|+.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           95 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             ECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            9999999999999643  3569999999999999999999999   8999999999999999999999999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH--HHHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~--~~~~~~~~~~~~~~~~  366 (498)
                      ......      .....||+.|+|||.+.+..++.++|||||||++|+|+| |.+||.....  ....+..+.       
T Consensus       170 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-------  236 (327)
T 3lzb_A          170 EEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------  236 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred             cccccc------ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            322111      123347889999999999999999999999999999999 9999976432  222222221       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                       ....+...+..+.+++.+||..+|.+||++.+ +++.|+.+..
T Consensus       237 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~  278 (327)
T 3lzb_A          237 -RLPQPPICTIDVYMIMRKCWMIDADSRPKFRE-LIIEFSKMAR  278 (327)
T ss_dssp             -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHT
T ss_pred             -CCCCCccCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHHHh
Confidence             11234445678999999999999999999998 7788887753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.7e-43  Score=345.76  Aligned_cols=249  Identities=25%  Similarity=0.362  Sum_probs=191.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-CCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      .++|...+.||+|+||+||+|.+ .+..||||++.......  ...+.+|+.++++++||||+++++++.+  ..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            45788899999999999999998 46889999997543322  3568899999999999999999999854  5789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++ +|.+.+..  ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9975 78888753  33569999999999999999999999   899999999999999999999999999998764332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH---HHH-hCccc-----
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY---ALD-TGKLK-----  361 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~---~~~-~~~~~-----  361 (498)
                      ..        .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||........   ... .+...     
T Consensus       174 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          174 RS--------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             C-----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             cc--------ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            11        123458999999999976 5689999999999999999999999975432211   111 00000     


Q ss_pred             ccc------C---CCCCC-----CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          362 NLL------D---PLAGD-----WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       362 ~~~------~---~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...      .   .....     .....+..+.+|+.+||..||.+||++.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  297 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD  297 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence            000      0   00000     01123467899999999999999999988

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=358.48  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=194.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC---C--eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec---CcceEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR---H--MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLV  209 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~---~--~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~---~~~~lV  209 (498)
                      .|.+.+.||+|+||.||+|.+.   +  ..||||.+..... .....|.+|+.++++++||||++++++|.   +..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4566778999999999999873   2  4689999875432 23467899999999999999999999862   357899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++..  ....+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999953  34568899999999999999999999   8999999999999999999999999999986644


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~  366 (498)
                      ......    .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..  ...+..+.       
T Consensus       245 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-------  313 (373)
T 3c1x_A          245 KEFDSV----HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------  313 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-------
T ss_pred             cccccc----cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-------
Confidence            321111    11233457889999999999999999999999999999999 78888654321  12222221       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                       ....|..++..+.+++.+||+.+|.+||++.+ +++.|+.+....
T Consensus       314 -~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~e-ll~~L~~i~~~~  357 (373)
T 3c1x_A          314 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE-LVSRISAIFSTF  357 (373)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHTC
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHHhc
Confidence             11123445678999999999999999999998 888888887643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.3e-43  Score=343.84  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=202.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-----eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV  209 (498)
                      ..+|.+.+.||+|+||.||+|.+.+     ..||||++..... .....+.+|+.+++.++||||+++++++.+ ..++|
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v   90 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence            4578888999999999999998742     3599999876532 234578899999999999999999999854 57899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++...  ...+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           91 MELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            9999999999999643  3458999999999999999999999   8999999999999999999999999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH--HHHHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK--EVQYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~--~~~~~~~~~~~~~~~~~  366 (498)
                      .....       .....||+.|+|||++.+..++.++|||||||++|+|+| |++||....  .....+..+..      
T Consensus       166 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~------  232 (281)
T 3cc6_A          166 EDYYK-------ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR------  232 (281)
T ss_dssp             --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC------
T ss_pred             ccccc-------cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC------
Confidence            32111       123347889999999999999999999999999999998 999996432  22222222211      


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                        ...+...+..+.+++.+||..+|.+||++.+ ++..|+.+..
T Consensus       233 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e-ll~~L~~~~~  273 (281)
T 3cc6_A          233 --LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTE-LVCSLSDVYQ  273 (281)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCchhCcCHHH-HHHHHHHHHH
Confidence              1123345678999999999999999999998 7788887754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=350.58  Aligned_cols=263  Identities=25%  Similarity=0.371  Sum_probs=195.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHH--HcCCCCCeeeeeceec-------Ccce
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDIL--SKIRHPNLVTLVGACP-------EVWT  207 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il--~~l~hpniv~l~g~~~-------~~~~  207 (498)
                      .++|.+.+.||+|+||.||+|...+..||||++...   ....+..|..++  ..++||||+++++.+.       ...+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            357888899999999999999999999999998643   234555555554  4589999999997542       1468


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CcccCCCCCCcEEEcCCCceeE
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH---------SIVHGDLKPANILLDANFVSKL  278 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---------~ivHrDlkp~NiLl~~~~~~kl  278 (498)
                      +||||+++|+|.+++...    .+++..+..|+.|++.||.|||+   .         ||+||||||+||||+.++.+||
T Consensus        89 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence            999999999999999532    35889999999999999999999   6         9999999999999999999999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-------CCCCCccchHhHHHHHHHHHhCCCCCC-CcH-
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLTGRPALG-ITK-  349 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltG~~pf~-~~~-  349 (498)
                      +|||++..+...................||+.|+|||++.+       ..++.++|||||||++|||+||..||. ... 
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987654432211111122234569999999999987       356678999999999999999976552 111 


Q ss_pred             ------------------HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          350 ------------------EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       350 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                                        ..............+.. ........+..+.+|+.+||+.||.+||++.+ +++.|+.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-~l~~L~~ll~~  319 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-AWKENSLAVRSLKETIEDCWDQDAEARLTAQX-AEERMAELMMI  319 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH-HHHHHHHHHHC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-ccccccchHHHHHHHHHHHhcCChhhCcchHH-HHHHHHHHHHH
Confidence                              11111111111111111 11112346778999999999999999999998 88888888754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-43  Score=344.11  Aligned_cols=249  Identities=26%  Similarity=0.445  Sum_probs=200.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec---CcceEEEeeC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYL  213 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~---~~~~lV~E~~  213 (498)
                      .++|.+.+.||+|+||.||+|.+++..||||++....  ..+.+.+|+.++++++||||+++++++.   ...++||||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            4578888999999999999999999999999987543  4567999999999999999999999863   3579999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++.... ...+++..+..++.+++.||.|||+   +|++||||||+|||++.++.+||+|||++.......  
T Consensus        98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            9999999995321 1237889999999999999999999   899999999999999999999999999987544321  


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  370 (498)
                               ....+|+.|+|||.+.+..++.++||||||+++|+|+| |++||......  ...+..+        ....
T Consensus       172 ---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--------~~~~  234 (278)
T 1byg_A          172 ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMD  234 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------CCCC
T ss_pred             ---------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------CCCC
Confidence                     12247899999999999999999999999999999998 99999754321  1112111        1122


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .+...+..+.+++..||+.+|.+||++.+ +.+.|+.+...
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~-l~~~L~~i~~~  274 (278)
T 1byg_A          235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQ-LREQLEHIKTH  274 (278)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             CcccCCHHHHHHHHHHhcCChhhCCCHHH-HHHHHHHHHhh
Confidence            34455688999999999999999999998 88888887653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-42  Score=345.46  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=183.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ..+|...+.||+|+||.||+|...  +..||||++..... .....+.+|+.+++.++||||+++++++.  +..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            347888999999999999999874  68899999876543 33467889999999999999999999984  35899999


Q ss_pred             eCCCCCHHhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          212 YLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       212 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      |++ |+|.+++...   .....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 5999988532   122458999999999999999999999   899999999999999999999999999998764


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Ccccc-
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GKLKN-  362 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~~~~-  362 (498)
                      .....        .....||+.|+|||++.+. .++.++|||||||++|+|+||++||...+........    +.... 
T Consensus       160 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  231 (317)
T 2pmi_A          160 IPVNT--------FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES  231 (317)
T ss_dssp             SCCCC--------CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred             CCccc--------CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            32211        1234589999999999764 6899999999999999999999999765543221111    10000 


Q ss_pred             -------c--cCCCC-------------CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 -------L--LDPLA-------------GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 -------~--~~~~~-------------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                             .  ..+..             ...+...+..+.+++.+||+.||.+||++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  290 (317)
T 2pmi_A          232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ  290 (317)
T ss_dssp             TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence                   0  00000             0001124568999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.3e-43  Score=345.77  Aligned_cols=255  Identities=24%  Similarity=0.406  Sum_probs=204.4

Q ss_pred             hcCCCCCC-cccccCceEEEEEEEC----CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec-CcceE
Q 010882          137 THNFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL  208 (498)
Q Consensus       137 ~~~~~~~~-~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~l  208 (498)
                      ..+|.+.. .||+|+||.||+|.+.    +..||||++.......  ...+.+|+.+++.++||||+++++++. +..++
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l   94 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML   94 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence            34677766 8999999999999662    4789999997654322  457899999999999999999999984 35789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+++|+|.+++..   ...+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++....
T Consensus        95 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            9999999999999954   3458999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLD  365 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~  365 (498)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|+|+| |++||.......  ..+..+.      
T Consensus       169 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------  237 (291)
T 1xbb_A          169 ADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------  237 (291)
T ss_dssp             TTCSEE-----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------
T ss_pred             cCCCcc-----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------
Confidence            432111     11123347889999999998889999999999999999999 999997654432  2222221      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                        ....|...+..+.+++.+||+.+|.+||++.+ +.+.|+.+...
T Consensus       238 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-l~~~L~~~~~~  280 (291)
T 1xbb_A          238 --RMGCPAGCPREMYDLMNLCWTYDVENRPGFAA-VELRLRNYYYD  280 (291)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHHHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHHH
Confidence              12234456688999999999999999999988 88888887654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.5e-43  Score=345.15  Aligned_cols=261  Identities=24%  Similarity=0.407  Sum_probs=204.4

Q ss_pred             cCCCCCCcccccCceEEEEEEE------CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec----Ccc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~----~~~  206 (498)
                      ..|...+.||+|+||.||+|.+      .+..||||++..... .....+.+|+.+++.++||||+++++++.    ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3578888999999999999985      468899999985432 34567999999999999999999999984    347


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+++|+|.+++...  ...+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence            8999999999999999533  3458999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC--------
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG--------  358 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~--------  358 (498)
                      .......     ........||..|+|||++.+..++.++|||||||++|+|+||..|+.............        
T Consensus       176 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          176 IETDKEY-----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             CCTTCCE-----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred             ccCCCcc-----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence            6543211     111234568999999999999999999999999999999999999875332211100000        


Q ss_pred             c-cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          359 K-LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       359 ~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      . ............+...+..+.+++.+||+.+|.+||++.+ +++.|+.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-ll~~L~~ll  301 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN-LIEGFEALL  301 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHh
Confidence            0 0000011122234556688999999999999999999998 878887764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-43  Score=349.50  Aligned_cols=263  Identities=25%  Similarity=0.364  Sum_probs=200.4

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcC--CCCCeeeeeceec------Ccc
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGACP------EVW  206 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~hpniv~l~g~~~------~~~  206 (498)
                      ...++|.+.+.||+|+||.||+|.+++..||||++...   ....+..|.+++..+  +||||+++++++.      ...
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            34568999999999999999999999999999998642   234566677777665  8999999999873      357


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                      ++||||+++|+|.+++..    ..+++..++.++.+++.||.|||+.     +..||+||||||+|||++.++.+||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            899999999999999953    3589999999999999999999982     0129999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCc------cchHhHHHHHHHHHhC----------CCCC
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK------SDVYSFGIILLRLLTG----------RPAL  345 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltG----------~~pf  345 (498)
                      |++..+........    .......||+.|+|||++.+..++..      +|||||||++|||+||          ..||
T Consensus       187 g~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          187 GLAVKFISDTNEVD----IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             TTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             CCceeecccccccc----CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99986654332111    11123469999999999988766665      9999999999999999          6666


Q ss_pred             CCc-------HHHHHHHHhCccccccCCCCCCC-CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          346 GIT-------KEVQYALDTGKLKNLLDPLAGDW-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       346 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ...       ...............+   ...+ +..++..+.+++.+||+.+|.+||++.+ +++.|+.+....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e-ll~~L~~l~~~~  333 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALR-VKKTLAKMSESQ  333 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH-HHHHHHHHHHTT
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccc---cccchhhHHHHHHHHHHHHhhhhChhhCCCHHH-HHHHHHHHHhhc
Confidence            431       1112111111111110   0001 2257788999999999999999999998 888898887643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-43  Score=349.02  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCceEEEEEEECC------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      .+|...+.||+|+||.||+|.+..      ..||||++...... ....+.+|+.+++.++||||+++++++.  ...++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            356667899999999999998742      35999999754321 2346889999999999999999999985  36799


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+++|+|.+++...  ...+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++....
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999643  3569999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLD  365 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~  365 (498)
                      .......     ......||+.|+|||++.+..++.++|||||||++|+|+| |+.||.......  ..+..+.      
T Consensus       199 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~------  267 (333)
T 1mqb_A          199 DDPEATY-----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------  267 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------
T ss_pred             ccccccc-----ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC------
Confidence            4321111     1123347889999999999999999999999999999999 999997554322  2222211      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                        ....+...+..+.+++.+||+.+|.+||++.+ +++.|+.+...
T Consensus       268 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~-l~~~L~~~~~~  310 (333)
T 1mqb_A          268 --RLPTPMDCPSAIYQLMMQCWQQERARRPKFAD-IVSILDKLIRA  310 (333)
T ss_dssp             --CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHHHHS
T ss_pred             --cCCCcccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHhc
Confidence              11123445678999999999999999999998 88888877653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-43  Score=344.95  Aligned_cols=255  Identities=27%  Similarity=0.481  Sum_probs=209.4

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      ....+|.+.+.||+|+||.||+|.+.  +..||||++.... ...+.+.+|+.+++.++||||+++++++.+  ..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            34567888999999999999999996  6889999997533 345678999999999999999999999854  579999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++... ....+++..+..++.+++.||.|||+   +||+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            999999999999643 33569999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~~  367 (498)
                      ...       ......||+.|+|||.+.+..++.++|||||||++|+|+| |.+||...+..  ...+...        .
T Consensus       165 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~--------~  229 (288)
T 3kfa_A          165 TYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------Y  229 (288)
T ss_dssp             SSE-------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------C
T ss_pred             ccc-------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc--------C
Confidence            211       1123347889999999999999999999999999999999 99999754322  2222211        1


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ....+...+..+.+++..||..+|.+||++.+ +.+.|+.+..
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-~~~~l~~~~~  271 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAE-IHQAFETMFQ  271 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHH-HHHHHHHHHH
Confidence            11234445678999999999999999999998 7788877654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.7e-43  Score=347.87  Aligned_cols=261  Identities=22%  Similarity=0.347  Sum_probs=200.0

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceecC-
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE-  204 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~~-  204 (498)
                      +....++|.+.+.||+|+||.||+|.+.     +..||||++.......  ...+.+|+.++++++||||+++++++.+ 
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3344567888899999999999999873     2479999987553322  3568899999999999999999999843 


Q ss_pred             ------cceEEEeeCCCCCHHhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          205 ------VWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       205 ------~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                            ..++||||+++|+|.+++...   .....+++..++.++.+++.||.|||+   +||+||||||+|||++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCc
Confidence                  348999999999999998432   234569999999999999999999999   89999999999999999999


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--H
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--Q  352 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~  352 (498)
                      +||+|||++...........      .....|++.|+|||.+.+..++.++|||||||++|+|+| |.+||......  .
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  259 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQ------GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY  259 (313)
T ss_dssp             EEECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             EEEeecCcceecccccccCc------ccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence            99999999987654321111      122347889999999999999999999999999999999 99999754322  1


Q ss_pred             HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          353 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .....+.        ....+...+..+.+++.+||..+|.+||++.+ +...|+.+...
T Consensus       260 ~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-l~~~L~~l~~~  309 (313)
T 3brb_A          260 DYLLHGH--------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSV-LRLQLEKLLES  309 (313)
T ss_dssp             HHHHTTC--------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             HHHHcCC--------CCCCCccccHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHHh
Confidence            1122211        11233445678999999999999999999998 88888887653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.7e-43  Score=350.01  Aligned_cols=258  Identities=24%  Similarity=0.409  Sum_probs=208.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC---------CeEEEEEEecCCCC-CChhhHHHHHHHHHcC-CCCCeeeeeceec--
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--  203 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~hpniv~l~g~~~--  203 (498)
                      .++|.+.+.||+|+||.||+|.+.         +..||||++..... .....+.+|+.+++++ +||||++++++|.  
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            457888999999999999999873         35799999875432 1235688999999999 8999999999984  


Q ss_pred             CcceEEEeeCCCCCHHhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL  270 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl  270 (498)
                      +..++||||+++|+|.+++.....             ...+++..++.++.+++.||.|||+   +||+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence            468999999999999999964331             2348999999999999999999999   899999999999999


Q ss_pred             cCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH
Q 010882          271 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK  349 (498)
Q Consensus       271 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  349 (498)
                      +.++.+||+|||++.........      .......||+.|+|||++.+..++.++|||||||++|+|+| |.+||....
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSE------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cCCCCEEEccccccccccccccc------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            99999999999999866543211      11233457899999999998899999999999999999999 999997654


Q ss_pred             HHH--HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          350 EVQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       350 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ...  ..+..+.        ....+...+..+.+++.+||..+|.+||++.+ +++.|+.+....
T Consensus       265 ~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~l~~~~  320 (334)
T 2pvf_A          265 VEELFKLLKEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ-LVEDLDRILTLT  320 (334)
T ss_dssp             HHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCC--------CCCCCccCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHhcc
Confidence            322  2222221        11233445678999999999999999999998 888888887653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.1e-43  Score=346.98  Aligned_cols=259  Identities=27%  Similarity=0.418  Sum_probs=204.4

Q ss_pred             CCCCCcccccCceEEEEEEE------CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC----cceE
Q 010882          140 FDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTL  208 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~~l  208 (498)
                      |...+.||+|+||.||++.+      .+..||||++..... .....+.+|+.+++.++||||+++++++.+    ..++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            47888999999999999876      467899999986432 124568899999999999999999999843    4689


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+++|+|.+++...    .+++..++.++.+++.||.|||+   .||+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            99999999999999532    48999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH--------hCcc
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--------TGKL  360 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~--------~~~~  360 (498)
                      .....     ........||+.|+|||++.+..++.++|||||||++|+|+||..||...........        ...+
T Consensus       186 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          186 EGHEY-----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             TTCSE-----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccccc-----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            43211     1112344588899999999998999999999999999999999999975432211000        0000


Q ss_pred             cccc-CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          361 KNLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       361 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ...+ .......+...+..+.+|+.+||+.+|.+||++.+ +++.|+.+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e-ll~~L~~l~~~  311 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFEN-LIPILKTVHEK  311 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHHHHh
Confidence            1111 11112234456688999999999999999999998 78888887654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-43  Score=354.04  Aligned_cols=260  Identities=23%  Similarity=0.391  Sum_probs=207.8

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceec
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP  203 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~  203 (498)
                      +.....+|.+.+.||+|+||.||+|.+.+       ..||+|++...... ....+.+|+.+++.+ +||||++++++|.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            44456788999999999999999999843       37999999764322 245688999999999 8999999999984


Q ss_pred             --CcceEEEeeCCCCCHHhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE
Q 010882          204 --EVWTLVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL  270 (498)
Q Consensus       204 --~~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl  270 (498)
                        +..++||||+++|+|.+++....           ....+++..++.++.+++.||.|||+   +||+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence              46899999999999999985421           13468999999999999999999999   899999999999999


Q ss_pred             cCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH
Q 010882          271 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK  349 (498)
Q Consensus       271 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  349 (498)
                      +.++.+||+|||++.........      .......||+.|+|||++.+..++.++|||||||++|+|+| |.+||....
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNY------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTS------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCCCeEEECccccccccccccce------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            99999999999999865443211      11223447889999999999999999999999999999999 999997532


Q ss_pred             ---HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          350 ---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       350 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                         ........+.        ....|...+..+.+++..||+.+|.+||++.+ +++.|+.+..
T Consensus       272 ~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~-l~~~L~~~~~  326 (333)
T 2i1m_A          272 VNSKFYKLVKDGY--------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ-ICSFLQEQAQ  326 (333)
T ss_dssp             SSHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             hhHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHH-HHHHHHHHHH
Confidence               2222222211        11123344678999999999999999999998 7778877654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.3e-42  Score=337.76  Aligned_cols=238  Identities=24%  Similarity=0.397  Sum_probs=198.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~  213 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..||+|++........+.+.+|+.+++.++||||++++++|.+  ..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            46888899999999999999985  46899999987666667889999999999999999999999854  578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE---cCCCceeEeecccccccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~~~  290 (498)
                      ++++|.+++..   ...+++..+..++.+++.||.|||+   +||+||||||+|||+   +.++.+||+|||++......
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           89 TGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            99999998853   3458999999999999999999999   899999999999999   78899999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~  368 (498)
                      ..         .....||+.|+|||++.+. ++.++|||||||++|+|+||++||.........  +..+...       
T Consensus       163 ~~---------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  225 (277)
T 3f3z_A          163 KM---------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT-------  225 (277)
T ss_dssp             SC---------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred             cc---------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-------
Confidence            21         1234599999999998654 899999999999999999999999765443322  2222111       


Q ss_pred             CCCCH----HHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          369 GDWPF----VQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       369 ~~~~~----~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        +|.    ..+..+.+++.+||+.+|.+||++.++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~  259 (277)
T 3f3z_A          226 --FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA  259 (277)
T ss_dssp             --CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             --CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence              122    245789999999999999999999883

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-42  Score=339.27  Aligned_cols=256  Identities=25%  Similarity=0.359  Sum_probs=203.0

Q ss_pred             CCCCCCcccccCceEEEEEEEC--C---eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--c-ceEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--V-WTLV  209 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~-~~lV  209 (498)
                      .|...+.||+|+||+||+|.+.  +   ..||+|++..... ...+.+.+|+.+++.++||||+++++++.+  . .++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4556688999999999999873  2   3699999875332 224578899999999999999999999843  3 4899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+.+|+|.+++..  ....+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++.....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999953  34568999999999999999999999   8999999999999999999999999999986654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDP  366 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~  366 (498)
                      ......    .......||+.|+|||.+.+..++.++|||||||++|+|+| |.+||...+..  ...+..+.       
T Consensus       177 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------  245 (298)
T 3pls_A          177 REYYSV----QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-------  245 (298)
T ss_dssp             GGGGCS----CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-------
T ss_pred             Cccccc----ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-------
Confidence            332111    11234458999999999999999999999999999999999 55666543322  22222211       


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                       ....+...+..+.+++.+||+.+|.+||++.+ +++.|+.+....
T Consensus       246 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~-ll~~l~~~~~~l  289 (298)
T 3pls_A          246 -RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRV-LVGEVEQIVSAL  289 (298)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHHC
T ss_pred             -CCCCCccchHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHHHH
Confidence             11123345678999999999999999999988 888888877654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.5e-43  Score=356.60  Aligned_cols=259  Identities=17%  Similarity=0.238  Sum_probs=198.0

Q ss_pred             hhcCCCCCCccccc--CceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--Ccce
Q 010882          136 ATHNFDPSLKIGEG--GYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWT  207 (498)
Q Consensus       136 ~~~~~~~~~~lG~G--~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~  207 (498)
                      ..++|.+.+.||+|  +||.||+|.+.  +..||||++.......  ...+.+|+.+++.++||||++++++|.  ...+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34578899999999  99999999995  7899999997643222  356788999999999999999999984  4689


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+++|+|.+++.... ...+++..+..|+.|++.||.|||+   ++|+||||||+||||+.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999996432 3459999999999999999999999   89999999999999999999999999998765


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH--hCccccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNL  363 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~--~~~~~~~  363 (498)
                      ........ ..........||+.|+|||++.+  ..++.++|||||||++|+|+||++||...+.......  .+.....
T Consensus       179 ~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          179 ISHGQRQR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             EETTEECS-CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             cccccccc-ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            43321111 11111233469999999999987  5799999999999999999999999965332211111  0000000


Q ss_pred             cCC-------------------------------------CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          364 LDP-------------------------------------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       364 ~~~-------------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ++.                                     ....++...+..+.+|+.+||+.||.+||++.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            000                                     001123345678999999999999999999988

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=356.45  Aligned_cols=239  Identities=23%  Similarity=0.323  Sum_probs=190.8

Q ss_pred             CCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          143 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      .+.||+|+||.||+|...  +..||||++........+.+.+|+.+|++++||||++++++|.  +..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            567999999999999984  6889999998755445677999999999999999999999984  357999999999999


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE--cCCCceeEeeccccccccccccCCCC
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl--~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      .+++..  ....+++..+..++.|++.||.|||+   .+|+||||||+|||+  +.++.+||+|||+++........   
T Consensus       174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---  245 (373)
T 2x4f_A          174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---  245 (373)
T ss_dssp             HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred             HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence            998853  23468999999999999999999999   899999999999999  56789999999999876543211   


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH--HhCccccccCCCCCCCCHH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGDWPFV  374 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  374 (498)
                            ....||+.|+|||++.+..++.++|||||||++|+|+||++||...+......  ....+.  +.  . .....
T Consensus       246 ------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~~--~-~~~~~  314 (373)
T 2x4f_A          246 ------KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--LE--D-EEFQD  314 (373)
T ss_dssp             ------CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--SC--S-GGGTT
T ss_pred             ------ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CC--h-hhhcc
Confidence                  22359999999999998899999999999999999999999998665433221  111111  00  0 01123


Q ss_pred             HHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          375 QAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       375 ~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+..+.+|+.+||..+|.+||++.++
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e~  340 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASEA  340 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            45789999999999999999999883

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=355.10  Aligned_cols=260  Identities=24%  Similarity=0.330  Sum_probs=208.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC----cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~~lV~  210 (498)
                      .+|.+.+.||+|+||.||+|.+.  +..||||++..... ...+.+.+|+.++++++||||+++++++.+    ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            46888899999999999999995  78999999975432 335678899999999999999999998842    468999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE----cCCCceeEeecccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISRF  286 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGla~~  286 (498)
                      ||+++|+|.+++........+++..++.++.+++.||.|||+   +||+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            999999999999755444559999999999999999999999   899999999999999    7788899999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhcc--------CCCCCccchHhHHHHHHHHHhCCCCCCC------cHHHH
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--------GELTPKSDVYSFGIILLRLLTGRPALGI------TKEVQ  352 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltG~~pf~~------~~~~~  352 (498)
                      .......         ....||+.|+|||++.+        ..++.++|||||||++|||+||+.||..      .....
T Consensus       166 ~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  236 (396)
T 4eut_A          166 LEDDEQF---------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (396)
T ss_dssp             CCCGGGS---------SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred             ccCCCcc---------ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence            6543211         23459999999999875        4677899999999999999999999952      12222


Q ss_pred             HHHHhCcccccc----------------CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          353 YALDTGKLKNLL----------------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       353 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ..+..+.....+                .+.....+...+..+.+++..||+.||.+||++.+ +++.++.+..
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e-~l~~l~~il~  309 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ-FFAETSDILH  309 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH-HHHHHHHHHT
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH-HHHHHHHHhh
Confidence            222222111000                01122345678889999999999999999999988 7777777654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.4e-43  Score=364.18  Aligned_cols=239  Identities=26%  Similarity=0.404  Sum_probs=199.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..||||++....   ......+.+|+.+|+.++||||+++++++.  +..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            47888899999999999999985  7899999986532   233467899999999999999999999984  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++......
T Consensus        96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999994   34569999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHH--HHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~  367 (498)
                      ..         .....||+.|+|||++.+..+ +.++|||||||++|+|+||++||...+...  ..+..+..       
T Consensus       170 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------  233 (476)
T 2y94_A          170 EF---------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-------  233 (476)
T ss_dssp             CC---------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-------
T ss_pred             cc---------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-------
Confidence            21         123359999999999988765 689999999999999999999997654322  22222211       


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        ..|...+..+.+|+.+||..||.+||++.++
T Consensus       234 --~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~ei  264 (476)
T 2y94_A          234 --YTPQYLNPSVISLLKHMLQVDPMKRATIKDI  264 (476)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             --CCCccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence              1234456789999999999999999999883

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-42  Score=339.84  Aligned_cols=248  Identities=25%  Similarity=0.300  Sum_probs=191.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ++|...+.||+|+||+||+|.+.  +..||||++.......  ...+.+|+.++++++||||+++++++.  +..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            36788889999999999999984  6889999997654332  357889999999999999999999984  46799999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++ +|.+.+..  ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9976 55555532  23569999999999999999999999   899999999999999999999999999998764332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCC-CCcHHHHHHHHh----Ccc-----
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDT----GKL-----  360 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf-~~~~~~~~~~~~----~~~-----  360 (498)
                      ..        .....||+.|+|||++.+.. ++.++|||||||++|+|+||..|| ...+........    +..     
T Consensus       156 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~  227 (292)
T 3o0g_A          156 RC--------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             SC--------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred             cc--------ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence            11        13345899999999998765 899999999999999999887764 433322211110    000     


Q ss_pred             ---ccccC----------CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 ---KNLLD----------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 ---~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                         ....+          ..........+..+.+|+.+||+.||.+||++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  279 (292)
T 3o0g_A          228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE  279 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH
Confidence               00000          0001112235678899999999999999999988

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=362.62  Aligned_cols=252  Identities=22%  Similarity=0.250  Sum_probs=198.0

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceecC--c
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--V  205 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~  205 (498)
                      +.....+|.+.+.||+|+||.||+|..+  +..||||++.+...   .....+.+|+.++..++||||++++++|.+  .
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            3344568999999999999999999984  78999999865321   223458899999999999999999999854  5


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .|+||||++||+|.+++...  ...+++..+..++.+++.||.|||+   ++|+||||||+||||+.+|++||+|||+|+
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhhe
Confidence            89999999999999999643  2368999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhc-------cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG  358 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (498)
                      ........       ......||+.|+|||++.       ...++.++|||||||++|||+||++||...+.........
T Consensus       211 ~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  283 (412)
T 2vd5_A          211 KLRADGTV-------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV  283 (412)
T ss_dssp             ECCTTSCE-------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             eccCCCcc-------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            76543211       112346999999999997       3568999999999999999999999998765443222111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCC---ChhH
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGK  399 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---~~~~  399 (498)
                      .....+.  ....+...+..+.+|+.+||. +|.+|+   ++.+
T Consensus       284 ~~~~~~~--~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~e  324 (412)
T 2vd5_A          284 HYKEHLS--LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGD  324 (412)
T ss_dssp             THHHHCC--CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHH
T ss_pred             hcccCcC--CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence            1111110  011123456789999999999 999985   6655

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.6e-43  Score=377.90  Aligned_cols=246  Identities=25%  Similarity=0.418  Sum_probs=198.8

Q ss_pred             CcccccCceEEEEEEEC----CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEEeeCCCC
Q 010882          144 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEYLPNG  216 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~E~~~~g  216 (498)
                      +.||+|+||.||+|.+.    +..||||+++.....  ..+.|.+|+.+|++++|||||+++++|.+ ..++||||+++|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG  454 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence            36999999999999763    467999999764332  24679999999999999999999999954 578999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++..   ...+++..+..|+.|++.||.|||+   ++||||||||+||||+.++.+||+|||+++.+.......  
T Consensus       455 ~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--  526 (635)
T 4fl3_A          455 PLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--  526 (635)
T ss_dssp             EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc--
Confidence            99999953   3568999999999999999999999   899999999999999999999999999998765433211  


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCCCCCCCCH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                         .......||+.|+|||++.+..++.++|||||||+||||+| |+.||......  ...+..+.        ....|.
T Consensus       527 ---~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------~~~~p~  595 (635)
T 4fl3_A          527 ---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------RMGCPA  595 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCT
T ss_pred             ---ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCCC
Confidence               11123347889999999999999999999999999999998 99999765443  22333321        122345


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      .++..+.+|+..||+.+|.+||++.+ +.+.|+.+.
T Consensus       596 ~~~~~l~~li~~cl~~dP~~RPs~~~-l~~~L~~~~  630 (635)
T 4fl3_A          596 GCPREMYDLMNLCWTYDVENRPGFAA-VELRLRNYY  630 (635)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHH
Confidence            56688999999999999999999998 777777664

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.1e-42  Score=340.72  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=197.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      ..+|.+.+.||+|+||.||+|..  .+..||||++.......   ...+.+|+.+++.++||||+++++++.  +..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            34788899999999999999997  47899999998644333   346889999999999999999999984  468899


Q ss_pred             EeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          210 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      |||+++|+|.+++... .....+++..++.++.+++.||.|||+   .|++||||||+|||++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998532 234568999999999999999999999   899999999999999999999999999998654


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH----HHHHHHhCcccccc
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE----VQYALDTGKLKNLL  364 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~----~~~~~~~~~~~~~~  364 (498)
                      .....        .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.....    ....+..+..... 
T Consensus       188 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  258 (310)
T 2wqm_A          188 SKTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL-  258 (310)
T ss_dssp             -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC-
T ss_pred             CCCcc--------ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC-
Confidence            33211        1233589999999999999999999999999999999999999965321    1112222211110 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhcC
Q 010882          365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG  413 (498)
Q Consensus       365 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~~  413 (498)
                            .+...+..+.+++.+||..||.+||++.+ +++.|+.+.+...
T Consensus       259 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~-il~~l~~l~~~~~  300 (310)
T 2wqm_A          259 ------PSDHYSEELRQLVNMCINPDPEKRPDVTY-VYDVAKRMHACTA  300 (310)
T ss_dssp             ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHHHC
T ss_pred             ------cccccCHHHHHHHHHHcCCChhhCCCHHH-HHHHHHHHHHhhh
Confidence                  11234578999999999999999999998 8899999987653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-42  Score=338.25  Aligned_cols=245  Identities=25%  Similarity=0.391  Sum_probs=203.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC----------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~----------  204 (498)
                      ..+|...+.||+|+||.||+|.+.  +..||||++...    ...+.+|+.+++.++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            346888899999999999999985  789999998753    2578899999999999999999998732          


Q ss_pred             --------cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          205 --------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       205 --------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                              ..++||||+++|+|.+++.... ...+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence                    3689999999999999996432 3468999999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD  356 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (498)
                      ||+|||++........         .....||+.|+|||++.+..++.++|||||||++|+|+||..||...........
T Consensus       162 kl~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~  232 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK---------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR  232 (284)
T ss_dssp             EECCCTTCEESSCCSC---------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHH
T ss_pred             EECcchhheecccccc---------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhh
Confidence            9999999987654321         1233589999999999999999999999999999999999998854333322222


Q ss_pred             hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          357 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      .+.           .+...+..+.+++.+||..+|.+||++.+ +++.|..+..
T Consensus       233 ~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e-~l~~l~~~~~  274 (284)
T 2a19_B          233 DGI-----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSE-ILRTLTVWKK  274 (284)
T ss_dssp             TTC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHTC
T ss_pred             ccc-----------ccccCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHhh
Confidence            221           22334567899999999999999999988 7788877754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=342.15  Aligned_cols=250  Identities=28%  Similarity=0.375  Sum_probs=194.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC-----CChhhHHHHHHHHHcCC---CCCeeeeeceecC--
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIR---HPNLVTLVGACPE--  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~---hpniv~l~g~~~~--  204 (498)
                      .++|.+.+.||+|+||+||+|.+  .+..||||++.....     .....+.+|+.+++.+.   ||||++++++|..  
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            46899999999999999999996  468899999874322     12346778888888775   9999999999843  


Q ss_pred             -----cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEe
Q 010882          205 -----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS  279 (498)
Q Consensus       205 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  279 (498)
                           ..++||||+. |+|.+++.... ...+++..+..|+.|++.||.|||+   ++|+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence                 3689999996 69999986432 2349999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc
Q 010882          280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK  359 (498)
Q Consensus       280 DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (498)
                      |||++.........         ....||+.|+|||++.+..++.++|||||||++|+|+||++||...+..........
T Consensus       163 Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          163 DFGLARIYSYQMAL---------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             SCSCTTTSTTCCCS---------GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             eCccccccCCCccc---------CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999866433211         223489999999999999999999999999999999999999977654433221110


Q ss_pred             cccccC----C-----------CCCC-----CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 LKNLLD----P-----------LAGD-----WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 ~~~~~~----~-----------~~~~-----~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ......    +           ....     .....+..+.+|+.+||+.||.+||++.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  294 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA  294 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHH
Confidence            000000    0           0000     011245788999999999999999999883

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=337.30  Aligned_cols=246  Identities=26%  Similarity=0.401  Sum_probs=196.4

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      .|.....||+|+||.||+|.+.  +..||||.+..........+.+|+.+++.++||||+++++++.  +..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3455568999999999999984  6789999998766555678999999999999999999999984  45789999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-CCceeEeeccccccccccccC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~~~~  293 (498)
                      +|+|.+++........+++..+..++.+++.||.|||+   +||+||||||+|||++. ++.+||+|||++.........
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            99999999765555567899999999999999999999   89999999999999987 899999999999866432211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCC--CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH-HHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-LDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~  370 (498)
                              .....||+.|+|||++.+..  ++.++|||||||++|+|+||++||......... ......     .....
T Consensus       180 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~  246 (295)
T 2clq_A          180 --------TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-----KVHPE  246 (295)
T ss_dssp             ---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-----CCCCC
T ss_pred             --------ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-----ccccc
Confidence                    12345899999999997653  889999999999999999999999643222111 111100     11122


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+...+..+.+++.+||+.+|.+||++.++
T Consensus       247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  276 (295)
T 2clq_A          247 IPESMSAEAKAFILKCFEPDPDKRACANDL  276 (295)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            344566889999999999999999999883

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.4e-43  Score=365.73  Aligned_cols=241  Identities=22%  Similarity=0.282  Sum_probs=189.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      .++|.+.+.||+|+||.||+|...  +..||||++...   .......+.+|+.+++.++||||++++++|.  +..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            357888999999999999999984  688999998753   2233456788999999999999999999984  468999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||++||+|.+++..   ...+++..+..++.|++.||.|||+.  +||+||||||+||||+.++.+||+|||+|+....
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999953   34689999999999999999999962  5899999999999999999999999999985433


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPL  367 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~  367 (498)
                      ....        .....||+.|+|||++.+..++.++|||||||+||||+||++||...+....  .+....        
T Consensus       302 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  365 (446)
T 4ejn_A          302 DGAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------  365 (446)
T ss_dssp             -------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             CCcc--------cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------
Confidence            2211        1334699999999999999999999999999999999999999976544322  121111        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCC-----ChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRP-----ELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----~~~~  399 (498)
                       ..+|...+..+.+|+.+||+.||.+||     ++.+
T Consensus       366 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~e  401 (446)
T 4ejn_A          366 -IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE  401 (446)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHH
Confidence             123445668899999999999999999     7766

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-42  Score=346.11  Aligned_cols=244  Identities=22%  Similarity=0.307  Sum_probs=199.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC------ChhhHHHHHHHHHcCCCCCeeeeeceecC--cce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~  207 (498)
                      +.|.+.+.||+|+||.||+|...  +..||||++......      ..+.+.+|+.+++.++||||+++++++.+  ..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46888999999999999999984  688999999765332      24679999999999999999999999843  579


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC----ceeEeeccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI  283 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFGl  283 (498)
                      +||||+++|+|.+++..   ...+++..+..++.+++.||.|||+   +||+||||||+|||++.++    .+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            99999999999999953   3568999999999999999999999   8999999999999999887    799999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      +........         .....||+.|+|||++.+..++.++|||||||++|+|+||..||..................
T Consensus       166 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  236 (321)
T 2a2a_A          166 AHEIEDGVE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD  236 (321)
T ss_dssp             CEECCTTCC---------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             ceecCcccc---------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc
Confidence            987654321         12345999999999999999999999999999999999999999765543322221111100


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+   ...+...+..+.+++.+||..+|.+||++.+
T Consensus       237 ~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  269 (321)
T 2a2a_A          237 FD---EEFFSHTSELAKDFIRKLLVKETRKRLTIQE  269 (321)
T ss_dssp             CC---HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHH
T ss_pred             cC---hhhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence            00   0011224567999999999999999999988

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=347.06  Aligned_cols=239  Identities=24%  Similarity=0.265  Sum_probs=188.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|...++||+|+||+||+|.+.  +..||||++.......  ...+..|+..+..+ +||||++++++|.  ...++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46888889999999999999985  7899999987543322  22345566666555 8999999999984  4588999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+ +|+|.+++...  ...+++..+..|+.+++.||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus       137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 77999988643  3469999999999999999999999   89999999999999999999999999998866433


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      ..         .....||+.|+|||++.+ .++.++|||||||++|||++|.+|+......... ..+...       ..
T Consensus       211 ~~---------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~-------~~  272 (311)
T 3p1a_A          211 GA---------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-RQGYLP-------PE  272 (311)
T ss_dssp             -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH-TTTCCC-------HH
T ss_pred             CC---------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-hccCCC-------cc
Confidence            21         123359999999999875 7999999999999999999997776554443322 111111       01


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ++...+..+.+++.+||+.+|.+||++.++
T Consensus       273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  302 (311)
T 3p1a_A          273 FTAGLSSELRSVLVMMLEPDPKLRATAEAL  302 (311)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             cccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            122345789999999999999999999883

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-43  Score=350.56  Aligned_cols=259  Identities=23%  Similarity=0.290  Sum_probs=197.3

Q ss_pred             HHHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC-----CCCChhhHHHHHHHHHcCCCCCeeeeeceecC
Q 010882          132 EIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH-----SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE  204 (498)
Q Consensus       132 ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~  204 (498)
                      ++....++|.+.+.||+|+||.||+|...  +..||||++...     .......+.+|+.+++.++||||++++++|.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34555678999999999999999999984  578999998643     22335678999999999999999999999854


Q ss_pred             --cceEEEeeCCCCCHHhhhccCC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 010882          205 --VWTLVYEYLPNGSLEDRLSCKD-------------------------------------NSPPLSWQTRIRIATELCS  245 (498)
Q Consensus       205 --~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~  245 (498)
                        ..++||||++||+|.+++....                                     ....+++..+..|+.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence              5789999999999999984210                                     0122456778899999999


Q ss_pred             HHHHHHhcCCCCcccCCCCCCcEEEcCCC--ceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc--CC
Q 010882          246 VLIFLHSCKPHSIVHGDLKPANILLDANF--VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GE  321 (498)
Q Consensus       246 ~L~~LH~~~~~~ivHrDlkp~NiLl~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~  321 (498)
                      ||.|||+   ++|+||||||+|||++.++  .+||+|||++..+........    .......||+.|+|||++.+  ..
T Consensus       180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY----YGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc----ccccccCCCccccCchhhccCCCC
Confidence            9999999   8999999999999998776  899999999986644321111    11234469999999999975  67


Q ss_pred             CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          322 LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       322 ~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ++.++|||||||++|+|+||++||...................   ........+..+.+++.+||+.+|.+||++.++
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  328 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF---ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA  328 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT---TSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc---CCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            8999999999999999999999997655433222111000000   000112346789999999999999999999883

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.6e-42  Score=335.66  Aligned_cols=263  Identities=20%  Similarity=0.284  Sum_probs=205.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee---cCcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~---~~~~~lV~E  211 (498)
                      .++|.+.+.||+|+||.||+|.+  .+..||||++....  ....+.+|+.+++.++|++++..++.+   ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            45788899999999999999997  47899999987543  335789999999999998877777665   345789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE---cCCCceeEeecccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS  288 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~  288 (498)
                      |+ +|+|.+++...  ...+++..+..++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999999532  3469999999999999999999999   899999999999999   488999999999998766


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH-----HHHHHHhCccccc
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKNL  363 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-----~~~~~~~~~~~~~  363 (498)
                      ....... ..........||+.|+|||++.+..++.++|||||||++|+|+||+.||.....     ....+........
T Consensus       160 ~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          160 DARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCB-CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccccc-cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            5432111 111112445699999999999999999999999999999999999999975211     1111111111111


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhcC
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG  413 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~~  413 (498)
                      ...    .+...+..+.+++.+||+.+|.+||++.+ +.+.|+.+....+
T Consensus       239 ~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~-l~~~l~~~~~~~~  283 (296)
T 3uzp_A          239 IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHRQG  283 (296)
T ss_dssp             HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHH-HHHHHHHHHHHTT
T ss_pred             hHH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHH-HHHHHHHHHHhcC
Confidence            000    11223478999999999999999999988 8888988876654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-42  Score=337.31  Aligned_cols=246  Identities=24%  Similarity=0.348  Sum_probs=193.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      +.|.+.+.||+|+||.||++...  +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+  ..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            36888999999999999999984  6789999987653 3345789999999999999999999999854  57899999


Q ss_pred             CCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE---cCCCceeEeecccccccc
Q 010882          213 LPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS  288 (498)
Q Consensus       213 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~  288 (498)
                      +++|+|.+.+... .....+++..+..|+.+++.||.|||+   .||+||||||+|||+   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988532 223569999999999999999999999   899999999999999   456889999999998654


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      ....         .....||+.|+|||++. ..++.++|||||||++|+|+||+.||...................... 
T Consensus       179 ~~~~---------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  247 (285)
T 3is5_A          179 SDEH---------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-  247 (285)
T ss_dssp             -----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred             Cccc---------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-
Confidence            4321         12345899999999985 578899999999999999999999997654432221111001111101 


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                         ....+..+.+++.+||+.||.+||++.++
T Consensus       248 ---~~~~~~~~~~li~~~L~~dP~~Rps~~e~  276 (285)
T 3is5_A          248 ---CRPLTPQAVDLLKQMLTKDPERRPSAAQV  276 (285)
T ss_dssp             ----CCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             ---cCcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence               11135678999999999999999999883

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=354.25  Aligned_cols=262  Identities=19%  Similarity=0.244  Sum_probs=193.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCC-----------ChhhHHHHHHHHHcCCCCCeeeeece
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-----------GPSEFQQEIDILSKIRHPNLVTLVGA  201 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~hpniv~l~g~  201 (498)
                      ++|.+.+.||+|+||.||+|.+.     +..||||++......           ....+.+|+.+++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57888999999999999999984     467999998765321           12236678889999999999999998


Q ss_pred             ec------CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-
Q 010882          202 CP------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-  274 (498)
Q Consensus       202 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-  274 (498)
                      +.      ...++||||+ +++|.+++...   ..+++..++.|+.|++.||.|||+   +||+||||||+|||++.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence            73      3578999999 99999999543   379999999999999999999999   8999999999999999887 


Q ss_pred             -ceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCc--HHH
Q 010882          275 -VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT--KEV  351 (498)
Q Consensus       275 -~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~--~~~  351 (498)
                       .+||+|||+++.+......... .........||+.|+|||++.+..++.++|||||||++|||+||+.||...  ...
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQY-QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCC-CCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CcEEEEeCCCceecccccccccc-hhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence             9999999999877544321111 111124456999999999999999999999999999999999999999531  111


Q ss_pred             HHHHHhCccccccCCCCCC--CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          352 QYALDTGKLKNLLDPLAGD--WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      ............+......  .+...+..+.+++..||..+|.+||++.+ +.+.|+.+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-l~~~L~~~  326 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQA-LKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHH-HHHHHCTT
T ss_pred             HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHH-HHHHHhcc
Confidence            1111111111111000000  00134568999999999999999999988 76776654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.8e-42  Score=365.99  Aligned_cols=241  Identities=22%  Similarity=0.310  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      .+|...+.||+|+||.||+|...  +..||||++....   ......+..|+.+|+.++||||++++++|.  +..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            46888889999999999999984  7899999996532   233467889999999999999999999984  3589999


Q ss_pred             eeCCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          211 EYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      ||++||+|.+++.... ....+++..+..++.|++.||.|||+   +||+||||||+||||+.+|++||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986432 24569999999999999999999999   8999999999999999999999999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH------HHHHHHHhCccccc
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK------EVQYALDTGKLKNL  363 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~~~~~~~~~~~~  363 (498)
                      ....        .....||+.|+|||++.+..++.++|||||||++|||+||++||....      .....+..+     
T Consensus       342 ~~~~--------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-----  408 (543)
T 3c4z_A          342 GQTK--------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-----  408 (543)
T ss_dssp             TCCC--------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----
T ss_pred             CCcc--------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----
Confidence            3211        123469999999999999999999999999999999999999997542      122222111     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChh
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG  398 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  398 (498)
                          ...+|...+..+.+|+.+||..+|.+||++.
T Consensus       409 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          409 ----AVTYPDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             ----ccCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence                1124555678899999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.5e-43  Score=347.64  Aligned_cols=235  Identities=24%  Similarity=0.360  Sum_probs=172.9

Q ss_pred             CCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceecC--cceEEEeeCCCCC
Q 010882          143 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE--VWTLVYEYLPNGS  217 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~--~~~lV~E~~~~gs  217 (498)
                      .+.||+|+||.||+|.+.  +..||||++...   ....+.+|+.+++.+. ||||++++++|.+  ..++||||++||+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            467999999999999985  688999998642   3457889999999997 9999999999854  5789999999999


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC---ceeEeeccccccccccccCC
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~~~~~~~~~  294 (498)
                      |.+++..   ...+++..+..|+.+++.||.|||+   +||+||||||+|||++.++   .+||+|||+++........ 
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-  165 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-  165 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence            9999953   3569999999999999999999999   8999999999999998665   8999999999865443211 


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH---------HHHHHhCccccccC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV---------QYALDTGKLKNLLD  365 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~---------~~~~~~~~~~~~~~  365 (498)
                             .....||+.|+|||++.+..++.++|||||||++|+|+||++||......         ...+..+....   
T Consensus       166 -------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~---  235 (325)
T 3kn6_A          166 -------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF---  235 (325)
T ss_dssp             -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC---
T ss_pred             -------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC---
Confidence                   12345899999999999999999999999999999999999999754321         11111111100   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        ........+..+.+|+..||..||.+||++.+
T Consensus       236 --~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  267 (325)
T 3kn6_A          236 --EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG  267 (325)
T ss_dssp             --CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTT
T ss_pred             --CcccccCCCHHHHHHHHHHCCCChhHCCCHHH
Confidence              00001234678999999999999999999988

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=345.24  Aligned_cols=264  Identities=23%  Similarity=0.395  Sum_probs=208.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEE------CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC----cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~----~~  206 (498)
                      ..+|.+.+.||+|+||.||+|.+      .+..||||++..........+.+|+.++++++||||+++++++..    ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            34688889999999999999985      468899999987554445679999999999999999999998732    57


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+++|+|.+++...  ...+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            8999999999999999643  3458999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH-HHHHHhC-------
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTG-------  358 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~-------  358 (498)
                      .......     ........||..|+|||.+.+..++.++|||||||++|+|+||..||...... .......       
T Consensus       195 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          195 LPQDKEY-----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             CCSSCSE-----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred             ccccccc-----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence            6543211     11122345788899999999988999999999999999999999998643211 1100000       


Q ss_pred             -cccccc-CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          359 -KLKNLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       359 -~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                       .+...+ .......+...+..+.+++.+||+.+|.+||++.+ +++.|+.++..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-l~~~L~~l~~~  323 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD-LALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHHH
Confidence             000000 01111234456688999999999999999999988 88888887653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.9e-43  Score=352.93  Aligned_cols=240  Identities=25%  Similarity=0.292  Sum_probs=186.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      ..+|.+.+.||+|+||+||++...  +..||||++.... ...+.+.+|+.+++.++||||+++++++.  +..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            457889999999999999999984  6889999997543 23467889999999999999999999984  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc--eeEeecccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGISRFLSQN  290 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~DFGla~~~~~~  290 (498)
                      ++||+|.+++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999853   2459999999999999999999999   89999999999999987765  999999998743322


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCc-cchHhHHHHHHHHHhCCCCCCCcHHH------HHHHHhCccccc
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK-SDVYSFGIILLRLLTGRPALGITKEV------QYALDTGKLKNL  363 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltG~~pf~~~~~~------~~~~~~~~~~~~  363 (498)
                      ..         .....||+.|+|||++.+..++.+ +|||||||++|+|+||++||......      ...+......  
T Consensus       172 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--  240 (361)
T 3uc3_A          172 SQ---------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS--  240 (361)
T ss_dssp             ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC--
T ss_pred             CC---------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC--
Confidence            11         123359999999999988887665 89999999999999999999754321      1111111110  


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                           ...+...+..+.+|+.+||..+|.+||++.+
T Consensus       241 -----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e  271 (361)
T 3uc3_A          241 -----IPDDIRISPECCHLISRIFVADPATRISIPE  271 (361)
T ss_dssp             -----CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             -----CCCcCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence                 0011124578999999999999999999988

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-42  Score=349.81  Aligned_cols=258  Identities=24%  Similarity=0.335  Sum_probs=201.4

Q ss_pred             CCCCChHHHHHhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-----CCCeee
Q 010882          125 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----HPNLVT  197 (498)
Q Consensus       125 ~~~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----hpniv~  197 (498)
                      ...+++.+.....++|.+.+.||+|+||.||+|.+  .+..||||++.... .....+..|+.+++.+.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34455555556677899999999999999999998  46889999986421 22356778999999996     999999


Q ss_pred             eeceec--CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---
Q 010882          198 LVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---  272 (498)
Q Consensus       198 l~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---  272 (498)
                      +++++.  +..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+   +||+||||||+|||++.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence            999884  4688999999 999999996433 2459999999999999999999999   89999999999999975   


Q ss_pred             ----------------------CCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHh
Q 010882          273 ----------------------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYS  330 (498)
Q Consensus       273 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS  330 (498)
                                            ++.+||+|||++.......           ....||+.|+|||++.+..++.++||||
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Diws  244 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----------GSIINTRQYRAPEVILNLGWDVSSDMWS  244 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----------CSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----------cCccCcccccCcHHHcCCCCCCccchHH
Confidence                                  7899999999998644321           2345899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCcHHHHHHHHhCcc-----------------ccccCC--CCCCCCH------------------
Q 010882          331 FGIILLRLLTGRPALGITKEVQYALDTGKL-----------------KNLLDP--LAGDWPF------------------  373 (498)
Q Consensus       331 lGvil~elltG~~pf~~~~~~~~~~~~~~~-----------------~~~~~~--~~~~~~~------------------  373 (498)
                      |||++|+|+||++||...+...........                 ...+..  ....||.                  
T Consensus       245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  324 (360)
T 3llt_A          245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY  324 (360)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence            999999999999999765433221111000                 000000  0001111                  


Q ss_pred             --HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          374 --VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       374 --~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        ..+..+.+|+.+||+.||.+||++.+
T Consensus       325 ~~~~~~~l~~li~~~L~~dP~~Rpta~e  352 (360)
T 3llt_A          325 KIIKHELFCDFLYSILQIDPTLRPSPAE  352 (360)
T ss_dssp             HHCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             ccchHHHHHHHHHHHhcCChhhCCCHHH
Confidence              01256789999999999999999988

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.6e-43  Score=339.47  Aligned_cols=241  Identities=27%  Similarity=0.444  Sum_probs=196.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      ..+|.+.+.||+|+||.||+|.+.  +..||||++....   ......+.+|+.+++.++||||++++++|.+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            457888899999999999999985  5689999986432   1234568899999999999999999999854  57899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++...   ..+++..+..++.+++.||.|||+   .||+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999998533   458999999999999999999999   8999999999999999999999999999865433


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ..          .....||+.|+|||.+.+..++.++||||||+++|+|++|.+||...............       ..
T Consensus       162 ~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~~  224 (279)
T 3fdn_A          162 SR----------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------EF  224 (279)
T ss_dssp             ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------CC
T ss_pred             cc----------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-------CC
Confidence            21          12335899999999999999999999999999999999999999866543322111111       11


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+|...+..+.+++.+||+.+|.+||++.++
T Consensus       225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  255 (279)
T 3fdn_A          225 TFPDFVTEGARDLISRLLKHNPSQRPMLREV  255 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCcCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            2344456789999999999999999999883

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.9e-42  Score=336.38  Aligned_cols=263  Identities=20%  Similarity=0.284  Sum_probs=203.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee---cCcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~---~~~~~lV~E  211 (498)
                      .++|.+.+.||+|+||.||+|.+  .+..||||++....  ....+.+|+.+++.++|+|++..++.+   .+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            45799999999999999999997  47899999876543  234688999999999998888877766   345789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE---cCCCceeEeecccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS  288 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~  288 (498)
                      |+ +|+|.+++...  ...+++..+..++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            99 99999998532  3469999999999999999999999   899999999999999   788999999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH-----HHHHHHhCccccc
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKNL  363 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-----~~~~~~~~~~~~~  363 (498)
                      ....... ..........||+.|+|||.+.+..++.++|||||||++|+|+||++||.....     .............
T Consensus       160 ~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          160 DARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCB-CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CcccCcc-CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            5432111 111122345699999999999999999999999999999999999999964221     0111111111110


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhcC
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG  413 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~~  413 (498)
                      ...    .....+..+.+++..||+.+|.+||++.+ +.+.|+.+....+
T Consensus       239 ~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~-l~~~l~~~~~~~~  283 (296)
T 4hgt_A          239 IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHRQG  283 (296)
T ss_dssp             HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHH-HHHHHHHHHHHHT
T ss_pred             hhh----hhccCCHHHHHHHHHHHhcCCCCCCCHHH-HHHHHHHHHHHhC
Confidence            000    01123478999999999999999999988 8888888876654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.4e-42  Score=344.38  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=202.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeE--EEEEEecCCC-CCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQ--VAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~--vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV  209 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..  ||||.+.... ......+.+|+.+++++ +||||+++++++.  +..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            46888899999999999999874  444  5999887532 23456799999999999 8999999999984  458899


Q ss_pred             EeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          210 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                      |||+++|+|.+++....             ....+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence            99999999999996432             23479999999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHH
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL  355 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~  355 (498)
                      ||+|||+++.......         .....+|+.|+|||++.+..++.++|||||||++|+|+| |++||..........
T Consensus       182 kL~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVK---------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  252 (327)
T ss_dssp             EECCTTCEESSCEECC---------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EEcccCcCcccccccc---------ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence            9999999874332211         122347889999999998889999999999999999998 999997665433221


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ...      .......+...+..+.+++.+||..+|.+||++.+ ++..|..+...
T Consensus       253 ~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~~  301 (327)
T 1fvr_A          253 KLP------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRMLEE  301 (327)
T ss_dssp             HGG------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHS
T ss_pred             Hhh------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHHh
Confidence            111      11111234455688999999999999999999998 77888877654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=348.49  Aligned_cols=236  Identities=23%  Similarity=0.401  Sum_probs=196.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC--------ChhhHHHHHHHHHcCCCCCeeeeeceecC--
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIRHPNLVTLVGACPE--  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~hpniv~l~g~~~~--  204 (498)
                      .++|...+.||+|+||.||+|.+  .+..||||++......        ....+.+|+.+|+.++||||++++++|.+  
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            45789999999999999999987  4788999999865422        23467889999999999999999999854  


Q ss_pred             cceEEEeeCCCC-CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          205 VWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       205 ~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                      ..++||||+.+| +|.+++.   ....+++..+..|+.+++.||.|||+   +||+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            578999999777 9999984   34569999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      +.........         ....||+.|+|||++.+..+ +.++|||||||++|+|+||..||......        ...
T Consensus       177 a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~  239 (335)
T 3dls_A          177 AAYLERGKLF---------YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEA  239 (335)
T ss_dssp             CEECCTTCCB---------CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTT
T ss_pred             ceECCCCCce---------eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------Hhh
Confidence            9876543211         12348999999999988876 78899999999999999999999653221        011


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                           ....|...+..+.+|+..||+.+|.+||++.++
T Consensus       240 -----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~el  272 (335)
T 3dls_A          240 -----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKL  272 (335)
T ss_dssp             -----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -----ccCCCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence                 111233356789999999999999999999883

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-42  Score=345.99  Aligned_cols=251  Identities=26%  Similarity=0.328  Sum_probs=191.0

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC-----hhhHHHHHHHHHcCCCCCeeeeeceec--Cc
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTLVGACP--EV  205 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~hpniv~l~g~~~--~~  205 (498)
                      ...++|...+.||+|+||.||+|.+.  +..||||++.......     ...+.+|+.+++.++||||++++++|.  +.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34568999999999999999999985  6889999987543211     346889999999999999999999984  46


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .++||||+++ +|.+++..  ....+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            8999999975 89888853  33568888999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Ccc
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GKL  360 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~~  360 (498)
                      .+......        .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+........    +..
T Consensus       161 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~  232 (346)
T 1ua2_A          161 SFGSPNRA--------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP  232 (346)
T ss_dssp             TTTSCCCC--------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eccCCccc--------CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            76433211        1234589999999999764 5889999999999999999999999876544322211    100


Q ss_pred             c-----cc---cCC----CCCCCC-----HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 K-----NL---LDP----LAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 ~-----~~---~~~----~~~~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .     ..   .+.    .....|     ...+..+.+|+.+||..||.+||++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  288 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ  288 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH
Confidence            0     00   000    000011     234578999999999999999999988

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.7e-43  Score=352.62  Aligned_cols=240  Identities=23%  Similarity=0.392  Sum_probs=194.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceecC--cceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      ..+|.+.+.||+|+||.||+|...  +..||||++.....    .+.+|+.++.++ +||||+++++++.+  ..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            346888899999999999999985  78899999976432    346789999888 79999999999854  5789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC----CceeEeeccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN----FVSKLSDFGISRFL  287 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~~~  287 (498)
                      |++||+|.+++..   ...+++..+..++.+++.||.|||+   +||+||||||+|||+..+    +.+||+|||++...
T Consensus        97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999999953   3569999999999999999999999   899999999999998432    35999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCc-----HHHHHHHHhCcccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT-----KEVQYALDTGKLKN  362 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~-----~~~~~~~~~~~~~~  362 (498)
                      ......        .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...     ..+...+..+.+..
T Consensus       171 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  242 (342)
T 2qr7_A          171 RAENGL--------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL  242 (342)
T ss_dssp             BCTTCC--------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred             cCCCCc--------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence            543211        12345899999999998888999999999999999999999999742     22233333332221


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                           ...++...+..+.+|+.+||..||.+||++.+
T Consensus       243 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~  274 (342)
T 2qr7_A          243 -----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAAL  274 (342)
T ss_dssp             -----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             -----CccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence                 11122345678999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8e-43  Score=370.74  Aligned_cols=256  Identities=31%  Similarity=0.484  Sum_probs=209.7

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEE
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY  210 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~  210 (498)
                      ++....+|.+.+.||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|++++||||++++++|. +..++||
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~  340 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT  340 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEee
Confidence            33445678888999999999999999975 679999998654 34678999999999999999999999985 4688999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.++|... ....+++..++.|+.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+++.....
T Consensus       341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            999999999999532 12458999999999999999999999   89999999999999999999999999999876533


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~  367 (498)
                      ....       .....+++.|+|||++....++.++|||||||+||||+| |+.||.......  ..+..+.        
T Consensus       417 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------  481 (535)
T 2h8h_A          417 EYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------  481 (535)
T ss_dssp             HHHT-------TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC--------
T ss_pred             ceec-------ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            2111       123347889999999999999999999999999999999 999997654322  2222221        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ....+..++..+.+|+.+||+.+|.+||++.+ +...|+.+.
T Consensus       482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~-l~~~L~~~~  522 (535)
T 2h8h_A          482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEY-LQAFLEDYF  522 (535)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHTSS
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHHh
Confidence            11234455678999999999999999999988 777777654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-42  Score=341.24  Aligned_cols=256  Identities=20%  Similarity=0.283  Sum_probs=195.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      .++|.+.+.||+|+||.||+|.+.  +..||||++.......   ...+.+|+.+++.++||||+++++++.  +..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            457889999999999999999984  7889999987543322   256889999999999999999999984  468899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++++|.+++...   .++++..+..++.+++.||.|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            9999999999999533   468999999999999999999999   8999999999999999999999999999986554


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      .....       .....||+.|+|||++.+..++.++|||||||++|+|+||++||.............   ... +...
T Consensus       187 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~-~~~~  255 (309)
T 2h34_A          187 EKLTQ-------LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN---QAI-PRPS  255 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---SCC-CCGG
T ss_pred             ccccc-------ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---cCC-CCcc
Confidence            32111       123458999999999999999999999999999999999999998765432211111   000 0111


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCC-ChhHHHHHHhHHHHh
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRP-ELGKDVWRVLEPMRA  410 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP-~~~~~v~~~L~~~~~  410 (498)
                      ..+...+..+.+++.+||+.+|.+|| ++.+ +...|+.+..
T Consensus       256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~-l~~~l~~~l~  296 (309)
T 2h34_A          256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGD-LSAAAHAALA  296 (309)
T ss_dssp             GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHH-HHHHHHHTCC
T ss_pred             ccCCCCCHHHHHHHHHhccCCHHHHHHhHHH-HHHHHHHHHH
Confidence            12334557899999999999999999 5655 7777776543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=350.12  Aligned_cols=262  Identities=17%  Similarity=0.228  Sum_probs=203.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC----------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeee---------
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR----------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL---------  198 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l---------  198 (498)
                      ++|.+.+.||+|+||.||+|.+.          +..||||++...     ..+.+|+.++++++||||+++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            57888999999999999999884          568999998743     478999999999999999983         


Q ss_pred             ------ecee---cCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEE
Q 010882          199 ------VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL  269 (498)
Q Consensus       199 ------~g~~---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiL  269 (498)
                            ++++   ....++||||+ +|+|.+++.... ...+++..++.|+.|++.||.|||+   +||+||||||+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence                  4444   24578999999 999999996431 3569999999999999999999999   89999999999999


Q ss_pred             EcCCC--ceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          270 LDANF--VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       270 l~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                      ++.++  .+||+|||+++.+......... .........||+.|+|||++.+..++.++|||||||+||+|+||+.||..
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY-VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCC-CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccc-cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99998  9999999999876644321110 11112344699999999999999999999999999999999999999975


Q ss_pred             cH--H--HHHHHH--hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhcC
Q 010882          348 TK--E--VQYALD--TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG  413 (498)
Q Consensus       348 ~~--~--~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~~  413 (498)
                      ..  .  ......  ............  .....+..+.+++.+||..+|.+||++.+ +.+.|+.+....+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~-l~~~L~~~~~~~~  339 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAM-LRNNLEALLQDLR  339 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHH-HHHHHHHHHHHTT
T ss_pred             CCcCHHHHHHHHHhccCChhhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHH-HHHHHHHHHHhcC
Confidence            42  1  111111  001111111000  01123578999999999999999999988 8888888876654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.1e-42  Score=348.01  Aligned_cols=237  Identities=28%  Similarity=0.376  Sum_probs=193.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ..|...+.||+|+||.||+|..  .+..||||++.......   ...+.+|+.++++++||||++++++|.  +..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4578888999999999999997  47899999997654332   246889999999999999999999984  4688999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+. |+|.+++...  ..++++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++......
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 6888887432  3569999999999999999999999   89999999999999999999999999999765432


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH--hCccccccC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLD  365 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~--~~~~~~~~~  365 (498)
                                  ....||+.|+|||++.   ...++.++|||||||++|||+||++||...+.......  .+....   
T Consensus       208 ------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---  272 (348)
T 1u5q_A          208 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---  272 (348)
T ss_dssp             ------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---
T ss_pred             ------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---
Confidence                        2235999999999985   46789999999999999999999999976544332221  111110   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                          ..+...+..+.+++.+||+.+|.+||++.+
T Consensus       273 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~  302 (348)
T 1u5q_A          273 ----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  302 (348)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence                112234577999999999999999999988

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=349.29  Aligned_cols=257  Identities=16%  Similarity=0.171  Sum_probs=205.0

Q ss_pred             HHHHhhcCCCCCCcccccCceEEEEEE-------ECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC---CCCeeeeece
Q 010882          132 EIEGATHNFDPSLKIGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR---HPNLVTLVGA  201 (498)
Q Consensus       132 ei~~~~~~~~~~~~lG~G~~g~Vy~~~-------~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~g~  201 (498)
                      ++.....+|.+.+.||+|+||+||+|.       ..+..||||++...   ....+..|+.++..++   |+||+.++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            334455678888999999999999994       24678999999753   4567889999999987   9999999999


Q ss_pred             e--cCcceEEEeeCCCCCHHhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-----
Q 010882          202 C--PEVWTLVYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-----  272 (498)
Q Consensus       202 ~--~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-----  272 (498)
                      +  .+..++||||++||+|.+++...  .....+++..++.|+.|++.||.|||+   +|||||||||+||||+.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCc
Confidence            8  45689999999999999999632  134569999999999999999999999   89999999999999998     


Q ss_pred             ------CCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCC
Q 010882          273 ------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG  346 (498)
Q Consensus       273 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~  346 (498)
                            ++.+||+|||+|+.+......      .......||+.|+|||++.+..++.++|||||||++|||+||++||.
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKG------TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTT------EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCC------ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence                  899999999999765422111      11244569999999999999999999999999999999999999995


Q ss_pred             CcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          347 ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ....       +.  ..+.......  .....+.+++..|++.+|.+||+..+.+.+.|+.+...
T Consensus       287 ~~~~-------~~--~~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          287 KNEG-------GE--CKPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EEET-------TE--EEECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCC-------Cc--eeechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            4321       10  1111111112  23677899999999999999977666688888776654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=348.95  Aligned_cols=244  Identities=25%  Similarity=0.383  Sum_probs=190.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCC--CCeeeeeceec--CcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRH--PNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h--pniv~l~g~~~--~~~~lV  209 (498)
                      ...|.+.+.||+|+||.||+|... +..||||++.......  ...+.+|+.+|+.++|  |||+++++++.  ...++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            456888999999999999999874 6789999987654322  3568899999999976  99999999984  457899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      || +.+|+|.+++..   ...+++..+..|+.|++.||.|||+   ++|+||||||+|||++ ++.+||+|||+++....
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899999954   3568999999999999999999999   8999999999999997 57899999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhcc-----------CCCCCccchHhHHHHHHHHHhCCCCCCCcH-HHHHHHHh
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDT  357 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~~  357 (498)
                      .....      ......||+.|+|||++.+           ..++.++|||||||++|+|+||++||.... ......  
T Consensus       160 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--  231 (343)
T 3dbq_A          160 DTTSV------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--  231 (343)
T ss_dssp             ----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH--
T ss_pred             ccccc------cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH--
Confidence            32211      1123469999999999965           678899999999999999999999997532 211111  


Q ss_pred             CccccccCC-CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          358 GKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       358 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                          ..+++ ....+|...+..+.+|+..||+.+|.+||++.++
T Consensus       232 ----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~  271 (343)
T 3dbq_A          232 ----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  271 (343)
T ss_dssp             ----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ----HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence                11111 1223444556789999999999999999999884

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-42  Score=360.79  Aligned_cols=246  Identities=20%  Similarity=0.268  Sum_probs=189.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      .++|...+.||+|+||+||+|.+.  +..||||++.....  .....+.+|+.+|+.++||||+++++++..        
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            457899999999999999999884  78899999975421  224568899999999999999999999832        


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||+.+ +|.+.+.     ..+++..+..++.|++.||.|||+   +||+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            35999999976 4666663     248899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc----
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----  360 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~----  360 (498)
                      +.......         .....||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+........-..    
T Consensus       212 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          212 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  282 (464)
T ss_dssp             -----CCC---------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             eecCCCcc---------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            86543321         13346999999999999999999999999999999999999999876543322111000    


Q ss_pred             ------------ccccC--CCCCC------CC-----------HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          361 ------------KNLLD--PLAGD------WP-----------FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       361 ------------~~~~~--~~~~~------~~-----------~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                  ...+.  +....      +|           ...+..+.+|+.+||..||.+||++.++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  353 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA  353 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                        00000  00000      00           1126779999999999999999999883

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.1e-42  Score=335.30  Aligned_cols=242  Identities=24%  Similarity=0.392  Sum_probs=197.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..||+|++......  ....+.+|+.++++++||||+++++++.+  ..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            57888899999999999999985  688999998754332  23568899999999999999999999854  5789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc---eeEeecccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGISRFLS  288 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGla~~~~  288 (498)
                      |+++|+|.+.+...   ..+++..+..++.+++.||.|||+   .||+||||||+|||++.++.   +||+|||++....
T Consensus        86 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           86 LVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999888533   468999999999999999999999   89999999999999986654   9999999997655


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDP  366 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~  366 (498)
                      ....         .....||+.|+|||++.+..++.++|||||||++|+|++|++||........  .+..+..... .+
T Consensus       160 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~  229 (284)
T 3kk8_A          160 DSEA---------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-SP  229 (284)
T ss_dssp             SSCB---------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-TT
T ss_pred             cCcc---------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC-ch
Confidence            4321         1234589999999999999999999999999999999999999976544322  2222222111 11


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                          .....+..+.+++.+||+.+|.+||++.+
T Consensus       230 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~  258 (284)
T 3kk8_A          230 ----EWDTVTPEAKSLIDSMLTVNPKKRITADQ  258 (284)
T ss_dssp             ----TTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ----hhcccCHHHHHHHHHHcccChhhCCCHHH
Confidence                11234578999999999999999999988

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=349.93  Aligned_cols=269  Identities=22%  Similarity=0.277  Sum_probs=191.7

Q ss_pred             hHHHHHhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceec---
Q 010882          130 FSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP---  203 (498)
Q Consensus       130 ~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~---  203 (498)
                      -..+.....+|.+.+.||+|+||.||+|.+  .+..||||++..........+.+|+.++.++. ||||+++++++.   
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            334444556899999999999999999998  57899999986554444567889999999996 999999999872   


Q ss_pred             -----C--cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cccCCCCCCcEEEcCCC
Q 010882          204 -----E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANF  274 (498)
Q Consensus       204 -----~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NiLl~~~~  274 (498)
                           .  ..++||||+. |+|.+++.......++++..++.|+.+++.||.|||+   .+  |+||||||+|||++.++
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTS
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCC
Confidence                 1  3689999995 7999988654445679999999999999999999999   77  99999999999999999


Q ss_pred             ceeEeeccccccccccccCCCC----ccceeccCCCCCCCcCChhhh---ccCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          275 VSKLSDFGISRFLSQNEISSNN----TTLCCRTDPKGTFAYMDPEFL---ASGELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       275 ~~kl~DFGla~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                      .+||+|||++............    ..........||+.|+|||++   .+..++.++|||||||++|+|+||+.||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999876543321100    000111234589999999998   456788999999999999999999999975


Q ss_pred             cHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          348 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      .........  ...       ...+...+..+.+++.+||+.+|.+||++.+ +++.|..+....
T Consensus       256 ~~~~~~~~~--~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-~l~~l~~~~~~~  310 (337)
T 3ll6_A          256 GAKLRIVNG--KYS-------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAE-VVHQLQEIAAAR  310 (337)
T ss_dssp             ------------CC-------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHH-HHHHHHHHHHHT
T ss_pred             hhHHHhhcC--ccc-------CCcccccchHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHhcc
Confidence            443221111  111       0111223356889999999999999999988 888888887653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.6e-42  Score=339.67  Aligned_cols=245  Identities=23%  Similarity=0.325  Sum_probs=190.1

Q ss_pred             CCCC-CCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEEEee
Q 010882          139 NFDP-SLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       139 ~~~~-~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .|.+ .+.||+|+||.||+|..  .+..||||++..........+.+|+.++.++ +||||+++++++.  +..++||||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   92 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK   92 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence            5666 36899999999999987  4789999999876655677899999999985 7999999999984  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc---eeEeeccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGISRFLSQ  289 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGla~~~~~  289 (498)
                      +++|+|.+++...   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.   +||+|||++.....
T Consensus        93 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           93 MRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             CCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999543   468999999999999999999999   89999999999999998765   99999999986543


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCCcH---------------
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITK---------------  349 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~---------------  349 (498)
                      ....... .........||+.|+|||++..     ..++.++|||||||++|+|+||++||....               
T Consensus       167 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          167 NGDCSPI-STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             CCccccc-cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            3211100 0011123459999999999975     458899999999999999999999996532               


Q ss_pred             --HHHHHHHhCccccccCCCCCCCCH----HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          350 --EVQYALDTGKLKNLLDPLAGDWPF----VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       350 --~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        .....+..+..         .+|.    ..+..+.+|+.+||..||.+||++.+
T Consensus       246 ~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (316)
T 2ac3_A          246 QNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ  292 (316)
T ss_dssp             HHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence              11122222211         1222    24568999999999999999999988

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.5e-42  Score=344.25  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=201.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEE-------CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~  206 (498)
                      ..+|.+.+.||+|+||.||+|.+       .+..||||++..... .....+.+|+.++++++||||+++++++.+  ..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            45799999999999999999984       245799999974322 224568899999999999999999999844  57


Q ss_pred             eEEEeeCCCCCHHhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---CCceeEe
Q 010882          207 TLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLS  279 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~  279 (498)
                      ++||||+++|+|.+++.....    ...+++..++.++.+++.||.|||+   +||+||||||+|||++.   ++.+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999965432    2458999999999999999999999   89999999999999984   4569999


Q ss_pred             eccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHH
Q 010882          280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALD  356 (498)
Q Consensus       280 DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~  356 (498)
                      |||++...........      .....||+.|+|||++.+..++.++|||||||++|+|+| |.+||.......  ..+.
T Consensus       186 Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRK------GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             CCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             cccccccccccccccc------CCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            9999986543321111      122347899999999999999999999999999999998 999997654332  2222


Q ss_pred             hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          357 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      .+.        ....+...+..+.+++.+||+.+|.+||++.+ +++.|..+..
T Consensus       260 ~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-ll~~l~~~~~  304 (327)
T 2yfx_A          260 SGG--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI-ILERIEYCTQ  304 (327)
T ss_dssp             TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             cCC--------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHH-HHHHHHHHhc
Confidence            221        11223445678999999999999999999988 7788877754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=339.31  Aligned_cols=249  Identities=27%  Similarity=0.357  Sum_probs=191.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ++|...+.||+|+||.||+|.+.  +..||||++.......  ...+.+|+.++++++||||+++++++.  +..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            46888899999999999999985  7889999987654322  345789999999999999999999984  45789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++++|.+++.   ....+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999999884   33568999999999999999999999   899999999999999999999999999998765332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC------------
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG------------  358 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~------------  358 (498)
                      ..        .....||+.|+|||++.+ ..++.++|||||||++|+|+||.+||.............            
T Consensus       157 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (311)
T 4agu_A          157 DY--------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ  228 (311)
T ss_dssp             -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             cc--------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence            11        123358999999999976 578999999999999999999999997654433221110            


Q ss_pred             -----ccc-cccCCCCCCC-C-----HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 -----KLK-NLLDPLAGDW-P-----FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 -----~~~-~~~~~~~~~~-~-----~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                           ... ....+..... +     ...+..+.+++.+||+.||.+||++.++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  282 (311)
T 4agu_A          229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL  282 (311)
T ss_dssp             HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH
Confidence                 000 0000000000 0     1345678999999999999999999883

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=335.54  Aligned_cols=243  Identities=24%  Similarity=0.389  Sum_probs=178.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      ..+|.+.+.||+|+||.||+|..  .+..||||++....   ......+.+|+.+++.++||||+++++++.+  ..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35688889999999999999997  47889999986432   2234678999999999999999999999854  57899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++|+|.+++..  ...++++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999953  33569999999999999999999999   8999999999999999999999999999987643


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ....        .....||+.|+|||.+.+..++.++|||||||++|+|+||++||.........      ..... ...
T Consensus       165 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~  229 (278)
T 3cok_A          165 PHEK--------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVVL-ADY  229 (278)
T ss_dssp             -----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-SCC
T ss_pred             CCCc--------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHhh-ccc
Confidence            3211        12235899999999999889999999999999999999999999754321111      00100 111


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..|...+..+.+++.+||..+|.+||++.+
T Consensus       230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  259 (278)
T 3cok_A          230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSS  259 (278)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCccccCHHHHHHHHHHcccCHhhCCCHHH
Confidence            234456678999999999999999999988

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.5e-42  Score=336.88  Aligned_cols=240  Identities=28%  Similarity=0.420  Sum_probs=200.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ...|...+.||+|+||.||+|...  +..||||++..... .....+.+|+.+++.++||||+++++++.  ...++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            346888899999999999999884  68899999976543 34577999999999999999999999884  46789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++++|.+++.    ..++++..+..++.+++.||.|||+   .||+||||||+|||++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999984    2468999999999999999999999   899999999999999999999999999998765432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  369 (498)
                      ..        .....||+.|+|||++.+..++.++|||||||++|+|+||++||.........  +..+..        .
T Consensus       174 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~  237 (303)
T 3a7i_A          174 IK--------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--------P  237 (303)
T ss_dssp             CC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--------C
T ss_pred             cc--------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC--------C
Confidence            11        13345899999999999999999999999999999999999999765443322  112111        1


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+...+..+.+++..||..+|.+||++.+
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  267 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKE  267 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHH
Confidence            123344578999999999999999999988

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.7e-42  Score=339.60  Aligned_cols=246  Identities=24%  Similarity=0.351  Sum_probs=196.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      ...|.+.+.||+|+||.||+|.+.  +..||+|++..........+.+|+.+++.++||||+++++++.  +..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            357889999999999999999995  6889999998766666788999999999999999999999884  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++...  ...+++..+..++.+++.||.|||+   .|++||||||+|||++.++.+||+|||++........
T Consensus        98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            9999999988532  3458999999999999999999999   8999999999999999999999999999764332211


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                      .        .....||+.|+|||++.     +..++.++|||||||++|+|+||.+||...+............    +.
T Consensus       173 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~  240 (302)
T 2j7t_A          173 K--------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD----PP  240 (302)
T ss_dssp             C-------------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----CC
T ss_pred             c--------cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC----Cc
Confidence            1        12235899999999984     5678999999999999999999999998655433322111100    00


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ....+...+..+.+++.+||..+|.+||++.+
T Consensus       241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  272 (302)
T 2j7t_A          241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ  272 (302)
T ss_dssp             CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             ccCCccccCHHHHHHHHHHcccChhhCCCHHH
Confidence            11123445678999999999999999999988

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.2e-42  Score=365.17  Aligned_cols=238  Identities=24%  Similarity=0.340  Sum_probs=198.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      .++|...+.||+|+||.||+|...  +..||||++...   .......+.+|+.+|+.++||||+++++++.  +..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            456888999999999999999984  789999998653   2234556889999999999999999999984  468999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||++||+|.+++.... ...+++..+..++.|++.||.|||+   +||+||||||+||||+.+|++||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999986432 3459999999999999999999999   8999999999999999999999999999987653


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH------HHHHHHHhCccccc
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK------EVQYALDTGKLKNL  363 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~~~~~~~~~~~~  363 (498)
                      ...         .....||+.|+|||++.+..++.++|||||||++|||+||++||....      .+...+...     
T Consensus       339 ~~~---------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-----  404 (576)
T 2acx_A          339 GQT---------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----  404 (576)
T ss_dssp             TCC---------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----
T ss_pred             Ccc---------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----
Confidence            321         123469999999999999899999999999999999999999997542      122222211     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCC
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                          ...+|...+..+.+|+.+||..||.+||+
T Consensus       405 ----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g  433 (576)
T 2acx_A          405 ----PEEYSERFSPQARSLCSQLLCKDPAERLG  433 (576)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred             ----cccCCccCCHHHHHHHHHhccCCHHHcCC
Confidence                12245556788999999999999999994

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.7e-42  Score=344.52  Aligned_cols=252  Identities=26%  Similarity=0.389  Sum_probs=196.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      .++|.+.+.||+|+||.||+|.+.  +..||||++......  ....+.+|+.+++.++||||++++++|..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            357888999999999999999984  689999998755332  24578899999999999999999998843        


Q ss_pred             --cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecc
Q 010882          205 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG  282 (498)
Q Consensus       205 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  282 (498)
                        ..++||||+.+ +|.+.+..  ....+++..+..|+.|++.||.|||+   +||+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence              36899999975 77777743  33469999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccc
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK  361 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (498)
                      ++..+.........    ......||+.|+|||++.+ ..++.++|||||||++|+|+||.+||................
T Consensus       170 ~a~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  245 (351)
T 3mi9_A          170 LARAFSLAKNSQPN----RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  245 (351)
T ss_dssp             TCEECCCCSSSSCC----CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             hccccccccccccc----ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99876543222111    1234568999999999976 458999999999999999999999998765433222111111


Q ss_pred             cccCCCCCCCCH---------------------------HHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 NLLDPLAGDWPF---------------------------VQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 ~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ....+.  .|+.                           ..+..+.+|+.+||..||.+||++.++
T Consensus       246 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  309 (351)
T 3mi9_A          246 GSITPE--VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA  309 (351)
T ss_dssp             CCCCTT--TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCChh--hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence            100000  0110                           014568899999999999999999883

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-42  Score=344.78  Aligned_cols=249  Identities=24%  Similarity=0.351  Sum_probs=188.6

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEE
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV  209 (498)
                      ...+|.+.+.||+|+||+||+|...  +..||||++......  ....+.+|+.++++++||||+++++++.  +..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3457999999999999999999874  789999999755332  2356789999999999999999999984  468999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc-----CCCceeEeecccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-----ANFVSKLSDFGIS  284 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~-----~~~~~kl~DFGla  284 (498)
                      |||++ |+|.+++..   ...+++..+..|+.|++.||.|||+   ++|+||||||+|||++     .++.+||+|||++
T Consensus       112 ~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99997 599999853   3459999999999999999999999   8999999999999994     4556999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      .........        .....||+.|+|||++.+. .++.++|||||||++|+|+||++||..................
T Consensus       185 ~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  256 (329)
T 3gbz_A          185 RAFGIPIRQ--------FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL  256 (329)
T ss_dssp             HHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cccCCcccc--------cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence            876433211        1233589999999999875 5899999999999999999999999876554333221110000


Q ss_pred             cCCC-----------CCCC------------CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          364 LDPL-----------AGDW------------PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       364 ~~~~-----------~~~~------------~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .+..           ...+            +...+..+.+|+.+||+.||.+||++.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  315 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN  315 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence            0000           0000            0114578899999999999999999988

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.6e-42  Score=336.30  Aligned_cols=242  Identities=21%  Similarity=0.279  Sum_probs=199.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      .++|...+.||+|+||.||+|.+.  +..||+|++.......   .+.+.+|+.+++.++||||+++++++.+  ..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356888899999999999999985  6789999987643322   3568899999999999999999999854  57899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+++++|.+++..   ...+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998853   2468999999999999999999999   8999999999999999999999999999987643


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG  369 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (498)
                      ....        .....||+.|+|||++.+..++.++||||||+++|+|+||+.||...............       ..
T Consensus       168 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------~~  232 (294)
T 2rku_A          168 DGER--------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EY  232 (294)
T ss_dssp             TTCC--------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------CC
T ss_pred             Cccc--------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------cC
Confidence            3211        12345899999999999888999999999999999999999999865443322111100       11


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..|...+..+.+++.+||+.+|.+||++.+
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  262 (294)
T 2rku_A          233 SIPKHINPVAASLIQKMLQTDPTARPTINE  262 (294)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             CCccccCHHHHHHHHHHcccChhhCcCHHH
Confidence            234445678999999999999999999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-42  Score=347.29  Aligned_cols=244  Identities=21%  Similarity=0.293  Sum_probs=189.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      ..+|...+.||+|+||.||+|.+.  +..||||++......  ....+.+|+.+|+.++||||+++++++..        
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            457888999999999999999984  788999998654322  13567899999999999999999999843        


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||+ +++|.+++..    ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            259999999 8899999853    358999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Cc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK  359 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~  359 (498)
                      +......           ....||+.|+|||++.+ ..++.++|||||||++|||+||++||...+........    +.
T Consensus       176 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  244 (367)
T 1cm8_A          176 RQADSEM-----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  244 (367)
T ss_dssp             EECCSSC-----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccc-----------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            8654321           23458999999999987 67999999999999999999999999866543322111    00


Q ss_pred             c--------------------ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          360 L--------------------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       360 ~--------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .                    ...............+..+.+|+.+||..||.+||++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e  304 (367)
T 1cm8_A          245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE  304 (367)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence            0                    000000011122344678999999999999999999988

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-42  Score=358.44  Aligned_cols=245  Identities=25%  Similarity=0.407  Sum_probs=189.2

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--------CChhhHHHHHHHHHcCCCCCeeeeeceec-C
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--------QGPSEFQQEIDILSKIRHPNLVTLVGACP-E  204 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~hpniv~l~g~~~-~  204 (498)
                      ...+|.+.+.||+|+||.||+|...  +..||||++.....        .....+.+|+.+|++++||||+++++++. +
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4568999999999999999999985  57899999875321        12235889999999999999999999984 4


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC---CceeEeec
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDF  281 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DF  281 (498)
                      ..++||||+++|+|.+++.   ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.+   +.+||+||
T Consensus       213 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             ceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeec
Confidence            5789999999999999984   34569999999999999999999999   899999999999999754   45999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCCcHH---HHHHH
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYAL  355 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~  355 (498)
                      |+++.......         .....||+.|+|||++.+   ..++.++|||||||++|+|+||++||.....   ....+
T Consensus       287 G~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i  357 (419)
T 3i6u_A          287 GHSKILGETSL---------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI  357 (419)
T ss_dssp             STTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH
T ss_pred             ccceecCCCcc---------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH
Confidence            99987654321         123459999999999864   5688899999999999999999999964321   22222


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..+.....     .......+..+.+++.+||+.+|.+||++.++
T Consensus       358 ~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~  397 (419)
T 3i6u_A          358 TSGKYNFI-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEA  397 (419)
T ss_dssp             HTTCCCCC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hcCCCCCC-----chhhcccCHHHHHHHHHHccCChhHCcCHHHH
Confidence            22211110     00011245789999999999999999999883

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.3e-42  Score=345.04  Aligned_cols=260  Identities=22%  Similarity=0.321  Sum_probs=205.0

Q ss_pred             HHhhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHc--CCCCCeeeeeceecC------c
Q 010882          134 EGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACPE------V  205 (498)
Q Consensus       134 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~g~~~~------~  205 (498)
                      ....++|.+.+.||+|+||.||+|.+++..||||++...   ....+.+|++++..  ++||||+++++++..      .
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            344568999999999999999999999999999998643   34567889999987  789999999999833      5


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcccCCCCCCcEEEcCCCcee
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH--------SCKPHSIVHGDLKPANILLDANFVSK  277 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivHrDlkp~NiLl~~~~~~k  277 (498)
                      .++||||+++|+|.+++..    ..+++..++.++.+++.||.|||        +   .+|+||||||+||||+.++.+|
T Consensus       115 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEE
T ss_pred             eEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEE
Confidence            7899999999999999953    35899999999999999999999        6   8999999999999999999999


Q ss_pred             EeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCC------CCCccchHhHHHHHHHHHhC----------
Q 010882          278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE------LTPKSDVYSFGIILLRLLTG----------  341 (498)
Q Consensus       278 l~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG----------  341 (498)
                      |+|||++..........    ........||+.|+|||++.+..      ++.++|||||||++|||+||          
T Consensus       188 L~Dfg~~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             ECCCTTCEEEETTTTEE----EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             EEECCCceecccccccc----ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            99999998665432110    01123446999999999998752      33689999999999999999          


Q ss_pred             CCCCCCc-------HHHHHHHHhCccccccCCCCC-C-CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          342 RPALGIT-------KEVQYALDTGKLKNLLDPLAG-D-WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       342 ~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ..||...       ......+......    +... . .+...+..+.+|+.+||+.+|.+||++.+ +++.|+.+....
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~-i~~~L~~i~~~~  338 (342)
T 1b6c_B          264 QLPYYDLVPSDPSVEEMRKVVCEQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR-IKKTLSQLSQQE  338 (342)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCC----CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH-HHHHHHHHHHTT
T ss_pred             ccCccccCcCcccHHHHHHHHHHHHhC----CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH-HHHHHHHHHHHh
Confidence            6788542       1122222111111    1111 1 12356778999999999999999999998 888888886543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.2e-42  Score=356.11  Aligned_cols=204  Identities=25%  Similarity=0.328  Sum_probs=156.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec-------Ccc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------EVW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~-------~~~  206 (498)
                      .+|.+.+.||+|+||+||+|.+.  +..||||++......  ....+.+|+.+|+.++||||++++++|.       ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            57999999999999999999875  678999998754322  2356889999999999999999999882       247


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      |+||||+ +|+|.+++.   ....+++..+..|+.|++.||.|||+   .|||||||||+||||+.++.+||+|||+|+.
T Consensus       133 ~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            9999998 579999984   33569999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccCCCCc-------------------cceeccCCCCCCCcCChhhh-ccCCCCCccchHhHHHHHHHHHh------
Q 010882          287 LSQNEISSNNT-------------------TLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLT------  340 (498)
Q Consensus       287 ~~~~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt------  340 (498)
                      ...........                   ........+||+.|+|||++ ....++.++|||||||+||||+|      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            65332111000                   00112445789999999986 45679999999999999999999      


Q ss_pred             -----CCCCCCCc
Q 010882          341 -----GRPALGIT  348 (498)
Q Consensus       341 -----G~~pf~~~  348 (498)
                           |+++|.+.
T Consensus       286 ~~~~~~~p~f~g~  298 (458)
T 3rp9_A          286 AYHADRGPLFPGS  298 (458)
T ss_dssp             SSGGGCCCSCC--
T ss_pred             cccccccccCCCC
Confidence                 77777554

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-42  Score=351.05  Aligned_cols=255  Identities=25%  Similarity=0.344  Sum_probs=186.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCC-CCCeeeeeceec--C--cce
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR-HPNLVTLVGACP--E--VWT  207 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~-hpniv~l~g~~~--~--~~~  207 (498)
                      ..+|.+.+.||+|+||.||+|.+.  +..||||++......  ....+.+|+.+|..+. ||||+++++++.  +  ..+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            457899999999999999999884  788999998654222  2345779999999997 999999999983  2  479


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||++ |+|.+++..    ..+++..+..++.|++.||.|||+   .||+||||||+|||++.++.+||+|||+|+.+
T Consensus        88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            9999997 689998853    358999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCC-------------ccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH
Q 010882          288 SQNEISSNN-------------TTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY  353 (498)
Q Consensus       288 ~~~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~  353 (498)
                      .........             ..........||+.|+|||++.+ ..++.++|||||||+||||+||++||.+.+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            432111100             00111234579999999999987 6789999999999999999999999987654432


Q ss_pred             HHHhCcccccc---------------------------CC-CCCCC------------CHHHHHHHHHHHHHhhhcccCC
Q 010882          354 ALDTGKLKNLL---------------------------DP-LAGDW------------PFVQAEQLANLAMRCCEMSRKS  393 (498)
Q Consensus       354 ~~~~~~~~~~~---------------------------~~-~~~~~------------~~~~~~~l~~li~~cl~~~p~~  393 (498)
                      ....-......                           .. ....+            +...+..+.+|+.+||..||.+
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            21110000000                           00 00000            0123567899999999999999


Q ss_pred             CCChhH
Q 010882          394 RPELGK  399 (498)
Q Consensus       394 RP~~~~  399 (498)
                      ||++.+
T Consensus       320 R~t~~e  325 (388)
T 3oz6_A          320 RISAND  325 (388)
T ss_dssp             SCCHHH
T ss_pred             CCCHHH
Confidence            999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.2e-42  Score=351.07  Aligned_cols=240  Identities=23%  Similarity=0.378  Sum_probs=186.4

Q ss_pred             cCCCCC-CcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHc-CCCCCeeeeeceec------Ccce
Q 010882          138 HNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSK-IRHPNLVTLVGACP------EVWT  207 (498)
Q Consensus       138 ~~~~~~-~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~g~~~------~~~~  207 (498)
                      .+|... +.||+|+||+||+|.+.  +..||||++..     ...+.+|+.++.+ .+||||++++++|.      ...+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            355554 68999999999999985  67899999863     3467889998854 58999999999873      2478


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---CCceeEeecccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS  284 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla  284 (498)
                      +||||++||+|.+++... ....+++..+..|+.|++.||.|||+   +||+||||||+||||+.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999643 23469999999999999999999999   89999999999999997   789999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH------HHHHHHhC
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDTG  358 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~------~~~~~~~~  358 (498)
                      +.......         .....||+.|+|||++.+..++.++|||||||+||+|+||++||.....      ....+..+
T Consensus       212 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~  282 (400)
T 1nxk_A          212 KETTSHNS---------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  282 (400)
T ss_dssp             EECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred             cccCCCCc---------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence            86543221         1234589999999999999999999999999999999999999965432      12222222


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+...    ...| ...+..+.+|+.+||..||.+||++.++
T Consensus       283 ~~~~~----~~~~-~~~s~~~~~li~~~L~~dP~~Rpt~~ei  319 (400)
T 1nxk_A          283 QYEFP----NPEW-SEVSEEVKMLIRNLLKTEPTQRMTITEF  319 (400)
T ss_dssp             CCCCC----TTTT-TTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             cccCC----Cccc-ccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            22110    0111 2356789999999999999999999883

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.7e-42  Score=335.15  Aligned_cols=240  Identities=23%  Similarity=0.383  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC---CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|...  +..||||++....   ......+.+|+.+++.++||||+++++++.  +..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999985  6789999986431   223467899999999999999999999984  4578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.+++...   ..+++..+..++.+++.||.|||+   +||+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999999543   358999999999999999999999   89999999999999999999999999998755432


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      .          .....||+.|+|||++.+..++.++||||||+++|+|+||.+||..............       ....
T Consensus       168 ~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------~~~~  230 (284)
T 2vgo_A          168 R----------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-------VDLK  230 (284)
T ss_dssp             C----------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TCCC
T ss_pred             c----------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-------cccC
Confidence            1          1234589999999999999999999999999999999999999986544332211110       0112


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      +|...+..+.+++.+||..+|.+||++.++
T Consensus       231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  260 (284)
T 2vgo_A          231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGV  260 (284)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCcCCHHHHHHHHHHhhcCHhhCCCHHHH
Confidence            344556789999999999999999999883

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.4e-42  Score=338.83  Aligned_cols=242  Identities=25%  Similarity=0.355  Sum_probs=196.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~~  213 (498)
                      ++|.+.+.||+|+||.||+|...  +..||||++..........+.+|+.+++.++||||+++++++.+  ..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            46888899999999999999984  78899999986655455678999999999999999999999843  578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE---cCCCceeEeecccccccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~~~  290 (498)
                      ++|+|.+++...   ..+++..+..++.+++.||.|||+   .||+||||||+|||+   +.++.+||+|||++......
T Consensus        89 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           89 SGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             CCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            999999998532   468999999999999999999999   899999999999999   78899999999998754322


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH--HHHHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~  368 (498)
                      .    .      ....||+.|+|||++.+..++.++|||||||++|+|+||.+||.......  ..+..+... .    .
T Consensus       163 ~----~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~----~  227 (304)
T 2jam_A          163 I----M------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-F----E  227 (304)
T ss_dssp             T----T------HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-C----C
T ss_pred             c----c------ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-C----C
Confidence            1    0      11238999999999999999999999999999999999999997654332  222222211 0    1


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ...+...+..+.+++.+||..+|.+||++.++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~  259 (304)
T 2jam_A          228 SPFWDDISESAKDFICHLLEKDPNERYTCEKA  259 (304)
T ss_dssp             TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            11223456789999999999999999999883

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1e-42  Score=338.68  Aligned_cols=244  Identities=26%  Similarity=0.414  Sum_probs=197.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeecee----cCcceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~----~~~~~l  208 (498)
                      .++|.+.+.||+|+||.||+|...  +..||+|++......  ....+.+|+.++++++||||+++++++    ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357888899999999999999984  688999999765432  235688999999999999999999987    235789


Q ss_pred             EEeeCCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----cccCCCCCCcEEEcCCCceeEeecc
Q 010882          209 VYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHS-----IVHGDLKPANILLDANFVSKLSDFG  282 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivHrDlkp~NiLl~~~~~~kl~DFG  282 (498)
                      ||||+++|+|.+++.... ....+++..++.++.+++.||.|||+   .+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999996432 33459999999999999999999999   66     9999999999999999999999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHH--HHHHhCcc
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKL  360 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~  360 (498)
                      ++.........        .....||+.|+|||.+.+..++.++|||||||++|+|+||++||...+...  ..+..+..
T Consensus       162 ~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  233 (279)
T 2w5a_A          162 LARILNHDTSF--------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF  233 (279)
T ss_dssp             HHHHC---CHH--------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             hheeecccccc--------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc
Confidence            99865432210        011248999999999999999999999999999999999999998654332  22233322


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .        ..+...+..+.+++.+||+.+|.+||++.+
T Consensus       234 ~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  264 (279)
T 2w5a_A          234 R--------RIPYRYSDELNEIITRMLNLKDYHRPSVEE  264 (279)
T ss_dssp             C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             c--------cCCcccCHHHHHHHHHHcCCCcccCCCHHH
Confidence            1        234445678999999999999999999988

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=336.72  Aligned_cols=244  Identities=26%  Similarity=0.377  Sum_probs=196.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      ..+|.+.+.||+|+||.||+|.+.  +..||||++....  ....+.+|+.+++.++||||+++++++.  ...++||||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            457888999999999999999985  7889999997543  4567999999999999999999999884  457999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++..  ....+++..+..++.+++.||.|||+   .|++||||||+||+++.++.+||+|||++........
T Consensus       106 ~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          106 CGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             CTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            999999999852  23568999999999999999999999   8999999999999999999999999999986654321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (498)
                      .        .....||+.|+|||++.+..++.++|||||||++|+|+||++||................    +.....+
T Consensus       181 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~  248 (314)
T 3com_A          181 K--------RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP----PPTFRKP  248 (314)
T ss_dssp             C--------BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----CCCCSSG
T ss_pred             c--------cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC----CcccCCc
Confidence            1        123458999999999999999999999999999999999999997655433222111000    0011123


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...+..+.+++.+||..+|.+||++.+
T Consensus       249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~  275 (314)
T 3com_A          249 ELWSDNFTDFVKQCLVKSPEQRATATQ  275 (314)
T ss_dssp             GGSCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            345678999999999999999999988

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=343.95  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=188.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      ++|...+.||+|+||.||+|...  +..||||++...... ....+.+|+.+++.++||||+++++++.  +..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            36788889999999999999985  688999999754322 2234568999999999999999999984  467999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      ++ |+|.+++...  ...+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 5898888543  3468999999999999999999999   8999999999999999999999999999986543221


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      .        .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+.............  .+....|
T Consensus       156 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~  225 (324)
T 3mtl_A          156 T--------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG--TPTEETW  225 (324)
T ss_dssp             ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC--CCCTTTS
T ss_pred             c--------cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--CCChHhc
Confidence            1        123358999999999977 5689999999999999999999999987654332211110000  0000001


Q ss_pred             -------------------------CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          372 -------------------------PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       372 -------------------------~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                               +...+..+.+|+.+||+.||.+||++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  278 (324)
T 3mtl_A          226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED  278 (324)
T ss_dssp             TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHH
Confidence                                     1123567899999999999999999988

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=342.74  Aligned_cols=255  Identities=27%  Similarity=0.376  Sum_probs=198.0

Q ss_pred             CCCChHHHHHhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeecee
Q 010882          126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC  202 (498)
Q Consensus       126 ~~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~  202 (498)
                      ..+.+.++....++|.+.+.||+|+||.||+|.+  .+..||||++.... .....+.+|+.+++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            3445555666778899999999999999999998  57899999987543 3456899999999999 799999999988


Q ss_pred             c--------CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC
Q 010882          203 P--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF  274 (498)
Q Consensus       203 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  274 (498)
                      .        ...++||||+++|+|.+++.... ...+++..+..++.+++.||.|||+   +||+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCC
Confidence            3        35789999999999999996432 3468999999999999999999999   8999999999999999999


Q ss_pred             ceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCCcH
Q 010882          275 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITK  349 (498)
Q Consensus       275 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~  349 (498)
                      .+||+|||++.........        .....||+.|+|||++.     +..++.++|||||||++|+|+||.+||....
T Consensus       167 ~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRTVGR--------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             CEEECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEeeCcCceecCcCccc--------cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999865432211        12335899999999997     4568899999999999999999999997655


Q ss_pred             HHHHHHH--hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          350 EVQYALD--TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       350 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .......  ......       ..+...+..+.+++.+||..+|.+||++.++
T Consensus       239 ~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  284 (326)
T 2x7f_A          239 PMRALFLIPRNPAPR-------LKSKKWSKKFQSFIESCLVKNHSQRPATEQL  284 (326)
T ss_dssp             HHHHHHHHHHSCCCC-------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             HHHHHHHhhcCcccc-------CCccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence            4433221  111111       1122345789999999999999999999883

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.8e-42  Score=351.56  Aligned_cols=243  Identities=25%  Similarity=0.385  Sum_probs=189.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCC--CCCeeeeecee--cCcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR--HPNLVTLVGAC--PEVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~--hpniv~l~g~~--~~~~~lV~  210 (498)
                      ..|.+.+.||+|+||.||+|... +..||||++......  ....+.+|+.+|+.+.  ||||+++++++  .+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            45888999999999999999875 678999999765432  2356899999999996  59999999987  34689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      | +.+|+|.+++...   ..+++..+..|+.|++.||.|||+   ++|+||||||+||||+ ++.+||+|||+++.+...
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 5688999999543   468899999999999999999999   8999999999999996 579999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhcc-----------CCCCCccchHhHHHHHHHHHhCCCCCCCcH-HHHHHHHhC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDTG  358 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~~~~  358 (498)
                      ....      ......||+.|+|||++.+           ..++.++|||||||+||||+||++||.... ......   
T Consensus       208 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---  278 (390)
T 2zmd_A          208 TTSV------VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---  278 (390)
T ss_dssp             ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH---
T ss_pred             Cccc------cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH---
Confidence            2111      1133469999999999975           368899999999999999999999997532 111111   


Q ss_pred             ccccccCCC-CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          359 KLKNLLDPL-AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       359 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                         ..+++. ...+|...+..+.+|+.+||..+|.+||++.++
T Consensus       279 ---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el  318 (390)
T 2zmd_A          279 ---AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  318 (390)
T ss_dssp             ---HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ---HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHH
Confidence               111111 112343446789999999999999999999883

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.5e-42  Score=333.41  Aligned_cols=243  Identities=26%  Similarity=0.364  Sum_probs=196.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      ++|.+.+.||+|+||.||+|...  +..||||++..... ...+.+.+|+.+++.++||||+++++++.  ...++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            46888889999999999999985  78899999875433 23467899999999999999999999984  357899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +++|+|.+++.   ....+++..+..++.+++.||.|||+   +||+||||||+||+++.++.+||+|||++........
T Consensus        87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            99999999984   34569999999999999999999999   8999999999999999999999999999986643321


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHH---HHHHHhCccccccCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEV---QYALDTGKLKNLLDPLA  368 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~---~~~~~~~~~~~~~~~~~  368 (498)
                      ..      ......||+.|+|||.+.+..+ +.++|||||||++|+|+||+.||......   ...+....  ..     
T Consensus       161 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~-----  227 (276)
T 2yex_A          161 ER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TY-----  227 (276)
T ss_dssp             EC------CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC--TT-----
T ss_pred             hh------cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc--cc-----
Confidence            11      1133458999999999987765 67899999999999999999999754321   11111110  00     


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .......+..+.+++.+||..+|.+||++.+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  258 (276)
T 2yex_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPD  258 (276)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cCchhhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence            0111234678999999999999999999988

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.9e-42  Score=335.21  Aligned_cols=246  Identities=24%  Similarity=0.348  Sum_probs=196.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC------ChhhHHHHHHHHHcCCCCCeeeeeceec--Ccce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~  207 (498)
                      ++|.+.+.||+|+||.||+|...  +..||+|++......      ..+.+.+|+.++++++||||+++++++.  ...+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            35788899999999999999985  689999998764322      3567999999999999999999999984  3578


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC----ceeEeeccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI  283 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFGl  283 (498)
                      +||||+++++|.+++..   ...+++..+..++.+++.||.|||+   +||+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999953   3468999999999999999999999   8999999999999998877    899999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      +........         .....||+.|+|||++.+..++.++||||||+++|+|+||.+||..................
T Consensus       159 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  229 (283)
T 3bhy_A          159 AHKIEAGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD  229 (283)
T ss_dssp             CEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             ceeccCCCc---------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence            986643321         12335899999999999999999999999999999999999999765543322211111100


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ..   ...+...+..+.+++.+||..+|.+||++.+++
T Consensus       230 ~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l  264 (283)
T 3bhy_A          230 FD---EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL  264 (283)
T ss_dssp             CC---HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             Cc---chhcccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence            00   001122356799999999999999999998843

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.7e-42  Score=342.53  Aligned_cols=240  Identities=20%  Similarity=0.285  Sum_probs=199.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceecC--cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      ..+|...+.||+|+||.||++.+.  +..||+|++.......   .+.+.+|+.+++.++||||+++++++.+  ..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            457888999999999999999985  5789999987543322   3568899999999999999999999854  57899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||+.+++|.+++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999998853   2468999999999999999999999   8999999999999999999999999999987643


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL  367 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~  367 (498)
                      ....        .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.........  +..+.        
T Consensus       194 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------  257 (335)
T 2owb_A          194 DGER--------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------  257 (335)
T ss_dssp             TTCC--------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--------
T ss_pred             Cccc--------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--------
Confidence            3211        12345999999999999989999999999999999999999999865433222  11211        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       ...|...+..+.+++.+||+.||.+||++.+
T Consensus       258 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  288 (335)
T 2owb_A          258 -YSIPKHINPVAASLIQKMLQTDPTARPTINE  288 (335)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             -CCCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence             1133445578999999999999999999988

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.5e-42  Score=372.51  Aligned_cols=240  Identities=20%  Similarity=0.273  Sum_probs=200.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcC-CCCCeeeeeceecC--cceE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTL  208 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~l  208 (498)
                      ..+|.+.+.||+|+||.||+|...  +..||||++.+.   .......+..|..+|..+ +||||+.+++++.+  ..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            457888999999999999999985  577999998753   223456788999999988 79999999999854  5899


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||++||+|.+++...   ..+++..+..|+.|++.||.|||+   +|||||||||+||||+.+|++||+|||+|+...
T Consensus       420 V~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999643   469999999999999999999999   899999999999999999999999999998543


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (498)
                      .....        .....||+.|+|||++.+..|+.++|||||||+||||+||++||...+..........       ..
T Consensus       494 ~~~~~--------~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-------~~  558 (674)
T 3pfq_A          494 WDGVT--------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------HN  558 (674)
T ss_dssp             CTTCC--------BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS-------SC
T ss_pred             cCCcc--------cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------CC
Confidence            32211        1344699999999999999999999999999999999999999987654432221110       11


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      ..+|...+..+.+|+..||+.||.+||++
T Consensus       559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          559 VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence            23555677899999999999999999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9e-42  Score=344.98  Aligned_cols=256  Identities=21%  Similarity=0.251  Sum_probs=193.1

Q ss_pred             hHHHHHhhcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCC-----------hhhHHHHHHHHHcCCCCCeee
Q 010882          130 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG-----------PSEFQQEIDILSKIRHPNLVT  197 (498)
Q Consensus       130 ~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~E~~il~~l~hpniv~  197 (498)
                      +.++....++|.+.+.||+|+||.||+|... +..||||++.......           ...+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            3456677789999999999999999999874 6889999987543322           156889999999999999999


Q ss_pred             eeceec-----C--cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE
Q 010882          198 LVGACP-----E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL  270 (498)
Q Consensus       198 l~g~~~-----~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl  270 (498)
                      +++++.     .  ..++||||+. |+|.+.+.  .....+++..+..++.+++.||.|||+   +||+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEE
Confidence            999872     1  4689999997 68888885  334569999999999999999999999   899999999999999


Q ss_pred             cCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcH
Q 010882          271 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITK  349 (498)
Q Consensus       271 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~  349 (498)
                      +.++.+||+|||++........         .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADAN---------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             CTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCCCEEEEecCcccccccccc---------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999975443221         123358999999999987 678999999999999999999999998654


Q ss_pred             HHHHHHHhC------c-----------cccccCCCCC--------CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          350 EVQYALDTG------K-----------LKNLLDPLAG--------DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       350 ~~~~~~~~~------~-----------~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .........      .           ....+.....        ..+...+..+.+|+.+||+.+|.+||++.++
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  314 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA  314 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            332211110      0           0000000000        0112235679999999999999999999883

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.3e-42  Score=332.98  Aligned_cols=240  Identities=22%  Similarity=0.304  Sum_probs=195.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV  209 (498)
                      ..+|.+.+.||+|+||.||+|.+.  +..||||++.......  ...+.+|+.++..+ +||||+++++++.  +..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            356888899999999999999995  7899999998653332  45688999999999 9999999999984  468899


Q ss_pred             EeeCCCCCHHhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC---------------
Q 010882          210 YEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---------------  273 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---------------  273 (498)
                      |||+++|+|.+++.... ....+++..+..|+.|++.||.|||+   +||+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999996432 12568999999999999999999999   899999999999999844               


Q ss_pred             ----CceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCc
Q 010882          274 ----FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGIT  348 (498)
Q Consensus       274 ----~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~  348 (498)
                          +.+||+|||++.......            ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cCCceEEEEcccccccccCCcc------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                479999999998664322            22489999999999876 5678999999999999999999888665


Q ss_pred             HHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          349 KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..... +..+..        ...|...+..+.+++.+||+.||.+||++.++
T Consensus       235 ~~~~~-~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  277 (289)
T 1x8b_A          235 DQWHE-IRQGRL--------PRIPQVLSQEFTELLKVMIHPDPERRPSAMAL  277 (289)
T ss_dssp             HHHHH-HHTTCC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hHHHH-HHcCCC--------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHH
Confidence            54332 222222        12344456789999999999999999999883

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.7e-42  Score=360.19  Aligned_cols=242  Identities=25%  Similarity=0.380  Sum_probs=198.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      .+|...+.||+|+||.||+|...  +..||||++.....   .....+.+|+.++++++||||++++++|.+  ..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46888999999999999999984  68999999975432   345679999999999999999999999854  588999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE---cCCCceeEeeccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFL  287 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~  287 (498)
                      ||+.||+|.+++..   ...+++..+..|+.|++.||.|||+   +||+||||||+|||+   +.++.+||+|||++..+
T Consensus       106 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          106 EVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             CCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999853   3569999999999999999999999   899999999999999   56789999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~  365 (498)
                      .....         .....||+.|+|||++.+ .++.++|||||||++|+|+||.+||...+....  .+..+.....  
T Consensus       180 ~~~~~---------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--  247 (484)
T 3nyv_A          180 EASKK---------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE--  247 (484)
T ss_dssp             CCCCS---------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--
T ss_pred             ccccc---------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            54321         112349999999999865 699999999999999999999999987655432  2233222111  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        .. .....+..+.+|+.+||..+|.+||++.++
T Consensus       248 --~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~  279 (484)
T 3nyv_A          248 --LP-QWKKVSESAKDLIRKMLTYVPSMRISARDA  279 (484)
T ss_dssp             --SG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --Cc-ccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence              01 112456789999999999999999999883

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-41  Score=332.72  Aligned_cols=241  Identities=22%  Similarity=0.365  Sum_probs=190.8

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC------cceE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE------VWTL  208 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~------~~~l  208 (498)
                      .|.+...||+|+||.||+|.+.  +..||+|++......  ....+.+|+.+++.++||||++++++|..      ..++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3566778999999999999984  578999998754322  24568899999999999999999998732      3789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cccCCCCCCcEEEc-CCCceeEeeccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD-ANFVSKLSDFGISR  285 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NiLl~-~~~~~kl~DFGla~  285 (498)
                      ||||+++|+|.+++...   ..+++..+..|+.+++.||.|||+   .+  |+||||||+|||++ .++.+||+|||++.
T Consensus       107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999999532   468999999999999999999999   67  99999999999998 78999999999997


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccC
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD  365 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (498)
                      .......          ....||+.|+|||++. +.++.++|||||||++|+|+||+.||.............  .....
T Consensus       181 ~~~~~~~----------~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~~~~~  247 (290)
T 1t4h_A          181 LKRASFA----------KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--TSGVK  247 (290)
T ss_dssp             GCCTTSB----------EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH--TTTCC
T ss_pred             ccccccc----------ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH--hccCC
Confidence            5433211          2235899999999886 458999999999999999999999997543322221110  00000


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        ...++...+..+.+++..||+.+|.+||++.++
T Consensus       248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  280 (290)
T 1t4h_A          248 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL  280 (290)
T ss_dssp             --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             --ccccCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence              011222334679999999999999999999883

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-42  Score=338.47  Aligned_cols=257  Identities=26%  Similarity=0.390  Sum_probs=195.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC---C--eEEEEEEecCCCCC---ChhhHHHHHHHHHcCCCCCeeeeeceecC-cce
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR---H--MQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE-VWT  207 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~---~--~~vavK~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~  207 (498)
                      ..+|.+.+.||+|+||.||+|.+.   +  ..||||++......   ..+.+.+|+.+++.++||||+++++++.+ ..+
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   96 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence            347888899999999999999863   2  36999998765322   24578899999999999999999999843 588


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+++|+|.+++...  ...+++..+..++.+++.||.|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            999999999999999643  2458999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      ......     ........||+.|+|||++.+..++.++|||||||++|+|+| |++||...+.............    
T Consensus       172 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----  242 (291)
T 1u46_A          172 PQNDDH-----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE----  242 (291)
T ss_dssp             CC-CCE-----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC----
T ss_pred             cccccc-----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC----
Confidence            543211     111123457889999999998889999999999999999999 9999976544332211110000    


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                       ....+...+..+.+++.+||..+|.+||++.+ +.+.|+.+.
T Consensus       243 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~-l~~~l~~~~  283 (291)
T 1u46_A          243 -RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA-LRDFLLEAQ  283 (291)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHC
T ss_pred             -CCCCCcCcCHHHHHHHHHHccCCcccCcCHHH-HHHHHHHhC
Confidence             11123345678999999999999999999998 777777664

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.6e-43  Score=355.61  Aligned_cols=238  Identities=12%  Similarity=0.123  Sum_probs=184.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHHHH---HHHHcCCCCCeeeeecee------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEI---DILSKIRHPNLVTLVGAC------  202 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~---~il~~l~hpniv~l~g~~------  202 (498)
                      ..+|.+.+.||+|+||.||+|.+.  +..||||++.....   ...+.+.+|+   .+|+.++||||+++++.+      
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            457888899999999999999963  78999999975422   2346788999   555566899999998443      


Q ss_pred             -cC-------------------cceEEEeeCCCCCHHhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 010882          203 -PE-------------------VWTLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSI  258 (498)
Q Consensus       203 -~~-------------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  258 (498)
                       .+                   ..++||||+ +|+|.+++.....    ...+++..++.|+.|++.||.|||+   +||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence             21                   268999999 6899999964311    1234568888999999999999999   899


Q ss_pred             ccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-----------CCCCccc
Q 010882          259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----------ELTPKSD  327 (498)
Q Consensus       259 vHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~D  327 (498)
                      +||||||+||||+.++.+||+|||+++.....           .....| +.|+|||++.+.           .++.++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCCc-----------ccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence            99999999999999999999999999853321           123357 999999999887           8999999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          328 VYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       328 vwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ||||||+||||+||++||.......      ....... ..    ...+..+.+|+.+||+.||.+||++.+++
T Consensus       296 vwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~-~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPITKDAALG------GSEWIFR-SC----KNIPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC------C------CSGGGGS-SC----CCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCccccccc------chhhhhh-hc----cCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            9999999999999999996543211      1111111 11    23357899999999999999999998843

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-41  Score=358.60  Aligned_cols=242  Identities=28%  Similarity=0.467  Sum_probs=193.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      ..|.+.+.||+|+||+||+|...  +..||||++....  ......+.+|+.+++.++||||++++++|.+  ..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46888999999999999999984  6789999997653  2335678999999999999999999999854  5889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---CCceeEeecccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLS  288 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla~~~~  288 (498)
                      |++||+|.+.+...   ..+++..+..|+.|++.||.|||+   +||+||||||+|||++.   ++.+||+|||++....
T Consensus       117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            99999999988533   468999999999999999999999   89999999999999976   4569999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDP  366 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~  366 (498)
                      ....         .....||+.|+|||++. ..++.++|||||||++|+|++|.+||........  .+..+.....   
T Consensus       191 ~~~~---------~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---  257 (494)
T 3lij_A          191 NQKK---------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD---  257 (494)
T ss_dssp             TTBC---------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             CCcc---------ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            4321         12345999999999986 5699999999999999999999999986654332  2222222110   


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       ...| ...+..+.+|+.+||+.+|.+||++.++
T Consensus       258 -~~~~-~~~s~~~~~li~~~L~~dp~~R~s~~e~  289 (494)
T 3lij_A          258 -SPEW-KNVSEGAKDLIKQMLQFDSQRRISAQQA  289 (494)
T ss_dssp             -SGGG-TTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             -chhc-ccCCHHHHHHHHHHCCCChhhCccHHHH
Confidence             0111 1345789999999999999999999884

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-41  Score=338.92  Aligned_cols=255  Identities=22%  Similarity=0.293  Sum_probs=200.2

Q ss_pred             ChHHHHHhhcCCCCC-CcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcC-CCCCeeeeecee
Q 010882          129 SFSEIEGATHNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKI-RHPNLVTLVGAC  202 (498)
Q Consensus       129 ~~~ei~~~~~~~~~~-~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~hpniv~l~g~~  202 (498)
                      .+.....-.+.|.+. +.||+|+||.||+|...  +..||||++.....  .....+.+|+.++..+ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344444455567666 78999999999999985  78999999876432  2356789999999999 469999999998


Q ss_pred             cC--cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---CCcee
Q 010882          203 PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSK  277 (498)
Q Consensus       203 ~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~k  277 (498)
                      .+  ..++||||+++|+|.+++... ....+++..+..++.+++.||.|||+   +||+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEE
Confidence            43  578999999999999998532 23569999999999999999999999   89999999999999997   78999


Q ss_pred             EeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh
Q 010882          278 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT  357 (498)
Q Consensus       278 l~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (498)
                      |+|||++........         .....||+.|+|||++.+..++.++|||||||++|+|+||++||............
T Consensus       175 L~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  245 (327)
T 3lm5_A          175 IVDFGMSRKIGHACE---------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI  245 (327)
T ss_dssp             ECCGGGCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EeeCccccccCCccc---------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence            999999987653321         12345999999999999999999999999999999999999999766544332221


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          358 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .....   ......+...+..+.+++.+||+.+|.+||++.+
T Consensus       246 ~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~  284 (327)
T 3lm5_A          246 SQVNV---DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEI  284 (327)
T ss_dssp             HHTCC---CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             Hhccc---ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence            11111   1111122345678999999999999999999988

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=350.65  Aligned_cols=240  Identities=26%  Similarity=0.365  Sum_probs=193.5

Q ss_pred             cCCCCCCcccccCceEEEEEEE-----CCeEEEEEEecCCC----CCChhhHHHHHHHHHcC-CCCCeeeeeceec--Cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EV  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~  205 (498)
                      .+|.+.+.||+|+||.||+|..     .+..||||++....    ......+.+|+.+|+.+ +||||+++++++.  ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788999999999999999988     46899999987532    23345678899999999 6999999999884  46


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            88999999999999999543   468999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC--CCCCccchHhHHHHHHHHHhCCCCCCCcHH------HHHHHHh
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDT  357 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~------~~~~~~~  357 (498)
                      .+.......       .....||+.|+|||++.+.  .++.++|||||||+||+|+||+.||.....      +......
T Consensus       208 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  280 (355)
T 1vzo_A          208 EFVADETER-------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK  280 (355)
T ss_dssp             ECCGGGGGG-------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred             ecccCCCCc-------ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc
Confidence            664432211       1223499999999999863  478999999999999999999999964221      1111111


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCC-----ChhH
Q 010882          358 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP-----ELGK  399 (498)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----~~~~  399 (498)
                               ....+|...+..+.+|+.+||..||.+||     ++.+
T Consensus       281 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~e  318 (355)
T 1vzo_A          281 ---------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE  318 (355)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHH
T ss_pred             ---------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHH
Confidence                     11224455667899999999999999999     6655

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-41  Score=339.81  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=192.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ++|...+.||+|+||.||+|.+.  +..||||++.......  ...+.+|+.+++.++||||++++++|.  ...++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            46888899999999999999985  7889999987554322  345779999999999999999999984  45789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+++++|.+++.   ....+++..+..++.+++.||.|||+   .||+||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999998874   23469999999999999999999999   899999999999999999999999999998654432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Cc-------
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK-------  359 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~-------  359 (498)
                      ..        .....||+.|+|||++.+. .++.++|||||||++|+|+||++||............    +.       
T Consensus       179 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          179 EV--------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             cc--------cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence            11        1234589999999999875 7899999999999999999999999765543322111    00       


Q ss_pred             -------cccccCCC-CCCC-----CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          360 -------LKNLLDPL-AGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       360 -------~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                             ......+. ....     ....+..+.+|+.+||+.||.+||++.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  303 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE  303 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence                   00000000 0000     1134678999999999999999999988

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=344.23  Aligned_cols=262  Identities=23%  Similarity=0.314  Sum_probs=201.4

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec------Ccce
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWT  207 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~------~~~~  207 (498)
                      ..++|.+.+.||+|+||.||++..  .+..||||++..........+.+|+.+++.++||||+++++++.      ...+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            345789999999999999999997  47899999987654444567899999999999999999999883      2578


Q ss_pred             EEEeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          208 LVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      +||||+++|+|.+++... .....+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999998642 234679999999999999999999999   8999999999999999999999999999876


Q ss_pred             ccccccCCCCc-cceeccCCCCCCCcCChhhhccCC---CCCccchHhHHHHHHHHHhCCCCCCCcHH----HHHHHHhC
Q 010882          287 LSQNEISSNNT-TLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITKE----VQYALDTG  358 (498)
Q Consensus       287 ~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~pf~~~~~----~~~~~~~~  358 (498)
                      ........... .........||+.|+|||++.+..   ++.++|||||||++|+|+||+.||.....    ....... 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence            54321110000 000011224799999999987654   68899999999999999999999953211    1111111 


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ..       ....+...+..+.+++.+||+.+|.+||++.+ +++.|+.+.
T Consensus       263 ~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-ll~~L~~~~  305 (317)
T 2buj_A          263 QL-------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPL-LLSQLEALQ  305 (317)
T ss_dssp             C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHTC
T ss_pred             cC-------CCCccccCCHHHHHHHHHHhhcChhhCCCHHH-HHHHhhhcC
Confidence            00       01112334578999999999999999999988 777777653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1e-41  Score=331.00  Aligned_cols=239  Identities=27%  Similarity=0.418  Sum_probs=190.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..||||++...   .......+.+|+.+++.++||||+++++++.  +..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            47888899999999999999985  789999998643   2234567889999999999999999999984  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++++|.+++...   ..+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999999533   458999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~  367 (498)
                      ..         .....||+.|+|||.+.+..+ +.++||||||+++|+|+||+.||........  .+..+.        
T Consensus       165 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------  227 (276)
T 2h6d_A          165 EF---------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--------  227 (276)
T ss_dssp             ---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             cc---------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--------
Confidence            21         122358999999999988765 6899999999999999999999976543221  122211        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       ...|...+..+.+++.+||+.+|.+||++.++
T Consensus       228 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~  259 (276)
T 2h6d_A          228 -FYIPEYLNRSVATLLMHMLQVDPLKRATIKDI  259 (276)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -ccCchhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence             11334456789999999999999999999883

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-41  Score=357.08  Aligned_cols=244  Identities=28%  Similarity=0.453  Sum_probs=195.5

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-------------CChhhHHHHHHHHHcCCCCCeeeeec
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-------------QGPSEFQQEIDILSKIRHPNLVTLVG  200 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~hpniv~l~g  200 (498)
                      ....|.+.+.||+|+||+||+|...  +..||||++.....             .....+.+|+.+|+.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3567999999999999999999985  57899999876432             22456889999999999999999999


Q ss_pred             eecC--cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC---c
Q 010882          201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---V  275 (498)
Q Consensus       201 ~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~  275 (498)
                      +|.+  ..++|||||+||+|.+++...   ..+++..+..|+.|++.||.|||+   +||+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCcc
Confidence            9854  578999999999999988533   469999999999999999999999   8999999999999998776   6


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--  353 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--  353 (498)
                      +||+|||++........         .....||+.|+|||++. +.++.++|||||||++|+|++|.+||...+....  
T Consensus       188 ~kl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK---------LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK  257 (504)
T ss_dssp             EEECCCTTCEECCTTSC---------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEEEECCCCEEcCCCCc---------cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999987654321         12345999999999986 5699999999999999999999999987654332  


Q ss_pred             HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+..+......    ..| ...+..+.+|+.+||..+|.+||++.++
T Consensus       258 ~i~~~~~~~~~----~~~-~~~s~~~~~li~~~L~~dp~~R~t~~e~  299 (504)
T 3q5i_A          258 KVEKGKYYFDF----NDW-KNISDEAKELIKLMLTYDYNKRCTAEEA  299 (504)
T ss_dssp             HHHHCCCCCCH----HHH-TTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHcCCCCCCc----ccc-CCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            22232211100    000 1245789999999999999999999883

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.4e-41  Score=342.27  Aligned_cols=246  Identities=20%  Similarity=0.261  Sum_probs=186.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      .++|...+.||+|+||.||+|...  +..||||++......  ....+.+|+.+++.++||||+++++++..        
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            357889999999999999999884  788999998754322  23468899999999999999999998842        


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||+. |+|.+.+.     ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            4689999997 47888874     248899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc-c--
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-K--  361 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~--  361 (498)
                      +.......         .....||+.|+|||++.+..++.++|||||||++|+|+||++||...+........-.. .  
T Consensus       175 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          175 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  245 (371)
T ss_dssp             ------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred             cccccccc---------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            86543211         12345899999999999999999999999999999999999999876543322111000 0  


Q ss_pred             --------------------------------cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 --------------------------------NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 --------------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                                      ....+.....+...+..+.+|+.+||..||.+||++.++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  316 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  316 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence                                            000000000112236789999999999999999999883

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-41  Score=358.02  Aligned_cols=242  Identities=29%  Similarity=0.428  Sum_probs=197.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC--CCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      .+|.+.+.||+|+||+||+|...  +..||||++...  .......+.+|+.+|++++||||+++++++.+  ..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            46889999999999999999985  788999998643  23345678999999999999999999999854  5889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc---CCCceeEeecccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLS  288 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~~~  288 (498)
                      |++||+|.+.+...   ..+++..+..|+.|++.||.|||+   +||+||||||+|||++   .++.+||+|||++....
T Consensus       102 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999988533   468999999999999999999999   8999999999999995   45689999999998664


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDP  366 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~  366 (498)
                      ....         .....||+.|+|||++.+ .++.++|||||||++|+|+||.+||...+....  .+..+......  
T Consensus       176 ~~~~---------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  243 (486)
T 3mwu_A          176 QNTK---------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--  243 (486)
T ss_dssp             CC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS--
T ss_pred             CCCc---------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence            3321         123459999999999875 599999999999999999999999976654332  22232221110  


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                        . .....+..+.+|+.+||..+|.+||++.++
T Consensus       244 --~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~  274 (486)
T 3mwu_A          244 --P-QWRTISDDAKDLIRKMLTFHPSLRITATQC  274 (486)
T ss_dssp             --G-GGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             --c-ccCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence              1 112356789999999999999999999883

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.9e-42  Score=336.49  Aligned_cols=259  Identities=24%  Similarity=0.327  Sum_probs=182.7

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCC-CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ...+|.+.+.||+|+||.||+|.+  .+..||||++.... ......+.+|+.++++++||||+++++++.  +..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            345788999999999999999987  57889999987543 233467889999999999999999999884  4689999


Q ss_pred             eeCCCCCHHhhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          211 EYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       211 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      ||+++|+|.+++...     .....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999998531     134569999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH--HhCcccc
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKN  362 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~  362 (498)
                      ...........   .......||+.|+|||++.+ ..++.++|||||||++|+|+||++||..........  ..+....
T Consensus       170 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          170 FLATGGDITRN---KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             eeccCCCccch---hhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            66543211100   11133469999999999976 578999999999999999999999997643322111  1111111


Q ss_pred             ccCC-CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          363 LLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       363 ~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .... .........+..+.+++.+||+.+|.+||++.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  285 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL  285 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence            1000 0111222345789999999999999999999883

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.7e-42  Score=346.28  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=195.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      .+|...+.||+|+||.||+|.+.  +..||+|++...... ....+.+|+.+++.++||||+++++++.  +..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            46888899999999999999996  788999998765321 2356889999999999999999999884  468999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      ++||+|.+++...   ..+++..+..++.+++.||.|||+   . ||+||||||+|||++.++.+||+|||++.......
T Consensus       113 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          113 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999999543   458999999999999999999998   5 89999999999999999999999999997653321


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc-----------
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-----------  360 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-----------  360 (498)
                                .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+........+..           
T Consensus       187 ----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          187 ----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             --------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             ----------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence                      12235899999999999999999999999999999999999999754332211100000           


Q ss_pred             -------------------------ccccCCCCCCC-CHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          361 -------------------------KNLLDPLAGDW-PFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       361 -------------------------~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                               ........... +...+..+.+|+.+||+.||.+||++.++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  322 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL  322 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHH
Confidence                                     00000000011 11245689999999999999999999883

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5e-42  Score=340.35  Aligned_cols=263  Identities=21%  Similarity=0.339  Sum_probs=200.0

Q ss_pred             HHHHHhhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--Ccc
Q 010882          131 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW  206 (498)
Q Consensus       131 ~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~  206 (498)
                      .+......+|.+.+.||+|+||.||+|.+.+ .||+|++.....  ...+.+.+|+.++++++||||+++++++.  +..
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            3444456789999999999999999999876 499999875432  23456889999999999999999999984  468


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||++|++|.+++..  ....+++..+..++.+++.||.|||+   +||+||||||+|||++ ++.+||+|||++..
T Consensus       105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999999953  23468999999999999999999999   8999999999999998 67999999999876


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhcc---------CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--H
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--L  355 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~  355 (498)
                      ..........   .......||+.|+|||++..         ..++.++|||||||++|+|+||+.||.........  +
T Consensus       179 ~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          179 SGVLQAGRRE---DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             ---------C---CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             cccccccccc---cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            5322211111   11233458999999999974         35788999999999999999999999765443222  2


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ..+.....       .+...+..+.+++..||..+|.+||++.+ +++.|+.+...
T Consensus       256 ~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~-l~~~l~~l~~~  303 (319)
T 2y4i_B          256 GTGMKPNL-------SQIGMGKEISDILLFCWAFEQEERPTFTK-LMDMLEKLPKR  303 (319)
T ss_dssp             HTTCCCCC-------CCSSCCTTHHHHHHHHHCSSTTTSCCHHH-HHHHHTTC---
T ss_pred             ccCCCCCC-------CcCCCCHHHHHHHHHHhcCChhhCcCHHH-HHHHHHHHHHh
Confidence            22211111       11123457999999999999999999988 87888776543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.4e-41  Score=334.64  Aligned_cols=243  Identities=19%  Similarity=0.328  Sum_probs=192.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceecC----cceEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE----VWTLV  209 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~----~~~lV  209 (498)
                      ..+|.+.+.||+|+||.||+|..  .+..||||++..   .....+.+|+.+++.++ ||||+++++++.+    ..++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            35788899999999999999987  468999999874   34578999999999997 9999999999843    47899


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-ceeEeecccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLS  288 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~  288 (498)
                      |||+++++|.+++.      .++...+..++.|++.||.|||+   +||+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999983      38889999999999999999999   8999999999999999776 89999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCc-HHHHHH------------
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGIT-KEVQYA------------  354 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~-~~~~~~------------  354 (498)
                      ....         .....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||... ......            
T Consensus       183 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~  253 (330)
T 3nsz_A          183 PGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  253 (330)
T ss_dssp             TTCC---------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             CCCc---------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence            4321         123358999999999987 67899999999999999999999999422 111100            


Q ss_pred             ---HHhCccc---------------cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          355 ---LDTGKLK---------------NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       355 ---~~~~~~~---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                         +......               ..........+...+..+.+|+.+||+.||.+||++.++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~  317 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA  317 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence               0000000               000000111122356889999999999999999999883

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.4e-41  Score=329.03  Aligned_cols=243  Identities=24%  Similarity=0.325  Sum_probs=196.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC----CCChhhHHHHHHHHHcCCCCCeeeeecee--c--Ccce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRHPNLVTLVGAC--P--EVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~g~~--~--~~~~  207 (498)
                      ++|.+.+.||+|+||.||+|...  +..||||++....    ......+.+|+.+++.++||||+++++++  .  ...+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            57999999999999999999984  6789999987532    22346789999999999999999999987  2  2579


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+++| |.+++... ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++...
T Consensus        85 lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            999999876 77777543 23569999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCC--CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNL  363 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~  363 (498)
                      .......      ......||+.|+|||++.+..  ++.++|||||||++|+|+||+.||...+.....  +..+..   
T Consensus       160 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---  230 (305)
T 2wtk_C          160 HPFAADD------TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY---  230 (305)
T ss_dssp             CTTCSSC------EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC---
T ss_pred             Ccccccc------ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC---
Confidence            4322111      113345999999999998654  377999999999999999999999865543322  222211   


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                            ..+...+..+.+++.+||..||.+||++.++
T Consensus       231 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  261 (305)
T 2wtk_C          231 ------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI  261 (305)
T ss_dssp             ------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ------CCCCccCHHHHHHHHHHccCChhhCCCHHHH
Confidence                  1333456789999999999999999999883

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-41  Score=368.80  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=205.0

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEEC-----CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC-cce
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE-VWT  207 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~  207 (498)
                      ....+|.+.+.||+|+||.||+|.+.     +..||||++...... ..+.|.+|+.++++++||||++++|++.+ ..+
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  466 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW  466 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence            34457888889999999999999984     356999998754322 23578899999999999999999999854 588


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +||||+++|+|.+++...  ...+++..++.++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++..
T Consensus       467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            999999999999999633  3468999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCcccccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLL  364 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~  364 (498)
                      .......       .....||+.|+|||++.+..++.++|||||||++|||++ |.+||........  .+..+.     
T Consensus       542 ~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-----  609 (656)
T 2j0j_A          542 EDSTYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-----  609 (656)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-----
T ss_pred             CCCccee-------ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----
Confidence            4432111       122347889999999999999999999999999999997 9999976544322  222221     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       365 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                         ....|...+..+.+++.+||..+|.+||++.+ +.+.|+.+..
T Consensus       610 ---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~e-l~~~L~~il~  651 (656)
T 2j0j_A          610 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE-LKAQLSTILE  651 (656)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             ---CCCCCccccHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHHHH
Confidence               11234455688999999999999999999998 7788877754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-41  Score=337.79  Aligned_cols=244  Identities=25%  Similarity=0.401  Sum_probs=191.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--------CChhhHHHHHHHHHcCCCCCeeeeeceec-Cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--------QGPSEFQQEIDILSKIRHPNLVTLVGACP-EV  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~  205 (498)
                      .++|.+.+.||+|+||.||+|.+.  +..||||++.....        .....+.+|+.+|+.++||||+++++++. +.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            346888999999999999999984  68899999875422        12345889999999999999999999984 45


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc---eeEeecc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFG  282 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFG  282 (498)
                      .++||||+++|+|.+++.   ....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.   +||+|||
T Consensus        89 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            899999999999999984   34579999999999999999999999   89999999999999987654   9999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCCcHH---HHHHHH
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALD  356 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~  356 (498)
                      ++.........         ....||+.|+|||++.   ...++.++|||||||++|+|+||.+||.....   ....+.
T Consensus       163 ~~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  233 (322)
T 2ycf_A          163 HSKILGETSLM---------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT  233 (322)
T ss_dssp             TCEECCCCHHH---------HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH
T ss_pred             cceeccccccc---------ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH
Confidence            99876433210         1123899999999974   45788999999999999999999999965321   222222


Q ss_pred             hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          357 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .+.....     ...+...+..+.+++.+||..||.+||++.++
T Consensus       234 ~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~  272 (322)
T 2ycf_A          234 SGKYNFI-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEA  272 (322)
T ss_dssp             HTCCCCC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hCccccC-----chhhhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence            2221110     00011235789999999999999999999884

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-41  Score=344.36  Aligned_cols=245  Identities=22%  Similarity=0.325  Sum_probs=178.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--------C
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--------E  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--------~  204 (498)
                      ..+|...+.||+|+||.||+|.+.  +..||||++......  ....+.+|+.+|+.++||||+++++++.        .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            467999999999999999999874  789999998754322  2356789999999999999999999873        2


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      ..++||||+ +++|.+++..    ..+++..+..++.|++.||.|||+   .||+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            468999999 7899998842    469999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccc--
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK--  361 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--  361 (498)
                      +......           ....||+.|+|||++.+ ..++.++|||||||++|||+||++||...+........-...  
T Consensus       180 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  248 (367)
T 2fst_X          180 RHTADEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  248 (367)
T ss_dssp             ----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             ccccccC-----------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            8654321           23458999999999987 678999999999999999999999998765433221110000  


Q ss_pred             ---------------cccC--CCCCCCC-----HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 ---------------NLLD--PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 ---------------~~~~--~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                     ..+.  +.....+     ...+..+.+|+.+||..||.+||++.++
T Consensus       249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~  309 (367)
T 2fst_X          249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  309 (367)
T ss_dssp             CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH
Confidence                           0000  0000011     1235678999999999999999999883

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.2e-41  Score=330.89  Aligned_cols=246  Identities=23%  Similarity=0.282  Sum_probs=179.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      .++|.+.+.||+|+||.||+|.+  .+..||||++.......  ...+..+...++.++||||+++++++.  +..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            45788889999999999999998  57899999997543221  123445555688889999999999984  4689999


Q ss_pred             eeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          211 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       211 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||++ |+|.+++... .....+++..+..|+.|++.||.|||+   + ||+||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 5888777431 234579999999999999999999999   7 99999999999999999999999999998665


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhh----ccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccccc
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFL----ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL  364 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (498)
                      .....         ....||+.|+|||++    .+..++.++|||||||++|+|+||+.||.................  
T Consensus       162 ~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--  230 (290)
T 3fme_A          162 DDVAK---------DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP--  230 (290)
T ss_dssp             -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC--
T ss_pred             ccccc---------cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC--
Confidence            43211         223589999999996    456789999999999999999999999974221111111000000  


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       365 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                        .....+...+..+.+++.+||+.+|.+||++.+
T Consensus       231 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e  263 (290)
T 3fme_A          231 --SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE  263 (290)
T ss_dssp             --CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --CCCcccccCCHHHHHHHHHHhhcChhhCcCHHH
Confidence              001112234578999999999999999999988

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.2e-41  Score=339.57  Aligned_cols=246  Identities=28%  Similarity=0.448  Sum_probs=197.6

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--------hhhHHHHHHHHHcC-CCCCeeeeeceec
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--------PSEFQQEIDILSKI-RHPNLVTLVGACP  203 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l-~hpniv~l~g~~~  203 (498)
                      ....+|.+...||+|+||.||+|.+.  +..||||++.......        ...+.+|+.+++++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            34467889999999999999999985  7899999987654221        24578899999999 7999999999984


Q ss_pred             --CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          204 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       204 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                        ...++||||++||+|.+++..   ...+++..+..++.|++.||.|||+   .||+||||||+|||++.+|.+||+||
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEec
Confidence              468999999999999999953   3468999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhcc------CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH-
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-  354 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~-  354 (498)
                      |++..+.....         .....||+.|+|||++.+      ..++.++|||||||++|+|+||++||......... 
T Consensus       245 G~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  315 (365)
T 2y7j_A          245 GFSCHLEPGEK---------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR  315 (365)
T ss_dssp             TTCEECCTTCC---------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CcccccCCCcc---------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99987654321         123459999999999864      35888999999999999999999999765443221 


Q ss_pred             -HHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          355 -LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       355 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       +..+..... .+.   | ...+..+.+++.+||+.+|.+||++.++
T Consensus       316 ~i~~~~~~~~-~~~---~-~~~~~~~~~li~~~L~~dP~~Rps~~el  357 (365)
T 2y7j_A          316 MIMEGQYQFS-SPE---W-DDRSSTVKDLISRLLQVDPEARLTAEQA  357 (365)
T ss_dssp             HHHHTCCCCC-HHH---H-SSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHhCCCCCC-Ccc---c-ccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence             222211100 000   0 1234679999999999999999999883

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.9e-41  Score=339.08  Aligned_cols=255  Identities=22%  Similarity=0.272  Sum_probs=186.1

Q ss_pred             HHHHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC----
Q 010882          131 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----  204 (498)
Q Consensus       131 ~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~----  204 (498)
                      .......++|.+.+.||+|+||.||+|.+.  +..||||++.... .....+.+++..++.++||||++++++|..    
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            344566778999999999999999999985  6889999886543 334567788999999999999999998822    


Q ss_pred             -----cceEEEeeCCCCCHHhhhc-cCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCcccCCCCCCcEEEcC-CCc
Q 010882          205 -----VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLH--SCKPHSIVHGDLKPANILLDA-NFV  275 (498)
Q Consensus       205 -----~~~lV~E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivHrDlkp~NiLl~~-~~~  275 (498)
                           ..++||||+++ +|.+.+. .......+++..+..++.+++.||.|||  +   +||+||||||+||||+. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence                 26899999986 4444332 2234567899999999999999999999  6   89999999999999996 899


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA  354 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  354 (498)
                      +||+|||++.........         ....||+.|+|||++.+. .++.++|||||||++|+|+||++||...+.....
T Consensus       171 ~kl~Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  241 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEPN---------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL  241 (360)
T ss_dssp             EEECCCTTCBCCCTTSCC---------CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEEeeCCCceecCCCCCc---------ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH
Confidence            999999999876543211         233589999999999765 4899999999999999999999999865443222


Q ss_pred             HHhCcc------------------ccccCCC-------CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          355 LDTGKL------------------KNLLDPL-------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       355 ~~~~~~------------------~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ......                  .......       ....+...+..+.+|+.+||+.||.+||++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  311 (360)
T 3e3p_A          242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE  311 (360)
T ss_dssp             HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence            111000                  0000000       01112225678999999999999999999988

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.9e-41  Score=343.24  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=192.4

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      ....+|.+.+.||+|+||.||+|.+  .+..||||++....    ....+|+.+|+.++||||++++++|..        
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            3456899999999999999999988  46899999986442    233489999999999999999998721        


Q ss_pred             --------------------------------cceEEEeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 010882          205 --------------------------------VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLH  251 (498)
Q Consensus       205 --------------------------------~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH  251 (498)
                                                      ..++||||++ |+|.+.+... .....+++..+..++.|++.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                            2679999997 5887776431 23457999999999999999999999


Q ss_pred             hcCCCCcccCCCCCCcEEEc-CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchH
Q 010882          252 SCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVY  329 (498)
Q Consensus       252 ~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw  329 (498)
                      +   .||+||||||+|||++ .++.+||+|||+++........         ....||+.|+|||++.+. .++.++|||
T Consensus       159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---------VAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---------CCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---------cCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            9   8999999999999998 6899999999999876443211         233589999999998875 589999999


Q ss_pred             hHHHHHHHHHhCCCCCCCcHHHHHHHHhCc----------------cccccCCC--CCC----CCHHHHHHHHHHHHHhh
Q 010882          330 SFGIILLRLLTGRPALGITKEVQYALDTGK----------------LKNLLDPL--AGD----WPFVQAEQLANLAMRCC  387 (498)
Q Consensus       330 SlGvil~elltG~~pf~~~~~~~~~~~~~~----------------~~~~~~~~--~~~----~~~~~~~~l~~li~~cl  387 (498)
                      ||||++|+|++|++||...+........-.                .....-+.  ...    ++...+..+.+|+.+||
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            999999999999999987654433222100                00000000  001    23345678999999999


Q ss_pred             hcccCCCCChhHH
Q 010882          388 EMSRKSRPELGKD  400 (498)
Q Consensus       388 ~~~p~~RP~~~~~  400 (498)
                      ..+|.+||++.++
T Consensus       307 ~~dP~~R~t~~e~  319 (383)
T 3eb0_A          307 RYEPDLRINPYEA  319 (383)
T ss_dssp             CSSGGGSCCHHHH
T ss_pred             cCChhhCCCHHHH
Confidence            9999999999884

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.6e-41  Score=347.43  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=190.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--------cceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------VWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------~~~l  208 (498)
                      .+|...+.||+|+||+||+|.+. +..||+|++.....    ...+|+.+|+.++||||++++++|..        ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46888999999999999999984 56699998764322    23479999999999999999998821        2679


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc-CCCceeEeeccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFL  287 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~  287 (498)
                      ||||++++.+............+++..+..++.|++.||.|||+   +||+||||||+||||+ .++.+||+|||+|+..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            99999876444433222334579999999999999999999999   8999999999999999 7999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc-------
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-------  359 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-------  359 (498)
                      ......         ....||+.|+|||++.+. .++.++|||||||++|||++|++||...+........-.       
T Consensus       193 ~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  263 (394)
T 4e7w_A          193 IAGEPN---------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR  263 (394)
T ss_dssp             CTTCCC---------CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cCCCCC---------cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            443211         233589999999999765 589999999999999999999999987654433221110       


Q ss_pred             ---------cccccCCCCC------CCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 ---------LKNLLDPLAG------DWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 ---------~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                               .....-+...      .++...+..+.+|+.+||..||.+||++.++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA  319 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH
Confidence                     0000000000      1222355789999999999999999999883

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.8e-40  Score=347.12  Aligned_cols=261  Identities=22%  Similarity=0.288  Sum_probs=201.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeee-eece--ecCcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT-LVGA--CPEVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~-l~g~--~~~~~~lV~E  211 (498)
                      .++|.+.+.||+|+||.||+|.+.  +..||||++.....  ...+..|+.+++.|.|++++. +..+  ..+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            357899999999999999999984  78999998875432  346889999999998754443 3333  3556899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE---cCCCceeEeecccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS  288 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~  288 (498)
                      |+ +++|.+++...  ...+++..++.|+.||+.||.|||+   ++||||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999999632  3469999999999999999999999   899999999999999   688999999999998766


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH-----HHHHHHhCccccc
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKNL  363 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-----~~~~~~~~~~~~~  363 (498)
                      ....... ..........||+.|+|||++.+..++.++|||||||+||||+||+.||.....     ....+....+...
T Consensus       158 ~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQH-IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccc-cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            5432211 111122355699999999999999999999999999999999999999975221     1111111111111


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      +....    ...+..+.+|+..||+.+|.+||++.+ |.+.|+.+...
T Consensus       237 ~~~l~----~~~p~~l~~li~~cl~~dP~~RPs~~e-l~~~L~~l~~~  279 (483)
T 3sv0_A          237 IEALC----RGYPTEFASYFHYCRSLRFDDKPDYSY-LKRLFRDLFIR  279 (483)
T ss_dssp             HHHHH----TTSCHHHHHHHHHHHTCCTTCCCCHHH-HHHHHHHHHHH
T ss_pred             HHHHh----cCCcHHHHHHHHHHhcCChhhCcCHHH-HHHHHHHHHHH
Confidence            11111    123468999999999999999999988 88888887654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.3e-41  Score=349.18  Aligned_cols=246  Identities=26%  Similarity=0.333  Sum_probs=189.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec------C--cce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------E--VWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~------~--~~~  207 (498)
                      .+|...+.||+|+||.||+|.+.  +..||||++....    ..+.+|+.+|+.++||||++++++|.      +  ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            36888899999999999999994  7899999986532    23457999999999999999999872      1  257


Q ss_pred             EEEeeCCCCCHHhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-CceeEeeccccc
Q 010882          208 LVYEYLPNGSLEDRLSC-KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISR  285 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~  285 (498)
                      +||||+++ +|.+.+.. ......+++..+..++.|++.||.|||+   +||+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999976 56655532 1234579999999999999999999999   899999999999999965 678999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCc-----
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-----  359 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-----  359 (498)
                      .+.....         .....||+.|+|||++.+. .++.++|||||||+||||++|++||...+........-+     
T Consensus       206 ~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p  276 (420)
T 1j1b_A          206 QLVRGEP---------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  276 (420)
T ss_dssp             ECCTTCC---------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             hcccCCC---------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            7643321         1234589999999999765 799999999999999999999999987654332221100     


Q ss_pred             -----------cccccCCCCC--C----CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 -----------LKNLLDPLAG--D----WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 -----------~~~~~~~~~~--~----~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                 ......+...  .    ++...+..+.+|+.+||..||.+||++.++
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~  334 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA  334 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH
Confidence                       0000001000  0    122345789999999999999999999883

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-42  Score=350.83  Aligned_cols=247  Identities=14%  Similarity=0.105  Sum_probs=176.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcC--CCCCeeeeeceec------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKI--RHPNLVTLVGACP------  203 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l--~hpniv~l~g~~~------  203 (498)
                      ..+|...+.||+|+||.||+|.+.  +..||||++.......   ...+.+|+.+++.|  +||||++++..+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888899999999999999984  7889999998765422   34567785444444  6999888653221      


Q ss_pred             --------------------CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 010882          204 --------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR------IRIATELCSVLIFLHSCKPHS  257 (498)
Q Consensus       204 --------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~  257 (498)
                                          ...++||||++ |+|.+++....  ..+++..+      ..++.|++.||.|||+   +|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQS---KG  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence                                23799999998 89999996432  23444556      7888999999999999   89


Q ss_pred             cccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHH
Q 010882          258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIIL  335 (498)
Q Consensus       258 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil  335 (498)
                      |+||||||+||||+.++.+||+|||+++......           ....||+.|+|||++.+  ..++.++|||||||+|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il  283 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSI  283 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence            9999999999999999999999999998654321           01237799999999987  6799999999999999


Q ss_pred             HHHHhCCCCCCCcHHHHHH-HHhCccccccC-CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          336 LRLLTGRPALGITKEVQYA-LDTGKLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       336 ~elltG~~pf~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      |||+||++||......... ........... ......+...+..+.+|+.+||+.||.+||++.++
T Consensus       284 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  350 (371)
T 3q60_A          284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA  350 (371)
T ss_dssp             HHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred             HHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            9999999999765321100 00000000000 00011112456889999999999999999999883

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.4e-41  Score=349.13  Aligned_cols=201  Identities=25%  Similarity=0.314  Sum_probs=161.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec-------Cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------EV  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~-------~~  205 (498)
                      ..+|.+.+.||+|+||.||+|.+.  +..||||++......  ....+.+|+.+|+.++||||+++++++.       ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            347999999999999999999984  688999999754322  2356889999999999999999999883       34


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .|+||||+. |+|.+++.   ....+++..+..++.|++.||.|||+   .||+||||||+||||+.++.+||+|||+|+
T Consensus       105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            799999985 69999995   33569999999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccCCCC--------------ccceeccCCCCCCCcCChhhh-ccCCCCCccchHhHHHHHHHHHhCCCC
Q 010882          286 FLSQNEISSNN--------------TTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPA  344 (498)
Q Consensus       286 ~~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~p  344 (498)
                      ...........              .........+||+.|+|||++ ....++.++|||||||+||||+||..|
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            76543211000              000112456799999999986 456799999999999999999984333

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-40  Score=330.15  Aligned_cols=251  Identities=27%  Similarity=0.372  Sum_probs=197.6

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC---CeEEEEEEecCCCC--CChhhHHHHHHHHHcC---CCCCeeeeeceec----
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL--QGPSEFQQEIDILSKI---RHPNLVTLVGACP----  203 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~hpniv~l~g~~~----  203 (498)
                      ...+|.+.+.||+|+||.||+|.+.   +..||||++.....  .....+.+|+.+++.+   +||||++++++|.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4568999999999999999999983   67899999875332  2345678888888777   8999999999874    


Q ss_pred             ---CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEee
Q 010882          204 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD  280 (498)
Q Consensus       204 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  280 (498)
                         ...++||||+. |+|.+++.... ...+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence               24789999997 69999986432 3458999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh---
Q 010882          281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT---  357 (498)
Q Consensus       281 FGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~---  357 (498)
                      ||++........         .....||+.|+|||++.+..++.++|||||||++|+|+||++||............   
T Consensus       164 fg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  234 (326)
T 1blx_A          164 FGLARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV  234 (326)
T ss_dssp             CCSCCCCCGGGG---------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CcccccccCCCC---------ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            999986543321         13345899999999999999999999999999999999999999865543322111   


Q ss_pred             -Cc-----cccc-------cC----CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          358 -GK-----LKNL-------LD----PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       358 -~~-----~~~~-------~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                       +.     +...       ..    .....++...+..+.+|+.+||..+|.+||++.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  294 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA  294 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence             00     0000       00    00011223456789999999999999999999883

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-40  Score=338.71  Aligned_cols=244  Identities=23%  Similarity=0.319  Sum_probs=190.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceecC--c-----
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE--V-----  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~~--~-----  205 (498)
                      .++|...+.||+|+||.||+|.+.  +..||||++.......  ...+.+|+.+++.++||||++++++|..  .     
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            457888999999999999999984  7899999997643322  3568899999999999999999999843  2     


Q ss_pred             -ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          206 -WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       206 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                       .++||||+. |+|.+.+.     ..+++..+..++.+++.||.|||+   +||+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence             389999997 68988872     348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccc--
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK--  361 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--  361 (498)
                      +......           ....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........-...  
T Consensus       192 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  260 (371)
T 4exu_A          192 RHADAEM-----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  260 (371)
T ss_dssp             -------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccCc-----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            8654321           23458999999999987 678999999999999999999999998655433221110000  


Q ss_pred             -------------------cccCCCCCC---CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 -------------------NLLDPLAGD---WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 -------------------~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                         .........   .+...+..+.+|+.+||+.||.+||++.++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  321 (371)
T 4exu_A          261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  321 (371)
T ss_dssp             CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence                               000000000   112345789999999999999999999883

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.5e-40  Score=326.49  Aligned_cols=243  Identities=27%  Similarity=0.396  Sum_probs=197.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---------hhhHHHHHHHHHcCC-CCCeeeeeceecC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---------PSEFQQEIDILSKIR-HPNLVTLVGACPE  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---------~~~~~~E~~il~~l~-hpniv~l~g~~~~  204 (498)
                      ..+|...+.||+|+||.||+|.+.  +..||||++.......         .+.+.+|+.+++++. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            357888899999999999999984  6899999997654211         245779999999995 9999999999853


Q ss_pred             --cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecc
Q 010882          205 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG  282 (498)
Q Consensus       205 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  282 (498)
                        ..++||||+++|+|.+++..   ...+++..+..++.+++.||.|||+   +|++||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence              57899999999999999953   3468999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccccccCCCCccceeccCCCCCCCcCChhhhc------cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--H
Q 010882          283 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--A  354 (498)
Q Consensus       283 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~  354 (498)
                      ++........         .....||+.|+|||++.      ...++.++|||||||++|+|++|++||...+....  .
T Consensus       170 ~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  240 (298)
T 1phk_A          170 FSCQLDPGEK---------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM  240 (298)
T ss_dssp             TCEECCTTCC---------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             chhhcCCCcc---------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence            9987653321         12345899999999985      45688999999999999999999999976544322  2


Q ss_pred             HHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          355 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +..+.....     .......+..+.+++.+||+.+|.+||++.+
T Consensus       241 ~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  280 (298)
T 1phk_A          241 IMSGNYQFG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE  280 (298)
T ss_dssp             HHHTCCCCC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HhcCCcccC-----cccccccCHHHHHHHHHHccCCcccCCCHHH
Confidence            222221110     0111245678999999999999999999988

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=334.04  Aligned_cols=250  Identities=22%  Similarity=0.310  Sum_probs=187.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec------------
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------------  203 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~------------  203 (498)
                      ++|...+.||+|+||.||+|.+.  +..||||++..........+.+|+.+++.++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            47888899999999999999985  7899999987654444567889999999999999999998762            


Q ss_pred             ----CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc-CCCceeE
Q 010882          204 ----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKL  278 (498)
Q Consensus       204 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl  278 (498)
                          ...++||||+. |+|.+++.    ..++++..+..++.|++.||.|||+   +||+||||||+|||++ .++.+||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence                34689999997 69999984    2468999999999999999999999   8999999999999997 5679999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT  357 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (498)
                      +|||++...........     ......||+.|+|||.+.+ ..++.++|||||||++|+|+||++||............
T Consensus       163 ~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKG-----HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             CCCTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccCccccccCCCccccc-----ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999987643221111     0122347999999998876 67899999999999999999999999865543221111


Q ss_pred             Ccccc---------------------ccCCCC--CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          358 GKLKN---------------------LLDPLA--GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       358 ~~~~~---------------------~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .....                     ...+..  ...+...+..+.+++.+||+.||.+||++.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  303 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA  303 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence            00000                     000000  00112345789999999999999999999883

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5e-41  Score=340.03  Aligned_cols=251  Identities=24%  Similarity=0.296  Sum_probs=194.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC-------cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE-------VW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~-------~~  206 (498)
                      ..+|.+.+.||+|+||.||+|.+.  +..||||++...... ....+.+|+.+|++++||||+++++++..       ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457899999999999999999884  688999999753322 23568899999999999999999998832       47


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+. |+|.+++..    ..+++..+..|+.|++.||.|||+   +||+||||||+|||++.++.+||+|||++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            89999996 599998853    358999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Ccc-
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GKL-  360 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~~-  360 (498)
                      .........     ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........    +.. 
T Consensus       178 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  252 (364)
T 3qyz_A          178 ADPDHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  252 (364)
T ss_dssp             CCGGGCBCC-----TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred             cCCCCCccc-----cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            654432111     1133469999999998765 45899999999999999999999999754322111000    000 


Q ss_pred             ----------------ccccCCCCCC---CCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          361 ----------------KNLLDPLAGD---WPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       361 ----------------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                      ..........   .....+..+.+|+.+||..||.+||++.++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  311 (364)
T 3qyz_A          253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA  311 (364)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                            0000000000   112245679999999999999999999883

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=333.14  Aligned_cols=243  Identities=22%  Similarity=0.308  Sum_probs=191.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceecC--------c
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE--------V  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~~--------~  205 (498)
                      .+|...+.||+|+||.||+|.+.  +..||||++.......  ...+.+|+.+++.++||||+++++++..        .
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888899999999999999984  7899999997643222  3568899999999999999999999843        2


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .++||||+. |+|.+++.     ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++.
T Consensus       104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            489999997 68888773     248999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Cc-
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK-  359 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~-  359 (498)
                      ......           ....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........    +. 
T Consensus       175 ~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  243 (353)
T 3coi_A          175 HADAEM-----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  243 (353)
T ss_dssp             C-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBC
T ss_pred             CCCCCc-----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            643221           23358999999999987 67899999999999999999999999765443221111    00 


Q ss_pred             -------------------cccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          360 -------------------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       360 -------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                         +...........+...+..+.+|+.+||..||.+||++.++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  303 (353)
T 3coi_A          244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  303 (353)
T ss_dssp             CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                               00000001112233456889999999999999999999883

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.9e-41  Score=337.47  Aligned_cols=251  Identities=21%  Similarity=0.317  Sum_probs=199.1

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCCh-----------------hhHHHHHHHHHcCCCCCeeeee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP-----------------SEFQQEIDILSKIRHPNLVTLV  199 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~E~~il~~l~hpniv~l~  199 (498)
                      .++|.+.+.||+|+||.||+|.+.+..||||++........                 ..+.+|+.++++++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            35788999999999999999999999999999875322111                 6799999999999999999999


Q ss_pred             ceec--CcceEEEeeCCCCCHHhh------hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc
Q 010882          200 GACP--EVWTLVYEYLPNGSLEDR------LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD  271 (498)
Q Consensus       200 g~~~--~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~  271 (498)
                      +++.  +..++||||+++|+|.++      +.. .....+++..+..++.+++.||.|||+.  +||+||||||+|||++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMD  186 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEEC
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEc
Confidence            9984  468999999999999998      532 1246799999999999999999999972  5899999999999999


Q ss_pred             CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCC-ccchHhHHHHHHHHHhCCCCCCCcH
Q 010882          272 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTP-KSDVYSFGIILLRLLTGRPALGITK  349 (498)
Q Consensus       272 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltG~~pf~~~~  349 (498)
                      .++.+||+|||++.......          .....||+.|+|||++.+. .++. ++|||||||++|+|+||.+||....
T Consensus       187 ~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDKK----------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             TTSCEEECCCTTCEECBTTE----------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCcEEEecccccccccccc----------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999998754331          1334589999999999887 6666 8999999999999999999997643


Q ss_pred             H---HHHHHHhCccccccCCCC----------CCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          350 E---VQYALDTGKLKNLLDPLA----------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       350 ~---~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .   ....+..+......+...          ...+...+..+.+++.+||+.+|.+||++.++
T Consensus       257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~  320 (348)
T 2pml_X          257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA  320 (348)
T ss_dssp             CSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence            2   222222222211100000          00013456789999999999999999999883

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-40  Score=344.33  Aligned_cols=198  Identities=27%  Similarity=0.360  Sum_probs=167.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC------CCCCeeeeeceec--Ccc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI------RHPNLVTLVGACP--EVW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~hpniv~l~g~~~--~~~  206 (498)
                      ..+|.+.+.||+|+||.||+|.+.  +..||||++.... .....+.+|+.+++.+      +||||++++++|.  ...
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            346888999999999999999885  6889999997432 2235677899988887      5789999999884  468


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc--eeEeecccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGIS  284 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~DFGla  284 (498)
                      ++||||+. |+|.+++.... ...+++..+..|+.|++.||.|||+   ++|+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            89999995 69999886433 3459999999999999999999999   89999999999999999887  999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV  351 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~  351 (498)
                      .......           ....||+.|+|||++.+..++.++|||||||+||||+||++||...+..
T Consensus       250 ~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          250 CYEHQRV-----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             EETTCCC-----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             eecCCcc-----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            7544321           2335899999999999999999999999999999999999999865543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=340.87  Aligned_cols=198  Identities=25%  Similarity=0.402  Sum_probs=150.9

Q ss_pred             CCC-CCcccccCceEEEEEEEC----CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee----cCcceEEE
Q 010882          140 FDP-SLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTLVY  210 (498)
Q Consensus       140 ~~~-~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~----~~~~~lV~  210 (498)
                      |.. .++||+|+||.||+|.+.    +..||||++....  ....+.+|+.+|+.++||||++++++|    ....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            544 457999999999999975    5679999997543  345788999999999999999999998    33588999


Q ss_pred             eeCCCCCHHhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE----cCCCceeEee
Q 010882          211 EYLPNGSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSD  280 (498)
Q Consensus       211 E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~D  280 (498)
                      ||+. |+|.+++...      .....+++..+..|+.|++.||.|||+   +||+||||||+||||    +.++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9996 5788777421      122359999999999999999999999   899999999999999    6789999999


Q ss_pred             ccccccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCc
Q 010882          281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGIT  348 (498)
Q Consensus       281 FGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~  348 (498)
                      ||+++.+.......     .......||+.|+|||++.+. .++.++|||||||+||+|+||++||...
T Consensus       176 fg~a~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          176 MGFARLFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             TTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             CCCceecCCCCccc-----ccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99998765432111     112344699999999999874 5899999999999999999999999643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1e-40  Score=327.79  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=187.9

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec------------
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------------  203 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~------------  203 (498)
                      ++|...+.||+|+||.||+|..  .+..||||++.... .....+.+|+.+++.++||||++++++|.            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            4688889999999999999998  47889999986421 22456889999999999999999999762            


Q ss_pred             ---CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEee
Q 010882          204 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD  280 (498)
Q Consensus       204 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  280 (498)
                         ...++||||+++|+|.+++...  ...+++..++.++.+++.||.|||+   +||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence               3478999999999999999642  3457888999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccccccCCC------CccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH
Q 010882          281 FGISRFLSQNEISSN------NTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQY  353 (498)
Q Consensus       281 FGla~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~  353 (498)
                      ||++...........      ...........||+.|+|||++.+. .++.++|||||||++|+|+|   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            999987643211000      0000112344699999999999865 68999999999999999999   5543222111


Q ss_pred             HHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          354 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ....  +..........++...+..+.+++.+||+.||.+||++.++
T Consensus       237 ~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  281 (303)
T 1zy4_A          237 ILKK--LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL  281 (303)
T ss_dssp             HHHH--HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHh--ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHH
Confidence            1111  01111111223445566789999999999999999999883

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-40  Score=333.67  Aligned_cols=255  Identities=23%  Similarity=0.306  Sum_probs=193.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec-------Ccc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-------EVW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~-------~~~  206 (498)
                      .++|.+.+.||+|+||.||+|.+.  +..||||++...... ....+.+|+.+++.++||||+++++++.       ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            357888999999999999999985  789999999643221 2346789999999999999999999873       347


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ++||||+. |+|.+++..    ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            89999996 689998853    358999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccCCCCc--cceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Cc
Q 010882          287 LSQNEISSNNT--TLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK  359 (498)
Q Consensus       287 ~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~  359 (498)
                      ...........  .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+........    +.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            65432211110  0011234568999999998765 67899999999999999999999999876543222111    00


Q ss_pred             cc--c------------ccC--CCCC-----CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          360 LK--N------------LLD--PLAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       360 ~~--~------------~~~--~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..  .            .+.  +...     ..+...+..+.+|+.+||..||.+||++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  302 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE  302 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence            00  0            000  0000     001234578899999999999999999988

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-40  Score=340.52  Aligned_cols=247  Identities=21%  Similarity=0.303  Sum_probs=193.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCC--------CCCeeeeeceec---
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR--------HPNLVTLVGACP---  203 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------hpniv~l~g~~~---  203 (498)
                      .++|.+.+.||+|+||.||+|...  +..||||++.... .....+.+|+.+++.++        ||||++++++|.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            357999999999999999999884  6889999997431 23456889999999985        788999999874   


Q ss_pred             ---CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCCcEEEcCCC-----
Q 010882          204 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANF-----  274 (498)
Q Consensus       204 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NiLl~~~~-----  274 (498)
                         ...++||||+ +|+|.+.+... ....+++..+..|+.|++.||.|||+   + ||+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence               2578999999 56666666432 23569999999999999999999999   7 999999999999999775     


Q ss_pred             --------------------------------------------ceeEeeccccccccccccCCCCccceeccCCCCCCC
Q 010882          275 --------------------------------------------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA  310 (498)
Q Consensus       275 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~  310 (498)
                                                                  .+||+|||++.......           ....||+.
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----------~~~~gt~~  258 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----------TEDIQTRQ  258 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----------CSCCSCGG
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----------ccCCCCCc
Confidence                                                        79999999998764321           23358999


Q ss_pred             cCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH------HHH---HHHH-hCc----------cc-cccCC---
Q 010882          311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK------EVQ---YALD-TGK----------LK-NLLDP---  366 (498)
Q Consensus       311 y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~------~~~---~~~~-~~~----------~~-~~~~~---  366 (498)
                      |+|||++.+..++.++|||||||+||+|+||++||...+      ...   .... .+.          .. .....   
T Consensus       259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  338 (397)
T 1wak_A          259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD  338 (397)
T ss_dssp             GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred             ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence            999999999999999999999999999999999996422      111   1000 000          00 00000   


Q ss_pred             -----------------CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          367 -----------------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       367 -----------------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                       ....++...+..+.+|+.+||+.||.+||++.++
T Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  389 (397)
T 1wak_A          339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC  389 (397)
T ss_dssp             BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH
T ss_pred             cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHH
Confidence                             0113466778899999999999999999999883

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-40  Score=331.46  Aligned_cols=245  Identities=23%  Similarity=0.302  Sum_probs=193.4

Q ss_pred             cCCCCCCcccccCceEEEEEEE---CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC------eeeeeceec--Ccc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL---RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN------LVTLVGACP--EVW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn------iv~l~g~~~--~~~  206 (498)
                      .+|.+.+.||+|+||.||+|.+   .+..||||++.... ...+.+.+|+.+++.++|+|      |+++++++.  +..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            4788899999999999999987   36889999986432 22456889999999987654      999999884  468


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC--------------
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--------------  272 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~--------------  272 (498)
                      ++||||+ +++|.+++.... ..++++..+..++.|++.||.|||+   +||+||||||+|||++.              
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            9999999 899999986432 3468999999999999999999999   89999999999999987              


Q ss_pred             -----CCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          273 -----NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       273 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                           ++.+||+|||++.......           ....||+.|+|||++.+..++.++|||||||++|||+||.+||..
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEHH-----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSCC-----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccCCCceEeeCcccccCcccc-----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                 6789999999998644321           233589999999999999999999999999999999999999976


Q ss_pred             cHHHHHHHHh----Cccc----------cccCCC-----------------------CCCCCHHHHHHHHHHHHHhhhcc
Q 010882          348 TKEVQYALDT----GKLK----------NLLDPL-----------------------AGDWPFVQAEQLANLAMRCCEMS  390 (498)
Q Consensus       348 ~~~~~~~~~~----~~~~----------~~~~~~-----------------------~~~~~~~~~~~l~~li~~cl~~~  390 (498)
                      .+........    +.+.          ......                       ....+...+..+.+|+.+||..|
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            5432211110    0000          000000                       01123345778999999999999


Q ss_pred             cCCCCChhH
Q 010882          391 RKSRPELGK  399 (498)
Q Consensus       391 p~~RP~~~~  399 (498)
                      |.+||++.+
T Consensus       317 P~~Rpt~~e  325 (339)
T 1z57_A          317 PAKRITLRE  325 (339)
T ss_dssp             TTTSCCHHH
T ss_pred             cccccCHHH
Confidence            999999988

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.8e-41  Score=339.10  Aligned_cols=247  Identities=18%  Similarity=0.301  Sum_probs=193.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-----------CCCeeeeeceec
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----------HPNLVTLVGACP  203 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------hpniv~l~g~~~  203 (498)
                      ..+|.+.+.||+|+||.||+|.+  .+..||||++.... .....+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35788999999999999999997  47899999987432 23456889999999886           899999999884


Q ss_pred             C------cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCCcEEEc-----
Q 010882          204 E------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLD-----  271 (498)
Q Consensus       204 ~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NiLl~-----  271 (498)
                      .      ..++||||+ +++|.+++.... ...+++..+..|+.|++.||.|||+   + ||+||||||+||||+     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence            2      578999999 899999986432 3458999999999999999999999   7 999999999999994     


Q ss_pred             -CCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHH
Q 010882          272 -ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE  350 (498)
Q Consensus       272 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~  350 (498)
                       ..+.+||+|||++.......           ....||+.|+|||++.+..++.++|||||||++|||+||++||.....
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  240 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  240 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             cCcceEEEcccccccccCCCC-----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence             44589999999998664321           223589999999999999999999999999999999999999975431


Q ss_pred             H---------HHHHH-hCccc---------------------cccC----------CCCCCCCHHHHHHHHHHHHHhhhc
Q 010882          351 V---------QYALD-TGKLK---------------------NLLD----------PLAGDWPFVQAEQLANLAMRCCEM  389 (498)
Q Consensus       351 ~---------~~~~~-~~~~~---------------------~~~~----------~~~~~~~~~~~~~l~~li~~cl~~  389 (498)
                      .         ..... .+...                     ....          .....++...+..+.+|+.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  320 (373)
T 1q8y_A          241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  320 (373)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence            1         01000 00000                     0000          001134567788999999999999


Q ss_pred             ccCCCCChhHH
Q 010882          390 SRKSRPELGKD  400 (498)
Q Consensus       390 ~p~~RP~~~~~  400 (498)
                      ||.+||++.++
T Consensus       321 dP~~Rpt~~el  331 (373)
T 1q8y_A          321 DPRKRADAGGL  331 (373)
T ss_dssp             STTTCBCHHHH
T ss_pred             CccccCCHHHH
Confidence            99999999883

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.4e-41  Score=331.86  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=193.4

Q ss_pred             CCCChHHHHHhhcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCC--CCCeeeeec
Q 010882          126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR--HPNLVTLVG  200 (498)
Q Consensus       126 ~~~~~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~--hpniv~l~g  200 (498)
                      .++.+..+.....+|.+.+.||+|+||.||++... +..||||++......  ....+.+|+.++++++  ||||+++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            44555556666778999999999999999999885 678999999754332  2356889999999997  599999999


Q ss_pred             eec--CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeE
Q 010882          201 ACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL  278 (498)
Q Consensus       201 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  278 (498)
                      ++.  +..++||| +.+|+|.+++..   ...+++..+..++.+++.||.|||+   ++|+||||||+|||++. +.+||
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEE
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEE
Confidence            884  45789999 568899999953   3468999999999999999999999   89999999999999975 89999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-----------CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRPALGI  347 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~pf~~  347 (498)
                      +|||++..........      ......||+.|+|||++.+           ..++.++|||||||++|+|+||+.||..
T Consensus       168 ~Dfg~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          168 IDFGIANQMQPDTTSV------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             CCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             eeccccccccCccccc------cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            9999998765432111      1123458999999999875           4688899999999999999999999975


Q ss_pred             cHHHHHHHHhCccccccCCC-CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          348 TKEVQYALDTGKLKNLLDPL-AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .........     ..+++. ...++...+..+.+++.+||+.+|.+||++.++
T Consensus       242 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  290 (313)
T 3cek_A          242 IINQISKLH-----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  290 (313)
T ss_dssp             CCSHHHHHH-----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHH-----HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHH
Confidence            321111111     111111 112334446789999999999999999999883

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.9e-40  Score=329.18  Aligned_cols=249  Identities=25%  Similarity=0.316  Sum_probs=172.8

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHH-HHHcCCCCCeeeeeceec--CcceEEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEID-ILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~-il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ..+|...+.||+|+||.||+|...  +..||||++...... ....+..|+. +++.++||||+++++++.  +..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            357888999999999999999995  789999999754321 2234556666 677789999999999884  4678999


Q ss_pred             eeCCCCCHHhhhcc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          211 EYLPNGSLEDRLSC--KDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       211 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      ||+++ +|.+++..  ......+++..+..++.+++.||.|||+   . ||+||||||+|||++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88877742  1224578999999999999999999999   7 9999999999999999999999999999866


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhh----ccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFL----ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      .....         .....||+.|+|||++    .+..++.++|||||||++|+|+||+.||............. ....
T Consensus       177 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~  246 (327)
T 3aln_A          177 VDSIA---------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGD  246 (327)
T ss_dssp             --------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-CCSC
T ss_pred             ccccc---------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-hcCC
Confidence            43321         1223589999999999    45678999999999999999999999997654322211110 0000


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ........+...+..+.+++.+||..+|.+||++.+
T Consensus       247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  282 (327)
T 3aln_A          247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE  282 (327)
T ss_dssp             CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence            000111112235678999999999999999999988

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=329.97  Aligned_cols=237  Identities=27%  Similarity=0.430  Sum_probs=191.9

Q ss_pred             HhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC------ChhhHHHHHHHHHcC----CCCCeeeeecee
Q 010882          135 GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ------GPSEFQQEIDILSKI----RHPNLVTLVGAC  202 (498)
Q Consensus       135 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l----~hpniv~l~g~~  202 (498)
                      ...++|.+.+.||+|+||.||+|.+  .+..||||++......      ....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3456899999999999999999988  4678999999765432      233466899999998    899999999998


Q ss_pred             c--CcceEEEee-CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc-CCCceeE
Q 010882          203 P--EVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKL  278 (498)
Q Consensus       203 ~--~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl  278 (498)
                      .  +..++|||| +.+++|.+++..   ...+++..+..++.+++.||.|||+   +||+||||||+|||++ .++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence            4  468899999 789999999954   3468999999999999999999999   8999999999999999 8899999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCC-CccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDT  357 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (498)
                      +|||++........          ....||+.|+|||++.+..+. .++|||||||++|+|+||+.||........    
T Consensus       182 ~dfg~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----  247 (312)
T 2iwi_A          182 IDFGSGALLHDEPY----------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE----  247 (312)
T ss_dssp             CCCSSCEECCSSCB----------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----
T ss_pred             EEcchhhhcccCcc----------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh----
Confidence            99999987654321          233589999999999877764 589999999999999999999987654321    


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          358 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ..         ..++...+..+.+++.+||+.+|.+||++.++
T Consensus       248 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  281 (312)
T 2iwi_A          248 AE---------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI  281 (312)
T ss_dssp             TC---------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hc---------cCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            11         11334456789999999999999999999883

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.9e-40  Score=320.87  Aligned_cols=243  Identities=29%  Similarity=0.439  Sum_probs=195.6

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCC--CCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      .++|.+.+.||+|+||.||+|...  +..||||++....  ......+.+|+.++++++||||+++++++.  ...++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            357888999999999999999984  7889999986543  234567899999999999999999999984  3578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC---CceeEeeccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFL  287 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla~~~  287 (498)
                      ||+++++|.+.+...   ..+++..+..++.+++.||.|||+   +|++||||||+|||++.+   +.+||+|||++...
T Consensus       101 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            999999999988533   358999999999999999999999   899999999999999754   47999999999866


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~  365 (498)
                      ......         ....||+.|+|||.+.+ .++.++||||||+++|+|+||.+||...+....  .+..+...... 
T Consensus       175 ~~~~~~---------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  243 (287)
T 2wei_A          175 QQNTKM---------KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-  243 (287)
T ss_dssp             CCCSSC---------SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-
T ss_pred             cCCCcc---------ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-
Confidence            443211         12237999999999865 489999999999999999999999976544322  22232221110 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      +    .....+..+.+++.+||..+|.+||++.++
T Consensus       244 ~----~~~~~~~~~~~li~~~l~~dp~~Rps~~el  274 (287)
T 2wei_A          244 P----QWRTISDDAKDLIRKMLTFHPSLRITATQC  274 (287)
T ss_dssp             G----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             h----hhhhcCHHHHHHHHHHcccChhhCcCHHHH
Confidence            0    012345789999999999999999999883

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.6e-41  Score=331.96  Aligned_cols=237  Identities=23%  Similarity=0.375  Sum_probs=195.4

Q ss_pred             HHhhcCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCC------ChhhHHHHHHHHHcCC--CCCeeeeeceec
Q 010882          134 EGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIR--HPNLVTLVGACP  203 (498)
Q Consensus       134 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--hpniv~l~g~~~  203 (498)
                      .....+|.+.+.||+|+||.||+|..  .+..||||++......      ....+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            33456799999999999999999988  4789999999765332      2346778999999996  599999999984


Q ss_pred             --CcceEEEeeCCC-CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc-CCCceeEe
Q 010882          204 --EVWTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLS  279 (498)
Q Consensus       204 --~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~  279 (498)
                        +..++||||+.+ ++|.+++..   ...+++..+..++.|++.||.|||+   .+|+||||||+|||++ .++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence              468899999976 899999853   3468999999999999999999999   8999999999999999 78999999


Q ss_pred             eccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC
Q 010882          280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG  358 (498)
Q Consensus       280 DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (498)
                      |||++........          ....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||........    +
T Consensus       193 Dfg~~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~  258 (320)
T 3a99_A          193 DFGSGALLKDTVY----------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR----G  258 (320)
T ss_dssp             CCTTCEECCSSCB----------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----C
T ss_pred             eCccccccccccc----------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc----c
Confidence            9999987653321          23458999999999987765 6789999999999999999999987653221    1


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..         .++...+..+.+++.+||+.+|.+||++.+
T Consensus       259 ~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  290 (320)
T 3a99_A          259 QV---------FFRQRVSSECQHLIRWCLALRPSDRPTFEE  290 (320)
T ss_dssp             CC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cc---------cccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            11         122334578999999999999999999988

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8e-40  Score=333.44  Aligned_cols=204  Identities=30%  Similarity=0.390  Sum_probs=168.3

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CC-----Ceeeeecee--
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HP-----NLVTLVGAC--  202 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hp-----niv~l~g~~--  202 (498)
                      ......+|.+.+.||+|+||.||+|...  +..||||++.... .....+..|+.++..++ |+     +|+++++++  
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3344678999999999999999999985  6889999997432 12356778999998885 55     489999887  


Q ss_pred             cCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc--CCCceeEee
Q 010882          203 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSD  280 (498)
Q Consensus       203 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~D  280 (498)
                      .+..++||||+. |+|.+++.... ...+++..+..++.|++.||.|||.. ..||+||||||+||||+  .++.+||+|
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            456899999995 59999986432 24589999999999999999999952 26899999999999995  478899999


Q ss_pred             ccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH
Q 010882          281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV  351 (498)
Q Consensus       281 FGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~  351 (498)
                      ||++.......           ....||+.|+|||++.+..++.++|||||||++|||+||++||...+..
T Consensus       205 FG~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          205 FGSSCQLGQRI-----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             CTTCEETTCCC-----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccCceeccccc-----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99998764321           2345899999999999999999999999999999999999999865543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.7e-40  Score=329.35  Aligned_cols=246  Identities=22%  Similarity=0.323  Sum_probs=168.1

Q ss_pred             hcCCCCCC-cccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC------cce
Q 010882          137 THNFDPSL-KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE------VWT  207 (498)
Q Consensus       137 ~~~~~~~~-~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~------~~~  207 (498)
                      .++|.+.+ .||+|+||.||+|.+.  +..||||++...    ..........++.+.||||+++++++..      ..+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            34788744 6999999999999996  789999998642    2223333344667799999999998832      378


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---CCceeEeecccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS  284 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla  284 (498)
                      +||||++||+|.+++.... ...+++..+..++.+++.||.|||+   +||+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999996432 3469999999999999999999999   89999999999999976   456999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhC-ccccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-KLKNL  363 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~~~  363 (498)
                      ........          ....||+.|+|||++.+..++.++|||||||++|+|+||++||............. .+...
T Consensus       179 ~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (336)
T 3fhr_A          179 KETTQNAL----------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG  248 (336)
T ss_dssp             EEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             eecccccc----------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc
Confidence            86543221          22358999999999988889999999999999999999999996543322110000 00000


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ............+..+.+|+.+||..+|.+||++.++
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  285 (336)
T 3fhr_A          249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF  285 (336)
T ss_dssp             --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            0000011112356789999999999999999999883

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.8e-40  Score=340.05  Aligned_cols=249  Identities=23%  Similarity=0.308  Sum_probs=181.3

Q ss_pred             CCCCCcccccCceEEEE-EEECCeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceecC--cceEEEeeCCC
Q 010882          140 FDPSLKIGEGGYGSIYK-GLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYEYLPN  215 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~lV~E~~~~  215 (498)
                      |...+.||+|+||+||. +...+..||||++...   ..+.+.+|+.+|.++ +||||+++++++.+  ..++||||+. 
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            34467899999999964 4557899999998642   235678999999886 89999999999853  5789999995 


Q ss_pred             CCHHhhhccCCCCCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC-------------CceeE
Q 010882          216 GSLEDRLSCKDNSPP----LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-------------FVSKL  278 (498)
Q Consensus       216 gsL~~~l~~~~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-------------~~~kl  278 (498)
                      |+|.+++........    .++..++.|+.|++.||.|||+   +||+||||||+||||+.+             +.+||
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            699999964322111    1233457899999999999999   899999999999999754             48999


Q ss_pred             eeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc-------CCCCCccchHhHHHHHHHHHh-CCCCCCCcHH
Q 010882          279 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITKE  350 (498)
Q Consensus       279 ~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~  350 (498)
                      +|||+++...........    ......||+.|+|||++.+       ..++.++|||||||++|||+| |.+||+....
T Consensus       170 ~DFG~a~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRT----NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             CCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             cccccceecCCCCcccee----eecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            999999976543321110    1123469999999999976       568999999999999999999 9999975433


Q ss_pred             HHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          351 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                      ....+..+....  .......+...+..+.+++.+||+.+|.+||++.+++
T Consensus       246 ~~~~i~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil  294 (434)
T 2rio_A          246 RESNIIRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL  294 (434)
T ss_dssp             HHHHHHHTCCCC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hHHHHhcCCCCc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence            322222222111  1111112445778899999999999999999998843

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=340.81  Aligned_cols=248  Identities=25%  Similarity=0.342  Sum_probs=185.4

Q ss_pred             hhcCCCCCCcccccCceE-EEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceecC--cceEEEe
Q 010882          136 ATHNFDPSLKIGEGGYGS-IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      ...+|...+.||+|+||+ ||++...++.||||++...   ....+.+|+.+|+.+ +||||+++++++.+  ..++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            344688888999999998 5666778899999998653   234577999999999 79999999999844  5789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-----CCceeEeecccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-----NFVSKLSDFGISRF  286 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-----~~~~kl~DFGla~~  286 (498)
                      |+. |+|.+++....  ..++...+..++.|++.||.|||+   ++|+||||||+||||+.     ...+||+|||+|+.
T Consensus        99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            996 69999996433  234445667899999999999999   89999999999999953     23578999999987


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCcccc
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      ........     .......||+.|+|||++.+   ..++.++|||||||++|||+| |.+||+...........+....
T Consensus       173 ~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  247 (432)
T 3p23_A          173 LAVGRHSF-----SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL  247 (432)
T ss_dssp             C-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC
T ss_pred             ccCCCcce-----eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc
Confidence            65432111     11234569999999999974   567889999999999999999 9999975543332222211110


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV  401 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v  401 (498)
                          .....+...+..+.+|+.+||+.||.+||++.+++
T Consensus       248 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          248 ----DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             ----TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             ----cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence                11112334567789999999999999999998843

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.3e-39  Score=325.53  Aligned_cols=246  Identities=24%  Similarity=0.323  Sum_probs=190.7

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--C-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC------eeeeeceec--Cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--H-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN------LVTLVGACP--EV  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn------iv~l~g~~~--~~  205 (498)
                      .++|.+.+.||+|+||.||+|...  + ..||||++.... .....+.+|+.+++.++|+|      ++.+++++.  ..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            357889999999999999999984  3 689999997432 23456888999999997665      888888773  46


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE---------------
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---------------  270 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl---------------  270 (498)
                      .++||||+ +|+|.+.+... ...++++..+..++.|++.||.|||+   +||+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence            89999999 66777776533 23469999999999999999999999   899999999999999               


Q ss_pred             ----cCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCC
Q 010882          271 ----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG  346 (498)
Q Consensus       271 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~  346 (498)
                          +.++.+||+|||++.......           ....||+.|+|||++.+..++.++|||||||++|||+||++||.
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccCCCcEEEeecCccccccccc-----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                668899999999998643321           23359999999999999999999999999999999999999997


Q ss_pred             CcHHHHHHHHh----Cccc----------cccCCC-----------------------CCCCCHHHHHHHHHHHHHhhhc
Q 010882          347 ITKEVQYALDT----GKLK----------NLLDPL-----------------------AGDWPFVQAEQLANLAMRCCEM  389 (498)
Q Consensus       347 ~~~~~~~~~~~----~~~~----------~~~~~~-----------------------~~~~~~~~~~~l~~li~~cl~~  389 (498)
                      ...........    +...          ......                       ........+..+.+|+.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            65433221110    0000          000000                       0011223456899999999999


Q ss_pred             ccCCCCChhH
Q 010882          390 SRKSRPELGK  399 (498)
Q Consensus       390 ~p~~RP~~~~  399 (498)
                      ||.+||++.+
T Consensus       321 dP~~Rpt~~e  330 (355)
T 2eu9_A          321 DPAQRITLAE  330 (355)
T ss_dssp             STTTSCCHHH
T ss_pred             ChhhCcCHHH
Confidence            9999999988

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.3e-39  Score=348.72  Aligned_cols=260  Identities=25%  Similarity=0.349  Sum_probs=199.1

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--------Ccc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--------~~~  206 (498)
                      ++|.+.+.||+|+||.||+|.+  .+..||||++..... .....+.+|+.++++++||||+++++++.        +..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            5799999999999999999987  368899999875422 22456889999999999999999999863        346


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc---eeEeeccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGI  283 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGl  283 (498)
                      ++||||++||+|.+++........+++..+..|+.+++.||.|||+   .||+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            8999999999999999765555579999999999999999999999   89999999999999997664   99999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH--------
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--------  355 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--------  355 (498)
                      +.........         ....||+.|+|||++.+..++.++|||||||++|+|+||..||..........        
T Consensus       171 a~~~~~~~~~---------~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          171 AKELDQGELC---------TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN  241 (676)
T ss_dssp             CCBTTSCCCC---------CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred             cccccccccc---------ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence            9876543211         23459999999999999999999999999999999999999996532211100        


Q ss_pred             HhCccccccC---------CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH----HHHHhHHHH
Q 010882          356 DTGKLKNLLD---------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD----VWRVLEPMR  409 (498)
Q Consensus       356 ~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~----v~~~L~~~~  409 (498)
                      ..........         +.....+...+..+.+++..||..||.+||++.+.    .+..++.+.
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            0000000000         11123445678899999999999999999999762    344455554

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=319.10  Aligned_cols=243  Identities=23%  Similarity=0.322  Sum_probs=173.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ..+|...+.||+|+||.||+|.+.  +..||||++.......  ...+..+..+++.++||||+++++++.  +..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457888899999999999999984  7899999997643221  123445556788889999999999984  4679999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      ||+ ++.+..++...  ...+++..+..++.+++.||.|||+   . ||+||||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 55666655322  3568999999999999999999998   5 899999999999999999999999999976543


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCCcH-H--HHHHHHhCccc
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITK-E--VQYALDTGKLK  361 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~-~--~~~~~~~~~~~  361 (498)
                      ...         .....||+.|+|||++.     ...++.++|||||||++|+|+||+.||.... .  .......+...
T Consensus       178 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (318)
T 2dyl_A          178 DKA---------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP  248 (318)
T ss_dssp             ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC
T ss_pred             Ccc---------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC
Confidence            321         12235899999999995     4568899999999999999999999997532 1  11111111111


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      .  .+.    ....+..+.+++.+||+.+|.+||++.++
T Consensus       249 ~--~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l  281 (318)
T 2dyl_A          249 L--LPG----HMGFSGDFQSFVKDCLTKDHRKRPKYNKL  281 (318)
T ss_dssp             C--CCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             C--CCc----cCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            0  011    11245789999999999999999999883

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.6e-39  Score=349.46  Aligned_cols=237  Identities=25%  Similarity=0.297  Sum_probs=191.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC---CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceecC--c-----
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--V-----  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~-----  205 (498)
                      .++|.+.+.||+|+||.||+|.+.   +..||||++..... .....+.+|+.++++++||||++++++|..  .     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            367999999999999999999984   68899999875332 223468899999999999999999999842  2     


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .|+||||++|++|.+++..     .+++..++.|+.|++.||.|||+   +|||||||||+||||+.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence            5999999999999987732     69999999999999999999999   899999999999999986 89999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccC
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD  365 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (498)
                      .....            ....||+.|+|||++.+.. +.++|||||||+||+|++|.+||....           .   +
T Consensus       230 ~~~~~------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~-----------~---~  282 (681)
T 2pzi_A          230 RINSF------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY-----------V---D  282 (681)
T ss_dssp             ETTCC------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE-----------C---S
T ss_pred             hcccC------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc-----------c---c
Confidence            65432            2235999999999997654 889999999999999999999986421           0   0


Q ss_pred             CCCCCC-CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          366 PLAGDW-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       366 ~~~~~~-~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ...... ....+..+.+++.+||+.+|.+||+..+++...|..+.
T Consensus       283 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          283 GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            001111 12244679999999999999999988887777776554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.9e-39  Score=312.78  Aligned_cols=227  Identities=17%  Similarity=0.119  Sum_probs=178.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..||||++.......   ...+.+|+.++++++||||+++++++.  +..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888999999999999999995  7899999998665433   257889999999999999999999984  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++|++|.+++..   .  ........|+.|++.||.|||+   +||+||||||+||||+.+|.+||+++|        
T Consensus       111 e~~~g~~L~~~l~~---~--~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT---S--PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT---C--CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhc---C--CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999942   1  3455788999999999999999   899999999999999999999998543        


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCC-
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG-  369 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  369 (498)
                                          |++       .++.++|||||||++|+|+||+.||...+......   .....+..... 
T Consensus       175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~~~~  224 (286)
T 3uqc_A          175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQPIE  224 (286)
T ss_dssp             --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSCBCC
T ss_pred             --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccCCCC
Confidence                                233       36789999999999999999999997543211000   00000000000 


Q ss_pred             --CCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          370 --DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       370 --~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                        ..+...+..+.+++.+||+.||.+| ++.+ +++.|+.+....
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~e-l~~~L~~~~~~~  267 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SAST-LLNLMQQATAVA  267 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHH-HHHHHHHHHC--
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHH-HHHHHHHHhccC
Confidence              1122355789999999999999999 9988 888888876543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3e-38  Score=316.05  Aligned_cols=237  Identities=18%  Similarity=0.153  Sum_probs=180.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCC--------ChhhHHHHHHHHHcCC---------CCCeeeee
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIR---------HPNLVTLV  199 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~---------hpniv~l~  199 (498)
                      ..+|.+.+.||+|+||+||+|.+++..||||++......        ..+.+.+|+.+|+.++         ||||+++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            356888999999999999999999999999999865321        2367899999999886         66666665


Q ss_pred             ce-----------------e---------------cCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHH
Q 010882          200 GA-----------------C---------------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL  247 (498)
Q Consensus       200 g~-----------------~---------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L  247 (498)
                      ++                 +               ....++||||+++|++.+.+..    ..+++..+..|+.|++.||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence            54                 2               3468999999999977776632    4589999999999999999


Q ss_pred             HHHH-hcCCCCcccCCCCCCcEEEcCCC--------------------ceeEeeccccccccccccCCCCccceeccCCC
Q 010882          248 IFLH-SCKPHSIVHGDLKPANILLDANF--------------------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPK  306 (498)
Q Consensus       248 ~~LH-~~~~~~ivHrDlkp~NiLl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~  306 (498)
                      .||| +   ++|+||||||+||||+.++                    .+||+|||+|+......             ..
T Consensus       175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~-------------~~  238 (336)
T 2vuw_A          175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI-------------VV  238 (336)
T ss_dssp             HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTE-------------EE
T ss_pred             HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCc-------------EE
Confidence            9999 8   7999999999999999887                    99999999998664321             14


Q ss_pred             CCCCcCChhhhccCCCCCccchHhHHHH-HHHHHhCCCCCCCcHHHHHHHHhCc-cccccCCCCCCCCHHHHHHHHHHHH
Q 010882          307 GTFAYMDPEFLASGELTPKSDVYSFGII-LLRLLTGRPALGITKEVQYALDTGK-LKNLLDPLAGDWPFVQAEQLANLAM  384 (498)
Q Consensus       307 gt~~y~aPE~~~~~~~~~~~DvwSlGvi-l~elltG~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~  384 (498)
                      ||+.|+|||++.+.. +.++||||||++ .+++++|..||....+.......-. ............+...+..+.+|+.
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence            899999999998766 889999998777 7889999999965332222111100 0000000111123457889999999


Q ss_pred             HhhhcccCCCCChhH
Q 010882          385 RCCEMSRKSRPELGK  399 (498)
Q Consensus       385 ~cl~~~p~~RP~~~~  399 (498)
                      +||+.+     ++.+
T Consensus       318 ~~L~~d-----sa~e  327 (336)
T 2vuw_A          318 TMLNFS-----SATD  327 (336)
T ss_dssp             HGGGSS-----SHHH
T ss_pred             HHhccC-----CHHH
Confidence            999966     6655

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.4e-38  Score=322.15  Aligned_cols=237  Identities=13%  Similarity=0.108  Sum_probs=179.1

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC---ChhhHHHHHHHHHcCCC-CCeee------------
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRH-PNLVT------------  197 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h-pniv~------------  197 (498)
                      .+.+|...+.||+|+||+||+|.+.  +..||||++......   ..+.|.+|+.+++.+.| +|...            
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3445777789999999999999986  789999998844332   25679999999999987 32211            


Q ss_pred             ---e------eceec-------CcceEEEeeCCCCCHHhhhcc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 010882          198 ---L------VGACP-------EVWTLVYEYLPNGSLEDRLSC----KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS  257 (498)
Q Consensus       198 ---l------~g~~~-------~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  257 (498)
                         +      +.++.       ...+++|+++ +|+|.+++..    ......+++..++.|+.|++.||.|||+   ++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence               1      11111       1245666655 7899998841    1234468888999999999999999999   89


Q ss_pred             cccCCCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhh----------ccCCCCCccc
Q 010882          258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL----------ASGELTPKSD  327 (498)
Q Consensus       258 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D  327 (498)
                      ||||||||+||||+.++.+||+|||+++.....           .....| +.|+|||++          .+..++.++|
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D  299 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD  299 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence            999999999999999999999999998865433           123457 999999999          4456888999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          328 VYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       328 vwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ||||||++|||+||+.||.......      .....+. ...    ..+..+.+|+.+||+.+|.+||++.+
T Consensus       300 vwSlGvil~elltg~~Pf~~~~~~~------~~~~~~~-~~~----~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          300 TWTLGLAIYWIWCADLPNTDDAALG------GSEWIFR-SCK----NIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHHHHSSCCCCTTGGGS------CSGGGGS-SCC----CCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCcchhh------hHHHHHh-hcc----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999999999997654211      1111111 111    23478999999999999999999866

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.4e-37  Score=301.82  Aligned_cols=221  Identities=21%  Similarity=0.355  Sum_probs=173.6

Q ss_pred             cCCCCC-CcccccCceEEEEEEE--CCeEEEEEEecCCCCCChhhHHHHHHHH-HcCCCCCeeeeeceec------Ccce
Q 010882          138 HNFDPS-LKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDIL-SKIRHPNLVTLVGACP------EVWT  207 (498)
Q Consensus       138 ~~~~~~-~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~g~~~------~~~~  207 (498)
                      .+|... +.||+|+||.||+|..  .+..||||++..     ...+.+|+.++ +.++||||+++++++.      ...+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456665 6799999999999998  468899999863     35688999998 5568999999999873      2478


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---CCceeEeecccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS  284 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla  284 (498)
                      +||||+++|+|.+++.... ...+++..+..++.+++.||.|||+   +||+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            9999999999999996532 3469999999999999999999999   89999999999999998   789999999988


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL  364 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (498)
                      ....                              +..++.++|||||||++|+|+||++||.........  . .....+
T Consensus       168 ~~~~------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~-~~~~~~  214 (299)
T 3m2w_A          168 KETT------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P-GMKTRI  214 (299)
T ss_dssp             EECT------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------C-CSCCSS
T ss_pred             cccc------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--H-HHHHHH
Confidence            6432                              234667899999999999999999999765433211  0 111111


Q ss_pred             CCCCCCCC----HHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          365 DPLAGDWP----FVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       365 ~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                      ......++    ...+..+.+++.+||+.+|.+||++.++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~  254 (299)
T 3m2w_A          215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF  254 (299)
T ss_dssp             CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHH
Confidence            11111223    2346789999999999999999999883

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=6.5e-32  Score=287.94  Aligned_cols=181  Identities=20%  Similarity=0.158  Sum_probs=123.6

Q ss_pred             ccccCceEEEEEE--ECCeEEEEEEecCCCCCC----------hhhHHHHHHHHHcC-CCCCeeeeeceecC--cceEEE
Q 010882          146 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQG----------PSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       146 lG~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~----------~~~~~~E~~il~~l-~hpniv~l~g~~~~--~~~lV~  210 (498)
                      ++.|++|.+..+.  +.+..||+|++.......          ...|.+|+++|+++ .|+||+++++++.+  ..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            3455555554432  246779999997653221          24589999999999 79999999999954  589999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.++|..   ..+++..   .|+.||+.||.|||+   +|||||||||+||||+.+|++||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999953   3456654   588999999999999   99999999999999999999999999999876544


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA  344 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p  344 (498)
                      ....        ...+||+.|+|||++.+ .+..++|+||+|++++++.+|..+
T Consensus       393 ~~~~--------~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWP--------TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCS--------HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Cccc--------cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            3211        22359999999999865 467789999999998888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6.8e-29  Score=263.16  Aligned_cols=188  Identities=16%  Similarity=0.218  Sum_probs=146.5

Q ss_pred             CCCCcccccCceEEEEEEECCeEEEEEEecCCCCCC--------hhhHHHHHHHHHcCCCCCee--eeeceecCcceEEE
Q 010882          141 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPNLV--TLVGACPEVWTLVY  210 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~il~~l~hpniv--~l~g~~~~~~~lV~  210 (498)
                      ...+.||+|+||.||+|...+..+++|.........        .+.+.+|+.+|++++||||+  .+++...+..++||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            446689999999999998889999999876543322        13478999999999999999  66777677889999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||++||+|.+++..           +..|+.|++.||.|||+   ++|+||||||+|||++.  .+||+|||+|+.....
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999999943           56899999999999999   89999999999999998  9999999999977543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPAL  345 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf  345 (498)
                      ....... ........||+.|+|||++..  ..|+..+|+||.++-.++.+.++.+|
T Consensus       483 ~~~~~~~-~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDL-IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHH-HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccch-hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2111000 000112348999999999987  57888899999999999998888776

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2.3e-25  Score=216.86  Aligned_cols=157  Identities=16%  Similarity=0.132  Sum_probs=123.3

Q ss_pred             hhcCCCCCCcccccCceEEEEEEE-CCeEEEEEEecCCCCC------------------ChhhHHHHHHHHHcCCCCCee
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQ------------------GPSEFQQEIDILSKIRHPNLV  196 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~------------------~~~~~~~E~~il~~l~hpniv  196 (498)
                      ....|.+.+.||+|+||.||+|.+ .+..||||++......                  ....+.+|+.+|++++  | +
T Consensus        88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~  164 (282)
T 1zar_A           88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L  164 (282)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred             CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence            344566778999999999999999 4789999999753221                  1345889999999999  4 5


Q ss_pred             eeecee-cCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCc
Q 010882          197 TLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV  275 (498)
Q Consensus       197 ~l~g~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  275 (498)
                      ++++++ .+..++||||++||+|.+ +..         .....++.+++.||.|||+   +||+||||||+|||++ ++.
T Consensus       165 ~v~~~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~  230 (282)
T 1zar_A          165 AVPKVYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEG  230 (282)
T ss_dssp             SSCCEEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTE
T ss_pred             CcCeEEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCc
Confidence            555554 346799999999999998 521         1345799999999999999   8999999999999999 999


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhcc----------CCCCCccchHh
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS----------GELTPKSDVYS  330 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwS  330 (498)
                      +||+|||+|+                     ++..|.|||++..          ..|+..+|+|.
T Consensus       231 vkl~DFG~a~---------------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          231 IWIIDFPQSV---------------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EEECCCTTCE---------------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EEEEECCCCe---------------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9999999986                     3456789998853          34555666665

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=1.6e-21  Score=187.22  Aligned_cols=135  Identities=16%  Similarity=0.070  Sum_probs=104.9

Q ss_pred             CCCCCcccccCceEEEEEEE--CCeE--EEEEEecCCCCCC------------------------hhhHHHHHHHHHcCC
Q 010882          140 FDPSLKIGEGGYGSIYKGLL--RHMQ--VAIKMLHPHSLQG------------------------PSEFQQEIDILSKIR  191 (498)
Q Consensus       140 ~~~~~~lG~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~il~~l~  191 (498)
                      |.+...||+|+||.||+|.+  .+..  ||||+++......                        ...+.+|+.+|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45667899999999999998  6888  9999976532110                        025789999999998


Q ss_pred             CCCe--eeeeceecCcceEEEeeCCC-C----CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcccCCC
Q 010882          192 HPNL--VTLVGACPEVWTLVYEYLPN-G----SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH-SCKPHSIVHGDL  263 (498)
Q Consensus       192 hpni--v~l~g~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivHrDl  263 (498)
                      |+|+  +.+++  ....+|||||+.+ |    +|.++...      .++.....++.+++.||.||| .   .||+||||
T Consensus       129 ~~~i~~p~~~~--~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYT--YMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEE--EETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred             hCCCCCCeEEE--cCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence            8764  33443  2467899999942 3    67776521      223467789999999999999 8   89999999


Q ss_pred             CCCcEEEcCCCceeEeeccccccc
Q 010882          264 KPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       264 kp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      ||.|||++.  .++|+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999998754

>1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2

Probab=99.70  E-value=2.9e-17  Score=132.08  Aligned_cols=72  Identities=29%  Similarity=0.498  Sum_probs=68.3

Q ss_pred             CCCCCCcCCCccccccCCceeccCC-ceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADG-FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g-~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      ..+|++|.|||+.++|.|||++++| |+||+.+|..|+.. +.+||+|+.++...+|+||++||++|+.|+.++
T Consensus        17 ~~~p~~~~CpI~~~~m~dPV~~~cG~htf~r~cI~~~l~~-~~~cP~~~~~l~~~~L~pn~~Lk~~I~~~~~~~   89 (98)
T 1wgm_A           17 ADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAER   89 (98)
T ss_dssp             CSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHHS
T ss_pred             hcCcHhcCCcCccccccCCeECCCCCeEECHHHHHHHHHh-CCCCCCCCCCCChhhceEcHHHHHHHHHHHHHc
Confidence            4689999999999999999999999 99999999999987 789999999999999999999999999999764

>2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus}

Probab=99.69  E-value=2e-17  Score=129.64  Aligned_cols=71  Identities=24%  Similarity=0.439  Sum_probs=67.7

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHh
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ  497 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~  497 (498)
                      ..+|++|.|||+.++|.|||++++|++|++.+|..|+.. +.+||+|+.++...+|+||.+||++|+.|+.+
T Consensus         9 ~~~p~~~~CpI~~~~m~dPV~~~cGhtf~r~~I~~~l~~-~~~cP~~~~~l~~~~l~pn~~L~~~i~~~~~~   79 (85)
T 2kr4_A            9 SDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLN-SPTDPFNRQMLTESMLEPVPELKEQIQAWMRE   79 (85)
T ss_dssp             TTCCTTTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHH-CSBCTTTCCBCCGGGCEECHHHHHHHHHHHHH
T ss_pred             hcCchheECcccCchhcCCeECCCCCEECHHHHHHHHhc-CCCCCCCcCCCChHhcchHHHHHHHHHHHHHH
Confidence            468999999999999999999999999999999999986 78999999999999999999999999999875

>2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B

Probab=99.69  E-value=3.4e-17  Score=132.17  Aligned_cols=72  Identities=24%  Similarity=0.444  Sum_probs=68.4

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      ..+|++|.|||+.++|.|||++++|++||+.+|..|+.. +.+||+|+.+++..+|+||.+||++|+.|+.++
T Consensus        24 ~~~p~~~~CpI~~~~m~dPV~~~cGhtf~r~~I~~~l~~-~~~cP~~~~~l~~~~L~pn~~Lk~~I~~~~~~~   95 (100)
T 2kre_A           24 SDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLN-SPTDPFNRQTLTESMLEPVPELKEQIQAWMREK   95 (100)
T ss_dssp             SSCSTTTBCTTTCSBCSSEEEETTTEEEEHHHHHHHTTS-CSBCSSSCCBCCTTSSEECHHHHHHHHHHHHTT
T ss_pred             ccCcHhhCCcCccCcccCCeECCCCCEEchHHHHHHHHc-CCCCCCCCCCCChhhceECHHHHHHHHHHHHHh
Confidence            468999999999999999999999999999999999986 789999999999999999999999999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=1.5e-17  Score=166.62  Aligned_cols=136  Identities=15%  Similarity=0.202  Sum_probs=96.2

Q ss_pred             CCCCCCcccccCceEEEEEEE-CCeEEEEEEecCCCCC--------------ChhhH--------HHHHHHHHcCCCCCe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQ--------------GPSEF--------QQEIDILSKIRHPNL  195 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~--------------~~~~~--------~~E~~il~~l~hpni  195 (498)
                      -|.+...||.|+||.||+|.. .|..||||+++.....              .....        .+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            488899999999999999987 4789999998643110              00112        234555555543332


Q ss_pred             eeeeceecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-
Q 010882          196 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-  274 (498)
Q Consensus       196 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-  274 (498)
                      ....-+.....+|||||++|++|..+..       .  .....++.|++.+|.+||.   .|||||||||.||||+.+| 
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCC
Confidence            1111111224579999999999876542       1  1235688999999999999   8999999999999998876 


Q ss_pred             ---------ceeEeecccccc
Q 010882          275 ---------VSKLSDFGISRF  286 (498)
Q Consensus       275 ---------~~kl~DFGla~~  286 (498)
                               .+.|+||+-+..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                     389999997653

>2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C

Probab=99.65  E-value=8.1e-17  Score=142.69  Aligned_cols=73  Identities=30%  Similarity=0.593  Sum_probs=68.6

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      ..+|++|.|||+.++|.|||++++|++||+.+|..|+..++.+||+|+.+++..+|+||++||++|+.|+..+
T Consensus       101 ~~ip~~f~CPI~~elm~DPV~~~~Ghtfer~~I~~~l~~~~~tcP~t~~~l~~~~L~pN~~Lk~~Ie~~~~~~  173 (179)
T 2f42_A          101 REIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQDQLIPNLAMKEVIDAFIQEN  173 (179)
T ss_dssp             CCCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCEECHHHHHHHHHHHHHC
T ss_pred             cCCcHhhcccCccccCCCCeECCCCCEECHHHHHHHHHhCCCCCCCCcCCCChhhCcchHHHHHHHHHHHHHC
Confidence            4679999999999999999999999999999999999885568999999999999999999999999999764

>3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A

Probab=99.53  E-value=3.9e-15  Score=160.77  Aligned_cols=72  Identities=26%  Similarity=0.479  Sum_probs=68.5

Q ss_pred             CCCCCCcCCCccccccCCceeccCC-ceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADG-FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g-~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      ..+|++|.|||+.++|.|||++++| +||||++|.+|+.+ +++||+|+++|++.+++||++||++|++|+.++
T Consensus       886 ~~iP~~F~cPIs~~lM~DPVilpsG~~TydR~~I~~wl~~-~~tdP~Tr~~L~~~~liPN~~Lk~~I~~w~~~~  958 (968)
T 3m62_A          886 GDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIKAHLLS-DSTDPFNRMPLKLEDVTPNEELRQKILCFKKQK  958 (968)
T ss_dssp             CCSCGGGBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHTT-CCBCTTTCCBCCGGGCEECHHHHHHHHHHHHHH
T ss_pred             cCCcHHhCCcchhhHHhCCeEcCCCCEEECHHHHHHHHhc-CCCCCCCCCCCCcccccccHHHHHHHHHHHHHH
Confidence            5789999999999999999999997 79999999999998 789999999999999999999999999999763

>2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.52  E-value=7.3e-15  Score=117.46  Aligned_cols=72  Identities=29%  Similarity=0.472  Sum_probs=64.4

Q ss_pred             CCCCCcCCCccccccCCceecc-CCceecHHHHHHHHhcC-----CCCCCCCCCC---CCCCCCCccHHHHHHHHHHHHh
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSG-----HETSPMTNLP---LAHKNLVPNLALRSAIQEWLQQ  497 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~-~g~t~~~~~i~~w~~~~-----~~~~p~~~~~---~~~~~~~pn~~l~~~i~~~~~~  497 (498)
                      ..+++|.|||+.++|.|||+++ +||+|++.+|..|+..+     ..+||+|+.+   +...+|+||.+||++|+.|+..
T Consensus         3 ~~~~~~~CPI~~~~~~dPV~~~~cGh~f~r~cI~~~l~~~~~~~~~~~CP~tgc~~~~l~~~~L~pn~~L~~~I~~~~~~   82 (94)
T 2yu4_A            3 SGSSGFTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLIQDEALRRAIENHNKK   82 (94)
T ss_dssp             SCSSCCBCTTTCSBCSSEEEESSSCCEEEHHHHHHHHHHHHTTTCCBCCCSTTCCCCCBCGGGEEECHHHHHHHHHHHTT
T ss_pred             CCCcEeECcCcCchhcCCEEcCCCCCeecHHHHHHHHHHccCcCCCCCCCcCcCcccccCHhhCcCCHHHHHHHHHHHHH
Confidence            4578999999999999999996 99999999999999863     3599997666   8899999999999999999875


Q ss_pred             C
Q 010882          498 H  498 (498)
Q Consensus       498 ~  498 (498)
                      +
T Consensus        83 ~   83 (94)
T 2yu4_A           83 R   83 (94)
T ss_dssp             C
T ss_pred             h
Confidence            3

>1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2

Probab=99.49  E-value=3.2e-14  Score=109.79  Aligned_cols=72  Identities=43%  Similarity=0.845  Sum_probs=68.7

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      .+|++|.|||+.++|.||+++++||+|++.+|.+|+..++.+||+|+.++...+++||.+|+++|++|+.++
T Consensus         4 ~~~~~~~C~IC~~~~~~Pv~~~CgH~fc~~Ci~~~~~~~~~~CP~C~~~~~~~~l~~n~~l~~~i~~~~~~~   75 (78)
T 1t1h_A            4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN   75 (78)
T ss_dssp             CCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred             CCcccCCCCCccccccCCEEcCCCCeecHHHHHHHHHHCcCCCCCCcCCCChhhCccCHHHHHHHHHHHHHc
Confidence            578999999999999999999999999999999999988899999999999999999999999999999864

>2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2

Probab=99.48  E-value=2.8e-14  Score=138.36  Aligned_cols=73  Identities=27%  Similarity=0.583  Sum_probs=69.1

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      ..+|++|.|||+.++|.|||+++||||||+.||..|+..++.+||+|+.+++..+|+||++||++|+.|+.++
T Consensus       203 ~~~~~~~~c~i~~~~~~dPv~~~~gh~f~~~~i~~~~~~~~~~cP~~~~~~~~~~l~~n~~l~~~i~~~~~~~  275 (281)
T 2c2l_A          203 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISEN  275 (281)
T ss_dssp             CCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTTC
T ss_pred             CCCCcccCCcCcCCHhcCCeECCCCCEECHHHHHHHHHHCCCCCcCCCCCCchhcCcccHHHHHHHHHHHHHC
Confidence            4689999999999999999999999999999999999887778999999999999999999999999999764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=4.9e-13  Score=127.98  Aligned_cols=141  Identities=16%  Similarity=0.138  Sum_probs=110.0

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceec--CcceEEEeeC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ...|.....+|.|+++.||+....+..+++|+...........+.+|+.+++.+. +.+++++++++.  +..++||||+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            3467777778889999999988778899999987532233457999999999985 667888887764  3578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------------  254 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------  254 (498)
                      +|.+|.+.+.        +......++.+++.+|..||+..                                       
T Consensus        93 ~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           93 DGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             SSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             CCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            9999988641        11233478889999999999821                                       


Q ss_pred             -----------------CCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          255 -----------------PHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       255 -----------------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                                       +..++|||++|.|||++.++.+.|+||+.+.
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             1458999999999999876667899999764

>2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A

Probab=99.38  E-value=1.2e-13  Score=100.39  Aligned_cols=55  Identities=22%  Similarity=0.412  Sum_probs=51.3

Q ss_pred             CcCCCccccccCCceec-cCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHH
Q 010882          431 YFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA  486 (498)
Q Consensus       431 ~~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~  486 (498)
                      .|.|||+.++|.|||++ ++|++||+.+|.+|+.. +.+||+|+++|+..+|+||+.
T Consensus         3 ~~~CpIs~~~m~dPV~~~~sG~~yer~~I~~~l~~-~~~cP~t~~~L~~~~Lip~~~   58 (61)
T 2bay_A            3 HMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEIVP   58 (61)
T ss_dssp             -CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEECCC
T ss_pred             eEEecCCCCCCCCCEEeCCCCcEEcHHHHHHHHHh-CCCCcCCcCCCChhhcEECcc
Confidence            58999999999999999 89999999999999987 568999999999999999974

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=2.6e-11  Score=121.57  Aligned_cols=140  Identities=17%  Similarity=0.261  Sum_probs=107.0

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEec--CCC-CCChhhHHHHHHHHHcCC--CCCeeeeeceecCc-----ceEEEee
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLH--PHS-LQGPSEFQQEIDILSKIR--HPNLVTLVGACPEV-----WTLVYEY  212 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~il~~l~--hpniv~l~g~~~~~-----~~lV~E~  212 (498)
                      .+.|+.|.++.||+....+..+++|+..  ... ......+.+|+.+++.|.  +.+++++++.+.+.     .++||||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            4568999999999988878889999876  322 123457889999999997  45678888888543     7899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK--------------------------------------  254 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  254 (498)
                      ++|.++.+..     ...++...+..++.+++.+|..||...                                      
T Consensus       123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9998875422     134778888999999999999999841                                      


Q ss_pred             -----------------CCCcccCCCCCCcEEEcCCCc--eeEeeccccccc
Q 010882          255 -----------------PHSIVHGDLKPANILLDANFV--SKLSDFGISRFL  287 (498)
Q Consensus       255 -----------------~~~ivHrDlkp~NiLl~~~~~--~kl~DFGla~~~  287 (498)
                                       +..++|||++|.|||++.++.  +.|+||+.+...
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             257999999999999997753  689999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.17  E-value=5.1e-11  Score=113.27  Aligned_cols=125  Identities=18%  Similarity=0.151  Sum_probs=92.9

Q ss_pred             cccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC--eeeeeceecC--cceEEEeeCCCCCHHhh
Q 010882          147 GEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGACPE--VWTLVYEYLPNGSLEDR  221 (498)
Q Consensus       147 G~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~g~~~~--~~~lV~E~~~~gsL~~~  221 (498)
                      +.|..+.||++... +..+++|+....   ....+..|+.+++.+.+.+  ++++++++.+  ..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            45566999998764 567999997643   3356889999999986444  4557776643  578999999998884  


Q ss_pred             hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 010882          222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK-----------------------------------------------  254 (498)
Q Consensus       222 l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------------  254 (498)
                      ..  .    .+   ...++.+++..|..||+..                                               
T Consensus       104 ~~--~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 SS--H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             TS--C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             cC--c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence            31  1    11   2357778888888888743                                               


Q ss_pred             --------CCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          255 --------PHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       255 --------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                              +..++|||++|.|||++.++.+.|+|||.+.
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                    1239999999999999887777899999765

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=7.3e-11  Score=115.49  Aligned_cols=181  Identities=20%  Similarity=0.214  Sum_probs=122.0

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCC--eeeeeceecC-----cceEEEeeCC
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPN--LVTLVGACPE-----VWTLVYEYLP  214 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpn--iv~l~g~~~~-----~~~lV~E~~~  214 (498)
                      ...++.|.+..||+..   ..+++|+....  .....+.+|..+|+.+. +..  +.++++...+     ..|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            3458999999999753   56889986432  22457889999998873 322  3444444322     2478999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK----------------------------------------  254 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  254 (498)
                      |.+|.+...     ..++..++..++.+++..|..||...                                        
T Consensus       100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            988875432     24677788889999999999999621                                        


Q ss_pred             ---------------CCCcccCCCCCCcEEEcC--CCceeEeeccccccccccccCCCCccceeccCCCCCCCc---CCh
Q 010882          255 ---------------PHSIVHGDLKPANILLDA--NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY---MDP  314 (498)
Q Consensus       255 ---------------~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y---~aP  314 (498)
                                     +..++|+|++|.||+++.  ++.+.|+||+.+........-.            ....+   .+|
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------------~~~~~~~~~~~  242 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------------SLMEDDEEYGM  242 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------------TTCCTTTSCCH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------------HHHhhccccCH
Confidence                           135799999999999998  5668999999987543211000            01111   233


Q ss_pred             hhhcc-----CCC---------CCccchHhHHHHHHHHHhCCCCC
Q 010882          315 EFLAS-----GEL---------TPKSDVYSFGIILLRLLTGRPAL  345 (498)
Q Consensus       315 E~~~~-----~~~---------~~~~DvwSlGvil~elltG~~pf  345 (498)
                      +....     +..         ....+.|++|+++|.+.+|.++|
T Consensus       243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            32211     111         11358999999999999998776

>3ztg_A E3 ubiquitin-protein ligase RBBP6; PACT, U-BOX, mRNA processing, mRNA splicing; NMR {Homo sapiens}

Probab=99.02  E-value=6.6e-10  Score=88.25  Aligned_cols=72  Identities=24%  Similarity=0.332  Sum_probs=65.0

Q ss_pred             CCCCCCcCCCccccccCCceecc-CCceecHHHHHHHHhc-CCCCCCCCCCCC-CCCCCCccHHHHHHHHHHHHh
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDS-GHETSPMTNLPL-AHKNLVPNLALRSAIQEWLQQ  497 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~-~g~t~~~~~i~~w~~~-~~~~~p~~~~~~-~~~~~~pn~~l~~~i~~~~~~  497 (498)
                      ...+++|.|||+.+++.+|++++ +||+|++.+|..|+.. +..+||+++.++ ....+.||..|+++|+.|+..
T Consensus         8 ~~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~~CP~Cr~~~~~~~~~~~n~~l~~~i~~~~~~   82 (92)
T 3ztg_A            8 DPIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALIANKFLRQAVNNFKNE   82 (92)
T ss_dssp             CCCCTTTEETTTTEECSSCEECTTTCCEECHHHHHHHHHHCTTCCCTTTCCSSCCTTSCEECHHHHHHHHHHHHH
T ss_pred             ccCCcCCCCCCCChhhcCceECCCCCCHHHHHHHHHHHHhcCCCcCcCCCCcCCCccccCcCHHHHHHHHHHHHH
Confidence            45789999999999999999999 8999999999999864 447999999997 567899999999999999864

>3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae}

Probab=98.89  E-value=6.8e-10  Score=102.92  Aligned_cols=71  Identities=11%  Similarity=0.233  Sum_probs=64.2

Q ss_pred             CCCCCcCCCccccccCCceec-cCCceecHHHHHHHHhcC-CCCCCC--CCCCCCCCCCCccHHHHHHHHHHHHh
Q 010882          427 EPPPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSG-HETSPM--TNLPLAHKNLVPNLALRSAIQEWLQQ  497 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~~~~-~~~~p~--~~~~~~~~~~~pn~~l~~~i~~~~~~  497 (498)
                      .....|.|||+.+.|.|||+. .+||+||+.||..|+..+ ..+||+  |+.++...+|+||..|++.|+.|..+
T Consensus       177 ~~~~el~CPIcl~~f~DPVts~~CGHsFcR~cI~~~~~~~~~~~CPvtGCr~~l~~~dL~pN~~L~~lve~~k~r  251 (267)
T 3htk_C          177 GGKIELTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIMELRCKIAKMK  251 (267)
T ss_dssp             SSBCCSBCTTTSSBCSSEEEESSSCCEEEHHHHHHHSTTCSCEECSGGGCSCEECGGGEEECHHHHHHHHHHHHH
T ss_pred             CCceeeECcCccCcccCCeeeCCCCCcccHHHHHHHHHhCCCCCCCcccccCcCchhhCCcCHHHHHHHHHHHHH
Confidence            457899999999999999986 899999999999998763 458999  88999999999999999999999763

>3fl2_A E3 ubiquitin-protein ligase UHRF1; cell cycle, DNA damage, DNA repair, ring finger domain, metal binding, DNA replication; 1.75A {Homo sapiens}

Probab=98.83  E-value=3.1e-09  Score=89.32  Aligned_cols=68  Identities=15%  Similarity=0.201  Sum_probs=62.7

Q ss_pred             CCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCC-CCCCccHHHHHHHHHHHH
Q 010882          429 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH-KNLVPNLALRSAIQEWLQ  496 (498)
Q Consensus       429 P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~-~~~~pn~~l~~~i~~~~~  496 (498)
                      ++.+.|||+.+.+.+|+++++||+|++.+|..|+..+..+||+|+.++.. ..+.||..|+++|+.|..
T Consensus        50 ~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~n~~l~~~i~~~~p  118 (124)
T 3fl2_A           50 EETFQCICCQELVFRPITTVCQHNVCKDCLDRSFRAQVFSCPACRYDLGRSYAMQVNQPLQTVLNQLFP  118 (124)
T ss_dssp             HHHTBCTTTSSBCSSEEECTTSCEEEHHHHHHHHHTTCCBCTTTCCBCCTTCCCCCCHHHHHHHHHHST
T ss_pred             ccCCCCCcCChHHcCcEEeeCCCcccHHHHHHHHhHCcCCCCCCCccCCCCCCCCCCHHHHHHHHHHcc
Confidence            46688999999999999999999999999999998766799999999987 789999999999999864

>1z6u_A NP95-like ring finger protein isoform B; structural genomics consortium, ligase, ubiquitin-protein ligase, cell cycle regulation, SGC; 2.10A {Homo sapiens}

Probab=98.80  E-value=3.5e-09  Score=91.89  Aligned_cols=69  Identities=16%  Similarity=0.234  Sum_probs=63.7

Q ss_pred             CCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCC-CCCccHHHHHHHHHHHH
Q 010882          428 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHK-NLVPNLALRSAIQEWLQ  496 (498)
Q Consensus       428 ~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~-~~~pn~~l~~~i~~~~~  496 (498)
                      .++.+.|||+.+++.+|+++++||+|++.+|..|+..+..+||+|+.++... .+.||..|+++|..|..
T Consensus        75 l~~~~~C~IC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~l~~n~~l~~lv~~~~p  144 (150)
T 1z6u_A           75 LEQSFMCVCCQELVYQPVTTECFHNVCKDCLQRSFKAQVFSCPACRHDLGQNYIMIPNEILQTLLDLFFP  144 (150)
T ss_dssp             HHHHTBCTTTSSBCSSEEECTTSCEEEHHHHHHHHHTTCCBCTTTCCBCCTTCCCCBCHHHHHHHHHHST
T ss_pred             CccCCEeecCChhhcCCEEcCCCCchhHHHHHHHHHhCCCcCCCCCccCCCCCCCCCCHHHHHHHHHHhh
Confidence            4567899999999999999999999999999999998666999999999987 89999999999999864

>2y43_A E3 ubiquitin-protein ligase RAD18; DNA repair, metal-binding, translesion synthesis, UB conjugation pathway; 1.80A {Homo sapiens}

Probab=98.69  E-value=1.3e-08  Score=81.84  Aligned_cols=69  Identities=13%  Similarity=0.181  Sum_probs=63.4

Q ss_pred             CCCCcCCCccccccCCceec-cCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHh
Q 010882          428 PPPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ  497 (498)
Q Consensus       428 ~P~~~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~  497 (498)
                      .++.+.|||+.+.+.+|++. ++||+|+..+|..|+.. +.+||+++.++...++.||..|+++|+.|+..
T Consensus        19 ~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~~~l~~n~~l~~~i~~~~~~   88 (99)
T 2y43_A           19 IDDLLRCGICFEYFNIAMIIPQCSHNYCSLCIRKFLSY-KTQCPTCCVTVTEPDLKNNRILDELVKSLNFA   88 (99)
T ss_dssp             HHHHTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHTT-CCBCTTTCCBCCGGGCEECHHHHHHHHHHHHH
T ss_pred             CCCCCCcccCChhhCCcCEECCCCCHhhHHHHHHHHHC-CCCCCCCCCcCChhhCCcCHHHHHHHHHHHHH
Confidence            35678999999999999998 89999999999999987 67999999999988999999999999999763

>2ecw_A Tripartite motif-containing protein 30; metal binding protein, structural genomics, NPPSFA; NMR {Mus musculus}

Probab=98.57  E-value=2e-08  Score=78.16  Aligned_cols=66  Identities=24%  Similarity=0.410  Sum_probs=59.4

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhc-----CCCCCCCCCCCCCCCCCCccHHHHHHH
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS-----GHETSPMTNLPLAHKNLVPNLALRSAI  491 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~-----~~~~~p~~~~~~~~~~~~pn~~l~~~i  491 (498)
                      ....+.+.|||+.+.+.+|++.++||+|+..+|..|+..     +..+||+++.++....+.||+.|+++|
T Consensus        14 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~~~~CP~Cr~~~~~~~~~~n~~l~~~v   84 (85)
T 2ecw_A           14 EMIKEEVTCPICLELLKEPVSADCNHSFCRACITLNYESNRNTDGKGNCPVCRVPYPFGNLKPNLHVANIV   84 (85)
T ss_dssp             CCCCTTTSCTTTCSCCSSCEECTTSCCBCHHHHHHHHHHSBCTTSCBCCTTTCCCCCTTCCEECSCCCSSC
T ss_pred             HhCccCCCCcCCChhhCcceeCCCCCHHHHHHHHHHHHhccCCCCCCCCCCCCCcCCHHhCCcCHHHHHhh
Confidence            456789999999999999999999999999999999987     367999999999999999999887654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.55  E-value=1.7e-07  Score=93.50  Aligned_cols=77  Identities=5%  Similarity=0.027  Sum_probs=54.7

Q ss_pred             Ccc-cccCceEEEEEEEC--------CeEEEEEEecCCC---CCChhhHHHHHHHHHcCC-C--CCeeeeeceecC----
Q 010882          144 LKI-GEGGYGSIYKGLLR--------HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIR-H--PNLVTLVGACPE----  204 (498)
Q Consensus       144 ~~l-G~G~~g~Vy~~~~~--------~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h--pniv~l~g~~~~----  204 (498)
                      +.| +.|..+.+|+....        +..+++|+.....   ......+..|+.+|+.|. +  -.+.++++++.+    
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            356 78888999987765        6778999865432   112356889999998884 2  356777777643    


Q ss_pred             -cceEEEeeCCCCCHHh
Q 010882          205 -VWTLVYEYLPNGSLED  220 (498)
Q Consensus       205 -~~~lV~E~~~~gsL~~  220 (498)
                       ..++||||++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence             3579999999877654

>2ckl_A Polycomb group ring finger protein 4; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_B 2h0d_A

Probab=98.54  E-value=6.6e-08  Score=78.99  Aligned_cols=68  Identities=10%  Similarity=0.261  Sum_probs=62.0

Q ss_pred             CCCCcCCCccccccCCceec-cCCceecHHHHHHHHhcCCCCCCCCCCCCCCC----CCCccHHHHHHHHHHHH
Q 010882          428 PPPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHK----NLVPNLALRSAIQEWLQ  496 (498)
Q Consensus       428 ~P~~~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~----~~~pn~~l~~~i~~~~~  496 (498)
                      .++.+.|||+.+.+.+|++. ++||+|+..+|..|+.. +.+||+++..+...    .+.+|..|+++|..|..
T Consensus        12 ~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~l~~n~~l~~~i~~~~~   84 (108)
T 2ckl_A           12 LNPHLMCVLCGGYFIDATTIIECLHSFCKTCIVRYLET-SKYCPICDVQVHKTRPLLNIRSDKTLQDIVYKLVP   84 (108)
T ss_dssp             HGGGTBCTTTSSBCSSEEEETTTCCEEEHHHHHHHHTS-CSBCTTTCCBSCSSCGGGGEEECHHHHHHHHHHST
T ss_pred             cCCcCCCccCChHHhCcCEeCCCCChhhHHHHHHHHHh-CCcCcCCCccccccCcccccCcCHHHHHHHHHHhh
Confidence            46789999999999999998 99999999999999988 58999999999876    78999999999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.54  E-value=2.7e-07  Score=90.12  Aligned_cols=133  Identities=20%  Similarity=0.223  Sum_probs=93.0

Q ss_pred             CcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCC---Ceeeeeceec---CcceEEEeeCCCCC
Q 010882          144 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP---NLVTLVGACP---EVWTLVYEYLPNGS  217 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp---niv~l~g~~~---~~~~lV~E~~~~gs  217 (498)
                      ..++.|....||+.   +..+++|+...  ......+..|..+|..|.+.   .+.+.+.++.   ...++||+|++|.+
T Consensus        25 ~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45788888899987   67788898532  11235688999999999642   2455555542   34689999999988


Q ss_pred             HHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 010882          218 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK-------------------------------------------  254 (498)
Q Consensus       218 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------  254 (498)
                      |.+...     ..++...+..++.+++..|..||+..                                           
T Consensus       100 l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A          100 LGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             CHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             Cchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            876321     12455566666666666666666532                                           


Q ss_pred             --------------CCCcccCCCCCCcEEEcC---CCc-eeEeecccccc
Q 010882          255 --------------PHSIVHGDLKPANILLDA---NFV-SKLSDFGISRF  286 (498)
Q Consensus       255 --------------~~~ivHrDlkp~NiLl~~---~~~-~kl~DFGla~~  286 (498)
                                    +..++|+|+.|.|||++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          235699999999999987   344 58999997753

>2ecv_A Tripartite motif-containing protein 5; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.50  E-value=3.1e-08  Score=77.03  Aligned_cols=66  Identities=20%  Similarity=0.386  Sum_probs=59.4

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhc-----CCCCCCCCCCCCCCCCCCccHHHHHHH
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS-----GHETSPMTNLPLAHKNLVPNLALRSAI  491 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~-----~~~~~p~~~~~~~~~~~~pn~~l~~~i  491 (498)
                      ....+.+.|||+.+.+.+|++.++||+|+..+|..|+..     +..+||+++.++...++.||+.|++.|
T Consensus        14 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~~~~CP~Cr~~~~~~~~~~n~~l~~~v   84 (85)
T 2ecv_A           14 VNVKEEVTCPICLELLTQPLSLDCGHSFCQACLTANHKKSMLDKGESSCPVCRISYQPENIRPNRHVANIV   84 (85)
T ss_dssp             CCCCCCCCCTTTCSCCSSCBCCSSSCCBCTTHHHHHHHHHHHTTSCCCCTTTCCSSCSSSCCCSCCCCCCC
T ss_pred             HHccCCCCCCCCCcccCCceeCCCCCHHHHHHHHHHHHHhhcCCCCCcCCCCCCccCHHhcCccHHHHHhh
Confidence            457789999999999999999999999999999999876     467999999999999999999887654

>1jm7_B BARD1, BRCA1-associated ring domain protein 1; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1

Probab=98.49  E-value=6.4e-08  Score=80.32  Aligned_cols=65  Identities=15%  Similarity=0.242  Sum_probs=60.5

Q ss_pred             CCCcCCCccccccCCceec-cCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHH
Q 010882          429 PPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQ  496 (498)
Q Consensus       429 P~~~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~  496 (498)
                      .+.+.|||+.+++.+|++. ++||+|++.+|..|+.   .+||+++.++....+.||+.|+++|..|..
T Consensus        20 ~~~~~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~---~~CP~Cr~~~~~~~~~~n~~l~~l~~~~~~   85 (117)
T 1jm7_B           20 EKLLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIG---TGCPVCYTPAWIQDLKINRQLDSMIQLCSK   85 (117)
T ss_dssp             HHTTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTT---TBCSSSCCBCSCSSCCCCHHHHHHHHHHHH
T ss_pred             hhCCCCCCCChHhhCccEeCCCCCHHHHHHHHHHhc---CCCcCCCCcCccccccccHHHHHHHHHHHH
Confidence            4578899999999999999 8999999999999987   689999999998999999999999998865

>3hct_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.10A {Homo sapiens} PDB: 3hcu_A 2eci_A 2jmd_A

Probab=98.48  E-value=6.8e-08  Score=80.26  Aligned_cols=69  Identities=14%  Similarity=0.237  Sum_probs=63.8

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHH
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW  494 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~  494 (498)
                      ...++.|.|||+.+++.+|+++++||+|++.+|..|+..+..+||+++.++...++.||..+++.|..+
T Consensus        13 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~l~~~i~~l   81 (118)
T 3hct_A           13 PPLESKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAKREILSL   81 (118)
T ss_dssp             SCCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHHCSBCTTTCCBCCGGGCEECHHHHHHHHTS
T ss_pred             cCCCCCCCCCcCChhhcCeEECCcCChhhHHHHHHHHhhCCCCCCCCCCCcCHHhcccCHHHHHHHccc
Confidence            357889999999999999999999999999999999988666999999999999999999999999865

>2ckl_B Ubiquitin ligase protein RING2; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_C 2h0d_B

Probab=98.47  E-value=6.7e-08  Score=85.41  Aligned_cols=70  Identities=17%  Similarity=0.307  Sum_probs=62.5

Q ss_pred             CCCCCcCCCccccccCCceec-cCCceecHHHHHHHHhcCCCCCCCCCCCCC-CCCCCccHHHHHHHHHHHH
Q 010882          427 EPPPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLA-HKNLVPNLALRSAIQEWLQ  496 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~-~~~~~pn~~l~~~i~~~~~  496 (498)
                      ...+.+.|||+.+.+.+|++. ++||+|+..||..|+..++.+||+|+.++. ...+.||..|+++|..|..
T Consensus        50 ~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~l~~~~~l~~~i~~~~~  121 (165)
T 2ckl_B           50 SLHSELMCPICLDMLKNTMTTKECLHRFCADCIITALRSGNKECPTCRKKLVSKRSLRPDPNFDALISKIYP  121 (165)
T ss_dssp             CCHHHHBCTTTSSBCSSEEEETTTCCEEEHHHHHHHHHTTCCBCTTTCCBCCSGGGEEECHHHHHHHHHHC-
T ss_pred             hCCCCCCCcccChHhhCcCEeCCCCChhHHHHHHHHHHhCcCCCCCCCCcCCCcccCCcCHHHHHHHHHHHc
Confidence            345778999999999999998 899999999999999988889999999984 5679999999999998854

>2egp_A Tripartite motif-containing protein 34; ZF-C3HC4 domain, tripartite motif protein 34, interferon- responsive finger protein 1; NMR {Homo sapiens}

Probab=98.46  E-value=1.3e-08  Score=78.02  Aligned_cols=65  Identities=17%  Similarity=0.300  Sum_probs=58.8

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcC------CCCCCCCCCCCCCCCCCccHHHHHHH
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSG------HETSPMTNLPLAHKNLVPNLALRSAI  491 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~------~~~~p~~~~~~~~~~~~pn~~l~~~i  491 (498)
                      ...+.+.|||+.+.+.+|++.+.||+|+..+|..|+...      ..+||+++.++...++.||+.|+++|
T Consensus         8 ~~~~~~~C~IC~~~~~~p~~l~CgH~fC~~Ci~~~~~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~lv   78 (79)
T 2egp_A            8 NVQEEVTCPICLELLTEPLSLDCGHSLCRACITVSNKEAVTSMGGKSSCPVCGISYSFEHLQANQHLANIV   78 (79)
T ss_dssp             CCCCCCEETTTTEECSSCCCCSSSCCCCHHHHSCCCCCCSSSCCCCCCCSSSCCCCCSSGGGTCSSSCCCC
T ss_pred             hcccCCCCcCCCcccCCeeECCCCCHHHHHHHHHHHHhcccCCCCCCcCCCCCCcCCHhhCCcCHHHHHhh
Confidence            567889999999999999999999999999999999863      67999999999999999999887654

>3lrq_A E3 ubiquitin-protein ligase TRIM37; structural genomics, PSI-2, protein structure initiative, northeast structural genomics consortium, NESG; HET: MSE; 2.29A {Homo sapiens}

Probab=98.42  E-value=1.2e-07  Score=76.33  Aligned_cols=67  Identities=19%  Similarity=0.271  Sum_probs=61.0

Q ss_pred             CCCcCCCccccccCCcee-ccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHH
Q 010882          429 PPYFTCPIFQEVMQDPHV-AADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWL  495 (498)
Q Consensus       429 P~~~~cpi~~e~~~dp~~-~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~  495 (498)
                      .+.+.|||+.+.+.+|+. .++||+|+..+|..|+.....+||+++.++...++++|..+.+.++...
T Consensus        20 ~~~~~C~IC~~~~~~p~~~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~~~~~~~l~~~~~~~~i~~~~~   87 (100)
T 3lrq_A           20 AEVFRCFICMEKLRDARLCPHCSKLCCFSCIRRWLTEQRAQCPHCRAPLQLRELVNCRWAEEVTQQLD   87 (100)
T ss_dssp             HHHTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCEECTTHHHHHHHHH
T ss_pred             CCCCCCccCCccccCccccCCCCChhhHHHHHHHHHHCcCCCCCCCCcCCHHHhHhhHHHHHHHHHHH
Confidence            467889999999999999 9999999999999999985579999999999999999999988887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.40  E-value=9.6e-07  Score=89.39  Aligned_cols=74  Identities=18%  Similarity=0.132  Sum_probs=52.0

Q ss_pred             CCcccccCceEEEEEEE--CCeEEEEEEecCCCC-------CChhhHHHHHHHHHcCCC--C-CeeeeeceecCcceEEE
Q 010882          143 SLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-------QGPSEFQQEIDILSKIRH--P-NLVTLVGACPEVWTLVY  210 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~h--p-niv~l~g~~~~~~~lV~  210 (498)
                      .+.||.|.++.||++..  .+..|+||.......       .....+..|..+|+.+..  | .+++++.+..+..++||
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm  114 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM  114 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence            34689999999999954  457899998654221       234567889999988742  3 45566766666788999


Q ss_pred             eeCCCC
Q 010882          211 EYLPNG  216 (498)
Q Consensus       211 E~~~~g  216 (498)
                      ||++|.
T Consensus       115 E~l~g~  120 (397)
T 2olc_A          115 EDLSHL  120 (397)
T ss_dssp             CCCTTS
T ss_pred             EeCCCc
Confidence            999874

>2csy_A Zinc finger protein 183-like 1; ring finger protein 161, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.40  E-value=2.7e-07  Score=71.08  Aligned_cols=65  Identities=17%  Similarity=0.229  Sum_probs=57.6

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHH
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQE  493 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~  493 (498)
                      ...+.+.|||+.+.+.+|++.++||+|+..+|..|+.. ..+||+++.++. ..+.||..|...+..
T Consensus        11 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~-~~~~~~~~l~~~~~~   75 (81)
T 2csy_A           11 EEEIPFRCFICRQAFQNPVVTKCRHYFCESCALEHFRA-TPRCYICDQPTG-GIFNPAKELMAKLQK   75 (81)
T ss_dssp             CCCCCSBCSSSCSBCCSEEECTTSCEEEHHHHHHHHHH-CSBCSSSCCBCC-SCCEECHHHHHHHSS
T ss_pred             cCCCCCCCcCCCchhcCeeEccCCCHhHHHHHHHHHHC-CCcCCCcCcccc-ccCCcHHHHHHHHHh
Confidence            45678999999999999999999999999999999987 779999999997 678899887766654

>3l11_A E3 ubiquitin-protein ligase RNF168; E3 ligase, ring domain, DNA damage, chromatin regulator, CHR protein, DNA repair, metal-binding, nucleus; 2.12A {Homo sapiens}

Probab=98.38  E-value=1.3e-07  Score=78.12  Aligned_cols=69  Identities=16%  Similarity=0.239  Sum_probs=62.8

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCC-------CCCCccHHHHHHHHHHH
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH-------KNLVPNLALRSAIQEWL  495 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~-------~~~~pn~~l~~~i~~~~  495 (498)
                      ...++|.|||+.+.+.+|++.++||+|+..+|..|+..+..+||+++.++..       ..+.+|..|.+.|..|.
T Consensus        11 ~~~~~~~C~iC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~~~~n~~l~~~i~~~~   86 (115)
T 3l11_A           11 PSLSECQCGICMEILVEPVTLPCNHTLCKPCFQSTVEKASLCCPFCRRRVSSWTRYHTRRNSLVNVELWTIIQKHY   86 (115)
T ss_dssp             CCHHHHBCTTTCSBCSSCEECTTSCEECHHHHCCCCCTTTSBCTTTCCBCHHHHHHHHHTTCCBCHHHHHHHHHHS
T ss_pred             CCCCCCCCccCCcccCceeEcCCCCHHhHHHHHHHHhHCcCCCCCCCcccCccccccccccchhhHHHHHHHHHHC
Confidence            3456899999999999999999999999999999998878899999999864       67889999999999986

>1jm7_A BRCA1, breast cancer type 1 susceptibility protein; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1

Probab=98.33  E-value=3.2e-07  Score=75.32  Aligned_cols=67  Identities=15%  Similarity=0.328  Sum_probs=60.4

Q ss_pred             CCcCCCccccccCCceeccCCceecHHHHHHHHhcC--CCCCCCCCCCCCCCCCCccHHHHHHHHHHHH
Q 010882          430 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSG--HETSPMTNLPLAHKNLVPNLALRSAIQEWLQ  496 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~--~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~  496 (498)
                      +.+.|||+.+.+.+|+++++||+|+..+|..|+...  ..+||+++.++....+.+|..+.+.++.++.
T Consensus        20 ~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~~~~~~~l~~~~~~~~~   88 (112)
T 1jm7_A           20 KILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLK   88 (112)
T ss_dssp             HHTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHHH
T ss_pred             CCCCCcccChhhcCeEECCCCCHHHHHHHHHHHHhCCCCCCCcCCCCcCCHhhcCccHHHHHHHHHHHH
Confidence            456799999999999999999999999999999863  3599999999999999999999998888764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.32  E-value=1e-06  Score=84.07  Aligned_cols=132  Identities=20%  Similarity=0.179  Sum_probs=91.6

Q ss_pred             cccccCce-EEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeecee--cCcceEEEeeCCCCCH
Q 010882          145 KIGEGGYG-SIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSL  218 (498)
Q Consensus       145 ~lG~G~~g-~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~--~~~~~lV~E~~~~gsL  218 (498)
                      .+..|..| .||+....  +..+.+|+-...   ....+..|..+|+.|. +--+.++++++  .+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            35556555 68986553  457899986532   2456889999998884 22356677766  3457899999999888


Q ss_pred             HhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 010882          219 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK--------------------------------------------  254 (498)
Q Consensus       219 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------------  254 (498)
                      .+.....       ......++.+++..|..||...                                            
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            7765211       1233456667777777777532                                            


Q ss_pred             -----------CCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          255 -----------PHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       255 -----------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                                 +..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       11378999999999999887778999997653

>2djb_A Polycomb group ring finger protein 6; PCGF6, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.28  E-value=1.6e-06  Score=65.03  Aligned_cols=59  Identities=15%  Similarity=0.239  Sum_probs=53.7

Q ss_pred             CCCCCCcCCCccccccCCceec-cCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccH
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL  485 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~  485 (498)
                      ....+.+.|||+.+.+.+|++. +.||+|+..+|..|+.. ..+||+++.++...++.+|.
T Consensus        10 ~~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~   69 (72)
T 2djb_A           10 SELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYY-SNRCPKCNIVVHQTQPLSGP   69 (72)
T ss_dssp             CCCCGGGSCTTTSSCCSSCEECSSSCCEECHHHHHHHHHH-CSSCTTTCCCCCSSCSCCCC
T ss_pred             hhcCCCCCCCCCChHHHCcCEECCCCCHHHHHHHHHHHHc-CCcCCCcCcccCcccccccC
Confidence            4567899999999999999997 89999999999999987 78999999999999888873

>2yur_A Retinoblastoma-binding protein 6; P53-associated cellular protein of testis, proliferation potential-related protein, protein P2P-R; NMR {Homo sapiens}

Probab=98.28  E-value=1.1e-06  Score=66.18  Aligned_cols=60  Identities=22%  Similarity=0.253  Sum_probs=50.8

Q ss_pred             CCCCCCCcCCCccccccCCceecc-CCceecHHHHHHHHhcC-CCCCCCCCCCC-CCCCCCcc
Q 010882          425 RCEPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSG-HETSPMTNLPL-AHKNLVPN  484 (498)
Q Consensus       425 ~~~~P~~~~cpi~~e~~~dp~~~~-~g~t~~~~~i~~w~~~~-~~~~p~~~~~~-~~~~~~pn  484 (498)
                      ....++.+.|||+.+.+.+|++++ .||+|+..+|..|+... ..+||+++.+. ....+.+|
T Consensus         9 ~~~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~~CP~Cr~~~~~~~~~~~n   71 (74)
T 2yur_A            9 DDPIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALSGP   71 (74)
T ss_dssp             CCCSCGGGSCSSSCCCCTTCEECSSSCCEECTTHHHHHHHHSSSSCCSSSCCSSCCTTTTTCT
T ss_pred             cccCCCCCCCcCCChHHhCCeEcCCCCCHHHHHHHHHHHHhcCCCcCCCCCCcCCCccccccC
Confidence            346789999999999999999999 99999999999999863 36999999984 44556666

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.27  E-value=2.4e-06  Score=84.23  Aligned_cols=137  Identities=15%  Similarity=0.120  Sum_probs=80.5

Q ss_pred             cccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC--CCCeeeeece--------ecCcceEEEeeCC
Q 010882          145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR--HPNLVTLVGA--------CPEVWTLVYEYLP  214 (498)
Q Consensus       145 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~g~--------~~~~~~lV~E~~~  214 (498)
                      .|+.|..+.||+....+..+++|+...    ....+..|..++..|.  .-.+++++..        ..+..++||+|++
T Consensus        39 ~l~gG~~n~~~~v~~~~~~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSGAVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             ECC----CEEEEEEETTEEEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             eccccccCcEEEEEeCCCCEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            466677899999888777799999875    2345556666666553  1123344331        2345689999999


Q ss_pred             CCCHH--------------hhhccC--CC--C-------CCCCHHHHH-------------------------------H
Q 010882          215 NGSLE--------------DRLSCK--DN--S-------PPLSWQTRI-------------------------------R  238 (498)
Q Consensus       215 ~gsL~--------------~~l~~~--~~--~-------~~l~~~~~~-------------------------------~  238 (498)
                      |.++.              ..|+..  ..  .       ..-.|...+                               .
T Consensus       115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  194 (346)
T 2q83_A          115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG  194 (346)
T ss_dssp             CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence            86542              111110  00  0       011232110                               0


Q ss_pred             HHHHHHHHHHHHHh----------cCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          239 IATELCSVLIFLHS----------CKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       239 i~~~i~~~L~~LH~----------~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      +...+..++.+|+.          ..+..++|||+.+.|||++.++.+.|+||+.+.
T Consensus       195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            11123345666653          134789999999999999888899999999764

>4ayc_A E3 ubiquitin-protein ligase RNF8; DNA damage, K63 chains; HET: CPQ; 1.90A {Homo sapiens} PDB: 4epo_C

Probab=98.24  E-value=6.6e-07  Score=76.45  Aligned_cols=63  Identities=14%  Similarity=0.299  Sum_probs=52.9

Q ss_pred             CCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHH
Q 010882          430 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWL  495 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~  495 (498)
                      +++.|||+.+.+.+|++.++||+|+..+|..|+.. +.+||+|+.++...  .+|+.+.+.|..+.
T Consensus        52 ~~~~C~iC~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~--~~~~~~~~~i~~~~  114 (138)
T 4ayc_A           52 NELQCIICSEYFIEAVTLNCAHSFCSYCINEWMKR-KIECPICRKDIKSK--TYSLVLDNCINKMV  114 (138)
T ss_dssp             HHSBCTTTCSBCSSEEEETTSCEEEHHHHHHHTTT-CSBCTTTCCBCCCE--EECHHHHHHHHHHH
T ss_pred             ccCCCcccCcccCCceECCCCCCccHHHHHHHHHc-CCcCCCCCCcCCCC--CCccchhHHHHHHH
Confidence            46789999999999999999999999999999987 78999999998643  35666666665553

>3hcs_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.20A {Homo sapiens}

Probab=98.24  E-value=5.9e-07  Score=79.68  Aligned_cols=69  Identities=14%  Similarity=0.237  Sum_probs=63.6

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHH
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW  494 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~  494 (498)
                      ..+++.|.|||..+++.+|++++.|++|++.+|.+|+..+..+||+++.++...++.||.++++.|.++
T Consensus        13 ~~~~~~~~C~IC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~~~~i~~l   81 (170)
T 3hcs_A           13 PPLESKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAKREILSL   81 (170)
T ss_dssp             SCCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHHCSBCTTTCCBCCGGGCEECHHHHHHHHTS
T ss_pred             cCCCCCCCCCCCChhhcCcEECCCCCHHHHHHHHHHHHhCCCCCCCCccCcchhhhhhhHHHHHHHhhc
Confidence            367899999999999999999999999999999999988667999999999999999999999988754

>2ecy_A TNF receptor-associated factor 3; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.23  E-value=2e-06  Score=63.28  Aligned_cols=55  Identities=11%  Similarity=0.224  Sum_probs=50.0

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCC
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL  481 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~  481 (498)
                      ..++.+.|||..+.+.+|++++.||+|+..+|..|+..+..+||+++.++...++
T Consensus        11 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~i   65 (66)
T 2ecy_A           11 TVEDKYKCEKCHLVLCSPKQTECGHRFCESCMAALLSSSSPKCTACQESIVKDKV   65 (66)
T ss_dssp             SCCCCEECTTTCCEESSCCCCSSSCCCCHHHHHHHHTTSSCCCTTTCCCCCTTTC
T ss_pred             cCCcCCCCCCCChHhcCeeECCCCCHHHHHHHHHHHHhCcCCCCCCCcCCChhhc
Confidence            4678999999999999999999999999999999997667899999999887654

>1rmd_A RAG1; V(D)J recombination, antibody, MAD, ring finger, zinc binuclear cluster, zinc finger, DNA-binding protein; 2.10A {Mus musculus} SCOP: g.37.1.1 g.44.1.1

Probab=98.13  E-value=1.4e-06  Score=72.03  Aligned_cols=67  Identities=13%  Similarity=0.183  Sum_probs=58.3

Q ss_pred             CCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCC-ccHHHHHHHHHH
Q 010882          428 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV-PNLALRSAIQEW  494 (498)
Q Consensus       428 ~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~-pn~~l~~~i~~~  494 (498)
                      .++.+.|||+.+.+.+|++++.||+|+..+|..|+..++.+||+++.++...++. |+..+.++|..+
T Consensus        20 ~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~l~~~i~~l   87 (116)
T 1rmd_A           20 FVKSISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNILNSL   87 (116)
T ss_dssp             HHHHTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHHHHC
T ss_pred             ccCCCCCCCCCcHhcCcEEcCCCCcccHHHHHHHHhHCcCcCCCCCCCCCHhhccccHHHHHHHHHHh
Confidence            4567899999999999999999999999999999988778999999999877765 567777777653

>2ysl_A Tripartite motif-containing protein 31; ring-type zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.10  E-value=9.6e-06  Score=60.76  Aligned_cols=56  Identities=14%  Similarity=0.316  Sum_probs=49.8

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHh--cCCCCCCCCCCCCCCCCC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLD--SGHETSPMTNLPLAHKNL  481 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~--~~~~~~p~~~~~~~~~~~  481 (498)
                      ....+.+.|||+.+.+.+|++.+.||+|+..+|..|+.  .+..+||+++.++...++
T Consensus        15 ~~~~~~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~~   72 (73)
T 2ysl_A           15 NKLQEEVICPICLDILQKPVTIDCGHNFCLKCITQIGETSCGFFKCPLCKTSVRKNAI   72 (73)
T ss_dssp             CCCCCCCBCTTTCSBCSSEEECTTCCEEEHHHHHHHCSSSCSCCCCSSSCCCCCCCCC
T ss_pred             HhCccCCEeccCCcccCCeEEcCCCChhhHHHHHHHHHcCCCCCCCCCCCCcCCcccC
Confidence            35678999999999999999999999999999999997  346799999999887655

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.10  E-value=9.3e-06  Score=82.78  Aligned_cols=73  Identities=15%  Similarity=0.104  Sum_probs=46.8

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCCC-------CChhhHHHHHHHHHcC---CCCCeeeeeceecCcceEEEee
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL-------QGPSEFQQEIDILSKI---RHPNLVTLVGACPEVWTLVYEY  212 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l---~hpniv~l~g~~~~~~~lV~E~  212 (498)
                      ...||.|..+.||++...+..++||...+...       ........|.+++..+   ....+++++++..+..++||||
T Consensus        39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~~~~~~lv~e~  118 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFDRTMALIGMRY  118 (420)
T ss_dssp             EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEETTTTEEEECC
T ss_pred             EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEECCCccEEEEee
Confidence            34689999999999876677899995332111       1112223344433332   2345677777777778999999


Q ss_pred             C-CC
Q 010882          213 L-PN  215 (498)
Q Consensus       213 ~-~~  215 (498)
                      + +|
T Consensus       119 l~~g  122 (420)
T 2pyw_A          119 LEPP  122 (420)
T ss_dssp             CCTT
T ss_pred             cCCc
Confidence            9 77

>3knv_A TNF receptor-associated factor 2; cross-brace, alternative splicing, apoptosis, cytoplasm, metal-binding, UBL conjugation, zinc, zinc-finger; 1.90A {Homo sapiens}

Probab=98.08  E-value=5.6e-07  Score=77.00  Aligned_cols=67  Identities=19%  Similarity=0.288  Sum_probs=58.3

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCC---------CCCCCccHHHHHHHHH
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLA---------HKNLVPNLALRSAIQE  493 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~---------~~~~~pn~~l~~~i~~  493 (498)
                      ..++.|.|||+.+++.+|+.+++||+|++.+|..|+..+..+||+++.++.         ...+.||.++++.|..
T Consensus        27 ~l~~~~~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~l~~~~~~~d~~~~~~i~~  102 (141)
T 3knv_A           27 KLEAKYLCSACRNVLRRPFQAQCGHRYCSFCLASILSSGPQNCAACVHEGIYEEGISILESSSAFPDNAARREVES  102 (141)
T ss_dssp             GCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHGGGSCEECHHHHHTTCCCTTTTEECGGGCEECHHHHHHHHT
T ss_pred             cCCcCcCCCCCChhhcCcEECCCCCccCHHHHHHHHhcCCCCCCCCCCcccccccccccchhhhcccHHHHHHHcc
Confidence            467899999999999999999999999999999999887779999988643         3356699999988864

>1g25_A CDK-activating kinase assembly factor MAT1; ring finger (C3HC4), metal binding protein; NMR {Homo sapiens} SCOP: g.44.1.1

Probab=98.03  E-value=4.6e-06  Score=61.05  Aligned_cols=56  Identities=21%  Similarity=0.294  Sum_probs=50.2

Q ss_pred             CCcCCCcccc-ccCCc----eeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccH
Q 010882          430 PYFTCPIFQE-VMQDP----HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL  485 (498)
Q Consensus       430 ~~~~cpi~~e-~~~dp----~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~  485 (498)
                      +++.|||..+ .+.+|    ++.+.||+|+..+|.+|+..+..+||+++.++...++.||+
T Consensus         2 ~~~~C~IC~~~~~~~~~~~~~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~   62 (65)
T 1g25_A            2 DDQGCPRCKTTKYRNPSLKLMVNVCGHTLCESCVDLLFVRGAGNCPECGTPLRKSNFRVQL   62 (65)
T ss_dssp             CTTCCSTTTTHHHHCSSCCEEECTTCCCEEHHHHHHHHHTTSSSCTTTCCCCSSCCCEEEC
T ss_pred             CCCcCCcCCCCccCCCccCeecCCCCCHhHHHHHHHHHHcCCCcCCCCCCccccccceeec
Confidence            5678999999 99999    46799999999999999888778999999999999998873

>3ng2_A RNF4, snurf, ring finger protein 4; ring domain, E3 ligase, ubiquitylation, sumoylation, zinc-FI metal binding protein; 1.80A {Rattus norvegicus}

Probab=98.00  E-value=2.9e-06  Score=63.28  Aligned_cols=58  Identities=21%  Similarity=0.370  Sum_probs=52.3

Q ss_pred             CCCCCcCCCccccccCCc-------eeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccH
Q 010882          427 EPPPYFTCPIFQEVMQDP-------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL  485 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp-------~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~  485 (498)
                      ...+.+.|||..+.+.+|       ++.+.||+|...+|..|+.. +.+||+++.++...++.|++
T Consensus         6 ~~~~~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~   70 (71)
T 3ng2_A            6 RPSGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINHKRYHPIY   70 (71)
T ss_dssp             CCTTCCBCTTTCCBHHHHHTTTCCEEECTTSCEEEHHHHHHHHHH-CSBCTTTCCBCCCCSCCCCC
T ss_pred             CCCCCCCCcccChhhhccccccCCeEeCCCCChHhHHHHHHHHHc-CCCCCCCCCccChhheeecc
Confidence            346788999999999998       88899999999999999988 67999999999999998875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.90  E-value=6.2e-05  Score=72.41  Aligned_cols=75  Identities=16%  Similarity=0.091  Sum_probs=55.2

Q ss_pred             CCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCC---CCeeeeeceecCcceEEEeeCCCCC
Q 010882          142 PSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH---PNLVTLVGACPEVWTLVYEYLPNGS  217 (498)
Q Consensus       142 ~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---pniv~l~g~~~~~~~lV~E~~~~gs  217 (498)
                      ....+|.|..+.||+.... |+.|.+|+...........|..|+..|+.|.-   --++++++..  ..++||||++++.
T Consensus        19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~~lv~e~l~~~~   96 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TTEEEEECCCCCC
T ss_pred             EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--CceEEEEeecccC
Confidence            3456899999999999884 78999998765554445678999999998842   1344555543  4579999998765


Q ss_pred             H
Q 010882          218 L  218 (498)
Q Consensus       218 L  218 (498)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.89  E-value=5.9e-05  Score=73.61  Aligned_cols=156  Identities=13%  Similarity=0.178  Sum_probs=88.2

Q ss_pred             CChHHHHHhhcCCCCC-----CcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC--eeeeec
Q 010882          128 FSFSEIEGATHNFDPS-----LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVG  200 (498)
Q Consensus       128 ~~~~ei~~~~~~~~~~-----~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~g  200 (498)
                      ++..++......|...     +.|+.|....||+....+..+++|+....  .....+..|+.++..|...+  +.+++.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            4445555444455442     34667888899998876668999998753  23456778888887774212  333432


Q ss_pred             e--------ecCcceEEEeeCCCCCHHh--------------hhccC--C-CCC---CC---CHHHHHH-----------
Q 010882          201 A--------CPEVWTLVYEYLPNGSLED--------------RLSCK--D-NSP---PL---SWQTRIR-----------  238 (498)
Q Consensus       201 ~--------~~~~~~lV~E~~~~gsL~~--------------~l~~~--~-~~~---~l---~~~~~~~-----------  238 (498)
                      .        ..+..++||+|++|.++..              .++..  . ...   ..   .|...+.           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            2        1234678999999865321              01111  0 000   01   1222110           


Q ss_pred             -HHHHHHHHHHHHHhc----CCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          239 -IATELCSVLIFLHSC----KPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       239 -i~~~i~~~L~~LH~~----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                       +...+...+..++..    .+.+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             001134455555532    23579999999999999987666899999765

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.84  E-value=4.7e-05  Score=74.23  Aligned_cols=135  Identities=20%  Similarity=0.153  Sum_probs=87.1

Q ss_pred             CcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC---CCCeeeeeceec--CcceEEEeeCCCCCH
Q 010882          144 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR---HPNLVTLVGACP--EVWTLVYEYLPNGSL  218 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~g~~~--~~~~lV~E~~~~gsL  218 (498)
                      ..|+.|.+..+|+....+..+++|+....   ....+..|...|+.|.   ...++++++.+.  +..++||||++|.++
T Consensus        42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            45899999999998777788999987542   3557889999998884   355777777653  467999999998764


Q ss_pred             H--------h---hhccCCCCC-------------------CCCHHHHH---HHH----------------HHHHHH-HH
Q 010882          219 E--------D---RLSCKDNSP-------------------PLSWQTRI---RIA----------------TELCSV-LI  248 (498)
Q Consensus       219 ~--------~---~l~~~~~~~-------------------~l~~~~~~---~i~----------------~~i~~~-L~  248 (498)
                      .        .   .|+......                   .-+|..-.   ++.                ..+... ..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            2        1   122211100                   11343221   111                111111 12


Q ss_pred             HHHh-cCCCCcccCCCCCCcEEEcCCCceeEeecc
Q 010882          249 FLHS-CKPHSIVHGDLKPANILLDANFVSKLSDFG  282 (498)
Q Consensus       249 ~LH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  282 (498)
                      .|.. ..+..+||+|+.+.|++++.++ +.|.||+
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3421 1235799999999999999887 8899984

>2ysj_A Tripartite motif-containing protein 31; ring-type zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.83  E-value=4.5e-05  Score=55.20  Aligned_cols=47  Identities=17%  Similarity=0.350  Sum_probs=41.7

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhc--CCCCCCCC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS--GHETSPMT  472 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~--~~~~~p~~  472 (498)
                      ....+.+.|||..+.+.+|++++.||+|++.+|.+|+..  +..+||++
T Consensus        15 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~C   63 (63)
T 2ysj_A           15 NKLQEEVICPICLDILQKPVTIDCGHNFCLKCITQIGETSCGFFKCPLC   63 (63)
T ss_dssp             CCCCCCCBCTTTCSBCSSCEECTTSSEECHHHHHHHHHHCSSCCCCSCC
T ss_pred             HhCccCCCCCcCCchhCCeEEeCCCCcchHHHHHHHHHcCCCCCcCcCC
Confidence            356789999999999999999999999999999999974  45689875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.83  E-value=6.4e-05  Score=72.80  Aligned_cols=71  Identities=8%  Similarity=0.059  Sum_probs=47.8

Q ss_pred             CCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceecCcceEEEeeC-CCCCH
Q 010882          143 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYL-PNGSL  218 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~~~~lV~E~~-~~gsL  218 (498)
                      .+.|+.|....+|+.    ..+++|+....... .-....|+.+++.+. +.-..++++.+.+..++|+||+ +|.+|
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccC
Confidence            457888999999988    56888987653211 123457888887774 2222567777776678999999 66444

>2xeu_A Ring finger protein 4; transcription, zinc-finger, metal-binding; HET: SUC; 1.50A {Homo sapiens}

Probab=97.79  E-value=6.6e-06  Score=59.82  Aligned_cols=55  Identities=20%  Similarity=0.361  Sum_probs=49.3

Q ss_pred             CCcCCCccccccCCc-------eeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccH
Q 010882          430 PYFTCPIFQEVMQDP-------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL  485 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp-------~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~  485 (498)
                      +.+.|||..+.+.+|       ++.+.||.|...+|..|+.. +.+||+++.++...++.|++
T Consensus         2 ~~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~   63 (64)
T 2xeu_A            2 AMVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINHKRYHPIY   63 (64)
T ss_dssp             CCCBCTTTCCBHHHHHHTTCCEEEETTSCEEEHHHHHHHHHH-CSBCTTTCCBCTTTCEEECC
T ss_pred             CCCCCCccChhhhCccccCCCEEeCCCCCchhHHHHHHHHHc-CCCCCCCCccCCccceeeee
Confidence            457899999999887       78899999999999999988 78999999999988888764

>2ct2_A Tripartite motif protein 32; zinc-finger protein HT2A, TAT- interacting protein, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.79  E-value=2.4e-05  Score=60.85  Aligned_cols=63  Identities=22%  Similarity=0.282  Sum_probs=53.0

Q ss_pred             CCCCCCcCCCccccccCC----ceeccCCceecHHHHHHHHhcC--CCCCCCCCCCCCC---CCCCccHHHH
Q 010882          426 CEPPPYFTCPIFQEVMQD----PHVAADGFTYEAEALKGWLDSG--HETSPMTNLPLAH---KNLVPNLALR  488 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~d----p~~~~~g~t~~~~~i~~w~~~~--~~~~p~~~~~~~~---~~~~pn~~l~  488 (498)
                      ....+.+.|||+.+.+.+    |++.++||+|+..+|..|+...  ..+||+++.++..   ..|.+|+.+.
T Consensus        10 ~~~~~~~~C~IC~~~~~~~~~~~~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~i~~l~~n~~~~   81 (88)
T 2ct2_A           10 DALREVLECPICMESFTEEQLRPKLLHCGHTICRQCLEKLLASSINGVRCPFCSKITRITSLTQLTDNLTVL   81 (88)
T ss_dssp             CCCCSCCBCTTTCCBCCTTSSCEEECSSSCEEEHHHHHHHHHHCSSCBCCTTTCCCBCCSSTTTSEECTTTT
T ss_pred             hhccCCCCCccCCccccccCCCeEECCCCChhhHHHHHHHHHcCCCCcCCCCCCCcccchhHHHHHHHHHHH
Confidence            356788999999999999    9999999999999999999874  4799999998754   3566776553

>2ect_A Ring finger protein 126; metal binding protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus}

Probab=97.71  E-value=4.4e-05  Score=57.93  Aligned_cols=57  Identities=18%  Similarity=0.365  Sum_probs=49.3

Q ss_pred             CCCCCcCCCccccccCCc---eeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCcc
Q 010882          427 EPPPYFTCPIFQEVMQDP---HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN  484 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp---~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn  484 (498)
                      ...+.+.|||+.+.+.++   .+.++||.|+..+|.+|+.. +.+||+++.++...++.||
T Consensus        11 ~~~~~~~C~IC~~~~~~~~~~~~~~C~H~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~   70 (78)
T 2ect_A           11 HVGSGLECPVCKEDYALGESVRQLPCNHLFHDSCIVPWLEQ-HDSCPVCRKSLTGQNTATN   70 (78)
T ss_dssp             TSSSSCCCTTTTSCCCTTSCEEECTTSCEEETTTTHHHHTT-TCSCTTTCCCCCCSCSCCC
T ss_pred             cCCCCCCCeeCCccccCCCCEEEeCCCCeecHHHHHHHHHc-CCcCcCcCCccCCcccCCC
Confidence            456788999999999876   44589999999999999987 6899999999998888776

>2d8t_A Dactylidin, ring finger protein 146; RNF146, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.71  E-value=1.6e-05  Score=59.17  Aligned_cols=52  Identities=10%  Similarity=0.040  Sum_probs=46.7

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCC
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHK  479 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~  479 (498)
                      ...+.+.|||+.+.+.+|++.+.||+|+..+|..|+.. +.+||+++.++...
T Consensus        11 ~~~~~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~~   62 (71)
T 2d8t_A           11 PSLTVPECAICLQTCVHPVSLPCKHVFCYLCVKGASWL-GKRCALCRQEIPED   62 (71)
T ss_dssp             SSSSCCBCSSSSSBCSSEEEETTTEEEEHHHHHHCTTC-SSBCSSSCCBCCHH
T ss_pred             cCCCCCCCccCCcccCCCEEccCCCHHHHHHHHHHHHC-CCcCcCcCchhCHh
Confidence            34677899999999999999999999999999999988 58999999988644

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.64  E-value=0.00026  Score=69.46  Aligned_cols=140  Identities=11%  Similarity=0.053  Sum_probs=74.8

Q ss_pred             cccccCceE-EEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCC--CCeeeeeceecCcceEEEeeCCCCCHHh
Q 010882          145 KIGEGGYGS-IYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGACPEVWTLVYEYLPNGSLED  220 (498)
Q Consensus       145 ~lG~G~~g~-Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~g~~~~~~~lV~E~~~~gsL~~  220 (498)
                      .|+.|+... +|+.... +..+++|......   ...+..|+.++..|..  -.+.+++.+..+..++|||++.+.++.+
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~~  101 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFTE  101 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHHH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchHH
Confidence            465555444 6676653 6677777654322   1345667777777642  2355667665555579999997766654


Q ss_pred             hhccC---------------------CC--CCCCCHHHHH-------H-H------------HHHHHHHHHHHH---hcC
Q 010882          221 RLSCK---------------------DN--SPPLSWQTRI-------R-I------------ATELCSVLIFLH---SCK  254 (498)
Q Consensus       221 ~l~~~---------------------~~--~~~l~~~~~~-------~-i------------~~~i~~~L~~LH---~~~  254 (498)
                      .+...                     ..  .+.+......       . +            ...+...+..|.   ...
T Consensus       102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~  181 (333)
T 3csv_A          102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG  181 (333)
T ss_dssp             HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred             HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence            33210                     00  1112221100       0 0            001111222221   123


Q ss_pred             CCCcccCCCCCCcEEEcCC----CceeEeeccccccc
Q 010882          255 PHSIVHGDLKPANILLDAN----FVSKLSDFGISRFL  287 (498)
Q Consensus       255 ~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~~~  287 (498)
                      +..++|||+.+.||+++.+    +.+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4689999999999999874    67899999988653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.63  E-value=0.00018  Score=73.85  Aligned_cols=72  Identities=14%  Similarity=0.083  Sum_probs=48.9

Q ss_pred             CcccccCceEEEEEEECC--eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCe-eeeeceecCcceEEEeeCCCCCH
Q 010882          144 LKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSL  218 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~g~~~~~~~lV~E~~~~gsL  218 (498)
                      ..|+.|-...+|+....+  ..+++|+....... .-....|..++..|...++ +++++.+.+  .+||||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC--eEEEEeeCCccC
Confidence            457788889999998876  78999987543211 1123689999998864444 567777753  369999988544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.62  E-value=7.3e-05  Score=76.33  Aligned_cols=71  Identities=18%  Similarity=0.225  Sum_probs=50.0

Q ss_pred             CcccccCceEEEEEEEC---------CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC-eeeeeceecCcceEEEeeC
Q 010882          144 LKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEYL  213 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~g~~~~~~~lV~E~~  213 (498)
                      ..|+.|....||+....         +..+++|+....  .....+..|..++..|...+ .+++++.+.+  .+||||+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--g~v~e~l  154 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI  154 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--CEEEEEe
Confidence            35788888999998864         367999988432  12256678999998885333 3567777764  3899999


Q ss_pred             CCCCH
Q 010882          214 PNGSL  218 (498)
Q Consensus       214 ~~gsL  218 (498)
                      +|.+|
T Consensus       155 ~G~~l  159 (429)
T 1nw1_A          155 PSRPL  159 (429)
T ss_dssp             CEEEC
T ss_pred             CCccc
Confidence            87443

>2ea6_A Ring finger protein 4; RNF4, RES4-26, ring domain, zinc- binding domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.61  E-value=5.7e-05  Score=55.64  Aligned_cols=52  Identities=19%  Similarity=0.362  Sum_probs=46.4

Q ss_pred             CCCCCCcCCCccccccCCc-------eeccCCceecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          426 CEPPPYFTCPIFQEVMQDP-------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp-------~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      ...++.+.|||..+.+.+|       ++.+.||.|...+|..|+.. +.+||+++.++..
T Consensus        10 ~~~~~~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~   68 (69)
T 2ea6_A           10 LRPSGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINH   68 (69)
T ss_dssp             CCTTCCCCCTTTCCCHHHHTTTTCCEEECSSSCEEEHHHHHHHHHH-CSSCTTTCCCCCC
T ss_pred             cCCCCCCCCcccCccccccccccCCeEeCCCCChhcHHHHHHHHHc-CCCCCCCCCccCc
Confidence            3467889999999999988       88899999999999999988 7899999998764

>2ecj_A Tripartite motif-containing protein 39; TRIM39, ring domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.56  E-value=0.00014  Score=51.52  Aligned_cols=47  Identities=13%  Similarity=0.350  Sum_probs=41.3

Q ss_pred             CCCCCCcCCCccccccCCceeccCCceecHHHHHHHHhc--CCCCCCCC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS--GHETSPMT  472 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~--~~~~~p~~  472 (498)
                      ....+.+.|||..+.+.+|++.+.||+|...+|..|+..  +..+||++
T Consensus        10 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~C   58 (58)
T 2ecj_A           10 ENLQVEASCSVCLEYLKEPVIIECGHNFCKACITRWWEDLERDFPCPVC   58 (58)
T ss_dssp             SCSCCCCBCSSSCCBCSSCCCCSSCCCCCHHHHHHHTTSSCCSCCCSCC
T ss_pred             hccccCCCCccCCcccCccEeCCCCCccCHHHHHHHHHhcCCCCCCCCC
Confidence            356788999999999999999999999999999999765  56788874

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.54  E-value=0.0002  Score=71.60  Aligned_cols=140  Identities=21%  Similarity=0.261  Sum_probs=83.1

Q ss_pred             CcccccCceEEEEEEEC---------CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceecCcceEEEeeC
Q 010882          144 LKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYL  213 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~~~~lV~E~~  213 (498)
                      +.|..|-...+|+....         +..|++|+... .......+.+|..+++.|. +.-..++++.+.+.  +||||+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g--~v~e~i  132 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG--RLEQYI  132 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE--EEEECC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc--cEEEEe
Confidence            35766778889988763         36789998533 2234556779999998884 33346778777653  999999


Q ss_pred             CCCCHHhh-----------------hccCCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHHH--
Q 010882          214 PNGSLEDR-----------------LSCKDN--SPPL--SWQTRIRIATELCS-------------------VLIFLH--  251 (498)
Q Consensus       214 ~~gsL~~~-----------------l~~~~~--~~~l--~~~~~~~i~~~i~~-------------------~L~~LH--  251 (498)
                      +|.+|...                 |+....  ..+.  -+.++.++..++..                   .+..|.  
T Consensus       133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~  212 (379)
T 3feg_A          133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL  212 (379)
T ss_dssp             SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred             cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence            98655311                 111110  1112  23444444433321                   223332  


Q ss_pred             --h-cCCCCcccCCCCCCcEEEcCC----CceeEeecccccc
Q 010882          252 --S-CKPHSIVHGDLKPANILLDAN----FVSKLSDFGISRF  286 (498)
Q Consensus       252 --~-~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~~  286 (498)
                        . ..+..++|+|+.+.||+++.+    +.+.|+||..|..
T Consensus       213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              2 123468999999999999876    7899999998753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.30  E-value=0.00028  Score=70.35  Aligned_cols=72  Identities=14%  Similarity=0.135  Sum_probs=44.5

Q ss_pred             CcccccCceEEEEEEECC----------eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC-eeeeeceecCcceEEEee
Q 010882          144 LKIGEGGYGSIYKGLLRH----------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEY  212 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~g~~~~~~~lV~E~  212 (498)
                      ..|+.|....+|+....+          ..+++|+...... .......|..+++.|...+ ++++++.+.  .++||+|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~~~v~e~  115 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN--GGRIEEW  115 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET--TEEEEEC
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC--CcEEEEE
Confidence            357778888999988754          6788888654211 1113467888888875333 446666553  4689999


Q ss_pred             CCCCCH
Q 010882          213 LPNGSL  218 (498)
Q Consensus       213 ~~~gsL  218 (498)
                      ++|.++
T Consensus       116 i~G~~l  121 (369)
T 3c5i_A          116 LYGDPL  121 (369)
T ss_dssp             CCSEEC
T ss_pred             ecCCcC
Confidence            988543

>4ap4_A E3 ubiquitin ligase RNF4; ligase-signalling protein complex, chimera; 2.21A {Rattus norvegicus}

Probab=97.28  E-value=0.00011  Score=61.65  Aligned_cols=56  Identities=20%  Similarity=0.335  Sum_probs=50.2

Q ss_pred             CCCcCCCccccccCCc-------eeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccH
Q 010882          429 PPYFTCPIFQEVMQDP-------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL  485 (498)
Q Consensus       429 P~~~~cpi~~e~~~dp-------~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~  485 (498)
                      ++.+.|||..+.+.+|       ++.+.||+|...+|.+|+.. ..+||+++.++....+.+++
T Consensus         5 ~~~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~l~~l~   67 (133)
T 4ap4_A            5 SGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINHKRYHPIY   67 (133)
T ss_dssp             CCSCBCTTTCCBHHHHHHTTCCEEEETTCCEEEHHHHHHHHTT-CSBCTTTCCBCTTTCEEECB
T ss_pred             CCCCCCcccChhhhCccccccCeEecCCCChhhHHHHHHHHHh-CCCCCCCCCcCccccccccc
Confidence            5788999999999999       89999999999999999987 66999999999888776653

>2ep4_A Ring finger protein 24; zinc binding, ubiquitin, E3 enzyme, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.22  E-value=0.00067  Score=50.60  Aligned_cols=52  Identities=17%  Similarity=0.336  Sum_probs=45.1

Q ss_pred             CCCCCcCCCccccccCCceec---cCCceecHHHHHHHHhcCCCCCCCCCCCCCCC
Q 010882          427 EPPPYFTCPIFQEVMQDPHVA---ADGFTYEAEALKGWLDSGHETSPMTNLPLAHK  479 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~---~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~  479 (498)
                      ...+...|||+.+.+.++...   +.||.|...+|..|+.. +.+||+++.++...
T Consensus        11 ~~~~~~~C~IC~~~~~~~~~~~~~~C~H~f~~~Ci~~~~~~-~~~CP~Cr~~~~~~   65 (74)
T 2ep4_A           11 ELNLHELCAVCLEDFKPRDELGICPCKHAFHRKCLIKWLEV-RKVCPLCNMPVLQL   65 (74)
T ss_dssp             CCCCSCBCSSSCCBCCSSSCEEEETTTEEEEHHHHHHHHHH-CSBCTTTCCBCSSC
T ss_pred             cCCCCCCCcCCCcccCCCCcEEEcCCCCEecHHHHHHHHHc-CCcCCCcCcccccc
Confidence            456788999999999887666   89999999999999988 56999999998654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.19  E-value=0.0033  Score=61.17  Aligned_cols=158  Identities=12%  Similarity=0.135  Sum_probs=87.9

Q ss_pred             CCCCChHHHHHhhcCCCC-----CCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCC--Cee
Q 010882          125 FSDFSFSEIEGATHNFDP-----SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLV  196 (498)
Q Consensus       125 ~~~~~~~ei~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hp--niv  196 (498)
                      +...+...+......|..     ...|+ |....||+.... +..+++|...... .....+..|..++..|...  .++
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence            334444555444333322     23466 888899987664 4579999986432 2456778899888887421  244


Q ss_pred             eeece-------ecCcceEEEeeCCCCCHH-----h------h---hccC----C--CCCCCCHHHH----HHH------
Q 010882          197 TLVGA-------CPEVWTLVYEYLPNGSLE-----D------R---LSCK----D--NSPPLSWQTR----IRI------  239 (498)
Q Consensus       197 ~l~g~-------~~~~~~lV~E~~~~gsL~-----~------~---l~~~----~--~~~~l~~~~~----~~i------  239 (498)
                      +++..       ..+..++||+|++|.++.     .      .   ++..    .  ....+++...    ..+      
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            44443       123346899999885432     0      0   1110    0  0112222211    001      


Q ss_pred             ---------HHHHHHHHHHHHhc----CCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          240 ---------ATELCSVLIFLHSC----KPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       240 ---------~~~i~~~L~~LH~~----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                               ...+...+..+...    .+..++|||+++.|||++ + .+.|+||+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     11111223333321    346789999999999999 4 889999997653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.12  E-value=0.0016  Score=64.01  Aligned_cols=32  Identities=16%  Similarity=0.269  Sum_probs=28.2

Q ss_pred             CCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          256 HSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       256 ~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            57999999999999998888999999877643

>1chc_A Equine herpes virus-1 ring domain; viral protein; NMR {Equid herpesvirus 1} SCOP: g.44.1.1

Probab=97.08  E-value=0.00054  Score=50.15  Aligned_cols=48  Identities=17%  Similarity=0.302  Sum_probs=42.4

Q ss_pred             CCcCCCccccccCCc-eeccCCceecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQDP-HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp-~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      +...|||+.+.+.+| +..+.||.|+..+|..|+.. +.+||+++.++..
T Consensus         4 ~~~~C~IC~~~~~~~~~~~~C~H~fc~~Ci~~~~~~-~~~CP~Cr~~~~~   52 (68)
T 1chc_A            4 VAERCPICLEDPSNYSMALPCLHAFCYVCITRWIRQ-NPTCPLCKVPVES   52 (68)
T ss_dssp             CCCCCSSCCSCCCSCEEETTTTEEESTTHHHHHHHH-SCSTTTTCCCCCC
T ss_pred             CCCCCeeCCccccCCcEecCCCCeeHHHHHHHHHhC-cCcCcCCChhhHh
Confidence            456799999999997 77889999999999999987 6899999998863

>2ecn_A Ring finger protein 141; RNF141, ring domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.05  E-value=0.0003  Score=51.90  Aligned_cols=53  Identities=17%  Similarity=0.313  Sum_probs=46.8

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCC
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL  481 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~  481 (498)
                      ...+.+.|||..+.+.+ ++.+.||+|+..+|..|+.. +.+||+++.++...+.
T Consensus        11 ~~~~~~~C~IC~~~~~~-~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~   63 (70)
T 2ecn_A           11 QLTDEEECCICMDGRAD-LILPCAHSFCQKCIDKWSDR-HRNCPICRLQMTGANE   63 (70)
T ss_dssp             CCCCCCCCSSSCCSCCS-EEETTTEEECHHHHHHSSCC-CSSCHHHHHCTTCCCC
T ss_pred             cCCCCCCCeeCCcCccC-cccCCCCcccHHHHHHHHHC-cCcCCCcCCcccCCCc
Confidence            45778999999999999 99999999999999999985 8899999988875543

>2y1n_A E3 ubiquitin-protein ligase; ligase-transferase complex, ubiquitin ring E3 ligase; HET: PTR; 2.00A {Homo sapiens} PDB: 2y1m_A* 4a4c_A* 4a4b_A* 1fbv_A* 3vgo_A 4a49_A* 2k4d_A 2ldr_A*

Probab=97.02  E-value=0.0003  Score=69.55  Aligned_cols=50  Identities=18%  Similarity=0.345  Sum_probs=45.1

Q ss_pred             CcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 010882          431 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKN  480 (498)
Q Consensus       431 ~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~  480 (498)
                      ...|||+.+.+.+|+..++||.+|..||..|+.+.+.+||+|+.++....
T Consensus       332 ~~~C~ICle~~~~pv~lpCGH~FC~~Ci~~wl~~~~~~CP~CR~~i~~~~  381 (389)
T 2y1n_A          332 FQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTE  381 (389)
T ss_dssp             SSBCTTTSSSBCCEEEETTCCEECHHHHHHHHHHTCSBCTTTCCBCCEEE
T ss_pred             CCCCCccCcCCCCeEEeCCCChhhHHHHHHHHhcCCCCCCCCCCccCCce
Confidence            46799999999999999999999999999999866889999999887543

>2kiz_A E3 ubiquitin-protein ligase arkadia; ring-H2 finger, E3 ligase, Zn binding domain, metal zinc, zinc-finger, metal binding protein; NMR {Homo sapiens}

Probab=97.01  E-value=0.0015  Score=47.85  Aligned_cols=52  Identities=13%  Similarity=0.307  Sum_probs=43.7

Q ss_pred             CCCCCcCCCccccccC---CceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCC
Q 010882          427 EPPPYFTCPIFQEVMQ---DPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHK  479 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~---dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~  479 (498)
                      .......|||+.+.+.   ++++.+.||.|...+|..|+.. +.+||+++.++...
T Consensus        10 ~~~~~~~C~IC~~~~~~~~~~~~~~C~H~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~   64 (69)
T 2kiz_A           10 EEDTEEKCTICLSILEEGEDVRRLPCMHLFHQVCVDQWLIT-NKKCPICRVDIEAQ   64 (69)
T ss_dssp             STTCCCSBTTTTBCCCSSSCEEECTTSCEEEHHHHHHHHHH-CSBCTTTCSBSCSC
T ss_pred             cCCCCCCCeeCCccccCCCcEEEeCCCCHHHHHHHHHHHHc-CCCCcCcCccccCc
Confidence            4456788999988774   5677889999999999999988 67999999998753

>1e4u_A Transcriptional repressor NOT4; gene regulation, transcriptional control; NMR {Homo sapiens} SCOP: g.44.1.1 PDB: 1ur6_B

Probab=96.98  E-value=0.0014  Score=49.52  Aligned_cols=55  Identities=13%  Similarity=0.172  Sum_probs=45.7

Q ss_pred             CCCCCcCCCcccccc--CCceecc--CCceecHHHHHHHHhcCCCCCCCCCCCCCCCCC
Q 010882          427 EPPPYFTCPIFQEVM--QDPHVAA--DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL  481 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~--~dp~~~~--~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~  481 (498)
                      ...+++.|||+.+.+  .|+.+.+  .||++++.++.++...+...||++|.++....+
T Consensus         7 ~~~~~~~CpICle~~~~~d~~~~p~~CGH~fC~~Cl~~~~~~~~~~CP~CR~~~~~~~~   65 (78)
T 1e4u_A            7 AKEDPVECPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDENGLCPACRKPYPEDPA   65 (78)
T ss_dssp             CCCCCCBCTTTCCBCCTTTTTCCSSTTSCCCCHHHHHHHTTSSCSBCTTTCCBCSSCSS
T ss_pred             ccccCCcCCccCccCccccccccccCCCCCcCHHHHHHHHhcCCCCCCCCCCccCCCch
Confidence            356789999999977  4666666  999999999999876677899999999876554

>2ecm_A Ring finger and CHY zinc finger domain- containing protein 1; RCHY1, ring domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Mus musculus} PDB: 2jrj_A

Probab=96.97  E-value=0.00071  Score=47.12  Aligned_cols=47  Identities=21%  Similarity=0.296  Sum_probs=41.2

Q ss_pred             CCcCCCccccccCC----ceeccCCceecHHHHHHHHhcCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQD----PHVAADGFTYEAEALKGWLDSGHETSPMTNLPLA  477 (498)
Q Consensus       430 ~~~~cpi~~e~~~d----p~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~  477 (498)
                      +...|||..+.+.+    +++.+.||.|...+|..|+.. +.+||+++.++.
T Consensus         4 ~~~~C~IC~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~   54 (55)
T 2ecm_A            4 GSSGCPICLEDIHTSRVVAHVLPCGHLLHRTCYEEMLKE-GYRCPLCSGPSS   54 (55)
T ss_dssp             CCCSCTTTCCCCCTTTSCEEECTTSCEEETTHHHHHHHH-TCCCTTSCCSSC
T ss_pred             CCCcCcccChhhcCCCcCeEecCCCCcccHHHHHHHHHc-CCcCCCCCCcCC
Confidence            45679999998866    788899999999999999998 489999998875

>1iym_A EL5; ring-H2 finger, ubiquitin ligase, DNA binding protein; NMR {Oryza sativa} SCOP: g.44.1.1

Probab=96.92  E-value=0.001  Score=46.30  Aligned_cols=48  Identities=25%  Similarity=0.508  Sum_probs=41.2

Q ss_pred             CCCcCCCccccccCC---ceecc-CCceecHHHHHHHHhcCCCCCCCCCCCCC
Q 010882          429 PPYFTCPIFQEVMQD---PHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLA  477 (498)
Q Consensus       429 P~~~~cpi~~e~~~d---p~~~~-~g~t~~~~~i~~w~~~~~~~~p~~~~~~~  477 (498)
                      .+...|||..+.+.+   +++.+ .||.|...+|..|+.. +.+||+++.++.
T Consensus         3 ~~~~~C~IC~~~~~~~~~~~~~~~C~H~f~~~Ci~~w~~~-~~~CP~Cr~~~~   54 (55)
T 1iym_A            3 DDGVECAVCLAELEDGEEARFLPRCGHGFHAECVDMWLGS-HSTCPLCRLTVV   54 (55)
T ss_dssp             CCSCCCTTTCCCCCTTSCCEECSSSCCEECTTHHHHTTTT-CCSCSSSCCCSC
T ss_pred             CCCCcCccCCccccCCCceEECCCCCCcccHHHHHHHHHc-CCcCcCCCCEeE
Confidence            355679999998887   77776 9999999999999987 789999998764

>2l0b_A E3 ubiquitin-protein ligase praja-1; zinc finger, NESG, structural genomics, PSI-2, protein struc initiative; NMR {Homo sapiens}

Probab=96.86  E-value=0.001  Score=51.90  Aligned_cols=50  Identities=14%  Similarity=0.215  Sum_probs=43.7

Q ss_pred             CCCCcCCCccccccCC---ceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          428 PPPYFTCPIFQEVMQD---PHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       428 ~P~~~~cpi~~e~~~d---p~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      ..+...|||+.+.+.+   +++.++||.|...+|..|+.. +.+||+++.++..
T Consensus        37 ~~~~~~C~IC~~~~~~~~~~~~l~C~H~Fh~~Ci~~wl~~-~~~CP~Cr~~~~~   89 (91)
T 2l0b_A           37 VGQEMCCPICCSEYVKGDVATELPCHHYFHKPCVSIWLQK-SGTCPVCRCMFPP   89 (91)
T ss_dssp             SSSCSEETTTTEECCTTCEEEEETTTEEEEHHHHHHHHTT-TCBCTTTCCBSSC
T ss_pred             cCCCCCCcccChhhcCCCcEEecCCCChHHHHHHHHHHHc-CCcCcCcCccCCC
Confidence            3467789999998887   888899999999999999987 7799999988764

>1v87_A Deltex protein 2; ring-H2 domain, zinc-binding domain, notch signaling, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: g.44.1.1

Probab=96.74  E-value=0.0015  Score=53.30  Aligned_cols=49  Identities=14%  Similarity=0.148  Sum_probs=41.1

Q ss_pred             CCcCCCccccccCCce------------------eccCCceecHHHHHHHHh----cCCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQDPH------------------VAADGFTYEAEALKGWLD----SGHETSPMTNLPLAH  478 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~------------------~~~~g~t~~~~~i~~w~~----~~~~~~p~~~~~~~~  478 (498)
                      .+..|||+.+.+.+|.                  +.++||.|...+|..|+.    ..+.+||+++..+..
T Consensus        24 ~~~~C~ICl~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~H~Fh~~Ci~~wl~~~~~~~~~~CP~CR~~~~~   94 (114)
T 1v87_A           24 PEEDCIICMEKLAVASGYSDMTDSKALGPMVVGRLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKTIYGE   94 (114)
T ss_dssp             CSCEETTTTEETTSCCSTTTTCCCSSSCSSCCEEESSSCCEECHHHHHHHHHHTCCSSCCBCTTTCCBSSS
T ss_pred             CCCcCccCChhhcCcccccccccccccCcccceecCCCCCcccHHHHHHHHHcccCCCCCcCCCCCCccCC
Confidence            4568999999998775                  678999999999999995    346799999988753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.74  E-value=0.0022  Score=64.97  Aligned_cols=139  Identities=14%  Similarity=0.187  Sum_probs=83.9

Q ss_pred             CcccccCceEEEEEEEC---------CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceecCcceEEEeeC
Q 010882          144 LKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYL  213 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~~~~lV~E~~  213 (498)
                      +.|..|-...+|+....         +..|++++..... ...-...+|..+++.|. +.-..++++.+.  .++||+|+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~~~I~efI  152 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP--EGRIEEFI  152 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET--TEEEEECC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--CCEEEEEe
Confidence            34666778899998876         5779999865432 12223468888888884 333456666554  47899999


Q ss_pred             CCCCHHh--------------h---hccC-------C---CCCCCCHHHHHHHHHHH-------------------HHHH
Q 010882          214 PNGSLED--------------R---LSCK-------D---NSPPLSWQTRIRIATEL-------------------CSVL  247 (498)
Q Consensus       214 ~~gsL~~--------------~---l~~~-------~---~~~~l~~~~~~~i~~~i-------------------~~~L  247 (498)
                      +|.+|..              .   |+..       .   ...+..+.++..+..++                   ...+
T Consensus       153 ~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~  232 (424)
T 3mes_A          153 DGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEI  232 (424)
T ss_dssp             CSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHH
T ss_pred             CCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHH
Confidence            9865421              0   0100       0   11122244433333222                   1222


Q ss_pred             HHHHh---------------------cCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          248 IFLHS---------------------CKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       248 ~~LH~---------------------~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ..|..                     ..+..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus       233 ~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          233 DQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            33321                     12346899999999999 7788999999998763

>4ap4_A E3 ubiquitin ligase RNF4; ligase-signalling protein complex, chimera; 2.21A {Rattus norvegicus}

Probab=96.69  E-value=0.00039  Score=58.30  Aligned_cols=57  Identities=19%  Similarity=0.320  Sum_probs=51.0

Q ss_pred             CCCCcCCCccccccCCc-------eeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccH
Q 010882          428 PPPYFTCPIFQEVMQDP-------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL  485 (498)
Q Consensus       428 ~P~~~~cpi~~e~~~dp-------~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~  485 (498)
                      .++.+.|||..+.+.+|       +..+.||.|...+|..|+.. +.+||+++.++...++.|++
T Consensus        69 ~~~~~~C~iC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~  132 (133)
T 4ap4_A           69 GSGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINHKRYHPIY  132 (133)
T ss_dssp             SSSSCBCTTTCCBHHHHHHTTCCEEEETTSBEEEHHHHHHHHHH-CSBCTTTCCBCCGGGEEEEC
T ss_pred             CCCCCCCCCCCCccccccccCcceEeCCCCChhhHHHHHHHHHc-CCCCCCCCCcCChhcceeee
Confidence            46778899999998887       88899999999999999988 67999999999998888875

>1x4j_A Ring finger protein 38; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=96.65  E-value=0.0013  Score=49.13  Aligned_cols=50  Identities=14%  Similarity=0.286  Sum_probs=43.6

Q ss_pred             CCCCcCCCccccccCCc---eeccCCceecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          428 PPPYFTCPIFQEVMQDP---HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       428 ~P~~~~cpi~~e~~~dp---~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      ..+...|||+.+.+.++   +..+.||.|...+|..|+.. +.+||+++..+..
T Consensus        20 ~~~~~~C~IC~~~~~~~~~~~~l~C~H~fh~~Ci~~w~~~-~~~CP~Cr~~~~~   72 (75)
T 1x4j_A           20 QSEQTLCVVCMCDFESRQLLRVLPCNHEFHAKCVDKWLKA-NRTCPICRADSGP   72 (75)
T ss_dssp             SSSCCEETTTTEECCBTCEEEEETTTEEEETTHHHHHHHH-CSSCTTTCCCCCC
T ss_pred             cCCCCCCeECCcccCCCCeEEEECCCCHhHHHHHHHHHHc-CCcCcCcCCcCCC
Confidence            34667899999999887   77889999999999999988 6799999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.64  E-value=0.0067  Score=55.01  Aligned_cols=124  Identities=15%  Similarity=0.083  Sum_probs=76.1

Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      -||.++|...  +.++++.+++.++.|.+.+|.-+-... .+ ..+=+.|..|+|..+|.|-+.+ +.+.          
T Consensus        33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence            3788998643  478999999999999999987762211 11 1223357999999999887664 2110          


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCHHH
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ  375 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (498)
                                .....+.|||... ...+.+.=|||||+++|.-+--..|=                        +-+...
T Consensus        98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e------------------------~eE~eL  142 (229)
T 2yle_A           98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE------------------------NEEREL  142 (229)
T ss_dssp             -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT------------------------TEEECC
T ss_pred             ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc------------------------ccchhh
Confidence                      0233566888763 33456778999999999887632211                        122334


Q ss_pred             HHHHHHHHHHhhhc
Q 010882          376 AEQLANLAMRCCEM  389 (498)
Q Consensus       376 ~~~l~~li~~cl~~  389 (498)
                      ++.|..||..|...
T Consensus       143 S~~LE~LL~~Mt~~  156 (229)
T 2yle_A          143 SPPLEQLIDHMANT  156 (229)
T ss_dssp             CHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHhc
Confidence            56777788777755

>1bor_A Transcription factor PML; proto-oncogene, nuclear bodies (PODS), leukemia, transcription regulation; NMR {Homo sapiens} SCOP: g.44.1.1

Probab=96.04  E-value=0.0023  Score=44.81  Aligned_cols=47  Identities=15%  Similarity=0.172  Sum_probs=41.2

Q ss_pred             CCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCC
Q 010882          429 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHK  479 (498)
Q Consensus       429 P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~  479 (498)
                      .+.+.|||..+.+.+|++.+.||+|+..+|..|    ..+||+++..+...
T Consensus         4 ~~~~~C~IC~~~~~~p~~l~CgH~fC~~Ci~~~----~~~CP~Cr~~~~~~   50 (56)
T 1bor_A            4 FQFLRCQQCQAEAKCPKLLPCLHTLCSGCLEAS----GMQCPICQAPWPLG   50 (56)
T ss_dssp             CCCSSCSSSCSSCBCCSCSTTSCCSBTTTCSSS----SSSCSSCCSSSSCC
T ss_pred             ccCCCceEeCCccCCeEEcCCCCcccHHHHccC----CCCCCcCCcEeecC
Confidence            467899999999999999999999999988774    57999999987643

>2ecl_A Ring-box protein 2; RNF7, ring domian, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=95.97  E-value=0.0071  Score=45.90  Aligned_cols=48  Identities=15%  Similarity=0.252  Sum_probs=38.9

Q ss_pred             CCcCCCccccccCC--------------ceecc-CCceecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQD--------------PHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       430 ~~~~cpi~~e~~~d--------------p~~~~-~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      +.-.|+|..+.+.+              +++.+ .||.|...+|.+|+.. +.+||++|.++..
T Consensus        14 ~~~~C~IC~~~~~~~C~iC~~~~~~~~~~~~~~~C~H~FH~~Ci~~Wl~~-~~~CP~CR~~~~~   76 (81)
T 2ecl_A           14 ECDTCAICRVQVMDACLRCQAENKQEDCVVVWGECNHSFHNCCMSLWVKQ-NNRCPLCQQDWVV   76 (81)
T ss_dssp             CCSCBTTTTBCTTSCCTTHHHHTCTTTCCEEEETTSCEEEHHHHHHHTTT-CCBCTTTCCBCCE
T ss_pred             CCCCCcccChhhhccCcccccccCCCceEEEeCCCCCccChHHHHHHHHh-CCCCCCcCCCcch
Confidence            34558888887766              44554 9999999999999988 6799999998764

>4ic3_A E3 ubiquitin-protein ligase XIAP; ring domain, zinc-finger, E3 ligase; 1.78A {Homo sapiens} PDB: 4ic2_A

Probab=95.56  E-value=0.0043  Score=46.20  Aligned_cols=44  Identities=11%  Similarity=0.058  Sum_probs=40.0

Q ss_pred             CCcCCCccccccCCceeccCCce-ecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQDPHVAADGFT-YEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~~~g~t-~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      +.+.|+|..+.+.+|+..+.||. ++..++..|     .+||+++.++..
T Consensus        23 ~~~~C~iC~~~~~~~~~~pCgH~~~C~~C~~~~-----~~CP~Cr~~i~~   67 (74)
T 4ic3_A           23 EEKLCKICMDRNIAIVFVPCGHLVTCKQCAEAV-----DKCPMCYTVITF   67 (74)
T ss_dssp             HHTBCTTTSSSBCCEEEETTCCBCCCHHHHTTC-----SBCTTTCCBCSE
T ss_pred             cCCCCCCCCCCCCCEEEcCCCChhHHHHhhhcC-----ccCCCcCcCccC
Confidence            45679999999999999999999 999999999     699999998764

>3dpl_R Ring-box protein 1; ubiquitin, NEDD8, cullin, HOST-virus interaction, receptor, UBL conjugation, UBL conjugation pathway, acetylation, cytoplasm; 2.60A {Homo sapiens} SCOP: g.44.1.1 PDB: 3dqv_R 3rtr_B 4f52_B 1u6g_B 2hye_D* 4a0c_D 4a0l_F* 1ldj_B 1ldk_C 2lgv_A

Probab=95.17  E-value=0.022  Score=45.57  Aligned_cols=45  Identities=16%  Similarity=0.369  Sum_probs=37.4

Q ss_pred             cCCCccccccCCc------------------eeccCCceecHHHHHHHHhcCCCCCCCCCCCCC
Q 010882          432 FTCPIFQEVMQDP------------------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLA  477 (498)
Q Consensus       432 ~~cpi~~e~~~dp------------------~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~  477 (498)
                      -.|+|+.+.+.++                  +..++||.|...+|..|+.. +.+||+++....
T Consensus        38 d~CaIC~~~~~~~c~~C~~~~~~~~~~~~~~~~~~C~H~FH~~Ci~~Wl~~-~~~CP~Cr~~~~  100 (106)
T 3dpl_R           38 DNCAICRNHIMDLCIECQANQASATSEECTVAWGVCNHAFHFHCISRWLKT-RQVCPLDNREWE  100 (106)
T ss_dssp             CCCSSSCSCTTSCCTTHHHHTTCC---CCCEEEETTSCEEEHHHHHHHHTT-CSBCSSSCSBCC
T ss_pred             CCCccCChhHhCcCchhhccccccCCccceEeecccCcEECHHHHHHHHHc-CCcCcCCCCcce
Confidence            4588888877765                  34679999999999999988 889999998753

>1wim_A KIAA0161 protein; ring finger domain, UBCM4-interacting protein 4, UIP4, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.1

Probab=94.82  E-value=0.0081  Score=46.99  Aligned_cols=67  Identities=10%  Similarity=0.152  Sum_probs=48.7

Q ss_pred             CCCcCCCccccccCCceec---cCCceecHHHHHHHHhc----C---CCCCCC--CCCC--CCCCCCCccHHHHHHHHHH
Q 010882          429 PPYFTCPIFQEVMQDPHVA---ADGFTYEAEALKGWLDS----G---HETSPM--TNLP--LAHKNLVPNLALRSAIQEW  494 (498)
Q Consensus       429 P~~~~cpi~~e~~~dp~~~---~~g~t~~~~~i~~w~~~----~---~~~~p~--~~~~--~~~~~~~pn~~l~~~i~~~  494 (498)
                      .+.|.|||+.+.+.+|+..   ++||.|++.++..|+..    |   .-+||.  ++..  ++...+ .|+...+.++.|
T Consensus         3 ~~~~~C~IC~~~~~~~~~~~l~~CgH~FC~~Cl~~~~~~~i~~g~~~~i~CP~~~C~~~~~~~~~~i-~~ll~~~~~~ky   81 (94)
T 1wim_A            3 SGSSGCKLCLGEYPVEQMTTIAQCQCIFCTLCLKQYVELLIKEGLETAISCPDAACPKQGHLQENEI-ECMVAAEIMQRY   81 (94)
T ss_dssp             CSBCCCSSSCCCCBGGGEEEETTTTEEEEHHHHHHHHHHHHHHCSCCCEECSCTTCSSCCEECHHHH-HHHSCHHHHHHH
T ss_pred             CCCcCCcccCcccccccceEcCCCCCcccHHHHHHHHHHHhhcCCcccccCccccCCCCCccCHHHH-HHHCCHHHHHHH
Confidence            3578899999999888765   69999999999997653    2   248999  8887  554332 344445666666


Q ss_pred             HH
Q 010882          495 LQ  496 (498)
Q Consensus       495 ~~  496 (498)
                      .+
T Consensus        82 ~~   83 (94)
T 1wim_A           82 KK   83 (94)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>2vje_A E3 ubiquitin-protein ligase MDM2; proto-oncogene, phosphorylation, alternative splicing, HOST-virus interaction, UBL conjugation pathway, zinc-finger, polymorphism; HET: FLC; 2.20A {Homo sapiens} PDB: 2vjf_A* 2hdp_A

Probab=94.49  E-value=0.031  Score=40.14  Aligned_cols=48  Identities=15%  Similarity=0.180  Sum_probs=42.2

Q ss_pred             CCCcCCCccccccCCceec--cCCce-ecHHHHHHHHhcCCCCCCCCCCCCC
Q 010882          429 PPYFTCPIFQEVMQDPHVA--ADGFT-YEAEALKGWLDSGHETSPMTNLPLA  477 (498)
Q Consensus       429 P~~~~cpi~~e~~~dp~~~--~~g~t-~~~~~i~~w~~~~~~~~p~~~~~~~  477 (498)
                      ++...|+|..+...|+++.  +.||. ++..++..|... +.+||++|.++.
T Consensus         6 ~~~~~C~IC~~~~~~~~~~~~pCgH~~~C~~C~~~~~~~-~~~CPiCR~~i~   56 (64)
T 2vje_A            6 NAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKR-NKPCPVCRQPIQ   56 (64)
T ss_dssp             GGGSCCTTTSSSCSCEEEEETTEEEEEECHHHHHHHHHT-TCCCTTTCCCCC
T ss_pred             CCcCCCCcCCCCCCCEEEECCCCCChhhHHHHHHHHHHc-CCcCCCcCcchh
Confidence            3556799999999999987  99999 799999999876 679999999886

>2ecg_A Baculoviral IAP repeat-containing protein 4; BIRC4, ring domian, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=94.16  E-value=0.027  Score=41.82  Aligned_cols=45  Identities=13%  Similarity=0.085  Sum_probs=39.1

Q ss_pred             CCcCCCccccccCCceeccCCce-ecHHHHHHHHhcCCCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQDPHVAADGFT-YEAEALKGWLDSGHETSPMTNLPLAHK  479 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~~~g~t-~~~~~i~~w~~~~~~~~p~~~~~~~~~  479 (498)
                      +.+.|||..+.+.+|+..+.||. ++..++..     ...||+++.++...
T Consensus        24 ~~~~C~IC~~~~~~~~~~pCgH~~~C~~C~~~-----~~~CP~Cr~~i~~~   69 (75)
T 2ecg_A           24 EEKLCKICMDRNIAIVFVPCGHLVTCKQCAEA-----VDKCPMCYTVITFK   69 (75)
T ss_dssp             HHHSCSSSCSSCCCBCCSSSCCCCBCHHHHHH-----CSBCTTTCCBCCCC
T ss_pred             CCCCCCcCCCCCCCEEEecCCCHHHHHHHhhC-----CCCCccCCceecCc
Confidence            45679999999999999999999 99999864     37999999998753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.71  E-value=0.13  Score=51.61  Aligned_cols=30  Identities=33%  Similarity=0.444  Sum_probs=25.1

Q ss_pred             CcccCCCCCCcEEE------cCCCceeEeecccccc
Q 010882          257 SIVHGDLKPANILL------DANFVSKLSDFGISRF  286 (498)
Q Consensus       257 ~ivHrDlkp~NiLl------~~~~~~kl~DFGla~~  286 (498)
                      .++|+|+.+.|||+      +.+..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4467799999998764

>2d8s_A Cellular modulator of immune recognition; C-MIR, march8, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=93.60  E-value=0.11  Score=39.15  Aligned_cols=51  Identities=14%  Similarity=0.262  Sum_probs=40.8

Q ss_pred             CCCCcCCCcccccc--CCceeccCC-----ceecHHHHHHHHhcCC-CCCCCCCCCCCC
Q 010882          428 PPPYFTCPIFQEVM--QDPHVAADG-----FTYEAEALKGWLDSGH-ETSPMTNLPLAH  478 (498)
Q Consensus       428 ~P~~~~cpi~~e~~--~dp~~~~~g-----~t~~~~~i~~w~~~~~-~~~p~~~~~~~~  478 (498)
                      ..+.-.|+|+.+-+  .++++.+.+     +.|...+|.+|+...+ .+||+++..+..
T Consensus        12 ~~~~~~C~IC~~~~~~~~~l~~pC~C~Gs~h~fH~~Cl~~Wl~~~~~~~CplCr~~~~~   70 (80)
T 2d8s_A           12 PSSQDICRICHCEGDDESPLITPCHCTGSLHFVHQACLQQWIKSSDTRCCELCKYEFIM   70 (80)
T ss_dssp             CTTSCCCSSSCCCCCSSSCEECSSSCCSSSCCEETTHHHHHHHHHCCSBCSSSCCBCCC
T ss_pred             CCCCCCCeEcCccccCCCeeEeccccCCcCCeeCHHHHHHHHhhCCCCCCCCCCCeeec
Confidence            44566799998655  568888875     9999999999998733 699999999864

>2vje_B MDM4 protein; proto-oncogene, phosphorylation, alternative splicing, HOST-virus interaction, UBL conjugation pathway, zinc-finger, polymorphism; HET: FLC; 2.20A {Homo sapiens} PDB: 2vjf_B*

Probab=93.59  E-value=0.047  Score=39.01  Aligned_cols=48  Identities=8%  Similarity=0.150  Sum_probs=41.6

Q ss_pred             CCcCCCccccccCCceec--cCCce-ecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQDPHVA--ADGFT-YEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~--~~g~t-~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      ....|+|..+...|+++.  +.||. ++..++..|... +.+||++|.++..
T Consensus         6 ~~~~C~IC~~~~~~~~~~~~pCgH~~~C~~C~~~~~~~-~~~CPiCR~~i~~   56 (63)
T 2vje_B            6 LLKPCSLCEKRPRDGNIIHGRTGHLVTCFHCARRLKKA-GASCPICKKEIQL   56 (63)
T ss_dssp             GGSBCTTTSSSBSCEEEEETTEEEEEECHHHHHHHHHT-TCBCTTTCCBCCE
T ss_pred             cCCCCcccCCcCCCeEEEecCCCCHhHHHHHHHHHHHh-CCcCCCcCchhhc
Confidence            345699999999999988  99998 899999998877 5799999998863

>3t6p_A Baculoviral IAP repeat-containing protein 2; ring, BIR, CARD, UBA, apoptosis, ubiquitin ligase, SMAC/ ubiquitin, caspase, IAP family, SMAC mimetic; 1.90A {Homo sapiens} PDB: 1qbh_A 2l9m_A 3eb5_A 3eb6_A 4auq_B

Probab=93.42  E-value=0.023  Score=55.63  Aligned_cols=45  Identities=11%  Similarity=0.048  Sum_probs=41.2

Q ss_pred             CCCcCCCccccccCCceeccCCce-ecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          429 PPYFTCPIFQEVMQDPHVAADGFT-YEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       429 P~~~~cpi~~e~~~dp~~~~~g~t-~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      .+.+.|||+.+.+.+|+..++||. ++..|+..|     ..||+|+.++..
T Consensus       293 ~~~~~C~IC~~~~~~~v~lpCgH~~fC~~C~~~~-----~~CP~CR~~i~~  338 (345)
T 3t6p_A          293 QEERTCKVCMDKEVSVVFIPCGHLVVCQECAPSL-----RKCPICRGIIKG  338 (345)
T ss_dssp             HTTCBCTTTSSSBCCEEEETTCCEEECTTTGGGC-----SBCTTTCCBCCE
T ss_pred             cCCCCCCccCCcCCceEEcCCCChhHhHHHHhcC-----CcCCCCCCCccC
Confidence            467899999999999999999999 999999988     689999998864

>2yho_A E3 ubiquitin-protein ligase mylip; ligase, E2 ligase-E3 ligase complex, ring zinc-finger, UBL conjugation pathway; 2.10A {Homo sapiens} PDB: 2yhn_A

Probab=91.93  E-value=0.026  Score=42.47  Aligned_cols=54  Identities=15%  Similarity=0.174  Sum_probs=42.1

Q ss_pred             CcCCCccccccCCceeccCCce-ecHHHHHHHHhcCCCCCCCCCCCCCCC---CCCccHHHHH
Q 010882          431 YFTCPIFQEVMQDPHVAADGFT-YEAEALKGWLDSGHETSPMTNLPLAHK---NLVPNLALRS  489 (498)
Q Consensus       431 ~~~cpi~~e~~~dp~~~~~g~t-~~~~~i~~w~~~~~~~~p~~~~~~~~~---~~~pn~~l~~  489 (498)
                      ...|+|..+...+|+..+.||. ++..++..|     ..||+++.++...   .+.||..+.+
T Consensus        18 ~~~C~IC~~~~~~~v~~pCgH~~~C~~C~~~~-----~~CP~Cr~~i~~~~~i~~p~~~~~~~   75 (79)
T 2yho_A           18 AMLCMVCCEEEINSTFCPCGHTVCCESCAAQL-----QSCPVCRSRVEHVQHVYLPTHTSLLN   75 (79)
T ss_dssp             HTBCTTTSSSBCCEEEETTCBCCBCHHHHTTC-----SBCTTTCCBCCEEEECBCTTCCC---
T ss_pred             CCEeEEeCcccCcEEEECCCCHHHHHHHHHhc-----CcCCCCCchhhCeEEEEeCcchhhhh
Confidence            3469999999999999999999 999999887     3999999988644   3445655554

>4a0k_B E3 ubiquitin-protein ligase RBX1; ligase-DNA-binding protein-DNA complex, DNA-binding protein- complex; HET: DNA 3DR; 5.93A {Mus musculus}

Probab=91.90  E-value=0.03  Score=45.58  Aligned_cols=44  Identities=16%  Similarity=0.428  Sum_probs=0.0

Q ss_pred             CCCccccccCCce-----------------e-ccCCceecHHHHHHHHhcCCCCCCCCCCCCC
Q 010882          433 TCPIFQEVMQDPH-----------------V-AADGFTYEAEALKGWLDSGHETSPMTNLPLA  477 (498)
Q Consensus       433 ~cpi~~e~~~dp~-----------------~-~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~  477 (498)
                      .|+|+.+.+.++.                 + .++||.|...+|..|+.. +.+||+++.+..
T Consensus        50 ~CaICl~~~~~~c~~C~~~~~~~~~~~~~v~~~~C~H~FH~~CI~~Wl~~-~~~CP~Cr~~~~  111 (117)
T 4a0k_B           50 NCAICRNHIMDLCIECQANQASATSEECTVAWGVCNHAFHFHCISRWLKT-RQVCPLDNREWE  111 (117)
T ss_dssp             ---------------------------------------------------------------
T ss_pred             cCeECChhhcCcChhhhcccccccccccccccCCcCceEcHHHHHHHHHc-CCcCCCCCCeee
Confidence            5888887776642                 2 479999999999999988 889999998754

>2kkx_A Uncharacterized protein ECS2156; methods development, U-box domain, structural genomics, PSI- protein structure initiative; NMR {Escherichia coli} PDB: 2kky_A

Probab=91.89  E-value=0.19  Score=38.68  Aligned_cols=64  Identities=22%  Similarity=0.337  Sum_probs=50.1

Q ss_pred             CCCCCCCCCCCCCCcCCCccccccCCceecc--CCc----eecHHHHHHHHhcCCCCCCCCCCCCCCCCCC
Q 010882          418 YRLGSEERCEPPPYFTCPIFQEVMQDPHVAA--DGF----TYEAEALKGWLDSGHETSPMTNLPLAHKNLV  482 (498)
Q Consensus       418 ~~~~~~~~~~~P~~~~cpi~~e~~~dp~~~~--~g~----t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~  482 (498)
                      |...+....-+++++.|||+.++-..-|...  .|.    =|+..++.+-... +...|++|++++..+++
T Consensus        14 F~V~~~~f~C~ee~l~CPITL~~PE~GVFvkNs~~S~VCsLyD~~Al~~Lv~~-~~~HPLSREpit~sMIv   83 (102)
T 2kkx_A           14 FSVCPERLQCPLEAIQCPITLEQPEKGIFVKNSDGSDVCTLFDAAAFSRLVGE-GLPHPLTREPITASIIV   83 (102)
T ss_dssp             EECCTTTTTCCTGGGCBTTTTBCCSEEEEEEETTTTSEEEEEEHHHHHHHHHH-TCCCTTTCCCCCTTTEE
T ss_pred             cccChhhccCCHHHcCCCeEEeeCCcceEEecCCCCccceecCHHHHHHHHhc-CCCCCCccCCCCHhhEe
Confidence            4445666667889999999999988876654  332    2999999999888 66999999999877653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.96  E-value=0.34  Score=43.75  Aligned_cols=113  Identities=7%  Similarity=0.196  Sum_probs=73.6

Q ss_pred             CCCCeeee-eceecCcceEEEeeCCCC-CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcE
Q 010882          191 RHPNLVTL-VGACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI  268 (498)
Q Consensus       191 ~hpniv~l-~g~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Ni  268 (498)
                      .||+++.. +..-.+.+.+.|+.-+.+ ++.. +      ..++...+++++..++....+++.     -+|--|.|+||
T Consensus        43 ~~~~Fl~~~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDAELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCEEEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccceEEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            58887754 222234344444433221 2322 2      347788999999999887766554     57889999999


Q ss_pred             EEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCC
Q 010882          269 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL  345 (498)
Q Consensus       269 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf  345 (498)
                      +++.++.+++.-.|+-..+.                         |.     .++...=+-.+=|++..+++|+..|
T Consensus       111 ~f~~~~~p~i~~RGik~~l~-------------------------P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVD-------------------------PL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             EECTTSCEEESCCEETTTBS-------------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EEcCCCCEEEEEccCccCCC-------------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999999888643221                         11     1111222445788999999998887

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.56  E-value=0.58  Score=42.35  Aligned_cols=113  Identities=18%  Similarity=0.176  Sum_probs=74.7

Q ss_pred             CCCCeeeeeceecCcceEEEeeCCCC-CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCcccCCCCCCcE
Q 010882          191 RHPNLVTLVGACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLI-FLHSCKPHSIVHGDLKPANI  268 (498)
Q Consensus       191 ~hpniv~l~g~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivHrDlkp~Ni  268 (498)
                      .||++..-+..-.+.+.+.++.-+++ ++..+       ..++...+++++..++.... +++.     -+|--|.|+||
T Consensus        48 ~~~~f~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCIVRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSSEEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred             cCCCCCeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence            57887444444455566666654333 34433       23677899999888887666 4544     78889999999


Q ss_pred             EEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCC
Q 010882          269 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL  345 (498)
Q Consensus       269 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf  345 (498)
                      ++|.++.++|.-.|+-..+.+..                    +.+|-+          +-++=|++..++.++..|
T Consensus       116 ~f~~~~~p~i~hRGi~~~lpP~e--------------------~~ee~f----------l~qyKali~all~~K~~F  162 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESLPPDE--------------------WDDERL----------LREVKATVLALTEGEYRF  162 (219)
T ss_dssp             EECTTCCEEESCCEETTTBSSCS--------------------CCHHHH----------HHHHHHHHHHHTTCSSCH
T ss_pred             EEeCCCcEEEEEcCCcccCCCCC--------------------CCHHHH----------HHHHHHHHHHHHcCCCCH
Confidence            99999999999988643221110                    122222          345778888888888777

>2ea5_A Cell growth regulator with ring finger domain protein 1; CGRRF1, ring domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=88.93  E-value=0.56  Score=33.85  Aligned_cols=47  Identities=13%  Similarity=0.038  Sum_probs=40.3

Q ss_pred             CCCCCcCCCccccccCCceeccCCce-ecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFT-YEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t-~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      .-.+...|+|..+...+++..+.||. ++..++..     ..+||+++.++..
T Consensus        11 ~~~~~~~C~IC~~~~~~~v~~pCgH~~~C~~C~~~-----~~~CP~CR~~i~~   58 (68)
T 2ea5_A           11 SEENSKDCVVCQNGTVNWVLLPCRHTCLCDGCVKY-----FQQCPMCRQFVQE   58 (68)
T ss_dssp             SCCCSSCCSSSSSSCCCCEETTTTBCCSCTTHHHH-----CSSCTTTCCCCCC
T ss_pred             cCCCCCCCCCcCcCCCCEEEECCCChhhhHHHHhc-----CCCCCCCCcchhc
Confidence            34567889999999999999999999 99988873     4799999998864

>2ct0_A Non-SMC element 1 homolog; ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=87.47  E-value=1  Score=33.14  Aligned_cols=47  Identities=15%  Similarity=0.254  Sum_probs=35.9

Q ss_pred             cCCCccccccCCceec-cCCceecHHHHHHHHhcC-CCCCCCCCCCCCC
Q 010882          432 FTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSG-HETSPMTNLPLAH  478 (498)
Q Consensus       432 ~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~~~~-~~~~p~~~~~~~~  478 (498)
                      -.|+|+.+++..-..- ..++.|...+|.+||... ..+||+++.....
T Consensus        16 ~~C~IC~~~i~~g~~C~~C~h~fH~~Ci~kWl~~~~~~~CP~Cr~~w~~   64 (74)
T 2ct0_A           16 KICNICHSLLIQGQSCETCGIRMHLPCVAKYFQSNAEPRCPHCNDYWPH   64 (74)
T ss_dssp             CBCSSSCCBCSSSEECSSSCCEECHHHHHHHSTTCSSCCCTTTCSCCCS
T ss_pred             CcCcchhhHcccCCccCCCCchhhHHHHHHHHHhcCCCCCCCCcCcCCC
Confidence            4588888776543322 588999999999999773 2799999988763

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.26  E-value=0.099  Score=53.51  Aligned_cols=57  Identities=9%  Similarity=0.107  Sum_probs=16.0

Q ss_pred             CCcccccCceEEEEEEECC--eEEEE------EEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeecee
Q 010882          143 SLKIGEGGYGSIYKGLLRH--MQVAI------KMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC  202 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~--~~vav------K~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~  202 (498)
                      .+.||   ||+||+|.+.+  .+|||      |..+....  .....|.+|..++..++|||+++.+++.
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            45576   99999999864  57888      76554222  2234688899999999999999987753

>3ghg_A Fibrinogen alpha chain; triple-stranded coiled coil, beta sheets, alpha helices, AMY amyloidosis, blood coagulation, disease mutation, glycoprot phosphoprotein; HET: NAG NDG BMA MAN GAL SIA; 2.90A {Homo sapiens} PDB: 3h32_A* 2a45_G*

Probab=82.02  E-value=28  Score=35.11  Aligned_cols=37  Identities=16%  Similarity=0.241  Sum_probs=17.4

Q ss_pred             hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 010882           65 ESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKA  101 (498)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  101 (498)
                      +.+.....++.++...+..++.++...+++..+..++
T Consensus       114 ELRRrIqyLKekVdnQlsnIrvLQsnLedq~~kIQRL  150 (562)
T 3ghg_A          114 DLRSRIEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRL  150 (562)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            3344455555555555544444444444444333333

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	498
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-55
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-49
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-48
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-25
d1t1ha_	78	g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre	1e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18
d2c2la2	80	g.44.1.2 (A:225-304) STIP1 homology and U box-cont	2e-14
d1wgma_	98	g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu	4e-12
d1jm7a_	103	g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie	1e-07
d2baya1	56	g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {	2e-04
d1eq1a_	166	a.63.1.1 (A:) Apolipophorin-III {Manduca sexta [Ta	8e-04
d1f5na1	300	a.114.1.1 (A:284-583) Interferon-induced guanylate	0.001

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 1e-66
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 26/276 (9%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +IG G +G++YKG      VA+KML+  +   Q    F+ E+ +L K RH N++  +G  
Sbjct: 15  RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 203 PEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
                 +V ++    SL   L              I IA +    + +LH     SI+H 
Sbjct: 74  TAPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL---A 318
           DLK  NI L  +   K+ DFG++   S+   S     L       G+  +M PE +    
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVIRMQD 182

Query: 319 SGELTPKSDVYSFGIILLRLLTGRP---ALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 375
               + +SDVY+FGI+L  L+TG+     +    ++ + +  G L   L  +  + P   
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP--- 239

Query: 376 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 411
            + +  L   C +  R  RP     +   +E +  S
Sbjct: 240 -KAMKRLMAECLKKKRDERPLF-PQILASIELLARS 273

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-58
 Identities = 73/270 (27%), Positives = 120/270 (44%), Gaps = 22/270 (8%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           ++G G +G ++ G    H +VA+K L   S   P  F  E +++ +++H  LV L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 203 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   ++ EY+ NGSL D L    +   L+    + +A ++   + F+      + +H D
Sbjct: 79  QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134

Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+      K++DFG++R +  NE          R   K    +  PE +  G  
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNE-------YTAREGAKFPIKWTAPEAINYGTF 187

Query: 323 TPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 381
           T KSDV+SFGI+L  ++T GR         +       ++NL        P    E+L  
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCPEELYQ 241

Query: 382 LAMRCCEMSRKSRPELGKDVWRVLEPMRAS 411
           L   C +   + RP     +  VLE    +
Sbjct: 242 LMRLCWKERPEDRPTF-DYLRSVLEDFFTA 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-56
 Identities = 65/269 (24%), Positives = 114/269 (42%), Gaps = 28/269 (10%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 202
            IG+G +G +  G  R  +VA+K +   +      F  E  +++++RH NLV L+G    
Sbjct: 14  TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71

Query: 203 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
                 +V EY+  GSL D L  +  S  L     ++ + ++C  + +L     ++ VH 
Sbjct: 72  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N+L+  + V+K+SDFG+++  S             +   K    +  PE L   +
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASST-----------QDTGKLPVKWTAPEALREKK 176

Query: 322 LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 380
            + KSDV+SFGI+L  + + GR                 +  +      D P      + 
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPAVY 230

Query: 381 NLAMRCCEMSRKSRPELGKDVWRVLEPMR 409
            +   C  +    RP     +   LE ++
Sbjct: 231 EVMKNCWHLDAAMRPSF-LQLREQLEHIK 258

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (475), Expect = 4e-56
 Identities = 72/304 (23%), Positives = 129/304 (42%), Gaps = 35/304 (11%)

Query: 124 FFSDFSFSEIEGATHNFDPSL---------KIGEGGYGSIYKGLLR-----HMQVAIKML 169
           F   F+F +   A   F   +          IG G +G +  G L+      + VAIK L
Sbjct: 3   FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62

Query: 170 HP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKD 226
              ++ +   +F  E  I+ +  HPN++ L G         ++ E++ NGSL+     + 
Sbjct: 63  KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF--LRQ 120

Query: 227 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 286
           N    +    + +   + + + +L      + VH DL   NIL+++N V K+SDFG+SRF
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPA 344
           L  +   +++ T       K    +  PE +   + T  SDV+S+GI++  +++   RP 
Sbjct: 178 LEDD---TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234

Query: 345 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 404
             +T +         +  +        P      L  L + C +  R  RP+    +   
Sbjct: 235 WDMTNQDV-------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF-GQIVNT 286

Query: 405 LEPM 408
           L+ M
Sbjct: 287 LDKM 290

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 6e-56
 Identities = 60/270 (22%), Positives = 119/270 (44%), Gaps = 22/270 (8%)

Query: 145 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           +IG G +G ++ G   +   VAIK +   +     +F +E +++ K+ HP LV L G C 
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70

Query: 203 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 261
                 LV+E++ +G L D    +      + +T + +  ++C  +      +   ++H 
Sbjct: 71  EQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHR 125

Query: 262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 321
           DL   N L+  N V K+SDFG++RF+  ++ +S+  T       K    +  PE  +   
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 178

Query: 322 LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 381
            + KSDV+SFG+++  + +        +          ++++        P + +  +  
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQ 233

Query: 382 LAMRCCEMSRKSRPELGKDVWRVLEPMRAS 411
           +   C +   + RP     + R L  +  S
Sbjct: 234 IMNHCWKERPEDRPAF-SRLLRQLAEIAES 262

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 7e-56
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 20/216 (9%)

Query: 133 IEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSK 189
           +E    +F+   ++G G  G ++K   +   + +A K++H        ++  +E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 190 IRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
              P +V   GA       ++  E++  GSL+  L     +  +  Q   +++  +   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117

Query: 248 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            +L     H I+H D+KP+NIL+++    KL DFG+S  L  +                G
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----------ANSFVG 165

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           T +YM PE L     + +SD++S G+ L+ +  GR 
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-55
 Identities = 78/269 (28%), Positives = 119/269 (44%), Gaps = 20/269 (7%)

Query: 145 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 202
           K+G+G +G ++ G      +VAIK L P +   P  F QE  ++ K+RH  LV L     
Sbjct: 24  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82

Query: 203 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 262
            E   +V EY+  GSL       +    L     + +A ++ S + ++      + VH D
Sbjct: 83  EEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 138

Query: 263 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 322
           L+ ANIL+  N V K++DFG++R +  NE ++       R   K    +  PE    G  
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRF 191

Query: 323 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 382
           T KSDV+SFGI+L  L T           +  LD    +    P   + P    E L +L
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECP----ESLHDL 246

Query: 383 AMRCCEMSRKSRPELGKDVWRVLEPMRAS 411
             +C     + RP   + +   LE    S
Sbjct: 247 MCQCWRKEPEERPTF-EYLQAFLEDYFTS 274

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-55
 Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 42/297 (14%)

Query: 145 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 202
            IG+G +G +++G  R  +VA+K+      +     + EI     +RH N++  + A   
Sbjct: 10  SIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68

Query: 203 ----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS-----C 253
                    LV +Y  +GSL D L    N   ++ +  I++A    S L  LH       
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
              +I H DLK  NIL+  N    ++D G++        S+ +T         GT  YM 
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD----SATDTIDIAPNHRVGTKRYMA 180

Query: 314 PEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-------------A 354
           PE L         E   ++D+Y+ G++   +       GI ++ Q               
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 355 LDTGKLKNLLDP-LAGDWPFVQA-EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 409
           +     +  L P +   W   +A   +A +   C   +  +R      + + L  + 
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLS 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (465), Expect = 9e-55
 Identities = 72/288 (25%), Positives = 140/288 (48%), Gaps = 24/288 (8%)

Query: 126 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQE 183
           S  ++ + E    +     K+G G YG +Y+G+ +   + VA+K L   +++   EF +E
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63

Query: 184 IDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 241
             ++ +I+HPNLV L+G C     + ++ E++  G+L D L  + N   +S    + +AT
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMAT 122

Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 301
           ++ S + +L      + +H DL   N L+  N + K++DFG+SR ++ +  +++      
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA--- 176

Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 361
               K    +  PE LA  + + KSDV++FG++L  + T   +          +D  ++ 
Sbjct: 177 ----KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVY 226

Query: 362 NLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
            LL+     + P    E++  L   C + +   RP    ++ +  E M
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETM 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-54
 Identities = 56/262 (21%), Positives = 105/262 (40%), Gaps = 30/262 (11%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 200
           +IG G + ++YKGL     ++VA   L    L       F++E ++L  ++HPN+V    
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 201 AC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           +        +   LV E + +G+L+  L        +  +       ++   L FLH+  
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 255 PHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           P  I+H DLK  NI +       K+ D G++        +S    +       GT  +M 
Sbjct: 133 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVI------GTPEFMA 181

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 373
           PE +   +     DVY+FG+ +L + T        +         ++ + + P    +  
Sbjct: 182 PE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR--RVTSGVKPA--SFDK 236

Query: 374 VQAEQLANLAMRCCEMSRKSRP 395
           V   ++  +   C   ++  R 
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERY 258

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 61/272 (22%), Positives = 115/272 (42%), Gaps = 23/272 (8%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 197
           +     ++G G +G +  G  R    VAIKM+   S     EF +E  ++  + H  LV 
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 198 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           L G C       ++ EY+ NG L + L    +      Q  + +  ++C  + +L     
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---S 118

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
              +H DL   N L++   V K+SDFG+SR++  +E +S           K    +  PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-------SVGSKFPVRWSPPE 171

Query: 316 FLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 374
            L   + + KSD+++FG+++  + + G+         +        +++   L    P +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQGLRLYRPHL 225

Query: 375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 406
            +E++  +   C       RP     +  +L+
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 2e-54
 Identities = 57/270 (21%), Positives = 110/270 (40%), Gaps = 24/270 (8%)

Query: 144 LKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 198
           +++G G +GS+ +G+ R     + VAIK+L   + +    E  +E  I+ ++ +P +V L
Sbjct: 15  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74

Query: 199 VGACPEV-WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C      LV E    G L   L        +       +  ++   + +L      +
Sbjct: 75  IGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLE---EKN 129

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L  ++      +            +  PE +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK-----WPLKWYAPECI 184

Query: 318 ASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 376
              + + +SDV+S+G+ +   L+ G+      K  +       +  +      + P    
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGKRMECPPECP 238

Query: 377 EQLANLAMRCCEMSRKSRPELGKDVWRVLE 406
            +L  L   C     + RP+    V + + 
Sbjct: 239 PELYALMSDCWIYKWEDRPDF-LTVEQRMR 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-53
 Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 30/274 (10%)

Query: 145 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 198
           ++G G +G++ KG  +       VA+K+L   +       E   E +++ ++ +P +V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 199 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G C  E W LV E    G L   L     +  +  +  I +  ++   + +L      +
Sbjct: 74  IGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH DL   N+LL     +K+SDFG+S+ L      ++      +T  K    +  PE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR-----ADENYYKAQTHGKWPVKWYAPECI 182

Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 374
              + + KSDV+SFG+++    +   +P  G+   EV   L+ G+            P  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----RMGCPAGCP-- 236

Query: 375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
              ++ +L   C     ++RP     V   L   
Sbjct: 237 --REMYDLMNLCWTYDVENRPGF-AAVELRLRNY 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-53
 Identities = 63/268 (23%), Positives = 106/268 (39%), Gaps = 25/268 (9%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPN 194
           +++    IG G YG   K   +     +  K L   S+          E+++L +++HPN
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 195 LVTLVGAC----PEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 249
           +V               +V EY   G L   ++        L  +  +R+ T+L   L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 250 LH--SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 307
            H  S   H+++H DLKPAN+ LD     KL DFG++R L+ +  +S             
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVG------ 176

Query: 308 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 367
           T  YM PE +       KSD++S G +L  L    P      + +          + +  
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREGK 230

Query: 368 AGDWPFVQAEQLANLAMRCCEMSRKSRP 395
               P+  +++L  +  R   +    RP
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRP 258

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-52
 Identities = 71/274 (25%), Positives = 113/274 (41%), Gaps = 27/274 (9%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNL 195
           ++D    +GEG YG +   + R     VA+K++    ++  P   ++EI I   + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 196 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
           V   G      +  L  EY   G L DR+        +      R   +L + +++LH  
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG- 121

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
               I H D+KP N+LLD     K+SDFG++     N        +C      GT  Y+ 
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVA 173

Query: 314 PEFLASGEL-TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDW 371
           PE L   E      DV+S GI+L  +L G       +   Q   D  + K  L+P    W
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----W 229

Query: 372 PFVQAEQLANLAMRCCEMSRKSRP---ELGKDVW 402
             + +     L  +    +  +R    ++ KD W
Sbjct: 230 KKIDSA-PLALLHKILVENPSARITIPDIKKDRW 262

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-52
 Identities = 61/260 (23%), Positives = 108/260 (41%), Gaps = 26/260 (10%)

Query: 145 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           ++G+G +G +YK   +      A K++   S +   ++  EIDIL+   HPN+V L+ A 
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                  ++ E+   G+++  +   +   PL+      +  +    L +LH    + I+H
Sbjct: 79  YYENNLWILIEFCAGGAVDAVM--LELERPLTESQIQVVCKQTLDALNYLHD---NKIIH 133

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS- 319
            DLK  NIL   +   KL+DFG+S   ++        T+  R    GT  +M PE +   
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTR--------TIQRRDSFIGTPYWMAPEVVMCE 185

Query: 320 ----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 375
                    K+DV+S GI L+ +    P       ++  L   K +         W    
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS--- 242

Query: 376 AEQLANLAMRCCEMSRKSRP 395
                +   +C E +  +R 
Sbjct: 243 -SNFKDFLKKCLEKNVDARW 261

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-52
 Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 26/277 (9%)

Query: 145 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 198
            IG G +G +Y G L       +  A+K L+  +  G  S+F  E  I+    HPN+++L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 199 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           +G C        +V  Y+ +G L +    ++ +   + +  I    ++   +        
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
              VH DL   N +LD  F  K++DFG++R +   E      ++  +T  K    +M  E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMALE 204

Query: 316 FLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 374
            L + + T KSDV+SFG++L  L+T G P           +   + + LL P     P  
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--EYCP-- 260

Query: 375 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 411
             + L  + ++C     + RP    ++   +  + ++
Sbjct: 261 --DPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFST 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-52
 Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 27/290 (9%)

Query: 131 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQG-PSEFQQE 183
           +EI            IG G +G +YKG+L+       + VAIK L     +    +F  E
Sbjct: 2   TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59

Query: 184 IDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 241
             I+ +  H N++ L G   +     ++ EY+ NG+L+     ++     S    + +  
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLR 117

Query: 242 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 301
            + + + +L +      VH DL   NIL+++N V K+SDFG+SR L  +  ++  T+   
Sbjct: 118 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174

Query: 302 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 361
                    +  PE ++  + T  SDV+SFGI++  ++T                   +K
Sbjct: 175 -----IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MK 224

Query: 362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 411
            + D      P      +  L M+C +  R  RP+   D+  +L+ +  +
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIRA 273

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 6e-52
 Identities = 65/260 (25%), Positives = 107/260 (41%), Gaps = 23/260 (8%)

Query: 145 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLV 196
           K+G+G +G + +G       + + VA+K L P  L   +   +F +E++ +  + H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 197 TLVGACPEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
            L G        +V E  P GSL DR   + +       T  R A ++   + +L S   
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLGTLSRYAVQVAEGMGYLES--- 129

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
              +H DL   N+LL    + K+ DFG+ R L QN+                 FA+  PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK-----VPFAWCAPE 184

Query: 316 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 375
            L +   +  SD + FG+ L  + T      I       L     +    P   D P   
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP--- 241

Query: 376 AEQLANLAMRCCEMSRKSRP 395
            + + N+ ++C     + RP
Sbjct: 242 -QDIYNVMVQCWAHKPEDRP 260

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-51
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 30/264 (11%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 193
           +F+    +G+G +G++Y    +     +A+K+L    L+      + ++E++I S +RHP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 194 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           N++ L G         L+ EY P G++   L           Q      TEL + L + H
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH 123

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           S     ++H D+KP N+LL +    K++DFG S        SS  TTLC      GT  Y
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC------GTLDY 170

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 371
           + PE +       K D++S G++    L G+P          A    +    +  +   +
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFTF 223

Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    E   +L  R  + +   RP
Sbjct: 224 PDFVTEGARDLISRLLKHNPSQRP 247

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (440), Expect = 6e-51
 Identities = 65/261 (24%), Positives = 100/261 (38%), Gaps = 33/261 (12%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLV 199
           +IG G +G++Y          VAIK +     Q      +  +E+  L K+RHPN +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 200 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           G         LV EY    + +     + +  PL       +       L +LHS   H+
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDL---LEVHKKPLQEVEIAAVTHGALQGLAYLHS---HN 135

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           ++H D+K  NILL    + KL DFG +  ++                  GT  +M PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------------NSFVGTPYWMAPEVI 183

Query: 318 AS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 374
            +   G+   K DV+S GI  + L   +P L     +  AL            +G W   
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWS-- 240

Query: 375 QAEQLANLAMRCCEMSRKSRP 395
             E   N    C +   + RP
Sbjct: 241 --EYFRNFVDSCLQKIPQDRP 259

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (438), Expect = 9e-51
 Identities = 72/315 (22%), Positives = 129/315 (40%), Gaps = 50/315 (15%)

Query: 127 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQG-PS 178
           +     +E   +N +    IGEG +G +++     +        VA+KML   +     +
Sbjct: 2   NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 179 EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------- 222
           +FQ+E  ++++  +PN+V L+G C   +   L++EY+  G L + L              
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 223 -------SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 275
                        PPLS   ++ IA ++ + + +L   K    VH DL   N L+  N V
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMV 178

Query: 276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 335
            K++DFG+SR +   +    +              +M PE +     T +SDV+++G++L
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDA------IPIRWMPPESIFYNRYTTESDVWAYGVVL 232

Query: 336 LRLLTGR--PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 393
             + +    P  G+  E         +  + D      P     +L NL   C       
Sbjct: 233 WEIFSYGLQPYYGMAHEEV-------IYYVRDGNILACPENCPLELYNLMRLCWSKLPAD 285

Query: 394 RPELGKDVWRVLEPM 408
           RP     + R+L+ M
Sbjct: 286 RPSF-CSIHRILQRM 299

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-49
 Identities = 60/255 (23%), Positives = 108/255 (42%), Gaps = 23/255 (9%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           KIG+G  G++Y  +      +VAI+ ++            EI ++ + ++PN+V  + + 
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
              +   +V EYL  GSL D ++       +       +  E    L FLHS   + ++H
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIH 139

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            D+K  NILL  +   KL+DFG    ++  +          R+   GT  +M PE +   
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--------SKRSTMVGTPYWMAPEVVTRK 191

Query: 321 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 380
              PK D++S GI+ + ++ G P       ++       +     P   +   + A    
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTPELQNPEKLSAI-FR 247

Query: 381 NLAMRCCEMSRKSRP 395
           +   RC +M  + R 
Sbjct: 248 DFLNRCLDMDVEKRG 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-49
 Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 48/284 (16%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKI-RHPNL 195
            +G G +G +              +QVA+KML   +          E+ +++++  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 196 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK--------------------DNSPPLSW 233
           V L+GAC       L++EY   G L + L  K                    ++   L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 234 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 293
           +  +  A ++   + FL      S VH DL   N+L+    V K+ DFG++R +  +   
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEV 351
                            +M PE L  G  T KSDV+S+GI+L  + +    P  GI  + 
Sbjct: 221 VVRGNAR------LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 352 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
            +       K + +    D PF   E++  +   C     + RP
Sbjct: 275 NF------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-48
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 31/278 (11%)

Query: 145 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 198
            IGEG +G +++G+        + VAIK     +     E F QE   + +  HP++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 199 VGACPEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
           +G   E    ++ E    G L      +     L   + I  A +L + L +L S +   
Sbjct: 74  IGVITENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYLESKR--- 128

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
            VH D+   N+L+ +N   KL DFG+SR++  +            +  K    +M PE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-------SKGKLPIKWMAPESI 181

Query: 318 ASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 375
                T  SDV+ FG+ +  +L    +P  G+                  P+  + P   
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCP--- 235

Query: 376 AEQLANLAMRCCEMSRKSRP---ELGKDVWRVLEPMRA 410
              L +L  +C       RP   EL   +  +LE  +A
Sbjct: 236 -PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 7e-48
 Identities = 74/308 (24%), Positives = 125/308 (40%), Gaps = 55/308 (17%)

Query: 125 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPH-SLQGPSE 179
           ++D  F +             IGEG +G + K  ++     M  AIK +  + S     +
Sbjct: 9   WNDIKFQD------------VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 180 FQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------S 223
           F  E+++L K+  HPN++ L+GAC       L  EY P+G+L D L              
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 224 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 283
               +  LS Q  +  A ++   + +L        +H DL   NIL+  N+V+K++DFG+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173

Query: 284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR- 342
           SR                +T  +    +M  E L     T  SDV+S+G++L  +++   
Sbjct: 174 SRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224

Query: 343 -PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 401
            P  G+T    Y       + L      + P    +++ +L  +C       RP     +
Sbjct: 225 TPYCGMTCAELY-------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQI 276

Query: 402 WRVLEPMR 409
              L  M 
Sbjct: 277 LVSLNRML 284

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-47
 Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 40/290 (13%)

Query: 145 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKI-RHPNL 195
            +G G +G + +            M VA+KML P +          E+ +LS +  H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 196 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK---------------DNSPPLSWQTRIR 238
           V L+GAC       ++ EY   G L + L  K               D+   L  +  + 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
            + ++   + FL S    + +H DL   NILL    ++K+ DFG++R +       N++ 
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI------KNDSN 200

Query: 299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 358
              + + +    +M PE + +   T +SDV+S+GI L  L +   +      V       
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--- 257

Query: 359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
             K + +      P     ++ ++   C +     RP   K + +++E  
Sbjct: 258 -YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQ 305

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (412), Expect = 3e-47
 Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 25/276 (9%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLV 199
            +G GG   ++       H  VA+K+L     + PS    F++E    + + HP +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 200 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
                      +  +V EY+   +L D +  +    P++ +  I +  + C  L F H  
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ- 129

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
             + I+H D+KPANI++ A    K+ DFGI+R ++ +  S   T         GT  Y+ 
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-----GTAQYLS 182

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 373
           PE      +  +SDVYS G +L  +LTG P       V  A     ++    P +     
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HVREDPIPPSARHEG 240

Query: 374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 409
           + +  L  + ++    + ++R +   ++   L  + 
Sbjct: 241 L-SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  164 bits (417), Expect = 4e-47
 Identities = 54/258 (20%), Positives = 98/258 (37%), Gaps = 25/258 (9%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           ++G G +G +++   R      A K +           ++EI  +S +RHP LV L  A 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                  ++YE++  G L ++++ + N   +S    +    ++C  L  +H    ++ VH
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147

Query: 261 GDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
            DLKP NI+     +   KL DFG++  L                   GT  +  PE   
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---------QSVKVTTGTAEFAAPEVAE 198

Query: 319 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 377
              +   +D++S G++   LL+G     G   +           N+ D           E
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS----E 254

Query: 378 QLANLAMRCCEMSRKSRP 395
              +   +       +R 
Sbjct: 255 DGKDFIRKLLLADPNTRM 272

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-46
 Identities = 62/313 (19%), Positives = 121/313 (38%), Gaps = 29/313 (9%)

Query: 140 FDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRH 192
           F     +G G +G++YKGL         + VAIK L    S +   E   E  +++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 193 PNLVTLVGACPE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
           P++  L+G C      L+ + +P G L D    +++   +  Q  +    ++   + +L 
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 +VH DL   N+L+      K++DFG+++ L   E              K    +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE------KEYHAEGGKVPIKW 179

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 370
           M  E +     T +SDV+S+G+ +  L+T G          +          L       
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLP 233

Query: 371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPP 430
            P +    +  + ++C  +   SRP+  +++      M           +  +ER   P 
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMARDP--QRYLVIQGDERMHLPS 290

Query: 431 YFTCPIFQEVMQD 443
                 ++ +M +
Sbjct: 291 PTDSNFYRALMDE 303

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  162 bits (411), Expect = 3e-46
 Identities = 54/257 (21%), Positives = 104/257 (40%), Gaps = 23/257 (8%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           ++G G +G +++ + +        K ++          + EI I++++ HP L+ L  A 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
                  L+ E+L  G L DR+        +S    I    + C  L  +H    HSIVH
Sbjct: 96  EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150

Query: 261 GDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
            D+KP NI+ +    S  K+ DFG++  L+ +EI    T          T  +  PE + 
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---------ATAEFAAPEIVD 201

Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 378
              +   +D+++ G++   LL+G        +++   +    +   +     +  V  E 
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--KRCDWEFDEDAFSSVSPE- 258

Query: 379 LANLAMRCCEMSRKSRP 395
             +      +   + R 
Sbjct: 259 AKDFIKNLLQKEPRKRL 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-45
 Identities = 51/258 (19%), Positives = 101/258 (39%), Gaps = 26/258 (10%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
            +G G +G +++ +          K +           ++EI IL+  RH N++ L  + 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 203 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
              E   +++E++    + +R+    ++  L+ +  +    ++C  L FLHS   H+I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 261 GDLKPANILLDA--NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
            D++P NI+     +   K+ +FG +R L   +                   Y  PE   
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------NFRLLFTAPEYYAPEVHQ 176

Query: 319 SGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 377
              ++  +D++S G ++  LL+G  P L  T +              +    +       
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS----I 232

Query: 378 QLANLAMRCCEMSRKSRP 395
           +  +   R     RKSR 
Sbjct: 233 EAMDFVDRLLVKERKSRM 250

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-45
 Identities = 67/294 (22%), Positives = 125/294 (42%), Gaps = 34/294 (11%)

Query: 122 PQFFSDFSF---SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHP 171
           P++FS        E E A      S ++G+G +G +Y+G+ + +       +VAIK ++ 
Sbjct: 1   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60

Query: 172 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNS 228
             S++   EF  E  ++ +    ++V L+G     +   ++ E +  G L+  L     +
Sbjct: 61  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120

Query: 229 -------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 281
                   P S    I++A E+   + +L++   +  VH DL   N ++  +F  K+ DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 177

Query: 282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 341
           G++R + + +                   +M PE L  G  T  SDV+SFG++L  + T 
Sbjct: 178 GMTRDIYETDYYRKGGKGL------LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231

Query: 342 RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                     +       L+ +++    D P    + L  L   C + + K RP
Sbjct: 232 AEQPYQGLSNEQV-----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 280

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 8e-45
 Identities = 60/264 (22%), Positives = 100/264 (37%), Gaps = 26/264 (9%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 193
           +F     +GEG + ++          + AIK+L    +   +      +E D++S++ HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 194 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
             V L       E       Y  NG L   +                   E+ S L +LH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLH 125

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                 I+H DLKP NILL+ +   +++DFG ++ LS     +   +        GT  Y
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTAQY 176

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 371
           + PE L        SD+++ G I+ +L+ G P      E        KL+        D+
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-------YDF 229

Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P     +  +L  +   +    R 
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRL 253

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 5e-44
 Identities = 63/260 (24%), Positives = 100/260 (38%), Gaps = 28/260 (10%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGA 201
            +G G +  +     +     VAIK +   +L+G     + EI +L KI+HPN+V L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 202 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                   L+ + +  G L DR+  K      + +   R+  ++   + +LH      IV
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IV 129

Query: 260 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           H DLKP N+L    D +    +SDFG+S+      +    +T C      GT  Y+ PE 
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STAC------GTPGYVAPEV 180

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQ 375
           LA    +   D +S G+I   LL G P          +            P   D     
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS--- 237

Query: 376 AEQLANLAMRCCEMSRKSRP 395
            +   +      E   + R 
Sbjct: 238 -DSAKDFIRHLMEKDPEKRF 256

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  153 bits (387), Expect = 1e-43
 Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 40/278 (14%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---------FQQEIDIL 187
           N++P   +G G    + + + +    + A+K++        S            +E+DIL
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 188 SKIR-HPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 244
            K+  HPN++ L           LV++ +  G L D L+       LS +   +I   L 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120

Query: 245 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 304
            V+  LH     +IVH DLKP NILLD +   KL+DFG S  L   E            +
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---------KLRE 168

Query: 305 PKGTFAYMDPEFLASGEL------TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDT 357
             GT +Y+ PE +             + D++S G+I+  LL G P      + +   +  
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228

Query: 358 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
                   P   D+     + + +L  R   +  + R 
Sbjct: 229 SGNYQFGSPEWDDYS----DTVKDLVSRFLVVQPQKRY 262

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (381), Expect = 1e-42
 Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 20/261 (7%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           KIG G +G IY G       +VAIK+    +     +   E  I   ++    +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
               +   +V E L     +        S   S +T + +A ++ S + ++HS    + +
Sbjct: 72  GAEGDYNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFI 125

Query: 260 HGDLKPANIL---LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 316
           H D+KP N L        +  + DFG+++       +  +       +  GT  Y     
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR-THQHIPYRENKNLTGTARYASINT 184

Query: 317 LASGELTPKSDVYSFGIILLRLLTGRPAL--GITKEVQYALDTGKLKNLLDPLAGDWPFV 374
               E + + D+ S G +L+    G            +   +    K +  P+       
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244

Query: 375 QAEQLANLAMRCCEMSRKSRP 395
            +E  A     C  +    +P
Sbjct: 245 PSE-FATYLNFCRSLRFDDKP 264

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 7e-41
 Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 41/292 (14%)

Query: 145 KIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHP 193
            +GEG +G +                 +VA+KML   + +   S+   E++++  I +H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 194 NLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIR 238
           N++ L+GAC +     ++ EY   G+L + L  +             +    LS +  + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 239 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 298
            A ++   + +L S      +H DL   N+L+  + V K++DFG++R +   +     T 
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 299 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 358
                       +M PE L     T +SDV+SFG++L  + T   +      V+      
Sbjct: 197 GR------LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---- 246

Query: 359 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 410
             K L +    D P     +L  +   C       RP   K +   L+ + A
Sbjct: 247 -FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVA 296

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  146 bits (368), Expect = 9e-41
 Identities = 49/266 (18%), Positives = 92/266 (34%), Gaps = 28/266 (10%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           +IGEG +G I++G  LL + QVAIK     S     + + E      +     +  V   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 203 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                   LV + L     +            S +T    A ++ + +  +H     S+V
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDL---LDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123

Query: 260 HGDLKPANILLDANFVS-----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 314
           + D+KP N L+            + DFG+ +F   + ++  +     + +  GT  YM  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR-DPVTKQHIPYREKKNLSGTARYMSI 182

Query: 315 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP-----LAG 369
                 E + + D+ + G + +  L G       K         ++           L  
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 370 DWPFVQAEQLANLAMRCCEMSRKSRP 395
            +P    E+          ++  + P
Sbjct: 243 GFP----EEFYKYMHYARNLAFDATP 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  146 bits (369), Expect = 1e-40
 Identities = 62/264 (23%), Positives = 104/264 (39%), Gaps = 31/264 (11%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 193
           +F     +G G +G ++    RH     A+K+L    +    +      E  +LS + HP
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 194 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
            ++ + G     +   ++ +Y+  G L   L      P          A E+C  L +LH
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLH 121

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           S     I++ DLKP NILLD N   K++DFG ++++                   GT  Y
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----------TYTLCGTPDY 167

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 371
           + PE +++       D +SFGI++  +L G           Y  +T K    +      +
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-------YDSNTMKTYEKILNAELRF 220

Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
           P    E + +L  R        R 
Sbjct: 221 PPFFNEDVKDLLSRLITRDLSQRL 244

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-40
 Identities = 62/265 (23%), Positives = 102/265 (38%), Gaps = 29/265 (10%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSK-IRH 192
           +F     +G+G +G ++    +      AIK L    +    +      E  +LS    H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 193 PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
           P L  +       E    V EYL  G L   +    +            A E+   L FL
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           HS     IV+ DLK  NILLD +   K++DFG+ +     +  +   T C      GT  
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFC------GTPD 168

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 370
           Y+ PE L   +     D +SFG++L  +L G+          +  D  +L + +      
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-------HGQDEEELFHSIRMDNPF 221

Query: 371 WPFVQAEQLANLAMRCCEMSRKSRP 395
           +P    ++  +L ++      + R 
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRL 246

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 39/289 (13%)

Query: 145 KIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQGP-SEFQQEIDILSKIRH-PNL 195
            +G G +G + +     +        VA+KML   +          E+ IL  I H  N+
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 196 VTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSP-------------PLSWQTRIRI 239
           V L+GAC +      ++ E+   G+L   L  K N                L+ +  I  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 240 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 299
           + ++   + FL S      +H DL   NILL    V K+ DFG++R + ++         
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 300 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 359
                      +M PE +     T +SDV+SFG++L  + +   +     ++        
Sbjct: 197 R------LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---- 246

Query: 360 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
            + L +      P     ++    + C       RP    ++   L  +
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNL 294

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 7e-40
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 16/263 (6%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGA 201
            IGEG YG +         ++VAIK + P   Q       +EI IL + RH N++ +   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 202 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
              P +  +   YL    +   L     +  LS         ++   L ++HS    +++
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 319
           H DLKP+N+LL+     K+ DFG++R         ++      T+   T  Y  PE + +
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARV-----ADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 320 GEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 378
            +  T   D++S G IL  +L+ RP       +        L  L  P   D   +   +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDLNCIINLK 244

Query: 379 LANLAMRCCEMSRKSRPELGKDV 401
             N  +     ++     L  + 
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNA 267

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 9e-39
 Identities = 55/264 (20%), Positives = 105/264 (39%), Gaps = 33/264 (12%)

Query: 146 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 202
           +G G  G + +   +    + A+KML         + ++E+++  +  + P++V +V   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 74

Query: 203 PEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 256
             ++       +V E L  G L  R+         + +    I   +   + +LHS    
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 257 SIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 313
           +I H D+KP N+L  +   N + KL+DFG ++  + +            T P  T  Y+ 
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYTPYYVA 181

Query: 314 PEFLASGELTPKSDVYSFGIILLRLLTGRPAL--GITKEVQYALDTGKLKNLLDPLAGDW 371
           PE L   +     D++S G+I+  LL G P         +   + T       +    +W
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 372 PFVQAEQLANLAMRCCEMSRKSRP 395
             V +E++  L     +     R 
Sbjct: 242 SEV-SEEVKMLIRNLLKTEPTQRM 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-38
 Identities = 60/266 (22%), Positives = 104/266 (39%), Gaps = 34/266 (12%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGP------SEFQQEIDILSKIRHPNLV 196
           ++G G +  + K   +   +Q A K +     +         + ++E+ IL +I+HPN++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 197 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 254
           TL           L+ E +  G L D          L+ +       ++ + + +LHS  
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFD---FLAEKESLTEEEATEFLKQILNGVYYLHS-- 131

Query: 255 PHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
              I H DLKP NI+L    V     K+ DFG++  +                +  GT  
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---------EFKNIFGTPE 181

Query: 311 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 369
           ++ PE +    L  ++D++S G+I   LL+G  P LG TK+   A  +       D    
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241

Query: 370 DWPFVQAEQLANLAMRCCEMSRKSRP 395
           +          +   R      K R 
Sbjct: 242 NTS----ALAKDFIRRLLVKDPKKRM 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 33/269 (12%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQE---IDILSKI 190
           +F     IG GG+G +Y           A+K L    +   QG +    E   + ++S  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 191 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 248
             P +V +  A   P+  + + + +  G L   LS        S       A E+   L 
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLE 121

Query: 249 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 308
            +H+     +V+ DLKPANILLD +   ++SD G++   S+ +               GT
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----------PHASVGT 168

Query: 309 FAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDP 366
             YM PE L  G      +D +S G +L +LL G  P      + ++ +D   L   +  
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-- 226

Query: 367 LAGDWPFVQAEQLANLAMRCCEMSRKSRP 395
              + P   + +L +L     +     R 
Sbjct: 227 ---ELPDSFSPELRSLLEGLLQRDVNRRL 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-37
 Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 36/239 (15%)

Query: 116 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 173
           ++    P    + S+++ +           IG G +G +Y+  L      VAIK +    
Sbjct: 8   ATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKV---- 53

Query: 174 LQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCK 225
           LQ      +E+ I+ K+ H N+V L                 LV +Y+P           
Sbjct: 54  LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113

Query: 226 DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 284
                L          +L   L ++HS     I H D+KP N+LLD +  V KL DFG +
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170

Query: 285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
           + L + E           +     +         + + T   DV+S G +L  LL G+P
Sbjct: 171 KQLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-37
 Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 29/274 (10%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVG 200
           KIG+G +G ++K   R    +VA+K +   + +   P    +EI IL  ++H N+V L+ 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 201 ACPEVWT----------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 250
            C    +          LV+++  +          +     +     R+   L + L ++
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LSNVLVKFTLSEIKRVMQMLLNGLYYI 133

Query: 251 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 310
           H  K   I+H D+K AN+L+  + V KL+DFG++R  S  +    N+     T+   T  
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK----NSQPNRYTNRVVTLW 186

Query: 311 YMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLA 368
           Y  PE L    +  P  D++  G I+  + T  P + G T++ Q AL     +       
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLCGSITP 243

Query: 369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 402
             WP V   +L           RK +  L   V 
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR 277

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 6e-37
 Identities = 71/289 (24%), Positives = 111/289 (38%), Gaps = 33/289 (11%)

Query: 136 ATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI 190
           A   ++   +IGEG YG ++K          VA+K +   + +   P    +E+ +L  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 191 ---RHPNLVTLVGACPEVWT-------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 240
               HPN+V L   C    T       LV+E++           K   P +  +T   + 
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMM 122

Query: 241 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 300
            +L   L FLHS   H +VH DLKP NIL+ ++   KL+DFG++R  S            
Sbjct: 123 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---------M 170

Query: 301 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGK 359
             T    T  Y  PE L         D++S G I   +   +P   G +   Q       
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---I 227

Query: 360 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 408
           L  +  P   DWP   A        +  +   K   ++ +    +L   
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 2e-35
 Identities = 54/265 (20%), Positives = 97/265 (36%), Gaps = 42/265 (15%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE------FQQEIDILSKIR--HPN 194
            +G GG+GS+Y G+    ++ VAIK +    +    E         E+ +L K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           ++ L+     P+ + L+ E             +     L  +       ++   +   H+
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128

Query: 253 CKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
                ++H D+K  NIL+D N    KL DFG    L               TD  GT  Y
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------VYTDFDGTRVY 175

Query: 312 MDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 370
             PE++         + V+S GI+L  ++ G       +E+      G++          
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQV---------F 222

Query: 371 WPFVQAEQLANLAMRCCEMSRKSRP 395
           +    + +  +L   C  +    RP
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRP 247

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 24/209 (11%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLVT 197
            +GEG + ++YK   ++    VAIK +         +       +EI +L ++ HPN++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 198 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 255
           L+ A       +LV++++           KDNS  L+              L +LH    
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVI---IKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--- 118

Query: 256 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 315
           H I+H DLKP N+LLD N V KL+DFG+++                 T    T  Y  PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--------RAYTHQVVTRWYRAPE 170

Query: 316 FLASGEL-TPKSDVYSFGIILLRLLTGRP 343
            L    +     D+++ G IL  LL   P
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVP 199

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 7e-35
 Identities = 62/269 (23%), Positives = 104/269 (38%), Gaps = 28/269 (10%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 193
           +FD    +G+G +G +     +      A+K+L    +    E      E  +L   RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 194 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 251
            L  L  A    +    V EY   G L   LS        + +       E+ S L +LH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH 122

Query: 252 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 311
           S     +V+ D+K  N++LD +   K++DFG+ +     E  S+  T+       GT  Y
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFC---GTPEY 171

Query: 312 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 371
           + PE L   +     D +  G+++  ++ GR          Y  D  +L  L+      +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-------YNQDHERLFELILMEEIRF 224

Query: 372 PFVQAEQLANLAMRCCEMSRKSRPELGKD 400
           P   + +  +L     +   K R   G  
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  127 bits (320), Expect = 5e-34
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 20/205 (9%)

Query: 145 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGA 201
           KIGEG YG +YK    + +  A+K +         PS   +EI IL +++H N+V L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 202 CPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 259
                   LV+E+L     +    C+     L   T      +L + + + H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVL 122

Query: 260 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA- 318
           H DLKP N+L++     K++DFG++R          +  +           Y  P+ L  
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--------LWYRAPDVLMG 174

Query: 319 SGELTPKSDVYSFGIILLRLLTGRP 343
           S + +   D++S G I   ++ G P
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTP 199

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 6e-34
 Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 20/212 (9%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPN 194
           NF    KIGEG YG +YK   +     VA+K +   +     PS   +EI +L ++ HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 195 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
           +V L+          LV+E+L       +         +          +L   L F HS
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
              H ++H DLKP N+L++     KL+DFG++R           T             Y 
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTL------WYR 169

Query: 313 DPEFLA-SGELTPKSDVYSFGIILLRLLTGRP 343
            PE L      +   D++S G I   ++T R 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 55/315 (17%), Positives = 111/315 (35%), Gaps = 47/315 (14%)

Query: 88  KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 147
           KK  ++  ++   A  + + L+K    + +++ + QF       +             +G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQF-------DRIK---------TLG 50

Query: 148 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGAC 202
            G +G +     +      A+K+L    +    +      E  IL  +  P LV L  + 
Sbjct: 51  TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110

Query: 203 PEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 260
            +   L  V EY+  G +   L         S       A ++     +LHS     +++
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164

Query: 261 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 320
            DLKP N+L+D     +++DFG ++                     GT   + PE + S 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKR-----------VKGRTWTLCGTPEALAPEIILSK 213

Query: 321 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 380
                 D ++ G+++  +  G P         +A    ++   +      +P   +  L 
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF-------FADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 381 NLAMRCCEMSRKSRP 395
           +L     ++    R 
Sbjct: 267 DLLRNLLQVDLTKRF 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-31
 Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 34/270 (12%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 200
            +G G YG++   +      +VAIK L+             +E+ +L  +RH N++ L+ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 201 ACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
                 T        LV  ++  G+   +L        L       +  ++   L ++H+
Sbjct: 85  VFTPDETLDDFTDFYLVMPFM--GTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHA 139

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
                  H DLKP N+ ++ +   K+ DFG++R                 T    T  Y 
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----------MTGYVVTRWYR 185

Query: 313 DPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 371
            PE + +    T   D++S G I+  ++TG+     +  +        +K    P A   
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFV 243

Query: 372 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 401
             +Q+++  N      E+ +K    +  + 
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNA 273

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (303), Expect = 3e-31
 Identities = 50/246 (20%), Positives = 105/246 (42%), Gaps = 31/246 (12%)

Query: 110 KSRKEASSSSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAI 166
           ++R     ++H P+ + D+    +E G   ++    K+G G Y  +++ +    + +V +
Sbjct: 6   RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65

Query: 167 KMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE----VWTLVYEYLPNGSLEDR 221
           K+L P   +   + ++EI IL  +R  PN++TL     +       LV+E++ N   +  
Sbjct: 66  KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122

Query: 222 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSD 280
                    L+         E+   L + HS     I+H D+KP N+++D  +   +L D
Sbjct: 123 YQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLID 173

Query: 281 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLL 339
           +G++ F    +                +  +  PE L   ++     D++S G +L  ++
Sbjct: 174 WGLAEFYHPGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224

Query: 340 TGRPAL 345
             +   
Sbjct: 225 FRKEPF 230

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-30
 Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 20/236 (8%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 200
           KIGEG YG+++K   R  H  VA+K +         PS   +EI +L +++H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 201 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 258
                   TLV+E+      +   SC  +      +       +L   L F H     ++
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH---SRNV 122

Query: 259 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 318
           +H DLKP N+L++ N   KL++FG++R            +    T     +         
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI---PVRCYSAEVVT----LWYRPPDVLFG 175

Query: 319 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 374
           +   +   D++S G I   L      L    +V   L     + L  P    WP +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWPSM 230

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 5e-29
 Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 30/276 (10%)

Query: 139 NFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSL----QGPSEFQQEIDILSK 189
           NF+    +G G YG ++              A+K+L   ++    +     + E  +L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 190 IRH-PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 246
           IR  P LVTL  A        L+ +Y+  G L   LS ++       Q  +        +
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG------EI 138

Query: 247 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
           ++ L       I++ D+K  NILLD+N    L+DFG+S+    +E            D  
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-------RAYDFC 191

Query: 307 GTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 364
           GT  YM P+ +  G+       D +S G+++  LLTG     +  E     +  +     
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251

Query: 365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 400
           +P    +P   +    +L  R      K R   G  
Sbjct: 252 EP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 6e-28
 Identities = 53/265 (20%), Positives = 97/265 (36%), Gaps = 24/265 (9%)

Query: 145 KIGEGGYGSIYKGLLRH--MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVG 200
            +G G YGS+         ++VA+K L     S+       +E+ +L  ++H N++ L+ 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 201 AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 257
                  +      YL    +   L+       L+      +  ++   L ++HS     
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141

Query: 258 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 317
           I+H DLKP+N+ ++ +   K+ DFG++R                       +       L
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDD----------EMTGYVATRWYRAPEIML 191

Query: 318 ASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQA 376
                    D++S G I+  LLTGR    G     Q  L    L+ +  P A     + +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLKKISS 248

Query: 377 EQLANLAMRCCEMSRKSRPELGKDV 401
           E   N      +M + +   +    
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGA 273

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 7e-27
 Identities = 42/211 (19%), Positives = 76/211 (36%), Gaps = 30/211 (14%)

Query: 145 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 200
            IG G  G +           VAIK L              +E+ ++  + H N+++L+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 201 ACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 252
                 T        LV E +     +      D       +    +  ++   +  LHS
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137

Query: 253 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 312
                 +H DLKP+NI++ ++   K+ DFG++R    +            T    T  Y 
Sbjct: 138 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---------MMTPYVVTRYYR 185

Query: 313 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            PE +         D++S G I+  ++  + 
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (260), Expect = 3e-25
 Identities = 37/217 (17%), Positives = 77/217 (35%), Gaps = 27/217 (12%)

Query: 145 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 202
           K+G G + +++    ++ +  VA+K++    +      + EI +L ++   +        
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 203 ---------------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 247
                          P    +V  +   G     L  K     +      +I+ +L   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 248 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 306
            ++   +   I+H D+KP N+L++       L    I+   +      + T         
Sbjct: 139 DYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI------ 190

Query: 307 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 343
            T  Y  PE L        +D++S   ++  L+TG  
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227

>d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: U-box
domain: E3 ubiquitin ligase PUB14
species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 84.0 bits (207), Expect = 1e-20
 Identities = 31/72 (43%), Positives = 44/72 (61%)

Query: 427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 486
           E P YF CPI  E+M+DP + + G TYE  +++ WLD+GH+T P +   L H  L PN  
Sbjct: 4   EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYV 63

Query: 487 LRSAIQEWLQQH 498
           L+S I  W + +
Sbjct: 64  LKSLIALWCESN 75

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 1e-18
 Identities = 24/158 (15%), Positives = 46/158 (29%), Gaps = 19/158 (12%)

Query: 145 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL----------QGPSEFQQEIDILSKIRHP 193
            +GEG   +++        +  +K                  G   F       ++    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 194 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 253
            L  L G         Y +  N  L + L        +  +    +   +   +   +  
Sbjct: 67  ALQKLQGLAVPKV---YAWEGNAVLME-LIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121

Query: 254 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 291
               IVHGDL   N+L+    +  + DF  S  + +  
Sbjct: 122 --RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

>d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: U-box
domain: STIP1 homology and U box-containing protein 1, STUB1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 66.0 bits (160), Expect = 2e-14
 Identities = 20/72 (27%), Positives = 39/72 (54%)

Query: 427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 486
           + P Y    I  E+M++P +   G TY+ + ++  L      +P+T  PL  + L+PNLA
Sbjct: 3   DIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLA 62

Query: 487 LRSAIQEWLQQH 498
           ++  I  ++ ++
Sbjct: 63  MKEVIDAFISEN 74

>d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: U-box
domain: Ubiquitin conjugation factor E4A
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (145), Expect = 4e-12
 Identities = 25/90 (27%), Positives = 34/90 (37%), Gaps = 2/90 (2%)

Query: 410 ASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGF-TYEAEALKGWLDSGHET 468
            S G S   +   E   +    F  PI   +M DP V      T +   +   L S  +T
Sbjct: 1   GSSGSSGLQQQEEETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQT 59

Query: 469 SPMTNLPLAHKNLVPNLALRSAIQEWLQQH 498
            P    PL    + PN  L+  IQ WL + 
Sbjct: 60  DPFNRSPLTMDQIRPNTELKEKIQRWLAER 89

>d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: brca1 RING domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (113), Expect = 1e-07
 Identities = 11/67 (16%), Positives = 26/67 (38%), Gaps = 2/67 (2%)

Query: 432 FTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS--GHETSPMTNLPLAHKNLVPNLALRS 489
             CPI  E++++P        +    +   L+   G    P+    +  ++L  +     
Sbjct: 22  LECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQ 81

Query: 490 AIQEWLQ 496
            ++E L+
Sbjct: 82  LVEELLK 88

>d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 56

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: U-box
domain: Pre-mRNA splicing factor Prp19
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 37.0 bits (85), Expect = 2e-04
 Identities = 12/52 (23%), Positives = 24/52 (46%), Gaps = 2/52 (3%)

Query: 433 TCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVP 483
            C I  +V + P ++      +E   L+ ++       P+TN PL+ + +V 
Sbjct: 2   LCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVE 52

>d1f5na1 a.114.1.1 (A:284-583) Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 300

class: All alpha proteins
fold: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain
superfamily: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain
family: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain
domain: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 0.001
 Identities = 18/106 (16%), Positives = 50/106 (47%)

Query: 5   LQAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIA 64
           LQ   + +   +E++  +   E+       L  M+++++++ME+ + +  +     ++  
Sbjct: 193 LQTDQTLTEKEKEIEVERVKAESAQASAKMLHEMQRKNEQMMEQKERSYQEHLKQLTEKM 252

Query: 65  ESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 110
           E+D+     EQ+   A++L +  +  ++  Q E      E ++L+ 
Sbjct: 253 ENDRVQLLKEQERTLALKLQEQEQLLKEGFQKESRIMKNEIQDLQT 298

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	498
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1wgma_	98	Ubiquitin conjugation factor E4A {Human (Homo sapi	99.72
d1t1ha_	78	E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi	99.71
d2c2la2	80	STIP1 homology and U box-containing protein 1, STU	99.71
d2baya1	56	Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac	98.98
d1jm7b_	97	bard1 RING domain {Human (Homo sapiens) [TaxId: 96	98.72
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.72
d1jm7a_	103	brca1 RING domain {Human (Homo sapiens) [TaxId: 96	98.69
d1rmda2	86	V(D)J recombination activating protein 1 (RAG1), d	98.69
d1fbva4	79	CBL {Human (Homo sapiens) [TaxId: 9606]}	98.31
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.97
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.92
d1g25a_	65	TFIIH Mat1 subunit {Human (Homo sapiens) [TaxId: 9	97.62
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.51
d1chca_	68	Immediate early protein, IEEHV {Equine herpesvirus	97.39
d1bora_	56	Acute promyelocytic leukaemia proto-oncoprotein PM	97.33
d1iyma_	55	EL5 RING-H2 domain {Rice (Oryza sativa) [TaxId: 45	97.03
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.91
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.9
d1ur6b_	52	Not-4 N-terminal RING finger domain {Human (Homo s	96.51
d1v87a_	114	Deltex protein 2 RING-H2 domain {Mouse (Mus muscul	95.95
d3dplr1	88	RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase	95.56
d1vyxa_	60	IE1B protein (ORF K3), N-terminal domain {Kaposi's	95.23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=427.18  Aligned_cols=258  Identities=27%  Similarity=0.452  Sum_probs=206.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYL  213 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~  213 (498)
                      .++|.+.+.||+|+||+||+|.+++ .||||+++....  ...+.|.+|+.+|++++|||||+++|++. +..++|||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~   85 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC   85 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence            4578999999999999999998765 599999975533  23467899999999999999999999985 4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      +||+|.+++...  ...+++..++.|+.|++.||.|||+   ++||||||||+||||+.++.+||+|||+|+........
T Consensus        86 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          86 EGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            999999999633  3569999999999999999999999   89999999999999999999999999999876543221


Q ss_pred             CCCccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCCcHH---HHHHHHhCccccccCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDTGKLKNLLDPL  367 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~---~~~~~~~~~~~~~~~~~  367 (498)
                      ..      .....||+.|+|||++.+   ..|+.++|||||||+||||+||+.||...+.   ....+..+...    +.
T Consensus       161 ~~------~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----p~  230 (276)
T d1uwha_         161 HQ------FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS----PD  230 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC----CC
T ss_pred             cc------ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----Cc
Confidence            11      134569999999999965   3588999999999999999999999975432   22233333222    22


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ....+..++..+.+|+.+||+.+|.+|||+.+ +++.|+.+.++
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~-il~~Le~l~~~  273 (276)
T d1uwha_         231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQ-ILASIELLARS  273 (276)
T ss_dssp             GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHT
T ss_pred             chhccccchHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHHHc
Confidence            22234445688999999999999999999988 88888888754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=412.53  Aligned_cols=252  Identities=26%  Similarity=0.486  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      ++|.+.+.||+|+||+||+|.+. +..||||++.... ...+.|.+|+.++++++|||||+++|+|.  +..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            46778889999999999999995 5789999997543 45678999999999999999999999984  56899999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++..  ....+++..++.|+.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+++.........
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999853  34568999999999999999999999   899999999999999999999999999998765443211


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  371 (498)
                             .....||+.|+|||++.+..|+.++|||||||+||||+| |.+||...+...  ..+..+        .....
T Consensus       159 -------~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~--------~~~~~  223 (263)
T d1sm2a_         159 -------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------FRLYK  223 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT--------CCCCC
T ss_pred             -------ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc--------CCCCC
Confidence                   123458999999999999999999999999999999999 577776544332  222222        11223


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      |..++..+.+|+.+||+.+|.+||++.+ +++.|+.+..+
T Consensus       224 p~~~~~~l~~li~~cl~~~p~~Rps~~~-il~~L~~i~es  262 (263)
T d1sm2a_         224 PRLASTHVYQIMNHCWKERPEDRPAFSR-LLRQLAEIAES  262 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHccCCHhHCcCHHH-HHHHHHHHHhC
Confidence            4455688999999999999999999998 88888888654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-54  Score=420.17  Aligned_cols=255  Identities=26%  Similarity=0.448  Sum_probs=196.2

Q ss_pred             CCCCCCcccccCceEEEEEEECC-----eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      +|.+.+.||+|+||+||+|.++.     ..||||.+...... ..+.|.+|+.+|++++|||||+++|+|.  +..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            34556789999999999999842     35899988754322 2457999999999999999999999984  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |||++|+|.+++..  ....+++.+++.|+.|++.||.|||+   ++||||||||+||||+.++++||+|||+|+.+...
T Consensus       107 Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         107 EFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             ECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999998853  34569999999999999999999999   89999999999999999999999999999877544


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~~~~  367 (498)
                      .....   ........||+.|+|||++.++.++.++|||||||+||||+| |++||........  .+..+        .
T Consensus       182 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~--------~  250 (299)
T d1jpaa_         182 TSDPT---YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD--------Y  250 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------C
T ss_pred             CCcce---eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------C
Confidence            32211   111233458999999999999999999999999999999998 8999976544322  22221        1


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ....|..++..+.+|+.+||+.+|.+||++.+ |++.|+.+..
T Consensus       251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e-i~~~L~~~l~  292 (299)
T d1jpaa_         251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ-IVNTLDKMIR  292 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHhc
Confidence            12234556788999999999999999999998 8888888764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-54  Score=413.89  Aligned_cols=253  Identities=28%  Similarity=0.480  Sum_probs=208.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCC
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLP  214 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~  214 (498)
                      ..+|.+.+.||+|+||+||+|.++ +..||||++.... ...+.|.+|+.+|++++|||||+++|+|. +..++||||++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~   90 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME   90 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCC
Confidence            357888899999999999999996 5789999997543 45678999999999999999999999984 46789999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++.... ..++++..++.|+.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+|+........ 
T Consensus        91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-  165 (272)
T d1qpca_          91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-  165 (272)
T ss_dssp             TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred             CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc-
Confidence            999999875322 2359999999999999999999999   89999999999999999999999999999976543321 


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhC-CCCCCCcHHHH--HHHHhCccccccCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQ--YALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  371 (498)
                            ......||+.|+|||++.++.++.++|||||||+||||+|| .+||.......  ..+..+        .....
T Consensus       166 ------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~--------~~~~~  231 (272)
T d1qpca_         166 ------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------YRMVR  231 (272)
T ss_dssp             ------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCC
T ss_pred             ------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--------CCCCC
Confidence                  12345699999999999999999999999999999999995 56665544322  222221        11223


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      |...+..+.+|+.+||+.+|.+|||+.+ |.+.|+++-.
T Consensus       232 p~~~~~~l~~li~~cl~~~P~~Rpt~~e-i~~~L~~~ft  269 (272)
T d1qpca_         232 PDNCPEELYQLMRLCWKERPEDRPTFDY-LRSVLEDFFT  269 (272)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             cccChHHHHHHHHHHcCCCHhHCcCHHH-HHHHhhhhhh
Confidence            4456678999999999999999999988 8888887643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=413.50  Aligned_cols=243  Identities=24%  Similarity=0.378  Sum_probs=204.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .+|...+.||+|+||+||+|.++  +..||||++........+.+.+|+.+|+.++|||||+++++|.  +..++|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            36889999999999999999974  7899999998766666778999999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      +||+|.+++..    ..+++..+..|+.|++.||.|||+   +|||||||||+||||+.+|++||+|||+|+.+......
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            99999998753    359999999999999999999999   89999999999999999999999999999876543211


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCCCH
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (498)
                              .....||+.|+|||++.+..|+.++|||||||++|+|+||++||...+.............    .....|.
T Consensus       173 --------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~----~~~~~~~  240 (293)
T d1yhwa1         173 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----PELQNPE  240 (293)
T ss_dssp             --------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS----CCCSSGG
T ss_pred             --------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC----CCCCCcc
Confidence                    1344699999999999999999999999999999999999999976655433222110000    0112345


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+..+.+|+.+||+.||.+||++.+
T Consensus       241 ~~s~~~~~li~~~L~~dP~~R~s~~e  266 (293)
T d1yhwa1         241 KLSAIFRDFLNRCLDMDVEKRGSAKE  266 (293)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHH
Confidence            56788999999999999999999988

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=411.74  Aligned_cols=246  Identities=26%  Similarity=0.353  Sum_probs=196.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      ++|++.+.||+|+||+||+|.++  +..||||++..... ...+.+.+|+.+|++++|||||++++++.  +..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            36888899999999999999985  68899999976533 33467999999999999999999999984  458899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      |+||+|.+++.   ....+++..+..|+.|++.||.|||+   +||+||||||+||||+.++.+||+|||+|+.......
T Consensus        85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999994   34579999999999999999999999   8999999999999999999999999999997654322


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      ..      .....+||+.|+|||++.+..+ +.++|||||||+||||+||++||..................    ....
T Consensus       159 ~~------~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~----~~~~  228 (271)
T d1nvra_         159 ER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----YLNP  228 (271)
T ss_dssp             EC------CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----TSTT
T ss_pred             cc------cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----CCCc
Confidence            11      1234579999999999988876 57899999999999999999999654322111111000000    0111


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +...+..+.+|+.+||+.||.+||++.+
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~e  256 (271)
T d1nvra_         229 WKKIDSAPLALLHKILVENPSARITIPD  256 (271)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            2334678899999999999999999988

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=407.99  Aligned_cols=238  Identities=26%  Similarity=0.438  Sum_probs=201.2

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      +|.+.+.||+|+||+||+|.++  +..||||++.+.   .......+.+|+.+|+.++|||||++++++.+  ..++|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            6888899999999999999985  678999998643   23345678999999999999999999999844  5889999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      ||+||+|.+++..   ...+++..+..|+.|++.||.|||+   +|||||||||+||||+.++.+||+|||+|.......
T Consensus        87 y~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          87 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             ecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            9999999999953   3469999999999999999999999   899999999999999999999999999998654322


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                      .          ....||+.|+|||++.+..++.++|||||||+||||+||++||...+.........+.       ...+
T Consensus       161 ~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------~~~~  223 (263)
T d2j4za1         161 R----------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------EFTF  223 (263)
T ss_dssp             C----------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------CCCC
T ss_pred             c----------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------CCCC
Confidence            1          2235999999999999999999999999999999999999999876544332221111       1124


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      |...+..+.+|+.+||+.||.+|||+.+
T Consensus       224 p~~~s~~~~~li~~~L~~dp~~R~t~~e  251 (263)
T d2j4za1         224 PDFVTEGARDLISRLLKHNPSQRPMLRE  251 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            4556788999999999999999999988

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=412.47  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=206.0

Q ss_pred             CCCCCC-cccccCceEEEEEEEC----CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEe
Q 010882          139 NFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~-~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E  211 (498)
                      +|.... +||+|+||+||+|.++    +..||||+++..... ..+.|.+|+.+|++++|||||+++|+|. +..++|||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE   88 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME   88 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEE
Confidence            444445 4999999999999874    357999999764322 2467999999999999999999999995 46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++.  .....+++..+..|+.|++.||.|||+   ++||||||||+||||+.++.+||+|||+|+.+....
T Consensus        89 ~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          89 MAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             CCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             eCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999999984  334579999999999999999999999   899999999999999999999999999999775433


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHH--HHHHHHhCccccccCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPLA  368 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~--~~~~~~~~~~~~~~~~~~  368 (498)
                      ...     .......||+.|+|||++.++.++.++|||||||++|||+| |++||...+.  +...+..+.        .
T Consensus       164 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--------~  230 (285)
T d1u59a_         164 SYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------R  230 (285)
T ss_dssp             CEE-----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--------C
T ss_pred             ccc-----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------C
Confidence            211     11234468999999999999999999999999999999998 9999975433  223333322        1


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ...|..++..+.+|+.+||+.+|.+||++.+ |.+.|+.+-
T Consensus       231 ~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~-i~~~L~~~~  270 (285)
T d1u59a_         231 MECPPECPPELYALMSDCWIYKWEDRPDFLT-VEQRMRACY  270 (285)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHH
Confidence            2345566788999999999999999999998 777777654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-53  Score=413.40  Aligned_cols=253  Identities=27%  Similarity=0.473  Sum_probs=207.8

Q ss_pred             hhcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          136 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       136 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ...+|.+.+.||+|+||+||+|.++  +..||||+++... ...+.|.+|+.+|++++|||||+++|+|.  +..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3457888899999999999999985  6889999987543 45678999999999999999999999984  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      ||++|+|.+++... ....+++..++.|+.|++.||.|||+   ++||||||||+||||+.++.+||+|||+|+......
T Consensus        94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            99999999998643 34579999999999999999999999   899999999999999999999999999998765432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCC-CCCcHHH--HHHHHhCccccccCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA-LGITKEV--QYALDTGKLKNLLDPLA  368 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p-f~~~~~~--~~~~~~~~~~~~~~~~~  368 (498)
                      ..       ......||+.|+|||++.+..|+.++|||||||++|||+||..| |...+..  ...+..+        ..
T Consensus       170 ~~-------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~--------~~  234 (287)
T d1opja_         170 YT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YR  234 (287)
T ss_dssp             SE-------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------CC
T ss_pred             ce-------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC--------CC
Confidence            21       11233489999999999999999999999999999999996655 4443322  2222221        11


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ...|...+..+.+|+.+||+.||.+||++.+ +.+.|+.+.
T Consensus       235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-i~~~L~~~~  274 (287)
T d1opja_         235 MERPEGCPEKVYELMRACWQWNPSDRPSFAE-IHQAFETMF  274 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHTT
T ss_pred             CCCCccchHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHH
Confidence            2244556688999999999999999999998 777777653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-53  Score=408.21  Aligned_cols=245  Identities=25%  Similarity=0.436  Sum_probs=198.2

Q ss_pred             CcccccCceEEEEEEEC----CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEEeeCCCC
Q 010882          144 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG  216 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~E~~~~g  216 (498)
                      ++||+|+||+||+|.++    +..||||+++......  .+.|.+|+.+|++++|||||+++|+|. +..++||||+++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            46999999999999874    2579999997543322  357999999999999999999999995 4678999999999


Q ss_pred             CHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCCC
Q 010882          217 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN  296 (498)
Q Consensus       217 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  296 (498)
                      +|.+++..   ..++++..++.|+.|++.||.|||+   ++||||||||+||||+.++.+||+|||+|+.+......   
T Consensus        93 ~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~---  163 (277)
T d1xbba_          93 PLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---  163 (277)
T ss_dssp             EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE---
T ss_pred             cHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc---
Confidence            99999853   3569999999999999999999999   89999999999999999999999999999876543221   


Q ss_pred             ccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHH--HHHHhCccccccCCCCCCCCH
Q 010882          297 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPF  373 (498)
Q Consensus       297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  373 (498)
                        ........||+.|+|||++.+..++.++|||||||++|||+| |++||...+...  ..+..+.        ....|.
T Consensus       164 --~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~--------~~~~p~  233 (277)
T d1xbba_         164 --YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------RMGCPA  233 (277)
T ss_dssp             --EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCT
T ss_pred             --cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC--------CCCCCc
Confidence              111234569999999999999999999999999999999998 899997654332  2233321        123455


Q ss_pred             HHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          374 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       374 ~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      .++..+.+|+.+||+.||.+||++.+ |...|+..
T Consensus       234 ~~~~~~~~li~~cl~~dp~~RPs~~~-i~~~L~~~  267 (277)
T d1xbba_         234 GCPREMYDLMNLCWTYDVENRPGFAA-VELRLRNY  267 (277)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCCHhHCcCHHH-HHHHhhCH
Confidence            56788999999999999999999998 66666553

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=410.06  Aligned_cols=246  Identities=26%  Similarity=0.415  Sum_probs=193.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec----CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~----~~~~lV  209 (498)
                      .+|++.+.||+|+||+||+|..+  +..||||++.......  .+.+.+|+.+|++++|||||++++++.    ...|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            46888999999999999999985  6889999998654332  346889999999999999999999883    247899


Q ss_pred             EeeCCCCCHHhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          210 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      ||||+||+|.+++... .....+++..++.++.|++.||.|||+..  ..+||||||||+||||+.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998532 23457999999999999999999999832  13599999999999999999999999999997


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHH--HHHhCcccccc
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLL  364 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~  364 (498)
                      +......        .....||+.|+|||++.+..|+.++|||||||++|||+||++||...+....  .+..+...   
T Consensus       164 ~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~---  232 (269)
T d2java1         164 LNHDTSF--------AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---  232 (269)
T ss_dssp             C-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---
T ss_pred             cccCCCc--------cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            6543211        1234699999999999999999999999999999999999999987554332  22333222   


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          365 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       365 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                           ..|...+..+.+|+.+||+.||.+||++.+
T Consensus       233 -----~~~~~~s~~l~~li~~~L~~dp~~Rps~~e  262 (269)
T d2java1         233 -----RIPYRYSDELNEIITRMLNLKDYHRPSVEE  262 (269)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -----CCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence                 234455678999999999999999999988

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=411.36  Aligned_cols=243  Identities=24%  Similarity=0.357  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      +.|++.+.||+|+||+||+|.+.  +..||||++........+.|.+|+++|++++|||||+++++|.  +..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            35788899999999999999984  6789999998766666778999999999999999999999984  4688999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      +||+|.+++...  ..++++..+..|+.|++.||.|||+   +||+||||||+||||+.+|.+||+|||+|+....... 
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            999999987532  3469999999999999999999999   8999999999999999999999999999986543321 


Q ss_pred             CCCccceeccCCCCCCCcCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP  366 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~  366 (498)
                             ......||+.|+|||++.     ...|+.++|||||||+||||+||++||...+.....  +..+...     
T Consensus       166 -------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~-----  233 (288)
T d2jfla1         166 -------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP-----  233 (288)
T ss_dssp             -------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-----
T ss_pred             -------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence                   113446999999999984     456899999999999999999999999765433222  2222111     


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       ....|...+..+.+|+.+||+.||.+|||+.+
T Consensus       234 -~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e  265 (288)
T d2jfla1         234 -TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ  265 (288)
T ss_dssp             -CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             -CCCccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence             11234456788999999999999999999988

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=397.62  Aligned_cols=246  Identities=25%  Similarity=0.469  Sum_probs=206.5

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP  214 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~~  214 (498)
                      ++|.+.++||+|+||+||+|.++ +..||||+++... ...+.|.+|+.++++++||||++++|+|.  ...++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57899999999999999999996 5689999998654 35678999999999999999999999985  46899999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.+++..  ....+++..++.|+.|++.||.|||+   +||+||||||+|||++.++.+||+|||+++.........
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            9999999753  34568999999999999999999999   899999999999999999999999999998765443211


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHH--HHHhCccccccCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  371 (498)
                             .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+.  .+..+        .....
T Consensus       158 -------~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~--------~~~~~  222 (258)
T d1k2pa_         158 -------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--------LRLYR  222 (258)
T ss_dssp             -------CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT--------CCCCC
T ss_pred             -------ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC--------CCCCC
Confidence                   133468999999999999999999999999999999998 8999987554332  22222        11223


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHh
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL  405 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L  405 (498)
                      |...+..+.+|+.+||+.+|.+||++.+ ++..|
T Consensus       223 p~~~~~~l~~li~~cl~~dP~~RPt~~e-il~~L  255 (258)
T d1k2pa_         223 PHLASEKVYTIMYSCWHEKADERPTFKI-LLSNI  255 (258)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHH
T ss_pred             cccccHHHHHHHHHHccCCHhHCcCHHH-HHHHh
Confidence            4556688999999999999999999988 54444

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=404.57  Aligned_cols=254  Identities=27%  Similarity=0.455  Sum_probs=198.7

Q ss_pred             cCCCCCCcccccCceEEEEEEECC------eEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~l  208 (498)
                      ..|+..++||+|+||+||+|.+++      ..||||++...... ....|.+|+.+|++++|||||+++|+|.  +..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            457778899999999999998753      36999999754322 2346889999999999999999999984  46899


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+.+|+|.+.+..  ....+++..++.|+.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+|+...
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999998753  33569999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCC-CCCCCcHH--HHHHHHhCccccccC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKE--VQYALDTGKLKNLLD  365 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~pf~~~~~--~~~~~~~~~~~~~~~  365 (498)
                      .......     ......||+.|+|||++.++.++.++|||||||+||||+||. +|+.....  +...+..+       
T Consensus       162 ~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-------  229 (283)
T d1mqba_         162 DDPEATY-----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-------  229 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------
T ss_pred             CCCccce-----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-------
Confidence            4332111     123345899999999999999999999999999999999954 55544332  22222222       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                       .....|...+..+.+|+.+||+.+|.+||++.+ |++.|+.+..
T Consensus       230 -~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-il~~L~~l~~  272 (283)
T d1mqba_         230 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD-IVSILDKLIR  272 (283)
T ss_dssp             -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHHHH
T ss_pred             -CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHH-HHHHHHHHhh
Confidence             122345556688999999999999999999998 7788888765

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-53  Score=408.83  Aligned_cols=243  Identities=24%  Similarity=0.355  Sum_probs=200.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      .+|++.+.||+|+||+||+|.++  +..||||++...   .....+.+.+|+.+|++++||||++++++|.+  ..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46889999999999999999985  688999998643   22345679999999999999999999999843  689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |||+||+|.+++..   ...+++..+..++.|++.||.|||+   +|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998853   3469999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (498)
                      .....      .....||+.|+|||++.+..|+.++|||||||+||||+||++||...+.........+.       ...
T Consensus       162 ~~~~~------~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------~~~  228 (288)
T d1uu3a_         162 SKQAR------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------EYD  228 (288)
T ss_dssp             --------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-------CCC
T ss_pred             Ccccc------cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-------CCC
Confidence            22111      13346999999999999999999999999999999999999999876554332221111       112


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +|...+..+.+|+.+||+.||.+|||+.+
T Consensus       229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e  257 (288)
T d1uu3a_         229 FPEKFFPKARDLVEKLLVLDATKRLGCEE  257 (288)
T ss_dssp             CCTTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            45556788999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=413.68  Aligned_cols=252  Identities=27%  Similarity=0.447  Sum_probs=202.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCC-CCChhhHHHHHHHHHcC-CCCCeeeeeceec--Cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EV  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~  205 (498)
                      .++|.+.+.||+|+||+||+|.+.+       ..||||++.... ......+.+|+.+|.++ +|||||+++|+|.  +.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3578888999999999999998743       369999987543 23456789999999998 8999999999994  46


Q ss_pred             ceEEEeeCCCCCHHhhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCC
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDN--------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKP  265 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp  265 (498)
                      .++|||||+||+|.++|.....                    ...+++..++.|+.|++.||.|||+   ++||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence            8999999999999999964321                    2458999999999999999999999   8999999999


Q ss_pred             CcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCC
Q 010882          266 ANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPA  344 (498)
Q Consensus       266 ~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p  344 (498)
                      +|||++.++++||+|||+|+.........      ......||+.|+|||++.++.++.++|||||||+||||+| |++|
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P  266 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYV------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  266 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             hccccccCCeEEEeeccccccccCCCcee------eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence            99999999999999999998765433211      1123458999999999999999999999999999999998 8999


Q ss_pred             CCCcHH---HHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhH
Q 010882          345 LGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE  406 (498)
Q Consensus       345 f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~  406 (498)
                      |...+.   ....+..+        ...+.|..++..+.+|+.+||+.+|.+|||+.+ |++.|.
T Consensus       267 f~~~~~~~~~~~~~~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e-i~~~L~  322 (325)
T d1rjba_         267 YPGIPVDANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN-LTSFLG  322 (325)
T ss_dssp             STTCCCSHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHH
T ss_pred             CCCCCHHHHHHHHHhcC--------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHh
Confidence            975432   22222221        112345566789999999999999999999988 666654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-52  Score=405.49  Aligned_cols=259  Identities=27%  Similarity=0.478  Sum_probs=210.5

Q ss_pred             HHHhhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCCCC-hhhHHHHHHHHHcCCCCCeeeeeceec-
Q 010882          133 IEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP-  203 (498)
Q Consensus       133 i~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpniv~l~g~~~-  203 (498)
                      ++...++|++.+.||+|+||+||+|.+++       ..||||+++...... .+.|.+|+.+|++++||||++++++|. 
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            44456689999999999999999998753       679999987543322 456999999999999999999999984 


Q ss_pred             -CcceEEEeeCCCCCHHhhhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccC
Q 010882          204 -EVWTLVYEYLPNGSLEDRLSCKD---------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG  261 (498)
Q Consensus       204 -~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHr  261 (498)
                       +..++||||+++|+|.+++....                     ....+++..++.|+.|++.||.|||+   ++||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEee
Confidence             46899999999999999985422                     12358999999999999999999999   899999


Q ss_pred             CCCCCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhC
Q 010882          262 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG  341 (498)
Q Consensus       262 Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG  341 (498)
                      ||||+|||||.++.+||+|||+|+..........      .+...||+.|+|||++.+..|+.++|||||||+||||+||
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKA------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccc------cCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence            9999999999999999999999986654332111      1334589999999999999999999999999999999998


Q ss_pred             C-CCCCCcHHHH--HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          342 R-PALGITKEVQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       342 ~-~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      . +||...+..+  ..+..+..        ...|...+..+.+|+.+||+.+|.+|||+.+ |.+.|+.+.
T Consensus       239 ~~~p~~~~~~~e~~~~v~~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~e-v~~~L~~i~  300 (301)
T d1lufa_         239 GLQPYYGMAHEEVIYYVRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCS-IHRILQRMC  300 (301)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHTT
T ss_pred             CCCCCCCCCHHHHHHHHHcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHhc
Confidence            5 7887655433  22333322        2245556678999999999999999999998 788888763

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-51  Score=404.47  Aligned_cols=242  Identities=24%  Similarity=0.343  Sum_probs=185.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E~  212 (498)
                      +.|.+.+.||+|+||+||+|.++  +..||||++...... ....+.+|+.+|+.++|||||++++++.+  ..|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45888999999999999999985  688999999765432 34568899999999999999999999844  58999999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc---CCCceeEeeccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~~~~  289 (498)
                      |+||+|.++|..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++   .++.+||+|||+|+....
T Consensus        89 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          89 VSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             cCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            999999999953   4569999999999999999999999   8999999999999995   578999999999986654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL  367 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~  367 (498)
                      ...         ....+||+.|+|||++.+..|+.++|||||||+||||+||++||.........  +..+....     
T Consensus       163 ~~~---------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-----  228 (307)
T d1a06a_         163 GSV---------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-----  228 (307)
T ss_dssp             -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC-----
T ss_pred             CCe---------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-----
Confidence            321         12345999999999999999999999999999999999999999866543322  22221111     


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ....+...++.+.+|+.+||+.||.+|||+.+
T Consensus       229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  260 (307)
T d1a06a_         229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ  260 (307)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCccccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            11122345678999999999999999999988

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=398.00  Aligned_cols=238  Identities=22%  Similarity=0.386  Sum_probs=190.0

Q ss_pred             CCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceecC------cceEEE
Q 010882          141 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE------VWTLVY  210 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~~------~~~lV~  210 (498)
                      .+...||+|+||+||+|.+.  +..||+|++......  ..+.|.+|+++|++++|||||+++++|.+      ..++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45567999999999999985  578999998764322  23568899999999999999999998732      368999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cccCCCCCCcEEEc-CCCceeEeeccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD-ANFVSKLSDFGISRFL  287 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~  287 (498)
                      ||++||+|.+++..   ...+++..+..|+.|++.||.|||+   ++  |+||||||+||||+ .++.+||+|||+|+..
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            99999999999953   3469999999999999999999999   66  99999999999996 5789999999999864


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                      ....          .....||+.|+|||++.+ +++.++|||||||+||||+||++||............  +.....  
T Consensus       166 ~~~~----------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~--i~~~~~--  230 (270)
T d1t4ha_         166 RASF----------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVK--  230 (270)
T ss_dssp             CTTS----------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HTTTCC--
T ss_pred             cCCc----------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH--HHcCCC--
Confidence            3321          123459999999999865 6999999999999999999999999754332222111  000000  


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...++...++.+.+|+.+||+.||++|||+.+
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~e  262 (270)
T d1t4ha_         231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  262 (270)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CcccCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            11123334567999999999999999999988

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-51  Score=405.49  Aligned_cols=236  Identities=27%  Similarity=0.356  Sum_probs=195.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .|+..+.||+|+||+||+|.+.  +..||||++.......   .+.+.+|+.+|++++|||||+++|+|.  +..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888899999999999999984  6889999998654433   245889999999999999999999984  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      ||++|+|..++.   ...++++..+..|+.|++.||.|||+   +|||||||||+||||+.++.+||+|||+|...... 
T Consensus        96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            999999987663   23569999999999999999999999   89999999999999999999999999999865432 


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH--hCccccccCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLDP  366 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~--~~~~~~~~~~  366 (498)
                                 ....||+.|+|||++.+   +.|+.++|||||||++|||+||++||...+.......  .+.....   
T Consensus       169 -----------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~---  234 (309)
T d1u5ra_         169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---  234 (309)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---
T ss_pred             -----------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence                       22359999999999964   4589999999999999999999999976554433222  2211111   


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                          .+...+..+.+|+.+||+.||.+|||+.+
T Consensus       235 ----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  263 (309)
T d1u5ra_         235 ----QSGHWSEYFRNFVDSCLQKIPQDRPTSEV  263 (309)
T ss_dssp             ----SCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----CCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence                12234578999999999999999999988

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-52  Score=410.40  Aligned_cols=248  Identities=24%  Similarity=0.373  Sum_probs=196.4

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .++|++.+.||+|+||+||+|.+.  +..||||+++..... ....+.+|+.+|+.++|||||+++++|.  +..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457889999999999999999984  789999999765332 2467899999999999999999999994  45899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |++||+|.+++...   ..+++..+..++.|++.||.|||+.  +||+||||||+||||+.+|++||+|||+|+.+....
T Consensus        85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            99999999999543   4599999999999999999999972  389999999999999999999999999998764332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHH-----hCcccc----
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-----TGKLKN----  362 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~-----~~~~~~----  362 (498)
                      .          ...+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+.......     .+....    
T Consensus       160 ~----------~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (322)
T d1s9ja_         160 A----------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  229 (322)
T ss_dssp             C-------------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred             c----------ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence            1          234699999999999999999999999999999999999999964321110000     000000    


Q ss_pred             ---------------------------ccCCCCCCCC-HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 ---------------------------LLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 ---------------------------~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                                 .........+ ...+..+.+|+.+||..||.+|||+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e  294 (322)
T d1s9ja_         230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ  294 (322)
T ss_dssp             ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence                                       0000000011 123567899999999999999999988

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=396.82  Aligned_cols=247  Identities=26%  Similarity=0.447  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec---CcceEEEeeCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYLP  214 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~---~~~~lV~E~~~  214 (498)
                      ++|.+.+.||+|+||.||+|.+++..||||+++..  ...+.|.+|+.++++++||||++++|+|.   +.+++||||++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            35677888999999999999999999999999653  34578999999999999999999999883   34789999999


Q ss_pred             CCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCC
Q 010882          215 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS  294 (498)
Q Consensus       215 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  294 (498)
                      +|+|.++|.... ...+++..++.|+.|++.||.|||+   ++|+||||||+|||++.+|.+||+|||+++......   
T Consensus        85 ~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          85 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             TEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence            999999995432 2358999999999999999999999   899999999999999999999999999998654322   


Q ss_pred             CCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCCCCCCC
Q 010882          295 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~  371 (498)
                              ....+|+.|+|||++.++.+++++|||||||++|||+| |++||......  ...+..+        .....
T Consensus       158 --------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------~~~~~  221 (262)
T d1byga_         158 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDA  221 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------CCCCC
T ss_pred             --------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------CCCCC
Confidence                    12347999999999999999999999999999999998 78888754332  2222221        12234


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      |...+..+.+|+.+||..||.+||++.+ +.+.|+.++.
T Consensus       222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~-l~~~L~~i~~  259 (262)
T d1byga_         222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQ-LREQLEHIKT  259 (262)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcccCHhHCcCHHH-HHHHHHHHHh
Confidence            5556688999999999999999999998 8888888764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=398.90  Aligned_cols=251  Identities=31%  Similarity=0.478  Sum_probs=200.8

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEEeeCCC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEYLPN  215 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~E~~~~  215 (498)
                      .+|.+.+.||+|+||+||+|.+++ ..||||+++.. ....+.|.+|+.+|++++|||||+++|+|.+ ..++||||+++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~   95 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK   95 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence            468889999999999999999964 67999999754 3456789999999999999999999999944 58899999999


Q ss_pred             CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccCCC
Q 010882          216 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN  295 (498)
Q Consensus       216 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  295 (498)
                      |+|..++.... ...+++..++.|+.+++.||.|||+   ++|+||||||+|||||.++++||+|||+|+......... 
T Consensus        96 g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  170 (285)
T d1fmka3          96 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-  170 (285)
T ss_dssp             CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             Cchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee-
Confidence            99999885432 2459999999999999999999999   899999999999999999999999999998765433211 


Q ss_pred             CccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhC-CCCCCCcHHH--HHHHHhCccccccCCCCCCCC
Q 010882          296 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEV--QYALDTGKLKNLLDPLAGDWP  372 (498)
Q Consensus       296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  372 (498)
                            .....||+.|+|||++..+.++.++|||||||+||||+|| .+|+......  ...+..+.        ....+
T Consensus       171 ------~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~--------~~~~~  236 (285)
T d1fmka3         171 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------RMPCP  236 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCC
T ss_pred             ------eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--------CCCCC
Confidence                  1334589999999999999999999999999999999995 4555544332  22222221        12234


Q ss_pred             HHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          373 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       373 ~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ..++..+.+++.+||+.+|++||++.+ |...|+...
T Consensus       237 ~~~~~~l~~li~~cl~~dP~~Rps~~~-i~~~L~~~~  272 (285)
T d1fmka3         237 PECPESLHDLMCQCWRKEPEERPTFEY-LQAFLEDYF  272 (285)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHTTT
T ss_pred             cccCHHHHHHHHHHcccCHhHCcCHHH-HHHHHhhhh
Confidence            556688999999999999999999998 677777654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.9e-51  Score=408.28  Aligned_cols=243  Identities=22%  Similarity=0.346  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ++|.+.+.||+|+||+||+|.++  +..||||++........+.+.+|+.+|++++|||||+++++|.  +..++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47999999999999999999985  7899999997665445667899999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc--CCCceeEeeccccccccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~DFGla~~~~~~~  291 (498)
                      +||+|.+++..  ....+++..+..|+.||+.||.|||+   +|||||||||+||||+  .++.+||+|||+|+.+....
T Consensus       106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999999853  33569999999999999999999999   8999999999999996  46889999999998765432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH--HhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~~~~~~  369 (498)
                      ..         ....||+.|+|||++.+..++.++|||||||++|+|+||++||...+......  ..+....  .   .
T Consensus       181 ~~---------~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~---~  246 (350)
T d1koaa2         181 SV---------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM--D---D  246 (350)
T ss_dssp             CE---------EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS--C---C
T ss_pred             cc---------ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--C---c
Confidence            11         22359999999999999999999999999999999999999998665443322  2221110  0   1


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+...+..+.+|+.+||..||.+|||+.+
T Consensus       247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e  276 (350)
T d1koaa2         247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQ  276 (350)
T ss_dssp             GGGGGCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            112345678999999999999999999988

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=398.79  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=196.9

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-----eEEEEEEecCCCCCC-hhhHHHHHHHHHcCCCCCeeeeeceec-CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~-~~~~~~E~~il~~l~hpniv~l~g~~~-~~~~lV~  210 (498)
                      .+|++.+.||+|+||.||+|.+..     ..||||++....... .+.|.+|+.+|++++|||||+++|+|. +..++||
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~   86 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM   86 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence            468888999999999999998742     468999886543322 356899999999999999999999985 4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+++|+|.+++..  ...++++..++.++.|++.||.|||+   ++||||||||+|||++.++.+||+|||+|+.....
T Consensus        87 E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          87 ELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             ECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999998753  33568999999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHH--HHHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~--~~~~~~~~~~~~~~~~  367 (498)
                      ....       .....||+.|+|||++.+..++.++|||||||+||||+| |.+||...+..  ...+..+.        
T Consensus       162 ~~~~-------~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~--------  226 (273)
T d1mp8a_         162 TYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------  226 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred             ccee-------ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            2211       123458999999999999999999999999999999998 89999765432  22222221        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ....|...+..+.+|+.+||+.||.+|||+.+ |.+.|+.+..
T Consensus       227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e-i~~~L~~i~~  268 (273)
T d1mp8a_         227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE-LKAQLSTILE  268 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHHH
Confidence            12244556788999999999999999999998 7777777653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=400.81  Aligned_cols=251  Identities=24%  Similarity=0.416  Sum_probs=204.0

Q ss_pred             CCCCCCcccccCceEEEEEEECC------eEEEEEEecCC-CCCChhhHHHHHHHHHcCCCCCeeeeeceecC-cceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~lV~  210 (498)
                      +|+..+.||+|+||+||+|.+..      .+||||.+... .....+.|.+|+.+|++++|||||+++|+|.+ ..+++|
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~   89 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT   89 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEE
Confidence            68888999999999999998842      36999998754 33446789999999999999999999999954 578999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      ||+.+|+|.+.+..  ....+++..++.|+.|++.||.|||+   ++||||||||+||||+.++++||+|||+|+.....
T Consensus        90 e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          90 QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             ECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            99999999998853  34579999999999999999999999   89999999999999999999999999999976544


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH--HHHHHHHhCccccccCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK--EVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~--~~~~~~~~~~~~~~~~~~  367 (498)
                      .....      .....||+.|+|||++.++.++.++|||||||+||||+| |.+||...+  .+...+..+.        
T Consensus       165 ~~~~~------~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~--------  230 (317)
T d1xkka_         165 EKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------  230 (317)
T ss_dssp             CC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC--------
T ss_pred             ccccc------ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            32211      123458999999999999999999999999999999999 899997643  2333333321        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                      ....|..++..+.+|+.+||+.+|.+||++.+ ++..|..+.
T Consensus       231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~e-il~~l~~~~  271 (317)
T d1xkka_         231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRE-LIIEFSKMA  271 (317)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHhCCCChhhCcCHHH-HHHHHHHHH
Confidence            12234556788999999999999999999998 666676664

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7e-51  Score=406.69  Aligned_cols=243  Identities=21%  Similarity=0.340  Sum_probs=202.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ..|++.+.||+|+||+||+|.+.  +..||||++..........+.+|+.+|++++|||||+++++|.  +..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46899999999999999999984  7889999997655444567889999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc--CCCceeEeeccccccccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~DFGla~~~~~~~  291 (498)
                      +||+|.+.+.  ....++++..+..|+.|++.||.|||+   +|||||||||+||||+  .++.+||+|||+|+.+....
T Consensus       109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            9999998874  234569999999999999999999999   8999999999999998  57899999999998775432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  369 (498)
                      ..         ....||+.|+|||++.+..++.++|||||||+||+|+||++||...+.....  +..+....     ..
T Consensus       184 ~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-----~~  249 (352)
T d1koba_         184 IV---------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF-----DE  249 (352)
T ss_dssp             CE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC-----CS
T ss_pred             ce---------eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----Cc
Confidence            11         1234899999999999999999999999999999999999999876554432  22222111     11


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+...+..+.+|+.+||+.||.+||++.+
T Consensus       250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  279 (352)
T d1koba_         250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHD  279 (352)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            122345678999999999999999999988

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=400.86  Aligned_cols=236  Identities=22%  Similarity=0.293  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~  210 (498)
                      ++|.+.+.||+|+||.||+|..+  +..||||++.+.   .......+.+|+.+|++++||||++++++|.+  .+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            46889999999999999999984  789999999753   22345678899999999999999999999954  589999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |||+||+|.+++..   ...+++..+..++.|++.||.|||+   +|||||||||+||||+.+|.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999854   3468999999999999999999999   89999999999999999999999999999865433


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~  368 (498)
                      ...        .....||+.|+|||++.+..|+.++|||||||+||||+||++||...+.....  +..+.         
T Consensus       159 ~~~--------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~---------  221 (337)
T d1o6la_         159 GAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------  221 (337)
T ss_dssp             TCC--------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             Ccc--------cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC---------
Confidence            211        12345999999999999999999999999999999999999999876553322  22211         


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCCC
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRPE  396 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP~  396 (498)
                      ..+|...+..+.+|+.+||+.||.+||+
T Consensus       222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~  249 (337)
T d1o6la_         222 IRFPRTLSPEAKSLLAGLLKKDPKQRLG  249 (337)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred             CCCCccCCHHHHHHHHhhccCCchhhcc
Confidence            2245566788999999999999999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=395.14  Aligned_cols=244  Identities=23%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC------ChhhHHHHHHHHHcCCCCCeeeeeceecC--cce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~  207 (498)
                      +.|.+.+.||+|+||+||+|.++  +..||||++.+....      ..+.|.+|+.+|++++|||||+++++|.+  ..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46899999999999999999985  789999999754322      24578999999999999999999999854  578


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC----ceeEeeccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI  283 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFGl  283 (498)
                      +|||||+||+|.+++...   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++    .+||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence            999999999999999543   469999999999999999999999   8999999999999998776    599999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL  363 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (498)
                      |........         .....||+.|+|||++.+..++.++|||||||+||||+||++||...+..............
T Consensus       164 a~~~~~~~~---------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~  234 (293)
T d1jksa_         164 AHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE  234 (293)
T ss_dssp             CEECTTSCB---------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred             hhhcCCCcc---------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Confidence            987654321         12345899999999999999999999999999999999999999876554432221111100


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          364 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      .   ....+...+..+.+|+.+||+.||.+||++.+
T Consensus       235 ~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  267 (293)
T d1jksa_         235 F---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD  267 (293)
T ss_dssp             C---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             C---CchhcCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            0   00011234578899999999999999999988

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=394.70  Aligned_cols=254  Identities=26%  Similarity=0.385  Sum_probs=195.4

Q ss_pred             cCCCCCCcccccCceEEEEEEECC-----eEEEEEEecCCCCCC---hhhHHHHHHHHHcCCCCCeeeeeceecC-cceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE-VWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~g~~~~-~~~l  208 (498)
                      ++|++.+.||+|+||.||+|.+.+     ..||||++.......   .+.|.+|+.+|++++|||||+++|+|.+ ..++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l   87 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM   87 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence            468888899999999999998732     469999987654322   3578999999999999999999999954 5789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      ||||+++|+|.+.+...  ..++++..++.++.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            99999999999988533  3469999999999999999999999   899999999999999999999999999999765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcHHHHHHHHhCccccccCCC
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL  367 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (498)
                      ......     .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.........+-.     .
T Consensus       163 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~-----~  232 (273)
T d1u46a_         163 QNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-----E  232 (273)
T ss_dssp             C-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-----C
T ss_pred             cCCCcc-----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC-----C
Confidence            443211     11233458889999999999999999999999999999998 899997665544322211111     1


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP  407 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~  407 (498)
                      ..+.+...+..+.+|+.+||+.||++|||+.+ |.+.|+.
T Consensus       233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e-i~~~L~~  271 (273)
T d1u46a_         233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA-LRDFLLE  271 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHcCCChhHCcCHHH-HHHHHHh
Confidence            11233445578999999999999999999998 7777765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-51  Score=397.89  Aligned_cols=264  Identities=25%  Similarity=0.351  Sum_probs=200.6

Q ss_pred             hHHHHHhhcCCCCCCcccccCceEEEEEEECC-------eEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeec
Q 010882          130 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVG  200 (498)
Q Consensus       130 ~~ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g  200 (498)
                      .++++...++|.+.+.||+|+||.||+|.+.+       +.||||+++..... ....+.+|..++.++ +||||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            33444445678899999999999999998732       57999998754322 234677888888777 6899999999


Q ss_pred             eec---CcceEEEeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 010882          201 ACP---EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK  264 (498)
Q Consensus       201 ~~~---~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk  264 (498)
                      ++.   ...++|||||++|+|.++|....             ....+++..+..++.|++.||.|||+   ++|||||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCC
Confidence            873   25789999999999999996432             13458999999999999999999999   899999999


Q ss_pred             CCcEEEcCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhC-CC
Q 010882          265 PANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RP  343 (498)
Q Consensus       265 p~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~  343 (498)
                      |+||||+.++++||+|||+|+..........      .....||+.|+|||++.+..++.++|||||||++|||+|| .+
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~  235 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  235 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCC------TTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccc------cCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCC
Confidence            9999999999999999999986654332211      2345699999999999999999999999999999999996 56


Q ss_pred             CCCCcH---HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          344 ALGITK---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       344 pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      ||....   .+...+..+..        ...|...++.+.+++.+||+.||.+||++.+ +++.|+.+..+
T Consensus       236 p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e-il~~L~~ilq~  297 (299)
T d1ywna1         236 PYPGVKIDEEFCRRLKEGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE-LVEHLGNLLQA  297 (299)
T ss_dssp             SSTTCCCSHHHHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHhcCCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHHHhC
Confidence            786532   23333333321        1234455678999999999999999999998 88888887643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.2e-50  Score=396.44  Aligned_cols=232  Identities=25%  Similarity=0.388  Sum_probs=197.4

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~  210 (498)
                      ++|++.+.||+|+||+||+|.++  +..||||+++..   .....+.+.+|+.+|+.++|||||++++++.  +..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            36888999999999999999985  789999998743   2334567899999999999999999999984  4689999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN  290 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  290 (498)
                      |||+||+|..++.   ....+++..+..++.|++.||.|||+   +|||||||||+||||+.+|.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999885   34568888999999999999999999   89999999999999999999999999999876543


Q ss_pred             ccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCCC
Q 010882          291 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLA  368 (498)
Q Consensus       291 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~  368 (498)
                      .           ....||+.|+|||++.+..|+.++|||||||+||||+||++||...+.....  +..+.         
T Consensus       158 ~-----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---------  217 (316)
T d1fota_         158 T-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---------  217 (316)
T ss_dssp             B-----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC---------
T ss_pred             c-----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC---------
Confidence            2           2346999999999999999999999999999999999999999876554332  22221         


Q ss_pred             CCCCHHHHHHHHHHHHHhhhcccCCCC
Q 010882          369 GDWPFVQAEQLANLAMRCCEMSRKSRP  395 (498)
Q Consensus       369 ~~~~~~~~~~l~~li~~cl~~~p~~RP  395 (498)
                      ..+|...+..+.+++.+||..||.+||
T Consensus       218 ~~~p~~~s~~~~~li~~~L~~dp~~R~  244 (316)
T d1fota_         218 LRFPPFFNEDVKDLLSRLITRDLSQRL  244 (316)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred             CCCCCCCCHHHHHHHHHHhhhCHHhcc
Confidence            123445667899999999999999997

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.6e-50  Score=388.77  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCCh---hhHHHHHHHHHcCCCCCeeeeeceecC------cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE------VW  206 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~hpniv~l~g~~~~------~~  206 (498)
                      ++|.+.+.||+|+||+||+|.+.  ++.||||++......+.   ..|.+|+.+|+.++||||+++++++..      ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            46888999999999999999984  78999999987654443   468899999999999999999998732      26


Q ss_pred             eEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccc
Q 010882          207 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF  286 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  286 (498)
                      |+||||++||+|.+++..   ..++++.++..|+.|++.||.|||+   +|||||||||+||||+.++..+|+|||++..
T Consensus        87 ~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence            899999999999998853   3469999999999999999999999   8999999999999999999999999999886


Q ss_pred             ccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCC
Q 010882          287 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP  366 (498)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (498)
                      ........     .......||+.|+|||++.+..++.++|||||||++|||+||++||...+........-.-... .+
T Consensus       161 ~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~-~~  234 (277)
T d1o6ya_         161 IADSGNSV-----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PP  234 (277)
T ss_dssp             CC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-CG
T ss_pred             hccccccc-----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC-CC
Confidence            54432211     1123456999999999999999999999999999999999999999876654433221110000 00


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHH
Q 010882          367 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR  409 (498)
Q Consensus       367 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~  409 (498)
                        ...+...+..+.+++.+||+.||.+||+..+++...|..+.
T Consensus       235 --~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 --SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence              01122345789999999999999999954444666665553

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=389.97  Aligned_cols=251  Identities=26%  Similarity=0.411  Sum_probs=201.5

Q ss_pred             CCcccccCceEEEEEEECC-----eEEEEEEecCCCC-CChhhHHHHHHHHHcCCCCCeeeeeceec---CcceEEEeeC
Q 010882          143 SLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYL  213 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~g~~~---~~~~lV~E~~  213 (498)
                      .++||+|+||+||+|.+..     ..||||+++.... ...+.|.+|+++|++++||||++++|+|.   ...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4579999999999999842     3599999975322 23467999999999999999999999873   3578999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      ++|+|.+++..  ....+++..++.++.|++.||.|||+   .+|+||||||+||||+.++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999863  34567888999999999999999999   89999999999999999999999999999977654322


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH---HHHHHhCccccccCCCCCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV---QYALDTGKLKNLLDPLAGD  370 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~  370 (498)
                      ...    ......||+.|+|||.+.++.++.++|||||||+||||+||..||......   ...+..+.        ...
T Consensus       187 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--------~~~  254 (311)
T d1r0pa_         187 SVH----NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLL  254 (311)
T ss_dssp             CTT----CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--------CCC
T ss_pred             cce----ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------CCC
Confidence            211    123456999999999999999999999999999999999977766543221   11222221        112


Q ss_pred             CCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          371 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       371 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                      .|..++..+.+|+.+||+.||.+||++.+ |++.|+.+...
T Consensus       255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~e-i~~~L~~i~~~  294 (311)
T d1r0pa_         255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSE-LVSRISAIFST  294 (311)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHT
T ss_pred             CcccCcHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHHHHh
Confidence            34455678999999999999999999998 77888888754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-50  Score=393.44  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=204.0

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--Ce--EEEEEEecCC-CCCChhhHHHHHHHHHcC-CCCCeeeeeceec--CcceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HM--QVAIKMLHPH-SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~--~~~~lV  209 (498)
                      ++|++.+.||+|+||+||+|.++  +.  .||||.+... .....+.|.+|+.+|+++ +|||||+++|+|.  +..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            46777889999999999999984  33  5888887643 333456799999999999 7999999999984  468999


Q ss_pred             EeeCCCCCHHhhhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCce
Q 010882          210 YEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS  276 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  276 (498)
                      |||++||+|.++|...             .....+++..+..++.|++.||.|||+   ++||||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            9999999999999643             234679999999999999999999999   899999999999999999999


Q ss_pred             eEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCC-CCCCCcHHHHHHH
Q 010882          277 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYAL  355 (498)
Q Consensus       277 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~pf~~~~~~~~~~  355 (498)
                      ||+|||+|+........         ....||+.|+|||.+.++.++.++|||||||++|||+||. +||...+......
T Consensus       167 kl~DfG~a~~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKK---------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  237 (309)
T ss_dssp             EECCTTCEESSCEECCC-------------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EEccccccccccccccc---------cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999999865443211         2234899999999999999999999999999999999965 6786654433221


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                      ..      ........|...++.+.+|+.+||+.||++||++.+ |++.|+.+..
T Consensus       238 ~i------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e-il~~L~~i~~  285 (309)
T d1fvra_         238 KL------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRMLE  285 (309)
T ss_dssp             HG------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             HH------HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHHHh
Confidence            11      111122345566789999999999999999999998 7788888765

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-50  Score=390.73  Aligned_cols=258  Identities=25%  Similarity=0.401  Sum_probs=206.2

Q ss_pred             hcCCCCCCcccccCceEEEEEEECC---------eEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceec--
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--  203 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~--  203 (498)
                      .++|.+.+.||+|+||.||+|...+         ..||||+++..... ....+.+|+..+.++ +|||||+++|+|.  
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3478888999999999999998632         46999999765432 245788899999888 7999999999994  


Q ss_pred             CcceEEEeeCCCCCHHhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL  270 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl  270 (498)
                      +..++||||+++|+|.++|....             ....+++.+++.++.|++.||.|||+   ++||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence            36899999999999999996432             13468999999999999999999999   899999999999999


Q ss_pred             cCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH
Q 010882          271 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK  349 (498)
Q Consensus       271 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  349 (498)
                      +.++.+||+|||+++..........      .....||+.|+|||.+.++.|+.++|||||||++|||+| |.+||...+
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCC------CTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cCCCCeEeccchhhccccccccccc------cccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            9999999999999997765432221      133458999999999999999999999999999999998 789997554


Q ss_pred             HHH--HHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          350 EVQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       350 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ...  ..+..+        .....|...+..+.+|+.+||+.+|.+|||+.+ |++.|+.+.+..
T Consensus       243 ~~~~~~~i~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~e-il~~L~~i~a~~  298 (299)
T d1fgka_         243 VEELFKLLKEG--------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ-LVEDLDRIVALT  298 (299)
T ss_dssp             HHHHHHHHHTT--------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHHC
T ss_pred             HHHHHHHHHcC--------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHH-HHHHHHHHhhcC
Confidence            322  222222        122345556688999999999999999999998 888999887653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-49  Score=397.00  Aligned_cols=237  Identities=21%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCC---CCCChhhHHHHHHHHHcCCCCCeeeeeceecC--cceEEEe
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE  211 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--~~~lV~E  211 (498)
                      +|++.+.||+|+||.||+|.++  +..||||++...   .....+.+.+|+.+|+.++|||||++++++.+  ..++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            6888999999999999999985  789999998643   22345678999999999999999999999844  5789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+.||+|.+++...   ..+++..+..|+.|++.||.|||+   ++||||||||+||||+.+|++||+|||+|+.+....
T Consensus       122 ~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         122 YVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             CCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             cccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence            99999999999543   469999999999999999999999   899999999999999999999999999998765322


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccccCCCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW  371 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (498)
                                 ....||+.|+|||++.+..++.++|||||||+||||+||++||...+...........       ....
T Consensus       196 -----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------~~~~  257 (350)
T d1rdqe_         196 -----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------KVRF  257 (350)
T ss_dssp             -----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CCCC
T ss_pred             -----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-------CCCC
Confidence                       2235999999999999999999999999999999999999999876654432221111       1123


Q ss_pred             CHHHHHHHHHHHHHhhhcccCCCC-----ChhH
Q 010882          372 PFVQAEQLANLAMRCCEMSRKSRP-----ELGK  399 (498)
Q Consensus       372 ~~~~~~~l~~li~~cl~~~p~~RP-----~~~~  399 (498)
                      |...+..+.+|+.+||..||.+|+     ++.+
T Consensus       258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~e  290 (350)
T d1rdqe_         258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND  290 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHH
T ss_pred             CccCCHHHHHHHHHHhhhCHHhccccccccHHH
Confidence            445567899999999999999995     5655

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=391.11  Aligned_cols=239  Identities=24%  Similarity=0.317  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCC---CCCChhhHHHHHHHHH-cCCCCCeeeeeceecC--cceEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPH---SLQGPSEFQQEIDILS-KIRHPNLVTLVGACPE--VWTLV  209 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~il~-~l~hpniv~l~g~~~~--~~~lV  209 (498)
                      .+|.+.+.||+|+||+||+|.+  .++.||||++.+.   .....+.+..|..++. .++|||||++++++.+  ..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            3688889999999999999999  4789999999753   2234456777877765 6899999999999844  58999


Q ss_pred             EeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccc
Q 010882          210 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       210 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  289 (498)
                      |||++||+|.+++..   ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++++||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999953   3468999999999999999999999   8999999999999999999999999999986543


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL  367 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~  367 (498)
                      ....        .....||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+.....  +..+.        
T Consensus       156 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------  219 (320)
T d1xjda_         156 GDAK--------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------  219 (320)
T ss_dssp             TTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             cccc--------ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Confidence            3211        13346999999999999999999999999999999999999999876544322  22211        


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                       ..+|...+..+.+|+.+||..||.+||++..
T Consensus       220 -~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~  250 (320)
T d1xjda_         220 -PFYPRWLEKEAKDLLVKLFVREPEKRLGVRG  250 (320)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBS
T ss_pred             -CCCCccCCHHHHHHHHHhcccCCCCCcCHHH
Confidence             1245556788999999999999999999863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=389.84  Aligned_cols=254  Identities=24%  Similarity=0.377  Sum_probs=206.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceec--Ccc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVW  206 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~  206 (498)
                      .++|...+.||+|+||+||+|.++       +..||||+++..... ....|.+|+.++++++|||||+++|+|.  +..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            457888899999999999999874       367999999754322 2345889999999999999999999984  568


Q ss_pred             eEEEeeCCCCCHHhhhccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEe
Q 010882          207 TLVYEYLPNGSLEDRLSCK-------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS  279 (498)
Q Consensus       207 ~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  279 (498)
                      ++||||+++|+|.+++...       .....+++..+..|+.+++.||.|||+   ++|+||||||+||||+.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence            9999999999999988532       233468999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhC-CCCCCCcHHHH--HHHH
Q 010882          280 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQ--YALD  356 (498)
Q Consensus       280 DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~--~~~~  356 (498)
                      |||+|+........      .......||+.|+|||.+.+..++.++|||||||+||||+|| .+||...+...  ..+.
T Consensus       176 DFGla~~~~~~~~~------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYY------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             CTTCCCGGGGGGCE------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             ecccceeccCCcce------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999876544321      112334589999999999999999999999999999999998 57887654432  2222


Q ss_pred             hCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHH
Q 010882          357 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM  408 (498)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~  408 (498)
                      .+.        ..+.|..++..+.+|+.+||+.+|.+||++.+ |++.|+..
T Consensus       250 ~~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~-il~~L~~~  292 (308)
T d1p4oa_         250 EGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-IISSIKEE  292 (308)
T ss_dssp             TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHGGG
T ss_pred             hCC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHh
Confidence            222        22234456688999999999999999999998 66666654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=388.99  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=196.8

Q ss_pred             CCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHH--HHHHHcCCCCCeeeeeceecC------cceEEE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQE--IDILSKIRHPNLVTLVGACPE------VWTLVY  210 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~il~~l~hpniv~l~g~~~~------~~~lV~  210 (498)
                      +|...+.||+|+||.||+|.+++..||||++...   ....+..|  +..++.++|||||+++|+|.+      ..++||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4556678999999999999999999999998643   23344444  445567899999999999832      368999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      ||+++|+|.++|..    .++++..++.++.+++.||.|||+.     +.+|||||||||+||||+.+|.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999963    3589999999999999999999973     34699999999999999999999999999999


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCC------CCCccchHhHHHHHHHHHhCCCCCCCcH----------
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE------LTPKSDVYSFGIILLRLLTGRPALGITK----------  349 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~pf~~~~----------  349 (498)
                      ..........    .......||+.|+|||++.+..      ++.++|||||||+||||+||.+||+...          
T Consensus       157 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         157 RHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             EEETTTTEEC----C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             cccCCCccee----ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            7654332111    1123457999999999987642      5678999999999999999998874211          


Q ss_pred             -------HHHHHHHhCccccccCCCCCC-C-CHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          350 -------EVQYALDTGKLKNLLDPLAGD-W-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       350 -------~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                             ........+.+    .|.... + +......+.+|+.+||+.||.+||++.+ |.+.|+.+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e-i~~~L~~i~~~~  299 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR-IKKTLSQLSQQE  299 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH-HHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH-HHHHHHHHHHhc
Confidence                   11112211111    111111 1 2235567999999999999999999998 888888887543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.2e-49  Score=379.48  Aligned_cols=242  Identities=27%  Similarity=0.398  Sum_probs=199.6

Q ss_pred             cCCCCCCcccccCceEEEEEEE--CCeEEEEEEecCCCCCCh---------hhHHHHHHHHHcCC-CCCeeeeeceecC-
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGP---------SEFQQEIDILSKIR-HPNLVTLVGACPE-  204 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~---------~~~~~E~~il~~l~-hpniv~l~g~~~~-  204 (498)
                      .+|++.+.||+|+||+||+|..  .++.||||++........         +.+.+|+.+|++++ ||||+++++++.+ 
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            4688889999999999999998  468999999976543321         24789999999997 9999999999954 


Q ss_pred             -cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          205 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       205 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                       ..|+|||||+||||.++|..   ..++++..+..++.|++.||.|||+   +||+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchh
Confidence             58999999999999999953   3469999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhcc------CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--H
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--L  355 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~  355 (498)
                      |+.+.....         .....||+.|+|||++.+      ..++.++||||+||+||+|+||++||...+.....  +
T Consensus       157 a~~~~~~~~---------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i  227 (277)
T d1phka_         157 SCQLDPGEK---------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI  227 (277)
T ss_dssp             CEECCTTCC---------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eeEccCCCc---------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH
Confidence            987654321         133469999999999864      34788999999999999999999999876544322  2


Q ss_pred             HhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          356 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+....     ....+...++++.+|+.+||+.+|.+||++.+
T Consensus       228 ~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e  266 (277)
T d1phka_         228 MSGNYQF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE  266 (277)
T ss_dssp             HHTCCCC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HhCCCCC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            2222211     11122346688999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.3e-49  Score=396.48  Aligned_cols=239  Identities=26%  Similarity=0.332  Sum_probs=191.7

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC---CChhhHHH---HHHHHHcCCCCCeeeeeceec--Ccce
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQ---EIDILSKIRHPNLVTLVGACP--EVWT  207 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~---E~~il~~l~hpniv~l~g~~~--~~~~  207 (498)
                      ++|.+.+.||+|+||.||+|.+.  +..||||++.+...   .....+.+   ++.+++.++|||||+++++|.  +..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            47888999999999999999984  78899999864321   22233444   467777889999999999984  4689


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL  287 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  287 (498)
                      +|||||+||+|.++|..   ...+++..+..++.|++.||.|||+   +|||||||||+||||+.+|.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999953   3468899999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHH-HHHHHhCccccccC
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLD  365 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~~~~~~~  365 (498)
                      .....          ....||+.|+|||++.. ..|+.++|||||||+||||+||++||...+.. ...+....     .
T Consensus       158 ~~~~~----------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-----~  222 (364)
T d1omwa3         158 SKKKP----------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----L  222 (364)
T ss_dssp             SSSCC----------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-----S
T ss_pred             CCCcc----------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----c
Confidence            54321          23459999999999975 46899999999999999999999999754321 11111111     1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          366 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       366 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      .....+|...++.+.+|+.+||..||.+||+.
T Consensus       223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  254 (364)
T d1omwa3         223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGC  254 (364)
T ss_dssp             SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred             cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence            11122444567889999999999999999995

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-49  Score=386.03  Aligned_cols=256  Identities=24%  Similarity=0.392  Sum_probs=206.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC-------CeEEEEEEecCCCCC-ChhhHHHHHHHHHcC-CCCCeeeeeceecC--c
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACPE--V  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~hpniv~l~g~~~~--~  205 (498)
                      ..+|++.+.||+|+||.||+|.+.       +..||||+++..... ....|.+|+.+++++ +|||||+++|+|.+  .
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            357888899999999999999873       257999999865432 244688999999999 69999999999954  5


Q ss_pred             ceEEEeeCCCCCHHhhhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEE
Q 010882          206 WTLVYEYLPNGSLEDRLSCKD---------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL  270 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl  270 (498)
                      .++|||||++|+|.+++....               ....+++..+..|+.|++.||.|||+   +++|||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence            899999999999999986432               23468999999999999999999999   899999999999999


Q ss_pred             cCCCceeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCCcH
Q 010882          271 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK  349 (498)
Q Consensus       271 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  349 (498)
                      +.++.+||+|||+++........      .......||+.|+|||++.++.++.++|||||||++|||+| |.+||...+
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccCcccccccchheeccCCCcc------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999876543221      11234568999999999999999999999999999999999 667775432


Q ss_pred             ---HHHHHHHhCccccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHh
Q 010882          350 ---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA  410 (498)
Q Consensus       350 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~  410 (498)
                         .+...+..+.        ....|...+..+.+|+.+||+.||.+||++.+ ++++|+.+..
T Consensus       253 ~~~~~~~~i~~~~--------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~-il~~L~~~i~  307 (311)
T d1t46a_         253 VDSKFYKMIKEGF--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ-IVQLIEKQIS  307 (311)
T ss_dssp             SSHHHHHHHHHTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred             HHHHHHHHHhcCC--------CCCCcccccHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHhhc
Confidence               2333333321        11123445678999999999999999999998 7788876544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=381.57  Aligned_cols=243  Identities=26%  Similarity=0.292  Sum_probs=189.5

Q ss_pred             CCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC-----hhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          143 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       143 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      .++||+|+||+||+|.++  ++.||||++.......     ...+.+|+.+|++++|||||++++++.  +..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            457999999999999984  6889999987543221     346889999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccccC
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS  293 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  293 (498)
                      .+|++..++   .....+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+|+........
T Consensus        83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            988877766   344568889999999999999999999   89999999999999999999999999999876543321


Q ss_pred             CCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc------ccccCC
Q 010882          294 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------KNLLDP  366 (498)
Q Consensus       294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~------~~~~~~  366 (498)
                              .....||+.|+|||++... .|+.++|||||||++|||+||.+||...+...........      ....+.
T Consensus       157 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         157 --------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             --------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             --------ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence                    1234599999999998765 5799999999999999999999999876655433221100      000000


Q ss_pred             ----------CCCCCC-----HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          367 ----------LAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       367 ----------~~~~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                .....+     ...+..+.+|+.+||+.||.+|||+.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e  276 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ  276 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence                      000111     123568999999999999999999988

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=384.20  Aligned_cols=242  Identities=21%  Similarity=0.309  Sum_probs=197.2

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEeeC
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL  213 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~~  213 (498)
                      ++|.+.+.||+|+||+||+|.+.  +..||||+++... .....+.+|+.+|+.++|||||++++++.  +..|+|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            46888899999999999999985  6889999997543 23446889999999999999999999984  4689999999


Q ss_pred             CCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCC--CceeEeeccccccccccc
Q 010882          214 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       214 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~DFGla~~~~~~~  291 (498)
                      +||+|.+++..  ...++++.++..|+.|++.||.|||+   +||+||||||+|||++.+  +.+||+|||+++......
T Consensus        84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            99999999953  23469999999999999999999999   899999999999999854  589999999998764332


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHH--HhCccccccCCCCC
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAG  369 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~~~~~~  369 (498)
                      ..         ....||+.|+|||.+.+..|+.++|||||||++|+|+||.+||...+......  ..+...  ++   .
T Consensus       159 ~~---------~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~---~  224 (321)
T d1tkia_         159 NF---------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FD---E  224 (321)
T ss_dssp             EE---------EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CC---H
T ss_pred             cc---------cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CC---h
Confidence            11         12248999999999999999999999999999999999999998765543222  221111  00   0


Q ss_pred             CCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          370 DWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       370 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ..+...+..+.+|+.+||..||.+||++.+
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  254 (321)
T d1tkia_         225 EAFKEISIEAMDFVDRLLVKERKSRMTASE  254 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             hhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            001124577899999999999999999988

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-49  Score=389.13  Aligned_cols=241  Identities=22%  Similarity=0.363  Sum_probs=191.8

Q ss_pred             cCCCCCC-cccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcC-CCCCeeeeeceec------Ccce
Q 010882          138 HNFDPSL-KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP------EVWT  207 (498)
Q Consensus       138 ~~~~~~~-~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~g~~~------~~~~  207 (498)
                      ++|.+.. .||+|+||+||+|.+.  +..||||++..     ...+.+|+.++.++ +|||||+++++|.      ...|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            4787764 5999999999999984  68899999863     35788999997655 8999999999874      3479


Q ss_pred             EEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC---CCceeEeecccc
Q 010882          208 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS  284 (498)
Q Consensus       208 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla  284 (498)
                      +|||||+||+|.++|... ....+++.++..|+.|++.||.|||+   +||+||||||+|||++.   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence            999999999999999643 23469999999999999999999999   89999999999999985   567999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccccc
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL  364 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (498)
                      +.......         .....||+.|+|||++.+..|+.++|||||||+||+|+||++||...+........   ...+
T Consensus       162 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i  229 (335)
T d2ozaa1         162 KETTSHNS---------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRI  229 (335)
T ss_dssp             EECCCCCC---------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC
T ss_pred             eeccCCCc---------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHH
Confidence            87654331         12345999999999999999999999999999999999999999654321111000   0000


Q ss_pred             CCCCCCCC----HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          365 DPLAGDWP----FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       365 ~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ......+|    ...+..+.+|+.+||+.||.+||++.+
T Consensus       230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  268 (335)
T d2ozaa1         230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE  268 (335)
T ss_dssp             CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            00111122    245678999999999999999999988

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-49  Score=378.94  Aligned_cols=233  Identities=23%  Similarity=0.364  Sum_probs=192.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC------hhhHHHHHHHHHcCC--CCCeeeeeceecC--c
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG------PSEFQQEIDILSKIR--HPNLVTLVGACPE--V  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~------~~~~~~E~~il~~l~--hpniv~l~g~~~~--~  205 (498)
                      ++|.+.+.||+|+||+||+|.+.  +..||||++.......      ...+.+|+.+|++++  |||||++++++.+  .
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            46888899999999999999984  7899999987543322      234779999999997  8999999999844  6


Q ss_pred             ceEEEeeCCC-CCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-CCceeEeeccc
Q 010882          206 WTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGI  283 (498)
Q Consensus       206 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGl  283 (498)
                      .++||||+.+ +++.+++..   ...+++..+..++.|++.||.|||+   +||+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence            7999999976 678888743   3469999999999999999999999   89999999999999985 47999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      |+......          .....||+.|+|||++.+..+ +.++|||||||+||||+||++||...+.+..    +.   
T Consensus       158 a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~----~~---  220 (273)
T d1xwsa_         158 GALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR----GQ---  220 (273)
T ss_dssp             CEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----CC---
T ss_pred             ceeccccc----------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhh----cc---
Confidence            98654332          133469999999999988775 5678999999999999999999987654321    11   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                            ..++...+..+.+|+.+||..||.+|||+.+
T Consensus       221 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  251 (273)
T d1xwsa_         221 ------VFFRQRVSSECQHLIRWCLALRPSDRPTFEE  251 (273)
T ss_dssp             ------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence                  1133345678999999999999999999988

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=374.11  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=192.6

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      .+|...+.||+|+||+||+|.+.  ++.||||+++....  .....+.+|+++|++++|||||+++++|.  +..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            37888899999999999999985  78999999975432  23567899999999999999999999984  46899999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+.++ +.+++.. .....+++..+..++.|++.||.|||+   +|||||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~-~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQD-LKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEE-HHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCc-hhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765 4444432 234569999999999999999999999   899999999999999999999999999998765432


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----CccccccC-
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GKLKNLLD-  365 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~~~~~~~-  365 (498)
                      ..        .....||+.|+|||.+.... ++.++|||||||++|+|+||++||...+........    +......- 
T Consensus       157 ~~--------~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         157 RT--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             BC--------TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cc--------ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence            11        12345999999999987765 578999999999999999999999876544332211    11000000 


Q ss_pred             ------CCCCCC-----------CHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          366 ------PLAGDW-----------PFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       366 ------~~~~~~-----------~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                            .....+           ....+..+.+|+.+||..||.+|||+.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e  279 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA  279 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence                  000000           0123467899999999999999999988

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=374.67  Aligned_cols=249  Identities=26%  Similarity=0.347  Sum_probs=195.5

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC---CeEEEEEEecCCCC--CChhhHHHHHHHHHcC---CCCCeeeeeceec-----
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL--QGPSEFQQEIDILSKI---RHPNLVTLVGACP-----  203 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~hpniv~l~g~~~-----  203 (498)
                      .++|++.+.||+|+||+||+|.+.   ++.||||++.....  .....+.+|+.+|+.|   +||||++++++|.     
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            357999999999999999999984   46799999865422  2344677888887776   7999999999873     


Q ss_pred             --CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          204 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       204 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                        ...+++|||+.+|++.....  .....+++..+..++.|++.||.|||+   ++||||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecch
Confidence              24789999999887765443  344568999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----  357 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----  357 (498)
                      |+++.......         .....||+.|+|||++.+..|+.++|||||||++|||+||++||...+........    
T Consensus       161 g~~~~~~~~~~---------~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  231 (305)
T d1blxa_         161 GLARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  231 (305)
T ss_dssp             CSCCCCCGGGG---------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             hhhhhhccccc---------CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence            99886543321         23456999999999999999999999999999999999999999876554332211    


Q ss_pred             Cc-----cc-----------cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          358 GK-----LK-----------NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       358 ~~-----~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      +.     +.           .........++...+..+.+|+.+||+.||.+|||+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e  289 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  289 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence            00     00           00000011123345678899999999999999999988

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.5e-47  Score=368.74  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=194.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC-CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E~  212 (498)
                      ++|...+.||+|+||+||+|.++ +..||||++.....  ...+.+.+|+.+|++++|||||+++++|.  +..++||||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            36888899999999999999985 68899999976432  23567999999999999999999999984  468899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI  292 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  292 (498)
                      +.++.+..+.   .....+++..+..|+.|++.||.|||+   ++||||||||+||||+.++.+||+|||+|........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9887777766   334679999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             CCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----Cc--------
Q 010882          293 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK--------  359 (498)
Q Consensus       293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~~--------  359 (498)
                      .        .....||+.|+|||.+.+. .++.++|||||||++|||+||++||...+........    +.        
T Consensus       156 ~--------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (286)
T d1ob3a_         156 K--------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (286)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             c--------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence            1        1233589999999999765 5689999999999999999999999766543322211    00        


Q ss_pred             cccc------cCCC----CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          360 LKNL------LDPL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       360 ~~~~------~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ....      ....    ....+...+..+.+|+.+||+.||++|||+.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e  277 (286)
T d1ob3a_         228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ  277 (286)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            0000      0000    00112234578899999999999999999988

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-46  Score=366.03  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=192.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCC--CChhhHHHHHHHHHcCCCCCeeeeeceec----------
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP----------  203 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~g~~~----------  203 (498)
                      ++|.+.+.||+|+||+||+|.+.  ++.||||++.....  .....+.+|+.+|++++||||+++++++.          
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            57888999999999999999984  68999999865432  23467889999999999999999999872          


Q ss_pred             CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccc
Q 010882          204 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI  283 (498)
Q Consensus       204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  283 (498)
                      ...++||||+.++++....   .....++...+..|+.|++.||.|||+   +||+||||||+||||+.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence            2468999999887776555   344568999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccc
Q 010882          284 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN  362 (498)
Q Consensus       284 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (498)
                      ++.+.........    ......||+.|+|||++.+. .++.++|||||||++|||+||++||...+.............
T Consensus       164 ~~~~~~~~~~~~~----~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         164 ARAFSLAKNSQPN----RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CEECCC-----CC----CCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             eeecccccccccc----cccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9876644322211    12344699999999999765 689999999999999999999999976554333221111100


Q ss_pred             ccCC-----------------C-CCCCCH-------HHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          363 LLDP-----------------L-AGDWPF-------VQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       363 ~~~~-----------------~-~~~~~~-------~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                      ...+                 . ....+.       ..+..+.+|+.+||+.||++|||+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e  301 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD  301 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence            0000                 0 000000       12346778999999999999999988

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-46  Score=370.28  Aligned_cols=245  Identities=26%  Similarity=0.336  Sum_probs=189.9

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeeceecC--------cceE
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------VWTL  208 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~~~--------~~~l  208 (498)
                      +|...++||+|+||+||+|.+.  ++.||||++.....    .+.+|+.+|++++||||++++++|..        ..++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5777789999999999999994  78899999975432    34589999999999999999998721        3689


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-ceeEeeccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL  287 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~  287 (498)
                      |||||++|.+..+.........+++..+..|+.|++.||.|||+   +||+||||||+||||+.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            99999876555544333455679999999999999999999999   8999999999999999765 8999999999876


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh----C----
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G----  358 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~----~----  358 (498)
                      ......         ....||+.|+|||.+.+ ..++.++|||||||++|||+||++||...+........    |    
T Consensus       174 ~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~  244 (350)
T d1q5ka_         174 VRGEPN---------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  244 (350)
T ss_dssp             CTTSCC---------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cCCccc---------ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence            543211         23459999999998875 47899999999999999999999999765543322111    0    


Q ss_pred             --------ccccccCCC------CCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          359 --------KLKNLLDPL------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       359 --------~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                              ......-+.      ........++.+.+|+.+||..||.+|||+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e  299 (350)
T d1q5ka_         245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE  299 (350)
T ss_dssp             HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence                    000000000      00112234678999999999999999999988

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-46  Score=363.79  Aligned_cols=263  Identities=20%  Similarity=0.277  Sum_probs=197.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCeeeeecee---cCcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~g~~---~~~~~lV~E~  212 (498)
                      ++|.+.+.||+|+||+||+|.+.  ++.||||++....  ....+..|+++++.++|+|++..++.|   .+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            36889999999999999999985  7899999987643  335688999999999888776666554   3467899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEc---CCCceeEeeccccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQ  289 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~~~~  289 (498)
                      + +|+|.+.+..  ....+++..+..++.|++.||.|||+   +|||||||||+|||++   .++.+||+|||+|+.+..
T Consensus        85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 5677666642  33569999999999999999999999   8999999999999986   456799999999998765


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHH--HHhCccccccCCC
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL  367 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~~  367 (498)
                      ....... .........||+.|+|||++.+..++.++|||||||++|||+||++||.........  ...........+.
T Consensus       159 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBC-CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccce-eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            4322211 112234567999999999999999999999999999999999999999653322111  0000000000000


Q ss_pred             CCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhh
Q 010882          368 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS  411 (498)
Q Consensus       368 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~  411 (498)
                       ...+...+..+.+++..||+.+|.+||++.+ +.+.|+.+...
T Consensus       238 -~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~-i~~~l~~~~~~  279 (299)
T d1ckia_         238 -EVLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHR  279 (299)
T ss_dssp             -HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH-HHHHHHHHHHH
T ss_pred             -hHhccCCCHHHHHHHHHHccCChhHCcCHHH-HHHHHHHHHHH
Confidence             0011234578999999999999999999987 77778776543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.3e-45  Score=355.18  Aligned_cols=261  Identities=20%  Similarity=0.240  Sum_probs=202.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCCC-CCeeeeecee--cCcceEEEee
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEVWTLVYEY  212 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~g~~--~~~~~lV~E~  212 (498)
                      ++|.+.+.||+|+||+||+|.+.  ++.||||++....  ....+.+|+++++.+.| +|++.+++++  ....++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57889999999999999999984  7899999986543  34568899999999975 8999998877  3467899999


Q ss_pred             CCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcC-----CCceeEeeccccccc
Q 010882          213 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-----NFVSKLSDFGISRFL  287 (498)
Q Consensus       213 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~-----~~~~kl~DFGla~~~  287 (498)
                      + +|+|.+++...  ...++..++..++.|++.||.|||+   +|||||||||+||||+.     ++.+||+|||+|+.+
T Consensus        83 ~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          83 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9 78999988533  3468999999999999999999999   89999999999999974     578999999999987


Q ss_pred             cccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcH---HHH--HHHHhCcccc
Q 010882          288 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK---EVQ--YALDTGKLKN  362 (498)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~---~~~--~~~~~~~~~~  362 (498)
                      ........ ..........||+.|+|||++.+..++.++|||||||++|||+||..||....   ...  ..+...+...
T Consensus       157 ~~~~~~~~-~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         157 RDPVTKQH-IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             BCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             ccCccccc-eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            65432211 11122345679999999999999999999999999999999999999996421   111  1111111110


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHHHHHHhHHHHhhc
Q 010882          363 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC  412 (498)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~v~~~L~~~~~~~  412 (498)
                      ....    .+...++++.+++..|+..+|.+||++.. +.+.|+.+....
T Consensus       236 ~~~~----l~~~~p~~l~~ii~~~~~~~~~~rP~y~~-l~~~l~~~~~~~  280 (293)
T d1csna_         236 PLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDY-LQGLFSKVLERL  280 (293)
T ss_dssp             CHHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHH-HHHHHHHHHHHT
T ss_pred             ChHH----hcCCCCHHHHHHHHHHhcCCcccCcCHHH-HHHHHHHHHHHc
Confidence            0000    11223467999999999999999999977 778888776543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-46  Score=370.36  Aligned_cols=250  Identities=24%  Similarity=0.295  Sum_probs=191.3

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC-ChhhHHHHHHHHHcCCCCCeeeeeceecC------cceE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE------VWTL  208 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~g~~~~------~~~l  208 (498)
                      .+|.+.+.||+|+||+||+|.++  ++.||||++.+.... ..+.+.+|+.+|+.++||||+++++++..      ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            36888999999999999999985  789999999754322 23568899999999999999999999843      2356


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccccccc
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS  288 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  288 (498)
                      +++|+.||+|.+++..    ..+++..+..++.|++.||.|||+   +|||||||||+||||+.++.+||+|||+|....
T Consensus        88 l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            6677889999999953    359999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccCCCCccceeccCCCCCCCcCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCccccc----
Q 010882          289 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL----  363 (498)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~----  363 (498)
                      ........     ....+||+.|+|||++.. ..++.++||||+||++|+|+||++||...+..............    
T Consensus       161 ~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         161 PDHDHTGF-----LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             GGGCBCCT-----TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             CCCcccee-----eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            54322111     234569999999999855 56789999999999999999999999765432221111000000    


Q ss_pred             ---------------cCCCCCCCC-----HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          364 ---------------LDPLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       364 ---------------~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                     ..+.....+     ...+..+.+|+.+||..||.+||++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e  291 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ  291 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence                           000001111     123457899999999999999999988

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=368.01  Aligned_cols=245  Identities=21%  Similarity=0.293  Sum_probs=188.3

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceecC--------
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE--------  204 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~~--------  204 (498)
                      ..+|.+.+.||+|+||+||+|.++  ++.||||++.......  .+.+.+|+.+|+.++|||||+++++|..        
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357888999999999999999985  7889999997643322  3468899999999999999999999842        


Q ss_pred             cceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeecccc
Q 010882          205 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS  284 (498)
Q Consensus       205 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  284 (498)
                      .+++||||+ +++|..++..    ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccce
Confidence            368999999 6678877642    459999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcc---
Q 010882          285 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---  360 (498)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~---  360 (498)
                      +......           +...||+.|+|||++.+. .++.++|||||||++|+|+||++||...+...........   
T Consensus       169 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~  237 (346)
T d1cm8a_         169 RQADSEM-----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  237 (346)
T ss_dssp             EECCSSC-----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eccCCcc-----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence            8664332           234599999999998775 5689999999999999999999999765443222111000   


Q ss_pred             ---------------------ccccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhHH
Q 010882          361 ---------------------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD  400 (498)
Q Consensus       361 ---------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~~  400 (498)
                                           ...............+..+.+|+.+||..||.+|||+.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei  298 (346)
T d1cm8a_         238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA  298 (346)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                                 0000000011122345678999999999999999999883

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-45  Score=360.86  Aligned_cols=242  Identities=28%  Similarity=0.375  Sum_probs=192.4

Q ss_pred             cCCCCCCcccccCceEEEEEEE-----CCeEEEEEEecCCC----CCChhhHHHHHHHHHcCCC-CCeeeeeceec--Cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRH-PNLVTLVGACP--EV  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h-pniv~l~g~~~--~~  205 (498)
                      ++|.+.+.||+|+||+||+|..     ++..||||+++...    ....+.+.+|+.+|++++| |||+++++++.  ..
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            4688999999999999999987     35789999987532    2335678899999999976 89999999984  46


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .++||||+.+|+|.+++...   ..++......++.|++.||.|||+   ++|+||||||+||||+.+|.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchh
Confidence            88999999999999999533   457788999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC--CCCCccchHhHHHHHHHHHhCCCCCCCcHHH--HHHHHhCccc
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLK  361 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~  361 (498)
                      .+........       ....||+.|+|||.+.+.  .++.++|||||||+||+|+||++||...+..  ...+..+...
T Consensus       178 ~~~~~~~~~~-------~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~  250 (322)
T d1vzoa_         178 EFVADETERA-------YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK  250 (322)
T ss_dssp             ECCGGGGGGG-------CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred             hhcccccccc-------cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence            7654432211       223489999999999765  4688999999999999999999999654321  1111111111


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCCh
Q 010882          362 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL  397 (498)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  397 (498)
                      .     ....|...+..+.+|+.+||+.||.+||++
T Consensus       251 ~-----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         251 S-----EPPYPQEMSALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             C-----CCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence            1     112345567899999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-44  Score=349.09  Aligned_cols=248  Identities=25%  Similarity=0.267  Sum_probs=194.9

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCC--ChhhHHHHHHHHHcCCCCCeeeeeceec--CcceEEEe
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE  211 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~g~~~--~~~~lV~E  211 (498)
                      ++|++.+.||+|+||+||+|.+.  +..||||+++.....  ....+.+|+.+|+.++||||++++++|.  +..++||+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            36888899999999999999984  678999999765432  2467899999999999999999999984  46789999


Q ss_pred             eCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccccccccc
Q 010882          212 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE  291 (498)
Q Consensus       212 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  291 (498)
                      |+.+++|..++.   ....+++..+..++.|++.||.|||.   ++|+||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988874   34568899999999999999999999   899999999999999999999999999998765443


Q ss_pred             cCCCCccceeccCCCCCCCcCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCC-CcHHHHHHHH----hCcc-----
Q 010882          292 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALG-ITKEVQYALD----TGKL-----  360 (498)
Q Consensus       292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~-~~~~~~~~~~----~~~~-----  360 (498)
                      ...        ....+++.|+|||.+.... ++.++|||||||++|||+||+.||. ..+.......    .+..     
T Consensus       156 ~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (292)
T d1unla_         156 RCY--------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             SCC--------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred             ccc--------eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence            211        2234788999999998765 6899999999999999999998863 3332221111    0000     


Q ss_pred             ---ccccC----------CCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          361 ---KNLLD----------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       361 ---~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                         ....+          ......+...+..+.+|+.+||+.||.+|||+.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e  279 (292)
T d1unla_         228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE  279 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence               00000          0011123344578899999999999999999988

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.8e-44  Score=353.65  Aligned_cols=241  Identities=20%  Similarity=0.337  Sum_probs=190.1

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceec----CcceEEE
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP----EVWTLVY  210 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~----~~~~lV~  210 (498)
                      ++|.+.++||+|+||+||+|.+.  ++.||||+++..   ..+.+.+|+.+|+.+. ||||++++++|.    ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            47899999999999999999984  789999998743   3567899999999995 999999999883    2488999


Q ss_pred             eeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC-ceeEeeccccccccc
Q 010882          211 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQ  289 (498)
Q Consensus       211 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~  289 (498)
                      |||.+|+|....      ..+++..+..++.|++.||.|||+   +|||||||||+||||+.++ .+||+|||+|+....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999998764      358999999999999999999999   8999999999999998654 699999999987654


Q ss_pred             cccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcH-HHHHHH------------
Q 010882          290 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITK-EVQYAL------------  355 (498)
Q Consensus       290 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~-~~~~~~------------  355 (498)
                      ...         .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.... ......            
T Consensus       183 ~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~  253 (328)
T d3bqca1         183 GQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY  253 (328)
T ss_dssp             TCC---------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred             CCc---------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence            321         1234589999999998875 47999999999999999999999996432 111000            


Q ss_pred             ---HhCc------cccccCC---------CCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          356 ---DTGK------LKNLLDP---------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       356 ---~~~~------~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                         ....      +......         .........+.++.+|+.+||..||.+|||+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e  315 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE  315 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence               0000      0000000         000111234578899999999999999999988

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-44  Score=358.67  Aligned_cols=244  Identities=20%  Similarity=0.252  Sum_probs=183.8

Q ss_pred             cCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec--------Cc
Q 010882          138 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--------EV  205 (498)
Q Consensus       138 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~--------~~  205 (498)
                      ++|.+.++||+|+||+||+|.+.  +..||||++.......  ...+.+|+.+|++++|||||+++++|.        ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            46889999999999999999985  7899999997654322  345889999999999999999999983        35


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .|+||||+.++.+. .+.     ..+++..+..++.|++.||.|||+   +||+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence            68999999765554 442     358999999999999999999999   899999999999999999999999999988


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHh--------
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--------  357 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--------  357 (498)
                      .......         .....||+.|+|||++.+..+++++||||+||++|+|++|++||...+........        
T Consensus       168 ~~~~~~~---------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         168 TAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_dssp             ----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccccc---------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence            6554321         13345899999999999999999999999999999999999999755433211100        


Q ss_pred             ----------------Ccc-------c----cccCCCCCCCCHHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          358 ----------------GKL-------K----NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       358 ----------------~~~-------~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                      +..       .    ....+.....+...+..+.+|+.+||..||++|||+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e  307 (355)
T d2b1pa1         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD  307 (355)
T ss_dssp             HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence                            000       0    00000001112335678999999999999999999988

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-44  Score=357.28  Aligned_cols=245  Identities=21%  Similarity=0.288  Sum_probs=189.9

Q ss_pred             hcCCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCC--hhhHHHHHHHHHcCCCCCeeeeeceec-------Cc
Q 010882          137 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-------EV  205 (498)
Q Consensus       137 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~hpniv~l~g~~~-------~~  205 (498)
                      ..+|.+.+.||+|+||+||+|.+.  ++.||||++.......  .+.+.+|+.+|+.++|||||++++++.       ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            357999999999999999999984  7899999998654322  346889999999999999999999873       13


Q ss_pred             ceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          206 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       206 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .++||+|+.||+|.+++..    ..+++..+..++.|++.||.|||+   +||+||||||+|||++.+|.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence            4677888899999999842    359999999999999999999999   899999999999999999999999999987


Q ss_pred             cccccccCCCCccceeccCCCCCCCcCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCCcHHHHHHHHhCcccccc
Q 010882          286 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL  364 (498)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (498)
                      ......           ....||+.|+|||.+.+. .++.++|||||||++|+|+||++||...+...............
T Consensus       170 ~~~~~~-----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~  238 (348)
T d2gfsa1         170 HTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  238 (348)
T ss_dssp             CCTGGG-----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccCccc-----------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            654332           234589999999987775 46889999999999999999999997655432221110000000


Q ss_pred             -----------------C--CCCCCCC-----HHHHHHHHHHHHHhhhcccCCCCChhH
Q 010882          365 -----------------D--PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK  399 (498)
Q Consensus       365 -----------------~--~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~  399 (498)
                                       .  +.....+     ...+..+.+|+.+||..||.+|||+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e  297 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ  297 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence                             0  0000001     123567899999999999999999988

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.6e-40  Score=328.66  Aligned_cols=247  Identities=17%  Similarity=0.245  Sum_probs=185.6

Q ss_pred             CCCCCCcccccCceEEEEEEEC--CeEEEEEEecCCCCCChhhHHHHHHHHHcCC-----------CCCeeeeeceec--
Q 010882          139 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----------HPNLVTLVGACP--  203 (498)
Q Consensus       139 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------hpniv~l~g~~~--  203 (498)
                      +|.+.++||+|+||+||+|...  +..||||+++.... ..+.+.+|+.+++.++           ||||+++++++.  
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5889999999999999999984  78999999975421 2456788999998875           578999988873  


Q ss_pred             --CcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCC------c
Q 010882          204 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF------V  275 (498)
Q Consensus       204 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~------~  275 (498)
                        ...+++|+++..+..............+++..+..++.|++.||.|||+.  .||+||||||+||||+.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence              24567777776655444443345556789999999999999999999973  6899999999999998665      3


Q ss_pred             eeEeeccccccccccccCCCCccceeccCCCCCCCcCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCCcHHH----
Q 010882          276 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV----  351 (498)
Q Consensus       276 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~----  351 (498)
                      +|++|||.+.......           ....||+.|+|||++....++.++||||+||++++|+||++||......    
T Consensus       171 ~kl~dfg~s~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         171 IKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             EEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             eeEeeccccccccccc-----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence            8999999988654322           2345999999999999999999999999999999999999999643211    


Q ss_pred             --HHH----HHhCc----------c-cc---------ccCC-----------CCCCCCHHHHHHHHHHHHHhhhcccCCC
Q 010882          352 --QYA----LDTGK----------L-KN---------LLDP-----------LAGDWPFVQAEQLANLAMRCCEMSRKSR  394 (498)
Q Consensus       352 --~~~----~~~~~----------~-~~---------~~~~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~R  394 (498)
                        ...    ...|.          . ..         .+..           .....+...+..+.+|+.+||..||.+|
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence              000    00000          0 00         0000           0112345667889999999999999999


Q ss_pred             CChhH
Q 010882          395 PELGK  399 (498)
Q Consensus       395 P~~~~  399 (498)
                      ||+.+
T Consensus       320 pta~e  324 (362)
T d1q8ya_         320 ADAGG  324 (362)
T ss_dssp             BCHHH
T ss_pred             cCHHH
Confidence            99988

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=6e-25  Score=199.27  Aligned_cols=162  Identities=14%  Similarity=0.126  Sum_probs=118.4

Q ss_pred             CCCCcccccCceEEEEEEE-CCeEEEEEEecCCCCC-----C-------------hhhHHHHHHHHHcCCCCCeeeeece
Q 010882          141 DPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQ-----G-------------PSEFQQEIDILSKIRHPNLVTLVGA  201 (498)
Q Consensus       141 ~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-----~-------------~~~~~~E~~il~~l~hpniv~l~g~  201 (498)
                      .+.++||+|+||+||+|.+ ++..||||+++.....     .             ...+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3467899999999999987 5789999987643111     0             0124568889999999999988876


Q ss_pred             ecCcceEEEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCcEEEcCCCceeEeec
Q 010882          202 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF  281 (498)
Q Consensus       202 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  281 (498)
                      .  ..++||||++++.+.++          +......++.+++.+|.|||.   +||+||||||+|||+++++ ++|+||
T Consensus        83 ~--~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~~-~~liDF  146 (191)
T d1zara2          83 E--GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEEG-IWIIDF  146 (191)
T ss_dssp             E--TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETTE-EEECCC
T ss_pred             c--CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCCC-EEEEEC
Confidence            4  34799999988665432          223456789999999999999   8999999999999999764 899999


Q ss_pred             cccccccccccCCCCccceeccCCCCCCCcCCh------hhhccCCCCCccchHhHHHHH
Q 010882          282 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP------EFLASGELTPKSDVYSFGIIL  335 (498)
Q Consensus       282 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwSlGvil  335 (498)
                      |+|........                ..|...      +.+ ...|+.++|+||..--+
T Consensus       147 G~a~~~~~~~~----------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGW----------------REILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTH----------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCc----------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            99875432210                111111      111 35678899999976544

>d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: U-box
domain: Ubiquitin conjugation factor E4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=5e-18  Score=134.38  Aligned_cols=72  Identities=29%  Similarity=0.498  Sum_probs=67.5

Q ss_pred             CCCCCCcCCCccccccCCceeccCC-ceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          426 CEPPPYFTCPIFQEVMQDPHVAADG-FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       426 ~~~P~~~~cpi~~e~~~dp~~~~~g-~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      ..+|++|.|||+.++|.|||++++| ++||+.+|.+|+.. +.+||+|+.++...+|+||.+||++|++|+.++
T Consensus        17 ~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~-~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~~~   89 (98)
T d1wgma_          17 ADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAER   89 (98)
T ss_dssp             CSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHHS
T ss_pred             cCCcHHhCCcCchhHHHHHHhcccccchhhHHHHHHHHHh-cCCcccccccccchhhcchHHHHHHHHHHHHHH
Confidence            5789999999999999999999976 59999999999987 679999999999999999999999999999864

>d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: U-box
domain: E3 ubiquitin ligase PUB14
species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=99.71  E-value=3.2e-18  Score=130.17  Aligned_cols=72  Identities=43%  Similarity=0.845  Sum_probs=69.3

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      ++|++|.|||+.++|.|||++++||+|++.+|.+|+..++.+||.|+.++...+++||++||++|++|+.+|
T Consensus         4 eiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~~   75 (78)
T d1t1ha_           4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN   75 (78)
T ss_dssp             CCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred             CCCccCCCcCcCchhhCceEccCCCcchHHHHHHHHHHCCCCCCcccccCCcccccchHHHHHHHHHHHHHh
Confidence            689999999999999999999999999999999999987889999999999999999999999999999876

>d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: U-box
domain: STIP1 homology and U box-containing protein 1, STUB1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.71  E-value=4e-18  Score=130.22  Aligned_cols=72  Identities=28%  Similarity=0.601  Sum_probs=69.2

Q ss_pred             CCCCCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHHhC
Q 010882          427 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH  498 (498)
Q Consensus       427 ~~P~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~~~  498 (498)
                      ++|++|.|||+.++|.|||++++||+|++.+|.+|+..++.+||+|+.+++..+|+||.+||++|++|+++|
T Consensus         3 eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~~   74 (80)
T d2c2la2           3 DIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISEN   74 (80)
T ss_dssp             CCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTTC
T ss_pred             CCCccccCcCcCchhhhhcccCCcCeecHHHHHHHHhcCCccCCCccccccccccccHHHHHHHHHHHHHHC
Confidence            689999999999999999999999999999999999988889999999999999999999999999999875

>d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: U-box
domain: Pre-mRNA splicing factor Prp19
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.98  E-value=6.8e-11  Score=82.49  Aligned_cols=52  Identities=23%  Similarity=0.441  Sum_probs=48.2

Q ss_pred             cCCCccccccCCceecc-CCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCcc
Q 010882          432 FTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN  484 (498)
Q Consensus       432 ~~cpi~~e~~~dp~~~~-~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn  484 (498)
                      +.|||+.++|.|||+++ +||+|++++|.+|+.+ +.+||+|+.+++..+|+|.
T Consensus         1 l~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~-~~~CP~c~~~l~~~dLipi   53 (56)
T d2baya1           1 MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEI   53 (56)
T ss_dssp             CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEEC
T ss_pred             CCCccCCchHHhcCccCCCCCcccHHHHHHHHhh-ccCCCccCCcCCHHhceeC
Confidence            46999999999999985 8999999999999998 7799999999999999874

>d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: bard1 RING domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.72  E-value=5.3e-09  Score=81.80  Aligned_cols=64  Identities=16%  Similarity=0.257  Sum_probs=57.8

Q ss_pred             CCcCCCccccccCCceec-cCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCccHHHHHHHHHHHH
Q 010882          430 PYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQ  496 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~-~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~  496 (498)
                      +.+.|||+.++|.+|++. .+||+|++.+|.+|+.+   +||+++.++...++.||.+|+++|..+..
T Consensus        21 ~~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~~---~CP~Cr~~~~~~~l~~n~~l~~lv~~~~~   85 (97)
T d1jm7b_          21 KLLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIGT---GCPVCYTPAWIQDLKINRQLDSMIQLCSK   85 (97)
T ss_dssp             HTTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTTT---BCSSSCCBCSCSSCCCCHHHHHHHHHHHH
T ss_pred             hcCCCccCCchhhcCceeCCCCCchhHHHHHHHHhc---cccccCCcCchhhCcccHHHHHHHHHHHH
Confidence            457899999999999975 69999999999999854   69999999999999999999999988754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.72  E-value=1.7e-08  Score=93.78  Aligned_cols=146  Identities=16%  Similarity=0.150  Sum_probs=99.9

Q ss_pred             HHHHhhcCCCCCCcccccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeecee--cCcceE
Q 010882          132 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTL  208 (498)
Q Consensus       132 ei~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~--~~~~~l  208 (498)
                      +++.....|...+..+.|+.+.||+....+..+.+|+...........+.+|..++..+. +--+.++++++  .+..++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            445545566555544445557899987778889999887655555567889999988774 32355666655  345789


Q ss_pred             EEeeCCCCCHHhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 010882          209 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK----------------------------------  254 (498)
Q Consensus       209 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  254 (498)
                      ||++++|.++.+.....        .....++.+++..|..||+..                                  
T Consensus        88 v~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999998887654211        112334555666666666432                                  


Q ss_pred             ----------------------CCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          255 ----------------------PHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       255 ----------------------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                                            +..++|+|+.|.|||++.++.+-|.||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  1237899999999999987777799999765

>d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: brca1 RING domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.69  E-value=4.6e-09  Score=83.10  Aligned_cols=67  Identities=15%  Similarity=0.328  Sum_probs=60.0

Q ss_pred             CCcCCCccccccCCceeccCCceecHHHHHHHHhcC--CCCCCCCCCCCCCCCCCccHHHHHHHHHHHH
Q 010882          430 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSG--HETSPMTNLPLAHKNLVPNLALRSAIQEWLQ  496 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~--~~~~p~~~~~~~~~~~~pn~~l~~~i~~~~~  496 (498)
                      +.|.|||+.+++.+|+.+++||+|++.+|.+|+...  ..+||+++.++....+.||..+++.|+.+++
T Consensus        20 ~~l~CpIC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~~ve~l~~   88 (103)
T d1jm7a_          20 KILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLK   88 (103)
T ss_dssp             HHTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHHH
T ss_pred             cCcCCCccCchhCCeEEcCCCCchhhHHHHHHHHHCCCCCcCcCCCCcCChhhCCcCHHHHHHHHHHHH
Confidence            346799999999999999999999999999999663  3589999999999999999999999988864

>d1rmda2 g.44.1.1 (A:1-86) V(D)J recombination activating protein 1 (RAG1), dimerization domain {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: V(D)J recombination activating protein 1 (RAG1), dimerization domain
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.69  E-value=8.4e-09  Score=77.94  Aligned_cols=63  Identities=14%  Similarity=0.227  Sum_probs=56.0

Q ss_pred             CCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCC-ccHHHHHHHH
Q 010882          430 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV-PNLALRSAIQ  492 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~-pn~~l~~~i~  492 (498)
                      +.+.|||+.+.+.+|++++.||+|++.+|.+|+..++.+||+++.++...++. |..++.+.+.
T Consensus        22 ~~l~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~p~~~~~l~~P~~~~l~~l~   85 (86)
T d1rmda2          22 KSISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNILN   85 (86)
T ss_dssp             HHTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHHH
T ss_pred             cCcCCccCCcchhcceecCCCChhhHHHHHHHHhhCCCcCcccCCCCChhhccCHHHHHHHHhc
Confidence            45689999999999999999999999999999988788999999999877765 7888887764

>d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: CBL
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=4.8e-07  Score=67.25  Aligned_cols=51  Identities=18%  Similarity=0.323  Sum_probs=46.1

Q ss_pred             CcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCC
Q 010882          431 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL  481 (498)
Q Consensus       431 ~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~  481 (498)
                      ...|||+.+.+.+|++.++||+|++.+|..|+.+++.+||++|..+...+.
T Consensus        23 ~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~wl~~~~~~CP~Cr~~i~~~~~   73 (79)
T d1fbva4          23 FQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEP   73 (79)
T ss_dssp             TTBCTTTSSSBCCEECSSSCCEECHHHHHHHHHTTCCSCTTTCCCCCCCCC
T ss_pred             CCCCccCCCcCCCeEEeCCCCeeeHHHHHHHHHHCcCcCCCCCcCccCCce
Confidence            346999999999999999999999999999999878899999999976543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.97  E-value=8.3e-06  Score=74.51  Aligned_cols=126  Identities=17%  Similarity=0.128  Sum_probs=80.1

Q ss_pred             ccccCc-eEEEEEEECC-eEEEEEEecCCCCCChhhHHHHHHHHHcCCC--CCeeeeecee--cCcceEEEeeCCCCCHH
Q 010882          146 IGEGGY-GSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGAC--PEVWTLVYEYLPNGSLE  219 (498)
Q Consensus       146 lG~G~~-g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~g~~--~~~~~lV~E~~~~gsL~  219 (498)
                      +..|.. +.||+....+ ..+.+|......   ...+..|+..|+.+..  -.+.++++++  .+..++||+|++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            445543 6789887754 457888765433   3457888888887743  2355666655  34578999999986654


Q ss_pred             hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 010882          220 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------------------  254 (498)
Q Consensus       220 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------------  254 (498)
                      +..        +..   ..++.+++..|..||...                                             
T Consensus        95 ~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          95 SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            321        111   112233334444444211                                             


Q ss_pred             ----------CCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          255 ----------PHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       255 ----------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                                +..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                      1237999999999999987777899999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.92  E-value=9.7e-06  Score=79.46  Aligned_cols=74  Identities=16%  Similarity=0.086  Sum_probs=51.8

Q ss_pred             CcccccCceEEEEEEEC--CeEEEEEEecCC----C---CCChhhHHHHHHHHHcCC---CCCeeeeeceecCcceEEEe
Q 010882          144 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPH----S---LQGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVYE  211 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~---~~~~~~~~~E~~il~~l~---hpniv~l~g~~~~~~~lV~E  211 (498)
                      +.||.|....||+....  +..|+||.-.+.    .   ....+....|..+|..+.   ...+++++++..+..++|||
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE  111 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME  111 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEEe
Confidence            35899999999998753  467899965431    1   123345667888887763   24577788888888899999


Q ss_pred             eCCCCC
Q 010882          212 YLPNGS  217 (498)
Q Consensus       212 ~~~~gs  217 (498)
                      ++.+..
T Consensus       112 ~L~~~~  117 (392)
T d2pula1         112 DLSHLK  117 (392)
T ss_dssp             CCTTSE
T ss_pred             ccCCcc
Confidence            997754

>d1g25a_ g.44.1.1 (A:) TFIIH Mat1 subunit {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: TFIIH Mat1 subunit
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.62  E-value=2.1e-05  Score=55.66  Aligned_cols=52  Identities=19%  Similarity=0.215  Sum_probs=42.5

Q ss_pred             CCcCCCccccccCC-----ceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQD-----PHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL  481 (498)
Q Consensus       430 ~~~~cpi~~e~~~d-----p~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~  481 (498)
                      ++..|||..+.+..     .++.+.||+|...+|..|+..+..+||++|.++...++
T Consensus         2 dd~~CpIC~~~~~~~~~~~~~~~~C~H~fc~~Ci~~~~~~~~~~CP~CR~~i~~~~~   58 (65)
T d1g25a_           2 DDQGCPRCKTTKYRNPSLKLMVNVCGHTLCESCVDLLFVRGAGNCPECGTPLRKSNF   58 (65)
T ss_dssp             CTTCCSTTTTHHHHCSSCCEEECTTCCCEEHHHHHHHHHTTSSSCTTTCCCCSSCCC
T ss_pred             CCCCCCcCCceeecCCceEEEeCccChHhhHHHHHHHhCcCcCCCCCCCcCcccccc
Confidence            45679999875432     25678999999999999998878899999999977655

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.51  E-value=0.00017  Score=67.77  Aligned_cols=156  Identities=12%  Similarity=0.075  Sum_probs=84.0

Q ss_pred             CChHHHHHhhcCCCCCCcc-----cccCceEEEEEEECCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCC--eeeeec
Q 010882          128 FSFSEIEGATHNFDPSLKI-----GEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVG  200 (498)
Q Consensus       128 ~~~~ei~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~g  200 (498)
                      .+.+|+.....+|.++...     ..|---+.|+....+..+++|+....  .+...+..|+.++..|...+  ++..+-
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccce
Confidence            4556777777778765543     34555778998887778999998653  23456677788887774222  221111


Q ss_pred             e--------ecCcceEEEeeCCCCCHHh--------------hhcc--CCC--C--CCCCHH------------------
Q 010882          201 A--------CPEVWTLVYEYLPNGSLED--------------RLSC--KDN--S--PPLSWQ------------------  234 (498)
Q Consensus       201 ~--------~~~~~~lV~E~~~~gsL~~--------------~l~~--~~~--~--~~l~~~------------------  234 (498)
                      .        .......++.++.|.....              .++.  ...  .  ......                  
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            1        1334556677766643211              0000  000  0  000000                  


Q ss_pred             HHHHHHHHHHHHHHHHHh-cCCCCcccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          235 TRIRIATELCSVLIFLHS-CKPHSIVHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       235 ~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      .....+......+.-.+. .-+.|+||+|+.++||+++.+...-|.||+.|.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            011111122222222221 224689999999999999988777899999764

>d1chca_ g.44.1.1 (A:) Immediate early protein, IEEHV {Equine herpesvirus 1 [TaxId: 10326]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: Immediate early protein, IEEHV
species: Equine herpesvirus 1 [TaxId: 10326]

Probab=97.39  E-value=5.5e-05  Score=53.92  Aligned_cols=44  Identities=18%  Similarity=0.410  Sum_probs=39.3

Q ss_pred             CCCccccccCCcee-ccCCceecHHHHHHHHhcCCCCCCCCCCCCC
Q 010882          433 TCPIFQEVMQDPHV-AADGFTYEAEALKGWLDSGHETSPMTNLPLA  477 (498)
Q Consensus       433 ~cpi~~e~~~dp~~-~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~  477 (498)
                      .|||+.+.+.+|++ .+.||+|+..+|.+|+.. +.+||++|.++.
T Consensus         7 ~C~IC~~~~~~~~~~~~C~H~Fc~~Ci~~w~~~-~~~CP~CR~~i~   51 (68)
T d1chca_           7 RCPICLEDPSNYSMALPCLHAFCYVCITRWIRQ-NPTCPLCKVPVE   51 (68)
T ss_dssp             CCSSCCSCCCSCEEETTTTEEESTTHHHHHHHH-SCSTTTTCCCCC
T ss_pred             CCccCCcCccCCcEEeCCCCcCcHHHHHHHHHh-CCcCCCCCcchH
Confidence            49999998888755 789999999999999998 789999999875

>d1bora_ g.44.1.1 (A:) Acute promyelocytic leukaemia proto-oncoprotein PML {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: Acute promyelocytic leukaemia proto-oncoprotein PML
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.33  E-value=2.1e-05  Score=53.63  Aligned_cols=51  Identities=16%  Similarity=0.203  Sum_probs=44.2

Q ss_pred             CCcCCCccccccCCceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCCCCCCcc
Q 010882          430 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN  484 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~~~~~pn  484 (498)
                      +.+.|||..+.+.+|++.+.||+|...+|.+|    ..+||+++.+++...-.|+
T Consensus         5 ~~l~C~IC~~~~~~p~~lpCgH~fC~~Ci~~~----~~~CP~Cr~~~~~~~~~~a   55 (56)
T d1bora_           5 QFLRCQQCQAEAKCPKLLPCLHTLCSGCLEAS----GMQCPICQAPWPLGADTPA   55 (56)
T ss_dssp             CCSSCSSSCSSCBCCSCSTTSCCSBTTTCSSS----SSSCSSCCSSSSCCSSCCC
T ss_pred             CCCCCcccCcccCCCEEecCCCHHhHHHHHcC----CCcCcCCCCcccCCCCCCC
Confidence            34689999999999999999999999998776    5689999999987766554

>d1iyma_ g.44.1.1 (A:) EL5 RING-H2 domain {Rice (Oryza sativa) [TaxId: 4530]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: EL5 RING-H2 domain
species: Rice (Oryza sativa) [TaxId: 4530]

Probab=97.03  E-value=0.00031  Score=47.45  Aligned_cols=47  Identities=26%  Similarity=0.498  Sum_probs=38.5

Q ss_pred             CCCcCCCccccccCCc---eec-cCCceecHHHHHHHHhcCCCCCCCCCCCC
Q 010882          429 PPYFTCPIFQEVMQDP---HVA-ADGFTYEAEALKGWLDSGHETSPMTNLPL  476 (498)
Q Consensus       429 P~~~~cpi~~e~~~dp---~~~-~~g~t~~~~~i~~w~~~~~~~~p~~~~~~  476 (498)
                      .+...|||..+-+.+.   ... ..||.|...+|.+|+.. +.+||++|.++
T Consensus         3 ed~~~C~ICl~~~~~~~~~~~l~~C~H~Fh~~Ci~~Wl~~-~~~CP~CR~~i   53 (55)
T d1iyma_           3 DDGVECAVCLAELEDGEEARFLPRCGHGFHAECVDMWLGS-HSTCPLCRLTV   53 (55)
T ss_dssp             CCSCCCTTTCCCCCTTSCCEECSSSCCEECTTHHHHTTTT-CCSCSSSCCCS
T ss_pred             CCCCCCeEECccccCCCEEEEeCCCCCcccHHHHHHHHHh-CCcCCCCCCEe
Confidence            3566799998887652   333 59999999999999988 88999999876

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.91  E-value=0.0016  Score=61.22  Aligned_cols=131  Identities=12%  Similarity=0.154  Sum_probs=73.8

Q ss_pred             eEEEEEEE-CCeEEEEEEecCCCCCChhhHHHHHHHHHcCCCCCe--eeeece-------ecCcceEEEeeCCCCCHH--
Q 010882          152 GSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL--VTLVGA-------CPEVWTLVYEYLPNGSLE--  219 (498)
Q Consensus       152 g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~hpni--v~l~g~-------~~~~~~lV~E~~~~gsL~--  219 (498)
                      -.||+... .|..|++|+..+. ..+.+++..|...+..|...+|  +..+..       ..+..+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            58999877 4678999998754 2356778889998888742221  111111       134567889998774321  


Q ss_pred             ----------------hhhccCC--CCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCCc
Q 010882          220 ----------------DRLSCKD--NSPPLSWQ-------------------TRIRIATELCSVLIFLHS----CKPHSI  258 (498)
Q Consensus       220 ----------------~~l~~~~--~~~~l~~~-------------------~~~~i~~~i~~~L~~LH~----~~~~~i  258 (498)
                                      .......  ....+++.                   .+..+...+...+..+..    ..+.++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                            1111000  01112211                   111111122223333322    234679


Q ss_pred             ccCCCCCCcEEEcCCCceeEeeccccc
Q 010882          259 VHGDLKPANILLDANFVSKLSDFGISR  285 (498)
Q Consensus       259 vHrDlkp~NiLl~~~~~~kl~DFGla~  285 (498)
                      ||+|+.|.|||++.+  ..++||+-|.
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             ecCCCCcccEEEeCC--ceEEechhcc
Confidence            999999999999743  4589999775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.90  E-value=0.0012  Score=64.03  Aligned_cols=71  Identities=18%  Similarity=0.207  Sum_probs=48.4

Q ss_pred             CcccccCceEEEEEEECC---------eEEEEEEecCCCCCChhhHHHHHHHHHcCC-CCCeeeeeceecCcceEEEeeC
Q 010882          144 LKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYL  213 (498)
Q Consensus       144 ~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~g~~~~~~~lV~E~~  213 (498)
                      +.|+.|-.-.+|+.....         ..|.+++...  ....-...+|..+++.+. +.-.++++++|.+  .+||||+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi  123 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI  123 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--ceEEEEe
Confidence            357778888999987632         3577776642  223345668999998885 4334577888764  6899999


Q ss_pred             CCCCH
Q 010882          214 PNGSL  218 (498)
Q Consensus       214 ~~gsL  218 (498)
                      +|.+|
T Consensus       124 ~g~~l  128 (395)
T d1nw1a_         124 PSRPL  128 (395)
T ss_dssp             CEEEC
T ss_pred             ccccC
Confidence            87544

>d1ur6b_ g.44.1.1 (B:) Not-4 N-terminal RING finger domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: Not-4 N-terminal RING finger domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.51  E-value=0.001  Score=44.18  Aligned_cols=46  Identities=13%  Similarity=0.186  Sum_probs=36.9

Q ss_pred             CCCccccccCC----ceeccCCceecHHHHHHHHhcCCCCCCCCCCCCCC
Q 010882          433 TCPIFQEVMQD----PHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH  478 (498)
Q Consensus       433 ~cpi~~e~~~d----p~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~~  478 (498)
                      .|||..+-+.+    +.+.+.||.|...+|.+|+..++.+||++|.++..
T Consensus         2 eCpICl~~~~~~~~~~~~~~CgH~~c~~C~~~w~~~~~~~CP~CR~~~~~   51 (52)
T d1ur6b_           2 ECPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDENGLCPACRKPYPE   51 (52)
T ss_dssp             EETTTTEECCGGGTTCCSSSSSCCCCHHHHHHHTTTSCCBCTTTCCBCSC
T ss_pred             CCcCCChhhhCCCceEEecCCCCccchHHHHHHHhhcCCCCCccCCcCCC
Confidence            37777766543    34557999999999999998877789999998864

>d1v87a_ g.44.1.1 (A:) Deltex protein 2 RING-H2 domain {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: Deltex protein 2 RING-H2 domain
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=95.95  E-value=0.0034  Score=49.17  Aligned_cols=49  Identities=14%  Similarity=0.156  Sum_probs=38.1

Q ss_pred             CCcCCCccccccCCc------------------eeccCCceecHHHHHHHHhc----CCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQDP------------------HVAADGFTYEAEALKGWLDS----GHETSPMTNLPLAH  478 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp------------------~~~~~g~t~~~~~i~~w~~~----~~~~~p~~~~~~~~  478 (498)
                      .+..|+|+.+-|.++                  .+.++||.|...+|..|+..    ++.+||+||.++..
T Consensus        24 ~~~~C~IC~e~l~~~~~~~~~~~~~~~~~~~~~~~~~CgH~FH~~Ci~~Wl~~~~~~~~~~CP~CR~~~~~   94 (114)
T d1v87a_          24 PEEDCIICMEKLAVASGYSDMTDSKALGPMVVGRLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKTIYGE   94 (114)
T ss_dssp             CSCEETTTTEETTSCCSTTTTCCCSSSCSSCCEEESSSCCEECHHHHHHHHHHTCCSSCCBCTTTCCBSSS
T ss_pred             ccccccchhheecccccccccccccccccccceEECCCCChhhHHHHHHHHHhcCcCCCCccccccchhcc
Confidence            344688888876543                  35679999999999999975    34589999988743

>d3dplr1 g.44.1.1 (R:19-106) RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase complex {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: RING finger domain, C3HC4
domain: RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase complex
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.56  E-value=0.0051  Score=45.64  Aligned_cols=33  Identities=12%  Similarity=0.330  Sum_probs=28.8

Q ss_pred             ceeccCCceecHHHHHHHHhcCCCCCCCCCCCCC
Q 010882          444 PHVAADGFTYEAEALKGWLDSGHETSPMTNLPLA  477 (498)
Q Consensus       444 p~~~~~g~t~~~~~i~~w~~~~~~~~p~~~~~~~  477 (498)
                      ++..++||.|...+|.+||.. +.+||++|++..
T Consensus        52 ~~~~~C~H~FH~~Ci~~Wl~~-~~~CP~CR~~~~   84 (88)
T d3dplr1          52 VAWGVCNHAFHFHCISRWLKT-RQVCPLDNREWE   84 (88)
T ss_dssp             EEEETTSCEEEHHHHHHHHTT-CSBCSSSCSBCC
T ss_pred             eEEccccCcccHHHHHHHHHH-CCcCCCCCCccc
Confidence            355679999999999999998 789999998764

>d1vyxa_ g.44.1.3 (A:) IE1B protein (ORF K3), N-terminal domain {Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8 [TaxId: 37296]}

class: Small proteins
fold: RING/U-box
superfamily: RING/U-box
family: Variant RING domain
domain: IE1B protein (ORF K3), N-terminal domain
species: Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8 [TaxId: 37296]

Probab=95.23  E-value=0.0079  Score=40.98  Aligned_cols=48  Identities=17%  Similarity=0.189  Sum_probs=39.6

Q ss_pred             CCcCCCccccccCCceeccC-----CceecHHHHHHHHh-cCCCCCCCCCCCCC
Q 010882          430 PYFTCPIFQEVMQDPHVAAD-----GFTYEAEALKGWLD-SGHETSPMTNLPLA  477 (498)
Q Consensus       430 ~~~~cpi~~e~~~dp~~~~~-----g~t~~~~~i~~w~~-~~~~~~p~~~~~~~  477 (498)
                      +...|+|..+.+.++.+.+.     ++.|...+|.+|+. +++.+||+++.++.
T Consensus         5 d~~~C~IC~~~~~~~~~~~c~c~~c~h~~H~~Cl~~W~~~~~~~~CP~Cr~~~~   58 (60)
T d1vyxa_           5 DVPVCWICNEELGNERFRACGCTGELENVHRSCLSTWLTISRNTACQICGVVYN   58 (60)
T ss_dssp             SCCEETTTTEECSCCCCCSCCCSSGGGSCCHHHHHHHHHHHTCSBCTTTCCBCC
T ss_pred             CCCCCccCCccCCCceeEecccCCCCCEEcHHHHHHHHhhCCCCCCcccCCeee
Confidence            45679999998888887764     48899999999995 46779999998865